data_2mdr_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mdr _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 716' ' ' ILE . . . . . 0.538 ' HA ' HD23 ' A' ' 719' ' ' LEU . 47.9 mm . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.918 0.39 . . . . 74.510000000000005 110.861 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -59.36 -32.41 72.45 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 121.086 -0.578 . . . . 72.129999999999995 112.634 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 718' ' ' GLU . . . . . 0.708 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 39.3 mt-10 -79.69 -21.83 44.17 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.856 -0.338 . . . . 62.140000000000001 111.266 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 719' ' ' LEU . . . . . 0.54 HD12 HD21 ' A' ' 789' ' ' LEU . 3.5 mm? -67.02 -32.11 73.11 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.225 -0.657 . . . . 73.409999999999997 109.225 172.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 720' ' ' VAL . . . . . 0.492 HG22 HD13 ' A' ' 793' ' ' ILE . 39.3 t -70.49 -31.81 47.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.364 -0.835 . . . . 74.109999999999999 110.379 176.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 721' ' ' ARG . . . . . 0.708 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 6.1 ptt180 -66.61 -28.12 68.24 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 120.943 0.401 . . . . 74.510000000000005 110.16 179.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -77.17 -31.86 55.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.239 -0.437 . . . . 75.219999999999999 111.322 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 723' ' ' LEU . . . . . 0.51 HD22 ' HB2' ' A' ' 789' ' ' LEU . 96.3 mt -61.11 -32.3 71.98 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.514 0.673 . . . . 72.439999999999998 109.629 173.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -84.95 -16.6 40.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.851 -1.068 . . . . 72.129999999999995 110.905 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 23.5 m -119.37 -81.61 0.63 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.783 0.325 . . . . 75.519999999999996 111.536 -176.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 726' ' ' ASN . . . . . 0.4 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 37.5 t30 -139.25 104.9 7.19 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.292 -0.413 . . . . 65.120000000000005 110.21 -178.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 727' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 24.6 Cg_endo -62.23 -37.61 61.06 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.822 2.348 . . . . 65.5 112.584 -177.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 49.4 t -61.33 -49.0 86.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.23 -0.441 . . . . 64.430000000000007 110.544 -177.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -63.41 -31.49 80.93 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.899 -0.667 . . . . 62.119999999999997 111.887 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -71.03 -40.04 62.65 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.06 -0.591 . . . . 41.240000000000002 112.633 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -66.05 -39.65 90.3 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.401 -0.592 . . . . 75.030000000000001 109.401 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 732' ' ' LEU . . . . . 0.439 HD21 ' HB2' ' A' ' 742' ' ' ALA . 83.1 mt -65.45 -38.53 90.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.926 -0.579 . . . . 73.340000000000003 110.427 175.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 733' ' ' GLU . . . . . 0.56 ' O ' ' HG2' ' A' ' 736' ' ' ARG . 4.2 tp10 -66.41 -48.17 70.93 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.809 -0.632 . . . . 73.5 110.928 -179.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 734' ' ' TYR . . . . . 0.526 ' HB2' HD13 ' A' ' 719' ' ' LEU . 12.4 t80 -56.75 -47.74 79.39 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.132 -0.485 . . . . 64.409999999999997 110.752 178.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -66.43 -46.14 77.53 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.139 -0.482 . . . . 72.5 111.184 -177.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 736' ' ' ARG . . . . . 0.56 ' HG2' ' O ' ' A' ' 733' ' ' GLU . 22.4 ptt180 -62.12 -35.33 78.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.015 0.436 . . . . 74.209999999999994 110.85 -176.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 33.1 t -81.19 -23.72 37.97 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.922 -0.581 . . . . 63.420000000000002 111.304 -178.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -104.71 2.84 30.78 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.781 0.289 . . . . 61.350000000000001 111.781 -175.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 79.82 17.82 74.17 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.574 -0.822 . . . . 74.219999999999999 113.002 176.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -102.27 162.16 13.13 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 122.628 -0.336 . . . . 70.340000000000003 110.263 176.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 741' ' ' ALA . . . . . 0.518 ' O ' ' HA ' ' A' ' 764' ' ' VAL . . . -105.43 135.42 46.85 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.865 -0.42 . . . . 74.239999999999995 109.865 175.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 742' ' ' ALA . . . . . 0.439 ' HB2' HD21 ' A' ' 732' ' ' LEU . . . -103.46 108.77 20.16 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.224 -0.444 . . . . 71.530000000000001 110.505 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 743' ' ' GLU . . . . . 0.545 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 41.2 mt-10 -115.73 113.35 23.35 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.033 -0.531 . . . . 71.430000000000007 111.121 -178.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -93.91 100.91 12.98 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.644 -0.707 . . . . 73.409999999999997 109.605 175.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -113.99 155.96 24.92 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.04 0.448 . . . . 75.310000000000002 110.783 -178.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 746' ' ' LEU . . . . . . . . . . . . . 1.7 tt -94.06 120.42 34.3 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.759 -0.83 . . . . 74.109999999999999 108.759 177.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 84.6 t -81.98 -52.3 13.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.315 -0.402 . . . . 75.140000000000001 111.182 -176.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -155.58 151.33 27.43 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.386 -0.37 . . . . 70.150000000000006 110.803 -175.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -126.75 87.11 2.6 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.702 -0.481 . . . . 73.450000000000003 109.702 -178.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 5.3 p -128.1 98.93 5.28 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.177 0.513 . . . . 75.530000000000001 111.261 -176.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . -166.54 158.04 30.79 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 111.57 -0.612 . . . . 70.120000000000005 111.57 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 752' ' ' PRO . . . . . 0.657 ' HG2' ' HB2' ' A' ' 755' ' ' GLU . 20.5 Cg_endo -60.45 162.15 18.45 Favored 'Trans proline' 0 CA--C 1.531 0.35 0 C-N-CA 122.846 2.364 . . . . 74.0 112.038 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.68 -31.91 92.59 Favored 'Trans proline' 0 CA--C 1.527 0.16 0 C-N-CA 122.71 2.273 . . . . 72.430000000000007 112.612 -178.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 37.5 p-80 -86.82 -17.82 32.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.206 -0.452 . . . . 72.409999999999997 111.309 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 755' ' ' GLU . . . . . 0.657 ' HB2' ' HG2' ' A' ' 752' ' ' PRO . 37.9 mm-40 -136.48 70.88 60.02 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.461 -0.336 . . . . 74.450000000000003 110.751 178.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 756' ' ' PRO . . . . . 0.475 ' HB2' ' CE2' ' A' ' 758' ' ' PHE . 28.9 Cg_endo -63.42 116.99 3.96 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.264 1.976 . . . . 72.319999999999993 111.414 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 757' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -97.7 115.46 28.01 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.251 -0.432 . . . . 75.010000000000005 110.427 -176.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 758' ' ' PHE . . . . . 0.475 ' CE2' ' HB2' ' A' ' 756' ' ' PRO . 90.4 m-85 -108.05 113.21 26.21 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.008 -0.542 . . . . 74.420000000000002 110.355 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 24.3 t -85.82 111.28 20.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.74 -0.664 . . . . 65.25 109.8 179.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 760' ' ' TYR . . . . . 0.402 ' OH ' ' HG2' ' A' ' 777' ' ' LYS . 2.1 m-85 -110.81 143.13 41.85 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.248 -0.433 . . . . 73.540000000000006 110.758 -179.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 761' ' ' GLN . . . . . 0.502 ' HA ' ' O ' ' A' ' 770' ' ' PRO . 56.8 tt0 -135.77 135.19 39.73 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.141 -0.481 . . . . 72.409999999999997 109.743 178.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 762' ' ' ALA . . . . . 0.412 ' HB2' ' O ' ' A' ' 769' ' ' PHE . . . -93.56 112.84 24.82 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.306 0.574 . . . . 74.129999999999995 110.605 -178.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 763' ' ' LYS . . . . . 0.603 ' HD2' ' CH2' ' A' ' 768' ' ' TRP . 59.3 tttm -91.82 101.84 14.43 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.844 -0.617 . . . . 71.349999999999994 109.778 177.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 764' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' A' ' 741' ' ' ALA . 59.4 t -107.57 100.86 11.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.02 -0.536 . . . . 70.019999999999996 109.986 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 71.71 -115.25 5.49 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 115.586 -0.733 . . . . 64.219999999999999 111.482 -177.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -106.22 8.1 41.18 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.828 -0.701 . . . . 74.219999999999999 112.012 177.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 767' ' ' ARG . . . . . . . . . . . . . 55.0 mtt180 -108.07 147.17 31.56 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.963 0.411 . . . . 74.010000000000005 110.797 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 768' ' ' TRP . . . . . 0.603 ' CH2' ' HD2' ' A' ' 763' ' ' LYS . 53.0 m95 -118.21 100.76 7.72 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.764 -0.653 . . . . 75.200000000000003 109.284 178.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 769' ' ' PHE . . . . . 0.412 ' O ' ' HB2' ' A' ' 762' ' ' ALA . 21.4 p90 -167.49 139.3 2.58 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 120.777 0.322 . . . . 74.530000000000001 110.969 -176.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 770' ' ' PRO . . . . . 0.57 ' HD3' ' HB1' ' A' ' 788' ' ' ALA . 71.5 Cg_endo -97.54 -171.46 2.46 Favored 'Cis proline' 0 N--CA 1.453 -0.872 0 C-N-CA 123.716 -1.368 . . . . 64.239999999999995 111.751 -4.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -122.23 112.44 18.16 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.63 -0.508 . . . . 74.510000000000005 109.63 175.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 36.0 m -122.46 159.24 25.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.247 -0.433 . . . . 60.340000000000003 110.839 -176.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 8.0 p -124.45 107.65 11.32 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.007 0.432 . . . . 71.530000000000001 109.948 177.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -103.11 -179.66 4.01 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.07 -0.514 . . . . 75.109999999999999 111.203 -176.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 775' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -93.28 -5.39 49.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 73.409999999999997 110.349 -177.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 19.4 t -161.01 170.44 20.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.338 -0.392 . . . . 73.209999999999994 110.518 -177.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 777' ' ' LYS . . . . . 0.402 ' HG2' ' OH ' ' A' ' 760' ' ' TYR . 1.4 tmtp? -69.72 -50.15 46.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.065 -0.516 . . . . 75.409999999999997 111.447 -174.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -60.48 -40.75 92.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.965 0.412 . . . . 64.409999999999997 110.308 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 779' ' ' GLN . . . . . 0.528 ' O ' ' HG2' ' A' ' 783' ' ' GLU . 76.9 mt-30 -58.3 -49.18 78.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.696 -0.683 . . . . 73.219999999999999 111.099 175.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -52.73 -44.12 60.34 Favored Glycine 0 C--N 1.334 0.434 0 CA-C-N 116.168 -0.469 . . . . 73.140000000000001 113.095 -176.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -59.23 -47.71 84.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.273 0.559 . . . . 72.030000000000001 110.772 178.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -70.91 -42.83 69.4 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.443 -0.799 . . . . 63.109999999999999 111.61 -175.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 783' ' ' GLU . . . . . 0.528 ' HG2' ' O ' ' A' ' 779' ' ' GLN . 21.2 mm-40 -60.44 -41.48 94.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.978 0.418 . . . . 72.450000000000003 110.301 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -66.17 -47.84 72.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.845 -0.616 . . . . 75.510000000000005 110.662 178.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 785' ' ' ALA . . . . . 0.513 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -63.08 -41.93 99.53 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.218 -0.446 . . . . 73.099999999999994 111.324 -178.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 786' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -57.21 -53.31 59.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.242 0.544 . . . . 71.450000000000003 110.277 178.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 787' ' ' ALA . . . . . 0.595 ' O ' HG21 ' A' ' 791' ' ' VAL . . . -64.01 -37.78 88.67 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.597 -0.729 . . . . 74.349999999999994 111.052 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 788' ' ' ALA . . . . . 0.57 ' HB1' ' HD3' ' A' ' 770' ' ' PRO . . . -60.38 -47.44 86.07 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.425 -0.352 . . . . 73.25 111.582 -178.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 789' ' ' LEU . . . . . 0.54 HD21 HD12 ' A' ' 719' ' ' LEU . 64.4 mt -62.74 -39.36 93.86 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.641 -0.503 . . . . 73.439999999999998 109.641 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 790' ' ' ARG . . . . . . . . . . . . . 54.6 mtp180 -64.46 -32.09 73.57 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.594 -0.73 . . . . 75.209999999999994 111.197 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 791' ' ' VAL . . . . . 0.595 HG21 ' O ' ' A' ' 787' ' ' ALA . 60.7 t -63.51 -52.94 51.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 109.433 -0.58 . . . . 71.099999999999994 109.433 173.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 792' ' ' LEU . . . . . 0.556 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 32.8 mt -57.39 -50.44 72.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.339 -0.846 . . . . 72.010000000000005 110.836 -177.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 793' ' ' ILE . . . . . 0.492 HD13 HG22 ' A' ' 720' ' ' VAL . 77.5 mt -57.94 -49.47 81.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.642 -0.708 . . . . 73.219999999999999 110.568 177.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -63.28 -30.71 78.37 Favored Glycine 0 CA--C 1.519 0.325 0 CA-C-N 115.952 -0.567 . . . . 73.439999999999998 112.814 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 795' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 791' ' ' VAL . 59.7 mm-40 -67.26 -36.73 82.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.46 0.13 . . . . 74.540000000000006 110.874 178.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 6.5 t30 . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.533 -0.303 . . . . 71.310000000000002 111.15 -175.831 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 716' ' ' ILE . . . . . 0.526 ' HA ' HD22 ' A' ' 719' ' ' LEU . 47.1 mm . . . . . 0 C--O 1.233 0.235 0 CA-C-O 120.934 0.397 . . . . 71.109999999999999 110.803 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -62.11 -34.03 87.71 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.828 -0.701 . . . . 70.409999999999997 111.992 176.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 718' ' ' GLU . . . . . 0.704 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 38.1 mt-10 -77.26 -25.0 51.04 Favored 'General case' 0 C--O 1.222 -0.385 0 O-C-N 122.623 -0.34 . . . . 74.319999999999993 111.125 178.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 719' ' ' LEU . . . . . 0.539 HD12 HD23 ' A' ' 789' ' ' LEU . 4.4 mm? -61.51 -32.94 73.0 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.473 -0.565 . . . . 73.349999999999994 109.473 172.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 720' ' ' VAL . . . . . 0.452 HG22 HD13 ' A' ' 793' ' ' ILE . 58.2 t -70.21 -36.26 66.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.477 -0.783 . . . . 74.400000000000006 110.76 177.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 721' ' ' ARG . . . . . 0.704 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 8.9 ptt180 -62.72 -29.52 70.73 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.02 0.438 . . . . 64.319999999999993 110.167 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -76.28 -31.55 58.3 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.197 -0.456 . . . . 74.319999999999993 110.596 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 723' ' ' LEU . . . . . 0.547 HD22 ' HB2' ' A' ' 789' ' ' LEU . 89.3 mt -63.76 -24.89 67.95 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.177 0.513 . . . . 72.439999999999998 110.601 174.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -92.07 -23.87 19.34 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.756 -0.656 . . . . 74.439999999999998 110.872 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 10.9 m -111.04 -76.79 0.6 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.423 -0.353 . . . . 73.420000000000002 111.241 -175.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 726' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -141.6 103.52 5.9 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 120.628 0.251 . . . . 53.049999999999997 110.768 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 727' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.77 -37.09 89.1 Favored 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 123.032 2.488 . . . . 71.329999999999998 112.348 -179.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 728' ' ' VAL . . . . . 0.404 ' O ' ' HG ' ' A' ' 732' ' ' LEU . 48.9 t -59.96 -47.94 89.75 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 CA-C-N 116.007 -0.542 . . . . 71.140000000000001 110.162 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -62.35 -35.33 91.5 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.656 -0.702 . . . . 42.350000000000001 112.01 178.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -65.41 -43.16 95.38 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.097 -0.573 . . . . 61.109999999999999 112.641 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -65.93 -40.27 91.28 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.725 -0.472 . . . . 73.150000000000006 109.725 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 732' ' ' LEU . . . . . 0.424 HD22 ' HB2' ' A' ' 742' ' ' ALA . 85.7 mt -65.37 -38.02 88.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.949 -0.569 . . . . 74.329999999999998 110.602 176.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 733' ' ' GLU . . . . . 0.439 ' O ' ' HG2' ' A' ' 736' ' ' ARG . 5.2 tp10 -66.98 -47.12 72.52 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 115.967 -0.56 . . . . 73.310000000000002 110.911 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 734' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -56.64 -46.69 80.85 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.214 -0.448 . . . . 72.430000000000007 110.458 177.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -65.28 -44.66 87.3 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.093 -0.503 . . . . 63.229999999999997 111.232 -177.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 736' ' ' ARG . . . . . 0.439 ' HG2' ' O ' ' A' ' 733' ' ' GLU . 14.5 ptm180 -68.85 -33.04 73.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.598 0.713 . . . . 72.340000000000003 109.825 -173.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 73.2 m -75.01 -36.47 61.95 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 114.792 -1.095 . . . . 75.120000000000005 111.766 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 12.7 m170 -94.27 0.57 55.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.338 -0.392 . . . . 74.209999999999994 111.327 -175.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 85.86 9.17 78.24 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.735 -0.745 . . . . 74.0 112.987 175.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -93.45 162.15 14.09 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.698 0.285 . . . . 71.530000000000001 110.336 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -107.48 115.99 31.14 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.993 -0.373 . . . . 71.549999999999997 109.993 176.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 742' ' ' ALA . . . . . 0.424 ' HB2' HD22 ' A' ' 732' ' ' LEU . . . -81.94 112.17 18.79 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.238 -0.437 . . . . 65.129999999999995 110.888 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 743' ' ' GLU . . . . . 0.46 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 43.9 mt-10 -123.06 127.74 49.17 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.297 -0.41 . . . . 73.129999999999995 110.945 -177.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -105.85 114.34 28.43 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.02 -0.536 . . . . 65.019999999999996 110.021 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -121.34 153.66 37.46 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.164 0.507 . . . . 72.439999999999998 110.803 177.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 746' ' ' LEU . . . . . 0.442 HD12 ' CE2' ' A' ' 760' ' ' TYR . 51.3 tp -95.93 101.33 12.99 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.475 -0.784 . . . . 75.230000000000004 109.803 178.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 49.1 t -69.33 -43.88 80.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.796 -0.638 . . . . 73.450000000000003 111.275 -174.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -146.25 147.49 31.47 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.064 0.459 . . . . 74.219999999999999 111.246 -176.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -141.47 93.66 2.6 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.997 -0.742 . . . . 73.340000000000003 108.997 177.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 16.7 t -129.84 176.75 7.78 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.906 -0.588 . . . . 74.409999999999997 110.213 -173.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 104.88 -176.17 22.71 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.712 -0.756 . . . . 74.299999999999997 112.353 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 752' ' ' PRO . . . . . 0.516 ' HG2' ' HB2' ' A' ' 755' ' ' GLU . 60.4 Cg_endo -73.62 157.82 48.08 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.899 2.399 . . . . 75.219999999999999 111.88 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -62.98 -22.54 73.86 Favored 'Trans proline' 0 CA--C 1.529 0.246 0 C-N-CA 122.656 2.238 . . . . 73.099999999999994 112.773 -177.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 39.2 p-80 -91.85 -7.57 49.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.924 0.392 . . . . 75.209999999999994 110.907 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 755' ' ' GLU . . . . . 0.516 ' HB2' ' HG2' ' A' ' 752' ' ' PRO . 5.5 mm-40 -146.84 63.58 8.46 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.318 -0.401 . . . . 72.400000000000006 110.987 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 756' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.85 122.43 8.49 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.094 1.862 . . . . 72.519999999999996 111.317 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 757' ' ' LYS . . . . . 0.422 ' HZ3' ' HB2' ' A' ' 757' ' ' LYS . 0.1 OUTLIER -92.95 112.2 24.08 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.07 0.462 . . . . 73.319999999999993 110.327 -178.181 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 758' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -95.1 107.52 19.58 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.579 -0.737 . . . . 75.409999999999997 110.501 -178.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 759' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 773' ' ' CYS . 40.9 t -86.65 98.13 6.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.037 -0.528 . . . . 71.420000000000002 109.896 178.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 760' ' ' TYR . . . . . 0.442 ' CE2' HD12 ' A' ' 746' ' ' LEU . 7.5 m-85 -98.08 141.07 31.48 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.074 -0.512 . . . . 74.25 110.379 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 761' ' ' GLN . . . . . 0.474 ' HA ' ' O ' ' A' ' 770' ' ' PRO . 54.6 tt0 -135.41 129.3 33.08 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.993 -0.549 . . . . 75.239999999999995 109.784 178.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 762' ' ' ALA . . . . . . . . . . . . . . . -85.99 117.23 24.71 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.474 0.654 . . . . 74.540000000000006 110.819 -177.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 763' ' ' LYS . . . . . 0.46 ' HB3' ' HB2' ' A' ' 743' ' ' GLU . 58.9 tttt -93.71 108.8 20.5 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.184 -0.916 . . . . 71.0 109.572 178.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 38.7 t -128.78 108.26 17.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.805 0.336 . . . . 65.340000000000003 110.936 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 69.16 25.1 75.7 Favored Glycine 0 CA--C 1.51 -0.219 0 C-N-CA 121.112 -0.566 . . . . 41.149999999999999 112.585 176.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 91.31 -10.27 75.3 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.652 -0.785 . . . . 73.319999999999993 111.859 -177.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 767' ' ' ARG . . . . . 0.417 ' HD3' ' HA ' ' A' ' 767' ' ' ARG . 30.1 mmt180 -91.32 128.51 37.17 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.033 0.445 . . . . 73.409999999999997 110.303 177.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 768' ' ' TRP . . . . . . . . . . . . . 51.0 m95 -104.1 96.1 6.43 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.519 -0.764 . . . . 73.230000000000004 109.94 -176.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 769' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -162.42 138.59 5.78 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.314 -0.403 . . . . 72.239999999999995 110.412 -177.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 770' ' ' PRO . . . . . 0.628 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 64.8 Cg_endo -95.0 175.15 12.68 Favored 'Cis proline' 0 N--CA 1.451 -0.978 0 C-N-CA 123.351 -1.521 . . . . 72.120000000000005 111.873 -3.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -107.66 98.15 7.78 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.681 -0.489 . . . . 72.0 109.681 174.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 29.2 m -112.73 131.31 64.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.358 0.599 . . . . 75.420000000000002 111.183 -175.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 773' ' ' CYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 759' ' ' VAL . 7.3 p -99.46 98.75 9.62 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.776 -0.647 . . . . 53.520000000000003 110.462 177.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -100.55 146.32 27.25 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.107 -0.497 . . . . 72.439999999999998 110.233 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 775' ' ' HIS . . . . . . . . . . . . . 1.1 p80 -86.11 17.3 3.67 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.272 0.558 . . . . 72.120000000000005 111.068 -178.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 34.3 t -150.02 140.51 22.44 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.633 -0.712 . . . . 71.230000000000004 109.282 175.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 777' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -66.04 -42.54 89.44 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.5 -0.318 . . . . 64.129999999999995 110.614 -175.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -60.49 -36.39 78.2 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.967 -0.56 . . . . 72.450000000000003 110.498 177.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 779' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -70.15 -42.77 72.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.034 -0.53 . . . . 73.030000000000001 110.802 177.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -50.2 -46.66 43.1 Favored Glycine 0 C--N 1.331 0.272 0 O-C-N 123.398 0.436 . . . . 44.219999999999999 113.083 -177.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -65.76 -49.25 69.07 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.781 0.324 . . . . 72.010000000000005 110.911 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -67.66 -46.89 71.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.149 -0.478 . . . . 73.099999999999994 111.771 -175.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -64.59 -37.47 87.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.683 -0.235 . . . . 73.420000000000002 110.63 -177.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -62.34 -52.0 65.39 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.272 -0.422 . . . . 71.0 110.438 177.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 785' ' ' ALA . . . . . 0.644 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -61.58 -43.68 98.41 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.22 -0.445 . . . . 74.120000000000005 110.648 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 786' ' ' ASP . . . . . 0.593 ' O ' ' HG2' ' A' ' 790' ' ' ARG . 8.2 t70 -57.5 -52.67 64.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.869 -0.605 . . . . 63.100000000000001 110.648 178.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 787' ' ' ALA . . . . . 0.539 ' HB3' ' HG3' ' A' ' 770' ' ' PRO . . . -68.09 -27.19 66.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.916 -0.584 . . . . 64.120000000000005 111.285 -176.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 788' ' ' ALA . . . . . 0.628 ' HB2' ' HD3' ' A' ' 770' ' ' PRO . . . -66.72 -41.41 87.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.406 -0.361 . . . . 60.299999999999997 110.567 177.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 789' ' ' LEU . . . . . 0.644 ' HG ' ' O ' ' A' ' 785' ' ' ALA . 21.2 mt -67.27 -34.4 77.34 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.547 -0.538 . . . . 74.409999999999997 109.547 178.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 790' ' ' ARG . . . . . 0.593 ' HG2' ' O ' ' A' ' 786' ' ' ASP . 28.3 mmt180 -55.47 -45.9 76.89 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.142 -0.481 . . . . 74.239999999999995 109.837 175.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 791' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 787' ' ' ALA . 48.7 t -58.66 -52.35 60.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.468 -0.787 . . . . 75.310000000000002 110.581 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 792' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 27.7 mt -61.16 -49.13 78.46 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.522 -0.763 . . . . 71.040000000000006 111.003 -177.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 793' ' ' ILE . . . . . 0.452 HD13 HG22 ' A' ' 720' ' ' VAL . 93.5 mt -63.62 -42.78 97.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.621 -0.718 . . . . 74.239999999999995 110.516 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -62.31 -27.18 68.85 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 121.029 -0.605 . . . . 55.43 112.569 178.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -77.71 -23.63 49.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.625 0.25 . . . . 75.230000000000004 111.437 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 . . . . . 0 C--N 1.327 -0.378 0 N-CA-C 111.942 0.349 . . . . 75.239999999999995 111.942 -177.83 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 716' ' ' ILE . . . . . 0.558 ' HA ' HD21 ' A' ' 719' ' ' LEU . 46.7 mm . . . . . 0 C--O 1.234 0.258 0 CA-C-O 120.936 0.398 . . . . 64.239999999999995 111.156 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -58.19 -28.77 61.89 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.866 -0.683 . . . . 62.5 112.551 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -68.61 -35.79 77.79 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 122.869 -0.195 . . . . 73.439999999999998 111.275 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 719' ' ' LEU . . . . . 0.558 HD21 ' HA ' ' A' ' 716' ' ' ILE . 3.2 mm? -64.94 -33.82 76.93 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.614 -0.513 . . . . 73.239999999999995 109.614 178.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 720' ' ' VAL . . . . . 0.491 HG23 HD13 ' A' ' 793' ' ' ILE . 45.5 t -66.33 -37.12 78.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.881 -0.599 . . . . 72.310000000000002 109.997 176.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 721' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.49 -32.04 71.05 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.839 -0.619 . . . . 72.340000000000003 110.158 177.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -79.46 -25.7 41.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.844 -0.616 . . . . 73.319999999999993 111.275 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 723' ' ' LEU . . . . . 0.505 HD23 ' HB2' ' A' ' 789' ' ' LEU . 60.1 mt -63.71 -29.95 71.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.991 0.424 . . . . 74.540000000000006 110.282 175.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -85.4 -35.63 21.21 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.653 -0.703 . . . . 74.200000000000003 110.83 176.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 24.7 m -92.55 -79.69 0.39 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.216 -0.447 . . . . 63.32 111.764 -174.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 726' ' ' ASN . . . . . 0.424 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 30.8 t30 -146.29 109.05 4.23 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-O 120.809 0.338 . . . . 74.129999999999995 110.235 -179.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 727' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 20.0 Cg_endo -61.24 -35.69 83.74 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.707 2.271 . . . . 65.140000000000001 112.436 -178.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 53.2 t -62.76 -48.08 89.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.244 -0.435 . . . . 74.109999999999999 110.615 -178.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -63.55 -33.16 86.5 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.825 -0.703 . . . . 72.310000000000002 111.944 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -71.19 -41.54 59.66 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.252 -0.499 . . . . 74.140000000000001 112.811 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -63.71 -38.94 93.0 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.469 -0.567 . . . . 62.439999999999998 109.469 178.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 732' ' ' LEU . . . . . 0.408 HD22 ' HB2' ' A' ' 742' ' ' ALA . 96.1 mt -69.63 -33.5 72.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.847 -0.615 . . . . 61.520000000000003 110.555 176.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 733' ' ' GLU . . . . . 0.546 ' O ' ' HG2' ' A' ' 736' ' ' ARG . 4.2 tp10 -67.95 -48.46 65.81 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 123.016 0.526 . . . . 73.209999999999994 110.417 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 734' ' ' TYR . . . . . 0.526 ' HB2' HD13 ' A' ' 719' ' ' LEU . 8.8 t80 -54.67 -47.19 73.91 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.777 -0.647 . . . . 70.450000000000003 110.642 176.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -67.37 -49.73 62.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.191 -0.459 . . . . 70.349999999999994 110.849 -177.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 736' ' ' ARG . . . . . 0.546 ' HG2' ' O ' ' A' ' 733' ' ' GLU . 13.5 ptm180 -60.41 -38.52 84.28 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.297 -0.41 . . . . 72.140000000000001 111.221 -175.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 32.9 t -77.36 -29.11 53.17 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.123 -0.489 . . . . 73.530000000000001 111.172 -177.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -95.58 -8.19 35.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.82 0.343 . . . . 74.049999999999997 111.433 -176.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 93.4 10.89 58.93 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.689 -0.767 . . . . 73.510000000000005 113.118 176.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -93.58 161.61 14.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.965 0.412 . . . . 73.549999999999997 110.734 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -106.89 113.03 26.27 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.796 -0.638 . . . . 72.239999999999995 109.631 176.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 742' ' ' ALA . . . . . 0.408 ' HB2' HD22 ' A' ' 732' ' ' LEU . . . -97.45 126.74 42.89 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.152 -0.477 . . . . 73.430000000000007 110.638 -178.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 743' ' ' GLU . . . . . 0.436 ' HG3' ' HB3' ' A' ' 763' ' ' LYS . 13.4 pt-20 -140.26 140.18 35.69 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.026 0.441 . . . . 72.140000000000001 110.569 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -108.27 114.73 28.83 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.741 -0.663 . . . . 74.019999999999996 109.718 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -120.89 149.91 41.88 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.083 0.468 . . . . 73.409999999999997 111.191 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 746' ' ' LEU . . . . . 0.471 HD23 ' HB3' ' A' ' 749' ' ' GLN . 60.6 tp -91.58 116.82 29.18 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.596 -0.729 . . . . 73.239999999999995 109.825 177.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 47.7 t -79.29 -47.42 22.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.05 -0.523 . . . . 72.129999999999995 110.498 -178.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -154.62 147.46 24.45 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.449 -0.341 . . . . 62.329999999999998 111.064 -179.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 749' ' ' GLN . . . . . 0.471 ' HB3' HD23 ' A' ' 746' ' ' LEU . 17.2 pt20 -129.84 109.98 11.36 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.137 -0.483 . . . . 73.109999999999999 109.864 177.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 27.5 t -155.36 159.28 39.79 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.379 -0.373 . . . . 44.509999999999998 110.385 -175.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 141.25 171.72 12.81 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.699 -0.762 . . . . 70.129999999999995 112.433 176.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 752' ' ' PRO . . . . . 0.744 ' HG2' ' HB2' ' A' ' 755' ' ' GLU . 37.3 Cg_endo -66.94 167.97 18.38 Favored 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 123.089 2.526 . . . . 75.219999999999999 111.906 176.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.46 -31.06 94.09 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.658 2.238 . . . . 75.400000000000006 112.777 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 44.4 p-80 -86.33 -8.09 57.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.889 0.376 . . . . 74.230000000000004 111.022 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 755' ' ' GLU . . . . . 0.744 ' HB2' ' HG2' ' A' ' 752' ' ' PRO . 17.4 mm-40 -142.81 67.12 18.12 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.164 -0.471 . . . . 75.510000000000005 111.622 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 756' ' ' PRO . . . . . 0.511 ' O ' ' HA ' ' A' ' 775' ' ' HIS . 48.1 Cg_endo -71.1 88.13 0.7 Allowed 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 121.845 1.697 . . . . 75.319999999999993 110.084 173.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 757' ' ' LYS . . . . . 0.851 ' HZ1' ' HB2' ' A' ' 757' ' ' LYS . 3.6 ttmp? -87.26 116.25 25.22 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.583 0.706 . . . . 64.010000000000005 111.726 -168.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 758' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -97.83 120.87 39.0 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.88 -1.054 . . . . 72.319999999999993 110.133 177.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 15.9 t -88.84 100.14 10.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 109.239 -0.652 . . . . 51.310000000000002 109.239 177.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -103.93 141.88 35.39 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.012 -0.54 . . . . 74.230000000000004 110.812 -177.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -132.04 136.45 47.24 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.07 -0.513 . . . . 72.120000000000005 109.844 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 762' ' ' ALA . . . . . . . . . . . . . . . -94.5 117.49 30.2 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.226 0.536 . . . . 74.420000000000002 110.388 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 763' ' ' LYS . . . . . 0.669 ' HD2' ' CH2' ' A' ' 768' ' ' TRP . 56.5 tttm -101.74 112.02 24.47 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.996 -0.547 . . . . 75.519999999999996 110.025 178.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 89.9 t -117.15 105.99 19.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.17 0.51 . . . . 63.340000000000003 110.041 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 74.22 -115.89 5.04 Favored Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 110.955 -0.858 . . . . 71.239999999999995 110.955 -175.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -110.21 4.24 29.98 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.524 -0.846 . . . . 73.340000000000003 112.348 177.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 767' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -103.48 149.21 25.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.933 0.397 . . . . 74.420000000000002 110.94 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 768' ' ' TRP . . . . . 0.669 ' CH2' ' HD2' ' A' ' 763' ' ' LYS . 58.4 m95 -117.76 104.38 10.92 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.698 -0.683 . . . . 75.510000000000005 109.822 -178.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 769' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -172.86 137.84 0.82 Allowed Pre-proline 0 C--N 1.324 -0.524 0 CA-C-O 121.065 0.46 . . . . 75.329999999999998 110.925 -177.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 770' ' ' PRO . . . . . 0.558 ' HD3' ' HB1' ' A' ' 788' ' ' ALA . 71.4 Cg_endo -97.16 176.9 8.68 Favored 'Cis proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.381 -1.508 . . . . 73.540000000000006 112.093 -3.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -112.51 109.73 19.48 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.536 -0.542 . . . . 72.5 109.536 173.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 34.1 m -116.61 174.8 3.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.039 -0.528 . . . . 75.230000000000004 110.891 -174.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 11.8 p -138.08 129.05 27.12 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.856 -0.611 . . . . 70.329999999999998 110.615 178.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -140.04 153.76 46.9 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.984 -0.553 . . . . 72.400000000000006 109.963 178.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 775' ' ' HIS . . . . . 0.511 ' HA ' ' O ' ' A' ' 756' ' ' PRO . 1.5 p-80 -86.3 12.58 9.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.181 0.515 . . . . 70.209999999999994 111.151 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 776' ' ' SER . . . . . 0.43 ' HB3' ' HB2' ' A' ' 779' ' ' GLN . 40.7 t -138.22 141.2 39.98 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.79 -0.641 . . . . 75.409999999999997 109.361 176.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 777' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -68.07 -41.91 81.25 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.267 -0.424 . . . . 75.340000000000003 110.17 -178.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -64.99 -40.74 95.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.991 -0.55 . . . . 72.239999999999995 110.075 178.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 779' ' ' GLN . . . . . 0.502 ' O ' ' HG2' ' A' ' 783' ' ' GLU . 49.1 mt-30 -63.18 -44.14 96.25 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 116.155 -0.475 . . . . 71.530000000000001 110.791 177.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -51.65 -42.21 51.6 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 121.317 -0.468 . . . . 55.229999999999997 112.857 -178.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -62.81 -47.65 82.54 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.349 0.595 . . . . 73.239999999999995 110.682 177.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -69.1 -41.9 76.85 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.291 -0.868 . . . . 74.310000000000002 111.401 -176.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 783' ' ' GLU . . . . . 0.502 ' HG2' ' O ' ' A' ' 779' ' ' GLN . 25.5 mm-40 -57.53 -46.3 84.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.069 0.462 . . . . 74.340000000000003 110.1 177.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -63.45 -49.53 73.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.675 -0.693 . . . . 62.509999999999998 110.803 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 785' ' ' ALA . . . . . 0.468 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -63.15 -40.66 98.21 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.284 -0.417 . . . . 74.0 111.33 -178.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 786' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -58.38 -54.75 43.5 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.148 0.499 . . . . 74.129999999999995 110.319 177.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 787' ' ' ALA . . . . . 0.607 ' O ' HG22 ' A' ' 791' ' ' VAL . . . -61.3 -40.43 94.15 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.425 -0.807 . . . . 74.349999999999994 110.708 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 788' ' ' ALA . . . . . 0.694 ' O ' ' HG ' ' A' ' 792' ' ' LEU . . . -56.93 -49.9 74.23 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.17 -0.468 . . . . 70.299999999999997 111.33 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 789' ' ' LEU . . . . . 0.538 HD23 HD12 ' A' ' 719' ' ' LEU . 80.2 mt -61.05 -43.16 99.3 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 110.156 -0.313 . . . . 72.439999999999998 110.156 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 790' ' ' ARG . . . . . . . . . . . . . 52.8 mtp180 -59.54 -36.17 75.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.124 -0.489 . . . . 73.310000000000002 111.328 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 791' ' ' VAL . . . . . 0.607 HG22 ' O ' ' A' ' 787' ' ' ALA . 64.4 t -64.61 -54.05 35.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 109.845 -0.428 . . . . 74.439999999999998 109.845 173.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 792' ' ' LEU . . . . . 0.694 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 45.6 mt -55.73 -48.68 74.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.69 -0.686 . . . . 73.209999999999994 111.185 -177.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 793' ' ' ILE . . . . . 0.491 HD13 HG23 ' A' ' 720' ' ' VAL . 93.0 mt -59.41 -52.27 62.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.588 -0.733 . . . . 74.409999999999997 110.933 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -64.58 -44.0 95.7 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.672 -0.775 . . . . 63.539999999999999 112.48 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -64.82 -47.69 77.1 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.745 0.276 . . . . 74.319999999999993 111.745 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 796' ' ' ASN . . . . . 0.425 HD21 ' HA ' ' A' ' 796' ' ' ASN . 1.0 OUTLIER . . . . . 0 C--N 1.326 -0.431 0 C-N-CA 120.708 -0.397 . . . . 75.25 110.709 -175.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 716' ' ' ILE . . . . . 0.561 ' HA ' HD22 ' A' ' 719' ' ' LEU . 46.2 mm . . . . . 0 C--O 1.237 0.419 0 CA-C-O 120.932 0.396 . . . . 74.230000000000004 111.43 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -59.17 -24.5 58.78 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.967 -0.635 . . . . 72.340000000000003 112.0 177.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -71.42 -36.02 71.17 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 120.469 0.176 . . . . 75.120000000000005 110.783 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 719' ' ' LEU . . . . . 0.561 HD22 ' HA ' ' A' ' 716' ' ' ILE . 3.3 mm? -63.14 -32.87 74.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.026 0.441 . . . . 72.530000000000001 109.873 178.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 720' ' ' VAL . . . . . 0.463 HG21 HD12 ' A' ' 793' ' ' ILE . 47.7 t -63.68 -38.73 83.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 115.887 -0.597 . . . . 73.400000000000006 110.171 174.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 721' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -67.07 -32.32 73.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.769 -0.651 . . . . 71.420000000000002 110.049 178.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -70.99 -32.95 69.91 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-N 116.206 -0.452 . . . . 74.239999999999995 110.747 177.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 723' ' ' LEU . . . . . 0.53 HD22 ' HB2' ' A' ' 789' ' ' LEU . 96.1 mt -56.31 -33.51 65.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.232 0.539 . . . . 74.109999999999999 110.163 174.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -77.76 -48.7 15.99 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.574 -0.739 . . . . 73.040000000000006 111.654 177.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 33.7 m -92.28 -67.81 0.83 Allowed 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.445 0.535 . . . . 64.450000000000003 112.445 -172.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 726' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -146.36 102.85 4.03 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 120.64 0.257 . . . . 73.450000000000003 110.439 -178.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 727' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -62.86 -38.02 51.03 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.773 2.315 . . . . 74.530000000000001 112.035 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 46.7 t -62.69 -47.48 92.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.003 -0.544 . . . . 62.130000000000003 110.644 -177.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -62.68 -38.82 97.08 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.793 -0.717 . . . . 51.329999999999998 111.624 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -66.1 -42.84 94.27 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 121.069 -0.586 . . . . 74.120000000000005 112.728 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -62.21 -44.67 96.06 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.027 0.441 . . . . 74.340000000000003 109.991 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 732' ' ' LEU . . . . . . . . . . . . . 87.8 mt -67.93 -36.94 81.01 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.033 -0.531 . . . . 73.129999999999995 110.881 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 733' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -69.82 -43.35 72.19 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 122.834 0.454 . . . . 71.5 110.831 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 734' ' ' TYR . . . . . 0.517 ' HB2' HD12 ' A' ' 719' ' ' LEU . 8.5 t80 -55.21 -48.17 74.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.928 0.394 . . . . 74.049999999999997 110.373 176.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -66.46 -50.45 63.29 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.868 -0.605 . . . . 71.310000000000002 110.97 -177.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 736' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -63.66 -31.1 72.17 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.03 0.443 . . . . 74.439999999999998 111.191 -175.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 34.8 t -77.13 -29.39 54.69 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.905 -0.589 . . . . 75.239999999999995 111.011 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 16.4 m170 -98.63 -11.52 21.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.815 0.34 . . . . 73.219999999999999 111.655 -176.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 103.63 -4.26 46.71 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.733 -0.746 . . . . 64.219999999999999 112.971 177.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -79.26 157.77 27.71 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.847 0.356 . . . . 65.040000000000006 110.494 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -102.99 122.81 45.37 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.148 -0.686 . . . . 60.100000000000001 109.148 175.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 742' ' ' ALA . . . . . 0.498 ' HA ' ' O ' ' A' ' 763' ' ' LYS . . . -114.16 122.64 47.45 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 123.379 0.424 . . . . 63.310000000000002 111.076 -176.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 743' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -145.3 138.36 26.33 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.176 -0.465 . . . . 65.310000000000002 110.844 178.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -101.15 110.83 22.91 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.842 -0.617 . . . . 65.420000000000002 109.457 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 745' ' ' LYS . . . . . 0.465 ' HZ3' ' HB3' ' A' ' 745' ' ' LYS . 0.9 OUTLIER -115.68 148.85 39.25 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.062 0.458 . . . . 74.150000000000006 110.886 -179.204 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 746' ' ' LEU . . . . . . . . . . . . . 59.2 tp -77.88 117.45 19.25 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.682 -0.69 . . . . 73.319999999999993 110.229 178.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 93.6 t -72.83 -51.45 27.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 116.111 -0.495 . . . . 74.510000000000005 109.807 176.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -169.57 155.65 6.18 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.655 -0.702 . . . . 64.299999999999997 109.899 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 749' ' ' GLN . . . . . 0.539 ' HA ' ' O ' ' A' ' 757' ' ' LYS . 14.7 pt20 -130.69 98.97 4.8 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.413 0.625 . . . . 63.200000000000003 110.323 175.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 35.7 m -141.96 133.57 26.86 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.676 -0.693 . . . . 63.409999999999997 110.695 -177.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 170.04 -172.6 43.91 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 121.081 -0.581 . . . . 55.229999999999997 111.764 178.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 752' ' ' PRO . . . . . 0.797 ' HG2' ' HB2' ' A' ' 755' ' ' GLU . 39.0 Cg_endo -67.56 157.9 59.61 Favored 'Trans proline' 0 N--CA 1.464 -0.217 0 C-N-CA 122.774 2.316 . . . . 71.019999999999996 111.569 177.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -58.73 -32.35 96.79 Favored 'Trans proline' 0 CA--C 1.532 0.405 0 C-N-CA 122.52 2.146 . . . . 73.5 113.109 -177.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 47.9 p-80 -83.04 -18.59 39.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.958 0.408 . . . . 75.430000000000007 111.081 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 755' ' ' GLU . . . . . 0.797 ' HB2' ' HG2' ' A' ' 752' ' ' PRO . 58.9 mm-40 -129.4 74.1 81.16 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.114 -0.493 . . . . 74.230000000000004 110.832 179.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 756' ' ' PRO . . . . . 0.715 ' O ' ' HA ' ' A' ' 775' ' ' HIS . 29.5 Cg_endo -64.51 102.6 0.41 Allowed 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.083 1.855 . . . . 65.120000000000005 110.23 174.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 757' ' ' LYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 749' ' ' GLN . 0.8 OUTLIER -89.51 105.43 17.79 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.088 0.471 . . . . 73.140000000000001 111.366 -170.01 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 758' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -92.29 110.11 21.5 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.464 -0.789 . . . . 74.099999999999994 109.752 177.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 13.8 t -84.57 109.24 17.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.607 -0.724 . . . . 74.340000000000003 109.423 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -110.81 135.79 50.84 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.269 -0.423 . . . . 74.340000000000003 110.895 -178.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 761' ' ' GLN . . . . . 0.553 ' HA ' ' O ' ' A' ' 770' ' ' PRO . 57.7 tt0 -128.35 130.85 48.37 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.119 -0.491 . . . . 74.209999999999994 109.973 179.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 762' ' ' ALA . . . . . . . . . . . . . . . -89.59 117.73 28.7 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.18 0.514 . . . . 73.340000000000003 110.749 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 763' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 742' ' ' ALA . 60.5 tttm -89.62 113.98 25.51 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.222 -0.658 . . . . 64.430000000000007 109.222 175.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 92.8 t -124.0 101.35 8.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.363 0.601 . . . . 73.140000000000001 110.162 178.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 73.14 -116.05 5.39 Favored Glycine 0 N--CA 1.442 -0.923 0 CA-C-N 115.187 -0.915 . . . . 74.099999999999994 111.426 -177.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -102.36 -11.23 36.69 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.801 -0.714 . . . . 73.239999999999995 111.998 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 767' ' ' ARG . . . . . . . . . . . . . 62.9 mtt180 -99.81 146.28 26.78 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.259 0.552 . . . . 73.420000000000002 111.673 -178.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 768' ' ' TRP . . . . . 0.467 ' CH2' ' HD2' ' A' ' 763' ' ' LYS . 63.0 m95 -111.77 107.36 16.41 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.208 -0.905 . . . . 74.329999999999998 109.404 179.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 769' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -169.19 141.0 2.02 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-O 121.048 0.452 . . . . 75.239999999999995 111.124 -176.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 770' ' ' PRO . . . . . 0.689 ' HD3' ' HB1' ' A' ' 788' ' ' ALA . 74.8 Cg_endo -98.46 176.94 7.65 Favored 'Cis proline' 0 N--CA 1.449 -1.089 0 C-N-CA 123.301 -1.541 . . . . 75.430000000000007 111.397 -5.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -111.55 99.29 8.07 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.991 0.424 . . . . 73.510000000000005 109.978 173.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 34.4 m -106.22 161.04 5.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.881 -0.6 . . . . 75.129999999999995 110.926 -177.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 773' ' ' CYS . . . . . 0.42 ' HB3' ' CG ' ' A' ' 757' ' ' LYS . 39.3 m -125.58 114.25 18.49 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.219 -0.446 . . . . 54.020000000000003 110.633 -178.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -128.61 153.48 47.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.224 -0.443 . . . . 72.439999999999998 109.947 178.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 775' ' ' HIS . . . . . 0.715 ' HA ' ' O ' ' A' ' 756' ' ' PRO . 1.9 p-80 -84.11 19.47 1.8 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.992 0.425 . . . . 73.299999999999997 111.492 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 24.9 t -153.32 143.19 22.06 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.396 -0.594 . . . . 75.219999999999999 109.396 175.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 777' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -60.65 -55.24 35.68 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.163 -0.472 . . . . 73.019999999999996 111.97 -175.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -65.92 -31.41 72.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.558 -0.292 . . . . 74.129999999999995 110.592 -175.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 779' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -62.0 -46.74 87.88 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.486 -0.561 . . . . 74.099999999999994 109.486 172.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -56.88 -47.73 84.19 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.698 -0.683 . . . . 71.200000000000003 112.169 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -59.21 -43.89 92.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.534 0.207 . . . . 75.450000000000003 111.364 177.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -68.58 -46.37 69.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.706 -0.225 . . . . 71.450000000000003 111.441 -178.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -64.05 -39.27 93.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.653 0.263 . . . . 72.340000000000003 110.522 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -62.37 -49.39 75.73 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 116.254 -0.43 . . . . 62.43 110.438 176.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 785' ' ' ALA . . . . . 0.584 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -61.38 -42.17 98.28 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.181 -0.463 . . . . 75.420000000000002 111.151 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 786' ' ' ASP . . . . . 0.611 ' O ' ' HG2' ' A' ' 790' ' ' ARG . 10.4 t70 -58.91 -54.22 49.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 70.129999999999995 110.375 178.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 787' ' ' ALA . . . . . 0.55 ' HB3' ' HG3' ' A' ' 770' ' ' PRO . . . -65.41 -33.91 77.06 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.966 -0.561 . . . . 63.439999999999998 111.097 -178.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 788' ' ' ALA . . . . . 0.689 ' HB1' ' HD3' ' A' ' 770' ' ' PRO . . . -61.3 -44.52 97.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.476 -0.329 . . . . 63.140000000000001 110.729 177.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 789' ' ' LEU . . . . . 0.584 ' HG ' ' O ' ' A' ' 785' ' ' ALA . 53.3 mt -63.19 -36.16 82.71 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.483 -0.326 . . . . 74.209999999999994 110.199 179.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 790' ' ' ARG . . . . . 0.611 ' HG2' ' O ' ' A' ' 786' ' ' ASP . 21.2 mmt180 -58.15 -45.63 87.06 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 109.739 -0.467 . . . . 71.120000000000005 109.739 177.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 791' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 787' ' ' ALA . 30.4 t -61.34 -46.71 96.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.62 -0.718 . . . . 74.140000000000001 110.388 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 792' ' ' LEU . . . . . 0.666 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 45.8 mt -62.2 -50.65 70.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.665 -0.698 . . . . 75.120000000000005 110.915 -178.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 793' ' ' ILE . . . . . 0.463 HD12 HG21 ' A' ' 720' ' ' VAL . 91.4 mt -59.25 -53.81 42.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.587 -0.733 . . . . 71.200000000000003 110.774 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -60.5 -31.85 75.92 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.857 -0.687 . . . . 61.420000000000002 112.615 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -65.23 -48.27 73.89 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.145 0.497 . . . . 75.209999999999994 109.991 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 . . . . . 0 C--N 1.323 -0.572 0 CA-C-N 116.054 -0.521 . . . . 74.129999999999995 111.623 -175.137 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 716' ' ' ILE . . . . . 0.444 ' HA ' HD23 ' A' ' 719' ' ' LEU . 50.1 mm . . . . . 0 C--O 1.233 0.206 0 CA-C-O 120.889 0.376 . . . . 71.040000000000006 111.398 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -56.45 -29.53 57.35 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 121.187 -0.53 . . . . 41.450000000000003 112.435 177.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 718' ' ' GLU . . . . . 0.614 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 9.3 mm-40 -60.57 -53.36 58.42 Favored 'General case' 0 C--O 1.225 -0.236 0 N-CA-C 109.985 -0.376 . . . . 74.430000000000007 109.985 176.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 719' ' ' LEU . . . . . 0.515 HD12 HD21 ' A' ' 789' ' ' LEU . 2.7 mm? -60.35 -35.88 76.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.042 -0.527 . . . . 70.109999999999999 110.461 -177.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 720' ' ' VAL . . . . . 0.402 HG21 HD11 ' A' ' 793' ' ' ILE . 58.7 t -62.09 -41.37 90.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 116.07 -0.514 . . . . 74.420000000000002 110.871 178.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 721' ' ' ARG . . . . . 0.614 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 19.1 ptt180 -66.82 -26.05 66.74 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.308 -0.405 . . . . 73.230000000000004 110.064 -178.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -77.33 -30.67 54.12 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 116.293 -0.412 . . . . 74.420000000000002 110.787 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 723' ' ' LEU . . . . . 0.51 HD22 ' HB2' ' A' ' 789' ' ' LEU . 55.8 mt -64.01 -23.97 67.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.167 0.508 . . . . 74.030000000000001 110.002 173.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -89.51 -26.38 20.92 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.748 -0.66 . . . . 75.5 110.989 176.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 10.9 m -106.29 -77.47 0.59 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.909 0.385 . . . . 74.430000000000007 111.407 -175.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 726' ' ' ASN . . . . . 0.413 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 29.3 t30 -145.31 108.19 4.51 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.347 -0.388 . . . . 72.439999999999998 110.231 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 727' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 13.6 Cg_endo -57.6 -38.48 93.45 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.966 2.444 . . . . 60.030000000000001 112.413 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 55.8 t -60.57 -47.5 92.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.244 -0.434 . . . . 72.120000000000005 110.34 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -62.43 -32.28 82.47 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.67 -0.695 . . . . 53.420000000000002 111.822 178.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -67.89 -43.73 81.92 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.092 -0.575 . . . . 71.439999999999998 112.461 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -64.9 -40.46 95.11 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.633 -0.506 . . . . 72.450000000000003 109.633 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 732' ' ' LEU . . . . . 0.41 HD22 ' HB2' ' A' ' 742' ' ' ALA . 84.6 mt -63.67 -41.51 98.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.842 -0.617 . . . . 64.040000000000006 110.451 176.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 733' ' ' GLU . . . . . 0.466 ' O ' ' HG2' ' A' ' 736' ' ' ARG . 2.5 tp10 -65.55 -44.59 86.31 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 123.052 0.541 . . . . 74.530000000000001 110.86 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 734' ' ' TYR . . . . . 0.449 ' HB2' HD13 ' A' ' 719' ' ' LEU . 27.1 t80 -56.23 -51.63 67.4 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.974 -0.557 . . . . 72.340000000000003 111.08 178.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -66.13 -46.86 76.04 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.393 -0.367 . . . . 64.010000000000005 111.291 -177.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 736' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' A' ' 733' ' ' GLU . 25.7 ptt180 -64.32 -29.34 70.42 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.201 0.524 . . . . 71.099999999999994 111.239 -175.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 33.8 t -83.64 -35.11 24.84 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.778 -0.646 . . . . 64.430000000000007 111.222 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 13.2 m170 -93.6 -10.29 35.18 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.201 0.445 . . . . 70.120000000000005 112.201 -172.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 103.1 3.92 48.05 Favored Glycine 0 N--CA 1.453 -0.172 0 C-N-CA 120.417 -0.897 . . . . 73.519999999999996 112.751 176.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -90.91 178.29 6.07 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.042 0.448 . . . . 75.319999999999993 110.542 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 741' ' ' ALA . . . . . 0.529 ' O ' ' HA ' ' A' ' 764' ' ' VAL . . . -120.16 134.55 55.23 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.847 -0.615 . . . . 75.200000000000003 109.492 174.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 742' ' ' ALA . . . . . 0.41 ' HB2' HD22 ' A' ' 732' ' ' LEU . . . -102.18 113.29 26.44 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.526 -0.306 . . . . 72.099999999999994 110.808 -177.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 743' ' ' GLU . . . . . 0.531 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 46.2 mt-10 -123.84 140.62 52.81 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.172 -0.467 . . . . 63.210000000000001 110.818 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -121.96 105.15 10.06 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.569 -0.53 . . . . 74.439999999999998 109.569 176.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.52 153.3 35.57 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.566 -0.454 . . . . 75.319999999999993 111.453 -177.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 746' ' ' LEU . . . . . . . . . . . . . 57.0 tp -82.03 116.14 21.5 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.473 -0.785 . . . . 74.310000000000002 109.407 173.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 52.2 t -88.06 -47.72 15.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 116.292 -0.413 . . . . 73.200000000000003 110.323 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -141.42 143.97 34.21 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.203 -0.453 . . . . 70.120000000000005 111.261 -176.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -130.06 100.6 5.49 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.816 -0.629 . . . . 75.450000000000003 109.395 174.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 750' ' ' SER . . . . . 0.403 ' O ' ' HB3' ' A' ' 757' ' ' LYS . 20.1 m -136.37 110.53 8.35 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.993 -0.548 . . . . 63.409999999999997 110.547 -177.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 174.15 177.9 43.67 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.976 -0.631 . . . . 64.450000000000003 111.803 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 752' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -71.01 155.87 61.06 Favored 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 122.85 2.367 . . . . 72.120000000000005 111.959 178.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -64.82 -30.29 58.62 Favored 'Trans proline' 0 CA--C 1.528 0.202 0 C-N-CA 122.603 2.202 . . . . 63.439999999999998 112.975 -176.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 56.0 p-80 -84.35 -23.61 30.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.772 0.32 . . . . 74.5 111.024 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -133.01 71.7 77.55 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.147 -0.479 . . . . 73.420000000000002 110.431 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 756' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -64.41 143.13 81.55 Favored 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 122.362 2.041 . . . . 70.310000000000002 112.08 -176.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 757' ' ' LYS . . . . . 0.403 ' HB3' ' O ' ' A' ' 750' ' ' SER . 23.3 ttmm -116.44 114.93 24.92 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.054 -0.521 . . . . 73.349999999999994 109.735 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 758' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -107.02 113.08 26.34 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.889 -0.596 . . . . 71.319999999999993 110.663 -177.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 759' ' ' VAL . . . . . 0.433 HG21 ' HB3' ' A' ' 773' ' ' CYS . 29.1 t -87.26 98.11 7.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.848 -0.615 . . . . 71.239999999999995 109.556 176.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 760' ' ' TYR . . . . . 0.53 ' OH ' ' HG3' ' A' ' 777' ' ' LYS . 6.3 m-85 -100.1 143.04 30.77 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.893 -0.594 . . . . 74.030000000000001 110.236 179.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -131.77 137.44 48.18 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.12 -0.491 . . . . 74.129999999999995 109.695 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 762' ' ' ALA . . . . . . . . . . . . . . . -86.28 114.01 22.74 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.037 -0.529 . . . . 75.150000000000006 110.489 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 763' ' ' LYS . . . . . 0.531 ' HB3' ' HB2' ' A' ' 743' ' ' GLU . 59.3 tttm -96.82 100.44 11.98 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.771 -0.65 . . . . 73.540000000000006 109.699 178.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 764' ' ' VAL . . . . . 0.529 ' HA ' ' O ' ' A' ' 741' ' ' ALA . 61.1 t -104.21 100.81 11.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 N-CA-C 109.448 -0.575 . . . . 75.209999999999994 109.448 -179.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 69.96 -122.49 11.66 Favored Glycine 0 N--CA 1.442 -0.904 0 N-CA-C 110.479 -1.048 . . . . 73.549999999999997 110.479 -172.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -104.01 20.21 41.48 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.596 -0.811 . . . . 70.510000000000005 111.545 174.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 767' ' ' ARG . . . . . . . . . . . . . 41.6 ttt180 -115.53 122.76 46.65 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.735 0.302 . . . . 74.400000000000006 110.394 -176.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 768' ' ' TRP . . . . . 0.487 ' CH2' ' HD2' ' A' ' 763' ' ' LYS . 44.1 m95 -98.21 103.18 15.1 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.243 -0.435 . . . . 75.549999999999997 110.204 -178.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 769' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -171.56 138.97 1.11 Allowed Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 120.822 0.344 . . . . 74.319999999999993 110.554 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 770' ' ' PRO . . . . . 0.572 ' HD3' ' HB3' ' A' ' 788' ' ' ALA . 82.8 Cg_endo -96.58 -176.49 5.16 Favored 'Cis proline' 0 N--CA 1.452 -0.947 0 C-N-CA 123.622 -1.407 . . . . 72.540000000000006 111.769 -4.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -117.4 129.79 56.07 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.077 -0.342 . . . . 73.109999999999999 110.077 176.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 30.7 m -136.63 145.97 29.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.748 0.309 . . . . 70.120000000000005 111.044 -178.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 773' ' ' CYS . . . . . 0.433 ' HB3' HG21 ' A' ' 759' ' ' VAL . 5.0 p -113.36 103.39 11.26 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.105 0.479 . . . . 74.030000000000001 110.695 178.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -106.43 -179.24 3.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.291 -0.413 . . . . 74.099999999999994 111.125 -176.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 775' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 -93.77 -8.65 40.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.286 0.565 . . . . 74.230000000000004 110.231 -177.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 63.6 m -150.75 166.05 31.63 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.754 -0.657 . . . . 63.149999999999999 110.403 -179.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 777' ' ' LYS . . . . . 0.53 ' HG3' ' OH ' ' A' ' 760' ' ' TYR . 31.2 ttmt -64.33 -57.64 8.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.269 -0.423 . . . . 74.219999999999999 111.741 -178.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -61.67 -35.96 79.47 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.054 -0.521 . . . . 74.319999999999993 110.039 -175.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 779' ' ' GLN . . . . . 0.465 ' O ' ' HG2' ' A' ' 783' ' ' GLU . 73.9 mt-30 -52.91 -56.2 17.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 75.25 110.18 170.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -57.37 -47.68 86.21 Favored Glycine 0 C--N 1.332 0.33 0 CA-C-N 115.698 -0.683 . . . . 36.149999999999999 112.764 -177.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -57.48 -44.52 84.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.754 0.311 . . . . 74.319999999999993 111.177 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -69.83 -45.18 68.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.418 -0.356 . . . . 74.120000000000005 111.176 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 783' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 779' ' ' GLN . 30.0 mm-40 -59.86 -40.39 88.43 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.902 0.382 . . . . 72.209999999999994 110.768 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -65.38 -49.87 67.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 72.409999999999997 110.612 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 785' ' ' ALA . . . . . 0.501 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -64.79 -40.09 94.66 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.312 -0.404 . . . . 70.349999999999994 111.18 -178.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 786' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -60.76 -50.05 75.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.984 -0.553 . . . . 75.299999999999997 110.108 178.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 787' ' ' ALA . . . . . 0.605 ' O ' HG23 ' A' ' 791' ' ' VAL . . . -62.6 -39.64 94.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.757 -0.656 . . . . 72.239999999999995 110.712 178.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 788' ' ' ALA . . . . . 0.587 ' O ' ' HG ' ' A' ' 792' ' ' LEU . . . -59.05 -47.36 85.53 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.072 -0.513 . . . . 70.230000000000004 111.338 -179.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 789' ' ' LEU . . . . . 0.515 HD21 HD12 ' A' ' 719' ' ' LEU . 77.9 mt -61.42 -41.77 97.69 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 110.109 -0.33 . . . . 75.200000000000003 110.109 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 790' ' ' ARG . . . . . 0.537 ' HD2' ' HA ' ' A' ' 787' ' ' ALA . 69.8 mtt-85 -57.38 -39.36 75.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 73.230000000000004 110.943 176.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 791' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 787' ' ' ALA . 60.1 t -63.33 -57.31 12.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.102 -0.499 . . . . 65.129999999999995 110.037 176.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 792' ' ' LEU . . . . . 0.587 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 37.1 mt -55.93 -47.72 77.01 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.487 -0.779 . . . . 75.409999999999997 111.522 -176.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 793' ' ' ILE . . . . . 0.402 HD11 HG21 ' A' ' 720' ' ' VAL . 95.7 mt -61.14 -46.47 96.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.795 -0.639 . . . . 74.239999999999995 110.934 178.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -60.69 -39.46 96.66 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.949 -0.643 . . . . 71.140000000000001 112.252 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 795' ' ' GLU . . . . . 0.545 ' HG2' ' O ' ' A' ' 791' ' ' VAL . 21.5 mm-40 -52.44 -44.13 65.31 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.08 0.467 . . . . 74.549999999999997 110.901 177.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 8.0 t30 . . . . . 0 C--N 1.326 -0.418 0 CA-C-N 115.934 -0.575 . . . . 55.210000000000001 112.008 -175.408 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 716' ' ' ILE . . . . . 0.521 HG21 ' HA ' ' A' ' 793' ' ' ILE . 38.5 mm . . . . . 0 CA--C 1.531 0.247 0 N-CA-C 112.694 0.628 . . . . 74.150000000000006 112.694 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -63.81 -30.66 78.35 Favored Glycine 0 C--O 1.237 0.29 0 C-N-CA 120.785 -0.721 . . . . 63.030000000000001 112.358 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 718' ' ' GLU . . . . . 0.654 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 35.4 mt-10 -73.03 -37.84 66.75 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 110.127 -0.323 . . . . 75.030000000000001 110.127 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 719' ' ' LEU . . . . . 0.548 HD11 ' HB2' ' A' ' 734' ' ' TYR . 2.6 mm? -58.1 -35.04 70.85 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.013 0.435 . . . . 75.219999999999999 110.308 175.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 720' ' ' VAL . . . . . 0.454 HG21 HD12 ' A' ' 793' ' ' ILE . 71.6 t -61.92 -41.16 89.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.856 -0.611 . . . . 72.420000000000002 110.997 178.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 721' ' ' ARG . . . . . 0.654 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 8.2 ptt180 -65.15 -25.35 67.71 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.979 0.419 . . . . 74.430000000000007 110.506 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -77.14 -29.17 54.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.398 -0.365 . . . . 74.319999999999993 110.767 178.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 723' ' ' LEU . . . . . 0.521 HD23 ' HB2' ' A' ' 789' ' ' LEU . 95.8 mt -62.06 -30.03 70.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.371 0.605 . . . . 72.409999999999997 109.742 173.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -81.95 -40.1 22.72 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.283 -0.871 . . . . 72.010000000000005 110.428 176.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 12.1 m -93.02 -83.44 0.31 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.983 -0.553 . . . . 75.329999999999998 111.416 -176.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 726' ' ' ASN . . . . . 0.405 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 44.9 t30 -140.76 110.2 6.67 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.789 0.328 . . . . 63.200000000000003 110.504 -176.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 727' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 28.5 Cg_endo -63.68 -37.24 47.67 Favored 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 122.814 2.343 . . . . 73.299999999999997 112.312 -178.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 44.0 t -61.24 -49.03 86.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.187 -0.46 . . . . 70.150000000000006 110.501 -178.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -64.02 -35.83 92.49 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.963 -0.637 . . . . 74.310000000000002 111.836 178.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -66.8 -41.61 93.51 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 121.063 -0.589 . . . . 74.120000000000005 112.457 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -63.48 -41.2 98.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.095 0.474 . . . . 75.120000000000005 109.733 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 732' ' ' LEU . . . . . 0.424 HD22 ' HB2' ' A' ' 742' ' ' ALA . 75.4 mt -68.29 -39.14 82.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.829 -0.623 . . . . 75.540000000000006 110.65 177.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 733' ' ' GLU . . . . . 0.528 ' O ' ' HG2' ' A' ' 736' ' ' ARG . 2.2 tp10 -65.29 -45.11 85.72 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 123.391 0.676 . . . . 72.400000000000006 111.067 -179.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 734' ' ' TYR . . . . . 0.548 ' HB2' HD11 ' A' ' 719' ' ' LEU . 7.4 t80 -60.21 -46.78 88.56 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.389 -0.369 . . . . 54.100000000000001 110.66 176.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 735' ' ' ALA . . . . . 0.426 ' HA ' ' HB2' ' A' ' 740' ' ' PHE . . . -64.11 -49.02 73.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.133 -0.485 . . . . 61.109999999999999 110.891 -177.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 736' ' ' ARG . . . . . 0.528 ' HG2' ' O ' ' A' ' 733' ' ' GLU . 23.3 ptt180 -59.97 -38.58 82.96 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.869 -0.605 . . . . 73.349999999999994 111.111 -176.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 32.9 t -78.46 -23.27 46.58 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.969 -0.559 . . . . 73.230000000000004 111.461 -177.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -108.91 4.96 23.97 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.118 0.414 . . . . 71.329999999999998 112.118 -174.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 89.04 2.76 77.33 Favored Glycine 0 C--O 1.229 -0.177 0 C-N-CA 120.736 -0.745 . . . . 73.25 113.261 174.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 740' ' ' PHE . . . . . 0.426 ' HB2' ' HA ' ' A' ' 735' ' ' ALA . 90.3 m-85 -83.52 161.26 21.29 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.874 0.369 . . . . 72.420000000000002 110.842 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -115.01 104.24 11.71 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.879 -0.6 . . . . 62.140000000000001 109.538 176.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 742' ' ' ALA . . . . . 0.424 ' HB2' HD22 ' A' ' 732' ' ' LEU . . . -86.4 125.7 33.86 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.04 -0.527 . . . . 72.049999999999997 111.208 -176.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 743' ' ' GLU . . . . . 0.413 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 43.3 mt-10 -137.82 134.72 35.5 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.047 -0.524 . . . . 75.109999999999999 110.382 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -107.21 105.74 15.87 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.5 -0.556 . . . . 74.120000000000005 109.5 176.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.53 147.25 44.68 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.053 0.454 . . . . 64.530000000000001 111.131 -174.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 746' ' ' LEU . . . . . . . . . . . . . 51.3 tp -77.22 122.01 24.46 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.701 -0.681 . . . . 73.439999999999998 110.006 176.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 60.1 t -81.76 -50.35 16.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.09 -0.505 . . . . 74.349999999999994 109.694 177.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -165.99 156.26 12.68 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.697 -0.683 . . . . 74.030000000000001 110.032 -177.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -114.32 119.14 35.94 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.98 -0.378 . . . . 74.540000000000006 109.98 174.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 750' ' ' SER . . . . . 0.498 ' O ' ' HB3' ' A' ' 757' ' ' LYS . 67.6 m -135.56 107.38 7.05 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.107 -0.497 . . . . 50.299999999999997 110.142 179.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 174.81 153.38 10.01 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.261 -0.971 . . . . 71.010000000000005 112.745 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 752' ' ' PRO . . . . . 0.679 ' HG2' ' HB2' ' A' ' 755' ' ' GLU . 36.2 Cg_endo -66.53 168.69 15.85 Favored 'Trans proline' 0 CA--C 1.533 0.427 0 C-N-CA 123.348 2.698 . . . . 71.430000000000007 111.968 176.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.61 -31.88 95.09 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.595 2.197 . . . . 75.010000000000005 112.88 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 42.9 p-80 -87.5 -5.05 58.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.415 -0.357 . . . . 64.450000000000003 111.259 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 755' ' ' GLU . . . . . 0.679 ' HB2' ' HG2' ' A' ' 752' ' ' PRO . 12.2 mm-40 -150.39 64.21 6.5 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.156 -0.475 . . . . 72.140000000000001 110.715 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 756' ' ' PRO . . . . . 0.465 ' O ' ' HA ' ' A' ' 775' ' ' HIS . 14.4 Cg_exo -68.42 92.15 0.41 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.711 2.274 . . . . 71.230000000000004 111.33 178.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 757' ' ' LYS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 775' ' ' HIS . 15.0 ttmt -89.05 111.73 22.53 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.522 0.677 . . . . 65.329999999999998 111.262 -174.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 758' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -90.76 130.85 36.7 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.943 -1.026 . . . . 74.040000000000006 109.832 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 29.2 t -92.87 109.04 21.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.609 -0.515 . . . . 73.150000000000006 109.609 175.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -111.92 141.19 45.87 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.303 -0.408 . . . . 74.319999999999993 110.646 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -126.97 137.82 53.17 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.977 -0.556 . . . . 74.209999999999994 109.92 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 762' ' ' ALA . . . . . 0.467 ' HB2' ' O ' ' A' ' 769' ' ' PHE . . . -85.44 109.82 18.73 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.402 0.62 . . . . 74.239999999999995 110.428 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 763' ' ' LYS . . . . . 0.413 ' HB3' ' HB2' ' A' ' 743' ' ' GLU . 75.1 tttt -94.08 104.29 16.33 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.228 -0.896 . . . . 72.109999999999999 109.483 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 48.4 t -117.2 98.04 6.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 120.939 0.4 . . . . 73.209999999999994 111.176 -175.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 60.5 37.27 93.03 Favored Glycine 0 CA--C 1.517 0.193 0 CA-C-N 115.716 -0.674 . . . . 61.009999999999998 113.143 176.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 94.86 -16.11 61.98 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.545 -0.836 . . . . 72.230000000000004 112.62 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 767' ' ' ARG . . . . . . . . . . . . . 79.0 mtt180 -90.64 129.28 36.78 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.054 -0.35 . . . . 63.420000000000002 110.054 176.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 768' ' ' TRP . . . . . . . . . . . . . 68.3 m95 -106.58 99.15 8.74 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.408 -0.36 . . . . 72.239999999999995 110.484 -176.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 769' ' ' PHE . . . . . 0.467 ' O ' ' HB2' ' A' ' 762' ' ' ALA . 36.3 p90 -170.22 136.86 1.29 Allowed Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.533 -0.303 . . . . 74.5 110.327 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 770' ' ' PRO . . . . . 0.595 ' HG3' ' HB3' ' A' ' 787' ' ' ALA . 62.5 Cg_endo -94.89 179.02 9.23 Favored 'Cis proline' 0 N--CA 1.45 -1.04 0 C-N-CA 123.484 -1.465 . . . . 72.140000000000001 111.978 -3.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -115.56 104.14 11.43 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.938 -0.393 . . . . 62.340000000000003 109.938 175.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 29.6 m -113.67 164.27 9.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.001 0.429 . . . . 74.239999999999995 111.05 -175.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 773' ' ' CYS . . . . . 0.445 ' HB2' ' HG2' ' A' ' 757' ' ' LYS . 10.6 p -127.87 119.19 25.1 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.082 -0.508 . . . . 63.340000000000003 110.193 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -135.91 144.33 45.46 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.41 -0.359 . . . . 73.439999999999998 110.612 -178.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 775' ' ' HIS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 757' ' ' LYS . 1.1 p-80 -76.45 16.5 0.47 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.496 0.554 . . . . 74.420000000000002 112.496 -177.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 776' ' ' SER . . . . . 0.566 ' HB2' ' CG ' ' A' ' 779' ' ' GLN . 11.8 m -147.13 140.32 25.3 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.654 -0.498 . . . . 61.149999999999999 109.654 177.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 777' ' ' LYS . . . . . 0.431 ' HE3' ' HB3' ' A' ' 777' ' ' LYS . 2.2 tmmt? -61.46 -46.25 90.84 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.435 -0.348 . . . . 72.430000000000007 111.227 -178.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 778' ' ' LYS . . . . . 0.503 ' O ' ' HG3' ' A' ' 782' ' ' GLN . 63.7 pttt -66.5 -35.48 80.37 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.929 -0.308 . . . . 75.430000000000007 110.442 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 779' ' ' GLN . . . . . 0.566 ' CG ' ' HB2' ' A' ' 776' ' ' SER . 16.0 mm100 -63.79 -43.9 94.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.337 -0.392 . . . . 75.310000000000002 110.05 177.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -57.52 -40.46 92.38 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.002 -0.618 . . . . 72.099999999999994 111.92 178.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 30.3 mtpp -66.5 -47.0 74.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.639 0.257 . . . . 75.329999999999998 110.831 178.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 782' ' ' GLN . . . . . 0.503 ' HG3' ' O ' ' A' ' 778' ' ' LYS . 22.8 mt-30 -68.25 -48.17 65.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.221 -0.445 . . . . 65.329999999999998 111.228 -177.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -58.76 -46.15 88.12 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 123.25 0.344 . . . . 70.450000000000003 110.999 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -63.17 -48.01 80.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.305 -0.407 . . . . 75.510000000000005 110.893 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 785' ' ' ALA . . . . . 0.623 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -62.64 -42.19 99.46 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.268 -0.424 . . . . 74.400000000000006 111.089 -178.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 786' ' ' ASP . . . . . 0.521 ' O ' ' HG2' ' A' ' 790' ' ' ARG . 11.7 t70 -59.48 -55.74 30.77 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.04 -0.527 . . . . 72.430000000000007 110.129 179.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 787' ' ' ALA . . . . . 0.595 ' HB3' ' HG3' ' A' ' 770' ' ' PRO . . . -61.52 -34.68 75.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.75 -0.659 . . . . 73.209999999999994 111.203 -178.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 788' ' ' ALA . . . . . 0.585 ' O ' ' HG ' ' A' ' 792' ' ' LEU . . . -61.22 -42.78 99.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.421 -0.354 . . . . 72.310000000000002 110.888 178.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 789' ' ' LEU . . . . . 0.623 ' HG ' ' O ' ' A' ' 785' ' ' ALA . 35.5 mt -66.05 -33.93 76.92 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.421 -0.354 . . . . 74.340000000000003 110.122 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 790' ' ' ARG . . . . . 0.521 ' HG2' ' O ' ' A' ' 786' ' ' ASP . 6.2 mmm180 -61.71 -44.47 96.85 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.493 -0.558 . . . . 72.409999999999997 109.493 178.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 791' ' ' VAL . . . . . 0.547 HG21 ' O ' ' A' ' 787' ' ' ALA . 41.2 t -57.69 -44.26 85.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.512 -0.767 . . . . 74.319999999999993 110.559 178.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 792' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 30.3 mt -68.15 -52.06 38.95 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.732 -0.667 . . . . 73.549999999999997 110.713 -178.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 793' ' ' ILE . . . . . 0.521 ' HA ' HG21 ' A' ' 716' ' ' ILE . 95.7 mt -60.23 -47.33 92.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.539 -0.755 . . . . 75.030000000000001 111.456 -177.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -68.71 -26.36 74.54 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.766 -0.731 . . . . 55.130000000000003 112.506 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -77.81 -44.28 27.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.876 0.37 . . . . 61.439999999999998 110.921 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 796' ' ' ASN . . . . . 0.408 ' HB3' HG13 ' A' ' 716' ' ' ILE . 1.6 t30 . . . . . 0 C--N 1.324 -0.513 0 CA-C-O 121.007 0.432 . . . . 74.420000000000002 110.664 -176.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 716' ' ' ILE . . . . . 0.538 HG22 HG12 ' A' ' 793' ' ' ILE . 44.7 mm . . . . . 0 N--CA 1.455 -0.216 0 CA-C-O 120.768 0.318 . . . . 75.409999999999997 111.166 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -58.71 -29.1 63.81 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.742 -0.742 . . . . 74.340000000000003 111.645 175.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 718' ' ' GLU . . . . . 0.692 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 43.7 mm-40 -70.17 -40.43 74.71 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-O 120.707 0.289 . . . . 72.530000000000001 110.77 178.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 719' ' ' LEU . . . . . 0.525 HD22 ' HA ' ' A' ' 716' ' ' ILE . 3.1 mm? -64.4 -27.08 68.76 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.127 0.489 . . . . 71.329999999999998 109.929 177.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 720' ' ' VAL . . . . . . . . . . . . . 98.2 t -76.18 -36.85 31.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.789 -0.641 . . . . 74.310000000000002 111.346 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 721' ' ' ARG . . . . . 0.692 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 5.9 ptm180 -67.89 -22.77 65.08 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.34 0.591 . . . . 74.340000000000003 109.762 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -77.22 -31.02 54.88 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.929 -0.578 . . . . 74.030000000000001 110.622 175.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 723' ' ' LEU . . . . . 0.506 HD22 ' HB2' ' A' ' 789' ' ' LEU . 85.3 mt -60.13 -30.41 69.27 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.284 0.564 . . . . 74.310000000000002 109.894 174.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -87.98 -39.49 14.66 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.352 -0.84 . . . . 72.430000000000007 111.303 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 30.7 m -90.23 -76.17 0.44 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.756 0.312 . . . . 71.430000000000007 111.761 -177.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 726' ' ' ASN . . . . . 0.453 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 25.2 t30 -150.84 105.56 3.03 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.458 -0.337 . . . . 71.340000000000003 110.453 -178.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 727' ' ' PRO . . . . . 0.453 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 18.1 Cg_endo -60.63 -32.55 93.44 Favored 'Trans proline' 0 N--CA 1.464 -0.207 0 C-N-CA 123.131 2.554 . . . . 74.420000000000002 112.47 -178.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 43.4 t -61.88 -48.05 90.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.09 -0.505 . . . . 73.040000000000006 110.47 -177.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -63.06 -32.66 84.91 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.925 -0.655 . . . . 72.219999999999999 112.183 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -73.88 -44.48 30.76 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.753 -0.737 . . . . 71.450000000000003 112.5 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -64.1 -40.97 97.38 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.85 0.357 . . . . 73.340000000000003 110.147 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 732' ' ' LEU . . . . . . . . . . . . . 93.3 mt -64.19 -40.85 96.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.119 -0.492 . . . . 73.129999999999995 111.523 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 733' ' ' GLU . . . . . 0.528 ' HA ' ' HG2' ' A' ' 736' ' ' ARG . 6.5 pt-20 -78.35 -31.24 48.46 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.404 -0.518 . . . . 73.510000000000005 110.971 -178.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 734' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -53.76 -45.61 70.67 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 121.056 0.455 . . . . 75.319999999999993 109.942 175.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -66.06 -53.28 40.3 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.727 -0.67 . . . . 65.540000000000006 110.708 -178.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 736' ' ' ARG . . . . . 0.528 ' HG2' ' HA ' ' A' ' 733' ' ' GLU . 19.2 ptt85 -61.36 -34.42 75.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.092 -0.504 . . . . 73.329999999999998 111.209 -175.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 15.6 t -73.44 -36.4 65.91 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.815 -0.63 . . . . 75.400000000000006 111.137 178.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 13.4 m170 -95.64 3.19 54.21 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.948 0.351 . . . . 73.439999999999998 111.948 -173.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 95.08 0.01 63.88 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.519 -0.848 . . . . 74.120000000000005 113.367 173.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -94.27 -179.1 4.82 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.798 0.332 . . . . 75.099999999999994 110.393 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 741' ' ' ALA . . . . . 0.424 ' O ' ' HA ' ' A' ' 764' ' ' VAL . . . -127.2 134.64 50.1 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.212 -0.662 . . . . 64.099999999999994 109.212 173.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 742' ' ' ALA . . . . . . . . . . . . . . . -110.89 131.39 55.09 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.741 0.305 . . . . 62.229999999999997 111.166 -176.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 743' ' ' GLU . . . . . 0.45 ' HG3' ' HB3' ' A' ' 763' ' ' LYS . 12.7 pt-20 -147.57 153.27 39.23 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.92 -0.582 . . . . 73.310000000000002 110.435 178.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -120.6 118.26 29.69 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.061 -0.518 . . . . 72.239999999999995 109.781 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -122.2 138.19 54.57 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.524 -0.47 . . . . 74.209999999999994 111.246 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 746' ' ' LEU . . . . . . . . . . . . . 6.8 tt -74.24 119.14 18.03 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.501 -0.772 . . . . 73.299999999999997 109.176 176.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 43.9 t -94.89 -44.99 13.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.279 -0.419 . . . . 74.230000000000004 110.959 -177.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -149.29 158.02 43.83 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.402 -0.363 . . . . 74.25 110.77 -176.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -141.36 113.41 7.93 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.332 -0.618 . . . . 71.319999999999993 109.332 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 6.1 t -143.83 -167.29 2.56 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.869 -0.332 . . . . 72.329999999999998 110.324 -177.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 97.23 -150.38 19.52 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.853 -0.689 . . . . 72.219999999999999 111.787 -177.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 752' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -80.06 158.38 23.71 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.364 2.042 . . . . 73.420000000000002 111.802 178.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -73.13 -36.17 4.51 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.661 2.24 . . . . 71.129999999999995 112.376 -177.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -76.33 -29.27 57.21 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.96 -0.564 . . . . 73.340000000000003 110.834 -177.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -130.98 74.02 80.37 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 72.439999999999998 110.614 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 756' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -62.95 132.05 35.35 Favored 'Trans proline' 0 N--CA 1.465 -0.152 0 C-N-CA 122.685 2.257 . . . . 73.409999999999997 112.018 -177.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 757' ' ' LYS . . . . . 0.527 ' HG2' ' HB2' ' A' ' 773' ' ' CYS . 39.1 ttmt -98.83 111.83 24.1 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.279 0.561 . . . . 65.120000000000005 109.796 178.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 758' ' ' PHE . . . . . 0.417 ' O ' ' HA ' ' A' ' 773' ' ' CYS . 61.3 m-85 -90.27 123.25 33.89 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.116 -0.947 . . . . 74.510000000000005 110.595 -175.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 56.4 t -88.91 108.0 18.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.998 -0.547 . . . . 61.109999999999999 109.725 176.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -111.22 135.19 52.11 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.795 -0.639 . . . . 74.319999999999993 110.676 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -120.76 126.85 51.18 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.829 -0.623 . . . . 72.299999999999997 109.658 178.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 762' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 769' ' ' PHE . . . -83.94 120.92 26.68 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.179 0.514 . . . . 73.0 110.19 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 763' ' ' LYS . . . . . 0.684 ' HD2' ' CH2' ' A' ' 768' ' ' TRP . 49.4 tttm -104.32 107.3 18.15 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.842 -0.617 . . . . 65.150000000000006 110.054 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 764' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' A' ' 741' ' ' ALA . 48.4 t -114.94 102.66 14.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.988 -0.551 . . . . 73.409999999999997 109.868 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 72.77 -123.15 8.67 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 110.821 -0.912 . . . . 74.230000000000004 110.821 -174.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -101.2 2.54 54.66 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.123 -0.791 . . . . 72.409999999999997 111.123 173.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 767' ' ' ARG . . . . . 0.435 ' NE ' ' HA ' ' A' ' 767' ' ' ARG . 2.6 mmp_? -97.28 127.52 43.31 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.099 0.476 . . . . 72.430000000000007 110.839 -177.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 768' ' ' TRP . . . . . 0.684 ' CH2' ' HD2' ' A' ' 763' ' ' LYS . 51.1 m95 -103.63 112.15 24.94 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.669 -0.696 . . . . 75.209999999999994 109.27 178.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 769' ' ' PHE . . . . . 0.416 ' O ' ' HB3' ' A' ' 762' ' ' ALA . 27.0 p90 -176.78 136.98 0.43 Allowed Pre-proline 0 C--N 1.323 -0.584 0 CA-C-O 120.955 0.407 . . . . 73.430000000000007 110.248 -178.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 770' ' ' PRO . . . . . 0.563 ' HG3' ' HB1' ' A' ' 787' ' ' ALA . 55.6 Cg_endo -95.51 -170.74 2.81 Favored 'Cis proline' 0 N--CA 1.451 -0.976 0 C-N-CA 123.395 -1.502 . . . . 52.25 111.828 -3.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -120.83 100.18 6.95 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.431 -0.581 . . . . 73.310000000000002 109.431 175.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 28.6 m -109.88 163.98 6.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.243 -0.435 . . . . 75.519999999999996 110.973 -175.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 773' ' ' CYS . . . . . 0.527 ' HB2' ' HG2' ' A' ' 757' ' ' LYS . 6.3 p -138.21 110.69 7.49 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.975 -0.557 . . . . 62.409999999999997 110.002 178.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -118.17 147.61 43.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.539 -0.3 . . . . 73.129999999999995 111.023 -176.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 775' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -76.33 13.33 0.96 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.316 -0.402 . . . . 74.420000000000002 111.828 -177.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 49.9 m -150.02 136.56 19.09 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.249 -0.648 . . . . 74.329999999999998 109.249 174.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 777' ' ' LYS . . . . . 0.424 ' HE3' ' HB3' ' A' ' 777' ' ' LYS . 0.8 OUTLIER -61.87 -40.57 95.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.384 -0.371 . . . . 75.109999999999999 111.372 -174.709 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -66.68 -29.23 69.19 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.11 0.481 . . . . 65.239999999999995 110.39 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 779' ' ' GLN . . . . . 0.489 ' O ' ' HG2' ' A' ' 783' ' ' GLU . 96.4 mt-30 -74.7 -38.38 62.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.944 -0.571 . . . . 75.540000000000006 110.03 178.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -53.18 -44.89 64.15 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 121.324 -0.465 . . . . 65.019999999999996 112.391 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -62.46 -46.63 87.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.976 0.417 . . . . 71.349999999999994 110.649 177.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -66.92 -48.04 69.88 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.869 -0.605 . . . . 74.219999999999999 111.596 -177.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 783' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 779' ' ' GLN . 34.5 mm-40 -59.66 -41.43 90.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.758 0.313 . . . . 73.120000000000005 110.527 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -62.39 -48.01 81.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.07 -0.514 . . . . 55.549999999999997 110.493 178.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 785' ' ' ALA . . . . . 0.564 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -65.26 -40.07 93.46 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.333 -0.394 . . . . 70.299999999999997 110.858 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 786' ' ' ASP . . . . . 0.6 ' O ' ' HD3' ' A' ' 790' ' ' ARG . 13.7 t70 -60.61 -55.65 30.81 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.961 -0.563 . . . . 64.129999999999995 110.299 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 787' ' ' ALA . . . . . 0.563 ' HB1' ' HG3' ' A' ' 770' ' ' PRO . . . -64.14 -31.09 72.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.078 -0.51 . . . . 74.219999999999999 110.904 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 788' ' ' ALA . . . . . 0.681 ' O ' ' HG ' ' A' ' 792' ' ' LEU . . . -62.14 -46.56 88.47 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.286 -0.264 . . . . 72.430000000000007 110.286 176.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 789' ' ' LEU . . . . . 0.564 ' HG ' ' O ' ' A' ' 785' ' ' ALA . 70.1 mt -63.69 -34.78 78.62 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.741 -0.466 . . . . 74.109999999999999 109.741 178.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 790' ' ' ARG . . . . . 0.6 ' HD3' ' O ' ' A' ' 786' ' ' ASP . 0.3 OUTLIER -57.43 -45.71 84.35 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.223 -0.444 . . . . 71.530000000000001 110.185 174.897 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 791' ' ' VAL . . . . . 0.502 HG22 ' O ' ' A' ' 787' ' ' ALA . 48.4 t -61.63 -49.69 83.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.028 -0.533 . . . . 70.540000000000006 110.381 177.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 792' ' ' LEU . . . . . 0.681 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 39.6 mt -59.92 -50.79 72.37 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.988 -0.551 . . . . 75.430000000000007 110.901 -177.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 793' ' ' ILE . . . . . 0.538 HG12 HG22 ' A' ' 716' ' ' ILE . 95.9 mt -60.72 -49.51 84.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.844 -0.616 . . . . 65.530000000000001 110.578 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -61.8 -36.64 93.06 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 121.057 -0.592 . . . . 63.109999999999999 112.625 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -65.51 -43.91 88.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.049 0.452 . . . . 70.129999999999995 110.129 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 116.07 -0.514 . . . . 74.209999999999994 110.925 179.686 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 716' ' ' ILE . . . . . 0.562 ' HA ' HD21 ' A' ' 719' ' ' LEU . 37.0 mm . . . . . 0 C--O 1.234 0.253 0 CA-C-O 121.013 0.435 . . . . 72.230000000000004 111.117 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -60.55 -29.69 70.16 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 121.008 -0.615 . . . . 55.229999999999997 112.518 175.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -75.54 -25.4 57.14 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 122.651 -0.323 . . . . 75.340000000000003 110.654 178.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 719' ' ' LEU . . . . . 0.562 HD21 ' HA ' ' A' ' 716' ' ' ILE . 4.2 mm? -66.38 -34.77 78.72 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.464 -0.569 . . . . 73.540000000000006 109.464 174.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 720' ' ' VAL . . . . . 0.52 HG22 HD13 ' A' ' 793' ' ' ILE . 22.0 t -68.15 -33.09 58.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.826 -0.625 . . . . 74.019999999999996 109.979 175.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 721' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.29 -35.71 78.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.722 -0.672 . . . . 72.109999999999999 110.04 178.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -71.05 -32.33 69.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.0 -0.546 . . . . 72.049999999999997 111.1 178.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 723' ' ' LEU . . . . . 0.403 HD22 ' HB2' ' A' ' 789' ' ' LEU . 95.3 mt -58.02 -32.03 67.55 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.119 0.485 . . . . 74.430000000000007 109.928 175.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 54.0 m-20 -71.54 -49.9 36.43 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.622 -0.717 . . . . 73.329999999999998 110.839 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 47.4 m -93.12 -70.78 0.68 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.049 0.388 . . . . 75.109999999999999 112.049 -174.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 726' ' ' ASN . . . . . 0.403 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 43.5 t30 -145.12 104.79 4.41 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-O 120.827 0.346 . . . . 75.329999999999998 110.86 -178.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 727' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 18.6 Cg_endo -60.57 -34.52 92.4 Favored 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.821 2.347 . . . . 61.210000000000001 112.064 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 47.6 t -61.76 -48.37 88.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 64.530000000000001 110.364 -178.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -63.15 -31.2 79.92 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 121.026 -0.607 . . . . 55.399999999999999 111.811 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -70.35 -41.98 66.45 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.948 -0.644 . . . . 73.239999999999995 112.376 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 731' ' ' LEU . . . . . 0.413 ' N ' HD23 ' A' ' 789' ' ' LEU . 3.0 tm? -65.57 -40.33 92.66 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.412 -0.588 . . . . 71.140000000000001 109.412 178.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 732' ' ' LEU . . . . . . . . . . . . . 79.4 mt -66.16 -39.25 89.63 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.702 -0.681 . . . . 75.040000000000006 110.78 176.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 733' ' ' GLU . . . . . 0.465 ' O ' ' HG2' ' A' ' 736' ' ' ARG . 4.1 tp10 -65.8 -46.31 79.13 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 116.266 -0.425 . . . . 63.420000000000002 110.57 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 734' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -54.96 -48.2 73.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.994 -0.548 . . . . 73.049999999999997 110.677 177.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -65.92 -48.26 72.01 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.122 -0.49 . . . . 75.409999999999997 111.236 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 736' ' ' ARG . . . . . 0.465 ' HG2' ' O ' ' A' ' 733' ' ' GLU . 31.9 ptt180 -65.22 -33.03 75.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.14 0.495 . . . . 74.530000000000001 111.345 -175.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 38.0 t -78.12 -36.64 47.62 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.859 -0.61 . . . . 75.400000000000006 111.156 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 15.5 m170 -89.02 -29.21 19.64 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.43 -0.35 . . . . 74.450000000000003 111.846 -174.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 109.07 21.93 7.14 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.555 -0.831 . . . . 73.409999999999997 112.273 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -96.99 167.46 11.06 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.738 0.304 . . . . 74.439999999999998 110.405 175.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -109.91 114.11 27.38 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.461 -0.57 . . . . 73.420000000000002 109.461 175.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 742' ' ' ALA . . . . . . . . . . . . . . . -93.6 110.2 21.81 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.968 0.413 . . . . 72.099999999999994 110.433 -178.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 743' ' ' GLU . . . . . 0.522 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 44.7 mt-10 -120.82 117.09 26.52 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.942 -0.572 . . . . 75.310000000000002 111.281 -177.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 744' ' ' PHE . . . . . 0.412 ' CB ' ' HE3' ' A' ' 781' ' ' LYS . 96.2 m-85 -100.16 100.81 11.7 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.785 -0.643 . . . . 74.450000000000003 109.285 175.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 745' ' ' LYS . . . . . 0.437 ' HB3' ' HE2' ' A' ' 745' ' ' LYS . 16.9 ptpt -120.76 152.81 37.84 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.238 -0.585 . . . . 71.010000000000005 111.116 -177.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 746' ' ' LEU . . . . . 0.554 HD22 ' HB2' ' A' ' 749' ' ' GLN . 51.9 tp -80.14 128.12 33.13 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.426 -0.806 . . . . 75.409999999999997 110.089 -178.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 56.4 t -90.46 -47.56 14.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.109 0.48 . . . . 73.400000000000006 109.879 178.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -154.75 149.35 26.4 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.771 -0.65 . . . . 75.099999999999994 110.331 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 749' ' ' GLN . . . . . 0.554 ' HB2' HD22 ' A' ' 746' ' ' LEU . 24.5 tt0 -125.19 106.64 10.04 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.509 -0.552 . . . . 73.099999999999994 109.509 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 56.7 m -141.86 178.18 7.68 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.658 0.266 . . . . 53.100000000000001 110.285 -178.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 117.52 172.61 16.04 Favored Glycine 0 N--CA 1.443 -0.899 0 C-N-CA 120.331 -0.938 . . . . 65.439999999999998 112.822 177.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 752' ' ' PRO . . . . . 0.714 ' HG2' ' HB2' ' A' ' 755' ' ' GLU . 34.3 Cg_endo -64.8 166.4 18.26 Favored 'Trans proline' 0 CA--C 1.529 0.272 0 C-N-CA 123.473 2.782 . . . . 71.109999999999999 112.752 178.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -65.44 -31.74 51.09 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.592 2.194 . . . . 70.409999999999997 112.534 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 754' ' ' HIS . . . . . 0.554 ' CD2' ' HG3' ' A' ' 755' ' ' GLU . 54.0 p-80 -83.02 -23.41 33.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.522 -0.308 . . . . 63.140000000000001 110.938 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 755' ' ' GLU . . . . . 0.714 ' HB2' ' HG2' ' A' ' 752' ' ' PRO . 45.8 mt-10 -132.24 78.07 69.39 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.445 -0.343 . . . . 72.409999999999997 111.503 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 756' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -68.12 105.86 1.26 Allowed 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 121.936 1.757 . . . . 74.0 110.73 172.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 757' ' ' LYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 774' ' ' ALA . 57.8 mtmt -92.8 108.67 20.17 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.733 0.777 . . . . 72.140000000000001 110.973 -175.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 758' ' ' PHE . . . . . 0.431 ' O ' ' HA ' ' A' ' 773' ' ' CYS . 89.4 m-85 -87.63 116.69 25.94 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.722 -1.127 . . . . 74.340000000000003 110.478 -178.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 21.5 t -84.28 101.39 8.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.468 -0.567 . . . . 71.049999999999997 109.468 176.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -106.48 145.56 31.65 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.048 -0.524 . . . . 73.409999999999997 111.113 -178.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -132.54 135.12 45.75 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.871 -0.604 . . . . 73.209999999999994 109.663 177.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 762' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 769' ' ' PHE . . . -89.89 110.82 21.74 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.804 -0.635 . . . . 71.439999999999998 110.421 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 763' ' ' LYS . . . . . 0.522 ' HB3' ' HB2' ' A' ' 743' ' ' GLU . 50.5 tttt -94.64 107.02 19.03 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.494 -0.775 . . . . 74.409999999999997 109.607 177.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 47.5 t -112.88 100.48 10.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 120.977 0.418 . . . . 72.239999999999995 110.844 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 68.86 22.59 75.68 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.731 -0.668 . . . . 73.140000000000001 112.74 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 99.8 -2.64 57.1 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.712 -0.756 . . . . 64.010000000000005 112.103 -178.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 767' ' ' ARG . . . . . . . . . . . . . 18.3 ttm180 -100.91 122.3 43.23 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.292 -0.633 . . . . 73.409999999999997 109.292 178.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 768' ' ' TRP . . . . . . . . . . . . . 42.4 m95 -99.31 100.08 11.11 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.407 -0.36 . . . . 74.200000000000003 110.765 -172.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 769' ' ' PHE . . . . . 0.447 ' HA ' ' HA ' ' A' ' 770' ' ' PRO . 25.9 p90 -166.5 136.25 2.52 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.331 -0.395 . . . . 74.099999999999994 110.419 -178.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 770' ' ' PRO . . . . . 0.723 ' HG3' ' HB2' ' A' ' 787' ' ' ALA . 68.5 Cg_endo -94.66 -173.31 4.31 Favored 'Cis proline' 0 N--CA 1.451 -0.974 0 C-N-CA 123.412 -1.495 . . . . 73.299999999999997 111.424 -4.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -122.52 107.83 12.46 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.33 -0.248 . . . . 45.329999999999998 110.33 175.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 29.1 m -130.35 167.28 25.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.533 -0.303 . . . . 74.209999999999994 111.195 -176.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 773' ' ' CYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 758' ' ' PHE . 17.7 p -132.78 145.12 50.73 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.458 -0.337 . . . . 71.450000000000003 110.573 178.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 774' ' ' ALA . . . . . 0.453 ' O ' ' HA ' ' A' ' 757' ' ' LYS . . . -146.2 154.52 41.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.432 -0.349 . . . . 75.030000000000001 110.544 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 775' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -75.4 -2.62 29.41 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.068 0.461 . . . . 73.219999999999999 111.458 -176.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 776' ' ' SER . . . . . 0.627 ' HB2' ' HG3' ' A' ' 779' ' ' GLN . 36.3 m -131.19 140.2 49.86 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.206 -0.665 . . . . 70.319999999999993 109.206 175.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 777' ' ' LYS . . . . . . . . . . . . . 6.1 tmmm? -61.12 -45.75 93.39 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 123.431 0.457 . . . . 75.200000000000003 111.274 -174.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 778' ' ' LYS . . . . . 0.424 ' HE2' ' OE1' ' A' ' 782' ' ' GLN . 87.9 tttt -64.56 -39.28 93.46 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.981 -0.288 . . . . 74.400000000000006 110.644 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 779' ' ' GLN . . . . . 0.627 ' HG3' ' HB2' ' A' ' 776' ' ' SER . 23.6 mt-30 -60.35 -39.38 86.94 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.658 -0.246 . . . . 63.450000000000003 110.563 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -60.51 -43.53 98.72 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.88 -0.676 . . . . 50.009999999999998 111.694 177.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 781' ' ' LYS . . . . . 0.412 ' HE3' ' CB ' ' A' ' 744' ' ' PHE . 50.6 mtpt -68.13 -40.55 82.44 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.735 0.302 . . . . 73.129999999999995 110.729 178.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 782' ' ' GLN . . . . . 0.424 ' OE1' ' HE2' ' A' ' 778' ' ' LYS . 26.6 mt-30 -62.04 -51.66 67.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.047 -0.524 . . . . 73.120000000000005 111.047 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -65.27 -33.92 77.12 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 123.063 0.227 . . . . 74.510000000000005 110.909 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -59.62 -53.86 53.11 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.893 -0.41 . . . . 74.430000000000007 109.893 175.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 785' ' ' ALA . . . . . 0.603 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -65.38 -40.01 92.97 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.18 -0.463 . . . . 75.150000000000006 110.897 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 786' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -54.28 -56.08 21.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.903 -0.59 . . . . 72.430000000000007 110.83 178.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 787' ' ' ALA . . . . . 0.723 ' HB2' ' HG3' ' A' ' 770' ' ' PRO . . . -65.7 -38.32 88.91 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.838 -0.619 . . . . 62.140000000000001 110.768 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 788' ' ' ALA . . . . . 0.584 ' O ' ' HG ' ' A' ' 792' ' ' LEU . . . -60.61 -45.8 92.65 Favored 'General case' 0 CA--C 1.521 -0.159 0 O-C-N 123.327 0.392 . . . . 74.420000000000002 111.23 -177.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 789' ' ' LEU . . . . . 0.603 ' HG ' ' O ' ' A' ' 785' ' ' ALA . 69.2 mt -58.86 -45.67 89.56 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 109.977 -0.379 . . . . 74.209999999999994 109.977 179.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 790' ' ' ARG . . . . . . . . . . . . . 78.6 mtt180 -65.07 -26.58 68.3 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.138 0.422 . . . . 74.420000000000002 112.138 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 791' ' ' VAL . . . . . 0.663 HG23 ' O ' ' A' ' 787' ' ' ALA . 60.1 t -66.5 -45.17 89.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 109.456 -0.572 . . . . 72.340000000000003 109.456 173.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 792' ' ' LEU . . . . . 0.584 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 18.2 mt -67.84 -44.82 76.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.221 -0.899 . . . . 72.319999999999993 110.188 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 793' ' ' ILE . . . . . 0.52 HD13 HG22 ' A' ' 720' ' ' VAL . 97.0 mt -58.38 -55.21 23.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.162 -0.926 . . . . 74.140000000000001 110.647 177.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -58.47 -40.51 94.45 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 121.14 -0.552 . . . . 62.219999999999999 112.244 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -55.98 -46.69 78.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.951 0.405 . . . . 72.310000000000002 110.218 178.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 6.5 t30 . . . . . 0 C--N 1.323 -0.562 0 CA-C-N 116.06 -0.518 . . . . 71.510000000000005 111.246 -175.268 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 716' ' ' ILE . . . . . 0.622 HG23 HG12 ' A' ' 793' ' ' ILE . 48.4 mm . . . . . 0 C--O 1.235 0.326 0 N-CA-C 112.316 0.488 . . . . 75.420000000000002 112.316 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -56.3 -31.41 59.49 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.009 -0.615 . . . . 74.329999999999998 112.12 178.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -72.01 -41.62 67.38 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.355 -0.239 . . . . 74.430000000000007 110.355 178.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 719' ' ' LEU . . . . . 0.548 HD23 ' HA ' ' A' ' 716' ' ' ILE . 3.0 mm? -62.79 -36.11 82.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.479 -0.328 . . . . 74.099999999999994 110.727 -179.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 720' ' ' VAL . . . . . 0.458 HG21 HD11 ' A' ' 793' ' ' ILE . 48.0 t -66.65 -39.03 82.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.118 0.485 . . . . 74.129999999999995 109.963 175.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 721' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.08 -35.03 74.28 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.871 -0.604 . . . . 70.129999999999995 110.172 177.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -74.32 -29.0 61.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.05 -0.523 . . . . 74.150000000000006 111.4 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 723' ' ' LEU . . . . . 0.516 HD23 ' HB2' ' A' ' 789' ' ' LEU . 51.0 mt -59.02 -39.35 81.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.856 0.36 . . . . 75.409999999999997 110.726 177.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -86.51 -17.37 34.29 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.108 -0.496 . . . . 74.129999999999995 111.341 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 16.3 m -108.37 -83.3 0.55 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.637 0.256 . . . . 60.229999999999997 111.421 -176.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 726' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -138.97 104.01 7.41 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.801 0.334 . . . . 70.439999999999998 110.373 -177.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 727' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -62.75 -41.4 30.89 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.758 2.305 . . . . 62.439999999999998 112.552 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 48.3 t -61.71 -46.07 97.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.275 -0.421 . . . . 74.310000000000002 110.659 -176.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -64.65 -32.64 84.87 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.868 -0.682 . . . . 74.099999999999994 112.0 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -72.45 -42.66 47.95 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 121.134 -0.555 . . . . 73.409999999999997 112.827 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -63.24 -41.06 99.03 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.623 -0.51 . . . . 71.420000000000002 109.623 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 732' ' ' LEU . . . . . 0.489 HD21 ' HB2' ' A' ' 742' ' ' ALA . 96.2 mt -64.83 -42.66 94.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.94 -0.573 . . . . 74.209999999999994 110.649 176.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 733' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -64.69 -42.64 95.17 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 116.201 -0.454 . . . . 64.430000000000007 110.802 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 734' ' ' TYR . . . . . 0.531 ' HB2' HD12 ' A' ' 719' ' ' LEU . 14.4 t80 -54.43 -53.18 57.59 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.349 -0.387 . . . . 74.430000000000007 110.621 176.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -62.73 -48.45 79.16 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.093 -0.503 . . . . 72.329999999999998 110.395 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 736' ' ' ARG . . . . . . . . . . . . . 62.3 ttt180 -54.96 -50.87 67.84 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.544 -0.753 . . . . 75.129999999999995 111.939 -178.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 18.1 t -73.95 -24.58 59.66 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.424 -0.353 . . . . 74.239999999999995 111.404 -175.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -94.7 -19.78 20.11 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.821 -0.352 . . . . 62.229999999999997 111.935 -175.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 104.39 14.0 25.07 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.17 -1.014 . . . . 37.579999999999998 112.837 177.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -101.81 166.29 10.74 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.816 -0.439 . . . . 64.230000000000004 109.816 175.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -110.14 126.43 54.06 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.708 -0.479 . . . . 64.310000000000002 109.708 173.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 742' ' ' ALA . . . . . 0.489 ' HB2' HD21 ' A' ' 732' ' ' LEU . . . -99.03 108.59 21.3 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.059 0.457 . . . . 72.239999999999995 110.361 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 743' ' ' GLU . . . . . 0.53 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 40.8 mt-10 -113.93 116.75 29.75 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.796 -0.638 . . . . 72.150000000000006 111.466 -176.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -93.28 121.62 34.84 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.679 -0.691 . . . . 75.209999999999994 109.401 176.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 745' ' ' LYS . . . . . 0.499 ' HB3' ' HZ3' ' A' ' 745' ' ' LYS . 0.5 OUTLIER -132.38 147.94 52.4 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.282 0.563 . . . . 74.450000000000003 111.663 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 746' ' ' LEU . . . . . 0.508 HD23 ' HB2' ' A' ' 749' ' ' GLN . 6.8 tt -86.87 108.09 18.61 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.143 -0.935 . . . . 63.039999999999999 108.992 177.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 49.0 t -82.56 -53.99 10.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.136 -0.484 . . . . 75.200000000000003 110.771 -176.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 748' ' ' ASP . . . . . 0.493 ' HB3' ' CG2' ' A' ' 759' ' ' VAL . 25.7 t70 -129.8 149.76 51.4 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.283 -0.417 . . . . 75.420000000000002 111.19 -176.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 749' ' ' GLN . . . . . 0.508 ' HB2' HD23 ' A' ' 746' ' ' LEU . 8.1 tt0 -145.84 100.07 3.36 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.514 -0.767 . . . . 64.530000000000001 108.971 177.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 10.0 t -144.98 -173.71 4.16 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.484 -0.326 . . . . 72.120000000000005 110.476 -174.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 100.77 -173.74 24.94 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.924 -0.655 . . . . 54.420000000000002 112.473 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 752' ' ' PRO . . . . . 0.671 ' HG2' ' HB2' ' A' ' 755' ' ' GLU . 52.8 Cg_endo -69.11 164.35 34.24 Favored 'Trans proline' 0 N--CA 1.465 -0.154 0 C-N-CA 122.908 2.406 . . . . 74.239999999999995 111.993 178.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -69.81 -34.68 13.93 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 122.469 2.112 . . . . 75.0 112.065 -177.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 35.2 p-80 -76.09 -26.81 56.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.174 -0.466 . . . . 73.430000000000007 110.936 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 755' ' ' GLU . . . . . 0.671 ' HB2' ' HG2' ' A' ' 752' ' ' PRO . 28.5 mm-40 -126.53 72.76 73.72 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.566 -0.288 . . . . 72.349999999999994 110.885 178.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 756' ' ' PRO . . . . . 0.511 ' O ' ' HA ' ' A' ' 775' ' ' HIS . 40.0 Cg_endo -68.82 113.66 3.29 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.222 1.948 . . . . 75.310000000000002 111.453 177.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 757' ' ' LYS . . . . . 0.404 ' HE3' ' HB3' ' A' ' 757' ' ' LYS . 1.5 tmmt? -89.51 112.4 23.56 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.322 0.582 . . . . 74.310000000000002 110.538 -176.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 758' ' ' PHE . . . . . 0.47 ' O ' ' HA ' ' A' ' 773' ' ' CYS . 79.0 m-85 -99.59 123.34 43.76 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.204 -0.907 . . . . 72.140000000000001 110.115 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 759' ' ' VAL . . . . . 0.493 ' CG2' ' HB3' ' A' ' 748' ' ' ASP . 48.6 t -98.4 106.6 18.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.564 -0.532 . . . . 71.439999999999998 109.564 175.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -105.61 141.05 37.74 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.005 -0.543 . . . . 74.319999999999993 110.691 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 761' ' ' GLN . . . . . 0.416 ' HA ' ' O ' ' A' ' 770' ' ' PRO . 33.7 tt0 -133.46 134.61 43.75 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.865 -0.607 . . . . 64.099999999999994 109.503 177.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 762' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 769' ' ' PHE . . . -92.9 117.08 29.65 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.25 0.548 . . . . 63.439999999999998 110.706 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 763' ' ' LYS . . . . . 0.595 ' HD2' ' CH2' ' A' ' 768' ' ' TRP . 54.7 tttm -93.77 103.53 15.66 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.681 -0.69 . . . . 73.150000000000006 109.893 177.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 61.7 t -109.01 101.58 12.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.136 0.493 . . . . 74.409999999999997 109.739 178.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 69.17 -115.69 6.63 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 110.955 -0.858 . . . . 71.010000000000005 110.955 -173.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -110.62 13.99 29.91 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.003 -0.618 . . . . 74.219999999999999 111.684 176.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 767' ' ' ARG . . . . . 0.605 ' HD2' ' CD1' ' A' ' 769' ' ' PHE . 0.6 OUTLIER -110.43 120.45 42.46 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.507 -0.553 . . . . 73.140000000000001 109.507 -179.766 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 768' ' ' TRP . . . . . 0.595 ' CH2' ' HD2' ' A' ' 763' ' ' LYS . 69.4 m95 -94.88 108.15 20.18 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.645 -0.502 . . . . 74.099999999999994 109.645 178.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 769' ' ' PHE . . . . . 0.605 ' CD1' ' HD2' ' A' ' 767' ' ' ARG . 9.8 p90 -168.86 139.9 2.01 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-O 120.838 0.351 . . . . 74.219999999999999 110.915 -178.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 770' ' ' PRO . . . . . 0.787 ' HD3' ' HB3' ' A' ' 788' ' ' ALA . 96.1 Cg_endo -98.4 -170.69 1.95 Allowed 'Cis proline' 0 N--CA 1.449 -1.121 0 C-N-CA 123.71 -1.371 . . . . 63.140000000000001 111.677 -3.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -114.81 104.29 11.8 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.518 -0.549 . . . . 63.329999999999998 109.518 174.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 33.5 m -118.94 161.97 17.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.303 -0.408 . . . . 73.239999999999995 110.846 -176.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 773' ' ' CYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 758' ' ' PHE . 8.8 p -137.0 141.91 42.53 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.249 -0.432 . . . . 60.240000000000002 110.425 177.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -149.53 161.15 42.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.054 -0.521 . . . . 71.430000000000007 109.829 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 775' ' ' HIS . . . . . 0.511 ' HA ' ' O ' ' A' ' 756' ' ' PRO . 0.8 OUTLIER -87.14 -0.75 57.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.251 0.548 . . . . 73.120000000000005 110.889 179.501 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 51.1 m -134.04 135.16 43.16 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.634 -0.712 . . . . 71.010000000000005 109.292 175.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 777' ' ' LYS . . . . . . . . . . . . . 25.4 ttmt -57.24 -48.82 77.89 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.103 -0.499 . . . . 71.239999999999995 111.448 -175.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -57.95 -38.59 76.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.848 -0.614 . . . . 64.140000000000001 110.822 -177.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 779' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -68.25 -37.88 81.24 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-N 116.36 -0.382 . . . . 74.109999999999999 110.146 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -60.5 -47.17 92.48 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.827 -0.701 . . . . 43.340000000000003 111.881 178.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -62.55 -44.79 95.47 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.746 0.308 . . . . 75.439999999999998 110.649 177.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -62.37 -50.43 71.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.056 -0.52 . . . . 72.340000000000003 111.206 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -60.09 -36.57 77.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.298 -0.41 . . . . 72.439999999999998 111.445 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -60.05 -55.08 38.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.871 0.367 . . . . 74.510000000000005 110.373 177.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 785' ' ' ALA . . . . . 0.64 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -63.09 -41.81 99.47 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.134 -0.485 . . . . 75.439999999999998 110.897 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 786' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -56.83 -54.88 41.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.546 -0.752 . . . . 73.319999999999993 110.934 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 787' ' ' ALA . . . . . 0.459 ' O ' HG21 ' A' ' 791' ' ' VAL . . . -65.29 -35.09 79.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.832 -0.622 . . . . 75.450000000000003 111.254 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 788' ' ' ALA . . . . . 0.787 ' HB3' ' HD3' ' A' ' 770' ' ' PRO . . . -64.64 -35.64 81.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.313 -0.403 . . . . 63.549999999999997 111.391 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 789' ' ' LEU . . . . . 0.64 ' HG ' ' O ' ' A' ' 785' ' ' ALA . 59.1 mt -64.66 -42.04 95.69 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 121.048 -0.261 . . . . 75.329999999999998 110.445 -179.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 790' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.67 -31.71 72.65 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 120.734 -0.386 . . . . 75.310000000000002 111.207 177.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 791' ' ' VAL . . . . . 0.459 HG21 ' O ' ' A' ' 787' ' ' ALA . 57.2 t -61.67 -51.89 67.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.104 0.478 . . . . 71.510000000000005 109.773 175.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 792' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 32.9 mt -61.84 -47.53 84.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.349 -0.842 . . . . 75.420000000000002 110.83 -178.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 793' ' ' ILE . . . . . 0.622 HG12 HG23 ' A' ' 716' ' ' ILE . 95.9 mt -58.8 -56.26 17.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.521 -0.763 . . . . 73.549999999999997 111.24 179.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -60.79 -37.69 94.05 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 121.079 -0.582 . . . . 62.049999999999997 112.321 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -63.25 -44.0 96.41 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.905 0.383 . . . . 73.400000000000006 110.734 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 . . . . . 0 C--N 1.33 -0.275 0 CA-C-O 120.909 0.385 . . . . 72.510000000000005 110.822 -177.299 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 716' ' ' ILE . . . . . 0.538 ' HA ' HD23 ' A' ' 719' ' ' LEU . 46.8 mm . . . . . 0 N--CA 1.454 -0.245 0 CA-C-O 120.73 0.3 . . . . 75.140000000000001 111.489 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -59.95 -24.87 61.04 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.97 -0.633 . . . . 64.150000000000006 112.112 176.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 718' ' ' GLU . . . . . 0.671 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 47.1 mt-10 -76.85 -38.73 53.18 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 122.787 -0.243 . . . . 75.120000000000005 110.658 177.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 719' ' ' LEU . . . . . 0.538 HD23 ' HA ' ' A' ' 716' ' ' ILE . 3.1 mm? -61.38 -32.98 72.92 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.155 0.502 . . . . 72.430000000000007 109.769 176.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 720' ' ' VAL . . . . . 0.485 HG21 HD11 ' A' ' 793' ' ' ILE . 58.1 t -68.4 -38.49 79.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.809 -0.632 . . . . 74.239999999999995 110.757 175.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 721' ' ' ARG . . . . . 0.671 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 4.4 ptm180 -64.74 -28.2 69.43 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 109.841 -0.429 . . . . 74.129999999999995 109.841 179.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -73.12 -31.9 64.61 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 116.312 -0.404 . . . . 74.430000000000007 110.782 177.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 723' ' ' LEU . . . . . 0.52 HD21 ' HB2' ' A' ' 789' ' ' LEU . 98.1 mt -62.24 -28.67 69.87 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.407 0.622 . . . . 72.329999999999998 110.033 174.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -90.81 -15.07 30.7 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.492 -0.776 . . . . 71.319999999999993 111.234 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 11.1 m -118.69 -73.48 0.64 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.856 0.36 . . . . 75.150000000000006 111.666 -175.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 726' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -149.13 101.58 3.37 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.174 -0.467 . . . . 73.329999999999998 110.112 -177.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 727' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -61.87 -40.33 45.16 Favored 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 122.906 2.404 . . . . 63.350000000000001 112.115 -178.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 57.5 t -62.21 -45.32 99.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.096 -0.502 . . . . 70.200000000000003 110.809 -178.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -65.49 -35.15 90.93 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.664 -0.779 . . . . 72.239999999999995 111.669 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -70.17 -41.58 69.29 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 121.073 -0.584 . . . . 74.230000000000004 112.573 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -65.48 -43.3 90.66 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.989 -0.374 . . . . 73.329999999999998 109.989 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 732' ' ' LEU . . . . . . . . . . . . . 96.8 mt -66.17 -38.07 87.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.244 -0.435 . . . . 71.140000000000001 110.745 178.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 733' ' ' GLU . . . . . 0.452 ' O ' ' HG2' ' A' ' 736' ' ' ARG . 1.8 tp10 -66.14 -43.99 85.44 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 116.325 -0.398 . . . . 73.010000000000005 110.355 177.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 734' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -53.47 -48.66 68.67 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.141 -0.481 . . . . 71.439999999999998 110.658 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 735' ' ' ALA . . . . . 0.434 ' HB3' ' HB1' ' A' ' 742' ' ' ALA . . . -65.62 -50.22 65.83 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.232 -0.44 . . . . 71.530000000000001 110.927 -177.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 736' ' ' ARG . . . . . 0.452 ' HG2' ' O ' ' A' ' 733' ' ' GLU . 33.8 ptt180 -64.35 -31.48 72.7 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.11 0.481 . . . . 64.450000000000003 110.914 -175.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 28.8 t -78.07 -29.12 49.02 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.599 -0.728 . . . . 71.340000000000003 111.451 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -101.13 -3.09 29.84 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 111.885 0.328 . . . . 74.430000000000007 111.885 -173.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 90.98 12.88 59.79 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.407 -0.901 . . . . 72.340000000000003 112.675 177.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -95.98 169.36 10.03 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.791 0.329 . . . . 75.109999999999999 110.165 175.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -121.68 105.81 10.76 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.284 -0.636 . . . . 72.140000000000001 109.284 175.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 742' ' ' ALA . . . . . 0.434 ' HB1' ' HB3' ' A' ' 735' ' ' ALA . . . -90.4 122.55 33.37 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.311 -0.404 . . . . 74.319999999999993 111.454 -174.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 743' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -127.79 166.13 18.78 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.782 -0.644 . . . . 75.430000000000007 110.698 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -134.25 108.8 8.45 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.961 -0.563 . . . . 73.439999999999998 109.996 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -110.84 148.55 32.16 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.007 0.432 . . . . 74.209999999999994 111.155 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 746' ' ' LEU . . . . . 0.426 HD11 ' CD1' ' A' ' 758' ' ' PHE . 6.1 tt -87.58 106.82 18.27 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.384 -0.969 . . . . 72.25 108.384 174.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 54.0 t -83.16 -53.06 12.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.982 -0.554 . . . . 71.319999999999993 110.938 -174.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -128.39 146.01 50.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.083 -0.508 . . . . 63.210000000000001 110.798 -176.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -132.7 93.59 3.25 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.284 0.564 . . . . 73.439999999999998 110.026 176.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 20.6 m -104.64 82.36 1.89 Allowed 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.242 -1.021 . . . . 64.040000000000006 108.242 173.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 751' ' ' GLY . . . . . 0.588 ' CA ' ' HA ' ' A' ' 756' ' ' PRO . . . -127.39 94.74 0.41 Allowed Glycine 0 N--CA 1.439 -1.101 0 C-N-CA 119.92 -1.133 . . . . 75.0 114.278 -170.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 752' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.95 165.61 11.85 Favored 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 122.474 2.116 . . . . 54.399999999999999 110.225 164.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -58.54 -36.51 97.26 Favored 'Trans proline' 0 CA--C 1.528 0.191 0 C-N-CA 122.109 1.873 . . . . 73.420000000000002 112.495 -177.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 49.9 p-80 -82.28 -25.01 34.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.364 -0.38 . . . . 71.129999999999995 111.644 -177.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -141.06 74.31 25.48 Favored Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 112.043 0.386 . . . . 74.040000000000006 112.043 -176.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 756' ' ' PRO . . . . . 0.588 ' HA ' ' CA ' ' A' ' 751' ' ' GLY . 52.3 Cg_endo -72.23 84.84 1.09 Allowed 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.0 1.8 . . . . 53.020000000000003 111.632 175.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 757' ' ' LYS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 775' ' ' HIS . 27.4 ttpp -91.58 113.69 26.03 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.545 0.688 . . . . 74.099999999999994 111.247 -174.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 758' ' ' PHE . . . . . 0.446 ' O ' ' HA ' ' A' ' 773' ' ' CYS . 60.9 m-85 -99.44 144.77 28.16 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.286 -0.87 . . . . 71.519999999999996 110.171 -178.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 759' ' ' VAL . . . . . 0.429 HG22 ' HB3' ' A' ' 773' ' ' CYS . 47.7 t -109.57 112.13 39.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.996 -0.372 . . . . 70.519999999999996 109.996 176.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -107.27 138.14 44.0 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.263 -0.426 . . . . 71.329999999999998 110.517 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 761' ' ' GLN . . . . . 0.422 ' HA ' ' O ' ' A' ' 770' ' ' PRO . 62.2 tt0 -125.5 135.48 52.34 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.916 -0.583 . . . . 75.430000000000007 109.432 177.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 762' ' ' ALA . . . . . 0.51 ' HB2' ' O ' ' A' ' 769' ' ' PHE . . . -91.52 119.5 31.52 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.252 0.549 . . . . 74.019999999999996 110.586 -178.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -98.16 97.28 8.73 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.713 -0.676 . . . . 72.430000000000007 109.339 177.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 764' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 742' ' ' ALA . 57.7 t -99.9 98.3 6.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.125 0.488 . . . . 72.530000000000001 109.854 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 68.54 -108.03 2.31 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 110.743 -0.943 . . . . 37.649999999999999 110.743 -175.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -114.72 9.4 21.63 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.626 -0.797 . . . . 71.409999999999997 111.821 176.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 767' ' ' ARG . . . . . 0.571 ' HD2' ' CD1' ' A' ' 769' ' ' PHE . 0.2 OUTLIER -107.65 120.69 42.92 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.93 -0.396 . . . . 73.349999999999994 109.93 -178.615 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 768' ' ' TRP . . . . . . . . . . . . . 58.6 m95 -94.3 110.91 22.63 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.158 -0.474 . . . . 75.420000000000002 109.857 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 769' ' ' PHE . . . . . 0.571 ' CD1' ' HD2' ' A' ' 767' ' ' ARG . 15.7 p90 -174.76 138.32 0.62 Allowed Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 120.692 0.282 . . . . 64.239999999999995 110.65 -179.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 770' ' ' PRO . . . . . 0.733 ' HD3' ' HB3' ' A' ' 788' ' ' ALA . 69.7 Cg_endo -99.15 -170.25 1.6 Allowed 'Cis proline' 0 N--CA 1.449 -1.14 0 C-N-CA 123.675 -1.386 . . . . 71.010000000000005 111.164 -6.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -121.14 105.52 10.68 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.797 -0.445 . . . . 74.120000000000005 109.797 174.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 35.3 m -121.32 160.29 22.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.487 -0.324 . . . . 75.109999999999999 111.006 -176.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 773' ' ' CYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 758' ' ' PHE . 20.2 p -126.01 145.81 50.15 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.073 -0.512 . . . . 74.450000000000003 110.565 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -158.14 146.86 19.06 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.22 -0.445 . . . . 75.519999999999996 110.226 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 775' ' ' HIS . . . . . 0.532 ' HA ' ' O ' ' A' ' 756' ' ' PRO . 1.4 p-80 -78.95 17.4 0.74 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.147 0.499 . . . . 70.420000000000002 111.538 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 42.4 t -142.84 130.62 21.51 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.994 -0.743 . . . . 74.519999999999996 108.994 175.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 777' ' ' LYS . . . . . 0.441 ' HD2' ' C ' ' A' ' 777' ' ' LYS . 5.3 tmmm? -58.34 -42.68 87.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.864 0.364 . . . . 74.239999999999995 110.125 -178.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -58.12 -46.99 84.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.62 -0.718 . . . . 64.329999999999998 110.542 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 779' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -62.52 -41.82 99.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.914 -0.584 . . . . 70.25 110.717 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -56.35 -43.83 89.77 Favored Glycine 0 C--N 1.329 0.187 0 C-N-CA 121.161 -0.543 . . . . 63.340000000000003 112.398 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -71.93 -43.79 64.71 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.699 0.285 . . . . 74.510000000000005 111.046 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -66.42 -45.63 79.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.222 -0.445 . . . . 75.120000000000005 111.505 -176.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -66.67 -33.87 76.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.709 0.29 . . . . 73.310000000000002 110.686 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -60.56 -52.04 66.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.347 -0.388 . . . . 74.310000000000002 110.177 177.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 785' ' ' ALA . . . . . 0.574 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -65.4 -38.59 90.45 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.167 -0.469 . . . . 73.230000000000004 110.744 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 786' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -59.9 -51.07 71.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.919 -0.582 . . . . 75.310000000000002 110.852 178.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 787' ' ' ALA . . . . . 0.557 ' HA ' ' HD2' ' A' ' 790' ' ' ARG . . . -67.85 -35.8 79.2 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.071 -0.513 . . . . 63.25 111.039 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 788' ' ' ALA . . . . . 0.733 ' HB3' ' HD3' ' A' ' 770' ' ' PRO . . . -60.96 -41.05 95.59 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.361 -0.382 . . . . 74.209999999999994 111.032 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 789' ' ' LEU . . . . . 0.574 ' HG ' ' O ' ' A' ' 785' ' ' ALA . 75.9 mt -64.23 -40.36 95.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.406 -0.361 . . . . 72.109999999999999 110.21 178.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 790' ' ' ARG . . . . . 0.557 ' HD2' ' HA ' ' A' ' 787' ' ' ALA . 84.9 mtt180 -60.01 -35.06 74.25 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.501 -0.318 . . . . 63.439999999999998 111.209 177.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 791' ' ' VAL . . . . . 0.46 HG21 ' O ' ' A' ' 787' ' ' ALA . 62.1 t -61.5 -50.53 79.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.249 0.547 . . . . 65.420000000000002 109.898 175.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 792' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 23.7 mt -61.98 -47.88 82.84 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.395 -0.82 . . . . 72.230000000000004 110.743 -179.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 793' ' ' ILE . . . . . 0.485 HD11 HG21 ' A' ' 720' ' ' VAL . 95.8 mt -59.85 -45.36 94.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.481 -0.781 . . . . 75.230000000000004 110.904 178.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -68.32 -33.8 78.57 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.833 -0.699 . . . . 71.0 112.703 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -70.66 -41.09 72.54 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.902 0.382 . . . . 74.109999999999999 110.642 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 5.4 t30 . . . . . 0 C--N 1.325 -0.46 0 C-N-CA 120.786 -0.366 . . . . 63.039999999999999 110.188 179.326 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 716' ' ' ILE . . . . . 0.506 ' HA ' HD23 ' A' ' 719' ' ' LEU . 42.1 mm . . . . . 0 C--O 1.233 0.222 0 CA-C-O 120.852 0.358 . . . . 73.310000000000002 110.85 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -60.63 -26.1 64.28 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 121.008 -0.615 . . . . 73.329999999999998 112.014 175.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 718' ' ' GLU . . . . . 0.789 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 9.0 mm-40 -68.75 -34.39 75.51 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-O 120.543 0.211 . . . . 72.319999999999993 110.551 178.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 719' ' ' LEU . . . . . 0.506 HD23 ' HA ' ' A' ' 716' ' ' ILE . 2.7 mm? -69.04 -29.25 67.37 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.522 -0.471 . . . . 73.010000000000005 109.917 177.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 720' ' ' VAL . . . . . 0.433 HG21 HD13 ' A' ' 793' ' ' ILE . 60.3 t -67.52 -40.96 85.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.844 -0.616 . . . . 74.430000000000007 110.804 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 721' ' ' ARG . . . . . 0.789 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 12.9 ptm180 -64.86 -29.92 70.9 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.4 -0.364 . . . . 72.209999999999994 110.249 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -71.83 -35.48 69.9 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-N 116.341 -0.39 . . . . 73.420000000000002 110.69 177.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 723' ' ' LEU . . . . . 0.526 HD21 ' HB2' ' A' ' 789' ' ' LEU . 82.0 mt -56.3 -30.68 62.84 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.138 0.494 . . . . 73.340000000000003 110.407 175.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -83.86 -55.37 4.28 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.835 -0.62 . . . . 75.120000000000005 110.935 176.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 27.2 m -75.44 -73.06 0.27 Allowed 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.119 0.414 . . . . 74.230000000000004 112.119 -176.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 726' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -148.49 100.31 3.56 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 120.804 0.335 . . . . 64.219999999999999 110.633 -175.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 727' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -61.7 -39.97 49.39 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.021 2.481 . . . . 61.340000000000003 112.667 -176.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 30.1 t -59.24 -47.88 88.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.008 -0.542 . . . . 72.5 110.787 -176.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -65.66 -31.35 79.7 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.86 -0.609 . . . . 54.119999999999997 111.812 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -68.24 -41.73 85.33 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.903 -0.665 . . . . 64.439999999999998 112.269 178.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -65.04 -41.29 95.35 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.526 -0.546 . . . . 73.120000000000005 109.526 178.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 732' ' ' LEU . . . . . . . . . . . . . 83.8 mt -68.79 -31.55 70.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.88 -0.6 . . . . 75.099999999999994 110.99 178.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 733' ' ' GLU . . . . . 0.481 ' O ' ' HG2' ' A' ' 736' ' ' ARG . 0.7 OUTLIER -73.28 -43.54 60.83 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 116.165 -0.471 . . . . 72.510000000000005 110.392 178.901 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 734' ' ' TYR . . . . . 0.449 ' HB2' HD12 ' A' ' 719' ' ' LEU . 7.6 t80 -55.45 -46.41 76.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.978 -0.556 . . . . 74.450000000000003 110.615 176.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -64.78 -48.12 75.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.923 -0.581 . . . . 73.319999999999993 111.095 -178.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 736' ' ' ARG . . . . . 0.481 ' HG2' ' O ' ' A' ' 733' ' ' GLU . 11.3 ptt180 -64.54 -35.74 81.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.009 0.433 . . . . 70.209999999999994 111.078 -175.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 48.4 t -74.2 -35.06 63.9 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.013 -0.539 . . . . 75.310000000000002 111.036 -178.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -89.0 -32.02 17.82 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.286 -0.415 . . . . 74.129999999999995 111.803 -174.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 112.45 22.07 5.94 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.47 -0.872 . . . . 61.32 112.013 -178.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -99.51 169.99 8.92 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.869 0.366 . . . . 65.120000000000005 110.543 176.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -117.25 111.49 19.48 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.457 -0.572 . . . . 71.450000000000003 109.457 174.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 742' ' ' ALA . . . . . . . . . . . . . . . -94.58 130.26 41.09 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.909 0.385 . . . . 73.239999999999995 111.464 -175.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 743' ' ' GLU . . . . . 0.55 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 49.5 mt-10 -132.98 140.52 47.82 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.959 -0.564 . . . . 74.310000000000002 110.738 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -114.94 100.28 8.08 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.195 -0.668 . . . . 65.549999999999997 109.195 174.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 745' ' ' LYS . . . . . 0.468 ' HE2' ' HB3' ' A' ' 745' ' ' LYS . 14.4 ptpt -121.45 144.11 48.87 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.495 0.664 . . . . 72.439999999999998 111.909 -175.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 746' ' ' LEU . . . . . . . . . . . . . 6.6 tt -78.91 112.59 16.25 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.824 -1.08 . . . . 71.109999999999999 109.509 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 61.3 t -80.18 -50.01 18.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.985 0.422 . . . . 60.399999999999999 110.634 -178.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -155.56 148.93 24.88 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.929 -0.578 . . . . 62.549999999999997 110.252 -178.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 749' ' ' GLN . . . . . 0.421 ' O ' ' HG3' ' A' ' 749' ' ' GLN . 10.5 pt20 -133.69 108.59 8.62 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.194 0.521 . . . . 72.310000000000002 110.281 172.292 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 18.6 m -131.47 78.63 1.84 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.905 -0.588 . . . . 64.219999999999999 110.236 178.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . -139.24 150.31 21.21 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.658 -0.782 . . . . 74.230000000000004 112.138 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 752' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -62.67 160.55 32.04 Favored 'Trans proline' 0 CA--C 1.528 0.197 0 C-N-CA 123.019 2.479 . . . . 71.409999999999997 111.976 178.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -57.45 -34.63 98.29 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.797 2.332 . . . . 72.519999999999996 112.897 -178.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 47.9 p-80 -83.89 -15.91 46.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.268 -0.424 . . . . 75.420000000000002 111.357 -177.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -149.18 70.98 10.09 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.455 -0.339 . . . . 74.219999999999999 110.73 -177.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 756' ' ' PRO . . . . . 0.5 ' O ' ' HA ' ' A' ' 775' ' ' HIS . 51.8 Cg_exo -54.81 146.59 55.1 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.738 2.292 . . . . 72.450000000000003 112.176 178.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 757' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -129.96 113.33 14.46 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.254 -0.43 . . . . 72.420000000000002 109.911 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 758' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -112.74 117.54 32.49 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.799 -0.637 . . . . 72.129999999999995 110.79 -177.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 30.9 t -85.14 101.39 9.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.92 -0.582 . . . . 72.420000000000002 109.543 175.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -106.05 136.91 44.89 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.67 -0.695 . . . . 74.150000000000006 110.483 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 761' ' ' GLN . . . . . 0.504 ' HA ' ' O ' ' A' ' 770' ' ' PRO . 30.0 tt0 -135.18 131.95 37.37 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.749 -0.659 . . . . 72.150000000000006 110.033 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 762' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 769' ' ' PHE . . . -89.17 122.19 32.21 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.892 -0.594 . . . . 63.130000000000003 110.636 -178.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 763' ' ' LYS . . . . . 0.55 ' HB3' ' HB2' ' A' ' 743' ' ' GLU . 61.5 tttm -97.62 105.54 17.71 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.622 -0.717 . . . . 74.120000000000005 109.512 178.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 59.8 t -108.93 98.59 7.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.098 0.475 . . . . 72.040000000000006 109.792 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 70.72 -107.76 2.26 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 111.26 -0.736 . . . . 38.479999999999997 111.26 -176.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -109.6 1.05 30.65 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.743 -0.741 . . . . 73.040000000000006 112.068 177.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 767' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -102.75 138.74 39.24 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.16 0.505 . . . . 72.019999999999996 111.373 -177.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 768' ' ' TRP . . . . . 0.433 ' CH2' ' HD2' ' A' ' 763' ' ' LYS . 80.4 m95 -108.64 108.76 19.75 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.521 -0.763 . . . . 74.25 109.39 175.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 769' ' ' PHE . . . . . 0.416 ' O ' ' HB3' ' A' ' 762' ' ' ALA . 31.6 p90 -168.99 138.9 1.81 Allowed Pre-proline 0 C--N 1.322 -0.613 0 CA-C-O 120.946 0.403 . . . . 71.230000000000004 110.497 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 770' ' ' PRO . . . . . 0.656 ' HD3' ' HB1' ' A' ' 788' ' ' ALA . 59.7 Cg_endo -97.99 -175.64 3.95 Favored 'Cis proline' 0 N--CA 1.451 -1.028 0 C-N-CA 123.454 -1.478 . . . . 74.400000000000006 111.768 -4.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -110.9 106.54 15.7 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.605 -0.517 . . . . 75.530000000000001 109.605 173.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 30.0 m -114.52 146.49 18.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.018 0.437 . . . . 50.329999999999998 111.409 -177.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 5.7 p -111.98 95.87 5.72 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.792 -0.64 . . . . 72.450000000000003 109.847 178.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -94.18 166.73 11.97 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.05 -0.523 . . . . 75.340000000000003 111.776 -174.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 775' ' ' HIS . . . . . 0.5 ' HA ' ' O ' ' A' ' 756' ' ' PRO . 32.6 m-70 -91.84 -4.3 55.0 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.722 -0.672 . . . . 72.409999999999997 110.853 -178.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 63.5 p -159.13 173.58 16.19 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.693 -0.484 . . . . 73.430000000000007 109.693 176.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 777' ' ' LYS . . . . . 0.687 ' HE2' ' HD2' ' A' ' 781' ' ' LYS . 31.4 tttt -65.83 -52.51 49.89 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.709 0.263 . . . . 70.340000000000003 111.709 -176.206 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 51.9 tttp -63.5 -37.79 88.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.466 -0.334 . . . . 51.329999999999998 110.636 -174.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 779' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -60.61 -39.15 87.14 Favored 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 109.852 -0.425 . . . . 74.150000000000006 109.852 175.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -61.91 -48.49 83.35 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.991 -0.623 . . . . 75.25 112.061 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 781' ' ' LYS . . . . . 0.687 ' HD2' ' HE2' ' A' ' 777' ' ' LYS . 8.2 mtpm? -62.59 -38.25 89.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.652 0.263 . . . . 72.219999999999999 111.04 178.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -73.17 -50.54 22.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.539 -0.301 . . . . 74.409999999999997 111.316 -178.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -60.67 -38.4 84.78 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.67 0.271 . . . . 73.519999999999996 110.974 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -60.11 -51.2 70.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 74.150000000000006 110.146 177.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 785' ' ' ALA . . . . . 0.595 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -66.39 -41.72 88.94 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.252 -0.431 . . . . 61.520000000000003 110.923 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 786' ' ' ASP . . . . . 0.432 ' O ' ' HD3' ' A' ' 790' ' ' ARG . 9.9 t0 -56.34 -57.49 12.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.903 -0.59 . . . . 73.129999999999995 110.082 179.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 787' ' ' ALA . . . . . 0.637 ' HB1' ' HG3' ' A' ' 770' ' ' PRO . . . -64.77 -33.39 75.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.695 -0.684 . . . . 71.409999999999997 111.196 -178.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 788' ' ' ALA . . . . . 0.656 ' HB1' ' HD3' ' A' ' 770' ' ' PRO . . . -64.64 -44.47 90.38 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 123.174 0.296 . . . . 74.450000000000003 110.937 179.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 789' ' ' LEU . . . . . 0.595 ' HG ' ' O ' ' A' ' 785' ' ' ALA . 80.0 mt -61.35 -40.34 93.92 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.742 -0.466 . . . . 71.319999999999993 109.742 178.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 790' ' ' ARG . . . . . 0.432 ' HD3' ' O ' ' A' ' 786' ' ' ASP . 13.0 mtp180 -59.54 -35.34 74.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.032 -0.531 . . . . 72.430000000000007 111.162 176.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 791' ' ' VAL . . . . . 0.58 HG22 ' O ' ' A' ' 787' ' ' ALA . 54.3 t -66.19 -52.09 51.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 109.753 -0.462 . . . . 72.219999999999999 109.753 175.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 792' ' ' LEU . . . . . 0.612 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 31.3 mt -57.23 -49.09 77.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.647 -0.706 . . . . 75.540000000000006 110.575 -178.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 793' ' ' ILE . . . . . 0.433 HD13 HG21 ' A' ' 720' ' ' VAL . 94.2 mt -60.02 -51.46 72.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.414 -0.812 . . . . 74.340000000000003 110.734 177.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -61.83 -40.53 98.96 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 121.014 -0.612 . . . . 73.239999999999995 112.697 -178.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -60.29 -53.17 60.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.375 0.131 . . . . 73.209999999999994 111.24 178.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 . . . . . 0 C--N 1.326 -0.427 0 CA-C-O 120.928 0.394 . . . . 72.439999999999998 111.08 -176.189 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 716' ' ' ILE . . . . . 0.746 HG23 HG12 ' A' ' 793' ' ' ILE . 25.8 mm . . . . . 0 N--CA 1.452 -0.338 0 N-CA-C 111.961 0.356 . . . . 73.329999999999998 111.961 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -57.17 -28.69 58.93 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.959 -0.639 . . . . 74.420000000000002 112.293 176.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 718' ' ' GLU . . . . . 0.716 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 9.2 mm-40 -70.59 -36.42 73.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.841 0.353 . . . . 75.200000000000003 110.289 178.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 719' ' ' LEU . . . . . 0.54 HD21 ' HA ' ' A' ' 716' ' ' ILE . 3.2 mm? -66.86 -32.23 73.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.17 0.509 . . . . 70.239999999999995 109.864 177.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 720' ' ' VAL . . . . . 0.421 HG22 HD11 ' A' ' 793' ' ' ILE . 61.0 t -68.81 -34.81 66.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.696 -0.684 . . . . 74.310000000000002 110.636 177.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 721' ' ' ARG . . . . . 0.716 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 21.5 ptt180 -63.47 -28.93 70.3 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.261 0.553 . . . . 71.120000000000005 109.643 178.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -77.76 -30.79 51.69 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.908 -0.587 . . . . 74.040000000000006 111.392 178.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 723' ' ' LEU . . . . . 0.503 HD22 ' HB2' ' A' ' 789' ' ' LEU . 92.9 mt -58.18 -33.56 69.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.146 0.498 . . . . 73.150000000000006 110.052 175.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -82.83 -44.28 15.66 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.491 -0.777 . . . . 64.109999999999999 110.887 176.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 8.2 m -84.22 -79.82 0.21 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.358 -0.383 . . . . 65.450000000000003 111.46 -175.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 726' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 -148.08 109.58 3.73 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 109.768 -0.456 . . . . 71.120000000000005 109.768 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 727' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -63.06 -33.79 72.32 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.826 2.35 . . . . 75.420000000000002 112.467 -178.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 59.7 t -63.39 -48.45 87.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.044 0.45 . . . . 73.030000000000001 110.183 -178.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -66.03 -24.55 71.76 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.668 -0.696 . . . . 71.5 111.881 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -79.1 -39.15 20.58 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 121.149 -0.548 . . . . 72.109999999999999 112.644 178.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -65.35 -41.83 93.47 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.576 -0.527 . . . . 75.439999999999998 109.576 178.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 732' ' ' LEU . . . . . 0.437 HD22 ' HB3' ' A' ' 742' ' ' ALA . 90.0 mt -64.13 -37.77 88.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.83 -0.623 . . . . 71.439999999999998 110.193 175.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 733' ' ' GLU . . . . . 0.537 ' O ' ' HG2' ' A' ' 736' ' ' ARG . 4.1 tp10 -65.18 -49.45 69.74 Favored 'General case' 0 N--CA 1.437 -1.12 0 C-N-CA 123.423 0.689 . . . . 74.109999999999999 110.857 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 734' ' ' TYR . . . . . 0.514 ' HB2' HD12 ' A' ' 719' ' ' LEU . 11.0 t80 -54.7 -48.13 72.82 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.634 -0.712 . . . . 73.209999999999994 110.716 178.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -67.14 -47.93 69.6 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.88 -0.6 . . . . 75.230000000000004 111.22 -177.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 736' ' ' ARG . . . . . 0.537 ' HG2' ' O ' ' A' ' 733' ' ' GLU . 18.5 ptt180 -61.99 -32.95 73.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.997 0.427 . . . . 61.229999999999997 111.314 -175.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 44.6 t -80.3 -36.87 33.75 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.075 -0.511 . . . . 75.450000000000003 110.981 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -91.81 -2.35 56.95 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.105 0.409 . . . . 65.209999999999994 112.105 -172.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 89.47 13.37 61.57 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.61 -0.805 . . . . 74.439999999999998 112.936 175.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -97.93 157.89 15.84 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.849 0.357 . . . . 65.219999999999999 110.691 177.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -102.42 114.85 29.4 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.519 -0.548 . . . . 63.25 109.519 175.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 742' ' ' ALA . . . . . 0.437 ' HB3' HD22 ' A' ' 732' ' ' LEU . . . -92.38 114.81 27.46 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 123.237 0.336 . . . . 74.519999999999996 111.021 -177.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 743' ' ' GLU . . . . . 0.416 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 47.1 mt-10 -126.68 132.74 51.1 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.3 -0.409 . . . . 65.430000000000007 110.966 -178.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -106.14 100.76 10.28 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.181 -0.463 . . . . 75.310000000000002 110.292 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 745' ' ' LYS . . . . . 0.4 ' HE3' ' HZ3' ' A' ' 768' ' ' TRP . 10.4 ptpt -103.72 140.89 37.0 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.171 0.51 . . . . 71.450000000000003 111.204 -179.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 746' ' ' LEU . . . . . . . . . . . . . 6.6 tt -86.42 110.01 19.43 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.303 -0.999 . . . . 72.219999999999999 108.303 175.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 40.4 t -74.88 -53.88 15.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.077 -0.51 . . . . 74.120000000000005 110.347 -176.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -157.04 155.19 30.76 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.991 -0.55 . . . . 74.120000000000005 109.53 -178.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -139.62 96.81 3.14 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.514 0.673 . . . . 74.019999999999996 110.974 177.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 34.0 t -89.73 101.85 14.55 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.548 -0.908 . . . . 63.240000000000002 108.548 174.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 751' ' ' GLY . . . . . 0.598 ' HA2' ' HA ' ' A' ' 756' ' ' PRO . . . -120.25 81.17 0.33 Allowed Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.172 -1.013 . . . . 54.409999999999997 113.671 -173.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 752' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -64.59 160.24 40.95 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.169 1.913 . . . . 55.439999999999998 110.466 170.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.41 -27.36 84.79 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.513 2.142 . . . . 75.019999999999996 113.188 -174.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 50.9 p-80 -92.19 -15.18 27.95 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.499 -0.319 . . . . 74.140000000000001 111.596 -176.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -158.89 71.72 3.62 Favored Pre-proline 0 C--N 1.329 -0.289 0 N-CA-C 112.289 0.478 . . . . 71.120000000000005 112.289 -176.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 756' ' ' PRO . . . . . 0.598 ' HA ' ' HA2' ' A' ' 751' ' ' GLY . 40.2 Cg_exo -58.13 115.29 2.43 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 121.934 1.756 . . . . 61.240000000000002 111.199 171.077 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 757' ' ' LYS . . . . . 0.496 ' HD3' ' HB2' ' A' ' 773' ' ' CYS . 36.4 ttmt -122.4 137.06 54.99 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.958 0.408 . . . . 73.140000000000001 110.822 -176.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 758' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -123.21 119.61 30.73 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.813 -0.631 . . . . 74.129999999999995 110.45 -176.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 759' ' ' VAL . . . . . 0.484 HG22 ' HB3' ' A' ' 773' ' ' CYS . 25.3 t -94.49 115.92 34.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.005 -0.543 . . . . 62.130000000000003 110.761 -177.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -116.76 147.56 41.94 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.754 -0.657 . . . . 75.540000000000006 110.724 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 761' ' ' GLN . . . . . 0.408 ' OE1' ' HB3' ' A' ' 768' ' ' TRP . 34.4 tt0 -132.62 138.13 47.27 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.942 -0.572 . . . . 74.230000000000004 109.677 177.089 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 762' ' ' ALA . . . . . . . . . . . . . . . -95.19 112.66 24.34 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.316 0.579 . . . . 73.439999999999998 110.514 -177.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 763' ' ' LYS . . . . . 0.49 ' HD2' ' CH2' ' A' ' 768' ' ' TRP . 48.8 tttm -91.67 104.02 16.54 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.493 -0.776 . . . . 73.209999999999994 109.441 177.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 88.8 t -109.35 101.77 13.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.182 0.515 . . . . 73.329999999999998 109.851 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 71.68 -119.13 7.47 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 110.775 -0.93 . . . . 55.530000000000001 110.775 -174.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -102.14 7.06 54.24 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.635 -0.793 . . . . 73.140000000000001 111.224 175.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 767' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -99.9 148.56 24.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.054 0.454 . . . . 75.540000000000006 110.976 -177.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 768' ' ' TRP . . . . . 0.49 ' CH2' ' HD2' ' A' ' 763' ' ' LYS . 54.1 m95 -124.76 99.9 6.37 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.688 -0.687 . . . . 73.430000000000007 110.064 -179.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 769' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -171.04 141.57 1.41 Allowed Pre-proline 0 C--N 1.325 -0.468 0 CA-C-O 120.706 0.289 . . . . 64.219999999999999 110.397 -178.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 770' ' ' PRO . . . . . 0.53 ' HD3' ' HB1' ' A' ' 788' ' ' ALA . 60.7 Cg_endo -96.59 -168.54 1.78 Allowed 'Cis proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.755 -1.352 . . . . 73.319999999999993 112.126 -2.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -120.95 108.53 14.0 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.771 -0.455 . . . . 70.140000000000001 109.771 175.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 772' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 759' ' ' VAL . 32.9 m -116.87 157.54 17.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.83 0.348 . . . . 72.420000000000002 110.998 -176.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 773' ' ' CYS . . . . . 0.496 ' HB2' ' HD3' ' A' ' 757' ' ' LYS . 2.6 p -134.99 100.53 4.6 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.069 -0.514 . . . . 73.420000000000002 110.175 178.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -103.22 177.49 4.82 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.824 -0.626 . . . . 61.520000000000003 111.221 -174.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 775' ' ' HIS . . . . . . . . . . . . . 46.8 m-70 -85.32 -16.63 39.35 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.14 0.495 . . . . 73.129999999999995 110.324 -177.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 776' ' ' SER . . . . . 0.615 ' HB2' ' HB2' ' A' ' 779' ' ' GLN . 12.5 m -129.71 152.57 49.07 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.954 -0.567 . . . . 75.439999999999998 110.281 -177.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 777' ' ' LYS . . . . . . . . . . . . . 6.1 tmmm? -63.9 -49.69 71.67 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.372 -0.376 . . . . 75.0 110.96 -178.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -70.41 -26.56 63.74 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.644 -0.423 . . . . 71.400000000000006 110.231 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 779' ' ' GLN . . . . . 0.615 ' HB2' ' HB2' ' A' ' 776' ' ' SER . 6.5 mm-40 -66.71 -37.33 84.48 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 116.28 -0.418 . . . . 74.409999999999997 110.261 173.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -58.15 -45.98 93.31 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.787 -0.72 . . . . 74.340000000000003 111.501 175.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -61.94 -46.13 90.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.773 0.321 . . . . 73.450000000000003 110.76 176.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -64.56 -46.87 80.92 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.337 -0.392 . . . . 71.420000000000002 111.399 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -63.14 -39.57 95.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.496 -0.32 . . . . 73.540000000000006 111.235 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -63.19 -46.11 88.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.82 0.343 . . . . 75.140000000000001 110.11 177.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 785' ' ' ALA . . . . . 0.567 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -65.14 -45.11 86.35 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.902 -0.59 . . . . 75.400000000000006 110.986 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 786' ' ' ASP . . . . . 0.711 ' O ' ' HG2' ' A' ' 790' ' ' ARG . 14.1 t70 -58.41 -54.49 46.46 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 116.317 -0.401 . . . . 73.030000000000001 110.012 178.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 787' ' ' ALA . . . . . 0.51 ' O ' HG21 ' A' ' 791' ' ' VAL . . . -61.75 -33.79 74.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.759 -0.655 . . . . 73.329999999999998 111.21 -178.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 788' ' ' ALA . . . . . 0.705 ' O ' ' HG ' ' A' ' 792' ' ' LEU . . . -62.84 -46.62 87.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.363 -0.381 . . . . 63.530000000000001 110.448 177.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 789' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 785' ' ' ALA . 65.5 mt -62.58 -36.36 82.47 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.812 -0.44 . . . . 75.230000000000004 109.812 179.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 790' ' ' ARG . . . . . 0.711 ' HG2' ' O ' ' A' ' 786' ' ' ASP . 26.6 mmm-85 -58.95 -42.18 89.22 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.868 0.366 . . . . 75.230000000000004 110.033 177.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 791' ' ' VAL . . . . . 0.51 HG21 ' O ' ' A' ' 787' ' ' ALA . 59.0 t -64.31 -49.68 79.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.054 -0.521 . . . . 73.129999999999995 110.465 177.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 792' ' ' LEU . . . . . 0.705 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 22.5 mt -59.19 -46.59 88.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.033 -0.531 . . . . 73.439999999999998 110.457 -178.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 793' ' ' ILE . . . . . 0.746 HG12 HG23 ' A' ' 716' ' ' ILE . 96.7 mt -63.02 -45.49 98.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.422 -0.808 . . . . 74.409999999999997 110.675 177.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -65.69 -40.16 95.69 Favored Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 115.934 -0.575 . . . . 62.020000000000003 112.934 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -74.23 -16.58 60.96 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 122.377 -0.484 . . . . 73.230000000000004 111.277 -178.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 5.1 t30 . . . . . 0 C--N 1.323 -0.545 0 CA-C-O 121.436 0.636 . . . . 75.310000000000002 109.424 174.998 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 716' ' ' ILE . . . . . 0.465 ' HA ' HD21 ' A' ' 719' ' ' LEU . 48.1 mm . . . . . 0 C--O 1.233 0.192 0 CA-C-O 121.022 0.439 . . . . 75.129999999999995 110.68 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -60.29 -29.73 69.49 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.944 -0.646 . . . . 53.329999999999998 112.085 178.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 718' ' ' GLU . . . . . 0.647 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 30.0 mm-40 -57.87 -50.12 74.38 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-O 120.965 0.412 . . . . 73.540000000000006 110.168 176.004 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 719' ' ' LEU . . . . . 0.524 HD12 HD21 ' A' ' 789' ' ' LEU . 2.4 mm? -62.71 -29.67 70.84 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.164 0.507 . . . . 73.140000000000001 110.096 -177.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 720' ' ' VAL . . . . . . . . . . . . . 65.1 t -72.07 -42.96 67.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.617 -0.72 . . . . 75.549999999999997 110.639 178.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 721' ' ' ARG . . . . . 0.647 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 15.5 ptm180 -65.5 -24.05 67.04 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.919 0.39 . . . . 74.120000000000005 110.446 -179.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -76.91 -31.56 56.78 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 116.483 -0.326 . . . . 74.530000000000001 111.098 176.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 723' ' ' LEU . . . . . 0.457 HD21 ' HB2' ' A' ' 789' ' ' LEU . 92.3 mt -60.78 -30.9 70.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.266 0.555 . . . . 71.329999999999998 109.99 174.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -87.95 -17.26 31.69 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.281 -0.872 . . . . 70.299999999999997 111.317 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 21.2 m -118.04 -79.9 0.6 Allowed 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 120.674 0.274 . . . . 65.400000000000006 111.595 -177.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 726' ' ' ASN . . . . . 0.425 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 39.4 t30 -139.19 106.71 7.29 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 120.71 0.29 . . . . 65.310000000000002 110.669 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 727' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 21.1 Cg_endo -62.03 -38.48 56.91 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.745 2.297 . . . . 45.539999999999999 112.838 -178.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 29.9 t -63.12 -46.32 96.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.355 -0.384 . . . . 72.239999999999995 110.669 -175.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -61.58 -36.1 92.12 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.833 -0.698 . . . . 45.399999999999999 112.026 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -67.54 -42.07 89.17 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 121.095 -0.574 . . . . 73.109999999999999 112.593 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -65.66 -42.05 91.81 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.964 0.411 . . . . 75.299999999999997 109.933 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 732' ' ' LEU . . . . . . . . . . . . . 96.1 mt -65.37 -46.44 80.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.944 -0.571 . . . . 75.129999999999995 111.14 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 733' ' ' GLU . . . . . 0.511 ' HA ' ' HG2' ' A' ' 736' ' ' ARG . 0.0 OUTLIER -72.75 -31.38 64.88 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.899 -0.321 . . . . 75.109999999999999 110.994 -176.187 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 734' ' ' TYR . . . . . 0.522 ' HB2' HD13 ' A' ' 719' ' ' LEU . 11.8 t80 -57.22 -48.88 77.69 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 120.918 0.39 . . . . 72.420000000000002 110.089 175.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -65.02 -52.26 57.0 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.874 -0.603 . . . . 73.409999999999997 110.709 -176.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 736' ' ' ARG . . . . . 0.511 ' HG2' ' HA ' ' A' ' 733' ' ' GLU . 32.5 ptt180 -62.47 -33.04 74.05 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.686 -0.688 . . . . 74.120000000000005 111.399 -175.201 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 47.9 t -83.47 -11.68 57.21 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.909 -0.587 . . . . 42.340000000000003 111.673 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -113.03 -8.44 13.64 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.008 0.373 . . . . 73.299999999999997 112.008 -177.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 100.08 8.01 51.48 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.597 -0.811 . . . . 64.530000000000001 112.733 178.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -97.42 163.75 12.74 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 110.091 -0.337 . . . . 74.140000000000001 110.091 177.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -113.0 118.61 35.3 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.6 -0.519 . . . . 72.519999999999996 109.6 174.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 742' ' ' ALA . . . . . . . . . . . . . . . -94.06 128.3 40.35 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.21 -0.45 . . . . 53.539999999999999 111.029 -176.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 743' ' ' GLU . . . . . 0.541 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 45.6 mt-10 -139.54 154.81 47.74 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.872 -0.603 . . . . 71.510000000000005 110.393 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -128.5 113.18 15.17 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.209 -0.451 . . . . 73.420000000000002 109.795 178.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 745' ' ' LYS . . . . . 0.514 ' HE3' ' CZ3' ' A' ' 768' ' ' TRP . 13.1 ptpt -111.74 149.34 31.79 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.305 -0.558 . . . . 64.200000000000003 111.197 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 746' ' ' LEU . . . . . . . . . . . . . 6.7 tt -95.49 104.85 16.77 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.236 -1.024 . . . . 73.219999999999999 108.236 177.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 48.3 t -76.84 -44.14 32.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 116.226 -0.443 . . . . 74.450000000000003 111.009 -174.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -152.88 148.49 27.21 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.324 -0.398 . . . . 73.319999999999993 111.12 -175.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 749' ' ' GLN . . . . . 0.513 ' HA ' ' O ' ' A' ' 757' ' ' LYS . 18.1 pt20 -138.75 97.02 3.24 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.924 0.869 . . . . 72.140000000000001 109.759 173.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 9.8 p -129.5 -179.18 5.02 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.414 -0.812 . . . . 65.310000000000002 111.004 -174.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 103.64 178.5 25.87 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.586 -0.816 . . . . 44.039999999999999 112.229 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 752' ' ' PRO . . . . . 0.62 ' HG2' ' HB2' ' A' ' 755' ' ' GLU . 38.7 Cg_endo -64.98 160.3 42.15 Favored 'Trans proline' 0 CA--C 1.528 0.218 0 C-N-CA 123.118 2.545 . . . . 60.439999999999998 111.963 -178.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.37 -28.2 71.58 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.645 2.23 . . . . 70.200000000000003 112.658 -178.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 49.0 p-80 -86.49 -14.82 41.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.76 0.314 . . . . 54.420000000000002 110.989 -179.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 755' ' ' GLU . . . . . 0.62 ' HB2' ' HG2' ' A' ' 752' ' ' PRO . 18.8 mm-40 -138.9 74.0 38.5 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.252 -0.431 . . . . 73.329999999999998 110.718 178.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 756' ' ' PRO . . . . . 0.65 ' O ' ' HA ' ' A' ' 775' ' ' HIS . 56.1 Cg_endo -73.5 113.32 3.75 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.495 2.13 . . . . 74.099999999999994 111.723 177.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 757' ' ' LYS . . . . . 0.513 ' O ' ' HA ' ' A' ' 749' ' ' GLN . 6.1 ttpm? -88.61 114.08 24.85 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.903 0.382 . . . . 75.329999999999998 110.718 -177.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 758' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -99.06 115.11 28.22 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.532 -0.758 . . . . 70.209999999999994 110.013 179.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 22.1 t -88.24 105.69 15.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.627 -0.715 . . . . 71.099999999999994 109.373 177.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -107.63 144.43 34.69 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.981 -0.554 . . . . 74.310000000000002 110.669 -178.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 761' ' ' GLN . . . . . 0.456 ' HA ' ' O ' ' A' ' 770' ' ' PRO . 60.4 tt0 -136.6 128.18 28.72 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.703 -0.68 . . . . 74.319999999999993 109.512 178.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 762' ' ' ALA . . . . . 0.452 ' HB1' ' O ' ' A' ' 769' ' ' PHE . . . -86.29 129.56 34.81 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.332 0.587 . . . . 62.43 110.502 -178.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 763' ' ' LYS . . . . . 0.541 ' HB3' ' HB2' ' A' ' 743' ' ' GLU . 66.0 tttt -104.6 112.28 25.29 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.584 -0.735 . . . . 75.030000000000001 109.783 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 58.9 t -119.27 95.92 3.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.175 0.512 . . . . 74.209999999999994 109.758 177.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 72.86 -116.5 5.65 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.091 -0.803 . . . . 52.140000000000001 111.091 -175.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -101.36 -2.97 53.89 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.752 -0.737 . . . . 72.129999999999995 111.818 175.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 767' ' ' ARG . . . . . 0.44 ' HB3' ' CD1' ' A' ' 769' ' ' PHE . 0.2 OUTLIER -95.08 121.91 37.2 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.959 0.409 . . . . 72.530000000000001 111.457 -178.01 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 768' ' ' TRP . . . . . 0.514 ' CZ3' ' HE3' ' A' ' 745' ' ' LYS . 70.2 m95 -102.17 105.14 15.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.917 -0.583 . . . . 75.239999999999995 110.062 177.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 769' ' ' PHE . . . . . 0.452 ' O ' ' HB1' ' A' ' 762' ' ' ALA . 41.6 p90 -168.39 144.94 3.2 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 109.873 -0.417 . . . . 74.230000000000004 109.873 -177.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 770' ' ' PRO . . . . . 0.628 ' HD3' ' HB1' ' A' ' 788' ' ' ALA . 65.3 Cg_endo -97.56 -176.16 4.45 Favored 'Cis proline' 0 N--CA 1.451 -1.006 0 C-N-CA 123.736 -1.36 . . . . 53.329999999999998 112.188 -2.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -106.41 109.1 20.93 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.596 -0.52 . . . . 53.210000000000001 109.596 174.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 35.9 m -117.72 155.79 19.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.969 0.414 . . . . 73.200000000000003 110.997 -177.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 7.0 p -129.91 112.78 13.86 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.17 0.51 . . . . 65.019999999999996 110.442 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 774' ' ' ALA . . . . . 0.414 ' O ' ' HA ' ' A' ' 757' ' ' LYS . . . -116.73 -178.4 3.42 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.816 -0.629 . . . . 64.340000000000003 109.784 178.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 775' ' ' HIS . . . . . 0.65 ' HA ' ' O ' ' A' ' 756' ' ' PRO . 5.6 p80 -121.86 19.01 11.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.772 0.796 . . . . 65.109999999999999 110.187 176.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 49.3 m -148.35 139.22 23.05 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.837 -1.074 . . . . 73.420000000000002 108.405 171.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 777' ' ' LYS . . . . . . . . . . . . . 5.6 tmmm? -61.45 -44.77 96.53 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 123.018 0.199 . . . . 74.329999999999998 111.291 -172.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -64.85 -31.56 72.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.71 0.291 . . . . 70.120000000000005 110.799 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 779' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -72.03 -35.51 69.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.365 -0.38 . . . . 75.230000000000004 110.335 177.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -59.94 -42.94 98.48 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.904 -0.665 . . . . 45.310000000000002 111.493 176.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -61.25 -49.01 78.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.835 0.35 . . . . 75.430000000000007 110.488 176.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -61.73 -51.21 69.31 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 115.896 -0.593 . . . . 72.129999999999995 111.254 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -57.95 -43.34 86.34 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 123.196 0.31 . . . . 63.109999999999999 111.44 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -59.92 -50.68 72.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.373 -0.376 . . . . 64.209999999999994 110.622 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 785' ' ' ALA . . . . . 0.582 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -67.48 -42.46 82.94 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.318 -0.401 . . . . 55.310000000000002 111.025 -178.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 786' ' ' ASP . . . . . 0.463 ' O ' ' HG3' ' A' ' 790' ' ' ARG . 11.8 t70 -59.1 -51.74 68.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.984 -0.553 . . . . 65.200000000000003 110.717 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 787' ' ' ALA . . . . . 0.542 ' HA ' ' HD2' ' A' ' 790' ' ' ARG . . . -66.84 -35.46 80.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.034 -0.53 . . . . 71.409999999999997 110.8 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 788' ' ' ALA . . . . . 0.665 ' O ' ' HG ' ' A' ' 792' ' ' LEU . . . -61.46 -42.75 99.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.425 -0.352 . . . . 71.010000000000005 110.854 178.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 789' ' ' LEU . . . . . 0.582 ' HG ' ' O ' ' A' ' 785' ' ' ALA . 81.3 mt -58.92 -43.98 91.22 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 110.008 -0.367 . . . . 73.239999999999995 110.008 177.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 790' ' ' ARG . . . . . 0.542 ' HD2' ' HA ' ' A' ' 787' ' ' ALA . 53.9 mtt-85 -58.36 -37.53 75.39 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.206 -0.452 . . . . 75.530000000000001 111.009 177.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 791' ' ' VAL . . . . . 0.54 HG21 ' O ' ' A' ' 787' ' ' ALA . 48.3 t -65.81 -48.67 81.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.416 -0.356 . . . . 72.430000000000007 110.237 177.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 792' ' ' LEU . . . . . 0.665 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 39.6 mt -61.67 -46.37 90.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.747 -0.661 . . . . 73.049999999999997 110.749 -179.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 89.5 mt -62.17 -47.53 92.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.51 -0.768 . . . . 72.150000000000006 110.366 177.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -62.92 -36.4 93.36 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 121.018 -0.611 . . . . 71.150000000000006 112.342 178.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -57.56 -51.22 70.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.977 0.418 . . . . 71.439999999999998 110.44 177.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 . . . . . 0 C--N 1.327 -0.396 0 CA-C-O 121.171 0.51 . . . . 72.129999999999995 110.667 -177.514 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 716' ' ' ILE . . . . . 0.405 ' O ' HG21 ' A' ' 720' ' ' VAL . 46.1 mm . . . . . 0 N--CA 1.454 -0.243 0 CA-C-O 120.75 0.31 . . . . 72.319999999999993 110.587 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -61.09 -28.94 69.77 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.974 -0.631 . . . . 52.299999999999997 111.702 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 718' ' ' GLU . . . . . 0.747 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 5.8 mp0 -59.68 -46.94 87.55 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.913 0.387 . . . . 64.319999999999993 110.173 175.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 719' ' ' LEU . . . . . 0.531 HD11 HD21 ' A' ' 789' ' ' LEU . 2.9 mm? -67.61 -33.75 75.62 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.997 0.427 . . . . 75.340000000000003 110.36 -178.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 720' ' ' VAL . . . . . 0.448 HG22 HD13 ' A' ' 793' ' ' ILE . 61.6 t -63.39 -41.19 91.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 115.991 -0.55 . . . . 75.319999999999993 110.672 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 721' ' ' ARG . . . . . 0.747 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 14.7 ptm180 -68.92 -24.57 64.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 75.019999999999996 109.981 -178.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -76.73 -30.15 56.49 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.356 -0.384 . . . . 75.120000000000005 111.404 177.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 723' ' ' LEU . . . . . 0.523 HD23 ' HB2' ' A' ' 789' ' ' LEU . 84.7 mt -59.18 -32.57 70.04 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.476 -0.565 . . . . 74.239999999999995 109.476 172.094 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -82.97 -41.06 19.22 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.276 -0.875 . . . . 74.239999999999995 110.976 177.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 29.3 m -96.26 -78.49 0.46 Allowed 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 112.32 0.489 . . . . 72.540000000000006 112.32 -176.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 726' ' ' ASN . . . . . 0.405 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 37.7 t30 -142.11 100.9 5.82 Favored Pre-proline 0 C--O 1.234 0.27 0 CA-C-O 120.817 0.342 . . . . 75.120000000000005 111.065 -173.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 727' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 19.2 Cg_endo -61.86 -38.5 58.7 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 123.041 2.494 . . . . 65.239999999999995 112.844 -176.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 42.0 t -61.48 -48.49 88.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 75.510000000000005 110.939 -175.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -61.98 -38.46 96.09 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.765 -0.731 . . . . 54.240000000000002 112.12 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -66.85 -42.68 92.8 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.876 -0.678 . . . . 72.349999999999994 112.584 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -62.52 -40.36 96.5 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.807 -0.442 . . . . 71.430000000000007 109.807 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 732' ' ' LEU . . . . . . . . . . . . . 90.7 mt -64.74 -42.98 94.77 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.928 -0.578 . . . . 72.530000000000001 111.399 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 733' ' ' GLU . . . . . 0.503 ' O ' ' HG2' ' A' ' 736' ' ' ARG . 12.7 pt-20 -80.2 -25.95 39.43 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.924 -0.311 . . . . 74.450000000000003 111.55 -176.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 734' ' ' TYR . . . . . 0.497 ' HB2' HD12 ' A' ' 719' ' ' LEU . 3.2 t80 -56.89 -44.24 82.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.061 0.457 . . . . 74.239999999999995 109.84 173.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -66.93 -47.6 71.22 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.612 -0.722 . . . . 63.350000000000001 110.666 -177.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 736' ' ' ARG . . . . . 0.503 ' HG2' ' O ' ' A' ' 733' ' ' GLU . 34.4 ptt180 -63.39 -31.77 73.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.13 0.49 . . . . 74.310000000000002 110.992 -176.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 10.4 t -75.46 -33.59 60.87 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.756 -0.656 . . . . 74.230000000000004 110.993 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 18.2 m170 -97.02 -13.29 22.38 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.317 0.488 . . . . 73.540000000000006 112.317 -173.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 100.56 13.56 34.85 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.439 -0.886 . . . . 64.129999999999995 112.614 178.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -98.57 -174.14 2.73 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.025 0.44 . . . . 60.340000000000003 110.284 176.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 741' ' ' ALA . . . . . 0.563 ' O ' ' HA ' ' A' ' 764' ' ' VAL . . . -128.06 139.43 52.53 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.796 -0.638 . . . . 71.409999999999997 109.281 173.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 742' ' ' ALA . . . . . . . . . . . . . . . -110.11 115.73 30.28 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.773 0.32 . . . . 74.010000000000005 110.895 -176.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 743' ' ' GLU . . . . . 0.541 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 43.4 mt-10 -126.63 146.53 50.14 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.274 -0.421 . . . . 72.239999999999995 110.979 -178.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -123.15 104.3 9.09 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.37 -0.604 . . . . 71.040000000000006 109.37 176.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 8.0 ptpt -119.16 157.9 27.02 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.095 0.474 . . . . 61.140000000000001 111.307 -176.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 746' ' ' LEU . . . . . 0.457 HD11 ' HB3' ' A' ' 758' ' ' PHE . 57.2 tp -85.78 122.98 30.63 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.509 -0.769 . . . . 73.239999999999995 109.756 175.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 54.3 t -94.58 -47.73 13.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 120.959 0.409 . . . . 74.230000000000004 110.537 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -143.92 148.9 36.03 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.044 -0.525 . . . . 64.019999999999996 110.003 -177.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -133.32 102.5 5.57 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.691 -0.485 . . . . 71.209999999999994 109.691 176.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 33.7 m -143.65 131.61 21.63 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.243 -0.435 . . . . 74.310000000000002 110.562 -177.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 160.62 -165.52 35.08 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.653 -0.784 . . . . 64.140000000000001 112.261 178.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 752' ' ' PRO . . . . . 0.446 ' HG2' ' HB2' ' A' ' 755' ' ' GLU . 72.7 Cg_endo -78.0 163.81 27.96 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 123.015 2.477 . . . . 73.310000000000002 112.084 177.036 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -76.51 -27.94 7.23 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.543 2.162 . . . . 75.209999999999994 112.379 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 39.8 p-80 -79.33 -19.4 50.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.914 0.387 . . . . 72.549999999999997 110.709 178.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 755' ' ' GLU . . . . . 0.446 ' HB2' ' HG2' ' A' ' 752' ' ' PRO . 29.3 mt-10 -138.99 79.74 26.09 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.929 -0.578 . . . . 62.43 110.332 175.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 756' ' ' PRO . . . . . 0.483 ' O ' ' HA ' ' A' ' 775' ' ' HIS . 34.9 Cg_endo -65.94 102.38 0.53 Allowed 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.165 1.91 . . . . 73.319999999999993 111.3 177.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 757' ' ' LYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 775' ' ' HIS . 37.9 ttmt -87.69 114.69 24.54 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.437 0.637 . . . . 65.120000000000005 110.686 -176.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 758' ' ' PHE . . . . . 0.457 ' HB3' HD11 ' A' ' 746' ' ' LEU . 78.8 m-85 -97.95 126.12 43.19 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.016 -0.993 . . . . 75.319999999999993 110.48 -178.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 62.0 t -88.86 102.95 13.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 109.488 -0.56 . . . . 54.140000000000001 109.488 174.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 760' ' ' TYR . . . . . 0.454 ' OH ' ' HG3' ' A' ' 777' ' ' LYS . 7.1 m-85 -102.29 142.13 34.01 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.875 -0.602 . . . . 74.219999999999999 110.764 -178.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 761' ' ' GLN . . . . . 0.474 ' OE1' ' HB3' ' A' ' 768' ' ' TRP . 32.0 tt0 -133.75 136.04 44.33 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.717 -0.674 . . . . 73.329999999999998 110.084 179.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 762' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' A' ' 769' ' ' PHE . . . -87.43 116.28 25.43 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.94 -0.573 . . . . 74.120000000000005 110.441 -178.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 763' ' ' LYS . . . . . 0.541 ' HB3' ' HB2' ' A' ' 743' ' ' GLU . 58.6 tttm -94.94 100.39 12.25 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.716 -0.674 . . . . 75.439999999999998 109.631 178.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 764' ' ' VAL . . . . . 0.563 ' HA ' ' O ' ' A' ' 741' ' ' ALA . 58.3 t -104.75 100.7 11.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.965 -0.562 . . . . 74.049999999999997 109.842 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 69.84 -111.65 3.96 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 110.881 -0.888 . . . . 53.130000000000003 110.881 -174.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -112.13 10.99 26.86 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 111.407 -0.677 . . . . 71.450000000000003 111.407 175.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 767' ' ' ARG . . . . . . . . . . . . . 79.7 mtm180 -107.82 131.51 54.4 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.939 0.4 . . . . 72.549999999999997 110.567 -178.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 768' ' ' TRP . . . . . 0.474 ' HB3' ' OE1' ' A' ' 761' ' ' GLN . 43.1 m95 -108.39 101.25 10.46 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.906 -0.588 . . . . 74.329999999999998 109.991 -177.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 769' ' ' PHE . . . . . 0.416 ' O ' ' HB2' ' A' ' 762' ' ' ALA . 27.2 p90 -167.86 139.8 2.49 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-O 120.74 0.305 . . . . 73.209999999999994 110.61 -178.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 770' ' ' PRO . . . . . 0.643 ' HD3' ' HB1' ' A' ' 788' ' ' ALA . 68.7 Cg_endo -95.13 -170.09 2.71 Favored 'Cis proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.648 -1.397 . . . . 75.519999999999996 111.797 -3.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -122.17 101.49 7.56 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.996 -0.372 . . . . 72.409999999999997 109.996 176.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 27.0 m -110.51 168.04 4.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.135 -0.484 . . . . 73.530000000000001 110.81 -176.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 5.8 p -133.6 113.83 12.85 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.244 0.545 . . . . 71.329999999999998 110.995 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -132.03 149.4 52.43 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.866 -0.606 . . . . 64.450000000000003 109.926 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 775' ' ' HIS . . . . . 0.483 ' HA ' ' O ' ' A' ' 756' ' ' PRO . 1.3 p-80 -83.67 18.29 1.98 Allowed 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.592 -0.443 . . . . 73.230000000000004 111.669 -176.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 32.5 t -148.39 143.26 26.7 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.896 -0.409 . . . . 73.019999999999996 109.896 176.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 777' ' ' LYS . . . . . 0.454 ' HG3' ' OH ' ' A' ' 760' ' ' TYR . 8.4 ttmm -57.97 -49.8 75.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 72.510000000000005 110.752 178.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -58.94 -45.36 90.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.51 -0.768 . . . . 71.349999999999994 110.376 -178.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 779' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -63.58 -41.47 98.36 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-N 116.086 -0.506 . . . . 70.230000000000004 110.626 177.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -55.6 -44.85 86.04 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.028 -0.606 . . . . 51.340000000000003 112.036 178.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -66.24 -43.65 85.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.649 0.261 . . . . 72.040000000000006 111.024 177.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -63.88 -48.13 77.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.393 -0.367 . . . . 74.319999999999993 110.969 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -61.51 -43.52 98.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 64.439999999999998 110.927 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -63.2 -48.93 76.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.038 -0.528 . . . . 72.239999999999995 110.845 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 785' ' ' ALA . . . . . 0.597 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -65.1 -42.02 94.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.319 -0.401 . . . . 53.109999999999999 110.983 -178.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 786' ' ' ASP . . . . . 0.416 ' O ' ' HG3' ' A' ' 790' ' ' ARG . 12.7 t70 -57.64 -50.17 74.02 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.052 -0.522 . . . . 74.420000000000002 110.667 178.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 787' ' ' ALA . . . . . 0.52 ' HB3' ' HG3' ' A' ' 770' ' ' PRO . . . -67.4 -38.75 85.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.043 -0.526 . . . . 72.25 110.968 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 788' ' ' ALA . . . . . 0.643 ' HB1' ' HD3' ' A' ' 770' ' ' PRO . . . -61.48 -43.58 98.62 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.326 -0.397 . . . . 74.409999999999997 111.41 -178.275 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 789' ' ' LEU . . . . . 0.597 ' HG ' ' O ' ' A' ' 785' ' ' ALA . 52.1 mt -59.81 -43.57 94.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.565 -0.289 . . . . 73.209999999999994 110.409 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 790' ' ' ARG . . . . . 0.416 ' HG3' ' O ' ' A' ' 786' ' ' ASP . 67.0 mtt-85 -60.77 -34.34 74.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 75.040000000000006 110.989 178.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 791' ' ' VAL . . . . . 0.512 HG21 ' O ' ' A' ' 787' ' ' ALA . 56.8 t -64.9 -49.66 78.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.947 -0.39 . . . . 71.0 109.947 175.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 792' ' ' LEU . . . . . 0.614 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 29.6 mt -60.8 -51.49 69.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.859 -0.609 . . . . 72.25 110.884 -178.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 793' ' ' ILE . . . . . 0.448 HD13 HG22 ' A' ' 720' ' ' VAL . 81.9 mt -58.31 -54.33 34.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.399 -0.819 . . . . 75.420000000000002 111.18 178.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -64.49 -26.57 70.88 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 121.098 -0.572 . . . . 52.399999999999999 112.809 -177.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -66.74 -46.53 75.16 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.925 -0.398 . . . . 71.540000000000006 109.925 177.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 . . . . . 0 CA--C 1.516 -0.327 0 CA-C-N 116.27 -0.423 . . . . 75.439999999999998 110.498 179.738 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 716' ' ' ILE . . . . . 0.501 ' HA ' HD23 ' A' ' 719' ' ' LEU . 47.8 mm . . . . . 0 N--CA 1.452 -0.363 0 CA-C-O 120.951 0.405 . . . . 75.519999999999996 110.913 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -56.95 -25.13 52.65 Favored Glycine 0 N--CA 1.453 -0.232 0 CA-C-N 115.879 -0.601 . . . . 75.120000000000005 111.649 175.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 718' ' ' GLU . . . . . 0.739 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 13.6 mm-40 -62.67 -49.59 74.53 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 115.77 -0.215 . . . . 62.109999999999999 110.692 175.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 719' ' ' LEU . . . . . 0.529 HD13 ' HB2' ' A' ' 734' ' ' TYR . 2.5 mm? -62.03 -31.67 72.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.016 0.436 . . . . 72.120000000000005 110.436 -176.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 720' ' ' VAL . . . . . 0.401 HG21 HD12 ' A' ' 793' ' ' ILE . 63.4 t -64.58 -39.69 86.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.757 -0.656 . . . . 73.030000000000001 111.088 178.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 721' ' ' ARG . . . . . 0.739 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 11.5 ptt180 -67.38 -26.05 66.26 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.071 0.462 . . . . 75.200000000000003 109.932 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -79.02 -29.53 43.66 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.177 -0.465 . . . . 75.099999999999994 110.913 179.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 723' ' ' LEU . . . . . 0.514 HD22 ' HB2' ' A' ' 789' ' ' LEU . 96.5 mt -57.61 -38.94 75.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.176 0.512 . . . . 70.310000000000002 109.898 174.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -80.36 -42.16 23.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.333 -0.849 . . . . 72.299999999999997 111.151 177.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 22.1 m -82.16 -81.5 0.15 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.91 0.386 . . . . 70.530000000000001 111.591 -177.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 726' ' ' ASN . . . . . 0.414 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 38.4 t30 -148.19 105.88 3.6 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 109.756 -0.461 . . . . 73.129999999999995 109.756 -179.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 727' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 14.0 Cg_endo -58.32 -36.43 97.65 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.79 2.326 . . . . 71.209999999999994 112.351 -176.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 728' ' ' VAL . . . . . 0.4 ' O ' ' HG ' ' A' ' 732' ' ' LEU . 40.3 t -61.26 -49.02 86.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.005 -0.543 . . . . 61.539999999999999 110.936 -177.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -64.87 -28.77 73.87 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.901 -0.666 . . . . 72.230000000000004 111.907 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -71.85 -42.53 52.89 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 121.035 -0.603 . . . . 75.219999999999999 112.353 179.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -64.83 -40.43 95.17 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.48 -0.563 . . . . 71.310000000000002 109.48 178.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 732' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 728' ' ' VAL . 95.4 mt -62.78 -44.14 96.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.873 -0.603 . . . . 72.25 110.691 176.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 733' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -65.81 -42.82 90.18 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 122.929 0.492 . . . . 73.340000000000003 110.721 -178.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 734' ' ' TYR . . . . . 0.529 ' HB2' HD13 ' A' ' 719' ' ' LEU . 20.3 t80 -58.13 -51.64 68.86 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.278 -0.419 . . . . 73.409999999999997 110.356 176.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -63.95 -51.46 64.26 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.176 -0.466 . . . . 61.299999999999997 110.857 -177.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 736' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -60.88 -35.58 76.99 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.087 -0.506 . . . . 75.040000000000006 111.429 -174.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 8.1 t -83.25 -25.39 31.69 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.458 -0.337 . . . . 75.25 111.196 -177.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -95.29 -1.59 51.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.515 0.198 . . . . 73.319999999999993 111.445 -177.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 98.59 -5.91 60.56 Favored Glycine 0 CA--C 1.516 0.15 0 C-N-CA 120.783 -0.722 . . . . 61.25 112.771 175.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -81.82 167.4 19.08 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.941 0.401 . . . . 74.409999999999997 110.766 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -119.64 110.9 17.39 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.387 -0.597 . . . . 73.0 109.387 175.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 742' ' ' ALA . . . . . . . . . . . . . . . -85.28 132.14 34.31 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.0 0.428 . . . . 63.399999999999999 111.74 -175.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 743' ' ' GLU . . . . . 0.477 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 38.1 mt-10 -135.13 142.75 46.25 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.645 -0.707 . . . . 74.349999999999994 110.879 176.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -119.15 101.81 8.27 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.141 -0.688 . . . . 72.150000000000006 109.141 175.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 745' ' ' LYS . . . . . 0.714 ' HB3' ' HZ3' ' A' ' 745' ' ' LYS . 1.1 ptpm? -124.66 144.2 50.32 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.066 0.46 . . . . 71.329999999999998 111.114 -175.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 746' ' ' LEU . . . . . 0.414 HD12 ' HB3' ' A' ' 758' ' ' PHE . 56.8 tp -77.08 117.91 19.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.502 -0.772 . . . . 64.200000000000003 110.037 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 54.5 t -88.03 -49.63 14.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.202 0.525 . . . . 71.310000000000002 110.108 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 748' ' ' ASP . . . . . 0.439 ' O ' ' HB ' ' A' ' 759' ' ' VAL . 26.5 t70 -148.22 154.82 40.6 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.403 -0.817 . . . . 73.439999999999998 109.331 -178.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.87 112.86 12.26 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.447 0.642 . . . . 63.100000000000001 110.369 173.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 750' ' ' SER . . . . . 0.44 ' O ' ' HB3' ' A' ' 757' ' ' LYS . 11.3 m -101.78 89.53 3.71 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.363 -0.835 . . . . 72.409999999999997 109.438 177.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 751' ' ' GLY . . . . . 0.506 ' HA3' ' H ' ' A' ' 757' ' ' LYS . . . -152.95 123.5 1.45 Allowed Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 119.48 -1.343 . . . . 61.5 113.855 -174.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 752' ' ' PRO . . . . . 0.445 ' HD2' ' HA2' ' A' ' 751' ' ' GLY . 26.4 Cg_endo -63.51 167.95 12.3 Favored 'Trans proline' 0 CA--C 1.533 0.425 0 C-N-CA 123.002 2.468 . . . . 74.540000000000006 111.105 169.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -56.59 -33.65 93.6 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 122.523 2.148 . . . . 74.209999999999994 112.792 -178.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 39.2 p-80 -88.35 -9.35 53.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.199 -0.455 . . . . 75.239999999999995 111.984 -177.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -152.59 73.69 7.33 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 111.792 0.293 . . . . 71.239999999999995 111.792 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 756' ' ' PRO . . . . . 0.461 ' HA ' ' HA3' ' A' ' 751' ' ' GLY . 42.8 Cg_endo -70.1 103.05 1.16 Allowed 'Trans proline' 0 CA--C 1.528 0.224 0 C-N-CA 122.36 2.04 . . . . 65.140000000000001 112.198 176.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 757' ' ' LYS . . . . . 0.506 ' H ' ' HA3' ' A' ' 751' ' ' GLY . 40.1 ttmt -96.6 133.0 41.65 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.894 -0.41 . . . . 74.219999999999999 109.894 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 758' ' ' PHE . . . . . 0.414 ' HB3' HD12 ' A' ' 746' ' ' LEU . 95.5 m-85 -110.08 126.03 53.58 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.299 -0.41 . . . . 63.229999999999997 111.147 -176.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 759' ' ' VAL . . . . . 0.483 HG22 ' HB3' ' A' ' 773' ' ' CYS . 97.3 t -94.03 104.04 15.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-N 115.78 -0.646 . . . . 71.420000000000002 109.853 177.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -102.6 144.6 30.8 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.606 -0.725 . . . . 71.319999999999993 111.179 -177.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -132.46 131.7 41.98 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.305 -0.861 . . . . 75.299999999999997 109.385 178.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 762' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 769' ' ' PHE . . . -90.17 123.46 34.01 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.3 0.571 . . . . 63.549999999999997 110.646 -177.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 763' ' ' LYS . . . . . 0.543 ' HE2' ' HA2' ' A' ' 766' ' ' GLY . 45.5 tttt -99.29 105.88 17.94 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.044 -0.724 . . . . 74.219999999999999 109.044 177.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 50.7 t -108.33 91.87 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.233 0.539 . . . . 73.430000000000007 110.689 -178.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 77.8 -7.59 41.15 Favored Glycine 0 N--CA 1.454 -0.132 0 CA-C-N 115.627 -0.715 . . . . 63.210000000000001 112.56 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 766' ' ' GLY . . . . . 0.543 ' HA2' ' HE2' ' A' ' 763' ' ' LYS . . . 136.77 -29.62 2.74 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.31 -0.716 . . . . 65.540000000000006 111.31 -177.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 767' ' ' ARG . . . . . 0.462 ' HD2' ' CD1' ' A' ' 769' ' ' PHE . 0.7 OUTLIER -72.57 118.75 15.87 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.078 -0.712 . . . . 74.340000000000003 109.078 177.21 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 768' ' ' TRP . . . . . 0.406 ' CZ3' ' HD2' ' A' ' 745' ' ' LYS . 76.4 m95 -88.45 105.48 17.63 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.032 -0.531 . . . . 72.109999999999999 110.267 -178.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 769' ' ' PHE . . . . . 0.465 ' O ' ' HB3' ' A' ' 762' ' ' ALA . 13.0 p90 -168.43 137.83 1.94 Allowed Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 109.875 -0.417 . . . . 74.420000000000002 109.875 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 770' ' ' PRO . . . . . 0.695 ' HD3' ' HB1' ' A' ' 788' ' ' ALA . 58.5 Cg_endo -97.24 -167.75 1.41 Allowed 'Cis proline' 0 N--CA 1.451 -1.012 0 C-N-CA 123.779 -1.342 . . . . 62.350000000000001 112.018 -2.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -119.45 101.19 7.77 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.744 -0.465 . . . . 71.5 109.744 175.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 34.8 m -117.19 170.77 6.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.504 -0.317 . . . . 71.099999999999994 111.135 -174.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 773' ' ' CYS . . . . . 0.483 ' HB3' HG22 ' A' ' 759' ' ' VAL . 4.7 p -142.48 121.67 13.01 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.137 -0.483 . . . . 63.439999999999998 110.606 178.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -124.9 154.52 40.96 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.202 -0.454 . . . . 72.430000000000007 110.222 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 775' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -79.87 -4.45 52.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.007 0.432 . . . . 74.420000000000002 110.986 -177.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 54.9 m -131.22 144.62 51.46 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.134 -0.485 . . . . 72.329999999999998 109.998 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 777' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -65.33 -42.97 92.39 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.162 -0.472 . . . . 72.310000000000002 111.158 -175.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -65.88 -37.76 86.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.972 0.415 . . . . 73.109999999999999 110.078 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 779' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -66.72 -33.13 74.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.026 -0.533 . . . . 72.409999999999997 110.916 177.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -56.96 -42.99 93.01 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.845 -0.693 . . . . 54.140000000000001 111.714 177.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 781' ' ' LYS . . . . . 0.676 ' HZ3' ' HB3' ' A' ' 781' ' ' LYS . 7.7 mtpm? -64.79 -43.26 93.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.946 0.403 . . . . 71.239999999999995 110.418 176.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -67.24 -46.86 72.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.978 -0.555 . . . . 70.010000000000005 111.181 -178.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -61.51 -40.87 96.17 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 123.163 0.289 . . . . 72.219999999999999 110.894 -179.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -60.97 -52.3 65.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 72.109999999999999 110.431 178.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 785' ' ' ALA . . . . . 0.626 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -63.9 -42.05 97.53 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.091 -0.504 . . . . 71.299999999999997 111.095 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 786' ' ' ASP . . . . . 0.593 ' O ' ' HG2' ' A' ' 790' ' ' ARG . 21.3 t70 -57.09 -56.56 20.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.954 -0.566 . . . . 63.420000000000002 110.871 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 787' ' ' ALA . . . . . 0.564 ' O ' HG21 ' A' ' 791' ' ' VAL . . . -63.92 -33.58 76.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.873 -0.603 . . . . 63.450000000000003 110.972 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 788' ' ' ALA . . . . . 0.695 ' HB1' ' HD3' ' A' ' 770' ' ' PRO . . . -62.67 -41.85 99.3 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.637 0.256 . . . . 63.439999999999998 110.704 177.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 789' ' ' LEU . . . . . 0.626 ' HG ' ' O ' ' A' ' 785' ' ' ALA . 62.9 mt -64.82 -38.81 92.22 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.621 -0.511 . . . . 73.010000000000005 109.621 178.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 790' ' ' ARG . . . . . 0.593 ' HG2' ' O ' ' A' ' 786' ' ' ASP . 13.5 mmm180 -59.41 -39.42 83.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.853 -0.612 . . . . 74.140000000000001 110.254 177.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 791' ' ' VAL . . . . . 0.564 HG21 ' O ' ' A' ' 787' ' ' ALA . 83.4 t -59.84 -52.12 64.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.858 -0.61 . . . . 74.239999999999995 110.51 176.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 792' ' ' LEU . . . . . 0.593 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 25.0 mt -60.94 -49.59 76.83 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.624 -0.716 . . . . 65.400000000000006 110.767 -177.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 793' ' ' ILE . . . . . 0.401 HD12 HG21 ' A' ' 720' ' ' VAL . 85.9 mt -59.72 -41.34 85.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.596 -0.729 . . . . 73.510000000000005 110.965 178.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -65.78 -43.93 93.14 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 116.072 -0.513 . . . . 72.530000000000001 112.735 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -62.62 -44.8 95.39 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.676 0.274 . . . . 72.010000000000005 111.006 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 796' ' ' ASN . . . . . 0.418 ' CB ' HG13 ' A' ' 716' ' ' ILE . 10.8 t30 . . . . . 0 C--N 1.325 -0.492 0 CA-C-N 116.344 -0.389 . . . . 65.510000000000005 110.712 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 716' ' ' ILE . . . . . 0.534 ' HA ' HD23 ' A' ' 719' ' ' LEU . 50.7 mm . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 121.011 0.434 . . . . 60.130000000000003 110.88 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -57.2 -23.19 46.44 Favored Glycine 0 CA--C 1.521 0.412 0 CA-C-N 115.881 -0.599 . . . . 74.319999999999993 112.926 178.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 718' ' ' GLU . . . . . 0.737 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 4.7 mm-40 -73.83 -40.54 63.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.184 0.516 . . . . 73.129999999999995 110.136 178.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 719' ' ' LEU . . . . . 0.534 HD23 ' HA ' ' A' ' 716' ' ' ILE . 3.0 mm? -65.1 -31.78 73.15 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.282 0.563 . . . . 74.129999999999995 109.496 178.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 720' ' ' VAL . . . . . . . . . . . . . 89.8 t -64.07 -41.41 92.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.533 -0.758 . . . . 63.340000000000003 110.798 177.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 721' ' ' ARG . . . . . 0.737 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 26.7 ptt180 -63.59 -25.39 68.21 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.064 0.459 . . . . 73.25 110.28 -178.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 722' ' ' TYR . . . . . 0.505 ' HH ' ' CD ' ' A' ' 733' ' ' GLU . 50.3 m-85 -79.07 -26.62 43.05 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.392 -0.367 . . . . 74.230000000000004 111.622 178.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 723' ' ' LEU . . . . . 0.459 HD22 ' HB2' ' A' ' 789' ' ' LEU . 87.3 mt -65.08 -23.75 67.25 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.197 -0.668 . . . . 73.329999999999998 109.197 171.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -81.4 -54.66 5.27 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.378 -0.828 . . . . 72.439999999999998 110.538 174.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 15.7 m -89.41 -72.47 0.55 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.571 0.582 . . . . 74.530000000000001 112.571 -174.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 726' ' ' ASN . . . . . 0.416 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 26.6 t30 -145.65 101.53 4.3 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.693 0.282 . . . . 64.239999999999995 111.008 -172.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 727' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 17.8 Cg_endo -61.21 -38.59 65.08 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.913 2.409 . . . . 72.329999999999998 112.374 -178.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 728' ' ' VAL . . . . . 0.413 ' O ' ' HG ' ' A' ' 732' ' ' LEU . 41.5 t -60.64 -45.82 96.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.083 -0.508 . . . . 73.25 110.96 -177.036 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 729' ' ' GLY . . . . . 0.407 ' O ' ' HG2' ' A' ' 733' ' ' GLU . . . -65.52 -39.89 95.85 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.618 -0.801 . . . . 73.140000000000001 112.179 -177.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 730' ' ' GLY . . . . . 0.415 ' HA2' ' HG2' ' A' ' 733' ' ' GLU . . . -67.8 -38.45 89.48 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.908 -0.663 . . . . 51.439999999999998 112.583 -178.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -63.38 -41.05 98.77 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.13 0.49 . . . . 64.510000000000005 109.684 178.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 732' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 728' ' ' VAL . 94.0 mt -65.66 -43.64 88.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.701 -0.681 . . . . 72.319999999999993 111.27 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 733' ' ' GLU . . . . . 0.526 ' HA ' ' HG2' ' A' ' 736' ' ' ARG . 11.4 pt-20 -79.51 -25.26 41.81 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 120.544 -0.462 . . . . 72.209999999999994 111.783 -176.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 734' ' ' TYR . . . . . 0.473 ' HB2' HD12 ' A' ' 719' ' ' LEU . 7.1 t80 -56.63 -46.43 81.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.275 0.56 . . . . 73.420000000000002 109.493 171.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -68.02 -46.8 70.22 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.348 -0.842 . . . . 74.409999999999997 111.047 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 736' ' ' ARG . . . . . 0.526 ' HG2' ' HA ' ' A' ' 733' ' ' GLU . 29.7 ptt180 -60.76 -34.25 74.17 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.097 0.475 . . . . 75.109999999999999 110.706 -176.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 31.5 t -76.7 -38.07 55.02 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.75 -0.659 . . . . 64.150000000000006 110.909 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 16.6 m170 -95.59 0.66 53.15 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.0 0.37 . . . . 73.530000000000001 112.0 -172.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 90.65 4.94 69.52 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.693 -0.765 . . . . 73.549999999999997 113.34 174.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -91.47 173.92 7.64 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.99 0.424 . . . . 73.420000000000002 110.743 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 741' ' ' ALA . . . . . 0.627 ' O ' ' HA ' ' A' ' 764' ' ' VAL . . . -108.45 147.31 31.82 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.29 -0.633 . . . . 74.109999999999999 109.29 173.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 742' ' ' ALA . . . . . . . . . . . . . . . -128.89 110.88 12.49 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.825 0.345 . . . . 75.400000000000006 110.521 -178.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 743' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -136.12 154.41 51.0 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.286 -0.416 . . . . 74.200000000000003 110.922 -177.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -122.67 118.64 28.6 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.307 -0.406 . . . . 75.450000000000003 109.985 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 7.1 ptpt -117.65 148.49 41.91 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.051 0.453 . . . . 72.209999999999994 111.251 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 746' ' ' LEU . . . . . . . . . . . . . 6.9 tt -92.25 102.79 15.29 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.014 -1.106 . . . . 74.140000000000001 108.014 175.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 38.5 t -72.56 -45.74 57.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.101 -0.5 . . . . 72.430000000000007 110.654 -174.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -160.64 164.21 31.97 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.105 -0.702 . . . . 74.109999999999999 109.105 -179.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.69 125.67 21.21 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.11 0.481 . . . . 73.040000000000006 110.725 178.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 17.1 m -125.39 101.19 6.84 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.676 -0.693 . . . . 72.040000000000006 109.356 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 751' ' ' GLY . . . . . 0.823 ' HA3' ' HA ' ' A' ' 756' ' ' PRO . . . -174.27 134.62 2.88 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 119.534 -1.317 . . . . 74.120000000000005 113.779 -178.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 752' ' ' PRO . . . . . 0.417 ' HD2' ' HA2' ' A' ' 751' ' ' GLY . 25.6 Cg_endo -62.04 168.9 8.31 Favored 'Trans proline' 0 CA--C 1.529 0.262 0 C-N-CA 123.535 2.824 . . . . 64.340000000000003 111.432 171.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.71 -28.36 87.14 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.368 2.046 . . . . 72.25 112.6 -179.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 38.7 p-80 -87.6 -17.05 32.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.443 -0.344 . . . . 72.239999999999995 111.476 -178.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -153.1 69.43 6.85 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 111.94 0.348 . . . . 63.119999999999997 111.94 -175.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 756' ' ' PRO . . . . . 0.823 ' HA ' ' HA3' ' A' ' 751' ' ' GLY . 71.9 Cg_endo -80.28 108.2 2.14 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.27 1.98 . . . . 73.019999999999996 112.695 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 757' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -91.44 115.09 27.75 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.975 0.417 . . . . 75.310000000000002 110.476 176.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 758' ' ' PHE . . . . . 0.484 ' O ' ' HA ' ' A' ' 773' ' ' CYS . 58.9 m-85 -97.13 130.22 44.42 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.955 -0.566 . . . . 75.219999999999999 110.2 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 759' ' ' VAL . . . . . 0.466 HG23 ' HB3' ' A' ' 773' ' ' CYS . 48.3 t -92.96 105.27 16.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.989 0.424 . . . . 75.450000000000003 110.201 178.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -102.46 143.86 31.64 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.262 -0.881 . . . . 75.150000000000006 110.671 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 761' ' ' GLN . . . . . 0.562 ' HA ' ' O ' ' A' ' 770' ' ' PRO . 36.5 tt0 -135.06 135.09 41.01 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.978 -0.556 . . . . 74.230000000000004 109.978 177.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 762' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 769' ' ' PHE . . . -91.51 126.58 36.65 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.159 0.504 . . . . 74.349999999999994 111.025 -178.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -97.32 107.76 20.34 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.595 -0.73 . . . . 74.230000000000004 109.293 176.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 764' ' ' VAL . . . . . 0.627 ' HA ' ' O ' ' A' ' 741' ' ' ALA . 63.0 t -116.37 103.84 15.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.234 0.54 . . . . 64.439999999999998 110.055 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 70.09 -115.1 5.91 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 110.896 -0.882 . . . . 61.340000000000003 110.896 -174.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -109.57 9.82 32.72 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.77 -0.729 . . . . 60.039999999999999 111.328 175.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 767' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -106.84 143.56 34.75 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.075 0.464 . . . . 74.400000000000006 110.5 -177.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 768' ' ' TRP . . . . . 0.445 ' HB3' ' OE1' ' A' ' 761' ' ' GLN . 68.3 m95 -116.55 102.48 9.51 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.629 -0.714 . . . . 75.109999999999999 109.902 -178.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 769' ' ' PHE . . . . . 0.429 ' O ' ' HB3' ' A' ' 762' ' ' ALA . 33.1 p90 -168.91 141.83 2.27 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.343 -0.39 . . . . 74.0 110.23 -176.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 770' ' ' PRO . . . . . 0.583 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 62.5 Cg_endo -98.88 -179.7 5.64 Favored 'Cis proline' 0 N--CA 1.45 -1.034 0 C-N-CA 123.564 -1.432 . . . . 65.109999999999999 111.979 -4.12 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -110.98 112.43 24.24 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.553 -0.536 . . . . 53.130000000000003 109.553 174.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 34.3 m -124.47 149.48 28.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.356 -0.384 . . . . 73.019999999999996 110.937 -177.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 773' ' ' CYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 758' ' ' PHE . 7.7 p -118.02 115.3 24.6 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.938 0.399 . . . . 73.219999999999999 110.453 178.139 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -123.07 157.51 32.66 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.177 -0.465 . . . . 71.349999999999994 110.619 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 775' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -83.29 11.44 6.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.847 0.356 . . . . 73.530000000000001 111.759 -176.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 776' ' ' SER . . . . . 0.422 ' HB3' ' CG ' ' A' ' 779' ' ' GLN . 8.5 t -153.28 145.62 23.97 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.82 -0.437 . . . . 72.430000000000007 109.82 -178.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 777' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -59.63 -50.36 74.18 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.062 -0.517 . . . . 73.109999999999999 111.303 -177.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -62.4 -36.53 82.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.848 0.356 . . . . 75.420000000000002 110.401 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 779' ' ' GLN . . . . . 0.422 ' CG ' ' HB3' ' A' ' 776' ' ' SER . 16.2 mm100 -64.19 -41.92 96.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 54.450000000000003 110.2 178.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -55.87 -48.44 72.51 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.038 -0.601 . . . . 75.25 112.3 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -65.1 -45.47 85.03 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.852 0.358 . . . . 73.5 111.189 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -66.01 -47.2 75.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.23 -0.441 . . . . 72.439999999999998 111.519 -176.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -62.58 -39.07 92.53 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.684 0.278 . . . . 61.219999999999999 110.494 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -62.58 -46.85 86.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.269 -0.423 . . . . 75.450000000000003 110.748 177.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 785' ' ' ALA . . . . . 0.431 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -65.38 -42.55 92.57 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.234 -0.439 . . . . 75.430000000000007 110.953 -179.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 786' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -56.98 -51.17 70.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.337 0.589 . . . . 73.340000000000003 110.404 176.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 787' ' ' ALA . . . . . 0.634 ' O ' HG22 ' A' ' 791' ' ' VAL . . . -64.66 -38.72 91.96 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.333 -0.849 . . . . 72.549999999999997 111.066 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 788' ' ' ALA . . . . . 0.583 ' HB2' ' HD3' ' A' ' 770' ' ' PRO . . . -61.62 -47.0 87.4 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.383 -0.371 . . . . 71.0 111.077 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 789' ' ' LEU . . . . . 0.521 HD21 HD11 ' A' ' 719' ' ' LEU . 79.6 mt -60.97 -43.57 98.58 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.842 -0.429 . . . . 74.219999999999999 109.842 177.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 790' ' ' ARG . . . . . . . . . . . . . 30.7 mtt180 -63.52 -26.43 68.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 75.150000000000006 111.684 178.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 791' ' ' VAL . . . . . 0.634 HG22 ' O ' ' A' ' 787' ' ' ALA . 98.2 t -68.68 -50.43 55.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.747 -0.464 . . . . 75.299999999999997 109.747 172.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 792' ' ' LEU . . . . . 0.572 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 27.2 mt -61.44 -49.92 74.88 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.431 -0.804 . . . . 72.219999999999999 110.349 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 793' ' ' ILE . . . . . 0.417 HG12 ' CG2' ' A' ' 716' ' ' ILE . 95.7 mt -59.61 -43.45 91.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.258 -0.883 . . . . 74.439999999999998 110.881 178.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -68.01 -32.47 77.06 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 121.002 -0.618 . . . . 63.409999999999997 112.644 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -69.37 -44.16 72.09 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.169 0.509 . . . . 72.439999999999998 110.404 178.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 796' ' ' ASN . . . . . 0.527 ' HB3' HG13 ' A' ' 716' ' ' ILE . 2.7 t30 . . . . . 0 C--N 1.325 -0.486 0 CA-C-N 115.851 -0.613 . . . . 71.209999999999994 110.376 -175.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 716' ' ' ILE . . . . . 0.472 ' HA ' HD23 ' A' ' 719' ' ' LEU . 46.7 mm . . . . . 0 C--O 1.233 0.185 0 CA-C-O 120.791 0.329 . . . . 72.019999999999996 111.445 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -60.97 -27.89 67.82 Favored Glycine 0 C--N 1.33 0.208 0 C-N-CA 120.98 -0.629 . . . . 62.149999999999999 112.101 -179.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 718' ' ' GLU . . . . . 0.761 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 2.8 mp0 -63.19 -39.49 94.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.894 0.378 . . . . 72.140000000000001 110.593 177.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 719' ' ' LEU . . . . . 0.539 HD13 HD23 ' A' ' 789' ' ' LEU . 3.0 mm? -67.48 -29.78 69.31 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.073 0.463 . . . . 75.400000000000006 110.139 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 720' ' ' VAL . . . . . 0.464 HG21 HD12 ' A' ' 793' ' ' ILE . 56.6 t -66.65 -41.61 88.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.819 -0.628 . . . . 74.230000000000004 110.737 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 721' ' ' ARG . . . . . 0.761 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 11.8 ptm180 -65.11 -28.47 69.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.016 0.436 . . . . 70.340000000000003 109.907 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -74.19 -30.17 62.09 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.34 -0.391 . . . . 64.319999999999993 110.853 177.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 723' ' ' LEU . . . . . 0.519 HD21 ' HB2' ' A' ' 789' ' ' LEU . 90.9 mt -60.74 -27.55 68.01 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.252 0.549 . . . . 72.25 109.893 173.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 724' ' ' ASN . . . . . 0.506 ' N ' HD21 ' A' ' 724' ' ' ASN . 0.8 OUTLIER -86.45 -44.65 11.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.476 -0.784 . . . . 74.299999999999997 110.817 176.765 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 51.0 m -89.57 -76.64 0.41 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.296 -0.411 . . . . 74.109999999999999 112.043 -175.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 726' ' ' ASN . . . . . 0.433 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 53.8 t-20 -144.82 105.77 4.55 Favored Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 109.997 -0.371 . . . . 71.420000000000002 109.997 -177.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 727' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 20.0 Cg_endo -61.3 -35.97 81.73 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.881 2.387 . . . . 73.310000000000002 112.246 -179.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 728' ' ' VAL . . . . . 0.432 ' O ' ' HG ' ' A' ' 732' ' ' LEU . 59.7 t -64.31 -45.53 95.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.019 -0.537 . . . . 74.450000000000003 110.459 -178.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -61.63 -34.48 88.67 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.945 -0.645 . . . . 62.539999999999999 112.355 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -74.79 -41.32 34.44 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.796 -0.716 . . . . 74.299999999999997 112.56 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -63.12 -40.33 97.3 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.863 -0.421 . . . . 75.140000000000001 109.863 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 732' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 728' ' ' VAL . 95.5 mt -64.19 -46.28 84.62 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.027 -0.533 . . . . 74.25 111.281 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 733' ' ' GLU . . . . . 0.517 ' HA ' ' HG2' ' A' ' 736' ' ' ARG . 6.3 pt-20 -73.97 -31.47 63.02 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.41 -0.516 . . . . 72.340000000000003 110.981 -177.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 734' ' ' TYR . . . . . 0.404 ' HB2' HD11 ' A' ' 719' ' ' LEU . 9.3 t80 -57.29 -48.6 78.5 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 120.895 0.378 . . . . 71.310000000000002 110.063 175.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 735' ' ' ALA . . . . . 0.412 ' HA ' ' HB2' ' A' ' 740' ' ' PHE . . . -65.04 -51.18 63.0 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.985 -0.552 . . . . 64.329999999999998 110.643 -177.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 736' ' ' ARG . . . . . 0.517 ' HG2' ' HA ' ' A' ' 733' ' ' GLU . 12.2 ptm180 -61.7 -34.99 76.73 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.807 -0.633 . . . . 75.319999999999993 111.515 -174.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 47.0 t -77.56 -37.14 51.31 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.038 -0.528 . . . . 74.150000000000006 111.096 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -91.51 -2.53 57.16 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.119 0.414 . . . . 72.129999999999995 112.119 -171.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 94.81 7.93 59.66 Favored Glycine 0 CA--C 1.516 0.143 0 C-N-CA 120.45 -0.881 . . . . 74.439999999999998 112.719 176.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 740' ' ' PHE . . . . . 0.412 ' HB2' ' HA ' ' A' ' 735' ' ' ALA . 98.3 m-85 -93.15 177.81 5.94 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.032 0.444 . . . . 74.299999999999997 110.538 177.123 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -129.69 124.6 33.98 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.882 -0.599 . . . . 62.200000000000003 109.526 175.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 742' ' ' ALA . . . . . . . . . . . . . . . -94.05 115.7 28.05 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.774 0.321 . . . . 63.420000000000002 111.148 -176.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 743' ' ' GLU . . . . . 0.551 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 40.8 mt-10 -127.48 125.36 40.34 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.016 -0.538 . . . . 74.030000000000001 111.051 -179.077 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -105.25 117.27 33.59 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.115 -0.493 . . . . 75.329999999999998 110.414 179.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -134.2 150.42 51.07 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.184 0.516 . . . . 71.409999999999997 111.342 178.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 746' ' ' LEU . . . . . 0.457 HD22 ' HB3' ' A' ' 749' ' ' GLN . 4.9 tt -85.96 111.52 20.33 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.065 -1.087 . . . . 72.340000000000003 108.065 173.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 58.7 t -82.96 -46.25 18.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.895 0.379 . . . . 70.140000000000001 111.143 -174.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -152.03 149.69 29.14 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.407 -0.361 . . . . 61.229999999999997 110.374 -178.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 749' ' ' GLN . . . . . 0.457 ' HB3' HD22 ' A' ' 746' ' ' LEU . 0.0 OUTLIER -144.68 153.09 41.37 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.787 0.327 . . . . 65.340000000000003 110.946 179.515 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 20.9 t -174.75 -169.81 0.44 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.818 -0.808 . . . . 71.230000000000004 108.818 -178.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 107.83 175.18 22.25 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.524 -0.846 . . . . 43.310000000000002 112.733 176.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 752' ' ' PRO . . . . . 0.807 ' HG2' ' HB2' ' A' ' 755' ' ' GLU . 44.9 Cg_endo -69.32 164.35 34.45 Favored 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 123.084 2.523 . . . . 74.129999999999995 112.721 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -64.43 -33.65 56.94 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.62 2.213 . . . . 63.119999999999997 112.685 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 42.3 p-80 -82.95 -15.55 50.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.307 -0.406 . . . . 73.329999999999998 111.102 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 755' ' ' GLU . . . . . 0.807 ' HB2' ' HG2' ' A' ' 752' ' ' PRO . 45.0 mt-10 -135.27 73.75 63.28 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.401 -0.363 . . . . 75.219999999999999 110.798 177.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 756' ' ' PRO . . . . . 0.532 ' O ' ' HA ' ' A' ' 775' ' ' HIS . 42.1 Cg_endo -69.15 114.69 3.69 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.09 1.86 . . . . 72.129999999999995 111.329 178.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 757' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -100.43 117.42 34.57 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.032 0.444 . . . . 71.329999999999998 110.727 -176.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 758' ' ' PHE . . . . . 0.429 ' CD1' HD11 ' A' ' 746' ' ' LEU . 53.5 m-85 -115.12 121.23 42.39 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.602 -0.726 . . . . 74.219999999999999 109.872 -179.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 26.3 t -90.58 106.41 17.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 120.996 0.427 . . . . 71.25 110.313 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -99.26 139.26 35.16 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.688 -0.687 . . . . 72.25 110.285 178.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 761' ' ' GLN . . . . . 0.462 ' HA ' ' O ' ' A' ' 770' ' ' PRO . 55.9 tt0 -130.07 135.73 48.56 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.033 -0.53 . . . . 75.420000000000002 109.725 178.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 762' ' ' ALA . . . . . . . . . . . . . . . -90.56 112.42 24.1 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.967 -0.56 . . . . 73.230000000000004 110.71 -178.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 763' ' ' LYS . . . . . 0.566 ' HD2' ' CH2' ' A' ' 768' ' ' TRP . 61.0 tttm -88.32 104.66 16.95 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.065 -0.717 . . . . 73.409999999999997 109.065 175.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 56.9 t -109.9 100.72 11.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.349 0.595 . . . . 74.319999999999993 109.975 -179.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 75.19 -117.9 5.43 Favored Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 110.834 -0.906 . . . . 71.25 110.834 -175.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -103.36 3.97 47.48 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.662 -0.78 . . . . 63.219999999999999 111.627 176.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 767' ' ' ARG . . . . . . . . . . . . . 50.3 mtt180 -103.58 152.86 21.24 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.052 0.454 . . . . 72.239999999999995 111.029 -176.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 768' ' ' TRP . . . . . 0.566 ' CH2' ' HD2' ' A' ' 763' ' ' LYS . 59.2 m95 -118.83 105.15 11.23 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.687 -0.688 . . . . 74.099999999999994 109.386 176.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 769' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -171.47 139.09 1.14 Allowed Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 120.854 0.359 . . . . 72.349999999999994 110.925 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 770' ' ' PRO . . . . . 0.562 ' HD3' ' HB1' ' A' ' 788' ' ' ALA . 79.6 Cg_endo -99.54 -176.8 3.79 Favored 'Cis proline' 0 N--CA 1.453 -0.908 0 C-N-CA 123.718 -1.367 . . . . 63.119999999999997 111.947 -4.134 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -113.88 116.18 28.87 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.771 -0.455 . . . . 71.109999999999999 109.771 175.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 29.1 m -118.94 140.74 41.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.145 0.498 . . . . 75.430000000000007 111.269 -176.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 3.9 p -95.72 102.54 14.35 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.89 -0.596 . . . . 71.150000000000006 110.508 178.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -107.15 177.63 4.79 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.147 -0.479 . . . . 73.310000000000002 110.817 -177.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 775' ' ' HIS . . . . . 0.532 ' HA ' ' O ' ' A' ' 756' ' ' PRO . 28.5 m-70 -117.38 12.45 14.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.127 0.489 . . . . 70.400000000000006 110.066 178.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 33.7 t -167.76 154.06 7.72 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.533 -0.758 . . . . 65.340000000000003 109.692 -176.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 777' ' ' LYS . . . . . . . . . . . . . 5.4 tmmm? -62.53 -42.66 99.67 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.649 -0.5 . . . . 73.219999999999999 109.649 177.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -58.31 -40.46 82.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.417 -0.811 . . . . 71.239999999999995 110.723 178.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 779' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -70.06 -45.55 66.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.318 -0.401 . . . . 62.039999999999999 110.438 177.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -54.55 -47.59 69.31 Favored Glycine 0 C--O 1.226 -0.398 0 CA-C-N 115.909 -0.587 . . . . 61.310000000000002 113.072 -176.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -66.79 -44.79 80.39 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.621 0.248 . . . . 72.439999999999998 111.258 -178.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -67.63 -49.39 63.17 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.541 -0.3 . . . . 75.430000000000007 111.358 -177.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -63.68 -39.89 95.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.572 0.225 . . . . 65.129999999999995 110.938 -178.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -62.05 -50.78 70.62 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 116.486 -0.325 . . . . 64.439999999999998 110.527 178.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 785' ' ' ALA . . . . . 0.542 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -65.75 -39.11 90.74 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.324 -0.398 . . . . 64.239999999999995 110.968 -179.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 786' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -57.75 -54.17 49.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.031 -0.531 . . . . 71.200000000000003 110.476 177.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 787' ' ' ALA . . . . . 0.596 ' O ' HG23 ' A' ' 791' ' ' VAL . . . -64.82 -36.69 85.13 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.855 -0.611 . . . . 60.240000000000002 110.723 179.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 788' ' ' ALA . . . . . 0.627 ' O ' ' HG ' ' A' ' 792' ' ' LEU . . . -59.49 -48.61 80.98 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.556 -0.293 . . . . 75.430000000000007 110.98 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 789' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 785' ' ' ALA . 63.1 mt -61.49 -39.97 92.85 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.837 -0.431 . . . . 72.230000000000004 109.837 178.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 790' ' ' ARG . . . . . . . . . . . . . 65.4 mtp180 -64.31 -30.91 71.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.607 -0.724 . . . . 75.310000000000002 111.488 178.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 791' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 787' ' ' ALA . 91.5 t -66.94 -48.26 80.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.758 -0.46 . . . . 75.310000000000002 109.758 173.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 792' ' ' LEU . . . . . 0.627 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 23.0 mt -60.58 -54.57 43.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.724 -0.671 . . . . 72.0 110.436 -179.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 793' ' ' ILE . . . . . 0.464 HD12 HG21 ' A' ' 720' ' ' VAL . 76.6 mt -58.15 -45.73 88.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.382 -0.826 . . . . 75.439999999999998 110.594 177.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -59.5 -48.4 86.18 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 121.121 -0.561 . . . . 75.120000000000005 112.276 179.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -60.88 -31.3 70.78 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.568 0.211 . . . . 74.349999999999994 111.568 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 . . . . . 0 C--N 1.324 -0.535 0 CA-C-O 121.192 0.52 . . . . 75.129999999999995 110.518 176.439 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 716' ' ' ILE . . . . . 0.53 ' HA ' HD23 ' A' ' 719' ' ' LEU . 47.0 mm . . . . . 0 C--O 1.234 0.288 0 CA-C-O 120.89 0.376 . . . . 74.099999999999994 111.626 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -56.92 -30.63 60.36 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 121.196 -0.526 . . . . 65.310000000000002 112.893 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -66.32 -41.04 90.23 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.762 0.315 . . . . 73.299999999999997 110.79 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 719' ' ' LEU . . . . . 0.54 HD12 HD21 ' A' ' 789' ' ' LEU . 2.9 mm? -65.02 -36.3 83.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.016 0.436 . . . . 71.340000000000003 109.998 -178.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 720' ' ' VAL . . . . . 0.458 HG21 HD12 ' A' ' 793' ' ' ILE . 52.3 t -64.08 -37.5 80.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-N 115.82 -0.627 . . . . 53.539999999999999 110.173 176.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 721' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.12 -30.32 71.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.794 -0.639 . . . . 73.340000000000003 109.775 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -78.47 -25.04 45.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.898 -0.592 . . . . 74.420000000000002 111.471 179.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 91.1 mt -60.03 -30.6 69.28 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.425 0.631 . . . . 73.209999999999994 109.461 173.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -84.87 -56.59 3.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.312 -0.858 . . . . 73.540000000000006 111.219 174.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 24.4 m -77.91 -64.23 1.2 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.916 0.709 . . . . 71.120000000000005 112.916 -171.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 726' ' ' ASN . . . . . 0.401 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 30.6 t30 -159.94 100.76 1.45 Allowed Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 120.834 0.349 . . . . 73.129999999999995 110.914 -175.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 727' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 20.9 Cg_endo -62.36 -39.61 45.58 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.875 2.384 . . . . 71.010000000000005 112.317 -177.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 39.5 t -59.97 -42.3 89.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.998 -0.546 . . . . 70.530000000000001 110.958 -177.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 729' ' ' GLY . . . . . 0.474 ' O ' ' HG2' ' A' ' 733' ' ' GLU . . . -65.02 -47.38 82.99 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.611 -0.804 . . . . 72.329999999999998 111.939 -179.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -64.14 -39.31 97.02 Favored Glycine 0 C--O 1.226 -0.349 0 C-N-CA 121.09 -0.576 . . . . 72.129999999999995 113.259 -176.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -61.67 -39.76 92.56 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.894 -0.41 . . . . 74.010000000000005 109.894 179.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 732' ' ' LEU . . . . . . . . . . . . . 96.3 mt -68.04 -47.34 68.64 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.929 -0.578 . . . . 73.109999999999999 111.276 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 733' ' ' GLU . . . . . 0.487 ' HA ' ' HB3' ' A' ' 736' ' ' ARG . 9.1 pt-20 -75.15 -26.47 59.14 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.715 -0.394 . . . . 74.549999999999997 111.683 -176.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 734' ' ' TYR . . . . . 0.424 ' HB2' HD13 ' A' ' 719' ' ' LEU . 17.5 t80 -56.99 -50.17 73.52 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.347 -0.612 . . . . 74.230000000000004 109.347 172.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -64.29 -46.29 84.29 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.903 -0.589 . . . . 72.109999999999999 110.533 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 736' ' ' ARG . . . . . 0.487 ' HB3' ' HA ' ' A' ' 733' ' ' GLU . 1.4 ttt180 -55.49 -48.73 74.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.07 -0.514 . . . . 73.219999999999999 112.011 -178.083 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 22.7 t -81.59 -11.82 58.99 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.678 0.275 . . . . 72.150000000000006 111.224 -174.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -110.49 -2.61 16.44 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.817 -0.353 . . . . 71.409999999999997 111.592 -176.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 88.9 9.96 67.37 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.538 -0.839 . . . . 74.319999999999993 113.258 174.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -95.61 168.72 10.51 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.906 0.353 . . . . 64.340000000000003 110.4 177.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -114.1 114.48 26.14 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.219 -0.446 . . . . 60.119999999999997 110.025 176.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 742' ' ' ALA . . . . . . . . . . . . . . . -92.48 133.22 36.13 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.262 -0.427 . . . . 64.420000000000002 110.886 -178.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 743' ' ' GLU . . . . . 0.425 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 9.7 mm-40 -144.98 157.65 44.06 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.271 -0.422 . . . . 73.400000000000006 111.142 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -130.16 132.03 45.89 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.815 -0.63 . . . . 74.439999999999998 109.76 177.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -136.37 137.92 41.06 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.126 0.489 . . . . 73.129999999999995 111.748 177.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 746' ' ' LEU . . . . . . . . . . . . . 5.0 tt -82.69 105.33 13.63 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.385 -0.969 . . . . 75.150000000000006 108.385 173.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 46.0 t -70.98 -56.13 11.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.919 0.39 . . . . 72.530000000000001 110.686 -176.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -154.94 152.37 29.64 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.977 -0.556 . . . . 73.109999999999999 110.276 -178.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -134.06 122.75 23.4 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.951 -0.759 . . . . 74.549999999999997 108.951 174.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 67.3 m -146.56 148.28 31.99 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.722 0.296 . . . . 64.409999999999997 110.942 -176.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 139.77 -177.65 20.34 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.93 -0.652 . . . . 74.040000000000006 112.163 177.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 752' ' ' PRO . . . . . 0.413 ' HG2' ' CB ' ' A' ' 755' ' ' GLU . 54.9 Cg_endo -71.47 166.76 28.34 Favored 'Trans proline' 0 CA--C 1.533 0.442 0 C-N-CA 122.793 2.329 . . . . 73.340000000000003 111.962 176.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -63.76 -34.99 59.76 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.684 2.256 . . . . 72.409999999999997 112.824 -178.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 54.7 p-80 -84.51 -7.26 59.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.958 0.408 . . . . 70.109999999999999 111.069 -178.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 755' ' ' GLU . . . . . 0.413 ' CB ' ' HG2' ' A' ' 752' ' ' PRO . 0.4 OUTLIER -141.95 68.95 23.76 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 116.132 -0.485 . . . . 73.510000000000005 109.972 -178.694 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 756' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -79.64 109.26 2.42 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.405 2.07 . . . . 71.540000000000006 111.936 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 757' ' ' LYS . . . . . 0.772 ' HZ1' ' HB2' ' A' ' 757' ' ' LYS . 4.4 ttmp? -93.73 112.99 24.95 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.237 0.541 . . . . 73.5 110.58 -178.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 758' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -99.05 119.29 37.57 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.363 -0.835 . . . . 75.319999999999993 110.454 -178.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 16.7 t -92.67 105.85 17.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.19 -0.459 . . . . 74.540000000000006 109.904 178.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -108.92 141.9 40.32 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.984 -0.553 . . . . 72.530000000000001 110.735 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 761' ' ' GLN . . . . . 0.523 ' HA ' ' O ' ' A' ' 770' ' ' PRO . 35.4 tt0 -133.96 135.96 43.85 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.751 -0.658 . . . . 73.439999999999998 109.613 176.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 762' ' ' ALA . . . . . . . . . . . . . . . -96.86 147.69 23.69 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.799 -0.637 . . . . 73.540000000000006 110.443 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 763' ' ' LYS . . . . . 0.559 ' HE3' ' CZ2' ' A' ' 768' ' ' TRP . 68.1 tttt -118.46 127.86 54.06 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.295 -0.631 . . . . 74.319999999999993 109.295 178.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 62.9 t -127.64 102.0 8.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.146 0.498 . . . . 74.349999999999994 109.869 178.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 76.41 -101.99 1.56 Allowed Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 110.96 -0.856 . . . . 72.140000000000001 110.96 -176.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -121.0 4.81 11.37 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 111.219 -0.752 . . . . 71.540000000000006 111.219 174.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 767' ' ' ARG . . . . . . . . . . . . . 39.7 mmt180 -98.5 146.29 25.92 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.974 0.416 . . . . 73.019999999999996 110.903 -178.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 768' ' ' TRP . . . . . 0.559 ' CZ2' ' HE3' ' A' ' 763' ' ' LYS . 55.6 m95 -117.28 107.41 14.37 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.617 -0.719 . . . . 74.540000000000006 109.777 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 769' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -169.87 143.23 2.08 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 110.198 -0.297 . . . . 74.129999999999995 110.198 -177.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 770' ' ' PRO . . . . . 0.558 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 62.1 Cg_endo -99.07 178.53 6.38 Favored 'Cis proline' 0 N--CA 1.452 -0.933 0 C-N-CA 123.633 -1.403 . . . . 71.409999999999997 111.875 -4.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -105.13 102.24 11.75 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.626 -0.509 . . . . 75.299999999999997 109.626 173.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 24.0 m -116.92 135.44 57.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.077 0.465 . . . . 73.420000000000002 111.176 -176.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 1.5 p -110.22 102.71 11.36 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.0 -0.545 . . . . 74.340000000000003 110.174 177.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -100.29 178.97 4.61 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.726 -0.67 . . . . 75.200000000000003 111.175 -175.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 775' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -94.44 -8.82 37.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.052 0.453 . . . . 70.310000000000002 110.516 -176.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 55.2 m -145.91 158.02 43.88 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.693 -0.685 . . . . 75.230000000000004 109.765 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 777' ' ' LYS . . . . . . . . . . . . . 6.1 tmmm? -69.3 -39.71 78.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.589 -0.278 . . . . 64.310000000000002 110.539 -177.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -60.89 -47.41 86.52 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.861 -0.422 . . . . 72.540000000000006 109.861 175.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 779' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -52.92 -47.98 67.59 Favored 'General case' 0 C--O 1.226 -0.137 0 CA-C-N 115.709 -0.678 . . . . 71.25 110.966 174.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -53.83 -47.97 63.58 Favored Glycine 0 C--O 1.228 -0.24 0 CA-C-N 116.028 -0.533 . . . . 64.030000000000001 113.035 -177.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -66.42 -45.18 80.78 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.857 0.361 . . . . 74.409999999999997 110.982 -178.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -71.59 -37.0 71.05 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.233 -0.439 . . . . 73.140000000000001 111.399 -176.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -72.08 -35.68 69.31 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.524 0.202 . . . . 72.450000000000003 110.742 177.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -60.06 -49.53 77.27 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.949 -0.389 . . . . 73.230000000000004 109.949 176.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 785' ' ' ALA . . . . . 0.61 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -65.78 -42.16 91.1 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.073 -0.512 . . . . 64.340000000000003 110.793 178.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 786' ' ' ASP . . . . . 0.514 ' O ' ' HG2' ' A' ' 790' ' ' ARG . 12.4 t70 -56.71 -55.83 29.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.022 -0.535 . . . . 74.430000000000007 110.755 179.201 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 787' ' ' ALA . . . . . 0.536 ' O ' HG22 ' A' ' 791' ' ' VAL . . . -68.22 -31.07 70.32 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.952 -0.567 . . . . 72.299999999999997 111.212 -178.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 788' ' ' ALA . . . . . 0.675 ' O ' ' HG ' ' A' ' 792' ' ' LEU . . . -62.63 -42.83 99.81 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 120.812 0.339 . . . . 75.329999999999998 110.168 177.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 789' ' ' LEU . . . . . 0.61 ' HG ' ' O ' ' A' ' 785' ' ' ALA . 79.8 mt -61.82 -40.16 94.3 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.08 -0.509 . . . . 73.239999999999995 109.749 176.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 790' ' ' ARG . . . . . 0.514 ' HG2' ' O ' ' A' ' 786' ' ' ASP . 47.2 mmm-85 -59.79 -38.05 80.82 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.98 -0.554 . . . . 75.319999999999993 110.471 177.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 791' ' ' VAL . . . . . 0.536 HG22 ' O ' ' A' ' 787' ' ' ALA . 48.7 t -62.46 -53.18 50.66 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.31 0 N-CA-C 109.881 -0.414 . . . . 72.349999999999994 109.881 175.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 792' ' ' LEU . . . . . 0.675 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 22.1 mt -55.32 -48.01 74.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.263 0.554 . . . . 73.109999999999999 110.681 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 793' ' ' ILE . . . . . 0.495 HG12 HG21 ' A' ' 716' ' ' ILE . 90.6 mt -61.76 -48.59 87.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.1 -0.955 . . . . 72.439999999999998 111.079 177.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -66.28 -34.88 89.35 Favored Glycine 0 CA--C 1.519 0.299 0 CA-C-N 116.145 -0.479 . . . . 64.409999999999997 113.122 -178.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 795' ' ' GLU . . . . . 0.511 ' HG2' ' O ' ' A' ' 791' ' ' VAL . 44.7 mm-40 -66.64 -32.24 73.44 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.81 0.338 . . . . 74.420000000000002 110.782 178.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 . . . . . 0 C--N 1.327 -0.404 0 CA-C-O 120.998 0.427 . . . . 65.409999999999997 109.977 177.974 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 716' ' ' ILE . . . . . 0.541 HG23 ' HA ' ' A' ' 793' ' ' ILE . 42.1 mm . . . . . 0 C--O 1.235 0.337 0 CA-C-O 121.306 0.574 . . . . 72.230000000000004 110.715 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -58.27 -23.13 52.42 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.873 -0.603 . . . . 73.450000000000003 112.311 176.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 718' ' ' GLU . . . . . 0.605 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 44.1 mt-10 -68.25 -36.67 79.8 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 122.747 -0.267 . . . . 74.129999999999995 110.287 176.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 719' ' ' LEU . . . . . 0.539 HD22 ' HA ' ' A' ' 716' ' ' ILE . 3.4 mm? -61.02 -33.88 73.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.235 0.541 . . . . 73.129999999999995 110.009 175.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 720' ' ' VAL . . . . . 0.491 HG21 HD12 ' A' ' 793' ' ' ILE . 27.4 t -62.86 -36.3 74.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.624 -0.717 . . . . 74.349999999999994 110.949 177.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 721' ' ' ARG . . . . . 0.605 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 10.5 ptt180 -68.75 -28.62 66.97 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.892 0.377 . . . . 71.239999999999995 110.178 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -73.02 -32.05 64.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 72.239999999999995 110.629 177.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 723' ' ' LEU . . . . . 0.531 HD23 ' HB2' ' A' ' 789' ' ' LEU . 89.9 mt -57.81 -36.65 72.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.292 0.567 . . . . 74.200000000000003 109.939 173.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -69.49 -40.34 77.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.179 -0.919 . . . . 72.140000000000001 111.501 178.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 46.1 m -103.26 -80.87 0.51 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.055 0.391 . . . . 74.049999999999997 112.055 -176.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 726' ' ' ASN . . . . . 0.438 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 28.0 t30 -135.06 106.82 10.38 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-O 121.032 0.444 . . . . 70.340000000000003 110.8 -174.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 727' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 20.4 Cg_endo -62.2 -36.33 69.52 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 122.894 2.396 . . . . 53.119999999999997 112.579 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 34.4 t -61.47 -47.09 95.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.254 -0.43 . . . . 74.150000000000006 110.538 -177.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -61.09 -36.55 92.5 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.923 -0.656 . . . . 73.150000000000006 112.041 178.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 730' ' ' GLY . . . . . 0.464 ' O ' ' HG3' ' A' ' 733' ' ' GLU . . . -68.32 -45.3 70.44 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 121.106 -0.569 . . . . 75.040000000000006 112.532 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -64.46 -41.23 96.63 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.973 0.416 . . . . 73.219999999999999 110.06 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 732' ' ' LEU . . . . . . . . . . . . . 94.9 mt -67.24 -32.85 74.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.158 -0.474 . . . . 74.340000000000003 111.495 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 733' ' ' GLU . . . . . 0.464 ' HG3' ' O ' ' A' ' 730' ' ' GLY . 1.1 pp20? -85.17 -33.52 22.29 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.557 -0.457 . . . . 75.25 110.495 -178.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 734' ' ' TYR . . . . . 0.516 ' HB2' HD12 ' A' ' 719' ' ' LEU . 4.0 t80 -55.06 -45.18 75.27 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.837 0.351 . . . . 75.409999999999997 110.463 174.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -65.38 -52.92 50.27 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.112 -0.494 . . . . 64.0 110.299 -176.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 736' ' ' ARG . . . . . 0.413 ' HG2' ' O ' ' A' ' 733' ' ' GLU . 36.5 ptt180 -60.48 -37.84 82.34 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.971 -0.559 . . . . 72.120000000000005 110.94 -176.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 28.5 t -70.37 -32.26 69.85 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.875 -0.602 . . . . 75.219999999999999 111.452 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -97.19 -8.78 29.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.717 0.294 . . . . 74.439999999999998 111.689 -175.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 98.25 9.21 54.06 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.63 -0.795 . . . . 52.520000000000003 112.959 176.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -96.51 170.4 9.24 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.178 -0.304 . . . . 72.319999999999993 110.178 177.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -117.37 129.22 55.73 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.602 -0.518 . . . . 73.310000000000002 109.602 172.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 742' ' ' ALA . . . . . . . . . . . . . . . -100.87 120.97 40.92 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.913 0.387 . . . . 71.340000000000003 111.352 -175.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 743' ' ' GLU . . . . . 0.546 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 38.7 mt-10 -122.44 135.24 54.64 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.199 -0.455 . . . . 73.129999999999995 110.964 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -114.32 97.96 6.64 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.269 -0.641 . . . . 75.219999999999999 109.269 175.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -113.8 140.8 48.0 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.345 -0.542 . . . . 74.209999999999994 111.198 -177.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 746' ' ' LEU . . . . . . . . . . . . . 59.8 tp -74.72 116.05 14.99 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.643 -0.708 . . . . 74.340000000000003 109.332 174.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 60.2 t -75.35 -49.78 26.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.691 -0.485 . . . . 61.310000000000002 109.691 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -167.05 -175.42 3.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.833 -0.621 . . . . 73.519999999999996 109.667 178.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -138.72 128.8 25.4 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.382 -0.599 . . . . 74.0 109.382 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 750' ' ' SER . . . . . 0.401 ' O ' ' HB3' ' A' ' 757' ' ' LYS . 6.4 t -137.65 90.88 2.54 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.868 -0.419 . . . . 74.319999999999993 109.868 -177.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 179.54 154.33 13.09 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.353 -0.927 . . . . 63.439999999999998 112.477 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 752' ' ' PRO . . . . . 0.59 ' HG2' ' HB2' ' A' ' 755' ' ' GLU . 37.6 Cg_endo -66.59 168.38 16.7 Favored 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 123.309 2.673 . . . . 71.230000000000004 112.238 177.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -56.48 -33.13 91.68 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.751 2.301 . . . . 55.140000000000001 112.759 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 45.9 p-80 -87.83 -4.19 58.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.383 -0.371 . . . . 70.239999999999995 111.359 -178.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 755' ' ' GLU . . . . . 0.59 ' HB2' ' HG2' ' A' ' 752' ' ' PRO . 16.6 mm-40 -152.93 61.97 4.04 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.354 -0.385 . . . . 71.420000000000002 111.306 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 756' ' ' PRO . . . . . 0.417 ' O ' ' HA ' ' A' ' 775' ' ' HIS . 59.6 Cg_endo -73.2 99.3 1.09 Allowed 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.175 1.917 . . . . 71.209999999999994 111.583 -177.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 757' ' ' LYS . . . . . 0.441 ' HD3' ' HB2' ' A' ' 773' ' ' CYS . 38.3 ttmt -87.05 107.76 18.57 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.247 0.546 . . . . 50.109999999999999 110.384 -177.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 758' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -86.93 130.61 34.39 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.274 -0.876 . . . . 74.239999999999995 110.151 -179.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 43.4 t -95.45 104.34 15.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.841 -0.429 . . . . 75.349999999999994 109.841 177.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -105.98 138.89 41.4 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.048 -0.524 . . . . 70.319999999999993 110.644 -179.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 761' ' ' GLN . . . . . 0.411 ' HA ' ' O ' ' A' ' 770' ' ' PRO . 52.4 tt0 -128.65 128.87 45.0 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.557 -0.534 . . . . 65.129999999999995 109.557 177.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 762' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 769' ' ' PHE . . . -87.09 122.11 30.46 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.184 0.516 . . . . 72.129999999999995 110.407 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 763' ' ' LYS . . . . . 0.632 ' HD2' ' CH2' ' A' ' 768' ' ' TRP . 55.1 tttm -104.32 115.26 30.07 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.916 -0.584 . . . . 74.439999999999998 110.041 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 59.0 t -118.7 100.72 10.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.058 0.456 . . . . 73.129999999999995 110.114 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 74.54 -102.89 1.44 Allowed Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.681 -0.69 . . . . 71.409999999999997 111.408 -176.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -120.45 10.88 10.56 Favored Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 111.162 -0.775 . . . . 71.420000000000002 111.162 174.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 767' ' ' ARG . . . . . 0.463 ' HG3' ' CD1' ' A' ' 769' ' ' PHE . 13.9 tpt180 -108.18 121.98 45.98 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.825 0.345 . . . . 71.409999999999997 110.879 -177.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 768' ' ' TRP . . . . . 0.632 ' CH2' ' HD2' ' A' ' 763' ' ' LYS . 48.0 m95 -95.44 107.44 19.59 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.787 -0.642 . . . . 73.349999999999994 109.571 177.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 769' ' ' PHE . . . . . 0.463 ' CD1' ' HG3' ' A' ' 767' ' ' ARG . 8.7 p90 -170.89 136.84 1.12 Allowed Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 120.888 0.375 . . . . 74.310000000000002 110.472 -178.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 770' ' ' PRO . . . . . 0.539 ' HD3' ' HB1' ' A' ' 788' ' ' ALA . 74.5 Cg_endo -97.36 -179.27 6.3 Favored 'Cis proline' 0 N--CA 1.447 -1.221 0 C-N-CA 123.475 -1.469 . . . . 54.219999999999999 111.773 -4.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -109.91 105.78 15.09 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.473 -0.566 . . . . 73.349999999999994 109.473 173.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 33.7 m -111.72 163.29 8.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.995 0.426 . . . . 73.239999999999995 111.147 -175.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 773' ' ' CYS . . . . . 0.441 ' HB2' ' HD3' ' A' ' 757' ' ' LYS . 5.1 p -133.52 117.99 17.79 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.889 -0.596 . . . . 60.210000000000001 110.017 179.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -132.67 143.75 49.86 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.287 -0.415 . . . . 73.310000000000002 110.705 -177.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 775' ' ' HIS . . . . . 0.417 ' HA ' ' O ' ' A' ' 756' ' ' PRO . 0.5 OUTLIER -80.14 24.34 0.43 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.146 0.498 . . . . 73.430000000000007 111.442 -178.521 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 776' ' ' SER . . . . . 0.551 ' HB3' ' HB2' ' A' ' 779' ' ' GLN . 24.9 t -152.76 137.96 17.42 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.578 -0.897 . . . . 73.0 108.578 175.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 777' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -66.92 -42.69 84.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.78 0.324 . . . . 74.409999999999997 110.327 -176.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -63.23 -38.09 89.79 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.178 -0.465 . . . . 73.099999999999994 110.379 178.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 779' ' ' GLN . . . . . 0.551 ' HB2' ' HB3' ' A' ' 776' ' ' SER . 76.6 mm-40 -71.72 -33.07 68.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.93 -0.577 . . . . 74.530000000000001 110.975 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -56.11 -43.91 88.56 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.112 -0.566 . . . . 61.310000000000002 112.107 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -69.04 -43.34 74.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.583 0.23 . . . . 74.439999999999998 110.985 178.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -63.42 -45.19 92.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.334 -0.393 . . . . 72.420000000000002 110.953 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -61.96 -44.44 96.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.303 -0.408 . . . . 75.340000000000003 110.924 178.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -61.29 -43.92 98.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.272 -0.422 . . . . 64.120000000000005 110.745 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 785' ' ' ALA . . . . . 0.547 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -65.45 -46.04 81.44 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.012 -0.54 . . . . 53.219999999999999 111.106 -178.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 786' ' ' ASP . . . . . 0.639 ' O ' ' HG2' ' A' ' 790' ' ' ARG . 14.9 t70 -60.31 -54.22 48.34 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 109.879 -0.415 . . . . 74.109999999999999 109.879 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 787' ' ' ALA . . . . . 0.527 ' O ' HG23 ' A' ' 791' ' ' VAL . . . -59.55 -35.48 74.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.67 -0.695 . . . . 73.409999999999997 111.229 -178.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 788' ' ' ALA . . . . . 0.622 ' O ' ' HG ' ' A' ' 792' ' ' LEU . . . -62.14 -45.2 94.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.508 -0.315 . . . . 71.219999999999999 110.63 177.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 789' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 785' ' ' ALA . 50.4 mt -64.29 -35.26 80.28 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 109.835 -0.431 . . . . 73.549999999999997 109.835 179.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 790' ' ' ARG . . . . . 0.639 ' HG2' ' O ' ' A' ' 786' ' ' ASP . 13.0 mmm-85 -59.63 -41.27 90.08 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 109.794 -0.447 . . . . 74.140000000000001 109.794 177.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 791' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 787' ' ' ALA . 43.5 t -63.67 -51.27 72.16 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 CA-C-N 115.625 -0.716 . . . . 75.120000000000005 110.111 177.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 792' ' ' LEU . . . . . 0.622 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 47.3 mt -57.16 -52.68 64.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.017 -0.538 . . . . 74.230000000000004 111.171 -177.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 793' ' ' ILE . . . . . 0.541 ' HA ' HG23 ' A' ' 716' ' ' ILE . 70.3 mt -60.12 -52.55 59.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.709 -0.678 . . . . 73.450000000000003 111.176 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -62.77 -41.62 99.82 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.855 -0.688 . . . . 64.010000000000005 112.681 -178.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -66.57 -39.36 88.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.833 0.349 . . . . 63.310000000000002 110.529 -178.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 8.3 t30 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.031 -0.531 . . . . 71.519999999999996 110.037 179.452 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 716' ' ' ILE . . . . . 0.501 HG23 ' HA ' ' A' ' 793' ' ' ILE . 42.4 mm . . . . . 0 C--O 1.235 0.32 0 CA-C-O 121.221 0.534 . . . . 73.530000000000001 110.387 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -63.69 -21.17 64.8 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.787 -0.642 . . . . 70.310000000000002 111.971 177.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 718' ' ' GLU . . . . . 0.713 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 15.8 mm-40 -65.57 -40.75 93.12 Favored 'General case' 0 C--O 1.225 -0.234 0 N-CA-C 109.592 -0.521 . . . . 71.150000000000006 109.592 176.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 719' ' ' LEU . . . . . 0.506 HD12 HD23 ' A' ' 789' ' ' LEU . 2.9 mm? -65.37 -33.01 74.97 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.624 -0.51 . . . . 70.549999999999997 109.624 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 720' ' ' VAL . . . . . 0.466 HG23 HD13 ' A' ' 793' ' ' ILE . 57.6 t -65.76 -38.04 81.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.668 -0.696 . . . . 74.120000000000005 110.822 178.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 721' ' ' ARG . . . . . 0.713 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 22.5 ptt180 -65.71 -26.2 67.65 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.191 0.52 . . . . 61.119999999999997 109.785 179.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -80.52 -27.01 37.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.983 -0.553 . . . . 62.119999999999997 110.991 178.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 723' ' ' LEU . . . . . 0.508 HD21 ' HB2' ' A' ' 789' ' ' LEU . 87.7 mt -62.43 -27.2 68.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.137 0.494 . . . . 74.019999999999996 109.708 172.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -89.68 -38.96 13.51 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.336 -0.847 . . . . 71.400000000000006 110.938 177.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 18.5 m -93.89 -74.64 0.53 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.973 0.36 . . . . 55.210000000000001 111.973 -174.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 726' ' ' ASN . . . . . 0.455 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 38.0 t30 -153.36 106.84 2.59 Favored Pre-proline 0 C--O 1.236 0.359 0 CA-C-O 120.894 0.378 . . . . 73.010000000000005 110.354 -178.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 727' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 17.9 Cg_endo -60.0 -36.68 88.89 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 123.217 2.611 . . . . 74.340000000000003 112.964 -177.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 46.0 t -58.64 -49.96 80.73 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 CA-C-N 116.361 -0.381 . . . . 74.040000000000006 110.776 -177.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -61.54 -35.22 90.77 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.918 -0.658 . . . . 75.439999999999998 112.377 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -71.79 -44.19 48.54 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.837 -0.697 . . . . 70.109999999999999 112.811 -179.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -64.27 -39.5 94.06 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.777 -0.453 . . . . 74.019999999999996 109.777 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 732' ' ' LEU . . . . . 0.438 HD23 ' HB2' ' A' ' 742' ' ' ALA . 95.7 mt -63.83 -43.38 96.35 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.881 -0.6 . . . . 71.340000000000003 111.485 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 733' ' ' GLU . . . . . 0.561 ' HA ' ' HG2' ' A' ' 736' ' ' ARG . 8.4 pt-20 -77.42 -29.94 53.22 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 120.549 -0.46 . . . . 44.530000000000001 111.239 -176.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 734' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -55.42 -49.28 72.81 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.074 0.464 . . . . 63.43 109.793 173.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -66.5 -52.77 42.43 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.705 -0.68 . . . . 75.329999999999998 111.021 -177.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 736' ' ' ARG . . . . . 0.561 ' HG2' ' HA ' ' A' ' 733' ' ' GLU . 35.7 ptt180 -58.74 -36.07 73.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.036 -0.529 . . . . 71.040000000000006 111.384 -174.098 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 18.9 t -76.04 -37.09 58.73 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.008 -0.542 . . . . 52.149999999999999 110.842 -178.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -88.36 -7.64 56.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.467 -0.333 . . . . 74.510000000000005 111.483 -174.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 103.79 -3.31 45.45 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.611 -0.804 . . . . 72.409999999999997 113.096 175.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -88.56 170.26 11.01 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.928 0.394 . . . . 53.130000000000003 110.413 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -115.51 131.43 56.93 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.49 -0.559 . . . . 73.140000000000001 109.49 173.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 742' ' ' ALA . . . . . 0.438 ' HB2' HD23 ' A' ' 732' ' ' LEU . . . -98.87 110.28 22.91 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 123.22 0.325 . . . . 71.340000000000003 110.538 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 743' ' ' GLU . . . . . 0.539 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 47.0 mt-10 -115.04 132.73 56.5 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.103 -0.499 . . . . 71.319999999999993 111.074 -177.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -113.13 109.76 19.33 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.072 -0.513 . . . . 75.109999999999999 109.783 175.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -122.41 152.76 39.89 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.081 0.467 . . . . 75.230000000000004 111.393 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 746' ' ' LEU . . . . . . . . . . . . . 6.5 tt -82.92 113.8 20.77 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.833 -0.803 . . . . 75.200000000000003 108.833 175.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 54.8 t -82.36 -50.35 16.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.181 0.515 . . . . 73.510000000000005 110.671 -176.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -155.69 147.14 22.81 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.717 -0.674 . . . . 72.310000000000002 109.495 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.91 109.94 20.73 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.442 0.639 . . . . 72.510000000000005 110.167 175.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 6.6 m -108.88 80.64 1.35 Allowed 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.8 -0.815 . . . . 73.120000000000005 108.8 176.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 751' ' ' GLY . . . . . 0.505 ' HA2' ' HD2' ' A' ' 752' ' ' PRO . . . -131.41 113.46 1.36 Allowed Glycine 0 N--CA 1.439 -1.124 0 C-N-CA 119.895 -1.145 . . . . 62.240000000000002 114.131 -170.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 752' ' ' PRO . . . . . 0.505 ' HD2' ' HA2' ' A' ' 751' ' ' GLY . 20.1 Cg_endo -60.92 169.95 5.27 Favored 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 123.095 2.53 . . . . 61.009999999999998 111.029 167.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -61.42 -35.39 83.36 Favored 'Trans proline' 0 CA--C 1.529 0.228 0 C-N-CA 122.177 1.918 . . . . 75.209999999999994 112.777 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 55.7 p-80 -83.41 -20.95 33.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.752 0.311 . . . . 73.140000000000001 111.349 -177.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -142.4 74.8 19.96 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 111.923 0.342 . . . . 73.120000000000005 111.923 -176.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 756' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -58.06 92.87 0.06 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 122.096 1.864 . . . . 75.349999999999994 111.191 170.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 757' ' ' LYS . . . . . 0.514 ' HA ' ' HA ' ' A' ' 775' ' ' HIS . 36.1 ttpt -101.13 130.06 47.13 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.007 -0.542 . . . . 75.200000000000003 110.359 -175.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 758' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -113.72 135.08 54.33 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.94 -0.573 . . . . 74.109999999999999 110.632 -175.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 759' ' ' VAL . . . . . 0.441 HG22 ' HB3' ' A' ' 773' ' ' CYS . 26.3 t -94.19 112.62 27.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.812 -0.631 . . . . 74.099999999999994 109.876 177.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 760' ' ' TYR . . . . . 0.405 ' HH ' ' HG2' ' A' ' 777' ' ' LYS . 11.5 m-85 -111.11 143.18 42.24 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.917 -0.583 . . . . 55.219999999999999 110.565 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 761' ' ' GLN . . . . . 0.477 ' HA ' ' O ' ' A' ' 770' ' ' PRO . 53.1 tt0 -131.39 130.96 43.26 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.521 -0.548 . . . . 74.310000000000002 109.521 178.147 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 762' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 769' ' ' PHE . . . -87.7 113.77 23.68 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.352 0.596 . . . . 71.099999999999994 110.631 -179.037 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 763' ' ' LYS . . . . . 0.57 ' HD2' ' CH2' ' A' ' 768' ' ' TRP . 57.4 tttm -93.2 105.13 17.26 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.789 -0.641 . . . . 75.140000000000001 109.545 178.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 57.4 t -108.04 103.46 15.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.25 -0.648 . . . . 73.109999999999999 109.25 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 71.25 -117.21 6.63 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 110.683 -0.967 . . . . 61.240000000000002 110.683 -173.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -110.07 15.72 30.66 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.615 -0.803 . . . . 65.120000000000005 112.066 176.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 767' ' ' ARG . . . . . 0.524 ' HD2' ' CD1' ' A' ' 769' ' ' PHE . 0.0 OUTLIER -115.5 128.2 55.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.853 0.358 . . . . 74.040000000000006 110.218 -178.891 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 768' ' ' TRP . . . . . 0.57 ' CH2' ' HD2' ' A' ' 763' ' ' LYS . 40.6 m95 -97.43 103.14 15.05 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.065 -0.516 . . . . 73.540000000000006 110.018 -179.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 769' ' ' PHE . . . . . 0.524 ' CD1' ' HD2' ' A' ' 767' ' ' ARG . 16.5 p90 -162.16 136.39 5.01 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 120.853 0.359 . . . . 73.319999999999993 111.044 -178.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 770' ' ' PRO . . . . . 0.578 ' HD3' ' HB3' ' A' ' 788' ' ' ALA . 75.1 Cg_endo -99.34 -177.83 4.41 Favored 'Cis proline' 0 N--CA 1.449 -1.122 0 C-N-CA 123.684 -1.382 . . . . 70.129999999999995 111.496 -5.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -111.05 107.36 16.73 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.919 -0.4 . . . . 75.450000000000003 109.919 174.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 34.0 m -119.26 164.95 15.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.203 -0.453 . . . . 74.549999999999997 110.667 -176.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 773' ' ' CYS . . . . . 0.441 ' HB3' HG22 ' A' ' 759' ' ' VAL . 7.0 p -136.61 124.01 22.03 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.383 -0.371 . . . . 72.329999999999998 110.275 177.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -129.56 152.52 49.0 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.27 -0.423 . . . . 52.5 110.185 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 775' ' ' HIS . . . . . 0.514 ' HA ' ' HA ' ' A' ' 757' ' ' LYS . 13.2 p80 -78.22 17.47 0.62 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.859 0.362 . . . . 64.329999999999998 111.695 -176.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 15.7 t -153.15 139.88 18.95 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.484 -0.561 . . . . 54.109999999999999 109.484 177.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 777' ' ' LYS . . . . . 0.405 ' HG2' ' HH ' ' A' ' 760' ' ' TYR . 11.5 tmtt? -60.82 -40.46 92.83 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.453 -0.339 . . . . 64.239999999999995 111.123 -177.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -67.65 -37.25 82.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.852 0.358 . . . . 73.310000000000002 110.517 179.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 779' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -70.2 -37.37 75.06 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.147 -0.479 . . . . 73.340000000000003 110.738 -178.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -57.57 -41.84 93.76 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.966 -0.635 . . . . 74.439999999999998 112.279 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -63.83 -44.31 93.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.974 0.416 . . . . 72.450000000000003 110.622 177.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -69.44 -41.31 76.47 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.876 -0.602 . . . . 74.439999999999998 111.341 -177.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -61.26 -42.69 99.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.787 0.327 . . . . 73.129999999999995 110.838 177.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -62.72 -50.29 71.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.792 -0.64 . . . . 70.5 110.634 178.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 785' ' ' ALA . . . . . 0.535 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -62.95 -39.64 95.25 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.296 -0.411 . . . . 74.310000000000002 111.073 -178.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 786' ' ' ASP . . . . . 0.6 ' O ' ' HG2' ' A' ' 790' ' ' ARG . 11.7 t70 -60.48 -57.34 13.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.461 . . . . 72.0 110.447 179.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 787' ' ' ALA . . . . . 0.561 ' O ' HG21 ' A' ' 791' ' ' VAL . . . -62.68 -32.46 73.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.792 -0.64 . . . . 74.349999999999994 110.992 -178.228 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 788' ' ' ALA . . . . . 0.646 ' O ' ' HG ' ' A' ' 792' ' ' LEU . . . -62.12 -43.5 98.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.363 -0.38 . . . . 52.340000000000003 110.693 177.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 789' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 785' ' ' ALA . 79.2 mt -64.41 -37.32 87.12 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.782 -0.451 . . . . 72.209999999999994 109.782 178.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 790' ' ' ARG . . . . . 0.6 ' HG2' ' O ' ' A' ' 786' ' ' ASP . 8.7 mmm180 -59.86 -40.62 89.23 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 109.694 -0.484 . . . . 74.150000000000006 109.694 177.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 791' ' ' VAL . . . . . 0.561 HG21 ' O ' ' A' ' 787' ' ' ALA . 61.0 t -62.02 -50.7 79.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.816 -0.629 . . . . 75.030000000000001 110.56 176.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 792' ' ' LEU . . . . . 0.646 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 49.7 mt -60.27 -52.13 66.59 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.693 -0.685 . . . . 75.5 110.979 -177.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 793' ' ' ILE . . . . . 0.501 ' HA ' HG23 ' A' ' 716' ' ' ILE . 72.2 mt -59.55 -48.84 85.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.755 -0.657 . . . . 75.140000000000001 110.742 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -61.35 -44.02 98.6 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 121.06 -0.59 . . . . 72.510000000000005 112.774 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -57.64 -40.96 80.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.064 0.459 . . . . 54.219999999999999 110.15 178.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 4.4 t30 . . . . . 0 C--N 1.325 -0.46 0 CA-C-N 115.807 -0.633 . . . . 72.010000000000005 111.44 178.462 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 708' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.482 1.163 0 CA-C-O 120.778 0.323 . . . . 73.129999999999995 110.763 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 22.4 ttt -62.55 127.09 89.6 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.887 -0.597 . . . . 71.530000000000001 110.681 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.39 94.69 0.98 Allowed 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.313 2.009 . . . . 72.430000000000007 111.78 176.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 711' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -94.61 108.58 20.55 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.179 -0.464 . . . . 71.209999999999994 110.019 -178.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 712' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -115.93 96.18 5.47 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.256 -0.646 . . . . 74.129999999999995 109.256 177.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 713' ' ' VAL . . . . . . . . . . . . . 11.0 p -98.53 159.93 3.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.71 -0.677 . . . . 63.210000000000001 110.439 -176.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -68.24 87.14 0.28 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.543 0.687 . . . . 65.439999999999998 110.964 177.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 715' ' ' LYS . . . . . 0.467 ' HG2' ' OE2' ' A' ' 718' ' ' GLU . 22.5 tptm -83.07 72.98 10.09 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.546 -0.752 . . . . 74.409999999999997 109.996 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 716' ' ' ILE . . . . . 0.538 ' HA ' HD23 ' A' ' 719' ' ' LEU . 47.9 mm -67.19 -28.3 42.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.487 -0.779 . . . . 74.510000000000005 110.861 -175.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -59.36 -32.41 72.45 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 121.086 -0.578 . . . . 72.129999999999995 112.634 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 718' ' ' GLU . . . . . 0.708 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 39.3 mt-10 -79.69 -21.83 44.17 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.856 -0.338 . . . . 62.140000000000001 111.266 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 719' ' ' LEU . . . . . 0.54 HD12 HD21 ' A' ' 789' ' ' LEU . 3.5 mm? -67.02 -32.11 73.11 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.225 -0.657 . . . . 73.409999999999997 109.225 172.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 720' ' ' VAL . . . . . 0.492 HG22 HD13 ' A' ' 793' ' ' ILE . 39.3 t -70.49 -31.81 47.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.364 -0.835 . . . . 74.109999999999999 110.379 176.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 721' ' ' ARG . . . . . 0.708 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 6.1 ptt180 -66.61 -28.12 68.24 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 120.943 0.401 . . . . 74.510000000000005 110.16 179.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -77.17 -31.86 55.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.239 -0.437 . . . . 75.219999999999999 111.322 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 723' ' ' LEU . . . . . 0.51 HD22 ' HB2' ' A' ' 789' ' ' LEU . 96.3 mt -61.11 -32.3 71.98 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.514 0.673 . . . . 72.439999999999998 109.629 173.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -84.95 -16.6 40.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.851 -1.068 . . . . 72.129999999999995 110.905 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 23.5 m -119.37 -81.61 0.63 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.783 0.325 . . . . 75.519999999999996 111.536 -176.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 726' ' ' ASN . . . . . 0.4 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 37.5 t30 -139.25 104.9 7.19 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.292 -0.413 . . . . 65.120000000000005 110.21 -178.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 727' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 24.6 Cg_endo -62.23 -37.61 61.06 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.822 2.348 . . . . 65.5 112.584 -177.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 49.4 t -61.33 -49.0 86.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.23 -0.441 . . . . 64.430000000000007 110.544 -177.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -63.41 -31.49 80.93 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.899 -0.667 . . . . 62.119999999999997 111.887 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -71.03 -40.04 62.65 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.06 -0.591 . . . . 41.240000000000002 112.633 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -66.05 -39.65 90.3 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.401 -0.592 . . . . 75.030000000000001 109.401 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 732' ' ' LEU . . . . . 0.439 HD21 ' HB2' ' A' ' 742' ' ' ALA . 83.1 mt -65.45 -38.53 90.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.926 -0.579 . . . . 73.340000000000003 110.427 175.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 733' ' ' GLU . . . . . 0.56 ' O ' ' HG2' ' A' ' 736' ' ' ARG . 4.2 tp10 -66.41 -48.17 70.93 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.809 -0.632 . . . . 73.5 110.928 -179.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 734' ' ' TYR . . . . . 0.526 ' HB2' HD13 ' A' ' 719' ' ' LEU . 12.4 t80 -56.75 -47.74 79.39 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.132 -0.485 . . . . 64.409999999999997 110.752 178.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -66.43 -46.14 77.53 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.139 -0.482 . . . . 72.5 111.184 -177.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 736' ' ' ARG . . . . . 0.56 ' HG2' ' O ' ' A' ' 733' ' ' GLU . 22.4 ptt180 -62.12 -35.33 78.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.015 0.436 . . . . 74.209999999999994 110.85 -176.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 33.1 t -81.19 -23.72 37.97 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.922 -0.581 . . . . 63.420000000000002 111.304 -178.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -104.71 2.84 30.78 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.781 0.289 . . . . 61.350000000000001 111.781 -175.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 79.82 17.82 74.17 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.574 -0.822 . . . . 74.219999999999999 113.002 176.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -102.27 162.16 13.13 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 122.628 -0.336 . . . . 70.340000000000003 110.263 176.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 741' ' ' ALA . . . . . 0.518 ' O ' ' HA ' ' A' ' 764' ' ' VAL . . . -105.43 135.42 46.85 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.865 -0.42 . . . . 74.239999999999995 109.865 175.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 742' ' ' ALA . . . . . 0.439 ' HB2' HD21 ' A' ' 732' ' ' LEU . . . -103.46 108.77 20.16 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.224 -0.444 . . . . 71.530000000000001 110.505 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 743' ' ' GLU . . . . . 0.545 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 41.2 mt-10 -115.73 113.35 23.35 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.033 -0.531 . . . . 71.430000000000007 111.121 -178.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -93.91 100.91 12.98 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.644 -0.707 . . . . 73.409999999999997 109.605 175.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -113.99 155.96 24.92 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.04 0.448 . . . . 75.310000000000002 110.783 -178.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 746' ' ' LEU . . . . . . . . . . . . . 1.7 tt -94.06 120.42 34.3 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.759 -0.83 . . . . 74.109999999999999 108.759 177.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 84.6 t -81.98 -52.3 13.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.315 -0.402 . . . . 75.140000000000001 111.182 -176.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -155.58 151.33 27.43 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.386 -0.37 . . . . 70.150000000000006 110.803 -175.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -126.75 87.11 2.6 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.702 -0.481 . . . . 73.450000000000003 109.702 -178.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 5.3 p -128.1 98.93 5.28 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.177 0.513 . . . . 75.530000000000001 111.261 -176.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . -166.54 158.04 30.79 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 111.57 -0.612 . . . . 70.120000000000005 111.57 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 752' ' ' PRO . . . . . 0.657 ' HG2' ' HB2' ' A' ' 755' ' ' GLU . 20.5 Cg_endo -60.45 162.15 18.45 Favored 'Trans proline' 0 CA--C 1.531 0.35 0 C-N-CA 122.846 2.364 . . . . 74.0 112.038 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.68 -31.91 92.59 Favored 'Trans proline' 0 CA--C 1.527 0.16 0 C-N-CA 122.71 2.273 . . . . 72.430000000000007 112.612 -178.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 37.5 p-80 -86.82 -17.82 32.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.206 -0.452 . . . . 72.409999999999997 111.309 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 755' ' ' GLU . . . . . 0.657 ' HB2' ' HG2' ' A' ' 752' ' ' PRO . 37.9 mm-40 -136.48 70.88 60.02 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.461 -0.336 . . . . 74.450000000000003 110.751 178.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 756' ' ' PRO . . . . . 0.475 ' HB2' ' CE2' ' A' ' 758' ' ' PHE . 28.9 Cg_endo -63.42 116.99 3.96 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.264 1.976 . . . . 72.319999999999993 111.414 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 757' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -97.7 115.46 28.01 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.251 -0.432 . . . . 75.010000000000005 110.427 -176.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 758' ' ' PHE . . . . . 0.475 ' CE2' ' HB2' ' A' ' 756' ' ' PRO . 90.4 m-85 -108.05 113.21 26.21 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.008 -0.542 . . . . 74.420000000000002 110.355 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 24.3 t -85.82 111.28 20.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.74 -0.664 . . . . 65.25 109.8 179.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 760' ' ' TYR . . . . . 0.402 ' OH ' ' HG2' ' A' ' 777' ' ' LYS . 2.1 m-85 -110.81 143.13 41.85 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.248 -0.433 . . . . 73.540000000000006 110.758 -179.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 761' ' ' GLN . . . . . 0.502 ' HA ' ' O ' ' A' ' 770' ' ' PRO . 56.8 tt0 -135.77 135.19 39.73 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.141 -0.481 . . . . 72.409999999999997 109.743 178.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 762' ' ' ALA . . . . . 0.412 ' HB2' ' O ' ' A' ' 769' ' ' PHE . . . -93.56 112.84 24.82 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.306 0.574 . . . . 74.129999999999995 110.605 -178.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 763' ' ' LYS . . . . . 0.603 ' HD2' ' CH2' ' A' ' 768' ' ' TRP . 59.3 tttm -91.82 101.84 14.43 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.844 -0.617 . . . . 71.349999999999994 109.778 177.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 764' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' A' ' 741' ' ' ALA . 59.4 t -107.57 100.86 11.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.02 -0.536 . . . . 70.019999999999996 109.986 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 71.71 -115.25 5.49 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 115.586 -0.733 . . . . 64.219999999999999 111.482 -177.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -106.22 8.1 41.18 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.828 -0.701 . . . . 74.219999999999999 112.012 177.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 767' ' ' ARG . . . . . . . . . . . . . 55.0 mtt180 -108.07 147.17 31.56 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.963 0.411 . . . . 74.010000000000005 110.797 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 768' ' ' TRP . . . . . 0.603 ' CH2' ' HD2' ' A' ' 763' ' ' LYS . 53.0 m95 -118.21 100.76 7.72 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.764 -0.653 . . . . 75.200000000000003 109.284 178.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 769' ' ' PHE . . . . . 0.412 ' O ' ' HB2' ' A' ' 762' ' ' ALA . 21.4 p90 -167.49 139.3 2.58 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 120.777 0.322 . . . . 74.530000000000001 110.969 -176.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 770' ' ' PRO . . . . . 0.57 ' HD3' ' HB1' ' A' ' 788' ' ' ALA . 71.5 Cg_endo -97.54 -171.46 2.46 Favored 'Cis proline' 0 N--CA 1.453 -0.872 0 C-N-CA 123.716 -1.368 . . . . 64.239999999999995 111.751 -4.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -122.23 112.44 18.16 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.63 -0.508 . . . . 74.510000000000005 109.63 175.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 36.0 m -122.46 159.24 25.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.247 -0.433 . . . . 60.340000000000003 110.839 -176.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 8.0 p -124.45 107.65 11.32 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.007 0.432 . . . . 71.530000000000001 109.948 177.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -103.11 -179.66 4.01 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.07 -0.514 . . . . 75.109999999999999 111.203 -176.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 775' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -93.28 -5.39 49.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 73.409999999999997 110.349 -177.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 19.4 t -161.01 170.44 20.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.338 -0.392 . . . . 73.209999999999994 110.518 -177.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 777' ' ' LYS . . . . . 0.402 ' HG2' ' OH ' ' A' ' 760' ' ' TYR . 1.4 tmtp? -69.72 -50.15 46.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.065 -0.516 . . . . 75.409999999999997 111.447 -174.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -60.48 -40.75 92.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.965 0.412 . . . . 64.409999999999997 110.308 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 779' ' ' GLN . . . . . 0.528 ' O ' ' HG2' ' A' ' 783' ' ' GLU . 76.9 mt-30 -58.3 -49.18 78.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.696 -0.683 . . . . 73.219999999999999 111.099 175.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -52.73 -44.12 60.34 Favored Glycine 0 C--N 1.334 0.434 0 CA-C-N 116.168 -0.469 . . . . 73.140000000000001 113.095 -176.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -59.23 -47.71 84.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.273 0.559 . . . . 72.030000000000001 110.772 178.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -70.91 -42.83 69.4 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.443 -0.799 . . . . 63.109999999999999 111.61 -175.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 783' ' ' GLU . . . . . 0.528 ' HG2' ' O ' ' A' ' 779' ' ' GLN . 21.2 mm-40 -60.44 -41.48 94.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.978 0.418 . . . . 72.450000000000003 110.301 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -66.17 -47.84 72.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.845 -0.616 . . . . 75.510000000000005 110.662 178.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 785' ' ' ALA . . . . . 0.513 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -63.08 -41.93 99.53 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.218 -0.446 . . . . 73.099999999999994 111.324 -178.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 786' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -57.21 -53.31 59.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.242 0.544 . . . . 71.450000000000003 110.277 178.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 787' ' ' ALA . . . . . 0.595 ' O ' HG21 ' A' ' 791' ' ' VAL . . . -64.01 -37.78 88.67 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.597 -0.729 . . . . 74.349999999999994 111.052 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 788' ' ' ALA . . . . . 0.57 ' HB1' ' HD3' ' A' ' 770' ' ' PRO . . . -60.38 -47.44 86.07 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.425 -0.352 . . . . 73.25 111.582 -178.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 789' ' ' LEU . . . . . 0.54 HD21 HD12 ' A' ' 719' ' ' LEU . 64.4 mt -62.74 -39.36 93.86 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.641 -0.503 . . . . 73.439999999999998 109.641 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 790' ' ' ARG . . . . . . . . . . . . . 54.6 mtp180 -64.46 -32.09 73.57 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.594 -0.73 . . . . 75.209999999999994 111.197 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 791' ' ' VAL . . . . . 0.595 HG21 ' O ' ' A' ' 787' ' ' ALA . 60.7 t -63.51 -52.94 51.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 109.433 -0.58 . . . . 71.099999999999994 109.433 173.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 792' ' ' LEU . . . . . 0.556 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 32.8 mt -57.39 -50.44 72.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.339 -0.846 . . . . 72.010000000000005 110.836 -177.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 793' ' ' ILE . . . . . 0.492 HD13 HG22 ' A' ' 720' ' ' VAL . 77.5 mt -57.94 -49.47 81.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.642 -0.708 . . . . 73.219999999999999 110.568 177.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -63.28 -30.71 78.37 Favored Glycine 0 CA--C 1.519 0.325 0 CA-C-N 115.952 -0.567 . . . . 73.439999999999998 112.814 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 795' ' ' GLU . . . . . 0.603 ' O ' ' HB3' ' A' ' 799' ' ' ALA . 59.7 mm-40 -67.26 -36.73 82.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.46 0.13 . . . . 74.540000000000006 110.874 178.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -83.31 -33.77 25.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.533 -0.303 . . . . 71.310000000000002 111.15 -175.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 797' ' ' GLU . . . . . 0.48 ' HG3' ' O ' ' A' ' 793' ' ' ILE . 46.7 mt-10 -65.19 121.78 15.56 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.568 -0.287 . . . . 74.519999999999996 110.401 178.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 798' ' ' LYS . . . . . 0.609 ' HB2' ' HZ2' ' A' ' 798' ' ' LYS . 8.4 mtmp? 71.26 18.28 5.73 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 123.549 0.531 . . . . 74.409999999999997 110.936 -178.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 799' ' ' ALA . . . . . 0.603 ' HB3' ' O ' ' A' ' 795' ' ' GLU . . . -89.77 146.97 24.1 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.289 0.566 . . . . 51.350000000000001 111.656 -178.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 800' ' ' GLU . . . . . 0.465 ' H ' ' CD ' ' A' ' 800' ' ' GLU . 0.3 OUTLIER -99.27 -3.46 34.09 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.067 -0.97 . . . . 74.319999999999993 109.328 174.465 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 801' ' ' ARG . . . . . 0.482 ' HD3' ' HB1' ' A' ' 799' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.135 0 CA-C-N 115.069 -0.969 . . . . 72.230000000000004 109.661 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 708' ' ' MET . . . . . 0.435 ' O ' ' HG3' ' A' ' 708' ' ' MET . 14.8 tpt . . . . . 0 N--CA 1.477 0.924 0 CA-C-O 121.476 0.655 . . . . 75.450000000000003 109.942 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 709' ' ' MET . . . . . 0.435 ' HE2' ' HE3' ' A' ' 712' ' ' LYS . 48.0 ttp -126.43 96.69 35.55 Favored Pre-proline 0 C--N 1.326 -0.425 0 O-C-N 122.053 -0.404 . . . . 73.230000000000004 110.996 -177.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -77.02 -68.58 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 123.085 2.524 . . . . 74.439999999999998 110.978 174.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 711' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -79.68 109.97 14.58 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.271 -1.011 . . . . 74.329999999999998 108.271 172.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 712' ' ' LYS . . . . . 0.435 ' HE3' ' HE2' ' A' ' 709' ' ' MET . 33.0 mtpt -72.48 132.69 44.19 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.627 0.727 . . . . 74.120000000000005 112.293 -166.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 713' ' ' VAL . . . . . 0.492 HG22 ' H ' ' A' ' 714' ' ' ARG . 7.0 p -148.61 174.6 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 107.687 -1.227 . . . . 72.439999999999998 107.687 -178.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.492 ' H ' HG22 ' A' ' 713' ' ' VAL . 14.7 ttm180 -75.98 74.01 2.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 118.776 0.716 . . . . 74.5 109.666 176.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 715' ' ' LYS . . . . . 0.541 ' HG2' ' OE2' ' A' ' 718' ' ' GLU . 4.7 tppp? -83.71 84.05 7.69 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.842 -0.617 . . . . 72.230000000000004 110.051 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 716' ' ' ILE . . . . . 0.526 ' HA ' HD22 ' A' ' 719' ' ' LEU . 47.1 mm -71.81 -22.3 21.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.907 -0.588 . . . . 71.109999999999999 110.803 -176.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -62.11 -34.03 87.71 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.828 -0.701 . . . . 70.409999999999997 111.992 176.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 718' ' ' GLU . . . . . 0.704 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 38.1 mt-10 -77.26 -25.0 51.04 Favored 'General case' 0 C--O 1.222 -0.385 0 O-C-N 122.623 -0.34 . . . . 74.319999999999993 111.125 178.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 719' ' ' LEU . . . . . 0.539 HD12 HD23 ' A' ' 789' ' ' LEU . 4.4 mm? -61.51 -32.94 73.0 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.473 -0.565 . . . . 73.349999999999994 109.473 172.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 720' ' ' VAL . . . . . 0.452 HG22 HD13 ' A' ' 793' ' ' ILE . 58.2 t -70.21 -36.26 66.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.477 -0.783 . . . . 74.400000000000006 110.76 177.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 721' ' ' ARG . . . . . 0.704 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 8.9 ptt180 -62.72 -29.52 70.73 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.02 0.438 . . . . 64.319999999999993 110.167 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -76.28 -31.55 58.3 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.197 -0.456 . . . . 74.319999999999993 110.596 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 723' ' ' LEU . . . . . 0.547 HD22 ' HB2' ' A' ' 789' ' ' LEU . 89.3 mt -63.76 -24.89 67.95 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.177 0.513 . . . . 72.439999999999998 110.601 174.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -92.07 -23.87 19.34 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.756 -0.656 . . . . 74.439999999999998 110.872 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 10.9 m -111.04 -76.79 0.6 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.423 -0.353 . . . . 73.420000000000002 111.241 -175.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 726' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -141.6 103.52 5.9 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 120.628 0.251 . . . . 53.049999999999997 110.768 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 727' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.77 -37.09 89.1 Favored 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 123.032 2.488 . . . . 71.329999999999998 112.348 -179.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 728' ' ' VAL . . . . . 0.404 ' O ' ' HG ' ' A' ' 732' ' ' LEU . 48.9 t -59.96 -47.94 89.75 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 CA-C-N 116.007 -0.542 . . . . 71.140000000000001 110.162 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -62.35 -35.33 91.5 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.656 -0.702 . . . . 42.350000000000001 112.01 178.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -65.41 -43.16 95.38 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.097 -0.573 . . . . 61.109999999999999 112.641 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -65.93 -40.27 91.28 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.725 -0.472 . . . . 73.150000000000006 109.725 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 732' ' ' LEU . . . . . 0.424 HD22 ' HB2' ' A' ' 742' ' ' ALA . 85.7 mt -65.37 -38.02 88.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.949 -0.569 . . . . 74.329999999999998 110.602 176.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 733' ' ' GLU . . . . . 0.439 ' O ' ' HG2' ' A' ' 736' ' ' ARG . 5.2 tp10 -66.98 -47.12 72.52 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 115.967 -0.56 . . . . 73.310000000000002 110.911 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 734' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -56.64 -46.69 80.85 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.214 -0.448 . . . . 72.430000000000007 110.458 177.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -65.28 -44.66 87.3 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.093 -0.503 . . . . 63.229999999999997 111.232 -177.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 736' ' ' ARG . . . . . 0.439 ' HG2' ' O ' ' A' ' 733' ' ' GLU . 14.5 ptm180 -68.85 -33.04 73.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.598 0.713 . . . . 72.340000000000003 109.825 -173.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 73.2 m -75.01 -36.47 61.95 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 114.792 -1.095 . . . . 75.120000000000005 111.766 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 12.7 m170 -94.27 0.57 55.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.338 -0.392 . . . . 74.209999999999994 111.327 -175.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 85.86 9.17 78.24 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.735 -0.745 . . . . 74.0 112.987 175.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -93.45 162.15 14.09 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.698 0.285 . . . . 71.530000000000001 110.336 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -107.48 115.99 31.14 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.993 -0.373 . . . . 71.549999999999997 109.993 176.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 742' ' ' ALA . . . . . 0.424 ' HB2' HD22 ' A' ' 732' ' ' LEU . . . -81.94 112.17 18.79 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.238 -0.437 . . . . 65.129999999999995 110.888 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 743' ' ' GLU . . . . . 0.46 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 43.9 mt-10 -123.06 127.74 49.17 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.297 -0.41 . . . . 73.129999999999995 110.945 -177.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -105.85 114.34 28.43 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.02 -0.536 . . . . 65.019999999999996 110.021 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -121.34 153.66 37.46 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.164 0.507 . . . . 72.439999999999998 110.803 177.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 746' ' ' LEU . . . . . 0.442 HD12 ' CE2' ' A' ' 760' ' ' TYR . 51.3 tp -95.93 101.33 12.99 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.475 -0.784 . . . . 75.230000000000004 109.803 178.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 49.1 t -69.33 -43.88 80.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.796 -0.638 . . . . 73.450000000000003 111.275 -174.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -146.25 147.49 31.47 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.064 0.459 . . . . 74.219999999999999 111.246 -176.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -141.47 93.66 2.6 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.997 -0.742 . . . . 73.340000000000003 108.997 177.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 16.7 t -129.84 176.75 7.78 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.906 -0.588 . . . . 74.409999999999997 110.213 -173.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 104.88 -176.17 22.71 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.712 -0.756 . . . . 74.299999999999997 112.353 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 752' ' ' PRO . . . . . 0.516 ' HG2' ' HB2' ' A' ' 755' ' ' GLU . 60.4 Cg_endo -73.62 157.82 48.08 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.899 2.399 . . . . 75.219999999999999 111.88 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -62.98 -22.54 73.86 Favored 'Trans proline' 0 CA--C 1.529 0.246 0 C-N-CA 122.656 2.238 . . . . 73.099999999999994 112.773 -177.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 39.2 p-80 -91.85 -7.57 49.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.924 0.392 . . . . 75.209999999999994 110.907 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 755' ' ' GLU . . . . . 0.516 ' HB2' ' HG2' ' A' ' 752' ' ' PRO . 5.5 mm-40 -146.84 63.58 8.46 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.318 -0.401 . . . . 72.400000000000006 110.987 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 756' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.85 122.43 8.49 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.094 1.862 . . . . 72.519999999999996 111.317 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 757' ' ' LYS . . . . . 0.422 ' HZ3' ' HB2' ' A' ' 757' ' ' LYS . 0.1 OUTLIER -92.95 112.2 24.08 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.07 0.462 . . . . 73.319999999999993 110.327 -178.181 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 758' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -95.1 107.52 19.58 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.579 -0.737 . . . . 75.409999999999997 110.501 -178.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 759' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 773' ' ' CYS . 40.9 t -86.65 98.13 6.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.037 -0.528 . . . . 71.420000000000002 109.896 178.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 760' ' ' TYR . . . . . 0.442 ' CE2' HD12 ' A' ' 746' ' ' LEU . 7.5 m-85 -98.08 141.07 31.48 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.074 -0.512 . . . . 74.25 110.379 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 761' ' ' GLN . . . . . 0.474 ' HA ' ' O ' ' A' ' 770' ' ' PRO . 54.6 tt0 -135.41 129.3 33.08 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.993 -0.549 . . . . 75.239999999999995 109.784 178.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 762' ' ' ALA . . . . . . . . . . . . . . . -85.99 117.23 24.71 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.474 0.654 . . . . 74.540000000000006 110.819 -177.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 763' ' ' LYS . . . . . 0.46 ' HB3' ' HB2' ' A' ' 743' ' ' GLU . 58.9 tttt -93.71 108.8 20.5 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.184 -0.916 . . . . 71.0 109.572 178.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 38.7 t -128.78 108.26 17.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.805 0.336 . . . . 65.340000000000003 110.936 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 69.16 25.1 75.7 Favored Glycine 0 CA--C 1.51 -0.219 0 C-N-CA 121.112 -0.566 . . . . 41.149999999999999 112.585 176.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 91.31 -10.27 75.3 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.652 -0.785 . . . . 73.319999999999993 111.859 -177.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 767' ' ' ARG . . . . . 0.417 ' HD3' ' HA ' ' A' ' 767' ' ' ARG . 30.1 mmt180 -91.32 128.51 37.17 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.033 0.445 . . . . 73.409999999999997 110.303 177.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 768' ' ' TRP . . . . . . . . . . . . . 51.0 m95 -104.1 96.1 6.43 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.519 -0.764 . . . . 73.230000000000004 109.94 -176.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 769' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -162.42 138.59 5.78 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.314 -0.403 . . . . 72.239999999999995 110.412 -177.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 770' ' ' PRO . . . . . 0.628 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 64.8 Cg_endo -95.0 175.15 12.68 Favored 'Cis proline' 0 N--CA 1.451 -0.978 0 C-N-CA 123.351 -1.521 . . . . 72.120000000000005 111.873 -3.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -107.66 98.15 7.78 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.681 -0.489 . . . . 72.0 109.681 174.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 29.2 m -112.73 131.31 64.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.358 0.599 . . . . 75.420000000000002 111.183 -175.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 773' ' ' CYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 759' ' ' VAL . 7.3 p -99.46 98.75 9.62 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.776 -0.647 . . . . 53.520000000000003 110.462 177.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -100.55 146.32 27.25 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.107 -0.497 . . . . 72.439999999999998 110.233 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 775' ' ' HIS . . . . . . . . . . . . . 1.1 p80 -86.11 17.3 3.67 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.272 0.558 . . . . 72.120000000000005 111.068 -178.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 34.3 t -150.02 140.51 22.44 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.633 -0.712 . . . . 71.230000000000004 109.282 175.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 777' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -66.04 -42.54 89.44 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.5 -0.318 . . . . 64.129999999999995 110.614 -175.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -60.49 -36.39 78.2 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.967 -0.56 . . . . 72.450000000000003 110.498 177.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 779' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -70.15 -42.77 72.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.034 -0.53 . . . . 73.030000000000001 110.802 177.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -50.2 -46.66 43.1 Favored Glycine 0 C--N 1.331 0.272 0 O-C-N 123.398 0.436 . . . . 44.219999999999999 113.083 -177.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -65.76 -49.25 69.07 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.781 0.324 . . . . 72.010000000000005 110.911 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -67.66 -46.89 71.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.149 -0.478 . . . . 73.099999999999994 111.771 -175.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -64.59 -37.47 87.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.683 -0.235 . . . . 73.420000000000002 110.63 -177.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -62.34 -52.0 65.39 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.272 -0.422 . . . . 71.0 110.438 177.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 785' ' ' ALA . . . . . 0.644 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -61.58 -43.68 98.41 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.22 -0.445 . . . . 74.120000000000005 110.648 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 786' ' ' ASP . . . . . 0.593 ' O ' ' HG2' ' A' ' 790' ' ' ARG . 8.2 t70 -57.5 -52.67 64.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.869 -0.605 . . . . 63.100000000000001 110.648 178.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 787' ' ' ALA . . . . . 0.539 ' HB3' ' HG3' ' A' ' 770' ' ' PRO . . . -68.09 -27.19 66.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.916 -0.584 . . . . 64.120000000000005 111.285 -176.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 788' ' ' ALA . . . . . 0.628 ' HB2' ' HD3' ' A' ' 770' ' ' PRO . . . -66.72 -41.41 87.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.406 -0.361 . . . . 60.299999999999997 110.567 177.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 789' ' ' LEU . . . . . 0.644 ' HG ' ' O ' ' A' ' 785' ' ' ALA . 21.2 mt -67.27 -34.4 77.34 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.547 -0.538 . . . . 74.409999999999997 109.547 178.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 790' ' ' ARG . . . . . 0.593 ' HG2' ' O ' ' A' ' 786' ' ' ASP . 28.3 mmt180 -55.47 -45.9 76.89 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.142 -0.481 . . . . 74.239999999999995 109.837 175.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 791' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 787' ' ' ALA . 48.7 t -58.66 -52.35 60.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.468 -0.787 . . . . 75.310000000000002 110.581 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 792' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 27.7 mt -61.16 -49.13 78.46 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.522 -0.763 . . . . 71.040000000000006 111.003 -177.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 793' ' ' ILE . . . . . 0.452 HD13 HG22 ' A' ' 720' ' ' VAL . 93.5 mt -63.62 -42.78 97.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.621 -0.718 . . . . 74.239999999999995 110.516 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -62.31 -27.18 68.85 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 121.029 -0.605 . . . . 55.43 112.569 178.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -77.71 -23.63 49.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.625 0.25 . . . . 75.230000000000004 111.437 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -103.95 -25.77 12.89 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 111.942 0.349 . . . . 75.239999999999995 111.942 -177.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 797' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -57.96 110.03 0.85 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.823 0.344 . . . . 74.230000000000004 111.176 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 798' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm 63.7 17.14 10.25 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.407 -0.815 . . . . 72.140000000000001 111.846 176.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 799' ' ' ALA . . . . . . . . . . . . . . . -130.92 149.58 52.48 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.456 -0.338 . . . . 72.129999999999995 110.223 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 800' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -119.43 90.11 3.27 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.947 -0.39 . . . . 63.340000000000003 109.947 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 801' ' ' ARG . . . . . 0.681 ' NE ' ' HA ' ' A' ' 801' ' ' ARG . 3.9 mmp_? . . . . . 0 C--O 1.246 0.912 0 CA-C-O 118.644 -0.694 . . . . 75.120000000000005 109.704 174.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 708' ' ' MET . . . . . 0.426 ' SD ' ' HG3' ' A' ' 709' ' ' MET . 1.3 tmt? . . . . . 0 N--CA 1.476 0.863 0 N-CA-C 109.603 -0.517 . . . . 74.239999999999995 109.603 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 709' ' ' MET . . . . . 0.426 ' HG3' ' SD ' ' A' ' 708' ' ' MET . 59.5 mtt -155.32 159.21 31.91 Favored Pre-proline 0 CA--C 1.519 -0.219 0 N-CA-C 109.638 -0.504 . . . . 73.25 109.638 177.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -74.85 -163.97 0.21 Allowed 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.159 1.906 . . . . 72.430000000000007 110.364 167.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 711' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -74.19 76.79 1.79 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.232 0.539 . . . . 71.209999999999994 110.016 175.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 712' ' ' LYS . . . . . 0.421 ' O ' ' HD2' ' A' ' 714' ' ' ARG . 34.2 ttpt -126.45 20.77 7.28 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.883 -0.599 . . . . 74.019999999999996 109.68 176.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 713' ' ' VAL . . . . . . . . . . . . . 61.7 t -55.8 118.23 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 109.115 -0.698 . . . . 74.140000000000001 109.115 175.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.566 ' HB3' HG12 ' A' ' 716' ' ' ILE . 19.9 mmm180 -70.47 -27.24 64.07 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.256 -0.429 . . . . 73.319999999999993 111.336 -171.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt 63.76 24.42 13.81 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.085 -0.507 . . . . 75.439999999999998 110.767 178.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 716' ' ' ILE . . . . . 0.566 HG12 ' HB3' ' A' ' 714' ' ' ARG . 46.7 mm -75.86 -21.23 15.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.445 -0.798 . . . . 64.239999999999995 111.156 -174.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -58.19 -28.77 61.89 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.866 -0.683 . . . . 62.5 112.551 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -68.61 -35.79 77.79 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 122.869 -0.195 . . . . 73.439999999999998 111.275 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 719' ' ' LEU . . . . . 0.558 HD21 ' HA ' ' A' ' 716' ' ' ILE . 3.2 mm? -64.94 -33.82 76.93 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.614 -0.513 . . . . 73.239999999999995 109.614 178.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 720' ' ' VAL . . . . . 0.491 HG23 HD13 ' A' ' 793' ' ' ILE . 45.5 t -66.33 -37.12 78.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.881 -0.599 . . . . 72.310000000000002 109.997 176.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 721' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.49 -32.04 71.05 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.839 -0.619 . . . . 72.340000000000003 110.158 177.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -79.46 -25.7 41.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.844 -0.616 . . . . 73.319999999999993 111.275 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 723' ' ' LEU . . . . . 0.505 HD23 ' HB2' ' A' ' 789' ' ' LEU . 60.1 mt -63.71 -29.95 71.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.991 0.424 . . . . 74.540000000000006 110.282 175.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -85.4 -35.63 21.21 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.653 -0.703 . . . . 74.200000000000003 110.83 176.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 24.7 m -92.55 -79.69 0.39 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.216 -0.447 . . . . 63.32 111.764 -174.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 726' ' ' ASN . . . . . 0.424 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 30.8 t30 -146.29 109.05 4.23 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-O 120.809 0.338 . . . . 74.129999999999995 110.235 -179.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 727' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 20.0 Cg_endo -61.24 -35.69 83.74 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.707 2.271 . . . . 65.140000000000001 112.436 -178.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 53.2 t -62.76 -48.08 89.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.244 -0.435 . . . . 74.109999999999999 110.615 -178.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -63.55 -33.16 86.5 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.825 -0.703 . . . . 72.310000000000002 111.944 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -71.19 -41.54 59.66 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.252 -0.499 . . . . 74.140000000000001 112.811 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -63.71 -38.94 93.0 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.469 -0.567 . . . . 62.439999999999998 109.469 178.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 732' ' ' LEU . . . . . 0.408 HD22 ' HB2' ' A' ' 742' ' ' ALA . 96.1 mt -69.63 -33.5 72.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.847 -0.615 . . . . 61.520000000000003 110.555 176.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 733' ' ' GLU . . . . . 0.546 ' O ' ' HG2' ' A' ' 736' ' ' ARG . 4.2 tp10 -67.95 -48.46 65.81 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 123.016 0.526 . . . . 73.209999999999994 110.417 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 734' ' ' TYR . . . . . 0.526 ' HB2' HD13 ' A' ' 719' ' ' LEU . 8.8 t80 -54.67 -47.19 73.91 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.777 -0.647 . . . . 70.450000000000003 110.642 176.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -67.37 -49.73 62.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.191 -0.459 . . . . 70.349999999999994 110.849 -177.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 736' ' ' ARG . . . . . 0.546 ' HG2' ' O ' ' A' ' 733' ' ' GLU . 13.5 ptm180 -60.41 -38.52 84.28 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.297 -0.41 . . . . 72.140000000000001 111.221 -175.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 32.9 t -77.36 -29.11 53.17 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.123 -0.489 . . . . 73.530000000000001 111.172 -177.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -95.58 -8.19 35.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.82 0.343 . . . . 74.049999999999997 111.433 -176.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 93.4 10.89 58.93 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.689 -0.767 . . . . 73.510000000000005 113.118 176.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -93.58 161.61 14.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.965 0.412 . . . . 73.549999999999997 110.734 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -106.89 113.03 26.27 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.796 -0.638 . . . . 72.239999999999995 109.631 176.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 742' ' ' ALA . . . . . 0.408 ' HB2' HD22 ' A' ' 732' ' ' LEU . . . -97.45 126.74 42.89 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.152 -0.477 . . . . 73.430000000000007 110.638 -178.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 743' ' ' GLU . . . . . 0.436 ' HG3' ' HB3' ' A' ' 763' ' ' LYS . 13.4 pt-20 -140.26 140.18 35.69 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.026 0.441 . . . . 72.140000000000001 110.569 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -108.27 114.73 28.83 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.741 -0.663 . . . . 74.019999999999996 109.718 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -120.89 149.91 41.88 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.083 0.468 . . . . 73.409999999999997 111.191 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 746' ' ' LEU . . . . . 0.471 HD23 ' HB3' ' A' ' 749' ' ' GLN . 60.6 tp -91.58 116.82 29.18 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.596 -0.729 . . . . 73.239999999999995 109.825 177.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 47.7 t -79.29 -47.42 22.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.05 -0.523 . . . . 72.129999999999995 110.498 -178.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -154.62 147.46 24.45 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.449 -0.341 . . . . 62.329999999999998 111.064 -179.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 749' ' ' GLN . . . . . 0.471 ' HB3' HD23 ' A' ' 746' ' ' LEU . 17.2 pt20 -129.84 109.98 11.36 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.137 -0.483 . . . . 73.109999999999999 109.864 177.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 27.5 t -155.36 159.28 39.79 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.379 -0.373 . . . . 44.509999999999998 110.385 -175.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 141.25 171.72 12.81 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.699 -0.762 . . . . 70.129999999999995 112.433 176.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 752' ' ' PRO . . . . . 0.744 ' HG2' ' HB2' ' A' ' 755' ' ' GLU . 37.3 Cg_endo -66.94 167.97 18.38 Favored 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 123.089 2.526 . . . . 75.219999999999999 111.906 176.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.46 -31.06 94.09 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.658 2.238 . . . . 75.400000000000006 112.777 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 44.4 p-80 -86.33 -8.09 57.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.889 0.376 . . . . 74.230000000000004 111.022 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 755' ' ' GLU . . . . . 0.744 ' HB2' ' HG2' ' A' ' 752' ' ' PRO . 17.4 mm-40 -142.81 67.12 18.12 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.164 -0.471 . . . . 75.510000000000005 111.622 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 756' ' ' PRO . . . . . 0.511 ' O ' ' HA ' ' A' ' 775' ' ' HIS . 48.1 Cg_endo -71.1 88.13 0.7 Allowed 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 121.845 1.697 . . . . 75.319999999999993 110.084 173.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 757' ' ' LYS . . . . . 0.851 ' HZ1' ' HB2' ' A' ' 757' ' ' LYS . 3.6 ttmp? -87.26 116.25 25.22 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.583 0.706 . . . . 64.010000000000005 111.726 -168.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 758' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -97.83 120.87 39.0 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.88 -1.054 . . . . 72.319999999999993 110.133 177.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 15.9 t -88.84 100.14 10.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 109.239 -0.652 . . . . 51.310000000000002 109.239 177.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -103.93 141.88 35.39 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.012 -0.54 . . . . 74.230000000000004 110.812 -177.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -132.04 136.45 47.24 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.07 -0.513 . . . . 72.120000000000005 109.844 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 762' ' ' ALA . . . . . . . . . . . . . . . -94.5 117.49 30.2 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.226 0.536 . . . . 74.420000000000002 110.388 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 763' ' ' LYS . . . . . 0.669 ' HD2' ' CH2' ' A' ' 768' ' ' TRP . 56.5 tttm -101.74 112.02 24.47 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.996 -0.547 . . . . 75.519999999999996 110.025 178.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 89.9 t -117.15 105.99 19.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.17 0.51 . . . . 63.340000000000003 110.041 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 74.22 -115.89 5.04 Favored Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 110.955 -0.858 . . . . 71.239999999999995 110.955 -175.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -110.21 4.24 29.98 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.524 -0.846 . . . . 73.340000000000003 112.348 177.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 767' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -103.48 149.21 25.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.933 0.397 . . . . 74.420000000000002 110.94 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 768' ' ' TRP . . . . . 0.669 ' CH2' ' HD2' ' A' ' 763' ' ' LYS . 58.4 m95 -117.76 104.38 10.92 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.698 -0.683 . . . . 75.510000000000005 109.822 -178.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 769' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -172.86 137.84 0.82 Allowed Pre-proline 0 C--N 1.324 -0.524 0 CA-C-O 121.065 0.46 . . . . 75.329999999999998 110.925 -177.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 770' ' ' PRO . . . . . 0.558 ' HD3' ' HB1' ' A' ' 788' ' ' ALA . 71.4 Cg_endo -97.16 176.9 8.68 Favored 'Cis proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.381 -1.508 . . . . 73.540000000000006 112.093 -3.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -112.51 109.73 19.48 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.536 -0.542 . . . . 72.5 109.536 173.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 34.1 m -116.61 174.8 3.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.039 -0.528 . . . . 75.230000000000004 110.891 -174.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 11.8 p -138.08 129.05 27.12 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.856 -0.611 . . . . 70.329999999999998 110.615 178.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -140.04 153.76 46.9 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.984 -0.553 . . . . 72.400000000000006 109.963 178.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 775' ' ' HIS . . . . . 0.511 ' HA ' ' O ' ' A' ' 756' ' ' PRO . 1.5 p-80 -86.3 12.58 9.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.181 0.515 . . . . 70.209999999999994 111.151 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 776' ' ' SER . . . . . 0.43 ' HB3' ' HB2' ' A' ' 779' ' ' GLN . 40.7 t -138.22 141.2 39.98 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.79 -0.641 . . . . 75.409999999999997 109.361 176.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 777' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -68.07 -41.91 81.25 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.267 -0.424 . . . . 75.340000000000003 110.17 -178.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -64.99 -40.74 95.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.991 -0.55 . . . . 72.239999999999995 110.075 178.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 779' ' ' GLN . . . . . 0.502 ' O ' ' HG2' ' A' ' 783' ' ' GLU . 49.1 mt-30 -63.18 -44.14 96.25 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 116.155 -0.475 . . . . 71.530000000000001 110.791 177.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -51.65 -42.21 51.6 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 121.317 -0.468 . . . . 55.229999999999997 112.857 -178.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -62.81 -47.65 82.54 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.349 0.595 . . . . 73.239999999999995 110.682 177.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -69.1 -41.9 76.85 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.291 -0.868 . . . . 74.310000000000002 111.401 -176.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 783' ' ' GLU . . . . . 0.502 ' HG2' ' O ' ' A' ' 779' ' ' GLN . 25.5 mm-40 -57.53 -46.3 84.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.069 0.462 . . . . 74.340000000000003 110.1 177.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -63.45 -49.53 73.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.675 -0.693 . . . . 62.509999999999998 110.803 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 785' ' ' ALA . . . . . 0.468 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -63.15 -40.66 98.21 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.284 -0.417 . . . . 74.0 111.33 -178.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 786' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -58.38 -54.75 43.5 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.148 0.499 . . . . 74.129999999999995 110.319 177.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 787' ' ' ALA . . . . . 0.607 ' O ' HG22 ' A' ' 791' ' ' VAL . . . -61.3 -40.43 94.15 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.425 -0.807 . . . . 74.349999999999994 110.708 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 788' ' ' ALA . . . . . 0.694 ' O ' ' HG ' ' A' ' 792' ' ' LEU . . . -56.93 -49.9 74.23 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.17 -0.468 . . . . 70.299999999999997 111.33 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 789' ' ' LEU . . . . . 0.538 HD23 HD12 ' A' ' 719' ' ' LEU . 80.2 mt -61.05 -43.16 99.3 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 110.156 -0.313 . . . . 72.439999999999998 110.156 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 790' ' ' ARG . . . . . . . . . . . . . 52.8 mtp180 -59.54 -36.17 75.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.124 -0.489 . . . . 73.310000000000002 111.328 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 791' ' ' VAL . . . . . 0.607 HG22 ' O ' ' A' ' 787' ' ' ALA . 64.4 t -64.61 -54.05 35.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 109.845 -0.428 . . . . 74.439999999999998 109.845 173.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 792' ' ' LEU . . . . . 0.694 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 45.6 mt -55.73 -48.68 74.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.69 -0.686 . . . . 73.209999999999994 111.185 -177.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 793' ' ' ILE . . . . . 0.491 HD13 HG23 ' A' ' 720' ' ' VAL . 93.0 mt -59.41 -52.27 62.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.588 -0.733 . . . . 74.409999999999997 110.933 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -64.58 -44.0 95.7 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.672 -0.775 . . . . 63.539999999999999 112.48 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -64.82 -47.69 77.1 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.745 0.276 . . . . 74.319999999999993 111.745 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 796' ' ' ASN . . . . . 0.425 HD21 ' HA ' ' A' ' 796' ' ' ASN . 1.0 OUTLIER -72.14 -26.57 62.16 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.708 -0.397 . . . . 75.25 110.709 -175.948 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 797' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -72.92 -46.22 53.83 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.123 0.487 . . . . 73.400000000000006 109.967 174.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 798' ' ' LYS . . . . . . . . . . . . . 24.4 ttpp -64.42 -38.08 89.79 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.655 -0.702 . . . . 70.25 110.877 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 799' ' ' ALA . . . . . . . . . . . . . . . -72.77 -51.98 16.89 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.325 -0.398 . . . . 64.109999999999999 110.597 175.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 800' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 60.07 31.29 20.53 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.733 0.778 . . . . 75.150000000000006 110.285 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 801' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 . . . . . 0 C--O 1.245 0.868 0 CA-C-O 118.397 -0.811 . . . . 75.239999999999995 109.986 179.364 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 708' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 N--CA 1.479 1.004 0 CA-C-O 120.911 0.386 . . . . 72.400000000000006 110.274 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 60.1 mtm -131.62 92.24 31.74 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 116.396 -0.366 . . . . 73.239999999999995 111.376 -178.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -80.84 -5.95 13.2 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.184 1.923 . . . . 72.329999999999998 110.577 170.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 711' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -84.68 101.32 12.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.814 -1.084 . . . . 74.209999999999994 109.98 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 712' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -102.86 -14.73 16.45 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.162 0.506 . . . . 71.329999999999998 110.158 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 713' ' ' VAL . . . . . . . . . . . . . 12.4 p -140.82 146.04 24.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.494 -0.776 . . . . 73.400000000000006 109.182 176.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . . . . . . . . . 2.1 tpm_? -59.36 120.42 9.27 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 123.188 0.305 . . . . 74.140000000000001 110.419 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 715' ' ' LYS . . . . . 0.425 ' HD3' ' HA ' ' A' ' 715' ' ' LYS . 67.2 mmtt -117.05 163.19 16.62 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.091 0.472 . . . . 74.5 111.565 -177.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 716' ' ' ILE . . . . . 0.561 ' HA ' HD22 ' A' ' 719' ' ' LEU . 46.2 mm -73.03 -30.33 31.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 CA-C-N 115.651 -0.704 . . . . 74.230000000000004 111.43 -176.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -59.17 -24.5 58.78 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.967 -0.635 . . . . 72.340000000000003 112.0 177.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -71.42 -36.02 71.17 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 120.469 0.176 . . . . 75.120000000000005 110.783 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 719' ' ' LEU . . . . . 0.561 HD22 ' HA ' ' A' ' 716' ' ' ILE . 3.3 mm? -63.14 -32.87 74.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.026 0.441 . . . . 72.530000000000001 109.873 178.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 720' ' ' VAL . . . . . 0.463 HG21 HD12 ' A' ' 793' ' ' ILE . 47.7 t -63.68 -38.73 83.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 115.887 -0.597 . . . . 73.400000000000006 110.171 174.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 721' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -67.07 -32.32 73.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.769 -0.651 . . . . 71.420000000000002 110.049 178.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -70.99 -32.95 69.91 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-N 116.206 -0.452 . . . . 74.239999999999995 110.747 177.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 723' ' ' LEU . . . . . 0.53 HD22 ' HB2' ' A' ' 789' ' ' LEU . 96.1 mt -56.31 -33.51 65.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.232 0.539 . . . . 74.109999999999999 110.163 174.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -77.76 -48.7 15.99 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.574 -0.739 . . . . 73.040000000000006 111.654 177.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 33.7 m -92.28 -67.81 0.83 Allowed 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.445 0.535 . . . . 64.450000000000003 112.445 -172.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 726' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -146.36 102.85 4.03 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 120.64 0.257 . . . . 73.450000000000003 110.439 -178.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 727' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -62.86 -38.02 51.03 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.773 2.315 . . . . 74.530000000000001 112.035 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 46.7 t -62.69 -47.48 92.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.003 -0.544 . . . . 62.130000000000003 110.644 -177.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -62.68 -38.82 97.08 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.793 -0.717 . . . . 51.329999999999998 111.624 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -66.1 -42.84 94.27 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 121.069 -0.586 . . . . 74.120000000000005 112.728 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -62.21 -44.67 96.06 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.027 0.441 . . . . 74.340000000000003 109.991 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 732' ' ' LEU . . . . . . . . . . . . . 87.8 mt -67.93 -36.94 81.01 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.033 -0.531 . . . . 73.129999999999995 110.881 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 733' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -69.82 -43.35 72.19 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 122.834 0.454 . . . . 71.5 110.831 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 734' ' ' TYR . . . . . 0.517 ' HB2' HD12 ' A' ' 719' ' ' LEU . 8.5 t80 -55.21 -48.17 74.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.928 0.394 . . . . 74.049999999999997 110.373 176.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -66.46 -50.45 63.29 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.868 -0.605 . . . . 71.310000000000002 110.97 -177.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 736' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -63.66 -31.1 72.17 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.03 0.443 . . . . 74.439999999999998 111.191 -175.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 34.8 t -77.13 -29.39 54.69 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.905 -0.589 . . . . 75.239999999999995 111.011 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 16.4 m170 -98.63 -11.52 21.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.815 0.34 . . . . 73.219999999999999 111.655 -176.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 103.63 -4.26 46.71 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.733 -0.746 . . . . 64.219999999999999 112.971 177.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -79.26 157.77 27.71 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.847 0.356 . . . . 65.040000000000006 110.494 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -102.99 122.81 45.37 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.148 -0.686 . . . . 60.100000000000001 109.148 175.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 742' ' ' ALA . . . . . 0.498 ' HA ' ' O ' ' A' ' 763' ' ' LYS . . . -114.16 122.64 47.45 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 123.379 0.424 . . . . 63.310000000000002 111.076 -176.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 743' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -145.3 138.36 26.33 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.176 -0.465 . . . . 65.310000000000002 110.844 178.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -101.15 110.83 22.91 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.842 -0.617 . . . . 65.420000000000002 109.457 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 745' ' ' LYS . . . . . 0.465 ' HB3' ' HZ3' ' A' ' 745' ' ' LYS . 0.9 OUTLIER -115.68 148.85 39.25 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.062 0.458 . . . . 74.150000000000006 110.886 -179.204 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 746' ' ' LEU . . . . . . . . . . . . . 59.2 tp -77.88 117.45 19.25 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.682 -0.69 . . . . 73.319999999999993 110.229 178.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 93.6 t -72.83 -51.45 27.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 116.111 -0.495 . . . . 74.510000000000005 109.807 176.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -169.57 155.65 6.18 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.655 -0.702 . . . . 64.299999999999997 109.899 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 749' ' ' GLN . . . . . 0.539 ' HA ' ' O ' ' A' ' 757' ' ' LYS . 14.7 pt20 -130.69 98.97 4.8 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.413 0.625 . . . . 63.200000000000003 110.323 175.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 35.7 m -141.96 133.57 26.86 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.676 -0.693 . . . . 63.409999999999997 110.695 -177.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 170.04 -172.6 43.91 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 121.081 -0.581 . . . . 55.229999999999997 111.764 178.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 752' ' ' PRO . . . . . 0.797 ' HG2' ' HB2' ' A' ' 755' ' ' GLU . 39.0 Cg_endo -67.56 157.9 59.61 Favored 'Trans proline' 0 N--CA 1.464 -0.217 0 C-N-CA 122.774 2.316 . . . . 71.019999999999996 111.569 177.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -58.73 -32.35 96.79 Favored 'Trans proline' 0 CA--C 1.532 0.405 0 C-N-CA 122.52 2.146 . . . . 73.5 113.109 -177.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 47.9 p-80 -83.04 -18.59 39.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.958 0.408 . . . . 75.430000000000007 111.081 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 755' ' ' GLU . . . . . 0.797 ' HB2' ' HG2' ' A' ' 752' ' ' PRO . 58.9 mm-40 -129.4 74.1 81.16 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.114 -0.493 . . . . 74.230000000000004 110.832 179.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 756' ' ' PRO . . . . . 0.715 ' O ' ' HA ' ' A' ' 775' ' ' HIS . 29.5 Cg_endo -64.51 102.6 0.41 Allowed 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.083 1.855 . . . . 65.120000000000005 110.23 174.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 757' ' ' LYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 749' ' ' GLN . 0.8 OUTLIER -89.51 105.43 17.79 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.088 0.471 . . . . 73.140000000000001 111.366 -170.01 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 758' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -92.29 110.11 21.5 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.464 -0.789 . . . . 74.099999999999994 109.752 177.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 13.8 t -84.57 109.24 17.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.607 -0.724 . . . . 74.340000000000003 109.423 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -110.81 135.79 50.84 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.269 -0.423 . . . . 74.340000000000003 110.895 -178.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 761' ' ' GLN . . . . . 0.553 ' HA ' ' O ' ' A' ' 770' ' ' PRO . 57.7 tt0 -128.35 130.85 48.37 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.119 -0.491 . . . . 74.209999999999994 109.973 179.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 762' ' ' ALA . . . . . . . . . . . . . . . -89.59 117.73 28.7 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.18 0.514 . . . . 73.340000000000003 110.749 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 763' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 742' ' ' ALA . 60.5 tttm -89.62 113.98 25.51 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.222 -0.658 . . . . 64.430000000000007 109.222 175.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 92.8 t -124.0 101.35 8.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.363 0.601 . . . . 73.140000000000001 110.162 178.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 73.14 -116.05 5.39 Favored Glycine 0 N--CA 1.442 -0.923 0 CA-C-N 115.187 -0.915 . . . . 74.099999999999994 111.426 -177.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -102.36 -11.23 36.69 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.801 -0.714 . . . . 73.239999999999995 111.998 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 767' ' ' ARG . . . . . . . . . . . . . 62.9 mtt180 -99.81 146.28 26.78 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.259 0.552 . . . . 73.420000000000002 111.673 -178.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 768' ' ' TRP . . . . . 0.467 ' CH2' ' HD2' ' A' ' 763' ' ' LYS . 63.0 m95 -111.77 107.36 16.41 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.208 -0.905 . . . . 74.329999999999998 109.404 179.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 769' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -169.19 141.0 2.02 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-O 121.048 0.452 . . . . 75.239999999999995 111.124 -176.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 770' ' ' PRO . . . . . 0.689 ' HD3' ' HB1' ' A' ' 788' ' ' ALA . 74.8 Cg_endo -98.46 176.94 7.65 Favored 'Cis proline' 0 N--CA 1.449 -1.089 0 C-N-CA 123.301 -1.541 . . . . 75.430000000000007 111.397 -5.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -111.55 99.29 8.07 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.991 0.424 . . . . 73.510000000000005 109.978 173.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 34.4 m -106.22 161.04 5.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.881 -0.6 . . . . 75.129999999999995 110.926 -177.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 773' ' ' CYS . . . . . 0.42 ' HB3' ' CG ' ' A' ' 757' ' ' LYS . 39.3 m -125.58 114.25 18.49 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.219 -0.446 . . . . 54.020000000000003 110.633 -178.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -128.61 153.48 47.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.224 -0.443 . . . . 72.439999999999998 109.947 178.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 775' ' ' HIS . . . . . 0.715 ' HA ' ' O ' ' A' ' 756' ' ' PRO . 1.9 p-80 -84.11 19.47 1.8 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.992 0.425 . . . . 73.299999999999997 111.492 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 24.9 t -153.32 143.19 22.06 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.396 -0.594 . . . . 75.219999999999999 109.396 175.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 777' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -60.65 -55.24 35.68 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.163 -0.472 . . . . 73.019999999999996 111.97 -175.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -65.92 -31.41 72.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.558 -0.292 . . . . 74.129999999999995 110.592 -175.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 779' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -62.0 -46.74 87.88 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.486 -0.561 . . . . 74.099999999999994 109.486 172.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -56.88 -47.73 84.19 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.698 -0.683 . . . . 71.200000000000003 112.169 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -59.21 -43.89 92.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.534 0.207 . . . . 75.450000000000003 111.364 177.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -68.58 -46.37 69.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.706 -0.225 . . . . 71.450000000000003 111.441 -178.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -64.05 -39.27 93.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.653 0.263 . . . . 72.340000000000003 110.522 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -62.37 -49.39 75.73 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 116.254 -0.43 . . . . 62.43 110.438 176.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 785' ' ' ALA . . . . . 0.584 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -61.38 -42.17 98.28 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.181 -0.463 . . . . 75.420000000000002 111.151 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 786' ' ' ASP . . . . . 0.611 ' O ' ' HG2' ' A' ' 790' ' ' ARG . 10.4 t70 -58.91 -54.22 49.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 70.129999999999995 110.375 178.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 787' ' ' ALA . . . . . 0.55 ' HB3' ' HG3' ' A' ' 770' ' ' PRO . . . -65.41 -33.91 77.06 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.966 -0.561 . . . . 63.439999999999998 111.097 -178.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 788' ' ' ALA . . . . . 0.689 ' HB1' ' HD3' ' A' ' 770' ' ' PRO . . . -61.3 -44.52 97.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.476 -0.329 . . . . 63.140000000000001 110.729 177.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 789' ' ' LEU . . . . . 0.584 ' HG ' ' O ' ' A' ' 785' ' ' ALA . 53.3 mt -63.19 -36.16 82.71 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.483 -0.326 . . . . 74.209999999999994 110.199 179.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 790' ' ' ARG . . . . . 0.611 ' HG2' ' O ' ' A' ' 786' ' ' ASP . 21.2 mmt180 -58.15 -45.63 87.06 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 109.739 -0.467 . . . . 71.120000000000005 109.739 177.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 791' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 787' ' ' ALA . 30.4 t -61.34 -46.71 96.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.62 -0.718 . . . . 74.140000000000001 110.388 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 792' ' ' LEU . . . . . 0.666 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 45.8 mt -62.2 -50.65 70.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.665 -0.698 . . . . 75.120000000000005 110.915 -178.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 793' ' ' ILE . . . . . 0.463 HD12 HG21 ' A' ' 720' ' ' VAL . 91.4 mt -59.25 -53.81 42.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.587 -0.733 . . . . 71.200000000000003 110.774 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -60.5 -31.85 75.92 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.857 -0.687 . . . . 61.420000000000002 112.615 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 795' ' ' GLU . . . . . 0.538 ' HA ' ' HE3' ' A' ' 798' ' ' LYS . 3.5 tm-20 -65.23 -48.27 73.89 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.145 0.497 . . . . 75.209999999999994 109.991 178.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -80.0 -24.94 40.5 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.054 -0.521 . . . . 74.129999999999995 111.623 -175.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 797' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -63.91 -21.63 66.56 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.043 0.386 . . . . 74.299999999999997 112.043 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 798' ' ' LYS . . . . . 0.538 ' HE3' ' HA ' ' A' ' 795' ' ' GLU . 0.0 OUTLIER -114.61 26.96 9.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.362 0.601 . . . . 72.140000000000001 110.866 177.842 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 799' ' ' ALA . . . . . . . . . . . . . . . -94.99 91.53 6.42 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.708 -0.678 . . . . 71.420000000000002 109.422 177.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 800' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 71.27 9.56 6.59 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.068 -0.969 . . . . 74.329999999999998 111.047 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 801' ' ' ARG . . . . . . . . . . . . . 26.0 mmm180 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.406 -0.806 . . . . 73.299999999999997 110.57 -177.413 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 708' ' ' MET . . . . . . . . . . . . . 22.8 ptp . . . . . 0 N--CA 1.479 0.98 0 CA-C-O 120.76 0.314 . . . . 70.109999999999999 110.495 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 67.4 mtt -93.32 158.81 36.46 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.231 -0.441 . . . . 72.319999999999993 110.076 177.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.46 46.64 1.67 Allowed 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 122.99 2.46 . . . . 74.420000000000002 112.231 177.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 711' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -57.55 140.96 49.47 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.862 -0.608 . . . . 75.25 111.698 -177.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 712' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -98.8 118.29 35.2 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.438 -0.801 . . . . 73.299999999999997 110.247 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 713' ' ' VAL . . . . . . . . . . . . . 27.4 m -80.46 -177.27 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.873 -0.603 . . . . 73.109999999999999 110.944 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . . . . . . . . . 9.8 ptp180 -75.41 64.15 1.53 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.367 0.604 . . . . 75.25 111.296 178.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -74.48 101.55 4.19 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.37 -0.832 . . . . 74.209999999999994 109.044 175.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 716' ' ' ILE . . . . . 0.444 ' HA ' HD23 ' A' ' 719' ' ' LEU . 50.1 mm -71.53 -27.76 29.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.906 -0.588 . . . . 71.040000000000006 111.398 -173.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -56.45 -29.53 57.35 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 121.187 -0.53 . . . . 41.450000000000003 112.435 177.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 718' ' ' GLU . . . . . 0.614 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 9.3 mm-40 -60.57 -53.36 58.42 Favored 'General case' 0 C--O 1.225 -0.236 0 N-CA-C 109.985 -0.376 . . . . 74.430000000000007 109.985 176.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 719' ' ' LEU . . . . . 0.515 HD12 HD21 ' A' ' 789' ' ' LEU . 2.7 mm? -60.35 -35.88 76.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.042 -0.527 . . . . 70.109999999999999 110.461 -177.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 720' ' ' VAL . . . . . 0.402 HG21 HD11 ' A' ' 793' ' ' ILE . 58.7 t -62.09 -41.37 90.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 116.07 -0.514 . . . . 74.420000000000002 110.871 178.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 721' ' ' ARG . . . . . 0.614 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 19.1 ptt180 -66.82 -26.05 66.74 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.308 -0.405 . . . . 73.230000000000004 110.064 -178.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -77.33 -30.67 54.12 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 116.293 -0.412 . . . . 74.420000000000002 110.787 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 723' ' ' LEU . . . . . 0.51 HD22 ' HB2' ' A' ' 789' ' ' LEU . 55.8 mt -64.01 -23.97 67.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.167 0.508 . . . . 74.030000000000001 110.002 173.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -89.51 -26.38 20.92 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.748 -0.66 . . . . 75.5 110.989 176.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 10.9 m -106.29 -77.47 0.59 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.909 0.385 . . . . 74.430000000000007 111.407 -175.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 726' ' ' ASN . . . . . 0.413 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 29.3 t30 -145.31 108.19 4.51 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.347 -0.388 . . . . 72.439999999999998 110.231 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 727' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 13.6 Cg_endo -57.6 -38.48 93.45 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.966 2.444 . . . . 60.030000000000001 112.413 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 55.8 t -60.57 -47.5 92.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.244 -0.434 . . . . 72.120000000000005 110.34 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -62.43 -32.28 82.47 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.67 -0.695 . . . . 53.420000000000002 111.822 178.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -67.89 -43.73 81.92 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.092 -0.575 . . . . 71.439999999999998 112.461 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -64.9 -40.46 95.11 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.633 -0.506 . . . . 72.450000000000003 109.633 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 732' ' ' LEU . . . . . 0.41 HD22 ' HB2' ' A' ' 742' ' ' ALA . 84.6 mt -63.67 -41.51 98.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.842 -0.617 . . . . 64.040000000000006 110.451 176.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 733' ' ' GLU . . . . . 0.466 ' O ' ' HG2' ' A' ' 736' ' ' ARG . 2.5 tp10 -65.55 -44.59 86.31 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 123.052 0.541 . . . . 74.530000000000001 110.86 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 734' ' ' TYR . . . . . 0.449 ' HB2' HD13 ' A' ' 719' ' ' LEU . 27.1 t80 -56.23 -51.63 67.4 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.974 -0.557 . . . . 72.340000000000003 111.08 178.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -66.13 -46.86 76.04 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.393 -0.367 . . . . 64.010000000000005 111.291 -177.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 736' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' A' ' 733' ' ' GLU . 25.7 ptt180 -64.32 -29.34 70.42 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.201 0.524 . . . . 71.099999999999994 111.239 -175.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 33.8 t -83.64 -35.11 24.84 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.778 -0.646 . . . . 64.430000000000007 111.222 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 13.2 m170 -93.6 -10.29 35.18 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.201 0.445 . . . . 70.120000000000005 112.201 -172.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 103.1 3.92 48.05 Favored Glycine 0 N--CA 1.453 -0.172 0 C-N-CA 120.417 -0.897 . . . . 73.519999999999996 112.751 176.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -90.91 178.29 6.07 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.042 0.448 . . . . 75.319999999999993 110.542 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 741' ' ' ALA . . . . . 0.529 ' O ' ' HA ' ' A' ' 764' ' ' VAL . . . -120.16 134.55 55.23 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.847 -0.615 . . . . 75.200000000000003 109.492 174.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 742' ' ' ALA . . . . . 0.41 ' HB2' HD22 ' A' ' 732' ' ' LEU . . . -102.18 113.29 26.44 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.526 -0.306 . . . . 72.099999999999994 110.808 -177.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 743' ' ' GLU . . . . . 0.531 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 46.2 mt-10 -123.84 140.62 52.81 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.172 -0.467 . . . . 63.210000000000001 110.818 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -121.96 105.15 10.06 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.569 -0.53 . . . . 74.439999999999998 109.569 176.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.52 153.3 35.57 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.566 -0.454 . . . . 75.319999999999993 111.453 -177.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 746' ' ' LEU . . . . . . . . . . . . . 57.0 tp -82.03 116.14 21.5 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.473 -0.785 . . . . 74.310000000000002 109.407 173.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 52.2 t -88.06 -47.72 15.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 116.292 -0.413 . . . . 73.200000000000003 110.323 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -141.42 143.97 34.21 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.203 -0.453 . . . . 70.120000000000005 111.261 -176.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -130.06 100.6 5.49 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.816 -0.629 . . . . 75.450000000000003 109.395 174.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 750' ' ' SER . . . . . 0.403 ' O ' ' HB3' ' A' ' 757' ' ' LYS . 20.1 m -136.37 110.53 8.35 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.993 -0.548 . . . . 63.409999999999997 110.547 -177.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 174.15 177.9 43.67 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.976 -0.631 . . . . 64.450000000000003 111.803 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 752' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -71.01 155.87 61.06 Favored 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 122.85 2.367 . . . . 72.120000000000005 111.959 178.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -64.82 -30.29 58.62 Favored 'Trans proline' 0 CA--C 1.528 0.202 0 C-N-CA 122.603 2.202 . . . . 63.439999999999998 112.975 -176.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 56.0 p-80 -84.35 -23.61 30.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.772 0.32 . . . . 74.5 111.024 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -133.01 71.7 77.55 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.147 -0.479 . . . . 73.420000000000002 110.431 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 756' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -64.41 143.13 81.55 Favored 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 122.362 2.041 . . . . 70.310000000000002 112.08 -176.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 757' ' ' LYS . . . . . 0.403 ' HB3' ' O ' ' A' ' 750' ' ' SER . 23.3 ttmm -116.44 114.93 24.92 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.054 -0.521 . . . . 73.349999999999994 109.735 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 758' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -107.02 113.08 26.34 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.889 -0.596 . . . . 71.319999999999993 110.663 -177.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 759' ' ' VAL . . . . . 0.433 HG21 ' HB3' ' A' ' 773' ' ' CYS . 29.1 t -87.26 98.11 7.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.848 -0.615 . . . . 71.239999999999995 109.556 176.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 760' ' ' TYR . . . . . 0.53 ' OH ' ' HG3' ' A' ' 777' ' ' LYS . 6.3 m-85 -100.1 143.04 30.77 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.893 -0.594 . . . . 74.030000000000001 110.236 179.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -131.77 137.44 48.18 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.12 -0.491 . . . . 74.129999999999995 109.695 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 762' ' ' ALA . . . . . . . . . . . . . . . -86.28 114.01 22.74 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.037 -0.529 . . . . 75.150000000000006 110.489 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 763' ' ' LYS . . . . . 0.531 ' HB3' ' HB2' ' A' ' 743' ' ' GLU . 59.3 tttm -96.82 100.44 11.98 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.771 -0.65 . . . . 73.540000000000006 109.699 178.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 764' ' ' VAL . . . . . 0.529 ' HA ' ' O ' ' A' ' 741' ' ' ALA . 61.1 t -104.21 100.81 11.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 N-CA-C 109.448 -0.575 . . . . 75.209999999999994 109.448 -179.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 69.96 -122.49 11.66 Favored Glycine 0 N--CA 1.442 -0.904 0 N-CA-C 110.479 -1.048 . . . . 73.549999999999997 110.479 -172.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -104.01 20.21 41.48 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.596 -0.811 . . . . 70.510000000000005 111.545 174.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 767' ' ' ARG . . . . . . . . . . . . . 41.6 ttt180 -115.53 122.76 46.65 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.735 0.302 . . . . 74.400000000000006 110.394 -176.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 768' ' ' TRP . . . . . 0.487 ' CH2' ' HD2' ' A' ' 763' ' ' LYS . 44.1 m95 -98.21 103.18 15.1 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.243 -0.435 . . . . 75.549999999999997 110.204 -178.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 769' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -171.56 138.97 1.11 Allowed Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 120.822 0.344 . . . . 74.319999999999993 110.554 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 770' ' ' PRO . . . . . 0.572 ' HD3' ' HB3' ' A' ' 788' ' ' ALA . 82.8 Cg_endo -96.58 -176.49 5.16 Favored 'Cis proline' 0 N--CA 1.452 -0.947 0 C-N-CA 123.622 -1.407 . . . . 72.540000000000006 111.769 -4.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -117.4 129.79 56.07 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.077 -0.342 . . . . 73.109999999999999 110.077 176.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 30.7 m -136.63 145.97 29.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.748 0.309 . . . . 70.120000000000005 111.044 -178.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 773' ' ' CYS . . . . . 0.433 ' HB3' HG21 ' A' ' 759' ' ' VAL . 5.0 p -113.36 103.39 11.26 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.105 0.479 . . . . 74.030000000000001 110.695 178.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -106.43 -179.24 3.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.291 -0.413 . . . . 74.099999999999994 111.125 -176.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 775' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 -93.77 -8.65 40.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.286 0.565 . . . . 74.230000000000004 110.231 -177.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 63.6 m -150.75 166.05 31.63 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.754 -0.657 . . . . 63.149999999999999 110.403 -179.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 777' ' ' LYS . . . . . 0.53 ' HG3' ' OH ' ' A' ' 760' ' ' TYR . 31.2 ttmt -64.33 -57.64 8.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.269 -0.423 . . . . 74.219999999999999 111.741 -178.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -61.67 -35.96 79.47 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.054 -0.521 . . . . 74.319999999999993 110.039 -175.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 779' ' ' GLN . . . . . 0.465 ' O ' ' HG2' ' A' ' 783' ' ' GLU . 73.9 mt-30 -52.91 -56.2 17.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 75.25 110.18 170.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -57.37 -47.68 86.21 Favored Glycine 0 C--N 1.332 0.33 0 CA-C-N 115.698 -0.683 . . . . 36.149999999999999 112.764 -177.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -57.48 -44.52 84.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.754 0.311 . . . . 74.319999999999993 111.177 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -69.83 -45.18 68.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.418 -0.356 . . . . 74.120000000000005 111.176 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 783' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 779' ' ' GLN . 30.0 mm-40 -59.86 -40.39 88.43 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.902 0.382 . . . . 72.209999999999994 110.768 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -65.38 -49.87 67.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 72.409999999999997 110.612 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 785' ' ' ALA . . . . . 0.501 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -64.79 -40.09 94.66 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.312 -0.404 . . . . 70.349999999999994 111.18 -178.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 786' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -60.76 -50.05 75.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.984 -0.553 . . . . 75.299999999999997 110.108 178.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 787' ' ' ALA . . . . . 0.605 ' O ' HG23 ' A' ' 791' ' ' VAL . . . -62.6 -39.64 94.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.757 -0.656 . . . . 72.239999999999995 110.712 178.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 788' ' ' ALA . . . . . 0.587 ' O ' ' HG ' ' A' ' 792' ' ' LEU . . . -59.05 -47.36 85.53 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.072 -0.513 . . . . 70.230000000000004 111.338 -179.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 789' ' ' LEU . . . . . 0.515 HD21 HD12 ' A' ' 719' ' ' LEU . 77.9 mt -61.42 -41.77 97.69 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 110.109 -0.33 . . . . 75.200000000000003 110.109 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 790' ' ' ARG . . . . . 0.537 ' HD2' ' HA ' ' A' ' 787' ' ' ALA . 69.8 mtt-85 -57.38 -39.36 75.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 73.230000000000004 110.943 176.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 791' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 787' ' ' ALA . 60.1 t -63.33 -57.31 12.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.102 -0.499 . . . . 65.129999999999995 110.037 176.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 792' ' ' LEU . . . . . 0.587 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 37.1 mt -55.93 -47.72 77.01 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.487 -0.779 . . . . 75.409999999999997 111.522 -176.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 793' ' ' ILE . . . . . 0.402 HD11 HG21 ' A' ' 720' ' ' VAL . 95.7 mt -61.14 -46.47 96.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.795 -0.639 . . . . 74.239999999999995 110.934 178.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -60.69 -39.46 96.66 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.949 -0.643 . . . . 71.140000000000001 112.252 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 795' ' ' GLU . . . . . 0.923 ' HA ' ' HG3' ' A' ' 801' ' ' ARG . 21.5 mm-40 -52.44 -44.13 65.31 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.08 0.467 . . . . 74.549999999999997 110.901 177.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -84.26 -45.4 12.9 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.934 -0.575 . . . . 55.210000000000001 112.008 -175.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 797' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -66.16 -39.58 89.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.441 -0.345 . . . . 71.349999999999994 111.482 -174.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 798' ' ' LYS . . . . . . . . . . . . . 45.8 mtpt -78.14 -43.52 28.61 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.243 -0.651 . . . . 62.109999999999999 109.243 175.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 799' ' ' ALA . . . . . . . . . . . . . . . 63.6 8.37 3.62 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.594 -0.73 . . . . 73.150000000000006 112.322 175.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 800' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.27 20.32 18.8 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.823 0.82 . . . . 62.329999999999998 108.964 173.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 801' ' ' ARG . . . . . 0.923 ' HG3' ' HA ' ' A' ' 795' ' ' GLU . 30.9 mmm180 . . . . . 0 C--O 1.247 0.936 0 CA-C-N 114.288 -1.324 . . . . 75.400000000000006 109.826 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 708' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.998 0 N-CA-C 109.978 -0.379 . . . . 73.430000000000007 109.978 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 22.9 ptt? -109.11 112.36 59.83 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.309 -0.405 . . . . 64.25 110.122 177.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -67.34 101.25 0.61 Allowed 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.546 2.164 . . . . 65.549999999999997 111.896 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 711' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -110.5 85.27 2.08 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.235 -0.439 . . . . 75.129999999999995 110.963 -177.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 712' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -86.24 -25.12 25.74 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.379 -0.6 . . . . 72.120000000000005 109.379 173.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 713' ' ' VAL . . . . . . . . . . . . . 3.6 p -128.4 104.02 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-N 115.203 -0.908 . . . . 73.120000000000005 109.781 173.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -71.46 96.34 1.49 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.823 0.821 . . . . 74.349999999999994 109.948 177.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 715' ' ' LYS . . . . . 0.832 ' HG2' ' HB2' ' A' ' 718' ' ' GLU . 45.2 tttp -87.97 17.97 4.55 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.811 -1.086 . . . . 71.510000000000005 110.419 -174.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 716' ' ' ILE . . . . . 0.521 HG21 ' HA ' ' A' ' 793' ' ' ILE . 38.5 mm -52.48 -47.15 48.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.345 -0.843 . . . . 74.150000000000006 112.694 -171.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -63.81 -30.66 78.35 Favored Glycine 0 C--O 1.237 0.29 0 C-N-CA 120.785 -0.721 . . . . 63.030000000000001 112.358 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 718' ' ' GLU . . . . . 0.832 ' HB2' ' HG2' ' A' ' 715' ' ' LYS . 35.4 mt-10 -73.03 -37.84 66.75 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 110.127 -0.323 . . . . 75.030000000000001 110.127 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 719' ' ' LEU . . . . . 0.548 HD11 ' HB2' ' A' ' 734' ' ' TYR . 2.6 mm? -58.1 -35.04 70.85 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.013 0.435 . . . . 75.219999999999999 110.308 175.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 720' ' ' VAL . . . . . 0.454 HG21 HD12 ' A' ' 793' ' ' ILE . 71.6 t -61.92 -41.16 89.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.856 -0.611 . . . . 72.420000000000002 110.997 178.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 721' ' ' ARG . . . . . 0.654 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 8.2 ptt180 -65.15 -25.35 67.71 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.979 0.419 . . . . 74.430000000000007 110.506 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -77.14 -29.17 54.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.398 -0.365 . . . . 74.319999999999993 110.767 178.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 723' ' ' LEU . . . . . 0.521 HD23 ' HB2' ' A' ' 789' ' ' LEU . 95.8 mt -62.06 -30.03 70.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.371 0.605 . . . . 72.409999999999997 109.742 173.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -81.95 -40.1 22.72 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.283 -0.871 . . . . 72.010000000000005 110.428 176.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 12.1 m -93.02 -83.44 0.31 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.983 -0.553 . . . . 75.329999999999998 111.416 -176.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 726' ' ' ASN . . . . . 0.405 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 44.9 t30 -140.76 110.2 6.67 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.789 0.328 . . . . 63.200000000000003 110.504 -176.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 727' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 28.5 Cg_endo -63.68 -37.24 47.67 Favored 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 122.814 2.343 . . . . 73.299999999999997 112.312 -178.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 44.0 t -61.24 -49.03 86.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.187 -0.46 . . . . 70.150000000000006 110.501 -178.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -64.02 -35.83 92.49 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.963 -0.637 . . . . 74.310000000000002 111.836 178.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -66.8 -41.61 93.51 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 121.063 -0.589 . . . . 74.120000000000005 112.457 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -63.48 -41.2 98.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.095 0.474 . . . . 75.120000000000005 109.733 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 732' ' ' LEU . . . . . 0.424 HD22 ' HB2' ' A' ' 742' ' ' ALA . 75.4 mt -68.29 -39.14 82.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.829 -0.623 . . . . 75.540000000000006 110.65 177.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 733' ' ' GLU . . . . . 0.528 ' O ' ' HG2' ' A' ' 736' ' ' ARG . 2.2 tp10 -65.29 -45.11 85.72 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 123.391 0.676 . . . . 72.400000000000006 111.067 -179.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 734' ' ' TYR . . . . . 0.548 ' HB2' HD11 ' A' ' 719' ' ' LEU . 7.4 t80 -60.21 -46.78 88.56 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.389 -0.369 . . . . 54.100000000000001 110.66 176.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 735' ' ' ALA . . . . . 0.426 ' HA ' ' HB2' ' A' ' 740' ' ' PHE . . . -64.11 -49.02 73.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.133 -0.485 . . . . 61.109999999999999 110.891 -177.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 736' ' ' ARG . . . . . 0.528 ' HG2' ' O ' ' A' ' 733' ' ' GLU . 23.3 ptt180 -59.97 -38.58 82.96 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.869 -0.605 . . . . 73.349999999999994 111.111 -176.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 32.9 t -78.46 -23.27 46.58 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.969 -0.559 . . . . 73.230000000000004 111.461 -177.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -108.91 4.96 23.97 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.118 0.414 . . . . 71.329999999999998 112.118 -174.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 89.04 2.76 77.33 Favored Glycine 0 C--O 1.229 -0.177 0 C-N-CA 120.736 -0.745 . . . . 73.25 113.261 174.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 740' ' ' PHE . . . . . 0.426 ' HB2' ' HA ' ' A' ' 735' ' ' ALA . 90.3 m-85 -83.52 161.26 21.29 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.874 0.369 . . . . 72.420000000000002 110.842 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -115.01 104.24 11.71 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.879 -0.6 . . . . 62.140000000000001 109.538 176.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 742' ' ' ALA . . . . . 0.424 ' HB2' HD22 ' A' ' 732' ' ' LEU . . . -86.4 125.7 33.86 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.04 -0.527 . . . . 72.049999999999997 111.208 -176.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 743' ' ' GLU . . . . . 0.413 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 43.3 mt-10 -137.82 134.72 35.5 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.047 -0.524 . . . . 75.109999999999999 110.382 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -107.21 105.74 15.87 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.5 -0.556 . . . . 74.120000000000005 109.5 176.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.53 147.25 44.68 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.053 0.454 . . . . 64.530000000000001 111.131 -174.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 746' ' ' LEU . . . . . . . . . . . . . 51.3 tp -77.22 122.01 24.46 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.701 -0.681 . . . . 73.439999999999998 110.006 176.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 60.1 t -81.76 -50.35 16.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.09 -0.505 . . . . 74.349999999999994 109.694 177.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -165.99 156.26 12.68 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.697 -0.683 . . . . 74.030000000000001 110.032 -177.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -114.32 119.14 35.94 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.98 -0.378 . . . . 74.540000000000006 109.98 174.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 750' ' ' SER . . . . . 0.498 ' O ' ' HB3' ' A' ' 757' ' ' LYS . 67.6 m -135.56 107.38 7.05 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.107 -0.497 . . . . 50.299999999999997 110.142 179.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 174.81 153.38 10.01 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.261 -0.971 . . . . 71.010000000000005 112.745 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 752' ' ' PRO . . . . . 0.679 ' HG2' ' HB2' ' A' ' 755' ' ' GLU . 36.2 Cg_endo -66.53 168.69 15.85 Favored 'Trans proline' 0 CA--C 1.533 0.427 0 C-N-CA 123.348 2.698 . . . . 71.430000000000007 111.968 176.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.61 -31.88 95.09 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.595 2.197 . . . . 75.010000000000005 112.88 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 42.9 p-80 -87.5 -5.05 58.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.415 -0.357 . . . . 64.450000000000003 111.259 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 755' ' ' GLU . . . . . 0.679 ' HB2' ' HG2' ' A' ' 752' ' ' PRO . 12.2 mm-40 -150.39 64.21 6.5 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.156 -0.475 . . . . 72.140000000000001 110.715 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 756' ' ' PRO . . . . . 0.465 ' O ' ' HA ' ' A' ' 775' ' ' HIS . 14.4 Cg_exo -68.42 92.15 0.41 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.711 2.274 . . . . 71.230000000000004 111.33 178.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 757' ' ' LYS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 775' ' ' HIS . 15.0 ttmt -89.05 111.73 22.53 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.522 0.677 . . . . 65.329999999999998 111.262 -174.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 758' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -90.76 130.85 36.7 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.943 -1.026 . . . . 74.040000000000006 109.832 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 29.2 t -92.87 109.04 21.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.609 -0.515 . . . . 73.150000000000006 109.609 175.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -111.92 141.19 45.87 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.303 -0.408 . . . . 74.319999999999993 110.646 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -126.97 137.82 53.17 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.977 -0.556 . . . . 74.209999999999994 109.92 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 762' ' ' ALA . . . . . 0.467 ' HB2' ' O ' ' A' ' 769' ' ' PHE . . . -85.44 109.82 18.73 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.402 0.62 . . . . 74.239999999999995 110.428 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 763' ' ' LYS . . . . . 0.413 ' HB3' ' HB2' ' A' ' 743' ' ' GLU . 75.1 tttt -94.08 104.29 16.33 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.228 -0.896 . . . . 72.109999999999999 109.483 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 48.4 t -117.2 98.04 6.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 120.939 0.4 . . . . 73.209999999999994 111.176 -175.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 60.5 37.27 93.03 Favored Glycine 0 CA--C 1.517 0.193 0 CA-C-N 115.716 -0.674 . . . . 61.009999999999998 113.143 176.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 94.86 -16.11 61.98 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.545 -0.836 . . . . 72.230000000000004 112.62 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 767' ' ' ARG . . . . . . . . . . . . . 79.0 mtt180 -90.64 129.28 36.78 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.054 -0.35 . . . . 63.420000000000002 110.054 176.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 768' ' ' TRP . . . . . . . . . . . . . 68.3 m95 -106.58 99.15 8.74 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.408 -0.36 . . . . 72.239999999999995 110.484 -176.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 769' ' ' PHE . . . . . 0.467 ' O ' ' HB2' ' A' ' 762' ' ' ALA . 36.3 p90 -170.22 136.86 1.29 Allowed Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.533 -0.303 . . . . 74.5 110.327 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 770' ' ' PRO . . . . . 0.595 ' HG3' ' HB3' ' A' ' 787' ' ' ALA . 62.5 Cg_endo -94.89 179.02 9.23 Favored 'Cis proline' 0 N--CA 1.45 -1.04 0 C-N-CA 123.484 -1.465 . . . . 72.140000000000001 111.978 -3.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -115.56 104.14 11.43 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.938 -0.393 . . . . 62.340000000000003 109.938 175.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 29.6 m -113.67 164.27 9.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.001 0.429 . . . . 74.239999999999995 111.05 -175.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 773' ' ' CYS . . . . . 0.445 ' HB2' ' HG2' ' A' ' 757' ' ' LYS . 10.6 p -127.87 119.19 25.1 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.082 -0.508 . . . . 63.340000000000003 110.193 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -135.91 144.33 45.46 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.41 -0.359 . . . . 73.439999999999998 110.612 -178.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 775' ' ' HIS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 757' ' ' LYS . 1.1 p-80 -76.45 16.5 0.47 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.496 0.554 . . . . 74.420000000000002 112.496 -177.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 776' ' ' SER . . . . . 0.566 ' HB2' ' CG ' ' A' ' 779' ' ' GLN . 11.8 m -147.13 140.32 25.3 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.654 -0.498 . . . . 61.149999999999999 109.654 177.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 777' ' ' LYS . . . . . 0.431 ' HE3' ' HB3' ' A' ' 777' ' ' LYS . 2.2 tmmt? -61.46 -46.25 90.84 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.435 -0.348 . . . . 72.430000000000007 111.227 -178.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 778' ' ' LYS . . . . . 0.503 ' O ' ' HG3' ' A' ' 782' ' ' GLN . 63.7 pttt -66.5 -35.48 80.37 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.929 -0.308 . . . . 75.430000000000007 110.442 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 779' ' ' GLN . . . . . 0.566 ' CG ' ' HB2' ' A' ' 776' ' ' SER . 16.0 mm100 -63.79 -43.9 94.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.337 -0.392 . . . . 75.310000000000002 110.05 177.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -57.52 -40.46 92.38 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.002 -0.618 . . . . 72.099999999999994 111.92 178.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 30.3 mtpp -66.5 -47.0 74.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.639 0.257 . . . . 75.329999999999998 110.831 178.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 782' ' ' GLN . . . . . 0.503 ' HG3' ' O ' ' A' ' 778' ' ' LYS . 22.8 mt-30 -68.25 -48.17 65.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.221 -0.445 . . . . 65.329999999999998 111.228 -177.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -58.76 -46.15 88.12 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 123.25 0.344 . . . . 70.450000000000003 110.999 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -63.17 -48.01 80.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.305 -0.407 . . . . 75.510000000000005 110.893 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 785' ' ' ALA . . . . . 0.623 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -62.64 -42.19 99.46 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.268 -0.424 . . . . 74.400000000000006 111.089 -178.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 786' ' ' ASP . . . . . 0.521 ' O ' ' HG2' ' A' ' 790' ' ' ARG . 11.7 t70 -59.48 -55.74 30.77 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.04 -0.527 . . . . 72.430000000000007 110.129 179.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 787' ' ' ALA . . . . . 0.595 ' HB3' ' HG3' ' A' ' 770' ' ' PRO . . . -61.52 -34.68 75.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.75 -0.659 . . . . 73.209999999999994 111.203 -178.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 788' ' ' ALA . . . . . 0.585 ' O ' ' HG ' ' A' ' 792' ' ' LEU . . . -61.22 -42.78 99.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.421 -0.354 . . . . 72.310000000000002 110.888 178.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 789' ' ' LEU . . . . . 0.623 ' HG ' ' O ' ' A' ' 785' ' ' ALA . 35.5 mt -66.05 -33.93 76.92 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.421 -0.354 . . . . 74.340000000000003 110.122 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 790' ' ' ARG . . . . . 0.521 ' HG2' ' O ' ' A' ' 786' ' ' ASP . 6.2 mmm180 -61.71 -44.47 96.85 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.493 -0.558 . . . . 72.409999999999997 109.493 178.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 791' ' ' VAL . . . . . 0.547 HG21 ' O ' ' A' ' 787' ' ' ALA . 41.2 t -57.69 -44.26 85.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.512 -0.767 . . . . 74.319999999999993 110.559 178.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 792' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 30.3 mt -68.15 -52.06 38.95 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.732 -0.667 . . . . 73.549999999999997 110.713 -178.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 793' ' ' ILE . . . . . 0.521 ' HA ' HG21 ' A' ' 716' ' ' ILE . 95.7 mt -60.23 -47.33 92.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.539 -0.755 . . . . 75.030000000000001 111.456 -177.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -68.71 -26.36 74.54 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.766 -0.731 . . . . 55.130000000000003 112.506 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -77.81 -44.28 27.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.876 0.37 . . . . 61.439999999999998 110.921 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 796' ' ' ASN . . . . . 0.465 ' HA ' ' HB2' ' A' ' 799' ' ' ALA . 1.6 t30 -90.58 4.26 51.77 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.007 0.432 . . . . 74.420000000000002 110.664 -176.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 797' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -57.97 -53.69 55.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.629 -0.714 . . . . 53.119999999999997 110.287 178.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 798' ' ' LYS . . . . . . . . . . . . . 53.1 tttp -123.62 55.99 1.23 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.586 0.707 . . . . 64.409999999999997 109.444 175.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 799' ' ' ALA . . . . . 0.465 ' HB2' ' HA ' ' A' ' 796' ' ' ASN . . . -96.79 -175.19 3.21 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.283 -0.871 . . . . 73.129999999999995 110.297 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 800' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -92.33 -9.64 41.18 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.896 0.379 . . . . 71.510000000000005 110.465 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 801' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.676 -0.678 . . . . 73.340000000000003 110.4 -174.394 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 708' ' ' MET . . . . . . . . . . . . . 67.6 mtt . . . . . 0 N--CA 1.48 1.047 0 N-CA-C 110.407 -0.22 . . . . 74.200000000000003 110.407 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 26.4 mmt 71.04 136.95 0.05 OUTLIER Pre-proline 0 N--CA 1.467 0.376 0 O-C-N 124.062 0.851 . . . . 64.129999999999995 112.199 178.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -83.98 38.29 0.69 Allowed 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 123.16 2.573 . . . . 64.530000000000001 112.288 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 711' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -62.21 -43.67 98.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.219 0.533 . . . . 75.349999999999994 110.165 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 712' ' ' LYS . . . . . 0.428 ' HD3' ' O ' ' A' ' 713' ' ' VAL . 1.2 tmtp? -124.97 108.31 11.73 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.997 -0.742 . . . . 65.129999999999995 108.997 175.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 713' ' ' VAL . . . . . 0.428 ' O ' ' HD3' ' A' ' 712' ' ' LYS . 12.0 p -59.22 149.05 6.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.755 -0.657 . . . . 70.409999999999997 110.552 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . . . . . . . . . 30.5 ptt180 -76.22 50.28 0.62 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.465 0.65 . . . . 73.439999999999998 111.104 -177.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 715' ' ' LYS . . . . . 0.467 ' HD2' ' HG2' ' A' ' 718' ' ' GLU . 39.0 ttmt -65.85 105.76 1.38 Allowed 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.651 -0.704 . . . . 74.25 109.723 178.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 716' ' ' ILE . . . . . 0.538 HG22 HG12 ' A' ' 793' ' ' ILE . 44.7 mm -67.93 -26.17 34.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.916 -0.583 . . . . 75.409999999999997 111.166 -174.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -58.71 -29.1 63.81 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.742 -0.742 . . . . 74.340000000000003 111.645 175.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 718' ' ' GLU . . . . . 0.692 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 43.7 mm-40 -70.17 -40.43 74.71 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-O 120.707 0.289 . . . . 72.530000000000001 110.77 178.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 719' ' ' LEU . . . . . 0.525 HD22 ' HA ' ' A' ' 716' ' ' ILE . 3.1 mm? -64.4 -27.08 68.76 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.127 0.489 . . . . 71.329999999999998 109.929 177.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 720' ' ' VAL . . . . . . . . . . . . . 98.2 t -76.18 -36.85 31.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.789 -0.641 . . . . 74.310000000000002 111.346 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 721' ' ' ARG . . . . . 0.692 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 5.9 ptm180 -67.89 -22.77 65.08 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.34 0.591 . . . . 74.340000000000003 109.762 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -77.22 -31.02 54.88 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.929 -0.578 . . . . 74.030000000000001 110.622 175.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 723' ' ' LEU . . . . . 0.506 HD22 ' HB2' ' A' ' 789' ' ' LEU . 85.3 mt -60.13 -30.41 69.27 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.284 0.564 . . . . 74.310000000000002 109.894 174.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -87.98 -39.49 14.66 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.352 -0.84 . . . . 72.430000000000007 111.303 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 30.7 m -90.23 -76.17 0.44 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.756 0.312 . . . . 71.430000000000007 111.761 -177.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 726' ' ' ASN . . . . . 0.453 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 25.2 t30 -150.84 105.56 3.03 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.458 -0.337 . . . . 71.340000000000003 110.453 -178.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 727' ' ' PRO . . . . . 0.453 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 18.1 Cg_endo -60.63 -32.55 93.44 Favored 'Trans proline' 0 N--CA 1.464 -0.207 0 C-N-CA 123.131 2.554 . . . . 74.420000000000002 112.47 -178.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 43.4 t -61.88 -48.05 90.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.09 -0.505 . . . . 73.040000000000006 110.47 -177.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -63.06 -32.66 84.91 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.925 -0.655 . . . . 72.219999999999999 112.183 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -73.88 -44.48 30.76 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.753 -0.737 . . . . 71.450000000000003 112.5 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -64.1 -40.97 97.38 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.85 0.357 . . . . 73.340000000000003 110.147 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 732' ' ' LEU . . . . . . . . . . . . . 93.3 mt -64.19 -40.85 96.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.119 -0.492 . . . . 73.129999999999995 111.523 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 733' ' ' GLU . . . . . 0.528 ' HA ' ' HG2' ' A' ' 736' ' ' ARG . 6.5 pt-20 -78.35 -31.24 48.46 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.404 -0.518 . . . . 73.510000000000005 110.971 -178.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 734' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -53.76 -45.61 70.67 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 121.056 0.455 . . . . 75.319999999999993 109.942 175.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -66.06 -53.28 40.3 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.727 -0.67 . . . . 65.540000000000006 110.708 -178.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 736' ' ' ARG . . . . . 0.528 ' HG2' ' HA ' ' A' ' 733' ' ' GLU . 19.2 ptt85 -61.36 -34.42 75.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.092 -0.504 . . . . 73.329999999999998 111.209 -175.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 15.6 t -73.44 -36.4 65.91 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.815 -0.63 . . . . 75.400000000000006 111.137 178.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 13.4 m170 -95.64 3.19 54.21 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.948 0.351 . . . . 73.439999999999998 111.948 -173.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 95.08 0.01 63.88 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.519 -0.848 . . . . 74.120000000000005 113.367 173.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -94.27 -179.1 4.82 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.798 0.332 . . . . 75.099999999999994 110.393 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 741' ' ' ALA . . . . . 0.424 ' O ' ' HA ' ' A' ' 764' ' ' VAL . . . -127.2 134.64 50.1 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.212 -0.662 . . . . 64.099999999999994 109.212 173.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 742' ' ' ALA . . . . . . . . . . . . . . . -110.89 131.39 55.09 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.741 0.305 . . . . 62.229999999999997 111.166 -176.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 743' ' ' GLU . . . . . 0.45 ' HG3' ' HB3' ' A' ' 763' ' ' LYS . 12.7 pt-20 -147.57 153.27 39.23 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.92 -0.582 . . . . 73.310000000000002 110.435 178.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -120.6 118.26 29.69 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.061 -0.518 . . . . 72.239999999999995 109.781 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -122.2 138.19 54.57 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.524 -0.47 . . . . 74.209999999999994 111.246 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 746' ' ' LEU . . . . . . . . . . . . . 6.8 tt -74.24 119.14 18.03 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.501 -0.772 . . . . 73.299999999999997 109.176 176.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 43.9 t -94.89 -44.99 13.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.279 -0.419 . . . . 74.230000000000004 110.959 -177.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -149.29 158.02 43.83 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.402 -0.363 . . . . 74.25 110.77 -176.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -141.36 113.41 7.93 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.332 -0.618 . . . . 71.319999999999993 109.332 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 6.1 t -143.83 -167.29 2.56 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.869 -0.332 . . . . 72.329999999999998 110.324 -177.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 97.23 -150.38 19.52 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.853 -0.689 . . . . 72.219999999999999 111.787 -177.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 752' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -80.06 158.38 23.71 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.364 2.042 . . . . 73.420000000000002 111.802 178.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -73.13 -36.17 4.51 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.661 2.24 . . . . 71.129999999999995 112.376 -177.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -76.33 -29.27 57.21 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.96 -0.564 . . . . 73.340000000000003 110.834 -177.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -130.98 74.02 80.37 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 72.439999999999998 110.614 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 756' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -62.95 132.05 35.35 Favored 'Trans proline' 0 N--CA 1.465 -0.152 0 C-N-CA 122.685 2.257 . . . . 73.409999999999997 112.018 -177.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 757' ' ' LYS . . . . . 0.527 ' HG2' ' HB2' ' A' ' 773' ' ' CYS . 39.1 ttmt -98.83 111.83 24.1 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.279 0.561 . . . . 65.120000000000005 109.796 178.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 758' ' ' PHE . . . . . 0.417 ' O ' ' HA ' ' A' ' 773' ' ' CYS . 61.3 m-85 -90.27 123.25 33.89 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.116 -0.947 . . . . 74.510000000000005 110.595 -175.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 56.4 t -88.91 108.0 18.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.998 -0.547 . . . . 61.109999999999999 109.725 176.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -111.22 135.19 52.11 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.795 -0.639 . . . . 74.319999999999993 110.676 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -120.76 126.85 51.18 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.829 -0.623 . . . . 72.299999999999997 109.658 178.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 762' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 769' ' ' PHE . . . -83.94 120.92 26.68 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.179 0.514 . . . . 73.0 110.19 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 763' ' ' LYS . . . . . 0.684 ' HD2' ' CH2' ' A' ' 768' ' ' TRP . 49.4 tttm -104.32 107.3 18.15 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.842 -0.617 . . . . 65.150000000000006 110.054 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 764' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' A' ' 741' ' ' ALA . 48.4 t -114.94 102.66 14.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.988 -0.551 . . . . 73.409999999999997 109.868 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 72.77 -123.15 8.67 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 110.821 -0.912 . . . . 74.230000000000004 110.821 -174.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -101.2 2.54 54.66 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.123 -0.791 . . . . 72.409999999999997 111.123 173.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 767' ' ' ARG . . . . . 0.435 ' NE ' ' HA ' ' A' ' 767' ' ' ARG . 2.6 mmp_? -97.28 127.52 43.31 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.099 0.476 . . . . 72.430000000000007 110.839 -177.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 768' ' ' TRP . . . . . 0.684 ' CH2' ' HD2' ' A' ' 763' ' ' LYS . 51.1 m95 -103.63 112.15 24.94 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.669 -0.696 . . . . 75.209999999999994 109.27 178.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 769' ' ' PHE . . . . . 0.416 ' O ' ' HB3' ' A' ' 762' ' ' ALA . 27.0 p90 -176.78 136.98 0.43 Allowed Pre-proline 0 C--N 1.323 -0.584 0 CA-C-O 120.955 0.407 . . . . 73.430000000000007 110.248 -178.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 770' ' ' PRO . . . . . 0.563 ' HG3' ' HB1' ' A' ' 787' ' ' ALA . 55.6 Cg_endo -95.51 -170.74 2.81 Favored 'Cis proline' 0 N--CA 1.451 -0.976 0 C-N-CA 123.395 -1.502 . . . . 52.25 111.828 -3.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -120.83 100.18 6.95 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.431 -0.581 . . . . 73.310000000000002 109.431 175.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 28.6 m -109.88 163.98 6.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.243 -0.435 . . . . 75.519999999999996 110.973 -175.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 773' ' ' CYS . . . . . 0.527 ' HB2' ' HG2' ' A' ' 757' ' ' LYS . 6.3 p -138.21 110.69 7.49 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.975 -0.557 . . . . 62.409999999999997 110.002 178.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -118.17 147.61 43.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.539 -0.3 . . . . 73.129999999999995 111.023 -176.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 775' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -76.33 13.33 0.96 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.316 -0.402 . . . . 74.420000000000002 111.828 -177.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 49.9 m -150.02 136.56 19.09 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.249 -0.648 . . . . 74.329999999999998 109.249 174.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 777' ' ' LYS . . . . . 0.424 ' HE3' ' HB3' ' A' ' 777' ' ' LYS . 0.8 OUTLIER -61.87 -40.57 95.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.384 -0.371 . . . . 75.109999999999999 111.372 -174.709 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -66.68 -29.23 69.19 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.11 0.481 . . . . 65.239999999999995 110.39 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 779' ' ' GLN . . . . . 0.489 ' O ' ' HG2' ' A' ' 783' ' ' GLU . 96.4 mt-30 -74.7 -38.38 62.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.944 -0.571 . . . . 75.540000000000006 110.03 178.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -53.18 -44.89 64.15 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 121.324 -0.465 . . . . 65.019999999999996 112.391 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -62.46 -46.63 87.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.976 0.417 . . . . 71.349999999999994 110.649 177.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -66.92 -48.04 69.88 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.869 -0.605 . . . . 74.219999999999999 111.596 -177.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 783' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 779' ' ' GLN . 34.5 mm-40 -59.66 -41.43 90.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.758 0.313 . . . . 73.120000000000005 110.527 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -62.39 -48.01 81.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.07 -0.514 . . . . 55.549999999999997 110.493 178.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 785' ' ' ALA . . . . . 0.564 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -65.26 -40.07 93.46 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.333 -0.394 . . . . 70.299999999999997 110.858 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 786' ' ' ASP . . . . . 0.6 ' O ' ' HD3' ' A' ' 790' ' ' ARG . 13.7 t70 -60.61 -55.65 30.81 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.961 -0.563 . . . . 64.129999999999995 110.299 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 787' ' ' ALA . . . . . 0.563 ' HB1' ' HG3' ' A' ' 770' ' ' PRO . . . -64.14 -31.09 72.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.078 -0.51 . . . . 74.219999999999999 110.904 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 788' ' ' ALA . . . . . 0.681 ' O ' ' HG ' ' A' ' 792' ' ' LEU . . . -62.14 -46.56 88.47 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.286 -0.264 . . . . 72.430000000000007 110.286 176.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 789' ' ' LEU . . . . . 0.564 ' HG ' ' O ' ' A' ' 785' ' ' ALA . 70.1 mt -63.69 -34.78 78.62 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.741 -0.466 . . . . 74.109999999999999 109.741 178.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 790' ' ' ARG . . . . . 0.6 ' HD3' ' O ' ' A' ' 786' ' ' ASP . 0.3 OUTLIER -57.43 -45.71 84.35 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.223 -0.444 . . . . 71.530000000000001 110.185 174.897 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 791' ' ' VAL . . . . . 0.502 HG22 ' O ' ' A' ' 787' ' ' ALA . 48.4 t -61.63 -49.69 83.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.028 -0.533 . . . . 70.540000000000006 110.381 177.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 792' ' ' LEU . . . . . 0.681 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 39.6 mt -59.92 -50.79 72.37 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.988 -0.551 . . . . 75.430000000000007 110.901 -177.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 793' ' ' ILE . . . . . 0.538 HG12 HG22 ' A' ' 716' ' ' ILE . 95.9 mt -60.72 -49.51 84.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.844 -0.616 . . . . 65.530000000000001 110.578 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -61.8 -36.64 93.06 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 121.057 -0.592 . . . . 63.109999999999999 112.625 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 795' ' ' GLU . . . . . 0.533 ' HA ' ' HD3' ' A' ' 798' ' ' LYS . 9.7 tp10 -65.51 -43.91 88.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.049 0.452 . . . . 70.129999999999995 110.129 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -66.33 -32.34 73.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.07 -0.514 . . . . 74.209999999999994 110.925 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 797' ' ' GLU . . . . . 0.533 ' HG3' ' O ' ' A' ' 793' ' ' ILE . 47.2 mt-10 -65.47 -19.49 65.96 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.944 0.402 . . . . 74.420000000000002 110.916 177.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 798' ' ' LYS . . . . . 0.533 ' HD3' ' HA ' ' A' ' 795' ' ' GLU . 44.3 mtpt -81.38 -17.35 49.33 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.106 -0.497 . . . . 72.150000000000006 110.146 176.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 799' ' ' ALA . . . . . . . . . . . . . . . -97.62 -39.53 9.06 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.937 -0.574 . . . . 64.150000000000006 110.828 178.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 800' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -65.04 95.58 0.17 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.944 -0.571 . . . . 72.430000000000007 111.062 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 801' ' ' ARG . . . . . . . . . . . . . 61.0 mtm180 . . . . . 0 C--O 1.246 0.911 0 CA-C-N 115.244 -0.889 . . . . 71.319999999999993 109.931 177.459 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 708' ' ' MET . . . . . 0.428 ' HE1' ' HG3' ' A' ' 710' ' ' PRO . 12.5 tmm? . . . . . 0 N--CA 1.479 0.981 0 N-CA-C 109.422 -0.584 . . . . 75.450000000000003 109.422 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -112.18 110.08 53.93 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 116.324 -0.398 . . . . 74.540000000000006 110.7 -176.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 710' ' ' PRO . . . . . 0.428 ' HG3' ' HE1' ' A' ' 708' ' ' MET . 1.5 Cg_endo -82.88 126.73 4.57 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.201 2.601 . . . . 71.230000000000004 111.665 178.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 711' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -63.1 112.87 2.81 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.246 0.546 . . . . 71.209999999999994 109.619 176.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 712' ' ' LYS . . . . . 0.906 ' HE2' ' HA ' ' A' ' 712' ' ' LYS . 10.6 mmpt? -81.69 162.12 23.13 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.609 -0.723 . . . . 75.409999999999997 112.537 -169.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 713' ' ' VAL . . . . . 0.677 HG23 ' H ' ' A' ' 715' ' ' LYS . 7.1 p -165.88 133.99 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.89 -1.05 . . . . 75.120000000000005 109.039 176.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 714' ' ' ARG . 58.7 mtt-85 -92.69 17.16 10.73 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.039 0.447 . . . . 73.230000000000004 111.01 -177.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 715' ' ' LYS . . . . . 0.677 ' H ' HG23 ' A' ' 713' ' ' VAL . 96.6 mttt -103.86 25.36 9.96 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.698 -0.683 . . . . 72.200000000000003 110.159 178.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 716' ' ' ILE . . . . . 0.562 ' HA ' HD21 ' A' ' 719' ' ' LEU . 37.0 mm -58.91 -30.57 43.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.837 -0.619 . . . . 72.230000000000004 111.117 -178.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -60.55 -29.69 70.16 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 121.008 -0.615 . . . . 55.229999999999997 112.518 175.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -75.54 -25.4 57.14 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 122.651 -0.323 . . . . 75.340000000000003 110.654 178.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 719' ' ' LEU . . . . . 0.562 HD21 ' HA ' ' A' ' 716' ' ' ILE . 4.2 mm? -66.38 -34.77 78.72 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.464 -0.569 . . . . 73.540000000000006 109.464 174.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 720' ' ' VAL . . . . . 0.52 HG22 HD13 ' A' ' 793' ' ' ILE . 22.0 t -68.15 -33.09 58.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.826 -0.625 . . . . 74.019999999999996 109.979 175.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 721' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.29 -35.71 78.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.722 -0.672 . . . . 72.109999999999999 110.04 178.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -71.05 -32.33 69.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.0 -0.546 . . . . 72.049999999999997 111.1 178.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 723' ' ' LEU . . . . . 0.403 HD22 ' HB2' ' A' ' 789' ' ' LEU . 95.3 mt -58.02 -32.03 67.55 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.119 0.485 . . . . 74.430000000000007 109.928 175.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 54.0 m-20 -71.54 -49.9 36.43 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.622 -0.717 . . . . 73.329999999999998 110.839 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 47.4 m -93.12 -70.78 0.68 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.049 0.388 . . . . 75.109999999999999 112.049 -174.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 726' ' ' ASN . . . . . 0.403 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 43.5 t30 -145.12 104.79 4.41 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-O 120.827 0.346 . . . . 75.329999999999998 110.86 -178.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 727' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 18.6 Cg_endo -60.57 -34.52 92.4 Favored 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.821 2.347 . . . . 61.210000000000001 112.064 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 47.6 t -61.76 -48.37 88.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 64.530000000000001 110.364 -178.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -63.15 -31.2 79.92 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 121.026 -0.607 . . . . 55.399999999999999 111.811 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -70.35 -41.98 66.45 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.948 -0.644 . . . . 73.239999999999995 112.376 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 731' ' ' LEU . . . . . 0.413 ' N ' HD23 ' A' ' 789' ' ' LEU . 3.0 tm? -65.57 -40.33 92.66 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.412 -0.588 . . . . 71.140000000000001 109.412 178.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 732' ' ' LEU . . . . . . . . . . . . . 79.4 mt -66.16 -39.25 89.63 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.702 -0.681 . . . . 75.040000000000006 110.78 176.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 733' ' ' GLU . . . . . 0.465 ' O ' ' HG2' ' A' ' 736' ' ' ARG . 4.1 tp10 -65.8 -46.31 79.13 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 116.266 -0.425 . . . . 63.420000000000002 110.57 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 734' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -54.96 -48.2 73.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.994 -0.548 . . . . 73.049999999999997 110.677 177.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -65.92 -48.26 72.01 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.122 -0.49 . . . . 75.409999999999997 111.236 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 736' ' ' ARG . . . . . 0.465 ' HG2' ' O ' ' A' ' 733' ' ' GLU . 31.9 ptt180 -65.22 -33.03 75.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.14 0.495 . . . . 74.530000000000001 111.345 -175.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 38.0 t -78.12 -36.64 47.62 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.859 -0.61 . . . . 75.400000000000006 111.156 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 15.5 m170 -89.02 -29.21 19.64 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.43 -0.35 . . . . 74.450000000000003 111.846 -174.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 109.07 21.93 7.14 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.555 -0.831 . . . . 73.409999999999997 112.273 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -96.99 167.46 11.06 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.738 0.304 . . . . 74.439999999999998 110.405 175.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -109.91 114.11 27.38 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.461 -0.57 . . . . 73.420000000000002 109.461 175.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 742' ' ' ALA . . . . . . . . . . . . . . . -93.6 110.2 21.81 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.968 0.413 . . . . 72.099999999999994 110.433 -178.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 743' ' ' GLU . . . . . 0.522 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 44.7 mt-10 -120.82 117.09 26.52 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.942 -0.572 . . . . 75.310000000000002 111.281 -177.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 744' ' ' PHE . . . . . 0.412 ' CB ' ' HE3' ' A' ' 781' ' ' LYS . 96.2 m-85 -100.16 100.81 11.7 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.785 -0.643 . . . . 74.450000000000003 109.285 175.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 745' ' ' LYS . . . . . 0.437 ' HB3' ' HE2' ' A' ' 745' ' ' LYS . 16.9 ptpt -120.76 152.81 37.84 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.238 -0.585 . . . . 71.010000000000005 111.116 -177.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 746' ' ' LEU . . . . . 0.554 HD22 ' HB2' ' A' ' 749' ' ' GLN . 51.9 tp -80.14 128.12 33.13 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.426 -0.806 . . . . 75.409999999999997 110.089 -178.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 56.4 t -90.46 -47.56 14.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.109 0.48 . . . . 73.400000000000006 109.879 178.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -154.75 149.35 26.4 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.771 -0.65 . . . . 75.099999999999994 110.331 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 749' ' ' GLN . . . . . 0.554 ' HB2' HD22 ' A' ' 746' ' ' LEU . 24.5 tt0 -125.19 106.64 10.04 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.509 -0.552 . . . . 73.099999999999994 109.509 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 56.7 m -141.86 178.18 7.68 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.658 0.266 . . . . 53.100000000000001 110.285 -178.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 117.52 172.61 16.04 Favored Glycine 0 N--CA 1.443 -0.899 0 C-N-CA 120.331 -0.938 . . . . 65.439999999999998 112.822 177.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 752' ' ' PRO . . . . . 0.714 ' HG2' ' HB2' ' A' ' 755' ' ' GLU . 34.3 Cg_endo -64.8 166.4 18.26 Favored 'Trans proline' 0 CA--C 1.529 0.272 0 C-N-CA 123.473 2.782 . . . . 71.109999999999999 112.752 178.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -65.44 -31.74 51.09 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.592 2.194 . . . . 70.409999999999997 112.534 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 754' ' ' HIS . . . . . 0.554 ' CD2' ' HG3' ' A' ' 755' ' ' GLU . 54.0 p-80 -83.02 -23.41 33.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.522 -0.308 . . . . 63.140000000000001 110.938 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 755' ' ' GLU . . . . . 0.714 ' HB2' ' HG2' ' A' ' 752' ' ' PRO . 45.8 mt-10 -132.24 78.07 69.39 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.445 -0.343 . . . . 72.409999999999997 111.503 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 756' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -68.12 105.86 1.26 Allowed 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 121.936 1.757 . . . . 74.0 110.73 172.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 757' ' ' LYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 774' ' ' ALA . 57.8 mtmt -92.8 108.67 20.17 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.733 0.777 . . . . 72.140000000000001 110.973 -175.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 758' ' ' PHE . . . . . 0.431 ' O ' ' HA ' ' A' ' 773' ' ' CYS . 89.4 m-85 -87.63 116.69 25.94 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.722 -1.127 . . . . 74.340000000000003 110.478 -178.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 21.5 t -84.28 101.39 8.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.468 -0.567 . . . . 71.049999999999997 109.468 176.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -106.48 145.56 31.65 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.048 -0.524 . . . . 73.409999999999997 111.113 -178.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -132.54 135.12 45.75 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.871 -0.604 . . . . 73.209999999999994 109.663 177.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 762' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 769' ' ' PHE . . . -89.89 110.82 21.74 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.804 -0.635 . . . . 71.439999999999998 110.421 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 763' ' ' LYS . . . . . 0.522 ' HB3' ' HB2' ' A' ' 743' ' ' GLU . 50.5 tttt -94.64 107.02 19.03 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.494 -0.775 . . . . 74.409999999999997 109.607 177.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 47.5 t -112.88 100.48 10.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 120.977 0.418 . . . . 72.239999999999995 110.844 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 68.86 22.59 75.68 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.731 -0.668 . . . . 73.140000000000001 112.74 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 99.8 -2.64 57.1 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.712 -0.756 . . . . 64.010000000000005 112.103 -178.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 767' ' ' ARG . . . . . . . . . . . . . 18.3 ttm180 -100.91 122.3 43.23 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.292 -0.633 . . . . 73.409999999999997 109.292 178.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 768' ' ' TRP . . . . . . . . . . . . . 42.4 m95 -99.31 100.08 11.11 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.407 -0.36 . . . . 74.200000000000003 110.765 -172.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 769' ' ' PHE . . . . . 0.447 ' HA ' ' HA ' ' A' ' 770' ' ' PRO . 25.9 p90 -166.5 136.25 2.52 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.331 -0.395 . . . . 74.099999999999994 110.419 -178.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 770' ' ' PRO . . . . . 0.723 ' HG3' ' HB2' ' A' ' 787' ' ' ALA . 68.5 Cg_endo -94.66 -173.31 4.31 Favored 'Cis proline' 0 N--CA 1.451 -0.974 0 C-N-CA 123.412 -1.495 . . . . 73.299999999999997 111.424 -4.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -122.52 107.83 12.46 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.33 -0.248 . . . . 45.329999999999998 110.33 175.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 29.1 m -130.35 167.28 25.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.533 -0.303 . . . . 74.209999999999994 111.195 -176.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 773' ' ' CYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 758' ' ' PHE . 17.7 p -132.78 145.12 50.73 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.458 -0.337 . . . . 71.450000000000003 110.573 178.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 774' ' ' ALA . . . . . 0.453 ' O ' ' HA ' ' A' ' 757' ' ' LYS . . . -146.2 154.52 41.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.432 -0.349 . . . . 75.030000000000001 110.544 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 775' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -75.4 -2.62 29.41 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.068 0.461 . . . . 73.219999999999999 111.458 -176.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 776' ' ' SER . . . . . 0.627 ' HB2' ' HG3' ' A' ' 779' ' ' GLN . 36.3 m -131.19 140.2 49.86 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.206 -0.665 . . . . 70.319999999999993 109.206 175.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 777' ' ' LYS . . . . . . . . . . . . . 6.1 tmmm? -61.12 -45.75 93.39 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 123.431 0.457 . . . . 75.200000000000003 111.274 -174.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 778' ' ' LYS . . . . . 0.424 ' HE2' ' OE1' ' A' ' 782' ' ' GLN . 87.9 tttt -64.56 -39.28 93.46 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.981 -0.288 . . . . 74.400000000000006 110.644 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 779' ' ' GLN . . . . . 0.627 ' HG3' ' HB2' ' A' ' 776' ' ' SER . 23.6 mt-30 -60.35 -39.38 86.94 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.658 -0.246 . . . . 63.450000000000003 110.563 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -60.51 -43.53 98.72 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.88 -0.676 . . . . 50.009999999999998 111.694 177.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 781' ' ' LYS . . . . . 0.412 ' HE3' ' CB ' ' A' ' 744' ' ' PHE . 50.6 mtpt -68.13 -40.55 82.44 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.735 0.302 . . . . 73.129999999999995 110.729 178.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 782' ' ' GLN . . . . . 0.424 ' OE1' ' HE2' ' A' ' 778' ' ' LYS . 26.6 mt-30 -62.04 -51.66 67.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.047 -0.524 . . . . 73.120000000000005 111.047 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -65.27 -33.92 77.12 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 123.063 0.227 . . . . 74.510000000000005 110.909 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -59.62 -53.86 53.11 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.893 -0.41 . . . . 74.430000000000007 109.893 175.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 785' ' ' ALA . . . . . 0.603 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -65.38 -40.01 92.97 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.18 -0.463 . . . . 75.150000000000006 110.897 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 786' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -54.28 -56.08 21.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.903 -0.59 . . . . 72.430000000000007 110.83 178.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 787' ' ' ALA . . . . . 0.723 ' HB2' ' HG3' ' A' ' 770' ' ' PRO . . . -65.7 -38.32 88.91 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.838 -0.619 . . . . 62.140000000000001 110.768 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 788' ' ' ALA . . . . . 0.584 ' O ' ' HG ' ' A' ' 792' ' ' LEU . . . -60.61 -45.8 92.65 Favored 'General case' 0 CA--C 1.521 -0.159 0 O-C-N 123.327 0.392 . . . . 74.420000000000002 111.23 -177.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 789' ' ' LEU . . . . . 0.603 ' HG ' ' O ' ' A' ' 785' ' ' ALA . 69.2 mt -58.86 -45.67 89.56 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 109.977 -0.379 . . . . 74.209999999999994 109.977 179.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 790' ' ' ARG . . . . . . . . . . . . . 78.6 mtt180 -65.07 -26.58 68.3 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.138 0.422 . . . . 74.420000000000002 112.138 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 791' ' ' VAL . . . . . 0.663 HG23 ' O ' ' A' ' 787' ' ' ALA . 60.1 t -66.5 -45.17 89.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 109.456 -0.572 . . . . 72.340000000000003 109.456 173.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 792' ' ' LEU . . . . . 0.584 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 18.2 mt -67.84 -44.82 76.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.221 -0.899 . . . . 72.319999999999993 110.188 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 793' ' ' ILE . . . . . 0.52 HD13 HG22 ' A' ' 720' ' ' VAL . 97.0 mt -58.38 -55.21 23.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.162 -0.926 . . . . 74.140000000000001 110.647 177.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 794' ' ' GLY . . . . . 0.428 ' O ' ' HG3' ' A' ' 798' ' ' LYS . . . -58.47 -40.51 94.45 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 121.14 -0.552 . . . . 62.219999999999999 112.244 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -55.98 -46.69 78.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.951 0.405 . . . . 72.310000000000002 110.218 178.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -73.94 -38.54 64.22 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.06 -0.518 . . . . 71.510000000000005 111.246 -175.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 797' ' ' GLU . . . . . 0.462 ' HG3' ' O ' ' A' ' 793' ' ' ILE . 29.6 mt-10 -72.17 -19.62 61.72 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.768 0.284 . . . . 74.209999999999994 111.768 -176.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 798' ' ' LYS . . . . . 0.428 ' HG3' ' O ' ' A' ' 794' ' ' GLY . 99.0 mttt -85.76 0.65 52.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.898 0.38 . . . . 72.099999999999994 111.162 178.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 799' ' ' ALA . . . . . . . . . . . . . . . -107.6 166.51 10.62 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.452 -0.34 . . . . 70.439999999999998 110.883 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 800' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.64 20.96 5.85 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.416 0.627 . . . . 74.510000000000005 110.39 -177.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 801' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 . . . . . 0 C--O 1.248 1.015 0 CA-C-N 115.728 -0.669 . . . . 74.140000000000001 110.194 -176.059 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 708' ' ' MET . . . . . . . . . . . . . 22.9 mmt . . . . . 0 N--CA 1.481 1.097 0 CA-C-O 120.69 0.281 . . . . 72.319999999999993 111.66 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 67.9 mtm -132.43 86.67 44.76 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 109.77 -0.455 . . . . 63.43 109.77 176.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 710' ' ' PRO . . . . . 0.481 ' HB3' ' O ' ' A' ' 799' ' ' ALA . 38.7 Cg_endo -68.02 153.45 75.08 Favored 'Trans proline' 0 C--O 1.237 0.432 0 C-N-CA 122.524 2.149 . . . . 52.399999999999999 112.347 -177.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 711' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -58.58 -44.34 89.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.805 -0.634 . . . . 72.409999999999997 110.425 178.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 712' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -100.15 136.3 40.26 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.377 -0.601 . . . . 73.109999999999999 109.377 171.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 713' ' ' VAL . . . . . . . . . . . . . 18.5 m -75.19 165.69 3.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.148 0.499 . . . . 71.319999999999993 111.21 -175.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.415 ' HB2' HG12 ' A' ' 716' ' ' ILE . 1.4 ptp180 -111.37 126.67 55.16 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.998 -0.546 . . . . 75.409999999999997 110.352 175.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 17.1 tptm -110.58 25.24 11.99 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.122 -1.066 . . . . 73.230000000000004 108.122 175.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 716' ' ' ILE . . . . . 0.622 HG23 HG12 ' A' ' 793' ' ' ILE . 48.4 mm -61.81 -27.6 42.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 114.046 -1.434 . . . . 75.420000000000002 112.316 -172.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -56.3 -31.41 59.49 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.009 -0.615 . . . . 74.329999999999998 112.12 178.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -72.01 -41.62 67.38 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.355 -0.239 . . . . 74.430000000000007 110.355 178.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 719' ' ' LEU . . . . . 0.548 HD23 ' HA ' ' A' ' 716' ' ' ILE . 3.0 mm? -62.79 -36.11 82.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.479 -0.328 . . . . 74.099999999999994 110.727 -179.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 720' ' ' VAL . . . . . 0.458 HG21 HD11 ' A' ' 793' ' ' ILE . 48.0 t -66.65 -39.03 82.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.118 0.485 . . . . 74.129999999999995 109.963 175.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 721' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.08 -35.03 74.28 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.871 -0.604 . . . . 70.129999999999995 110.172 177.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -74.32 -29.0 61.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.05 -0.523 . . . . 74.150000000000006 111.4 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 723' ' ' LEU . . . . . 0.516 HD23 ' HB2' ' A' ' 789' ' ' LEU . 51.0 mt -59.02 -39.35 81.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.856 0.36 . . . . 75.409999999999997 110.726 177.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -86.51 -17.37 34.29 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.108 -0.496 . . . . 74.129999999999995 111.341 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 16.3 m -108.37 -83.3 0.55 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.637 0.256 . . . . 60.229999999999997 111.421 -176.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 726' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -138.97 104.01 7.41 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.801 0.334 . . . . 70.439999999999998 110.373 -177.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 727' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -62.75 -41.4 30.89 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.758 2.305 . . . . 62.439999999999998 112.552 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 48.3 t -61.71 -46.07 97.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.275 -0.421 . . . . 74.310000000000002 110.659 -176.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -64.65 -32.64 84.87 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.868 -0.682 . . . . 74.099999999999994 112.0 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -72.45 -42.66 47.95 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 121.134 -0.555 . . . . 73.409999999999997 112.827 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -63.24 -41.06 99.03 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.623 -0.51 . . . . 71.420000000000002 109.623 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 732' ' ' LEU . . . . . 0.489 HD21 ' HB2' ' A' ' 742' ' ' ALA . 96.2 mt -64.83 -42.66 94.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.94 -0.573 . . . . 74.209999999999994 110.649 176.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 733' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -64.69 -42.64 95.17 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 116.201 -0.454 . . . . 64.430000000000007 110.802 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 734' ' ' TYR . . . . . 0.531 ' HB2' HD12 ' A' ' 719' ' ' LEU . 14.4 t80 -54.43 -53.18 57.59 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.349 -0.387 . . . . 74.430000000000007 110.621 176.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -62.73 -48.45 79.16 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.093 -0.503 . . . . 72.329999999999998 110.395 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 736' ' ' ARG . . . . . . . . . . . . . 62.3 ttt180 -54.96 -50.87 67.84 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.544 -0.753 . . . . 75.129999999999995 111.939 -178.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 18.1 t -73.95 -24.58 59.66 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.424 -0.353 . . . . 74.239999999999995 111.404 -175.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -94.7 -19.78 20.11 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.821 -0.352 . . . . 62.229999999999997 111.935 -175.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 104.39 14.0 25.07 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.17 -1.014 . . . . 37.579999999999998 112.837 177.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -101.81 166.29 10.74 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.816 -0.439 . . . . 64.230000000000004 109.816 175.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -110.14 126.43 54.06 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.708 -0.479 . . . . 64.310000000000002 109.708 173.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 742' ' ' ALA . . . . . 0.489 ' HB2' HD21 ' A' ' 732' ' ' LEU . . . -99.03 108.59 21.3 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.059 0.457 . . . . 72.239999999999995 110.361 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 743' ' ' GLU . . . . . 0.53 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 40.8 mt-10 -113.93 116.75 29.75 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.796 -0.638 . . . . 72.150000000000006 111.466 -176.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -93.28 121.62 34.84 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.679 -0.691 . . . . 75.209999999999994 109.401 176.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 745' ' ' LYS . . . . . 0.499 ' HB3' ' HZ3' ' A' ' 745' ' ' LYS . 0.5 OUTLIER -132.38 147.94 52.4 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.282 0.563 . . . . 74.450000000000003 111.663 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 746' ' ' LEU . . . . . 0.508 HD23 ' HB2' ' A' ' 749' ' ' GLN . 6.8 tt -86.87 108.09 18.61 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.143 -0.935 . . . . 63.039999999999999 108.992 177.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 49.0 t -82.56 -53.99 10.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.136 -0.484 . . . . 75.200000000000003 110.771 -176.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 748' ' ' ASP . . . . . 0.493 ' HB3' ' CG2' ' A' ' 759' ' ' VAL . 25.7 t70 -129.8 149.76 51.4 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.283 -0.417 . . . . 75.420000000000002 111.19 -176.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 749' ' ' GLN . . . . . 0.508 ' HB2' HD23 ' A' ' 746' ' ' LEU . 8.1 tt0 -145.84 100.07 3.36 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.514 -0.767 . . . . 64.530000000000001 108.971 177.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 10.0 t -144.98 -173.71 4.16 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.484 -0.326 . . . . 72.120000000000005 110.476 -174.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 100.77 -173.74 24.94 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.924 -0.655 . . . . 54.420000000000002 112.473 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 752' ' ' PRO . . . . . 0.671 ' HG2' ' HB2' ' A' ' 755' ' ' GLU . 52.8 Cg_endo -69.11 164.35 34.24 Favored 'Trans proline' 0 N--CA 1.465 -0.154 0 C-N-CA 122.908 2.406 . . . . 74.239999999999995 111.993 178.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -69.81 -34.68 13.93 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 122.469 2.112 . . . . 75.0 112.065 -177.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 35.2 p-80 -76.09 -26.81 56.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.174 -0.466 . . . . 73.430000000000007 110.936 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 755' ' ' GLU . . . . . 0.671 ' HB2' ' HG2' ' A' ' 752' ' ' PRO . 28.5 mm-40 -126.53 72.76 73.72 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.566 -0.288 . . . . 72.349999999999994 110.885 178.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 756' ' ' PRO . . . . . 0.511 ' O ' ' HA ' ' A' ' 775' ' ' HIS . 40.0 Cg_endo -68.82 113.66 3.29 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.222 1.948 . . . . 75.310000000000002 111.453 177.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 757' ' ' LYS . . . . . 0.404 ' HE3' ' HB3' ' A' ' 757' ' ' LYS . 1.5 tmmt? -89.51 112.4 23.56 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.322 0.582 . . . . 74.310000000000002 110.538 -176.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 758' ' ' PHE . . . . . 0.47 ' O ' ' HA ' ' A' ' 773' ' ' CYS . 79.0 m-85 -99.59 123.34 43.76 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.204 -0.907 . . . . 72.140000000000001 110.115 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 759' ' ' VAL . . . . . 0.493 ' CG2' ' HB3' ' A' ' 748' ' ' ASP . 48.6 t -98.4 106.6 18.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.564 -0.532 . . . . 71.439999999999998 109.564 175.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -105.61 141.05 37.74 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.005 -0.543 . . . . 74.319999999999993 110.691 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 761' ' ' GLN . . . . . 0.416 ' HA ' ' O ' ' A' ' 770' ' ' PRO . 33.7 tt0 -133.46 134.61 43.75 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.865 -0.607 . . . . 64.099999999999994 109.503 177.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 762' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 769' ' ' PHE . . . -92.9 117.08 29.65 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.25 0.548 . . . . 63.439999999999998 110.706 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 763' ' ' LYS . . . . . 0.595 ' HD2' ' CH2' ' A' ' 768' ' ' TRP . 54.7 tttm -93.77 103.53 15.66 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.681 -0.69 . . . . 73.150000000000006 109.893 177.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 61.7 t -109.01 101.58 12.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.136 0.493 . . . . 74.409999999999997 109.739 178.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 69.17 -115.69 6.63 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 110.955 -0.858 . . . . 71.010000000000005 110.955 -173.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -110.62 13.99 29.91 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.003 -0.618 . . . . 74.219999999999999 111.684 176.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 767' ' ' ARG . . . . . 0.605 ' HD2' ' CD1' ' A' ' 769' ' ' PHE . 0.6 OUTLIER -110.43 120.45 42.46 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.507 -0.553 . . . . 73.140000000000001 109.507 -179.766 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 768' ' ' TRP . . . . . 0.595 ' CH2' ' HD2' ' A' ' 763' ' ' LYS . 69.4 m95 -94.88 108.15 20.18 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.645 -0.502 . . . . 74.099999999999994 109.645 178.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 769' ' ' PHE . . . . . 0.605 ' CD1' ' HD2' ' A' ' 767' ' ' ARG . 9.8 p90 -168.86 139.9 2.01 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-O 120.838 0.351 . . . . 74.219999999999999 110.915 -178.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 770' ' ' PRO . . . . . 0.787 ' HD3' ' HB3' ' A' ' 788' ' ' ALA . 96.1 Cg_endo -98.4 -170.69 1.95 Allowed 'Cis proline' 0 N--CA 1.449 -1.121 0 C-N-CA 123.71 -1.371 . . . . 63.140000000000001 111.677 -3.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -114.81 104.29 11.8 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.518 -0.549 . . . . 63.329999999999998 109.518 174.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 33.5 m -118.94 161.97 17.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.303 -0.408 . . . . 73.239999999999995 110.846 -176.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 773' ' ' CYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 758' ' ' PHE . 8.8 p -137.0 141.91 42.53 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.249 -0.432 . . . . 60.240000000000002 110.425 177.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -149.53 161.15 42.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.054 -0.521 . . . . 71.430000000000007 109.829 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 775' ' ' HIS . . . . . 0.511 ' HA ' ' O ' ' A' ' 756' ' ' PRO . 0.8 OUTLIER -87.14 -0.75 57.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.251 0.548 . . . . 73.120000000000005 110.889 179.501 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 51.1 m -134.04 135.16 43.16 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.634 -0.712 . . . . 71.010000000000005 109.292 175.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 777' ' ' LYS . . . . . . . . . . . . . 25.4 ttmt -57.24 -48.82 77.89 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.103 -0.499 . . . . 71.239999999999995 111.448 -175.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -57.95 -38.59 76.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.848 -0.614 . . . . 64.140000000000001 110.822 -177.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 779' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -68.25 -37.88 81.24 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-N 116.36 -0.382 . . . . 74.109999999999999 110.146 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -60.5 -47.17 92.48 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.827 -0.701 . . . . 43.340000000000003 111.881 178.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -62.55 -44.79 95.47 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.746 0.308 . . . . 75.439999999999998 110.649 177.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -62.37 -50.43 71.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.056 -0.52 . . . . 72.340000000000003 111.206 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -60.09 -36.57 77.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.298 -0.41 . . . . 72.439999999999998 111.445 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -60.05 -55.08 38.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.871 0.367 . . . . 74.510000000000005 110.373 177.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 785' ' ' ALA . . . . . 0.64 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -63.09 -41.81 99.47 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.134 -0.485 . . . . 75.439999999999998 110.897 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 786' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -56.83 -54.88 41.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.546 -0.752 . . . . 73.319999999999993 110.934 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 787' ' ' ALA . . . . . 0.459 ' O ' HG21 ' A' ' 791' ' ' VAL . . . -65.29 -35.09 79.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.832 -0.622 . . . . 75.450000000000003 111.254 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 788' ' ' ALA . . . . . 0.787 ' HB3' ' HD3' ' A' ' 770' ' ' PRO . . . -64.64 -35.64 81.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.313 -0.403 . . . . 63.549999999999997 111.391 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 789' ' ' LEU . . . . . 0.64 ' HG ' ' O ' ' A' ' 785' ' ' ALA . 59.1 mt -64.66 -42.04 95.69 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 121.048 -0.261 . . . . 75.329999999999998 110.445 -179.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 790' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.67 -31.71 72.65 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 120.734 -0.386 . . . . 75.310000000000002 111.207 177.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 791' ' ' VAL . . . . . 0.459 HG21 ' O ' ' A' ' 787' ' ' ALA . 57.2 t -61.67 -51.89 67.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.104 0.478 . . . . 71.510000000000005 109.773 175.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 792' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 32.9 mt -61.84 -47.53 84.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.349 -0.842 . . . . 75.420000000000002 110.83 -178.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 793' ' ' ILE . . . . . 0.622 HG12 HG23 ' A' ' 716' ' ' ILE . 95.9 mt -58.8 -56.26 17.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.521 -0.763 . . . . 73.549999999999997 111.24 179.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 794' ' ' GLY . . . . . 0.428 ' O ' ' HB2' ' A' ' 797' ' ' GLU . . . -60.79 -37.69 94.05 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 121.079 -0.582 . . . . 62.049999999999997 112.321 -178.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -63.25 -44.0 96.41 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.905 0.383 . . . . 73.400000000000006 110.734 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -73.86 -20.64 60.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.909 0.385 . . . . 72.510000000000005 110.822 -177.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 797' ' ' GLU . . . . . 0.428 ' HB2' ' O ' ' A' ' 794' ' ' GLY . 15.7 mm-40 -59.01 -21.51 59.16 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.103 0.478 . . . . 75.310000000000002 110.639 175.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 798' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -91.39 -8.97 46.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.926 -0.579 . . . . 72.209999999999994 111.309 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 799' ' ' ALA . . . . . 0.481 ' O ' ' HB3' ' A' ' 710' ' ' PRO . . . -94.5 -0.54 54.59 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.883 0.697 . . . . 72.340000000000003 112.883 -170.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 800' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -79.43 88.04 5.04 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.693 0.758 . . . . 72.239999999999995 111.237 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 801' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.064 -0.97 . . . . 73.129999999999995 110.219 179.211 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 708' ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 N--CA 1.482 1.155 0 N-CA-C 109.831 -0.433 . . . . 72.439999999999998 109.831 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.92 145.72 49.34 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 109.335 -0.617 . . . . 64.329999999999998 109.335 174.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -59.88 133.38 50.41 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.578 2.186 . . . . 72.409999999999997 111.631 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 711' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -73.47 177.8 5.05 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.076 0.465 . . . . 73.400000000000006 110.829 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 712' ' ' LYS . . . . . 0.473 ' HB3' ' OG ' ' A' ' 737' ' ' SER . 21.0 tptm -95.38 112.66 24.33 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.047 -0.524 . . . . 74.540000000000006 109.957 177.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 713' ' ' VAL . . . . . . . . . . . . . 34.5 m -67.4 158.11 5.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.913 -0.585 . . . . 74.25 110.659 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.496 ' HB3' ' CE1' ' A' ' 738' ' ' HIS . 22.0 ptt180 -80.3 78.7 6.96 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.453 0.644 . . . . 74.329999999999998 110.744 176.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 715' ' ' LYS . . . . . 0.428 ' HE3' ' HB2' ' A' ' 715' ' ' LYS . 30.3 ttmt -87.68 104.45 16.55 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.35 -0.841 . . . . 75.219999999999999 109.249 175.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 716' ' ' ILE . . . . . 0.538 ' HA ' HD23 ' A' ' 719' ' ' LEU . 46.8 mm -67.85 -27.89 39.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.449 -0.796 . . . . 75.140000000000001 111.489 -170.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -59.95 -24.87 61.04 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.97 -0.633 . . . . 64.150000000000006 112.112 176.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 718' ' ' GLU . . . . . 0.671 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 47.1 mt-10 -76.85 -38.73 53.18 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 122.787 -0.243 . . . . 75.120000000000005 110.658 177.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 719' ' ' LEU . . . . . 0.538 HD23 ' HA ' ' A' ' 716' ' ' ILE . 3.1 mm? -61.38 -32.98 72.92 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.155 0.502 . . . . 72.430000000000007 109.769 176.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 720' ' ' VAL . . . . . 0.485 HG21 HD11 ' A' ' 793' ' ' ILE . 58.1 t -68.4 -38.49 79.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.809 -0.632 . . . . 74.239999999999995 110.757 175.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 721' ' ' ARG . . . . . 0.671 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 4.4 ptm180 -64.74 -28.2 69.43 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 109.841 -0.429 . . . . 74.129999999999995 109.841 179.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -73.12 -31.9 64.61 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 116.312 -0.404 . . . . 74.430000000000007 110.782 177.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 723' ' ' LEU . . . . . 0.52 HD21 ' HB2' ' A' ' 789' ' ' LEU . 98.1 mt -62.24 -28.67 69.87 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.407 0.622 . . . . 72.329999999999998 110.033 174.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -90.81 -15.07 30.7 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.492 -0.776 . . . . 71.319999999999993 111.234 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 11.1 m -118.69 -73.48 0.64 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.856 0.36 . . . . 75.150000000000006 111.666 -175.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 726' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -149.13 101.58 3.37 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.174 -0.467 . . . . 73.329999999999998 110.112 -177.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 727' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -61.87 -40.33 45.16 Favored 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 122.906 2.404 . . . . 63.350000000000001 112.115 -178.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 57.5 t -62.21 -45.32 99.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.096 -0.502 . . . . 70.200000000000003 110.809 -178.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -65.49 -35.15 90.93 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.664 -0.779 . . . . 72.239999999999995 111.669 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -70.17 -41.58 69.29 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 121.073 -0.584 . . . . 74.230000000000004 112.573 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -65.48 -43.3 90.66 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.989 -0.374 . . . . 73.329999999999998 109.989 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 732' ' ' LEU . . . . . . . . . . . . . 96.8 mt -66.17 -38.07 87.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.244 -0.435 . . . . 71.140000000000001 110.745 178.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 733' ' ' GLU . . . . . 0.452 ' O ' ' HG2' ' A' ' 736' ' ' ARG . 1.8 tp10 -66.14 -43.99 85.44 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 116.325 -0.398 . . . . 73.010000000000005 110.355 177.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 734' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -53.47 -48.66 68.67 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.141 -0.481 . . . . 71.439999999999998 110.658 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 735' ' ' ALA . . . . . 0.434 ' HB3' ' HB1' ' A' ' 742' ' ' ALA . . . -65.62 -50.22 65.83 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.232 -0.44 . . . . 71.530000000000001 110.927 -177.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 736' ' ' ARG . . . . . 0.452 ' HG2' ' O ' ' A' ' 733' ' ' GLU . 33.8 ptt180 -64.35 -31.48 72.7 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.11 0.481 . . . . 64.450000000000003 110.914 -175.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 737' ' ' SER . . . . . 0.473 ' OG ' ' HB3' ' A' ' 712' ' ' LYS . 28.8 t -78.07 -29.12 49.02 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.599 -0.728 . . . . 71.340000000000003 111.451 178.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 738' ' ' HIS . . . . . 0.496 ' CE1' ' HB3' ' A' ' 714' ' ' ARG . 12.1 m170 -101.13 -3.09 29.84 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 111.885 0.328 . . . . 74.430000000000007 111.885 -173.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 90.98 12.88 59.79 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.407 -0.901 . . . . 72.340000000000003 112.675 177.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -95.98 169.36 10.03 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.791 0.329 . . . . 75.109999999999999 110.165 175.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -121.68 105.81 10.76 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.284 -0.636 . . . . 72.140000000000001 109.284 175.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 742' ' ' ALA . . . . . 0.434 ' HB1' ' HB3' ' A' ' 735' ' ' ALA . . . -90.4 122.55 33.37 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.311 -0.404 . . . . 74.319999999999993 111.454 -174.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 743' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -127.79 166.13 18.78 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.782 -0.644 . . . . 75.430000000000007 110.698 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -134.25 108.8 8.45 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.961 -0.563 . . . . 73.439999999999998 109.996 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -110.84 148.55 32.16 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.007 0.432 . . . . 74.209999999999994 111.155 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 746' ' ' LEU . . . . . 0.426 HD11 ' CD1' ' A' ' 758' ' ' PHE . 6.1 tt -87.58 106.82 18.27 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.384 -0.969 . . . . 72.25 108.384 174.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 54.0 t -83.16 -53.06 12.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.982 -0.554 . . . . 71.319999999999993 110.938 -174.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -128.39 146.01 50.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.083 -0.508 . . . . 63.210000000000001 110.798 -176.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -132.7 93.59 3.25 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.284 0.564 . . . . 73.439999999999998 110.026 176.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 20.6 m -104.64 82.36 1.89 Allowed 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.242 -1.021 . . . . 64.040000000000006 108.242 173.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 751' ' ' GLY . . . . . 0.588 ' CA ' ' HA ' ' A' ' 756' ' ' PRO . . . -127.39 94.74 0.41 Allowed Glycine 0 N--CA 1.439 -1.101 0 C-N-CA 119.92 -1.133 . . . . 75.0 114.278 -170.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 752' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.95 165.61 11.85 Favored 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 122.474 2.116 . . . . 54.399999999999999 110.225 164.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -58.54 -36.51 97.26 Favored 'Trans proline' 0 CA--C 1.528 0.191 0 C-N-CA 122.109 1.873 . . . . 73.420000000000002 112.495 -177.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 49.9 p-80 -82.28 -25.01 34.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.364 -0.38 . . . . 71.129999999999995 111.644 -177.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -141.06 74.31 25.48 Favored Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 112.043 0.386 . . . . 74.040000000000006 112.043 -176.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 756' ' ' PRO . . . . . 0.588 ' HA ' ' CA ' ' A' ' 751' ' ' GLY . 52.3 Cg_endo -72.23 84.84 1.09 Allowed 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.0 1.8 . . . . 53.020000000000003 111.632 175.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 757' ' ' LYS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 775' ' ' HIS . 27.4 ttpp -91.58 113.69 26.03 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.545 0.688 . . . . 74.099999999999994 111.247 -174.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 758' ' ' PHE . . . . . 0.446 ' O ' ' HA ' ' A' ' 773' ' ' CYS . 60.9 m-85 -99.44 144.77 28.16 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.286 -0.87 . . . . 71.519999999999996 110.171 -178.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 759' ' ' VAL . . . . . 0.429 HG22 ' HB3' ' A' ' 773' ' ' CYS . 47.7 t -109.57 112.13 39.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.996 -0.372 . . . . 70.519999999999996 109.996 176.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -107.27 138.14 44.0 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.263 -0.426 . . . . 71.329999999999998 110.517 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 761' ' ' GLN . . . . . 0.422 ' HA ' ' O ' ' A' ' 770' ' ' PRO . 62.2 tt0 -125.5 135.48 52.34 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.916 -0.583 . . . . 75.430000000000007 109.432 177.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 762' ' ' ALA . . . . . 0.51 ' HB2' ' O ' ' A' ' 769' ' ' PHE . . . -91.52 119.5 31.52 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.252 0.549 . . . . 74.019999999999996 110.586 -178.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -98.16 97.28 8.73 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.713 -0.676 . . . . 72.430000000000007 109.339 177.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 764' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 742' ' ' ALA . 57.7 t -99.9 98.3 6.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.125 0.488 . . . . 72.530000000000001 109.854 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 68.54 -108.03 2.31 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 110.743 -0.943 . . . . 37.649999999999999 110.743 -175.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -114.72 9.4 21.63 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.626 -0.797 . . . . 71.409999999999997 111.821 176.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 767' ' ' ARG . . . . . 0.571 ' HD2' ' CD1' ' A' ' 769' ' ' PHE . 0.2 OUTLIER -107.65 120.69 42.92 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.93 -0.396 . . . . 73.349999999999994 109.93 -178.615 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 768' ' ' TRP . . . . . . . . . . . . . 58.6 m95 -94.3 110.91 22.63 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.158 -0.474 . . . . 75.420000000000002 109.857 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 769' ' ' PHE . . . . . 0.571 ' CD1' ' HD2' ' A' ' 767' ' ' ARG . 15.7 p90 -174.76 138.32 0.62 Allowed Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 120.692 0.282 . . . . 64.239999999999995 110.65 -179.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 770' ' ' PRO . . . . . 0.733 ' HD3' ' HB3' ' A' ' 788' ' ' ALA . 69.7 Cg_endo -99.15 -170.25 1.6 Allowed 'Cis proline' 0 N--CA 1.449 -1.14 0 C-N-CA 123.675 -1.386 . . . . 71.010000000000005 111.164 -6.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -121.14 105.52 10.68 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.797 -0.445 . . . . 74.120000000000005 109.797 174.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 35.3 m -121.32 160.29 22.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.487 -0.324 . . . . 75.109999999999999 111.006 -176.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 773' ' ' CYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 758' ' ' PHE . 20.2 p -126.01 145.81 50.15 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.073 -0.512 . . . . 74.450000000000003 110.565 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -158.14 146.86 19.06 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.22 -0.445 . . . . 75.519999999999996 110.226 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 775' ' ' HIS . . . . . 0.532 ' HA ' ' O ' ' A' ' 756' ' ' PRO . 1.4 p-80 -78.95 17.4 0.74 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.147 0.499 . . . . 70.420000000000002 111.538 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 42.4 t -142.84 130.62 21.51 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.994 -0.743 . . . . 74.519999999999996 108.994 175.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 777' ' ' LYS . . . . . 0.441 ' HD2' ' C ' ' A' ' 777' ' ' LYS . 5.3 tmmm? -58.34 -42.68 87.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.864 0.364 . . . . 74.239999999999995 110.125 -178.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -58.12 -46.99 84.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.62 -0.718 . . . . 64.329999999999998 110.542 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 779' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -62.52 -41.82 99.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.914 -0.584 . . . . 70.25 110.717 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -56.35 -43.83 89.77 Favored Glycine 0 C--N 1.329 0.187 0 C-N-CA 121.161 -0.543 . . . . 63.340000000000003 112.398 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -71.93 -43.79 64.71 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.699 0.285 . . . . 74.510000000000005 111.046 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -66.42 -45.63 79.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.222 -0.445 . . . . 75.120000000000005 111.505 -176.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -66.67 -33.87 76.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.709 0.29 . . . . 73.310000000000002 110.686 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -60.56 -52.04 66.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.347 -0.388 . . . . 74.310000000000002 110.177 177.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 785' ' ' ALA . . . . . 0.574 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -65.4 -38.59 90.45 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.167 -0.469 . . . . 73.230000000000004 110.744 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 786' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -59.9 -51.07 71.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.919 -0.582 . . . . 75.310000000000002 110.852 178.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 787' ' ' ALA . . . . . 0.557 ' HA ' ' HD2' ' A' ' 790' ' ' ARG . . . -67.85 -35.8 79.2 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.071 -0.513 . . . . 63.25 111.039 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 788' ' ' ALA . . . . . 0.733 ' HB3' ' HD3' ' A' ' 770' ' ' PRO . . . -60.96 -41.05 95.59 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.361 -0.382 . . . . 74.209999999999994 111.032 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 789' ' ' LEU . . . . . 0.574 ' HG ' ' O ' ' A' ' 785' ' ' ALA . 75.9 mt -64.23 -40.36 95.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.406 -0.361 . . . . 72.109999999999999 110.21 178.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 790' ' ' ARG . . . . . 0.557 ' HD2' ' HA ' ' A' ' 787' ' ' ALA . 84.9 mtt180 -60.01 -35.06 74.25 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.501 -0.318 . . . . 63.439999999999998 111.209 177.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 791' ' ' VAL . . . . . 0.46 HG21 ' O ' ' A' ' 787' ' ' ALA . 62.1 t -61.5 -50.53 79.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.249 0.547 . . . . 65.420000000000002 109.898 175.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 792' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 23.7 mt -61.98 -47.88 82.84 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.395 -0.82 . . . . 72.230000000000004 110.743 -179.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 793' ' ' ILE . . . . . 0.485 HD11 HG21 ' A' ' 720' ' ' VAL . 95.8 mt -59.85 -45.36 94.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.481 -0.781 . . . . 75.230000000000004 110.904 178.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -68.32 -33.8 78.57 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.833 -0.699 . . . . 71.0 112.703 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -70.66 -41.09 72.54 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.902 0.382 . . . . 74.109999999999999 110.642 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 796' ' ' ASN . . . . . 0.406 HD22 ' HB3' ' A' ' 801' ' ' ARG . 5.4 t30 -79.1 -18.98 52.35 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.786 -0.366 . . . . 63.039999999999999 110.188 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 797' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -57.88 -40.39 80.12 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.595 -0.52 . . . . 75.239999999999995 109.595 176.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 798' ' ' LYS . . . . . . . . . . . . . 11.5 ptmm? -92.96 16.84 11.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.815 -0.629 . . . . 73.319999999999993 110.855 178.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 799' ' ' ALA . . . . . . . . . . . . . . . -118.07 149.13 41.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.202 -0.454 . . . . 65.450000000000003 110.079 177.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 800' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -84.54 111.62 19.68 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.622 0.725 . . . . 74.319999999999993 110.419 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 801' ' ' ARG . . . . . 0.406 ' HB3' HD22 ' A' ' 796' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.542 -0.742 . . . . 75.439999999999998 110.016 -178.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 708' ' ' MET . . . . . . . . . . . . . 64.9 mtt . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 120.72 0.295 . . . . 72.049999999999997 110.243 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -92.15 150.7 40.8 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 109.322 -0.622 . . . . 74.120000000000005 109.322 178.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.24 111.63 0.98 Allowed 'Trans proline' 0 C--O 1.236 0.382 0 C-N-CA 122.421 2.081 . . . . 75.530000000000001 111.869 178.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 711' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -59.1 126.68 28.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 71.010000000000005 110.451 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 712' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -74.94 142.44 43.97 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.886 -0.597 . . . . 72.239999999999995 111.419 -175.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 713' ' ' VAL . . . . . . . . . . . . . 10.3 p -64.58 146.36 13.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.766 -0.652 . . . . 71.209999999999994 109.413 172.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.759 ' HA ' ' HG3' ' A' ' 718' ' ' GLU . 32.4 mmt180 -70.35 101.16 1.87 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.067 0.461 . . . . 73.310000000000002 110.665 -179.02 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 715' ' ' LYS . . . . . 0.441 ' O ' ' HB2' ' A' ' 718' ' ' GLU . 74.3 mmtt -82.85 -176.18 6.18 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.875 -0.602 . . . . 74.239999999999995 110.094 175.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 716' ' ' ILE . . . . . 0.506 ' HA ' HD23 ' A' ' 719' ' ' LEU . 42.1 mm -65.48 -36.99 78.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.852 0.358 . . . . 73.310000000000002 110.85 -177.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -60.63 -26.1 64.28 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 121.008 -0.615 . . . . 73.329999999999998 112.014 175.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 718' ' ' GLU . . . . . 0.789 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 9.0 mm-40 -68.75 -34.39 75.51 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-O 120.543 0.211 . . . . 72.319999999999993 110.551 178.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 719' ' ' LEU . . . . . 0.506 HD23 ' HA ' ' A' ' 716' ' ' ILE . 2.7 mm? -69.04 -29.25 67.37 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.522 -0.471 . . . . 73.010000000000005 109.917 177.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 720' ' ' VAL . . . . . 0.433 HG21 HD13 ' A' ' 793' ' ' ILE . 60.3 t -67.52 -40.96 85.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.844 -0.616 . . . . 74.430000000000007 110.804 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 721' ' ' ARG . . . . . 0.789 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 12.9 ptm180 -64.86 -29.92 70.9 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.4 -0.364 . . . . 72.209999999999994 110.249 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -71.83 -35.48 69.9 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-N 116.341 -0.39 . . . . 73.420000000000002 110.69 177.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 723' ' ' LEU . . . . . 0.526 HD21 ' HB2' ' A' ' 789' ' ' LEU . 82.0 mt -56.3 -30.68 62.84 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.138 0.494 . . . . 73.340000000000003 110.407 175.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -83.86 -55.37 4.28 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.835 -0.62 . . . . 75.120000000000005 110.935 176.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 27.2 m -75.44 -73.06 0.27 Allowed 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.119 0.414 . . . . 74.230000000000004 112.119 -176.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 726' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -148.49 100.31 3.56 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 120.804 0.335 . . . . 64.219999999999999 110.633 -175.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 727' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -61.7 -39.97 49.39 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.021 2.481 . . . . 61.340000000000003 112.667 -176.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 30.1 t -59.24 -47.88 88.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.008 -0.542 . . . . 72.5 110.787 -176.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -65.66 -31.35 79.7 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.86 -0.609 . . . . 54.119999999999997 111.812 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -68.24 -41.73 85.33 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.903 -0.665 . . . . 64.439999999999998 112.269 178.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -65.04 -41.29 95.35 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.526 -0.546 . . . . 73.120000000000005 109.526 178.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 732' ' ' LEU . . . . . . . . . . . . . 83.8 mt -68.79 -31.55 70.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.88 -0.6 . . . . 75.099999999999994 110.99 178.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 733' ' ' GLU . . . . . 0.481 ' O ' ' HG2' ' A' ' 736' ' ' ARG . 0.7 OUTLIER -73.28 -43.54 60.83 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 116.165 -0.471 . . . . 72.510000000000005 110.392 178.901 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 734' ' ' TYR . . . . . 0.449 ' HB2' HD12 ' A' ' 719' ' ' LEU . 7.6 t80 -55.45 -46.41 76.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.978 -0.556 . . . . 74.450000000000003 110.615 176.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -64.78 -48.12 75.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.923 -0.581 . . . . 73.319999999999993 111.095 -178.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 736' ' ' ARG . . . . . 0.481 ' HG2' ' O ' ' A' ' 733' ' ' GLU . 11.3 ptt180 -64.54 -35.74 81.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.009 0.433 . . . . 70.209999999999994 111.078 -175.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 48.4 t -74.2 -35.06 63.9 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.013 -0.539 . . . . 75.310000000000002 111.036 -178.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -89.0 -32.02 17.82 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.286 -0.415 . . . . 74.129999999999995 111.803 -174.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 112.45 22.07 5.94 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.47 -0.872 . . . . 61.32 112.013 -178.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -99.51 169.99 8.92 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.869 0.366 . . . . 65.120000000000005 110.543 176.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -117.25 111.49 19.48 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.457 -0.572 . . . . 71.450000000000003 109.457 174.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 742' ' ' ALA . . . . . . . . . . . . . . . -94.58 130.26 41.09 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.909 0.385 . . . . 73.239999999999995 111.464 -175.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 743' ' ' GLU . . . . . 0.55 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 49.5 mt-10 -132.98 140.52 47.82 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.959 -0.564 . . . . 74.310000000000002 110.738 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -114.94 100.28 8.08 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.195 -0.668 . . . . 65.549999999999997 109.195 174.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 745' ' ' LYS . . . . . 0.468 ' HE2' ' HB3' ' A' ' 745' ' ' LYS . 14.4 ptpt -121.45 144.11 48.87 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.495 0.664 . . . . 72.439999999999998 111.909 -175.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 746' ' ' LEU . . . . . . . . . . . . . 6.6 tt -78.91 112.59 16.25 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.824 -1.08 . . . . 71.109999999999999 109.509 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 61.3 t -80.18 -50.01 18.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.985 0.422 . . . . 60.399999999999999 110.634 -178.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -155.56 148.93 24.88 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.929 -0.578 . . . . 62.549999999999997 110.252 -178.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 749' ' ' GLN . . . . . 0.421 ' O ' ' HG3' ' A' ' 749' ' ' GLN . 10.5 pt20 -133.69 108.59 8.62 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.194 0.521 . . . . 72.310000000000002 110.281 172.292 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 18.6 m -131.47 78.63 1.84 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.905 -0.588 . . . . 64.219999999999999 110.236 178.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . -139.24 150.31 21.21 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.658 -0.782 . . . . 74.230000000000004 112.138 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 752' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -62.67 160.55 32.04 Favored 'Trans proline' 0 CA--C 1.528 0.197 0 C-N-CA 123.019 2.479 . . . . 71.409999999999997 111.976 178.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -57.45 -34.63 98.29 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.797 2.332 . . . . 72.519999999999996 112.897 -178.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 47.9 p-80 -83.89 -15.91 46.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.268 -0.424 . . . . 75.420000000000002 111.357 -177.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -149.18 70.98 10.09 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.455 -0.339 . . . . 74.219999999999999 110.73 -177.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 756' ' ' PRO . . . . . 0.5 ' O ' ' HA ' ' A' ' 775' ' ' HIS . 51.8 Cg_exo -54.81 146.59 55.1 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.738 2.292 . . . . 72.450000000000003 112.176 178.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 757' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -129.96 113.33 14.46 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.254 -0.43 . . . . 72.420000000000002 109.911 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 758' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -112.74 117.54 32.49 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.799 -0.637 . . . . 72.129999999999995 110.79 -177.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 30.9 t -85.14 101.39 9.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.92 -0.582 . . . . 72.420000000000002 109.543 175.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -106.05 136.91 44.89 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.67 -0.695 . . . . 74.150000000000006 110.483 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 761' ' ' GLN . . . . . 0.504 ' HA ' ' O ' ' A' ' 770' ' ' PRO . 30.0 tt0 -135.18 131.95 37.37 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.749 -0.659 . . . . 72.150000000000006 110.033 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 762' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 769' ' ' PHE . . . -89.17 122.19 32.21 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.892 -0.594 . . . . 63.130000000000003 110.636 -178.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 763' ' ' LYS . . . . . 0.55 ' HB3' ' HB2' ' A' ' 743' ' ' GLU . 61.5 tttm -97.62 105.54 17.71 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.622 -0.717 . . . . 74.120000000000005 109.512 178.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 59.8 t -108.93 98.59 7.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.098 0.475 . . . . 72.040000000000006 109.792 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 70.72 -107.76 2.26 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 111.26 -0.736 . . . . 38.479999999999997 111.26 -176.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -109.6 1.05 30.65 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.743 -0.741 . . . . 73.040000000000006 112.068 177.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 767' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -102.75 138.74 39.24 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.16 0.505 . . . . 72.019999999999996 111.373 -177.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 768' ' ' TRP . . . . . 0.433 ' CH2' ' HD2' ' A' ' 763' ' ' LYS . 80.4 m95 -108.64 108.76 19.75 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.521 -0.763 . . . . 74.25 109.39 175.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 769' ' ' PHE . . . . . 0.416 ' O ' ' HB3' ' A' ' 762' ' ' ALA . 31.6 p90 -168.99 138.9 1.81 Allowed Pre-proline 0 C--N 1.322 -0.613 0 CA-C-O 120.946 0.403 . . . . 71.230000000000004 110.497 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 770' ' ' PRO . . . . . 0.656 ' HD3' ' HB1' ' A' ' 788' ' ' ALA . 59.7 Cg_endo -97.99 -175.64 3.95 Favored 'Cis proline' 0 N--CA 1.451 -1.028 0 C-N-CA 123.454 -1.478 . . . . 74.400000000000006 111.768 -4.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -110.9 106.54 15.7 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.605 -0.517 . . . . 75.530000000000001 109.605 173.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 30.0 m -114.52 146.49 18.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.018 0.437 . . . . 50.329999999999998 111.409 -177.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 5.7 p -111.98 95.87 5.72 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.792 -0.64 . . . . 72.450000000000003 109.847 178.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -94.18 166.73 11.97 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.05 -0.523 . . . . 75.340000000000003 111.776 -174.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 775' ' ' HIS . . . . . 0.5 ' HA ' ' O ' ' A' ' 756' ' ' PRO . 32.6 m-70 -91.84 -4.3 55.0 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.722 -0.672 . . . . 72.409999999999997 110.853 -178.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 63.5 p -159.13 173.58 16.19 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.693 -0.484 . . . . 73.430000000000007 109.693 176.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 777' ' ' LYS . . . . . 0.687 ' HE2' ' HD2' ' A' ' 781' ' ' LYS . 31.4 tttt -65.83 -52.51 49.89 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.709 0.263 . . . . 70.340000000000003 111.709 -176.206 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 51.9 tttp -63.5 -37.79 88.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.466 -0.334 . . . . 51.329999999999998 110.636 -174.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 779' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -60.61 -39.15 87.14 Favored 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 109.852 -0.425 . . . . 74.150000000000006 109.852 175.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -61.91 -48.49 83.35 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.991 -0.623 . . . . 75.25 112.061 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 781' ' ' LYS . . . . . 0.687 ' HD2' ' HE2' ' A' ' 777' ' ' LYS . 8.2 mtpm? -62.59 -38.25 89.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.652 0.263 . . . . 72.219999999999999 111.04 178.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -73.17 -50.54 22.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.539 -0.301 . . . . 74.409999999999997 111.316 -178.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -60.67 -38.4 84.78 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.67 0.271 . . . . 73.519999999999996 110.974 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -60.11 -51.2 70.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 74.150000000000006 110.146 177.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 785' ' ' ALA . . . . . 0.595 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -66.39 -41.72 88.94 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.252 -0.431 . . . . 61.520000000000003 110.923 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 786' ' ' ASP . . . . . 0.432 ' O ' ' HD3' ' A' ' 790' ' ' ARG . 9.9 t0 -56.34 -57.49 12.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.903 -0.59 . . . . 73.129999999999995 110.082 179.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 787' ' ' ALA . . . . . 0.637 ' HB1' ' HG3' ' A' ' 770' ' ' PRO . . . -64.77 -33.39 75.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.695 -0.684 . . . . 71.409999999999997 111.196 -178.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 788' ' ' ALA . . . . . 0.656 ' HB1' ' HD3' ' A' ' 770' ' ' PRO . . . -64.64 -44.47 90.38 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 123.174 0.296 . . . . 74.450000000000003 110.937 179.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 789' ' ' LEU . . . . . 0.595 ' HG ' ' O ' ' A' ' 785' ' ' ALA . 80.0 mt -61.35 -40.34 93.92 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.742 -0.466 . . . . 71.319999999999993 109.742 178.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 790' ' ' ARG . . . . . 0.432 ' HD3' ' O ' ' A' ' 786' ' ' ASP . 13.0 mtp180 -59.54 -35.34 74.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.032 -0.531 . . . . 72.430000000000007 111.162 176.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 791' ' ' VAL . . . . . 0.58 HG22 ' O ' ' A' ' 787' ' ' ALA . 54.3 t -66.19 -52.09 51.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 109.753 -0.462 . . . . 72.219999999999999 109.753 175.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 792' ' ' LEU . . . . . 0.612 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 31.3 mt -57.23 -49.09 77.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.647 -0.706 . . . . 75.540000000000006 110.575 -178.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 793' ' ' ILE . . . . . 0.433 HD13 HG21 ' A' ' 720' ' ' VAL . 94.2 mt -60.02 -51.46 72.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.414 -0.812 . . . . 74.340000000000003 110.734 177.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -61.83 -40.53 98.96 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 121.014 -0.612 . . . . 73.239999999999995 112.697 -178.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -60.29 -53.17 60.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.375 0.131 . . . . 73.209999999999994 111.24 178.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -71.22 -29.94 65.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.928 0.394 . . . . 72.439999999999998 111.08 -176.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 797' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -63.29 -34.37 77.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.542 0.687 . . . . 75.349999999999994 110.028 175.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 798' ' ' LYS . . . . . 0.594 ' HZ3' ' HB3' ' A' ' 798' ' ' LYS . 0.0 OUTLIER -90.55 -39.72 12.39 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.196 -0.911 . . . . 64.340000000000003 111.352 -177.401 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 799' ' ' ALA . . . . . . . . . . . . . . . -94.8 121.69 36.65 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.203 0.445 . . . . 71.129999999999995 112.203 -174.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 800' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -79.92 120.35 24.01 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.766 -0.652 . . . . 74.109999999999999 109.466 171.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 801' ' ' ARG . . . . . . . . . . . . . 1.9 ptm180 . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.76 -0.638 . . . . 74.400000000000006 110.664 -179.652 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 708' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 N--CA 1.479 1.004 0 N-CA-C 110.279 -0.267 . . . . 73.310000000000002 110.279 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 4.5 mpp? -93.37 137.87 23.29 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 116.413 -0.358 . . . . 71.340000000000003 110.121 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -74.07 172.55 15.73 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 123.011 2.474 . . . . 62.229999999999997 111.865 178.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 711' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -101.55 -24.48 14.13 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.899 0.381 . . . . 73.409999999999997 110.205 178.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 712' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.47 3.48 47.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.235 -0.439 . . . . 73.219999999999999 111.847 -179.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 713' ' ' VAL . . . . . . . . . . . . . 12.9 p -78.66 136.79 23.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.106 0.479 . . . . 75.129999999999995 110.317 -178.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.58 ' HG2' ' HB2' ' A' ' 801' ' ' ARG . 0.0 OUTLIER -125.01 85.19 2.37 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.207 0.527 . . . . 75.030000000000001 110.985 177.202 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -92.25 103.27 15.76 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.089 -0.708 . . . . 73.030000000000001 109.089 175.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 716' ' ' ILE . . . . . 0.746 HG23 HG12 ' A' ' 793' ' ' ILE . 25.8 mm -65.35 -26.99 40.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.533 -0.758 . . . . 73.329999999999998 111.961 -173.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -57.17 -28.69 58.93 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.959 -0.639 . . . . 74.420000000000002 112.293 176.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 718' ' ' GLU . . . . . 0.716 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 9.2 mm-40 -70.59 -36.42 73.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.841 0.353 . . . . 75.200000000000003 110.289 178.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 719' ' ' LEU . . . . . 0.54 HD21 ' HA ' ' A' ' 716' ' ' ILE . 3.2 mm? -66.86 -32.23 73.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.17 0.509 . . . . 70.239999999999995 109.864 177.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 720' ' ' VAL . . . . . 0.421 HG22 HD11 ' A' ' 793' ' ' ILE . 61.0 t -68.81 -34.81 66.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.696 -0.684 . . . . 74.310000000000002 110.636 177.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 721' ' ' ARG . . . . . 0.716 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 21.5 ptt180 -63.47 -28.93 70.3 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.261 0.553 . . . . 71.120000000000005 109.643 178.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -77.76 -30.79 51.69 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.908 -0.587 . . . . 74.040000000000006 111.392 178.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 723' ' ' LEU . . . . . 0.503 HD22 ' HB2' ' A' ' 789' ' ' LEU . 92.9 mt -58.18 -33.56 69.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.146 0.498 . . . . 73.150000000000006 110.052 175.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -82.83 -44.28 15.66 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.491 -0.777 . . . . 64.109999999999999 110.887 176.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 8.2 m -84.22 -79.82 0.21 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.358 -0.383 . . . . 65.450000000000003 111.46 -175.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 726' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 -148.08 109.58 3.73 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 109.768 -0.456 . . . . 71.120000000000005 109.768 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 727' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -63.06 -33.79 72.32 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.826 2.35 . . . . 75.420000000000002 112.467 -178.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 59.7 t -63.39 -48.45 87.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.044 0.45 . . . . 73.030000000000001 110.183 -178.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -66.03 -24.55 71.76 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.668 -0.696 . . . . 71.5 111.881 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -79.1 -39.15 20.58 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 121.149 -0.548 . . . . 72.109999999999999 112.644 178.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -65.35 -41.83 93.47 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.576 -0.527 . . . . 75.439999999999998 109.576 178.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 732' ' ' LEU . . . . . 0.437 HD22 ' HB3' ' A' ' 742' ' ' ALA . 90.0 mt -64.13 -37.77 88.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.83 -0.623 . . . . 71.439999999999998 110.193 175.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 733' ' ' GLU . . . . . 0.537 ' O ' ' HG2' ' A' ' 736' ' ' ARG . 4.1 tp10 -65.18 -49.45 69.74 Favored 'General case' 0 N--CA 1.437 -1.12 0 C-N-CA 123.423 0.689 . . . . 74.109999999999999 110.857 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 734' ' ' TYR . . . . . 0.514 ' HB2' HD12 ' A' ' 719' ' ' LEU . 11.0 t80 -54.7 -48.13 72.82 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.634 -0.712 . . . . 73.209999999999994 110.716 178.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -67.14 -47.93 69.6 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.88 -0.6 . . . . 75.230000000000004 111.22 -177.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 736' ' ' ARG . . . . . 0.537 ' HG2' ' O ' ' A' ' 733' ' ' GLU . 18.5 ptt180 -61.99 -32.95 73.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.997 0.427 . . . . 61.229999999999997 111.314 -175.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 44.6 t -80.3 -36.87 33.75 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.075 -0.511 . . . . 75.450000000000003 110.981 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -91.81 -2.35 56.95 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.105 0.409 . . . . 65.209999999999994 112.105 -172.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 89.47 13.37 61.57 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.61 -0.805 . . . . 74.439999999999998 112.936 175.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -97.93 157.89 15.84 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.849 0.357 . . . . 65.219999999999999 110.691 177.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -102.42 114.85 29.4 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.519 -0.548 . . . . 63.25 109.519 175.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 742' ' ' ALA . . . . . 0.437 ' HB3' HD22 ' A' ' 732' ' ' LEU . . . -92.38 114.81 27.46 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 123.237 0.336 . . . . 74.519999999999996 111.021 -177.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 743' ' ' GLU . . . . . 0.416 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 47.1 mt-10 -126.68 132.74 51.1 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.3 -0.409 . . . . 65.430000000000007 110.966 -178.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -106.14 100.76 10.28 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.181 -0.463 . . . . 75.310000000000002 110.292 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 745' ' ' LYS . . . . . 0.4 ' HE3' ' HZ3' ' A' ' 768' ' ' TRP . 10.4 ptpt -103.72 140.89 37.0 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.171 0.51 . . . . 71.450000000000003 111.204 -179.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 746' ' ' LEU . . . . . . . . . . . . . 6.6 tt -86.42 110.01 19.43 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.303 -0.999 . . . . 72.219999999999999 108.303 175.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 40.4 t -74.88 -53.88 15.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.077 -0.51 . . . . 74.120000000000005 110.347 -176.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -157.04 155.19 30.76 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.991 -0.55 . . . . 74.120000000000005 109.53 -178.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -139.62 96.81 3.14 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.514 0.673 . . . . 74.019999999999996 110.974 177.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 34.0 t -89.73 101.85 14.55 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.548 -0.908 . . . . 63.240000000000002 108.548 174.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 751' ' ' GLY . . . . . 0.598 ' HA2' ' HA ' ' A' ' 756' ' ' PRO . . . -120.25 81.17 0.33 Allowed Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.172 -1.013 . . . . 54.409999999999997 113.671 -173.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 752' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -64.59 160.24 40.95 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.169 1.913 . . . . 55.439999999999998 110.466 170.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.41 -27.36 84.79 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.513 2.142 . . . . 75.019999999999996 113.188 -174.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 50.9 p-80 -92.19 -15.18 27.95 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.499 -0.319 . . . . 74.140000000000001 111.596 -176.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -158.89 71.72 3.62 Favored Pre-proline 0 C--N 1.329 -0.289 0 N-CA-C 112.289 0.478 . . . . 71.120000000000005 112.289 -176.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 756' ' ' PRO . . . . . 0.598 ' HA ' ' HA2' ' A' ' 751' ' ' GLY . 40.2 Cg_exo -58.13 115.29 2.43 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 121.934 1.756 . . . . 61.240000000000002 111.199 171.077 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 757' ' ' LYS . . . . . 0.496 ' HD3' ' HB2' ' A' ' 773' ' ' CYS . 36.4 ttmt -122.4 137.06 54.99 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.958 0.408 . . . . 73.140000000000001 110.822 -176.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 758' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -123.21 119.61 30.73 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.813 -0.631 . . . . 74.129999999999995 110.45 -176.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 759' ' ' VAL . . . . . 0.484 HG22 ' HB3' ' A' ' 773' ' ' CYS . 25.3 t -94.49 115.92 34.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.005 -0.543 . . . . 62.130000000000003 110.761 -177.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -116.76 147.56 41.94 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.754 -0.657 . . . . 75.540000000000006 110.724 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 761' ' ' GLN . . . . . 0.408 ' OE1' ' HB3' ' A' ' 768' ' ' TRP . 34.4 tt0 -132.62 138.13 47.27 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.942 -0.572 . . . . 74.230000000000004 109.677 177.089 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 762' ' ' ALA . . . . . . . . . . . . . . . -95.19 112.66 24.34 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.316 0.579 . . . . 73.439999999999998 110.514 -177.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 763' ' ' LYS . . . . . 0.49 ' HD2' ' CH2' ' A' ' 768' ' ' TRP . 48.8 tttm -91.67 104.02 16.54 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.493 -0.776 . . . . 73.209999999999994 109.441 177.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 88.8 t -109.35 101.77 13.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.182 0.515 . . . . 73.329999999999998 109.851 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 71.68 -119.13 7.47 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 110.775 -0.93 . . . . 55.530000000000001 110.775 -174.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -102.14 7.06 54.24 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.635 -0.793 . . . . 73.140000000000001 111.224 175.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 767' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -99.9 148.56 24.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.054 0.454 . . . . 75.540000000000006 110.976 -177.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 768' ' ' TRP . . . . . 0.49 ' CH2' ' HD2' ' A' ' 763' ' ' LYS . 54.1 m95 -124.76 99.9 6.37 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.688 -0.687 . . . . 73.430000000000007 110.064 -179.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 769' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -171.04 141.57 1.41 Allowed Pre-proline 0 C--N 1.325 -0.468 0 CA-C-O 120.706 0.289 . . . . 64.219999999999999 110.397 -178.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 770' ' ' PRO . . . . . 0.53 ' HD3' ' HB1' ' A' ' 788' ' ' ALA . 60.7 Cg_endo -96.59 -168.54 1.78 Allowed 'Cis proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.755 -1.352 . . . . 73.319999999999993 112.126 -2.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -120.95 108.53 14.0 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.771 -0.455 . . . . 70.140000000000001 109.771 175.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 772' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 759' ' ' VAL . 32.9 m -116.87 157.54 17.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.83 0.348 . . . . 72.420000000000002 110.998 -176.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 773' ' ' CYS . . . . . 0.496 ' HB2' ' HD3' ' A' ' 757' ' ' LYS . 2.6 p -134.99 100.53 4.6 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.069 -0.514 . . . . 73.420000000000002 110.175 178.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -103.22 177.49 4.82 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.824 -0.626 . . . . 61.520000000000003 111.221 -174.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 775' ' ' HIS . . . . . . . . . . . . . 46.8 m-70 -85.32 -16.63 39.35 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.14 0.495 . . . . 73.129999999999995 110.324 -177.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 776' ' ' SER . . . . . 0.615 ' HB2' ' HB2' ' A' ' 779' ' ' GLN . 12.5 m -129.71 152.57 49.07 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.954 -0.567 . . . . 75.439999999999998 110.281 -177.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 777' ' ' LYS . . . . . . . . . . . . . 6.1 tmmm? -63.9 -49.69 71.67 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.372 -0.376 . . . . 75.0 110.96 -178.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -70.41 -26.56 63.74 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.644 -0.423 . . . . 71.400000000000006 110.231 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 779' ' ' GLN . . . . . 0.615 ' HB2' ' HB2' ' A' ' 776' ' ' SER . 6.5 mm-40 -66.71 -37.33 84.48 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 116.28 -0.418 . . . . 74.409999999999997 110.261 173.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -58.15 -45.98 93.31 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.787 -0.72 . . . . 74.340000000000003 111.501 175.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -61.94 -46.13 90.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.773 0.321 . . . . 73.450000000000003 110.76 176.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -64.56 -46.87 80.92 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.337 -0.392 . . . . 71.420000000000002 111.399 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -63.14 -39.57 95.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.496 -0.32 . . . . 73.540000000000006 111.235 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -63.19 -46.11 88.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.82 0.343 . . . . 75.140000000000001 110.11 177.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 785' ' ' ALA . . . . . 0.567 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -65.14 -45.11 86.35 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.902 -0.59 . . . . 75.400000000000006 110.986 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 786' ' ' ASP . . . . . 0.711 ' O ' ' HG2' ' A' ' 790' ' ' ARG . 14.1 t70 -58.41 -54.49 46.46 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 116.317 -0.401 . . . . 73.030000000000001 110.012 178.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 787' ' ' ALA . . . . . 0.51 ' O ' HG21 ' A' ' 791' ' ' VAL . . . -61.75 -33.79 74.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.759 -0.655 . . . . 73.329999999999998 111.21 -178.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 788' ' ' ALA . . . . . 0.705 ' O ' ' HG ' ' A' ' 792' ' ' LEU . . . -62.84 -46.62 87.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.363 -0.381 . . . . 63.530000000000001 110.448 177.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 789' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 785' ' ' ALA . 65.5 mt -62.58 -36.36 82.47 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.812 -0.44 . . . . 75.230000000000004 109.812 179.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 790' ' ' ARG . . . . . 0.711 ' HG2' ' O ' ' A' ' 786' ' ' ASP . 26.6 mmm-85 -58.95 -42.18 89.22 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.868 0.366 . . . . 75.230000000000004 110.033 177.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 791' ' ' VAL . . . . . 0.51 HG21 ' O ' ' A' ' 787' ' ' ALA . 59.0 t -64.31 -49.68 79.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.054 -0.521 . . . . 73.129999999999995 110.465 177.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 792' ' ' LEU . . . . . 0.705 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 22.5 mt -59.19 -46.59 88.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.033 -0.531 . . . . 73.439999999999998 110.457 -178.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 793' ' ' ILE . . . . . 0.746 HG12 HG23 ' A' ' 716' ' ' ILE . 96.7 mt -63.02 -45.49 98.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.422 -0.808 . . . . 74.409999999999997 110.675 177.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -65.69 -40.16 95.69 Favored Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 115.934 -0.575 . . . . 62.020000000000003 112.934 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -74.23 -16.58 60.96 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 122.377 -0.484 . . . . 73.230000000000004 111.277 -178.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -89.41 -12.94 38.84 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.436 0.636 . . . . 75.310000000000002 109.424 174.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 797' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.29 -32.18 64.49 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.949 -0.76 . . . . 72.349999999999994 108.949 175.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 798' ' ' LYS . . . . . . . . . . . . . 2.7 ptpp? -92.41 15.87 13.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.723 -0.671 . . . . 75.329999999999998 110.451 176.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 799' ' ' ALA . . . . . . . . . . . . . . . -145.79 -176.01 4.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.883 0.373 . . . . 74.25 111.226 -176.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 800' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -124.96 122.82 38.42 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.914 -0.585 . . . . 70.25 109.875 174.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 801' ' ' ARG . . . . . 0.58 ' HB2' ' HG2' ' A' ' 714' ' ' ARG . 8.0 ppt_? . . . . . 0 C--O 1.245 0.85 0 CA-C-N 115.938 -0.574 . . . . 71.409999999999997 111.736 -178.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 708' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 N--CA 1.478 0.957 0 CA-C-O 120.741 0.305 . . . . 74.150000000000006 110.38 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -105.71 151.69 39.94 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 110.075 -0.343 . . . . 74.010000000000005 110.075 178.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -58.29 -50.81 8.84 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 122.878 2.386 . . . . 75.310000000000002 113.148 -178.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 711' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -111.12 171.23 7.59 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.594 -0.275 . . . . 71.340000000000003 110.765 -177.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 712' ' ' LYS . . . . . 0.589 ' HE3' ' HG3' ' A' ' 718' ' ' GLU . 21.5 pttm -115.56 169.43 9.19 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.972 0.415 . . . . 71.209999999999994 111.156 -178.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 713' ' ' VAL . . . . . 0.853 HG22 ' H ' ' A' ' 714' ' ' ARG . 7.8 p -92.37 -167.14 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.705 -0.68 . . . . 71.349999999999994 109.363 177.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.853 ' H ' HG22 ' A' ' 713' ' ' VAL . 6.2 ptp85 -65.34 87.1 0.07 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.44 0.638 . . . . 74.340000000000003 110.955 175.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -107.36 105.63 15.67 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.815 -0.63 . . . . 74.420000000000002 109.997 177.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 716' ' ' ILE . . . . . 0.465 ' HA ' HD21 ' A' ' 719' ' ' LEU . 48.1 mm -78.31 -26.13 14.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.068 -0.514 . . . . 75.129999999999995 110.68 -176.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -60.29 -29.73 69.49 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.944 -0.646 . . . . 53.329999999999998 112.085 178.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 718' ' ' GLU . . . . . 0.647 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 30.0 mm-40 -57.87 -50.12 74.38 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-O 120.965 0.412 . . . . 73.540000000000006 110.168 176.004 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 719' ' ' LEU . . . . . 0.524 HD12 HD21 ' A' ' 789' ' ' LEU . 2.4 mm? -62.71 -29.67 70.84 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.164 0.507 . . . . 73.140000000000001 110.096 -177.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 720' ' ' VAL . . . . . . . . . . . . . 65.1 t -72.07 -42.96 67.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.617 -0.72 . . . . 75.549999999999997 110.639 178.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 721' ' ' ARG . . . . . 0.647 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 15.5 ptm180 -65.5 -24.05 67.04 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.919 0.39 . . . . 74.120000000000005 110.446 -179.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -76.91 -31.56 56.78 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 116.483 -0.326 . . . . 74.530000000000001 111.098 176.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 723' ' ' LEU . . . . . 0.457 HD21 ' HB2' ' A' ' 789' ' ' LEU . 92.3 mt -60.78 -30.9 70.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.266 0.555 . . . . 71.329999999999998 109.99 174.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -87.95 -17.26 31.69 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.281 -0.872 . . . . 70.299999999999997 111.317 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 21.2 m -118.04 -79.9 0.6 Allowed 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 120.674 0.274 . . . . 65.400000000000006 111.595 -177.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 726' ' ' ASN . . . . . 0.425 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 39.4 t30 -139.19 106.71 7.29 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 120.71 0.29 . . . . 65.310000000000002 110.669 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 727' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 21.1 Cg_endo -62.03 -38.48 56.91 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.745 2.297 . . . . 45.539999999999999 112.838 -178.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 29.9 t -63.12 -46.32 96.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.355 -0.384 . . . . 72.239999999999995 110.669 -175.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -61.58 -36.1 92.12 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.833 -0.698 . . . . 45.399999999999999 112.026 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -67.54 -42.07 89.17 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 121.095 -0.574 . . . . 73.109999999999999 112.593 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -65.66 -42.05 91.81 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.964 0.411 . . . . 75.299999999999997 109.933 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 732' ' ' LEU . . . . . . . . . . . . . 96.1 mt -65.37 -46.44 80.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.944 -0.571 . . . . 75.129999999999995 111.14 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 733' ' ' GLU . . . . . 0.511 ' HA ' ' HG2' ' A' ' 736' ' ' ARG . 0.0 OUTLIER -72.75 -31.38 64.88 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.899 -0.321 . . . . 75.109999999999999 110.994 -176.187 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 734' ' ' TYR . . . . . 0.522 ' HB2' HD13 ' A' ' 719' ' ' LEU . 11.8 t80 -57.22 -48.88 77.69 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 120.918 0.39 . . . . 72.420000000000002 110.089 175.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -65.02 -52.26 57.0 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.874 -0.603 . . . . 73.409999999999997 110.709 -176.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 736' ' ' ARG . . . . . 0.511 ' HG2' ' HA ' ' A' ' 733' ' ' GLU . 32.5 ptt180 -62.47 -33.04 74.05 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.686 -0.688 . . . . 74.120000000000005 111.399 -175.201 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 47.9 t -83.47 -11.68 57.21 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.909 -0.587 . . . . 42.340000000000003 111.673 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -113.03 -8.44 13.64 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.008 0.373 . . . . 73.299999999999997 112.008 -177.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 100.08 8.01 51.48 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.597 -0.811 . . . . 64.530000000000001 112.733 178.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -97.42 163.75 12.74 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 110.091 -0.337 . . . . 74.140000000000001 110.091 177.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -113.0 118.61 35.3 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.6 -0.519 . . . . 72.519999999999996 109.6 174.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 742' ' ' ALA . . . . . . . . . . . . . . . -94.06 128.3 40.35 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.21 -0.45 . . . . 53.539999999999999 111.029 -176.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 743' ' ' GLU . . . . . 0.541 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 45.6 mt-10 -139.54 154.81 47.74 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.872 -0.603 . . . . 71.510000000000005 110.393 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -128.5 113.18 15.17 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.209 -0.451 . . . . 73.420000000000002 109.795 178.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 745' ' ' LYS . . . . . 0.514 ' HE3' ' CZ3' ' A' ' 768' ' ' TRP . 13.1 ptpt -111.74 149.34 31.79 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.305 -0.558 . . . . 64.200000000000003 111.197 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 746' ' ' LEU . . . . . . . . . . . . . 6.7 tt -95.49 104.85 16.77 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.236 -1.024 . . . . 73.219999999999999 108.236 177.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 48.3 t -76.84 -44.14 32.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 116.226 -0.443 . . . . 74.450000000000003 111.009 -174.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -152.88 148.49 27.21 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.324 -0.398 . . . . 73.319999999999993 111.12 -175.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 749' ' ' GLN . . . . . 0.513 ' HA ' ' O ' ' A' ' 757' ' ' LYS . 18.1 pt20 -138.75 97.02 3.24 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.924 0.869 . . . . 72.140000000000001 109.759 173.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 9.8 p -129.5 -179.18 5.02 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.414 -0.812 . . . . 65.310000000000002 111.004 -174.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 103.64 178.5 25.87 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.586 -0.816 . . . . 44.039999999999999 112.229 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 752' ' ' PRO . . . . . 0.62 ' HG2' ' HB2' ' A' ' 755' ' ' GLU . 38.7 Cg_endo -64.98 160.3 42.15 Favored 'Trans proline' 0 CA--C 1.528 0.218 0 C-N-CA 123.118 2.545 . . . . 60.439999999999998 111.963 -178.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.37 -28.2 71.58 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.645 2.23 . . . . 70.200000000000003 112.658 -178.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 49.0 p-80 -86.49 -14.82 41.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.76 0.314 . . . . 54.420000000000002 110.989 -179.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 755' ' ' GLU . . . . . 0.62 ' HB2' ' HG2' ' A' ' 752' ' ' PRO . 18.8 mm-40 -138.9 74.0 38.5 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.252 -0.431 . . . . 73.329999999999998 110.718 178.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 756' ' ' PRO . . . . . 0.65 ' O ' ' HA ' ' A' ' 775' ' ' HIS . 56.1 Cg_endo -73.5 113.32 3.75 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.495 2.13 . . . . 74.099999999999994 111.723 177.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 757' ' ' LYS . . . . . 0.513 ' O ' ' HA ' ' A' ' 749' ' ' GLN . 6.1 ttpm? -88.61 114.08 24.85 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.903 0.382 . . . . 75.329999999999998 110.718 -177.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 758' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -99.06 115.11 28.22 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.532 -0.758 . . . . 70.209999999999994 110.013 179.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 22.1 t -88.24 105.69 15.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.627 -0.715 . . . . 71.099999999999994 109.373 177.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -107.63 144.43 34.69 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.981 -0.554 . . . . 74.310000000000002 110.669 -178.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 761' ' ' GLN . . . . . 0.456 ' HA ' ' O ' ' A' ' 770' ' ' PRO . 60.4 tt0 -136.6 128.18 28.72 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.703 -0.68 . . . . 74.319999999999993 109.512 178.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 762' ' ' ALA . . . . . 0.452 ' HB1' ' O ' ' A' ' 769' ' ' PHE . . . -86.29 129.56 34.81 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.332 0.587 . . . . 62.43 110.502 -178.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 763' ' ' LYS . . . . . 0.541 ' HB3' ' HB2' ' A' ' 743' ' ' GLU . 66.0 tttt -104.6 112.28 25.29 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.584 -0.735 . . . . 75.030000000000001 109.783 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 58.9 t -119.27 95.92 3.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.175 0.512 . . . . 74.209999999999994 109.758 177.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 72.86 -116.5 5.65 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.091 -0.803 . . . . 52.140000000000001 111.091 -175.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -101.36 -2.97 53.89 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.752 -0.737 . . . . 72.129999999999995 111.818 175.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 767' ' ' ARG . . . . . 0.44 ' HB3' ' CD1' ' A' ' 769' ' ' PHE . 0.2 OUTLIER -95.08 121.91 37.2 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.959 0.409 . . . . 72.530000000000001 111.457 -178.01 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 768' ' ' TRP . . . . . 0.514 ' CZ3' ' HE3' ' A' ' 745' ' ' LYS . 70.2 m95 -102.17 105.14 15.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.917 -0.583 . . . . 75.239999999999995 110.062 177.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 769' ' ' PHE . . . . . 0.452 ' O ' ' HB1' ' A' ' 762' ' ' ALA . 41.6 p90 -168.39 144.94 3.2 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 109.873 -0.417 . . . . 74.230000000000004 109.873 -177.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 770' ' ' PRO . . . . . 0.628 ' HD3' ' HB1' ' A' ' 788' ' ' ALA . 65.3 Cg_endo -97.56 -176.16 4.45 Favored 'Cis proline' 0 N--CA 1.451 -1.006 0 C-N-CA 123.736 -1.36 . . . . 53.329999999999998 112.188 -2.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -106.41 109.1 20.93 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.596 -0.52 . . . . 53.210000000000001 109.596 174.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 35.9 m -117.72 155.79 19.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.969 0.414 . . . . 73.200000000000003 110.997 -177.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 7.0 p -129.91 112.78 13.86 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.17 0.51 . . . . 65.019999999999996 110.442 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 774' ' ' ALA . . . . . 0.414 ' O ' ' HA ' ' A' ' 757' ' ' LYS . . . -116.73 -178.4 3.42 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.816 -0.629 . . . . 64.340000000000003 109.784 178.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 775' ' ' HIS . . . . . 0.65 ' HA ' ' O ' ' A' ' 756' ' ' PRO . 5.6 p80 -121.86 19.01 11.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.772 0.796 . . . . 65.109999999999999 110.187 176.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 49.3 m -148.35 139.22 23.05 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.837 -1.074 . . . . 73.420000000000002 108.405 171.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 777' ' ' LYS . . . . . . . . . . . . . 5.6 tmmm? -61.45 -44.77 96.53 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 123.018 0.199 . . . . 74.329999999999998 111.291 -172.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -64.85 -31.56 72.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.71 0.291 . . . . 70.120000000000005 110.799 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 779' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -72.03 -35.51 69.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.365 -0.38 . . . . 75.230000000000004 110.335 177.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -59.94 -42.94 98.48 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.904 -0.665 . . . . 45.310000000000002 111.493 176.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -61.25 -49.01 78.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.835 0.35 . . . . 75.430000000000007 110.488 176.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -61.73 -51.21 69.31 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 115.896 -0.593 . . . . 72.129999999999995 111.254 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -57.95 -43.34 86.34 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 123.196 0.31 . . . . 63.109999999999999 111.44 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -59.92 -50.68 72.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.373 -0.376 . . . . 64.209999999999994 110.622 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 785' ' ' ALA . . . . . 0.582 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -67.48 -42.46 82.94 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.318 -0.401 . . . . 55.310000000000002 111.025 -178.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 786' ' ' ASP . . . . . 0.463 ' O ' ' HG3' ' A' ' 790' ' ' ARG . 11.8 t70 -59.1 -51.74 68.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.984 -0.553 . . . . 65.200000000000003 110.717 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 787' ' ' ALA . . . . . 0.542 ' HA ' ' HD2' ' A' ' 790' ' ' ARG . . . -66.84 -35.46 80.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.034 -0.53 . . . . 71.409999999999997 110.8 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 788' ' ' ALA . . . . . 0.665 ' O ' ' HG ' ' A' ' 792' ' ' LEU . . . -61.46 -42.75 99.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.425 -0.352 . . . . 71.010000000000005 110.854 178.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 789' ' ' LEU . . . . . 0.582 ' HG ' ' O ' ' A' ' 785' ' ' ALA . 81.3 mt -58.92 -43.98 91.22 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 110.008 -0.367 . . . . 73.239999999999995 110.008 177.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 790' ' ' ARG . . . . . 0.542 ' HD2' ' HA ' ' A' ' 787' ' ' ALA . 53.9 mtt-85 -58.36 -37.53 75.39 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.206 -0.452 . . . . 75.530000000000001 111.009 177.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 791' ' ' VAL . . . . . 0.54 HG21 ' O ' ' A' ' 787' ' ' ALA . 48.3 t -65.81 -48.67 81.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.416 -0.356 . . . . 72.430000000000007 110.237 177.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 792' ' ' LEU . . . . . 0.665 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 39.6 mt -61.67 -46.37 90.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.747 -0.661 . . . . 73.049999999999997 110.749 -179.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 89.5 mt -62.17 -47.53 92.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.51 -0.768 . . . . 72.150000000000006 110.366 177.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -62.92 -36.4 93.36 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 121.018 -0.611 . . . . 71.150000000000006 112.342 178.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -57.56 -51.22 70.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.977 0.418 . . . . 71.439999999999998 110.44 177.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 796' ' ' ASN . . . . . 0.456 ' HA ' ' HB2' ' A' ' 799' ' ' ALA . 2.6 t-20 -86.44 0.39 54.24 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.171 0.51 . . . . 72.129999999999995 110.667 -177.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 797' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -83.05 -45.85 13.53 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.159 -0.682 . . . . 74.109999999999999 109.159 173.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 798' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -75.01 -24.51 58.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.652 -0.704 . . . . 74.420000000000002 109.783 177.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 799' ' ' ALA . . . . . 0.456 ' HB2' ' HA ' ' A' ' 796' ' ' ASN . . . -85.84 153.86 21.95 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.498 -0.774 . . . . 75.25 109.554 173.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 800' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -122.45 86.06 2.52 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.974 0.416 . . . . 63.439999999999998 110.471 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 801' ' ' ARG . . . . . 0.411 ' HA ' ' HE ' ' A' ' 801' ' ' ARG . 2.8 mmp_? . . . . . 0 C--O 1.246 0.904 0 CA-C-O 118.634 -0.698 . . . . 74.420000000000002 109.69 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 708' ' ' MET . . . . . . . . . . . . . 22.2 ptp . . . . . 0 N--CA 1.48 1.054 0 CA-C-O 120.754 0.312 . . . . 74.219999999999999 110.425 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 709' ' ' MET . . . . . 0.415 ' HA ' ' HD3' ' A' ' 710' ' ' PRO . 20.7 ptp -162.72 147.77 9.62 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 109.54 -0.541 . . . . 71.129999999999995 109.54 176.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 710' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 709' ' ' MET . 16.8 Cg_exo -66.85 150.96 83.14 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.322 2.015 . . . . 64.120000000000005 111.7 178.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 711' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -65.44 -40.88 93.8 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.24 -0.652 . . . . 73.510000000000005 109.24 175.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 712' ' ' LYS . . . . . 0.535 ' HA ' ' HE3' ' A' ' 712' ' ' LYS . 0.0 OUTLIER -126.31 127.01 44.88 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.109 -1.071 . . . . 65.329999999999998 108.109 169.865 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 713' ' ' VAL . . . . . . . . . . . . . 14.9 p -55.61 133.45 19.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 121.061 0.457 . . . . 72.239999999999995 110.717 -175.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.517 ' HG2' HG12 ' A' ' 716' ' ' ILE . 10.9 ttp180 -86.32 89.51 7.89 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.233 -0.44 . . . . 74.420000000000002 111.108 -172.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -98.37 93.35 6.14 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.669 -0.863 . . . . 73.019999999999996 108.669 171.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 716' ' ' ILE . . . . . 0.517 HG12 ' HG2' ' A' ' 714' ' ' ARG . 46.1 mm -122.42 -36.34 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.76 -0.655 . . . . 72.319999999999993 110.587 -175.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -61.09 -28.94 69.77 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.974 -0.631 . . . . 52.299999999999997 111.702 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 718' ' ' GLU . . . . . 0.747 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 5.8 mp0 -59.68 -46.94 87.55 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.913 0.387 . . . . 64.319999999999993 110.173 175.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 719' ' ' LEU . . . . . 0.531 HD11 HD21 ' A' ' 789' ' ' LEU . 2.9 mm? -67.61 -33.75 75.62 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.997 0.427 . . . . 75.340000000000003 110.36 -178.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 720' ' ' VAL . . . . . 0.448 HG22 HD13 ' A' ' 793' ' ' ILE . 61.6 t -63.39 -41.19 91.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 115.991 -0.55 . . . . 75.319999999999993 110.672 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 721' ' ' ARG . . . . . 0.747 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 14.7 ptm180 -68.92 -24.57 64.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 75.019999999999996 109.981 -178.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -76.73 -30.15 56.49 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.356 -0.384 . . . . 75.120000000000005 111.404 177.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 723' ' ' LEU . . . . . 0.523 HD23 ' HB2' ' A' ' 789' ' ' LEU . 84.7 mt -59.18 -32.57 70.04 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.476 -0.565 . . . . 74.239999999999995 109.476 172.094 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -82.97 -41.06 19.22 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.276 -0.875 . . . . 74.239999999999995 110.976 177.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 29.3 m -96.26 -78.49 0.46 Allowed 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 112.32 0.489 . . . . 72.540000000000006 112.32 -176.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 726' ' ' ASN . . . . . 0.405 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 37.7 t30 -142.11 100.9 5.82 Favored Pre-proline 0 C--O 1.234 0.27 0 CA-C-O 120.817 0.342 . . . . 75.120000000000005 111.065 -173.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 727' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 19.2 Cg_endo -61.86 -38.5 58.7 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 123.041 2.494 . . . . 65.239999999999995 112.844 -176.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 42.0 t -61.48 -48.49 88.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 75.510000000000005 110.939 -175.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -61.98 -38.46 96.09 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.765 -0.731 . . . . 54.240000000000002 112.12 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -66.85 -42.68 92.8 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.876 -0.678 . . . . 72.349999999999994 112.584 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -62.52 -40.36 96.5 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.807 -0.442 . . . . 71.430000000000007 109.807 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 732' ' ' LEU . . . . . . . . . . . . . 90.7 mt -64.74 -42.98 94.77 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.928 -0.578 . . . . 72.530000000000001 111.399 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 733' ' ' GLU . . . . . 0.503 ' O ' ' HG2' ' A' ' 736' ' ' ARG . 12.7 pt-20 -80.2 -25.95 39.43 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.924 -0.311 . . . . 74.450000000000003 111.55 -176.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 734' ' ' TYR . . . . . 0.497 ' HB2' HD12 ' A' ' 719' ' ' LEU . 3.2 t80 -56.89 -44.24 82.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.061 0.457 . . . . 74.239999999999995 109.84 173.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -66.93 -47.6 71.22 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.612 -0.722 . . . . 63.350000000000001 110.666 -177.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 736' ' ' ARG . . . . . 0.503 ' HG2' ' O ' ' A' ' 733' ' ' GLU . 34.4 ptt180 -63.39 -31.77 73.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.13 0.49 . . . . 74.310000000000002 110.992 -176.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 10.4 t -75.46 -33.59 60.87 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.756 -0.656 . . . . 74.230000000000004 110.993 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 18.2 m170 -97.02 -13.29 22.38 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.317 0.488 . . . . 73.540000000000006 112.317 -173.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 100.56 13.56 34.85 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.439 -0.886 . . . . 64.129999999999995 112.614 178.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -98.57 -174.14 2.73 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.025 0.44 . . . . 60.340000000000003 110.284 176.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 741' ' ' ALA . . . . . 0.563 ' O ' ' HA ' ' A' ' 764' ' ' VAL . . . -128.06 139.43 52.53 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.796 -0.638 . . . . 71.409999999999997 109.281 173.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 742' ' ' ALA . . . . . . . . . . . . . . . -110.11 115.73 30.28 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.773 0.32 . . . . 74.010000000000005 110.895 -176.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 743' ' ' GLU . . . . . 0.541 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 43.4 mt-10 -126.63 146.53 50.14 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.274 -0.421 . . . . 72.239999999999995 110.979 -178.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -123.15 104.3 9.09 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.37 -0.604 . . . . 71.040000000000006 109.37 176.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 8.0 ptpt -119.16 157.9 27.02 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.095 0.474 . . . . 61.140000000000001 111.307 -176.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 746' ' ' LEU . . . . . 0.457 HD11 ' HB3' ' A' ' 758' ' ' PHE . 57.2 tp -85.78 122.98 30.63 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.509 -0.769 . . . . 73.239999999999995 109.756 175.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 54.3 t -94.58 -47.73 13.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 120.959 0.409 . . . . 74.230000000000004 110.537 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -143.92 148.9 36.03 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.044 -0.525 . . . . 64.019999999999996 110.003 -177.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -133.32 102.5 5.57 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.691 -0.485 . . . . 71.209999999999994 109.691 176.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 33.7 m -143.65 131.61 21.63 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.243 -0.435 . . . . 74.310000000000002 110.562 -177.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 160.62 -165.52 35.08 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.653 -0.784 . . . . 64.140000000000001 112.261 178.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 752' ' ' PRO . . . . . 0.446 ' HG2' ' HB2' ' A' ' 755' ' ' GLU . 72.7 Cg_endo -78.0 163.81 27.96 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 123.015 2.477 . . . . 73.310000000000002 112.084 177.036 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -76.51 -27.94 7.23 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.543 2.162 . . . . 75.209999999999994 112.379 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 39.8 p-80 -79.33 -19.4 50.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.914 0.387 . . . . 72.549999999999997 110.709 178.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 755' ' ' GLU . . . . . 0.446 ' HB2' ' HG2' ' A' ' 752' ' ' PRO . 29.3 mt-10 -138.99 79.74 26.09 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.929 -0.578 . . . . 62.43 110.332 175.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 756' ' ' PRO . . . . . 0.483 ' O ' ' HA ' ' A' ' 775' ' ' HIS . 34.9 Cg_endo -65.94 102.38 0.53 Allowed 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.165 1.91 . . . . 73.319999999999993 111.3 177.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 757' ' ' LYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 775' ' ' HIS . 37.9 ttmt -87.69 114.69 24.54 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.437 0.637 . . . . 65.120000000000005 110.686 -176.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 758' ' ' PHE . . . . . 0.457 ' HB3' HD11 ' A' ' 746' ' ' LEU . 78.8 m-85 -97.95 126.12 43.19 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.016 -0.993 . . . . 75.319999999999993 110.48 -178.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 62.0 t -88.86 102.95 13.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 109.488 -0.56 . . . . 54.140000000000001 109.488 174.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 760' ' ' TYR . . . . . 0.454 ' OH ' ' HG3' ' A' ' 777' ' ' LYS . 7.1 m-85 -102.29 142.13 34.01 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.875 -0.602 . . . . 74.219999999999999 110.764 -178.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 761' ' ' GLN . . . . . 0.474 ' OE1' ' HB3' ' A' ' 768' ' ' TRP . 32.0 tt0 -133.75 136.04 44.33 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.717 -0.674 . . . . 73.329999999999998 110.084 179.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 762' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' A' ' 769' ' ' PHE . . . -87.43 116.28 25.43 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.94 -0.573 . . . . 74.120000000000005 110.441 -178.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 763' ' ' LYS . . . . . 0.541 ' HB3' ' HB2' ' A' ' 743' ' ' GLU . 58.6 tttm -94.94 100.39 12.25 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.716 -0.674 . . . . 75.439999999999998 109.631 178.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 764' ' ' VAL . . . . . 0.563 ' HA ' ' O ' ' A' ' 741' ' ' ALA . 58.3 t -104.75 100.7 11.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.965 -0.562 . . . . 74.049999999999997 109.842 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 69.84 -111.65 3.96 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 110.881 -0.888 . . . . 53.130000000000003 110.881 -174.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -112.13 10.99 26.86 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 111.407 -0.677 . . . . 71.450000000000003 111.407 175.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 767' ' ' ARG . . . . . . . . . . . . . 79.7 mtm180 -107.82 131.51 54.4 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.939 0.4 . . . . 72.549999999999997 110.567 -178.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 768' ' ' TRP . . . . . 0.474 ' HB3' ' OE1' ' A' ' 761' ' ' GLN . 43.1 m95 -108.39 101.25 10.46 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.906 -0.588 . . . . 74.329999999999998 109.991 -177.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 769' ' ' PHE . . . . . 0.416 ' O ' ' HB2' ' A' ' 762' ' ' ALA . 27.2 p90 -167.86 139.8 2.49 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-O 120.74 0.305 . . . . 73.209999999999994 110.61 -178.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 770' ' ' PRO . . . . . 0.643 ' HD3' ' HB1' ' A' ' 788' ' ' ALA . 68.7 Cg_endo -95.13 -170.09 2.71 Favored 'Cis proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.648 -1.397 . . . . 75.519999999999996 111.797 -3.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -122.17 101.49 7.56 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.996 -0.372 . . . . 72.409999999999997 109.996 176.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 27.0 m -110.51 168.04 4.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.135 -0.484 . . . . 73.530000000000001 110.81 -176.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 5.8 p -133.6 113.83 12.85 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.244 0.545 . . . . 71.329999999999998 110.995 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -132.03 149.4 52.43 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.866 -0.606 . . . . 64.450000000000003 109.926 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 775' ' ' HIS . . . . . 0.483 ' HA ' ' O ' ' A' ' 756' ' ' PRO . 1.3 p-80 -83.67 18.29 1.98 Allowed 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.592 -0.443 . . . . 73.230000000000004 111.669 -176.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 32.5 t -148.39 143.26 26.7 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.896 -0.409 . . . . 73.019999999999996 109.896 176.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 777' ' ' LYS . . . . . 0.454 ' HG3' ' OH ' ' A' ' 760' ' ' TYR . 8.4 ttmm -57.97 -49.8 75.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 72.510000000000005 110.752 178.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -58.94 -45.36 90.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.51 -0.768 . . . . 71.349999999999994 110.376 -178.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 779' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -63.58 -41.47 98.36 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-N 116.086 -0.506 . . . . 70.230000000000004 110.626 177.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -55.6 -44.85 86.04 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.028 -0.606 . . . . 51.340000000000003 112.036 178.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -66.24 -43.65 85.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.649 0.261 . . . . 72.040000000000006 111.024 177.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -63.88 -48.13 77.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.393 -0.367 . . . . 74.319999999999993 110.969 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -61.51 -43.52 98.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 64.439999999999998 110.927 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -63.2 -48.93 76.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.038 -0.528 . . . . 72.239999999999995 110.845 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 785' ' ' ALA . . . . . 0.597 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -65.1 -42.02 94.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.319 -0.401 . . . . 53.109999999999999 110.983 -178.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 786' ' ' ASP . . . . . 0.416 ' O ' ' HG3' ' A' ' 790' ' ' ARG . 12.7 t70 -57.64 -50.17 74.02 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.052 -0.522 . . . . 74.420000000000002 110.667 178.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 787' ' ' ALA . . . . . 0.52 ' HB3' ' HG3' ' A' ' 770' ' ' PRO . . . -67.4 -38.75 85.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.043 -0.526 . . . . 72.25 110.968 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 788' ' ' ALA . . . . . 0.643 ' HB1' ' HD3' ' A' ' 770' ' ' PRO . . . -61.48 -43.58 98.62 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.326 -0.397 . . . . 74.409999999999997 111.41 -178.275 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 789' ' ' LEU . . . . . 0.597 ' HG ' ' O ' ' A' ' 785' ' ' ALA . 52.1 mt -59.81 -43.57 94.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.565 -0.289 . . . . 73.209999999999994 110.409 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 790' ' ' ARG . . . . . 0.416 ' HG3' ' O ' ' A' ' 786' ' ' ASP . 67.0 mtt-85 -60.77 -34.34 74.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 75.040000000000006 110.989 178.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 791' ' ' VAL . . . . . 0.512 HG21 ' O ' ' A' ' 787' ' ' ALA . 56.8 t -64.9 -49.66 78.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.947 -0.39 . . . . 71.0 109.947 175.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 792' ' ' LEU . . . . . 0.614 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 29.6 mt -60.8 -51.49 69.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.859 -0.609 . . . . 72.25 110.884 -178.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 793' ' ' ILE . . . . . 0.448 HD13 HG22 ' A' ' 720' ' ' VAL . 81.9 mt -58.31 -54.33 34.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.399 -0.819 . . . . 75.420000000000002 111.18 178.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -64.49 -26.57 70.88 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 121.098 -0.572 . . . . 52.399999999999999 112.809 -177.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -66.74 -46.53 75.16 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.925 -0.398 . . . . 71.540000000000006 109.925 177.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 796' ' ' ASN . . . . . 0.407 ' OD1' ' HD2' ' A' ' 714' ' ' ARG . 26.2 t-20 -67.1 -50.23 62.26 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 116.27 -0.423 . . . . 75.439999999999998 110.498 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 797' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -69.02 -13.34 62.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.754 0.311 . . . . 75.439999999999998 111.74 -175.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 798' ' ' LYS . . . . . 0.788 ' HB2' ' HZ1' ' A' ' 798' ' ' LYS . 0.1 OUTLIER -69.74 -20.43 63.51 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.621 0.724 . . . . 74.239999999999995 109.167 174.003 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 799' ' ' ALA . . . . . . . . . . . . . . . -113.21 -33.7 5.9 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.015 -0.993 . . . . 72.340000000000003 110.573 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 800' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 62.1 85.19 0.13 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.034 -0.984 . . . . 64.129999999999995 110.22 -174.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 801' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 . . . . . 0 C--O 1.246 0.909 0 CA-C-O 117.655 -1.164 . . . . 74.329999999999998 110.075 -178.43 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 708' ' ' MET . . . . . . . . . . . . . 92.4 mtp . . . . . 0 N--CA 1.481 1.085 0 CA-C-O 120.822 0.344 . . . . 75.140000000000001 110.251 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 43.8 ttm -138.0 132.22 17.02 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 116.155 -0.475 . . . . 73.519999999999996 109.863 177.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -63.12 91.97 0.14 Allowed 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.476 2.117 . . . . 74.030000000000001 110.821 172.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 711' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -87.62 84.59 7.08 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.602 -0.727 . . . . 62.039999999999999 110.632 -172.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 712' ' ' LYS . . . . . 0.516 ' HD3' ' H ' ' A' ' 712' ' ' LYS . 0.0 OUTLIER -110.71 -26.96 9.12 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.176 -0.675 . . . . 74.510000000000005 109.176 170.404 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 713' ' ' VAL . . . . . 0.488 HG12 ' HG2' ' A' ' 715' ' ' LYS . 11.3 p -76.24 154.79 5.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.315 -0.857 . . . . 54.509999999999998 108.722 172.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.26 79.74 0.72 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.138 0.494 . . . . 74.140000000000001 112.026 -177.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 715' ' ' LYS . . . . . 0.488 ' HG2' HG12 ' A' ' 713' ' ' VAL . 72.1 mmtt -90.79 86.24 6.27 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.099 -0.704 . . . . 75.540000000000006 109.099 170.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 716' ' ' ILE . . . . . 0.501 ' HA ' HD23 ' A' ' 719' ' ' LEU . 47.8 mm -89.48 -25.91 5.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.403 -0.817 . . . . 75.519999999999996 110.913 -172.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -56.95 -25.13 52.65 Favored Glycine 0 N--CA 1.453 -0.232 0 CA-C-N 115.879 -0.601 . . . . 75.120000000000005 111.649 175.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 718' ' ' GLU . . . . . 0.739 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 13.6 mm-40 -62.67 -49.59 74.53 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 115.77 -0.215 . . . . 62.109999999999999 110.692 175.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 719' ' ' LEU . . . . . 0.529 HD13 ' HB2' ' A' ' 734' ' ' TYR . 2.5 mm? -62.03 -31.67 72.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.016 0.436 . . . . 72.120000000000005 110.436 -176.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 720' ' ' VAL . . . . . 0.401 HG21 HD12 ' A' ' 793' ' ' ILE . 63.4 t -64.58 -39.69 86.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.757 -0.656 . . . . 73.030000000000001 111.088 178.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 721' ' ' ARG . . . . . 0.739 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 11.5 ptt180 -67.38 -26.05 66.26 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.071 0.462 . . . . 75.200000000000003 109.932 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -79.02 -29.53 43.66 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.177 -0.465 . . . . 75.099999999999994 110.913 179.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 723' ' ' LEU . . . . . 0.514 HD22 ' HB2' ' A' ' 789' ' ' LEU . 96.5 mt -57.61 -38.94 75.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.176 0.512 . . . . 70.310000000000002 109.898 174.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -80.36 -42.16 23.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.333 -0.849 . . . . 72.299999999999997 111.151 177.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 22.1 m -82.16 -81.5 0.15 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.91 0.386 . . . . 70.530000000000001 111.591 -177.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 726' ' ' ASN . . . . . 0.414 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 38.4 t30 -148.19 105.88 3.6 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 109.756 -0.461 . . . . 73.129999999999995 109.756 -179.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 727' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 14.0 Cg_endo -58.32 -36.43 97.65 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.79 2.326 . . . . 71.209999999999994 112.351 -176.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 728' ' ' VAL . . . . . 0.4 ' O ' ' HG ' ' A' ' 732' ' ' LEU . 40.3 t -61.26 -49.02 86.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.005 -0.543 . . . . 61.539999999999999 110.936 -177.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -64.87 -28.77 73.87 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.901 -0.666 . . . . 72.230000000000004 111.907 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -71.85 -42.53 52.89 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 121.035 -0.603 . . . . 75.219999999999999 112.353 179.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -64.83 -40.43 95.17 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.48 -0.563 . . . . 71.310000000000002 109.48 178.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 732' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 728' ' ' VAL . 95.4 mt -62.78 -44.14 96.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.873 -0.603 . . . . 72.25 110.691 176.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 733' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -65.81 -42.82 90.18 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 122.929 0.492 . . . . 73.340000000000003 110.721 -178.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 734' ' ' TYR . . . . . 0.529 ' HB2' HD13 ' A' ' 719' ' ' LEU . 20.3 t80 -58.13 -51.64 68.86 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.278 -0.419 . . . . 73.409999999999997 110.356 176.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -63.95 -51.46 64.26 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.176 -0.466 . . . . 61.299999999999997 110.857 -177.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 736' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -60.88 -35.58 76.99 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.087 -0.506 . . . . 75.040000000000006 111.429 -174.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 8.1 t -83.25 -25.39 31.69 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.458 -0.337 . . . . 75.25 111.196 -177.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -95.29 -1.59 51.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.515 0.198 . . . . 73.319999999999993 111.445 -177.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 98.59 -5.91 60.56 Favored Glycine 0 CA--C 1.516 0.15 0 C-N-CA 120.783 -0.722 . . . . 61.25 112.771 175.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -81.82 167.4 19.08 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.941 0.401 . . . . 74.409999999999997 110.766 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -119.64 110.9 17.39 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.387 -0.597 . . . . 73.0 109.387 175.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 742' ' ' ALA . . . . . . . . . . . . . . . -85.28 132.14 34.31 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.0 0.428 . . . . 63.399999999999999 111.74 -175.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 743' ' ' GLU . . . . . 0.477 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 38.1 mt-10 -135.13 142.75 46.25 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.645 -0.707 . . . . 74.349999999999994 110.879 176.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -119.15 101.81 8.27 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.141 -0.688 . . . . 72.150000000000006 109.141 175.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 745' ' ' LYS . . . . . 0.714 ' HB3' ' HZ3' ' A' ' 745' ' ' LYS . 1.1 ptpm? -124.66 144.2 50.32 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.066 0.46 . . . . 71.329999999999998 111.114 -175.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 746' ' ' LEU . . . . . 0.414 HD12 ' HB3' ' A' ' 758' ' ' PHE . 56.8 tp -77.08 117.91 19.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.502 -0.772 . . . . 64.200000000000003 110.037 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 54.5 t -88.03 -49.63 14.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.202 0.525 . . . . 71.310000000000002 110.108 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 748' ' ' ASP . . . . . 0.439 ' O ' ' HB ' ' A' ' 759' ' ' VAL . 26.5 t70 -148.22 154.82 40.6 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.403 -0.817 . . . . 73.439999999999998 109.331 -178.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.87 112.86 12.26 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.447 0.642 . . . . 63.100000000000001 110.369 173.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 750' ' ' SER . . . . . 0.44 ' O ' ' HB3' ' A' ' 757' ' ' LYS . 11.3 m -101.78 89.53 3.71 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.363 -0.835 . . . . 72.409999999999997 109.438 177.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 751' ' ' GLY . . . . . 0.506 ' HA3' ' H ' ' A' ' 757' ' ' LYS . . . -152.95 123.5 1.45 Allowed Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 119.48 -1.343 . . . . 61.5 113.855 -174.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 752' ' ' PRO . . . . . 0.445 ' HD2' ' HA2' ' A' ' 751' ' ' GLY . 26.4 Cg_endo -63.51 167.95 12.3 Favored 'Trans proline' 0 CA--C 1.533 0.425 0 C-N-CA 123.002 2.468 . . . . 74.540000000000006 111.105 169.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -56.59 -33.65 93.6 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 122.523 2.148 . . . . 74.209999999999994 112.792 -178.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 39.2 p-80 -88.35 -9.35 53.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.199 -0.455 . . . . 75.239999999999995 111.984 -177.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -152.59 73.69 7.33 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 111.792 0.293 . . . . 71.239999999999995 111.792 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 756' ' ' PRO . . . . . 0.461 ' HA ' ' HA3' ' A' ' 751' ' ' GLY . 42.8 Cg_endo -70.1 103.05 1.16 Allowed 'Trans proline' 0 CA--C 1.528 0.224 0 C-N-CA 122.36 2.04 . . . . 65.140000000000001 112.198 176.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 757' ' ' LYS . . . . . 0.506 ' H ' ' HA3' ' A' ' 751' ' ' GLY . 40.1 ttmt -96.6 133.0 41.65 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.894 -0.41 . . . . 74.219999999999999 109.894 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 758' ' ' PHE . . . . . 0.414 ' HB3' HD12 ' A' ' 746' ' ' LEU . 95.5 m-85 -110.08 126.03 53.58 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.299 -0.41 . . . . 63.229999999999997 111.147 -176.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 759' ' ' VAL . . . . . 0.483 HG22 ' HB3' ' A' ' 773' ' ' CYS . 97.3 t -94.03 104.04 15.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-N 115.78 -0.646 . . . . 71.420000000000002 109.853 177.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -102.6 144.6 30.8 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.606 -0.725 . . . . 71.319999999999993 111.179 -177.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -132.46 131.7 41.98 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.305 -0.861 . . . . 75.299999999999997 109.385 178.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 762' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 769' ' ' PHE . . . -90.17 123.46 34.01 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.3 0.571 . . . . 63.549999999999997 110.646 -177.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 763' ' ' LYS . . . . . 0.543 ' HE2' ' HA2' ' A' ' 766' ' ' GLY . 45.5 tttt -99.29 105.88 17.94 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.044 -0.724 . . . . 74.219999999999999 109.044 177.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 50.7 t -108.33 91.87 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.233 0.539 . . . . 73.430000000000007 110.689 -178.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 77.8 -7.59 41.15 Favored Glycine 0 N--CA 1.454 -0.132 0 CA-C-N 115.627 -0.715 . . . . 63.210000000000001 112.56 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 766' ' ' GLY . . . . . 0.543 ' HA2' ' HE2' ' A' ' 763' ' ' LYS . . . 136.77 -29.62 2.74 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.31 -0.716 . . . . 65.540000000000006 111.31 -177.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 767' ' ' ARG . . . . . 0.462 ' HD2' ' CD1' ' A' ' 769' ' ' PHE . 0.7 OUTLIER -72.57 118.75 15.87 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.078 -0.712 . . . . 74.340000000000003 109.078 177.21 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 768' ' ' TRP . . . . . 0.406 ' CZ3' ' HD2' ' A' ' 745' ' ' LYS . 76.4 m95 -88.45 105.48 17.63 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.032 -0.531 . . . . 72.109999999999999 110.267 -178.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 769' ' ' PHE . . . . . 0.465 ' O ' ' HB3' ' A' ' 762' ' ' ALA . 13.0 p90 -168.43 137.83 1.94 Allowed Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 109.875 -0.417 . . . . 74.420000000000002 109.875 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 770' ' ' PRO . . . . . 0.695 ' HD3' ' HB1' ' A' ' 788' ' ' ALA . 58.5 Cg_endo -97.24 -167.75 1.41 Allowed 'Cis proline' 0 N--CA 1.451 -1.012 0 C-N-CA 123.779 -1.342 . . . . 62.350000000000001 112.018 -2.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -119.45 101.19 7.77 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.744 -0.465 . . . . 71.5 109.744 175.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 34.8 m -117.19 170.77 6.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.504 -0.317 . . . . 71.099999999999994 111.135 -174.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 773' ' ' CYS . . . . . 0.483 ' HB3' HG22 ' A' ' 759' ' ' VAL . 4.7 p -142.48 121.67 13.01 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.137 -0.483 . . . . 63.439999999999998 110.606 178.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -124.9 154.52 40.96 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.202 -0.454 . . . . 72.430000000000007 110.222 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 775' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -79.87 -4.45 52.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.007 0.432 . . . . 74.420000000000002 110.986 -177.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 54.9 m -131.22 144.62 51.46 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.134 -0.485 . . . . 72.329999999999998 109.998 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 777' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -65.33 -42.97 92.39 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.162 -0.472 . . . . 72.310000000000002 111.158 -175.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -65.88 -37.76 86.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.972 0.415 . . . . 73.109999999999999 110.078 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 779' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -66.72 -33.13 74.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.026 -0.533 . . . . 72.409999999999997 110.916 177.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -56.96 -42.99 93.01 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.845 -0.693 . . . . 54.140000000000001 111.714 177.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 781' ' ' LYS . . . . . 0.676 ' HZ3' ' HB3' ' A' ' 781' ' ' LYS . 7.7 mtpm? -64.79 -43.26 93.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.946 0.403 . . . . 71.239999999999995 110.418 176.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -67.24 -46.86 72.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.978 -0.555 . . . . 70.010000000000005 111.181 -178.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -61.51 -40.87 96.17 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 123.163 0.289 . . . . 72.219999999999999 110.894 -179.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -60.97 -52.3 65.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 72.109999999999999 110.431 178.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 785' ' ' ALA . . . . . 0.626 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -63.9 -42.05 97.53 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.091 -0.504 . . . . 71.299999999999997 111.095 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 786' ' ' ASP . . . . . 0.593 ' O ' ' HG2' ' A' ' 790' ' ' ARG . 21.3 t70 -57.09 -56.56 20.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.954 -0.566 . . . . 63.420000000000002 110.871 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 787' ' ' ALA . . . . . 0.564 ' O ' HG21 ' A' ' 791' ' ' VAL . . . -63.92 -33.58 76.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.873 -0.603 . . . . 63.450000000000003 110.972 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 788' ' ' ALA . . . . . 0.695 ' HB1' ' HD3' ' A' ' 770' ' ' PRO . . . -62.67 -41.85 99.3 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.637 0.256 . . . . 63.439999999999998 110.704 177.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 789' ' ' LEU . . . . . 0.626 ' HG ' ' O ' ' A' ' 785' ' ' ALA . 62.9 mt -64.82 -38.81 92.22 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.621 -0.511 . . . . 73.010000000000005 109.621 178.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 790' ' ' ARG . . . . . 0.593 ' HG2' ' O ' ' A' ' 786' ' ' ASP . 13.5 mmm180 -59.41 -39.42 83.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.853 -0.612 . . . . 74.140000000000001 110.254 177.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 791' ' ' VAL . . . . . 0.564 HG21 ' O ' ' A' ' 787' ' ' ALA . 83.4 t -59.84 -52.12 64.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.858 -0.61 . . . . 74.239999999999995 110.51 176.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 792' ' ' LEU . . . . . 0.593 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 25.0 mt -60.94 -49.59 76.83 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.624 -0.716 . . . . 65.400000000000006 110.767 -177.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 793' ' ' ILE . . . . . 0.401 HD12 HG21 ' A' ' 720' ' ' VAL . 85.9 mt -59.72 -41.34 85.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.596 -0.729 . . . . 73.510000000000005 110.965 178.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -65.78 -43.93 93.14 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 116.072 -0.513 . . . . 72.530000000000001 112.735 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -62.62 -44.8 95.39 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.676 0.274 . . . . 72.010000000000005 111.006 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 796' ' ' ASN . . . . . 0.418 ' CB ' HG13 ' A' ' 716' ' ' ILE . 10.8 t30 -65.84 -37.14 85.4 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.344 -0.389 . . . . 65.510000000000005 110.712 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 797' ' ' GLU . . . . . 0.623 ' O ' ' HG2' ' A' ' 801' ' ' ARG . 7.6 tp10 -64.25 -56.53 13.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.236 -0.438 . . . . 72.209999999999994 110.203 178.128 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 798' ' ' LYS . . . . . 0.616 ' HZ1' ' HB3' ' A' ' 798' ' ' LYS . 5.3 mmmp? -63.74 -17.38 62.97 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.984 0.364 . . . . 70.209999999999994 111.984 -177.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 799' ' ' ALA . . . . . . . . . . . . . . . -67.37 -25.24 65.87 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.037 0.446 . . . . 73.049999999999997 110.737 176.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 800' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -114.21 1.45 14.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.021 0.439 . . . . 64.420000000000002 110.881 178.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 801' ' ' ARG . . . . . 0.623 ' HG2' ' O ' ' A' ' 797' ' ' GLU . 22.5 mmt180 . . . . . 0 C--O 1.245 0.842 0 CA-C-O 118.407 -0.806 . . . . 72.230000000000004 109.551 178.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 708' ' ' MET . . . . . . . . . . . . . 72.1 mtm . . . . . 0 N--CA 1.48 1.06 0 CA-C-O 120.422 0.153 . . . . 72.420000000000002 110.664 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 63.7 mtt 63.58 83.77 0.19 Allowed Pre-proline 0 N--CA 1.465 0.306 0 CA-C-N 116.046 -0.525 . . . . 75.329999999999998 110.924 -177.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.06 107.01 2.39 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.914 2.409 . . . . 74.530000000000001 111.702 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 711' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -85.17 141.67 30.02 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.058 -0.519 . . . . 74.230000000000004 110.267 -177.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 712' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -78.71 79.1 5.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.437 0.637 . . . . 74.420000000000002 109.743 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 713' ' ' VAL . . . . . . . . . . . . . 32.1 m -86.43 159.25 3.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.624 -0.716 . . . . 75.239999999999995 111.779 -174.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -108.94 4.24 23.12 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.0 -1.0 . . . . 75.120000000000005 108.46 173.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -62.14 105.84 0.65 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.045 -0.979 . . . . 74.340000000000003 110.952 -177.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 716' ' ' ILE . . . . . 0.534 ' HA ' HD23 ' A' ' 719' ' ' LEU . 50.7 mm -73.34 -22.91 19.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.433 -0.803 . . . . 60.130000000000003 110.88 -178.168 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -57.2 -23.19 46.44 Favored Glycine 0 CA--C 1.521 0.412 0 CA-C-N 115.881 -0.599 . . . . 74.319999999999993 112.926 178.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 718' ' ' GLU . . . . . 0.737 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 4.7 mm-40 -73.83 -40.54 63.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.184 0.516 . . . . 73.129999999999995 110.136 178.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 719' ' ' LEU . . . . . 0.534 HD23 ' HA ' ' A' ' 716' ' ' ILE . 3.0 mm? -65.1 -31.78 73.15 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.282 0.563 . . . . 74.129999999999995 109.496 178.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 720' ' ' VAL . . . . . . . . . . . . . 89.8 t -64.07 -41.41 92.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.533 -0.758 . . . . 63.340000000000003 110.798 177.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 721' ' ' ARG . . . . . 0.737 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 26.7 ptt180 -63.59 -25.39 68.21 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.064 0.459 . . . . 73.25 110.28 -178.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 722' ' ' TYR . . . . . 0.505 ' HH ' ' CD ' ' A' ' 733' ' ' GLU . 50.3 m-85 -79.07 -26.62 43.05 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.392 -0.367 . . . . 74.230000000000004 111.622 178.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 723' ' ' LEU . . . . . 0.459 HD22 ' HB2' ' A' ' 789' ' ' LEU . 87.3 mt -65.08 -23.75 67.25 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.197 -0.668 . . . . 73.329999999999998 109.197 171.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -81.4 -54.66 5.27 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.378 -0.828 . . . . 72.439999999999998 110.538 174.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 15.7 m -89.41 -72.47 0.55 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.571 0.582 . . . . 74.530000000000001 112.571 -174.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 726' ' ' ASN . . . . . 0.416 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 26.6 t30 -145.65 101.53 4.3 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.693 0.282 . . . . 64.239999999999995 111.008 -172.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 727' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 17.8 Cg_endo -61.21 -38.59 65.08 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.913 2.409 . . . . 72.329999999999998 112.374 -178.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 728' ' ' VAL . . . . . 0.413 ' O ' ' HG ' ' A' ' 732' ' ' LEU . 41.5 t -60.64 -45.82 96.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.083 -0.508 . . . . 73.25 110.96 -177.036 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 729' ' ' GLY . . . . . 0.407 ' O ' ' HG2' ' A' ' 733' ' ' GLU . . . -65.52 -39.89 95.85 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.618 -0.801 . . . . 73.140000000000001 112.179 -177.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 730' ' ' GLY . . . . . 0.415 ' HA2' ' HG2' ' A' ' 733' ' ' GLU . . . -67.8 -38.45 89.48 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.908 -0.663 . . . . 51.439999999999998 112.583 -178.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -63.38 -41.05 98.77 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.13 0.49 . . . . 64.510000000000005 109.684 178.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 732' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 728' ' ' VAL . 94.0 mt -65.66 -43.64 88.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.701 -0.681 . . . . 72.319999999999993 111.27 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 733' ' ' GLU . . . . . 0.526 ' HA ' ' HG2' ' A' ' 736' ' ' ARG . 11.4 pt-20 -79.51 -25.26 41.81 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 120.544 -0.462 . . . . 72.209999999999994 111.783 -176.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 734' ' ' TYR . . . . . 0.473 ' HB2' HD12 ' A' ' 719' ' ' LEU . 7.1 t80 -56.63 -46.43 81.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.275 0.56 . . . . 73.420000000000002 109.493 171.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -68.02 -46.8 70.22 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.348 -0.842 . . . . 74.409999999999997 111.047 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 736' ' ' ARG . . . . . 0.526 ' HG2' ' HA ' ' A' ' 733' ' ' GLU . 29.7 ptt180 -60.76 -34.25 74.17 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.097 0.475 . . . . 75.109999999999999 110.706 -176.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 31.5 t -76.7 -38.07 55.02 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.75 -0.659 . . . . 64.150000000000006 110.909 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 16.6 m170 -95.59 0.66 53.15 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.0 0.37 . . . . 73.530000000000001 112.0 -172.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 90.65 4.94 69.52 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.693 -0.765 . . . . 73.549999999999997 113.34 174.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -91.47 173.92 7.64 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.99 0.424 . . . . 73.420000000000002 110.743 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 741' ' ' ALA . . . . . 0.627 ' O ' ' HA ' ' A' ' 764' ' ' VAL . . . -108.45 147.31 31.82 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.29 -0.633 . . . . 74.109999999999999 109.29 173.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 742' ' ' ALA . . . . . . . . . . . . . . . -128.89 110.88 12.49 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.825 0.345 . . . . 75.400000000000006 110.521 -178.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 743' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -136.12 154.41 51.0 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.286 -0.416 . . . . 74.200000000000003 110.922 -177.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -122.67 118.64 28.6 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.307 -0.406 . . . . 75.450000000000003 109.985 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 7.1 ptpt -117.65 148.49 41.91 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.051 0.453 . . . . 72.209999999999994 111.251 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 746' ' ' LEU . . . . . . . . . . . . . 6.9 tt -92.25 102.79 15.29 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.014 -1.106 . . . . 74.140000000000001 108.014 175.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 38.5 t -72.56 -45.74 57.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.101 -0.5 . . . . 72.430000000000007 110.654 -174.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -160.64 164.21 31.97 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.105 -0.702 . . . . 74.109999999999999 109.105 -179.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.69 125.67 21.21 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.11 0.481 . . . . 73.040000000000006 110.725 178.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 17.1 m -125.39 101.19 6.84 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.676 -0.693 . . . . 72.040000000000006 109.356 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 751' ' ' GLY . . . . . 0.823 ' HA3' ' HA ' ' A' ' 756' ' ' PRO . . . -174.27 134.62 2.88 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 119.534 -1.317 . . . . 74.120000000000005 113.779 -178.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 752' ' ' PRO . . . . . 0.417 ' HD2' ' HA2' ' A' ' 751' ' ' GLY . 25.6 Cg_endo -62.04 168.9 8.31 Favored 'Trans proline' 0 CA--C 1.529 0.262 0 C-N-CA 123.535 2.824 . . . . 64.340000000000003 111.432 171.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.71 -28.36 87.14 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.368 2.046 . . . . 72.25 112.6 -179.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 38.7 p-80 -87.6 -17.05 32.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.443 -0.344 . . . . 72.239999999999995 111.476 -178.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -153.1 69.43 6.85 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 111.94 0.348 . . . . 63.119999999999997 111.94 -175.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 756' ' ' PRO . . . . . 0.823 ' HA ' ' HA3' ' A' ' 751' ' ' GLY . 71.9 Cg_endo -80.28 108.2 2.14 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.27 1.98 . . . . 73.019999999999996 112.695 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 757' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -91.44 115.09 27.75 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.975 0.417 . . . . 75.310000000000002 110.476 176.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 758' ' ' PHE . . . . . 0.484 ' O ' ' HA ' ' A' ' 773' ' ' CYS . 58.9 m-85 -97.13 130.22 44.42 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.955 -0.566 . . . . 75.219999999999999 110.2 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 759' ' ' VAL . . . . . 0.466 HG23 ' HB3' ' A' ' 773' ' ' CYS . 48.3 t -92.96 105.27 16.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.989 0.424 . . . . 75.450000000000003 110.201 178.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -102.46 143.86 31.64 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.262 -0.881 . . . . 75.150000000000006 110.671 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 761' ' ' GLN . . . . . 0.562 ' HA ' ' O ' ' A' ' 770' ' ' PRO . 36.5 tt0 -135.06 135.09 41.01 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.978 -0.556 . . . . 74.230000000000004 109.978 177.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 762' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 769' ' ' PHE . . . -91.51 126.58 36.65 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.159 0.504 . . . . 74.349999999999994 111.025 -178.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -97.32 107.76 20.34 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.595 -0.73 . . . . 74.230000000000004 109.293 176.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 764' ' ' VAL . . . . . 0.627 ' HA ' ' O ' ' A' ' 741' ' ' ALA . 63.0 t -116.37 103.84 15.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.234 0.54 . . . . 64.439999999999998 110.055 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 70.09 -115.1 5.91 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 110.896 -0.882 . . . . 61.340000000000003 110.896 -174.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -109.57 9.82 32.72 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.77 -0.729 . . . . 60.039999999999999 111.328 175.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 767' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -106.84 143.56 34.75 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.075 0.464 . . . . 74.400000000000006 110.5 -177.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 768' ' ' TRP . . . . . 0.445 ' HB3' ' OE1' ' A' ' 761' ' ' GLN . 68.3 m95 -116.55 102.48 9.51 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.629 -0.714 . . . . 75.109999999999999 109.902 -178.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 769' ' ' PHE . . . . . 0.429 ' O ' ' HB3' ' A' ' 762' ' ' ALA . 33.1 p90 -168.91 141.83 2.27 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.343 -0.39 . . . . 74.0 110.23 -176.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 770' ' ' PRO . . . . . 0.583 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 62.5 Cg_endo -98.88 -179.7 5.64 Favored 'Cis proline' 0 N--CA 1.45 -1.034 0 C-N-CA 123.564 -1.432 . . . . 65.109999999999999 111.979 -4.12 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -110.98 112.43 24.24 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.553 -0.536 . . . . 53.130000000000003 109.553 174.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 34.3 m -124.47 149.48 28.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.356 -0.384 . . . . 73.019999999999996 110.937 -177.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 773' ' ' CYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 758' ' ' PHE . 7.7 p -118.02 115.3 24.6 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.938 0.399 . . . . 73.219999999999999 110.453 178.139 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -123.07 157.51 32.66 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.177 -0.465 . . . . 71.349999999999994 110.619 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 775' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -83.29 11.44 6.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.847 0.356 . . . . 73.530000000000001 111.759 -176.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 776' ' ' SER . . . . . 0.422 ' HB3' ' CG ' ' A' ' 779' ' ' GLN . 8.5 t -153.28 145.62 23.97 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.82 -0.437 . . . . 72.430000000000007 109.82 -178.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 777' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -59.63 -50.36 74.18 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.062 -0.517 . . . . 73.109999999999999 111.303 -177.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -62.4 -36.53 82.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.848 0.356 . . . . 75.420000000000002 110.401 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 779' ' ' GLN . . . . . 0.422 ' CG ' ' HB3' ' A' ' 776' ' ' SER . 16.2 mm100 -64.19 -41.92 96.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 54.450000000000003 110.2 178.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -55.87 -48.44 72.51 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.038 -0.601 . . . . 75.25 112.3 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -65.1 -45.47 85.03 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.852 0.358 . . . . 73.5 111.189 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -66.01 -47.2 75.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.23 -0.441 . . . . 72.439999999999998 111.519 -176.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -62.58 -39.07 92.53 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.684 0.278 . . . . 61.219999999999999 110.494 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -62.58 -46.85 86.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.269 -0.423 . . . . 75.450000000000003 110.748 177.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 785' ' ' ALA . . . . . 0.431 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -65.38 -42.55 92.57 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.234 -0.439 . . . . 75.430000000000007 110.953 -179.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 786' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -56.98 -51.17 70.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.337 0.589 . . . . 73.340000000000003 110.404 176.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 787' ' ' ALA . . . . . 0.634 ' O ' HG22 ' A' ' 791' ' ' VAL . . . -64.66 -38.72 91.96 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.333 -0.849 . . . . 72.549999999999997 111.066 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 788' ' ' ALA . . . . . 0.583 ' HB2' ' HD3' ' A' ' 770' ' ' PRO . . . -61.62 -47.0 87.4 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.383 -0.371 . . . . 71.0 111.077 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 789' ' ' LEU . . . . . 0.521 HD21 HD11 ' A' ' 719' ' ' LEU . 79.6 mt -60.97 -43.57 98.58 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.842 -0.429 . . . . 74.219999999999999 109.842 177.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 790' ' ' ARG . . . . . . . . . . . . . 30.7 mtt180 -63.52 -26.43 68.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 75.150000000000006 111.684 178.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 791' ' ' VAL . . . . . 0.634 HG22 ' O ' ' A' ' 787' ' ' ALA . 98.2 t -68.68 -50.43 55.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.747 -0.464 . . . . 75.299999999999997 109.747 172.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 792' ' ' LEU . . . . . 0.572 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 27.2 mt -61.44 -49.92 74.88 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.431 -0.804 . . . . 72.219999999999999 110.349 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 793' ' ' ILE . . . . . 0.417 HG12 ' CG2' ' A' ' 716' ' ' ILE . 95.7 mt -59.61 -43.45 91.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.258 -0.883 . . . . 74.439999999999998 110.881 178.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -68.01 -32.47 77.06 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 121.002 -0.618 . . . . 63.409999999999997 112.644 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -69.37 -44.16 72.09 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.169 0.509 . . . . 72.439999999999998 110.404 178.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 796' ' ' ASN . . . . . 0.527 ' HB3' HG13 ' A' ' 716' ' ' ILE . 2.7 t30 -93.24 9.52 35.8 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.851 -0.613 . . . . 71.209999999999994 110.376 -175.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 797' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -65.46 107.52 1.7 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.838 -0.619 . . . . 73.430000000000007 110.338 -176.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 798' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm 61.07 21.44 11.82 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.859 -0.61 . . . . 74.030000000000001 111.177 -176.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 799' ' ' ALA . . . . . . . . . . . . . . . -119.01 116.23 26.0 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.958 0.408 . . . . 72.420000000000002 110.605 -179.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 800' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -81.65 98.23 8.27 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.318 -0.401 . . . . 73.140000000000001 109.962 176.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 801' ' ' ARG . . . . . . . . . . . . . 16.4 mmm180 . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.355 -0.831 . . . . 72.510000000000005 109.659 177.728 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 708' ' ' MET . . . . . . . . . . . . . 24.4 mmt . . . . . 0 N--CA 1.477 0.894 0 N-CA-C 110.546 -0.168 . . . . 72.439999999999998 110.546 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 20.6 mmt 51.9 76.73 0.51 Allowed Pre-proline 0 N--CA 1.464 0.261 0 O-C-N 123.439 0.462 . . . . 65.209999999999994 111.418 -176.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -73.44 89.93 0.93 Allowed 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.494 2.129 . . . . 72.109999999999999 111.733 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 711' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -69.11 -32.06 71.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.316 0.579 . . . . 72.0 109.718 175.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 712' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -90.9 117.01 29.16 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.595 -0.891 . . . . 71.340000000000003 108.595 172.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 713' ' ' VAL . . . . . 0.47 HG23 ' HG3' ' A' ' 715' ' ' LYS . 26.9 m -61.44 151.54 6.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-O 121.233 0.539 . . . . 70.310000000000002 111.442 -176.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 714' ' ' ARG . 57.6 mtt180 -79.08 84.22 5.09 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.79 -0.641 . . . . 71.450000000000003 110.54 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 715' ' ' LYS . . . . . 0.47 ' HG3' HG23 ' A' ' 713' ' ' VAL . 7.5 mtpm? -76.75 106.51 8.46 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.601 -0.727 . . . . 72.450000000000003 109.901 177.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 716' ' ' ILE . . . . . 0.472 ' HA ' HD23 ' A' ' 719' ' ' LEU . 46.7 mm -117.01 -32.3 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.15 -0.477 . . . . 72.019999999999996 111.445 -172.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -60.97 -27.89 67.82 Favored Glycine 0 C--N 1.33 0.208 0 C-N-CA 120.98 -0.629 . . . . 62.149999999999999 112.101 -179.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 718' ' ' GLU . . . . . 0.761 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 2.8 mp0 -63.19 -39.49 94.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.894 0.378 . . . . 72.140000000000001 110.593 177.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 719' ' ' LEU . . . . . 0.539 HD13 HD23 ' A' ' 789' ' ' LEU . 3.0 mm? -67.48 -29.78 69.31 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.073 0.463 . . . . 75.400000000000006 110.139 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 720' ' ' VAL . . . . . 0.464 HG21 HD12 ' A' ' 793' ' ' ILE . 56.6 t -66.65 -41.61 88.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.819 -0.628 . . . . 74.230000000000004 110.737 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 721' ' ' ARG . . . . . 0.761 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 11.8 ptm180 -65.11 -28.47 69.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.016 0.436 . . . . 70.340000000000003 109.907 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -74.19 -30.17 62.09 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.34 -0.391 . . . . 64.319999999999993 110.853 177.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 723' ' ' LEU . . . . . 0.519 HD21 ' HB2' ' A' ' 789' ' ' LEU . 90.9 mt -60.74 -27.55 68.01 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.252 0.549 . . . . 72.25 109.893 173.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 724' ' ' ASN . . . . . 0.506 ' N ' HD21 ' A' ' 724' ' ' ASN . 0.8 OUTLIER -86.45 -44.65 11.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.476 -0.784 . . . . 74.299999999999997 110.817 176.765 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 51.0 m -89.57 -76.64 0.41 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.296 -0.411 . . . . 74.109999999999999 112.043 -175.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 726' ' ' ASN . . . . . 0.433 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 53.8 t-20 -144.82 105.77 4.55 Favored Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 109.997 -0.371 . . . . 71.420000000000002 109.997 -177.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 727' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 20.0 Cg_endo -61.3 -35.97 81.73 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.881 2.387 . . . . 73.310000000000002 112.246 -179.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 728' ' ' VAL . . . . . 0.432 ' O ' ' HG ' ' A' ' 732' ' ' LEU . 59.7 t -64.31 -45.53 95.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.019 -0.537 . . . . 74.450000000000003 110.459 -178.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -61.63 -34.48 88.67 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.945 -0.645 . . . . 62.539999999999999 112.355 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -74.79 -41.32 34.44 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.796 -0.716 . . . . 74.299999999999997 112.56 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -63.12 -40.33 97.3 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.863 -0.421 . . . . 75.140000000000001 109.863 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 732' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 728' ' ' VAL . 95.5 mt -64.19 -46.28 84.62 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.027 -0.533 . . . . 74.25 111.281 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 733' ' ' GLU . . . . . 0.517 ' HA ' ' HG2' ' A' ' 736' ' ' ARG . 6.3 pt-20 -73.97 -31.47 63.02 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.41 -0.516 . . . . 72.340000000000003 110.981 -177.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 734' ' ' TYR . . . . . 0.404 ' HB2' HD11 ' A' ' 719' ' ' LEU . 9.3 t80 -57.29 -48.6 78.5 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 120.895 0.378 . . . . 71.310000000000002 110.063 175.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 735' ' ' ALA . . . . . 0.412 ' HA ' ' HB2' ' A' ' 740' ' ' PHE . . . -65.04 -51.18 63.0 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.985 -0.552 . . . . 64.329999999999998 110.643 -177.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 736' ' ' ARG . . . . . 0.517 ' HG2' ' HA ' ' A' ' 733' ' ' GLU . 12.2 ptm180 -61.7 -34.99 76.73 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.807 -0.633 . . . . 75.319999999999993 111.515 -174.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 47.0 t -77.56 -37.14 51.31 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.038 -0.528 . . . . 74.150000000000006 111.096 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -91.51 -2.53 57.16 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.119 0.414 . . . . 72.129999999999995 112.119 -171.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 94.81 7.93 59.66 Favored Glycine 0 CA--C 1.516 0.143 0 C-N-CA 120.45 -0.881 . . . . 74.439999999999998 112.719 176.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 740' ' ' PHE . . . . . 0.412 ' HB2' ' HA ' ' A' ' 735' ' ' ALA . 98.3 m-85 -93.15 177.81 5.94 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.032 0.444 . . . . 74.299999999999997 110.538 177.123 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -129.69 124.6 33.98 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.882 -0.599 . . . . 62.200000000000003 109.526 175.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 742' ' ' ALA . . . . . . . . . . . . . . . -94.05 115.7 28.05 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.774 0.321 . . . . 63.420000000000002 111.148 -176.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 743' ' ' GLU . . . . . 0.551 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 40.8 mt-10 -127.48 125.36 40.34 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.016 -0.538 . . . . 74.030000000000001 111.051 -179.077 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -105.25 117.27 33.59 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.115 -0.493 . . . . 75.329999999999998 110.414 179.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -134.2 150.42 51.07 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.184 0.516 . . . . 71.409999999999997 111.342 178.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 746' ' ' LEU . . . . . 0.457 HD22 ' HB3' ' A' ' 749' ' ' GLN . 4.9 tt -85.96 111.52 20.33 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.065 -1.087 . . . . 72.340000000000003 108.065 173.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 58.7 t -82.96 -46.25 18.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.895 0.379 . . . . 70.140000000000001 111.143 -174.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -152.03 149.69 29.14 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.407 -0.361 . . . . 61.229999999999997 110.374 -178.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 749' ' ' GLN . . . . . 0.457 ' HB3' HD22 ' A' ' 746' ' ' LEU . 0.0 OUTLIER -144.68 153.09 41.37 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.787 0.327 . . . . 65.340000000000003 110.946 179.515 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 20.9 t -174.75 -169.81 0.44 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.818 -0.808 . . . . 71.230000000000004 108.818 -178.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 107.83 175.18 22.25 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.524 -0.846 . . . . 43.310000000000002 112.733 176.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 752' ' ' PRO . . . . . 0.807 ' HG2' ' HB2' ' A' ' 755' ' ' GLU . 44.9 Cg_endo -69.32 164.35 34.45 Favored 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 123.084 2.523 . . . . 74.129999999999995 112.721 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -64.43 -33.65 56.94 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.62 2.213 . . . . 63.119999999999997 112.685 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 42.3 p-80 -82.95 -15.55 50.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.307 -0.406 . . . . 73.329999999999998 111.102 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 755' ' ' GLU . . . . . 0.807 ' HB2' ' HG2' ' A' ' 752' ' ' PRO . 45.0 mt-10 -135.27 73.75 63.28 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.401 -0.363 . . . . 75.219999999999999 110.798 177.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 756' ' ' PRO . . . . . 0.532 ' O ' ' HA ' ' A' ' 775' ' ' HIS . 42.1 Cg_endo -69.15 114.69 3.69 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.09 1.86 . . . . 72.129999999999995 111.329 178.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 757' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -100.43 117.42 34.57 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.032 0.444 . . . . 71.329999999999998 110.727 -176.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 758' ' ' PHE . . . . . 0.429 ' CD1' HD11 ' A' ' 746' ' ' LEU . 53.5 m-85 -115.12 121.23 42.39 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.602 -0.726 . . . . 74.219999999999999 109.872 -179.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 26.3 t -90.58 106.41 17.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 120.996 0.427 . . . . 71.25 110.313 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -99.26 139.26 35.16 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.688 -0.687 . . . . 72.25 110.285 178.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 761' ' ' GLN . . . . . 0.462 ' HA ' ' O ' ' A' ' 770' ' ' PRO . 55.9 tt0 -130.07 135.73 48.56 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.033 -0.53 . . . . 75.420000000000002 109.725 178.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 762' ' ' ALA . . . . . . . . . . . . . . . -90.56 112.42 24.1 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.967 -0.56 . . . . 73.230000000000004 110.71 -178.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 763' ' ' LYS . . . . . 0.566 ' HD2' ' CH2' ' A' ' 768' ' ' TRP . 61.0 tttm -88.32 104.66 16.95 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.065 -0.717 . . . . 73.409999999999997 109.065 175.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 56.9 t -109.9 100.72 11.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.349 0.595 . . . . 74.319999999999993 109.975 -179.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 75.19 -117.9 5.43 Favored Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 110.834 -0.906 . . . . 71.25 110.834 -175.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -103.36 3.97 47.48 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.662 -0.78 . . . . 63.219999999999999 111.627 176.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 767' ' ' ARG . . . . . . . . . . . . . 50.3 mtt180 -103.58 152.86 21.24 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.052 0.454 . . . . 72.239999999999995 111.029 -176.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 768' ' ' TRP . . . . . 0.566 ' CH2' ' HD2' ' A' ' 763' ' ' LYS . 59.2 m95 -118.83 105.15 11.23 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.687 -0.688 . . . . 74.099999999999994 109.386 176.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 769' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -171.47 139.09 1.14 Allowed Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 120.854 0.359 . . . . 72.349999999999994 110.925 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 770' ' ' PRO . . . . . 0.562 ' HD3' ' HB1' ' A' ' 788' ' ' ALA . 79.6 Cg_endo -99.54 -176.8 3.79 Favored 'Cis proline' 0 N--CA 1.453 -0.908 0 C-N-CA 123.718 -1.367 . . . . 63.119999999999997 111.947 -4.134 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -113.88 116.18 28.87 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.771 -0.455 . . . . 71.109999999999999 109.771 175.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 29.1 m -118.94 140.74 41.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.145 0.498 . . . . 75.430000000000007 111.269 -176.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 3.9 p -95.72 102.54 14.35 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.89 -0.596 . . . . 71.150000000000006 110.508 178.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -107.15 177.63 4.79 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.147 -0.479 . . . . 73.310000000000002 110.817 -177.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 775' ' ' HIS . . . . . 0.532 ' HA ' ' O ' ' A' ' 756' ' ' PRO . 28.5 m-70 -117.38 12.45 14.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.127 0.489 . . . . 70.400000000000006 110.066 178.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 33.7 t -167.76 154.06 7.72 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.533 -0.758 . . . . 65.340000000000003 109.692 -176.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 777' ' ' LYS . . . . . . . . . . . . . 5.4 tmmm? -62.53 -42.66 99.67 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.649 -0.5 . . . . 73.219999999999999 109.649 177.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -58.31 -40.46 82.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.417 -0.811 . . . . 71.239999999999995 110.723 178.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 779' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -70.06 -45.55 66.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.318 -0.401 . . . . 62.039999999999999 110.438 177.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -54.55 -47.59 69.31 Favored Glycine 0 C--O 1.226 -0.398 0 CA-C-N 115.909 -0.587 . . . . 61.310000000000002 113.072 -176.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -66.79 -44.79 80.39 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.621 0.248 . . . . 72.439999999999998 111.258 -178.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -67.63 -49.39 63.17 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.541 -0.3 . . . . 75.430000000000007 111.358 -177.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -63.68 -39.89 95.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.572 0.225 . . . . 65.129999999999995 110.938 -178.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -62.05 -50.78 70.62 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 116.486 -0.325 . . . . 64.439999999999998 110.527 178.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 785' ' ' ALA . . . . . 0.542 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -65.75 -39.11 90.74 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.324 -0.398 . . . . 64.239999999999995 110.968 -179.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 786' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -57.75 -54.17 49.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.031 -0.531 . . . . 71.200000000000003 110.476 177.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 787' ' ' ALA . . . . . 0.596 ' O ' HG23 ' A' ' 791' ' ' VAL . . . -64.82 -36.69 85.13 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.855 -0.611 . . . . 60.240000000000002 110.723 179.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 788' ' ' ALA . . . . . 0.627 ' O ' ' HG ' ' A' ' 792' ' ' LEU . . . -59.49 -48.61 80.98 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.556 -0.293 . . . . 75.430000000000007 110.98 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 789' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 785' ' ' ALA . 63.1 mt -61.49 -39.97 92.85 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.837 -0.431 . . . . 72.230000000000004 109.837 178.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 790' ' ' ARG . . . . . . . . . . . . . 65.4 mtp180 -64.31 -30.91 71.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.607 -0.724 . . . . 75.310000000000002 111.488 178.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 791' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 787' ' ' ALA . 91.5 t -66.94 -48.26 80.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.758 -0.46 . . . . 75.310000000000002 109.758 173.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 792' ' ' LEU . . . . . 0.627 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 23.0 mt -60.58 -54.57 43.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.724 -0.671 . . . . 72.0 110.436 -179.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 793' ' ' ILE . . . . . 0.464 HD12 HG21 ' A' ' 720' ' ' VAL . 76.6 mt -58.15 -45.73 88.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.382 -0.826 . . . . 75.439999999999998 110.594 177.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 794' ' ' GLY . . . . . 0.637 ' O ' ' HG3' ' A' ' 798' ' ' LYS . . . -59.5 -48.4 86.18 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 121.121 -0.561 . . . . 75.120000000000005 112.276 179.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 795' ' ' GLU . . . . . 0.864 ' HA ' ' HD2' ' A' ' 798' ' ' LYS . 52.1 mm-40 -60.88 -31.3 70.78 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.568 0.211 . . . . 74.349999999999994 111.568 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -66.94 -42.77 84.7 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.192 0.52 . . . . 75.129999999999995 110.518 176.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 797' ' ' GLU . . . . . 0.432 ' HG3' ' O ' ' A' ' 793' ' ' ILE . 51.2 mt-10 -71.79 -24.6 61.77 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.585 -0.734 . . . . 73.340000000000003 111.966 -174.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 798' ' ' LYS . . . . . 0.864 ' HD2' ' HA ' ' A' ' 795' ' ' GLU . 0.0 OUTLIER -104.84 14.71 29.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.71 0.29 . . . . 75.340000000000003 111.542 178.616 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 799' ' ' ALA . . . . . . . . . . . . . . . -113.36 169.96 8.57 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.663 0.268 . . . . 63.310000000000002 110.497 177.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 800' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -84.07 104.63 14.3 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.44 -0.578 . . . . 73.340000000000003 109.44 177.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 801' ' ' ARG . . . . . . . . . . . . . 46.7 mtm180 . . . . . 0 C--O 1.247 0.958 0 CA-C-O 118.395 -0.812 . . . . 71.510000000000005 110.483 -177.418 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 708' ' ' MET . . . . . . . . . . . . . 25.8 mmt . . . . . 0 N--CA 1.482 1.157 0 CA-C-O 120.764 0.316 . . . . 71.040000000000006 111.257 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 63.9 mtm -121.56 110.01 34.13 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.389 -0.596 . . . . 70.310000000000002 109.389 174.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -56.58 111.3 0.75 Allowed 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 123.197 2.598 . . . . 71.109999999999999 112.95 -175.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 711' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -87.59 158.2 18.94 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.976 -0.556 . . . . 72.319999999999993 109.636 176.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 712' ' ' LYS . . . . . 0.771 ' HB2' ' HZ1' ' A' ' 712' ' ' LYS . 4.0 ttmp? -80.75 76.85 7.65 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.777 0.799 . . . . 74.239999999999995 109.809 179.273 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 713' ' ' VAL . . . . . . . . . . . . . 7.1 p -173.12 167.32 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 107.721 -1.215 . . . . 73.409999999999997 107.721 -179.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . . . . . . . . . 69.1 ttt180 -75.29 72.91 2.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.142 0.496 . . . . 74.129999999999995 110.332 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -92.5 106.11 18.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.724 -0.671 . . . . 71.430000000000007 109.644 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 716' ' ' ILE . . . . . 0.53 ' HA ' HD23 ' A' ' 719' ' ' LEU . 47.0 mm -78.79 -24.18 13.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.689 -0.687 . . . . 74.099999999999994 111.626 -173.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -56.92 -30.63 60.36 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 121.196 -0.526 . . . . 65.310000000000002 112.893 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -66.32 -41.04 90.23 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.762 0.315 . . . . 73.299999999999997 110.79 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 719' ' ' LEU . . . . . 0.54 HD12 HD21 ' A' ' 789' ' ' LEU . 2.9 mm? -65.02 -36.3 83.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.016 0.436 . . . . 71.340000000000003 109.998 -178.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 720' ' ' VAL . . . . . 0.458 HG21 HD12 ' A' ' 793' ' ' ILE . 52.3 t -64.08 -37.5 80.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-N 115.82 -0.627 . . . . 53.539999999999999 110.173 176.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 721' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.12 -30.32 71.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.794 -0.639 . . . . 73.340000000000003 109.775 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -78.47 -25.04 45.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.898 -0.592 . . . . 74.420000000000002 111.471 179.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 91.1 mt -60.03 -30.6 69.28 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.425 0.631 . . . . 73.209999999999994 109.461 173.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -84.87 -56.59 3.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.312 -0.858 . . . . 73.540000000000006 111.219 174.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 24.4 m -77.91 -64.23 1.2 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.916 0.709 . . . . 71.120000000000005 112.916 -171.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 726' ' ' ASN . . . . . 0.401 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 30.6 t30 -159.94 100.76 1.45 Allowed Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 120.834 0.349 . . . . 73.129999999999995 110.914 -175.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 727' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 20.9 Cg_endo -62.36 -39.61 45.58 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.875 2.384 . . . . 71.010000000000005 112.317 -177.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 39.5 t -59.97 -42.3 89.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.998 -0.546 . . . . 70.530000000000001 110.958 -177.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 729' ' ' GLY . . . . . 0.474 ' O ' ' HG2' ' A' ' 733' ' ' GLU . . . -65.02 -47.38 82.99 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.611 -0.804 . . . . 72.329999999999998 111.939 -179.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -64.14 -39.31 97.02 Favored Glycine 0 C--O 1.226 -0.349 0 C-N-CA 121.09 -0.576 . . . . 72.129999999999995 113.259 -176.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -61.67 -39.76 92.56 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.894 -0.41 . . . . 74.010000000000005 109.894 179.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 732' ' ' LEU . . . . . . . . . . . . . 96.3 mt -68.04 -47.34 68.64 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.929 -0.578 . . . . 73.109999999999999 111.276 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 733' ' ' GLU . . . . . 0.487 ' HA ' ' HB3' ' A' ' 736' ' ' ARG . 9.1 pt-20 -75.15 -26.47 59.14 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.715 -0.394 . . . . 74.549999999999997 111.683 -176.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 734' ' ' TYR . . . . . 0.424 ' HB2' HD13 ' A' ' 719' ' ' LEU . 17.5 t80 -56.99 -50.17 73.52 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.347 -0.612 . . . . 74.230000000000004 109.347 172.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -64.29 -46.29 84.29 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.903 -0.589 . . . . 72.109999999999999 110.533 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 736' ' ' ARG . . . . . 0.487 ' HB3' ' HA ' ' A' ' 733' ' ' GLU . 1.4 ttt180 -55.49 -48.73 74.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.07 -0.514 . . . . 73.219999999999999 112.011 -178.083 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 22.7 t -81.59 -11.82 58.99 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.678 0.275 . . . . 72.150000000000006 111.224 -174.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -110.49 -2.61 16.44 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.817 -0.353 . . . . 71.409999999999997 111.592 -176.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 88.9 9.96 67.37 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.538 -0.839 . . . . 74.319999999999993 113.258 174.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -95.61 168.72 10.51 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.906 0.353 . . . . 64.340000000000003 110.4 177.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -114.1 114.48 26.14 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.219 -0.446 . . . . 60.119999999999997 110.025 176.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 742' ' ' ALA . . . . . . . . . . . . . . . -92.48 133.22 36.13 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.262 -0.427 . . . . 64.420000000000002 110.886 -178.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 743' ' ' GLU . . . . . 0.425 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 9.7 mm-40 -144.98 157.65 44.06 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.271 -0.422 . . . . 73.400000000000006 111.142 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -130.16 132.03 45.89 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.815 -0.63 . . . . 74.439999999999998 109.76 177.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -136.37 137.92 41.06 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.126 0.489 . . . . 73.129999999999995 111.748 177.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 746' ' ' LEU . . . . . . . . . . . . . 5.0 tt -82.69 105.33 13.63 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.385 -0.969 . . . . 75.150000000000006 108.385 173.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 46.0 t -70.98 -56.13 11.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.919 0.39 . . . . 72.530000000000001 110.686 -176.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -154.94 152.37 29.64 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.977 -0.556 . . . . 73.109999999999999 110.276 -178.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -134.06 122.75 23.4 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.951 -0.759 . . . . 74.549999999999997 108.951 174.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 67.3 m -146.56 148.28 31.99 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.722 0.296 . . . . 64.409999999999997 110.942 -176.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 139.77 -177.65 20.34 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.93 -0.652 . . . . 74.040000000000006 112.163 177.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 752' ' ' PRO . . . . . 0.413 ' HG2' ' CB ' ' A' ' 755' ' ' GLU . 54.9 Cg_endo -71.47 166.76 28.34 Favored 'Trans proline' 0 CA--C 1.533 0.442 0 C-N-CA 122.793 2.329 . . . . 73.340000000000003 111.962 176.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -63.76 -34.99 59.76 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.684 2.256 . . . . 72.409999999999997 112.824 -178.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 54.7 p-80 -84.51 -7.26 59.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.958 0.408 . . . . 70.109999999999999 111.069 -178.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 755' ' ' GLU . . . . . 0.413 ' CB ' ' HG2' ' A' ' 752' ' ' PRO . 0.4 OUTLIER -141.95 68.95 23.76 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 116.132 -0.485 . . . . 73.510000000000005 109.972 -178.694 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 756' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -79.64 109.26 2.42 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.405 2.07 . . . . 71.540000000000006 111.936 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 757' ' ' LYS . . . . . 0.772 ' HZ1' ' HB2' ' A' ' 757' ' ' LYS . 4.4 ttmp? -93.73 112.99 24.95 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.237 0.541 . . . . 73.5 110.58 -178.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 758' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -99.05 119.29 37.57 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.363 -0.835 . . . . 75.319999999999993 110.454 -178.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 16.7 t -92.67 105.85 17.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.19 -0.459 . . . . 74.540000000000006 109.904 178.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -108.92 141.9 40.32 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.984 -0.553 . . . . 72.530000000000001 110.735 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 761' ' ' GLN . . . . . 0.523 ' HA ' ' O ' ' A' ' 770' ' ' PRO . 35.4 tt0 -133.96 135.96 43.85 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.751 -0.658 . . . . 73.439999999999998 109.613 176.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 762' ' ' ALA . . . . . . . . . . . . . . . -96.86 147.69 23.69 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.799 -0.637 . . . . 73.540000000000006 110.443 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 763' ' ' LYS . . . . . 0.559 ' HE3' ' CZ2' ' A' ' 768' ' ' TRP . 68.1 tttt -118.46 127.86 54.06 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.295 -0.631 . . . . 74.319999999999993 109.295 178.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 62.9 t -127.64 102.0 8.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.146 0.498 . . . . 74.349999999999994 109.869 178.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 76.41 -101.99 1.56 Allowed Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 110.96 -0.856 . . . . 72.140000000000001 110.96 -176.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -121.0 4.81 11.37 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 111.219 -0.752 . . . . 71.540000000000006 111.219 174.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 767' ' ' ARG . . . . . . . . . . . . . 39.7 mmt180 -98.5 146.29 25.92 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.974 0.416 . . . . 73.019999999999996 110.903 -178.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 768' ' ' TRP . . . . . 0.559 ' CZ2' ' HE3' ' A' ' 763' ' ' LYS . 55.6 m95 -117.28 107.41 14.37 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.617 -0.719 . . . . 74.540000000000006 109.777 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 769' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -169.87 143.23 2.08 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 110.198 -0.297 . . . . 74.129999999999995 110.198 -177.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 770' ' ' PRO . . . . . 0.558 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 62.1 Cg_endo -99.07 178.53 6.38 Favored 'Cis proline' 0 N--CA 1.452 -0.933 0 C-N-CA 123.633 -1.403 . . . . 71.409999999999997 111.875 -4.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -105.13 102.24 11.75 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.626 -0.509 . . . . 75.299999999999997 109.626 173.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 24.0 m -116.92 135.44 57.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.077 0.465 . . . . 73.420000000000002 111.176 -176.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 1.5 p -110.22 102.71 11.36 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.0 -0.545 . . . . 74.340000000000003 110.174 177.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -100.29 178.97 4.61 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.726 -0.67 . . . . 75.200000000000003 111.175 -175.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 775' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -94.44 -8.82 37.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.052 0.453 . . . . 70.310000000000002 110.516 -176.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 55.2 m -145.91 158.02 43.88 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.693 -0.685 . . . . 75.230000000000004 109.765 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 777' ' ' LYS . . . . . . . . . . . . . 6.1 tmmm? -69.3 -39.71 78.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.589 -0.278 . . . . 64.310000000000002 110.539 -177.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -60.89 -47.41 86.52 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.861 -0.422 . . . . 72.540000000000006 109.861 175.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 779' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -52.92 -47.98 67.59 Favored 'General case' 0 C--O 1.226 -0.137 0 CA-C-N 115.709 -0.678 . . . . 71.25 110.966 174.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -53.83 -47.97 63.58 Favored Glycine 0 C--O 1.228 -0.24 0 CA-C-N 116.028 -0.533 . . . . 64.030000000000001 113.035 -177.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -66.42 -45.18 80.78 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.857 0.361 . . . . 74.409999999999997 110.982 -178.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -71.59 -37.0 71.05 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.233 -0.439 . . . . 73.140000000000001 111.399 -176.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -72.08 -35.68 69.31 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.524 0.202 . . . . 72.450000000000003 110.742 177.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -60.06 -49.53 77.27 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.949 -0.389 . . . . 73.230000000000004 109.949 176.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 785' ' ' ALA . . . . . 0.61 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -65.78 -42.16 91.1 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.073 -0.512 . . . . 64.340000000000003 110.793 178.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 786' ' ' ASP . . . . . 0.514 ' O ' ' HG2' ' A' ' 790' ' ' ARG . 12.4 t70 -56.71 -55.83 29.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.022 -0.535 . . . . 74.430000000000007 110.755 179.201 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 787' ' ' ALA . . . . . 0.536 ' O ' HG22 ' A' ' 791' ' ' VAL . . . -68.22 -31.07 70.32 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.952 -0.567 . . . . 72.299999999999997 111.212 -178.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 788' ' ' ALA . . . . . 0.675 ' O ' ' HG ' ' A' ' 792' ' ' LEU . . . -62.63 -42.83 99.81 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 120.812 0.339 . . . . 75.329999999999998 110.168 177.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 789' ' ' LEU . . . . . 0.61 ' HG ' ' O ' ' A' ' 785' ' ' ALA . 79.8 mt -61.82 -40.16 94.3 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.08 -0.509 . . . . 73.239999999999995 109.749 176.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 790' ' ' ARG . . . . . 0.514 ' HG2' ' O ' ' A' ' 786' ' ' ASP . 47.2 mmm-85 -59.79 -38.05 80.82 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.98 -0.554 . . . . 75.319999999999993 110.471 177.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 791' ' ' VAL . . . . . 0.536 HG22 ' O ' ' A' ' 787' ' ' ALA . 48.7 t -62.46 -53.18 50.66 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.31 0 N-CA-C 109.881 -0.414 . . . . 72.349999999999994 109.881 175.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 792' ' ' LEU . . . . . 0.675 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 22.1 mt -55.32 -48.01 74.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.263 0.554 . . . . 73.109999999999999 110.681 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 793' ' ' ILE . . . . . 0.495 HG12 HG21 ' A' ' 716' ' ' ILE . 90.6 mt -61.76 -48.59 87.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.1 -0.955 . . . . 72.439999999999998 111.079 177.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -66.28 -34.88 89.35 Favored Glycine 0 CA--C 1.519 0.299 0 CA-C-N 116.145 -0.479 . . . . 64.409999999999997 113.122 -178.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 795' ' ' GLU . . . . . 0.511 ' HG2' ' O ' ' A' ' 791' ' ' VAL . 44.7 mm-40 -66.64 -32.24 73.44 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.81 0.338 . . . . 74.420000000000002 110.782 178.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -85.26 -23.91 28.0 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.998 0.427 . . . . 65.409999999999997 109.977 177.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 797' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -60.12 -32.5 71.05 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.786 -0.643 . . . . 70.329999999999998 110.205 176.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 798' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -101.47 16.62 25.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.552 -0.749 . . . . 75.25 110.929 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 799' ' ' ALA . . . . . . . . . . . . . . . -144.16 -173.45 4.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.033 0.444 . . . . 72.209999999999994 111.086 -176.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 800' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -114.6 127.07 55.59 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.981 -0.554 . . . . 73.099999999999994 109.556 174.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 801' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.951 0 CA-C-O 118.843 -0.598 . . . . 71.329999999999998 111.085 177.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 708' ' ' MET . . . . . . . . . . . . . 24.2 ttt . . . . . 0 N--CA 1.481 1.098 0 CA-C-O 120.987 0.422 . . . . 75.439999999999998 110.312 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 72.5 mtm -80.19 128.75 72.22 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.079 -0.51 . . . . 75.219999999999999 110.767 -177.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -89.55 -162.58 0.12 Allowed 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.181 2.587 . . . . 63.210000000000001 112.211 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 711' ' ' ASN . . . . . . . . . . . . . 20.0 m120 65.01 88.63 0.1 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.418 0.628 . . . . 74.519999999999996 111.085 177.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 712' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -117.88 159.27 23.38 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.49 -0.777 . . . . 63.25 109.702 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 713' ' ' VAL . . . . . . . . . . . . . 31.9 m -73.66 165.44 3.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.869 -0.419 . . . . 75.129999999999995 109.869 176.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.543 ' HD2' ' OE1' ' A' ' 718' ' ' GLU . 25.1 tpt180 -65.18 103.64 0.8 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.966 -0.383 . . . . 75.340000000000003 109.966 -179.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -148.56 -164.91 2.13 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.081 -0.509 . . . . 71.230000000000004 111.195 -178.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 716' ' ' ILE . . . . . 0.541 HG23 ' HA ' ' A' ' 793' ' ' ILE . 42.1 mm -89.32 -23.88 6.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.569 -0.741 . . . . 72.230000000000004 110.715 -175.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -58.27 -23.13 52.42 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.873 -0.603 . . . . 73.450000000000003 112.311 176.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 718' ' ' GLU . . . . . 0.605 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 44.1 mt-10 -68.25 -36.67 79.8 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 122.747 -0.267 . . . . 74.129999999999995 110.287 176.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 719' ' ' LEU . . . . . 0.539 HD22 ' HA ' ' A' ' 716' ' ' ILE . 3.4 mm? -61.02 -33.88 73.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.235 0.541 . . . . 73.129999999999995 110.009 175.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 720' ' ' VAL . . . . . 0.491 HG21 HD12 ' A' ' 793' ' ' ILE . 27.4 t -62.86 -36.3 74.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.624 -0.717 . . . . 74.349999999999994 110.949 177.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 721' ' ' ARG . . . . . 0.605 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 10.5 ptt180 -68.75 -28.62 66.97 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.892 0.377 . . . . 71.239999999999995 110.178 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -73.02 -32.05 64.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 72.239999999999995 110.629 177.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 723' ' ' LEU . . . . . 0.531 HD23 ' HB2' ' A' ' 789' ' ' LEU . 89.9 mt -57.81 -36.65 72.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.292 0.567 . . . . 74.200000000000003 109.939 173.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -69.49 -40.34 77.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.179 -0.919 . . . . 72.140000000000001 111.501 178.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 46.1 m -103.26 -80.87 0.51 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.055 0.391 . . . . 74.049999999999997 112.055 -176.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 726' ' ' ASN . . . . . 0.438 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 28.0 t30 -135.06 106.82 10.38 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-O 121.032 0.444 . . . . 70.340000000000003 110.8 -174.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 727' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 20.4 Cg_endo -62.2 -36.33 69.52 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 122.894 2.396 . . . . 53.119999999999997 112.579 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 34.4 t -61.47 -47.09 95.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.254 -0.43 . . . . 74.150000000000006 110.538 -177.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -61.09 -36.55 92.5 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.923 -0.656 . . . . 73.150000000000006 112.041 178.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 730' ' ' GLY . . . . . 0.464 ' O ' ' HG3' ' A' ' 733' ' ' GLU . . . -68.32 -45.3 70.44 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 121.106 -0.569 . . . . 75.040000000000006 112.532 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -64.46 -41.23 96.63 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.973 0.416 . . . . 73.219999999999999 110.06 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 732' ' ' LEU . . . . . . . . . . . . . 94.9 mt -67.24 -32.85 74.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.158 -0.474 . . . . 74.340000000000003 111.495 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 733' ' ' GLU . . . . . 0.464 ' HG3' ' O ' ' A' ' 730' ' ' GLY . 1.1 pp20? -85.17 -33.52 22.29 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.557 -0.457 . . . . 75.25 110.495 -178.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 734' ' ' TYR . . . . . 0.516 ' HB2' HD12 ' A' ' 719' ' ' LEU . 4.0 t80 -55.06 -45.18 75.27 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.837 0.351 . . . . 75.409999999999997 110.463 174.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -65.38 -52.92 50.27 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.112 -0.494 . . . . 64.0 110.299 -176.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 736' ' ' ARG . . . . . 0.413 ' HG2' ' O ' ' A' ' 733' ' ' GLU . 36.5 ptt180 -60.48 -37.84 82.34 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.971 -0.559 . . . . 72.120000000000005 110.94 -176.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 737' ' ' SER . . . . . 0.411 ' CB ' HH21 ' A' ' 714' ' ' ARG . 28.5 t -70.37 -32.26 69.85 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.875 -0.602 . . . . 75.219999999999999 111.452 -179.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -97.19 -8.78 29.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.717 0.294 . . . . 74.439999999999998 111.689 -175.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 98.25 9.21 54.06 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.63 -0.795 . . . . 52.520000000000003 112.959 176.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -96.51 170.4 9.24 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.178 -0.304 . . . . 72.319999999999993 110.178 177.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -117.37 129.22 55.73 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.602 -0.518 . . . . 73.310000000000002 109.602 172.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 742' ' ' ALA . . . . . . . . . . . . . . . -100.87 120.97 40.92 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.913 0.387 . . . . 71.340000000000003 111.352 -175.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 743' ' ' GLU . . . . . 0.546 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 38.7 mt-10 -122.44 135.24 54.64 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.199 -0.455 . . . . 73.129999999999995 110.964 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -114.32 97.96 6.64 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.269 -0.641 . . . . 75.219999999999999 109.269 175.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -113.8 140.8 48.0 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.345 -0.542 . . . . 74.209999999999994 111.198 -177.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 746' ' ' LEU . . . . . . . . . . . . . 59.8 tp -74.72 116.05 14.99 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.643 -0.708 . . . . 74.340000000000003 109.332 174.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 60.2 t -75.35 -49.78 26.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.691 -0.485 . . . . 61.310000000000002 109.691 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -167.05 -175.42 3.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.833 -0.621 . . . . 73.519999999999996 109.667 178.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -138.72 128.8 25.4 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.382 -0.599 . . . . 74.0 109.382 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 750' ' ' SER . . . . . 0.401 ' O ' ' HB3' ' A' ' 757' ' ' LYS . 6.4 t -137.65 90.88 2.54 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.868 -0.419 . . . . 74.319999999999993 109.868 -177.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 179.54 154.33 13.09 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.353 -0.927 . . . . 63.439999999999998 112.477 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 752' ' ' PRO . . . . . 0.59 ' HG2' ' HB2' ' A' ' 755' ' ' GLU . 37.6 Cg_endo -66.59 168.38 16.7 Favored 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 123.309 2.673 . . . . 71.230000000000004 112.238 177.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -56.48 -33.13 91.68 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.751 2.301 . . . . 55.140000000000001 112.759 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 45.9 p-80 -87.83 -4.19 58.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.383 -0.371 . . . . 70.239999999999995 111.359 -178.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 755' ' ' GLU . . . . . 0.59 ' HB2' ' HG2' ' A' ' 752' ' ' PRO . 16.6 mm-40 -152.93 61.97 4.04 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.354 -0.385 . . . . 71.420000000000002 111.306 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 756' ' ' PRO . . . . . 0.417 ' O ' ' HA ' ' A' ' 775' ' ' HIS . 59.6 Cg_endo -73.2 99.3 1.09 Allowed 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.175 1.917 . . . . 71.209999999999994 111.583 -177.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 757' ' ' LYS . . . . . 0.441 ' HD3' ' HB2' ' A' ' 773' ' ' CYS . 38.3 ttmt -87.05 107.76 18.57 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.247 0.546 . . . . 50.109999999999999 110.384 -177.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 758' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -86.93 130.61 34.39 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.274 -0.876 . . . . 74.239999999999995 110.151 -179.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 43.4 t -95.45 104.34 15.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.841 -0.429 . . . . 75.349999999999994 109.841 177.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -105.98 138.89 41.4 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.048 -0.524 . . . . 70.319999999999993 110.644 -179.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 761' ' ' GLN . . . . . 0.411 ' HA ' ' O ' ' A' ' 770' ' ' PRO . 52.4 tt0 -128.65 128.87 45.0 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.557 -0.534 . . . . 65.129999999999995 109.557 177.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 762' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 769' ' ' PHE . . . -87.09 122.11 30.46 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.184 0.516 . . . . 72.129999999999995 110.407 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 763' ' ' LYS . . . . . 0.632 ' HD2' ' CH2' ' A' ' 768' ' ' TRP . 55.1 tttm -104.32 115.26 30.07 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.916 -0.584 . . . . 74.439999999999998 110.041 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 59.0 t -118.7 100.72 10.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.058 0.456 . . . . 73.129999999999995 110.114 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 74.54 -102.89 1.44 Allowed Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.681 -0.69 . . . . 71.409999999999997 111.408 -176.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -120.45 10.88 10.56 Favored Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 111.162 -0.775 . . . . 71.420000000000002 111.162 174.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 767' ' ' ARG . . . . . 0.463 ' HG3' ' CD1' ' A' ' 769' ' ' PHE . 13.9 tpt180 -108.18 121.98 45.98 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.825 0.345 . . . . 71.409999999999997 110.879 -177.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 768' ' ' TRP . . . . . 0.632 ' CH2' ' HD2' ' A' ' 763' ' ' LYS . 48.0 m95 -95.44 107.44 19.59 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.787 -0.642 . . . . 73.349999999999994 109.571 177.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 769' ' ' PHE . . . . . 0.463 ' CD1' ' HG3' ' A' ' 767' ' ' ARG . 8.7 p90 -170.89 136.84 1.12 Allowed Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 120.888 0.375 . . . . 74.310000000000002 110.472 -178.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 770' ' ' PRO . . . . . 0.539 ' HD3' ' HB1' ' A' ' 788' ' ' ALA . 74.5 Cg_endo -97.36 -179.27 6.3 Favored 'Cis proline' 0 N--CA 1.447 -1.221 0 C-N-CA 123.475 -1.469 . . . . 54.219999999999999 111.773 -4.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -109.91 105.78 15.09 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.473 -0.566 . . . . 73.349999999999994 109.473 173.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 33.7 m -111.72 163.29 8.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.995 0.426 . . . . 73.239999999999995 111.147 -175.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 773' ' ' CYS . . . . . 0.441 ' HB2' ' HD3' ' A' ' 757' ' ' LYS . 5.1 p -133.52 117.99 17.79 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.889 -0.596 . . . . 60.210000000000001 110.017 179.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -132.67 143.75 49.86 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.287 -0.415 . . . . 73.310000000000002 110.705 -177.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 775' ' ' HIS . . . . . 0.417 ' HA ' ' O ' ' A' ' 756' ' ' PRO . 0.5 OUTLIER -80.14 24.34 0.43 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.146 0.498 . . . . 73.430000000000007 111.442 -178.521 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 776' ' ' SER . . . . . 0.551 ' HB3' ' HB2' ' A' ' 779' ' ' GLN . 24.9 t -152.76 137.96 17.42 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.578 -0.897 . . . . 73.0 108.578 175.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 777' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -66.92 -42.69 84.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.78 0.324 . . . . 74.409999999999997 110.327 -176.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -63.23 -38.09 89.79 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.178 -0.465 . . . . 73.099999999999994 110.379 178.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 779' ' ' GLN . . . . . 0.551 ' HB2' ' HB3' ' A' ' 776' ' ' SER . 76.6 mm-40 -71.72 -33.07 68.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.93 -0.577 . . . . 74.530000000000001 110.975 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -56.11 -43.91 88.56 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.112 -0.566 . . . . 61.310000000000002 112.107 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -69.04 -43.34 74.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.583 0.23 . . . . 74.439999999999998 110.985 178.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -63.42 -45.19 92.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.334 -0.393 . . . . 72.420000000000002 110.953 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -61.96 -44.44 96.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.303 -0.408 . . . . 75.340000000000003 110.924 178.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -61.29 -43.92 98.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.272 -0.422 . . . . 64.120000000000005 110.745 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 785' ' ' ALA . . . . . 0.547 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -65.45 -46.04 81.44 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.012 -0.54 . . . . 53.219999999999999 111.106 -178.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 786' ' ' ASP . . . . . 0.639 ' O ' ' HG2' ' A' ' 790' ' ' ARG . 14.9 t70 -60.31 -54.22 48.34 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 109.879 -0.415 . . . . 74.109999999999999 109.879 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 787' ' ' ALA . . . . . 0.527 ' O ' HG23 ' A' ' 791' ' ' VAL . . . -59.55 -35.48 74.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.67 -0.695 . . . . 73.409999999999997 111.229 -178.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 788' ' ' ALA . . . . . 0.622 ' O ' ' HG ' ' A' ' 792' ' ' LEU . . . -62.14 -45.2 94.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.508 -0.315 . . . . 71.219999999999999 110.63 177.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 789' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 785' ' ' ALA . 50.4 mt -64.29 -35.26 80.28 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 109.835 -0.431 . . . . 73.549999999999997 109.835 179.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 790' ' ' ARG . . . . . 0.639 ' HG2' ' O ' ' A' ' 786' ' ' ASP . 13.0 mmm-85 -59.63 -41.27 90.08 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 109.794 -0.447 . . . . 74.140000000000001 109.794 177.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 791' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 787' ' ' ALA . 43.5 t -63.67 -51.27 72.16 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 CA-C-N 115.625 -0.716 . . . . 75.120000000000005 110.111 177.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 792' ' ' LEU . . . . . 0.622 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 47.3 mt -57.16 -52.68 64.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.017 -0.538 . . . . 74.230000000000004 111.171 -177.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 793' ' ' ILE . . . . . 0.541 ' HA ' HG23 ' A' ' 716' ' ' ILE . 70.3 mt -60.12 -52.55 59.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.709 -0.678 . . . . 73.450000000000003 111.176 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 794' ' ' GLY . . . . . 0.615 ' O ' ' HG2' ' A' ' 798' ' ' LYS . . . -62.77 -41.62 99.82 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.855 -0.688 . . . . 64.010000000000005 112.681 -178.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -66.57 -39.36 88.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.833 0.349 . . . . 63.310000000000002 110.529 -178.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 796' ' ' ASN . . . . . 0.452 ' OD1' ' HB2' ' A' ' 801' ' ' ARG . 8.3 t30 -70.29 -29.17 65.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.031 -0.531 . . . . 71.519999999999996 110.037 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 797' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -69.0 -29.67 67.91 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.817 -0.629 . . . . 73.030000000000001 109.736 177.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 798' ' ' LYS . . . . . 0.615 ' HG2' ' O ' ' A' ' 794' ' ' GLY . 32.5 mmtp -76.48 -22.73 54.16 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.282 0.563 . . . . 74.349999999999994 110.052 176.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 799' ' ' ALA . . . . . . . . . . . . . . . -99.14 -166.36 1.34 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.627 -0.715 . . . . 64.409999999999997 110.361 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 800' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -127.09 88.45 2.81 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.994 0.426 . . . . 72.120000000000005 110.516 179.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 801' ' ' ARG . . . . . 0.452 ' HB2' ' OD1' ' A' ' 796' ' ' ASN . 36.7 mmt180 . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.617 -0.706 . . . . 75.540000000000006 109.667 178.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 708' ' ' MET . . . . . . . . . . . . . 66.0 mtm . . . . . 0 N--CA 1.478 0.959 0 CA-C-O 120.959 0.409 . . . . 71.540000000000006 110.461 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 86.0 mtp -102.53 146.41 32.31 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.059 -0.519 . . . . 60.020000000000003 109.666 175.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -60.01 84.82 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.158 2.572 . . . . 74.200000000000003 112.836 -179.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 711' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 165.83 -34.67 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.695 -1.224 . . . . 73.450000000000003 107.695 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 712' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -124.22 40.61 3.69 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.987 -1.006 . . . . 72.230000000000004 110.381 176.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 713' ' ' VAL . . . . . . . . . . . . . 47.6 t -67.63 129.03 31.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 108.847 -0.797 . . . . 64.439999999999998 108.847 176.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 -68.33 95.26 0.59 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.116 0.484 . . . . 65.310000000000002 110.803 -175.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 715' ' ' LYS . . . . . 0.512 ' O ' ' HG2' ' A' ' 718' ' ' GLU . 12.8 tptp -104.25 22.99 13.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.85 0.833 . . . . 74.109999999999999 108.998 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 716' ' ' ILE . . . . . 0.501 HG23 ' HA ' ' A' ' 793' ' ' ILE . 42.4 mm -68.61 -13.76 17.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.002 -0.999 . . . . 73.530000000000001 110.387 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -63.69 -21.17 64.8 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.787 -0.642 . . . . 70.310000000000002 111.971 177.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 718' ' ' GLU . . . . . 0.713 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 15.8 mm-40 -65.57 -40.75 93.12 Favored 'General case' 0 C--O 1.225 -0.234 0 N-CA-C 109.592 -0.521 . . . . 71.150000000000006 109.592 176.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 719' ' ' LEU . . . . . 0.506 HD12 HD23 ' A' ' 789' ' ' LEU . 2.9 mm? -65.37 -33.01 74.97 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.624 -0.51 . . . . 70.549999999999997 109.624 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 720' ' ' VAL . . . . . 0.466 HG23 HD13 ' A' ' 793' ' ' ILE . 57.6 t -65.76 -38.04 81.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.668 -0.696 . . . . 74.120000000000005 110.822 178.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 721' ' ' ARG . . . . . 0.713 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 22.5 ptt180 -65.71 -26.2 67.65 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.191 0.52 . . . . 61.119999999999997 109.785 179.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -80.52 -27.01 37.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.983 -0.553 . . . . 62.119999999999997 110.991 178.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 723' ' ' LEU . . . . . 0.508 HD21 ' HB2' ' A' ' 789' ' ' LEU . 87.7 mt -62.43 -27.2 68.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.137 0.494 . . . . 74.019999999999996 109.708 172.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -89.68 -38.96 13.51 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.336 -0.847 . . . . 71.400000000000006 110.938 177.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 18.5 m -93.89 -74.64 0.53 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.973 0.36 . . . . 55.210000000000001 111.973 -174.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 726' ' ' ASN . . . . . 0.455 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 38.0 t30 -153.36 106.84 2.59 Favored Pre-proline 0 C--O 1.236 0.359 0 CA-C-O 120.894 0.378 . . . . 73.010000000000005 110.354 -178.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 727' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 17.9 Cg_endo -60.0 -36.68 88.89 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 123.217 2.611 . . . . 74.340000000000003 112.964 -177.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 46.0 t -58.64 -49.96 80.73 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 CA-C-N 116.361 -0.381 . . . . 74.040000000000006 110.776 -177.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -61.54 -35.22 90.77 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.918 -0.658 . . . . 75.439999999999998 112.377 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -71.79 -44.19 48.54 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.837 -0.697 . . . . 70.109999999999999 112.811 -179.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -64.27 -39.5 94.06 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.777 -0.453 . . . . 74.019999999999996 109.777 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 732' ' ' LEU . . . . . 0.438 HD23 ' HB2' ' A' ' 742' ' ' ALA . 95.7 mt -63.83 -43.38 96.35 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.881 -0.6 . . . . 71.340000000000003 111.485 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 733' ' ' GLU . . . . . 0.561 ' HA ' ' HG2' ' A' ' 736' ' ' ARG . 8.4 pt-20 -77.42 -29.94 53.22 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 120.549 -0.46 . . . . 44.530000000000001 111.239 -176.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 734' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -55.42 -49.28 72.81 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.074 0.464 . . . . 63.43 109.793 173.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -66.5 -52.77 42.43 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.705 -0.68 . . . . 75.329999999999998 111.021 -177.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 736' ' ' ARG . . . . . 0.561 ' HG2' ' HA ' ' A' ' 733' ' ' GLU . 35.7 ptt180 -58.74 -36.07 73.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.036 -0.529 . . . . 71.040000000000006 111.384 -174.098 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 18.9 t -76.04 -37.09 58.73 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.008 -0.542 . . . . 52.149999999999999 110.842 -178.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -88.36 -7.64 56.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.467 -0.333 . . . . 74.510000000000005 111.483 -174.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 103.79 -3.31 45.45 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.611 -0.804 . . . . 72.409999999999997 113.096 175.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -88.56 170.26 11.01 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.928 0.394 . . . . 53.130000000000003 110.413 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -115.51 131.43 56.93 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.49 -0.559 . . . . 73.140000000000001 109.49 173.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 742' ' ' ALA . . . . . 0.438 ' HB2' HD23 ' A' ' 732' ' ' LEU . . . -98.87 110.28 22.91 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 123.22 0.325 . . . . 71.340000000000003 110.538 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 743' ' ' GLU . . . . . 0.539 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 47.0 mt-10 -115.04 132.73 56.5 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.103 -0.499 . . . . 71.319999999999993 111.074 -177.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -113.13 109.76 19.33 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.072 -0.513 . . . . 75.109999999999999 109.783 175.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -122.41 152.76 39.89 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.081 0.467 . . . . 75.230000000000004 111.393 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 746' ' ' LEU . . . . . . . . . . . . . 6.5 tt -82.92 113.8 20.77 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.833 -0.803 . . . . 75.200000000000003 108.833 175.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 54.8 t -82.36 -50.35 16.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.181 0.515 . . . . 73.510000000000005 110.671 -176.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -155.69 147.14 22.81 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.717 -0.674 . . . . 72.310000000000002 109.495 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.91 109.94 20.73 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.442 0.639 . . . . 72.510000000000005 110.167 175.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 6.6 m -108.88 80.64 1.35 Allowed 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.8 -0.815 . . . . 73.120000000000005 108.8 176.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 751' ' ' GLY . . . . . 0.505 ' HA2' ' HD2' ' A' ' 752' ' ' PRO . . . -131.41 113.46 1.36 Allowed Glycine 0 N--CA 1.439 -1.124 0 C-N-CA 119.895 -1.145 . . . . 62.240000000000002 114.131 -170.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 752' ' ' PRO . . . . . 0.505 ' HD2' ' HA2' ' A' ' 751' ' ' GLY . 20.1 Cg_endo -60.92 169.95 5.27 Favored 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 123.095 2.53 . . . . 61.009999999999998 111.029 167.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -61.42 -35.39 83.36 Favored 'Trans proline' 0 CA--C 1.529 0.228 0 C-N-CA 122.177 1.918 . . . . 75.209999999999994 112.777 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 55.7 p-80 -83.41 -20.95 33.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.752 0.311 . . . . 73.140000000000001 111.349 -177.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -142.4 74.8 19.96 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 111.923 0.342 . . . . 73.120000000000005 111.923 -176.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 756' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -58.06 92.87 0.06 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 122.096 1.864 . . . . 75.349999999999994 111.191 170.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 757' ' ' LYS . . . . . 0.514 ' HA ' ' HA ' ' A' ' 775' ' ' HIS . 36.1 ttpt -101.13 130.06 47.13 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.007 -0.542 . . . . 75.200000000000003 110.359 -175.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 758' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -113.72 135.08 54.33 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.94 -0.573 . . . . 74.109999999999999 110.632 -175.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 759' ' ' VAL . . . . . 0.441 HG22 ' HB3' ' A' ' 773' ' ' CYS . 26.3 t -94.19 112.62 27.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.812 -0.631 . . . . 74.099999999999994 109.876 177.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 760' ' ' TYR . . . . . 0.405 ' HH ' ' HG2' ' A' ' 777' ' ' LYS . 11.5 m-85 -111.11 143.18 42.24 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.917 -0.583 . . . . 55.219999999999999 110.565 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 761' ' ' GLN . . . . . 0.477 ' HA ' ' O ' ' A' ' 770' ' ' PRO . 53.1 tt0 -131.39 130.96 43.26 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.521 -0.548 . . . . 74.310000000000002 109.521 178.147 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 762' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 769' ' ' PHE . . . -87.7 113.77 23.68 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.352 0.596 . . . . 71.099999999999994 110.631 -179.037 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 763' ' ' LYS . . . . . 0.57 ' HD2' ' CH2' ' A' ' 768' ' ' TRP . 57.4 tttm -93.2 105.13 17.26 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.789 -0.641 . . . . 75.140000000000001 109.545 178.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 57.4 t -108.04 103.46 15.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.25 -0.648 . . . . 73.109999999999999 109.25 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 71.25 -117.21 6.63 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 110.683 -0.967 . . . . 61.240000000000002 110.683 -173.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -110.07 15.72 30.66 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.615 -0.803 . . . . 65.120000000000005 112.066 176.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 767' ' ' ARG . . . . . 0.524 ' HD2' ' CD1' ' A' ' 769' ' ' PHE . 0.0 OUTLIER -115.5 128.2 55.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.853 0.358 . . . . 74.040000000000006 110.218 -178.891 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 768' ' ' TRP . . . . . 0.57 ' CH2' ' HD2' ' A' ' 763' ' ' LYS . 40.6 m95 -97.43 103.14 15.05 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.065 -0.516 . . . . 73.540000000000006 110.018 -179.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 769' ' ' PHE . . . . . 0.524 ' CD1' ' HD2' ' A' ' 767' ' ' ARG . 16.5 p90 -162.16 136.39 5.01 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 120.853 0.359 . . . . 73.319999999999993 111.044 -178.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 770' ' ' PRO . . . . . 0.578 ' HD3' ' HB3' ' A' ' 788' ' ' ALA . 75.1 Cg_endo -99.34 -177.83 4.41 Favored 'Cis proline' 0 N--CA 1.449 -1.122 0 C-N-CA 123.684 -1.382 . . . . 70.129999999999995 111.496 -5.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -111.05 107.36 16.73 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.919 -0.4 . . . . 75.450000000000003 109.919 174.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 34.0 m -119.26 164.95 15.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.203 -0.453 . . . . 74.549999999999997 110.667 -176.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 773' ' ' CYS . . . . . 0.441 ' HB3' HG22 ' A' ' 759' ' ' VAL . 7.0 p -136.61 124.01 22.03 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.383 -0.371 . . . . 72.329999999999998 110.275 177.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -129.56 152.52 49.0 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.27 -0.423 . . . . 52.5 110.185 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 775' ' ' HIS . . . . . 0.514 ' HA ' ' HA ' ' A' ' 757' ' ' LYS . 13.2 p80 -78.22 17.47 0.62 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.859 0.362 . . . . 64.329999999999998 111.695 -176.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 15.7 t -153.15 139.88 18.95 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.484 -0.561 . . . . 54.109999999999999 109.484 177.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 777' ' ' LYS . . . . . 0.405 ' HG2' ' HH ' ' A' ' 760' ' ' TYR . 11.5 tmtt? -60.82 -40.46 92.83 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.453 -0.339 . . . . 64.239999999999995 111.123 -177.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -67.65 -37.25 82.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.852 0.358 . . . . 73.310000000000002 110.517 179.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 779' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -70.2 -37.37 75.06 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.147 -0.479 . . . . 73.340000000000003 110.738 -178.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -57.57 -41.84 93.76 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.966 -0.635 . . . . 74.439999999999998 112.279 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -63.83 -44.31 93.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.974 0.416 . . . . 72.450000000000003 110.622 177.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -69.44 -41.31 76.47 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.876 -0.602 . . . . 74.439999999999998 111.341 -177.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -61.26 -42.69 99.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.787 0.327 . . . . 73.129999999999995 110.838 177.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -62.72 -50.29 71.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.792 -0.64 . . . . 70.5 110.634 178.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 785' ' ' ALA . . . . . 0.535 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -62.95 -39.64 95.25 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.296 -0.411 . . . . 74.310000000000002 111.073 -178.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 786' ' ' ASP . . . . . 0.6 ' O ' ' HG2' ' A' ' 790' ' ' ARG . 11.7 t70 -60.48 -57.34 13.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.461 . . . . 72.0 110.447 179.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 787' ' ' ALA . . . . . 0.561 ' O ' HG21 ' A' ' 791' ' ' VAL . . . -62.68 -32.46 73.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.792 -0.64 . . . . 74.349999999999994 110.992 -178.228 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 788' ' ' ALA . . . . . 0.646 ' O ' ' HG ' ' A' ' 792' ' ' LEU . . . -62.12 -43.5 98.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.363 -0.38 . . . . 52.340000000000003 110.693 177.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 789' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 785' ' ' ALA . 79.2 mt -64.41 -37.32 87.12 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.782 -0.451 . . . . 72.209999999999994 109.782 178.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 790' ' ' ARG . . . . . 0.6 ' HG2' ' O ' ' A' ' 786' ' ' ASP . 8.7 mmm180 -59.86 -40.62 89.23 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 109.694 -0.484 . . . . 74.150000000000006 109.694 177.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 791' ' ' VAL . . . . . 0.561 HG21 ' O ' ' A' ' 787' ' ' ALA . 61.0 t -62.02 -50.7 79.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.816 -0.629 . . . . 75.030000000000001 110.56 176.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 792' ' ' LEU . . . . . 0.646 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 49.7 mt -60.27 -52.13 66.59 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.693 -0.685 . . . . 75.5 110.979 -177.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 793' ' ' ILE . . . . . 0.544 ' O ' ' HG3' ' A' ' 797' ' ' GLU . 72.2 mt -59.55 -48.84 85.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.755 -0.657 . . . . 75.140000000000001 110.742 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -61.35 -44.02 98.6 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 121.06 -0.59 . . . . 72.510000000000005 112.774 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -57.64 -40.96 80.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.064 0.459 . . . . 54.219999999999999 110.15 178.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -67.76 -44.58 77.17 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.807 -0.633 . . . . 72.010000000000005 111.44 178.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 797' ' ' GLU . . . . . 0.544 ' HG3' ' O ' ' A' ' 793' ' ' ILE . 47.9 mt-10 -62.53 -45.9 90.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.133 0.492 . . . . 73.209999999999994 111.474 -177.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 798' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -81.24 -0.96 43.06 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.748 -0.66 . . . . 64.510000000000005 111.502 -174.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 799' ' ' ALA . . . . . . . . . . . . . . . -84.67 -21.12 30.32 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.523 -0.308 . . . . 71.319999999999993 111.449 -178.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 800' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -103.45 6.16 37.44 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.758 -0.377 . . . . 74.549999999999997 111.867 -175.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 801' ' ' ARG . . . . . 0.467 ' O ' ' HG3' ' A' ' 801' ' ' ARG . 32.0 ptt180 . . . . . 0 C--O 1.245 0.85 0 C-N-CA 120.82 -0.352 . . . . 73.530000000000001 110.675 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 716' ' ' ILE . . . . . 0.561 ' HA ' HD23 ' A' ' 719' ' ' LEU . 47.9 mm . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.918 0.39 . . . . 74.510000000000005 110.861 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -59.36 -32.41 72.45 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 121.086 -0.578 . . . . 72.129999999999995 112.634 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 718' ' ' GLU . . . . . 0.706 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 39.3 mt-10 -79.69 -21.83 44.17 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.856 -0.338 . . . . 62.140000000000001 111.266 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 719' ' ' LEU . . . . . 0.563 HD12 HD22 ' A' ' 789' ' ' LEU . 3.5 mm? -67.02 -32.11 73.11 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.225 -0.657 . . . . 61.009999999999998 109.225 172.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 720' ' ' VAL . . . . . 0.575 HG22 HD13 ' A' ' 793' ' ' ILE . 39.3 t -70.49 -31.81 47.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.364 -0.835 . . . . 64.329999999999998 110.379 176.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 721' ' ' ARG . . . . . 0.706 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 6.1 ptt180 -66.61 -28.12 68.24 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 120.943 0.401 . . . . 74.510000000000005 110.16 179.078 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -77.17 -31.86 55.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.239 -0.437 . . . . 73.549999999999997 111.322 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 723' ' ' LEU . . . . . 0.551 HD21 ' HB2' ' A' ' 789' ' ' LEU . 96.3 mt -61.11 -32.3 71.98 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.514 0.673 . . . . 71.140000000000001 109.629 173.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -84.95 -16.6 40.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.851 -1.068 . . . . 60.229999999999997 110.905 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 23.5 m -119.37 -81.61 0.63 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.783 0.325 . . . . 75.519999999999996 111.536 -176.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 726' ' ' ASN . . . . . 0.415 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 37.5 t30 -139.25 104.9 7.19 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.292 -0.413 . . . . 65.120000000000005 110.21 -178.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 727' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 24.6 Cg_endo -62.23 -37.61 61.06 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.822 2.348 . . . . 65.5 112.584 -177.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 49.4 t -61.33 -49.0 86.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.23 -0.441 . . . . 64.430000000000007 110.544 -177.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -63.41 -31.49 80.93 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.899 -0.667 . . . . 62.119999999999997 111.887 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -71.03 -40.04 62.65 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.06 -0.591 . . . . 40.509999999999998 112.633 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -66.05 -39.65 90.3 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.401 -0.592 . . . . 75.030000000000001 109.401 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 732' ' ' LEU . . . . . 0.443 HD23 ' HB3' ' A' ' 742' ' ' ALA . 83.1 mt -65.45 -38.53 90.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.926 -0.579 . . . . 72.340000000000003 110.427 175.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 733' ' ' GLU . . . . . 0.578 ' O ' ' HG2' ' A' ' 736' ' ' ARG . 4.2 tp10 -66.41 -48.17 70.93 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.809 -0.632 . . . . 73.5 110.928 -179.007 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 734' ' ' TYR . . . . . 0.54 ' HB2' HD11 ' A' ' 719' ' ' LEU . 12.4 t80 -56.75 -47.74 79.39 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.132 -0.485 . . . . 64.409999999999997 110.752 178.068 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -66.43 -46.14 77.53 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.139 -0.482 . . . . 72.5 111.184 -177.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 736' ' ' ARG . . . . . 0.578 ' HG2' ' O ' ' A' ' 733' ' ' GLU . 22.4 ptt180 -62.12 -35.33 78.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.015 0.436 . . . . 62.420000000000002 110.85 -176.252 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 33.1 t -81.19 -23.72 37.97 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.922 -0.581 . . . . 63.420000000000002 111.304 -178.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -104.71 2.84 30.78 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.781 0.289 . . . . 54.219999999999999 111.781 -175.081 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 79.82 17.82 74.17 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.574 -0.822 . . . . 74.219999999999999 113.002 176.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -102.27 162.16 13.13 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 122.628 -0.336 . . . . 63.130000000000003 110.263 176.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 741' ' ' ALA . . . . . 0.52 ' O ' ' HA ' ' A' ' 764' ' ' VAL . . . -105.43 135.42 46.85 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.865 -0.42 . . . . 44.439999999999998 109.865 175.366 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 742' ' ' ALA . . . . . 0.443 ' HB3' HD23 ' A' ' 732' ' ' LEU . . . -103.46 108.77 20.16 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.224 -0.444 . . . . 71.530000000000001 110.505 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 743' ' ' GLU . . . . . 0.572 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 41.2 mt-10 -115.73 113.35 23.35 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.033 -0.531 . . . . 71.430000000000007 111.121 -178.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -93.91 100.91 12.98 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.644 -0.707 . . . . 73.409999999999997 109.605 175.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -113.99 155.96 24.92 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.04 0.448 . . . . 75.310000000000002 110.783 -178.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 746' ' ' LEU . . . . . . . . . . . . . 1.7 tt -94.06 120.42 34.3 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.759 -0.83 . . . . 71.409999999999997 108.759 177.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 84.6 t -81.98 -52.3 13.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.315 -0.402 . . . . 65.239999999999995 111.182 -176.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -155.58 151.33 27.43 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.386 -0.37 . . . . 51.109999999999999 110.803 -175.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -126.75 87.11 2.6 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.702 -0.481 . . . . 73.450000000000003 109.702 -178.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 750' ' ' SER . . . . . 0.402 ' O ' ' HB3' ' A' ' 757' ' ' LYS . 5.3 p -128.1 98.93 5.28 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.177 0.513 . . . . 72.230000000000004 111.261 -176.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . -166.54 158.04 30.79 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 111.57 -0.612 . . . . 70.120000000000005 111.57 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 752' ' ' PRO . . . . . 0.693 ' HG2' ' HB2' ' A' ' 755' ' ' GLU . 20.5 Cg_endo -60.45 162.15 18.45 Favored 'Trans proline' 0 CA--C 1.531 0.35 0 C-N-CA 122.846 2.364 . . . . 74.0 112.038 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.68 -31.91 92.59 Favored 'Trans proline' 0 CA--C 1.527 0.16 0 C-N-CA 122.71 2.273 . . . . 72.430000000000007 112.612 -178.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 37.5 p-80 -86.82 -17.82 32.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.206 -0.452 . . . . 72.409999999999997 111.309 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 755' ' ' GLU . . . . . 0.693 ' HB2' ' HG2' ' A' ' 752' ' ' PRO . 37.9 mm-40 -136.48 70.88 60.02 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.461 -0.336 . . . . 74.450000000000003 110.751 178.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 756' ' ' PRO . . . . . 0.485 ' HB2' ' CE2' ' A' ' 758' ' ' PHE . 28.9 Cg_endo -63.42 116.99 3.96 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.264 1.976 . . . . 71.209999999999994 111.414 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 757' ' ' LYS . . . . . 0.411 ' CG ' ' HB2' ' A' ' 773' ' ' CYS . 23.1 ttmm -97.7 115.46 28.01 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.251 -0.432 . . . . 74.209999999999994 110.427 -176.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 758' ' ' PHE . . . . . 0.485 ' CE2' ' HB2' ' A' ' 756' ' ' PRO . 90.4 m-85 -108.05 113.21 26.21 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.008 -0.542 . . . . 74.420000000000002 110.355 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 24.3 t -85.82 111.28 20.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.74 -0.664 . . . . 65.25 109.8 179.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 760' ' ' TYR . . . . . 0.421 ' OH ' ' HG2' ' A' ' 777' ' ' LYS . 2.1 m-85 -110.81 143.13 41.85 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.248 -0.433 . . . . 71.519999999999996 110.758 -179.031 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 761' ' ' GLN . . . . . 0.519 ' HA ' ' O ' ' A' ' 770' ' ' PRO . 56.8 tt0 -135.77 135.19 39.73 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.141 -0.481 . . . . 72.409999999999997 109.743 178.424 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 762' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 769' ' ' PHE . . . -93.56 112.84 24.82 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.306 0.574 . . . . 74.129999999999995 110.605 -178.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 763' ' ' LYS . . . . . 0.607 ' HD2' ' CH2' ' A' ' 768' ' ' TRP . 59.3 tttm -91.82 101.84 14.43 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.844 -0.617 . . . . 65.109999999999999 109.778 177.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 764' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 741' ' ' ALA . 59.4 t -107.57 100.86 11.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.02 -0.536 . . . . 70.019999999999996 109.986 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 71.71 -115.25 5.49 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 115.586 -0.733 . . . . 64.219999999999999 111.482 -177.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -106.22 8.1 41.18 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.828 -0.701 . . . . 72.040000000000006 112.012 177.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 767' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 767' ' ' ARG . 55.0 mtt180 -108.07 147.17 31.56 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.963 0.411 . . . . 74.010000000000005 110.797 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 768' ' ' TRP . . . . . 0.607 ' CH2' ' HD2' ' A' ' 763' ' ' LYS . 53.0 m95 -118.21 100.76 7.72 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.764 -0.653 . . . . 75.200000000000003 109.284 178.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 769' ' ' PHE . . . . . 0.487 ' HA ' ' HA ' ' A' ' 770' ' ' PRO . 21.4 p90 -167.49 139.3 2.58 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 120.777 0.322 . . . . 74.530000000000001 110.969 -176.091 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 770' ' ' PRO . . . . . 0.635 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 71.5 Cg_endo -97.54 -171.46 2.46 Favored 'Cis proline' 0 N--CA 1.453 -0.872 0 C-N-CA 123.716 -1.368 . . . . 64.239999999999995 111.751 -4.073 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -122.23 112.44 18.16 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.63 -0.508 . . . . 74.510000000000005 109.63 175.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 36.0 m -122.46 159.24 25.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.247 -0.433 . . . . 60.340000000000003 110.839 -176.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 773' ' ' CYS . . . . . 0.411 ' HB2' ' CG ' ' A' ' 757' ' ' LYS . 8.0 p -124.45 107.65 11.32 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.007 0.432 . . . . 71.530000000000001 109.948 177.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -103.11 -179.66 4.01 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.07 -0.514 . . . . 71.209999999999994 111.203 -176.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 775' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -93.28 -5.39 49.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 71.200000000000003 110.349 -177.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 19.4 t -161.01 170.44 20.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.338 -0.392 . . . . 73.209999999999994 110.518 -177.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 777' ' ' LYS . . . . . 0.421 ' HG2' ' OH ' ' A' ' 760' ' ' TYR . 1.4 tmtp? -69.72 -50.15 46.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.065 -0.516 . . . . 75.409999999999997 111.447 -174.337 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -60.48 -40.75 92.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.965 0.412 . . . . 63.140000000000001 110.308 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 779' ' ' GLN . . . . . 0.54 ' O ' ' HG2' ' A' ' 783' ' ' GLU . 76.9 mt-30 -58.3 -49.18 78.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.696 -0.683 . . . . 73.219999999999999 111.099 175.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -52.73 -44.12 60.34 Favored Glycine 0 C--N 1.334 0.434 0 CA-C-N 116.168 -0.469 . . . . 73.140000000000001 113.095 -176.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -59.23 -47.71 84.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.273 0.559 . . . . 44.100000000000001 110.772 178.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -70.91 -42.83 69.4 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.443 -0.799 . . . . 63.109999999999999 111.61 -175.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 783' ' ' GLU . . . . . 0.54 ' HG2' ' O ' ' A' ' 779' ' ' GLN . 21.2 mm-40 -60.44 -41.48 94.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.978 0.418 . . . . 72.450000000000003 110.301 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -66.17 -47.84 72.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.845 -0.616 . . . . 75.510000000000005 110.662 178.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 785' ' ' ALA . . . . . 0.524 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -63.08 -41.93 99.53 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.218 -0.446 . . . . 73.099999999999994 111.324 -178.466 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 786' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -57.21 -53.31 59.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.242 0.544 . . . . 71.450000000000003 110.277 178.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 787' ' ' ALA . . . . . 0.603 ' O ' HG23 ' A' ' 791' ' ' VAL . . . -64.01 -37.78 88.67 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.597 -0.729 . . . . 63.509999999999998 111.052 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 788' ' ' ALA . . . . . 0.635 ' HB2' ' HD3' ' A' ' 770' ' ' PRO . . . -60.38 -47.44 86.07 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.425 -0.352 . . . . 63.109999999999999 111.582 -178.466 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 789' ' ' LEU . . . . . 0.563 HD22 HD12 ' A' ' 719' ' ' LEU . 64.4 mt -62.74 -39.36 93.86 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.641 -0.503 . . . . 73.150000000000006 109.641 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 790' ' ' ARG . . . . . . . . . . . . . 54.6 mtp180 -64.46 -32.09 73.57 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.594 -0.73 . . . . 75.209999999999994 111.197 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 791' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 787' ' ' ALA . 60.7 t -63.51 -52.94 51.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 109.433 -0.58 . . . . 52.329999999999998 109.433 173.291 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 792' ' ' LEU . . . . . 0.563 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 32.8 mt -57.39 -50.44 72.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.339 -0.846 . . . . 71.519999999999996 110.836 -177.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 793' ' ' ILE . . . . . 0.575 HD13 HG22 ' A' ' 720' ' ' VAL . 77.5 mt -57.94 -49.47 81.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.642 -0.708 . . . . 73.219999999999999 110.568 177.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -63.28 -30.71 78.37 Favored Glycine 0 CA--C 1.519 0.325 0 CA-C-N 115.952 -0.567 . . . . 54.340000000000003 112.814 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 795' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 791' ' ' VAL . 59.7 mm-40 -67.26 -36.73 82.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.46 0.13 . . . . 74.540000000000006 110.874 178.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 6.5 t30 . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.533 -0.303 . . . . 53.520000000000003 111.15 -175.831 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 716' ' ' ILE . . . . . 0.545 ' HA ' HD23 ' A' ' 719' ' ' LEU . 47.1 mm . . . . . 0 C--O 1.233 0.235 0 CA-C-O 120.934 0.397 . . . . 64.450000000000003 110.803 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -62.11 -34.03 87.71 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.828 -0.701 . . . . 70.409999999999997 111.992 176.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 718' ' ' GLU . . . . . 0.707 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 38.1 mt-10 -77.26 -25.0 51.04 Favored 'General case' 0 C--O 1.222 -0.385 0 O-C-N 122.623 -0.34 . . . . 73.140000000000001 111.125 178.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 719' ' ' LEU . . . . . 0.57 HD12 HD22 ' A' ' 789' ' ' LEU . 4.4 mm? -61.51 -32.94 73.0 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.473 -0.565 . . . . 63.109999999999999 109.473 172.398 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 720' ' ' VAL . . . . . 0.495 HG22 HD13 ' A' ' 793' ' ' ILE . 58.2 t -70.21 -36.26 66.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.477 -0.783 . . . . 74.400000000000006 110.76 177.398 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 721' ' ' ARG . . . . . 0.707 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 8.9 ptt180 -62.72 -29.52 70.73 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.02 0.438 . . . . 64.319999999999993 110.167 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -76.28 -31.55 58.3 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.197 -0.456 . . . . 73.510000000000005 110.596 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 723' ' ' LEU . . . . . 0.606 HD21 ' HB2' ' A' ' 789' ' ' LEU . 89.3 mt -63.76 -24.89 67.95 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.177 0.513 . . . . 72.439999999999998 110.601 174.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -92.07 -23.87 19.34 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.756 -0.656 . . . . 62.100000000000001 110.872 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 10.9 m -111.04 -76.79 0.6 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.423 -0.353 . . . . 73.420000000000002 111.241 -175.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 726' ' ' ASN . . . . . 0.408 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 38.5 t30 -141.6 103.52 5.9 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 120.628 0.251 . . . . 44.229999999999997 110.768 -179.163 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 727' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 19.0 Cg_endo -59.77 -37.09 89.1 Favored 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 123.032 2.488 . . . . 61.329999999999998 112.348 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 728' ' ' VAL . . . . . 0.417 ' O ' ' HG ' ' A' ' 732' ' ' LEU . 48.9 t -59.96 -47.94 89.75 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 CA-C-N 116.007 -0.542 . . . . 71.140000000000001 110.162 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -62.35 -35.33 91.5 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.656 -0.702 . . . . 42.350000000000001 112.01 178.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -65.41 -43.16 95.38 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.097 -0.573 . . . . 61.109999999999999 112.641 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -65.93 -40.27 91.28 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.725 -0.472 . . . . 61.25 109.725 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 732' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 728' ' ' VAL . 85.7 mt -65.37 -38.02 88.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.949 -0.569 . . . . 62.32 110.602 176.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 733' ' ' GLU . . . . . 0.462 ' O ' ' HG2' ' A' ' 736' ' ' ARG . 5.2 tp10 -66.98 -47.12 72.52 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 115.967 -0.56 . . . . 73.310000000000002 110.911 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 734' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -56.64 -46.69 80.85 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.214 -0.448 . . . . 71.150000000000006 110.458 177.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -65.28 -44.66 87.3 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.093 -0.503 . . . . 32.520000000000003 111.232 -177.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 736' ' ' ARG . . . . . 0.462 ' HG2' ' O ' ' A' ' 733' ' ' GLU . 14.5 ptm180 -68.85 -33.04 73.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.598 0.713 . . . . 72.340000000000003 109.825 -173.073 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 73.2 m -75.01 -36.47 61.95 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 114.792 -1.095 . . . . 75.120000000000005 111.766 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 12.7 m170 -94.27 0.57 55.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.338 -0.392 . . . . 74.209999999999994 111.327 -175.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 85.86 9.17 78.24 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.735 -0.745 . . . . 74.0 112.987 175.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -93.45 162.15 14.09 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.698 0.285 . . . . 71.530000000000001 110.336 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -107.48 115.99 31.14 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.993 -0.373 . . . . 64.239999999999995 109.993 176.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 742' ' ' ALA . . . . . 0.417 ' HB3' HD23 ' A' ' 732' ' ' LEU . . . -81.94 112.17 18.79 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.238 -0.437 . . . . 65.129999999999995 110.888 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 743' ' ' GLU . . . . . 0.479 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 43.9 mt-10 -123.06 127.74 49.17 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.297 -0.41 . . . . 73.129999999999995 110.945 -177.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -105.85 114.34 28.43 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.02 -0.536 . . . . 65.019999999999996 110.021 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -121.34 153.66 37.46 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.164 0.507 . . . . 72.439999999999998 110.803 177.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 746' ' ' LEU . . . . . 0.451 HD13 ' CE2' ' A' ' 760' ' ' TYR . 51.3 tp -95.93 101.33 12.99 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.475 -0.784 . . . . 75.230000000000004 109.803 178.27 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 49.1 t -69.33 -43.88 80.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.796 -0.638 . . . . 61.340000000000003 111.275 -174.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -146.25 147.49 31.47 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.064 0.459 . . . . 74.219999999999999 111.246 -176.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -141.47 93.66 2.6 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.997 -0.742 . . . . 71.340000000000003 108.997 177.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 16.7 t -129.84 176.75 7.78 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.906 -0.588 . . . . 54.210000000000001 110.213 -173.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 104.88 -176.17 22.71 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.712 -0.756 . . . . 74.299999999999997 112.353 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 752' ' ' PRO . . . . . 0.56 ' HG2' ' HB2' ' A' ' 755' ' ' GLU . 60.4 Cg_endo -73.62 157.82 48.08 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.899 2.399 . . . . 75.219999999999999 111.88 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -62.98 -22.54 73.86 Favored 'Trans proline' 0 CA--C 1.529 0.246 0 C-N-CA 122.656 2.238 . . . . 73.099999999999994 112.773 -177.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 39.2 p-80 -91.85 -7.57 49.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.924 0.392 . . . . 75.209999999999994 110.907 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 755' ' ' GLU . . . . . 0.56 ' HB2' ' HG2' ' A' ' 752' ' ' PRO . 5.5 mm-40 -146.84 63.58 8.46 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.318 -0.401 . . . . 60.420000000000002 110.987 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 756' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.85 122.43 8.49 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.094 1.862 . . . . 72.519999999999996 111.317 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 757' ' ' LYS . . . . . 0.455 ' HG3' ' HB2' ' A' ' 773' ' ' CYS . 0.1 OUTLIER -92.95 112.2 24.08 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.07 0.462 . . . . 73.319999999999993 110.327 -178.181 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 758' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -95.1 107.52 19.58 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.579 -0.737 . . . . 73.040000000000006 110.501 -178.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 759' ' ' VAL . . . . . 0.47 HG22 ' HB3' ' A' ' 773' ' ' CYS . 40.9 t -86.65 98.13 6.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.037 -0.528 . . . . 71.349999999999994 109.896 178.084 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 760' ' ' TYR . . . . . 0.451 ' CE2' HD13 ' A' ' 746' ' ' LEU . 7.5 m-85 -98.08 141.07 31.48 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.074 -0.512 . . . . 74.25 110.379 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 761' ' ' GLN . . . . . 0.496 ' HA ' ' O ' ' A' ' 770' ' ' PRO . 54.6 tt0 -135.41 129.3 33.08 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.993 -0.549 . . . . 75.239999999999995 109.784 178.124 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 762' ' ' ALA . . . . . . . . . . . . . . . -85.99 117.23 24.71 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.474 0.654 . . . . 74.540000000000006 110.819 -177.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 763' ' ' LYS . . . . . 0.479 ' HB3' ' HB2' ' A' ' 743' ' ' GLU . 58.9 tttt -93.71 108.8 20.5 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.184 -0.916 . . . . 71.0 109.572 178.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 38.7 t -128.78 108.26 17.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.805 0.336 . . . . 65.340000000000003 110.936 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 69.16 25.1 75.7 Favored Glycine 0 CA--C 1.51 -0.219 0 C-N-CA 121.112 -0.566 . . . . 41.149999999999999 112.585 176.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 91.31 -10.27 75.3 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.652 -0.785 . . . . 73.109999999999999 111.859 -177.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 767' ' ' ARG . . . . . 0.434 ' HD3' ' HA ' ' A' ' 767' ' ' ARG . 30.1 mmt180 -91.32 128.51 37.17 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.033 0.445 . . . . 73.409999999999997 110.303 177.318 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 768' ' ' TRP . . . . . . . . . . . . . 51.0 m95 -104.1 96.1 6.43 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.519 -0.764 . . . . 73.230000000000004 109.94 -176.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 769' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -162.42 138.59 5.78 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.314 -0.403 . . . . 72.239999999999995 110.412 -177.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 770' ' ' PRO . . . . . 0.668 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 64.8 Cg_endo -95.0 175.15 12.68 Favored 'Cis proline' 0 N--CA 1.451 -0.978 0 C-N-CA 123.351 -1.521 . . . . 72.120000000000005 111.873 -3.383 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -107.66 98.15 7.78 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.681 -0.489 . . . . 61.310000000000002 109.681 174.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 29.2 m -112.73 131.31 64.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.358 0.599 . . . . 75.420000000000002 111.183 -175.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 773' ' ' CYS . . . . . 0.47 ' HB3' HG22 ' A' ' 759' ' ' VAL . 7.3 p -99.46 98.75 9.62 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.776 -0.647 . . . . 53.520000000000003 110.462 177.243 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -100.55 146.32 27.25 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.107 -0.497 . . . . 53.530000000000001 110.233 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 775' ' ' HIS . . . . . . . . . . . . . 1.1 p80 -86.11 17.3 3.67 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.272 0.558 . . . . 72.120000000000005 111.068 -178.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 34.3 t -150.02 140.51 22.44 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.633 -0.712 . . . . 62.539999999999999 109.282 175.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 777' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -66.04 -42.54 89.44 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.5 -0.318 . . . . 62.140000000000001 110.614 -175.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -60.49 -36.39 78.2 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.967 -0.56 . . . . 53.25 110.498 177.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 779' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -70.15 -42.77 72.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.034 -0.53 . . . . 73.030000000000001 110.802 177.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -50.2 -46.66 43.1 Favored Glycine 0 C--N 1.331 0.272 0 O-C-N 123.398 0.436 . . . . 44.219999999999999 113.083 -177.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -65.76 -49.25 69.07 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.781 0.324 . . . . 71.340000000000003 110.911 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -67.66 -46.89 71.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.149 -0.478 . . . . 73.099999999999994 111.771 -175.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -64.59 -37.47 87.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.683 -0.235 . . . . 73.420000000000002 110.63 -177.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -62.34 -52.0 65.39 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.272 -0.422 . . . . 71.0 110.438 177.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 785' ' ' ALA . . . . . 0.651 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -61.58 -43.68 98.41 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.22 -0.445 . . . . 74.120000000000005 110.648 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 786' ' ' ASP . . . . . 0.604 ' O ' ' HG2' ' A' ' 790' ' ' ARG . 8.2 t70 -57.5 -52.67 64.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.869 -0.605 . . . . 63.100000000000001 110.648 178.051 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 787' ' ' ALA . . . . . 0.514 ' O ' HG23 ' A' ' 791' ' ' VAL . . . -68.09 -27.19 66.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.916 -0.584 . . . . 64.120000000000005 111.285 -176.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 788' ' ' ALA . . . . . 0.668 ' HB2' ' HD3' ' A' ' 770' ' ' PRO . . . -66.72 -41.41 87.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.406 -0.361 . . . . 51.039999999999999 110.567 177.208 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 789' ' ' LEU . . . . . 0.651 ' HG ' ' O ' ' A' ' 785' ' ' ALA . 21.2 mt -67.27 -34.4 77.34 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.547 -0.538 . . . . 73.030000000000001 109.547 178.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 790' ' ' ARG . . . . . 0.604 ' HG2' ' O ' ' A' ' 786' ' ' ASP . 28.3 mmt180 -55.47 -45.9 76.89 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.142 -0.481 . . . . 73.209999999999994 109.837 175.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 791' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 787' ' ' ALA . 48.7 t -58.66 -52.35 60.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.468 -0.787 . . . . 73.049999999999997 110.581 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 792' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 27.7 mt -61.16 -49.13 78.46 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.522 -0.763 . . . . 71.040000000000006 111.003 -177.327 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 793' ' ' ILE . . . . . 0.495 HD13 HG22 ' A' ' 720' ' ' VAL . 93.5 mt -63.62 -42.78 97.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.621 -0.718 . . . . 74.239999999999995 110.516 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -62.31 -27.18 68.85 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 121.029 -0.605 . . . . 51.340000000000003 112.569 178.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -77.71 -23.63 49.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.625 0.25 . . . . 75.230000000000004 111.437 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 796' ' ' ASN . . . . . 0.408 ' CB ' HG13 ' A' ' 716' ' ' ILE . 27.6 t-20 . . . . . 0 C--N 1.327 -0.378 0 N-CA-C 111.942 0.349 . . . . 75.239999999999995 111.942 -177.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 716' ' ' ILE . . . . . 0.589 ' HA ' HD23 ' A' ' 719' ' ' LEU . 46.7 mm . . . . . 0 C--O 1.234 0.258 0 CA-C-O 120.936 0.398 . . . . 63.310000000000002 111.156 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -58.19 -28.77 61.89 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.866 -0.683 . . . . 62.5 112.551 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -68.61 -35.79 77.79 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 122.869 -0.195 . . . . 73.439999999999998 111.275 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 719' ' ' LEU . . . . . 0.589 HD23 ' HA ' ' A' ' 716' ' ' ILE . 3.2 mm? -64.94 -33.82 76.93 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.614 -0.513 . . . . 72.310000000000002 109.614 178.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 720' ' ' VAL . . . . . 0.543 HG22 HD13 ' A' ' 793' ' ' ILE . 45.5 t -66.33 -37.12 78.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.881 -0.599 . . . . 70.430000000000007 109.997 176.003 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 721' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.49 -32.04 71.05 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.839 -0.619 . . . . 72.209999999999994 110.158 177.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -79.46 -25.7 41.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.844 -0.616 . . . . 72.040000000000006 111.275 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 723' ' ' LEU . . . . . 0.531 HD21 ' HB2' ' A' ' 789' ' ' LEU . 60.1 mt -63.71 -29.95 71.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.991 0.424 . . . . 71.450000000000003 110.282 175.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -85.4 -35.63 21.21 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.653 -0.703 . . . . 71.019999999999996 110.83 176.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 24.7 m -92.55 -79.69 0.39 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.216 -0.447 . . . . 63.32 111.764 -174.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 726' ' ' ASN . . . . . 0.437 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 30.8 t30 -146.29 109.05 4.23 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-O 120.809 0.338 . . . . 74.129999999999995 110.235 -179.097 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 727' ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 20.0 Cg_endo -61.24 -35.69 83.74 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.707 2.271 . . . . 62.329999999999998 112.436 -178.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 53.2 t -62.76 -48.08 89.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.244 -0.435 . . . . 74.109999999999999 110.615 -178.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -63.55 -33.16 86.5 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.825 -0.703 . . . . 72.310000000000002 111.944 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -71.19 -41.54 59.66 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.252 -0.499 . . . . 74.140000000000001 112.811 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -63.71 -38.94 93.0 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.469 -0.567 . . . . 62.439999999999998 109.469 178.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 732' ' ' LEU . . . . . . . . . . . . . 96.1 mt -69.63 -33.5 72.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.847 -0.615 . . . . 53.43 110.555 176.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 733' ' ' GLU . . . . . 0.568 ' O ' ' HG2' ' A' ' 736' ' ' ARG . 4.2 tp10 -67.95 -48.46 65.81 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 123.016 0.526 . . . . 73.209999999999994 110.417 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 734' ' ' TYR . . . . . 0.558 ' HB2' HD11 ' A' ' 719' ' ' LEU . 8.8 t80 -54.67 -47.19 73.91 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.777 -0.647 . . . . 70.450000000000003 110.642 176.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -67.37 -49.73 62.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.191 -0.459 . . . . 70.230000000000004 110.849 -177.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 736' ' ' ARG . . . . . 0.568 ' HG2' ' O ' ' A' ' 733' ' ' GLU . 13.5 ptm180 -60.41 -38.52 84.28 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.297 -0.41 . . . . 64.329999999999998 111.221 -175.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 32.9 t -77.36 -29.11 53.17 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.123 -0.489 . . . . 73.530000000000001 111.172 -177.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -95.58 -8.19 35.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.82 0.343 . . . . 64.25 111.433 -176.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 93.4 10.89 58.93 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.689 -0.767 . . . . 73.510000000000005 113.118 176.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -93.58 161.61 14.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.965 0.412 . . . . 72.120000000000005 110.734 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -106.89 113.03 26.27 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.796 -0.638 . . . . 72.239999999999995 109.631 176.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 742' ' ' ALA . . . . . . . . . . . . . . . -97.45 126.74 42.89 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.152 -0.477 . . . . 72.420000000000002 110.638 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 743' ' ' GLU . . . . . 0.468 ' HG3' ' HB3' ' A' ' 763' ' ' LYS . 13.4 pt-20 -140.26 140.18 35.69 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.026 0.441 . . . . 64.040000000000006 110.569 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -108.27 114.73 28.83 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.741 -0.663 . . . . 74.019999999999996 109.718 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -120.89 149.91 41.88 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.083 0.468 . . . . 73.409999999999997 111.191 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 746' ' ' LEU . . . . . 0.485 HD21 ' HB3' ' A' ' 749' ' ' GLN . 60.6 tp -91.58 116.82 29.18 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.596 -0.729 . . . . 52.310000000000002 109.825 177.156 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 47.7 t -79.29 -47.42 22.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.05 -0.523 . . . . 51.229999999999997 110.498 -178.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -154.62 147.46 24.45 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.449 -0.341 . . . . 55.229999999999997 111.064 -179.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 749' ' ' GLN . . . . . 0.485 ' HB3' HD21 ' A' ' 746' ' ' LEU . 17.2 pt20 -129.84 109.98 11.36 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.137 -0.483 . . . . 73.109999999999999 109.864 177.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 27.5 t -155.36 159.28 39.79 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.379 -0.373 . . . . 44.509999999999998 110.385 -175.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 141.25 171.72 12.81 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.699 -0.762 . . . . 70.129999999999995 112.433 176.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 752' ' ' PRO . . . . . 0.772 ' HG2' ' HB2' ' A' ' 755' ' ' GLU . 37.3 Cg_endo -66.94 167.97 18.38 Favored 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 123.089 2.526 . . . . 75.219999999999999 111.906 176.218 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.46 -31.06 94.09 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.658 2.238 . . . . 75.400000000000006 112.777 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 44.4 p-80 -86.33 -8.09 57.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.889 0.376 . . . . 74.230000000000004 111.022 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 755' ' ' GLU . . . . . 0.772 ' HB2' ' HG2' ' A' ' 752' ' ' PRO . 17.4 mm-40 -142.81 67.12 18.12 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.164 -0.471 . . . . 75.510000000000005 111.622 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 756' ' ' PRO . . . . . 0.519 ' O ' ' HA ' ' A' ' 775' ' ' HIS . 48.1 Cg_endo -71.1 88.13 0.7 Allowed 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 121.845 1.697 . . . . 75.319999999999993 110.084 173.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 757' ' ' LYS . . . . . 0.618 ' HB2' ' HZ2' ' A' ' 757' ' ' LYS . 3.6 ttmp? -87.26 116.25 25.22 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.583 0.706 . . . . 64.010000000000005 111.726 -168.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 758' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -97.83 120.87 39.0 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.88 -1.054 . . . . 72.319999999999993 110.133 177.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 15.9 t -88.84 100.14 10.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 109.239 -0.652 . . . . 42.310000000000002 109.239 177.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -103.93 141.88 35.39 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.012 -0.54 . . . . 74.230000000000004 110.812 -177.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -132.04 136.45 47.24 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.07 -0.513 . . . . 72.120000000000005 109.844 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 762' ' ' ALA . . . . . . . . . . . . . . . -94.5 117.49 30.2 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.226 0.536 . . . . 41.530000000000001 110.388 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 763' ' ' LYS . . . . . 0.68 ' HD2' ' CH2' ' A' ' 768' ' ' TRP . 56.5 tttm -101.74 112.02 24.47 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.996 -0.547 . . . . 65.329999999999998 110.025 178.007 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 764' ' ' VAL . . . . . 0.41 HG11 ' HE2' ' A' ' 734' ' ' TYR . 89.9 t -117.15 105.99 19.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.17 0.51 . . . . 53.299999999999997 110.041 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 74.22 -115.89 5.04 Favored Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 110.955 -0.858 . . . . 63.340000000000003 110.955 -175.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -110.21 4.24 29.98 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.524 -0.846 . . . . 73.340000000000003 112.348 177.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 767' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -103.48 149.21 25.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.933 0.397 . . . . 74.420000000000002 110.94 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 768' ' ' TRP . . . . . 0.68 ' CH2' ' HD2' ' A' ' 763' ' ' LYS . 58.4 m95 -117.76 104.38 10.92 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.698 -0.683 . . . . 75.510000000000005 109.822 -178.298 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 769' ' ' PHE . . . . . 0.429 ' HA ' ' HA ' ' A' ' 770' ' ' PRO . 20.0 p90 -172.86 137.84 0.82 Allowed Pre-proline 0 C--N 1.324 -0.524 0 CA-C-O 121.065 0.46 . . . . 74.109999999999999 110.925 -177.107 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 770' ' ' PRO . . . . . 0.615 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 71.4 Cg_endo -97.16 176.9 8.68 Favored 'Cis proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.381 -1.508 . . . . 73.540000000000006 112.093 -3.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -112.51 109.73 19.48 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.536 -0.542 . . . . 64.239999999999995 109.536 173.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 34.1 m -116.61 174.8 3.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.039 -0.528 . . . . 75.230000000000004 110.891 -174.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 11.8 p -138.08 129.05 27.12 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.856 -0.611 . . . . 70.329999999999998 110.615 178.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 774' ' ' ALA . . . . . 0.413 ' HB2' ' HG3' ' A' ' 783' ' ' GLU . . . -140.04 153.76 46.9 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.984 -0.553 . . . . 72.400000000000006 109.963 178.231 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 775' ' ' HIS . . . . . 0.519 ' HA ' ' O ' ' A' ' 756' ' ' PRO . 1.5 p-80 -86.3 12.58 9.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.181 0.515 . . . . 70.209999999999994 111.151 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 776' ' ' SER . . . . . 0.419 ' HB3' ' HB2' ' A' ' 779' ' ' GLN . 40.7 t -138.22 141.2 39.98 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.79 -0.641 . . . . 75.409999999999997 109.361 176.166 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 777' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -68.07 -41.91 81.25 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.267 -0.424 . . . . 75.340000000000003 110.17 -178.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -64.99 -40.74 95.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.991 -0.55 . . . . 63.439999999999998 110.075 178.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 779' ' ' GLN . . . . . 0.516 ' O ' ' HG2' ' A' ' 783' ' ' GLU . 49.1 mt-30 -63.18 -44.14 96.25 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 116.155 -0.475 . . . . 71.530000000000001 110.791 177.214 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -51.65 -42.21 51.6 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 121.317 -0.468 . . . . 55.229999999999997 112.857 -178.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -62.81 -47.65 82.54 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.349 0.595 . . . . 73.219999999999999 110.682 177.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -69.1 -41.9 76.85 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.291 -0.868 . . . . 74.019999999999996 111.401 -176.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 783' ' ' GLU . . . . . 0.516 ' HG2' ' O ' ' A' ' 779' ' ' GLN . 25.5 mm-40 -57.53 -46.3 84.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.069 0.462 . . . . 74.340000000000003 110.1 177.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -63.45 -49.53 73.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.675 -0.693 . . . . 53.439999999999998 110.803 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 785' ' ' ALA . . . . . 0.481 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -63.15 -40.66 98.21 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.284 -0.417 . . . . 74.0 111.33 -178.435 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 786' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -58.38 -54.75 43.5 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.148 0.499 . . . . 74.129999999999995 110.319 177.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 787' ' ' ALA . . . . . 0.617 ' O ' HG23 ' A' ' 791' ' ' VAL . . . -61.3 -40.43 94.15 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.425 -0.807 . . . . 64.239999999999995 110.708 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 788' ' ' ALA . . . . . 0.705 ' O ' ' HG ' ' A' ' 792' ' ' LEU . . . -56.93 -49.9 74.23 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.17 -0.468 . . . . 43.109999999999999 111.33 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 789' ' ' LEU . . . . . 0.575 HD22 HD12 ' A' ' 719' ' ' LEU . 80.2 mt -61.05 -43.16 99.3 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 110.156 -0.313 . . . . 70.129999999999995 110.156 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 790' ' ' ARG . . . . . . . . . . . . . 52.8 mtp180 -59.54 -36.17 75.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.124 -0.489 . . . . 73.310000000000002 111.328 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 791' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 787' ' ' ALA . 64.4 t -64.61 -54.05 35.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 109.845 -0.428 . . . . 73.140000000000001 109.845 173.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 792' ' ' LEU . . . . . 0.705 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 45.6 mt -55.73 -48.68 74.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.69 -0.686 . . . . 73.209999999999994 111.185 -177.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 793' ' ' ILE . . . . . 0.543 HD13 HG22 ' A' ' 720' ' ' VAL . 93.0 mt -59.41 -52.27 62.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.588 -0.733 . . . . 74.409999999999997 110.933 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -64.58 -44.0 95.7 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.672 -0.775 . . . . 53.310000000000002 112.48 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -64.82 -47.69 77.1 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.745 0.276 . . . . 74.319999999999993 111.745 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 796' ' ' ASN . . . . . 0.456 HD22 ' HA ' ' A' ' 796' ' ' ASN . 1.0 OUTLIER . . . . . 0 C--N 1.326 -0.431 0 C-N-CA 120.708 -0.397 . . . . 75.25 110.709 -175.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 716' ' ' ILE . . . . . 0.614 ' HA ' HD23 ' A' ' 719' ' ' LEU . 46.2 mm . . . . . 0 C--O 1.237 0.419 0 CA-C-O 120.932 0.396 . . . . 74.230000000000004 111.43 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -59.17 -24.5 58.78 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.967 -0.635 . . . . 72.340000000000003 112.0 177.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -71.42 -36.02 71.17 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 120.469 0.176 . . . . 75.120000000000005 110.783 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 719' ' ' LEU . . . . . 0.659 HD12 HD22 ' A' ' 789' ' ' LEU . 3.3 mm? -63.14 -32.87 74.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.026 0.441 . . . . 72.530000000000001 109.873 178.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 720' ' ' VAL . . . . . 0.499 HG22 HD13 ' A' ' 793' ' ' ILE . 47.7 t -63.68 -38.73 83.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 115.887 -0.597 . . . . 71.209999999999994 110.171 174.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 721' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -67.07 -32.32 73.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.769 -0.651 . . . . 51.329999999999998 110.049 178.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -70.99 -32.95 69.91 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-N 116.206 -0.452 . . . . 62.420000000000002 110.747 177.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 723' ' ' LEU . . . . . 0.591 HD21 ' HB2' ' A' ' 789' ' ' LEU . 96.1 mt -56.31 -33.51 65.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.232 0.539 . . . . 74.109999999999999 110.163 174.035 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -77.76 -48.7 15.99 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.574 -0.739 . . . . 73.040000000000006 111.654 177.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 33.7 m -92.28 -67.81 0.83 Allowed 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.445 0.535 . . . . 64.239999999999995 112.445 -172.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 726' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -146.36 102.85 4.03 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 120.64 0.257 . . . . 73.450000000000003 110.439 -178.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 727' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -62.86 -38.02 51.03 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.773 2.315 . . . . 74.530000000000001 112.035 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 46.7 t -62.69 -47.48 92.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.003 -0.544 . . . . 54.030000000000001 110.644 -177.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -62.68 -38.82 97.08 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.793 -0.717 . . . . 23.43 111.624 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -66.1 -42.84 94.27 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 121.069 -0.586 . . . . 74.120000000000005 112.728 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -62.21 -44.67 96.06 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.027 0.441 . . . . 74.340000000000003 109.991 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 732' ' ' LEU . . . . . . . . . . . . . 87.8 mt -67.93 -36.94 81.01 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.033 -0.531 . . . . 72.219999999999999 110.881 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 733' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -69.82 -43.35 72.19 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 122.834 0.454 . . . . 71.5 110.831 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 734' ' ' TYR . . . . . 0.514 ' HB2' HD11 ' A' ' 719' ' ' LEU . 8.5 t80 -55.21 -48.17 74.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.928 0.394 . . . . 64.5 110.373 176.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -66.46 -50.45 63.29 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.868 -0.605 . . . . 71.310000000000002 110.97 -177.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 736' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -63.66 -31.1 72.17 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.03 0.443 . . . . 74.439999999999998 111.191 -175.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 34.8 t -77.13 -29.39 54.69 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.905 -0.589 . . . . 53.219999999999999 111.011 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 16.4 m170 -98.63 -11.52 21.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.815 0.34 . . . . 73.219999999999999 111.655 -176.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 103.63 -4.26 46.71 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.733 -0.746 . . . . 64.219999999999999 112.971 177.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -79.26 157.77 27.71 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.847 0.356 . . . . 64.209999999999994 110.494 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -102.99 122.81 45.37 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.148 -0.686 . . . . 60.100000000000001 109.148 175.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 742' ' ' ALA . . . . . 0.514 ' HA ' ' O ' ' A' ' 763' ' ' LYS . . . -114.16 122.64 47.45 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 123.379 0.424 . . . . 63.310000000000002 111.076 -176.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 743' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -145.3 138.36 26.33 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.176 -0.465 . . . . 65.310000000000002 110.844 178.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -101.15 110.83 22.91 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.842 -0.617 . . . . 64.319999999999993 109.457 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -115.68 148.85 39.25 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.062 0.458 . . . . 74.150000000000006 110.886 -179.204 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 746' ' ' LEU . . . . . . . . . . . . . 59.2 tp -77.88 117.45 19.25 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.682 -0.69 . . . . 73.319999999999993 110.229 178.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 93.6 t -72.83 -51.45 27.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 116.111 -0.495 . . . . 72.239999999999995 109.807 176.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -169.57 155.65 6.18 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.655 -0.702 . . . . 64.299999999999997 109.899 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 749' ' ' GLN . . . . . 0.554 ' HA ' ' O ' ' A' ' 757' ' ' LYS . 14.7 pt20 -130.69 98.97 4.8 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.413 0.625 . . . . 63.200000000000003 110.323 175.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 35.7 m -141.96 133.57 26.86 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.676 -0.693 . . . . 63.409999999999997 110.695 -177.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 170.04 -172.6 43.91 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 121.081 -0.581 . . . . 55.229999999999997 111.764 178.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 752' ' ' PRO . . . . . 0.836 ' HG2' ' HB2' ' A' ' 755' ' ' GLU . 39.0 Cg_endo -67.56 157.9 59.61 Favored 'Trans proline' 0 N--CA 1.464 -0.217 0 C-N-CA 122.774 2.316 . . . . 71.019999999999996 111.569 177.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -58.73 -32.35 96.79 Favored 'Trans proline' 0 CA--C 1.532 0.405 0 C-N-CA 122.52 2.146 . . . . 73.5 113.109 -177.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 47.9 p-80 -83.04 -18.59 39.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.958 0.408 . . . . 75.430000000000007 111.081 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 755' ' ' GLU . . . . . 0.836 ' HB2' ' HG2' ' A' ' 752' ' ' PRO . 58.9 mm-40 -129.4 74.1 81.16 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.114 -0.493 . . . . 74.230000000000004 110.832 179.145 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 756' ' ' PRO . . . . . 0.725 ' O ' ' HA ' ' A' ' 775' ' ' HIS . 29.5 Cg_endo -64.51 102.6 0.41 Allowed 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.083 1.855 . . . . 65.120000000000005 110.23 174.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 757' ' ' LYS . . . . . 0.554 ' O ' ' HA ' ' A' ' 749' ' ' GLN . 0.8 OUTLIER -89.51 105.43 17.79 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.088 0.471 . . . . 73.140000000000001 111.366 -170.01 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 758' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -92.29 110.11 21.5 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.464 -0.789 . . . . 73.319999999999993 109.752 177.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 13.8 t -84.57 109.24 17.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.607 -0.724 . . . . 62.310000000000002 109.423 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -110.81 135.79 50.84 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.269 -0.423 . . . . 72.400000000000006 110.895 -178.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 761' ' ' GLN . . . . . 0.567 ' HA ' ' O ' ' A' ' 770' ' ' PRO . 57.7 tt0 -128.35 130.85 48.37 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.119 -0.491 . . . . 74.209999999999994 109.973 179.291 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 762' ' ' ALA . . . . . . . . . . . . . . . -89.59 117.73 28.7 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.18 0.514 . . . . 45.450000000000003 110.749 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 763' ' ' LYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 742' ' ' ALA . 60.5 tttm -89.62 113.98 25.51 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.222 -0.658 . . . . 64.430000000000007 109.222 175.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 92.8 t -124.0 101.35 8.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.363 0.601 . . . . 73.140000000000001 110.162 178.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 73.14 -116.05 5.39 Favored Glycine 0 N--CA 1.442 -0.923 0 CA-C-N 115.187 -0.915 . . . . 74.099999999999994 111.426 -177.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -102.36 -11.23 36.69 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.801 -0.714 . . . . 73.239999999999995 111.998 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 767' ' ' ARG . . . . . . . . . . . . . 62.9 mtt180 -99.81 146.28 26.78 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.259 0.552 . . . . 64.319999999999993 111.673 -178.165 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 768' ' ' TRP . . . . . 0.467 ' CH2' ' HD2' ' A' ' 763' ' ' LYS . 63.0 m95 -111.77 107.36 16.41 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.208 -0.905 . . . . 74.329999999999998 109.404 179.132 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 769' ' ' PHE . . . . . 0.503 ' HA ' ' HA ' ' A' ' 770' ' ' PRO . 43.1 p90 -169.19 141.0 2.02 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-O 121.048 0.452 . . . . 75.239999999999995 111.124 -176.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 770' ' ' PRO . . . . . 0.726 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 74.8 Cg_endo -98.46 176.94 7.65 Favored 'Cis proline' 0 N--CA 1.449 -1.089 0 C-N-CA 123.301 -1.541 . . . . 75.430000000000007 111.397 -5.353 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -111.55 99.29 8.07 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.991 0.424 . . . . 71.310000000000002 109.978 173.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 34.4 m -106.22 161.04 5.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.881 -0.6 . . . . 75.129999999999995 110.926 -177.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 773' ' ' CYS . . . . . 0.433 ' HB3' ' CG ' ' A' ' 757' ' ' LYS . 39.3 m -125.58 114.25 18.49 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.219 -0.446 . . . . 54.020000000000003 110.633 -178.123 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -128.61 153.48 47.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.224 -0.443 . . . . 53.32 109.947 178.113 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 775' ' ' HIS . . . . . 0.725 ' HA ' ' O ' ' A' ' 756' ' ' PRO . 1.9 p-80 -84.11 19.47 1.8 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.992 0.425 . . . . 73.299999999999997 111.492 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 24.9 t -153.32 143.19 22.06 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.396 -0.594 . . . . 75.219999999999999 109.396 175.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 777' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -60.65 -55.24 35.68 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.163 -0.472 . . . . 73.019999999999996 111.97 -175.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -65.92 -31.41 72.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.558 -0.292 . . . . 74.129999999999995 110.592 -175.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 779' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -62.0 -46.74 87.88 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.486 -0.561 . . . . 74.099999999999994 109.486 172.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -56.88 -47.73 84.19 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.698 -0.683 . . . . 52.439999999999998 112.169 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -59.21 -43.89 92.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.534 0.207 . . . . 75.450000000000003 111.364 177.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -68.58 -46.37 69.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.706 -0.225 . . . . 71.450000000000003 111.441 -178.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -64.05 -39.27 93.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.653 0.263 . . . . 72.340000000000003 110.522 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -62.37 -49.39 75.73 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 116.254 -0.43 . . . . 62.43 110.438 176.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 785' ' ' ALA . . . . . 0.596 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -61.38 -42.17 98.28 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.181 -0.463 . . . . 53.32 111.151 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 786' ' ' ASP . . . . . 0.622 ' O ' ' HG2' ' A' ' 790' ' ' ARG . 10.4 t70 -58.91 -54.22 49.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 70.129999999999995 110.375 178.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 787' ' ' ALA . . . . . 0.558 ' O ' HG23 ' A' ' 791' ' ' VAL . . . -65.41 -33.91 77.06 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.966 -0.561 . . . . 63.439999999999998 111.097 -178.454 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 788' ' ' ALA . . . . . 0.726 ' HB2' ' HD3' ' A' ' 770' ' ' PRO . . . -61.3 -44.52 97.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.476 -0.329 . . . . 61.200000000000003 110.729 177.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 789' ' ' LEU . . . . . 0.659 HD22 HD12 ' A' ' 719' ' ' LEU . 53.3 mt -63.19 -36.16 82.71 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.483 -0.326 . . . . 74.209999999999994 110.199 179.291 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 790' ' ' ARG . . . . . 0.622 ' HG2' ' O ' ' A' ' 786' ' ' ASP . 21.2 mmt180 -58.15 -45.63 87.06 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 109.739 -0.467 . . . . 71.120000000000005 109.739 177.031 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 791' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 787' ' ' ALA . 30.4 t -61.34 -46.71 96.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.62 -0.718 . . . . 74.140000000000001 110.388 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 792' ' ' LEU . . . . . 0.676 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 45.8 mt -62.2 -50.65 70.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.665 -0.698 . . . . 75.120000000000005 110.915 -178.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 793' ' ' ILE . . . . . 0.499 HD13 HG22 ' A' ' 720' ' ' VAL . 91.4 mt -59.25 -53.81 42.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.587 -0.733 . . . . 64.299999999999997 110.774 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -60.5 -31.85 75.92 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.857 -0.687 . . . . 61.420000000000002 112.615 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -65.23 -48.27 73.89 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.145 0.497 . . . . 75.209999999999994 109.991 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 . . . . . 0 C--N 1.323 -0.572 0 CA-C-N 116.054 -0.521 . . . . 71.310000000000002 111.623 -175.137 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 716' ' ' ILE . . . . . 0.436 ' HA ' HD23 ' A' ' 719' ' ' LEU . 50.1 mm . . . . . 0 C--O 1.233 0.206 0 CA-C-O 120.889 0.376 . . . . 64.219999999999999 111.398 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -56.45 -29.53 57.35 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 121.187 -0.53 . . . . 41.450000000000003 112.435 177.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 718' ' ' GLU . . . . . 0.614 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 9.3 mm-40 -60.57 -53.36 58.42 Favored 'General case' 0 C--O 1.225 -0.236 0 N-CA-C 109.985 -0.376 . . . . 74.430000000000007 109.985 176.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 719' ' ' LEU . . . . . 0.547 HD12 HD22 ' A' ' 789' ' ' LEU . 2.7 mm? -60.35 -35.88 76.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.042 -0.527 . . . . 70.109999999999999 110.461 -177.033 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 720' ' ' VAL . . . . . 0.442 HG22 HD13 ' A' ' 793' ' ' ILE . 58.7 t -62.09 -41.37 90.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 116.07 -0.514 . . . . 73.319999999999993 110.871 178.41 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 721' ' ' ARG . . . . . 0.614 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 19.1 ptt180 -66.82 -26.05 66.74 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.308 -0.405 . . . . 54.200000000000003 110.064 -178.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -77.33 -30.67 54.12 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 116.293 -0.412 . . . . 74.409999999999997 110.787 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 723' ' ' LEU . . . . . 0.529 HD21 ' HB2' ' A' ' 789' ' ' LEU . 55.8 mt -64.01 -23.97 67.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.167 0.508 . . . . 74.030000000000001 110.002 173.244 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -89.51 -26.38 20.92 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.748 -0.66 . . . . 71.209999999999994 110.989 176.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 10.9 m -106.29 -77.47 0.59 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.909 0.385 . . . . 74.430000000000007 111.407 -175.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 726' ' ' ASN . . . . . 0.434 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 29.3 t30 -145.31 108.19 4.51 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.347 -0.388 . . . . 72.439999999999998 110.231 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 727' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 13.6 Cg_endo -57.6 -38.48 93.45 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.966 2.444 . . . . 60.030000000000001 112.413 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 728' ' ' VAL . . . . . 0.411 ' O ' ' HG ' ' A' ' 732' ' ' LEU . 55.8 t -60.57 -47.5 92.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.244 -0.434 . . . . 72.120000000000005 110.34 -179.076 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -62.43 -32.28 82.47 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.67 -0.695 . . . . 44.439999999999998 111.822 178.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -67.89 -43.73 81.92 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.092 -0.575 . . . . 71.439999999999998 112.461 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -64.9 -40.46 95.11 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.633 -0.506 . . . . 72.450000000000003 109.633 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 732' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 728' ' ' VAL . 84.6 mt -63.67 -41.51 98.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.842 -0.617 . . . . 64.040000000000006 110.451 176.193 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 733' ' ' GLU . . . . . 0.483 ' O ' ' HG2' ' A' ' 736' ' ' ARG . 2.5 tp10 -65.55 -44.59 86.31 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 123.052 0.541 . . . . 74.129999999999995 110.86 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 734' ' ' TYR . . . . . 0.478 ' HB2' HD11 ' A' ' 719' ' ' LEU . 27.1 t80 -56.23 -51.63 67.4 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.974 -0.557 . . . . 72.340000000000003 111.08 178.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -66.13 -46.86 76.04 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.393 -0.367 . . . . 64.010000000000005 111.291 -177.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 736' ' ' ARG . . . . . 0.483 ' HG2' ' O ' ' A' ' 733' ' ' GLU . 25.7 ptt180 -64.32 -29.34 70.42 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.201 0.524 . . . . 71.099999999999994 111.239 -175.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 33.8 t -83.64 -35.11 24.84 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.778 -0.646 . . . . 64.430000000000007 111.222 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 13.2 m170 -93.6 -10.29 35.18 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.201 0.445 . . . . 70.120000000000005 112.201 -172.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 103.1 3.92 48.05 Favored Glycine 0 N--CA 1.453 -0.172 0 C-N-CA 120.417 -0.897 . . . . 73.519999999999996 112.751 176.017 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -90.91 178.29 6.07 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.042 0.448 . . . . 71.099999999999994 110.542 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 741' ' ' ALA . . . . . 0.529 ' O ' ' HA ' ' A' ' 764' ' ' VAL . . . -120.16 134.55 55.23 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.847 -0.615 . . . . 55.140000000000001 109.492 174.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 742' ' ' ALA . . . . . 0.403 ' HB3' HD23 ' A' ' 732' ' ' LEU . . . -102.18 113.29 26.44 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.526 -0.306 . . . . 70.439999999999998 110.808 -177.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 743' ' ' GLU . . . . . 0.552 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 46.2 mt-10 -123.84 140.62 52.81 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.172 -0.467 . . . . 63.210000000000001 110.818 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -121.96 105.15 10.06 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.569 -0.53 . . . . 74.439999999999998 109.569 176.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.52 153.3 35.57 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.566 -0.454 . . . . 62.450000000000003 111.453 -177.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 746' ' ' LEU . . . . . . . . . . . . . 57.0 tp -82.03 116.14 21.5 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.473 -0.785 . . . . 54.32 109.407 173.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 52.2 t -88.06 -47.72 15.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 116.292 -0.413 . . . . 70.530000000000001 110.323 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -141.42 143.97 34.21 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.203 -0.453 . . . . 70.120000000000005 111.261 -176.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -130.06 100.6 5.49 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.816 -0.629 . . . . 74.430000000000007 109.395 174.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 750' ' ' SER . . . . . 0.418 ' O ' ' HB3' ' A' ' 757' ' ' LYS . 20.1 m -136.37 110.53 8.35 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.993 -0.548 . . . . 45.229999999999997 110.547 -177.588 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 174.15 177.9 43.67 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.976 -0.631 . . . . 64.450000000000003 111.803 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 752' ' ' PRO . . . . . 0.42 ' HG2' ' HB2' ' A' ' 755' ' ' GLU . 55.7 Cg_endo -71.01 155.87 61.06 Favored 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 122.85 2.367 . . . . 72.120000000000005 111.959 178.401 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -64.82 -30.29 58.62 Favored 'Trans proline' 0 CA--C 1.528 0.202 0 C-N-CA 122.603 2.202 . . . . 63.439999999999998 112.975 -176.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 56.0 p-80 -84.35 -23.61 30.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.772 0.32 . . . . 74.5 111.024 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 755' ' ' GLU . . . . . 0.42 ' HB2' ' HG2' ' A' ' 752' ' ' PRO . 23.8 mm-40 -133.01 71.7 77.55 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.147 -0.479 . . . . 73.420000000000002 110.431 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 756' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -64.41 143.13 81.55 Favored 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 122.362 2.041 . . . . 70.310000000000002 112.08 -176.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 757' ' ' LYS . . . . . 0.418 ' HB3' ' O ' ' A' ' 750' ' ' SER . 23.3 ttmm -116.44 114.93 24.92 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.054 -0.521 . . . . 64.340000000000003 109.735 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 758' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -107.02 113.08 26.34 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.889 -0.596 . . . . 71.319999999999993 110.663 -177.043 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 759' ' ' VAL . . . . . 0.471 HG22 ' HB3' ' A' ' 773' ' ' CYS . 29.1 t -87.26 98.11 7.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.848 -0.615 . . . . 60.350000000000001 109.556 176.412 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 760' ' ' TYR . . . . . 0.537 ' OH ' ' HG3' ' A' ' 777' ' ' LYS . 6.3 m-85 -100.1 143.04 30.77 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.893 -0.594 . . . . 45.149999999999999 110.236 179.228 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -131.77 137.44 48.18 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.12 -0.491 . . . . 53.310000000000002 109.695 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 762' ' ' ALA . . . . . . . . . . . . . . . -86.28 114.01 22.74 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.037 -0.529 . . . . 55.329999999999998 110.489 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 763' ' ' LYS . . . . . 0.552 ' HB3' ' HB2' ' A' ' 743' ' ' GLU . 59.3 tttm -96.82 100.44 11.98 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.771 -0.65 . . . . 65.030000000000001 109.699 178.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 764' ' ' VAL . . . . . 0.529 ' HA ' ' O ' ' A' ' 741' ' ' ALA . 61.1 t -104.21 100.81 11.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 N-CA-C 109.448 -0.575 . . . . 70.239999999999995 109.448 -179.343 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 69.96 -122.49 11.66 Favored Glycine 0 N--CA 1.442 -0.904 0 N-CA-C 110.479 -1.048 . . . . 73.549999999999997 110.479 -172.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -104.01 20.21 41.48 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.596 -0.811 . . . . 51.43 111.545 174.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 767' ' ' ARG . . . . . . . . . . . . . 41.6 ttt180 -115.53 122.76 46.65 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.735 0.302 . . . . 74.400000000000006 110.394 -176.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 768' ' ' TRP . . . . . 0.488 ' CH2' ' HD2' ' A' ' 763' ' ' LYS . 44.1 m95 -98.21 103.18 15.1 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.243 -0.435 . . . . 73.120000000000005 110.204 -178.333 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 769' ' ' PHE . . . . . 0.405 ' HA ' ' HA ' ' A' ' 770' ' ' PRO . 9.3 p90 -171.56 138.97 1.11 Allowed Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 120.822 0.344 . . . . 65.409999999999997 110.554 178.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 770' ' ' PRO . . . . . 0.633 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 82.8 Cg_endo -96.58 -176.49 5.16 Favored 'Cis proline' 0 N--CA 1.452 -0.947 0 C-N-CA 123.622 -1.407 . . . . 60.43 111.769 -4.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -117.4 129.79 56.07 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.077 -0.342 . . . . 32.130000000000003 110.077 176.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 30.7 m -136.63 145.97 29.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.748 0.309 . . . . 35.409999999999997 111.044 -178.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 773' ' ' CYS . . . . . 0.471 ' HB3' HG22 ' A' ' 759' ' ' VAL . 5.0 p -113.36 103.39 11.26 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.105 0.479 . . . . 74.030000000000001 110.695 178.324 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -106.43 -179.24 3.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.291 -0.413 . . . . 53.409999999999997 111.125 -176.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 775' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 -93.77 -8.65 40.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.286 0.565 . . . . 74.230000000000004 110.231 -177.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 63.6 m -150.75 166.05 31.63 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.754 -0.657 . . . . 50.539999999999999 110.403 -179.01 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 777' ' ' LYS . . . . . 0.537 ' HG3' ' OH ' ' A' ' 760' ' ' TYR . 31.2 ttmt -64.33 -57.64 8.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.269 -0.423 . . . . 74.219999999999999 111.741 -178.106 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -61.67 -35.96 79.47 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.054 -0.521 . . . . 65.340000000000003 110.039 -175.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 779' ' ' GLN . . . . . 0.474 ' O ' ' HG2' ' A' ' 783' ' ' GLU . 73.9 mt-30 -52.91 -56.2 17.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 75.25 110.18 170.263 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -57.37 -47.68 86.21 Favored Glycine 0 C--N 1.332 0.33 0 CA-C-N 115.698 -0.683 . . . . 34.340000000000003 112.764 -177.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -57.48 -44.52 84.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.754 0.311 . . . . 71.439999999999998 111.177 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -69.83 -45.18 68.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.418 -0.356 . . . . 74.120000000000005 111.176 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 783' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' A' ' 779' ' ' GLN . 30.0 mm-40 -59.86 -40.39 88.43 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.902 0.382 . . . . 52.520000000000003 110.768 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -65.38 -49.87 67.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 72.219999999999999 110.612 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 785' ' ' ALA . . . . . 0.513 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -64.79 -40.09 94.66 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.312 -0.404 . . . . 65.230000000000004 111.18 -178.362 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 786' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -60.76 -50.05 75.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.984 -0.553 . . . . 51.140000000000001 110.108 178.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 787' ' ' ALA . . . . . 0.616 ' O ' HG23 ' A' ' 791' ' ' VAL . . . -62.6 -39.64 94.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.757 -0.656 . . . . 72.239999999999995 110.712 178.276 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 788' ' ' ALA . . . . . 0.633 ' HB2' ' HD3' ' A' ' 770' ' ' PRO . . . -59.05 -47.36 85.53 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.072 -0.513 . . . . 64.109999999999999 111.338 -179.148 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 789' ' ' LEU . . . . . 0.547 HD22 HD12 ' A' ' 719' ' ' LEU . 77.9 mt -61.42 -41.77 97.69 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 110.109 -0.33 . . . . 75.200000000000003 110.109 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 790' ' ' ARG . . . . . 0.552 ' HD2' ' HA ' ' A' ' 787' ' ' ALA . 69.8 mtt-85 -57.38 -39.36 75.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 73.230000000000004 110.943 176.636 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 791' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 787' ' ' ALA . 60.1 t -63.33 -57.31 12.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.102 -0.499 . . . . 62.140000000000001 110.037 176.601 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 792' ' ' LEU . . . . . 0.595 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 37.1 mt -55.93 -47.72 77.01 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.487 -0.779 . . . . 75.409999999999997 111.522 -176.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 793' ' ' ILE . . . . . 0.442 HD13 HG22 ' A' ' 720' ' ' VAL . 95.7 mt -61.14 -46.47 96.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.795 -0.639 . . . . 72.329999999999998 110.934 178.545 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -60.69 -39.46 96.66 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.949 -0.643 . . . . 71.140000000000001 112.252 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 795' ' ' GLU . . . . . 0.564 ' HG2' ' O ' ' A' ' 791' ' ' VAL . 21.5 mm-40 -52.44 -44.13 65.31 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.08 0.467 . . . . 74.549999999999997 110.901 177.472 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 8.0 t30 . . . . . 0 C--N 1.326 -0.418 0 CA-C-N 115.934 -0.575 . . . . 55.210000000000001 112.008 -175.408 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 716' ' ' ILE . . . . . 0.537 HG23 ' HA ' ' A' ' 793' ' ' ILE . 38.5 mm . . . . . 0 CA--C 1.531 0.247 0 N-CA-C 112.694 0.628 . . . . 70.530000000000001 112.694 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -63.81 -30.66 78.35 Favored Glycine 0 C--O 1.237 0.29 0 C-N-CA 120.785 -0.721 . . . . 34.549999999999997 112.358 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 718' ' ' GLU . . . . . 0.658 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 35.4 mt-10 -73.03 -37.84 66.75 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 110.127 -0.323 . . . . 75.030000000000001 110.127 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 719' ' ' LEU . . . . . 0.705 HD12 HD22 ' A' ' 789' ' ' LEU . 2.6 mm? -58.1 -35.04 70.85 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.013 0.435 . . . . 75.219999999999999 110.308 175.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 720' ' ' VAL . . . . . 0.48 HG22 HD13 ' A' ' 793' ' ' ILE . 71.6 t -61.92 -41.16 89.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.856 -0.611 . . . . 71.219999999999999 110.997 178.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 721' ' ' ARG . . . . . 0.658 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 8.2 ptt180 -65.15 -25.35 67.71 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.979 0.419 . . . . 73.310000000000002 110.506 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -77.14 -29.17 54.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.398 -0.365 . . . . 74.319999999999993 110.767 178.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 723' ' ' LEU . . . . . 0.561 HD21 ' HB2' ' A' ' 789' ' ' LEU . 95.8 mt -62.06 -30.03 70.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.371 0.605 . . . . 70.310000000000002 109.742 173.095 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -81.95 -40.1 22.72 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.283 -0.871 . . . . 72.010000000000005 110.428 176.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 12.1 m -93.02 -83.44 0.31 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.983 -0.553 . . . . 63.149999999999999 111.416 -176.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 726' ' ' ASN . . . . . 0.421 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 44.9 t30 -140.76 110.2 6.67 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.789 0.328 . . . . 61.240000000000002 110.504 -176.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 727' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 28.5 Cg_endo -63.68 -37.24 47.67 Favored 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 122.814 2.343 . . . . 73.299999999999997 112.312 -178.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 44.0 t -61.24 -49.03 86.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.187 -0.46 . . . . 60.530000000000001 110.501 -178.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -64.02 -35.83 92.49 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.963 -0.637 . . . . 74.310000000000002 111.836 178.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -66.8 -41.61 93.51 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 121.063 -0.589 . . . . 74.120000000000005 112.457 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -63.48 -41.2 98.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.095 0.474 . . . . 65.040000000000006 109.733 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 732' ' ' LEU . . . . . 0.42 HD23 ' HB3' ' A' ' 742' ' ' ALA . 75.4 mt -68.29 -39.14 82.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.829 -0.623 . . . . 71.310000000000002 110.65 177.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 733' ' ' GLU . . . . . 0.549 ' O ' ' HG2' ' A' ' 736' ' ' ARG . 2.2 tp10 -65.29 -45.11 85.72 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 123.391 0.676 . . . . 64.109999999999999 111.067 -179.262 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 734' ' ' TYR . . . . . 0.617 ' HB2' HD11 ' A' ' 719' ' ' LEU . 7.4 t80 -60.21 -46.78 88.56 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.389 -0.369 . . . . 54.100000000000001 110.66 176.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 735' ' ' ALA . . . . . 0.446 ' HA ' ' HB2' ' A' ' 740' ' ' PHE . . . -64.11 -49.02 73.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.133 -0.485 . . . . 61.109999999999999 110.891 -177.184 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 736' ' ' ARG . . . . . 0.549 ' HG2' ' O ' ' A' ' 733' ' ' GLU . 23.3 ptt180 -59.97 -38.58 82.96 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.869 -0.605 . . . . 73.349999999999994 111.111 -176.145 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 32.9 t -78.46 -23.27 46.58 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.969 -0.559 . . . . 71.109999999999999 111.461 -177.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -108.91 4.96 23.97 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.118 0.414 . . . . 71.329999999999998 112.118 -174.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 89.04 2.76 77.33 Favored Glycine 0 C--O 1.229 -0.177 0 C-N-CA 120.736 -0.745 . . . . 73.25 113.261 174.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 740' ' ' PHE . . . . . 0.446 ' HB2' ' HA ' ' A' ' 735' ' ' ALA . 90.3 m-85 -83.52 161.26 21.29 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.874 0.369 . . . . 72.420000000000002 110.842 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -115.01 104.24 11.71 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.879 -0.6 . . . . 62.140000000000001 109.538 176.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 742' ' ' ALA . . . . . 0.42 ' HB3' HD23 ' A' ' 732' ' ' LEU . . . -86.4 125.7 33.86 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.04 -0.527 . . . . 72.049999999999997 111.208 -176.092 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 743' ' ' GLU . . . . . 0.426 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 43.3 mt-10 -137.82 134.72 35.5 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.047 -0.524 . . . . 75.109999999999999 110.382 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -107.21 105.74 15.87 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.5 -0.556 . . . . 74.120000000000005 109.5 176.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.53 147.25 44.68 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.053 0.454 . . . . 61.100000000000001 111.131 -174.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 746' ' ' LEU . . . . . . . . . . . . . 51.3 tp -77.22 122.01 24.46 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.701 -0.681 . . . . 54.130000000000003 110.006 176.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 60.1 t -81.76 -50.35 16.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.09 -0.505 . . . . 74.349999999999994 109.694 177.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -165.99 156.26 12.68 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.697 -0.683 . . . . 74.030000000000001 110.032 -177.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -114.32 119.14 35.94 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.98 -0.378 . . . . 64.230000000000004 109.98 174.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 750' ' ' SER . . . . . 0.506 ' O ' ' HB3' ' A' ' 757' ' ' LYS . 67.6 m -135.56 107.38 7.05 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.107 -0.497 . . . . 41.140000000000001 110.142 179.219 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 174.81 153.38 10.01 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.261 -0.971 . . . . 71.010000000000005 112.745 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 752' ' ' PRO . . . . . 0.709 ' HG2' ' HB2' ' A' ' 755' ' ' GLU . 36.2 Cg_endo -66.53 168.69 15.85 Favored 'Trans proline' 0 CA--C 1.533 0.427 0 C-N-CA 123.348 2.698 . . . . 71.430000000000007 111.968 176.007 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.61 -31.88 95.09 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.595 2.197 . . . . 75.010000000000005 112.88 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 42.9 p-80 -87.5 -5.05 58.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.415 -0.357 . . . . 64.310000000000002 111.259 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 755' ' ' GLU . . . . . 0.709 ' HB2' ' HG2' ' A' ' 752' ' ' PRO . 12.2 mm-40 -150.39 64.21 6.5 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.156 -0.475 . . . . 72.140000000000001 110.715 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 756' ' ' PRO . . . . . 0.472 ' O ' ' HA ' ' A' ' 775' ' ' HIS . 14.4 Cg_exo -68.42 92.15 0.41 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.711 2.274 . . . . 71.230000000000004 111.33 178.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 757' ' ' LYS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 775' ' ' HIS . 15.0 ttmt -89.05 111.73 22.53 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.522 0.677 . . . . 65.329999999999998 111.262 -174.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 758' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -90.76 130.85 36.7 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.943 -1.026 . . . . 74.040000000000006 109.832 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 29.2 t -92.87 109.04 21.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.609 -0.515 . . . . 73.150000000000006 109.609 175.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -111.92 141.19 45.87 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.303 -0.408 . . . . 71.140000000000001 110.646 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -126.97 137.82 53.17 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.977 -0.556 . . . . 72.150000000000006 109.92 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 762' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' A' ' 769' ' ' PHE . . . -85.44 109.82 18.73 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.402 0.62 . . . . 74.239999999999995 110.428 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 763' ' ' LYS . . . . . 0.426 ' HB3' ' HB2' ' A' ' 743' ' ' GLU . 75.1 tttt -94.08 104.29 16.33 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.228 -0.896 . . . . 61.310000000000002 109.483 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 48.4 t -117.2 98.04 6.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 120.939 0.4 . . . . 62.420000000000002 111.176 -175.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 60.5 37.27 93.03 Favored Glycine 0 CA--C 1.517 0.193 0 CA-C-N 115.716 -0.674 . . . . 61.009999999999998 113.143 176.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 94.86 -16.11 61.98 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.545 -0.836 . . . . 72.230000000000004 112.62 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 767' ' ' ARG . . . . . . . . . . . . . 79.0 mtt180 -90.64 129.28 36.78 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.054 -0.35 . . . . 63.420000000000002 110.054 176.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 768' ' ' TRP . . . . . . . . . . . . . 68.3 m95 -106.58 99.15 8.74 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.408 -0.36 . . . . 72.239999999999995 110.484 -176.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 769' ' ' PHE . . . . . 0.473 ' HA ' ' HA ' ' A' ' 770' ' ' PRO . 36.3 p90 -170.22 136.86 1.29 Allowed Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.533 -0.303 . . . . 71.019999999999996 110.327 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 770' ' ' PRO . . . . . 0.572 ' HG3' ' HB3' ' A' ' 787' ' ' ALA . 62.5 Cg_endo -94.89 179.02 9.23 Favored 'Cis proline' 0 N--CA 1.45 -1.04 0 C-N-CA 123.484 -1.465 . . . . 72.140000000000001 111.978 -3.313 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -115.56 104.14 11.43 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.938 -0.393 . . . . 62.340000000000003 109.938 175.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 29.6 m -113.67 164.27 9.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.001 0.429 . . . . 72.0 111.05 -175.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 773' ' ' CYS . . . . . 0.475 ' HB2' ' HG2' ' A' ' 757' ' ' LYS . 10.6 p -127.87 119.19 25.1 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.082 -0.508 . . . . 63.25 110.193 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -135.91 144.33 45.46 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.41 -0.359 . . . . 73.439999999999998 110.612 -178.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 775' ' ' HIS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 757' ' ' LYS . 1.1 p-80 -76.45 16.5 0.47 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.496 0.554 . . . . 73.349999999999994 112.496 -177.371 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 776' ' ' SER . . . . . 0.571 ' HB2' ' CG ' ' A' ' 779' ' ' GLN . 11.8 m -147.13 140.32 25.3 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.654 -0.498 . . . . 42.439999999999998 109.654 177.346 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 777' ' ' LYS . . . . . 0.434 ' HE3' ' HB3' ' A' ' 777' ' ' LYS . 2.2 tmmt? -61.46 -46.25 90.84 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.435 -0.348 . . . . 65.209999999999994 111.227 -178.369 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 778' ' ' LYS . . . . . 0.501 ' O ' ' HG3' ' A' ' 782' ' ' GLN . 63.7 pttt -66.5 -35.48 80.37 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.929 -0.308 . . . . 62.119999999999997 110.442 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 779' ' ' GLN . . . . . 0.571 ' CG ' ' HB2' ' A' ' 776' ' ' SER . 16.0 mm100 -63.79 -43.9 94.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.337 -0.392 . . . . 61.420000000000002 110.05 177.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -57.52 -40.46 92.38 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.002 -0.618 . . . . 42.32 111.92 178.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 30.3 mtpp -66.5 -47.0 74.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.639 0.257 . . . . 75.329999999999998 110.831 178.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 782' ' ' GLN . . . . . 0.501 ' HG3' ' O ' ' A' ' 778' ' ' LYS . 92.8 mt-30 -68.25 -48.17 65.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.221 -0.445 . . . . 65.329999999999998 111.228 -177.058 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -58.76 -46.15 88.12 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 123.25 0.344 . . . . 62.240000000000002 110.999 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -63.17 -48.01 80.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.305 -0.407 . . . . 75.510000000000005 110.893 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 785' ' ' ALA . . . . . 0.631 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -62.64 -42.19 99.46 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.268 -0.424 . . . . 31.32 111.089 -178.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 786' ' ' ASP . . . . . 0.523 ' O ' ' HG2' ' A' ' 790' ' ' ARG . 11.7 t70 -59.48 -55.74 30.77 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.04 -0.527 . . . . 72.430000000000007 110.129 179.262 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 787' ' ' ALA . . . . . 0.572 ' HB3' ' HG3' ' A' ' 770' ' ' PRO . . . -61.52 -34.68 75.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.75 -0.659 . . . . 71.209999999999994 111.203 -178.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 788' ' ' ALA . . . . . 0.592 ' O ' ' HG ' ' A' ' 792' ' ' LEU . . . -61.22 -42.78 99.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.421 -0.354 . . . . 65.239999999999995 110.888 178.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 789' ' ' LEU . . . . . 0.705 HD22 HD12 ' A' ' 719' ' ' LEU . 35.5 mt -66.05 -33.93 76.92 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.421 -0.354 . . . . 74.340000000000003 110.122 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 790' ' ' ARG . . . . . 0.523 ' HG2' ' O ' ' A' ' 786' ' ' ASP . 6.2 mmm180 -61.71 -44.47 96.85 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.493 -0.558 . . . . 72.409999999999997 109.493 178.574 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 791' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 787' ' ' ALA . 41.2 t -57.69 -44.26 85.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.512 -0.767 . . . . 74.219999999999999 110.559 178.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 792' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 30.3 mt -68.15 -52.06 38.95 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.732 -0.667 . . . . 73.549999999999997 110.713 -178.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 793' ' ' ILE . . . . . 0.537 ' HA ' HG23 ' A' ' 716' ' ' ILE . 95.7 mt -60.23 -47.33 92.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.539 -0.755 . . . . 75.030000000000001 111.456 -177.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -68.71 -26.36 74.54 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.766 -0.731 . . . . 55.130000000000003 112.506 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -77.81 -44.28 27.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.876 0.37 . . . . 61.439999999999998 110.921 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 796' ' ' ASN . . . . . 0.401 ' HB3' HG13 ' A' ' 716' ' ' ILE . 1.6 t30 . . . . . 0 C--N 1.324 -0.513 0 CA-C-O 121.007 0.432 . . . . 74.420000000000002 110.664 -176.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 716' ' ' ILE . . . . . 0.567 HG23 HG12 ' A' ' 793' ' ' ILE . 44.7 mm . . . . . 0 N--CA 1.455 -0.216 0 CA-C-O 120.768 0.318 . . . . 75.409999999999997 111.166 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -58.71 -29.1 63.81 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.742 -0.742 . . . . 74.340000000000003 111.645 175.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 718' ' ' GLU . . . . . 0.715 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 43.7 mm-40 -70.17 -40.43 74.71 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-O 120.707 0.289 . . . . 65.219999999999999 110.77 178.348 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 719' ' ' LEU . . . . . 0.581 HD12 HD22 ' A' ' 789' ' ' LEU . 3.1 mm? -64.4 -27.08 68.76 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.127 0.489 . . . . 65.140000000000001 109.929 177.558 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 720' ' ' VAL . . . . . 0.433 HG22 HD13 ' A' ' 793' ' ' ILE . 98.2 t -76.18 -36.85 31.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.789 -0.641 . . . . 74.310000000000002 111.346 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 721' ' ' ARG . . . . . 0.715 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 5.9 ptm180 -67.89 -22.77 65.08 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.34 0.591 . . . . 71.120000000000005 109.762 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -77.22 -31.02 54.88 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.929 -0.578 . . . . 73.450000000000003 110.622 175.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 723' ' ' LEU . . . . . 0.551 HD21 ' HB2' ' A' ' 789' ' ' LEU . 85.3 mt -60.13 -30.41 69.27 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.284 0.564 . . . . 71.140000000000001 109.894 174.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -87.98 -39.49 14.66 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.352 -0.84 . . . . 72.430000000000007 111.303 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 30.7 m -90.23 -76.17 0.44 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.756 0.312 . . . . 71.209999999999994 111.761 -177.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 726' ' ' ASN . . . . . 0.468 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 25.2 t30 -150.84 105.56 3.03 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.458 -0.337 . . . . 71.340000000000003 110.453 -178.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 727' ' ' PRO . . . . . 0.468 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 18.1 Cg_endo -60.63 -32.55 93.44 Favored 'Trans proline' 0 N--CA 1.464 -0.207 0 C-N-CA 123.131 2.554 . . . . 74.420000000000002 112.47 -178.276 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 43.4 t -61.88 -48.05 90.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.09 -0.505 . . . . 52.409999999999997 110.47 -177.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -63.06 -32.66 84.91 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.925 -0.655 . . . . 72.219999999999999 112.183 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -73.88 -44.48 30.76 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.753 -0.737 . . . . 71.450000000000003 112.5 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -64.1 -40.97 97.38 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.85 0.357 . . . . 72.400000000000006 110.147 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 732' ' ' LEU . . . . . . . . . . . . . 93.3 mt -64.19 -40.85 96.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.119 -0.492 . . . . 71.439999999999998 111.523 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 733' ' ' GLU . . . . . 0.511 ' HA ' ' HG2' ' A' ' 736' ' ' ARG . 6.5 pt-20 -78.35 -31.24 48.46 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.404 -0.518 . . . . 73.510000000000005 110.971 -178.258 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 734' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -53.76 -45.61 70.67 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 121.056 0.455 . . . . 75.319999999999993 109.942 175.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -66.06 -53.28 40.3 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.727 -0.67 . . . . 63.340000000000003 110.708 -178.106 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 736' ' ' ARG . . . . . 0.511 ' HG2' ' HA ' ' A' ' 733' ' ' GLU . 19.2 ptt85 -61.36 -34.42 75.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.092 -0.504 . . . . 73.329999999999998 111.209 -175.034 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 15.6 t -73.44 -36.4 65.91 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.815 -0.63 . . . . 63.140000000000001 111.137 178.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 13.4 m170 -95.64 3.19 54.21 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.948 0.351 . . . . 73.439999999999998 111.948 -173.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 95.08 0.01 63.88 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.519 -0.848 . . . . 74.030000000000001 113.367 173.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -94.27 -179.1 4.82 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.798 0.332 . . . . 64.010000000000005 110.393 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 741' ' ' ALA . . . . . 0.423 ' O ' ' HA ' ' A' ' 764' ' ' VAL . . . -127.2 134.64 50.1 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.212 -0.662 . . . . 64.099999999999994 109.212 173.105 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 742' ' ' ALA . . . . . . . . . . . . . . . -110.89 131.39 55.09 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.741 0.305 . . . . 45.109999999999999 111.166 -176.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 743' ' ' GLU . . . . . 0.487 ' HG3' ' HB3' ' A' ' 763' ' ' LYS . 12.7 pt-20 -147.57 153.27 39.23 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.92 -0.582 . . . . 73.310000000000002 110.435 178.156 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -120.6 118.26 29.69 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.061 -0.518 . . . . 72.239999999999995 109.781 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -122.2 138.19 54.57 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.524 -0.47 . . . . 74.209999999999994 111.246 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 746' ' ' LEU . . . . . 0.421 HD11 ' HD2' ' A' ' 758' ' ' PHE . 6.8 tt -74.24 119.14 18.03 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.501 -0.772 . . . . 73.299999999999997 109.176 176.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 43.9 t -94.89 -44.99 13.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.279 -0.419 . . . . 74.230000000000004 110.959 -177.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -149.29 158.02 43.83 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.402 -0.363 . . . . 74.25 110.77 -176.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -141.36 113.41 7.93 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.332 -0.618 . . . . 60.439999999999998 109.332 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 6.1 t -143.83 -167.29 2.56 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.869 -0.332 . . . . 62.439999999999998 110.324 -177.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 97.23 -150.38 19.52 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.853 -0.689 . . . . 72.219999999999999 111.787 -177.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 752' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -80.06 158.38 23.71 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.364 2.042 . . . . 73.420000000000002 111.802 178.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -73.13 -36.17 4.51 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.661 2.24 . . . . 64.420000000000002 112.376 -177.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -76.33 -29.27 57.21 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.96 -0.564 . . . . 73.340000000000003 110.834 -177.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -130.98 74.02 80.37 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 72.439999999999998 110.614 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 756' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -62.95 132.05 35.35 Favored 'Trans proline' 0 N--CA 1.465 -0.152 0 C-N-CA 122.685 2.257 . . . . 73.409999999999997 112.018 -177.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 757' ' ' LYS . . . . . 0.554 ' HG2' ' HB2' ' A' ' 773' ' ' CYS . 39.1 ttmt -98.83 111.83 24.1 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.279 0.561 . . . . 65.120000000000005 109.796 178.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 758' ' ' PHE . . . . . 0.436 ' O ' ' HA ' ' A' ' 773' ' ' CYS . 61.3 m-85 -90.27 123.25 33.89 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.116 -0.947 . . . . 74.510000000000005 110.595 -175.009 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 56.4 t -88.91 108.0 18.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.998 -0.547 . . . . 54.109999999999999 109.725 176.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -111.22 135.19 52.11 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.795 -0.639 . . . . 74.319999999999993 110.676 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -120.76 126.85 51.18 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.829 -0.623 . . . . 64.549999999999997 109.658 178.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 762' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 769' ' ' PHE . . . -83.94 120.92 26.68 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.179 0.514 . . . . 52.0 110.19 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 763' ' ' LYS . . . . . 0.69 ' HD2' ' CH2' ' A' ' 768' ' ' TRP . 49.4 tttm -104.32 107.3 18.15 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.842 -0.617 . . . . 65.150000000000006 110.054 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 764' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 741' ' ' ALA . 48.4 t -114.94 102.66 14.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.988 -0.551 . . . . 52.100000000000001 109.868 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 72.77 -123.15 8.67 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 110.821 -0.912 . . . . 74.230000000000004 110.821 -174.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -101.2 2.54 54.66 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.123 -0.791 . . . . 63.100000000000001 111.123 173.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 767' ' ' ARG . . . . . 0.44 ' NE ' ' HA ' ' A' ' 767' ' ' ARG . 2.6 mmp_? -97.28 127.52 43.31 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.099 0.476 . . . . 64.519999999999996 110.839 -177.596 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 768' ' ' TRP . . . . . 0.69 ' CH2' ' HD2' ' A' ' 763' ' ' LYS . 51.1 m95 -103.63 112.15 24.94 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.669 -0.696 . . . . 75.209999999999994 109.27 178.025 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 769' ' ' PHE . . . . . 0.491 ' HA ' ' HA ' ' A' ' 770' ' ' PRO . 27.0 p90 -176.78 136.98 0.43 Allowed Pre-proline 0 C--N 1.323 -0.584 0 CA-C-O 120.955 0.407 . . . . 73.430000000000007 110.248 -178.304 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 770' ' ' PRO . . . . . 0.623 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 55.6 Cg_endo -95.51 -170.74 2.81 Favored 'Cis proline' 0 N--CA 1.451 -0.976 0 C-N-CA 123.395 -1.502 . . . . 52.25 111.828 -3.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -120.83 100.18 6.95 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.431 -0.581 . . . . 73.310000000000002 109.431 175.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 28.6 m -109.88 163.98 6.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.243 -0.435 . . . . 75.519999999999996 110.973 -175.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 773' ' ' CYS . . . . . 0.554 ' HB2' ' HG2' ' A' ' 757' ' ' LYS . 6.3 p -138.21 110.69 7.49 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.975 -0.557 . . . . 62.409999999999997 110.002 178.141 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -118.17 147.61 43.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.539 -0.3 . . . . 73.129999999999995 111.023 -176.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 775' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -76.33 13.33 0.96 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.316 -0.402 . . . . 73.450000000000003 111.828 -177.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 49.9 m -150.02 136.56 19.09 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.249 -0.648 . . . . 62.210000000000001 109.249 174.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 777' ' ' LYS . . . . . 0.428 ' HE3' ' HB3' ' A' ' 777' ' ' LYS . 0.8 OUTLIER -61.87 -40.57 95.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.384 -0.371 . . . . 75.109999999999999 111.372 -174.709 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -66.68 -29.23 69.19 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.11 0.481 . . . . 65.239999999999995 110.39 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 779' ' ' GLN . . . . . 0.5 ' O ' ' HG2' ' A' ' 783' ' ' GLU . 96.4 mt-30 -74.7 -38.38 62.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.944 -0.571 . . . . 75.540000000000006 110.03 178.413 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -53.18 -44.89 64.15 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 121.324 -0.465 . . . . 65.019999999999996 112.391 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -62.46 -46.63 87.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.976 0.417 . . . . 71.349999999999994 110.649 177.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -66.92 -48.04 69.88 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.869 -0.605 . . . . 74.219999999999999 111.596 -177.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 783' ' ' GLU . . . . . 0.5 ' HG2' ' O ' ' A' ' 779' ' ' GLN . 34.5 mm-40 -59.66 -41.43 90.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.758 0.313 . . . . 73.120000000000005 110.527 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -62.39 -48.01 81.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.07 -0.514 . . . . 55.549999999999997 110.493 178.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 785' ' ' ALA . . . . . 0.576 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -65.26 -40.07 93.46 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.333 -0.394 . . . . 70.299999999999997 110.858 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 786' ' ' ASP . . . . . 0.599 ' O ' ' HD3' ' A' ' 790' ' ' ARG . 13.7 t70 -60.61 -55.65 30.81 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.961 -0.563 . . . . 64.129999999999995 110.299 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 787' ' ' ALA . . . . . 0.534 ' HB3' ' HG3' ' A' ' 770' ' ' PRO . . . -64.14 -31.09 72.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.078 -0.51 . . . . 74.219999999999999 110.904 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 788' ' ' ALA . . . . . 0.69 ' O ' ' HG ' ' A' ' 792' ' ' LEU . . . -62.14 -46.56 88.47 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.286 -0.264 . . . . 72.430000000000007 110.286 176.421 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 789' ' ' LEU . . . . . 0.581 HD22 HD12 ' A' ' 719' ' ' LEU . 70.1 mt -63.69 -34.78 78.62 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.741 -0.466 . . . . 65.340000000000003 109.741 178.11 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 790' ' ' ARG . . . . . 0.599 ' HD3' ' O ' ' A' ' 786' ' ' ASP . 0.3 OUTLIER -57.43 -45.71 84.35 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.223 -0.444 . . . . 71.310000000000002 110.185 174.897 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 791' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 787' ' ' ALA . 48.4 t -61.63 -49.69 83.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.028 -0.533 . . . . 70.540000000000006 110.381 177.313 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 792' ' ' LEU . . . . . 0.69 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 39.6 mt -59.92 -50.79 72.37 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.988 -0.551 . . . . 72.519999999999996 110.901 -177.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 793' ' ' ILE . . . . . 0.567 HG12 HG23 ' A' ' 716' ' ' ILE . 95.9 mt -60.72 -49.51 84.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.844 -0.616 . . . . 65.530000000000001 110.578 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -61.8 -36.64 93.06 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 121.057 -0.592 . . . . 63.109999999999999 112.625 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -65.51 -43.91 88.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.049 0.452 . . . . 70.129999999999995 110.129 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 116.07 -0.514 . . . . 74.209999999999994 110.925 179.686 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 716' ' ' ILE . . . . . 0.587 ' HA ' HD23 ' A' ' 719' ' ' LEU . 37.0 mm . . . . . 0 C--O 1.234 0.253 0 CA-C-O 121.013 0.435 . . . . 71.140000000000001 111.117 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -60.55 -29.69 70.16 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 121.008 -0.615 . . . . 55.229999999999997 112.518 175.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 718' ' ' GLU . . . . . 0.4 ' HA ' ' HB3' ' A' ' 721' ' ' ARG . 43.0 mt-10 -75.54 -25.4 57.14 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 122.651 -0.323 . . . . 75.340000000000003 110.654 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 719' ' ' LEU . . . . . 0.587 HD23 ' HA ' ' A' ' 716' ' ' ILE . 4.2 mm? -66.38 -34.77 78.72 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.464 -0.569 . . . . 73.540000000000006 109.464 174.15 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 720' ' ' VAL . . . . . 0.618 HG22 HD13 ' A' ' 793' ' ' ILE . 22.0 t -68.15 -33.09 58.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.826 -0.625 . . . . 74.019999999999996 109.979 175.177 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 721' ' ' ARG . . . . . 0.4 ' HB3' ' HA ' ' A' ' 718' ' ' GLU . 0.1 OUTLIER -61.29 -35.71 78.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.722 -0.672 . . . . 71.510000000000005 110.04 178.774 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -71.05 -32.33 69.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.0 -0.546 . . . . 71.510000000000005 111.1 178.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 723' ' ' LEU . . . . . 0.42 HD21 ' HB2' ' A' ' 789' ' ' LEU . 95.3 mt -58.02 -32.03 67.55 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.119 0.485 . . . . 74.430000000000007 109.928 175.435 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 54.0 m-20 -71.54 -49.9 36.43 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.622 -0.717 . . . . 73.329999999999998 110.839 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 47.4 m -93.12 -70.78 0.68 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.049 0.388 . . . . 73.319999999999993 112.049 -174.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 726' ' ' ASN . . . . . 0.414 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 43.5 t30 -145.12 104.79 4.41 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-O 120.827 0.346 . . . . 75.329999999999998 110.86 -178.099 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 727' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 18.6 Cg_endo -60.57 -34.52 92.4 Favored 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.821 2.347 . . . . 61.210000000000001 112.064 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 47.6 t -61.76 -48.37 88.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 64.409999999999997 110.364 -178.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -63.15 -31.2 79.92 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 121.026 -0.607 . . . . 55.399999999999999 111.811 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -70.35 -41.98 66.45 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.948 -0.644 . . . . 73.239999999999995 112.376 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 731' ' ' LEU . . . . . 0.422 ' N ' HD21 ' A' ' 789' ' ' LEU . 3.0 tm? -65.57 -40.33 92.66 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.412 -0.588 . . . . 71.140000000000001 109.412 178.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 732' ' ' LEU . . . . . . . . . . . . . 79.4 mt -66.16 -39.25 89.63 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.702 -0.681 . . . . 74.319999999999993 110.78 176.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 733' ' ' GLU . . . . . 0.483 ' O ' ' HG2' ' A' ' 736' ' ' ARG . 4.1 tp10 -65.8 -46.31 79.13 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 116.266 -0.425 . . . . 63.420000000000002 110.57 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 734' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -54.96 -48.2 73.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.994 -0.548 . . . . 73.049999999999997 110.677 177.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -65.92 -48.26 72.01 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.122 -0.49 . . . . 43.539999999999999 111.236 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 736' ' ' ARG . . . . . 0.483 ' HG2' ' O ' ' A' ' 733' ' ' GLU . 31.9 ptt180 -65.22 -33.03 75.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.14 0.495 . . . . 74.530000000000001 111.345 -175.476 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 38.0 t -78.12 -36.64 47.62 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.859 -0.61 . . . . 75.400000000000006 111.156 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 15.5 m170 -89.02 -29.21 19.64 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.43 -0.35 . . . . 73.219999999999999 111.846 -174.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 109.07 21.93 7.14 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.555 -0.831 . . . . 73.409999999999997 112.273 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -96.99 167.46 11.06 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.738 0.304 . . . . 64.439999999999998 110.405 175.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -109.91 114.11 27.38 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.461 -0.57 . . . . 72.010000000000005 109.461 175.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 742' ' ' ALA . . . . . . . . . . . . . . . -93.6 110.2 21.81 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.968 0.413 . . . . 61.420000000000002 110.433 -178.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 743' ' ' GLU . . . . . 0.543 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 44.7 mt-10 -120.82 117.09 26.52 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.942 -0.572 . . . . 75.310000000000002 111.281 -177.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 744' ' ' PHE . . . . . 0.424 ' CB ' ' HE3' ' A' ' 781' ' ' LYS . 96.2 m-85 -100.16 100.81 11.7 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.785 -0.643 . . . . 74.450000000000003 109.285 175.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 745' ' ' LYS . . . . . 0.44 ' HB3' ' HE2' ' A' ' 745' ' ' LYS . 16.9 ptpt -120.76 152.81 37.84 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.238 -0.585 . . . . 62.530000000000001 111.116 -177.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 746' ' ' LEU . . . . . 0.576 HD21 ' HB2' ' A' ' 749' ' ' GLN . 51.9 tp -80.14 128.12 33.13 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.426 -0.806 . . . . 75.409999999999997 110.089 -178.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 56.4 t -90.46 -47.56 14.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.109 0.48 . . . . 61.229999999999997 109.879 178.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -154.75 149.35 26.4 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.771 -0.65 . . . . 75.099999999999994 110.331 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 749' ' ' GLN . . . . . 0.576 ' HB2' HD21 ' A' ' 746' ' ' LEU . 24.5 tt0 -125.19 106.64 10.04 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.509 -0.552 . . . . 73.099999999999994 109.509 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 56.7 m -141.86 178.18 7.68 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.658 0.266 . . . . 53.100000000000001 110.285 -178.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 117.52 172.61 16.04 Favored Glycine 0 N--CA 1.443 -0.899 0 C-N-CA 120.331 -0.938 . . . . 65.439999999999998 112.822 177.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 752' ' ' PRO . . . . . 0.748 ' HG2' ' HB2' ' A' ' 755' ' ' GLU . 34.3 Cg_endo -64.8 166.4 18.26 Favored 'Trans proline' 0 CA--C 1.529 0.272 0 C-N-CA 123.473 2.782 . . . . 71.109999999999999 112.752 178.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -65.44 -31.74 51.09 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.592 2.194 . . . . 64.230000000000004 112.534 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 754' ' ' HIS . . . . . 0.554 ' CD2' ' HG3' ' A' ' 755' ' ' GLU . 54.0 p-80 -83.02 -23.41 33.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.522 -0.308 . . . . 63.140000000000001 110.938 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 755' ' ' GLU . . . . . 0.748 ' HB2' ' HG2' ' A' ' 752' ' ' PRO . 45.8 mt-10 -132.24 78.07 69.39 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.445 -0.343 . . . . 72.409999999999997 111.503 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 756' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -68.12 105.86 1.26 Allowed 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 121.936 1.757 . . . . 53.409999999999997 110.73 172.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 757' ' ' LYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 774' ' ' ALA . 57.8 mtmt -92.8 108.67 20.17 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.733 0.777 . . . . 72.140000000000001 110.973 -175.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 758' ' ' PHE . . . . . 0.447 ' O ' ' HA ' ' A' ' 773' ' ' CYS . 89.4 m-85 -87.63 116.69 25.94 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.722 -1.127 . . . . 72.349999999999994 110.478 -178.384 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 21.5 t -84.28 101.39 8.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.468 -0.567 . . . . 61.329999999999998 109.468 176.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 760' ' ' TYR . . . . . 0.413 ' CE2' ' HG2' ' A' ' 777' ' ' LYS . 3.2 m-85 -106.48 145.56 31.65 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.048 -0.524 . . . . 70.310000000000002 111.113 -178.38 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -132.54 135.12 45.75 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.871 -0.604 . . . . 73.209999999999994 109.663 177.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 762' ' ' ALA . . . . . . . . . . . . . . . -89.89 110.82 21.74 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.804 -0.635 . . . . 71.439999999999998 110.421 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 763' ' ' LYS . . . . . 0.543 ' HB3' ' HB2' ' A' ' 743' ' ' GLU . 50.5 tttt -94.64 107.02 19.03 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.494 -0.775 . . . . 71.299999999999997 109.607 177.223 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 47.5 t -112.88 100.48 10.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 120.977 0.418 . . . . 72.239999999999995 110.844 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 68.86 22.59 75.68 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.731 -0.668 . . . . 73.140000000000001 112.74 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 99.8 -2.64 57.1 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.712 -0.756 . . . . 64.010000000000005 112.103 -178.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 767' ' ' ARG . . . . . . . . . . . . . 18.3 ttm180 -100.91 122.3 43.23 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.292 -0.633 . . . . 64.510000000000005 109.292 178.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 768' ' ' TRP . . . . . . . . . . . . . 42.4 m95 -99.31 100.08 11.11 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.407 -0.36 . . . . 73.019999999999996 110.765 -172.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 769' ' ' PHE . . . . . 0.465 ' HA ' ' HA ' ' A' ' 770' ' ' PRO . 25.9 p90 -166.5 136.25 2.52 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.331 -0.395 . . . . 74.099999999999994 110.419 -178.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 770' ' ' PRO . . . . . 0.715 ' HG3' ' HB3' ' A' ' 787' ' ' ALA . 68.5 Cg_endo -94.66 -173.31 4.31 Favored 'Cis proline' 0 N--CA 1.451 -0.974 0 C-N-CA 123.412 -1.495 . . . . 73.299999999999997 111.424 -4.521 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -122.52 107.83 12.46 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.33 -0.248 . . . . 45.329999999999998 110.33 175.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 29.1 m -130.35 167.28 25.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.533 -0.303 . . . . 54.340000000000003 111.195 -176.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 773' ' ' CYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 758' ' ' PHE . 17.7 p -132.78 145.12 50.73 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.458 -0.337 . . . . 71.450000000000003 110.573 178.306 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 774' ' ' ALA . . . . . 0.463 ' O ' ' HA ' ' A' ' 757' ' ' LYS . . . -146.2 154.52 41.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.432 -0.349 . . . . 43.409999999999997 110.544 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 775' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -75.4 -2.62 29.41 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.068 0.461 . . . . 73.219999999999999 111.458 -176.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 776' ' ' SER . . . . . 0.629 ' HB2' ' HG3' ' A' ' 779' ' ' GLN . 36.3 m -131.19 140.2 49.86 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.206 -0.665 . . . . 70.319999999999993 109.206 175.205 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 777' ' ' LYS . . . . . 0.413 ' HG2' ' CE2' ' A' ' 760' ' ' TYR . 6.1 tmmm? -61.12 -45.75 93.39 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 123.431 0.457 . . . . 73.099999999999994 111.274 -174.202 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 778' ' ' LYS . . . . . 0.426 ' HE2' ' OE1' ' A' ' 782' ' ' GLN . 87.9 tttt -64.56 -39.28 93.46 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.981 -0.288 . . . . 73.310000000000002 110.644 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 779' ' ' GLN . . . . . 0.629 ' HG3' ' HB2' ' A' ' 776' ' ' SER . 23.6 mt-30 -60.35 -39.38 86.94 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.658 -0.246 . . . . 63.450000000000003 110.563 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -60.51 -43.53 98.72 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.88 -0.676 . . . . 50.009999999999998 111.694 177.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 781' ' ' LYS . . . . . 0.424 ' HE3' ' CB ' ' A' ' 744' ' ' PHE . 50.6 mtpt -68.13 -40.55 82.44 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.735 0.302 . . . . 73.129999999999995 110.729 178.154 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 782' ' ' GLN . . . . . 0.426 ' OE1' ' HE2' ' A' ' 778' ' ' LYS . 26.6 mt-30 -62.04 -51.66 67.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.047 -0.524 . . . . 73.120000000000005 111.047 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -65.27 -33.92 77.12 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 123.063 0.227 . . . . 74.510000000000005 110.909 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -59.62 -53.86 53.11 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.893 -0.41 . . . . 74.430000000000007 109.893 175.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 785' ' ' ALA . . . . . 0.613 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -65.38 -40.01 92.97 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.18 -0.463 . . . . 75.150000000000006 110.897 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 786' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -54.28 -56.08 21.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.903 -0.59 . . . . 72.430000000000007 110.83 178.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 787' ' ' ALA . . . . . 0.715 ' HB3' ' HG3' ' A' ' 770' ' ' PRO . . . -65.7 -38.32 88.91 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.838 -0.619 . . . . 62.140000000000001 110.768 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 788' ' ' ALA . . . . . 0.6 ' HB2' ' HD3' ' A' ' 770' ' ' PRO . . . -60.61 -45.8 92.65 Favored 'General case' 0 CA--C 1.521 -0.159 0 O-C-N 123.327 0.392 . . . . 74.420000000000002 111.23 -177.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 789' ' ' LEU . . . . . 0.613 ' HG ' ' O ' ' A' ' 785' ' ' ALA . 69.2 mt -58.86 -45.67 89.56 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 109.977 -0.379 . . . . 74.209999999999994 109.977 179.011 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 790' ' ' ARG . . . . . . . . . . . . . 78.6 mtt180 -65.07 -26.58 68.3 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.138 0.422 . . . . 61.310000000000002 112.138 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 791' ' ' VAL . . . . . 0.671 HG23 ' O ' ' A' ' 787' ' ' ALA . 60.1 t -66.5 -45.17 89.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 109.456 -0.572 . . . . 72.340000000000003 109.456 173.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 792' ' ' LEU . . . . . 0.59 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 18.2 mt -67.84 -44.82 76.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.221 -0.899 . . . . 65.319999999999993 110.188 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 793' ' ' ILE . . . . . 0.618 HD13 HG22 ' A' ' 720' ' ' VAL . 97.0 mt -58.38 -55.21 23.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.162 -0.926 . . . . 74.140000000000001 110.647 177.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -58.47 -40.51 94.45 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 121.14 -0.552 . . . . 62.219999999999999 112.244 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -55.98 -46.69 78.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.951 0.405 . . . . 72.129999999999995 110.218 178.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 6.5 t30 . . . . . 0 C--N 1.323 -0.562 0 CA-C-N 116.06 -0.518 . . . . 71.219999999999999 111.246 -175.268 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 716' ' ' ILE . . . . . 0.649 HG23 HG12 ' A' ' 793' ' ' ILE . 48.4 mm . . . . . 0 C--O 1.235 0.326 0 N-CA-C 112.316 0.488 . . . . 75.420000000000002 112.316 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -56.3 -31.41 59.49 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.009 -0.615 . . . . 74.329999999999998 112.12 178.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -72.01 -41.62 67.38 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.355 -0.239 . . . . 74.430000000000007 110.355 178.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 719' ' ' LEU . . . . . 0.641 HD23 ' HA ' ' A' ' 716' ' ' ILE . 3.0 mm? -62.79 -36.11 82.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.479 -0.328 . . . . 63.43 110.727 -179.186 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 720' ' ' VAL . . . . . 0.519 HG22 HD13 ' A' ' 793' ' ' ILE . 48.0 t -66.65 -39.03 82.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.118 0.485 . . . . 74.129999999999995 109.963 175.55 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 721' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.08 -35.03 74.28 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.871 -0.604 . . . . 64.400000000000006 110.172 177.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -74.32 -29.0 61.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.05 -0.523 . . . . 74.150000000000006 111.4 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 723' ' ' LEU . . . . . 0.577 HD21 ' HB2' ' A' ' 789' ' ' LEU . 51.0 mt -59.02 -39.35 81.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.856 0.36 . . . . 75.409999999999997 110.726 177.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -86.51 -17.37 34.29 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.108 -0.496 . . . . 72.400000000000006 111.341 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 16.3 m -108.37 -83.3 0.55 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.637 0.256 . . . . 60.229999999999997 111.421 -176.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 726' ' ' ASN . . . . . 0.413 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 30.0 t30 -138.97 104.01 7.41 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.801 0.334 . . . . 70.439999999999998 110.373 -177.468 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 727' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 25.4 Cg_endo -62.75 -41.4 30.89 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.758 2.305 . . . . 62.439999999999998 112.552 -177.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 48.3 t -61.71 -46.07 97.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.275 -0.421 . . . . 72.150000000000006 110.659 -176.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -64.65 -32.64 84.87 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.868 -0.682 . . . . 74.099999999999994 112.0 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -72.45 -42.66 47.95 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 121.134 -0.555 . . . . 65.519999999999996 112.827 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -63.24 -41.06 99.03 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.623 -0.51 . . . . 71.420000000000002 109.623 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 732' ' ' LEU . . . . . 0.504 HD23 ' HB3' ' A' ' 742' ' ' ALA . 96.2 mt -64.83 -42.66 94.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.94 -0.573 . . . . 65.120000000000005 110.649 176.483 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 733' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -64.69 -42.64 95.17 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 116.201 -0.454 . . . . 64.430000000000007 110.802 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 734' ' ' TYR . . . . . 0.549 ' HB2' HD11 ' A' ' 719' ' ' LEU . 14.4 t80 -54.43 -53.18 57.59 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.349 -0.387 . . . . 74.430000000000007 110.621 176.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -62.73 -48.45 79.16 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.093 -0.503 . . . . 72.329999999999998 110.395 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 736' ' ' ARG . . . . . . . . . . . . . 62.3 ttt180 -54.96 -50.87 67.84 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.544 -0.753 . . . . 75.129999999999995 111.939 -178.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 18.1 t -73.95 -24.58 59.66 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.424 -0.353 . . . . 74.239999999999995 111.404 -175.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -94.7 -19.78 20.11 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.821 -0.352 . . . . 52.310000000000002 111.935 -175.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 104.39 14.0 25.07 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.17 -1.014 . . . . 35.25 112.837 177.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -101.81 166.29 10.74 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.816 -0.439 . . . . 64.230000000000004 109.816 175.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -110.14 126.43 54.06 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.708 -0.479 . . . . 64.310000000000002 109.708 173.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 742' ' ' ALA . . . . . 0.504 ' HB3' HD23 ' A' ' 732' ' ' LEU . . . -99.03 108.59 21.3 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.059 0.457 . . . . 72.239999999999995 110.361 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 743' ' ' GLU . . . . . 0.543 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 40.8 mt-10 -113.93 116.75 29.75 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.796 -0.638 . . . . 72.150000000000006 111.466 -176.302 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -93.28 121.62 34.84 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.679 -0.691 . . . . 74.209999999999994 109.401 176.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -132.38 147.94 52.4 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.282 0.563 . . . . 64.409999999999997 111.663 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 746' ' ' LEU . . . . . 0.53 HD21 ' HB2' ' A' ' 749' ' ' GLN . 6.8 tt -86.87 108.09 18.61 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.143 -0.935 . . . . 62.25 108.992 177.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 49.0 t -82.56 -53.99 10.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.136 -0.484 . . . . 64.310000000000002 110.771 -176.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 748' ' ' ASP . . . . . 0.499 ' HB3' ' CG2' ' A' ' 759' ' ' VAL . 25.7 t70 -129.8 149.76 51.4 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.283 -0.417 . . . . 75.420000000000002 111.19 -176.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 749' ' ' GLN . . . . . 0.53 ' HB2' HD21 ' A' ' 746' ' ' LEU . 50.9 tt0 -145.84 100.07 3.36 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.514 -0.767 . . . . 64.530000000000001 108.971 177.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 10.0 t -144.98 -173.71 4.16 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.484 -0.326 . . . . 72.120000000000005 110.476 -174.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 100.77 -173.74 24.94 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.924 -0.655 . . . . 54.420000000000002 112.473 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 752' ' ' PRO . . . . . 0.711 ' HG2' ' HB2' ' A' ' 755' ' ' GLU . 52.8 Cg_endo -69.11 164.35 34.24 Favored 'Trans proline' 0 N--CA 1.465 -0.154 0 C-N-CA 122.908 2.406 . . . . 74.239999999999995 111.993 178.222 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -69.81 -34.68 13.93 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 122.469 2.112 . . . . 75.0 112.065 -177.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 754' ' ' HIS . . . . . 0.425 ' CE1' ' HB2' ' A' ' 752' ' ' PRO . 35.2 p-80 -76.09 -26.81 56.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.174 -0.466 . . . . 73.430000000000007 110.936 179.281 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 755' ' ' GLU . . . . . 0.711 ' HB2' ' HG2' ' A' ' 752' ' ' PRO . 28.5 mm-40 -126.53 72.76 73.72 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.566 -0.288 . . . . 61.409999999999997 110.885 178.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 756' ' ' PRO . . . . . 0.515 ' O ' ' HA ' ' A' ' 775' ' ' HIS . 40.0 Cg_endo -68.82 113.66 3.29 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.222 1.948 . . . . 73.519999999999996 111.453 177.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 757' ' ' LYS . . . . . 0.408 ' HE3' ' HB3' ' A' ' 757' ' ' LYS . 1.5 tmmt? -89.51 112.4 23.56 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.322 0.582 . . . . 72.25 110.538 -176.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 758' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 773' ' ' CYS . 79.0 m-85 -99.59 123.34 43.76 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.204 -0.907 . . . . 72.140000000000001 110.115 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 759' ' ' VAL . . . . . 0.499 ' CG2' ' HB3' ' A' ' 748' ' ' ASP . 48.6 t -98.4 106.6 18.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.564 -0.532 . . . . 71.439999999999998 109.564 175.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -105.61 141.05 37.74 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.005 -0.543 . . . . 74.319999999999993 110.691 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 761' ' ' GLN . . . . . 0.485 ' NE2' ' HB3' ' A' ' 768' ' ' TRP . 28.2 tt0 -133.46 134.61 43.75 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.865 -0.607 . . . . 64.099999999999994 109.503 177.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 762' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 769' ' ' PHE . . . -92.9 117.08 29.65 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.25 0.548 . . . . 63.439999999999998 110.706 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 763' ' ' LYS . . . . . 0.601 ' HD2' ' CH2' ' A' ' 768' ' ' TRP . 54.7 tttm -93.77 103.53 15.66 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.681 -0.69 . . . . 73.150000000000006 109.893 177.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 61.7 t -109.01 101.58 12.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.136 0.493 . . . . 53.299999999999997 109.739 178.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 69.17 -115.69 6.63 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 110.955 -0.858 . . . . 71.010000000000005 110.955 -173.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -110.62 13.99 29.91 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.003 -0.618 . . . . 74.219999999999999 111.684 176.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 767' ' ' ARG . . . . . 0.602 ' HD2' ' CD1' ' A' ' 769' ' ' PHE . 0.6 OUTLIER -110.43 120.45 42.46 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.507 -0.553 . . . . 71.540000000000006 109.507 -179.766 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 768' ' ' TRP . . . . . 0.601 ' CH2' ' HD2' ' A' ' 763' ' ' LYS . 69.4 m95 -94.88 108.15 20.18 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.645 -0.502 . . . . 74.099999999999994 109.645 178.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 769' ' ' PHE . . . . . 0.602 ' CD1' ' HD2' ' A' ' 767' ' ' ARG . 9.8 p90 -168.86 139.9 2.01 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-O 120.838 0.351 . . . . 74.219999999999999 110.915 -178.317 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 770' ' ' PRO . . . . . 0.799 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 96.1 Cg_endo -98.4 -170.69 1.95 Allowed 'Cis proline' 0 N--CA 1.449 -1.121 0 C-N-CA 123.71 -1.371 . . . . 63.140000000000001 111.677 -3.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -114.81 104.29 11.8 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.518 -0.549 . . . . 62.439999999999998 109.518 174.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 33.5 m -118.94 161.97 17.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.303 -0.408 . . . . 73.239999999999995 110.846 -176.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 773' ' ' CYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 758' ' ' PHE . 8.8 p -137.0 141.91 42.53 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.249 -0.432 . . . . 60.240000000000002 110.425 177.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -149.53 161.15 42.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.054 -0.521 . . . . 71.430000000000007 109.829 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 775' ' ' HIS . . . . . 0.515 ' HA ' ' O ' ' A' ' 756' ' ' PRO . 0.8 OUTLIER -87.14 -0.75 57.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.251 0.548 . . . . 73.120000000000005 110.889 179.501 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 51.1 m -134.04 135.16 43.16 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.634 -0.712 . . . . 71.010000000000005 109.292 175.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 777' ' ' LYS . . . . . . . . . . . . . 25.4 ttmt -57.24 -48.82 77.89 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.103 -0.499 . . . . 71.239999999999995 111.448 -175.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -57.95 -38.59 76.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.848 -0.614 . . . . 64.140000000000001 110.822 -177.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 779' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -68.25 -37.88 81.24 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-N 116.36 -0.382 . . . . 72.319999999999993 110.146 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -60.5 -47.17 92.48 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.827 -0.701 . . . . 43.340000000000003 111.881 178.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -62.55 -44.79 95.47 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.746 0.308 . . . . 72.530000000000001 110.649 177.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -62.37 -50.43 71.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.056 -0.52 . . . . 64.549999999999997 111.206 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -60.09 -36.57 77.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.298 -0.41 . . . . 53.109999999999999 111.445 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -60.05 -55.08 38.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.871 0.367 . . . . 74.510000000000005 110.373 177.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 785' ' ' ALA . . . . . 0.652 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -63.09 -41.81 99.47 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.134 -0.485 . . . . 53.119999999999997 110.897 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 786' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -56.83 -54.88 41.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.546 -0.752 . . . . 73.319999999999993 110.934 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 787' ' ' ALA . . . . . 0.468 ' O ' HG23 ' A' ' 791' ' ' VAL . . . -65.29 -35.09 79.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.832 -0.622 . . . . 75.450000000000003 111.254 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 788' ' ' ALA . . . . . 0.799 ' HB2' ' HD3' ' A' ' 770' ' ' PRO . . . -64.64 -35.64 81.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.313 -0.403 . . . . 63.549999999999997 111.391 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 789' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' A' ' 785' ' ' ALA . 59.1 mt -64.66 -42.04 95.69 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 121.048 -0.261 . . . . 65.340000000000003 110.445 -179.231 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 790' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.67 -31.71 72.65 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 120.734 -0.386 . . . . 75.310000000000002 111.207 177.281 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 791' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 787' ' ' ALA . 57.2 t -61.67 -51.89 67.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.104 0.478 . . . . 71.510000000000005 109.773 175.674 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 792' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 32.9 mt -61.84 -47.53 84.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.349 -0.842 . . . . 71.540000000000006 110.83 -178.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 793' ' ' ILE . . . . . 0.649 HG12 HG23 ' A' ' 716' ' ' ILE . 95.9 mt -58.8 -56.26 17.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.521 -0.763 . . . . 72.299999999999997 111.24 179.156 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -60.79 -37.69 94.05 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 121.079 -0.582 . . . . 62.049999999999997 112.321 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -63.25 -44.0 96.41 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.905 0.383 . . . . 73.400000000000006 110.734 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 . . . . . 0 C--N 1.33 -0.275 0 CA-C-O 120.909 0.385 . . . . 70.5 110.822 -177.299 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 716' ' ' ILE . . . . . 0.592 ' HA ' HD23 ' A' ' 719' ' ' LEU . 46.8 mm . . . . . 0 N--CA 1.454 -0.245 0 CA-C-O 120.73 0.3 . . . . 42.439999999999998 111.489 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -59.95 -24.87 61.04 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.97 -0.633 . . . . 64.150000000000006 112.112 176.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 718' ' ' GLU . . . . . 0.669 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 47.1 mt-10 -76.85 -38.73 53.18 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 122.787 -0.243 . . . . 75.120000000000005 110.658 177.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 719' ' ' LEU . . . . . 0.592 HD12 HD22 ' A' ' 789' ' ' LEU . 3.1 mm? -61.38 -32.98 72.92 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.155 0.502 . . . . 72.430000000000007 109.769 176.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 720' ' ' VAL . . . . . 0.54 HG22 HD13 ' A' ' 793' ' ' ILE . 58.1 t -68.4 -38.49 79.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.809 -0.632 . . . . 72.510000000000005 110.757 175.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 721' ' ' ARG . . . . . 0.669 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 4.4 ptm180 -64.74 -28.2 69.43 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 109.841 -0.429 . . . . 72.329999999999998 109.841 179.193 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -73.12 -31.9 64.61 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 116.312 -0.404 . . . . 61.439999999999998 110.782 177.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 723' ' ' LEU . . . . . 0.565 HD21 ' HB2' ' A' ' 789' ' ' LEU . 98.1 mt -62.24 -28.67 69.87 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.407 0.622 . . . . 72.329999999999998 110.033 174.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -90.81 -15.07 30.7 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.492 -0.776 . . . . 71.319999999999993 111.234 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 11.1 m -118.69 -73.48 0.64 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.856 0.36 . . . . 75.150000000000006 111.666 -175.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 726' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -149.13 101.58 3.37 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.174 -0.467 . . . . 34.119999999999997 110.112 -177.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 727' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -61.87 -40.33 45.16 Favored 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 122.906 2.404 . . . . 63.350000000000001 112.115 -178.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 57.5 t -62.21 -45.32 99.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.096 -0.502 . . . . 63.130000000000003 110.809 -178.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -65.49 -35.15 90.93 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.664 -0.779 . . . . 72.239999999999995 111.669 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -70.17 -41.58 69.29 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 121.073 -0.584 . . . . 74.230000000000004 112.573 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -65.48 -43.3 90.66 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.989 -0.374 . . . . 72.010000000000005 109.989 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 732' ' ' LEU . . . . . . . . . . . . . 96.8 mt -66.17 -38.07 87.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.244 -0.435 . . . . 63.329999999999998 110.745 178.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 733' ' ' GLU . . . . . 0.471 ' O ' ' HG2' ' A' ' 736' ' ' ARG . 1.8 tp10 -66.14 -43.99 85.44 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 116.325 -0.398 . . . . 73.010000000000005 110.355 177.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 734' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -53.47 -48.66 68.67 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.141 -0.481 . . . . 71.439999999999998 110.658 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 735' ' ' ALA . . . . . 0.41 ' HB2' ' HB2' ' A' ' 742' ' ' ALA . . . -65.62 -50.22 65.83 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.232 -0.44 . . . . 70.349999999999994 110.927 -177.345 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 736' ' ' ARG . . . . . 0.471 ' HG2' ' O ' ' A' ' 733' ' ' GLU . 33.8 ptt180 -64.35 -31.48 72.7 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.11 0.481 . . . . 62.350000000000001 110.914 -175.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 28.8 t -78.07 -29.12 49.02 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.599 -0.728 . . . . 63.210000000000001 111.451 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -101.13 -3.09 29.84 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 111.885 0.328 . . . . 74.430000000000007 111.885 -173.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 90.98 12.88 59.79 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.407 -0.901 . . . . 72.340000000000003 112.675 177.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -95.98 169.36 10.03 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.791 0.329 . . . . 73.439999999999998 110.165 175.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -121.68 105.81 10.76 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.284 -0.636 . . . . 72.140000000000001 109.284 175.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 742' ' ' ALA . . . . . 0.419 ' HA ' ' HA ' ' A' ' 764' ' ' VAL . . . -90.4 122.55 33.37 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.311 -0.404 . . . . 73.540000000000006 111.454 -174.373 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 743' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -127.79 166.13 18.78 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.782 -0.644 . . . . 75.430000000000007 110.698 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -134.25 108.8 8.45 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.961 -0.563 . . . . 73.439999999999998 109.996 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -110.84 148.55 32.16 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.007 0.432 . . . . 74.209999999999994 111.155 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 746' ' ' LEU . . . . . 0.432 HD11 ' CD1' ' A' ' 758' ' ' PHE . 6.1 tt -87.58 106.82 18.27 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.384 -0.969 . . . . 64.230000000000004 108.384 174.333 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 54.0 t -83.16 -53.06 12.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.982 -0.554 . . . . 71.319999999999993 110.938 -174.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -128.39 146.01 50.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.083 -0.508 . . . . 63.210000000000001 110.798 -176.115 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -132.7 93.59 3.25 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.284 0.564 . . . . 73.439999999999998 110.026 176.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 20.6 m -104.64 82.36 1.89 Allowed 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.242 -1.021 . . . . 52.130000000000003 108.242 173.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 751' ' ' GLY . . . . . 0.612 ' CA ' ' HA ' ' A' ' 756' ' ' PRO . . . -127.39 94.74 0.41 Allowed Glycine 0 N--CA 1.439 -1.101 0 C-N-CA 119.92 -1.133 . . . . 75.0 114.278 -170.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 752' ' ' PRO . . . . . 0.402 ' HD2' ' HA2' ' A' ' 751' ' ' GLY . 18.1 Cg_endo -60.95 165.61 11.85 Favored 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 122.474 2.116 . . . . 42.109999999999999 110.225 164.539 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -58.54 -36.51 97.26 Favored 'Trans proline' 0 CA--C 1.528 0.191 0 C-N-CA 122.109 1.873 . . . . 73.420000000000002 112.495 -177.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 49.9 p-80 -82.28 -25.01 34.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.364 -0.38 . . . . 61.240000000000002 111.644 -177.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -141.06 74.31 25.48 Favored Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 112.043 0.386 . . . . 53.530000000000001 112.043 -176.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 756' ' ' PRO . . . . . 0.612 ' HA ' ' CA ' ' A' ' 751' ' ' GLY . 52.3 Cg_endo -72.23 84.84 1.09 Allowed 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.0 1.8 . . . . 44.039999999999999 111.632 175.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 757' ' ' LYS . . . . . 0.531 ' HA ' ' HA ' ' A' ' 775' ' ' HIS . 27.4 ttpp -91.58 113.69 26.03 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.545 0.688 . . . . 71.040000000000006 111.247 -174.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 758' ' ' PHE . . . . . 0.463 ' O ' ' HA ' ' A' ' 773' ' ' CYS . 60.9 m-85 -99.44 144.77 28.16 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.286 -0.87 . . . . 70.010000000000005 110.171 -178.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 759' ' ' VAL . . . . . 0.468 HG22 ' HB3' ' A' ' 773' ' ' CYS . 47.7 t -109.57 112.13 39.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.996 -0.372 . . . . 64.129999999999995 109.996 176.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -107.27 138.14 44.0 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.263 -0.426 . . . . 71.329999999999998 110.517 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 761' ' ' GLN . . . . . 0.441 ' HA ' ' O ' ' A' ' 770' ' ' PRO . 62.2 tt0 -125.5 135.48 52.34 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.916 -0.583 . . . . 75.430000000000007 109.432 177.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 762' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' A' ' 769' ' ' PHE . . . -91.52 119.5 31.52 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.252 0.549 . . . . 74.019999999999996 110.586 -178.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -98.16 97.28 8.73 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.713 -0.676 . . . . 72.430000000000007 109.339 177.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 764' ' ' VAL . . . . . 0.419 ' HA ' ' HA ' ' A' ' 742' ' ' ALA . 57.7 t -99.9 98.3 6.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.125 0.488 . . . . 72.239999999999995 109.854 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 68.54 -108.03 2.31 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 110.743 -0.943 . . . . 33.340000000000003 110.743 -175.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -114.72 9.4 21.63 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.626 -0.797 . . . . 71.409999999999997 111.821 176.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 767' ' ' ARG . . . . . 0.576 ' HD2' ' CD1' ' A' ' 769' ' ' PHE . 0.2 OUTLIER -107.65 120.69 42.92 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.93 -0.396 . . . . 72.120000000000005 109.93 -178.615 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 768' ' ' TRP . . . . . . . . . . . . . 58.6 m95 -94.3 110.91 22.63 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.158 -0.474 . . . . 75.420000000000002 109.857 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 769' ' ' PHE . . . . . 0.576 ' CD1' ' HD2' ' A' ' 767' ' ' ARG . 15.7 p90 -174.76 138.32 0.62 Allowed Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 120.692 0.282 . . . . 64.239999999999995 110.65 -179.027 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 770' ' ' PRO . . . . . 0.786 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 69.7 Cg_endo -99.15 -170.25 1.6 Allowed 'Cis proline' 0 N--CA 1.449 -1.14 0 C-N-CA 123.675 -1.386 . . . . 71.010000000000005 111.164 -6.115 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -121.14 105.52 10.68 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.797 -0.445 . . . . 74.120000000000005 109.797 174.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 35.3 m -121.32 160.29 22.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.487 -0.324 . . . . 61.25 111.006 -176.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 773' ' ' CYS . . . . . 0.468 ' HB3' HG22 ' A' ' 759' ' ' VAL . 20.2 p -126.01 145.81 50.15 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.073 -0.512 . . . . 74.450000000000003 110.565 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -158.14 146.86 19.06 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.22 -0.445 . . . . 75.519999999999996 110.226 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 775' ' ' HIS . . . . . 0.538 ' HA ' ' O ' ' A' ' 756' ' ' PRO . 1.4 p-80 -78.95 17.4 0.74 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.147 0.499 . . . . 70.420000000000002 111.538 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 42.4 t -142.84 130.62 21.51 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.994 -0.743 . . . . 71.109999999999999 108.994 175.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 777' ' ' LYS . . . . . 0.436 ' HD2' ' C ' ' A' ' 777' ' ' LYS . 5.3 tmmm? -58.34 -42.68 87.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.864 0.364 . . . . 74.239999999999995 110.125 -178.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -58.12 -46.99 84.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.62 -0.718 . . . . 64.329999999999998 110.542 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 779' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -62.52 -41.82 99.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.914 -0.584 . . . . 63.420000000000002 110.717 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -56.35 -43.83 89.77 Favored Glycine 0 C--N 1.329 0.187 0 C-N-CA 121.161 -0.543 . . . . 63.340000000000003 112.398 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -71.93 -43.79 64.71 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.699 0.285 . . . . 73.430000000000007 111.046 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -66.42 -45.63 79.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.222 -0.445 . . . . 75.120000000000005 111.505 -176.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -66.67 -33.87 76.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.709 0.29 . . . . 72.340000000000003 110.686 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -60.56 -52.04 66.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.347 -0.388 . . . . 65.519999999999996 110.177 177.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 785' ' ' ALA . . . . . 0.586 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -65.4 -38.59 90.45 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.167 -0.469 . . . . 73.230000000000004 110.744 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 786' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -59.9 -51.07 71.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.919 -0.582 . . . . 75.310000000000002 110.852 178.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 787' ' ' ALA . . . . . 0.571 ' HA ' ' HD2' ' A' ' 790' ' ' ARG . . . -67.85 -35.8 79.2 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.071 -0.513 . . . . 43.43 111.039 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 788' ' ' ALA . . . . . 0.786 ' HB2' ' HD3' ' A' ' 770' ' ' PRO . . . -60.96 -41.05 95.59 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.361 -0.382 . . . . 32.409999999999997 111.032 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 789' ' ' LEU . . . . . 0.592 HD22 HD12 ' A' ' 719' ' ' LEU . 75.9 mt -64.23 -40.36 95.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.406 -0.361 . . . . 72.109999999999999 110.21 178.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 790' ' ' ARG . . . . . 0.571 ' HD2' ' HA ' ' A' ' 787' ' ' ALA . 84.9 mtt180 -60.01 -35.06 74.25 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.501 -0.318 . . . . 61.5 111.209 177.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 791' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 787' ' ' ALA . 62.1 t -61.5 -50.53 79.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.249 0.547 . . . . 65.420000000000002 109.898 175.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 792' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 23.7 mt -61.98 -47.88 82.84 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.395 -0.82 . . . . 64.239999999999995 110.743 -179.1 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 793' ' ' ILE . . . . . 0.54 HD13 HG22 ' A' ' 720' ' ' VAL . 95.8 mt -59.85 -45.36 94.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.481 -0.781 . . . . 75.230000000000004 110.904 178.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -68.32 -33.8 78.57 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.833 -0.699 . . . . 52.450000000000003 112.703 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -70.66 -41.09 72.54 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.902 0.382 . . . . 74.109999999999999 110.642 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 5.4 t30 . . . . . 0 C--N 1.325 -0.46 0 C-N-CA 120.786 -0.366 . . . . 54.119999999999997 110.188 179.326 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 716' ' ' ILE . . . . . 0.526 ' HA ' HD23 ' A' ' 719' ' ' LEU . 42.1 mm . . . . . 0 C--O 1.233 0.222 0 CA-C-O 120.852 0.358 . . . . 73.310000000000002 110.85 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -60.63 -26.1 64.28 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 121.008 -0.615 . . . . 73.329999999999998 112.014 175.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 718' ' ' GLU . . . . . 0.8 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 9.0 mm-40 -68.75 -34.39 75.51 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-O 120.543 0.211 . . . . 64.430000000000007 110.551 178.101 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 719' ' ' LEU . . . . . 0.556 HD12 HD22 ' A' ' 789' ' ' LEU . 2.7 mm? -69.04 -29.25 67.37 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.522 -0.471 . . . . 73.010000000000005 109.917 177.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 720' ' ' VAL . . . . . 0.488 HG22 HD13 ' A' ' 793' ' ' ILE . 60.3 t -67.52 -40.96 85.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.844 -0.616 . . . . 74.430000000000007 110.804 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 721' ' ' ARG . . . . . 0.8 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 12.9 ptm180 -64.86 -29.92 70.9 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.4 -0.364 . . . . 65.010000000000005 110.249 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -71.83 -35.48 69.9 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-N 116.341 -0.39 . . . . 73.420000000000002 110.69 177.026 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 723' ' ' LEU . . . . . 0.586 HD21 ' HB2' ' A' ' 789' ' ' LEU . 82.0 mt -56.3 -30.68 62.84 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.138 0.494 . . . . 73.340000000000003 110.407 175.414 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -83.86 -55.37 4.28 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.835 -0.62 . . . . 73.200000000000003 110.935 176.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 27.2 m -75.44 -73.06 0.27 Allowed 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.119 0.414 . . . . 64.450000000000003 112.119 -176.372 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 726' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -148.49 100.31 3.56 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 120.804 0.335 . . . . 64.219999999999999 110.633 -175.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 727' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -61.7 -39.97 49.39 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.021 2.481 . . . . 55.439999999999998 112.667 -176.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 30.1 t -59.24 -47.88 88.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.008 -0.542 . . . . 72.010000000000005 110.787 -176.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -65.66 -31.35 79.7 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.86 -0.609 . . . . 54.119999999999997 111.812 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -68.24 -41.73 85.33 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.903 -0.665 . . . . 64.439999999999998 112.269 178.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -65.04 -41.29 95.35 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.526 -0.546 . . . . 73.120000000000005 109.526 178.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 732' ' ' LEU . . . . . . . . . . . . . 83.8 mt -68.79 -31.55 70.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.88 -0.6 . . . . 74.25 110.99 178.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 733' ' ' GLU . . . . . 0.501 ' O ' ' HG2' ' A' ' 736' ' ' ARG . 0.7 OUTLIER -73.28 -43.54 60.83 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 116.165 -0.471 . . . . 71.129999999999995 110.392 178.901 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 734' ' ' TYR . . . . . 0.466 ' HB2' HD11 ' A' ' 719' ' ' LEU . 7.6 t80 -55.45 -46.41 76.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.978 -0.556 . . . . 74.450000000000003 110.615 176.387 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -64.78 -48.12 75.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.923 -0.581 . . . . 73.319999999999993 111.095 -178.465 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 736' ' ' ARG . . . . . 0.501 ' HG2' ' O ' ' A' ' 733' ' ' GLU . 11.3 ptt180 -64.54 -35.74 81.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.009 0.433 . . . . 64.219999999999999 111.078 -175.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 48.4 t -74.2 -35.06 63.9 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.013 -0.539 . . . . 75.310000000000002 111.036 -178.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -89.0 -32.02 17.82 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.286 -0.415 . . . . 74.129999999999995 111.803 -174.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 112.45 22.07 5.94 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.47 -0.872 . . . . 61.32 112.013 -178.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -99.51 169.99 8.92 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.869 0.366 . . . . 65.120000000000005 110.543 176.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -117.25 111.49 19.48 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.457 -0.572 . . . . 71.450000000000003 109.457 174.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 742' ' ' ALA . . . . . . . . . . . . . . . -94.58 130.26 41.09 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.909 0.385 . . . . 73.239999999999995 111.464 -175.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 743' ' ' GLU . . . . . 0.572 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 49.5 mt-10 -132.98 140.52 47.82 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.959 -0.564 . . . . 74.310000000000002 110.738 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -114.94 100.28 8.08 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.195 -0.668 . . . . 65.549999999999997 109.195 174.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 745' ' ' LYS . . . . . 0.471 ' HE2' ' HB3' ' A' ' 745' ' ' LYS . 14.4 ptpt -121.45 144.11 48.87 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.495 0.664 . . . . 63.340000000000003 111.909 -175.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 746' ' ' LEU . . . . . . . . . . . . . 6.6 tt -78.91 112.59 16.25 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.824 -1.08 . . . . 71.109999999999999 109.509 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 61.3 t -80.18 -50.01 18.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.985 0.422 . . . . 60.399999999999999 110.634 -178.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -155.56 148.93 24.88 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.929 -0.578 . . . . 62.549999999999997 110.252 -178.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 749' ' ' GLN . . . . . 0.42 ' O ' ' HG3' ' A' ' 749' ' ' GLN . 10.5 pt20 -133.69 108.59 8.62 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.194 0.521 . . . . 72.310000000000002 110.281 172.292 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 18.6 m -131.47 78.63 1.84 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.905 -0.588 . . . . 64.219999999999999 110.236 178.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . -139.24 150.31 21.21 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.658 -0.782 . . . . 74.230000000000004 112.138 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 752' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -62.67 160.55 32.04 Favored 'Trans proline' 0 CA--C 1.528 0.197 0 C-N-CA 123.019 2.479 . . . . 71.409999999999997 111.976 178.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -57.45 -34.63 98.29 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.797 2.332 . . . . 72.519999999999996 112.897 -178.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 47.9 p-80 -83.89 -15.91 46.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.268 -0.424 . . . . 54.200000000000003 111.357 -177.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -149.18 70.98 10.09 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.455 -0.339 . . . . 64.209999999999994 110.73 -177.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 756' ' ' PRO . . . . . 0.511 ' O ' ' HA ' ' A' ' 775' ' ' HIS . 51.8 Cg_exo -54.81 146.59 55.1 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.738 2.292 . . . . 72.450000000000003 112.176 178.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 757' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -129.96 113.33 14.46 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.254 -0.43 . . . . 64.409999999999997 109.911 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 758' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -112.74 117.54 32.49 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.799 -0.637 . . . . 54.340000000000003 110.79 -177.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 30.9 t -85.14 101.39 9.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.92 -0.582 . . . . 72.420000000000002 109.543 175.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -106.05 136.91 44.89 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.67 -0.695 . . . . 74.150000000000006 110.483 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 761' ' ' GLN . . . . . 0.526 ' HA ' ' O ' ' A' ' 770' ' ' PRO . 23.7 tt0 -135.18 131.95 37.37 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.749 -0.659 . . . . 72.150000000000006 110.033 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 762' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 769' ' ' PHE . . . -89.17 122.19 32.21 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.892 -0.594 . . . . 45.119999999999997 110.636 -178.426 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 763' ' ' LYS . . . . . 0.572 ' HB3' ' HB2' ' A' ' 743' ' ' GLU . 61.5 tttm -97.62 105.54 17.71 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.622 -0.717 . . . . 73.25 109.512 178.567 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 59.8 t -108.93 98.59 7.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.098 0.475 . . . . 72.040000000000006 109.792 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 70.72 -107.76 2.26 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 111.26 -0.736 . . . . 34.119999999999997 111.26 -176.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -109.6 1.05 30.65 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.743 -0.741 . . . . 73.040000000000006 112.068 177.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 767' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -102.75 138.74 39.24 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.16 0.505 . . . . 63.43 111.373 -177.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 768' ' ' TRP . . . . . 0.467 ' HB3' ' NE2' ' A' ' 761' ' ' GLN . 80.4 m95 -108.64 108.76 19.75 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.521 -0.763 . . . . 74.25 109.39 175.591 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 769' ' ' PHE . . . . . 0.5 ' HA ' ' HA ' ' A' ' 770' ' ' PRO . 31.6 p90 -168.99 138.9 1.81 Allowed Pre-proline 0 C--N 1.322 -0.613 0 CA-C-O 120.946 0.403 . . . . 71.230000000000004 110.497 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 770' ' ' PRO . . . . . 0.704 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 59.7 Cg_endo -97.99 -175.64 3.95 Favored 'Cis proline' 0 N--CA 1.451 -1.028 0 C-N-CA 123.454 -1.478 . . . . 74.400000000000006 111.768 -4.04 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -110.9 106.54 15.7 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.605 -0.517 . . . . 75.530000000000001 109.605 173.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 30.0 m -114.52 146.49 18.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.018 0.437 . . . . 45.039999999999999 111.409 -177.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 5.7 p -111.98 95.87 5.72 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.792 -0.64 . . . . 70.510000000000005 109.847 178.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -94.18 166.73 11.97 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.05 -0.523 . . . . 75.340000000000003 111.776 -174.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 775' ' ' HIS . . . . . 0.511 ' HA ' ' O ' ' A' ' 756' ' ' PRO . 32.6 m-70 -91.84 -4.3 55.0 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.722 -0.672 . . . . 72.409999999999997 110.853 -178.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 63.5 p -159.13 173.58 16.19 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.693 -0.484 . . . . 73.430000000000007 109.693 176.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 777' ' ' LYS . . . . . 0.701 ' HE2' ' HD2' ' A' ' 781' ' ' LYS . 31.4 tttt -65.83 -52.51 49.89 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.709 0.263 . . . . 65.120000000000005 111.709 -176.206 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 51.9 tttp -63.5 -37.79 88.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.466 -0.334 . . . . 50.049999999999997 110.636 -174.241 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 779' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -60.61 -39.15 87.14 Favored 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 109.852 -0.425 . . . . 74.150000000000006 109.852 175.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -61.91 -48.49 83.35 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.991 -0.623 . . . . 75.25 112.061 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 781' ' ' LYS . . . . . 0.701 ' HD2' ' HE2' ' A' ' 777' ' ' LYS . 8.2 mtpm? -62.59 -38.25 89.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.652 0.263 . . . . 72.219999999999999 111.04 178.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -73.17 -50.54 22.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.539 -0.301 . . . . 74.409999999999997 111.316 -178.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -60.67 -38.4 84.78 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.67 0.271 . . . . 73.519999999999996 110.974 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -60.11 -51.2 70.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 74.150000000000006 110.146 177.321 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 785' ' ' ALA . . . . . 0.609 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -66.39 -41.72 88.94 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.252 -0.431 . . . . 61.520000000000003 110.923 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 786' ' ' ASP . . . . . 0.444 ' O ' ' HD3' ' A' ' 790' ' ' ARG . 9.9 t0 -56.34 -57.49 12.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.903 -0.59 . . . . 73.129999999999995 110.082 179.045 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 787' ' ' ALA . . . . . 0.63 ' HB3' ' HG3' ' A' ' 770' ' ' PRO . . . -64.77 -33.39 75.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.695 -0.684 . . . . 71.409999999999997 111.196 -178.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 788' ' ' ALA . . . . . 0.704 ' HB2' ' HD3' ' A' ' 770' ' ' PRO . . . -64.64 -44.47 90.38 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 123.174 0.296 . . . . 54.43 110.937 179.326 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 789' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 785' ' ' ALA . 80.0 mt -61.35 -40.34 93.92 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.742 -0.466 . . . . 71.319999999999993 109.742 178.485 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 790' ' ' ARG . . . . . 0.444 ' HD3' ' O ' ' A' ' 786' ' ' ASP . 13.0 mtp180 -59.54 -35.34 74.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.032 -0.531 . . . . 63.329999999999998 111.162 176.401 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 791' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 787' ' ' ALA . 54.3 t -66.19 -52.09 51.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 109.753 -0.462 . . . . 72.219999999999999 109.753 175.393 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 792' ' ' LEU . . . . . 0.624 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 31.3 mt -57.23 -49.09 77.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.647 -0.706 . . . . 75.540000000000006 110.575 -178.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 793' ' ' ILE . . . . . 0.488 HD13 HG22 ' A' ' 720' ' ' VAL . 94.2 mt -60.02 -51.46 72.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.414 -0.812 . . . . 74.340000000000003 110.734 177.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -61.83 -40.53 98.96 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 121.014 -0.612 . . . . 73.239999999999995 112.697 -178.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -60.29 -53.17 60.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.375 0.131 . . . . 73.209999999999994 111.24 178.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 . . . . . 0 C--N 1.326 -0.427 0 CA-C-O 120.928 0.394 . . . . 72.439999999999998 111.08 -176.189 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 716' ' ' ILE . . . . . 0.779 HG23 HG12 ' A' ' 793' ' ' ILE . 25.8 mm . . . . . 0 N--CA 1.452 -0.338 0 N-CA-C 111.961 0.356 . . . . 71.329999999999998 111.961 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -57.17 -28.69 58.93 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.959 -0.639 . . . . 74.420000000000002 112.293 176.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 718' ' ' GLU . . . . . 0.711 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 9.2 mm-40 -70.59 -36.42 73.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.841 0.353 . . . . 73.25 110.289 178.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 719' ' ' LEU . . . . . 0.593 HD23 ' HA ' ' A' ' 716' ' ' ILE . 3.2 mm? -66.86 -32.23 73.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.17 0.509 . . . . 53.119999999999997 109.864 177.241 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 720' ' ' VAL . . . . . 0.459 HG22 HD13 ' A' ' 793' ' ' ILE . 61.0 t -68.81 -34.81 66.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.696 -0.684 . . . . 74.140000000000001 110.636 177.542 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 721' ' ' ARG . . . . . 0.711 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 21.5 ptt180 -63.47 -28.93 70.3 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.261 0.553 . . . . 71.120000000000005 109.643 178.091 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -77.76 -30.79 51.69 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.908 -0.587 . . . . 71.140000000000001 111.392 178.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 723' ' ' LEU . . . . . 0.521 HD21 ' HB2' ' A' ' 789' ' ' LEU . 92.9 mt -58.18 -33.56 69.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.146 0.498 . . . . 73.150000000000006 110.052 175.4 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -82.83 -44.28 15.66 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.491 -0.777 . . . . 45.149999999999999 110.887 176.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 8.2 m -84.22 -79.82 0.21 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.358 -0.383 . . . . 54.210000000000001 111.46 -175.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 726' ' ' ASN . . . . . 0.432 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 52.6 t-20 -148.08 109.58 3.73 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 109.768 -0.456 . . . . 71.120000000000005 109.768 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 727' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 28.0 Cg_endo -63.06 -33.79 72.32 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.826 2.35 . . . . 75.420000000000002 112.467 -178.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 59.7 t -63.39 -48.45 87.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.044 0.45 . . . . 72.310000000000002 110.183 -178.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -66.03 -24.55 71.76 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.668 -0.696 . . . . 71.5 111.881 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -79.1 -39.15 20.58 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 121.149 -0.548 . . . . 64.329999999999998 112.644 178.09 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -65.35 -41.83 93.47 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.576 -0.527 . . . . 72.140000000000001 109.576 178.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 732' ' ' LEU . . . . . 0.423 HD23 ' HB3' ' A' ' 742' ' ' ALA . 90.0 mt -64.13 -37.77 88.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.83 -0.623 . . . . 71.439999999999998 110.193 175.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 733' ' ' GLU . . . . . 0.553 ' O ' ' HG2' ' A' ' 736' ' ' ARG . 4.1 tp10 -65.18 -49.45 69.74 Favored 'General case' 0 N--CA 1.437 -1.12 0 C-N-CA 123.423 0.689 . . . . 74.109999999999999 110.857 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 734' ' ' TYR . . . . . 0.52 ' HB2' HD11 ' A' ' 719' ' ' LEU . 11.0 t80 -54.7 -48.13 72.82 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.634 -0.712 . . . . 72.329999999999998 110.716 178.241 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -67.14 -47.93 69.6 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.88 -0.6 . . . . 75.230000000000004 111.22 -177.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 736' ' ' ARG . . . . . 0.553 ' HG2' ' O ' ' A' ' 733' ' ' GLU . 18.5 ptt180 -61.99 -32.95 73.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.997 0.427 . . . . 53.240000000000002 111.314 -175.346 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 44.6 t -80.3 -36.87 33.75 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.075 -0.511 . . . . 75.450000000000003 110.981 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -91.81 -2.35 56.95 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.105 0.409 . . . . 65.209999999999994 112.105 -172.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 89.47 13.37 61.57 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.61 -0.805 . . . . 74.439999999999998 112.936 175.1 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -97.93 157.89 15.84 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.849 0.357 . . . . 65.219999999999999 110.691 177.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -102.42 114.85 29.4 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.519 -0.548 . . . . 52.109999999999999 109.519 175.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 742' ' ' ALA . . . . . 0.423 ' HB3' HD23 ' A' ' 732' ' ' LEU . . . -92.38 114.81 27.46 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 123.237 0.336 . . . . 61.109999999999999 111.021 -177.057 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 743' ' ' GLU . . . . . 0.431 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 47.1 mt-10 -126.68 132.74 51.1 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.3 -0.409 . . . . 65.299999999999997 110.966 -178.591 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -106.14 100.76 10.28 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.181 -0.463 . . . . 72.530000000000001 110.292 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 10.4 ptpt -103.72 140.89 37.0 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.171 0.51 . . . . 65.239999999999995 111.204 -179.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 746' ' ' LEU . . . . . . . . . . . . . 6.6 tt -86.42 110.01 19.43 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.303 -0.999 . . . . 72.219999999999999 108.303 175.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 40.4 t -74.88 -53.88 15.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.077 -0.51 . . . . 72.409999999999997 110.347 -176.034 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -157.04 155.19 30.76 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.991 -0.55 . . . . 52.240000000000002 109.53 -178.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -139.62 96.81 3.14 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.514 0.673 . . . . 74.019999999999996 110.974 177.418 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 34.0 t -89.73 101.85 14.55 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.548 -0.908 . . . . 63.240000000000002 108.548 174.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 751' ' ' GLY . . . . . 0.667 ' HA2' ' HA ' ' A' ' 756' ' ' PRO . . . -120.25 81.17 0.33 Allowed Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.172 -1.013 . . . . 54.409999999999997 113.671 -173.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 752' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -64.59 160.24 40.95 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.169 1.913 . . . . 55.439999999999998 110.466 170.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.41 -27.36 84.79 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.513 2.142 . . . . 75.019999999999996 113.188 -174.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 50.9 p-80 -92.19 -15.18 27.95 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.499 -0.319 . . . . 74.140000000000001 111.596 -176.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -158.89 71.72 3.62 Favored Pre-proline 0 C--N 1.329 -0.289 0 N-CA-C 112.289 0.478 . . . . 64.540000000000006 112.289 -176.45 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 756' ' ' PRO . . . . . 0.667 ' HA ' ' HA2' ' A' ' 751' ' ' GLY . 40.2 Cg_exo -58.13 115.29 2.43 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 121.934 1.756 . . . . 61.240000000000002 111.199 171.077 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 757' ' ' LYS . . . . . 0.488 ' HD3' ' HB2' ' A' ' 773' ' ' CYS . 36.4 ttmt -122.4 137.06 54.99 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.958 0.408 . . . . 72.549999999999997 110.822 -176.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 758' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -123.21 119.61 30.73 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.813 -0.631 . . . . 74.129999999999995 110.45 -176.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 759' ' ' VAL . . . . . 0.527 HG22 ' HB3' ' A' ' 773' ' ' CYS . 25.3 t -94.49 115.92 34.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.005 -0.543 . . . . 62.130000000000003 110.761 -177.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -116.76 147.56 41.94 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.754 -0.657 . . . . 75.540000000000006 110.724 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 761' ' ' GLN . . . . . 0.452 HE21 ' HB2' ' A' ' 771' ' ' ALA . 34.4 tt0 -132.62 138.13 47.27 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.942 -0.572 . . . . 74.230000000000004 109.677 177.089 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 762' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 769' ' ' PHE . . . -95.19 112.66 24.34 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.316 0.579 . . . . 73.439999999999998 110.514 -177.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 763' ' ' LYS . . . . . 0.488 ' HD2' ' CH2' ' A' ' 768' ' ' TRP . 48.8 tttm -91.67 104.02 16.54 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.493 -0.776 . . . . 70.209999999999994 109.441 177.492 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 88.8 t -109.35 101.77 13.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.182 0.515 . . . . 73.329999999999998 109.851 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 71.68 -119.13 7.47 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 110.775 -0.93 . . . . 55.530000000000001 110.775 -174.418 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -102.14 7.06 54.24 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.635 -0.793 . . . . 73.140000000000001 111.224 175.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 767' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -99.9 148.56 24.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.054 0.454 . . . . 75.540000000000006 110.976 -177.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 768' ' ' TRP . . . . . 0.488 ' CH2' ' HD2' ' A' ' 763' ' ' LYS . 54.1 m95 -124.76 99.9 6.37 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.688 -0.687 . . . . 73.430000000000007 110.064 -179.546 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 769' ' ' PHE . . . . . 0.414 ' HA ' ' HA ' ' A' ' 770' ' ' PRO . 34.5 p90 -171.04 141.57 1.41 Allowed Pre-proline 0 C--N 1.325 -0.468 0 CA-C-O 120.706 0.289 . . . . 64.219999999999999 110.397 -178.152 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 770' ' ' PRO . . . . . 0.58 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 60.7 Cg_endo -96.59 -168.54 1.78 Allowed 'Cis proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.755 -1.352 . . . . 64.030000000000001 112.126 -2.066 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 771' ' ' ALA . . . . . 0.452 ' HB2' HE21 ' A' ' 761' ' ' GLN . . . -120.95 108.53 14.0 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.771 -0.455 . . . . 70.140000000000001 109.771 175.392 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 772' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 759' ' ' VAL . 32.9 m -116.87 157.54 17.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.83 0.348 . . . . 60.039999999999999 110.998 -176.287 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 773' ' ' CYS . . . . . 0.527 ' HB3' HG22 ' A' ' 759' ' ' VAL . 2.6 p -134.99 100.53 4.6 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.069 -0.514 . . . . 73.420000000000002 110.175 178.479 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -103.22 177.49 4.82 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.824 -0.626 . . . . 61.520000000000003 111.221 -174.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 775' ' ' HIS . . . . . . . . . . . . . 46.8 m-70 -85.32 -16.63 39.35 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.14 0.495 . . . . 73.129999999999995 110.324 -177.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 776' ' ' SER . . . . . 0.605 ' HB2' ' HB2' ' A' ' 779' ' ' GLN . 12.5 m -129.71 152.57 49.07 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.954 -0.567 . . . . 75.439999999999998 110.281 -177.16 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 777' ' ' LYS . . . . . . . . . . . . . 6.1 tmmm? -63.9 -49.69 71.67 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.372 -0.376 . . . . 75.0 110.96 -178.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -70.41 -26.56 63.74 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.644 -0.423 . . . . 71.400000000000006 110.231 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 779' ' ' GLN . . . . . 0.605 ' HB2' ' HB2' ' A' ' 776' ' ' SER . 6.5 mm-40 -66.71 -37.33 84.48 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 116.28 -0.418 . . . . 74.409999999999997 110.261 173.408 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -58.15 -45.98 93.31 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.787 -0.72 . . . . 74.340000000000003 111.501 175.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -61.94 -46.13 90.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.773 0.321 . . . . 73.450000000000003 110.76 176.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -64.56 -46.87 80.92 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.337 -0.392 . . . . 61.450000000000003 111.399 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -63.14 -39.57 95.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.496 -0.32 . . . . 73.540000000000006 111.235 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -63.19 -46.11 88.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.82 0.343 . . . . 54.210000000000001 110.11 177.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 785' ' ' ALA . . . . . 0.578 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -65.14 -45.11 86.35 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.902 -0.59 . . . . 62.329999999999998 110.986 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 786' ' ' ASP . . . . . 0.718 ' O ' ' HG2' ' A' ' 790' ' ' ARG . 14.1 t70 -58.41 -54.49 46.46 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 116.317 -0.401 . . . . 73.030000000000001 110.012 178.581 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 787' ' ' ALA . . . . . 0.52 ' O ' HG23 ' A' ' 791' ' ' VAL . . . -61.75 -33.79 74.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.759 -0.655 . . . . 73.329999999999998 111.21 -178.52 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 788' ' ' ALA . . . . . 0.716 ' O ' ' HG ' ' A' ' 792' ' ' LEU . . . -62.84 -46.62 87.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.363 -0.381 . . . . 63.530000000000001 110.448 177.013 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 789' ' ' LEU . . . . . 0.587 HD22 HD12 ' A' ' 719' ' ' LEU . 65.5 mt -62.58 -36.36 82.47 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.812 -0.44 . . . . 75.230000000000004 109.812 179.37 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 790' ' ' ARG . . . . . 0.718 ' HG2' ' O ' ' A' ' 786' ' ' ASP . 26.6 mmm-85 -58.95 -42.18 89.22 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.868 0.366 . . . . 75.230000000000004 110.033 177.501 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 791' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 787' ' ' ALA . 59.0 t -64.31 -49.68 79.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.054 -0.521 . . . . 73.129999999999995 110.465 177.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 792' ' ' LEU . . . . . 0.716 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 22.5 mt -59.19 -46.59 88.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.033 -0.531 . . . . 52.100000000000001 110.457 -178.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 793' ' ' ILE . . . . . 0.779 HG12 HG23 ' A' ' 716' ' ' ILE . 96.7 mt -63.02 -45.49 98.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.422 -0.808 . . . . 74.409999999999997 110.675 177.097 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -65.69 -40.16 95.69 Favored Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 115.934 -0.575 . . . . 53.420000000000002 112.934 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -74.23 -16.58 60.96 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 122.377 -0.484 . . . . 73.230000000000004 111.277 -178.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 5.1 t30 . . . . . 0 C--N 1.323 -0.545 0 CA-C-O 121.436 0.636 . . . . 75.310000000000002 109.424 174.998 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 716' ' ' ILE . . . . . 0.447 ' HA ' HD23 ' A' ' 719' ' ' LEU . 48.1 mm . . . . . 0 C--O 1.233 0.192 0 CA-C-O 121.022 0.439 . . . . 75.129999999999995 110.68 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -60.29 -29.73 69.49 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.944 -0.646 . . . . 53.329999999999998 112.085 178.284 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 718' ' ' GLU . . . . . 0.671 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 30.0 mm-40 -57.87 -50.12 74.38 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-O 120.965 0.412 . . . . 73.540000000000006 110.168 176.004 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 719' ' ' LEU . . . . . 0.567 HD11 ' HB2' ' A' ' 734' ' ' TYR . 2.4 mm? -62.71 -29.67 70.84 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.164 0.507 . . . . 73.140000000000001 110.096 -177.09 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 720' ' ' VAL . . . . . 0.448 HG22 HD13 ' A' ' 793' ' ' ILE . 65.1 t -72.07 -42.96 67.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.617 -0.72 . . . . 74.319999999999993 110.639 178.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 721' ' ' ARG . . . . . 0.671 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 15.5 ptm180 -65.5 -24.05 67.04 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.919 0.39 . . . . 74.120000000000005 110.446 -179.339 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -76.91 -31.56 56.78 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 116.483 -0.326 . . . . 74.530000000000001 111.098 176.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 723' ' ' LEU . . . . . 0.479 HD21 ' HB2' ' A' ' 789' ' ' LEU . 92.3 mt -60.78 -30.9 70.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.266 0.555 . . . . 71.329999999999998 109.99 174.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -87.95 -17.26 31.69 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.281 -0.872 . . . . 70.299999999999997 111.317 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 21.2 m -118.04 -79.9 0.6 Allowed 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 120.674 0.274 . . . . 60.130000000000003 111.595 -177.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 726' ' ' ASN . . . . . 0.436 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 39.4 t30 -139.19 106.71 7.29 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 120.71 0.29 . . . . 64.549999999999997 110.669 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 727' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 21.1 Cg_endo -62.03 -38.48 56.91 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.745 2.297 . . . . 34.520000000000003 112.838 -178.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 29.9 t -63.12 -46.32 96.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.355 -0.384 . . . . 72.239999999999995 110.669 -175.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -61.58 -36.1 92.12 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.833 -0.698 . . . . 45.399999999999999 112.026 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -67.54 -42.07 89.17 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 121.095 -0.574 . . . . 73.109999999999999 112.593 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -65.66 -42.05 91.81 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.964 0.411 . . . . 75.299999999999997 109.933 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 732' ' ' LEU . . . . . . . . . . . . . 96.1 mt -65.37 -46.44 80.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.944 -0.571 . . . . 75.129999999999995 111.14 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 733' ' ' GLU . . . . . 0.515 ' HA ' ' HG2' ' A' ' 736' ' ' ARG . 0.0 OUTLIER -72.75 -31.38 64.88 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.899 -0.321 . . . . 75.109999999999999 110.994 -176.187 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 734' ' ' TYR . . . . . 0.567 ' HB2' HD11 ' A' ' 719' ' ' LEU . 11.8 t80 -57.22 -48.88 77.69 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 120.918 0.39 . . . . 71.319999999999993 110.089 175.333 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -65.02 -52.26 57.0 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.874 -0.603 . . . . 73.409999999999997 110.709 -176.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 736' ' ' ARG . . . . . 0.515 ' HG2' ' HA ' ' A' ' 733' ' ' GLU . 32.5 ptt180 -62.47 -33.04 74.05 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.686 -0.688 . . . . 72.400000000000006 111.399 -175.201 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 47.9 t -83.47 -11.68 57.21 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.909 -0.587 . . . . 42.340000000000003 111.673 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -113.03 -8.44 13.64 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.008 0.373 . . . . 64.409999999999997 112.008 -177.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 100.08 8.01 51.48 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.597 -0.811 . . . . 51.439999999999998 112.733 178.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -97.42 163.75 12.74 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 110.091 -0.337 . . . . 74.140000000000001 110.091 177.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -113.0 118.61 35.3 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.6 -0.519 . . . . 64.349999999999994 109.6 174.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 742' ' ' ALA . . . . . . . . . . . . . . . -94.06 128.3 40.35 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.21 -0.45 . . . . 53.539999999999999 111.029 -176.057 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 743' ' ' GLU . . . . . 0.567 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 45.6 mt-10 -139.54 154.81 47.74 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.872 -0.603 . . . . 71.510000000000005 110.393 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -128.5 113.18 15.17 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.209 -0.451 . . . . 73.420000000000002 109.795 178.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 745' ' ' LYS . . . . . 0.511 ' HE3' ' CZ3' ' A' ' 768' ' ' TRP . 13.1 ptpt -111.74 149.34 31.79 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.305 -0.558 . . . . 52.240000000000002 111.197 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 746' ' ' LEU . . . . . . . . . . . . . 6.7 tt -95.49 104.85 16.77 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.236 -1.024 . . . . 61.219999999999999 108.236 177.119 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 48.3 t -76.84 -44.14 32.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 116.226 -0.443 . . . . 74.450000000000003 111.009 -174.365 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -152.88 148.49 27.21 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.324 -0.398 . . . . 73.319999999999993 111.12 -175.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 749' ' ' GLN . . . . . 0.514 ' HA ' ' O ' ' A' ' 757' ' ' LYS . 18.1 pt20 -138.75 97.02 3.24 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.924 0.869 . . . . 72.140000000000001 109.759 173.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 9.8 p -129.5 -179.18 5.02 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.414 -0.812 . . . . 61.399999999999999 111.004 -174.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 103.64 178.5 25.87 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.586 -0.816 . . . . 31.100000000000001 112.229 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 752' ' ' PRO . . . . . 0.663 ' HG2' ' HB2' ' A' ' 755' ' ' GLU . 38.7 Cg_endo -64.98 160.3 42.15 Favored 'Trans proline' 0 CA--C 1.528 0.218 0 C-N-CA 123.118 2.545 . . . . 53.109999999999999 111.963 -178.19 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.37 -28.2 71.58 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.645 2.23 . . . . 70.200000000000003 112.658 -178.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 49.0 p-80 -86.49 -14.82 41.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.76 0.314 . . . . 54.420000000000002 110.989 -179.025 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 755' ' ' GLU . . . . . 0.663 ' HB2' ' HG2' ' A' ' 752' ' ' PRO . 18.8 mm-40 -138.9 74.0 38.5 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.252 -0.431 . . . . 64.519999999999996 110.718 178.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 756' ' ' PRO . . . . . 0.671 ' O ' ' HA ' ' A' ' 775' ' ' HIS . 56.1 Cg_endo -73.5 113.32 3.75 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.495 2.13 . . . . 74.099999999999994 111.723 177.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 757' ' ' LYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 749' ' ' GLN . 6.1 ttpm? -88.61 114.08 24.85 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.903 0.382 . . . . 71.25 110.718 -177.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 758' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -99.06 115.11 28.22 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.532 -0.758 . . . . 70.209999999999994 110.013 179.229 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 22.1 t -88.24 105.69 15.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.627 -0.715 . . . . 71.099999999999994 109.373 177.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -107.63 144.43 34.69 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.981 -0.554 . . . . 62.039999999999999 110.669 -178.087 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 761' ' ' GLN . . . . . 0.473 ' HA ' ' O ' ' A' ' 770' ' ' PRO . 60.4 tt0 -136.6 128.18 28.72 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.703 -0.68 . . . . 74.319999999999993 109.512 178.094 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 762' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 769' ' ' PHE . . . -86.29 129.56 34.81 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.332 0.587 . . . . 41.109999999999999 110.502 -178.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 763' ' ' LYS . . . . . 0.567 ' HB3' ' HB2' ' A' ' 743' ' ' GLU . 66.0 tttt -104.6 112.28 25.29 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.584 -0.735 . . . . 75.030000000000001 109.783 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 58.9 t -119.27 95.92 3.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.175 0.512 . . . . 53.219999999999999 109.758 177.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 72.86 -116.5 5.65 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.091 -0.803 . . . . 52.140000000000001 111.091 -175.097 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -101.36 -2.97 53.89 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.752 -0.737 . . . . 60.340000000000003 111.818 175.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 767' ' ' ARG . . . . . 0.455 ' HB3' ' CD1' ' A' ' 769' ' ' PHE . 0.2 OUTLIER -95.08 121.91 37.2 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.959 0.409 . . . . 72.530000000000001 111.457 -178.01 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 768' ' ' TRP . . . . . 0.511 ' CZ3' ' HE3' ' A' ' 745' ' ' LYS . 70.2 m95 -102.17 105.14 15.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.917 -0.583 . . . . 75.239999999999995 110.062 177.182 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 769' ' ' PHE . . . . . 0.455 ' CD1' ' HB3' ' A' ' 767' ' ' ARG . 41.6 p90 -168.39 144.94 3.2 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 109.873 -0.417 . . . . 74.230000000000004 109.873 -177.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 770' ' ' PRO . . . . . 0.666 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 65.3 Cg_endo -97.56 -176.16 4.45 Favored 'Cis proline' 0 N--CA 1.451 -1.006 0 C-N-CA 123.736 -1.36 . . . . 53.329999999999998 112.188 -2.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -106.41 109.1 20.93 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.596 -0.52 . . . . 50.200000000000003 109.596 174.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 35.9 m -117.72 155.79 19.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.969 0.414 . . . . 70.310000000000002 110.997 -177.015 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 7.0 p -129.91 112.78 13.86 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.17 0.51 . . . . 65.019999999999996 110.442 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 774' ' ' ALA . . . . . 0.421 ' O ' ' HA ' ' A' ' 757' ' ' LYS . . . -116.73 -178.4 3.42 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.816 -0.629 . . . . 64.340000000000003 109.784 178.608 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 775' ' ' HIS . . . . . 0.671 ' HA ' ' O ' ' A' ' 756' ' ' PRO . 5.6 p80 -121.86 19.01 11.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.772 0.796 . . . . 65.109999999999999 110.187 176.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 49.3 m -148.35 139.22 23.05 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.837 -1.074 . . . . 73.420000000000002 108.405 171.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 777' ' ' LYS . . . . . . . . . . . . . 5.6 tmmm? -61.45 -44.77 96.53 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 123.018 0.199 . . . . 65.129999999999995 111.291 -172.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -64.85 -31.56 72.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.71 0.291 . . . . 60.149999999999999 110.799 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 779' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -72.03 -35.51 69.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.365 -0.38 . . . . 75.230000000000004 110.335 177.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -59.94 -42.94 98.48 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.904 -0.665 . . . . 45.310000000000002 111.493 176.099 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -61.25 -49.01 78.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.835 0.35 . . . . 72.540000000000006 110.488 176.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -61.73 -51.21 69.31 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 115.896 -0.593 . . . . 72.129999999999995 111.254 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -57.95 -43.34 86.34 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 123.196 0.31 . . . . 60.539999999999999 111.44 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -59.92 -50.68 72.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.373 -0.376 . . . . 64.209999999999994 110.622 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 785' ' ' ALA . . . . . 0.596 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -67.48 -42.46 82.94 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.318 -0.401 . . . . 54.140000000000001 111.025 -178.719 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 786' ' ' ASP . . . . . 0.461 ' O ' ' HG3' ' A' ' 790' ' ' ARG . 11.8 t70 -59.1 -51.74 68.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.984 -0.553 . . . . 65.200000000000003 110.717 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 787' ' ' ALA . . . . . 0.55 ' O ' HG23 ' A' ' 791' ' ' VAL . . . -66.84 -35.46 80.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.034 -0.53 . . . . 64.120000000000005 110.8 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 788' ' ' ALA . . . . . 0.676 ' O ' ' HG ' ' A' ' 792' ' ' LEU . . . -61.46 -42.75 99.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.425 -0.352 . . . . 65.420000000000002 110.854 178.046 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 789' ' ' LEU . . . . . 0.596 ' HG ' ' O ' ' A' ' 785' ' ' ALA . 81.3 mt -58.92 -43.98 91.22 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 110.008 -0.367 . . . . 73.239999999999995 110.008 177.431 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 790' ' ' ARG . . . . . 0.548 ' HD2' ' HA ' ' A' ' 787' ' ' ALA . 53.9 mtt-85 -58.36 -37.53 75.39 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.206 -0.452 . . . . 75.530000000000001 111.009 177.301 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 791' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 787' ' ' ALA . 48.3 t -65.81 -48.67 81.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.416 -0.356 . . . . 72.430000000000007 110.237 177.109 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 792' ' ' LEU . . . . . 0.676 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 39.6 mt -61.67 -46.37 90.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.747 -0.661 . . . . 73.049999999999997 110.749 -179.103 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 793' ' ' ILE . . . . . 0.448 HD13 HG22 ' A' ' 720' ' ' VAL . 89.5 mt -62.17 -47.53 92.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.51 -0.768 . . . . 70.439999999999998 110.366 177.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -62.92 -36.4 93.36 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 121.018 -0.611 . . . . 71.030000000000001 112.342 178.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -57.56 -51.22 70.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.977 0.418 . . . . 71.329999999999998 110.44 177.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 . . . . . 0 C--N 1.327 -0.396 0 CA-C-O 121.171 0.51 . . . . 72.129999999999995 110.667 -177.514 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 716' ' ' ILE . . . . . 0.416 ' O ' HG23 ' A' ' 720' ' ' VAL . 46.1 mm . . . . . 0 N--CA 1.454 -0.243 0 CA-C-O 120.75 0.31 . . . . 72.319999999999993 110.587 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -61.09 -28.94 69.77 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.974 -0.631 . . . . 41.049999999999997 111.702 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 718' ' ' GLU . . . . . 0.759 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 5.8 mp0 -59.68 -46.94 87.55 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.913 0.387 . . . . 64.109999999999999 110.173 175.657 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 719' ' ' LEU . . . . . 0.641 HD12 HD22 ' A' ' 789' ' ' LEU . 2.9 mm? -67.61 -33.75 75.62 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.997 0.427 . . . . 75.340000000000003 110.36 -178.694 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 720' ' ' VAL . . . . . 0.496 HG22 HD13 ' A' ' 793' ' ' ILE . 61.6 t -63.39 -41.19 91.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 115.991 -0.55 . . . . 64.5 110.672 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 721' ' ' ARG . . . . . 0.759 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 14.7 ptm180 -68.92 -24.57 64.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 73.0 109.981 -178.174 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -76.73 -30.15 56.49 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.356 -0.384 . . . . 75.120000000000005 111.404 177.432 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 723' ' ' LEU . . . . . 0.564 HD21 ' HB2' ' A' ' 789' ' ' LEU . 84.7 mt -59.18 -32.57 70.04 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.476 -0.565 . . . . 74.239999999999995 109.476 172.094 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -82.97 -41.06 19.22 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.276 -0.875 . . . . 60.240000000000002 110.976 177.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 29.3 m -96.26 -78.49 0.46 Allowed 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 112.32 0.489 . . . . 72.540000000000006 112.32 -176.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 726' ' ' ASN . . . . . 0.422 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 37.7 t30 -142.11 100.9 5.82 Favored Pre-proline 0 C--O 1.234 0.27 0 CA-C-O 120.817 0.342 . . . . 75.120000000000005 111.065 -173.245 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 727' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 19.2 Cg_endo -61.86 -38.5 58.7 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 123.041 2.494 . . . . 55.399999999999999 112.844 -176.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 42.0 t -61.48 -48.49 88.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 75.510000000000005 110.939 -175.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -61.98 -38.46 96.09 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.765 -0.731 . . . . 54.130000000000003 112.12 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -66.85 -42.68 92.8 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.876 -0.678 . . . . 72.349999999999994 112.584 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -62.52 -40.36 96.5 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.807 -0.442 . . . . 71.219999999999999 109.807 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 732' ' ' LEU . . . . . . . . . . . . . 90.7 mt -64.74 -42.98 94.77 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.928 -0.578 . . . . 72.530000000000001 111.399 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 733' ' ' GLU . . . . . 0.522 ' O ' ' HG2' ' A' ' 736' ' ' ARG . 12.7 pt-20 -80.2 -25.95 39.43 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.924 -0.311 . . . . 74.450000000000003 111.55 -176.06 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 734' ' ' TYR . . . . . 0.52 ' HB2' HD11 ' A' ' 719' ' ' LEU . 3.2 t80 -56.89 -44.24 82.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.061 0.457 . . . . 71.030000000000001 109.84 173.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -66.93 -47.6 71.22 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.612 -0.722 . . . . 63.350000000000001 110.666 -177.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 736' ' ' ARG . . . . . 0.522 ' HG2' ' O ' ' A' ' 733' ' ' GLU . 34.4 ptt180 -63.39 -31.77 73.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.13 0.49 . . . . 74.310000000000002 110.992 -176.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 10.4 t -75.46 -33.59 60.87 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.756 -0.656 . . . . 74.230000000000004 110.993 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 18.2 m170 -97.02 -13.29 22.38 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.317 0.488 . . . . 73.540000000000006 112.317 -173.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 100.56 13.56 34.85 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.439 -0.886 . . . . 42.420000000000002 112.614 178.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -98.57 -174.14 2.73 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.025 0.44 . . . . 60.340000000000003 110.284 176.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 741' ' ' ALA . . . . . 0.564 ' O ' ' HA ' ' A' ' 764' ' ' VAL . . . -128.06 139.43 52.53 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.796 -0.638 . . . . 71.409999999999997 109.281 173.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 742' ' ' ALA . . . . . . . . . . . . . . . -110.11 115.73 30.28 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.773 0.32 . . . . 74.010000000000005 110.895 -176.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 743' ' ' GLU . . . . . 0.561 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 43.4 mt-10 -126.63 146.53 50.14 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.274 -0.421 . . . . 72.239999999999995 110.979 -178.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -123.15 104.3 9.09 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.37 -0.604 . . . . 71.040000000000006 109.37 176.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 8.0 ptpt -119.16 157.9 27.02 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.095 0.474 . . . . 44.439999999999998 111.307 -176.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 746' ' ' LEU . . . . . 0.471 HD13 ' HB3' ' A' ' 758' ' ' PHE . 57.2 tp -85.78 122.98 30.63 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.509 -0.769 . . . . 63.450000000000003 109.756 175.489 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 54.3 t -94.58 -47.73 13.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 120.959 0.409 . . . . 74.230000000000004 110.537 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -143.92 148.9 36.03 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.044 -0.525 . . . . 64.019999999999996 110.003 -177.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -133.32 102.5 5.57 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.691 -0.485 . . . . 71.209999999999994 109.691 176.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 33.7 m -143.65 131.61 21.63 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.243 -0.435 . . . . 74.310000000000002 110.562 -177.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 160.62 -165.52 35.08 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.653 -0.784 . . . . 64.140000000000001 112.261 178.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 752' ' ' PRO . . . . . 0.489 ' HG2' ' HB2' ' A' ' 755' ' ' GLU . 72.7 Cg_endo -78.0 163.81 27.96 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 123.015 2.477 . . . . 73.310000000000002 112.084 177.036 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 753' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 752' ' ' PRO . 3.8 Cg_exo -76.51 -27.94 7.23 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.543 2.162 . . . . 75.209999999999994 112.379 -179.292 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 754' ' ' HIS . . . . . 0.415 ' CE1' ' HB2' ' A' ' 752' ' ' PRO . 39.8 p-80 -79.33 -19.4 50.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.914 0.387 . . . . 72.549999999999997 110.709 178.381 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 755' ' ' GLU . . . . . 0.489 ' HB2' ' HG2' ' A' ' 752' ' ' PRO . 29.3 mt-10 -138.99 79.74 26.09 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.929 -0.578 . . . . 62.43 110.332 175.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 756' ' ' PRO . . . . . 0.493 ' O ' ' HA ' ' A' ' 775' ' ' HIS . 34.9 Cg_endo -65.94 102.38 0.53 Allowed 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.165 1.91 . . . . 73.319999999999993 111.3 177.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 757' ' ' LYS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 775' ' ' HIS . 37.9 ttmt -87.69 114.69 24.54 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.437 0.637 . . . . 65.120000000000005 110.686 -176.099 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 758' ' ' PHE . . . . . 0.471 ' HB3' HD13 ' A' ' 746' ' ' LEU . 78.8 m-85 -97.95 126.12 43.19 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.016 -0.993 . . . . 75.319999999999993 110.48 -178.489 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 62.0 t -88.86 102.95 13.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 109.488 -0.56 . . . . 54.130000000000003 109.488 174.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 760' ' ' TYR . . . . . 0.469 ' OH ' ' HG3' ' A' ' 777' ' ' LYS . 7.1 m-85 -102.29 142.13 34.01 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.875 -0.602 . . . . 64.409999999999997 110.764 -178.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 761' ' ' GLN . . . . . 0.483 ' OE1' ' HB3' ' A' ' 768' ' ' TRP . 32.0 tt0 -133.75 136.04 44.33 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.717 -0.674 . . . . 73.329999999999998 110.084 179.379 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 762' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 769' ' ' PHE . . . -87.43 116.28 25.43 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.94 -0.573 . . . . 74.120000000000005 110.441 -178.273 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 763' ' ' LYS . . . . . 0.561 ' HB3' ' HB2' ' A' ' 743' ' ' GLU . 58.6 tttm -94.94 100.39 12.25 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.716 -0.674 . . . . 53.109999999999999 109.631 178.131 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 764' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' A' ' 741' ' ' ALA . 58.3 t -104.75 100.7 11.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.965 -0.562 . . . . 74.049999999999997 109.842 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 69.84 -111.65 3.96 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 110.881 -0.888 . . . . 53.130000000000003 110.881 -174.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -112.13 10.99 26.86 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 111.407 -0.677 . . . . 71.010000000000005 111.407 175.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 767' ' ' ARG . . . . . . . . . . . . . 79.7 mtm180 -107.82 131.51 54.4 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.939 0.4 . . . . 72.549999999999997 110.567 -178.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 768' ' ' TRP . . . . . 0.483 ' HB3' ' OE1' ' A' ' 761' ' ' GLN . 43.1 m95 -108.39 101.25 10.46 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.906 -0.588 . . . . 74.329999999999998 109.991 -177.549 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 769' ' ' PHE . . . . . 0.446 ' HA ' ' HA ' ' A' ' 770' ' ' PRO . 27.2 p90 -167.86 139.8 2.49 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-O 120.74 0.305 . . . . 73.120000000000005 110.61 -178.01 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 770' ' ' PRO . . . . . 0.694 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 68.7 Cg_endo -95.13 -170.09 2.71 Favored 'Cis proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.648 -1.397 . . . . 63.32 111.797 -3.197 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 771' ' ' ALA . . . . . 0.412 ' HB2' HE21 ' A' ' 761' ' ' GLN . . . -122.17 101.49 7.56 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.996 -0.372 . . . . 72.409999999999997 109.996 176.503 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 27.0 m -110.51 168.04 4.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.135 -0.484 . . . . 54.119999999999997 110.81 -176.505 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 5.8 p -133.6 113.83 12.85 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.244 0.545 . . . . 71.329999999999998 110.995 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -132.03 149.4 52.43 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.866 -0.606 . . . . 54.420000000000002 109.926 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 775' ' ' HIS . . . . . 0.493 ' HA ' ' O ' ' A' ' 756' ' ' PRO . 1.3 p-80 -83.67 18.29 1.98 Allowed 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.592 -0.443 . . . . 73.230000000000004 111.669 -176.371 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 32.5 t -148.39 143.26 26.7 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.896 -0.409 . . . . 73.019999999999996 109.896 176.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 777' ' ' LYS . . . . . 0.469 ' HG3' ' OH ' ' A' ' 760' ' ' TYR . 8.4 ttmm -57.97 -49.8 75.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 72.510000000000005 110.752 178.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -58.94 -45.36 90.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.51 -0.768 . . . . 71.349999999999994 110.376 -178.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 779' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -63.58 -41.47 98.36 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-N 116.086 -0.506 . . . . 64.349999999999994 110.626 177.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -55.6 -44.85 86.04 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.028 -0.606 . . . . 51.340000000000003 112.036 178.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -66.24 -43.65 85.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.649 0.261 . . . . 72.040000000000006 111.024 177.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -63.88 -48.13 77.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.393 -0.367 . . . . 53.109999999999999 110.969 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -61.51 -43.52 98.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 64.439999999999998 110.927 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -63.2 -48.93 76.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.038 -0.528 . . . . 64.5 110.845 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 785' ' ' ALA . . . . . 0.608 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -65.1 -42.02 94.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.319 -0.401 . . . . 53.109999999999999 110.983 -178.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 786' ' ' ASP . . . . . 0.41 ' O ' ' HG3' ' A' ' 790' ' ' ARG . 12.7 t70 -57.64 -50.17 74.02 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.052 -0.522 . . . . 74.420000000000002 110.667 178.741 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 787' ' ' ALA . . . . . 0.523 ' O ' HG23 ' A' ' 791' ' ' VAL . . . -67.4 -38.75 85.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.043 -0.526 . . . . 72.25 110.968 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 788' ' ' ALA . . . . . 0.694 ' HB2' ' HD3' ' A' ' 770' ' ' PRO . . . -61.48 -43.58 98.62 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.326 -0.397 . . . . 53.340000000000003 111.41 -178.275 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 789' ' ' LEU . . . . . 0.641 HD22 HD12 ' A' ' 719' ' ' LEU . 52.1 mt -59.81 -43.57 94.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.565 -0.289 . . . . 61.439999999999998 110.409 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 790' ' ' ARG . . . . . 0.41 ' HG3' ' O ' ' A' ' 786' ' ' ASP . 67.0 mtt-85 -60.77 -34.34 74.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 75.040000000000006 110.989 178.489 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 791' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 787' ' ' ALA . 56.8 t -64.9 -49.66 78.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.947 -0.39 . . . . 71.0 109.947 175.24 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 792' ' ' LEU . . . . . 0.624 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 29.6 mt -60.8 -51.49 69.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.859 -0.609 . . . . 72.25 110.884 -178.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 793' ' ' ILE . . . . . 0.496 HD13 HG22 ' A' ' 720' ' ' VAL . 81.9 mt -58.31 -54.33 34.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.399 -0.819 . . . . 64.400000000000006 111.18 178.42 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -64.49 -26.57 70.88 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 121.098 -0.572 . . . . 52.399999999999999 112.809 -177.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -66.74 -46.53 75.16 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.925 -0.398 . . . . 52.100000000000001 109.925 177.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 . . . . . 0 CA--C 1.516 -0.327 0 CA-C-N 116.27 -0.423 . . . . 75.439999999999998 110.498 179.738 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 716' ' ' ILE . . . . . 0.5 ' HA ' HD23 ' A' ' 719' ' ' LEU . 47.8 mm . . . . . 0 N--CA 1.452 -0.363 0 CA-C-O 120.951 0.405 . . . . 75.519999999999996 110.913 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -56.95 -25.13 52.65 Favored Glycine 0 N--CA 1.453 -0.232 0 CA-C-N 115.879 -0.601 . . . . 53.200000000000003 111.649 175.099 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 718' ' ' GLU . . . . . 0.743 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 13.6 mm-40 -62.67 -49.59 74.53 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 115.77 -0.215 . . . . 62.109999999999999 110.692 175.511 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 719' ' ' LEU . . . . . 0.604 HD12 HD22 ' A' ' 789' ' ' LEU . 2.5 mm? -62.03 -31.67 72.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.016 0.436 . . . . 71.239999999999995 110.436 -176.407 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 720' ' ' VAL . . . . . 0.456 HG22 HD13 ' A' ' 793' ' ' ILE . 63.4 t -64.58 -39.69 86.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.757 -0.656 . . . . 73.030000000000001 111.088 178.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 721' ' ' ARG . . . . . 0.743 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 11.5 ptt180 -67.38 -26.05 66.26 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.071 0.462 . . . . 70.129999999999995 109.932 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -79.02 -29.53 43.66 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.177 -0.465 . . . . 74.439999999999998 110.913 179.262 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 723' ' ' LEU . . . . . 0.537 HD21 ' HB2' ' A' ' 789' ' ' LEU . 96.5 mt -57.61 -38.94 75.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.176 0.512 . . . . 70.310000000000002 109.898 174.32 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -80.36 -42.16 23.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.333 -0.849 . . . . 72.299999999999997 111.151 177.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 22.1 m -82.16 -81.5 0.15 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.91 0.386 . . . . 61.329999999999998 111.591 -177.104 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 726' ' ' ASN . . . . . 0.434 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 38.4 t30 -148.19 105.88 3.6 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 109.756 -0.461 . . . . 50.32 109.756 -179.197 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 727' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 14.0 Cg_endo -58.32 -36.43 97.65 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.79 2.326 . . . . 71.209999999999994 112.351 -176.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 728' ' ' VAL . . . . . 0.412 ' O ' ' HG ' ' A' ' 732' ' ' LEU . 40.3 t -61.26 -49.02 86.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.005 -0.543 . . . . 61.539999999999999 110.936 -177.349 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -64.87 -28.77 73.87 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.901 -0.666 . . . . 51.340000000000003 111.907 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -71.85 -42.53 52.89 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 121.035 -0.603 . . . . 75.219999999999999 112.353 179.255 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -64.83 -40.43 95.17 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.48 -0.563 . . . . 51.409999999999997 109.48 178.383 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 732' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 728' ' ' VAL . 95.4 mt -62.78 -44.14 96.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.873 -0.603 . . . . 55.130000000000003 110.691 176.608 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 733' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -65.81 -42.82 90.18 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 122.929 0.492 . . . . 53.520000000000003 110.721 -178.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 734' ' ' TYR . . . . . 0.537 ' HB2' HD11 ' A' ' 719' ' ' LEU . 20.3 t80 -58.13 -51.64 68.86 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.278 -0.419 . . . . 73.409999999999997 110.356 176.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -63.95 -51.46 64.26 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.176 -0.466 . . . . 61.299999999999997 110.857 -177.076 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 736' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -60.88 -35.58 76.99 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.087 -0.506 . . . . 75.040000000000006 111.429 -174.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 8.1 t -83.25 -25.39 31.69 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.458 -0.337 . . . . 43.100000000000001 111.196 -177.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -95.29 -1.59 51.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.515 0.198 . . . . 73.319999999999993 111.445 -177.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 98.59 -5.91 60.56 Favored Glycine 0 CA--C 1.516 0.15 0 C-N-CA 120.783 -0.722 . . . . 61.25 112.771 175.261 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 740' ' ' PHE . . . . . 0.41 ' HD1' ' HA3' ' A' ' 765' ' ' GLY . 95.0 m-85 -81.82 167.4 19.08 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.941 0.401 . . . . 65.129999999999995 110.766 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -119.64 110.9 17.39 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.387 -0.597 . . . . 73.0 109.387 175.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 742' ' ' ALA . . . . . . . . . . . . . . . -85.28 132.14 34.31 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.0 0.428 . . . . 62.32 111.74 -175.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 743' ' ' GLU . . . . . 0.505 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 38.1 mt-10 -135.13 142.75 46.25 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.645 -0.707 . . . . 74.349999999999994 110.879 176.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -119.15 101.81 8.27 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.141 -0.688 . . . . 62.329999999999998 109.141 175.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 745' ' ' LYS . . . . . 0.458 ' HB3' ' HZ3' ' A' ' 745' ' ' LYS . 1.1 ptpm? -124.66 144.2 50.32 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.066 0.46 . . . . 70.219999999999999 111.114 -175.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 746' ' ' LEU . . . . . 0.417 HD13 ' HB3' ' A' ' 758' ' ' PHE . 56.8 tp -77.08 117.91 19.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.502 -0.772 . . . . 64.200000000000003 110.037 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 54.5 t -88.03 -49.63 14.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.202 0.525 . . . . 62.530000000000001 110.108 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 748' ' ' ASP . . . . . 0.448 ' O ' ' HB ' ' A' ' 759' ' ' VAL . 26.5 t70 -148.22 154.82 40.6 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.403 -0.817 . . . . 73.340000000000003 109.331 -178.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -132.87 112.86 12.26 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.447 0.642 . . . . 55.020000000000003 110.369 173.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 750' ' ' SER . . . . . 0.457 ' O ' ' HB3' ' A' ' 757' ' ' LYS . 11.3 m -101.78 89.53 3.71 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.363 -0.835 . . . . 61.100000000000001 109.438 177.625 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 751' ' ' GLY . . . . . 0.535 ' HA3' ' HA ' ' A' ' 756' ' ' PRO . . . -152.95 123.5 1.45 Allowed Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 119.48 -1.343 . . . . 61.5 113.855 -174.184 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 752' ' ' PRO . . . . . 0.458 ' HD2' ' HA2' ' A' ' 751' ' ' GLY . 26.4 Cg_endo -63.51 167.95 12.3 Favored 'Trans proline' 0 CA--C 1.533 0.425 0 C-N-CA 123.002 2.468 . . . . 65.140000000000001 111.105 169.442 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -56.59 -33.65 93.6 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 122.523 2.148 . . . . 74.209999999999994 112.792 -178.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 39.2 p-80 -88.35 -9.35 53.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.199 -0.455 . . . . 75.239999999999995 111.984 -177.008 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -152.59 73.69 7.33 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 111.792 0.293 . . . . 71.239999999999995 111.792 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 756' ' ' PRO . . . . . 0.535 ' HA ' ' HA3' ' A' ' 751' ' ' GLY . 42.8 Cg_endo -70.1 103.05 1.16 Allowed 'Trans proline' 0 CA--C 1.528 0.224 0 C-N-CA 122.36 2.04 . . . . 62.420000000000002 112.198 176.327 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 757' ' ' LYS . . . . . 0.504 ' H ' ' HA3' ' A' ' 751' ' ' GLY . 40.1 ttmt -96.6 133.0 41.65 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.894 -0.41 . . . . 74.099999999999994 109.894 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 758' ' ' PHE . . . . . 0.417 ' HB3' HD13 ' A' ' 746' ' ' LEU . 95.5 m-85 -110.08 126.03 53.58 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.299 -0.41 . . . . 55.509999999999998 111.147 -176.245 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 759' ' ' VAL . . . . . 0.512 HG22 ' HB3' ' A' ' 773' ' ' CYS . 97.3 t -94.03 104.04 15.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-N 115.78 -0.646 . . . . 71.420000000000002 109.853 177.025 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -102.6 144.6 30.8 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.606 -0.725 . . . . 64.109999999999999 111.179 -177.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 761' ' ' GLN . . . . . 0.497 ' NE2' ' HB3' ' A' ' 768' ' ' TRP . 28.2 tt0 -132.46 131.7 41.98 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.305 -0.861 . . . . 75.299999999999997 109.385 178.208 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 762' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 769' ' ' PHE . . . -90.17 123.46 34.01 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.3 0.571 . . . . 63.549999999999997 110.646 -177.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 763' ' ' LYS . . . . . 0.564 ' HE2' ' HA2' ' A' ' 766' ' ' GLY . 45.5 tttt -99.29 105.88 17.94 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.044 -0.724 . . . . 72.030000000000001 109.044 177.146 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 50.7 t -108.33 91.87 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.233 0.539 . . . . 73.430000000000007 110.689 -178.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 765' ' ' GLY . . . . . 0.41 ' HA3' ' HD1' ' A' ' 740' ' ' PHE . . . 77.8 -7.59 41.15 Favored Glycine 0 N--CA 1.454 -0.132 0 CA-C-N 115.627 -0.715 . . . . 63.210000000000001 112.56 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 766' ' ' GLY . . . . . 0.564 ' HA2' ' HE2' ' A' ' 763' ' ' LYS . . . 136.77 -29.62 2.74 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.31 -0.716 . . . . 63.32 111.31 -177.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 767' ' ' ARG . . . . . 0.472 ' HD2' ' CD1' ' A' ' 769' ' ' PHE . 0.7 OUTLIER -72.57 118.75 15.87 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.078 -0.712 . . . . 74.340000000000003 109.078 177.21 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 768' ' ' TRP . . . . . 0.497 ' HB3' ' NE2' ' A' ' 761' ' ' GLN . 76.4 m95 -88.45 105.48 17.63 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.032 -0.531 . . . . 71.230000000000004 110.267 -178.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 769' ' ' PHE . . . . . 0.472 ' CD1' ' HD2' ' A' ' 767' ' ' ARG . 13.0 p90 -168.43 137.83 1.94 Allowed Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 109.875 -0.417 . . . . 73.540000000000006 109.875 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 770' ' ' PRO . . . . . 0.739 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 58.5 Cg_endo -97.24 -167.75 1.41 Allowed 'Cis proline' 0 N--CA 1.451 -1.012 0 C-N-CA 123.779 -1.342 . . . . 62.350000000000001 112.018 -2.494 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -119.45 101.19 7.77 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.744 -0.465 . . . . 63.240000000000002 109.744 175.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 34.8 m -117.19 170.77 6.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.504 -0.317 . . . . 61.119999999999997 111.135 -174.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 773' ' ' CYS . . . . . 0.512 ' HB3' HG22 ' A' ' 759' ' ' VAL . 4.7 p -142.48 121.67 13.01 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.137 -0.483 . . . . 60.020000000000003 110.606 178.187 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -124.9 154.52 40.96 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.202 -0.454 . . . . 53.140000000000001 110.222 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 775' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -79.87 -4.45 52.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.007 0.432 . . . . 62.329999999999998 110.986 -177.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 54.9 m -131.22 144.62 51.46 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.134 -0.485 . . . . 54.299999999999997 109.998 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 777' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -65.33 -42.97 92.39 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.162 -0.472 . . . . 65.420000000000002 111.158 -175.535 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -65.88 -37.76 86.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.972 0.415 . . . . 73.109999999999999 110.078 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 779' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -66.72 -33.13 74.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.026 -0.533 . . . . 72.209999999999994 110.916 177.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -56.96 -42.99 93.01 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.845 -0.693 . . . . 54.140000000000001 111.714 177.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -64.79 -43.26 93.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.946 0.403 . . . . 61.399999999999999 110.418 176.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -67.24 -46.86 72.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.978 -0.555 . . . . 63.219999999999999 111.181 -178.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -61.51 -40.87 96.17 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 123.163 0.289 . . . . 72.219999999999999 110.894 -179.272 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -60.97 -52.3 65.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 72.109999999999999 110.431 178.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 785' ' ' ALA . . . . . 0.639 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -63.9 -42.05 97.53 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.091 -0.504 . . . . 71.299999999999997 111.095 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 786' ' ' ASP . . . . . 0.603 ' O ' ' HG2' ' A' ' 790' ' ' ARG . 21.3 t70 -57.09 -56.56 20.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.954 -0.566 . . . . 63.420000000000002 110.871 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 787' ' ' ALA . . . . . 0.574 ' O ' HG23 ' A' ' 791' ' ' VAL . . . -63.92 -33.58 76.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.873 -0.603 . . . . 63.450000000000003 110.972 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 788' ' ' ALA . . . . . 0.739 ' HB2' ' HD3' ' A' ' 770' ' ' PRO . . . -62.67 -41.85 99.3 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.637 0.256 . . . . 62.420000000000002 110.704 177.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 789' ' ' LEU . . . . . 0.639 ' HG ' ' O ' ' A' ' 785' ' ' ALA . 62.9 mt -64.82 -38.81 92.22 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.621 -0.511 . . . . 73.010000000000005 109.621 178.036 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 790' ' ' ARG . . . . . 0.603 ' HG2' ' O ' ' A' ' 786' ' ' ASP . 13.5 mmm180 -59.41 -39.42 83.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.853 -0.612 . . . . 74.140000000000001 110.254 177.594 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 791' ' ' VAL . . . . . 0.574 HG23 ' O ' ' A' ' 787' ' ' ALA . 83.4 t -59.84 -52.12 64.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.858 -0.61 . . . . 74.239999999999995 110.51 176.294 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 792' ' ' LEU . . . . . 0.6 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 25.0 mt -60.94 -49.59 76.83 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.624 -0.716 . . . . 65.400000000000006 110.767 -177.56 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 793' ' ' ILE . . . . . 0.456 HD13 HG22 ' A' ' 720' ' ' VAL . 85.9 mt -59.72 -41.34 85.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.596 -0.729 . . . . 72.409999999999997 110.965 178.196 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -65.78 -43.93 93.14 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 116.072 -0.513 . . . . 60.439999999999998 112.735 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -62.62 -44.8 95.39 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.676 0.274 . . . . 72.010000000000005 111.006 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 796' ' ' ASN . . . . . 0.427 ' CG ' HG13 ' A' ' 716' ' ' ILE . 10.8 t30 . . . . . 0 C--N 1.325 -0.492 0 CA-C-N 116.344 -0.389 . . . . 65.510000000000005 110.712 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 716' ' ' ILE . . . . . 0.553 ' HA ' HD23 ' A' ' 719' ' ' LEU . 50.7 mm . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 121.011 0.434 . . . . 60.130000000000003 110.88 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -57.2 -23.19 46.44 Favored Glycine 0 CA--C 1.521 0.412 0 CA-C-N 115.881 -0.599 . . . . 74.319999999999993 112.926 178.121 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 718' ' ' GLU . . . . . 0.737 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 4.7 mm-40 -73.83 -40.54 63.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.184 0.516 . . . . 73.129999999999995 110.136 178.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 719' ' ' LEU . . . . . 0.563 HD12 HD22 ' A' ' 789' ' ' LEU . 3.0 mm? -65.1 -31.78 73.15 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.282 0.563 . . . . 74.129999999999995 109.496 178.327 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 720' ' ' VAL . . . . . 0.425 HG22 HD13 ' A' ' 793' ' ' ILE . 89.8 t -64.07 -41.41 92.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.533 -0.758 . . . . 62.140000000000001 110.798 177.212 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 721' ' ' ARG . . . . . 0.737 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 26.7 ptt180 -63.59 -25.39 68.21 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.064 0.459 . . . . 73.25 110.28 -178.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -79.07 -26.62 43.05 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.392 -0.367 . . . . 74.230000000000004 111.622 178.469 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 723' ' ' LEU . . . . . 0.482 HD21 ' HB2' ' A' ' 789' ' ' LEU . 87.3 mt -65.08 -23.75 67.25 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.197 -0.668 . . . . 54.409999999999997 109.197 171.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -81.4 -54.66 5.27 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.378 -0.828 . . . . 72.439999999999998 110.538 174.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 15.7 m -89.41 -72.47 0.55 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.571 0.582 . . . . 73.140000000000001 112.571 -174.254 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 726' ' ' ASN . . . . . 0.436 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 26.6 t30 -145.65 101.53 4.3 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.693 0.282 . . . . 53.32 111.008 -172.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 727' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 17.8 Cg_endo -61.21 -38.59 65.08 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.913 2.409 . . . . 72.329999999999998 112.374 -178.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 728' ' ' VAL . . . . . 0.422 ' O ' ' HG ' ' A' ' 732' ' ' LEU . 41.5 t -60.64 -45.82 96.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.083 -0.508 . . . . 73.25 110.96 -177.036 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -65.52 -39.89 95.85 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.618 -0.801 . . . . 73.140000000000001 112.179 -177.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 730' ' ' GLY . . . . . 0.417 ' HA2' ' HG2' ' A' ' 733' ' ' GLU . . . -67.8 -38.45 89.48 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.908 -0.663 . . . . 51.439999999999998 112.583 -178.64 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -63.38 -41.05 98.77 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.13 0.49 . . . . 64.510000000000005 109.684 178.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 732' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 728' ' ' VAL . 94.0 mt -65.66 -43.64 88.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.701 -0.681 . . . . 72.319999999999993 111.27 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 733' ' ' GLU . . . . . 0.525 ' HA ' ' HG2' ' A' ' 736' ' ' ARG . 11.4 pt-20 -79.51 -25.26 41.81 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 120.544 -0.462 . . . . 72.209999999999994 111.783 -176.128 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 734' ' ' TYR . . . . . 0.51 ' HB2' HD11 ' A' ' 719' ' ' LEU . 7.1 t80 -56.63 -46.43 81.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.275 0.56 . . . . 73.420000000000002 109.493 171.547 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -68.02 -46.8 70.22 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.348 -0.842 . . . . 74.409999999999997 111.047 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 736' ' ' ARG . . . . . 0.525 ' HG2' ' HA ' ' A' ' 733' ' ' GLU . 29.7 ptt180 -60.76 -34.25 74.17 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.097 0.475 . . . . 75.109999999999999 110.706 -176.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 31.5 t -76.7 -38.07 55.02 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.75 -0.659 . . . . 32.420000000000002 110.909 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 16.6 m170 -95.59 0.66 53.15 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.0 0.37 . . . . 73.230000000000004 112.0 -172.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 90.65 4.94 69.52 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.693 -0.765 . . . . 73.549999999999997 113.34 174.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -91.47 173.92 7.64 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.99 0.424 . . . . 72.129999999999995 110.743 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 741' ' ' ALA . . . . . 0.628 ' O ' ' HA ' ' A' ' 764' ' ' VAL . . . -108.45 147.31 31.82 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.29 -0.633 . . . . 74.109999999999999 109.29 173.658 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 742' ' ' ALA . . . . . . . . . . . . . . . -128.89 110.88 12.49 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.825 0.345 . . . . 73.400000000000006 110.521 -178.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 743' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -136.12 154.41 51.0 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.286 -0.416 . . . . 71.530000000000001 110.922 -177.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -122.67 118.64 28.6 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.307 -0.406 . . . . 74.329999999999998 109.985 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 7.1 ptpt -117.65 148.49 41.91 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.051 0.453 . . . . 72.209999999999994 111.251 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 746' ' ' LEU . . . . . . . . . . . . . 6.9 tt -92.25 102.79 15.29 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.014 -1.106 . . . . 74.140000000000001 108.014 175.455 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 38.5 t -72.56 -45.74 57.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.101 -0.5 . . . . 71.409999999999997 110.654 -174.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -160.64 164.21 31.97 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.105 -0.702 . . . . 74.109999999999999 109.105 -179.088 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -138.69 125.67 21.21 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.11 0.481 . . . . 73.040000000000006 110.725 178.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 17.1 m -125.39 101.19 6.84 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.676 -0.693 . . . . 72.040000000000006 109.356 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 751' ' ' GLY . . . . . 0.874 ' HA3' ' HA ' ' A' ' 756' ' ' PRO . . . -174.27 134.62 2.88 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 119.534 -1.317 . . . . 74.120000000000005 113.779 -178.421 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 752' ' ' PRO . . . . . 0.453 ' HD2' ' HA2' ' A' ' 751' ' ' GLY . 25.6 Cg_endo -62.04 168.9 8.31 Favored 'Trans proline' 0 CA--C 1.529 0.262 0 C-N-CA 123.535 2.824 . . . . 64.340000000000003 111.432 171.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.71 -28.36 87.14 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.368 2.046 . . . . 72.25 112.6 -179.101 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 38.7 p-80 -87.6 -17.05 32.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.443 -0.344 . . . . 63.219999999999999 111.476 -178.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -153.1 69.43 6.85 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 111.94 0.348 . . . . 53.310000000000002 111.94 -175.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 756' ' ' PRO . . . . . 0.874 ' HA ' ' HA3' ' A' ' 751' ' ' GLY . 71.9 Cg_endo -80.28 108.2 2.14 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.27 1.98 . . . . 61.409999999999997 112.695 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 757' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -91.44 115.09 27.75 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.975 0.417 . . . . 75.310000000000002 110.476 176.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 758' ' ' PHE . . . . . 0.499 ' O ' ' HA ' ' A' ' 773' ' ' CYS . 58.9 m-85 -97.13 130.22 44.42 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.955 -0.566 . . . . 75.219999999999999 110.2 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 759' ' ' VAL . . . . . 0.487 HG22 ' HB3' ' A' ' 773' ' ' CYS . 48.3 t -92.96 105.27 16.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.989 0.424 . . . . 75.450000000000003 110.201 178.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -102.46 143.86 31.64 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.262 -0.881 . . . . 75.150000000000006 110.671 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 761' ' ' GLN . . . . . 0.58 ' HA ' ' O ' ' A' ' 770' ' ' PRO . 36.5 tt0 -135.06 135.09 41.01 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.978 -0.556 . . . . 74.230000000000004 109.978 177.638 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 762' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 769' ' ' PHE . . . -91.51 126.58 36.65 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.159 0.504 . . . . 72.420000000000002 111.025 -178.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -97.32 107.76 20.34 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.595 -0.73 . . . . 72.329999999999998 109.293 176.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 764' ' ' VAL . . . . . 0.628 ' HA ' ' O ' ' A' ' 741' ' ' ALA . 63.0 t -116.37 103.84 15.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.234 0.54 . . . . 64.439999999999998 110.055 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 70.09 -115.1 5.91 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 110.896 -0.882 . . . . 61.340000000000003 110.896 -174.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -109.57 9.82 32.72 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.77 -0.729 . . . . 52.450000000000003 111.328 175.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 767' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -106.84 143.56 34.75 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.075 0.464 . . . . 64.319999999999993 110.5 -177.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 768' ' ' TRP . . . . . 0.454 ' HB3' ' OE1' ' A' ' 761' ' ' GLN . 68.3 m95 -116.55 102.48 9.51 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.629 -0.714 . . . . 72.030000000000001 109.902 -178.445 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 769' ' ' PHE . . . . . 0.43 ' HA ' ' HA ' ' A' ' 770' ' ' PRO . 33.1 p90 -168.91 141.83 2.27 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.343 -0.39 . . . . 74.0 110.23 -176.552 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 770' ' ' PRO . . . . . 0.634 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 62.5 Cg_endo -98.88 -179.7 5.64 Favored 'Cis proline' 0 N--CA 1.45 -1.034 0 C-N-CA 123.564 -1.432 . . . . 55.119999999999997 111.979 -4.12 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 771' ' ' ALA . . . . . 0.439 ' HB2' HE21 ' A' ' 761' ' ' GLN . . . -110.98 112.43 24.24 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.553 -0.536 . . . . 52.020000000000003 109.553 174.071 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 34.3 m -124.47 149.48 28.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.356 -0.384 . . . . 73.019999999999996 110.937 -177.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 773' ' ' CYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 758' ' ' PHE . 7.7 p -118.02 115.3 24.6 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.938 0.399 . . . . 72.010000000000005 110.453 178.139 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -123.07 157.51 32.66 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.177 -0.465 . . . . 63.409999999999997 110.619 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 775' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -83.29 11.44 6.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.847 0.356 . . . . 70.299999999999997 111.759 -176.434 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 776' ' ' SER . . . . . 0.439 ' HB3' ' CG ' ' A' ' 779' ' ' GLN . 8.5 t -153.28 145.62 23.97 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.82 -0.437 . . . . 62.210000000000001 109.82 -178.734 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 777' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -59.63 -50.36 74.18 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.062 -0.517 . . . . 73.109999999999999 111.303 -177.564 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -62.4 -36.53 82.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.848 0.356 . . . . 71.200000000000003 110.401 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 779' ' ' GLN . . . . . 0.439 ' CG ' ' HB3' ' A' ' 776' ' ' SER . 16.2 mm100 -64.19 -41.92 96.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 54.439999999999998 110.2 178.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -55.87 -48.44 72.51 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.038 -0.601 . . . . 75.25 112.3 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -65.1 -45.47 85.03 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.852 0.358 . . . . 73.5 111.189 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -66.01 -47.2 75.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.23 -0.441 . . . . 72.239999999999995 111.519 -176.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -62.58 -39.07 92.53 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.684 0.278 . . . . 61.219999999999999 110.494 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -62.58 -46.85 86.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.269 -0.423 . . . . 61.32 110.748 177.509 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 785' ' ' ALA . . . . . 0.444 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -65.38 -42.55 92.57 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.234 -0.439 . . . . 62.240000000000002 110.953 -179.601 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 786' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -56.98 -51.17 70.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.337 0.589 . . . . 73.340000000000003 110.404 176.272 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 787' ' ' ALA . . . . . 0.644 ' O ' HG23 ' A' ' 791' ' ' VAL . . . -64.66 -38.72 91.96 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.333 -0.849 . . . . 72.549999999999997 111.066 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 788' ' ' ALA . . . . . 0.634 ' HB2' ' HD3' ' A' ' 770' ' ' PRO . . . -61.62 -47.0 87.4 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.383 -0.371 . . . . 71.0 111.077 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 789' ' ' LEU . . . . . 0.563 HD22 HD12 ' A' ' 719' ' ' LEU . 79.6 mt -60.97 -43.57 98.58 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.842 -0.429 . . . . 73.450000000000003 109.842 177.719 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 790' ' ' ARG . . . . . . . . . . . . . 30.7 mtt180 -63.52 -26.43 68.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 72.329999999999998 111.684 178.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 791' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 787' ' ' ALA . 98.2 t -68.68 -50.43 55.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.747 -0.464 . . . . 70.140000000000001 109.747 172.69 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 792' ' ' LEU . . . . . 0.581 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 27.2 mt -61.44 -49.92 74.88 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.431 -0.804 . . . . 65.209999999999994 110.349 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 793' ' ' ILE . . . . . 0.432 HG12 ' CG2' ' A' ' 716' ' ' ILE . 95.7 mt -59.61 -43.45 91.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.258 -0.883 . . . . 74.439999999999998 110.881 178.39 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -68.01 -32.47 77.06 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 121.002 -0.618 . . . . 63.409999999999997 112.644 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -69.37 -44.16 72.09 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.169 0.509 . . . . 72.439999999999998 110.404 178.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 796' ' ' ASN . . . . . 0.526 ' HB3' HG13 ' A' ' 716' ' ' ILE . 2.7 t30 . . . . . 0 C--N 1.325 -0.486 0 CA-C-N 115.851 -0.613 . . . . 71.209999999999994 110.376 -175.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 716' ' ' ILE . . . . . 0.495 ' HA ' HD23 ' A' ' 719' ' ' LEU . 46.7 mm . . . . . 0 C--O 1.233 0.185 0 CA-C-O 120.791 0.329 . . . . 62.130000000000003 111.445 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -60.97 -27.89 67.82 Favored Glycine 0 C--N 1.33 0.208 0 C-N-CA 120.98 -0.629 . . . . 62.149999999999999 112.101 -179.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 718' ' ' GLU . . . . . 0.782 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 2.8 mp0 -63.19 -39.49 94.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.894 0.378 . . . . 72.140000000000001 110.593 177.349 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 719' ' ' LEU . . . . . 0.625 HD12 HD22 ' A' ' 789' ' ' LEU . 3.0 mm? -67.48 -29.78 69.31 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.073 0.463 . . . . 74.140000000000001 110.139 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 720' ' ' VAL . . . . . 0.517 HG22 HD13 ' A' ' 793' ' ' ILE . 56.6 t -66.65 -41.61 88.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.819 -0.628 . . . . 62.409999999999997 110.737 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 721' ' ' ARG . . . . . 0.782 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 11.8 ptm180 -65.11 -28.47 69.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.016 0.436 . . . . 70.340000000000003 109.907 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -74.19 -30.17 62.09 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.34 -0.391 . . . . 52.140000000000001 110.853 177.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 723' ' ' LEU . . . . . 0.575 HD21 ' HB2' ' A' ' 789' ' ' LEU . 90.9 mt -60.74 -27.55 68.01 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.252 0.549 . . . . 72.25 109.893 173.585 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -86.45 -44.65 11.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.476 -0.784 . . . . 74.299999999999997 110.817 176.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 51.0 m -89.57 -76.64 0.41 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.296 -0.411 . . . . 74.0 112.043 -175.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 726' ' ' ASN . . . . . 0.442 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 53.8 t-20 -144.82 105.77 4.55 Favored Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 109.997 -0.371 . . . . 53.409999999999997 109.997 -177.091 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 727' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 20.0 Cg_endo -61.3 -35.97 81.73 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.881 2.387 . . . . 73.310000000000002 112.246 -179.361 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 728' ' ' VAL . . . . . 0.445 ' O ' ' HG ' ' A' ' 732' ' ' LEU . 59.7 t -64.31 -45.53 95.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.019 -0.537 . . . . 74.450000000000003 110.459 -178.269 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -61.63 -34.48 88.67 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.945 -0.645 . . . . 62.539999999999999 112.355 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -74.79 -41.32 34.44 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.796 -0.716 . . . . 54.340000000000003 112.56 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -63.12 -40.33 97.3 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.863 -0.421 . . . . 75.140000000000001 109.863 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 732' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 728' ' ' VAL . 95.5 mt -64.19 -46.28 84.62 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.027 -0.533 . . . . 74.25 111.281 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 733' ' ' GLU . . . . . 0.5 ' HA ' ' HG2' ' A' ' 736' ' ' ARG . 6.3 pt-20 -73.97 -31.47 63.02 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.41 -0.516 . . . . 72.340000000000003 110.981 -177.523 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 734' ' ' TYR . . . . . 0.402 ' HB2' HD11 ' A' ' 719' ' ' LEU . 9.3 t80 -57.29 -48.6 78.5 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 120.895 0.378 . . . . 71.310000000000002 110.063 175.284 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 735' ' ' ALA . . . . . 0.43 ' HA ' ' HB2' ' A' ' 740' ' ' PHE . . . -65.04 -51.18 63.0 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.985 -0.552 . . . . 64.329999999999998 110.643 -177.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 736' ' ' ARG . . . . . 0.5 ' HG2' ' HA ' ' A' ' 733' ' ' GLU . 12.2 ptm180 -61.7 -34.99 76.73 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.807 -0.633 . . . . 71.420000000000002 111.515 -174.256 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 47.0 t -77.56 -37.14 51.31 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.038 -0.528 . . . . 74.150000000000006 111.096 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -91.51 -2.53 57.16 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.119 0.414 . . . . 72.129999999999995 112.119 -171.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 94.81 7.93 59.66 Favored Glycine 0 CA--C 1.516 0.143 0 C-N-CA 120.45 -0.881 . . . . 54.340000000000003 112.719 176.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 740' ' ' PHE . . . . . 0.43 ' HB2' ' HA ' ' A' ' 735' ' ' ALA . 98.3 m-85 -93.15 177.81 5.94 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.032 0.444 . . . . 54.119999999999997 110.538 177.123 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -129.69 124.6 33.98 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.882 -0.599 . . . . 62.200000000000003 109.526 175.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 742' ' ' ALA . . . . . . . . . . . . . . . -94.05 115.7 28.05 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.774 0.321 . . . . 54.219999999999999 111.148 -176.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 743' ' ' GLU . . . . . 0.573 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 40.8 mt-10 -127.48 125.36 40.34 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.016 -0.538 . . . . 74.030000000000001 111.051 -179.077 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -105.25 117.27 33.59 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.115 -0.493 . . . . 75.329999999999998 110.414 179.176 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -134.2 150.42 51.07 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.184 0.516 . . . . 62.240000000000002 111.342 178.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 746' ' ' LEU . . . . . 0.462 HD21 ' HB3' ' A' ' 749' ' ' GLN . 4.9 tt -85.96 111.52 20.33 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.065 -1.087 . . . . 72.340000000000003 108.065 173.353 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 58.7 t -82.96 -46.25 18.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.895 0.379 . . . . 70.140000000000001 111.143 -174.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -152.03 149.69 29.14 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.407 -0.361 . . . . 61.229999999999997 110.374 -178.049 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 749' ' ' GLN . . . . . 0.462 ' HB3' HD21 ' A' ' 746' ' ' LEU . 4.9 pp0? -144.68 153.09 41.37 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.787 0.327 . . . . 65.340000000000003 110.946 179.515 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 20.9 t -174.75 -169.81 0.44 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.818 -0.808 . . . . 71.230000000000004 108.818 -178.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 107.83 175.18 22.25 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.524 -0.846 . . . . 43.310000000000002 112.733 176.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 752' ' ' PRO . . . . . 0.839 ' HG2' ' HB2' ' A' ' 755' ' ' GLU . 44.9 Cg_endo -69.32 164.35 34.45 Favored 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 123.084 2.523 . . . . 72.25 112.721 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -64.43 -33.65 56.94 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.62 2.213 . . . . 61.219999999999999 112.685 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 22.3 p80 -82.95 -15.55 50.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.307 -0.406 . . . . 73.329999999999998 111.102 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 755' ' ' GLU . . . . . 0.839 ' HB2' ' HG2' ' A' ' 752' ' ' PRO . 45.0 mt-10 -135.27 73.75 63.28 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.401 -0.363 . . . . 75.219999999999999 110.798 177.593 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 756' ' ' PRO . . . . . 0.543 ' O ' ' HA ' ' A' ' 775' ' ' HIS . 42.1 Cg_endo -69.15 114.69 3.69 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.09 1.86 . . . . 65.340000000000003 111.329 178.377 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 757' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -100.43 117.42 34.57 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.032 0.444 . . . . 71.329999999999998 110.727 -176.287 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 758' ' ' PHE . . . . . 0.445 ' CZ ' ' HB2' ' A' ' 756' ' ' PRO . 53.5 m-85 -115.12 121.23 42.39 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.602 -0.726 . . . . 72.450000000000003 109.872 -179.207 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 26.3 t -90.58 106.41 17.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 120.996 0.427 . . . . 70.200000000000003 110.313 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -99.26 139.26 35.16 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.688 -0.687 . . . . 71.549999999999997 110.285 178.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 761' ' ' GLN . . . . . 0.479 ' HA ' ' O ' ' A' ' 770' ' ' PRO . 55.9 tt0 -130.07 135.73 48.56 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.033 -0.53 . . . . 75.420000000000002 109.725 178.724 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 762' ' ' ALA . . . . . . . . . . . . . . . -90.56 112.42 24.1 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.967 -0.56 . . . . 72.329999999999998 110.71 -178.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 763' ' ' LYS . . . . . 0.573 ' HB3' ' HB2' ' A' ' 743' ' ' GLU . 61.0 tttm -88.32 104.66 16.95 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.065 -0.717 . . . . 70.439999999999998 109.065 175.572 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 56.9 t -109.9 100.72 11.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.349 0.595 . . . . 73.310000000000002 109.975 -179.198 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 75.19 -117.9 5.43 Favored Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 110.834 -0.906 . . . . 53.43 110.834 -175.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -103.36 3.97 47.48 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.662 -0.78 . . . . 63.219999999999999 111.627 176.601 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 767' ' ' ARG . . . . . . . . . . . . . 50.3 mtt180 -103.58 152.86 21.24 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.052 0.454 . . . . 72.219999999999999 111.029 -176.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 768' ' ' TRP . . . . . 0.567 ' CH2' ' HD2' ' A' ' 763' ' ' LYS . 59.2 m95 -118.83 105.15 11.23 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.687 -0.688 . . . . 72.310000000000002 109.386 176.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 769' ' ' PHE . . . . . 0.434 ' HA ' ' HA ' ' A' ' 770' ' ' PRO . 21.4 p90 -171.47 139.09 1.14 Allowed Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 120.854 0.359 . . . . 72.349999999999994 110.925 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 770' ' ' PRO . . . . . 0.607 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 79.6 Cg_endo -99.54 -176.8 3.79 Favored 'Cis proline' 0 N--CA 1.453 -0.908 0 C-N-CA 123.718 -1.367 . . . . 63.119999999999997 111.947 -4.134 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -113.88 116.18 28.87 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.771 -0.455 . . . . 34.009999999999998 109.771 175.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 29.1 m -118.94 140.74 41.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.145 0.498 . . . . 72.450000000000003 111.269 -176.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 3.9 p -95.72 102.54 14.35 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.89 -0.596 . . . . 71.150000000000006 110.508 178.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -107.15 177.63 4.79 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.147 -0.479 . . . . 73.310000000000002 110.817 -177.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 775' ' ' HIS . . . . . 0.543 ' HA ' ' O ' ' A' ' 756' ' ' PRO . 28.5 m-70 -117.38 12.45 14.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.127 0.489 . . . . 65.530000000000001 110.066 178.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 33.7 t -167.76 154.06 7.72 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.533 -0.758 . . . . 65.340000000000003 109.692 -176.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 777' ' ' LYS . . . . . . . . . . . . . 5.4 tmmm? -62.53 -42.66 99.67 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.649 -0.5 . . . . 72.230000000000004 109.649 177.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -58.31 -40.46 82.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.417 -0.811 . . . . 65.420000000000002 110.723 178.112 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 779' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -70.06 -45.55 66.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.318 -0.401 . . . . 62.039999999999999 110.438 177.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -54.55 -47.59 69.31 Favored Glycine 0 C--O 1.226 -0.398 0 CA-C-N 115.909 -0.587 . . . . 61.310000000000002 113.072 -176.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -66.79 -44.79 80.39 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.621 0.248 . . . . 72.439999999999998 111.258 -178.249 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -67.63 -49.39 63.17 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.541 -0.3 . . . . 75.430000000000007 111.358 -177.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -63.68 -39.89 95.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.572 0.225 . . . . 65.129999999999995 110.938 -178.167 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -62.05 -50.78 70.62 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 116.486 -0.325 . . . . 64.439999999999998 110.527 178.025 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 785' ' ' ALA . . . . . 0.555 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -65.75 -39.11 90.74 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.324 -0.398 . . . . 62.240000000000002 110.968 -179.316 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 786' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -57.75 -54.17 49.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.031 -0.531 . . . . 71.200000000000003 110.476 177.459 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 787' ' ' ALA . . . . . 0.606 ' O ' HG23 ' A' ' 791' ' ' VAL . . . -64.82 -36.69 85.13 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.855 -0.611 . . . . 25.43 110.723 179.33 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 788' ' ' ALA . . . . . 0.634 ' O ' ' HG ' ' A' ' 792' ' ' LEU . . . -59.49 -48.61 80.98 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.556 -0.293 . . . . 75.430000000000007 110.98 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 789' ' ' LEU . . . . . 0.625 HD22 HD12 ' A' ' 719' ' ' LEU . 63.1 mt -61.49 -39.97 92.85 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.837 -0.431 . . . . 63.210000000000001 109.837 178.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 790' ' ' ARG . . . . . . . . . . . . . 65.4 mtp180 -64.31 -30.91 71.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.607 -0.724 . . . . 75.310000000000002 111.488 178.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 791' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 787' ' ' ALA . 91.5 t -66.94 -48.26 80.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.758 -0.46 . . . . 75.310000000000002 109.758 173.516 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 792' ' ' LEU . . . . . 0.634 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 23.0 mt -60.58 -54.57 43.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.724 -0.671 . . . . 64.120000000000005 110.436 -179.357 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 793' ' ' ILE . . . . . 0.517 HD13 HG22 ' A' ' 720' ' ' VAL . 76.6 mt -58.15 -45.73 88.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.382 -0.826 . . . . 75.439999999999998 110.594 177.318 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -59.5 -48.4 86.18 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 121.121 -0.561 . . . . 75.120000000000005 112.276 179.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -60.88 -31.3 70.78 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.568 0.211 . . . . 70.439999999999998 111.568 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 . . . . . 0 C--N 1.324 -0.535 0 CA-C-O 121.192 0.52 . . . . 72.430000000000007 110.518 176.439 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 716' ' ' ILE . . . . . 0.559 ' HA ' HD23 ' A' ' 719' ' ' LEU . 47.0 mm . . . . . 0 C--O 1.234 0.288 0 CA-C-O 120.89 0.376 . . . . 74.099999999999994 111.626 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -56.92 -30.63 60.36 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 121.196 -0.526 . . . . 65.310000000000002 112.893 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -66.32 -41.04 90.23 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.762 0.315 . . . . 73.299999999999997 110.79 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 719' ' ' LEU . . . . . 0.602 HD12 HD22 ' A' ' 789' ' ' LEU . 2.9 mm? -65.02 -36.3 83.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.016 0.436 . . . . 65.430000000000007 109.998 -178.794 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 720' ' ' VAL . . . . . 0.507 HG22 HD13 ' A' ' 793' ' ' ILE . 52.3 t -64.08 -37.5 80.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-N 115.82 -0.627 . . . . 53.539999999999999 110.173 176.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 721' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.12 -30.32 71.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.794 -0.639 . . . . 55.219999999999999 109.775 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -78.47 -25.04 45.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.898 -0.592 . . . . 74.420000000000002 111.471 179.059 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 91.1 mt -60.03 -30.6 69.28 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.425 0.631 . . . . 71.25 109.461 173.088 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -84.87 -56.59 3.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.312 -0.858 . . . . 73.540000000000006 111.219 174.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 24.4 m -77.91 -64.23 1.2 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.916 0.709 . . . . 62.32 112.916 -171.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 726' ' ' ASN . . . . . 0.42 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 30.6 t30 -159.94 100.76 1.45 Allowed Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 120.834 0.349 . . . . 73.129999999999995 110.914 -175.153 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 727' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 20.9 Cg_endo -62.36 -39.61 45.58 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.875 2.384 . . . . 71.010000000000005 112.317 -177.632 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 39.5 t -59.97 -42.3 89.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.998 -0.546 . . . . 70.530000000000001 110.958 -177.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 729' ' ' GLY . . . . . 0.473 ' O ' ' HG2' ' A' ' 733' ' ' GLU . . . -65.02 -47.38 82.99 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.611 -0.804 . . . . 72.329999999999998 111.939 -179.24 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -64.14 -39.31 97.02 Favored Glycine 0 C--O 1.226 -0.349 0 C-N-CA 121.09 -0.576 . . . . 72.129999999999995 113.259 -176.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -61.67 -39.76 92.56 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.894 -0.41 . . . . 53.119999999999997 109.894 179.295 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 732' ' ' LEU . . . . . . . . . . . . . 96.3 mt -68.04 -47.34 68.64 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.929 -0.578 . . . . 65.0 111.276 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 733' ' ' GLU . . . . . 0.502 ' HA ' ' HB3' ' A' ' 736' ' ' ARG . 9.1 pt-20 -75.15 -26.47 59.14 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.715 -0.394 . . . . 74.230000000000004 111.683 -176.233 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 734' ' ' TYR . . . . . 0.426 ' HB2' HD11 ' A' ' 719' ' ' LEU . 17.5 t80 -56.99 -50.17 73.52 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.347 -0.612 . . . . 74.230000000000004 109.347 172.595 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -64.29 -46.29 84.29 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.903 -0.589 . . . . 72.109999999999999 110.533 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 736' ' ' ARG . . . . . 0.502 ' HB3' ' HA ' ' A' ' 733' ' ' GLU . 1.4 ttt180 -55.49 -48.73 74.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.07 -0.514 . . . . 73.219999999999999 112.011 -178.083 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 22.7 t -81.59 -11.82 58.99 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.678 0.275 . . . . 64.519999999999996 111.224 -174.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -110.49 -2.61 16.44 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.817 -0.353 . . . . 71.230000000000004 111.592 -176.096 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 88.9 9.96 67.37 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.538 -0.839 . . . . 74.319999999999993 113.258 174.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -95.61 168.72 10.51 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.906 0.353 . . . . 64.340000000000003 110.4 177.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -114.1 114.48 26.14 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.219 -0.446 . . . . 60.119999999999997 110.025 176.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 742' ' ' ALA . . . . . . . . . . . . . . . -92.48 133.22 36.13 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.262 -0.427 . . . . 64.420000000000002 110.886 -178.129 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 743' ' ' GLU . . . . . 0.455 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 9.7 mm-40 -144.98 157.65 44.06 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.271 -0.422 . . . . 73.400000000000006 111.142 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -130.16 132.03 45.89 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.815 -0.63 . . . . 72.430000000000007 109.76 177.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -136.37 137.92 41.06 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.126 0.489 . . . . 65.019999999999996 111.748 177.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 746' ' ' LEU . . . . . . . . . . . . . 5.0 tt -82.69 105.33 13.63 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.385 -0.969 . . . . 75.150000000000006 108.385 173.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 46.0 t -70.98 -56.13 11.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.919 0.39 . . . . 53.399999999999999 110.686 -176.342 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -154.94 152.37 29.64 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.977 -0.556 . . . . 73.109999999999999 110.276 -178.386 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -134.06 122.75 23.4 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.951 -0.759 . . . . 74.549999999999997 108.951 174.029 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 67.3 m -146.56 148.28 31.99 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.722 0.296 . . . . 62.520000000000003 110.942 -176.031 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 139.77 -177.65 20.34 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.93 -0.652 . . . . 74.040000000000006 112.163 177.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 752' ' ' PRO . . . . . 0.433 ' HG2' ' CB ' ' A' ' 755' ' ' GLU . 54.9 Cg_endo -71.47 166.76 28.34 Favored 'Trans proline' 0 CA--C 1.533 0.442 0 C-N-CA 122.793 2.329 . . . . 73.340000000000003 111.962 176.492 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -63.76 -34.99 59.76 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.684 2.256 . . . . 55.140000000000001 112.824 -178.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 54.7 p-80 -84.51 -7.26 59.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.958 0.408 . . . . 70.109999999999999 111.069 -178.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 755' ' ' GLU . . . . . 0.433 ' CB ' ' HG2' ' A' ' 752' ' ' PRO . 0.4 OUTLIER -141.95 68.95 23.76 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 116.132 -0.485 . . . . 73.510000000000005 109.972 -178.694 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 756' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -79.64 109.26 2.42 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.405 2.07 . . . . 71.540000000000006 111.936 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 757' ' ' LYS . . . . . 0.435 ' NZ ' ' HB2' ' A' ' 757' ' ' LYS . 4.4 ttmp? -93.73 112.99 24.95 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.237 0.541 . . . . 73.329999999999998 110.58 -178.351 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 758' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -99.05 119.29 37.57 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.363 -0.835 . . . . 75.319999999999993 110.454 -178.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 16.7 t -92.67 105.85 17.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.19 -0.459 . . . . 74.299999999999997 109.904 178.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 760' ' ' TYR . . . . . 0.41 ' HE1' ' HG2' ' A' ' 777' ' ' LYS . 1.5 m-85 -108.92 141.9 40.32 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.984 -0.553 . . . . 72.530000000000001 110.735 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 761' ' ' GLN . . . . . 0.542 ' HA ' ' O ' ' A' ' 770' ' ' PRO . 29.7 tt0 -133.96 135.96 43.85 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.751 -0.658 . . . . 73.439999999999998 109.613 176.692 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 762' ' ' ALA . . . . . . . . . . . . . . . -96.86 147.69 23.69 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.799 -0.637 . . . . 73.540000000000006 110.443 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 763' ' ' LYS . . . . . 0.557 ' HE3' ' CZ2' ' A' ' 768' ' ' TRP . 68.1 tttt -118.46 127.86 54.06 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.295 -0.631 . . . . 73.319999999999993 109.295 178.167 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 62.9 t -127.64 102.0 8.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.146 0.498 . . . . 60.140000000000001 109.869 178.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 76.41 -101.99 1.56 Allowed Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 110.96 -0.856 . . . . 72.140000000000001 110.96 -176.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -121.0 4.81 11.37 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 111.219 -0.752 . . . . 71.540000000000006 111.219 174.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 767' ' ' ARG . . . . . . . . . . . . . 39.7 mmt180 -98.5 146.29 25.92 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.974 0.416 . . . . 72.239999999999995 110.903 -178.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 768' ' ' TRP . . . . . 0.557 ' CZ2' ' HE3' ' A' ' 763' ' ' LYS . 55.6 m95 -117.28 107.41 14.37 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.617 -0.719 . . . . 74.540000000000006 109.777 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 769' ' ' PHE . . . . . 0.469 ' HA ' ' HA ' ' A' ' 770' ' ' PRO . 47.2 p90 -169.87 143.23 2.08 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 110.198 -0.297 . . . . 74.129999999999995 110.198 -177.402 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 770' ' ' PRO . . . . . 0.592 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 62.1 Cg_endo -99.07 178.53 6.38 Favored 'Cis proline' 0 N--CA 1.452 -0.933 0 C-N-CA 123.633 -1.403 . . . . 64.0 111.875 -4.645 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -105.13 102.24 11.75 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.626 -0.509 . . . . 51.149999999999999 109.626 173.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 24.0 m -116.92 135.44 57.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.077 0.465 . . . . 72.549999999999997 111.176 -176.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 773' ' ' CYS . . . . . 0.408 ' HB2' ' CG ' ' A' ' 757' ' ' LYS . 1.5 p -110.22 102.71 11.36 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.0 -0.545 . . . . 74.340000000000003 110.174 177.493 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -100.29 178.97 4.61 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.726 -0.67 . . . . 75.200000000000003 111.175 -175.373 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 775' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -94.44 -8.82 37.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.052 0.453 . . . . 70.310000000000002 110.516 -176.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 55.2 m -145.91 158.02 43.88 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.693 -0.685 . . . . 75.230000000000004 109.765 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 777' ' ' LYS . . . . . 0.41 ' HG2' ' HE1' ' A' ' 760' ' ' TYR . 6.1 tmmm? -69.3 -39.71 78.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.589 -0.278 . . . . 62.43 110.539 -177.646 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 778' ' ' LYS . . . . . 0.414 ' HE3' ' OE1' ' A' ' 782' ' ' GLN . 58.1 tptt -60.89 -47.41 86.52 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.861 -0.422 . . . . 54.530000000000001 109.861 175.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 779' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -52.92 -47.98 67.59 Favored 'General case' 0 C--O 1.226 -0.137 0 CA-C-N 115.709 -0.678 . . . . 64.420000000000002 110.966 174.387 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -53.83 -47.97 63.58 Favored Glycine 0 C--O 1.228 -0.24 0 CA-C-N 116.028 -0.533 . . . . 64.030000000000001 113.035 -177.377 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -66.42 -45.18 80.78 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.857 0.361 . . . . 73.209999999999994 110.982 -178.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 782' ' ' GLN . . . . . 0.414 ' OE1' ' HE3' ' A' ' 778' ' ' LYS . 25.5 mt-30 -71.59 -37.0 71.05 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.233 -0.439 . . . . 73.140000000000001 111.399 -176.37 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -72.08 -35.68 69.31 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.524 0.202 . . . . 61.399999999999999 110.742 177.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -60.06 -49.53 77.27 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.949 -0.389 . . . . 64.519999999999996 109.949 176.015 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 785' ' ' ALA . . . . . 0.622 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -65.78 -42.16 91.1 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.073 -0.512 . . . . 44.399999999999999 110.793 178.457 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 786' ' ' ASP . . . . . 0.52 ' O ' ' HG2' ' A' ' 790' ' ' ARG . 12.4 t70 -56.71 -55.83 29.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.022 -0.535 . . . . 74.430000000000007 110.755 179.201 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 787' ' ' ALA . . . . . 0.544 ' O ' HG23 ' A' ' 791' ' ' VAL . . . -68.22 -31.07 70.32 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.952 -0.567 . . . . 71.439999999999998 111.212 -178.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 788' ' ' ALA . . . . . 0.683 ' O ' ' HG ' ' A' ' 792' ' ' LEU . . . -62.63 -42.83 99.81 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 120.812 0.339 . . . . 73.219999999999999 110.168 177.006 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 789' ' ' LEU . . . . . 0.622 ' HG ' ' O ' ' A' ' 785' ' ' ALA . 79.8 mt -61.82 -40.16 94.3 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.08 -0.509 . . . . 73.239999999999995 109.749 176.1 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 790' ' ' ARG . . . . . 0.52 ' HG2' ' O ' ' A' ' 786' ' ' ASP . 47.2 mmm-85 -59.79 -38.05 80.82 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.98 -0.554 . . . . 75.209999999999994 110.471 177.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 791' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 787' ' ' ALA . 48.7 t -62.46 -53.18 50.66 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.31 0 N-CA-C 109.881 -0.414 . . . . 53.32 109.881 175.657 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 792' ' ' LEU . . . . . 0.683 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 22.1 mt -55.32 -48.01 74.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.263 0.554 . . . . 73.109999999999999 110.681 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 793' ' ' ILE . . . . . 0.517 HG12 HG23 ' A' ' 716' ' ' ILE . 90.6 mt -61.76 -48.59 87.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.1 -0.955 . . . . 72.439999999999998 111.079 177.315 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -66.28 -34.88 89.35 Favored Glycine 0 CA--C 1.519 0.299 0 CA-C-N 116.145 -0.479 . . . . 61.119999999999997 113.122 -178.214 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 795' ' ' GLU . . . . . 0.518 ' HG2' ' O ' ' A' ' 791' ' ' VAL . 44.7 mm-40 -66.64 -32.24 73.44 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.81 0.338 . . . . 74.409999999999997 110.782 178.464 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 . . . . . 0 C--N 1.327 -0.404 0 CA-C-O 120.998 0.427 . . . . 65.409999999999997 109.977 177.974 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 716' ' ' ILE . . . . . 0.576 ' HA ' HD23 ' A' ' 719' ' ' LEU . 42.1 mm . . . . . 0 C--O 1.235 0.337 0 CA-C-O 121.306 0.574 . . . . 72.230000000000004 110.715 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -58.27 -23.13 52.42 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.873 -0.603 . . . . 73.450000000000003 112.311 176.488 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 718' ' ' GLU . . . . . 0.599 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 44.1 mt-10 -68.25 -36.67 79.8 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 122.747 -0.267 . . . . 74.129999999999995 110.287 176.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 719' ' ' LEU . . . . . 0.641 HD12 HD22 ' A' ' 789' ' ' LEU . 3.4 mm? -61.02 -33.88 73.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.235 0.541 . . . . 72.129999999999995 110.009 175.644 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 720' ' ' VAL . . . . . 0.576 HG22 HD13 ' A' ' 793' ' ' ILE . 27.4 t -62.86 -36.3 74.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.624 -0.717 . . . . 74.349999999999994 110.949 177.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 721' ' ' ARG . . . . . 0.599 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 10.5 ptt180 -68.75 -28.62 66.97 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.892 0.377 . . . . 71.239999999999995 110.178 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -73.02 -32.05 64.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 72.239999999999995 110.629 177.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 723' ' ' LEU . . . . . 0.576 HD21 ' HB2' ' A' ' 789' ' ' LEU . 89.9 mt -57.81 -36.65 72.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.292 0.567 . . . . 74.200000000000003 109.939 173.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -69.49 -40.34 77.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.179 -0.919 . . . . 31.129999999999999 111.501 178.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 46.1 m -103.26 -80.87 0.51 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.055 0.391 . . . . 65.230000000000004 112.055 -176.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 726' ' ' ASN . . . . . 0.467 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 28.0 t30 -135.06 106.82 10.38 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-O 121.032 0.444 . . . . 70.109999999999999 110.8 -174.674 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 727' ' ' PRO . . . . . 0.467 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 20.4 Cg_endo -62.2 -36.33 69.52 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 122.894 2.396 . . . . 44.43 112.579 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 34.4 t -61.47 -47.09 95.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.254 -0.43 . . . . 74.150000000000006 110.538 -177.222 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -61.09 -36.55 92.5 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.923 -0.656 . . . . 73.150000000000006 112.041 178.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 730' ' ' GLY . . . . . 0.473 ' O ' ' HG3' ' A' ' 733' ' ' GLU . . . -68.32 -45.3 70.44 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 121.106 -0.569 . . . . 75.040000000000006 112.532 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -64.46 -41.23 96.63 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.973 0.416 . . . . 72.140000000000001 110.06 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 732' ' ' LEU . . . . . . . . . . . . . 94.9 mt -67.24 -32.85 74.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.158 -0.474 . . . . 74.230000000000004 111.495 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 733' ' ' GLU . . . . . 0.473 ' HG3' ' O ' ' A' ' 730' ' ' GLY . 1.1 pp20? -85.17 -33.52 22.29 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.557 -0.457 . . . . 75.25 110.495 -178.196 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 734' ' ' TYR . . . . . 0.537 ' HB2' HD11 ' A' ' 719' ' ' LEU . 4.0 t80 -55.06 -45.18 75.27 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.837 0.351 . . . . 75.409999999999997 110.463 174.591 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -65.38 -52.92 50.27 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.112 -0.494 . . . . 62.039999999999999 110.299 -176.237 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 736' ' ' ARG . . . . . 0.437 ' HG2' ' O ' ' A' ' 733' ' ' GLU . 36.5 ptt180 -60.48 -37.84 82.34 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.971 -0.559 . . . . 60.229999999999997 110.94 -176.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 28.5 t -70.37 -32.26 69.85 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.875 -0.602 . . . . 75.219999999999999 111.452 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -97.19 -8.78 29.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.717 0.294 . . . . 74.439999999999998 111.689 -175.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 98.25 9.21 54.06 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.63 -0.795 . . . . 52.130000000000003 112.959 176.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -96.51 170.4 9.24 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.178 -0.304 . . . . 72.319999999999993 110.178 177.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -117.37 129.22 55.73 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.602 -0.518 . . . . 43.240000000000002 109.602 172.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 742' ' ' ALA . . . . . . . . . . . . . . . -100.87 120.97 40.92 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.913 0.387 . . . . 71.340000000000003 111.352 -175.108 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 743' ' ' GLU . . . . . 0.566 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 38.7 mt-10 -122.44 135.24 54.64 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.199 -0.455 . . . . 73.129999999999995 110.964 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -114.32 97.96 6.64 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.269 -0.641 . . . . 75.219999999999999 109.269 175.352 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -113.8 140.8 48.0 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.345 -0.542 . . . . 74.209999999999994 111.198 -177.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 746' ' ' LEU . . . . . . . . . . . . . 59.8 tp -74.72 116.05 14.99 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.643 -0.708 . . . . 74.340000000000003 109.332 174.224 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 60.2 t -75.35 -49.78 26.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.691 -0.485 . . . . 61.310000000000002 109.691 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -167.05 -175.42 3.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.833 -0.621 . . . . 73.519999999999996 109.667 178.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -138.72 128.8 25.4 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.382 -0.599 . . . . 74.0 109.382 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 750' ' ' SER . . . . . 0.418 ' O ' ' HB3' ' A' ' 757' ' ' LYS . 6.4 t -137.65 90.88 2.54 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.868 -0.419 . . . . 74.319999999999993 109.868 -177.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 179.54 154.33 13.09 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.353 -0.927 . . . . 63.439999999999998 112.477 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 752' ' ' PRO . . . . . 0.628 ' HG2' ' HB2' ' A' ' 755' ' ' GLU . 37.6 Cg_endo -66.59 168.38 16.7 Favored 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 123.309 2.673 . . . . 71.230000000000004 112.238 177.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -56.48 -33.13 91.68 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.751 2.301 . . . . 55.140000000000001 112.759 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 45.9 p-80 -87.83 -4.19 58.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.383 -0.371 . . . . 63.5 111.359 -178.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 755' ' ' GLU . . . . . 0.628 ' HB2' ' HG2' ' A' ' 752' ' ' PRO . 16.6 mm-40 -152.93 61.97 4.04 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.354 -0.385 . . . . 71.420000000000002 111.306 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 756' ' ' PRO . . . . . 0.428 ' O ' ' HA ' ' A' ' 775' ' ' HIS . 59.6 Cg_endo -73.2 99.3 1.09 Allowed 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.175 1.917 . . . . 70.25 111.583 -177.483 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 757' ' ' LYS . . . . . 0.437 ' HD3' ' HB2' ' A' ' 773' ' ' CYS . 38.3 ttmt -87.05 107.76 18.57 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.247 0.546 . . . . 50.109999999999999 110.384 -177.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 758' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -86.93 130.61 34.39 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.274 -0.876 . . . . 74.239999999999995 110.151 -179.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 43.4 t -95.45 104.34 15.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.841 -0.429 . . . . 75.349999999999994 109.841 177.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -105.98 138.89 41.4 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.048 -0.524 . . . . 70.319999999999993 110.644 -179.259 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 761' ' ' GLN . . . . . 0.431 ' HA ' ' O ' ' A' ' 770' ' ' PRO . 52.4 tt0 -128.65 128.87 45.0 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.557 -0.534 . . . . 65.129999999999995 109.557 177.767 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 762' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' A' ' 769' ' ' PHE . . . -87.09 122.11 30.46 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.184 0.516 . . . . 51.340000000000003 110.407 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 763' ' ' LYS . . . . . 0.646 ' HD2' ' CH2' ' A' ' 768' ' ' TRP . 55.1 tttm -104.32 115.26 30.07 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.916 -0.584 . . . . 70.319999999999993 110.041 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 764' ' ' VAL . . . . . 0.422 HG11 ' HE2' ' A' ' 734' ' ' TYR . 59.0 t -118.7 100.72 10.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.058 0.456 . . . . 62.409999999999997 110.114 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 74.54 -102.89 1.44 Allowed Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.681 -0.69 . . . . 51.420000000000002 111.408 -176.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -120.45 10.88 10.56 Favored Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 111.162 -0.775 . . . . 71.420000000000002 111.162 174.206 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 767' ' ' ARG . . . . . 0.483 ' HG3' ' CD1' ' A' ' 769' ' ' PHE . 13.9 tpt180 -108.18 121.98 45.98 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.825 0.345 . . . . 71.409999999999997 110.879 -177.481 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 768' ' ' TRP . . . . . 0.646 ' CH2' ' HD2' ' A' ' 763' ' ' LYS . 48.0 m95 -95.44 107.44 19.59 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.787 -0.642 . . . . 73.349999999999994 109.571 177.567 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 769' ' ' PHE . . . . . 0.483 ' CD1' ' HG3' ' A' ' 767' ' ' ARG . 8.7 p90 -170.89 136.84 1.12 Allowed Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 120.888 0.375 . . . . 70.219999999999999 110.472 -178.722 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 770' ' ' PRO . . . . . 0.593 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 74.5 Cg_endo -97.36 -179.27 6.3 Favored 'Cis proline' 0 N--CA 1.447 -1.221 0 C-N-CA 123.475 -1.469 . . . . 54.219999999999999 111.773 -4.477 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -109.91 105.78 15.09 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.473 -0.566 . . . . 73.349999999999994 109.473 173.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 33.7 m -111.72 163.29 8.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.995 0.426 . . . . 73.239999999999995 111.147 -175.342 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 773' ' ' CYS . . . . . 0.437 ' HB2' ' HD3' ' A' ' 757' ' ' LYS . 5.1 p -133.52 117.99 17.79 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.889 -0.596 . . . . 51.43 110.017 179.426 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -132.67 143.75 49.86 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.287 -0.415 . . . . 73.310000000000002 110.705 -177.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 775' ' ' HIS . . . . . 0.428 ' HA ' ' O ' ' A' ' 756' ' ' PRO . 0.5 OUTLIER -80.14 24.34 0.43 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.146 0.498 . . . . 73.430000000000007 111.442 -178.521 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 776' ' ' SER . . . . . 0.548 ' HB3' ' HB2' ' A' ' 779' ' ' GLN . 24.9 t -152.76 137.96 17.42 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.578 -0.897 . . . . 73.0 108.578 175.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 777' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -66.92 -42.69 84.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.78 0.324 . . . . 74.409999999999997 110.327 -176.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -63.23 -38.09 89.79 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.178 -0.465 . . . . 63.310000000000002 110.379 178.119 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 779' ' ' GLN . . . . . 0.548 ' HB2' ' HB3' ' A' ' 776' ' ' SER . 76.6 mm-40 -71.72 -33.07 68.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.93 -0.577 . . . . 74.530000000000001 110.975 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -56.11 -43.91 88.56 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.112 -0.566 . . . . 61.310000000000002 112.107 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -69.04 -43.34 74.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.583 0.23 . . . . 74.239999999999995 110.985 178.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -63.42 -45.19 92.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.334 -0.393 . . . . 72.420000000000002 110.953 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -61.96 -44.44 96.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.303 -0.408 . . . . 75.340000000000003 110.924 178.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -61.29 -43.92 98.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.272 -0.422 . . . . 64.120000000000005 110.745 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 785' ' ' ALA . . . . . 0.559 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -65.45 -46.04 81.44 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.012 -0.54 . . . . 24.120000000000001 111.106 -178.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 786' ' ' ASP . . . . . 0.643 ' O ' ' HG2' ' A' ' 790' ' ' ARG . 14.9 t70 -60.31 -54.22 48.34 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 109.879 -0.415 . . . . 74.109999999999999 109.879 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 787' ' ' ALA . . . . . 0.537 ' O ' HG23 ' A' ' 791' ' ' VAL . . . -59.55 -35.48 74.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.67 -0.695 . . . . 73.409999999999997 111.229 -178.66 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 788' ' ' ALA . . . . . 0.632 ' O ' ' HG ' ' A' ' 792' ' ' LEU . . . -62.14 -45.2 94.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.508 -0.315 . . . . 71.219999999999999 110.63 177.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 789' ' ' LEU . . . . . 0.641 HD22 HD12 ' A' ' 719' ' ' LEU . 50.4 mt -64.29 -35.26 80.28 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 109.835 -0.431 . . . . 73.549999999999997 109.835 179.23 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 790' ' ' ARG . . . . . 0.643 ' HG2' ' O ' ' A' ' 786' ' ' ASP . 13.0 mmm-85 -59.63 -41.27 90.08 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 109.794 -0.447 . . . . 74.140000000000001 109.794 177.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 791' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 787' ' ' ALA . 43.5 t -63.67 -51.27 72.16 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 CA-C-N 115.625 -0.716 . . . . 75.120000000000005 110.111 177.173 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 792' ' ' LEU . . . . . 0.632 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 47.3 mt -57.16 -52.68 64.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.017 -0.538 . . . . 54.030000000000001 111.171 -177.682 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 793' ' ' ILE . . . . . 0.576 HD13 HG22 ' A' ' 720' ' ' VAL . 70.3 mt -60.12 -52.55 59.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.709 -0.678 . . . . 73.450000000000003 111.176 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -62.77 -41.62 99.82 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.855 -0.688 . . . . 64.010000000000005 112.681 -178.395 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -66.57 -39.36 88.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.833 0.349 . . . . 62.0 110.529 -178.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 8.3 t30 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.031 -0.531 . . . . 71.519999999999996 110.037 179.452 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 716' ' ' ILE . . . . . 0.514 HG21 ' HA ' ' A' ' 793' ' ' ILE . 42.4 mm . . . . . 0 C--O 1.235 0.32 0 CA-C-O 121.221 0.534 . . . . 73.530000000000001 110.387 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -63.69 -21.17 64.8 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.787 -0.642 . . . . 70.310000000000002 111.971 177.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 718' ' ' GLU . . . . . 0.712 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 15.8 mm-40 -65.57 -40.75 93.12 Favored 'General case' 0 C--O 1.225 -0.234 0 N-CA-C 109.592 -0.521 . . . . 71.150000000000006 109.592 176.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 719' ' ' LEU . . . . . 0.554 HD12 HD22 ' A' ' 789' ' ' LEU . 2.9 mm? -65.37 -33.01 74.97 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.624 -0.51 . . . . 70.549999999999997 109.624 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 720' ' ' VAL . . . . . 0.512 HG22 HD13 ' A' ' 793' ' ' ILE . 57.6 t -65.76 -38.04 81.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.668 -0.696 . . . . 70.430000000000007 110.822 178.549 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 721' ' ' ARG . . . . . 0.712 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 22.5 ptt180 -65.71 -26.2 67.65 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.191 0.52 . . . . 51.310000000000002 109.785 179.365 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -80.52 -27.01 37.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.983 -0.553 . . . . 62.119999999999997 110.991 178.326 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 723' ' ' LEU . . . . . 0.551 HD21 ' HB2' ' A' ' 789' ' ' LEU . 87.7 mt -62.43 -27.2 68.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.137 0.494 . . . . 74.019999999999996 109.708 172.277 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -89.68 -38.96 13.51 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.336 -0.847 . . . . 71.400000000000006 110.938 177.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 18.5 m -93.89 -74.64 0.53 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.973 0.36 . . . . 55.210000000000001 111.973 -174.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 726' ' ' ASN . . . . . 0.468 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 38.0 t30 -153.36 106.84 2.59 Favored Pre-proline 0 C--O 1.236 0.359 0 CA-C-O 120.894 0.378 . . . . 73.010000000000005 110.354 -178.264 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 727' ' ' PRO . . . . . 0.468 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 17.9 Cg_endo -60.0 -36.68 88.89 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 123.217 2.611 . . . . 74.340000000000003 112.964 -177.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 46.0 t -58.64 -49.96 80.73 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 CA-C-N 116.361 -0.381 . . . . 74.040000000000006 110.776 -177.232 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -61.54 -35.22 90.77 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.918 -0.658 . . . . 73.299999999999997 112.377 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -71.79 -44.19 48.54 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.837 -0.697 . . . . 53.149999999999999 112.811 -179.443 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -64.27 -39.5 94.06 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.777 -0.453 . . . . 74.019999999999996 109.777 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 732' ' ' LEU . . . . . 0.43 HD23 ' HB3' ' A' ' 742' ' ' ALA . 95.7 mt -63.83 -43.38 96.35 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.881 -0.6 . . . . 71.340000000000003 111.485 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 733' ' ' GLU . . . . . 0.555 ' HA ' ' HG2' ' A' ' 736' ' ' ARG . 8.4 pt-20 -77.42 -29.94 53.22 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 120.549 -0.46 . . . . 43.520000000000003 111.239 -176.642 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 734' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -55.42 -49.28 72.81 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.074 0.464 . . . . 63.43 109.793 173.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -66.5 -52.77 42.43 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.705 -0.68 . . . . 45.0 111.021 -177.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 736' ' ' ARG . . . . . 0.555 ' HG2' ' HA ' ' A' ' 733' ' ' GLU . 35.7 ptt180 -58.74 -36.07 73.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.036 -0.529 . . . . 62.049999999999997 111.384 -174.098 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 18.9 t -76.04 -37.09 58.73 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.008 -0.542 . . . . 44.020000000000003 110.842 -178.325 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -88.36 -7.64 56.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.467 -0.333 . . . . 74.510000000000005 111.483 -174.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 103.79 -3.31 45.45 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.611 -0.804 . . . . 72.409999999999997 113.096 175.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -88.56 170.26 11.01 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.928 0.394 . . . . 53.130000000000003 110.413 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -115.51 131.43 56.93 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.49 -0.559 . . . . 73.140000000000001 109.49 173.06 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 742' ' ' ALA . . . . . 0.43 ' HB3' HD23 ' A' ' 732' ' ' LEU . . . -98.87 110.28 22.91 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 123.22 0.325 . . . . 64.319999999999993 110.538 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 743' ' ' GLU . . . . . 0.562 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 47.0 mt-10 -115.04 132.73 56.5 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.103 -0.499 . . . . 53.520000000000003 111.074 -177.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -113.13 109.76 19.33 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.072 -0.513 . . . . 75.109999999999999 109.783 175.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -122.41 152.76 39.89 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.081 0.467 . . . . 75.230000000000004 111.393 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 746' ' ' LEU . . . . . . . . . . . . . 6.5 tt -82.92 113.8 20.77 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.833 -0.803 . . . . 75.200000000000003 108.833 175.179 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 54.8 t -82.36 -50.35 16.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.181 0.515 . . . . 73.510000000000005 110.671 -176.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -155.69 147.14 22.81 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.717 -0.674 . . . . 72.310000000000002 109.495 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 2.7 pp0? -109.91 109.94 20.73 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.442 0.639 . . . . 72.200000000000003 110.167 175.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 6.6 m -108.88 80.64 1.35 Allowed 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.8 -0.815 . . . . 73.120000000000005 108.8 176.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 751' ' ' GLY . . . . . 0.514 ' HA2' ' HD2' ' A' ' 752' ' ' PRO . . . -131.41 113.46 1.36 Allowed Glycine 0 N--CA 1.439 -1.124 0 C-N-CA 119.895 -1.145 . . . . 62.240000000000002 114.131 -170.338 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 752' ' ' PRO . . . . . 0.514 ' HD2' ' HA2' ' A' ' 751' ' ' GLY . 20.1 Cg_endo -60.92 169.95 5.27 Favored 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 123.095 2.53 . . . . 55.119999999999997 111.029 167.529 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -61.42 -35.39 83.36 Favored 'Trans proline' 0 CA--C 1.529 0.228 0 C-N-CA 122.177 1.918 . . . . 75.209999999999994 112.777 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 55.7 p-80 -83.41 -20.95 33.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.752 0.311 . . . . 73.140000000000001 111.349 -177.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -142.4 74.8 19.96 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 111.923 0.342 . . . . 72.109999999999999 111.923 -176.259 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 756' ' ' PRO . . . . . 0.454 ' HA ' ' HA3' ' A' ' 751' ' ' GLY . 33.4 Cg_exo -58.06 92.87 0.06 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 122.096 1.864 . . . . 75.349999999999994 111.191 170.374 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 757' ' ' LYS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 775' ' ' HIS . 36.1 ttpt -101.13 130.06 47.13 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.007 -0.542 . . . . 75.200000000000003 110.359 -175.319 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 758' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -113.72 135.08 54.33 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.94 -0.573 . . . . 60.109999999999999 110.632 -175.024 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 759' ' ' VAL . . . . . 0.476 HG22 ' HB3' ' A' ' 773' ' ' CYS . 26.3 t -94.19 112.62 27.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.812 -0.631 . . . . 61.210000000000001 109.876 177.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -111.11 143.18 42.24 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.917 -0.583 . . . . 55.219999999999999 110.565 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 761' ' ' GLN . . . . . 0.5 ' HA ' ' O ' ' A' ' 770' ' ' PRO . 53.1 tt0 -131.39 130.96 43.26 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.521 -0.548 . . . . 74.310000000000002 109.521 178.147 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 762' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 769' ' ' PHE . . . -87.7 113.77 23.68 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.352 0.596 . . . . 71.099999999999994 110.631 -179.037 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 763' ' ' LYS . . . . . 0.579 ' HD2' ' CH2' ' A' ' 768' ' ' TRP . 57.4 tttm -93.2 105.13 17.26 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.789 -0.641 . . . . 55.140000000000001 109.545 178.204 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 57.4 t -108.04 103.46 15.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.25 -0.648 . . . . 73.109999999999999 109.25 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 71.25 -117.21 6.63 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 110.683 -0.967 . . . . 53.140000000000001 110.683 -173.147 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -110.07 15.72 30.66 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.615 -0.803 . . . . 65.120000000000005 112.066 176.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 767' ' ' ARG . . . . . 0.547 ' HD2' ' CD1' ' A' ' 769' ' ' PHE . 0.0 OUTLIER -115.5 128.2 55.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.853 0.358 . . . . 74.040000000000006 110.218 -178.891 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 768' ' ' TRP . . . . . 0.579 ' CH2' ' HD2' ' A' ' 763' ' ' LYS . 40.6 m95 -97.43 103.14 15.05 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.065 -0.516 . . . . 73.540000000000006 110.018 -179.109 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 769' ' ' PHE . . . . . 0.547 ' CD1' ' HD2' ' A' ' 767' ' ' ARG . 16.5 p90 -162.16 136.39 5.01 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 120.853 0.359 . . . . 73.319999999999993 111.044 -178.295 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 770' ' ' PRO . . . . . 0.63 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 75.1 Cg_endo -99.34 -177.83 4.41 Favored 'Cis proline' 0 N--CA 1.449 -1.122 0 C-N-CA 123.684 -1.382 . . . . 61.450000000000003 111.496 -5.597 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -111.05 107.36 16.73 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.919 -0.4 . . . . 75.450000000000003 109.919 174.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 34.0 m -119.26 164.95 15.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.203 -0.453 . . . . 74.549999999999997 110.667 -176.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 773' ' ' CYS . . . . . 0.476 ' HB3' HG22 ' A' ' 759' ' ' VAL . 7.0 p -136.61 124.01 22.03 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.383 -0.371 . . . . 72.019999999999996 110.275 177.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -129.56 152.52 49.0 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.27 -0.423 . . . . 31.539999999999999 110.185 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 775' ' ' HIS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 757' ' ' LYS . 13.2 p80 -78.22 17.47 0.62 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.859 0.362 . . . . 64.329999999999998 111.695 -176.584 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 15.7 t -153.15 139.88 18.95 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.484 -0.561 . . . . 45.140000000000001 109.484 177.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 777' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -60.82 -40.46 92.83 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.453 -0.339 . . . . 64.239999999999995 111.123 -177.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -67.65 -37.25 82.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.852 0.358 . . . . 60.100000000000001 110.517 179.234 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 779' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -70.2 -37.37 75.06 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.147 -0.479 . . . . 73.340000000000003 110.738 -178.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -57.57 -41.84 93.76 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.966 -0.635 . . . . 74.439999999999998 112.279 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -63.83 -44.31 93.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.974 0.416 . . . . 72.450000000000003 110.622 177.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -69.44 -41.31 76.47 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.876 -0.602 . . . . 74.439999999999998 111.341 -177.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -61.26 -42.69 99.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.787 0.327 . . . . 73.129999999999995 110.838 177.475 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -62.72 -50.29 71.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.792 -0.64 . . . . 70.5 110.634 178.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 785' ' ' ALA . . . . . 0.547 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -62.95 -39.64 95.25 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.296 -0.411 . . . . 74.310000000000002 111.073 -178.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 786' ' ' ASP . . . . . 0.612 ' O ' ' HG2' ' A' ' 790' ' ' ARG . 11.7 t70 -60.48 -57.34 13.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.461 . . . . 60.539999999999999 110.447 179.114 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 787' ' ' ALA . . . . . 0.571 ' O ' HG23 ' A' ' 791' ' ' VAL . . . -62.68 -32.46 73.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.792 -0.64 . . . . 63.549999999999997 110.992 -178.228 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 788' ' ' ALA . . . . . 0.655 ' O ' ' HG ' ' A' ' 792' ' ' LEU . . . -62.12 -43.5 98.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.363 -0.38 . . . . 43.200000000000003 110.693 177.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 789' ' ' LEU . . . . . 0.554 HD22 HD12 ' A' ' 719' ' ' LEU . 79.2 mt -64.41 -37.32 87.12 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.782 -0.451 . . . . 72.209999999999994 109.782 178.423 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 790' ' ' ARG . . . . . 0.612 ' HG2' ' O ' ' A' ' 786' ' ' ASP . 8.7 mmm180 -59.86 -40.62 89.23 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 109.694 -0.484 . . . . 74.150000000000006 109.694 177.309 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 791' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 787' ' ' ALA . 61.0 t -62.02 -50.7 79.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.816 -0.629 . . . . 75.030000000000001 110.56 176.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 792' ' ' LEU . . . . . 0.655 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 49.7 mt -60.27 -52.13 66.59 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.693 -0.685 . . . . 75.5 110.979 -177.378 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 793' ' ' ILE . . . . . 0.514 ' HA ' HG21 ' A' ' 716' ' ' ILE . 72.2 mt -59.55 -48.84 85.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.755 -0.657 . . . . 75.140000000000001 110.742 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -61.35 -44.02 98.6 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 121.06 -0.59 . . . . 72.510000000000005 112.774 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -57.64 -40.96 80.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.064 0.459 . . . . 54.219999999999999 110.15 178.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 4.4 t30 . . . . . 0 C--N 1.325 -0.46 0 CA-C-N 115.807 -0.633 . . . . 62.509999999999998 111.44 178.462 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 708' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.482 1.163 0 CA-C-O 120.778 0.323 . . . . 73.129999999999995 110.763 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 22.4 ttt -62.55 127.09 89.6 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.887 -0.597 . . . . 71.530000000000001 110.681 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.39 94.69 0.98 Allowed 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.313 2.009 . . . . 62.210000000000001 111.78 176.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 711' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -94.61 108.58 20.55 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.179 -0.464 . . . . 65.200000000000003 110.019 -178.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 712' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -115.93 96.18 5.47 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.256 -0.646 . . . . 63.43 109.256 177.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 713' ' ' VAL . . . . . . . . . . . . . 11.0 p -98.53 159.93 3.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.71 -0.677 . . . . 61.350000000000001 110.439 -176.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.414 ' H ' ' HG2' ' A' ' 714' ' ' ARG . 12.8 ptp180 -68.24 87.14 0.28 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.543 0.687 . . . . 65.439999999999998 110.964 177.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 715' ' ' LYS . . . . . 0.486 ' HG2' ' OE2' ' A' ' 718' ' ' GLU . 22.5 tptm -83.07 72.98 10.09 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.546 -0.752 . . . . 74.409999999999997 109.996 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 716' ' ' ILE . . . . . 0.561 ' HA ' HD23 ' A' ' 719' ' ' LEU . 47.9 mm -67.19 -28.3 42.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.487 -0.779 . . . . 74.510000000000005 110.861 -175.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -59.36 -32.41 72.45 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 121.086 -0.578 . . . . 72.129999999999995 112.634 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 718' ' ' GLU . . . . . 0.706 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 39.3 mt-10 -79.69 -21.83 44.17 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.856 -0.338 . . . . 62.140000000000001 111.266 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 719' ' ' LEU . . . . . 0.563 HD12 HD22 ' A' ' 789' ' ' LEU . 3.5 mm? -67.02 -32.11 73.11 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.225 -0.657 . . . . 61.009999999999998 109.225 172.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 720' ' ' VAL . . . . . 0.575 HG22 HD13 ' A' ' 793' ' ' ILE . 39.3 t -70.49 -31.81 47.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.364 -0.835 . . . . 64.329999999999998 110.379 176.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 721' ' ' ARG . . . . . 0.706 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 6.1 ptt180 -66.61 -28.12 68.24 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 120.943 0.401 . . . . 74.510000000000005 110.16 179.078 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -77.17 -31.86 55.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.239 -0.437 . . . . 73.549999999999997 111.322 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 723' ' ' LEU . . . . . 0.551 HD21 ' HB2' ' A' ' 789' ' ' LEU . 96.3 mt -61.11 -32.3 71.98 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.514 0.673 . . . . 71.140000000000001 109.629 173.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -84.95 -16.6 40.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.851 -1.068 . . . . 60.229999999999997 110.905 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 23.5 m -119.37 -81.61 0.63 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.783 0.325 . . . . 75.519999999999996 111.536 -176.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 726' ' ' ASN . . . . . 0.415 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 37.5 t30 -139.25 104.9 7.19 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.292 -0.413 . . . . 65.120000000000005 110.21 -178.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 727' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 24.6 Cg_endo -62.23 -37.61 61.06 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.822 2.348 . . . . 65.5 112.584 -177.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 49.4 t -61.33 -49.0 86.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.23 -0.441 . . . . 64.430000000000007 110.544 -177.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -63.41 -31.49 80.93 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.899 -0.667 . . . . 62.119999999999997 111.887 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -71.03 -40.04 62.65 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.06 -0.591 . . . . 40.509999999999998 112.633 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -66.05 -39.65 90.3 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.401 -0.592 . . . . 75.030000000000001 109.401 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 732' ' ' LEU . . . . . 0.443 HD23 ' HB3' ' A' ' 742' ' ' ALA . 83.1 mt -65.45 -38.53 90.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.926 -0.579 . . . . 72.340000000000003 110.427 175.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 733' ' ' GLU . . . . . 0.578 ' O ' ' HG2' ' A' ' 736' ' ' ARG . 4.2 tp10 -66.41 -48.17 70.93 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.809 -0.632 . . . . 73.5 110.928 -179.007 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 734' ' ' TYR . . . . . 0.54 ' HB2' HD11 ' A' ' 719' ' ' LEU . 12.4 t80 -56.75 -47.74 79.39 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.132 -0.485 . . . . 64.409999999999997 110.752 178.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -66.43 -46.14 77.53 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.139 -0.482 . . . . 72.5 111.184 -177.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 736' ' ' ARG . . . . . 0.578 ' HG2' ' O ' ' A' ' 733' ' ' GLU . 22.4 ptt180 -62.12 -35.33 78.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.015 0.436 . . . . 62.420000000000002 110.85 -176.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 33.1 t -81.19 -23.72 37.97 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.922 -0.581 . . . . 63.420000000000002 111.304 -178.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -104.71 2.84 30.78 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.781 0.289 . . . . 54.219999999999999 111.781 -175.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 79.82 17.82 74.17 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.574 -0.822 . . . . 74.219999999999999 113.002 176.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -102.27 162.16 13.13 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 122.628 -0.336 . . . . 63.130000000000003 110.263 176.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 741' ' ' ALA . . . . . 0.52 ' O ' ' HA ' ' A' ' 764' ' ' VAL . . . -105.43 135.42 46.85 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.865 -0.42 . . . . 44.439999999999998 109.865 175.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 742' ' ' ALA . . . . . 0.443 ' HB3' HD23 ' A' ' 732' ' ' LEU . . . -103.46 108.77 20.16 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.224 -0.444 . . . . 71.530000000000001 110.505 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 743' ' ' GLU . . . . . 0.572 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 41.2 mt-10 -115.73 113.35 23.35 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.033 -0.531 . . . . 71.430000000000007 111.121 -178.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -93.91 100.91 12.98 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.644 -0.707 . . . . 73.409999999999997 109.605 175.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -113.99 155.96 24.92 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.04 0.448 . . . . 75.310000000000002 110.783 -178.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 746' ' ' LEU . . . . . . . . . . . . . 1.7 tt -94.06 120.42 34.3 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.759 -0.83 . . . . 71.409999999999997 108.759 177.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 84.6 t -81.98 -52.3 13.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.315 -0.402 . . . . 65.239999999999995 111.182 -176.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -155.58 151.33 27.43 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.386 -0.37 . . . . 51.109999999999999 110.803 -175.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -126.75 87.11 2.6 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.702 -0.481 . . . . 73.450000000000003 109.702 -178.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 750' ' ' SER . . . . . 0.402 ' O ' ' HB3' ' A' ' 757' ' ' LYS . 5.3 p -128.1 98.93 5.28 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.177 0.513 . . . . 72.230000000000004 111.261 -176.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . -166.54 158.04 30.79 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 111.57 -0.612 . . . . 70.120000000000005 111.57 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 752' ' ' PRO . . . . . 0.693 ' HG2' ' HB2' ' A' ' 755' ' ' GLU . 20.5 Cg_endo -60.45 162.15 18.45 Favored 'Trans proline' 0 CA--C 1.531 0.35 0 C-N-CA 122.846 2.364 . . . . 74.0 112.038 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.68 -31.91 92.59 Favored 'Trans proline' 0 CA--C 1.527 0.16 0 C-N-CA 122.71 2.273 . . . . 72.430000000000007 112.612 -178.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 37.5 p-80 -86.82 -17.82 32.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.206 -0.452 . . . . 72.409999999999997 111.309 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 755' ' ' GLU . . . . . 0.693 ' HB2' ' HG2' ' A' ' 752' ' ' PRO . 37.9 mm-40 -136.48 70.88 60.02 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.461 -0.336 . . . . 74.450000000000003 110.751 178.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 756' ' ' PRO . . . . . 0.485 ' HB2' ' CE2' ' A' ' 758' ' ' PHE . 28.9 Cg_endo -63.42 116.99 3.96 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.264 1.976 . . . . 71.209999999999994 111.414 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 757' ' ' LYS . . . . . 0.411 ' CG ' ' HB2' ' A' ' 773' ' ' CYS . 23.1 ttmm -97.7 115.46 28.01 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.251 -0.432 . . . . 74.209999999999994 110.427 -176.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 758' ' ' PHE . . . . . 0.485 ' CE2' ' HB2' ' A' ' 756' ' ' PRO . 90.4 m-85 -108.05 113.21 26.21 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.008 -0.542 . . . . 74.420000000000002 110.355 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 24.3 t -85.82 111.28 20.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.74 -0.664 . . . . 65.25 109.8 179.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 760' ' ' TYR . . . . . 0.421 ' OH ' ' HG2' ' A' ' 777' ' ' LYS . 2.1 m-85 -110.81 143.13 41.85 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.248 -0.433 . . . . 71.519999999999996 110.758 -179.031 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 761' ' ' GLN . . . . . 0.519 ' HA ' ' O ' ' A' ' 770' ' ' PRO . 56.8 tt0 -135.77 135.19 39.73 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.141 -0.481 . . . . 72.409999999999997 109.743 178.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 762' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 769' ' ' PHE . . . -93.56 112.84 24.82 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.306 0.574 . . . . 74.129999999999995 110.605 -178.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 763' ' ' LYS . . . . . 0.607 ' HD2' ' CH2' ' A' ' 768' ' ' TRP . 59.3 tttm -91.82 101.84 14.43 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.844 -0.617 . . . . 65.109999999999999 109.778 177.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 764' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 741' ' ' ALA . 59.4 t -107.57 100.86 11.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.02 -0.536 . . . . 70.019999999999996 109.986 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 71.71 -115.25 5.49 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 115.586 -0.733 . . . . 64.219999999999999 111.482 -177.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -106.22 8.1 41.18 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.828 -0.701 . . . . 72.040000000000006 112.012 177.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 767' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 767' ' ' ARG . 55.0 mtt180 -108.07 147.17 31.56 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.963 0.411 . . . . 74.010000000000005 110.797 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 768' ' ' TRP . . . . . 0.607 ' CH2' ' HD2' ' A' ' 763' ' ' LYS . 53.0 m95 -118.21 100.76 7.72 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.764 -0.653 . . . . 75.200000000000003 109.284 178.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 769' ' ' PHE . . . . . 0.487 ' HA ' ' HA ' ' A' ' 770' ' ' PRO . 21.4 p90 -167.49 139.3 2.58 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 120.777 0.322 . . . . 74.530000000000001 110.969 -176.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 770' ' ' PRO . . . . . 0.635 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 71.5 Cg_endo -97.54 -171.46 2.46 Favored 'Cis proline' 0 N--CA 1.453 -0.872 0 C-N-CA 123.716 -1.368 . . . . 64.239999999999995 111.751 -4.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -122.23 112.44 18.16 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.63 -0.508 . . . . 74.510000000000005 109.63 175.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 36.0 m -122.46 159.24 25.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.247 -0.433 . . . . 60.340000000000003 110.839 -176.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 773' ' ' CYS . . . . . 0.411 ' HB2' ' CG ' ' A' ' 757' ' ' LYS . 8.0 p -124.45 107.65 11.32 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.007 0.432 . . . . 71.530000000000001 109.948 177.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -103.11 -179.66 4.01 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.07 -0.514 . . . . 71.209999999999994 111.203 -176.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 775' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -93.28 -5.39 49.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 71.200000000000003 110.349 -177.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 19.4 t -161.01 170.44 20.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.338 -0.392 . . . . 73.209999999999994 110.518 -177.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 777' ' ' LYS . . . . . 0.421 ' HG2' ' OH ' ' A' ' 760' ' ' TYR . 1.4 tmtp? -69.72 -50.15 46.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.065 -0.516 . . . . 75.409999999999997 111.447 -174.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -60.48 -40.75 92.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.965 0.412 . . . . 63.140000000000001 110.308 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 779' ' ' GLN . . . . . 0.54 ' O ' ' HG2' ' A' ' 783' ' ' GLU . 76.9 mt-30 -58.3 -49.18 78.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.696 -0.683 . . . . 73.219999999999999 111.099 175.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -52.73 -44.12 60.34 Favored Glycine 0 C--N 1.334 0.434 0 CA-C-N 116.168 -0.469 . . . . 73.140000000000001 113.095 -176.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -59.23 -47.71 84.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.273 0.559 . . . . 44.100000000000001 110.772 178.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -70.91 -42.83 69.4 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.443 -0.799 . . . . 63.109999999999999 111.61 -175.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 783' ' ' GLU . . . . . 0.54 ' HG2' ' O ' ' A' ' 779' ' ' GLN . 21.2 mm-40 -60.44 -41.48 94.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.978 0.418 . . . . 72.450000000000003 110.301 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -66.17 -47.84 72.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.845 -0.616 . . . . 75.510000000000005 110.662 178.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 785' ' ' ALA . . . . . 0.524 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -63.08 -41.93 99.53 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.218 -0.446 . . . . 73.099999999999994 111.324 -178.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 786' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -57.21 -53.31 59.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.242 0.544 . . . . 71.450000000000003 110.277 178.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 787' ' ' ALA . . . . . 0.603 ' O ' HG23 ' A' ' 791' ' ' VAL . . . -64.01 -37.78 88.67 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.597 -0.729 . . . . 63.509999999999998 111.052 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 788' ' ' ALA . . . . . 0.635 ' HB2' ' HD3' ' A' ' 770' ' ' PRO . . . -60.38 -47.44 86.07 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.425 -0.352 . . . . 63.109999999999999 111.582 -178.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 789' ' ' LEU . . . . . 0.563 HD22 HD12 ' A' ' 719' ' ' LEU . 64.4 mt -62.74 -39.36 93.86 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.641 -0.503 . . . . 73.150000000000006 109.641 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 790' ' ' ARG . . . . . . . . . . . . . 54.6 mtp180 -64.46 -32.09 73.57 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.594 -0.73 . . . . 75.209999999999994 111.197 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 791' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 787' ' ' ALA . 60.7 t -63.51 -52.94 51.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 109.433 -0.58 . . . . 52.329999999999998 109.433 173.291 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 792' ' ' LEU . . . . . 0.563 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 32.8 mt -57.39 -50.44 72.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.339 -0.846 . . . . 71.519999999999996 110.836 -177.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 793' ' ' ILE . . . . . 0.575 HD13 HG22 ' A' ' 720' ' ' VAL . 77.5 mt -57.94 -49.47 81.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.642 -0.708 . . . . 73.219999999999999 110.568 177.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -63.28 -30.71 78.37 Favored Glycine 0 CA--C 1.519 0.325 0 CA-C-N 115.952 -0.567 . . . . 54.340000000000003 112.814 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 795' ' ' GLU . . . . . 0.613 ' O ' ' HB2' ' A' ' 799' ' ' ALA . 59.7 mm-40 -67.26 -36.73 82.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.46 0.13 . . . . 74.540000000000006 110.874 178.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -83.31 -33.77 25.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.533 -0.303 . . . . 53.520000000000003 111.15 -175.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 797' ' ' GLU . . . . . 0.48 ' HG3' ' O ' ' A' ' 793' ' ' ILE . 46.7 mt-10 -65.19 121.78 15.56 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.568 -0.287 . . . . 74.519999999999996 110.401 178.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 798' ' ' LYS . . . . . 0.507 ' NZ ' ' HB2' ' A' ' 798' ' ' LYS . 8.4 mtmp? 71.26 18.28 5.73 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 123.549 0.531 . . . . 74.409999999999997 110.936 -178.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 799' ' ' ALA . . . . . 0.613 ' HB2' ' O ' ' A' ' 795' ' ' GLU . . . -89.77 146.97 24.1 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.289 0.566 . . . . 51.340000000000003 111.656 -178.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 800' ' ' GLU . . . . . 0.532 ' H ' ' CD ' ' A' ' 800' ' ' GLU . 0.3 OUTLIER -99.27 -3.46 34.09 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.067 -0.97 . . . . 74.319999999999993 109.328 174.465 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 801' ' ' ARG . . . . . 0.494 ' HD3' ' H ' ' A' ' 801' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.135 0 CA-C-N 115.069 -0.969 . . . . 60.450000000000003 109.661 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 708' ' ' MET . . . . . 0.423 ' O ' ' HG3' ' A' ' 708' ' ' MET . 14.8 tpt . . . . . 0 N--CA 1.477 0.924 0 CA-C-O 121.476 0.655 . . . . 75.450000000000003 109.942 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 709' ' ' MET . . . . . 0.428 ' HB2' ' OE2' ' A' ' 718' ' ' GLU . 48.0 ttp -126.43 96.69 35.55 Favored Pre-proline 0 C--N 1.326 -0.425 0 O-C-N 122.053 -0.404 . . . . 73.230000000000004 110.996 -177.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -77.02 -68.58 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 123.085 2.524 . . . . 61.409999999999997 110.978 174.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 711' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -79.68 109.97 14.58 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.271 -1.011 . . . . 74.329999999999998 108.271 172.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 712' ' ' LYS . . . . . . . . . . . . . 33.0 mtpt -72.48 132.69 44.19 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.627 0.727 . . . . 64.030000000000001 112.293 -166.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 713' ' ' VAL . . . . . 0.462 HG22 ' H ' ' A' ' 714' ' ' ARG . 7.0 p -148.61 174.6 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 107.687 -1.227 . . . . 72.439999999999998 107.687 -178.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.462 ' H ' HG22 ' A' ' 713' ' ' VAL . 14.7 ttm180 -75.98 74.01 2.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 118.776 0.716 . . . . 74.5 109.666 176.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 715' ' ' LYS . . . . . 0.542 ' HG2' ' OE2' ' A' ' 718' ' ' GLU . 4.7 tppp? -83.71 84.05 7.69 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.842 -0.617 . . . . 72.230000000000004 110.051 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 716' ' ' ILE . . . . . 0.545 ' HA ' HD23 ' A' ' 719' ' ' LEU . 47.1 mm -71.81 -22.3 21.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.907 -0.588 . . . . 64.450000000000003 110.803 -176.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -62.11 -34.03 87.71 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.828 -0.701 . . . . 70.409999999999997 111.992 176.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 718' ' ' GLU . . . . . 0.707 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 38.1 mt-10 -77.26 -25.0 51.04 Favored 'General case' 0 C--O 1.222 -0.385 0 O-C-N 122.623 -0.34 . . . . 73.140000000000001 111.125 178.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 719' ' ' LEU . . . . . 0.57 HD12 HD22 ' A' ' 789' ' ' LEU . 4.4 mm? -61.51 -32.94 73.0 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.473 -0.565 . . . . 63.109999999999999 109.473 172.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 720' ' ' VAL . . . . . 0.495 HG22 HD13 ' A' ' 793' ' ' ILE . 58.2 t -70.21 -36.26 66.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.477 -0.783 . . . . 74.400000000000006 110.76 177.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 721' ' ' ARG . . . . . 0.707 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 8.9 ptt180 -62.72 -29.52 70.73 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.02 0.438 . . . . 64.319999999999993 110.167 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -76.28 -31.55 58.3 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.197 -0.456 . . . . 73.510000000000005 110.596 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 723' ' ' LEU . . . . . 0.606 HD21 ' HB2' ' A' ' 789' ' ' LEU . 89.3 mt -63.76 -24.89 67.95 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.177 0.513 . . . . 72.439999999999998 110.601 174.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -92.07 -23.87 19.34 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.756 -0.656 . . . . 62.100000000000001 110.872 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 10.9 m -111.04 -76.79 0.6 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.423 -0.353 . . . . 73.420000000000002 111.241 -175.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 726' ' ' ASN . . . . . 0.408 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 38.5 t30 -141.6 103.52 5.9 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 120.628 0.251 . . . . 44.229999999999997 110.768 -179.163 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 727' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 19.0 Cg_endo -59.77 -37.09 89.1 Favored 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 123.032 2.488 . . . . 61.329999999999998 112.348 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 728' ' ' VAL . . . . . 0.417 ' O ' ' HG ' ' A' ' 732' ' ' LEU . 48.9 t -59.96 -47.94 89.75 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 CA-C-N 116.007 -0.542 . . . . 71.140000000000001 110.162 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -62.35 -35.33 91.5 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.656 -0.702 . . . . 42.350000000000001 112.01 178.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -65.41 -43.16 95.38 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.097 -0.573 . . . . 61.109999999999999 112.641 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -65.93 -40.27 91.28 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.725 -0.472 . . . . 61.25 109.725 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 732' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 728' ' ' VAL . 85.7 mt -65.37 -38.02 88.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.949 -0.569 . . . . 62.32 110.602 176.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 733' ' ' GLU . . . . . 0.462 ' O ' ' HG2' ' A' ' 736' ' ' ARG . 5.2 tp10 -66.98 -47.12 72.52 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 115.967 -0.56 . . . . 73.310000000000002 110.911 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 734' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -56.64 -46.69 80.85 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.214 -0.448 . . . . 71.150000000000006 110.458 177.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -65.28 -44.66 87.3 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.093 -0.503 . . . . 32.520000000000003 111.232 -177.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 736' ' ' ARG . . . . . 0.462 ' HG2' ' O ' ' A' ' 733' ' ' GLU . 14.5 ptm180 -68.85 -33.04 73.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.598 0.713 . . . . 72.340000000000003 109.825 -173.073 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 73.2 m -75.01 -36.47 61.95 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 114.792 -1.095 . . . . 75.120000000000005 111.766 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 12.7 m170 -94.27 0.57 55.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.338 -0.392 . . . . 74.209999999999994 111.327 -175.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 85.86 9.17 78.24 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.735 -0.745 . . . . 74.0 112.987 175.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -93.45 162.15 14.09 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.698 0.285 . . . . 71.530000000000001 110.336 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -107.48 115.99 31.14 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.993 -0.373 . . . . 64.239999999999995 109.993 176.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 742' ' ' ALA . . . . . 0.417 ' HB3' HD23 ' A' ' 732' ' ' LEU . . . -81.94 112.17 18.79 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.238 -0.437 . . . . 65.129999999999995 110.888 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 743' ' ' GLU . . . . . 0.479 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 43.9 mt-10 -123.06 127.74 49.17 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.297 -0.41 . . . . 73.129999999999995 110.945 -177.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -105.85 114.34 28.43 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.02 -0.536 . . . . 65.019999999999996 110.021 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -121.34 153.66 37.46 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.164 0.507 . . . . 72.439999999999998 110.803 177.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 746' ' ' LEU . . . . . 0.451 HD13 ' CE2' ' A' ' 760' ' ' TYR . 51.3 tp -95.93 101.33 12.99 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.475 -0.784 . . . . 75.230000000000004 109.803 178.27 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 49.1 t -69.33 -43.88 80.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.796 -0.638 . . . . 61.340000000000003 111.275 -174.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -146.25 147.49 31.47 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.064 0.459 . . . . 74.219999999999999 111.246 -176.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -141.47 93.66 2.6 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.997 -0.742 . . . . 71.340000000000003 108.997 177.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 16.7 t -129.84 176.75 7.78 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.906 -0.588 . . . . 54.210000000000001 110.213 -173.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 104.88 -176.17 22.71 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.712 -0.756 . . . . 74.299999999999997 112.353 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 752' ' ' PRO . . . . . 0.56 ' HG2' ' HB2' ' A' ' 755' ' ' GLU . 60.4 Cg_endo -73.62 157.82 48.08 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.899 2.399 . . . . 75.219999999999999 111.88 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -62.98 -22.54 73.86 Favored 'Trans proline' 0 CA--C 1.529 0.246 0 C-N-CA 122.656 2.238 . . . . 73.099999999999994 112.773 -177.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 39.2 p-80 -91.85 -7.57 49.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.924 0.392 . . . . 75.209999999999994 110.907 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 755' ' ' GLU . . . . . 0.56 ' HB2' ' HG2' ' A' ' 752' ' ' PRO . 5.5 mm-40 -146.84 63.58 8.46 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.318 -0.401 . . . . 60.420000000000002 110.987 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 756' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.85 122.43 8.49 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.094 1.862 . . . . 72.519999999999996 111.317 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 757' ' ' LYS . . . . . 0.455 ' HG3' ' HB2' ' A' ' 773' ' ' CYS . 0.1 OUTLIER -92.95 112.2 24.08 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.07 0.462 . . . . 73.319999999999993 110.327 -178.181 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 758' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -95.1 107.52 19.58 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.579 -0.737 . . . . 73.040000000000006 110.501 -178.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 759' ' ' VAL . . . . . 0.47 HG22 ' HB3' ' A' ' 773' ' ' CYS . 40.9 t -86.65 98.13 6.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.037 -0.528 . . . . 71.349999999999994 109.896 178.084 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 760' ' ' TYR . . . . . 0.451 ' CE2' HD13 ' A' ' 746' ' ' LEU . 7.5 m-85 -98.08 141.07 31.48 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.074 -0.512 . . . . 74.25 110.379 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 761' ' ' GLN . . . . . 0.496 ' HA ' ' O ' ' A' ' 770' ' ' PRO . 54.6 tt0 -135.41 129.3 33.08 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.993 -0.549 . . . . 75.239999999999995 109.784 178.124 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 762' ' ' ALA . . . . . . . . . . . . . . . -85.99 117.23 24.71 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.474 0.654 . . . . 74.540000000000006 110.819 -177.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 763' ' ' LYS . . . . . 0.479 ' HB3' ' HB2' ' A' ' 743' ' ' GLU . 58.9 tttt -93.71 108.8 20.5 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.184 -0.916 . . . . 71.0 109.572 178.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 38.7 t -128.78 108.26 17.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.805 0.336 . . . . 65.340000000000003 110.936 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 69.16 25.1 75.7 Favored Glycine 0 CA--C 1.51 -0.219 0 C-N-CA 121.112 -0.566 . . . . 41.149999999999999 112.585 176.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 91.31 -10.27 75.3 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.652 -0.785 . . . . 73.109999999999999 111.859 -177.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 767' ' ' ARG . . . . . 0.434 ' HD3' ' HA ' ' A' ' 767' ' ' ARG . 30.1 mmt180 -91.32 128.51 37.17 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.033 0.445 . . . . 73.409999999999997 110.303 177.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 768' ' ' TRP . . . . . . . . . . . . . 51.0 m95 -104.1 96.1 6.43 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.519 -0.764 . . . . 73.230000000000004 109.94 -176.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 769' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -162.42 138.59 5.78 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.314 -0.403 . . . . 72.239999999999995 110.412 -177.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 770' ' ' PRO . . . . . 0.668 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 64.8 Cg_endo -95.0 175.15 12.68 Favored 'Cis proline' 0 N--CA 1.451 -0.978 0 C-N-CA 123.351 -1.521 . . . . 72.120000000000005 111.873 -3.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -107.66 98.15 7.78 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.681 -0.489 . . . . 61.310000000000002 109.681 174.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 29.2 m -112.73 131.31 64.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.358 0.599 . . . . 75.420000000000002 111.183 -175.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 773' ' ' CYS . . . . . 0.47 ' HB3' HG22 ' A' ' 759' ' ' VAL . 7.3 p -99.46 98.75 9.62 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.776 -0.647 . . . . 53.520000000000003 110.462 177.243 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -100.55 146.32 27.25 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.107 -0.497 . . . . 53.530000000000001 110.233 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 775' ' ' HIS . . . . . . . . . . . . . 1.1 p80 -86.11 17.3 3.67 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.272 0.558 . . . . 72.120000000000005 111.068 -178.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 34.3 t -150.02 140.51 22.44 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.633 -0.712 . . . . 62.539999999999999 109.282 175.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 777' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -66.04 -42.54 89.44 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.5 -0.318 . . . . 62.140000000000001 110.614 -175.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -60.49 -36.39 78.2 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.967 -0.56 . . . . 53.25 110.498 177.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 779' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -70.15 -42.77 72.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.034 -0.53 . . . . 73.030000000000001 110.802 177.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -50.2 -46.66 43.1 Favored Glycine 0 C--N 1.331 0.272 0 O-C-N 123.398 0.436 . . . . 44.219999999999999 113.083 -177.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -65.76 -49.25 69.07 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.781 0.324 . . . . 71.340000000000003 110.911 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -67.66 -46.89 71.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.149 -0.478 . . . . 73.099999999999994 111.771 -175.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -64.59 -37.47 87.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.683 -0.235 . . . . 73.420000000000002 110.63 -177.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -62.34 -52.0 65.39 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.272 -0.422 . . . . 71.0 110.438 177.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 785' ' ' ALA . . . . . 0.651 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -61.58 -43.68 98.41 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.22 -0.445 . . . . 74.120000000000005 110.648 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 786' ' ' ASP . . . . . 0.604 ' O ' ' HG2' ' A' ' 790' ' ' ARG . 8.2 t70 -57.5 -52.67 64.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.869 -0.605 . . . . 63.100000000000001 110.648 178.051 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 787' ' ' ALA . . . . . 0.514 ' O ' HG23 ' A' ' 791' ' ' VAL . . . -68.09 -27.19 66.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.916 -0.584 . . . . 64.120000000000005 111.285 -176.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 788' ' ' ALA . . . . . 0.668 ' HB2' ' HD3' ' A' ' 770' ' ' PRO . . . -66.72 -41.41 87.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.406 -0.361 . . . . 51.039999999999999 110.567 177.208 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 789' ' ' LEU . . . . . 0.651 ' HG ' ' O ' ' A' ' 785' ' ' ALA . 21.2 mt -67.27 -34.4 77.34 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.547 -0.538 . . . . 73.030000000000001 109.547 178.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 790' ' ' ARG . . . . . 0.604 ' HG2' ' O ' ' A' ' 786' ' ' ASP . 28.3 mmt180 -55.47 -45.9 76.89 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.142 -0.481 . . . . 73.209999999999994 109.837 175.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 791' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 787' ' ' ALA . 48.7 t -58.66 -52.35 60.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.468 -0.787 . . . . 73.049999999999997 110.581 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 792' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 27.7 mt -61.16 -49.13 78.46 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.522 -0.763 . . . . 71.040000000000006 111.003 -177.327 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 793' ' ' ILE . . . . . 0.495 HD13 HG22 ' A' ' 720' ' ' VAL . 93.5 mt -63.62 -42.78 97.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.621 -0.718 . . . . 74.239999999999995 110.516 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -62.31 -27.18 68.85 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 121.029 -0.605 . . . . 51.340000000000003 112.569 178.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -77.71 -23.63 49.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.625 0.25 . . . . 75.230000000000004 111.437 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 796' ' ' ASN . . . . . 0.408 ' CB ' HG13 ' A' ' 716' ' ' ILE . 27.6 t-20 -103.95 -25.77 12.89 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 111.942 0.349 . . . . 75.239999999999995 111.942 -177.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 797' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -57.96 110.03 0.85 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.823 0.344 . . . . 74.230000000000004 111.176 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 798' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm 63.7 17.14 10.25 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.407 -0.815 . . . . 72.140000000000001 111.846 176.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 799' ' ' ALA . . . . . . . . . . . . . . . -130.92 149.58 52.48 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.456 -0.338 . . . . 64.230000000000004 110.223 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 800' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -119.43 90.11 3.27 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.947 -0.39 . . . . 63.030000000000001 109.947 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 801' ' ' ARG . . . . . 0.708 ' NE ' ' HA ' ' A' ' 801' ' ' ARG . 3.9 mmp_? . . . . . 0 C--O 1.246 0.912 0 CA-C-O 118.644 -0.694 . . . . 75.120000000000005 109.704 174.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 708' ' ' MET . . . . . 0.417 ' SD ' ' HG3' ' A' ' 709' ' ' MET . 1.3 tmt? . . . . . 0 N--CA 1.476 0.863 0 N-CA-C 109.603 -0.517 . . . . 74.239999999999995 109.603 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 709' ' ' MET . . . . . 0.417 ' HG3' ' SD ' ' A' ' 708' ' ' MET . 59.5 mtt -155.32 159.21 31.91 Favored Pre-proline 0 CA--C 1.519 -0.219 0 N-CA-C 109.638 -0.504 . . . . 73.25 109.638 177.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -74.85 -163.97 0.21 Allowed 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.159 1.906 . . . . 71.400000000000006 110.364 167.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 711' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -74.19 76.79 1.79 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.232 0.539 . . . . 71.209999999999994 110.016 175.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 712' ' ' LYS . . . . . 0.437 ' O ' ' HD2' ' A' ' 714' ' ' ARG . 34.2 ttpt -126.45 20.77 7.28 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.883 -0.599 . . . . 72.409999999999997 109.68 176.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 713' ' ' VAL . . . . . . . . . . . . . 61.7 t -55.8 118.23 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 109.115 -0.698 . . . . 71.010000000000005 109.115 175.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.597 ' HB3' HG12 ' A' ' 716' ' ' ILE . 19.9 mmm180 -70.47 -27.24 64.07 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.256 -0.429 . . . . 73.319999999999993 111.336 -171.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt 63.76 24.42 13.81 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.085 -0.507 . . . . 75.439999999999998 110.767 178.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 716' ' ' ILE . . . . . 0.597 HG12 ' HB3' ' A' ' 714' ' ' ARG . 46.7 mm -75.86 -21.23 15.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.445 -0.798 . . . . 63.310000000000002 111.156 -174.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -58.19 -28.77 61.89 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.866 -0.683 . . . . 62.5 112.551 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -68.61 -35.79 77.79 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 122.869 -0.195 . . . . 73.439999999999998 111.275 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 719' ' ' LEU . . . . . 0.589 HD23 ' HA ' ' A' ' 716' ' ' ILE . 3.2 mm? -64.94 -33.82 76.93 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.614 -0.513 . . . . 72.310000000000002 109.614 178.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 720' ' ' VAL . . . . . 0.543 HG22 HD13 ' A' ' 793' ' ' ILE . 45.5 t -66.33 -37.12 78.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.881 -0.599 . . . . 70.430000000000007 109.997 176.003 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 721' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.49 -32.04 71.05 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.839 -0.619 . . . . 72.209999999999994 110.158 177.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -79.46 -25.7 41.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.844 -0.616 . . . . 72.040000000000006 111.275 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 723' ' ' LEU . . . . . 0.531 HD21 ' HB2' ' A' ' 789' ' ' LEU . 60.1 mt -63.71 -29.95 71.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.991 0.424 . . . . 71.450000000000003 110.282 175.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -85.4 -35.63 21.21 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.653 -0.703 . . . . 71.019999999999996 110.83 176.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 24.7 m -92.55 -79.69 0.39 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.216 -0.447 . . . . 63.32 111.764 -174.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 726' ' ' ASN . . . . . 0.437 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 30.8 t30 -146.29 109.05 4.23 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-O 120.809 0.338 . . . . 74.129999999999995 110.235 -179.097 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 727' ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 20.0 Cg_endo -61.24 -35.69 83.74 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.707 2.271 . . . . 62.329999999999998 112.436 -178.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 53.2 t -62.76 -48.08 89.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.244 -0.435 . . . . 74.109999999999999 110.615 -178.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -63.55 -33.16 86.5 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.825 -0.703 . . . . 72.310000000000002 111.944 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -71.19 -41.54 59.66 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.252 -0.499 . . . . 74.140000000000001 112.811 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -63.71 -38.94 93.0 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.469 -0.567 . . . . 62.439999999999998 109.469 178.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 732' ' ' LEU . . . . . . . . . . . . . 96.1 mt -69.63 -33.5 72.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.847 -0.615 . . . . 53.43 110.555 176.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 733' ' ' GLU . . . . . 0.568 ' O ' ' HG2' ' A' ' 736' ' ' ARG . 4.2 tp10 -67.95 -48.46 65.81 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 123.016 0.526 . . . . 73.209999999999994 110.417 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 734' ' ' TYR . . . . . 0.558 ' HB2' HD11 ' A' ' 719' ' ' LEU . 8.8 t80 -54.67 -47.19 73.91 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.777 -0.647 . . . . 70.450000000000003 110.642 176.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -67.37 -49.73 62.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.191 -0.459 . . . . 70.230000000000004 110.849 -177.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 736' ' ' ARG . . . . . 0.568 ' HG2' ' O ' ' A' ' 733' ' ' GLU . 13.5 ptm180 -60.41 -38.52 84.28 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.297 -0.41 . . . . 64.329999999999998 111.221 -175.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 32.9 t -77.36 -29.11 53.17 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.123 -0.489 . . . . 73.530000000000001 111.172 -177.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -95.58 -8.19 35.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.82 0.343 . . . . 64.25 111.433 -176.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 93.4 10.89 58.93 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.689 -0.767 . . . . 73.510000000000005 113.118 176.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -93.58 161.61 14.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.965 0.412 . . . . 72.120000000000005 110.734 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -106.89 113.03 26.27 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.796 -0.638 . . . . 72.239999999999995 109.631 176.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 742' ' ' ALA . . . . . . . . . . . . . . . -97.45 126.74 42.89 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.152 -0.477 . . . . 72.420000000000002 110.638 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 743' ' ' GLU . . . . . 0.468 ' HG3' ' HB3' ' A' ' 763' ' ' LYS . 13.4 pt-20 -140.26 140.18 35.69 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.026 0.441 . . . . 64.040000000000006 110.569 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -108.27 114.73 28.83 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.741 -0.663 . . . . 74.019999999999996 109.718 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -120.89 149.91 41.88 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.083 0.468 . . . . 73.409999999999997 111.191 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 746' ' ' LEU . . . . . 0.485 HD21 ' HB3' ' A' ' 749' ' ' GLN . 60.6 tp -91.58 116.82 29.18 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.596 -0.729 . . . . 52.310000000000002 109.825 177.156 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 47.7 t -79.29 -47.42 22.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.05 -0.523 . . . . 51.229999999999997 110.498 -178.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -154.62 147.46 24.45 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.449 -0.341 . . . . 55.229999999999997 111.064 -179.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 749' ' ' GLN . . . . . 0.485 ' HB3' HD21 ' A' ' 746' ' ' LEU . 17.2 pt20 -129.84 109.98 11.36 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.137 -0.483 . . . . 73.109999999999999 109.864 177.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 27.5 t -155.36 159.28 39.79 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.379 -0.373 . . . . 44.509999999999998 110.385 -175.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 141.25 171.72 12.81 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.699 -0.762 . . . . 70.129999999999995 112.433 176.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 752' ' ' PRO . . . . . 0.772 ' HG2' ' HB2' ' A' ' 755' ' ' GLU . 37.3 Cg_endo -66.94 167.97 18.38 Favored 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 123.089 2.526 . . . . 75.219999999999999 111.906 176.218 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.46 -31.06 94.09 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.658 2.238 . . . . 75.400000000000006 112.777 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 44.4 p-80 -86.33 -8.09 57.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.889 0.376 . . . . 74.230000000000004 111.022 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 755' ' ' GLU . . . . . 0.772 ' HB2' ' HG2' ' A' ' 752' ' ' PRO . 17.4 mm-40 -142.81 67.12 18.12 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.164 -0.471 . . . . 75.510000000000005 111.622 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 756' ' ' PRO . . . . . 0.519 ' O ' ' HA ' ' A' ' 775' ' ' HIS . 48.1 Cg_endo -71.1 88.13 0.7 Allowed 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 121.845 1.697 . . . . 75.319999999999993 110.084 173.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 757' ' ' LYS . . . . . 0.618 ' HB2' ' HZ2' ' A' ' 757' ' ' LYS . 3.6 ttmp? -87.26 116.25 25.22 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.583 0.706 . . . . 64.010000000000005 111.726 -168.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 758' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -97.83 120.87 39.0 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.88 -1.054 . . . . 72.319999999999993 110.133 177.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 15.9 t -88.84 100.14 10.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 109.239 -0.652 . . . . 42.310000000000002 109.239 177.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -103.93 141.88 35.39 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.012 -0.54 . . . . 74.230000000000004 110.812 -177.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -132.04 136.45 47.24 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.07 -0.513 . . . . 72.120000000000005 109.844 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 762' ' ' ALA . . . . . . . . . . . . . . . -94.5 117.49 30.2 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.226 0.536 . . . . 41.530000000000001 110.388 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 763' ' ' LYS . . . . . 0.68 ' HD2' ' CH2' ' A' ' 768' ' ' TRP . 56.5 tttm -101.74 112.02 24.47 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.996 -0.547 . . . . 65.329999999999998 110.025 178.007 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 764' ' ' VAL . . . . . 0.41 HG11 ' HE2' ' A' ' 734' ' ' TYR . 89.9 t -117.15 105.99 19.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.17 0.51 . . . . 53.299999999999997 110.041 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 74.22 -115.89 5.04 Favored Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 110.955 -0.858 . . . . 63.340000000000003 110.955 -175.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -110.21 4.24 29.98 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.524 -0.846 . . . . 73.340000000000003 112.348 177.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 767' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -103.48 149.21 25.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.933 0.397 . . . . 74.420000000000002 110.94 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 768' ' ' TRP . . . . . 0.68 ' CH2' ' HD2' ' A' ' 763' ' ' LYS . 58.4 m95 -117.76 104.38 10.92 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.698 -0.683 . . . . 75.510000000000005 109.822 -178.298 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 769' ' ' PHE . . . . . 0.429 ' HA ' ' HA ' ' A' ' 770' ' ' PRO . 20.0 p90 -172.86 137.84 0.82 Allowed Pre-proline 0 C--N 1.324 -0.524 0 CA-C-O 121.065 0.46 . . . . 74.109999999999999 110.925 -177.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 770' ' ' PRO . . . . . 0.615 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 71.4 Cg_endo -97.16 176.9 8.68 Favored 'Cis proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.381 -1.508 . . . . 73.540000000000006 112.093 -3.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -112.51 109.73 19.48 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.536 -0.542 . . . . 64.239999999999995 109.536 173.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 34.1 m -116.61 174.8 3.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.039 -0.528 . . . . 75.230000000000004 110.891 -174.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 11.8 p -138.08 129.05 27.12 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.856 -0.611 . . . . 70.329999999999998 110.615 178.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 774' ' ' ALA . . . . . 0.413 ' HB2' ' HG3' ' A' ' 783' ' ' GLU . . . -140.04 153.76 46.9 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.984 -0.553 . . . . 72.400000000000006 109.963 178.231 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 775' ' ' HIS . . . . . 0.519 ' HA ' ' O ' ' A' ' 756' ' ' PRO . 1.5 p-80 -86.3 12.58 9.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.181 0.515 . . . . 70.209999999999994 111.151 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 776' ' ' SER . . . . . 0.419 ' HB3' ' HB2' ' A' ' 779' ' ' GLN . 40.7 t -138.22 141.2 39.98 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.79 -0.641 . . . . 75.409999999999997 109.361 176.166 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 777' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -68.07 -41.91 81.25 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.267 -0.424 . . . . 75.340000000000003 110.17 -178.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -64.99 -40.74 95.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.991 -0.55 . . . . 63.439999999999998 110.075 178.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 779' ' ' GLN . . . . . 0.516 ' O ' ' HG2' ' A' ' 783' ' ' GLU . 49.1 mt-30 -63.18 -44.14 96.25 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 116.155 -0.475 . . . . 71.530000000000001 110.791 177.214 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -51.65 -42.21 51.6 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 121.317 -0.468 . . . . 55.229999999999997 112.857 -178.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -62.81 -47.65 82.54 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.349 0.595 . . . . 73.219999999999999 110.682 177.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -69.1 -41.9 76.85 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.291 -0.868 . . . . 74.019999999999996 111.401 -176.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 783' ' ' GLU . . . . . 0.516 ' HG2' ' O ' ' A' ' 779' ' ' GLN . 25.5 mm-40 -57.53 -46.3 84.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.069 0.462 . . . . 74.340000000000003 110.1 177.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -63.45 -49.53 73.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.675 -0.693 . . . . 53.439999999999998 110.803 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 785' ' ' ALA . . . . . 0.481 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -63.15 -40.66 98.21 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.284 -0.417 . . . . 74.0 111.33 -178.435 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 786' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -58.38 -54.75 43.5 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.148 0.499 . . . . 74.129999999999995 110.319 177.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 787' ' ' ALA . . . . . 0.617 ' O ' HG23 ' A' ' 791' ' ' VAL . . . -61.3 -40.43 94.15 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.425 -0.807 . . . . 64.239999999999995 110.708 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 788' ' ' ALA . . . . . 0.705 ' O ' ' HG ' ' A' ' 792' ' ' LEU . . . -56.93 -49.9 74.23 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.17 -0.468 . . . . 43.109999999999999 111.33 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 789' ' ' LEU . . . . . 0.575 HD22 HD12 ' A' ' 719' ' ' LEU . 80.2 mt -61.05 -43.16 99.3 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 110.156 -0.313 . . . . 70.129999999999995 110.156 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 790' ' ' ARG . . . . . . . . . . . . . 52.8 mtp180 -59.54 -36.17 75.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.124 -0.489 . . . . 73.310000000000002 111.328 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 791' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 787' ' ' ALA . 64.4 t -64.61 -54.05 35.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 109.845 -0.428 . . . . 73.140000000000001 109.845 173.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 792' ' ' LEU . . . . . 0.705 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 45.6 mt -55.73 -48.68 74.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.69 -0.686 . . . . 73.209999999999994 111.185 -177.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 793' ' ' ILE . . . . . 0.543 HD13 HG22 ' A' ' 720' ' ' VAL . 93.0 mt -59.41 -52.27 62.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.588 -0.733 . . . . 74.409999999999997 110.933 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -64.58 -44.0 95.7 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.672 -0.775 . . . . 53.310000000000002 112.48 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -64.82 -47.69 77.1 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.745 0.276 . . . . 74.319999999999993 111.745 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 796' ' ' ASN . . . . . 0.456 HD22 ' HA ' ' A' ' 796' ' ' ASN . 1.0 OUTLIER -72.14 -26.57 62.16 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.708 -0.397 . . . . 75.25 110.709 -175.948 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 797' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -72.92 -46.22 53.83 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.123 0.487 . . . . 71.219999999999999 109.967 174.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 798' ' ' LYS . . . . . . . . . . . . . 24.4 ttpp -64.42 -38.08 89.79 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.655 -0.702 . . . . 54.109999999999999 110.877 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 799' ' ' ALA . . . . . . . . . . . . . . . -72.77 -51.98 16.89 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.325 -0.398 . . . . 64.109999999999999 110.597 175.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 800' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 60.07 31.29 20.53 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.733 0.778 . . . . 75.150000000000006 110.285 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 801' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 . . . . . 0 C--O 1.245 0.868 0 CA-C-O 118.397 -0.811 . . . . 74.409999999999997 109.986 179.364 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 708' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 N--CA 1.479 1.004 0 CA-C-O 120.911 0.386 . . . . 72.400000000000006 110.274 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 60.1 mtm -131.62 92.24 31.74 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 116.396 -0.366 . . . . 73.109999999999999 111.376 -178.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -80.84 -5.95 13.2 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.184 1.923 . . . . 72.329999999999998 110.577 170.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 711' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -84.68 101.32 12.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.814 -1.084 . . . . 74.209999999999994 109.98 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 712' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -102.86 -14.73 16.45 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.162 0.506 . . . . 62.329999999999998 110.158 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 713' ' ' VAL . . . . . . . . . . . . . 12.4 p -140.82 146.04 24.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.494 -0.776 . . . . 64.409999999999997 109.182 176.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 714' ' ' ARG . . . . . . . . . . . . . 2.1 tpm_? -59.36 120.42 9.27 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 123.188 0.305 . . . . 74.140000000000001 110.419 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 715' ' ' LYS . . . . . 0.43 ' HD3' ' HA ' ' A' ' 715' ' ' LYS . 67.2 mmtt -117.05 163.19 16.62 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.091 0.472 . . . . 65.430000000000007 111.565 -177.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 716' ' ' ILE . . . . . 0.614 ' HA ' HD23 ' A' ' 719' ' ' LEU . 46.2 mm -73.03 -30.33 31.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 CA-C-N 115.651 -0.704 . . . . 74.230000000000004 111.43 -176.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -59.17 -24.5 58.78 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.967 -0.635 . . . . 72.340000000000003 112.0 177.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -71.42 -36.02 71.17 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 120.469 0.176 . . . . 75.120000000000005 110.783 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 719' ' ' LEU . . . . . 0.659 HD12 HD22 ' A' ' 789' ' ' LEU . 3.3 mm? -63.14 -32.87 74.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.026 0.441 . . . . 72.530000000000001 109.873 178.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 720' ' ' VAL . . . . . 0.499 HG22 HD13 ' A' ' 793' ' ' ILE . 47.7 t -63.68 -38.73 83.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 115.887 -0.597 . . . . 71.209999999999994 110.171 174.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 721' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -67.07 -32.32 73.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.769 -0.651 . . . . 51.329999999999998 110.049 178.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -70.99 -32.95 69.91 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-N 116.206 -0.452 . . . . 62.420000000000002 110.747 177.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 723' ' ' LEU . . . . . 0.591 HD21 ' HB2' ' A' ' 789' ' ' LEU . 96.1 mt -56.31 -33.51 65.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.232 0.539 . . . . 74.109999999999999 110.163 174.035 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -77.76 -48.7 15.99 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.574 -0.739 . . . . 73.040000000000006 111.654 177.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 33.7 m -92.28 -67.81 0.83 Allowed 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.445 0.535 . . . . 64.239999999999995 112.445 -172.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 726' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -146.36 102.85 4.03 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 120.64 0.257 . . . . 73.450000000000003 110.439 -178.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 727' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -62.86 -38.02 51.03 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.773 2.315 . . . . 74.530000000000001 112.035 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 46.7 t -62.69 -47.48 92.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.003 -0.544 . . . . 54.030000000000001 110.644 -177.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -62.68 -38.82 97.08 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.793 -0.717 . . . . 23.43 111.624 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -66.1 -42.84 94.27 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 121.069 -0.586 . . . . 74.120000000000005 112.728 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -62.21 -44.67 96.06 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.027 0.441 . . . . 74.340000000000003 109.991 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 732' ' ' LEU . . . . . . . . . . . . . 87.8 mt -67.93 -36.94 81.01 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.033 -0.531 . . . . 72.219999999999999 110.881 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 733' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -69.82 -43.35 72.19 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 122.834 0.454 . . . . 71.5 110.831 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 734' ' ' TYR . . . . . 0.514 ' HB2' HD11 ' A' ' 719' ' ' LEU . 8.5 t80 -55.21 -48.17 74.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.928 0.394 . . . . 64.5 110.373 176.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -66.46 -50.45 63.29 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.868 -0.605 . . . . 71.310000000000002 110.97 -177.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 736' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -63.66 -31.1 72.17 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.03 0.443 . . . . 74.439999999999998 111.191 -175.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 34.8 t -77.13 -29.39 54.69 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.905 -0.589 . . . . 53.219999999999999 111.011 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 16.4 m170 -98.63 -11.52 21.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.815 0.34 . . . . 73.219999999999999 111.655 -176.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 103.63 -4.26 46.71 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.733 -0.746 . . . . 64.219999999999999 112.971 177.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -79.26 157.77 27.71 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.847 0.356 . . . . 64.209999999999994 110.494 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -102.99 122.81 45.37 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.148 -0.686 . . . . 60.100000000000001 109.148 175.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 742' ' ' ALA . . . . . 0.514 ' HA ' ' O ' ' A' ' 763' ' ' LYS . . . -114.16 122.64 47.45 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 123.379 0.424 . . . . 63.310000000000002 111.076 -176.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 743' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -145.3 138.36 26.33 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.176 -0.465 . . . . 65.310000000000002 110.844 178.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -101.15 110.83 22.91 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.842 -0.617 . . . . 64.319999999999993 109.457 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -115.68 148.85 39.25 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.062 0.458 . . . . 74.150000000000006 110.886 -179.204 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 746' ' ' LEU . . . . . . . . . . . . . 59.2 tp -77.88 117.45 19.25 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.682 -0.69 . . . . 73.319999999999993 110.229 178.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 93.6 t -72.83 -51.45 27.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 116.111 -0.495 . . . . 72.239999999999995 109.807 176.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -169.57 155.65 6.18 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.655 -0.702 . . . . 64.299999999999997 109.899 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 749' ' ' GLN . . . . . 0.554 ' HA ' ' O ' ' A' ' 757' ' ' LYS . 14.7 pt20 -130.69 98.97 4.8 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.413 0.625 . . . . 63.200000000000003 110.323 175.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 35.7 m -141.96 133.57 26.86 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.676 -0.693 . . . . 63.409999999999997 110.695 -177.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 170.04 -172.6 43.91 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 121.081 -0.581 . . . . 55.229999999999997 111.764 178.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 752' ' ' PRO . . . . . 0.836 ' HG2' ' HB2' ' A' ' 755' ' ' GLU . 39.0 Cg_endo -67.56 157.9 59.61 Favored 'Trans proline' 0 N--CA 1.464 -0.217 0 C-N-CA 122.774 2.316 . . . . 71.019999999999996 111.569 177.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -58.73 -32.35 96.79 Favored 'Trans proline' 0 CA--C 1.532 0.405 0 C-N-CA 122.52 2.146 . . . . 73.5 113.109 -177.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 47.9 p-80 -83.04 -18.59 39.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.958 0.408 . . . . 75.430000000000007 111.081 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 755' ' ' GLU . . . . . 0.836 ' HB2' ' HG2' ' A' ' 752' ' ' PRO . 58.9 mm-40 -129.4 74.1 81.16 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.114 -0.493 . . . . 74.230000000000004 110.832 179.145 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 756' ' ' PRO . . . . . 0.725 ' O ' ' HA ' ' A' ' 775' ' ' HIS . 29.5 Cg_endo -64.51 102.6 0.41 Allowed 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.083 1.855 . . . . 65.120000000000005 110.23 174.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 757' ' ' LYS . . . . . 0.554 ' O ' ' HA ' ' A' ' 749' ' ' GLN . 0.8 OUTLIER -89.51 105.43 17.79 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.088 0.471 . . . . 73.140000000000001 111.366 -170.01 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 758' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -92.29 110.11 21.5 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.464 -0.789 . . . . 73.319999999999993 109.752 177.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 13.8 t -84.57 109.24 17.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.607 -0.724 . . . . 62.310000000000002 109.423 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -110.81 135.79 50.84 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.269 -0.423 . . . . 72.400000000000006 110.895 -178.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 761' ' ' GLN . . . . . 0.567 ' HA ' ' O ' ' A' ' 770' ' ' PRO . 57.7 tt0 -128.35 130.85 48.37 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.119 -0.491 . . . . 74.209999999999994 109.973 179.291 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 762' ' ' ALA . . . . . . . . . . . . . . . -89.59 117.73 28.7 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.18 0.514 . . . . 45.450000000000003 110.749 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 763' ' ' LYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 742' ' ' ALA . 60.5 tttm -89.62 113.98 25.51 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.222 -0.658 . . . . 64.430000000000007 109.222 175.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 92.8 t -124.0 101.35 8.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.363 0.601 . . . . 73.140000000000001 110.162 178.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 73.14 -116.05 5.39 Favored Glycine 0 N--CA 1.442 -0.923 0 CA-C-N 115.187 -0.915 . . . . 74.099999999999994 111.426 -177.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -102.36 -11.23 36.69 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.801 -0.714 . . . . 73.239999999999995 111.998 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 767' ' ' ARG . . . . . . . . . . . . . 62.9 mtt180 -99.81 146.28 26.78 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.259 0.552 . . . . 64.319999999999993 111.673 -178.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 768' ' ' TRP . . . . . 0.467 ' CH2' ' HD2' ' A' ' 763' ' ' LYS . 63.0 m95 -111.77 107.36 16.41 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.208 -0.905 . . . . 74.329999999999998 109.404 179.132 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 769' ' ' PHE . . . . . 0.503 ' HA ' ' HA ' ' A' ' 770' ' ' PRO . 43.1 p90 -169.19 141.0 2.02 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-O 121.048 0.452 . . . . 75.239999999999995 111.124 -176.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 770' ' ' PRO . . . . . 0.726 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 74.8 Cg_endo -98.46 176.94 7.65 Favored 'Cis proline' 0 N--CA 1.449 -1.089 0 C-N-CA 123.301 -1.541 . . . . 75.430000000000007 111.397 -5.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -111.55 99.29 8.07 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.991 0.424 . . . . 71.310000000000002 109.978 173.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 34.4 m -106.22 161.04 5.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.881 -0.6 . . . . 75.129999999999995 110.926 -177.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 773' ' ' CYS . . . . . 0.433 ' HB3' ' CG ' ' A' ' 757' ' ' LYS . 39.3 m -125.58 114.25 18.49 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.219 -0.446 . . . . 54.020000000000003 110.633 -178.123 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -128.61 153.48 47.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.224 -0.443 . . . . 53.32 109.947 178.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 775' ' ' HIS . . . . . 0.725 ' HA ' ' O ' ' A' ' 756' ' ' PRO . 1.9 p-80 -84.11 19.47 1.8 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.992 0.425 . . . . 73.299999999999997 111.492 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 24.9 t -153.32 143.19 22.06 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.396 -0.594 . . . . 75.219999999999999 109.396 175.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 777' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -60.65 -55.24 35.68 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.163 -0.472 . . . . 73.019999999999996 111.97 -175.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -65.92 -31.41 72.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.558 -0.292 . . . . 74.129999999999995 110.592 -175.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 779' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -62.0 -46.74 87.88 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.486 -0.561 . . . . 74.099999999999994 109.486 172.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -56.88 -47.73 84.19 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.698 -0.683 . . . . 52.439999999999998 112.169 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -59.21 -43.89 92.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.534 0.207 . . . . 75.450000000000003 111.364 177.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -68.58 -46.37 69.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.706 -0.225 . . . . 71.450000000000003 111.441 -178.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -64.05 -39.27 93.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.653 0.263 . . . . 72.340000000000003 110.522 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -62.37 -49.39 75.73 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 116.254 -0.43 . . . . 62.43 110.438 176.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 785' ' ' ALA . . . . . 0.596 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -61.38 -42.17 98.28 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.181 -0.463 . . . . 53.32 111.151 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 786' ' ' ASP . . . . . 0.622 ' O ' ' HG2' ' A' ' 790' ' ' ARG . 10.4 t70 -58.91 -54.22 49.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 70.129999999999995 110.375 178.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 787' ' ' ALA . . . . . 0.558 ' O ' HG23 ' A' ' 791' ' ' VAL . . . -65.41 -33.91 77.06 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.966 -0.561 . . . . 63.439999999999998 111.097 -178.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 788' ' ' ALA . . . . . 0.726 ' HB2' ' HD3' ' A' ' 770' ' ' PRO . . . -61.3 -44.52 97.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.476 -0.329 . . . . 61.200000000000003 110.729 177.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 789' ' ' LEU . . . . . 0.659 HD22 HD12 ' A' ' 719' ' ' LEU . 53.3 mt -63.19 -36.16 82.71 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.483 -0.326 . . . . 74.209999999999994 110.199 179.291 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 790' ' ' ARG . . . . . 0.622 ' HG2' ' O ' ' A' ' 786' ' ' ASP . 21.2 mmt180 -58.15 -45.63 87.06 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 109.739 -0.467 . . . . 71.120000000000005 109.739 177.031 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 791' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 787' ' ' ALA . 30.4 t -61.34 -46.71 96.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.62 -0.718 . . . . 74.140000000000001 110.388 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 792' ' ' LEU . . . . . 0.676 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 45.8 mt -62.2 -50.65 70.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.665 -0.698 . . . . 75.120000000000005 110.915 -178.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 793' ' ' ILE . . . . . 0.499 HD13 HG22 ' A' ' 720' ' ' VAL . 91.4 mt -59.25 -53.81 42.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.587 -0.733 . . . . 64.299999999999997 110.774 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -60.5 -31.85 75.92 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.857 -0.687 . . . . 61.420000000000002 112.615 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 795' ' ' GLU . . . . . 0.58 ' HA ' ' HE3' ' A' ' 798' ' ' LYS . 3.5 tm-20 -65.23 -48.27 73.89 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.145 0.497 . . . . 75.209999999999994 109.991 178.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -80.0 -24.94 40.5 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.054 -0.521 . . . . 71.310000000000002 111.623 -175.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 797' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -63.91 -21.63 66.56 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.043 0.386 . . . . 74.299999999999997 112.043 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 798' ' ' LYS . . . . . 0.58 ' HE3' ' HA ' ' A' ' 795' ' ' GLU . 0.0 OUTLIER -114.61 26.96 9.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.362 0.601 . . . . 70.140000000000001 110.866 177.842 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 799' ' ' ALA . . . . . . . . . . . . . . . -94.99 91.53 6.42 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.708 -0.678 . . . . 71.420000000000002 109.422 177.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 800' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 71.27 9.56 6.59 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.068 -0.969 . . . . 61.149999999999999 111.047 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 801' ' ' ARG . . . . . . . . . . . . . 26.0 mmm180 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.406 -0.806 . . . . 72.349999999999994 110.57 -177.413 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 708' ' ' MET . . . . . . . . . . . . . 22.8 ptp . . . . . 0 N--CA 1.479 0.98 0 CA-C-O 120.76 0.314 . . . . 70.109999999999999 110.495 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 67.4 mtt -93.32 158.81 36.46 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.231 -0.441 . . . . 63.450000000000003 110.076 177.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.46 46.64 1.67 Allowed 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 122.99 2.46 . . . . 74.420000000000002 112.231 177.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 711' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -57.55 140.96 49.47 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.862 -0.608 . . . . 75.25 111.698 -177.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 712' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -98.8 118.29 35.2 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.438 -0.801 . . . . 73.239999999999995 110.247 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 713' ' ' VAL . . . . . . . . . . . . . 27.4 m -80.46 -177.27 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.873 -0.603 . . . . 52.420000000000002 110.944 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 714' ' ' ARG . . . . . . . . . . . . . 9.8 ptp180 -75.41 64.15 1.53 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.367 0.604 . . . . 75.25 111.296 178.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -74.48 101.55 4.19 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.37 -0.832 . . . . 64.120000000000005 109.044 175.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 716' ' ' ILE . . . . . 0.436 ' HA ' HD23 ' A' ' 719' ' ' LEU . 50.1 mm -71.53 -27.76 29.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.906 -0.588 . . . . 64.219999999999999 111.398 -173.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -56.45 -29.53 57.35 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 121.187 -0.53 . . . . 41.450000000000003 112.435 177.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 718' ' ' GLU . . . . . 0.614 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 9.3 mm-40 -60.57 -53.36 58.42 Favored 'General case' 0 C--O 1.225 -0.236 0 N-CA-C 109.985 -0.376 . . . . 74.430000000000007 109.985 176.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 719' ' ' LEU . . . . . 0.547 HD12 HD22 ' A' ' 789' ' ' LEU . 2.7 mm? -60.35 -35.88 76.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.042 -0.527 . . . . 70.109999999999999 110.461 -177.033 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 720' ' ' VAL . . . . . 0.442 HG22 HD13 ' A' ' 793' ' ' ILE . 58.7 t -62.09 -41.37 90.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 116.07 -0.514 . . . . 73.319999999999993 110.871 178.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 721' ' ' ARG . . . . . 0.614 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 19.1 ptt180 -66.82 -26.05 66.74 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.308 -0.405 . . . . 54.200000000000003 110.064 -178.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -77.33 -30.67 54.12 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 116.293 -0.412 . . . . 74.409999999999997 110.787 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 723' ' ' LEU . . . . . 0.529 HD21 ' HB2' ' A' ' 789' ' ' LEU . 55.8 mt -64.01 -23.97 67.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.167 0.508 . . . . 74.030000000000001 110.002 173.244 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -89.51 -26.38 20.92 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.748 -0.66 . . . . 71.209999999999994 110.989 176.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 10.9 m -106.29 -77.47 0.59 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.909 0.385 . . . . 74.430000000000007 111.407 -175.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 726' ' ' ASN . . . . . 0.434 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 29.3 t30 -145.31 108.19 4.51 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.347 -0.388 . . . . 72.439999999999998 110.231 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 727' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 13.6 Cg_endo -57.6 -38.48 93.45 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.966 2.444 . . . . 60.030000000000001 112.413 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 728' ' ' VAL . . . . . 0.411 ' O ' ' HG ' ' A' ' 732' ' ' LEU . 55.8 t -60.57 -47.5 92.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.244 -0.434 . . . . 72.120000000000005 110.34 -179.076 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -62.43 -32.28 82.47 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.67 -0.695 . . . . 44.439999999999998 111.822 178.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -67.89 -43.73 81.92 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.092 -0.575 . . . . 71.439999999999998 112.461 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -64.9 -40.46 95.11 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.633 -0.506 . . . . 72.450000000000003 109.633 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 732' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 728' ' ' VAL . 84.6 mt -63.67 -41.51 98.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.842 -0.617 . . . . 64.040000000000006 110.451 176.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 733' ' ' GLU . . . . . 0.483 ' O ' ' HG2' ' A' ' 736' ' ' ARG . 2.5 tp10 -65.55 -44.59 86.31 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 123.052 0.541 . . . . 74.129999999999995 110.86 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 734' ' ' TYR . . . . . 0.478 ' HB2' HD11 ' A' ' 719' ' ' LEU . 27.1 t80 -56.23 -51.63 67.4 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.974 -0.557 . . . . 72.340000000000003 111.08 178.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -66.13 -46.86 76.04 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.393 -0.367 . . . . 64.010000000000005 111.291 -177.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 736' ' ' ARG . . . . . 0.483 ' HG2' ' O ' ' A' ' 733' ' ' GLU . 25.7 ptt180 -64.32 -29.34 70.42 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.201 0.524 . . . . 71.099999999999994 111.239 -175.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 33.8 t -83.64 -35.11 24.84 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.778 -0.646 . . . . 64.430000000000007 111.222 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 13.2 m170 -93.6 -10.29 35.18 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.201 0.445 . . . . 70.120000000000005 112.201 -172.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 103.1 3.92 48.05 Favored Glycine 0 N--CA 1.453 -0.172 0 C-N-CA 120.417 -0.897 . . . . 73.519999999999996 112.751 176.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -90.91 178.29 6.07 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.042 0.448 . . . . 71.099999999999994 110.542 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 741' ' ' ALA . . . . . 0.529 ' O ' ' HA ' ' A' ' 764' ' ' VAL . . . -120.16 134.55 55.23 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.847 -0.615 . . . . 55.140000000000001 109.492 174.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 742' ' ' ALA . . . . . 0.403 ' HB3' HD23 ' A' ' 732' ' ' LEU . . . -102.18 113.29 26.44 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.526 -0.306 . . . . 70.439999999999998 110.808 -177.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 743' ' ' GLU . . . . . 0.552 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 46.2 mt-10 -123.84 140.62 52.81 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.172 -0.467 . . . . 63.210000000000001 110.818 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -121.96 105.15 10.06 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.569 -0.53 . . . . 74.439999999999998 109.569 176.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.52 153.3 35.57 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.566 -0.454 . . . . 62.450000000000003 111.453 -177.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 746' ' ' LEU . . . . . . . . . . . . . 57.0 tp -82.03 116.14 21.5 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.473 -0.785 . . . . 54.32 109.407 173.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 52.2 t -88.06 -47.72 15.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 116.292 -0.413 . . . . 70.530000000000001 110.323 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -141.42 143.97 34.21 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.203 -0.453 . . . . 70.120000000000005 111.261 -176.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -130.06 100.6 5.49 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.816 -0.629 . . . . 74.430000000000007 109.395 174.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 750' ' ' SER . . . . . 0.418 ' O ' ' HB3' ' A' ' 757' ' ' LYS . 20.1 m -136.37 110.53 8.35 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.993 -0.548 . . . . 45.229999999999997 110.547 -177.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 174.15 177.9 43.67 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.976 -0.631 . . . . 64.450000000000003 111.803 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 752' ' ' PRO . . . . . 0.42 ' HG2' ' HB2' ' A' ' 755' ' ' GLU . 55.7 Cg_endo -71.01 155.87 61.06 Favored 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 122.85 2.367 . . . . 72.120000000000005 111.959 178.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -64.82 -30.29 58.62 Favored 'Trans proline' 0 CA--C 1.528 0.202 0 C-N-CA 122.603 2.202 . . . . 63.439999999999998 112.975 -176.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 56.0 p-80 -84.35 -23.61 30.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.772 0.32 . . . . 74.5 111.024 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 755' ' ' GLU . . . . . 0.42 ' HB2' ' HG2' ' A' ' 752' ' ' PRO . 23.8 mm-40 -133.01 71.7 77.55 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.147 -0.479 . . . . 73.420000000000002 110.431 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 756' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -64.41 143.13 81.55 Favored 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 122.362 2.041 . . . . 70.310000000000002 112.08 -176.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 757' ' ' LYS . . . . . 0.418 ' HB3' ' O ' ' A' ' 750' ' ' SER . 23.3 ttmm -116.44 114.93 24.92 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.054 -0.521 . . . . 64.340000000000003 109.735 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 758' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -107.02 113.08 26.34 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.889 -0.596 . . . . 71.319999999999993 110.663 -177.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 759' ' ' VAL . . . . . 0.471 HG22 ' HB3' ' A' ' 773' ' ' CYS . 29.1 t -87.26 98.11 7.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.848 -0.615 . . . . 60.350000000000001 109.556 176.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 760' ' ' TYR . . . . . 0.537 ' OH ' ' HG3' ' A' ' 777' ' ' LYS . 6.3 m-85 -100.1 143.04 30.77 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.893 -0.594 . . . . 45.149999999999999 110.236 179.228 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -131.77 137.44 48.18 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.12 -0.491 . . . . 53.310000000000002 109.695 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 762' ' ' ALA . . . . . . . . . . . . . . . -86.28 114.01 22.74 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.037 -0.529 . . . . 55.329999999999998 110.489 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 763' ' ' LYS . . . . . 0.552 ' HB3' ' HB2' ' A' ' 743' ' ' GLU . 59.3 tttm -96.82 100.44 11.98 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.771 -0.65 . . . . 65.030000000000001 109.699 178.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 764' ' ' VAL . . . . . 0.529 ' HA ' ' O ' ' A' ' 741' ' ' ALA . 61.1 t -104.21 100.81 11.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 N-CA-C 109.448 -0.575 . . . . 70.239999999999995 109.448 -179.343 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 69.96 -122.49 11.66 Favored Glycine 0 N--CA 1.442 -0.904 0 N-CA-C 110.479 -1.048 . . . . 73.549999999999997 110.479 -172.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -104.01 20.21 41.48 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.596 -0.811 . . . . 51.43 111.545 174.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 767' ' ' ARG . . . . . . . . . . . . . 41.6 ttt180 -115.53 122.76 46.65 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.735 0.302 . . . . 74.400000000000006 110.394 -176.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 768' ' ' TRP . . . . . 0.488 ' CH2' ' HD2' ' A' ' 763' ' ' LYS . 44.1 m95 -98.21 103.18 15.1 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.243 -0.435 . . . . 73.120000000000005 110.204 -178.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 769' ' ' PHE . . . . . 0.405 ' HA ' ' HA ' ' A' ' 770' ' ' PRO . 9.3 p90 -171.56 138.97 1.11 Allowed Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 120.822 0.344 . . . . 65.409999999999997 110.554 178.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 770' ' ' PRO . . . . . 0.633 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 82.8 Cg_endo -96.58 -176.49 5.16 Favored 'Cis proline' 0 N--CA 1.452 -0.947 0 C-N-CA 123.622 -1.407 . . . . 60.43 111.769 -4.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -117.4 129.79 56.07 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.077 -0.342 . . . . 32.130000000000003 110.077 176.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 30.7 m -136.63 145.97 29.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.748 0.309 . . . . 35.409999999999997 111.044 -178.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 773' ' ' CYS . . . . . 0.471 ' HB3' HG22 ' A' ' 759' ' ' VAL . 5.0 p -113.36 103.39 11.26 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.105 0.479 . . . . 74.030000000000001 110.695 178.324 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -106.43 -179.24 3.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.291 -0.413 . . . . 53.409999999999997 111.125 -176.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 775' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 -93.77 -8.65 40.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.286 0.565 . . . . 74.230000000000004 110.231 -177.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 63.6 m -150.75 166.05 31.63 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.754 -0.657 . . . . 50.539999999999999 110.403 -179.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 777' ' ' LYS . . . . . 0.537 ' HG3' ' OH ' ' A' ' 760' ' ' TYR . 31.2 ttmt -64.33 -57.64 8.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.269 -0.423 . . . . 74.219999999999999 111.741 -178.106 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -61.67 -35.96 79.47 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.054 -0.521 . . . . 65.340000000000003 110.039 -175.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 779' ' ' GLN . . . . . 0.474 ' O ' ' HG2' ' A' ' 783' ' ' GLU . 73.9 mt-30 -52.91 -56.2 17.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 75.25 110.18 170.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -57.37 -47.68 86.21 Favored Glycine 0 C--N 1.332 0.33 0 CA-C-N 115.698 -0.683 . . . . 34.340000000000003 112.764 -177.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -57.48 -44.52 84.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.754 0.311 . . . . 71.439999999999998 111.177 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -69.83 -45.18 68.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.418 -0.356 . . . . 74.120000000000005 111.176 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 783' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' A' ' 779' ' ' GLN . 30.0 mm-40 -59.86 -40.39 88.43 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.902 0.382 . . . . 52.520000000000003 110.768 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -65.38 -49.87 67.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 72.219999999999999 110.612 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 785' ' ' ALA . . . . . 0.513 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -64.79 -40.09 94.66 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.312 -0.404 . . . . 65.230000000000004 111.18 -178.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 786' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -60.76 -50.05 75.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.984 -0.553 . . . . 51.140000000000001 110.108 178.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 787' ' ' ALA . . . . . 0.616 ' O ' HG23 ' A' ' 791' ' ' VAL . . . -62.6 -39.64 94.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.757 -0.656 . . . . 72.239999999999995 110.712 178.276 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 788' ' ' ALA . . . . . 0.633 ' HB2' ' HD3' ' A' ' 770' ' ' PRO . . . -59.05 -47.36 85.53 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.072 -0.513 . . . . 64.109999999999999 111.338 -179.148 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 789' ' ' LEU . . . . . 0.547 HD22 HD12 ' A' ' 719' ' ' LEU . 77.9 mt -61.42 -41.77 97.69 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 110.109 -0.33 . . . . 75.200000000000003 110.109 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 790' ' ' ARG . . . . . 0.552 ' HD2' ' HA ' ' A' ' 787' ' ' ALA . 69.8 mtt-85 -57.38 -39.36 75.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 73.230000000000004 110.943 176.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 791' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 787' ' ' ALA . 60.1 t -63.33 -57.31 12.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.102 -0.499 . . . . 62.140000000000001 110.037 176.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 792' ' ' LEU . . . . . 0.595 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 37.1 mt -55.93 -47.72 77.01 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.487 -0.779 . . . . 75.409999999999997 111.522 -176.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 793' ' ' ILE . . . . . 0.442 HD13 HG22 ' A' ' 720' ' ' VAL . 95.7 mt -61.14 -46.47 96.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.795 -0.639 . . . . 72.329999999999998 110.934 178.545 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -60.69 -39.46 96.66 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.949 -0.643 . . . . 71.140000000000001 112.252 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 795' ' ' GLU . . . . . 0.935 ' HA ' ' HG3' ' A' ' 801' ' ' ARG . 21.5 mm-40 -52.44 -44.13 65.31 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.08 0.467 . . . . 74.549999999999997 110.901 177.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -84.26 -45.4 12.9 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.934 -0.575 . . . . 55.210000000000001 112.008 -175.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 797' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -66.16 -39.58 89.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.441 -0.345 . . . . 71.349999999999994 111.482 -174.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 798' ' ' LYS . . . . . . . . . . . . . 45.8 mtpt -78.14 -43.52 28.61 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.243 -0.651 . . . . 55.520000000000003 109.243 175.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 799' ' ' ALA . . . . . . . . . . . . . . . 63.6 8.37 3.62 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.594 -0.73 . . . . 54.439999999999998 112.322 175.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 800' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.27 20.32 18.8 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.823 0.82 . . . . 62.329999999999998 108.964 173.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 801' ' ' ARG . . . . . 0.935 ' HG3' ' HA ' ' A' ' 795' ' ' GLU . 30.9 mmm180 . . . . . 0 C--O 1.247 0.936 0 CA-C-N 114.288 -1.324 . . . . 75.400000000000006 109.826 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 708' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.998 0 N-CA-C 109.978 -0.379 . . . . 73.430000000000007 109.978 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 22.9 ptt? -109.11 112.36 59.83 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.309 -0.405 . . . . 64.25 110.122 177.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -67.34 101.25 0.61 Allowed 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.546 2.164 . . . . 65.549999999999997 111.896 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 711' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -110.5 85.27 2.08 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.235 -0.439 . . . . 75.129999999999995 110.963 -177.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 712' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -86.24 -25.12 25.74 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.379 -0.6 . . . . 72.120000000000005 109.379 173.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 713' ' ' VAL . . . . . . . . . . . . . 3.6 p -128.4 104.02 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-N 115.203 -0.908 . . . . 73.120000000000005 109.781 173.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 714' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -71.46 96.34 1.49 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.823 0.821 . . . . 74.349999999999994 109.948 177.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 715' ' ' LYS . . . . . 0.864 ' HG2' ' HB2' ' A' ' 718' ' ' GLU . 45.2 tttp -87.97 17.97 4.55 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.811 -1.086 . . . . 70.430000000000007 110.419 -174.355 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 716' ' ' ILE . . . . . 0.537 HG23 ' HA ' ' A' ' 793' ' ' ILE . 38.5 mm -52.48 -47.15 48.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.345 -0.843 . . . . 70.530000000000001 112.694 -171.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -63.81 -30.66 78.35 Favored Glycine 0 C--O 1.237 0.29 0 C-N-CA 120.785 -0.721 . . . . 34.549999999999997 112.358 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 718' ' ' GLU . . . . . 0.864 ' HB2' ' HG2' ' A' ' 715' ' ' LYS . 35.4 mt-10 -73.03 -37.84 66.75 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 110.127 -0.323 . . . . 75.030000000000001 110.127 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 719' ' ' LEU . . . . . 0.705 HD12 HD22 ' A' ' 789' ' ' LEU . 2.6 mm? -58.1 -35.04 70.85 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.013 0.435 . . . . 75.219999999999999 110.308 175.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 720' ' ' VAL . . . . . 0.48 HG22 HD13 ' A' ' 793' ' ' ILE . 71.6 t -61.92 -41.16 89.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.856 -0.611 . . . . 71.219999999999999 110.997 178.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 721' ' ' ARG . . . . . 0.658 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 8.2 ptt180 -65.15 -25.35 67.71 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.979 0.419 . . . . 73.310000000000002 110.506 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -77.14 -29.17 54.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.398 -0.365 . . . . 74.319999999999993 110.767 178.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 723' ' ' LEU . . . . . 0.561 HD21 ' HB2' ' A' ' 789' ' ' LEU . 95.8 mt -62.06 -30.03 70.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.371 0.605 . . . . 70.310000000000002 109.742 173.095 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -81.95 -40.1 22.72 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.283 -0.871 . . . . 72.010000000000005 110.428 176.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 12.1 m -93.02 -83.44 0.31 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.983 -0.553 . . . . 63.149999999999999 111.416 -176.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 726' ' ' ASN . . . . . 0.421 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 44.9 t30 -140.76 110.2 6.67 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.789 0.328 . . . . 61.240000000000002 110.504 -176.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 727' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 28.5 Cg_endo -63.68 -37.24 47.67 Favored 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 122.814 2.343 . . . . 73.299999999999997 112.312 -178.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 44.0 t -61.24 -49.03 86.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.187 -0.46 . . . . 60.530000000000001 110.501 -178.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -64.02 -35.83 92.49 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.963 -0.637 . . . . 74.310000000000002 111.836 178.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -66.8 -41.61 93.51 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 121.063 -0.589 . . . . 74.120000000000005 112.457 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -63.48 -41.2 98.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.095 0.474 . . . . 65.040000000000006 109.733 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 732' ' ' LEU . . . . . 0.42 HD23 ' HB3' ' A' ' 742' ' ' ALA . 75.4 mt -68.29 -39.14 82.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.829 -0.623 . . . . 71.310000000000002 110.65 177.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 733' ' ' GLU . . . . . 0.549 ' O ' ' HG2' ' A' ' 736' ' ' ARG . 2.2 tp10 -65.29 -45.11 85.72 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 123.391 0.676 . . . . 64.109999999999999 111.067 -179.262 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 734' ' ' TYR . . . . . 0.617 ' HB2' HD11 ' A' ' 719' ' ' LEU . 7.4 t80 -60.21 -46.78 88.56 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.389 -0.369 . . . . 54.100000000000001 110.66 176.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 735' ' ' ALA . . . . . 0.446 ' HA ' ' HB2' ' A' ' 740' ' ' PHE . . . -64.11 -49.02 73.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.133 -0.485 . . . . 61.109999999999999 110.891 -177.184 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 736' ' ' ARG . . . . . 0.549 ' HG2' ' O ' ' A' ' 733' ' ' GLU . 23.3 ptt180 -59.97 -38.58 82.96 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.869 -0.605 . . . . 73.349999999999994 111.111 -176.145 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 32.9 t -78.46 -23.27 46.58 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.969 -0.559 . . . . 71.109999999999999 111.461 -177.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -108.91 4.96 23.97 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.118 0.414 . . . . 71.329999999999998 112.118 -174.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 89.04 2.76 77.33 Favored Glycine 0 C--O 1.229 -0.177 0 C-N-CA 120.736 -0.745 . . . . 73.25 113.261 174.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 740' ' ' PHE . . . . . 0.446 ' HB2' ' HA ' ' A' ' 735' ' ' ALA . 90.3 m-85 -83.52 161.26 21.29 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.874 0.369 . . . . 72.420000000000002 110.842 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -115.01 104.24 11.71 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.879 -0.6 . . . . 62.140000000000001 109.538 176.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 742' ' ' ALA . . . . . 0.42 ' HB3' HD23 ' A' ' 732' ' ' LEU . . . -86.4 125.7 33.86 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.04 -0.527 . . . . 72.049999999999997 111.208 -176.092 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 743' ' ' GLU . . . . . 0.426 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 43.3 mt-10 -137.82 134.72 35.5 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.047 -0.524 . . . . 75.109999999999999 110.382 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -107.21 105.74 15.87 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.5 -0.556 . . . . 74.120000000000005 109.5 176.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.53 147.25 44.68 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.053 0.454 . . . . 61.100000000000001 111.131 -174.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 746' ' ' LEU . . . . . . . . . . . . . 51.3 tp -77.22 122.01 24.46 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.701 -0.681 . . . . 54.130000000000003 110.006 176.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 60.1 t -81.76 -50.35 16.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.09 -0.505 . . . . 74.349999999999994 109.694 177.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -165.99 156.26 12.68 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.697 -0.683 . . . . 74.030000000000001 110.032 -177.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -114.32 119.14 35.94 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.98 -0.378 . . . . 64.230000000000004 109.98 174.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 750' ' ' SER . . . . . 0.506 ' O ' ' HB3' ' A' ' 757' ' ' LYS . 67.6 m -135.56 107.38 7.05 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.107 -0.497 . . . . 41.140000000000001 110.142 179.219 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 174.81 153.38 10.01 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.261 -0.971 . . . . 71.010000000000005 112.745 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 752' ' ' PRO . . . . . 0.709 ' HG2' ' HB2' ' A' ' 755' ' ' GLU . 36.2 Cg_endo -66.53 168.69 15.85 Favored 'Trans proline' 0 CA--C 1.533 0.427 0 C-N-CA 123.348 2.698 . . . . 71.430000000000007 111.968 176.007 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.61 -31.88 95.09 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.595 2.197 . . . . 75.010000000000005 112.88 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 42.9 p-80 -87.5 -5.05 58.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.415 -0.357 . . . . 64.310000000000002 111.259 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 755' ' ' GLU . . . . . 0.709 ' HB2' ' HG2' ' A' ' 752' ' ' PRO . 12.2 mm-40 -150.39 64.21 6.5 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.156 -0.475 . . . . 72.140000000000001 110.715 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 756' ' ' PRO . . . . . 0.472 ' O ' ' HA ' ' A' ' 775' ' ' HIS . 14.4 Cg_exo -68.42 92.15 0.41 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.711 2.274 . . . . 71.230000000000004 111.33 178.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 757' ' ' LYS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 775' ' ' HIS . 15.0 ttmt -89.05 111.73 22.53 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.522 0.677 . . . . 65.329999999999998 111.262 -174.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 758' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -90.76 130.85 36.7 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.943 -1.026 . . . . 74.040000000000006 109.832 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 29.2 t -92.87 109.04 21.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.609 -0.515 . . . . 73.150000000000006 109.609 175.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -111.92 141.19 45.87 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.303 -0.408 . . . . 71.140000000000001 110.646 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -126.97 137.82 53.17 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.977 -0.556 . . . . 72.150000000000006 109.92 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 762' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' A' ' 769' ' ' PHE . . . -85.44 109.82 18.73 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.402 0.62 . . . . 74.239999999999995 110.428 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 763' ' ' LYS . . . . . 0.426 ' HB3' ' HB2' ' A' ' 743' ' ' GLU . 75.1 tttt -94.08 104.29 16.33 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.228 -0.896 . . . . 61.310000000000002 109.483 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 48.4 t -117.2 98.04 6.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 120.939 0.4 . . . . 62.420000000000002 111.176 -175.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 60.5 37.27 93.03 Favored Glycine 0 CA--C 1.517 0.193 0 CA-C-N 115.716 -0.674 . . . . 61.009999999999998 113.143 176.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 94.86 -16.11 61.98 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.545 -0.836 . . . . 72.230000000000004 112.62 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 767' ' ' ARG . . . . . . . . . . . . . 79.0 mtt180 -90.64 129.28 36.78 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.054 -0.35 . . . . 63.420000000000002 110.054 176.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 768' ' ' TRP . . . . . . . . . . . . . 68.3 m95 -106.58 99.15 8.74 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.408 -0.36 . . . . 72.239999999999995 110.484 -176.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 769' ' ' PHE . . . . . 0.473 ' HA ' ' HA ' ' A' ' 770' ' ' PRO . 36.3 p90 -170.22 136.86 1.29 Allowed Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.533 -0.303 . . . . 71.019999999999996 110.327 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 770' ' ' PRO . . . . . 0.572 ' HG3' ' HB3' ' A' ' 787' ' ' ALA . 62.5 Cg_endo -94.89 179.02 9.23 Favored 'Cis proline' 0 N--CA 1.45 -1.04 0 C-N-CA 123.484 -1.465 . . . . 72.140000000000001 111.978 -3.313 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -115.56 104.14 11.43 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.938 -0.393 . . . . 62.340000000000003 109.938 175.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 29.6 m -113.67 164.27 9.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.001 0.429 . . . . 72.0 111.05 -175.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 773' ' ' CYS . . . . . 0.475 ' HB2' ' HG2' ' A' ' 757' ' ' LYS . 10.6 p -127.87 119.19 25.1 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.082 -0.508 . . . . 63.25 110.193 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -135.91 144.33 45.46 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.41 -0.359 . . . . 73.439999999999998 110.612 -178.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 775' ' ' HIS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 757' ' ' LYS . 1.1 p-80 -76.45 16.5 0.47 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.496 0.554 . . . . 73.349999999999994 112.496 -177.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 776' ' ' SER . . . . . 0.571 ' HB2' ' CG ' ' A' ' 779' ' ' GLN . 11.8 m -147.13 140.32 25.3 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.654 -0.498 . . . . 42.439999999999998 109.654 177.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 777' ' ' LYS . . . . . 0.434 ' HE3' ' HB3' ' A' ' 777' ' ' LYS . 2.2 tmmt? -61.46 -46.25 90.84 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.435 -0.348 . . . . 65.209999999999994 111.227 -178.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 778' ' ' LYS . . . . . 0.501 ' O ' ' HG3' ' A' ' 782' ' ' GLN . 63.7 pttt -66.5 -35.48 80.37 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.929 -0.308 . . . . 62.119999999999997 110.442 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 779' ' ' GLN . . . . . 0.571 ' CG ' ' HB2' ' A' ' 776' ' ' SER . 16.0 mm100 -63.79 -43.9 94.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.337 -0.392 . . . . 61.420000000000002 110.05 177.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -57.52 -40.46 92.38 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.002 -0.618 . . . . 42.32 111.92 178.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 30.3 mtpp -66.5 -47.0 74.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.639 0.257 . . . . 75.329999999999998 110.831 178.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 782' ' ' GLN . . . . . 0.501 ' HG3' ' O ' ' A' ' 778' ' ' LYS . 92.8 mt-30 -68.25 -48.17 65.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.221 -0.445 . . . . 65.329999999999998 111.228 -177.058 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -58.76 -46.15 88.12 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 123.25 0.344 . . . . 62.240000000000002 110.999 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -63.17 -48.01 80.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.305 -0.407 . . . . 75.510000000000005 110.893 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 785' ' ' ALA . . . . . 0.631 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -62.64 -42.19 99.46 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.268 -0.424 . . . . 31.32 111.089 -178.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 786' ' ' ASP . . . . . 0.523 ' O ' ' HG2' ' A' ' 790' ' ' ARG . 11.7 t70 -59.48 -55.74 30.77 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.04 -0.527 . . . . 72.430000000000007 110.129 179.262 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 787' ' ' ALA . . . . . 0.572 ' HB3' ' HG3' ' A' ' 770' ' ' PRO . . . -61.52 -34.68 75.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.75 -0.659 . . . . 71.209999999999994 111.203 -178.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 788' ' ' ALA . . . . . 0.592 ' O ' ' HG ' ' A' ' 792' ' ' LEU . . . -61.22 -42.78 99.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.421 -0.354 . . . . 65.239999999999995 110.888 178.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 789' ' ' LEU . . . . . 0.705 HD22 HD12 ' A' ' 719' ' ' LEU . 35.5 mt -66.05 -33.93 76.92 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.421 -0.354 . . . . 74.340000000000003 110.122 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 790' ' ' ARG . . . . . 0.523 ' HG2' ' O ' ' A' ' 786' ' ' ASP . 6.2 mmm180 -61.71 -44.47 96.85 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.493 -0.558 . . . . 72.409999999999997 109.493 178.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 791' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 787' ' ' ALA . 41.2 t -57.69 -44.26 85.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.512 -0.767 . . . . 74.219999999999999 110.559 178.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 792' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 30.3 mt -68.15 -52.06 38.95 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.732 -0.667 . . . . 73.549999999999997 110.713 -178.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 793' ' ' ILE . . . . . 0.537 ' HA ' HG23 ' A' ' 716' ' ' ILE . 95.7 mt -60.23 -47.33 92.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.539 -0.755 . . . . 75.030000000000001 111.456 -177.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -68.71 -26.36 74.54 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.766 -0.731 . . . . 55.130000000000003 112.506 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -77.81 -44.28 27.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.876 0.37 . . . . 61.439999999999998 110.921 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 796' ' ' ASN . . . . . 0.464 ' HA ' ' HB2' ' A' ' 799' ' ' ALA . 1.6 t30 -90.58 4.26 51.77 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.007 0.432 . . . . 74.420000000000002 110.664 -176.276 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 797' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -57.97 -53.69 55.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.629 -0.714 . . . . 52.520000000000003 110.287 178.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 798' ' ' LYS . . . . . . . . . . . . . 53.1 tttp -123.62 55.99 1.23 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.586 0.707 . . . . 64.409999999999997 109.444 175.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 799' ' ' ALA . . . . . 0.464 ' HB2' ' HA ' ' A' ' 796' ' ' ASN . . . -96.79 -175.19 3.21 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.283 -0.871 . . . . 73.129999999999995 110.297 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 800' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -92.33 -9.64 41.18 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.896 0.379 . . . . 71.510000000000005 110.465 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 801' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.676 -0.678 . . . . 62.219999999999999 110.4 -174.394 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 708' ' ' MET . . . . . . . . . . . . . 67.6 mtt . . . . . 0 N--CA 1.48 1.047 0 N-CA-C 110.407 -0.22 . . . . 74.200000000000003 110.407 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 26.4 mmt 71.04 136.95 0.05 OUTLIER Pre-proline 0 N--CA 1.467 0.376 0 O-C-N 124.062 0.851 . . . . 64.129999999999995 112.199 178.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -83.98 38.29 0.69 Allowed 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 123.16 2.573 . . . . 64.530000000000001 112.288 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 711' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -62.21 -43.67 98.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.219 0.533 . . . . 75.349999999999994 110.165 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 712' ' ' LYS . . . . . 0.437 ' HD3' ' O ' ' A' ' 713' ' ' VAL . 1.2 tmtp? -124.97 108.31 11.73 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.997 -0.742 . . . . 65.129999999999995 108.997 175.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 713' ' ' VAL . . . . . 0.437 ' O ' ' HD3' ' A' ' 712' ' ' LYS . 12.0 p -59.22 149.05 6.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.755 -0.657 . . . . 61.240000000000002 110.552 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 714' ' ' ARG . . . . . . . . . . . . . 30.5 ptt180 -76.22 50.28 0.62 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.465 0.65 . . . . 62.149999999999999 111.104 -177.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 715' ' ' LYS . . . . . 0.477 ' HD2' ' HG2' ' A' ' 718' ' ' GLU . 39.0 ttmt -65.85 105.76 1.38 Allowed 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.651 -0.704 . . . . 74.25 109.723 178.124 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 716' ' ' ILE . . . . . 0.567 HG23 HG12 ' A' ' 793' ' ' ILE . 44.7 mm -67.93 -26.17 34.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.916 -0.583 . . . . 75.409999999999997 111.166 -174.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -58.71 -29.1 63.81 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.742 -0.742 . . . . 74.340000000000003 111.645 175.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 718' ' ' GLU . . . . . 0.715 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 43.7 mm-40 -70.17 -40.43 74.71 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-O 120.707 0.289 . . . . 65.219999999999999 110.77 178.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 719' ' ' LEU . . . . . 0.581 HD12 HD22 ' A' ' 789' ' ' LEU . 3.1 mm? -64.4 -27.08 68.76 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.127 0.489 . . . . 65.140000000000001 109.929 177.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 720' ' ' VAL . . . . . 0.433 HG22 HD13 ' A' ' 793' ' ' ILE . 98.2 t -76.18 -36.85 31.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.789 -0.641 . . . . 74.310000000000002 111.346 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 721' ' ' ARG . . . . . 0.715 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 5.9 ptm180 -67.89 -22.77 65.08 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.34 0.591 . . . . 71.120000000000005 109.762 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -77.22 -31.02 54.88 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.929 -0.578 . . . . 73.450000000000003 110.622 175.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 723' ' ' LEU . . . . . 0.551 HD21 ' HB2' ' A' ' 789' ' ' LEU . 85.3 mt -60.13 -30.41 69.27 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.284 0.564 . . . . 71.140000000000001 109.894 174.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -87.98 -39.49 14.66 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.352 -0.84 . . . . 72.430000000000007 111.303 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 30.7 m -90.23 -76.17 0.44 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.756 0.312 . . . . 71.209999999999994 111.761 -177.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 726' ' ' ASN . . . . . 0.468 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 25.2 t30 -150.84 105.56 3.03 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.458 -0.337 . . . . 71.340000000000003 110.453 -178.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 727' ' ' PRO . . . . . 0.468 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 18.1 Cg_endo -60.63 -32.55 93.44 Favored 'Trans proline' 0 N--CA 1.464 -0.207 0 C-N-CA 123.131 2.554 . . . . 74.420000000000002 112.47 -178.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 43.4 t -61.88 -48.05 90.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.09 -0.505 . . . . 52.409999999999997 110.47 -177.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -63.06 -32.66 84.91 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.925 -0.655 . . . . 72.219999999999999 112.183 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -73.88 -44.48 30.76 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.753 -0.737 . . . . 71.450000000000003 112.5 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -64.1 -40.97 97.38 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.85 0.357 . . . . 72.400000000000006 110.147 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 732' ' ' LEU . . . . . . . . . . . . . 93.3 mt -64.19 -40.85 96.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.119 -0.492 . . . . 71.439999999999998 111.523 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 733' ' ' GLU . . . . . 0.511 ' HA ' ' HG2' ' A' ' 736' ' ' ARG . 6.5 pt-20 -78.35 -31.24 48.46 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.404 -0.518 . . . . 73.510000000000005 110.971 -178.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 734' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -53.76 -45.61 70.67 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 121.056 0.455 . . . . 75.319999999999993 109.942 175.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -66.06 -53.28 40.3 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.727 -0.67 . . . . 63.340000000000003 110.708 -178.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 736' ' ' ARG . . . . . 0.511 ' HG2' ' HA ' ' A' ' 733' ' ' GLU . 19.2 ptt85 -61.36 -34.42 75.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.092 -0.504 . . . . 73.329999999999998 111.209 -175.034 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 15.6 t -73.44 -36.4 65.91 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.815 -0.63 . . . . 63.140000000000001 111.137 178.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 13.4 m170 -95.64 3.19 54.21 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.948 0.351 . . . . 73.439999999999998 111.948 -173.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 95.08 0.01 63.88 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.519 -0.848 . . . . 74.030000000000001 113.367 173.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -94.27 -179.1 4.82 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.798 0.332 . . . . 64.010000000000005 110.393 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 741' ' ' ALA . . . . . 0.423 ' O ' ' HA ' ' A' ' 764' ' ' VAL . . . -127.2 134.64 50.1 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.212 -0.662 . . . . 64.099999999999994 109.212 173.105 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 742' ' ' ALA . . . . . . . . . . . . . . . -110.89 131.39 55.09 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.741 0.305 . . . . 45.109999999999999 111.166 -176.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 743' ' ' GLU . . . . . 0.487 ' HG3' ' HB3' ' A' ' 763' ' ' LYS . 12.7 pt-20 -147.57 153.27 39.23 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.92 -0.582 . . . . 73.310000000000002 110.435 178.156 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -120.6 118.26 29.69 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.061 -0.518 . . . . 72.239999999999995 109.781 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -122.2 138.19 54.57 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.524 -0.47 . . . . 74.209999999999994 111.246 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 746' ' ' LEU . . . . . 0.421 HD11 ' HD2' ' A' ' 758' ' ' PHE . 6.8 tt -74.24 119.14 18.03 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.501 -0.772 . . . . 73.299999999999997 109.176 176.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 43.9 t -94.89 -44.99 13.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.279 -0.419 . . . . 74.230000000000004 110.959 -177.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -149.29 158.02 43.83 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.402 -0.363 . . . . 74.25 110.77 -176.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -141.36 113.41 7.93 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.332 -0.618 . . . . 60.439999999999998 109.332 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 6.1 t -143.83 -167.29 2.56 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.869 -0.332 . . . . 62.439999999999998 110.324 -177.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 97.23 -150.38 19.52 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.853 -0.689 . . . . 72.219999999999999 111.787 -177.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 752' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -80.06 158.38 23.71 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.364 2.042 . . . . 73.420000000000002 111.802 178.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -73.13 -36.17 4.51 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.661 2.24 . . . . 64.420000000000002 112.376 -177.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -76.33 -29.27 57.21 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.96 -0.564 . . . . 73.340000000000003 110.834 -177.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -130.98 74.02 80.37 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 72.439999999999998 110.614 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 756' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -62.95 132.05 35.35 Favored 'Trans proline' 0 N--CA 1.465 -0.152 0 C-N-CA 122.685 2.257 . . . . 73.409999999999997 112.018 -177.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 757' ' ' LYS . . . . . 0.554 ' HG2' ' HB2' ' A' ' 773' ' ' CYS . 39.1 ttmt -98.83 111.83 24.1 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.279 0.561 . . . . 65.120000000000005 109.796 178.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 758' ' ' PHE . . . . . 0.436 ' O ' ' HA ' ' A' ' 773' ' ' CYS . 61.3 m-85 -90.27 123.25 33.89 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.116 -0.947 . . . . 74.510000000000005 110.595 -175.009 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 56.4 t -88.91 108.0 18.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.998 -0.547 . . . . 54.109999999999999 109.725 176.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -111.22 135.19 52.11 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.795 -0.639 . . . . 74.319999999999993 110.676 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -120.76 126.85 51.18 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.829 -0.623 . . . . 64.549999999999997 109.658 178.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 762' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 769' ' ' PHE . . . -83.94 120.92 26.68 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.179 0.514 . . . . 52.0 110.19 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 763' ' ' LYS . . . . . 0.69 ' HD2' ' CH2' ' A' ' 768' ' ' TRP . 49.4 tttm -104.32 107.3 18.15 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.842 -0.617 . . . . 65.150000000000006 110.054 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 764' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 741' ' ' ALA . 48.4 t -114.94 102.66 14.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.988 -0.551 . . . . 52.100000000000001 109.868 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 72.77 -123.15 8.67 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 110.821 -0.912 . . . . 74.230000000000004 110.821 -174.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -101.2 2.54 54.66 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.123 -0.791 . . . . 63.100000000000001 111.123 173.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 767' ' ' ARG . . . . . 0.44 ' NE ' ' HA ' ' A' ' 767' ' ' ARG . 2.6 mmp_? -97.28 127.52 43.31 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.099 0.476 . . . . 64.519999999999996 110.839 -177.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 768' ' ' TRP . . . . . 0.69 ' CH2' ' HD2' ' A' ' 763' ' ' LYS . 51.1 m95 -103.63 112.15 24.94 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.669 -0.696 . . . . 75.209999999999994 109.27 178.025 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 769' ' ' PHE . . . . . 0.491 ' HA ' ' HA ' ' A' ' 770' ' ' PRO . 27.0 p90 -176.78 136.98 0.43 Allowed Pre-proline 0 C--N 1.323 -0.584 0 CA-C-O 120.955 0.407 . . . . 73.430000000000007 110.248 -178.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 770' ' ' PRO . . . . . 0.623 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 55.6 Cg_endo -95.51 -170.74 2.81 Favored 'Cis proline' 0 N--CA 1.451 -0.976 0 C-N-CA 123.395 -1.502 . . . . 52.25 111.828 -3.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -120.83 100.18 6.95 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.431 -0.581 . . . . 73.310000000000002 109.431 175.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 28.6 m -109.88 163.98 6.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.243 -0.435 . . . . 75.519999999999996 110.973 -175.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 773' ' ' CYS . . . . . 0.554 ' HB2' ' HG2' ' A' ' 757' ' ' LYS . 6.3 p -138.21 110.69 7.49 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.975 -0.557 . . . . 62.409999999999997 110.002 178.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -118.17 147.61 43.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.539 -0.3 . . . . 73.129999999999995 111.023 -176.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 775' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -76.33 13.33 0.96 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.316 -0.402 . . . . 73.450000000000003 111.828 -177.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 49.9 m -150.02 136.56 19.09 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.249 -0.648 . . . . 62.210000000000001 109.249 174.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 777' ' ' LYS . . . . . 0.428 ' HE3' ' HB3' ' A' ' 777' ' ' LYS . 0.8 OUTLIER -61.87 -40.57 95.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.384 -0.371 . . . . 75.109999999999999 111.372 -174.709 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -66.68 -29.23 69.19 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.11 0.481 . . . . 65.239999999999995 110.39 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 779' ' ' GLN . . . . . 0.5 ' O ' ' HG2' ' A' ' 783' ' ' GLU . 96.4 mt-30 -74.7 -38.38 62.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.944 -0.571 . . . . 75.540000000000006 110.03 178.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -53.18 -44.89 64.15 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 121.324 -0.465 . . . . 65.019999999999996 112.391 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -62.46 -46.63 87.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.976 0.417 . . . . 71.349999999999994 110.649 177.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -66.92 -48.04 69.88 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.869 -0.605 . . . . 74.219999999999999 111.596 -177.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 783' ' ' GLU . . . . . 0.5 ' HG2' ' O ' ' A' ' 779' ' ' GLN . 34.5 mm-40 -59.66 -41.43 90.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.758 0.313 . . . . 73.120000000000005 110.527 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -62.39 -48.01 81.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.07 -0.514 . . . . 55.549999999999997 110.493 178.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 785' ' ' ALA . . . . . 0.576 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -65.26 -40.07 93.46 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.333 -0.394 . . . . 70.299999999999997 110.858 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 786' ' ' ASP . . . . . 0.599 ' O ' ' HD3' ' A' ' 790' ' ' ARG . 13.7 t70 -60.61 -55.65 30.81 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.961 -0.563 . . . . 64.129999999999995 110.299 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 787' ' ' ALA . . . . . 0.534 ' HB3' ' HG3' ' A' ' 770' ' ' PRO . . . -64.14 -31.09 72.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.078 -0.51 . . . . 74.219999999999999 110.904 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 788' ' ' ALA . . . . . 0.69 ' O ' ' HG ' ' A' ' 792' ' ' LEU . . . -62.14 -46.56 88.47 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.286 -0.264 . . . . 72.430000000000007 110.286 176.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 789' ' ' LEU . . . . . 0.581 HD22 HD12 ' A' ' 719' ' ' LEU . 70.1 mt -63.69 -34.78 78.62 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.741 -0.466 . . . . 65.340000000000003 109.741 178.11 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 790' ' ' ARG . . . . . 0.599 ' HD3' ' O ' ' A' ' 786' ' ' ASP . 0.3 OUTLIER -57.43 -45.71 84.35 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.223 -0.444 . . . . 71.310000000000002 110.185 174.897 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 791' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 787' ' ' ALA . 48.4 t -61.63 -49.69 83.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.028 -0.533 . . . . 70.540000000000006 110.381 177.313 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 792' ' ' LEU . . . . . 0.69 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 39.6 mt -59.92 -50.79 72.37 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.988 -0.551 . . . . 72.519999999999996 110.901 -177.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 793' ' ' ILE . . . . . 0.567 HG12 HG23 ' A' ' 716' ' ' ILE . 95.9 mt -60.72 -49.51 84.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.844 -0.616 . . . . 65.530000000000001 110.578 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -61.8 -36.64 93.06 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 121.057 -0.592 . . . . 63.109999999999999 112.625 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 795' ' ' GLU . . . . . 0.554 ' HA ' ' HD3' ' A' ' 798' ' ' LYS . 9.7 tp10 -65.51 -43.91 88.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.049 0.452 . . . . 70.129999999999995 110.129 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -66.33 -32.34 73.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.07 -0.514 . . . . 74.209999999999994 110.925 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 797' ' ' GLU . . . . . 0.538 ' HG3' ' O ' ' A' ' 793' ' ' ILE . 47.2 mt-10 -65.47 -19.49 65.96 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.944 0.402 . . . . 74.420000000000002 110.916 177.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 798' ' ' LYS . . . . . 0.554 ' HD3' ' HA ' ' A' ' 795' ' ' GLU . 44.3 mtpt -81.38 -17.35 49.33 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.106 -0.497 . . . . 72.150000000000006 110.146 176.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 799' ' ' ALA . . . . . . . . . . . . . . . -97.62 -39.53 9.06 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.937 -0.574 . . . . 21.100000000000001 110.828 178.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 800' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -65.04 95.58 0.17 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.944 -0.571 . . . . 72.430000000000007 111.062 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 801' ' ' ARG . . . . . . . . . . . . . 61.0 mtm180 . . . . . 0 C--O 1.246 0.911 0 CA-C-N 115.244 -0.889 . . . . 65.219999999999999 109.931 177.459 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 708' ' ' MET . . . . . . . . . . . . . 12.5 tmm? . . . . . 0 N--CA 1.479 0.981 0 N-CA-C 109.422 -0.584 . . . . 64.540000000000006 109.422 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -112.18 110.08 53.93 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 116.324 -0.398 . . . . 43.219999999999999 110.7 -176.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -82.88 126.73 4.57 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.201 2.601 . . . . 71.230000000000004 111.665 178.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 711' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -63.1 112.87 2.81 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.246 0.546 . . . . 63.149999999999999 109.619 176.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 712' ' ' LYS . . . . . 0.908 ' HE2' ' HA ' ' A' ' 712' ' ' LYS . 10.6 mmpt? -81.69 162.12 23.13 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.609 -0.723 . . . . 74.120000000000005 112.537 -169.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 713' ' ' VAL . . . . . 0.745 HG22 ' H ' ' A' ' 715' ' ' LYS . 7.1 p -165.88 133.99 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.89 -1.05 . . . . 71.0 109.039 176.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 714' ' ' ARG . 58.7 mtt-85 -92.69 17.16 10.73 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.039 0.447 . . . . 63.32 111.01 -177.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 715' ' ' LYS . . . . . 0.745 ' H ' HG22 ' A' ' 713' ' ' VAL . 96.6 mttt -103.86 25.36 9.96 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.698 -0.683 . . . . 72.200000000000003 110.159 178.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 716' ' ' ILE . . . . . 0.587 ' HA ' HD23 ' A' ' 719' ' ' LEU . 37.0 mm -58.91 -30.57 43.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.837 -0.619 . . . . 71.140000000000001 111.117 -178.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -60.55 -29.69 70.16 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 121.008 -0.615 . . . . 55.229999999999997 112.518 175.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 718' ' ' GLU . . . . . 0.4 ' HA ' ' HB3' ' A' ' 721' ' ' ARG . 43.0 mt-10 -75.54 -25.4 57.14 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 122.651 -0.323 . . . . 75.340000000000003 110.654 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 719' ' ' LEU . . . . . 0.587 HD23 ' HA ' ' A' ' 716' ' ' ILE . 4.2 mm? -66.38 -34.77 78.72 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.464 -0.569 . . . . 73.540000000000006 109.464 174.15 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 720' ' ' VAL . . . . . 0.618 HG22 HD13 ' A' ' 793' ' ' ILE . 22.0 t -68.15 -33.09 58.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.826 -0.625 . . . . 74.019999999999996 109.979 175.177 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 721' ' ' ARG . . . . . 0.4 ' HB3' ' HA ' ' A' ' 718' ' ' GLU . 0.1 OUTLIER -61.29 -35.71 78.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.722 -0.672 . . . . 71.510000000000005 110.04 178.774 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -71.05 -32.33 69.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.0 -0.546 . . . . 71.510000000000005 111.1 178.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 723' ' ' LEU . . . . . 0.42 HD21 ' HB2' ' A' ' 789' ' ' LEU . 95.3 mt -58.02 -32.03 67.55 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.119 0.485 . . . . 74.430000000000007 109.928 175.435 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 54.0 m-20 -71.54 -49.9 36.43 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.622 -0.717 . . . . 73.329999999999998 110.839 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 47.4 m -93.12 -70.78 0.68 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.049 0.388 . . . . 73.319999999999993 112.049 -174.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 726' ' ' ASN . . . . . 0.414 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 43.5 t30 -145.12 104.79 4.41 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-O 120.827 0.346 . . . . 75.329999999999998 110.86 -178.099 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 727' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 18.6 Cg_endo -60.57 -34.52 92.4 Favored 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.821 2.347 . . . . 61.210000000000001 112.064 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 47.6 t -61.76 -48.37 88.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 64.409999999999997 110.364 -178.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -63.15 -31.2 79.92 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 121.026 -0.607 . . . . 55.399999999999999 111.811 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -70.35 -41.98 66.45 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.948 -0.644 . . . . 73.239999999999995 112.376 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 731' ' ' LEU . . . . . 0.422 ' N ' HD21 ' A' ' 789' ' ' LEU . 3.0 tm? -65.57 -40.33 92.66 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.412 -0.588 . . . . 71.140000000000001 109.412 178.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 732' ' ' LEU . . . . . . . . . . . . . 79.4 mt -66.16 -39.25 89.63 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.702 -0.681 . . . . 74.319999999999993 110.78 176.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 733' ' ' GLU . . . . . 0.483 ' O ' ' HG2' ' A' ' 736' ' ' ARG . 4.1 tp10 -65.8 -46.31 79.13 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 116.266 -0.425 . . . . 63.420000000000002 110.57 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 734' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -54.96 -48.2 73.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.994 -0.548 . . . . 73.049999999999997 110.677 177.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -65.92 -48.26 72.01 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.122 -0.49 . . . . 43.539999999999999 111.236 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 736' ' ' ARG . . . . . 0.483 ' HG2' ' O ' ' A' ' 733' ' ' GLU . 31.9 ptt180 -65.22 -33.03 75.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.14 0.495 . . . . 74.530000000000001 111.345 -175.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 38.0 t -78.12 -36.64 47.62 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.859 -0.61 . . . . 75.400000000000006 111.156 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 15.5 m170 -89.02 -29.21 19.64 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.43 -0.35 . . . . 73.219999999999999 111.846 -174.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 109.07 21.93 7.14 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.555 -0.831 . . . . 73.409999999999997 112.273 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -96.99 167.46 11.06 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.738 0.304 . . . . 64.439999999999998 110.405 175.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -109.91 114.11 27.38 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.461 -0.57 . . . . 72.010000000000005 109.461 175.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 742' ' ' ALA . . . . . . . . . . . . . . . -93.6 110.2 21.81 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.968 0.413 . . . . 61.420000000000002 110.433 -178.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 743' ' ' GLU . . . . . 0.543 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 44.7 mt-10 -120.82 117.09 26.52 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.942 -0.572 . . . . 75.310000000000002 111.281 -177.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 744' ' ' PHE . . . . . 0.424 ' CB ' ' HE3' ' A' ' 781' ' ' LYS . 96.2 m-85 -100.16 100.81 11.7 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.785 -0.643 . . . . 74.450000000000003 109.285 175.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 745' ' ' LYS . . . . . 0.44 ' HB3' ' HE2' ' A' ' 745' ' ' LYS . 16.9 ptpt -120.76 152.81 37.84 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.238 -0.585 . . . . 62.530000000000001 111.116 -177.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 746' ' ' LEU . . . . . 0.576 HD21 ' HB2' ' A' ' 749' ' ' GLN . 51.9 tp -80.14 128.12 33.13 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.426 -0.806 . . . . 75.409999999999997 110.089 -178.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 56.4 t -90.46 -47.56 14.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.109 0.48 . . . . 61.229999999999997 109.879 178.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -154.75 149.35 26.4 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.771 -0.65 . . . . 75.099999999999994 110.331 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 749' ' ' GLN . . . . . 0.576 ' HB2' HD21 ' A' ' 746' ' ' LEU . 24.5 tt0 -125.19 106.64 10.04 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.509 -0.552 . . . . 73.099999999999994 109.509 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 56.7 m -141.86 178.18 7.68 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.658 0.266 . . . . 53.100000000000001 110.285 -178.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 117.52 172.61 16.04 Favored Glycine 0 N--CA 1.443 -0.899 0 C-N-CA 120.331 -0.938 . . . . 65.439999999999998 112.822 177.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 752' ' ' PRO . . . . . 0.748 ' HG2' ' HB2' ' A' ' 755' ' ' GLU . 34.3 Cg_endo -64.8 166.4 18.26 Favored 'Trans proline' 0 CA--C 1.529 0.272 0 C-N-CA 123.473 2.782 . . . . 71.109999999999999 112.752 178.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -65.44 -31.74 51.09 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.592 2.194 . . . . 64.230000000000004 112.534 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 754' ' ' HIS . . . . . 0.554 ' CD2' ' HG3' ' A' ' 755' ' ' GLU . 54.0 p-80 -83.02 -23.41 33.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.522 -0.308 . . . . 63.140000000000001 110.938 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 755' ' ' GLU . . . . . 0.748 ' HB2' ' HG2' ' A' ' 752' ' ' PRO . 45.8 mt-10 -132.24 78.07 69.39 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.445 -0.343 . . . . 72.409999999999997 111.503 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 756' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -68.12 105.86 1.26 Allowed 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 121.936 1.757 . . . . 53.409999999999997 110.73 172.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 757' ' ' LYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 774' ' ' ALA . 57.8 mtmt -92.8 108.67 20.17 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.733 0.777 . . . . 72.140000000000001 110.973 -175.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 758' ' ' PHE . . . . . 0.447 ' O ' ' HA ' ' A' ' 773' ' ' CYS . 89.4 m-85 -87.63 116.69 25.94 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.722 -1.127 . . . . 72.349999999999994 110.478 -178.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 21.5 t -84.28 101.39 8.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.468 -0.567 . . . . 61.329999999999998 109.468 176.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 760' ' ' TYR . . . . . 0.413 ' CE2' ' HG2' ' A' ' 777' ' ' LYS . 3.2 m-85 -106.48 145.56 31.65 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.048 -0.524 . . . . 70.310000000000002 111.113 -178.38 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -132.54 135.12 45.75 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.871 -0.604 . . . . 73.209999999999994 109.663 177.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 762' ' ' ALA . . . . . . . . . . . . . . . -89.89 110.82 21.74 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.804 -0.635 . . . . 71.439999999999998 110.421 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 763' ' ' LYS . . . . . 0.543 ' HB3' ' HB2' ' A' ' 743' ' ' GLU . 50.5 tttt -94.64 107.02 19.03 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.494 -0.775 . . . . 71.299999999999997 109.607 177.223 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 47.5 t -112.88 100.48 10.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 120.977 0.418 . . . . 72.239999999999995 110.844 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 68.86 22.59 75.68 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.731 -0.668 . . . . 73.140000000000001 112.74 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 99.8 -2.64 57.1 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.712 -0.756 . . . . 64.010000000000005 112.103 -178.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 767' ' ' ARG . . . . . . . . . . . . . 18.3 ttm180 -100.91 122.3 43.23 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.292 -0.633 . . . . 64.510000000000005 109.292 178.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 768' ' ' TRP . . . . . . . . . . . . . 42.4 m95 -99.31 100.08 11.11 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.407 -0.36 . . . . 73.019999999999996 110.765 -172.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 769' ' ' PHE . . . . . 0.465 ' HA ' ' HA ' ' A' ' 770' ' ' PRO . 25.9 p90 -166.5 136.25 2.52 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.331 -0.395 . . . . 74.099999999999994 110.419 -178.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 770' ' ' PRO . . . . . 0.715 ' HG3' ' HB3' ' A' ' 787' ' ' ALA . 68.5 Cg_endo -94.66 -173.31 4.31 Favored 'Cis proline' 0 N--CA 1.451 -0.974 0 C-N-CA 123.412 -1.495 . . . . 73.299999999999997 111.424 -4.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -122.52 107.83 12.46 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.33 -0.248 . . . . 45.329999999999998 110.33 175.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 29.1 m -130.35 167.28 25.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.533 -0.303 . . . . 54.340000000000003 111.195 -176.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 773' ' ' CYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 758' ' ' PHE . 17.7 p -132.78 145.12 50.73 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.458 -0.337 . . . . 71.450000000000003 110.573 178.306 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 774' ' ' ALA . . . . . 0.463 ' O ' ' HA ' ' A' ' 757' ' ' LYS . . . -146.2 154.52 41.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.432 -0.349 . . . . 43.409999999999997 110.544 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 775' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -75.4 -2.62 29.41 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.068 0.461 . . . . 73.219999999999999 111.458 -176.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 776' ' ' SER . . . . . 0.629 ' HB2' ' HG3' ' A' ' 779' ' ' GLN . 36.3 m -131.19 140.2 49.86 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.206 -0.665 . . . . 70.319999999999993 109.206 175.205 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 777' ' ' LYS . . . . . 0.413 ' HG2' ' CE2' ' A' ' 760' ' ' TYR . 6.1 tmmm? -61.12 -45.75 93.39 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 123.431 0.457 . . . . 73.099999999999994 111.274 -174.202 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 778' ' ' LYS . . . . . 0.426 ' HE2' ' OE1' ' A' ' 782' ' ' GLN . 87.9 tttt -64.56 -39.28 93.46 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.981 -0.288 . . . . 73.310000000000002 110.644 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 779' ' ' GLN . . . . . 0.629 ' HG3' ' HB2' ' A' ' 776' ' ' SER . 23.6 mt-30 -60.35 -39.38 86.94 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.658 -0.246 . . . . 63.450000000000003 110.563 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -60.51 -43.53 98.72 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.88 -0.676 . . . . 50.009999999999998 111.694 177.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 781' ' ' LYS . . . . . 0.424 ' HE3' ' CB ' ' A' ' 744' ' ' PHE . 50.6 mtpt -68.13 -40.55 82.44 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.735 0.302 . . . . 73.129999999999995 110.729 178.154 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 782' ' ' GLN . . . . . 0.426 ' OE1' ' HE2' ' A' ' 778' ' ' LYS . 26.6 mt-30 -62.04 -51.66 67.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.047 -0.524 . . . . 73.120000000000005 111.047 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -65.27 -33.92 77.12 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 123.063 0.227 . . . . 74.510000000000005 110.909 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -59.62 -53.86 53.11 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.893 -0.41 . . . . 74.430000000000007 109.893 175.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 785' ' ' ALA . . . . . 0.613 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -65.38 -40.01 92.97 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.18 -0.463 . . . . 75.150000000000006 110.897 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 786' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -54.28 -56.08 21.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.903 -0.59 . . . . 72.430000000000007 110.83 178.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 787' ' ' ALA . . . . . 0.715 ' HB3' ' HG3' ' A' ' 770' ' ' PRO . . . -65.7 -38.32 88.91 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.838 -0.619 . . . . 62.140000000000001 110.768 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 788' ' ' ALA . . . . . 0.6 ' HB2' ' HD3' ' A' ' 770' ' ' PRO . . . -60.61 -45.8 92.65 Favored 'General case' 0 CA--C 1.521 -0.159 0 O-C-N 123.327 0.392 . . . . 74.420000000000002 111.23 -177.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 789' ' ' LEU . . . . . 0.613 ' HG ' ' O ' ' A' ' 785' ' ' ALA . 69.2 mt -58.86 -45.67 89.56 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 109.977 -0.379 . . . . 74.209999999999994 109.977 179.011 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 790' ' ' ARG . . . . . . . . . . . . . 78.6 mtt180 -65.07 -26.58 68.3 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.138 0.422 . . . . 61.310000000000002 112.138 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 791' ' ' VAL . . . . . 0.671 HG23 ' O ' ' A' ' 787' ' ' ALA . 60.1 t -66.5 -45.17 89.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 109.456 -0.572 . . . . 72.340000000000003 109.456 173.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 792' ' ' LEU . . . . . 0.59 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 18.2 mt -67.84 -44.82 76.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.221 -0.899 . . . . 65.319999999999993 110.188 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 793' ' ' ILE . . . . . 0.618 HD13 HG22 ' A' ' 720' ' ' VAL . 97.0 mt -58.38 -55.21 23.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.162 -0.926 . . . . 74.140000000000001 110.647 177.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 794' ' ' GLY . . . . . 0.418 ' O ' ' HG3' ' A' ' 798' ' ' LYS . . . -58.47 -40.51 94.45 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 121.14 -0.552 . . . . 62.219999999999999 112.244 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -55.98 -46.69 78.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.951 0.405 . . . . 72.129999999999995 110.218 178.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -73.94 -38.54 64.22 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.06 -0.518 . . . . 71.219999999999999 111.246 -175.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 797' ' ' GLU . . . . . 0.466 ' HG3' ' O ' ' A' ' 793' ' ' ILE . 29.6 mt-10 -72.17 -19.62 61.72 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.768 0.284 . . . . 61.399999999999999 111.768 -176.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 798' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' A' ' 794' ' ' GLY . 99.0 mttt -85.76 0.65 52.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.898 0.38 . . . . 65.049999999999997 111.162 178.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 799' ' ' ALA . . . . . . . . . . . . . . . -107.6 166.51 10.62 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.452 -0.34 . . . . 60.119999999999997 110.883 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 800' ' ' GLU . . . . . 0.448 ' H ' ' CD ' ' A' ' 800' ' ' GLU . 0.4 OUTLIER -92.64 20.96 5.85 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.416 0.627 . . . . 63.100000000000001 110.39 -177.669 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 801' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 . . . . . 0 C--O 1.248 1.015 0 CA-C-N 115.728 -0.669 . . . . 62.149999999999999 110.194 -176.059 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 708' ' ' MET . . . . . . . . . . . . . 22.9 mmt . . . . . 0 N--CA 1.481 1.097 0 CA-C-O 120.69 0.281 . . . . 70.129999999999995 111.66 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 67.9 mtm -132.43 86.67 44.76 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 109.77 -0.455 . . . . 35.439999999999998 109.77 176.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 710' ' ' PRO . . . . . 0.497 ' HB3' ' O ' ' A' ' 799' ' ' ALA . 38.7 Cg_endo -68.02 153.45 75.08 Favored 'Trans proline' 0 C--O 1.237 0.432 0 C-N-CA 122.524 2.149 . . . . 51.240000000000002 112.347 -177.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 711' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -58.58 -44.34 89.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.805 -0.634 . . . . 72.409999999999997 110.425 178.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 712' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -100.15 136.3 40.26 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.377 -0.601 . . . . 44.130000000000003 109.377 171.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 713' ' ' VAL . . . . . . . . . . . . . 18.5 m -75.19 165.69 3.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.148 0.499 . . . . 71.319999999999993 111.21 -175.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.457 ' HB2' HG12 ' A' ' 716' ' ' ILE . 1.4 ptp180 -111.37 126.67 55.16 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.998 -0.546 . . . . 75.409999999999997 110.352 175.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 17.1 tptm -110.58 25.24 11.99 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.122 -1.066 . . . . 63.420000000000002 108.122 175.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 716' ' ' ILE . . . . . 0.649 HG23 HG12 ' A' ' 793' ' ' ILE . 48.4 mm -61.81 -27.6 42.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 114.046 -1.434 . . . . 75.420000000000002 112.316 -172.203 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -56.3 -31.41 59.49 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.009 -0.615 . . . . 74.329999999999998 112.12 178.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -72.01 -41.62 67.38 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.355 -0.239 . . . . 74.430000000000007 110.355 178.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 719' ' ' LEU . . . . . 0.641 HD23 ' HA ' ' A' ' 716' ' ' ILE . 3.0 mm? -62.79 -36.11 82.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.479 -0.328 . . . . 63.43 110.727 -179.186 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 720' ' ' VAL . . . . . 0.519 HG22 HD13 ' A' ' 793' ' ' ILE . 48.0 t -66.65 -39.03 82.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.118 0.485 . . . . 74.129999999999995 109.963 175.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 721' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.08 -35.03 74.28 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.871 -0.604 . . . . 64.400000000000006 110.172 177.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -74.32 -29.0 61.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.05 -0.523 . . . . 74.150000000000006 111.4 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 723' ' ' LEU . . . . . 0.577 HD21 ' HB2' ' A' ' 789' ' ' LEU . 51.0 mt -59.02 -39.35 81.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.856 0.36 . . . . 75.409999999999997 110.726 177.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -86.51 -17.37 34.29 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.108 -0.496 . . . . 72.400000000000006 111.341 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 16.3 m -108.37 -83.3 0.55 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.637 0.256 . . . . 60.229999999999997 111.421 -176.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 726' ' ' ASN . . . . . 0.413 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 30.0 t30 -138.97 104.01 7.41 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.801 0.334 . . . . 70.439999999999998 110.373 -177.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 727' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 25.4 Cg_endo -62.75 -41.4 30.89 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.758 2.305 . . . . 62.439999999999998 112.552 -177.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 48.3 t -61.71 -46.07 97.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.275 -0.421 . . . . 72.150000000000006 110.659 -176.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -64.65 -32.64 84.87 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.868 -0.682 . . . . 74.099999999999994 112.0 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -72.45 -42.66 47.95 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 121.134 -0.555 . . . . 65.519999999999996 112.827 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -63.24 -41.06 99.03 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.623 -0.51 . . . . 71.420000000000002 109.623 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 732' ' ' LEU . . . . . 0.504 HD23 ' HB3' ' A' ' 742' ' ' ALA . 96.2 mt -64.83 -42.66 94.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.94 -0.573 . . . . 65.120000000000005 110.649 176.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 733' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -64.69 -42.64 95.17 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 116.201 -0.454 . . . . 64.430000000000007 110.802 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 734' ' ' TYR . . . . . 0.549 ' HB2' HD11 ' A' ' 719' ' ' LEU . 14.4 t80 -54.43 -53.18 57.59 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.349 -0.387 . . . . 74.430000000000007 110.621 176.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -62.73 -48.45 79.16 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.093 -0.503 . . . . 72.329999999999998 110.395 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 736' ' ' ARG . . . . . . . . . . . . . 62.3 ttt180 -54.96 -50.87 67.84 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.544 -0.753 . . . . 75.129999999999995 111.939 -178.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 18.1 t -73.95 -24.58 59.66 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.424 -0.353 . . . . 74.239999999999995 111.404 -175.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -94.7 -19.78 20.11 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.821 -0.352 . . . . 52.310000000000002 111.935 -175.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 104.39 14.0 25.07 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.17 -1.014 . . . . 35.25 112.837 177.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -101.81 166.29 10.74 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.816 -0.439 . . . . 64.230000000000004 109.816 175.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -110.14 126.43 54.06 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.708 -0.479 . . . . 64.310000000000002 109.708 173.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 742' ' ' ALA . . . . . 0.504 ' HB3' HD23 ' A' ' 732' ' ' LEU . . . -99.03 108.59 21.3 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.059 0.457 . . . . 72.239999999999995 110.361 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 743' ' ' GLU . . . . . 0.543 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 40.8 mt-10 -113.93 116.75 29.75 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.796 -0.638 . . . . 72.150000000000006 111.466 -176.302 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -93.28 121.62 34.84 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.679 -0.691 . . . . 74.209999999999994 109.401 176.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -132.38 147.94 52.4 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.282 0.563 . . . . 64.409999999999997 111.663 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 746' ' ' LEU . . . . . 0.53 HD21 ' HB2' ' A' ' 749' ' ' GLN . 6.8 tt -86.87 108.09 18.61 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.143 -0.935 . . . . 62.25 108.992 177.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 49.0 t -82.56 -53.99 10.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.136 -0.484 . . . . 64.310000000000002 110.771 -176.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 748' ' ' ASP . . . . . 0.499 ' HB3' ' CG2' ' A' ' 759' ' ' VAL . 25.7 t70 -129.8 149.76 51.4 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.283 -0.417 . . . . 75.420000000000002 111.19 -176.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 749' ' ' GLN . . . . . 0.53 ' HB2' HD21 ' A' ' 746' ' ' LEU . 50.9 tt0 -145.84 100.07 3.36 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.514 -0.767 . . . . 64.530000000000001 108.971 177.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 10.0 t -144.98 -173.71 4.16 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.484 -0.326 . . . . 72.120000000000005 110.476 -174.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 100.77 -173.74 24.94 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.924 -0.655 . . . . 54.420000000000002 112.473 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 752' ' ' PRO . . . . . 0.711 ' HG2' ' HB2' ' A' ' 755' ' ' GLU . 52.8 Cg_endo -69.11 164.35 34.24 Favored 'Trans proline' 0 N--CA 1.465 -0.154 0 C-N-CA 122.908 2.406 . . . . 74.239999999999995 111.993 178.222 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -69.81 -34.68 13.93 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 122.469 2.112 . . . . 75.0 112.065 -177.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 754' ' ' HIS . . . . . 0.425 ' CE1' ' HB2' ' A' ' 752' ' ' PRO . 35.2 p-80 -76.09 -26.81 56.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.174 -0.466 . . . . 73.430000000000007 110.936 179.281 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 755' ' ' GLU . . . . . 0.711 ' HB2' ' HG2' ' A' ' 752' ' ' PRO . 28.5 mm-40 -126.53 72.76 73.72 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.566 -0.288 . . . . 61.409999999999997 110.885 178.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 756' ' ' PRO . . . . . 0.515 ' O ' ' HA ' ' A' ' 775' ' ' HIS . 40.0 Cg_endo -68.82 113.66 3.29 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.222 1.948 . . . . 73.519999999999996 111.453 177.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 757' ' ' LYS . . . . . 0.408 ' HE3' ' HB3' ' A' ' 757' ' ' LYS . 1.5 tmmt? -89.51 112.4 23.56 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.322 0.582 . . . . 72.25 110.538 -176.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 758' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 773' ' ' CYS . 79.0 m-85 -99.59 123.34 43.76 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.204 -0.907 . . . . 72.140000000000001 110.115 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 759' ' ' VAL . . . . . 0.499 ' CG2' ' HB3' ' A' ' 748' ' ' ASP . 48.6 t -98.4 106.6 18.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.564 -0.532 . . . . 71.439999999999998 109.564 175.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -105.61 141.05 37.74 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.005 -0.543 . . . . 74.319999999999993 110.691 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 761' ' ' GLN . . . . . 0.485 ' NE2' ' HB3' ' A' ' 768' ' ' TRP . 28.2 tt0 -133.46 134.61 43.75 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.865 -0.607 . . . . 64.099999999999994 109.503 177.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 762' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 769' ' ' PHE . . . -92.9 117.08 29.65 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.25 0.548 . . . . 63.439999999999998 110.706 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 763' ' ' LYS . . . . . 0.601 ' HD2' ' CH2' ' A' ' 768' ' ' TRP . 54.7 tttm -93.77 103.53 15.66 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.681 -0.69 . . . . 73.150000000000006 109.893 177.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 61.7 t -109.01 101.58 12.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.136 0.493 . . . . 53.299999999999997 109.739 178.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 69.17 -115.69 6.63 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 110.955 -0.858 . . . . 71.010000000000005 110.955 -173.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -110.62 13.99 29.91 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.003 -0.618 . . . . 74.219999999999999 111.684 176.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 767' ' ' ARG . . . . . 0.602 ' HD2' ' CD1' ' A' ' 769' ' ' PHE . 0.6 OUTLIER -110.43 120.45 42.46 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.507 -0.553 . . . . 71.540000000000006 109.507 -179.766 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 768' ' ' TRP . . . . . 0.601 ' CH2' ' HD2' ' A' ' 763' ' ' LYS . 69.4 m95 -94.88 108.15 20.18 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.645 -0.502 . . . . 74.099999999999994 109.645 178.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 769' ' ' PHE . . . . . 0.602 ' CD1' ' HD2' ' A' ' 767' ' ' ARG . 9.8 p90 -168.86 139.9 2.01 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-O 120.838 0.351 . . . . 74.219999999999999 110.915 -178.317 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 770' ' ' PRO . . . . . 0.799 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 96.1 Cg_endo -98.4 -170.69 1.95 Allowed 'Cis proline' 0 N--CA 1.449 -1.121 0 C-N-CA 123.71 -1.371 . . . . 63.140000000000001 111.677 -3.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -114.81 104.29 11.8 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.518 -0.549 . . . . 62.439999999999998 109.518 174.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 33.5 m -118.94 161.97 17.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.303 -0.408 . . . . 73.239999999999995 110.846 -176.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 773' ' ' CYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 758' ' ' PHE . 8.8 p -137.0 141.91 42.53 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.249 -0.432 . . . . 60.240000000000002 110.425 177.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -149.53 161.15 42.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.054 -0.521 . . . . 71.430000000000007 109.829 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 775' ' ' HIS . . . . . 0.515 ' HA ' ' O ' ' A' ' 756' ' ' PRO . 0.8 OUTLIER -87.14 -0.75 57.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.251 0.548 . . . . 73.120000000000005 110.889 179.501 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 51.1 m -134.04 135.16 43.16 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.634 -0.712 . . . . 71.010000000000005 109.292 175.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 777' ' ' LYS . . . . . . . . . . . . . 25.4 ttmt -57.24 -48.82 77.89 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.103 -0.499 . . . . 71.239999999999995 111.448 -175.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -57.95 -38.59 76.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.848 -0.614 . . . . 64.140000000000001 110.822 -177.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 779' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -68.25 -37.88 81.24 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-N 116.36 -0.382 . . . . 72.319999999999993 110.146 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -60.5 -47.17 92.48 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.827 -0.701 . . . . 43.340000000000003 111.881 178.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -62.55 -44.79 95.47 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.746 0.308 . . . . 72.530000000000001 110.649 177.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -62.37 -50.43 71.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.056 -0.52 . . . . 64.549999999999997 111.206 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -60.09 -36.57 77.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.298 -0.41 . . . . 53.109999999999999 111.445 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -60.05 -55.08 38.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.871 0.367 . . . . 74.510000000000005 110.373 177.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 785' ' ' ALA . . . . . 0.652 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -63.09 -41.81 99.47 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.134 -0.485 . . . . 53.119999999999997 110.897 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 786' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -56.83 -54.88 41.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.546 -0.752 . . . . 73.319999999999993 110.934 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 787' ' ' ALA . . . . . 0.468 ' O ' HG23 ' A' ' 791' ' ' VAL . . . -65.29 -35.09 79.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.832 -0.622 . . . . 75.450000000000003 111.254 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 788' ' ' ALA . . . . . 0.799 ' HB2' ' HD3' ' A' ' 770' ' ' PRO . . . -64.64 -35.64 81.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.313 -0.403 . . . . 63.549999999999997 111.391 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 789' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' A' ' 785' ' ' ALA . 59.1 mt -64.66 -42.04 95.69 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 121.048 -0.261 . . . . 65.340000000000003 110.445 -179.231 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 790' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.67 -31.71 72.65 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 120.734 -0.386 . . . . 75.310000000000002 111.207 177.281 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 791' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 787' ' ' ALA . 57.2 t -61.67 -51.89 67.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.104 0.478 . . . . 71.510000000000005 109.773 175.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 792' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 32.9 mt -61.84 -47.53 84.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.349 -0.842 . . . . 71.540000000000006 110.83 -178.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 793' ' ' ILE . . . . . 0.649 HG12 HG23 ' A' ' 716' ' ' ILE . 95.9 mt -58.8 -56.26 17.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.521 -0.763 . . . . 72.299999999999997 111.24 179.156 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 794' ' ' GLY . . . . . 0.427 ' O ' ' HB2' ' A' ' 797' ' ' GLU . . . -60.79 -37.69 94.05 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 121.079 -0.582 . . . . 62.049999999999997 112.321 -178.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -63.25 -44.0 96.41 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.905 0.383 . . . . 73.400000000000006 110.734 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -73.86 -20.64 60.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.909 0.385 . . . . 70.5 110.822 -177.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 797' ' ' GLU . . . . . 0.427 ' HB2' ' O ' ' A' ' 794' ' ' GLY . 15.7 mm-40 -59.01 -21.51 59.16 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.103 0.478 . . . . 75.310000000000002 110.639 175.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 798' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -91.39 -8.97 46.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.926 -0.579 . . . . 72.099999999999994 111.309 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 799' ' ' ALA . . . . . 0.497 ' O ' ' HB3' ' A' ' 710' ' ' PRO . . . -94.5 -0.54 54.59 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.883 0.697 . . . . 54.439999999999998 112.883 -170.036 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 800' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -79.43 88.04 5.04 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.693 0.758 . . . . 72.239999999999995 111.237 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 801' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.064 -0.97 . . . . 73.129999999999995 110.219 179.211 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 708' ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 N--CA 1.482 1.155 0 N-CA-C 109.831 -0.433 . . . . 72.439999999999998 109.831 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.92 145.72 49.34 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 109.335 -0.617 . . . . 64.329999999999998 109.335 174.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -59.88 133.38 50.41 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.578 2.186 . . . . 72.409999999999997 111.631 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 711' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -73.47 177.8 5.05 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.076 0.465 . . . . 73.400000000000006 110.829 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 712' ' ' LYS . . . . . 0.478 ' HB3' ' OG ' ' A' ' 737' ' ' SER . 21.0 tptm -95.38 112.66 24.33 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.047 -0.524 . . . . 74.540000000000006 109.957 177.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 713' ' ' VAL . . . . . . . . . . . . . 34.5 m -67.4 158.11 5.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.913 -0.585 . . . . 74.25 110.659 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 714' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -80.3 78.7 6.96 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.453 0.644 . . . . 74.329999999999998 110.744 176.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 715' ' ' LYS . . . . . 0.421 ' HE3' ' HB2' ' A' ' 715' ' ' LYS . 30.3 ttmt -87.68 104.45 16.55 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.35 -0.841 . . . . 75.219999999999999 109.249 175.366 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 716' ' ' ILE . . . . . 0.592 ' HA ' HD23 ' A' ' 719' ' ' LEU . 46.8 mm -67.85 -27.89 39.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.449 -0.796 . . . . 42.439999999999998 111.489 -170.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -59.95 -24.87 61.04 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.97 -0.633 . . . . 64.150000000000006 112.112 176.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 718' ' ' GLU . . . . . 0.669 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 47.1 mt-10 -76.85 -38.73 53.18 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 122.787 -0.243 . . . . 75.120000000000005 110.658 177.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 719' ' ' LEU . . . . . 0.592 HD12 HD22 ' A' ' 789' ' ' LEU . 3.1 mm? -61.38 -32.98 72.92 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.155 0.502 . . . . 72.430000000000007 109.769 176.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 720' ' ' VAL . . . . . 0.54 HG22 HD13 ' A' ' 793' ' ' ILE . 58.1 t -68.4 -38.49 79.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.809 -0.632 . . . . 72.510000000000005 110.757 175.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 721' ' ' ARG . . . . . 0.669 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 4.4 ptm180 -64.74 -28.2 69.43 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 109.841 -0.429 . . . . 72.329999999999998 109.841 179.193 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -73.12 -31.9 64.61 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 116.312 -0.404 . . . . 61.439999999999998 110.782 177.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 723' ' ' LEU . . . . . 0.565 HD21 ' HB2' ' A' ' 789' ' ' LEU . 98.1 mt -62.24 -28.67 69.87 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.407 0.622 . . . . 72.329999999999998 110.033 174.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -90.81 -15.07 30.7 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.492 -0.776 . . . . 71.319999999999993 111.234 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 11.1 m -118.69 -73.48 0.64 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.856 0.36 . . . . 75.150000000000006 111.666 -175.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 726' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -149.13 101.58 3.37 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.174 -0.467 . . . . 34.119999999999997 110.112 -177.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 727' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -61.87 -40.33 45.16 Favored 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 122.906 2.404 . . . . 63.350000000000001 112.115 -178.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 57.5 t -62.21 -45.32 99.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.096 -0.502 . . . . 63.130000000000003 110.809 -178.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -65.49 -35.15 90.93 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.664 -0.779 . . . . 72.239999999999995 111.669 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -70.17 -41.58 69.29 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 121.073 -0.584 . . . . 74.230000000000004 112.573 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -65.48 -43.3 90.66 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.989 -0.374 . . . . 72.010000000000005 109.989 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 732' ' ' LEU . . . . . . . . . . . . . 96.8 mt -66.17 -38.07 87.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.244 -0.435 . . . . 63.329999999999998 110.745 178.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 733' ' ' GLU . . . . . 0.471 ' O ' ' HG2' ' A' ' 736' ' ' ARG . 1.8 tp10 -66.14 -43.99 85.44 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 116.325 -0.398 . . . . 73.010000000000005 110.355 177.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 734' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -53.47 -48.66 68.67 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.141 -0.481 . . . . 71.439999999999998 110.658 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 735' ' ' ALA . . . . . 0.41 ' HB2' ' HB2' ' A' ' 742' ' ' ALA . . . -65.62 -50.22 65.83 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.232 -0.44 . . . . 70.349999999999994 110.927 -177.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 736' ' ' ARG . . . . . 0.471 ' HG2' ' O ' ' A' ' 733' ' ' GLU . 33.8 ptt180 -64.35 -31.48 72.7 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.11 0.481 . . . . 62.350000000000001 110.914 -175.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 737' ' ' SER . . . . . 0.478 ' OG ' ' HB3' ' A' ' 712' ' ' LYS . 28.8 t -78.07 -29.12 49.02 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.599 -0.728 . . . . 63.210000000000001 111.451 178.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -101.13 -3.09 29.84 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 111.885 0.328 . . . . 74.430000000000007 111.885 -173.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 90.98 12.88 59.79 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.407 -0.901 . . . . 72.340000000000003 112.675 177.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -95.98 169.36 10.03 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.791 0.329 . . . . 73.439999999999998 110.165 175.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -121.68 105.81 10.76 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.284 -0.636 . . . . 72.140000000000001 109.284 175.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 742' ' ' ALA . . . . . 0.419 ' HA ' ' HA ' ' A' ' 764' ' ' VAL . . . -90.4 122.55 33.37 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.311 -0.404 . . . . 73.540000000000006 111.454 -174.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 743' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -127.79 166.13 18.78 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.782 -0.644 . . . . 75.430000000000007 110.698 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -134.25 108.8 8.45 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.961 -0.563 . . . . 73.439999999999998 109.996 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -110.84 148.55 32.16 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.007 0.432 . . . . 74.209999999999994 111.155 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 746' ' ' LEU . . . . . 0.432 HD11 ' CD1' ' A' ' 758' ' ' PHE . 6.1 tt -87.58 106.82 18.27 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.384 -0.969 . . . . 64.230000000000004 108.384 174.333 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 54.0 t -83.16 -53.06 12.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.982 -0.554 . . . . 71.319999999999993 110.938 -174.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -128.39 146.01 50.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.083 -0.508 . . . . 63.210000000000001 110.798 -176.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -132.7 93.59 3.25 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.284 0.564 . . . . 73.439999999999998 110.026 176.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 20.6 m -104.64 82.36 1.89 Allowed 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.242 -1.021 . . . . 52.130000000000003 108.242 173.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 751' ' ' GLY . . . . . 0.612 ' CA ' ' HA ' ' A' ' 756' ' ' PRO . . . -127.39 94.74 0.41 Allowed Glycine 0 N--CA 1.439 -1.101 0 C-N-CA 119.92 -1.133 . . . . 75.0 114.278 -170.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 752' ' ' PRO . . . . . 0.402 ' HD2' ' HA2' ' A' ' 751' ' ' GLY . 18.1 Cg_endo -60.95 165.61 11.85 Favored 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 122.474 2.116 . . . . 42.109999999999999 110.225 164.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -58.54 -36.51 97.26 Favored 'Trans proline' 0 CA--C 1.528 0.191 0 C-N-CA 122.109 1.873 . . . . 73.420000000000002 112.495 -177.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 49.9 p-80 -82.28 -25.01 34.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.364 -0.38 . . . . 61.240000000000002 111.644 -177.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -141.06 74.31 25.48 Favored Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 112.043 0.386 . . . . 53.530000000000001 112.043 -176.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 756' ' ' PRO . . . . . 0.612 ' HA ' ' CA ' ' A' ' 751' ' ' GLY . 52.3 Cg_endo -72.23 84.84 1.09 Allowed 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.0 1.8 . . . . 44.039999999999999 111.632 175.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 757' ' ' LYS . . . . . 0.531 ' HA ' ' HA ' ' A' ' 775' ' ' HIS . 27.4 ttpp -91.58 113.69 26.03 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.545 0.688 . . . . 71.040000000000006 111.247 -174.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 758' ' ' PHE . . . . . 0.463 ' O ' ' HA ' ' A' ' 773' ' ' CYS . 60.9 m-85 -99.44 144.77 28.16 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.286 -0.87 . . . . 70.010000000000005 110.171 -178.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 759' ' ' VAL . . . . . 0.468 HG22 ' HB3' ' A' ' 773' ' ' CYS . 47.7 t -109.57 112.13 39.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.996 -0.372 . . . . 64.129999999999995 109.996 176.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -107.27 138.14 44.0 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.263 -0.426 . . . . 71.329999999999998 110.517 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 761' ' ' GLN . . . . . 0.441 ' HA ' ' O ' ' A' ' 770' ' ' PRO . 62.2 tt0 -125.5 135.48 52.34 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.916 -0.583 . . . . 75.430000000000007 109.432 177.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 762' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' A' ' 769' ' ' PHE . . . -91.52 119.5 31.52 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.252 0.549 . . . . 74.019999999999996 110.586 -178.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -98.16 97.28 8.73 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.713 -0.676 . . . . 72.430000000000007 109.339 177.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 764' ' ' VAL . . . . . 0.419 ' HA ' ' HA ' ' A' ' 742' ' ' ALA . 57.7 t -99.9 98.3 6.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.125 0.488 . . . . 72.239999999999995 109.854 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 68.54 -108.03 2.31 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 110.743 -0.943 . . . . 33.340000000000003 110.743 -175.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -114.72 9.4 21.63 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.626 -0.797 . . . . 71.409999999999997 111.821 176.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 767' ' ' ARG . . . . . 0.576 ' HD2' ' CD1' ' A' ' 769' ' ' PHE . 0.2 OUTLIER -107.65 120.69 42.92 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.93 -0.396 . . . . 72.120000000000005 109.93 -178.615 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 768' ' ' TRP . . . . . . . . . . . . . 58.6 m95 -94.3 110.91 22.63 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.158 -0.474 . . . . 75.420000000000002 109.857 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 769' ' ' PHE . . . . . 0.576 ' CD1' ' HD2' ' A' ' 767' ' ' ARG . 15.7 p90 -174.76 138.32 0.62 Allowed Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 120.692 0.282 . . . . 64.239999999999995 110.65 -179.027 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 770' ' ' PRO . . . . . 0.786 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 69.7 Cg_endo -99.15 -170.25 1.6 Allowed 'Cis proline' 0 N--CA 1.449 -1.14 0 C-N-CA 123.675 -1.386 . . . . 71.010000000000005 111.164 -6.115 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -121.14 105.52 10.68 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.797 -0.445 . . . . 74.120000000000005 109.797 174.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 35.3 m -121.32 160.29 22.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.487 -0.324 . . . . 61.25 111.006 -176.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 773' ' ' CYS . . . . . 0.468 ' HB3' HG22 ' A' ' 759' ' ' VAL . 20.2 p -126.01 145.81 50.15 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.073 -0.512 . . . . 74.450000000000003 110.565 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -158.14 146.86 19.06 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.22 -0.445 . . . . 75.519999999999996 110.226 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 775' ' ' HIS . . . . . 0.538 ' HA ' ' O ' ' A' ' 756' ' ' PRO . 1.4 p-80 -78.95 17.4 0.74 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.147 0.499 . . . . 70.420000000000002 111.538 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 42.4 t -142.84 130.62 21.51 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.994 -0.743 . . . . 71.109999999999999 108.994 175.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 777' ' ' LYS . . . . . 0.436 ' HD2' ' C ' ' A' ' 777' ' ' LYS . 5.3 tmmm? -58.34 -42.68 87.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.864 0.364 . . . . 74.239999999999995 110.125 -178.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -58.12 -46.99 84.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.62 -0.718 . . . . 64.329999999999998 110.542 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 779' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -62.52 -41.82 99.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.914 -0.584 . . . . 63.420000000000002 110.717 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -56.35 -43.83 89.77 Favored Glycine 0 C--N 1.329 0.187 0 C-N-CA 121.161 -0.543 . . . . 63.340000000000003 112.398 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -71.93 -43.79 64.71 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.699 0.285 . . . . 73.430000000000007 111.046 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -66.42 -45.63 79.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.222 -0.445 . . . . 75.120000000000005 111.505 -176.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -66.67 -33.87 76.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.709 0.29 . . . . 72.340000000000003 110.686 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -60.56 -52.04 66.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.347 -0.388 . . . . 65.519999999999996 110.177 177.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 785' ' ' ALA . . . . . 0.586 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -65.4 -38.59 90.45 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.167 -0.469 . . . . 73.230000000000004 110.744 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 786' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -59.9 -51.07 71.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.919 -0.582 . . . . 75.310000000000002 110.852 178.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 787' ' ' ALA . . . . . 0.571 ' HA ' ' HD2' ' A' ' 790' ' ' ARG . . . -67.85 -35.8 79.2 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.071 -0.513 . . . . 43.43 111.039 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 788' ' ' ALA . . . . . 0.786 ' HB2' ' HD3' ' A' ' 770' ' ' PRO . . . -60.96 -41.05 95.59 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.361 -0.382 . . . . 32.409999999999997 111.032 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 789' ' ' LEU . . . . . 0.592 HD22 HD12 ' A' ' 719' ' ' LEU . 75.9 mt -64.23 -40.36 95.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.406 -0.361 . . . . 72.109999999999999 110.21 178.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 790' ' ' ARG . . . . . 0.571 ' HD2' ' HA ' ' A' ' 787' ' ' ALA . 84.9 mtt180 -60.01 -35.06 74.25 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.501 -0.318 . . . . 61.5 111.209 177.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 791' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 787' ' ' ALA . 62.1 t -61.5 -50.53 79.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.249 0.547 . . . . 65.420000000000002 109.898 175.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 792' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 23.7 mt -61.98 -47.88 82.84 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.395 -0.82 . . . . 64.239999999999995 110.743 -179.1 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 793' ' ' ILE . . . . . 0.54 HD13 HG22 ' A' ' 720' ' ' VAL . 95.8 mt -59.85 -45.36 94.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.481 -0.781 . . . . 75.230000000000004 110.904 178.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -68.32 -33.8 78.57 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.833 -0.699 . . . . 52.450000000000003 112.703 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -70.66 -41.09 72.54 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.902 0.382 . . . . 74.109999999999999 110.642 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -79.1 -18.98 52.35 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.786 -0.366 . . . . 54.119999999999997 110.188 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 797' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -57.88 -40.39 80.12 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.595 -0.52 . . . . 75.239999999999995 109.595 176.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 798' ' ' LYS . . . . . . . . . . . . . 11.5 ptmm? -92.96 16.84 11.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.815 -0.629 . . . . 73.319999999999993 110.855 178.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 799' ' ' ALA . . . . . . . . . . . . . . . -118.07 149.13 41.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.202 -0.454 . . . . 65.450000000000003 110.079 177.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 800' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -84.54 111.62 19.68 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.622 0.725 . . . . 74.319999999999993 110.419 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 801' ' ' ARG . . . . . 0.432 ' HD3' ' H ' ' A' ' 801' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.542 -0.742 . . . . 75.439999999999998 110.016 -178.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 708' ' ' MET . . . . . . . . . . . . . 64.9 mtt . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 120.72 0.295 . . . . 72.049999999999997 110.243 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -92.15 150.7 40.8 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 109.322 -0.622 . . . . 73.219999999999999 109.322 178.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.24 111.63 0.98 Allowed 'Trans proline' 0 C--O 1.236 0.382 0 C-N-CA 122.421 2.081 . . . . 53.240000000000002 111.869 178.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 711' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -59.1 126.68 28.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 71.010000000000005 110.451 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 712' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -74.94 142.44 43.97 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.886 -0.597 . . . . 71.409999999999997 111.419 -175.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 713' ' ' VAL . . . . . . . . . . . . . 10.3 p -64.58 146.36 13.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.766 -0.652 . . . . 62.32 109.413 172.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.769 ' HA ' ' HG3' ' A' ' 718' ' ' GLU . 32.4 mmt180 -70.35 101.16 1.87 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.067 0.461 . . . . 73.219999999999999 110.665 -179.02 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 715' ' ' LYS . . . . . 0.434 ' O ' ' HB2' ' A' ' 718' ' ' GLU . 74.3 mmtt -82.85 -176.18 6.18 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.875 -0.602 . . . . 74.239999999999995 110.094 175.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 716' ' ' ILE . . . . . 0.526 ' HA ' HD23 ' A' ' 719' ' ' LEU . 42.1 mm -65.48 -36.99 78.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.852 0.358 . . . . 73.310000000000002 110.85 -177.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -60.63 -26.1 64.28 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 121.008 -0.615 . . . . 73.329999999999998 112.014 175.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 718' ' ' GLU . . . . . 0.8 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 9.0 mm-40 -68.75 -34.39 75.51 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-O 120.543 0.211 . . . . 64.430000000000007 110.551 178.101 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 719' ' ' LEU . . . . . 0.556 HD12 HD22 ' A' ' 789' ' ' LEU . 2.7 mm? -69.04 -29.25 67.37 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.522 -0.471 . . . . 73.010000000000005 109.917 177.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 720' ' ' VAL . . . . . 0.488 HG22 HD13 ' A' ' 793' ' ' ILE . 60.3 t -67.52 -40.96 85.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.844 -0.616 . . . . 74.430000000000007 110.804 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 721' ' ' ARG . . . . . 0.8 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 12.9 ptm180 -64.86 -29.92 70.9 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.4 -0.364 . . . . 65.010000000000005 110.249 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -71.83 -35.48 69.9 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-N 116.341 -0.39 . . . . 73.420000000000002 110.69 177.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 723' ' ' LEU . . . . . 0.586 HD21 ' HB2' ' A' ' 789' ' ' LEU . 82.0 mt -56.3 -30.68 62.84 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.138 0.494 . . . . 73.340000000000003 110.407 175.414 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -83.86 -55.37 4.28 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.835 -0.62 . . . . 73.200000000000003 110.935 176.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 27.2 m -75.44 -73.06 0.27 Allowed 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.119 0.414 . . . . 64.450000000000003 112.119 -176.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 726' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -148.49 100.31 3.56 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 120.804 0.335 . . . . 64.219999999999999 110.633 -175.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 727' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -61.7 -39.97 49.39 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.021 2.481 . . . . 55.439999999999998 112.667 -176.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 30.1 t -59.24 -47.88 88.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.008 -0.542 . . . . 72.010000000000005 110.787 -176.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -65.66 -31.35 79.7 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.86 -0.609 . . . . 54.119999999999997 111.812 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -68.24 -41.73 85.33 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.903 -0.665 . . . . 64.439999999999998 112.269 178.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -65.04 -41.29 95.35 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.526 -0.546 . . . . 73.120000000000005 109.526 178.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 732' ' ' LEU . . . . . . . . . . . . . 83.8 mt -68.79 -31.55 70.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.88 -0.6 . . . . 74.25 110.99 178.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 733' ' ' GLU . . . . . 0.501 ' O ' ' HG2' ' A' ' 736' ' ' ARG . 0.7 OUTLIER -73.28 -43.54 60.83 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 116.165 -0.471 . . . . 71.129999999999995 110.392 178.901 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 734' ' ' TYR . . . . . 0.466 ' HB2' HD11 ' A' ' 719' ' ' LEU . 7.6 t80 -55.45 -46.41 76.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.978 -0.556 . . . . 74.450000000000003 110.615 176.387 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -64.78 -48.12 75.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.923 -0.581 . . . . 73.319999999999993 111.095 -178.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 736' ' ' ARG . . . . . 0.501 ' HG2' ' O ' ' A' ' 733' ' ' GLU . 11.3 ptt180 -64.54 -35.74 81.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.009 0.433 . . . . 64.219999999999999 111.078 -175.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 48.4 t -74.2 -35.06 63.9 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.013 -0.539 . . . . 75.310000000000002 111.036 -178.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -89.0 -32.02 17.82 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.286 -0.415 . . . . 74.129999999999995 111.803 -174.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 112.45 22.07 5.94 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.47 -0.872 . . . . 61.32 112.013 -178.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -99.51 169.99 8.92 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.869 0.366 . . . . 65.120000000000005 110.543 176.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -117.25 111.49 19.48 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.457 -0.572 . . . . 71.450000000000003 109.457 174.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 742' ' ' ALA . . . . . . . . . . . . . . . -94.58 130.26 41.09 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.909 0.385 . . . . 73.239999999999995 111.464 -175.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 743' ' ' GLU . . . . . 0.572 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 49.5 mt-10 -132.98 140.52 47.82 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.959 -0.564 . . . . 74.310000000000002 110.738 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -114.94 100.28 8.08 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.195 -0.668 . . . . 65.549999999999997 109.195 174.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 745' ' ' LYS . . . . . 0.471 ' HE2' ' HB3' ' A' ' 745' ' ' LYS . 14.4 ptpt -121.45 144.11 48.87 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.495 0.664 . . . . 63.340000000000003 111.909 -175.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 746' ' ' LEU . . . . . . . . . . . . . 6.6 tt -78.91 112.59 16.25 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.824 -1.08 . . . . 71.109999999999999 109.509 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 61.3 t -80.18 -50.01 18.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.985 0.422 . . . . 60.399999999999999 110.634 -178.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -155.56 148.93 24.88 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.929 -0.578 . . . . 62.549999999999997 110.252 -178.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 749' ' ' GLN . . . . . 0.42 ' O ' ' HG3' ' A' ' 749' ' ' GLN . 10.5 pt20 -133.69 108.59 8.62 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.194 0.521 . . . . 72.310000000000002 110.281 172.292 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 18.6 m -131.47 78.63 1.84 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.905 -0.588 . . . . 64.219999999999999 110.236 178.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . -139.24 150.31 21.21 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.658 -0.782 . . . . 74.230000000000004 112.138 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 752' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -62.67 160.55 32.04 Favored 'Trans proline' 0 CA--C 1.528 0.197 0 C-N-CA 123.019 2.479 . . . . 71.409999999999997 111.976 178.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -57.45 -34.63 98.29 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.797 2.332 . . . . 72.519999999999996 112.897 -178.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 47.9 p-80 -83.89 -15.91 46.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.268 -0.424 . . . . 54.200000000000003 111.357 -177.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -149.18 70.98 10.09 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.455 -0.339 . . . . 64.209999999999994 110.73 -177.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 756' ' ' PRO . . . . . 0.511 ' O ' ' HA ' ' A' ' 775' ' ' HIS . 51.8 Cg_exo -54.81 146.59 55.1 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.738 2.292 . . . . 72.450000000000003 112.176 178.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 757' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -129.96 113.33 14.46 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.254 -0.43 . . . . 64.409999999999997 109.911 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 758' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -112.74 117.54 32.49 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.799 -0.637 . . . . 54.340000000000003 110.79 -177.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 30.9 t -85.14 101.39 9.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.92 -0.582 . . . . 72.420000000000002 109.543 175.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -106.05 136.91 44.89 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.67 -0.695 . . . . 74.150000000000006 110.483 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 761' ' ' GLN . . . . . 0.526 ' HA ' ' O ' ' A' ' 770' ' ' PRO . 23.7 tt0 -135.18 131.95 37.37 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.749 -0.659 . . . . 72.150000000000006 110.033 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 762' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 769' ' ' PHE . . . -89.17 122.19 32.21 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.892 -0.594 . . . . 45.119999999999997 110.636 -178.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 763' ' ' LYS . . . . . 0.572 ' HB3' ' HB2' ' A' ' 743' ' ' GLU . 61.5 tttm -97.62 105.54 17.71 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.622 -0.717 . . . . 73.25 109.512 178.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 59.8 t -108.93 98.59 7.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.098 0.475 . . . . 72.040000000000006 109.792 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 70.72 -107.76 2.26 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 111.26 -0.736 . . . . 34.119999999999997 111.26 -176.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -109.6 1.05 30.65 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.743 -0.741 . . . . 73.040000000000006 112.068 177.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 767' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -102.75 138.74 39.24 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.16 0.505 . . . . 63.43 111.373 -177.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 768' ' ' TRP . . . . . 0.467 ' HB3' ' NE2' ' A' ' 761' ' ' GLN . 80.4 m95 -108.64 108.76 19.75 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.521 -0.763 . . . . 74.25 109.39 175.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 769' ' ' PHE . . . . . 0.5 ' HA ' ' HA ' ' A' ' 770' ' ' PRO . 31.6 p90 -168.99 138.9 1.81 Allowed Pre-proline 0 C--N 1.322 -0.613 0 CA-C-O 120.946 0.403 . . . . 71.230000000000004 110.497 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 770' ' ' PRO . . . . . 0.704 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 59.7 Cg_endo -97.99 -175.64 3.95 Favored 'Cis proline' 0 N--CA 1.451 -1.028 0 C-N-CA 123.454 -1.478 . . . . 74.400000000000006 111.768 -4.04 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -110.9 106.54 15.7 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.605 -0.517 . . . . 75.530000000000001 109.605 173.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 30.0 m -114.52 146.49 18.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.018 0.437 . . . . 45.039999999999999 111.409 -177.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 5.7 p -111.98 95.87 5.72 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.792 -0.64 . . . . 70.510000000000005 109.847 178.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -94.18 166.73 11.97 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.05 -0.523 . . . . 75.340000000000003 111.776 -174.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 775' ' ' HIS . . . . . 0.511 ' HA ' ' O ' ' A' ' 756' ' ' PRO . 32.6 m-70 -91.84 -4.3 55.0 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.722 -0.672 . . . . 72.409999999999997 110.853 -178.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 63.5 p -159.13 173.58 16.19 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.693 -0.484 . . . . 73.430000000000007 109.693 176.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 777' ' ' LYS . . . . . 0.701 ' HE2' ' HD2' ' A' ' 781' ' ' LYS . 31.4 tttt -65.83 -52.51 49.89 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.709 0.263 . . . . 65.120000000000005 111.709 -176.206 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 51.9 tttp -63.5 -37.79 88.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.466 -0.334 . . . . 50.049999999999997 110.636 -174.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 779' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -60.61 -39.15 87.14 Favored 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 109.852 -0.425 . . . . 74.150000000000006 109.852 175.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -61.91 -48.49 83.35 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.991 -0.623 . . . . 75.25 112.061 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 781' ' ' LYS . . . . . 0.701 ' HD2' ' HE2' ' A' ' 777' ' ' LYS . 8.2 mtpm? -62.59 -38.25 89.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.652 0.263 . . . . 72.219999999999999 111.04 178.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -73.17 -50.54 22.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.539 -0.301 . . . . 74.409999999999997 111.316 -178.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -60.67 -38.4 84.78 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.67 0.271 . . . . 73.519999999999996 110.974 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -60.11 -51.2 70.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 74.150000000000006 110.146 177.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 785' ' ' ALA . . . . . 0.609 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -66.39 -41.72 88.94 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.252 -0.431 . . . . 61.520000000000003 110.923 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 786' ' ' ASP . . . . . 0.444 ' O ' ' HD3' ' A' ' 790' ' ' ARG . 9.9 t0 -56.34 -57.49 12.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.903 -0.59 . . . . 73.129999999999995 110.082 179.045 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 787' ' ' ALA . . . . . 0.63 ' HB3' ' HG3' ' A' ' 770' ' ' PRO . . . -64.77 -33.39 75.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.695 -0.684 . . . . 71.409999999999997 111.196 -178.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 788' ' ' ALA . . . . . 0.704 ' HB2' ' HD3' ' A' ' 770' ' ' PRO . . . -64.64 -44.47 90.38 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 123.174 0.296 . . . . 54.43 110.937 179.326 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 789' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 785' ' ' ALA . 80.0 mt -61.35 -40.34 93.92 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.742 -0.466 . . . . 71.319999999999993 109.742 178.485 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 790' ' ' ARG . . . . . 0.444 ' HD3' ' O ' ' A' ' 786' ' ' ASP . 13.0 mtp180 -59.54 -35.34 74.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.032 -0.531 . . . . 63.329999999999998 111.162 176.401 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 791' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 787' ' ' ALA . 54.3 t -66.19 -52.09 51.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 109.753 -0.462 . . . . 72.219999999999999 109.753 175.393 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 792' ' ' LEU . . . . . 0.624 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 31.3 mt -57.23 -49.09 77.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.647 -0.706 . . . . 75.540000000000006 110.575 -178.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 793' ' ' ILE . . . . . 0.488 HD13 HG22 ' A' ' 720' ' ' VAL . 94.2 mt -60.02 -51.46 72.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.414 -0.812 . . . . 74.340000000000003 110.734 177.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -61.83 -40.53 98.96 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 121.014 -0.612 . . . . 73.239999999999995 112.697 -178.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -60.29 -53.17 60.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.375 0.131 . . . . 73.209999999999994 111.24 178.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -71.22 -29.94 65.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.928 0.394 . . . . 72.439999999999998 111.08 -176.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 797' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -63.29 -34.37 77.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.542 0.687 . . . . 75.349999999999994 110.028 175.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 798' ' ' LYS . . . . . 0.512 ' HB3' ' NZ ' ' A' ' 798' ' ' LYS . 0.0 OUTLIER -90.55 -39.72 12.39 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.196 -0.911 . . . . 63.450000000000003 111.352 -177.401 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 799' ' ' ALA . . . . . . . . . . . . . . . -94.8 121.69 36.65 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.203 0.445 . . . . 52.009999999999998 112.203 -174.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 800' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -79.92 120.35 24.01 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.766 -0.652 . . . . 74.109999999999999 109.466 171.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 801' ' ' ARG . . . . . . . . . . . . . 1.9 ptm180 . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.76 -0.638 . . . . 71.510000000000005 110.664 -179.652 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 708' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 N--CA 1.479 1.004 0 N-CA-C 110.279 -0.267 . . . . 72.420000000000002 110.279 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 709' ' ' MET . . . . . 0.401 ' HA ' ' HD3' ' A' ' 710' ' ' PRO . 4.5 mpp? -93.37 137.87 23.29 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 116.413 -0.358 . . . . 63.149999999999999 110.121 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 710' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 709' ' ' MET . 6.5 Cg_exo -74.07 172.55 15.73 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 123.011 2.474 . . . . 62.039999999999999 111.865 178.306 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 711' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -101.55 -24.48 14.13 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.899 0.381 . . . . 73.409999999999997 110.205 178.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 712' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.47 3.48 47.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.235 -0.439 . . . . 73.219999999999999 111.847 -179.119 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 713' ' ' VAL . . . . . . . . . . . . . 12.9 p -78.66 136.79 23.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.106 0.479 . . . . 71.409999999999997 110.317 -178.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.618 ' HG2' ' HB2' ' A' ' 801' ' ' ARG . 0.0 OUTLIER -125.01 85.19 2.37 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.207 0.527 . . . . 74.25 110.985 177.202 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -92.25 103.27 15.76 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.089 -0.708 . . . . 43.43 109.089 175.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 716' ' ' ILE . . . . . 0.779 HG23 HG12 ' A' ' 793' ' ' ILE . 25.8 mm -65.35 -26.99 40.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.533 -0.758 . . . . 71.329999999999998 111.961 -173.211 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -57.17 -28.69 58.93 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.959 -0.639 . . . . 74.420000000000002 112.293 176.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 718' ' ' GLU . . . . . 0.711 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 9.2 mm-40 -70.59 -36.42 73.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.841 0.353 . . . . 73.25 110.289 178.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 719' ' ' LEU . . . . . 0.593 HD23 ' HA ' ' A' ' 716' ' ' ILE . 3.2 mm? -66.86 -32.23 73.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.17 0.509 . . . . 53.119999999999997 109.864 177.241 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 720' ' ' VAL . . . . . 0.459 HG22 HD13 ' A' ' 793' ' ' ILE . 61.0 t -68.81 -34.81 66.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.696 -0.684 . . . . 74.140000000000001 110.636 177.542 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 721' ' ' ARG . . . . . 0.711 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 21.5 ptt180 -63.47 -28.93 70.3 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.261 0.553 . . . . 71.120000000000005 109.643 178.091 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -77.76 -30.79 51.69 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.908 -0.587 . . . . 71.140000000000001 111.392 178.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 723' ' ' LEU . . . . . 0.521 HD21 ' HB2' ' A' ' 789' ' ' LEU . 92.9 mt -58.18 -33.56 69.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.146 0.498 . . . . 73.150000000000006 110.052 175.4 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -82.83 -44.28 15.66 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.491 -0.777 . . . . 45.149999999999999 110.887 176.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 8.2 m -84.22 -79.82 0.21 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.358 -0.383 . . . . 54.210000000000001 111.46 -175.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 726' ' ' ASN . . . . . 0.432 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 52.6 t-20 -148.08 109.58 3.73 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 109.768 -0.456 . . . . 71.120000000000005 109.768 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 727' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 28.0 Cg_endo -63.06 -33.79 72.32 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.826 2.35 . . . . 75.420000000000002 112.467 -178.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 59.7 t -63.39 -48.45 87.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.044 0.45 . . . . 72.310000000000002 110.183 -178.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -66.03 -24.55 71.76 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.668 -0.696 . . . . 71.5 111.881 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -79.1 -39.15 20.58 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 121.149 -0.548 . . . . 64.329999999999998 112.644 178.09 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -65.35 -41.83 93.47 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.576 -0.527 . . . . 72.140000000000001 109.576 178.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 732' ' ' LEU . . . . . 0.423 HD23 ' HB3' ' A' ' 742' ' ' ALA . 90.0 mt -64.13 -37.77 88.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.83 -0.623 . . . . 71.439999999999998 110.193 175.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 733' ' ' GLU . . . . . 0.553 ' O ' ' HG2' ' A' ' 736' ' ' ARG . 4.1 tp10 -65.18 -49.45 69.74 Favored 'General case' 0 N--CA 1.437 -1.12 0 C-N-CA 123.423 0.689 . . . . 74.109999999999999 110.857 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 734' ' ' TYR . . . . . 0.52 ' HB2' HD11 ' A' ' 719' ' ' LEU . 11.0 t80 -54.7 -48.13 72.82 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.634 -0.712 . . . . 72.329999999999998 110.716 178.241 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -67.14 -47.93 69.6 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.88 -0.6 . . . . 75.230000000000004 111.22 -177.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 736' ' ' ARG . . . . . 0.553 ' HG2' ' O ' ' A' ' 733' ' ' GLU . 18.5 ptt180 -61.99 -32.95 73.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.997 0.427 . . . . 53.240000000000002 111.314 -175.346 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 44.6 t -80.3 -36.87 33.75 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.075 -0.511 . . . . 75.450000000000003 110.981 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -91.81 -2.35 56.95 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.105 0.409 . . . . 65.209999999999994 112.105 -172.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 89.47 13.37 61.57 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.61 -0.805 . . . . 74.439999999999998 112.936 175.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -97.93 157.89 15.84 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.849 0.357 . . . . 65.219999999999999 110.691 177.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -102.42 114.85 29.4 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.519 -0.548 . . . . 52.109999999999999 109.519 175.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 742' ' ' ALA . . . . . 0.423 ' HB3' HD23 ' A' ' 732' ' ' LEU . . . -92.38 114.81 27.46 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 123.237 0.336 . . . . 61.109999999999999 111.021 -177.057 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 743' ' ' GLU . . . . . 0.431 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 47.1 mt-10 -126.68 132.74 51.1 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.3 -0.409 . . . . 65.299999999999997 110.966 -178.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -106.14 100.76 10.28 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.181 -0.463 . . . . 72.530000000000001 110.292 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 10.4 ptpt -103.72 140.89 37.0 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.171 0.51 . . . . 65.239999999999995 111.204 -179.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 746' ' ' LEU . . . . . . . . . . . . . 6.6 tt -86.42 110.01 19.43 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.303 -0.999 . . . . 72.219999999999999 108.303 175.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 40.4 t -74.88 -53.88 15.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.077 -0.51 . . . . 72.409999999999997 110.347 -176.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -157.04 155.19 30.76 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.991 -0.55 . . . . 52.240000000000002 109.53 -178.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -139.62 96.81 3.14 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.514 0.673 . . . . 74.019999999999996 110.974 177.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 34.0 t -89.73 101.85 14.55 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.548 -0.908 . . . . 63.240000000000002 108.548 174.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 751' ' ' GLY . . . . . 0.667 ' HA2' ' HA ' ' A' ' 756' ' ' PRO . . . -120.25 81.17 0.33 Allowed Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.172 -1.013 . . . . 54.409999999999997 113.671 -173.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 752' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -64.59 160.24 40.95 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.169 1.913 . . . . 55.439999999999998 110.466 170.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.41 -27.36 84.79 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.513 2.142 . . . . 75.019999999999996 113.188 -174.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 50.9 p-80 -92.19 -15.18 27.95 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.499 -0.319 . . . . 74.140000000000001 111.596 -176.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -158.89 71.72 3.62 Favored Pre-proline 0 C--N 1.329 -0.289 0 N-CA-C 112.289 0.478 . . . . 64.540000000000006 112.289 -176.45 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 756' ' ' PRO . . . . . 0.667 ' HA ' ' HA2' ' A' ' 751' ' ' GLY . 40.2 Cg_exo -58.13 115.29 2.43 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 121.934 1.756 . . . . 61.240000000000002 111.199 171.077 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 757' ' ' LYS . . . . . 0.488 ' HD3' ' HB2' ' A' ' 773' ' ' CYS . 36.4 ttmt -122.4 137.06 54.99 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.958 0.408 . . . . 72.549999999999997 110.822 -176.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 758' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -123.21 119.61 30.73 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.813 -0.631 . . . . 74.129999999999995 110.45 -176.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 759' ' ' VAL . . . . . 0.527 HG22 ' HB3' ' A' ' 773' ' ' CYS . 25.3 t -94.49 115.92 34.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.005 -0.543 . . . . 62.130000000000003 110.761 -177.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -116.76 147.56 41.94 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.754 -0.657 . . . . 75.540000000000006 110.724 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 761' ' ' GLN . . . . . 0.452 HE21 ' HB2' ' A' ' 771' ' ' ALA . 34.4 tt0 -132.62 138.13 47.27 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.942 -0.572 . . . . 74.230000000000004 109.677 177.089 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 762' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 769' ' ' PHE . . . -95.19 112.66 24.34 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.316 0.579 . . . . 73.439999999999998 110.514 -177.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 763' ' ' LYS . . . . . 0.488 ' HD2' ' CH2' ' A' ' 768' ' ' TRP . 48.8 tttm -91.67 104.02 16.54 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.493 -0.776 . . . . 70.209999999999994 109.441 177.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 88.8 t -109.35 101.77 13.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.182 0.515 . . . . 73.329999999999998 109.851 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 71.68 -119.13 7.47 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 110.775 -0.93 . . . . 55.530000000000001 110.775 -174.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -102.14 7.06 54.24 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.635 -0.793 . . . . 73.140000000000001 111.224 175.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 767' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -99.9 148.56 24.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.054 0.454 . . . . 75.540000000000006 110.976 -177.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 768' ' ' TRP . . . . . 0.488 ' CH2' ' HD2' ' A' ' 763' ' ' LYS . 54.1 m95 -124.76 99.9 6.37 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.688 -0.687 . . . . 73.430000000000007 110.064 -179.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 769' ' ' PHE . . . . . 0.414 ' HA ' ' HA ' ' A' ' 770' ' ' PRO . 34.5 p90 -171.04 141.57 1.41 Allowed Pre-proline 0 C--N 1.325 -0.468 0 CA-C-O 120.706 0.289 . . . . 64.219999999999999 110.397 -178.152 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 770' ' ' PRO . . . . . 0.58 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 60.7 Cg_endo -96.59 -168.54 1.78 Allowed 'Cis proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.755 -1.352 . . . . 64.030000000000001 112.126 -2.066 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 771' ' ' ALA . . . . . 0.452 ' HB2' HE21 ' A' ' 761' ' ' GLN . . . -120.95 108.53 14.0 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.771 -0.455 . . . . 70.140000000000001 109.771 175.392 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 772' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 759' ' ' VAL . 32.9 m -116.87 157.54 17.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.83 0.348 . . . . 60.039999999999999 110.998 -176.287 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 773' ' ' CYS . . . . . 0.527 ' HB3' HG22 ' A' ' 759' ' ' VAL . 2.6 p -134.99 100.53 4.6 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.069 -0.514 . . . . 73.420000000000002 110.175 178.479 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -103.22 177.49 4.82 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.824 -0.626 . . . . 61.520000000000003 111.221 -174.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 775' ' ' HIS . . . . . . . . . . . . . 46.8 m-70 -85.32 -16.63 39.35 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.14 0.495 . . . . 73.129999999999995 110.324 -177.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 776' ' ' SER . . . . . 0.605 ' HB2' ' HB2' ' A' ' 779' ' ' GLN . 12.5 m -129.71 152.57 49.07 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.954 -0.567 . . . . 75.439999999999998 110.281 -177.16 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 777' ' ' LYS . . . . . . . . . . . . . 6.1 tmmm? -63.9 -49.69 71.67 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.372 -0.376 . . . . 75.0 110.96 -178.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -70.41 -26.56 63.74 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.644 -0.423 . . . . 71.400000000000006 110.231 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 779' ' ' GLN . . . . . 0.605 ' HB2' ' HB2' ' A' ' 776' ' ' SER . 6.5 mm-40 -66.71 -37.33 84.48 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 116.28 -0.418 . . . . 74.409999999999997 110.261 173.408 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -58.15 -45.98 93.31 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.787 -0.72 . . . . 74.340000000000003 111.501 175.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -61.94 -46.13 90.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.773 0.321 . . . . 73.450000000000003 110.76 176.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -64.56 -46.87 80.92 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.337 -0.392 . . . . 61.450000000000003 111.399 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -63.14 -39.57 95.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.496 -0.32 . . . . 73.540000000000006 111.235 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -63.19 -46.11 88.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.82 0.343 . . . . 54.210000000000001 110.11 177.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 785' ' ' ALA . . . . . 0.578 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -65.14 -45.11 86.35 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.902 -0.59 . . . . 62.329999999999998 110.986 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 786' ' ' ASP . . . . . 0.718 ' O ' ' HG2' ' A' ' 790' ' ' ARG . 14.1 t70 -58.41 -54.49 46.46 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 116.317 -0.401 . . . . 73.030000000000001 110.012 178.581 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 787' ' ' ALA . . . . . 0.52 ' O ' HG23 ' A' ' 791' ' ' VAL . . . -61.75 -33.79 74.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.759 -0.655 . . . . 73.329999999999998 111.21 -178.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 788' ' ' ALA . . . . . 0.716 ' O ' ' HG ' ' A' ' 792' ' ' LEU . . . -62.84 -46.62 87.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.363 -0.381 . . . . 63.530000000000001 110.448 177.013 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 789' ' ' LEU . . . . . 0.587 HD22 HD12 ' A' ' 719' ' ' LEU . 65.5 mt -62.58 -36.36 82.47 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.812 -0.44 . . . . 75.230000000000004 109.812 179.37 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 790' ' ' ARG . . . . . 0.718 ' HG2' ' O ' ' A' ' 786' ' ' ASP . 26.6 mmm-85 -58.95 -42.18 89.22 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.868 0.366 . . . . 75.230000000000004 110.033 177.501 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 791' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 787' ' ' ALA . 59.0 t -64.31 -49.68 79.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.054 -0.521 . . . . 73.129999999999995 110.465 177.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 792' ' ' LEU . . . . . 0.716 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 22.5 mt -59.19 -46.59 88.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.033 -0.531 . . . . 52.100000000000001 110.457 -178.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 793' ' ' ILE . . . . . 0.779 HG12 HG23 ' A' ' 716' ' ' ILE . 96.7 mt -63.02 -45.49 98.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.422 -0.808 . . . . 74.409999999999997 110.675 177.097 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -65.69 -40.16 95.69 Favored Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 115.934 -0.575 . . . . 53.420000000000002 112.934 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -74.23 -16.58 60.96 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 122.377 -0.484 . . . . 73.230000000000004 111.277 -178.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -89.41 -12.94 38.84 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.436 0.636 . . . . 75.310000000000002 109.424 174.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 797' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.29 -32.18 64.49 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.949 -0.76 . . . . 70.310000000000002 108.949 175.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 798' ' ' LYS . . . . . . . . . . . . . 2.7 ptpp? -92.41 15.87 13.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.723 -0.671 . . . . 72.510000000000005 110.451 176.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 799' ' ' ALA . . . . . . . . . . . . . . . -145.79 -176.01 4.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.883 0.373 . . . . 65.140000000000001 111.226 -176.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 800' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -124.96 122.82 38.42 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.914 -0.585 . . . . 70.25 109.875 174.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 801' ' ' ARG . . . . . 0.618 ' HB2' ' HG2' ' A' ' 714' ' ' ARG . 8.0 ppt_? . . . . . 0 C--O 1.245 0.85 0 CA-C-N 115.938 -0.574 . . . . 71.409999999999997 111.736 -178.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 708' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 N--CA 1.478 0.957 0 CA-C-O 120.741 0.305 . . . . 74.150000000000006 110.38 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -105.71 151.69 39.94 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 110.075 -0.343 . . . . 74.010000000000005 110.075 178.377 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -58.29 -50.81 8.84 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 122.878 2.386 . . . . 75.310000000000002 113.148 -178.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 711' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -111.12 171.23 7.59 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.594 -0.275 . . . . 71.340000000000003 110.765 -177.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 712' ' ' LYS . . . . . 0.589 ' HE3' ' HG3' ' A' ' 718' ' ' GLU . 21.5 pttm -115.56 169.43 9.19 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.972 0.415 . . . . 71.209999999999994 111.156 -178.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 713' ' ' VAL . . . . . 0.853 HG22 ' H ' ' A' ' 714' ' ' ARG . 7.8 p -92.37 -167.14 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.705 -0.68 . . . . 71.349999999999994 109.363 177.195 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.853 ' H ' HG22 ' A' ' 713' ' ' VAL . 6.2 ptp85 -65.34 87.1 0.07 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.44 0.638 . . . . 65.510000000000005 110.955 175.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -107.36 105.63 15.67 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.815 -0.63 . . . . 74.420000000000002 109.997 177.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 716' ' ' ILE . . . . . 0.447 ' HA ' HD23 ' A' ' 719' ' ' LEU . 48.1 mm -78.31 -26.13 14.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.068 -0.514 . . . . 75.129999999999995 110.68 -176.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -60.29 -29.73 69.49 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.944 -0.646 . . . . 53.329999999999998 112.085 178.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 718' ' ' GLU . . . . . 0.671 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 30.0 mm-40 -57.87 -50.12 74.38 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-O 120.965 0.412 . . . . 73.540000000000006 110.168 176.004 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 719' ' ' LEU . . . . . 0.567 HD11 ' HB2' ' A' ' 734' ' ' TYR . 2.4 mm? -62.71 -29.67 70.84 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.164 0.507 . . . . 73.140000000000001 110.096 -177.09 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 720' ' ' VAL . . . . . 0.448 HG22 HD13 ' A' ' 793' ' ' ILE . 65.1 t -72.07 -42.96 67.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.617 -0.72 . . . . 74.319999999999993 110.639 178.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 721' ' ' ARG . . . . . 0.671 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 15.5 ptm180 -65.5 -24.05 67.04 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.919 0.39 . . . . 74.120000000000005 110.446 -179.339 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -76.91 -31.56 56.78 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 116.483 -0.326 . . . . 74.530000000000001 111.098 176.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 723' ' ' LEU . . . . . 0.479 HD21 ' HB2' ' A' ' 789' ' ' LEU . 92.3 mt -60.78 -30.9 70.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.266 0.555 . . . . 71.329999999999998 109.99 174.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -87.95 -17.26 31.69 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.281 -0.872 . . . . 70.299999999999997 111.317 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 21.2 m -118.04 -79.9 0.6 Allowed 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 120.674 0.274 . . . . 60.130000000000003 111.595 -177.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 726' ' ' ASN . . . . . 0.436 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 39.4 t30 -139.19 106.71 7.29 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 120.71 0.29 . . . . 64.549999999999997 110.669 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 727' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 21.1 Cg_endo -62.03 -38.48 56.91 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.745 2.297 . . . . 34.520000000000003 112.838 -178.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 29.9 t -63.12 -46.32 96.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.355 -0.384 . . . . 72.239999999999995 110.669 -175.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -61.58 -36.1 92.12 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.833 -0.698 . . . . 45.399999999999999 112.026 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -67.54 -42.07 89.17 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 121.095 -0.574 . . . . 73.109999999999999 112.593 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -65.66 -42.05 91.81 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.964 0.411 . . . . 75.299999999999997 109.933 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 732' ' ' LEU . . . . . . . . . . . . . 96.1 mt -65.37 -46.44 80.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.944 -0.571 . . . . 75.129999999999995 111.14 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 733' ' ' GLU . . . . . 0.515 ' HA ' ' HG2' ' A' ' 736' ' ' ARG . 0.0 OUTLIER -72.75 -31.38 64.88 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.899 -0.321 . . . . 75.109999999999999 110.994 -176.187 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 734' ' ' TYR . . . . . 0.567 ' HB2' HD11 ' A' ' 719' ' ' LEU . 11.8 t80 -57.22 -48.88 77.69 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 120.918 0.39 . . . . 71.319999999999993 110.089 175.333 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -65.02 -52.26 57.0 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.874 -0.603 . . . . 73.409999999999997 110.709 -176.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 736' ' ' ARG . . . . . 0.515 ' HG2' ' HA ' ' A' ' 733' ' ' GLU . 32.5 ptt180 -62.47 -33.04 74.05 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.686 -0.688 . . . . 72.400000000000006 111.399 -175.201 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 47.9 t -83.47 -11.68 57.21 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.909 -0.587 . . . . 42.340000000000003 111.673 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -113.03 -8.44 13.64 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.008 0.373 . . . . 64.409999999999997 112.008 -177.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 100.08 8.01 51.48 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.597 -0.811 . . . . 51.439999999999998 112.733 178.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -97.42 163.75 12.74 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 110.091 -0.337 . . . . 74.140000000000001 110.091 177.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -113.0 118.61 35.3 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.6 -0.519 . . . . 64.349999999999994 109.6 174.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 742' ' ' ALA . . . . . . . . . . . . . . . -94.06 128.3 40.35 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.21 -0.45 . . . . 53.539999999999999 111.029 -176.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 743' ' ' GLU . . . . . 0.567 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 45.6 mt-10 -139.54 154.81 47.74 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.872 -0.603 . . . . 71.510000000000005 110.393 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -128.5 113.18 15.17 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.209 -0.451 . . . . 73.420000000000002 109.795 178.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 745' ' ' LYS . . . . . 0.511 ' HE3' ' CZ3' ' A' ' 768' ' ' TRP . 13.1 ptpt -111.74 149.34 31.79 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.305 -0.558 . . . . 52.240000000000002 111.197 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 746' ' ' LEU . . . . . . . . . . . . . 6.7 tt -95.49 104.85 16.77 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.236 -1.024 . . . . 61.219999999999999 108.236 177.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 48.3 t -76.84 -44.14 32.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 116.226 -0.443 . . . . 74.450000000000003 111.009 -174.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -152.88 148.49 27.21 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.324 -0.398 . . . . 73.319999999999993 111.12 -175.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 749' ' ' GLN . . . . . 0.514 ' HA ' ' O ' ' A' ' 757' ' ' LYS . 18.1 pt20 -138.75 97.02 3.24 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.924 0.869 . . . . 72.140000000000001 109.759 173.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 9.8 p -129.5 -179.18 5.02 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.414 -0.812 . . . . 61.399999999999999 111.004 -174.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 103.64 178.5 25.87 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.586 -0.816 . . . . 31.100000000000001 112.229 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 752' ' ' PRO . . . . . 0.663 ' HG2' ' HB2' ' A' ' 755' ' ' GLU . 38.7 Cg_endo -64.98 160.3 42.15 Favored 'Trans proline' 0 CA--C 1.528 0.218 0 C-N-CA 123.118 2.545 . . . . 53.109999999999999 111.963 -178.19 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.37 -28.2 71.58 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.645 2.23 . . . . 70.200000000000003 112.658 -178.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 49.0 p-80 -86.49 -14.82 41.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.76 0.314 . . . . 54.420000000000002 110.989 -179.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 755' ' ' GLU . . . . . 0.663 ' HB2' ' HG2' ' A' ' 752' ' ' PRO . 18.8 mm-40 -138.9 74.0 38.5 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.252 -0.431 . . . . 64.519999999999996 110.718 178.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 756' ' ' PRO . . . . . 0.671 ' O ' ' HA ' ' A' ' 775' ' ' HIS . 56.1 Cg_endo -73.5 113.32 3.75 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.495 2.13 . . . . 74.099999999999994 111.723 177.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 757' ' ' LYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 749' ' ' GLN . 6.1 ttpm? -88.61 114.08 24.85 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.903 0.382 . . . . 71.25 110.718 -177.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 758' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -99.06 115.11 28.22 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.532 -0.758 . . . . 70.209999999999994 110.013 179.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 22.1 t -88.24 105.69 15.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.627 -0.715 . . . . 71.099999999999994 109.373 177.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -107.63 144.43 34.69 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.981 -0.554 . . . . 62.039999999999999 110.669 -178.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 761' ' ' GLN . . . . . 0.473 ' HA ' ' O ' ' A' ' 770' ' ' PRO . 60.4 tt0 -136.6 128.18 28.72 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.703 -0.68 . . . . 74.319999999999993 109.512 178.094 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 762' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 769' ' ' PHE . . . -86.29 129.56 34.81 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.332 0.587 . . . . 41.109999999999999 110.502 -178.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 763' ' ' LYS . . . . . 0.567 ' HB3' ' HB2' ' A' ' 743' ' ' GLU . 66.0 tttt -104.6 112.28 25.29 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.584 -0.735 . . . . 75.030000000000001 109.783 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 58.9 t -119.27 95.92 3.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.175 0.512 . . . . 53.219999999999999 109.758 177.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 72.86 -116.5 5.65 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.091 -0.803 . . . . 52.140000000000001 111.091 -175.097 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -101.36 -2.97 53.89 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.752 -0.737 . . . . 60.340000000000003 111.818 175.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 767' ' ' ARG . . . . . 0.455 ' HB3' ' CD1' ' A' ' 769' ' ' PHE . 0.2 OUTLIER -95.08 121.91 37.2 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.959 0.409 . . . . 72.530000000000001 111.457 -178.01 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 768' ' ' TRP . . . . . 0.511 ' CZ3' ' HE3' ' A' ' 745' ' ' LYS . 70.2 m95 -102.17 105.14 15.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.917 -0.583 . . . . 75.239999999999995 110.062 177.182 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 769' ' ' PHE . . . . . 0.455 ' CD1' ' HB3' ' A' ' 767' ' ' ARG . 41.6 p90 -168.39 144.94 3.2 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 109.873 -0.417 . . . . 74.230000000000004 109.873 -177.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 770' ' ' PRO . . . . . 0.666 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 65.3 Cg_endo -97.56 -176.16 4.45 Favored 'Cis proline' 0 N--CA 1.451 -1.006 0 C-N-CA 123.736 -1.36 . . . . 53.329999999999998 112.188 -2.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -106.41 109.1 20.93 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.596 -0.52 . . . . 50.200000000000003 109.596 174.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 35.9 m -117.72 155.79 19.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.969 0.414 . . . . 70.310000000000002 110.997 -177.015 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 7.0 p -129.91 112.78 13.86 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.17 0.51 . . . . 65.019999999999996 110.442 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 774' ' ' ALA . . . . . 0.421 ' O ' ' HA ' ' A' ' 757' ' ' LYS . . . -116.73 -178.4 3.42 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.816 -0.629 . . . . 64.340000000000003 109.784 178.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 775' ' ' HIS . . . . . 0.671 ' HA ' ' O ' ' A' ' 756' ' ' PRO . 5.6 p80 -121.86 19.01 11.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.772 0.796 . . . . 65.109999999999999 110.187 176.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 49.3 m -148.35 139.22 23.05 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.837 -1.074 . . . . 73.420000000000002 108.405 171.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 777' ' ' LYS . . . . . . . . . . . . . 5.6 tmmm? -61.45 -44.77 96.53 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 123.018 0.199 . . . . 65.129999999999995 111.291 -172.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -64.85 -31.56 72.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.71 0.291 . . . . 60.149999999999999 110.799 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 779' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -72.03 -35.51 69.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.365 -0.38 . . . . 75.230000000000004 110.335 177.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -59.94 -42.94 98.48 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.904 -0.665 . . . . 45.310000000000002 111.493 176.099 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -61.25 -49.01 78.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.835 0.35 . . . . 72.540000000000006 110.488 176.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -61.73 -51.21 69.31 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 115.896 -0.593 . . . . 72.129999999999995 111.254 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -57.95 -43.34 86.34 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 123.196 0.31 . . . . 60.539999999999999 111.44 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -59.92 -50.68 72.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.373 -0.376 . . . . 64.209999999999994 110.622 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 785' ' ' ALA . . . . . 0.596 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -67.48 -42.46 82.94 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.318 -0.401 . . . . 54.140000000000001 111.025 -178.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 786' ' ' ASP . . . . . 0.461 ' O ' ' HG3' ' A' ' 790' ' ' ARG . 11.8 t70 -59.1 -51.74 68.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.984 -0.553 . . . . 65.200000000000003 110.717 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 787' ' ' ALA . . . . . 0.55 ' O ' HG23 ' A' ' 791' ' ' VAL . . . -66.84 -35.46 80.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.034 -0.53 . . . . 64.120000000000005 110.8 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 788' ' ' ALA . . . . . 0.676 ' O ' ' HG ' ' A' ' 792' ' ' LEU . . . -61.46 -42.75 99.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.425 -0.352 . . . . 65.420000000000002 110.854 178.046 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 789' ' ' LEU . . . . . 0.596 ' HG ' ' O ' ' A' ' 785' ' ' ALA . 81.3 mt -58.92 -43.98 91.22 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 110.008 -0.367 . . . . 73.239999999999995 110.008 177.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 790' ' ' ARG . . . . . 0.548 ' HD2' ' HA ' ' A' ' 787' ' ' ALA . 53.9 mtt-85 -58.36 -37.53 75.39 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.206 -0.452 . . . . 75.530000000000001 111.009 177.301 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 791' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 787' ' ' ALA . 48.3 t -65.81 -48.67 81.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.416 -0.356 . . . . 72.430000000000007 110.237 177.109 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 792' ' ' LEU . . . . . 0.676 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 39.6 mt -61.67 -46.37 90.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.747 -0.661 . . . . 73.049999999999997 110.749 -179.103 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 793' ' ' ILE . . . . . 0.448 HD13 HG22 ' A' ' 720' ' ' VAL . 89.5 mt -62.17 -47.53 92.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.51 -0.768 . . . . 70.439999999999998 110.366 177.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 794' ' ' GLY . . . . . 0.401 ' O ' ' HG2' ' A' ' 798' ' ' LYS . . . -62.92 -36.4 93.36 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 121.018 -0.611 . . . . 71.030000000000001 112.342 178.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -57.56 -51.22 70.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.977 0.418 . . . . 71.329999999999998 110.44 177.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 796' ' ' ASN . . . . . 0.498 ' HA ' ' HB3' ' A' ' 799' ' ' ALA . 2.6 t-20 -86.44 0.39 54.24 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.171 0.51 . . . . 72.129999999999995 110.667 -177.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 797' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -83.05 -45.85 13.53 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.159 -0.682 . . . . 74.109999999999999 109.159 173.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 798' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 794' ' ' GLY . 72.0 mmtt -75.01 -24.51 58.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.652 -0.704 . . . . 74.420000000000002 109.783 177.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 799' ' ' ALA . . . . . 0.498 ' HB3' ' HA ' ' A' ' 796' ' ' ASN . . . -85.84 153.86 21.95 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.498 -0.774 . . . . 64.209999999999994 109.554 173.155 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 800' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -122.45 86.06 2.52 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.974 0.416 . . . . 63.439999999999998 110.471 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 801' ' ' ARG . . . . . 0.443 ' HE ' ' HA ' ' A' ' 801' ' ' ARG . 2.8 mmp_? . . . . . 0 C--O 1.246 0.904 0 CA-C-O 118.634 -0.698 . . . . 64.230000000000004 109.69 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 708' ' ' MET . . . . . . . . . . . . . 22.2 ptp . . . . . 0 N--CA 1.48 1.054 0 CA-C-O 120.754 0.312 . . . . 54.399999999999999 110.425 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 709' ' ' MET . . . . . 0.424 ' HA ' ' HD3' ' A' ' 710' ' ' PRO . 20.7 ptp -162.72 147.77 9.62 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 109.54 -0.541 . . . . 63.149999999999999 109.54 176.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 710' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 709' ' ' MET . 16.8 Cg_exo -66.85 150.96 83.14 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.322 2.015 . . . . 41.240000000000002 111.7 178.47 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 711' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -65.44 -40.88 93.8 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.24 -0.652 . . . . 73.510000000000005 109.24 175.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 712' ' ' LYS . . . . . 0.562 ' HA ' ' HE3' ' A' ' 712' ' ' LYS . 0.0 OUTLIER -126.31 127.01 44.88 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.109 -1.071 . . . . 65.329999999999998 108.109 169.865 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 713' ' ' VAL . . . . . . . . . . . . . 14.9 p -55.61 133.45 19.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 121.061 0.457 . . . . 71.349999999999994 110.717 -175.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.567 ' HG2' HG12 ' A' ' 716' ' ' ILE . 10.9 ttp180 -86.32 89.51 7.89 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.233 -0.44 . . . . 65.549999999999997 111.108 -172.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 715' ' ' LYS . . . . . 0.413 ' HD3' ' HA ' ' A' ' 715' ' ' LYS . 72.4 mmtt -98.37 93.35 6.14 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.669 -0.863 . . . . 70.540000000000006 108.669 171.399 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 716' ' ' ILE . . . . . 0.567 HG12 ' HG2' ' A' ' 714' ' ' ARG . 46.1 mm -122.42 -36.34 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.76 -0.655 . . . . 72.319999999999993 110.587 -175.285 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -61.09 -28.94 69.77 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.974 -0.631 . . . . 41.049999999999997 111.702 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 718' ' ' GLU . . . . . 0.759 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 5.8 mp0 -59.68 -46.94 87.55 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.913 0.387 . . . . 64.109999999999999 110.173 175.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 719' ' ' LEU . . . . . 0.641 HD12 HD22 ' A' ' 789' ' ' LEU . 2.9 mm? -67.61 -33.75 75.62 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.997 0.427 . . . . 75.340000000000003 110.36 -178.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 720' ' ' VAL . . . . . 0.496 HG22 HD13 ' A' ' 793' ' ' ILE . 61.6 t -63.39 -41.19 91.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 115.991 -0.55 . . . . 64.5 110.672 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 721' ' ' ARG . . . . . 0.759 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 14.7 ptm180 -68.92 -24.57 64.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 73.0 109.981 -178.174 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -76.73 -30.15 56.49 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.356 -0.384 . . . . 75.120000000000005 111.404 177.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 723' ' ' LEU . . . . . 0.564 HD21 ' HB2' ' A' ' 789' ' ' LEU . 84.7 mt -59.18 -32.57 70.04 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.476 -0.565 . . . . 74.239999999999995 109.476 172.094 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -82.97 -41.06 19.22 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.276 -0.875 . . . . 60.240000000000002 110.976 177.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 29.3 m -96.26 -78.49 0.46 Allowed 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 112.32 0.489 . . . . 72.540000000000006 112.32 -176.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 726' ' ' ASN . . . . . 0.422 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 37.7 t30 -142.11 100.9 5.82 Favored Pre-proline 0 C--O 1.234 0.27 0 CA-C-O 120.817 0.342 . . . . 75.120000000000005 111.065 -173.245 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 727' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 19.2 Cg_endo -61.86 -38.5 58.7 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 123.041 2.494 . . . . 55.399999999999999 112.844 -176.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 42.0 t -61.48 -48.49 88.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 75.510000000000005 110.939 -175.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -61.98 -38.46 96.09 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.765 -0.731 . . . . 54.130000000000003 112.12 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -66.85 -42.68 92.8 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.876 -0.678 . . . . 72.349999999999994 112.584 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -62.52 -40.36 96.5 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.807 -0.442 . . . . 71.219999999999999 109.807 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 732' ' ' LEU . . . . . . . . . . . . . 90.7 mt -64.74 -42.98 94.77 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.928 -0.578 . . . . 72.530000000000001 111.399 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 733' ' ' GLU . . . . . 0.522 ' O ' ' HG2' ' A' ' 736' ' ' ARG . 12.7 pt-20 -80.2 -25.95 39.43 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.924 -0.311 . . . . 74.450000000000003 111.55 -176.06 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 734' ' ' TYR . . . . . 0.52 ' HB2' HD11 ' A' ' 719' ' ' LEU . 3.2 t80 -56.89 -44.24 82.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.061 0.457 . . . . 71.030000000000001 109.84 173.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -66.93 -47.6 71.22 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.612 -0.722 . . . . 63.350000000000001 110.666 -177.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 736' ' ' ARG . . . . . 0.522 ' HG2' ' O ' ' A' ' 733' ' ' GLU . 34.4 ptt180 -63.39 -31.77 73.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.13 0.49 . . . . 74.310000000000002 110.992 -176.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 10.4 t -75.46 -33.59 60.87 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.756 -0.656 . . . . 74.230000000000004 110.993 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 18.2 m170 -97.02 -13.29 22.38 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.317 0.488 . . . . 73.540000000000006 112.317 -173.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 100.56 13.56 34.85 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.439 -0.886 . . . . 42.420000000000002 112.614 178.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -98.57 -174.14 2.73 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.025 0.44 . . . . 60.340000000000003 110.284 176.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 741' ' ' ALA . . . . . 0.564 ' O ' ' HA ' ' A' ' 764' ' ' VAL . . . -128.06 139.43 52.53 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.796 -0.638 . . . . 71.409999999999997 109.281 173.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 742' ' ' ALA . . . . . . . . . . . . . . . -110.11 115.73 30.28 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.773 0.32 . . . . 74.010000000000005 110.895 -176.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 743' ' ' GLU . . . . . 0.561 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 43.4 mt-10 -126.63 146.53 50.14 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.274 -0.421 . . . . 72.239999999999995 110.979 -178.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -123.15 104.3 9.09 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.37 -0.604 . . . . 71.040000000000006 109.37 176.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 8.0 ptpt -119.16 157.9 27.02 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.095 0.474 . . . . 44.439999999999998 111.307 -176.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 746' ' ' LEU . . . . . 0.471 HD13 ' HB3' ' A' ' 758' ' ' PHE . 57.2 tp -85.78 122.98 30.63 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.509 -0.769 . . . . 63.450000000000003 109.756 175.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 54.3 t -94.58 -47.73 13.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 120.959 0.409 . . . . 74.230000000000004 110.537 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -143.92 148.9 36.03 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.044 -0.525 . . . . 64.019999999999996 110.003 -177.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -133.32 102.5 5.57 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.691 -0.485 . . . . 71.209999999999994 109.691 176.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 33.7 m -143.65 131.61 21.63 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.243 -0.435 . . . . 74.310000000000002 110.562 -177.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 160.62 -165.52 35.08 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.653 -0.784 . . . . 64.140000000000001 112.261 178.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 752' ' ' PRO . . . . . 0.489 ' HG2' ' HB2' ' A' ' 755' ' ' GLU . 72.7 Cg_endo -78.0 163.81 27.96 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 123.015 2.477 . . . . 73.310000000000002 112.084 177.036 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 753' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 752' ' ' PRO . 3.8 Cg_exo -76.51 -27.94 7.23 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.543 2.162 . . . . 75.209999999999994 112.379 -179.292 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 754' ' ' HIS . . . . . 0.415 ' CE1' ' HB2' ' A' ' 752' ' ' PRO . 39.8 p-80 -79.33 -19.4 50.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.914 0.387 . . . . 72.549999999999997 110.709 178.381 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 755' ' ' GLU . . . . . 0.489 ' HB2' ' HG2' ' A' ' 752' ' ' PRO . 29.3 mt-10 -138.99 79.74 26.09 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.929 -0.578 . . . . 62.43 110.332 175.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 756' ' ' PRO . . . . . 0.493 ' O ' ' HA ' ' A' ' 775' ' ' HIS . 34.9 Cg_endo -65.94 102.38 0.53 Allowed 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.165 1.91 . . . . 73.319999999999993 111.3 177.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 757' ' ' LYS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 775' ' ' HIS . 37.9 ttmt -87.69 114.69 24.54 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.437 0.637 . . . . 65.120000000000005 110.686 -176.099 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 758' ' ' PHE . . . . . 0.471 ' HB3' HD13 ' A' ' 746' ' ' LEU . 78.8 m-85 -97.95 126.12 43.19 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.016 -0.993 . . . . 75.319999999999993 110.48 -178.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 62.0 t -88.86 102.95 13.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 109.488 -0.56 . . . . 54.130000000000003 109.488 174.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 760' ' ' TYR . . . . . 0.469 ' OH ' ' HG3' ' A' ' 777' ' ' LYS . 7.1 m-85 -102.29 142.13 34.01 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.875 -0.602 . . . . 64.409999999999997 110.764 -178.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 761' ' ' GLN . . . . . 0.483 ' OE1' ' HB3' ' A' ' 768' ' ' TRP . 32.0 tt0 -133.75 136.04 44.33 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.717 -0.674 . . . . 73.329999999999998 110.084 179.379 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 762' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 769' ' ' PHE . . . -87.43 116.28 25.43 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.94 -0.573 . . . . 74.120000000000005 110.441 -178.273 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 763' ' ' LYS . . . . . 0.561 ' HB3' ' HB2' ' A' ' 743' ' ' GLU . 58.6 tttm -94.94 100.39 12.25 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.716 -0.674 . . . . 53.109999999999999 109.631 178.131 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 764' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' A' ' 741' ' ' ALA . 58.3 t -104.75 100.7 11.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.965 -0.562 . . . . 74.049999999999997 109.842 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 69.84 -111.65 3.96 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 110.881 -0.888 . . . . 53.130000000000003 110.881 -174.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -112.13 10.99 26.86 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 111.407 -0.677 . . . . 71.010000000000005 111.407 175.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 767' ' ' ARG . . . . . . . . . . . . . 79.7 mtm180 -107.82 131.51 54.4 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.939 0.4 . . . . 72.549999999999997 110.567 -178.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 768' ' ' TRP . . . . . 0.483 ' HB3' ' OE1' ' A' ' 761' ' ' GLN . 43.1 m95 -108.39 101.25 10.46 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.906 -0.588 . . . . 74.329999999999998 109.991 -177.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 769' ' ' PHE . . . . . 0.446 ' HA ' ' HA ' ' A' ' 770' ' ' PRO . 27.2 p90 -167.86 139.8 2.49 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-O 120.74 0.305 . . . . 73.120000000000005 110.61 -178.01 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 770' ' ' PRO . . . . . 0.694 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 68.7 Cg_endo -95.13 -170.09 2.71 Favored 'Cis proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.648 -1.397 . . . . 63.32 111.797 -3.197 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 771' ' ' ALA . . . . . 0.412 ' HB2' HE21 ' A' ' 761' ' ' GLN . . . -122.17 101.49 7.56 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.996 -0.372 . . . . 72.409999999999997 109.996 176.503 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 27.0 m -110.51 168.04 4.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.135 -0.484 . . . . 54.119999999999997 110.81 -176.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 5.8 p -133.6 113.83 12.85 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.244 0.545 . . . . 71.329999999999998 110.995 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -132.03 149.4 52.43 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.866 -0.606 . . . . 54.420000000000002 109.926 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 775' ' ' HIS . . . . . 0.493 ' HA ' ' O ' ' A' ' 756' ' ' PRO . 1.3 p-80 -83.67 18.29 1.98 Allowed 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.592 -0.443 . . . . 73.230000000000004 111.669 -176.371 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 32.5 t -148.39 143.26 26.7 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.896 -0.409 . . . . 73.019999999999996 109.896 176.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 777' ' ' LYS . . . . . 0.469 ' HG3' ' OH ' ' A' ' 760' ' ' TYR . 8.4 ttmm -57.97 -49.8 75.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 72.510000000000005 110.752 178.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -58.94 -45.36 90.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.51 -0.768 . . . . 71.349999999999994 110.376 -178.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 779' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -63.58 -41.47 98.36 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-N 116.086 -0.506 . . . . 64.349999999999994 110.626 177.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -55.6 -44.85 86.04 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.028 -0.606 . . . . 51.340000000000003 112.036 178.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -66.24 -43.65 85.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.649 0.261 . . . . 72.040000000000006 111.024 177.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -63.88 -48.13 77.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.393 -0.367 . . . . 53.109999999999999 110.969 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -61.51 -43.52 98.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 64.439999999999998 110.927 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -63.2 -48.93 76.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.038 -0.528 . . . . 64.5 110.845 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 785' ' ' ALA . . . . . 0.608 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -65.1 -42.02 94.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.319 -0.401 . . . . 53.109999999999999 110.983 -178.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 786' ' ' ASP . . . . . 0.41 ' O ' ' HG3' ' A' ' 790' ' ' ARG . 12.7 t70 -57.64 -50.17 74.02 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.052 -0.522 . . . . 74.420000000000002 110.667 178.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 787' ' ' ALA . . . . . 0.523 ' O ' HG23 ' A' ' 791' ' ' VAL . . . -67.4 -38.75 85.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.043 -0.526 . . . . 72.25 110.968 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 788' ' ' ALA . . . . . 0.694 ' HB2' ' HD3' ' A' ' 770' ' ' PRO . . . -61.48 -43.58 98.62 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.326 -0.397 . . . . 53.340000000000003 111.41 -178.275 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 789' ' ' LEU . . . . . 0.641 HD22 HD12 ' A' ' 719' ' ' LEU . 52.1 mt -59.81 -43.57 94.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.565 -0.289 . . . . 61.439999999999998 110.409 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 790' ' ' ARG . . . . . 0.41 ' HG3' ' O ' ' A' ' 786' ' ' ASP . 67.0 mtt-85 -60.77 -34.34 74.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 75.040000000000006 110.989 178.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 791' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 787' ' ' ALA . 56.8 t -64.9 -49.66 78.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.947 -0.39 . . . . 71.0 109.947 175.24 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 792' ' ' LEU . . . . . 0.624 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 29.6 mt -60.8 -51.49 69.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.859 -0.609 . . . . 72.25 110.884 -178.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 793' ' ' ILE . . . . . 0.496 HD13 HG22 ' A' ' 720' ' ' VAL . 81.9 mt -58.31 -54.33 34.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.399 -0.819 . . . . 64.400000000000006 111.18 178.42 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 794' ' ' GLY . . . . . 0.41 ' O ' ' HB2' ' A' ' 798' ' ' LYS . . . -64.49 -26.57 70.88 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 121.098 -0.572 . . . . 52.399999999999999 112.809 -177.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -66.74 -46.53 75.16 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.925 -0.398 . . . . 52.100000000000001 109.925 177.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 796' ' ' ASN . . . . . 0.415 ' OD1' ' HD2' ' A' ' 714' ' ' ARG . 26.2 t-20 -67.1 -50.23 62.26 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 116.27 -0.423 . . . . 75.439999999999998 110.498 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 797' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -69.02 -13.34 62.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.754 0.311 . . . . 75.439999999999998 111.74 -175.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 798' ' ' LYS . . . . . 0.437 ' NZ ' ' HB2' ' A' ' 798' ' ' LYS . 0.1 OUTLIER -69.74 -20.43 63.51 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.621 0.724 . . . . 71.049999999999997 109.167 174.003 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 799' ' ' ALA . . . . . . . . . . . . . . . -113.21 -33.7 5.9 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.015 -0.993 . . . . 72.340000000000003 110.573 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 800' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 62.1 85.19 0.13 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.034 -0.984 . . . . 63.229999999999997 110.22 -174.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 801' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 . . . . . 0 C--O 1.246 0.909 0 CA-C-O 117.655 -1.164 . . . . 74.329999999999998 110.075 -178.43 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 708' ' ' MET . . . . . . . . . . . . . 92.4 mtp . . . . . 0 N--CA 1.481 1.085 0 CA-C-O 120.822 0.344 . . . . 73.25 110.251 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 43.8 ttm -138.0 132.22 17.02 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 116.155 -0.475 . . . . 63.32 109.863 177.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -63.12 91.97 0.14 Allowed 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.476 2.117 . . . . 64.140000000000001 110.821 172.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 711' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -87.62 84.59 7.08 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.602 -0.727 . . . . 62.039999999999999 110.632 -172.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 712' ' ' LYS . . . . . 0.601 ' HD3' ' H ' ' A' ' 712' ' ' LYS . 0.0 OUTLIER -110.71 -26.96 9.12 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.176 -0.675 . . . . 74.510000000000005 109.176 170.404 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 713' ' ' VAL . . . . . 0.508 HG13 ' HG2' ' A' ' 715' ' ' LYS . 11.3 p -76.24 154.79 5.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.315 -0.857 . . . . 54.140000000000001 108.722 172.434 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 714' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.26 79.74 0.72 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.138 0.494 . . . . 74.129999999999995 112.026 -177.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 715' ' ' LYS . . . . . 0.508 ' HG2' HG13 ' A' ' 713' ' ' VAL . 72.1 mmtt -90.79 86.24 6.27 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.099 -0.704 . . . . 75.540000000000006 109.099 170.347 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 716' ' ' ILE . . . . . 0.5 ' HA ' HD23 ' A' ' 719' ' ' LEU . 47.8 mm -89.48 -25.91 5.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.403 -0.817 . . . . 75.519999999999996 110.913 -172.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -56.95 -25.13 52.65 Favored Glycine 0 N--CA 1.453 -0.232 0 CA-C-N 115.879 -0.601 . . . . 53.200000000000003 111.649 175.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 718' ' ' GLU . . . . . 0.743 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 13.6 mm-40 -62.67 -49.59 74.53 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 115.77 -0.215 . . . . 62.109999999999999 110.692 175.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 719' ' ' LEU . . . . . 0.604 HD12 HD22 ' A' ' 789' ' ' LEU . 2.5 mm? -62.03 -31.67 72.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.016 0.436 . . . . 71.239999999999995 110.436 -176.407 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 720' ' ' VAL . . . . . 0.456 HG22 HD13 ' A' ' 793' ' ' ILE . 63.4 t -64.58 -39.69 86.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.757 -0.656 . . . . 73.030000000000001 111.088 178.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 721' ' ' ARG . . . . . 0.743 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 11.5 ptt180 -67.38 -26.05 66.26 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.071 0.462 . . . . 70.129999999999995 109.932 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -79.02 -29.53 43.66 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.177 -0.465 . . . . 74.439999999999998 110.913 179.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 723' ' ' LEU . . . . . 0.537 HD21 ' HB2' ' A' ' 789' ' ' LEU . 96.5 mt -57.61 -38.94 75.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.176 0.512 . . . . 70.310000000000002 109.898 174.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -80.36 -42.16 23.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.333 -0.849 . . . . 72.299999999999997 111.151 177.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 22.1 m -82.16 -81.5 0.15 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.91 0.386 . . . . 61.329999999999998 111.591 -177.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 726' ' ' ASN . . . . . 0.434 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 38.4 t30 -148.19 105.88 3.6 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 109.756 -0.461 . . . . 50.32 109.756 -179.197 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 727' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 14.0 Cg_endo -58.32 -36.43 97.65 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.79 2.326 . . . . 71.209999999999994 112.351 -176.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 728' ' ' VAL . . . . . 0.412 ' O ' ' HG ' ' A' ' 732' ' ' LEU . 40.3 t -61.26 -49.02 86.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.005 -0.543 . . . . 61.539999999999999 110.936 -177.349 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -64.87 -28.77 73.87 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.901 -0.666 . . . . 51.340000000000003 111.907 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -71.85 -42.53 52.89 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 121.035 -0.603 . . . . 75.219999999999999 112.353 179.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -64.83 -40.43 95.17 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.48 -0.563 . . . . 51.409999999999997 109.48 178.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 732' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 728' ' ' VAL . 95.4 mt -62.78 -44.14 96.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.873 -0.603 . . . . 55.130000000000003 110.691 176.608 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 733' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -65.81 -42.82 90.18 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 122.929 0.492 . . . . 53.520000000000003 110.721 -178.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 734' ' ' TYR . . . . . 0.537 ' HB2' HD11 ' A' ' 719' ' ' LEU . 20.3 t80 -58.13 -51.64 68.86 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.278 -0.419 . . . . 73.409999999999997 110.356 176.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -63.95 -51.46 64.26 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.176 -0.466 . . . . 61.299999999999997 110.857 -177.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 736' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -60.88 -35.58 76.99 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.087 -0.506 . . . . 75.040000000000006 111.429 -174.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 8.1 t -83.25 -25.39 31.69 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.458 -0.337 . . . . 43.100000000000001 111.196 -177.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -95.29 -1.59 51.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.515 0.198 . . . . 73.319999999999993 111.445 -177.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 98.59 -5.91 60.56 Favored Glycine 0 CA--C 1.516 0.15 0 C-N-CA 120.783 -0.722 . . . . 61.25 112.771 175.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 740' ' ' PHE . . . . . 0.41 ' HD1' ' HA3' ' A' ' 765' ' ' GLY . 95.0 m-85 -81.82 167.4 19.08 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.941 0.401 . . . . 65.129999999999995 110.766 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -119.64 110.9 17.39 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.387 -0.597 . . . . 73.0 109.387 175.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 742' ' ' ALA . . . . . . . . . . . . . . . -85.28 132.14 34.31 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.0 0.428 . . . . 62.32 111.74 -175.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 743' ' ' GLU . . . . . 0.505 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 38.1 mt-10 -135.13 142.75 46.25 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.645 -0.707 . . . . 74.349999999999994 110.879 176.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -119.15 101.81 8.27 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.141 -0.688 . . . . 62.329999999999998 109.141 175.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 745' ' ' LYS . . . . . 0.458 ' HB3' ' HZ3' ' A' ' 745' ' ' LYS . 1.1 ptpm? -124.66 144.2 50.32 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.066 0.46 . . . . 70.219999999999999 111.114 -175.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 746' ' ' LEU . . . . . 0.417 HD13 ' HB3' ' A' ' 758' ' ' PHE . 56.8 tp -77.08 117.91 19.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.502 -0.772 . . . . 64.200000000000003 110.037 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 54.5 t -88.03 -49.63 14.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.202 0.525 . . . . 62.530000000000001 110.108 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 748' ' ' ASP . . . . . 0.448 ' O ' ' HB ' ' A' ' 759' ' ' VAL . 26.5 t70 -148.22 154.82 40.6 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.403 -0.817 . . . . 73.340000000000003 109.331 -178.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -132.87 112.86 12.26 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.447 0.642 . . . . 55.020000000000003 110.369 173.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 750' ' ' SER . . . . . 0.457 ' O ' ' HB3' ' A' ' 757' ' ' LYS . 11.3 m -101.78 89.53 3.71 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.363 -0.835 . . . . 61.100000000000001 109.438 177.625 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 751' ' ' GLY . . . . . 0.535 ' HA3' ' HA ' ' A' ' 756' ' ' PRO . . . -152.95 123.5 1.45 Allowed Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 119.48 -1.343 . . . . 61.5 113.855 -174.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 752' ' ' PRO . . . . . 0.458 ' HD2' ' HA2' ' A' ' 751' ' ' GLY . 26.4 Cg_endo -63.51 167.95 12.3 Favored 'Trans proline' 0 CA--C 1.533 0.425 0 C-N-CA 123.002 2.468 . . . . 65.140000000000001 111.105 169.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -56.59 -33.65 93.6 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 122.523 2.148 . . . . 74.209999999999994 112.792 -178.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 39.2 p-80 -88.35 -9.35 53.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.199 -0.455 . . . . 75.239999999999995 111.984 -177.008 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -152.59 73.69 7.33 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 111.792 0.293 . . . . 71.239999999999995 111.792 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 756' ' ' PRO . . . . . 0.535 ' HA ' ' HA3' ' A' ' 751' ' ' GLY . 42.8 Cg_endo -70.1 103.05 1.16 Allowed 'Trans proline' 0 CA--C 1.528 0.224 0 C-N-CA 122.36 2.04 . . . . 62.420000000000002 112.198 176.327 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 757' ' ' LYS . . . . . 0.504 ' H ' ' HA3' ' A' ' 751' ' ' GLY . 40.1 ttmt -96.6 133.0 41.65 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.894 -0.41 . . . . 74.099999999999994 109.894 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 758' ' ' PHE . . . . . 0.417 ' HB3' HD13 ' A' ' 746' ' ' LEU . 95.5 m-85 -110.08 126.03 53.58 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.299 -0.41 . . . . 55.509999999999998 111.147 -176.245 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 759' ' ' VAL . . . . . 0.512 HG22 ' HB3' ' A' ' 773' ' ' CYS . 97.3 t -94.03 104.04 15.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-N 115.78 -0.646 . . . . 71.420000000000002 109.853 177.025 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -102.6 144.6 30.8 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.606 -0.725 . . . . 64.109999999999999 111.179 -177.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 761' ' ' GLN . . . . . 0.497 ' NE2' ' HB3' ' A' ' 768' ' ' TRP . 28.2 tt0 -132.46 131.7 41.98 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.305 -0.861 . . . . 75.299999999999997 109.385 178.208 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 762' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 769' ' ' PHE . . . -90.17 123.46 34.01 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.3 0.571 . . . . 63.549999999999997 110.646 -177.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 763' ' ' LYS . . . . . 0.564 ' HE2' ' HA2' ' A' ' 766' ' ' GLY . 45.5 tttt -99.29 105.88 17.94 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.044 -0.724 . . . . 72.030000000000001 109.044 177.146 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 50.7 t -108.33 91.87 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.233 0.539 . . . . 73.430000000000007 110.689 -178.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 765' ' ' GLY . . . . . 0.41 ' HA3' ' HD1' ' A' ' 740' ' ' PHE . . . 77.8 -7.59 41.15 Favored Glycine 0 N--CA 1.454 -0.132 0 CA-C-N 115.627 -0.715 . . . . 63.210000000000001 112.56 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 766' ' ' GLY . . . . . 0.564 ' HA2' ' HE2' ' A' ' 763' ' ' LYS . . . 136.77 -29.62 2.74 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.31 -0.716 . . . . 63.32 111.31 -177.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 767' ' ' ARG . . . . . 0.472 ' HD2' ' CD1' ' A' ' 769' ' ' PHE . 0.7 OUTLIER -72.57 118.75 15.87 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.078 -0.712 . . . . 74.340000000000003 109.078 177.21 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 768' ' ' TRP . . . . . 0.497 ' HB3' ' NE2' ' A' ' 761' ' ' GLN . 76.4 m95 -88.45 105.48 17.63 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.032 -0.531 . . . . 71.230000000000004 110.267 -178.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 769' ' ' PHE . . . . . 0.472 ' CD1' ' HD2' ' A' ' 767' ' ' ARG . 13.0 p90 -168.43 137.83 1.94 Allowed Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 109.875 -0.417 . . . . 73.540000000000006 109.875 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 770' ' ' PRO . . . . . 0.739 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 58.5 Cg_endo -97.24 -167.75 1.41 Allowed 'Cis proline' 0 N--CA 1.451 -1.012 0 C-N-CA 123.779 -1.342 . . . . 62.350000000000001 112.018 -2.494 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -119.45 101.19 7.77 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.744 -0.465 . . . . 63.240000000000002 109.744 175.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 34.8 m -117.19 170.77 6.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.504 -0.317 . . . . 61.119999999999997 111.135 -174.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 773' ' ' CYS . . . . . 0.512 ' HB3' HG22 ' A' ' 759' ' ' VAL . 4.7 p -142.48 121.67 13.01 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.137 -0.483 . . . . 60.020000000000003 110.606 178.187 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -124.9 154.52 40.96 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.202 -0.454 . . . . 53.140000000000001 110.222 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 775' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -79.87 -4.45 52.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.007 0.432 . . . . 62.329999999999998 110.986 -177.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 54.9 m -131.22 144.62 51.46 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.134 -0.485 . . . . 54.299999999999997 109.998 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 777' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -65.33 -42.97 92.39 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.162 -0.472 . . . . 65.420000000000002 111.158 -175.535 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -65.88 -37.76 86.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.972 0.415 . . . . 73.109999999999999 110.078 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 779' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -66.72 -33.13 74.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.026 -0.533 . . . . 72.209999999999994 110.916 177.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -56.96 -42.99 93.01 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.845 -0.693 . . . . 54.140000000000001 111.714 177.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -64.79 -43.26 93.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.946 0.403 . . . . 61.399999999999999 110.418 176.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -67.24 -46.86 72.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.978 -0.555 . . . . 63.219999999999999 111.181 -178.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -61.51 -40.87 96.17 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 123.163 0.289 . . . . 72.219999999999999 110.894 -179.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -60.97 -52.3 65.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 72.109999999999999 110.431 178.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 785' ' ' ALA . . . . . 0.639 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -63.9 -42.05 97.53 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.091 -0.504 . . . . 71.299999999999997 111.095 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 786' ' ' ASP . . . . . 0.603 ' O ' ' HG2' ' A' ' 790' ' ' ARG . 21.3 t70 -57.09 -56.56 20.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.954 -0.566 . . . . 63.420000000000002 110.871 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 787' ' ' ALA . . . . . 0.574 ' O ' HG23 ' A' ' 791' ' ' VAL . . . -63.92 -33.58 76.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.873 -0.603 . . . . 63.450000000000003 110.972 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 788' ' ' ALA . . . . . 0.739 ' HB2' ' HD3' ' A' ' 770' ' ' PRO . . . -62.67 -41.85 99.3 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.637 0.256 . . . . 62.420000000000002 110.704 177.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 789' ' ' LEU . . . . . 0.639 ' HG ' ' O ' ' A' ' 785' ' ' ALA . 62.9 mt -64.82 -38.81 92.22 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.621 -0.511 . . . . 73.010000000000005 109.621 178.036 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 790' ' ' ARG . . . . . 0.603 ' HG2' ' O ' ' A' ' 786' ' ' ASP . 13.5 mmm180 -59.41 -39.42 83.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.853 -0.612 . . . . 74.140000000000001 110.254 177.594 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 791' ' ' VAL . . . . . 0.574 HG23 ' O ' ' A' ' 787' ' ' ALA . 83.4 t -59.84 -52.12 64.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.858 -0.61 . . . . 74.239999999999995 110.51 176.294 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 792' ' ' LEU . . . . . 0.6 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 25.0 mt -60.94 -49.59 76.83 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.624 -0.716 . . . . 65.400000000000006 110.767 -177.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 793' ' ' ILE . . . . . 0.456 HD13 HG22 ' A' ' 720' ' ' VAL . 85.9 mt -59.72 -41.34 85.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.596 -0.729 . . . . 72.409999999999997 110.965 178.196 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -65.78 -43.93 93.14 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 116.072 -0.513 . . . . 60.439999999999998 112.735 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -62.62 -44.8 95.39 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.676 0.274 . . . . 72.010000000000005 111.006 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 796' ' ' ASN . . . . . 0.427 ' CG ' HG13 ' A' ' 716' ' ' ILE . 10.8 t30 -65.84 -37.14 85.4 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.344 -0.389 . . . . 65.510000000000005 110.712 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 797' ' ' GLU . . . . . 0.636 ' O ' ' HG2' ' A' ' 801' ' ' ARG . 7.6 tp10 -64.25 -56.53 13.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.236 -0.438 . . . . 72.209999999999994 110.203 178.128 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 798' ' ' LYS . . . . . 0.442 ' HA ' ' HD2' ' A' ' 798' ' ' LYS . 5.3 mmmp? -63.74 -17.38 62.97 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.984 0.364 . . . . 70.209999999999994 111.984 -177.601 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 799' ' ' ALA . . . . . . . . . . . . . . . -67.37 -25.24 65.87 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.037 0.446 . . . . 73.049999999999997 110.737 176.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 800' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -114.21 1.45 14.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.021 0.439 . . . . 64.420000000000002 110.881 178.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 801' ' ' ARG . . . . . 0.636 ' HG2' ' O ' ' A' ' 797' ' ' GLU . 22.5 mmt180 . . . . . 0 C--O 1.245 0.842 0 CA-C-O 118.407 -0.806 . . . . 71.439999999999998 109.551 178.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 708' ' ' MET . . . . . . . . . . . . . 72.1 mtm . . . . . 0 N--CA 1.48 1.06 0 CA-C-O 120.422 0.153 . . . . 72.420000000000002 110.664 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 63.7 mtt 63.58 83.77 0.19 Allowed Pre-proline 0 N--CA 1.465 0.306 0 CA-C-N 116.046 -0.525 . . . . 75.329999999999998 110.924 -177.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.06 107.01 2.39 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.914 2.409 . . . . 74.230000000000004 111.702 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 711' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -85.17 141.67 30.02 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.058 -0.519 . . . . 74.230000000000004 110.267 -177.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 712' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -78.71 79.1 5.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.437 0.637 . . . . 74.420000000000002 109.743 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 713' ' ' VAL . . . . . . . . . . . . . 32.1 m -86.43 159.25 3.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.624 -0.716 . . . . 75.019999999999996 111.779 -174.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 714' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -108.94 4.24 23.12 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.0 -1.0 . . . . 74.409999999999997 108.46 173.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -62.14 105.84 0.65 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.045 -0.979 . . . . 62.340000000000003 110.952 -177.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 716' ' ' ILE . . . . . 0.553 ' HA ' HD23 ' A' ' 719' ' ' LEU . 50.7 mm -73.34 -22.91 19.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.433 -0.803 . . . . 60.130000000000003 110.88 -178.168 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -57.2 -23.19 46.44 Favored Glycine 0 CA--C 1.521 0.412 0 CA-C-N 115.881 -0.599 . . . . 74.319999999999993 112.926 178.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 718' ' ' GLU . . . . . 0.737 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 4.7 mm-40 -73.83 -40.54 63.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.184 0.516 . . . . 73.129999999999995 110.136 178.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 719' ' ' LEU . . . . . 0.563 HD12 HD22 ' A' ' 789' ' ' LEU . 3.0 mm? -65.1 -31.78 73.15 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.282 0.563 . . . . 74.129999999999995 109.496 178.327 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 720' ' ' VAL . . . . . 0.425 HG22 HD13 ' A' ' 793' ' ' ILE . 89.8 t -64.07 -41.41 92.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.533 -0.758 . . . . 62.140000000000001 110.798 177.212 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 721' ' ' ARG . . . . . 0.737 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 26.7 ptt180 -63.59 -25.39 68.21 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.064 0.459 . . . . 73.25 110.28 -178.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -79.07 -26.62 43.05 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.392 -0.367 . . . . 74.230000000000004 111.622 178.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 723' ' ' LEU . . . . . 0.482 HD21 ' HB2' ' A' ' 789' ' ' LEU . 87.3 mt -65.08 -23.75 67.25 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.197 -0.668 . . . . 54.409999999999997 109.197 171.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -81.4 -54.66 5.27 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.378 -0.828 . . . . 72.439999999999998 110.538 174.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 15.7 m -89.41 -72.47 0.55 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.571 0.582 . . . . 73.140000000000001 112.571 -174.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 726' ' ' ASN . . . . . 0.436 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 26.6 t30 -145.65 101.53 4.3 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.693 0.282 . . . . 53.32 111.008 -172.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 727' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 17.8 Cg_endo -61.21 -38.59 65.08 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.913 2.409 . . . . 72.329999999999998 112.374 -178.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 728' ' ' VAL . . . . . 0.422 ' O ' ' HG ' ' A' ' 732' ' ' LEU . 41.5 t -60.64 -45.82 96.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.083 -0.508 . . . . 73.25 110.96 -177.036 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -65.52 -39.89 95.85 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.618 -0.801 . . . . 73.140000000000001 112.179 -177.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 730' ' ' GLY . . . . . 0.417 ' HA2' ' HG2' ' A' ' 733' ' ' GLU . . . -67.8 -38.45 89.48 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.908 -0.663 . . . . 51.439999999999998 112.583 -178.64 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -63.38 -41.05 98.77 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.13 0.49 . . . . 64.510000000000005 109.684 178.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 732' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 728' ' ' VAL . 94.0 mt -65.66 -43.64 88.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.701 -0.681 . . . . 72.319999999999993 111.27 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 733' ' ' GLU . . . . . 0.525 ' HA ' ' HG2' ' A' ' 736' ' ' ARG . 11.4 pt-20 -79.51 -25.26 41.81 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 120.544 -0.462 . . . . 72.209999999999994 111.783 -176.128 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 734' ' ' TYR . . . . . 0.51 ' HB2' HD11 ' A' ' 719' ' ' LEU . 7.1 t80 -56.63 -46.43 81.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.275 0.56 . . . . 73.420000000000002 109.493 171.547 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -68.02 -46.8 70.22 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.348 -0.842 . . . . 74.409999999999997 111.047 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 736' ' ' ARG . . . . . 0.525 ' HG2' ' HA ' ' A' ' 733' ' ' GLU . 29.7 ptt180 -60.76 -34.25 74.17 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.097 0.475 . . . . 75.109999999999999 110.706 -176.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 31.5 t -76.7 -38.07 55.02 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.75 -0.659 . . . . 32.420000000000002 110.909 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 16.6 m170 -95.59 0.66 53.15 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.0 0.37 . . . . 73.230000000000004 112.0 -172.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 90.65 4.94 69.52 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.693 -0.765 . . . . 73.549999999999997 113.34 174.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -91.47 173.92 7.64 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.99 0.424 . . . . 72.129999999999995 110.743 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 741' ' ' ALA . . . . . 0.628 ' O ' ' HA ' ' A' ' 764' ' ' VAL . . . -108.45 147.31 31.82 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.29 -0.633 . . . . 74.109999999999999 109.29 173.658 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 742' ' ' ALA . . . . . . . . . . . . . . . -128.89 110.88 12.49 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.825 0.345 . . . . 73.400000000000006 110.521 -178.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 743' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -136.12 154.41 51.0 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.286 -0.416 . . . . 71.530000000000001 110.922 -177.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -122.67 118.64 28.6 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.307 -0.406 . . . . 74.329999999999998 109.985 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 7.1 ptpt -117.65 148.49 41.91 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.051 0.453 . . . . 72.209999999999994 111.251 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 746' ' ' LEU . . . . . . . . . . . . . 6.9 tt -92.25 102.79 15.29 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.014 -1.106 . . . . 74.140000000000001 108.014 175.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 38.5 t -72.56 -45.74 57.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.101 -0.5 . . . . 71.409999999999997 110.654 -174.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -160.64 164.21 31.97 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.105 -0.702 . . . . 74.109999999999999 109.105 -179.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -138.69 125.67 21.21 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.11 0.481 . . . . 73.040000000000006 110.725 178.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 17.1 m -125.39 101.19 6.84 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.676 -0.693 . . . . 72.040000000000006 109.356 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 751' ' ' GLY . . . . . 0.874 ' HA3' ' HA ' ' A' ' 756' ' ' PRO . . . -174.27 134.62 2.88 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 119.534 -1.317 . . . . 74.120000000000005 113.779 -178.421 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 752' ' ' PRO . . . . . 0.453 ' HD2' ' HA2' ' A' ' 751' ' ' GLY . 25.6 Cg_endo -62.04 168.9 8.31 Favored 'Trans proline' 0 CA--C 1.529 0.262 0 C-N-CA 123.535 2.824 . . . . 64.340000000000003 111.432 171.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.71 -28.36 87.14 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.368 2.046 . . . . 72.25 112.6 -179.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 38.7 p-80 -87.6 -17.05 32.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.443 -0.344 . . . . 63.219999999999999 111.476 -178.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -153.1 69.43 6.85 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 111.94 0.348 . . . . 53.310000000000002 111.94 -175.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 756' ' ' PRO . . . . . 0.874 ' HA ' ' HA3' ' A' ' 751' ' ' GLY . 71.9 Cg_endo -80.28 108.2 2.14 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.27 1.98 . . . . 61.409999999999997 112.695 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 757' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -91.44 115.09 27.75 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.975 0.417 . . . . 75.310000000000002 110.476 176.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 758' ' ' PHE . . . . . 0.499 ' O ' ' HA ' ' A' ' 773' ' ' CYS . 58.9 m-85 -97.13 130.22 44.42 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.955 -0.566 . . . . 75.219999999999999 110.2 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 759' ' ' VAL . . . . . 0.487 HG22 ' HB3' ' A' ' 773' ' ' CYS . 48.3 t -92.96 105.27 16.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.989 0.424 . . . . 75.450000000000003 110.201 178.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -102.46 143.86 31.64 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.262 -0.881 . . . . 75.150000000000006 110.671 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 761' ' ' GLN . . . . . 0.58 ' HA ' ' O ' ' A' ' 770' ' ' PRO . 36.5 tt0 -135.06 135.09 41.01 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.978 -0.556 . . . . 74.230000000000004 109.978 177.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 762' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 769' ' ' PHE . . . -91.51 126.58 36.65 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.159 0.504 . . . . 72.420000000000002 111.025 -178.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -97.32 107.76 20.34 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.595 -0.73 . . . . 72.329999999999998 109.293 176.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 764' ' ' VAL . . . . . 0.628 ' HA ' ' O ' ' A' ' 741' ' ' ALA . 63.0 t -116.37 103.84 15.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.234 0.54 . . . . 64.439999999999998 110.055 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 70.09 -115.1 5.91 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 110.896 -0.882 . . . . 61.340000000000003 110.896 -174.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -109.57 9.82 32.72 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.77 -0.729 . . . . 52.450000000000003 111.328 175.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 767' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -106.84 143.56 34.75 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.075 0.464 . . . . 64.319999999999993 110.5 -177.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 768' ' ' TRP . . . . . 0.454 ' HB3' ' OE1' ' A' ' 761' ' ' GLN . 68.3 m95 -116.55 102.48 9.51 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.629 -0.714 . . . . 72.030000000000001 109.902 -178.445 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 769' ' ' PHE . . . . . 0.43 ' HA ' ' HA ' ' A' ' 770' ' ' PRO . 33.1 p90 -168.91 141.83 2.27 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.343 -0.39 . . . . 74.0 110.23 -176.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 770' ' ' PRO . . . . . 0.634 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 62.5 Cg_endo -98.88 -179.7 5.64 Favored 'Cis proline' 0 N--CA 1.45 -1.034 0 C-N-CA 123.564 -1.432 . . . . 55.119999999999997 111.979 -4.12 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 771' ' ' ALA . . . . . 0.439 ' HB2' HE21 ' A' ' 761' ' ' GLN . . . -110.98 112.43 24.24 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.553 -0.536 . . . . 52.020000000000003 109.553 174.071 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 34.3 m -124.47 149.48 28.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.356 -0.384 . . . . 73.019999999999996 110.937 -177.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 773' ' ' CYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 758' ' ' PHE . 7.7 p -118.02 115.3 24.6 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.938 0.399 . . . . 72.010000000000005 110.453 178.139 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -123.07 157.51 32.66 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.177 -0.465 . . . . 63.409999999999997 110.619 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 775' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -83.29 11.44 6.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.847 0.356 . . . . 70.299999999999997 111.759 -176.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 776' ' ' SER . . . . . 0.439 ' HB3' ' CG ' ' A' ' 779' ' ' GLN . 8.5 t -153.28 145.62 23.97 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.82 -0.437 . . . . 62.210000000000001 109.82 -178.734 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 777' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -59.63 -50.36 74.18 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.062 -0.517 . . . . 73.109999999999999 111.303 -177.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -62.4 -36.53 82.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.848 0.356 . . . . 71.200000000000003 110.401 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 779' ' ' GLN . . . . . 0.439 ' CG ' ' HB3' ' A' ' 776' ' ' SER . 16.2 mm100 -64.19 -41.92 96.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 54.439999999999998 110.2 178.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -55.87 -48.44 72.51 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.038 -0.601 . . . . 75.25 112.3 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -65.1 -45.47 85.03 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.852 0.358 . . . . 73.5 111.189 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -66.01 -47.2 75.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.23 -0.441 . . . . 72.239999999999995 111.519 -176.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -62.58 -39.07 92.53 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.684 0.278 . . . . 61.219999999999999 110.494 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -62.58 -46.85 86.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.269 -0.423 . . . . 61.32 110.748 177.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 785' ' ' ALA . . . . . 0.444 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -65.38 -42.55 92.57 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.234 -0.439 . . . . 62.240000000000002 110.953 -179.601 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 786' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -56.98 -51.17 70.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.337 0.589 . . . . 73.340000000000003 110.404 176.272 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 787' ' ' ALA . . . . . 0.644 ' O ' HG23 ' A' ' 791' ' ' VAL . . . -64.66 -38.72 91.96 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.333 -0.849 . . . . 72.549999999999997 111.066 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 788' ' ' ALA . . . . . 0.634 ' HB2' ' HD3' ' A' ' 770' ' ' PRO . . . -61.62 -47.0 87.4 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.383 -0.371 . . . . 71.0 111.077 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 789' ' ' LEU . . . . . 0.563 HD22 HD12 ' A' ' 719' ' ' LEU . 79.6 mt -60.97 -43.57 98.58 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.842 -0.429 . . . . 73.450000000000003 109.842 177.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 790' ' ' ARG . . . . . . . . . . . . . 30.7 mtt180 -63.52 -26.43 68.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 72.329999999999998 111.684 178.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 791' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 787' ' ' ALA . 98.2 t -68.68 -50.43 55.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.747 -0.464 . . . . 70.140000000000001 109.747 172.69 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 792' ' ' LEU . . . . . 0.581 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 27.2 mt -61.44 -49.92 74.88 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.431 -0.804 . . . . 65.209999999999994 110.349 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 793' ' ' ILE . . . . . 0.432 HG12 ' CG2' ' A' ' 716' ' ' ILE . 95.7 mt -59.61 -43.45 91.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.258 -0.883 . . . . 74.439999999999998 110.881 178.39 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -68.01 -32.47 77.06 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 121.002 -0.618 . . . . 63.409999999999997 112.644 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -69.37 -44.16 72.09 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.169 0.509 . . . . 72.439999999999998 110.404 178.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 796' ' ' ASN . . . . . 0.526 ' HB3' HG13 ' A' ' 716' ' ' ILE . 2.7 t30 -93.24 9.52 35.8 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.851 -0.613 . . . . 71.209999999999994 110.376 -175.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 797' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -65.46 107.52 1.7 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.838 -0.619 . . . . 64.519999999999996 110.338 -176.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 798' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm 61.07 21.44 11.82 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.859 -0.61 . . . . 73.409999999999997 111.177 -176.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 799' ' ' ALA . . . . . . . . . . . . . . . -119.01 116.23 26.0 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.958 0.408 . . . . 72.420000000000002 110.605 -179.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 800' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -81.65 98.23 8.27 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.318 -0.401 . . . . 61.43 109.962 176.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 801' ' ' ARG . . . . . . . . . . . . . 16.4 mmm180 . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.355 -0.831 . . . . 70.209999999999994 109.659 177.728 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 708' ' ' MET . . . . . . . . . . . . . 24.4 mmt . . . . . 0 N--CA 1.477 0.894 0 N-CA-C 110.546 -0.168 . . . . 72.439999999999998 110.546 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 20.6 mmt 51.9 76.73 0.51 Allowed Pre-proline 0 N--CA 1.464 0.261 0 O-C-N 123.439 0.462 . . . . 54.109999999999999 111.418 -176.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -73.44 89.93 0.93 Allowed 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.494 2.129 . . . . 72.109999999999999 111.733 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 711' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -69.11 -32.06 71.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.316 0.579 . . . . 72.0 109.718 175.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 712' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -90.9 117.01 29.16 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.595 -0.891 . . . . 61.140000000000001 108.595 172.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 713' ' ' VAL . . . . . 0.495 HG23 ' HG3' ' A' ' 715' ' ' LYS . 26.9 m -61.44 151.54 6.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-O 121.233 0.539 . . . . 70.310000000000002 111.442 -176.314 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.441 HH11 ' HD2' ' A' ' 714' ' ' ARG . 57.6 mtt180 -79.08 84.22 5.09 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.79 -0.641 . . . . 71.450000000000003 110.54 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 715' ' ' LYS . . . . . 0.495 ' HG3' HG23 ' A' ' 713' ' ' VAL . 7.5 mtpm? -76.75 106.51 8.46 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.601 -0.727 . . . . 71.120000000000005 109.901 177.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 716' ' ' ILE . . . . . 0.495 ' HA ' HD23 ' A' ' 719' ' ' LEU . 46.7 mm -117.01 -32.3 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.15 -0.477 . . . . 62.130000000000003 111.445 -172.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -60.97 -27.89 67.82 Favored Glycine 0 C--N 1.33 0.208 0 C-N-CA 120.98 -0.629 . . . . 62.149999999999999 112.101 -179.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 718' ' ' GLU . . . . . 0.782 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 2.8 mp0 -63.19 -39.49 94.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.894 0.378 . . . . 72.140000000000001 110.593 177.349 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 719' ' ' LEU . . . . . 0.625 HD12 HD22 ' A' ' 789' ' ' LEU . 3.0 mm? -67.48 -29.78 69.31 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.073 0.463 . . . . 74.140000000000001 110.139 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 720' ' ' VAL . . . . . 0.517 HG22 HD13 ' A' ' 793' ' ' ILE . 56.6 t -66.65 -41.61 88.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.819 -0.628 . . . . 62.409999999999997 110.737 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 721' ' ' ARG . . . . . 0.782 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 11.8 ptm180 -65.11 -28.47 69.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.016 0.436 . . . . 70.340000000000003 109.907 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -74.19 -30.17 62.09 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.34 -0.391 . . . . 52.140000000000001 110.853 177.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 723' ' ' LEU . . . . . 0.575 HD21 ' HB2' ' A' ' 789' ' ' LEU . 90.9 mt -60.74 -27.55 68.01 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.252 0.549 . . . . 72.25 109.893 173.585 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -86.45 -44.65 11.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.476 -0.784 . . . . 74.299999999999997 110.817 176.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 51.0 m -89.57 -76.64 0.41 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.296 -0.411 . . . . 74.0 112.043 -175.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 726' ' ' ASN . . . . . 0.442 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 53.8 t-20 -144.82 105.77 4.55 Favored Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 109.997 -0.371 . . . . 53.409999999999997 109.997 -177.091 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 727' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 20.0 Cg_endo -61.3 -35.97 81.73 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.881 2.387 . . . . 73.310000000000002 112.246 -179.361 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 728' ' ' VAL . . . . . 0.445 ' O ' ' HG ' ' A' ' 732' ' ' LEU . 59.7 t -64.31 -45.53 95.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.019 -0.537 . . . . 74.450000000000003 110.459 -178.269 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -61.63 -34.48 88.67 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.945 -0.645 . . . . 62.539999999999999 112.355 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -74.79 -41.32 34.44 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.796 -0.716 . . . . 54.340000000000003 112.56 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -63.12 -40.33 97.3 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.863 -0.421 . . . . 75.140000000000001 109.863 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 732' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 728' ' ' VAL . 95.5 mt -64.19 -46.28 84.62 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.027 -0.533 . . . . 74.25 111.281 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 733' ' ' GLU . . . . . 0.5 ' HA ' ' HG2' ' A' ' 736' ' ' ARG . 6.3 pt-20 -73.97 -31.47 63.02 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.41 -0.516 . . . . 72.340000000000003 110.981 -177.523 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 734' ' ' TYR . . . . . 0.402 ' HB2' HD11 ' A' ' 719' ' ' LEU . 9.3 t80 -57.29 -48.6 78.5 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 120.895 0.378 . . . . 71.310000000000002 110.063 175.284 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 735' ' ' ALA . . . . . 0.43 ' HA ' ' HB2' ' A' ' 740' ' ' PHE . . . -65.04 -51.18 63.0 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.985 -0.552 . . . . 64.329999999999998 110.643 -177.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 736' ' ' ARG . . . . . 0.5 ' HG2' ' HA ' ' A' ' 733' ' ' GLU . 12.2 ptm180 -61.7 -34.99 76.73 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.807 -0.633 . . . . 71.420000000000002 111.515 -174.256 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 47.0 t -77.56 -37.14 51.31 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.038 -0.528 . . . . 74.150000000000006 111.096 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -91.51 -2.53 57.16 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.119 0.414 . . . . 72.129999999999995 112.119 -171.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 94.81 7.93 59.66 Favored Glycine 0 CA--C 1.516 0.143 0 C-N-CA 120.45 -0.881 . . . . 54.340000000000003 112.719 176.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 740' ' ' PHE . . . . . 0.43 ' HB2' ' HA ' ' A' ' 735' ' ' ALA . 98.3 m-85 -93.15 177.81 5.94 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.032 0.444 . . . . 54.119999999999997 110.538 177.123 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -129.69 124.6 33.98 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.882 -0.599 . . . . 62.200000000000003 109.526 175.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 742' ' ' ALA . . . . . . . . . . . . . . . -94.05 115.7 28.05 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.774 0.321 . . . . 54.219999999999999 111.148 -176.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 743' ' ' GLU . . . . . 0.573 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 40.8 mt-10 -127.48 125.36 40.34 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.016 -0.538 . . . . 74.030000000000001 111.051 -179.077 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -105.25 117.27 33.59 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.115 -0.493 . . . . 75.329999999999998 110.414 179.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -134.2 150.42 51.07 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.184 0.516 . . . . 62.240000000000002 111.342 178.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 746' ' ' LEU . . . . . 0.462 HD21 ' HB3' ' A' ' 749' ' ' GLN . 4.9 tt -85.96 111.52 20.33 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.065 -1.087 . . . . 72.340000000000003 108.065 173.353 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 58.7 t -82.96 -46.25 18.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.895 0.379 . . . . 70.140000000000001 111.143 -174.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -152.03 149.69 29.14 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.407 -0.361 . . . . 61.229999999999997 110.374 -178.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 749' ' ' GLN . . . . . 0.462 ' HB3' HD21 ' A' ' 746' ' ' LEU . 4.9 pp0? -144.68 153.09 41.37 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.787 0.327 . . . . 65.340000000000003 110.946 179.515 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 20.9 t -174.75 -169.81 0.44 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.818 -0.808 . . . . 71.230000000000004 108.818 -178.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 107.83 175.18 22.25 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.524 -0.846 . . . . 43.310000000000002 112.733 176.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 752' ' ' PRO . . . . . 0.839 ' HG2' ' HB2' ' A' ' 755' ' ' GLU . 44.9 Cg_endo -69.32 164.35 34.45 Favored 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 123.084 2.523 . . . . 72.25 112.721 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -64.43 -33.65 56.94 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.62 2.213 . . . . 61.219999999999999 112.685 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 22.3 p80 -82.95 -15.55 50.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.307 -0.406 . . . . 73.329999999999998 111.102 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 755' ' ' GLU . . . . . 0.839 ' HB2' ' HG2' ' A' ' 752' ' ' PRO . 45.0 mt-10 -135.27 73.75 63.28 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.401 -0.363 . . . . 75.219999999999999 110.798 177.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 756' ' ' PRO . . . . . 0.543 ' O ' ' HA ' ' A' ' 775' ' ' HIS . 42.1 Cg_endo -69.15 114.69 3.69 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.09 1.86 . . . . 65.340000000000003 111.329 178.377 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 757' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -100.43 117.42 34.57 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.032 0.444 . . . . 71.329999999999998 110.727 -176.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 758' ' ' PHE . . . . . 0.445 ' CZ ' ' HB2' ' A' ' 756' ' ' PRO . 53.5 m-85 -115.12 121.23 42.39 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.602 -0.726 . . . . 72.450000000000003 109.872 -179.207 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 26.3 t -90.58 106.41 17.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 120.996 0.427 . . . . 70.200000000000003 110.313 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -99.26 139.26 35.16 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.688 -0.687 . . . . 71.549999999999997 110.285 178.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 761' ' ' GLN . . . . . 0.479 ' HA ' ' O ' ' A' ' 770' ' ' PRO . 55.9 tt0 -130.07 135.73 48.56 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.033 -0.53 . . . . 75.420000000000002 109.725 178.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 762' ' ' ALA . . . . . . . . . . . . . . . -90.56 112.42 24.1 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.967 -0.56 . . . . 72.329999999999998 110.71 -178.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 763' ' ' LYS . . . . . 0.573 ' HB3' ' HB2' ' A' ' 743' ' ' GLU . 61.0 tttm -88.32 104.66 16.95 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.065 -0.717 . . . . 70.439999999999998 109.065 175.572 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 56.9 t -109.9 100.72 11.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.349 0.595 . . . . 73.310000000000002 109.975 -179.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 75.19 -117.9 5.43 Favored Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 110.834 -0.906 . . . . 53.43 110.834 -175.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -103.36 3.97 47.48 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.662 -0.78 . . . . 63.219999999999999 111.627 176.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 767' ' ' ARG . . . . . . . . . . . . . 50.3 mtt180 -103.58 152.86 21.24 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.052 0.454 . . . . 72.219999999999999 111.029 -176.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 768' ' ' TRP . . . . . 0.567 ' CH2' ' HD2' ' A' ' 763' ' ' LYS . 59.2 m95 -118.83 105.15 11.23 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.687 -0.688 . . . . 72.310000000000002 109.386 176.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 769' ' ' PHE . . . . . 0.434 ' HA ' ' HA ' ' A' ' 770' ' ' PRO . 21.4 p90 -171.47 139.09 1.14 Allowed Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 120.854 0.359 . . . . 72.349999999999994 110.925 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 770' ' ' PRO . . . . . 0.607 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 79.6 Cg_endo -99.54 -176.8 3.79 Favored 'Cis proline' 0 N--CA 1.453 -0.908 0 C-N-CA 123.718 -1.367 . . . . 63.119999999999997 111.947 -4.134 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -113.88 116.18 28.87 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.771 -0.455 . . . . 34.009999999999998 109.771 175.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 29.1 m -118.94 140.74 41.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.145 0.498 . . . . 72.450000000000003 111.269 -176.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 3.9 p -95.72 102.54 14.35 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.89 -0.596 . . . . 71.150000000000006 110.508 178.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -107.15 177.63 4.79 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.147 -0.479 . . . . 73.310000000000002 110.817 -177.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 775' ' ' HIS . . . . . 0.543 ' HA ' ' O ' ' A' ' 756' ' ' PRO . 28.5 m-70 -117.38 12.45 14.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.127 0.489 . . . . 65.530000000000001 110.066 178.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 33.7 t -167.76 154.06 7.72 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.533 -0.758 . . . . 65.340000000000003 109.692 -176.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 777' ' ' LYS . . . . . . . . . . . . . 5.4 tmmm? -62.53 -42.66 99.67 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.649 -0.5 . . . . 72.230000000000004 109.649 177.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -58.31 -40.46 82.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.417 -0.811 . . . . 65.420000000000002 110.723 178.112 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 779' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -70.06 -45.55 66.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.318 -0.401 . . . . 62.039999999999999 110.438 177.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -54.55 -47.59 69.31 Favored Glycine 0 C--O 1.226 -0.398 0 CA-C-N 115.909 -0.587 . . . . 61.310000000000002 113.072 -176.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -66.79 -44.79 80.39 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.621 0.248 . . . . 72.439999999999998 111.258 -178.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -67.63 -49.39 63.17 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.541 -0.3 . . . . 75.430000000000007 111.358 -177.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -63.68 -39.89 95.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.572 0.225 . . . . 65.129999999999995 110.938 -178.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -62.05 -50.78 70.62 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 116.486 -0.325 . . . . 64.439999999999998 110.527 178.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 785' ' ' ALA . . . . . 0.555 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -65.75 -39.11 90.74 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.324 -0.398 . . . . 62.240000000000002 110.968 -179.316 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 786' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -57.75 -54.17 49.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.031 -0.531 . . . . 71.200000000000003 110.476 177.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 787' ' ' ALA . . . . . 0.606 ' O ' HG23 ' A' ' 791' ' ' VAL . . . -64.82 -36.69 85.13 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.855 -0.611 . . . . 25.43 110.723 179.33 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 788' ' ' ALA . . . . . 0.634 ' O ' ' HG ' ' A' ' 792' ' ' LEU . . . -59.49 -48.61 80.98 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.556 -0.293 . . . . 75.430000000000007 110.98 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 789' ' ' LEU . . . . . 0.625 HD22 HD12 ' A' ' 719' ' ' LEU . 63.1 mt -61.49 -39.97 92.85 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.837 -0.431 . . . . 63.210000000000001 109.837 178.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 790' ' ' ARG . . . . . . . . . . . . . 65.4 mtp180 -64.31 -30.91 71.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.607 -0.724 . . . . 75.310000000000002 111.488 178.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 791' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 787' ' ' ALA . 91.5 t -66.94 -48.26 80.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.758 -0.46 . . . . 75.310000000000002 109.758 173.516 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 792' ' ' LEU . . . . . 0.634 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 23.0 mt -60.58 -54.57 43.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.724 -0.671 . . . . 64.120000000000005 110.436 -179.357 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 793' ' ' ILE . . . . . 0.517 HD13 HG22 ' A' ' 720' ' ' VAL . 76.6 mt -58.15 -45.73 88.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.382 -0.826 . . . . 75.439999999999998 110.594 177.318 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 794' ' ' GLY . . . . . 0.648 ' O ' ' HG3' ' A' ' 798' ' ' LYS . . . -59.5 -48.4 86.18 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 121.121 -0.561 . . . . 75.120000000000005 112.276 179.475 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 795' ' ' GLU . . . . . 0.882 ' HA ' ' HD2' ' A' ' 798' ' ' LYS . 52.1 mm-40 -60.88 -31.3 70.78 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.568 0.211 . . . . 70.439999999999998 111.568 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -66.94 -42.77 84.7 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.192 0.52 . . . . 72.430000000000007 110.518 176.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 797' ' ' GLU . . . . . 0.436 ' HG3' ' O ' ' A' ' 793' ' ' ILE . 51.2 mt-10 -71.79 -24.6 61.77 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.585 -0.734 . . . . 73.340000000000003 111.966 -174.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 798' ' ' LYS . . . . . 0.882 ' HD2' ' HA ' ' A' ' 795' ' ' GLU . 0.0 OUTLIER -104.84 14.71 29.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.71 0.29 . . . . 75.340000000000003 111.542 178.616 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 799' ' ' ALA . . . . . . . . . . . . . . . -113.36 169.96 8.57 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.663 0.268 . . . . 63.310000000000002 110.497 177.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 800' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -84.07 104.63 14.3 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.44 -0.578 . . . . 71.340000000000003 109.44 177.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 801' ' ' ARG . . . . . . . . . . . . . 46.7 mtm180 . . . . . 0 C--O 1.247 0.958 0 CA-C-O 118.395 -0.812 . . . . 71.510000000000005 110.483 -177.418 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 708' ' ' MET . . . . . . . . . . . . . 25.8 mmt . . . . . 0 N--CA 1.482 1.157 0 CA-C-O 120.764 0.316 . . . . 64.129999999999995 111.257 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 63.9 mtm -121.56 110.01 34.13 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.389 -0.596 . . . . 23.399999999999999 109.389 174.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -56.58 111.3 0.75 Allowed 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 123.197 2.598 . . . . 71.109999999999999 112.95 -175.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 711' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -87.59 158.2 18.94 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.976 -0.556 . . . . 62.100000000000001 109.636 176.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 712' ' ' LYS . . . . . 0.467 ' NZ ' ' HB2' ' A' ' 712' ' ' LYS . 4.0 ttmp? -80.75 76.85 7.65 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.777 0.799 . . . . 74.239999999999995 109.809 179.273 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 713' ' ' VAL . . . . . . . . . . . . . 7.1 p -173.12 167.32 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 107.721 -1.215 . . . . 73.409999999999997 107.721 -179.112 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 714' ' ' ARG . . . . . . . . . . . . . 69.1 ttt180 -75.29 72.91 2.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.142 0.496 . . . . 62.200000000000003 110.332 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -92.5 106.11 18.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.724 -0.671 . . . . 53.310000000000002 109.644 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 716' ' ' ILE . . . . . 0.559 ' HA ' HD23 ' A' ' 719' ' ' LEU . 47.0 mm -78.79 -24.18 13.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.689 -0.687 . . . . 74.099999999999994 111.626 -173.567 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -56.92 -30.63 60.36 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 121.196 -0.526 . . . . 65.310000000000002 112.893 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -66.32 -41.04 90.23 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.762 0.315 . . . . 73.299999999999997 110.79 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 719' ' ' LEU . . . . . 0.602 HD12 HD22 ' A' ' 789' ' ' LEU . 2.9 mm? -65.02 -36.3 83.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.016 0.436 . . . . 65.430000000000007 109.998 -178.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 720' ' ' VAL . . . . . 0.507 HG22 HD13 ' A' ' 793' ' ' ILE . 52.3 t -64.08 -37.5 80.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-N 115.82 -0.627 . . . . 53.539999999999999 110.173 176.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 721' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.12 -30.32 71.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.794 -0.639 . . . . 55.219999999999999 109.775 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -78.47 -25.04 45.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.898 -0.592 . . . . 74.420000000000002 111.471 179.059 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 91.1 mt -60.03 -30.6 69.28 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.425 0.631 . . . . 71.25 109.461 173.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -84.87 -56.59 3.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.312 -0.858 . . . . 73.540000000000006 111.219 174.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 24.4 m -77.91 -64.23 1.2 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.916 0.709 . . . . 62.32 112.916 -171.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 726' ' ' ASN . . . . . 0.42 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 30.6 t30 -159.94 100.76 1.45 Allowed Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 120.834 0.349 . . . . 73.129999999999995 110.914 -175.153 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 727' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 20.9 Cg_endo -62.36 -39.61 45.58 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.875 2.384 . . . . 71.010000000000005 112.317 -177.632 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 39.5 t -59.97 -42.3 89.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.998 -0.546 . . . . 70.530000000000001 110.958 -177.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 729' ' ' GLY . . . . . 0.473 ' O ' ' HG2' ' A' ' 733' ' ' GLU . . . -65.02 -47.38 82.99 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.611 -0.804 . . . . 72.329999999999998 111.939 -179.24 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -64.14 -39.31 97.02 Favored Glycine 0 C--O 1.226 -0.349 0 C-N-CA 121.09 -0.576 . . . . 72.129999999999995 113.259 -176.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -61.67 -39.76 92.56 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.894 -0.41 . . . . 53.119999999999997 109.894 179.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 732' ' ' LEU . . . . . . . . . . . . . 96.3 mt -68.04 -47.34 68.64 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.929 -0.578 . . . . 65.0 111.276 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 733' ' ' GLU . . . . . 0.502 ' HA ' ' HB3' ' A' ' 736' ' ' ARG . 9.1 pt-20 -75.15 -26.47 59.14 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.715 -0.394 . . . . 74.230000000000004 111.683 -176.233 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 734' ' ' TYR . . . . . 0.426 ' HB2' HD11 ' A' ' 719' ' ' LEU . 17.5 t80 -56.99 -50.17 73.52 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.347 -0.612 . . . . 74.230000000000004 109.347 172.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -64.29 -46.29 84.29 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.903 -0.589 . . . . 72.109999999999999 110.533 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 736' ' ' ARG . . . . . 0.502 ' HB3' ' HA ' ' A' ' 733' ' ' GLU . 1.4 ttt180 -55.49 -48.73 74.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.07 -0.514 . . . . 73.219999999999999 112.011 -178.083 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 22.7 t -81.59 -11.82 58.99 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.678 0.275 . . . . 64.519999999999996 111.224 -174.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -110.49 -2.61 16.44 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.817 -0.353 . . . . 71.230000000000004 111.592 -176.096 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 88.9 9.96 67.37 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.538 -0.839 . . . . 74.319999999999993 113.258 174.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -95.61 168.72 10.51 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.906 0.353 . . . . 64.340000000000003 110.4 177.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -114.1 114.48 26.14 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.219 -0.446 . . . . 60.119999999999997 110.025 176.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 742' ' ' ALA . . . . . . . . . . . . . . . -92.48 133.22 36.13 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.262 -0.427 . . . . 64.420000000000002 110.886 -178.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 743' ' ' GLU . . . . . 0.455 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 9.7 mm-40 -144.98 157.65 44.06 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.271 -0.422 . . . . 73.400000000000006 111.142 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -130.16 132.03 45.89 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.815 -0.63 . . . . 72.430000000000007 109.76 177.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -136.37 137.92 41.06 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.126 0.489 . . . . 65.019999999999996 111.748 177.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 746' ' ' LEU . . . . . . . . . . . . . 5.0 tt -82.69 105.33 13.63 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.385 -0.969 . . . . 75.150000000000006 108.385 173.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 46.0 t -70.98 -56.13 11.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.919 0.39 . . . . 53.399999999999999 110.686 -176.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -154.94 152.37 29.64 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.977 -0.556 . . . . 73.109999999999999 110.276 -178.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -134.06 122.75 23.4 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.951 -0.759 . . . . 74.549999999999997 108.951 174.029 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 67.3 m -146.56 148.28 31.99 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.722 0.296 . . . . 62.520000000000003 110.942 -176.031 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 139.77 -177.65 20.34 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.93 -0.652 . . . . 74.040000000000006 112.163 177.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 752' ' ' PRO . . . . . 0.433 ' HG2' ' CB ' ' A' ' 755' ' ' GLU . 54.9 Cg_endo -71.47 166.76 28.34 Favored 'Trans proline' 0 CA--C 1.533 0.442 0 C-N-CA 122.793 2.329 . . . . 73.340000000000003 111.962 176.492 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -63.76 -34.99 59.76 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.684 2.256 . . . . 55.140000000000001 112.824 -178.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 54.7 p-80 -84.51 -7.26 59.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.958 0.408 . . . . 70.109999999999999 111.069 -178.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 755' ' ' GLU . . . . . 0.433 ' CB ' ' HG2' ' A' ' 752' ' ' PRO . 0.4 OUTLIER -141.95 68.95 23.76 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 116.132 -0.485 . . . . 73.510000000000005 109.972 -178.694 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 756' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -79.64 109.26 2.42 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.405 2.07 . . . . 71.540000000000006 111.936 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 757' ' ' LYS . . . . . 0.435 ' NZ ' ' HB2' ' A' ' 757' ' ' LYS . 4.4 ttmp? -93.73 112.99 24.95 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.237 0.541 . . . . 73.329999999999998 110.58 -178.351 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 758' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -99.05 119.29 37.57 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.363 -0.835 . . . . 75.319999999999993 110.454 -178.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 16.7 t -92.67 105.85 17.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.19 -0.459 . . . . 74.299999999999997 109.904 178.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 760' ' ' TYR . . . . . 0.41 ' HE1' ' HG2' ' A' ' 777' ' ' LYS . 1.5 m-85 -108.92 141.9 40.32 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.984 -0.553 . . . . 72.530000000000001 110.735 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 761' ' ' GLN . . . . . 0.542 ' HA ' ' O ' ' A' ' 770' ' ' PRO . 29.7 tt0 -133.96 135.96 43.85 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.751 -0.658 . . . . 73.439999999999998 109.613 176.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 762' ' ' ALA . . . . . . . . . . . . . . . -96.86 147.69 23.69 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.799 -0.637 . . . . 73.540000000000006 110.443 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 763' ' ' LYS . . . . . 0.557 ' HE3' ' CZ2' ' A' ' 768' ' ' TRP . 68.1 tttt -118.46 127.86 54.06 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.295 -0.631 . . . . 73.319999999999993 109.295 178.167 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 62.9 t -127.64 102.0 8.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.146 0.498 . . . . 60.140000000000001 109.869 178.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 76.41 -101.99 1.56 Allowed Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 110.96 -0.856 . . . . 72.140000000000001 110.96 -176.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -121.0 4.81 11.37 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 111.219 -0.752 . . . . 71.540000000000006 111.219 174.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 767' ' ' ARG . . . . . . . . . . . . . 39.7 mmt180 -98.5 146.29 25.92 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.974 0.416 . . . . 72.239999999999995 110.903 -178.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 768' ' ' TRP . . . . . 0.557 ' CZ2' ' HE3' ' A' ' 763' ' ' LYS . 55.6 m95 -117.28 107.41 14.37 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.617 -0.719 . . . . 74.540000000000006 109.777 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 769' ' ' PHE . . . . . 0.469 ' HA ' ' HA ' ' A' ' 770' ' ' PRO . 47.2 p90 -169.87 143.23 2.08 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 110.198 -0.297 . . . . 74.129999999999995 110.198 -177.402 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 770' ' ' PRO . . . . . 0.592 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 62.1 Cg_endo -99.07 178.53 6.38 Favored 'Cis proline' 0 N--CA 1.452 -0.933 0 C-N-CA 123.633 -1.403 . . . . 64.0 111.875 -4.645 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -105.13 102.24 11.75 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.626 -0.509 . . . . 51.149999999999999 109.626 173.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 24.0 m -116.92 135.44 57.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.077 0.465 . . . . 72.549999999999997 111.176 -176.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 773' ' ' CYS . . . . . 0.408 ' HB2' ' CG ' ' A' ' 757' ' ' LYS . 1.5 p -110.22 102.71 11.36 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.0 -0.545 . . . . 74.340000000000003 110.174 177.493 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -100.29 178.97 4.61 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.726 -0.67 . . . . 75.200000000000003 111.175 -175.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 775' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -94.44 -8.82 37.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.052 0.453 . . . . 70.310000000000002 110.516 -176.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 55.2 m -145.91 158.02 43.88 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.693 -0.685 . . . . 75.230000000000004 109.765 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 777' ' ' LYS . . . . . 0.41 ' HG2' ' HE1' ' A' ' 760' ' ' TYR . 6.1 tmmm? -69.3 -39.71 78.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.589 -0.278 . . . . 62.43 110.539 -177.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 778' ' ' LYS . . . . . 0.414 ' HE3' ' OE1' ' A' ' 782' ' ' GLN . 58.1 tptt -60.89 -47.41 86.52 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.861 -0.422 . . . . 54.530000000000001 109.861 175.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 779' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -52.92 -47.98 67.59 Favored 'General case' 0 C--O 1.226 -0.137 0 CA-C-N 115.709 -0.678 . . . . 64.420000000000002 110.966 174.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -53.83 -47.97 63.58 Favored Glycine 0 C--O 1.228 -0.24 0 CA-C-N 116.028 -0.533 . . . . 64.030000000000001 113.035 -177.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -66.42 -45.18 80.78 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.857 0.361 . . . . 73.209999999999994 110.982 -178.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 782' ' ' GLN . . . . . 0.414 ' OE1' ' HE3' ' A' ' 778' ' ' LYS . 25.5 mt-30 -71.59 -37.0 71.05 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.233 -0.439 . . . . 73.140000000000001 111.399 -176.37 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -72.08 -35.68 69.31 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.524 0.202 . . . . 61.399999999999999 110.742 177.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -60.06 -49.53 77.27 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.949 -0.389 . . . . 64.519999999999996 109.949 176.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 785' ' ' ALA . . . . . 0.622 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -65.78 -42.16 91.1 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.073 -0.512 . . . . 44.399999999999999 110.793 178.457 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 786' ' ' ASP . . . . . 0.52 ' O ' ' HG2' ' A' ' 790' ' ' ARG . 12.4 t70 -56.71 -55.83 29.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.022 -0.535 . . . . 74.430000000000007 110.755 179.201 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 787' ' ' ALA . . . . . 0.544 ' O ' HG23 ' A' ' 791' ' ' VAL . . . -68.22 -31.07 70.32 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.952 -0.567 . . . . 71.439999999999998 111.212 -178.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 788' ' ' ALA . . . . . 0.683 ' O ' ' HG ' ' A' ' 792' ' ' LEU . . . -62.63 -42.83 99.81 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 120.812 0.339 . . . . 73.219999999999999 110.168 177.006 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 789' ' ' LEU . . . . . 0.622 ' HG ' ' O ' ' A' ' 785' ' ' ALA . 79.8 mt -61.82 -40.16 94.3 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.08 -0.509 . . . . 73.239999999999995 109.749 176.1 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 790' ' ' ARG . . . . . 0.52 ' HG2' ' O ' ' A' ' 786' ' ' ASP . 47.2 mmm-85 -59.79 -38.05 80.82 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.98 -0.554 . . . . 75.209999999999994 110.471 177.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 791' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 787' ' ' ALA . 48.7 t -62.46 -53.18 50.66 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.31 0 N-CA-C 109.881 -0.414 . . . . 53.32 109.881 175.657 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 792' ' ' LEU . . . . . 0.683 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 22.1 mt -55.32 -48.01 74.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.263 0.554 . . . . 73.109999999999999 110.681 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 793' ' ' ILE . . . . . 0.517 HG12 HG23 ' A' ' 716' ' ' ILE . 90.6 mt -61.76 -48.59 87.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.1 -0.955 . . . . 72.439999999999998 111.079 177.315 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -66.28 -34.88 89.35 Favored Glycine 0 CA--C 1.519 0.299 0 CA-C-N 116.145 -0.479 . . . . 61.119999999999997 113.122 -178.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 795' ' ' GLU . . . . . 0.518 ' HG2' ' O ' ' A' ' 791' ' ' VAL . 44.7 mm-40 -66.64 -32.24 73.44 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.81 0.338 . . . . 74.409999999999997 110.782 178.464 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -85.26 -23.91 28.0 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.998 0.427 . . . . 65.409999999999997 109.977 177.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 797' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -60.12 -32.5 71.05 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.786 -0.643 . . . . 70.329999999999998 110.205 176.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 798' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -101.47 16.62 25.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.552 -0.749 . . . . 75.25 110.929 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 799' ' ' ALA . . . . . . . . . . . . . . . -144.16 -173.45 4.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.033 0.444 . . . . 63.149999999999999 111.086 -176.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 800' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -114.6 127.07 55.59 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.981 -0.554 . . . . 52.409999999999997 109.556 174.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 801' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.951 0 CA-C-O 118.843 -0.598 . . . . 71.329999999999998 111.085 177.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 708' ' ' MET . . . . . . . . . . . . . 24.2 ttt . . . . . 0 N--CA 1.481 1.098 0 CA-C-O 120.987 0.422 . . . . 62.229999999999997 110.312 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 72.5 mtm -80.19 128.75 72.22 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.079 -0.51 . . . . 75.219999999999999 110.767 -177.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -89.55 -162.58 0.12 Allowed 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.181 2.587 . . . . 53.409999999999997 112.211 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 711' ' ' ASN . . . . . . . . . . . . . 20.0 m120 65.01 88.63 0.1 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.418 0.628 . . . . 74.519999999999996 111.085 177.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 712' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -117.88 159.27 23.38 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.49 -0.777 . . . . 55.350000000000001 109.702 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 713' ' ' VAL . . . . . . . . . . . . . 31.9 m -73.66 165.44 3.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.869 -0.419 . . . . 72.420000000000002 109.869 176.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.557 ' HD2' ' OE1' ' A' ' 718' ' ' GLU . 25.1 tpt180 -65.18 103.64 0.8 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.966 -0.383 . . . . 75.340000000000003 109.966 -179.483 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -148.56 -164.91 2.13 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.081 -0.509 . . . . 71.230000000000004 111.195 -178.017 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 716' ' ' ILE . . . . . 0.576 ' HA ' HD23 ' A' ' 719' ' ' LEU . 42.1 mm -89.32 -23.88 6.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.569 -0.741 . . . . 72.230000000000004 110.715 -175.282 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -58.27 -23.13 52.42 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.873 -0.603 . . . . 73.450000000000003 112.311 176.488 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 718' ' ' GLU . . . . . 0.599 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 44.1 mt-10 -68.25 -36.67 79.8 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 122.747 -0.267 . . . . 74.129999999999995 110.287 176.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 719' ' ' LEU . . . . . 0.641 HD12 HD22 ' A' ' 789' ' ' LEU . 3.4 mm? -61.02 -33.88 73.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.235 0.541 . . . . 72.129999999999995 110.009 175.644 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 720' ' ' VAL . . . . . 0.576 HG22 HD13 ' A' ' 793' ' ' ILE . 27.4 t -62.86 -36.3 74.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.624 -0.717 . . . . 74.349999999999994 110.949 177.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 721' ' ' ARG . . . . . 0.599 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 10.5 ptt180 -68.75 -28.62 66.97 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.892 0.377 . . . . 71.239999999999995 110.178 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -73.02 -32.05 64.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 72.239999999999995 110.629 177.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 723' ' ' LEU . . . . . 0.576 HD21 ' HB2' ' A' ' 789' ' ' LEU . 89.9 mt -57.81 -36.65 72.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.292 0.567 . . . . 74.200000000000003 109.939 173.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -69.49 -40.34 77.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.179 -0.919 . . . . 31.129999999999999 111.501 178.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 46.1 m -103.26 -80.87 0.51 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.055 0.391 . . . . 65.230000000000004 112.055 -176.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 726' ' ' ASN . . . . . 0.467 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 28.0 t30 -135.06 106.82 10.38 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-O 121.032 0.444 . . . . 70.109999999999999 110.8 -174.674 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 727' ' ' PRO . . . . . 0.467 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 20.4 Cg_endo -62.2 -36.33 69.52 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 122.894 2.396 . . . . 44.43 112.579 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 34.4 t -61.47 -47.09 95.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.254 -0.43 . . . . 74.150000000000006 110.538 -177.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -61.09 -36.55 92.5 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.923 -0.656 . . . . 73.150000000000006 112.041 178.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 730' ' ' GLY . . . . . 0.473 ' O ' ' HG3' ' A' ' 733' ' ' GLU . . . -68.32 -45.3 70.44 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 121.106 -0.569 . . . . 75.040000000000006 112.532 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -64.46 -41.23 96.63 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.973 0.416 . . . . 72.140000000000001 110.06 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 732' ' ' LEU . . . . . . . . . . . . . 94.9 mt -67.24 -32.85 74.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.158 -0.474 . . . . 74.230000000000004 111.495 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 733' ' ' GLU . . . . . 0.473 ' HG3' ' O ' ' A' ' 730' ' ' GLY . 1.1 pp20? -85.17 -33.52 22.29 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.557 -0.457 . . . . 75.25 110.495 -178.196 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 734' ' ' TYR . . . . . 0.537 ' HB2' HD11 ' A' ' 719' ' ' LEU . 4.0 t80 -55.06 -45.18 75.27 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.837 0.351 . . . . 75.409999999999997 110.463 174.591 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -65.38 -52.92 50.27 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.112 -0.494 . . . . 62.039999999999999 110.299 -176.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 736' ' ' ARG . . . . . 0.437 ' HG2' ' O ' ' A' ' 733' ' ' GLU . 36.5 ptt180 -60.48 -37.84 82.34 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.971 -0.559 . . . . 60.229999999999997 110.94 -176.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 737' ' ' SER . . . . . 0.431 ' CB ' HH21 ' A' ' 714' ' ' ARG . 28.5 t -70.37 -32.26 69.85 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.875 -0.602 . . . . 75.219999999999999 111.452 -179.329 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -97.19 -8.78 29.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.717 0.294 . . . . 74.439999999999998 111.689 -175.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 98.25 9.21 54.06 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.63 -0.795 . . . . 52.130000000000003 112.959 176.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -96.51 170.4 9.24 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.178 -0.304 . . . . 72.319999999999993 110.178 177.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -117.37 129.22 55.73 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.602 -0.518 . . . . 43.240000000000002 109.602 172.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 742' ' ' ALA . . . . . . . . . . . . . . . -100.87 120.97 40.92 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.913 0.387 . . . . 71.340000000000003 111.352 -175.108 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 743' ' ' GLU . . . . . 0.566 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 38.7 mt-10 -122.44 135.24 54.64 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.199 -0.455 . . . . 73.129999999999995 110.964 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -114.32 97.96 6.64 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.269 -0.641 . . . . 75.219999999999999 109.269 175.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -113.8 140.8 48.0 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.345 -0.542 . . . . 74.209999999999994 111.198 -177.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 746' ' ' LEU . . . . . . . . . . . . . 59.8 tp -74.72 116.05 14.99 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.643 -0.708 . . . . 74.340000000000003 109.332 174.224 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 60.2 t -75.35 -49.78 26.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.691 -0.485 . . . . 61.310000000000002 109.691 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -167.05 -175.42 3.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.833 -0.621 . . . . 73.519999999999996 109.667 178.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -138.72 128.8 25.4 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.382 -0.599 . . . . 74.0 109.382 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 750' ' ' SER . . . . . 0.418 ' O ' ' HB3' ' A' ' 757' ' ' LYS . 6.4 t -137.65 90.88 2.54 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.868 -0.419 . . . . 74.319999999999993 109.868 -177.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 179.54 154.33 13.09 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.353 -0.927 . . . . 63.439999999999998 112.477 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 752' ' ' PRO . . . . . 0.628 ' HG2' ' HB2' ' A' ' 755' ' ' GLU . 37.6 Cg_endo -66.59 168.38 16.7 Favored 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 123.309 2.673 . . . . 71.230000000000004 112.238 177.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -56.48 -33.13 91.68 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.751 2.301 . . . . 55.140000000000001 112.759 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 45.9 p-80 -87.83 -4.19 58.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.383 -0.371 . . . . 63.5 111.359 -178.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 755' ' ' GLU . . . . . 0.628 ' HB2' ' HG2' ' A' ' 752' ' ' PRO . 16.6 mm-40 -152.93 61.97 4.04 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.354 -0.385 . . . . 71.420000000000002 111.306 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 756' ' ' PRO . . . . . 0.428 ' O ' ' HA ' ' A' ' 775' ' ' HIS . 59.6 Cg_endo -73.2 99.3 1.09 Allowed 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.175 1.917 . . . . 70.25 111.583 -177.483 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 757' ' ' LYS . . . . . 0.437 ' HD3' ' HB2' ' A' ' 773' ' ' CYS . 38.3 ttmt -87.05 107.76 18.57 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.247 0.546 . . . . 50.109999999999999 110.384 -177.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 758' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -86.93 130.61 34.39 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.274 -0.876 . . . . 74.239999999999995 110.151 -179.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 43.4 t -95.45 104.34 15.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.841 -0.429 . . . . 75.349999999999994 109.841 177.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -105.98 138.89 41.4 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.048 -0.524 . . . . 70.319999999999993 110.644 -179.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 761' ' ' GLN . . . . . 0.431 ' HA ' ' O ' ' A' ' 770' ' ' PRO . 52.4 tt0 -128.65 128.87 45.0 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.557 -0.534 . . . . 65.129999999999995 109.557 177.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 762' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' A' ' 769' ' ' PHE . . . -87.09 122.11 30.46 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.184 0.516 . . . . 51.340000000000003 110.407 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 763' ' ' LYS . . . . . 0.646 ' HD2' ' CH2' ' A' ' 768' ' ' TRP . 55.1 tttm -104.32 115.26 30.07 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.916 -0.584 . . . . 70.319999999999993 110.041 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 764' ' ' VAL . . . . . 0.422 HG11 ' HE2' ' A' ' 734' ' ' TYR . 59.0 t -118.7 100.72 10.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.058 0.456 . . . . 62.409999999999997 110.114 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 74.54 -102.89 1.44 Allowed Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.681 -0.69 . . . . 51.420000000000002 111.408 -176.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -120.45 10.88 10.56 Favored Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 111.162 -0.775 . . . . 71.420000000000002 111.162 174.206 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 767' ' ' ARG . . . . . 0.483 ' HG3' ' CD1' ' A' ' 769' ' ' PHE . 13.9 tpt180 -108.18 121.98 45.98 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.825 0.345 . . . . 71.409999999999997 110.879 -177.481 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 768' ' ' TRP . . . . . 0.646 ' CH2' ' HD2' ' A' ' 763' ' ' LYS . 48.0 m95 -95.44 107.44 19.59 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.787 -0.642 . . . . 73.349999999999994 109.571 177.567 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 769' ' ' PHE . . . . . 0.483 ' CD1' ' HG3' ' A' ' 767' ' ' ARG . 8.7 p90 -170.89 136.84 1.12 Allowed Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 120.888 0.375 . . . . 70.219999999999999 110.472 -178.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 770' ' ' PRO . . . . . 0.593 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 74.5 Cg_endo -97.36 -179.27 6.3 Favored 'Cis proline' 0 N--CA 1.447 -1.221 0 C-N-CA 123.475 -1.469 . . . . 54.219999999999999 111.773 -4.477 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -109.91 105.78 15.09 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.473 -0.566 . . . . 73.349999999999994 109.473 173.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 33.7 m -111.72 163.29 8.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.995 0.426 . . . . 73.239999999999995 111.147 -175.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 773' ' ' CYS . . . . . 0.437 ' HB2' ' HD3' ' A' ' 757' ' ' LYS . 5.1 p -133.52 117.99 17.79 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.889 -0.596 . . . . 51.43 110.017 179.426 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -132.67 143.75 49.86 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.287 -0.415 . . . . 73.310000000000002 110.705 -177.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 775' ' ' HIS . . . . . 0.428 ' HA ' ' O ' ' A' ' 756' ' ' PRO . 0.5 OUTLIER -80.14 24.34 0.43 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.146 0.498 . . . . 73.430000000000007 111.442 -178.521 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 776' ' ' SER . . . . . 0.548 ' HB3' ' HB2' ' A' ' 779' ' ' GLN . 24.9 t -152.76 137.96 17.42 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.578 -0.897 . . . . 73.0 108.578 175.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 777' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -66.92 -42.69 84.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.78 0.324 . . . . 74.409999999999997 110.327 -176.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -63.23 -38.09 89.79 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.178 -0.465 . . . . 63.310000000000002 110.379 178.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 779' ' ' GLN . . . . . 0.548 ' HB2' ' HB3' ' A' ' 776' ' ' SER . 76.6 mm-40 -71.72 -33.07 68.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.93 -0.577 . . . . 74.530000000000001 110.975 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -56.11 -43.91 88.56 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.112 -0.566 . . . . 61.310000000000002 112.107 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -69.04 -43.34 74.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.583 0.23 . . . . 74.239999999999995 110.985 178.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -63.42 -45.19 92.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.334 -0.393 . . . . 72.420000000000002 110.953 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -61.96 -44.44 96.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.303 -0.408 . . . . 75.340000000000003 110.924 178.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -61.29 -43.92 98.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.272 -0.422 . . . . 64.120000000000005 110.745 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 785' ' ' ALA . . . . . 0.559 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -65.45 -46.04 81.44 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.012 -0.54 . . . . 24.120000000000001 111.106 -178.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 786' ' ' ASP . . . . . 0.643 ' O ' ' HG2' ' A' ' 790' ' ' ARG . 14.9 t70 -60.31 -54.22 48.34 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 109.879 -0.415 . . . . 74.109999999999999 109.879 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 787' ' ' ALA . . . . . 0.537 ' O ' HG23 ' A' ' 791' ' ' VAL . . . -59.55 -35.48 74.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.67 -0.695 . . . . 73.409999999999997 111.229 -178.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 788' ' ' ALA . . . . . 0.632 ' O ' ' HG ' ' A' ' 792' ' ' LEU . . . -62.14 -45.2 94.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.508 -0.315 . . . . 71.219999999999999 110.63 177.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 789' ' ' LEU . . . . . 0.641 HD22 HD12 ' A' ' 719' ' ' LEU . 50.4 mt -64.29 -35.26 80.28 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 109.835 -0.431 . . . . 73.549999999999997 109.835 179.23 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 790' ' ' ARG . . . . . 0.643 ' HG2' ' O ' ' A' ' 786' ' ' ASP . 13.0 mmm-85 -59.63 -41.27 90.08 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 109.794 -0.447 . . . . 74.140000000000001 109.794 177.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 791' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 787' ' ' ALA . 43.5 t -63.67 -51.27 72.16 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 CA-C-N 115.625 -0.716 . . . . 75.120000000000005 110.111 177.173 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 792' ' ' LEU . . . . . 0.632 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 47.3 mt -57.16 -52.68 64.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.017 -0.538 . . . . 54.030000000000001 111.171 -177.682 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 793' ' ' ILE . . . . . 0.576 HD13 HG22 ' A' ' 720' ' ' VAL . 70.3 mt -60.12 -52.55 59.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.709 -0.678 . . . . 73.450000000000003 111.176 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 794' ' ' GLY . . . . . 0.629 ' O ' ' HG2' ' A' ' 798' ' ' LYS . . . -62.77 -41.62 99.82 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.855 -0.688 . . . . 64.010000000000005 112.681 -178.395 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -66.57 -39.36 88.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.833 0.349 . . . . 62.0 110.529 -178.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 796' ' ' ASN . . . . . 0.466 ' OD1' ' HB2' ' A' ' 801' ' ' ARG . 8.3 t30 -70.29 -29.17 65.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.031 -0.531 . . . . 71.519999999999996 110.037 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 797' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -69.0 -29.67 67.91 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.817 -0.629 . . . . 73.030000000000001 109.736 177.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 798' ' ' LYS . . . . . 0.629 ' HG2' ' O ' ' A' ' 794' ' ' GLY . 32.5 mmtp -76.48 -22.73 54.16 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.282 0.563 . . . . 72.0 110.052 176.028 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 799' ' ' ALA . . . . . . . . . . . . . . . -99.14 -166.36 1.34 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.627 -0.715 . . . . 64.409999999999997 110.361 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 800' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -127.09 88.45 2.81 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.994 0.426 . . . . 72.120000000000005 110.516 179.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 801' ' ' ARG . . . . . 0.466 ' HB2' ' OD1' ' A' ' 796' ' ' ASN . 36.7 mmt180 . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.617 -0.706 . . . . 75.239999999999995 109.667 178.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 708' ' ' MET . . . . . . . . . . . . . 66.0 mtm . . . . . 0 N--CA 1.478 0.959 0 CA-C-O 120.959 0.409 . . . . 71.540000000000006 110.461 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 709' ' ' MET . . . . . 0.412 ' HA ' ' HD3' ' A' ' 710' ' ' PRO . 86.0 mtp -102.53 146.41 32.31 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.059 -0.519 . . . . 60.020000000000003 109.666 175.184 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 710' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 709' ' ' MET . 33.0 Cg_exo -60.01 84.82 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.158 2.572 . . . . 74.200000000000003 112.836 -179.05 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 711' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 165.83 -34.67 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.695 -1.224 . . . . 73.450000000000003 107.695 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 712' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -124.22 40.61 3.69 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.987 -1.006 . . . . 72.099999999999994 110.381 176.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 713' ' ' VAL . . . . . . . . . . . . . 47.6 t -67.63 129.03 31.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 108.847 -0.797 . . . . 64.439999999999998 108.847 176.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 714' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 -68.33 95.26 0.59 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.116 0.484 . . . . 65.310000000000002 110.803 -175.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 715' ' ' LYS . . . . . 0.521 ' O ' ' HG2' ' A' ' 718' ' ' GLU . 12.8 tptp -104.25 22.99 13.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.85 0.833 . . . . 74.109999999999999 108.998 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 716' ' ' ILE . . . . . 0.514 HG21 ' HA ' ' A' ' 793' ' ' ILE . 42.4 mm -68.61 -13.76 17.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.002 -0.999 . . . . 73.530000000000001 110.387 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -63.69 -21.17 64.8 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.787 -0.642 . . . . 70.310000000000002 111.971 177.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 718' ' ' GLU . . . . . 0.712 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 15.8 mm-40 -65.57 -40.75 93.12 Favored 'General case' 0 C--O 1.225 -0.234 0 N-CA-C 109.592 -0.521 . . . . 71.150000000000006 109.592 176.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 719' ' ' LEU . . . . . 0.554 HD12 HD22 ' A' ' 789' ' ' LEU . 2.9 mm? -65.37 -33.01 74.97 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.624 -0.51 . . . . 70.549999999999997 109.624 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 720' ' ' VAL . . . . . 0.512 HG22 HD13 ' A' ' 793' ' ' ILE . 57.6 t -65.76 -38.04 81.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.668 -0.696 . . . . 70.430000000000007 110.822 178.549 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 721' ' ' ARG . . . . . 0.712 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 22.5 ptt180 -65.71 -26.2 67.65 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.191 0.52 . . . . 51.310000000000002 109.785 179.365 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -80.52 -27.01 37.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.983 -0.553 . . . . 62.119999999999997 110.991 178.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 723' ' ' LEU . . . . . 0.551 HD21 ' HB2' ' A' ' 789' ' ' LEU . 87.7 mt -62.43 -27.2 68.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.137 0.494 . . . . 74.019999999999996 109.708 172.277 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -89.68 -38.96 13.51 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.336 -0.847 . . . . 71.400000000000006 110.938 177.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 18.5 m -93.89 -74.64 0.53 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.973 0.36 . . . . 55.210000000000001 111.973 -174.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 726' ' ' ASN . . . . . 0.468 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 38.0 t30 -153.36 106.84 2.59 Favored Pre-proline 0 C--O 1.236 0.359 0 CA-C-O 120.894 0.378 . . . . 73.010000000000005 110.354 -178.264 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 727' ' ' PRO . . . . . 0.468 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 17.9 Cg_endo -60.0 -36.68 88.89 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 123.217 2.611 . . . . 74.340000000000003 112.964 -177.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 46.0 t -58.64 -49.96 80.73 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 CA-C-N 116.361 -0.381 . . . . 74.040000000000006 110.776 -177.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -61.54 -35.22 90.77 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.918 -0.658 . . . . 73.299999999999997 112.377 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -71.79 -44.19 48.54 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.837 -0.697 . . . . 53.149999999999999 112.811 -179.443 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -64.27 -39.5 94.06 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.777 -0.453 . . . . 74.019999999999996 109.777 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 732' ' ' LEU . . . . . 0.43 HD23 ' HB3' ' A' ' 742' ' ' ALA . 95.7 mt -63.83 -43.38 96.35 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.881 -0.6 . . . . 71.340000000000003 111.485 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 733' ' ' GLU . . . . . 0.555 ' HA ' ' HG2' ' A' ' 736' ' ' ARG . 8.4 pt-20 -77.42 -29.94 53.22 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 120.549 -0.46 . . . . 43.520000000000003 111.239 -176.642 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 734' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -55.42 -49.28 72.81 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.074 0.464 . . . . 63.43 109.793 173.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -66.5 -52.77 42.43 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.705 -0.68 . . . . 45.0 111.021 -177.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 736' ' ' ARG . . . . . 0.555 ' HG2' ' HA ' ' A' ' 733' ' ' GLU . 35.7 ptt180 -58.74 -36.07 73.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.036 -0.529 . . . . 62.049999999999997 111.384 -174.098 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 18.9 t -76.04 -37.09 58.73 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.008 -0.542 . . . . 44.020000000000003 110.842 -178.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -88.36 -7.64 56.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.467 -0.333 . . . . 74.510000000000005 111.483 -174.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 103.79 -3.31 45.45 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.611 -0.804 . . . . 72.409999999999997 113.096 175.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -88.56 170.26 11.01 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.928 0.394 . . . . 53.130000000000003 110.413 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -115.51 131.43 56.93 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.49 -0.559 . . . . 73.140000000000001 109.49 173.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 742' ' ' ALA . . . . . 0.43 ' HB3' HD23 ' A' ' 732' ' ' LEU . . . -98.87 110.28 22.91 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 123.22 0.325 . . . . 64.319999999999993 110.538 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 743' ' ' GLU . . . . . 0.562 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 47.0 mt-10 -115.04 132.73 56.5 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.103 -0.499 . . . . 53.520000000000003 111.074 -177.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -113.13 109.76 19.33 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.072 -0.513 . . . . 75.109999999999999 109.783 175.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -122.41 152.76 39.89 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.081 0.467 . . . . 75.230000000000004 111.393 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 746' ' ' LEU . . . . . . . . . . . . . 6.5 tt -82.92 113.8 20.77 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.833 -0.803 . . . . 75.200000000000003 108.833 175.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 54.8 t -82.36 -50.35 16.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.181 0.515 . . . . 73.510000000000005 110.671 -176.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -155.69 147.14 22.81 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.717 -0.674 . . . . 72.310000000000002 109.495 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 2.7 pp0? -109.91 109.94 20.73 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.442 0.639 . . . . 72.200000000000003 110.167 175.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 6.6 m -108.88 80.64 1.35 Allowed 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.8 -0.815 . . . . 73.120000000000005 108.8 176.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 751' ' ' GLY . . . . . 0.514 ' HA2' ' HD2' ' A' ' 752' ' ' PRO . . . -131.41 113.46 1.36 Allowed Glycine 0 N--CA 1.439 -1.124 0 C-N-CA 119.895 -1.145 . . . . 62.240000000000002 114.131 -170.338 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 752' ' ' PRO . . . . . 0.514 ' HD2' ' HA2' ' A' ' 751' ' ' GLY . 20.1 Cg_endo -60.92 169.95 5.27 Favored 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 123.095 2.53 . . . . 55.119999999999997 111.029 167.529 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -61.42 -35.39 83.36 Favored 'Trans proline' 0 CA--C 1.529 0.228 0 C-N-CA 122.177 1.918 . . . . 75.209999999999994 112.777 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 55.7 p-80 -83.41 -20.95 33.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.752 0.311 . . . . 73.140000000000001 111.349 -177.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -142.4 74.8 19.96 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 111.923 0.342 . . . . 72.109999999999999 111.923 -176.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 756' ' ' PRO . . . . . 0.454 ' HA ' ' HA3' ' A' ' 751' ' ' GLY . 33.4 Cg_exo -58.06 92.87 0.06 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 122.096 1.864 . . . . 75.349999999999994 111.191 170.374 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 757' ' ' LYS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 775' ' ' HIS . 36.1 ttpt -101.13 130.06 47.13 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.007 -0.542 . . . . 75.200000000000003 110.359 -175.319 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 758' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -113.72 135.08 54.33 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.94 -0.573 . . . . 60.109999999999999 110.632 -175.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 759' ' ' VAL . . . . . 0.476 HG22 ' HB3' ' A' ' 773' ' ' CYS . 26.3 t -94.19 112.62 27.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.812 -0.631 . . . . 61.210000000000001 109.876 177.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -111.11 143.18 42.24 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.917 -0.583 . . . . 55.219999999999999 110.565 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 761' ' ' GLN . . . . . 0.5 ' HA ' ' O ' ' A' ' 770' ' ' PRO . 53.1 tt0 -131.39 130.96 43.26 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.521 -0.548 . . . . 74.310000000000002 109.521 178.147 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 762' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 769' ' ' PHE . . . -87.7 113.77 23.68 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.352 0.596 . . . . 71.099999999999994 110.631 -179.037 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 763' ' ' LYS . . . . . 0.579 ' HD2' ' CH2' ' A' ' 768' ' ' TRP . 57.4 tttm -93.2 105.13 17.26 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.789 -0.641 . . . . 55.140000000000001 109.545 178.204 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 57.4 t -108.04 103.46 15.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.25 -0.648 . . . . 73.109999999999999 109.25 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 71.25 -117.21 6.63 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 110.683 -0.967 . . . . 53.140000000000001 110.683 -173.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -110.07 15.72 30.66 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.615 -0.803 . . . . 65.120000000000005 112.066 176.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 767' ' ' ARG . . . . . 0.547 ' HD2' ' CD1' ' A' ' 769' ' ' PHE . 0.0 OUTLIER -115.5 128.2 55.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.853 0.358 . . . . 74.040000000000006 110.218 -178.891 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 768' ' ' TRP . . . . . 0.579 ' CH2' ' HD2' ' A' ' 763' ' ' LYS . 40.6 m95 -97.43 103.14 15.05 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.065 -0.516 . . . . 73.540000000000006 110.018 -179.109 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 769' ' ' PHE . . . . . 0.547 ' CD1' ' HD2' ' A' ' 767' ' ' ARG . 16.5 p90 -162.16 136.39 5.01 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 120.853 0.359 . . . . 73.319999999999993 111.044 -178.295 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 770' ' ' PRO . . . . . 0.63 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 75.1 Cg_endo -99.34 -177.83 4.41 Favored 'Cis proline' 0 N--CA 1.449 -1.122 0 C-N-CA 123.684 -1.382 . . . . 61.450000000000003 111.496 -5.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -111.05 107.36 16.73 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.919 -0.4 . . . . 75.450000000000003 109.919 174.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 34.0 m -119.26 164.95 15.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.203 -0.453 . . . . 74.549999999999997 110.667 -176.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 773' ' ' CYS . . . . . 0.476 ' HB3' HG22 ' A' ' 759' ' ' VAL . 7.0 p -136.61 124.01 22.03 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.383 -0.371 . . . . 72.019999999999996 110.275 177.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -129.56 152.52 49.0 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.27 -0.423 . . . . 31.539999999999999 110.185 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 775' ' ' HIS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 757' ' ' LYS . 13.2 p80 -78.22 17.47 0.62 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.859 0.362 . . . . 64.329999999999998 111.695 -176.584 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 15.7 t -153.15 139.88 18.95 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.484 -0.561 . . . . 45.140000000000001 109.484 177.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 777' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -60.82 -40.46 92.83 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.453 -0.339 . . . . 64.239999999999995 111.123 -177.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -67.65 -37.25 82.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.852 0.358 . . . . 60.100000000000001 110.517 179.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 779' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -70.2 -37.37 75.06 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.147 -0.479 . . . . 73.340000000000003 110.738 -178.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -57.57 -41.84 93.76 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.966 -0.635 . . . . 74.439999999999998 112.279 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -63.83 -44.31 93.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.974 0.416 . . . . 72.450000000000003 110.622 177.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -69.44 -41.31 76.47 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.876 -0.602 . . . . 74.439999999999998 111.341 -177.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -61.26 -42.69 99.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.787 0.327 . . . . 73.129999999999995 110.838 177.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -62.72 -50.29 71.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.792 -0.64 . . . . 70.5 110.634 178.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 785' ' ' ALA . . . . . 0.547 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -62.95 -39.64 95.25 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.296 -0.411 . . . . 74.310000000000002 111.073 -178.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 786' ' ' ASP . . . . . 0.612 ' O ' ' HG2' ' A' ' 790' ' ' ARG . 11.7 t70 -60.48 -57.34 13.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.461 . . . . 60.539999999999999 110.447 179.114 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 787' ' ' ALA . . . . . 0.571 ' O ' HG23 ' A' ' 791' ' ' VAL . . . -62.68 -32.46 73.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.792 -0.64 . . . . 63.549999999999997 110.992 -178.228 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 788' ' ' ALA . . . . . 0.655 ' O ' ' HG ' ' A' ' 792' ' ' LEU . . . -62.12 -43.5 98.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.363 -0.38 . . . . 43.200000000000003 110.693 177.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 789' ' ' LEU . . . . . 0.554 HD22 HD12 ' A' ' 719' ' ' LEU . 79.2 mt -64.41 -37.32 87.12 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.782 -0.451 . . . . 72.209999999999994 109.782 178.423 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 790' ' ' ARG . . . . . 0.612 ' HG2' ' O ' ' A' ' 786' ' ' ASP . 8.7 mmm180 -59.86 -40.62 89.23 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 109.694 -0.484 . . . . 74.150000000000006 109.694 177.309 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 791' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 787' ' ' ALA . 61.0 t -62.02 -50.7 79.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.816 -0.629 . . . . 75.030000000000001 110.56 176.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 792' ' ' LEU . . . . . 0.655 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 49.7 mt -60.27 -52.13 66.59 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.693 -0.685 . . . . 75.5 110.979 -177.378 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 793' ' ' ILE . . . . . 0.548 ' O ' ' HG3' ' A' ' 797' ' ' GLU . 72.2 mt -59.55 -48.84 85.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.755 -0.657 . . . . 75.140000000000001 110.742 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -61.35 -44.02 98.6 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 121.06 -0.59 . . . . 72.510000000000005 112.774 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -57.64 -40.96 80.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.064 0.459 . . . . 54.219999999999999 110.15 178.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -67.76 -44.58 77.17 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.807 -0.633 . . . . 62.509999999999998 111.44 178.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 797' ' ' GLU . . . . . 0.548 ' HG3' ' O ' ' A' ' 793' ' ' ILE . 47.9 mt-10 -62.53 -45.9 90.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.133 0.492 . . . . 54.039999999999999 111.474 -177.53 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 798' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -81.24 -0.96 43.06 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.748 -0.66 . . . . 64.510000000000005 111.502 -174.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 799' ' ' ALA . . . . . . . . . . . . . . . -84.67 -21.12 30.32 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.523 -0.308 . . . . 71.319999999999993 111.449 -178.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 800' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -103.45 6.16 37.44 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.758 -0.377 . . . . 74.549999999999997 111.867 -175.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 801' ' ' ARG . . . . . 0.467 ' O ' ' HG3' ' A' ' 801' ' ' ARG . 32.0 ptt180 . . . . . 0 C--O 1.245 0.85 0 C-N-CA 120.82 -0.352 . . . . 73.530000000000001 110.675 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 716' ' ' ILE . . . . . 0.561 ' HA ' HD23 ' A' ' 719' ' ' LEU . 47.9 mm . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.918 0.39 . . . . 74.510000000000005 110.861 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -59.36 -32.41 72.45 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 121.086 -0.578 . . . . 72.129999999999995 112.634 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 718' ' ' GLU . . . . . 0.706 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 39.3 mt-10 -79.69 -21.83 44.17 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.856 -0.338 . . . . 62.140000000000001 111.266 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 719' ' ' LEU . . . . . 0.563 HD12 HD22 ' A' ' 789' ' ' LEU . 3.5 mm? -67.02 -32.11 73.11 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.225 -0.657 . . . . 61.009999999999998 109.225 172.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 720' ' ' VAL . . . . . 0.575 HG22 HD13 ' A' ' 793' ' ' ILE . 39.3 t -70.49 -31.81 47.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.364 -0.835 . . . . 64.329999999999998 110.379 176.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 721' ' ' ARG . . . . . 0.706 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 6.1 ptt180 -66.61 -28.12 68.24 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 120.943 0.401 . . . . 74.510000000000005 110.16 179.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -77.17 -31.86 55.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.239 -0.437 . . . . 73.549999999999997 111.322 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 723' ' ' LEU . . . . . 0.551 HD21 ' HB2' ' A' ' 789' ' ' LEU . 96.3 mt -61.11 -32.3 71.98 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.514 0.673 . . . . 71.140000000000001 109.629 173.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -84.95 -16.6 40.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.851 -1.068 . . . . 60.229999999999997 110.905 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 23.5 m -119.37 -81.61 0.63 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.783 0.325 . . . . 75.519999999999996 111.536 -176.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 726' ' ' ASN . . . . . 0.415 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 37.5 t30 -139.25 104.9 7.19 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.292 -0.413 . . . . 65.120000000000005 110.21 -178.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 727' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 24.6 Cg_endo -62.23 -37.61 61.06 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.822 2.348 . . . . 65.5 112.584 -177.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 49.4 t -61.33 -49.0 86.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.23 -0.441 . . . . 64.430000000000007 110.544 -177.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -63.41 -31.49 80.93 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.899 -0.667 . . . . 62.119999999999997 111.887 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -71.03 -40.04 62.65 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.06 -0.591 . . . . 40.509999999999998 112.633 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -66.05 -39.65 90.3 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.401 -0.592 . . . . 75.030000000000001 109.401 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 732' ' ' LEU . . . . . 0.443 HD23 ' HB3' ' A' ' 742' ' ' ALA . 83.1 mt -65.45 -38.53 90.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.926 -0.579 . . . . 72.340000000000003 110.427 175.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 733' ' ' GLU . . . . . 0.578 ' O ' ' HG2' ' A' ' 736' ' ' ARG . 4.2 tp10 -66.41 -48.17 70.93 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.809 -0.632 . . . . 73.5 110.928 -179.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 734' ' ' TYR . . . . . 0.54 ' HB2' HD11 ' A' ' 719' ' ' LEU . 12.4 t80 -56.75 -47.74 79.39 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.132 -0.485 . . . . 64.409999999999997 110.752 178.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -66.43 -46.14 77.53 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.139 -0.482 . . . . 72.5 111.184 -177.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 736' ' ' ARG . . . . . 0.578 ' HG2' ' O ' ' A' ' 733' ' ' GLU . 22.4 ptt180 -62.12 -35.33 78.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.015 0.436 . . . . 62.420000000000002 110.85 -176.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 33.1 t -81.19 -23.72 37.97 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.922 -0.581 . . . . 63.420000000000002 111.304 -178.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -104.71 2.84 30.78 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.781 0.289 . . . . 54.219999999999999 111.781 -175.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 79.82 17.82 74.17 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.574 -0.822 . . . . 74.219999999999999 113.002 176.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -102.27 162.16 13.13 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 122.628 -0.336 . . . . 63.130000000000003 110.263 176.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 741' ' ' ALA . . . . . 0.52 ' O ' ' HA ' ' A' ' 764' ' ' VAL . . . -105.43 135.42 46.85 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.865 -0.42 . . . . 44.439999999999998 109.865 175.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 742' ' ' ALA . . . . . 0.443 ' HB3' HD23 ' A' ' 732' ' ' LEU . . . -103.46 108.77 20.16 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.224 -0.444 . . . . 71.530000000000001 110.505 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 743' ' ' GLU . . . . . 0.572 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 41.2 mt-10 -115.73 113.35 23.35 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.033 -0.531 . . . . 71.430000000000007 111.121 -178.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -93.91 100.91 12.98 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.644 -0.707 . . . . 73.409999999999997 109.605 175.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -113.99 155.96 24.92 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.04 0.448 . . . . 75.310000000000002 110.783 -178.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 746' ' ' LEU . . . . . . . . . . . . . 1.7 tt -94.06 120.42 34.3 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.759 -0.83 . . . . 71.409999999999997 108.759 177.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 84.6 t -81.98 -52.3 13.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.315 -0.402 . . . . 65.239999999999995 111.182 -176.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -155.58 151.33 27.43 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.386 -0.37 . . . . 51.109999999999999 110.803 -175.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -126.75 87.11 2.6 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.702 -0.481 . . . . 73.450000000000003 109.702 -178.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 750' ' ' SER . . . . . 0.402 ' O ' ' HB3' ' A' ' 757' ' ' LYS . 5.3 p -128.1 98.93 5.28 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.177 0.513 . . . . 72.230000000000004 111.261 -176.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . -166.54 158.04 30.79 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 111.57 -0.612 . . . . 70.120000000000005 111.57 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 752' ' ' PRO . . . . . 0.693 ' HG2' ' HB2' ' A' ' 755' ' ' GLU . 20.5 Cg_endo -60.45 162.15 18.45 Favored 'Trans proline' 0 CA--C 1.531 0.35 0 C-N-CA 122.846 2.364 . . . . 74.0 112.038 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.68 -31.91 92.59 Favored 'Trans proline' 0 CA--C 1.527 0.16 0 C-N-CA 122.71 2.273 . . . . 72.430000000000007 112.612 -178.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 37.5 p-80 -86.82 -17.82 32.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.206 -0.452 . . . . 72.409999999999997 111.309 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 755' ' ' GLU . . . . . 0.693 ' HB2' ' HG2' ' A' ' 752' ' ' PRO . 37.9 mm-40 -136.48 70.88 60.02 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.461 -0.336 . . . . 74.450000000000003 110.751 178.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 756' ' ' PRO . . . . . 0.485 ' HB2' ' CE2' ' A' ' 758' ' ' PHE . 28.9 Cg_endo -63.42 116.99 3.96 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.264 1.976 . . . . 71.209999999999994 111.414 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 757' ' ' LYS . . . . . 0.411 ' CG ' ' HB2' ' A' ' 773' ' ' CYS . 23.1 ttmm -97.7 115.46 28.01 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.251 -0.432 . . . . 74.209999999999994 110.427 -176.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 758' ' ' PHE . . . . . 0.485 ' CE2' ' HB2' ' A' ' 756' ' ' PRO . 90.4 m-85 -108.05 113.21 26.21 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.008 -0.542 . . . . 74.420000000000002 110.355 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 24.3 t -85.82 111.28 20.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.74 -0.664 . . . . 65.25 109.8 179.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 760' ' ' TYR . . . . . 0.421 ' OH ' ' HG2' ' A' ' 777' ' ' LYS . 2.1 m-85 -110.81 143.13 41.85 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.248 -0.433 . . . . 71.519999999999996 110.758 -179.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 761' ' ' GLN . . . . . 0.519 ' HA ' ' O ' ' A' ' 770' ' ' PRO . 56.8 tt0 -135.77 135.19 39.73 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.141 -0.481 . . . . 72.409999999999997 109.743 178.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 762' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 769' ' ' PHE . . . -93.56 112.84 24.82 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.306 0.574 . . . . 74.129999999999995 110.605 -178.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 763' ' ' LYS . . . . . 0.607 ' HD2' ' CH2' ' A' ' 768' ' ' TRP . 59.3 tttm -91.82 101.84 14.43 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.844 -0.617 . . . . 65.109999999999999 109.778 177.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 764' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 741' ' ' ALA . 59.4 t -107.57 100.86 11.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.02 -0.536 . . . . 70.019999999999996 109.986 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 71.71 -115.25 5.49 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 115.586 -0.733 . . . . 64.219999999999999 111.482 -177.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -106.22 8.1 41.18 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.828 -0.701 . . . . 72.040000000000006 112.012 177.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 767' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 767' ' ' ARG . 55.0 mtt180 -108.07 147.17 31.56 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.963 0.411 . . . . 74.010000000000005 110.797 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 768' ' ' TRP . . . . . 0.607 ' CH2' ' HD2' ' A' ' 763' ' ' LYS . 53.0 m95 -118.21 100.76 7.72 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.764 -0.653 . . . . 75.200000000000003 109.284 178.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 769' ' ' PHE . . . . . 0.487 ' HA ' ' HA ' ' A' ' 770' ' ' PRO . 21.4 p90 -167.49 139.3 2.58 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 120.777 0.322 . . . . 74.530000000000001 110.969 -176.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 770' ' ' PRO . . . . . 0.635 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 71.5 Cg_endo -97.54 -171.46 2.46 Favored 'Cis proline' 0 N--CA 1.453 -0.872 0 C-N-CA 123.716 -1.368 . . . . 64.239999999999995 111.751 -4.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -122.23 112.44 18.16 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.63 -0.508 . . . . 74.510000000000005 109.63 175.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 36.0 m -122.46 159.24 25.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.247 -0.433 . . . . 60.340000000000003 110.839 -176.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 773' ' ' CYS . . . . . 0.411 ' HB2' ' CG ' ' A' ' 757' ' ' LYS . 8.0 p -124.45 107.65 11.32 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.007 0.432 . . . . 71.530000000000001 109.948 177.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -103.11 -179.66 4.01 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.07 -0.514 . . . . 71.209999999999994 111.203 -176.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 775' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -93.28 -5.39 49.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 71.200000000000003 110.349 -177.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 19.4 t -161.01 170.44 20.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.338 -0.392 . . . . 73.209999999999994 110.518 -177.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 777' ' ' LYS . . . . . 0.421 ' HG2' ' OH ' ' A' ' 760' ' ' TYR . 1.4 tmtp? -69.72 -50.15 46.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.065 -0.516 . . . . 75.409999999999997 111.447 -174.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -60.48 -40.75 92.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.965 0.412 . . . . 63.140000000000001 110.308 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 779' ' ' GLN . . . . . 0.54 ' O ' ' HG2' ' A' ' 783' ' ' GLU . 76.9 mt-30 -58.3 -49.18 78.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.696 -0.683 . . . . 73.219999999999999 111.099 175.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -52.73 -44.12 60.34 Favored Glycine 0 C--N 1.334 0.434 0 CA-C-N 116.168 -0.469 . . . . 73.140000000000001 113.095 -176.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -59.23 -47.71 84.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.273 0.559 . . . . 44.100000000000001 110.772 178.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -70.91 -42.83 69.4 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.443 -0.799 . . . . 63.109999999999999 111.61 -175.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 783' ' ' GLU . . . . . 0.54 ' HG2' ' O ' ' A' ' 779' ' ' GLN . 21.2 mm-40 -60.44 -41.48 94.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.978 0.418 . . . . 72.450000000000003 110.301 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -66.17 -47.84 72.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.845 -0.616 . . . . 75.510000000000005 110.662 178.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 785' ' ' ALA . . . . . 0.524 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -63.08 -41.93 99.53 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.218 -0.446 . . . . 73.099999999999994 111.324 -178.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 786' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -57.21 -53.31 59.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.242 0.544 . . . . 71.450000000000003 110.277 178.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 787' ' ' ALA . . . . . 0.603 ' O ' HG23 ' A' ' 791' ' ' VAL . . . -64.01 -37.78 88.67 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.597 -0.729 . . . . 63.509999999999998 111.052 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 788' ' ' ALA . . . . . 0.635 ' HB2' ' HD3' ' A' ' 770' ' ' PRO . . . -60.38 -47.44 86.07 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.425 -0.352 . . . . 63.109999999999999 111.582 -178.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 789' ' ' LEU . . . . . 0.563 HD22 HD12 ' A' ' 719' ' ' LEU . 64.4 mt -62.74 -39.36 93.86 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.641 -0.503 . . . . 73.150000000000006 109.641 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 790' ' ' ARG . . . . . . . . . . . . . 54.6 mtp180 -64.46 -32.09 73.57 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.594 -0.73 . . . . 75.209999999999994 111.197 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 791' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 787' ' ' ALA . 60.7 t -63.51 -52.94 51.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 109.433 -0.58 . . . . 52.329999999999998 109.433 173.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 792' ' ' LEU . . . . . 0.563 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 32.8 mt -57.39 -50.44 72.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.339 -0.846 . . . . 71.519999999999996 110.836 -177.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 793' ' ' ILE . . . . . 0.575 HD13 HG22 ' A' ' 720' ' ' VAL . 77.5 mt -57.94 -49.47 81.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.642 -0.708 . . . . 73.219999999999999 110.568 177.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -63.28 -30.71 78.37 Favored Glycine 0 CA--C 1.519 0.325 0 CA-C-N 115.952 -0.567 . . . . 54.340000000000003 112.814 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 795' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 791' ' ' VAL . 59.7 mm-40 -67.26 -36.73 82.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.46 0.13 . . . . 74.540000000000006 110.874 178.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 6.5 t30 . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.533 -0.303 . . . . 53.520000000000003 111.15 -175.831 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 716' ' ' ILE . . . . . 0.545 ' HA ' HD23 ' A' ' 719' ' ' LEU . 47.1 mm . . . . . 0 C--O 1.233 0.235 0 CA-C-O 120.934 0.397 . . . . 64.450000000000003 110.803 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -62.11 -34.03 87.71 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.828 -0.701 . . . . 70.409999999999997 111.992 176.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 718' ' ' GLU . . . . . 0.707 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 38.1 mt-10 -77.26 -25.0 51.04 Favored 'General case' 0 C--O 1.222 -0.385 0 O-C-N 122.623 -0.34 . . . . 73.140000000000001 111.125 178.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 719' ' ' LEU . . . . . 0.57 HD12 HD22 ' A' ' 789' ' ' LEU . 4.4 mm? -61.51 -32.94 73.0 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.473 -0.565 . . . . 63.109999999999999 109.473 172.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 720' ' ' VAL . . . . . 0.495 HG22 HD13 ' A' ' 793' ' ' ILE . 58.2 t -70.21 -36.26 66.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.477 -0.783 . . . . 74.400000000000006 110.76 177.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 721' ' ' ARG . . . . . 0.707 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 8.9 ptt180 -62.72 -29.52 70.73 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.02 0.438 . . . . 64.319999999999993 110.167 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -76.28 -31.55 58.3 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.197 -0.456 . . . . 73.510000000000005 110.596 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 723' ' ' LEU . . . . . 0.606 HD21 ' HB2' ' A' ' 789' ' ' LEU . 89.3 mt -63.76 -24.89 67.95 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.177 0.513 . . . . 72.439999999999998 110.601 174.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -92.07 -23.87 19.34 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.756 -0.656 . . . . 62.100000000000001 110.872 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 10.9 m -111.04 -76.79 0.6 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.423 -0.353 . . . . 73.420000000000002 111.241 -175.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 726' ' ' ASN . . . . . 0.408 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 38.5 t30 -141.6 103.52 5.9 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 120.628 0.251 . . . . 44.229999999999997 110.768 -179.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 727' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 19.0 Cg_endo -59.77 -37.09 89.1 Favored 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 123.032 2.488 . . . . 61.329999999999998 112.348 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 728' ' ' VAL . . . . . 0.417 ' O ' ' HG ' ' A' ' 732' ' ' LEU . 48.9 t -59.96 -47.94 89.75 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 CA-C-N 116.007 -0.542 . . . . 71.140000000000001 110.162 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -62.35 -35.33 91.5 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.656 -0.702 . . . . 42.350000000000001 112.01 178.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -65.41 -43.16 95.38 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.097 -0.573 . . . . 61.109999999999999 112.641 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -65.93 -40.27 91.28 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.725 -0.472 . . . . 61.25 109.725 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 732' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 728' ' ' VAL . 85.7 mt -65.37 -38.02 88.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.949 -0.569 . . . . 62.32 110.602 176.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 733' ' ' GLU . . . . . 0.462 ' O ' ' HG2' ' A' ' 736' ' ' ARG . 5.2 tp10 -66.98 -47.12 72.52 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 115.967 -0.56 . . . . 73.310000000000002 110.911 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 734' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -56.64 -46.69 80.85 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.214 -0.448 . . . . 71.150000000000006 110.458 177.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -65.28 -44.66 87.3 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.093 -0.503 . . . . 32.520000000000003 111.232 -177.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 736' ' ' ARG . . . . . 0.462 ' HG2' ' O ' ' A' ' 733' ' ' GLU . 14.5 ptm180 -68.85 -33.04 73.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.598 0.713 . . . . 72.340000000000003 109.825 -173.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 73.2 m -75.01 -36.47 61.95 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 114.792 -1.095 . . . . 75.120000000000005 111.766 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 12.7 m170 -94.27 0.57 55.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.338 -0.392 . . . . 74.209999999999994 111.327 -175.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 85.86 9.17 78.24 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.735 -0.745 . . . . 74.0 112.987 175.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -93.45 162.15 14.09 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.698 0.285 . . . . 71.530000000000001 110.336 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -107.48 115.99 31.14 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.993 -0.373 . . . . 64.239999999999995 109.993 176.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 742' ' ' ALA . . . . . 0.417 ' HB3' HD23 ' A' ' 732' ' ' LEU . . . -81.94 112.17 18.79 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.238 -0.437 . . . . 65.129999999999995 110.888 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 743' ' ' GLU . . . . . 0.479 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 43.9 mt-10 -123.06 127.74 49.17 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.297 -0.41 . . . . 73.129999999999995 110.945 -177.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -105.85 114.34 28.43 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.02 -0.536 . . . . 65.019999999999996 110.021 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -121.34 153.66 37.46 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.164 0.507 . . . . 72.439999999999998 110.803 177.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 746' ' ' LEU . . . . . 0.451 HD13 ' CE2' ' A' ' 760' ' ' TYR . 51.3 tp -95.93 101.33 12.99 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.475 -0.784 . . . . 75.230000000000004 109.803 178.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 49.1 t -69.33 -43.88 80.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.796 -0.638 . . . . 61.340000000000003 111.275 -174.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -146.25 147.49 31.47 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.064 0.459 . . . . 74.219999999999999 111.246 -176.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -141.47 93.66 2.6 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.997 -0.742 . . . . 71.340000000000003 108.997 177.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 16.7 t -129.84 176.75 7.78 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.906 -0.588 . . . . 54.210000000000001 110.213 -173.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 104.88 -176.17 22.71 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.712 -0.756 . . . . 74.299999999999997 112.353 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 752' ' ' PRO . . . . . 0.56 ' HG2' ' HB2' ' A' ' 755' ' ' GLU . 60.4 Cg_endo -73.62 157.82 48.08 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.899 2.399 . . . . 75.219999999999999 111.88 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -62.98 -22.54 73.86 Favored 'Trans proline' 0 CA--C 1.529 0.246 0 C-N-CA 122.656 2.238 . . . . 73.099999999999994 112.773 -177.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 39.2 p-80 -91.85 -7.57 49.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.924 0.392 . . . . 75.209999999999994 110.907 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 755' ' ' GLU . . . . . 0.56 ' HB2' ' HG2' ' A' ' 752' ' ' PRO . 5.5 mm-40 -146.84 63.58 8.46 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.318 -0.401 . . . . 60.420000000000002 110.987 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 756' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.85 122.43 8.49 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.094 1.862 . . . . 72.519999999999996 111.317 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 757' ' ' LYS . . . . . 0.455 ' HG3' ' HB2' ' A' ' 773' ' ' CYS . 0.1 OUTLIER -92.95 112.2 24.08 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.07 0.462 . . . . 73.319999999999993 110.327 -178.181 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 758' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -95.1 107.52 19.58 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.579 -0.737 . . . . 73.040000000000006 110.501 -178.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 759' ' ' VAL . . . . . 0.47 HG22 ' HB3' ' A' ' 773' ' ' CYS . 40.9 t -86.65 98.13 6.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.037 -0.528 . . . . 71.349999999999994 109.896 178.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 760' ' ' TYR . . . . . 0.451 ' CE2' HD13 ' A' ' 746' ' ' LEU . 7.5 m-85 -98.08 141.07 31.48 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.074 -0.512 . . . . 74.25 110.379 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 761' ' ' GLN . . . . . 0.496 ' HA ' ' O ' ' A' ' 770' ' ' PRO . 54.6 tt0 -135.41 129.3 33.08 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.993 -0.549 . . . . 75.239999999999995 109.784 178.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 762' ' ' ALA . . . . . . . . . . . . . . . -85.99 117.23 24.71 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.474 0.654 . . . . 74.540000000000006 110.819 -177.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 763' ' ' LYS . . . . . 0.479 ' HB3' ' HB2' ' A' ' 743' ' ' GLU . 58.9 tttt -93.71 108.8 20.5 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.184 -0.916 . . . . 71.0 109.572 178.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 38.7 t -128.78 108.26 17.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.805 0.336 . . . . 65.340000000000003 110.936 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 69.16 25.1 75.7 Favored Glycine 0 CA--C 1.51 -0.219 0 C-N-CA 121.112 -0.566 . . . . 41.149999999999999 112.585 176.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 91.31 -10.27 75.3 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.652 -0.785 . . . . 73.109999999999999 111.859 -177.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 767' ' ' ARG . . . . . 0.434 ' HD3' ' HA ' ' A' ' 767' ' ' ARG . 30.1 mmt180 -91.32 128.51 37.17 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.033 0.445 . . . . 73.409999999999997 110.303 177.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 768' ' ' TRP . . . . . . . . . . . . . 51.0 m95 -104.1 96.1 6.43 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.519 -0.764 . . . . 73.230000000000004 109.94 -176.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 769' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -162.42 138.59 5.78 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.314 -0.403 . . . . 72.239999999999995 110.412 -177.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 770' ' ' PRO . . . . . 0.668 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 64.8 Cg_endo -95.0 175.15 12.68 Favored 'Cis proline' 0 N--CA 1.451 -0.978 0 C-N-CA 123.351 -1.521 . . . . 72.120000000000005 111.873 -3.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -107.66 98.15 7.78 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.681 -0.489 . . . . 61.310000000000002 109.681 174.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 29.2 m -112.73 131.31 64.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.358 0.599 . . . . 75.420000000000002 111.183 -175.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 773' ' ' CYS . . . . . 0.47 ' HB3' HG22 ' A' ' 759' ' ' VAL . 7.3 p -99.46 98.75 9.62 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.776 -0.647 . . . . 53.520000000000003 110.462 177.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -100.55 146.32 27.25 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.107 -0.497 . . . . 53.530000000000001 110.233 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 775' ' ' HIS . . . . . . . . . . . . . 1.1 p80 -86.11 17.3 3.67 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.272 0.558 . . . . 72.120000000000005 111.068 -178.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 34.3 t -150.02 140.51 22.44 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.633 -0.712 . . . . 62.539999999999999 109.282 175.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 777' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -66.04 -42.54 89.44 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.5 -0.318 . . . . 62.140000000000001 110.614 -175.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -60.49 -36.39 78.2 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.967 -0.56 . . . . 53.25 110.498 177.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 779' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -70.15 -42.77 72.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.034 -0.53 . . . . 73.030000000000001 110.802 177.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -50.2 -46.66 43.1 Favored Glycine 0 C--N 1.331 0.272 0 O-C-N 123.398 0.436 . . . . 44.219999999999999 113.083 -177.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -65.76 -49.25 69.07 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.781 0.324 . . . . 71.340000000000003 110.911 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -67.66 -46.89 71.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.149 -0.478 . . . . 73.099999999999994 111.771 -175.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -64.59 -37.47 87.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.683 -0.235 . . . . 73.420000000000002 110.63 -177.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -62.34 -52.0 65.39 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.272 -0.422 . . . . 71.0 110.438 177.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 785' ' ' ALA . . . . . 0.651 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -61.58 -43.68 98.41 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.22 -0.445 . . . . 74.120000000000005 110.648 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 786' ' ' ASP . . . . . 0.604 ' O ' ' HG2' ' A' ' 790' ' ' ARG . 8.2 t70 -57.5 -52.67 64.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.869 -0.605 . . . . 63.100000000000001 110.648 178.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 787' ' ' ALA . . . . . 0.514 ' O ' HG23 ' A' ' 791' ' ' VAL . . . -68.09 -27.19 66.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.916 -0.584 . . . . 64.120000000000005 111.285 -176.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 788' ' ' ALA . . . . . 0.668 ' HB2' ' HD3' ' A' ' 770' ' ' PRO . . . -66.72 -41.41 87.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.406 -0.361 . . . . 51.039999999999999 110.567 177.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 789' ' ' LEU . . . . . 0.651 ' HG ' ' O ' ' A' ' 785' ' ' ALA . 21.2 mt -67.27 -34.4 77.34 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.547 -0.538 . . . . 73.030000000000001 109.547 178.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 790' ' ' ARG . . . . . 0.604 ' HG2' ' O ' ' A' ' 786' ' ' ASP . 28.3 mmt180 -55.47 -45.9 76.89 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.142 -0.481 . . . . 73.209999999999994 109.837 175.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 791' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 787' ' ' ALA . 48.7 t -58.66 -52.35 60.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.468 -0.787 . . . . 73.049999999999997 110.581 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 792' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 27.7 mt -61.16 -49.13 78.46 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.522 -0.763 . . . . 71.040000000000006 111.003 -177.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 793' ' ' ILE . . . . . 0.495 HD13 HG22 ' A' ' 720' ' ' VAL . 93.5 mt -63.62 -42.78 97.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.621 -0.718 . . . . 74.239999999999995 110.516 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -62.31 -27.18 68.85 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 121.029 -0.605 . . . . 51.340000000000003 112.569 178.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -77.71 -23.63 49.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.625 0.25 . . . . 75.230000000000004 111.437 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 796' ' ' ASN . . . . . 0.408 ' CB ' HG13 ' A' ' 716' ' ' ILE . 27.6 t-20 . . . . . 0 C--N 1.327 -0.378 0 N-CA-C 111.942 0.349 . . . . 75.239999999999995 111.942 -177.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 716' ' ' ILE . . . . . 0.589 ' HA ' HD23 ' A' ' 719' ' ' LEU . 46.7 mm . . . . . 0 C--O 1.234 0.258 0 CA-C-O 120.936 0.398 . . . . 63.310000000000002 111.156 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -58.19 -28.77 61.89 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.866 -0.683 . . . . 62.5 112.551 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -68.61 -35.79 77.79 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 122.869 -0.195 . . . . 73.439999999999998 111.275 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 719' ' ' LEU . . . . . 0.589 HD23 ' HA ' ' A' ' 716' ' ' ILE . 3.2 mm? -64.94 -33.82 76.93 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.614 -0.513 . . . . 72.310000000000002 109.614 178.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 720' ' ' VAL . . . . . 0.543 HG22 HD13 ' A' ' 793' ' ' ILE . 45.5 t -66.33 -37.12 78.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.881 -0.599 . . . . 70.430000000000007 109.997 176.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 721' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.49 -32.04 71.05 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.839 -0.619 . . . . 72.209999999999994 110.158 177.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -79.46 -25.7 41.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.844 -0.616 . . . . 72.040000000000006 111.275 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 723' ' ' LEU . . . . . 0.531 HD21 ' HB2' ' A' ' 789' ' ' LEU . 60.1 mt -63.71 -29.95 71.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.991 0.424 . . . . 71.450000000000003 110.282 175.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -85.4 -35.63 21.21 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.653 -0.703 . . . . 71.019999999999996 110.83 176.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 24.7 m -92.55 -79.69 0.39 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.216 -0.447 . . . . 63.32 111.764 -174.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 726' ' ' ASN . . . . . 0.437 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 30.8 t30 -146.29 109.05 4.23 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-O 120.809 0.338 . . . . 74.129999999999995 110.235 -179.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 727' ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 20.0 Cg_endo -61.24 -35.69 83.74 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.707 2.271 . . . . 62.329999999999998 112.436 -178.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 53.2 t -62.76 -48.08 89.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.244 -0.435 . . . . 74.109999999999999 110.615 -178.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -63.55 -33.16 86.5 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.825 -0.703 . . . . 72.310000000000002 111.944 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -71.19 -41.54 59.66 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.252 -0.499 . . . . 74.140000000000001 112.811 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -63.71 -38.94 93.0 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.469 -0.567 . . . . 62.439999999999998 109.469 178.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 732' ' ' LEU . . . . . . . . . . . . . 96.1 mt -69.63 -33.5 72.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.847 -0.615 . . . . 53.43 110.555 176.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 733' ' ' GLU . . . . . 0.568 ' O ' ' HG2' ' A' ' 736' ' ' ARG . 4.2 tp10 -67.95 -48.46 65.81 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 123.016 0.526 . . . . 73.209999999999994 110.417 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 734' ' ' TYR . . . . . 0.558 ' HB2' HD11 ' A' ' 719' ' ' LEU . 8.8 t80 -54.67 -47.19 73.91 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.777 -0.647 . . . . 70.450000000000003 110.642 176.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -67.37 -49.73 62.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.191 -0.459 . . . . 70.230000000000004 110.849 -177.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 736' ' ' ARG . . . . . 0.568 ' HG2' ' O ' ' A' ' 733' ' ' GLU . 13.5 ptm180 -60.41 -38.52 84.28 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.297 -0.41 . . . . 64.329999999999998 111.221 -175.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 32.9 t -77.36 -29.11 53.17 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.123 -0.489 . . . . 73.530000000000001 111.172 -177.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -95.58 -8.19 35.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.82 0.343 . . . . 64.25 111.433 -176.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 93.4 10.89 58.93 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.689 -0.767 . . . . 73.510000000000005 113.118 176.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -93.58 161.61 14.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.965 0.412 . . . . 72.120000000000005 110.734 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -106.89 113.03 26.27 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.796 -0.638 . . . . 72.239999999999995 109.631 176.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 742' ' ' ALA . . . . . . . . . . . . . . . -97.45 126.74 42.89 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.152 -0.477 . . . . 72.420000000000002 110.638 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 743' ' ' GLU . . . . . 0.468 ' HG3' ' HB3' ' A' ' 763' ' ' LYS . 13.4 pt-20 -140.26 140.18 35.69 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.026 0.441 . . . . 64.040000000000006 110.569 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -108.27 114.73 28.83 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.741 -0.663 . . . . 74.019999999999996 109.718 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -120.89 149.91 41.88 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.083 0.468 . . . . 73.409999999999997 111.191 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 746' ' ' LEU . . . . . 0.485 HD21 ' HB3' ' A' ' 749' ' ' GLN . 60.6 tp -91.58 116.82 29.18 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.596 -0.729 . . . . 52.310000000000002 109.825 177.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 47.7 t -79.29 -47.42 22.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.05 -0.523 . . . . 51.229999999999997 110.498 -178.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -154.62 147.46 24.45 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.449 -0.341 . . . . 55.229999999999997 111.064 -179.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 749' ' ' GLN . . . . . 0.485 ' HB3' HD21 ' A' ' 746' ' ' LEU . 17.2 pt20 -129.84 109.98 11.36 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.137 -0.483 . . . . 73.109999999999999 109.864 177.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 27.5 t -155.36 159.28 39.79 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.379 -0.373 . . . . 44.509999999999998 110.385 -175.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 141.25 171.72 12.81 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.699 -0.762 . . . . 70.129999999999995 112.433 176.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 752' ' ' PRO . . . . . 0.772 ' HG2' ' HB2' ' A' ' 755' ' ' GLU . 37.3 Cg_endo -66.94 167.97 18.38 Favored 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 123.089 2.526 . . . . 75.219999999999999 111.906 176.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.46 -31.06 94.09 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.658 2.238 . . . . 75.400000000000006 112.777 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 44.4 p-80 -86.33 -8.09 57.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.889 0.376 . . . . 74.230000000000004 111.022 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 755' ' ' GLU . . . . . 0.772 ' HB2' ' HG2' ' A' ' 752' ' ' PRO . 17.4 mm-40 -142.81 67.12 18.12 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.164 -0.471 . . . . 75.510000000000005 111.622 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 756' ' ' PRO . . . . . 0.519 ' O ' ' HA ' ' A' ' 775' ' ' HIS . 48.1 Cg_endo -71.1 88.13 0.7 Allowed 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 121.845 1.697 . . . . 75.319999999999993 110.084 173.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 757' ' ' LYS . . . . . 0.618 ' HB2' ' HZ2' ' A' ' 757' ' ' LYS . 3.6 ttmp? -87.26 116.25 25.22 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.583 0.706 . . . . 64.010000000000005 111.726 -168.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 758' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -97.83 120.87 39.0 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.88 -1.054 . . . . 72.319999999999993 110.133 177.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 15.9 t -88.84 100.14 10.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 109.239 -0.652 . . . . 42.310000000000002 109.239 177.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -103.93 141.88 35.39 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.012 -0.54 . . . . 74.230000000000004 110.812 -177.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -132.04 136.45 47.24 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.07 -0.513 . . . . 72.120000000000005 109.844 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 762' ' ' ALA . . . . . . . . . . . . . . . -94.5 117.49 30.2 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.226 0.536 . . . . 41.530000000000001 110.388 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 763' ' ' LYS . . . . . 0.68 ' HD2' ' CH2' ' A' ' 768' ' ' TRP . 56.5 tttm -101.74 112.02 24.47 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.996 -0.547 . . . . 65.329999999999998 110.025 178.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 764' ' ' VAL . . . . . 0.41 HG11 ' HE2' ' A' ' 734' ' ' TYR . 89.9 t -117.15 105.99 19.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.17 0.51 . . . . 53.299999999999997 110.041 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 74.22 -115.89 5.04 Favored Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 110.955 -0.858 . . . . 63.340000000000003 110.955 -175.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -110.21 4.24 29.98 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.524 -0.846 . . . . 73.340000000000003 112.348 177.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 767' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -103.48 149.21 25.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.933 0.397 . . . . 74.420000000000002 110.94 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 768' ' ' TRP . . . . . 0.68 ' CH2' ' HD2' ' A' ' 763' ' ' LYS . 58.4 m95 -117.76 104.38 10.92 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.698 -0.683 . . . . 75.510000000000005 109.822 -178.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 769' ' ' PHE . . . . . 0.429 ' HA ' ' HA ' ' A' ' 770' ' ' PRO . 20.0 p90 -172.86 137.84 0.82 Allowed Pre-proline 0 C--N 1.324 -0.524 0 CA-C-O 121.065 0.46 . . . . 74.109999999999999 110.925 -177.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 770' ' ' PRO . . . . . 0.615 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 71.4 Cg_endo -97.16 176.9 8.68 Favored 'Cis proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.381 -1.508 . . . . 73.540000000000006 112.093 -3.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -112.51 109.73 19.48 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.536 -0.542 . . . . 64.239999999999995 109.536 173.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 34.1 m -116.61 174.8 3.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.039 -0.528 . . . . 75.230000000000004 110.891 -174.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 11.8 p -138.08 129.05 27.12 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.856 -0.611 . . . . 70.329999999999998 110.615 178.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 774' ' ' ALA . . . . . 0.413 ' HB2' ' HG3' ' A' ' 783' ' ' GLU . . . -140.04 153.76 46.9 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.984 -0.553 . . . . 72.400000000000006 109.963 178.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 775' ' ' HIS . . . . . 0.519 ' HA ' ' O ' ' A' ' 756' ' ' PRO . 1.5 p-80 -86.3 12.58 9.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.181 0.515 . . . . 70.209999999999994 111.151 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 776' ' ' SER . . . . . 0.419 ' HB3' ' HB2' ' A' ' 779' ' ' GLN . 40.7 t -138.22 141.2 39.98 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.79 -0.641 . . . . 75.409999999999997 109.361 176.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 777' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -68.07 -41.91 81.25 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.267 -0.424 . . . . 75.340000000000003 110.17 -178.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -64.99 -40.74 95.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.991 -0.55 . . . . 63.439999999999998 110.075 178.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 779' ' ' GLN . . . . . 0.516 ' O ' ' HG2' ' A' ' 783' ' ' GLU . 49.1 mt-30 -63.18 -44.14 96.25 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 116.155 -0.475 . . . . 71.530000000000001 110.791 177.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -51.65 -42.21 51.6 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 121.317 -0.468 . . . . 55.229999999999997 112.857 -178.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -62.81 -47.65 82.54 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.349 0.595 . . . . 73.219999999999999 110.682 177.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -69.1 -41.9 76.85 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.291 -0.868 . . . . 74.019999999999996 111.401 -176.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 783' ' ' GLU . . . . . 0.516 ' HG2' ' O ' ' A' ' 779' ' ' GLN . 25.5 mm-40 -57.53 -46.3 84.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.069 0.462 . . . . 74.340000000000003 110.1 177.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -63.45 -49.53 73.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.675 -0.693 . . . . 53.439999999999998 110.803 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 785' ' ' ALA . . . . . 0.481 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -63.15 -40.66 98.21 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.284 -0.417 . . . . 74.0 111.33 -178.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 786' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -58.38 -54.75 43.5 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.148 0.499 . . . . 74.129999999999995 110.319 177.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 787' ' ' ALA . . . . . 0.617 ' O ' HG23 ' A' ' 791' ' ' VAL . . . -61.3 -40.43 94.15 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.425 -0.807 . . . . 64.239999999999995 110.708 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 788' ' ' ALA . . . . . 0.705 ' O ' ' HG ' ' A' ' 792' ' ' LEU . . . -56.93 -49.9 74.23 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.17 -0.468 . . . . 43.109999999999999 111.33 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 789' ' ' LEU . . . . . 0.575 HD22 HD12 ' A' ' 719' ' ' LEU . 80.2 mt -61.05 -43.16 99.3 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 110.156 -0.313 . . . . 70.129999999999995 110.156 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 790' ' ' ARG . . . . . . . . . . . . . 52.8 mtp180 -59.54 -36.17 75.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.124 -0.489 . . . . 73.310000000000002 111.328 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 791' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 787' ' ' ALA . 64.4 t -64.61 -54.05 35.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 109.845 -0.428 . . . . 73.140000000000001 109.845 173.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 792' ' ' LEU . . . . . 0.705 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 45.6 mt -55.73 -48.68 74.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.69 -0.686 . . . . 73.209999999999994 111.185 -177.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 793' ' ' ILE . . . . . 0.543 HD13 HG22 ' A' ' 720' ' ' VAL . 93.0 mt -59.41 -52.27 62.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.588 -0.733 . . . . 74.409999999999997 110.933 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -64.58 -44.0 95.7 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.672 -0.775 . . . . 53.310000000000002 112.48 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -64.82 -47.69 77.1 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.745 0.276 . . . . 74.319999999999993 111.745 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 796' ' ' ASN . . . . . 0.456 HD22 ' HA ' ' A' ' 796' ' ' ASN . 1.0 OUTLIER . . . . . 0 C--N 1.326 -0.431 0 C-N-CA 120.708 -0.397 . . . . 75.25 110.709 -175.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 716' ' ' ILE . . . . . 0.614 ' HA ' HD23 ' A' ' 719' ' ' LEU . 46.2 mm . . . . . 0 C--O 1.237 0.419 0 CA-C-O 120.932 0.396 . . . . 74.230000000000004 111.43 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -59.17 -24.5 58.78 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.967 -0.635 . . . . 72.340000000000003 112.0 177.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -71.42 -36.02 71.17 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 120.469 0.176 . . . . 75.120000000000005 110.783 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 719' ' ' LEU . . . . . 0.659 HD12 HD22 ' A' ' 789' ' ' LEU . 3.3 mm? -63.14 -32.87 74.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.026 0.441 . . . . 72.530000000000001 109.873 178.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 720' ' ' VAL . . . . . 0.499 HG22 HD13 ' A' ' 793' ' ' ILE . 47.7 t -63.68 -38.73 83.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 115.887 -0.597 . . . . 71.209999999999994 110.171 174.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 721' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -67.07 -32.32 73.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.769 -0.651 . . . . 51.329999999999998 110.049 178.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -70.99 -32.95 69.91 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-N 116.206 -0.452 . . . . 62.420000000000002 110.747 177.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 723' ' ' LEU . . . . . 0.591 HD21 ' HB2' ' A' ' 789' ' ' LEU . 96.1 mt -56.31 -33.51 65.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.232 0.539 . . . . 74.109999999999999 110.163 174.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -77.76 -48.7 15.99 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.574 -0.739 . . . . 73.040000000000006 111.654 177.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 33.7 m -92.28 -67.81 0.83 Allowed 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.445 0.535 . . . . 64.239999999999995 112.445 -172.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 726' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -146.36 102.85 4.03 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 120.64 0.257 . . . . 73.450000000000003 110.439 -178.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 727' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -62.86 -38.02 51.03 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.773 2.315 . . . . 74.530000000000001 112.035 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 46.7 t -62.69 -47.48 92.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.003 -0.544 . . . . 54.030000000000001 110.644 -177.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -62.68 -38.82 97.08 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.793 -0.717 . . . . 23.43 111.624 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -66.1 -42.84 94.27 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 121.069 -0.586 . . . . 74.120000000000005 112.728 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -62.21 -44.67 96.06 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.027 0.441 . . . . 74.340000000000003 109.991 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 732' ' ' LEU . . . . . . . . . . . . . 87.8 mt -67.93 -36.94 81.01 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.033 -0.531 . . . . 72.219999999999999 110.881 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 733' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -69.82 -43.35 72.19 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 122.834 0.454 . . . . 71.5 110.831 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 734' ' ' TYR . . . . . 0.514 ' HB2' HD11 ' A' ' 719' ' ' LEU . 8.5 t80 -55.21 -48.17 74.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.928 0.394 . . . . 64.5 110.373 176.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -66.46 -50.45 63.29 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.868 -0.605 . . . . 71.310000000000002 110.97 -177.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 736' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -63.66 -31.1 72.17 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.03 0.443 . . . . 74.439999999999998 111.191 -175.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 34.8 t -77.13 -29.39 54.69 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.905 -0.589 . . . . 53.219999999999999 111.011 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 16.4 m170 -98.63 -11.52 21.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.815 0.34 . . . . 73.219999999999999 111.655 -176.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 103.63 -4.26 46.71 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.733 -0.746 . . . . 64.219999999999999 112.971 177.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -79.26 157.77 27.71 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.847 0.356 . . . . 64.209999999999994 110.494 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -102.99 122.81 45.37 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.148 -0.686 . . . . 60.100000000000001 109.148 175.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 742' ' ' ALA . . . . . 0.514 ' HA ' ' O ' ' A' ' 763' ' ' LYS . . . -114.16 122.64 47.45 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 123.379 0.424 . . . . 63.310000000000002 111.076 -176.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 743' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -145.3 138.36 26.33 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.176 -0.465 . . . . 65.310000000000002 110.844 178.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -101.15 110.83 22.91 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.842 -0.617 . . . . 64.319999999999993 109.457 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -115.68 148.85 39.25 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.062 0.458 . . . . 74.150000000000006 110.886 -179.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 746' ' ' LEU . . . . . . . . . . . . . 59.2 tp -77.88 117.45 19.25 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.682 -0.69 . . . . 73.319999999999993 110.229 178.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 93.6 t -72.83 -51.45 27.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 116.111 -0.495 . . . . 72.239999999999995 109.807 176.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -169.57 155.65 6.18 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.655 -0.702 . . . . 64.299999999999997 109.899 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 749' ' ' GLN . . . . . 0.554 ' HA ' ' O ' ' A' ' 757' ' ' LYS . 14.7 pt20 -130.69 98.97 4.8 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.413 0.625 . . . . 63.200000000000003 110.323 175.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 35.7 m -141.96 133.57 26.86 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.676 -0.693 . . . . 63.409999999999997 110.695 -177.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 170.04 -172.6 43.91 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 121.081 -0.581 . . . . 55.229999999999997 111.764 178.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 752' ' ' PRO . . . . . 0.836 ' HG2' ' HB2' ' A' ' 755' ' ' GLU . 39.0 Cg_endo -67.56 157.9 59.61 Favored 'Trans proline' 0 N--CA 1.464 -0.217 0 C-N-CA 122.774 2.316 . . . . 71.019999999999996 111.569 177.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -58.73 -32.35 96.79 Favored 'Trans proline' 0 CA--C 1.532 0.405 0 C-N-CA 122.52 2.146 . . . . 73.5 113.109 -177.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 47.9 p-80 -83.04 -18.59 39.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.958 0.408 . . . . 75.430000000000007 111.081 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 755' ' ' GLU . . . . . 0.836 ' HB2' ' HG2' ' A' ' 752' ' ' PRO . 58.9 mm-40 -129.4 74.1 81.16 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.114 -0.493 . . . . 74.230000000000004 110.832 179.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 756' ' ' PRO . . . . . 0.725 ' O ' ' HA ' ' A' ' 775' ' ' HIS . 29.5 Cg_endo -64.51 102.6 0.41 Allowed 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.083 1.855 . . . . 65.120000000000005 110.23 174.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 757' ' ' LYS . . . . . 0.554 ' O ' ' HA ' ' A' ' 749' ' ' GLN . 0.8 OUTLIER -89.51 105.43 17.79 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.088 0.471 . . . . 73.140000000000001 111.366 -170.01 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 758' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -92.29 110.11 21.5 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.464 -0.789 . . . . 73.319999999999993 109.752 177.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 13.8 t -84.57 109.24 17.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.607 -0.724 . . . . 62.310000000000002 109.423 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -110.81 135.79 50.84 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.269 -0.423 . . . . 72.400000000000006 110.895 -178.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 761' ' ' GLN . . . . . 0.567 ' HA ' ' O ' ' A' ' 770' ' ' PRO . 57.7 tt0 -128.35 130.85 48.37 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.119 -0.491 . . . . 74.209999999999994 109.973 179.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 762' ' ' ALA . . . . . . . . . . . . . . . -89.59 117.73 28.7 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.18 0.514 . . . . 45.450000000000003 110.749 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 763' ' ' LYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 742' ' ' ALA . 60.5 tttm -89.62 113.98 25.51 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.222 -0.658 . . . . 64.430000000000007 109.222 175.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 92.8 t -124.0 101.35 8.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.363 0.601 . . . . 73.140000000000001 110.162 178.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 73.14 -116.05 5.39 Favored Glycine 0 N--CA 1.442 -0.923 0 CA-C-N 115.187 -0.915 . . . . 74.099999999999994 111.426 -177.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -102.36 -11.23 36.69 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.801 -0.714 . . . . 73.239999999999995 111.998 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 767' ' ' ARG . . . . . . . . . . . . . 62.9 mtt180 -99.81 146.28 26.78 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.259 0.552 . . . . 64.319999999999993 111.673 -178.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 768' ' ' TRP . . . . . 0.467 ' CH2' ' HD2' ' A' ' 763' ' ' LYS . 63.0 m95 -111.77 107.36 16.41 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.208 -0.905 . . . . 74.329999999999998 109.404 179.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 769' ' ' PHE . . . . . 0.503 ' HA ' ' HA ' ' A' ' 770' ' ' PRO . 43.1 p90 -169.19 141.0 2.02 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-O 121.048 0.452 . . . . 75.239999999999995 111.124 -176.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 770' ' ' PRO . . . . . 0.726 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 74.8 Cg_endo -98.46 176.94 7.65 Favored 'Cis proline' 0 N--CA 1.449 -1.089 0 C-N-CA 123.301 -1.541 . . . . 75.430000000000007 111.397 -5.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -111.55 99.29 8.07 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.991 0.424 . . . . 71.310000000000002 109.978 173.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 34.4 m -106.22 161.04 5.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.881 -0.6 . . . . 75.129999999999995 110.926 -177.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 773' ' ' CYS . . . . . 0.433 ' HB3' ' CG ' ' A' ' 757' ' ' LYS . 39.3 m -125.58 114.25 18.49 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.219 -0.446 . . . . 54.020000000000003 110.633 -178.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -128.61 153.48 47.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.224 -0.443 . . . . 53.32 109.947 178.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 775' ' ' HIS . . . . . 0.725 ' HA ' ' O ' ' A' ' 756' ' ' PRO . 1.9 p-80 -84.11 19.47 1.8 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.992 0.425 . . . . 73.299999999999997 111.492 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 24.9 t -153.32 143.19 22.06 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.396 -0.594 . . . . 75.219999999999999 109.396 175.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 777' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -60.65 -55.24 35.68 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.163 -0.472 . . . . 73.019999999999996 111.97 -175.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -65.92 -31.41 72.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.558 -0.292 . . . . 74.129999999999995 110.592 -175.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 779' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -62.0 -46.74 87.88 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.486 -0.561 . . . . 74.099999999999994 109.486 172.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -56.88 -47.73 84.19 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.698 -0.683 . . . . 52.439999999999998 112.169 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -59.21 -43.89 92.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.534 0.207 . . . . 75.450000000000003 111.364 177.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -68.58 -46.37 69.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.706 -0.225 . . . . 71.450000000000003 111.441 -178.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -64.05 -39.27 93.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.653 0.263 . . . . 72.340000000000003 110.522 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -62.37 -49.39 75.73 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 116.254 -0.43 . . . . 62.43 110.438 176.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 785' ' ' ALA . . . . . 0.596 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -61.38 -42.17 98.28 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.181 -0.463 . . . . 53.32 111.151 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 786' ' ' ASP . . . . . 0.622 ' O ' ' HG2' ' A' ' 790' ' ' ARG . 10.4 t70 -58.91 -54.22 49.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 70.129999999999995 110.375 178.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 787' ' ' ALA . . . . . 0.558 ' O ' HG23 ' A' ' 791' ' ' VAL . . . -65.41 -33.91 77.06 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.966 -0.561 . . . . 63.439999999999998 111.097 -178.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 788' ' ' ALA . . . . . 0.726 ' HB2' ' HD3' ' A' ' 770' ' ' PRO . . . -61.3 -44.52 97.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.476 -0.329 . . . . 61.200000000000003 110.729 177.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 789' ' ' LEU . . . . . 0.659 HD22 HD12 ' A' ' 719' ' ' LEU . 53.3 mt -63.19 -36.16 82.71 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.483 -0.326 . . . . 74.209999999999994 110.199 179.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 790' ' ' ARG . . . . . 0.622 ' HG2' ' O ' ' A' ' 786' ' ' ASP . 21.2 mmt180 -58.15 -45.63 87.06 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 109.739 -0.467 . . . . 71.120000000000005 109.739 177.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 791' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 787' ' ' ALA . 30.4 t -61.34 -46.71 96.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.62 -0.718 . . . . 74.140000000000001 110.388 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 792' ' ' LEU . . . . . 0.676 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 45.8 mt -62.2 -50.65 70.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.665 -0.698 . . . . 75.120000000000005 110.915 -178.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 793' ' ' ILE . . . . . 0.499 HD13 HG22 ' A' ' 720' ' ' VAL . 91.4 mt -59.25 -53.81 42.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.587 -0.733 . . . . 64.299999999999997 110.774 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -60.5 -31.85 75.92 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.857 -0.687 . . . . 61.420000000000002 112.615 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -65.23 -48.27 73.89 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.145 0.497 . . . . 75.209999999999994 109.991 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 . . . . . 0 C--N 1.323 -0.572 0 CA-C-N 116.054 -0.521 . . . . 71.310000000000002 111.623 -175.137 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 716' ' ' ILE . . . . . 0.436 ' HA ' HD23 ' A' ' 719' ' ' LEU . 50.1 mm . . . . . 0 C--O 1.233 0.206 0 CA-C-O 120.889 0.376 . . . . 64.219999999999999 111.398 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -56.45 -29.53 57.35 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 121.187 -0.53 . . . . 41.450000000000003 112.435 177.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 718' ' ' GLU . . . . . 0.614 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 9.3 mm-40 -60.57 -53.36 58.42 Favored 'General case' 0 C--O 1.225 -0.236 0 N-CA-C 109.985 -0.376 . . . . 74.430000000000007 109.985 176.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 719' ' ' LEU . . . . . 0.547 HD12 HD22 ' A' ' 789' ' ' LEU . 2.7 mm? -60.35 -35.88 76.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.042 -0.527 . . . . 70.109999999999999 110.461 -177.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 720' ' ' VAL . . . . . 0.442 HG22 HD13 ' A' ' 793' ' ' ILE . 58.7 t -62.09 -41.37 90.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 116.07 -0.514 . . . . 73.319999999999993 110.871 178.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 721' ' ' ARG . . . . . 0.614 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 19.1 ptt180 -66.82 -26.05 66.74 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.308 -0.405 . . . . 54.200000000000003 110.064 -178.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -77.33 -30.67 54.12 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 116.293 -0.412 . . . . 74.409999999999997 110.787 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 723' ' ' LEU . . . . . 0.529 HD21 ' HB2' ' A' ' 789' ' ' LEU . 55.8 mt -64.01 -23.97 67.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.167 0.508 . . . . 74.030000000000001 110.002 173.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -89.51 -26.38 20.92 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.748 -0.66 . . . . 71.209999999999994 110.989 176.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 10.9 m -106.29 -77.47 0.59 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.909 0.385 . . . . 74.430000000000007 111.407 -175.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 726' ' ' ASN . . . . . 0.434 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 29.3 t30 -145.31 108.19 4.51 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.347 -0.388 . . . . 72.439999999999998 110.231 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 727' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 13.6 Cg_endo -57.6 -38.48 93.45 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.966 2.444 . . . . 60.030000000000001 112.413 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 728' ' ' VAL . . . . . 0.411 ' O ' ' HG ' ' A' ' 732' ' ' LEU . 55.8 t -60.57 -47.5 92.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.244 -0.434 . . . . 72.120000000000005 110.34 -179.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -62.43 -32.28 82.47 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.67 -0.695 . . . . 44.439999999999998 111.822 178.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -67.89 -43.73 81.92 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.092 -0.575 . . . . 71.439999999999998 112.461 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -64.9 -40.46 95.11 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.633 -0.506 . . . . 72.450000000000003 109.633 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 732' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 728' ' ' VAL . 84.6 mt -63.67 -41.51 98.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.842 -0.617 . . . . 64.040000000000006 110.451 176.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 733' ' ' GLU . . . . . 0.483 ' O ' ' HG2' ' A' ' 736' ' ' ARG . 2.5 tp10 -65.55 -44.59 86.31 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 123.052 0.541 . . . . 74.129999999999995 110.86 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 734' ' ' TYR . . . . . 0.478 ' HB2' HD11 ' A' ' 719' ' ' LEU . 27.1 t80 -56.23 -51.63 67.4 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.974 -0.557 . . . . 72.340000000000003 111.08 178.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -66.13 -46.86 76.04 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.393 -0.367 . . . . 64.010000000000005 111.291 -177.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 736' ' ' ARG . . . . . 0.483 ' HG2' ' O ' ' A' ' 733' ' ' GLU . 25.7 ptt180 -64.32 -29.34 70.42 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.201 0.524 . . . . 71.099999999999994 111.239 -175.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 33.8 t -83.64 -35.11 24.84 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.778 -0.646 . . . . 64.430000000000007 111.222 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 13.2 m170 -93.6 -10.29 35.18 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.201 0.445 . . . . 70.120000000000005 112.201 -172.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 103.1 3.92 48.05 Favored Glycine 0 N--CA 1.453 -0.172 0 C-N-CA 120.417 -0.897 . . . . 73.519999999999996 112.751 176.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -90.91 178.29 6.07 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.042 0.448 . . . . 71.099999999999994 110.542 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 741' ' ' ALA . . . . . 0.529 ' O ' ' HA ' ' A' ' 764' ' ' VAL . . . -120.16 134.55 55.23 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.847 -0.615 . . . . 55.140000000000001 109.492 174.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 742' ' ' ALA . . . . . 0.403 ' HB3' HD23 ' A' ' 732' ' ' LEU . . . -102.18 113.29 26.44 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.526 -0.306 . . . . 70.439999999999998 110.808 -177.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 743' ' ' GLU . . . . . 0.552 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 46.2 mt-10 -123.84 140.62 52.81 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.172 -0.467 . . . . 63.210000000000001 110.818 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -121.96 105.15 10.06 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.569 -0.53 . . . . 74.439999999999998 109.569 176.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.52 153.3 35.57 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.566 -0.454 . . . . 62.450000000000003 111.453 -177.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 746' ' ' LEU . . . . . . . . . . . . . 57.0 tp -82.03 116.14 21.5 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.473 -0.785 . . . . 54.32 109.407 173.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 52.2 t -88.06 -47.72 15.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 116.292 -0.413 . . . . 70.530000000000001 110.323 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -141.42 143.97 34.21 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.203 -0.453 . . . . 70.120000000000005 111.261 -176.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -130.06 100.6 5.49 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.816 -0.629 . . . . 74.430000000000007 109.395 174.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 750' ' ' SER . . . . . 0.418 ' O ' ' HB3' ' A' ' 757' ' ' LYS . 20.1 m -136.37 110.53 8.35 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.993 -0.548 . . . . 45.229999999999997 110.547 -177.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 174.15 177.9 43.67 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.976 -0.631 . . . . 64.450000000000003 111.803 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 752' ' ' PRO . . . . . 0.42 ' HG2' ' HB2' ' A' ' 755' ' ' GLU . 55.7 Cg_endo -71.01 155.87 61.06 Favored 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 122.85 2.367 . . . . 72.120000000000005 111.959 178.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -64.82 -30.29 58.62 Favored 'Trans proline' 0 CA--C 1.528 0.202 0 C-N-CA 122.603 2.202 . . . . 63.439999999999998 112.975 -176.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 56.0 p-80 -84.35 -23.61 30.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.772 0.32 . . . . 74.5 111.024 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 755' ' ' GLU . . . . . 0.42 ' HB2' ' HG2' ' A' ' 752' ' ' PRO . 23.8 mm-40 -133.01 71.7 77.55 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.147 -0.479 . . . . 73.420000000000002 110.431 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 756' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -64.41 143.13 81.55 Favored 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 122.362 2.041 . . . . 70.310000000000002 112.08 -176.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 757' ' ' LYS . . . . . 0.418 ' HB3' ' O ' ' A' ' 750' ' ' SER . 23.3 ttmm -116.44 114.93 24.92 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.054 -0.521 . . . . 64.340000000000003 109.735 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 758' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -107.02 113.08 26.34 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.889 -0.596 . . . . 71.319999999999993 110.663 -177.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 759' ' ' VAL . . . . . 0.471 HG22 ' HB3' ' A' ' 773' ' ' CYS . 29.1 t -87.26 98.11 7.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.848 -0.615 . . . . 60.350000000000001 109.556 176.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 760' ' ' TYR . . . . . 0.537 ' OH ' ' HG3' ' A' ' 777' ' ' LYS . 6.3 m-85 -100.1 143.04 30.77 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.893 -0.594 . . . . 45.149999999999999 110.236 179.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -131.77 137.44 48.18 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.12 -0.491 . . . . 53.310000000000002 109.695 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 762' ' ' ALA . . . . . . . . . . . . . . . -86.28 114.01 22.74 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.037 -0.529 . . . . 55.329999999999998 110.489 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 763' ' ' LYS . . . . . 0.552 ' HB3' ' HB2' ' A' ' 743' ' ' GLU . 59.3 tttm -96.82 100.44 11.98 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.771 -0.65 . . . . 65.030000000000001 109.699 178.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 764' ' ' VAL . . . . . 0.529 ' HA ' ' O ' ' A' ' 741' ' ' ALA . 61.1 t -104.21 100.81 11.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 N-CA-C 109.448 -0.575 . . . . 70.239999999999995 109.448 -179.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 69.96 -122.49 11.66 Favored Glycine 0 N--CA 1.442 -0.904 0 N-CA-C 110.479 -1.048 . . . . 73.549999999999997 110.479 -172.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -104.01 20.21 41.48 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.596 -0.811 . . . . 51.43 111.545 174.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 767' ' ' ARG . . . . . . . . . . . . . 41.6 ttt180 -115.53 122.76 46.65 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.735 0.302 . . . . 74.400000000000006 110.394 -176.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 768' ' ' TRP . . . . . 0.488 ' CH2' ' HD2' ' A' ' 763' ' ' LYS . 44.1 m95 -98.21 103.18 15.1 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.243 -0.435 . . . . 73.120000000000005 110.204 -178.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 769' ' ' PHE . . . . . 0.405 ' HA ' ' HA ' ' A' ' 770' ' ' PRO . 9.3 p90 -171.56 138.97 1.11 Allowed Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 120.822 0.344 . . . . 65.409999999999997 110.554 178.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 770' ' ' PRO . . . . . 0.633 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 82.8 Cg_endo -96.58 -176.49 5.16 Favored 'Cis proline' 0 N--CA 1.452 -0.947 0 C-N-CA 123.622 -1.407 . . . . 60.43 111.769 -4.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -117.4 129.79 56.07 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.077 -0.342 . . . . 32.130000000000003 110.077 176.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 30.7 m -136.63 145.97 29.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.748 0.309 . . . . 35.409999999999997 111.044 -178.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 773' ' ' CYS . . . . . 0.471 ' HB3' HG22 ' A' ' 759' ' ' VAL . 5.0 p -113.36 103.39 11.26 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.105 0.479 . . . . 74.030000000000001 110.695 178.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -106.43 -179.24 3.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.291 -0.413 . . . . 53.409999999999997 111.125 -176.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 775' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 -93.77 -8.65 40.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.286 0.565 . . . . 74.230000000000004 110.231 -177.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 63.6 m -150.75 166.05 31.63 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.754 -0.657 . . . . 50.539999999999999 110.403 -179.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 777' ' ' LYS . . . . . 0.537 ' HG3' ' OH ' ' A' ' 760' ' ' TYR . 31.2 ttmt -64.33 -57.64 8.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.269 -0.423 . . . . 74.219999999999999 111.741 -178.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -61.67 -35.96 79.47 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.054 -0.521 . . . . 65.340000000000003 110.039 -175.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 779' ' ' GLN . . . . . 0.474 ' O ' ' HG2' ' A' ' 783' ' ' GLU . 73.9 mt-30 -52.91 -56.2 17.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 75.25 110.18 170.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -57.37 -47.68 86.21 Favored Glycine 0 C--N 1.332 0.33 0 CA-C-N 115.698 -0.683 . . . . 34.340000000000003 112.764 -177.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -57.48 -44.52 84.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.754 0.311 . . . . 71.439999999999998 111.177 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -69.83 -45.18 68.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.418 -0.356 . . . . 74.120000000000005 111.176 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 783' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' A' ' 779' ' ' GLN . 30.0 mm-40 -59.86 -40.39 88.43 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.902 0.382 . . . . 52.520000000000003 110.768 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -65.38 -49.87 67.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 72.219999999999999 110.612 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 785' ' ' ALA . . . . . 0.513 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -64.79 -40.09 94.66 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.312 -0.404 . . . . 65.230000000000004 111.18 -178.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 786' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -60.76 -50.05 75.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.984 -0.553 . . . . 51.140000000000001 110.108 178.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 787' ' ' ALA . . . . . 0.616 ' O ' HG23 ' A' ' 791' ' ' VAL . . . -62.6 -39.64 94.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.757 -0.656 . . . . 72.239999999999995 110.712 178.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 788' ' ' ALA . . . . . 0.633 ' HB2' ' HD3' ' A' ' 770' ' ' PRO . . . -59.05 -47.36 85.53 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.072 -0.513 . . . . 64.109999999999999 111.338 -179.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 789' ' ' LEU . . . . . 0.547 HD22 HD12 ' A' ' 719' ' ' LEU . 77.9 mt -61.42 -41.77 97.69 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 110.109 -0.33 . . . . 75.200000000000003 110.109 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 790' ' ' ARG . . . . . 0.552 ' HD2' ' HA ' ' A' ' 787' ' ' ALA . 69.8 mtt-85 -57.38 -39.36 75.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 73.230000000000004 110.943 176.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 791' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 787' ' ' ALA . 60.1 t -63.33 -57.31 12.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.102 -0.499 . . . . 62.140000000000001 110.037 176.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 792' ' ' LEU . . . . . 0.595 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 37.1 mt -55.93 -47.72 77.01 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.487 -0.779 . . . . 75.409999999999997 111.522 -176.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 793' ' ' ILE . . . . . 0.442 HD13 HG22 ' A' ' 720' ' ' VAL . 95.7 mt -61.14 -46.47 96.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.795 -0.639 . . . . 72.329999999999998 110.934 178.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -60.69 -39.46 96.66 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.949 -0.643 . . . . 71.140000000000001 112.252 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 795' ' ' GLU . . . . . 0.564 ' HG2' ' O ' ' A' ' 791' ' ' VAL . 21.5 mm-40 -52.44 -44.13 65.31 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.08 0.467 . . . . 74.549999999999997 110.901 177.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 8.0 t30 . . . . . 0 C--N 1.326 -0.418 0 CA-C-N 115.934 -0.575 . . . . 55.210000000000001 112.008 -175.408 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 716' ' ' ILE . . . . . 0.537 HG23 ' HA ' ' A' ' 793' ' ' ILE . 38.5 mm . . . . . 0 CA--C 1.531 0.247 0 N-CA-C 112.694 0.628 . . . . 70.530000000000001 112.694 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -63.81 -30.66 78.35 Favored Glycine 0 C--O 1.237 0.29 0 C-N-CA 120.785 -0.721 . . . . 34.549999999999997 112.358 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 718' ' ' GLU . . . . . 0.658 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 35.4 mt-10 -73.03 -37.84 66.75 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 110.127 -0.323 . . . . 75.030000000000001 110.127 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 719' ' ' LEU . . . . . 0.705 HD12 HD22 ' A' ' 789' ' ' LEU . 2.6 mm? -58.1 -35.04 70.85 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.013 0.435 . . . . 75.219999999999999 110.308 175.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 720' ' ' VAL . . . . . 0.48 HG22 HD13 ' A' ' 793' ' ' ILE . 71.6 t -61.92 -41.16 89.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.856 -0.611 . . . . 71.219999999999999 110.997 178.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 721' ' ' ARG . . . . . 0.658 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 8.2 ptt180 -65.15 -25.35 67.71 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.979 0.419 . . . . 73.310000000000002 110.506 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -77.14 -29.17 54.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.398 -0.365 . . . . 74.319999999999993 110.767 178.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 723' ' ' LEU . . . . . 0.561 HD21 ' HB2' ' A' ' 789' ' ' LEU . 95.8 mt -62.06 -30.03 70.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.371 0.605 . . . . 70.310000000000002 109.742 173.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -81.95 -40.1 22.72 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.283 -0.871 . . . . 72.010000000000005 110.428 176.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 12.1 m -93.02 -83.44 0.31 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.983 -0.553 . . . . 63.149999999999999 111.416 -176.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 726' ' ' ASN . . . . . 0.421 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 44.9 t30 -140.76 110.2 6.67 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.789 0.328 . . . . 61.240000000000002 110.504 -176.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 727' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 28.5 Cg_endo -63.68 -37.24 47.67 Favored 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 122.814 2.343 . . . . 73.299999999999997 112.312 -178.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 44.0 t -61.24 -49.03 86.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.187 -0.46 . . . . 60.530000000000001 110.501 -178.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -64.02 -35.83 92.49 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.963 -0.637 . . . . 74.310000000000002 111.836 178.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -66.8 -41.61 93.51 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 121.063 -0.589 . . . . 74.120000000000005 112.457 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -63.48 -41.2 98.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.095 0.474 . . . . 65.040000000000006 109.733 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 732' ' ' LEU . . . . . 0.42 HD23 ' HB3' ' A' ' 742' ' ' ALA . 75.4 mt -68.29 -39.14 82.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.829 -0.623 . . . . 71.310000000000002 110.65 177.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 733' ' ' GLU . . . . . 0.549 ' O ' ' HG2' ' A' ' 736' ' ' ARG . 2.2 tp10 -65.29 -45.11 85.72 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 123.391 0.676 . . . . 64.109999999999999 111.067 -179.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 734' ' ' TYR . . . . . 0.617 ' HB2' HD11 ' A' ' 719' ' ' LEU . 7.4 t80 -60.21 -46.78 88.56 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.389 -0.369 . . . . 54.100000000000001 110.66 176.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 735' ' ' ALA . . . . . 0.446 ' HA ' ' HB2' ' A' ' 740' ' ' PHE . . . -64.11 -49.02 73.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.133 -0.485 . . . . 61.109999999999999 110.891 -177.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 736' ' ' ARG . . . . . 0.549 ' HG2' ' O ' ' A' ' 733' ' ' GLU . 23.3 ptt180 -59.97 -38.58 82.96 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.869 -0.605 . . . . 73.349999999999994 111.111 -176.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 32.9 t -78.46 -23.27 46.58 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.969 -0.559 . . . . 71.109999999999999 111.461 -177.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -108.91 4.96 23.97 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.118 0.414 . . . . 71.329999999999998 112.118 -174.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 89.04 2.76 77.33 Favored Glycine 0 C--O 1.229 -0.177 0 C-N-CA 120.736 -0.745 . . . . 73.25 113.261 174.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 740' ' ' PHE . . . . . 0.446 ' HB2' ' HA ' ' A' ' 735' ' ' ALA . 90.3 m-85 -83.52 161.26 21.29 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.874 0.369 . . . . 72.420000000000002 110.842 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -115.01 104.24 11.71 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.879 -0.6 . . . . 62.140000000000001 109.538 176.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 742' ' ' ALA . . . . . 0.42 ' HB3' HD23 ' A' ' 732' ' ' LEU . . . -86.4 125.7 33.86 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.04 -0.527 . . . . 72.049999999999997 111.208 -176.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 743' ' ' GLU . . . . . 0.426 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 43.3 mt-10 -137.82 134.72 35.5 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.047 -0.524 . . . . 75.109999999999999 110.382 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -107.21 105.74 15.87 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.5 -0.556 . . . . 74.120000000000005 109.5 176.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.53 147.25 44.68 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.053 0.454 . . . . 61.100000000000001 111.131 -174.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 746' ' ' LEU . . . . . . . . . . . . . 51.3 tp -77.22 122.01 24.46 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.701 -0.681 . . . . 54.130000000000003 110.006 176.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 60.1 t -81.76 -50.35 16.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.09 -0.505 . . . . 74.349999999999994 109.694 177.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -165.99 156.26 12.68 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.697 -0.683 . . . . 74.030000000000001 110.032 -177.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -114.32 119.14 35.94 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.98 -0.378 . . . . 64.230000000000004 109.98 174.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 750' ' ' SER . . . . . 0.506 ' O ' ' HB3' ' A' ' 757' ' ' LYS . 67.6 m -135.56 107.38 7.05 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.107 -0.497 . . . . 41.140000000000001 110.142 179.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 174.81 153.38 10.01 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.261 -0.971 . . . . 71.010000000000005 112.745 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 752' ' ' PRO . . . . . 0.709 ' HG2' ' HB2' ' A' ' 755' ' ' GLU . 36.2 Cg_endo -66.53 168.69 15.85 Favored 'Trans proline' 0 CA--C 1.533 0.427 0 C-N-CA 123.348 2.698 . . . . 71.430000000000007 111.968 176.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.61 -31.88 95.09 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.595 2.197 . . . . 75.010000000000005 112.88 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 42.9 p-80 -87.5 -5.05 58.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.415 -0.357 . . . . 64.310000000000002 111.259 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 755' ' ' GLU . . . . . 0.709 ' HB2' ' HG2' ' A' ' 752' ' ' PRO . 12.2 mm-40 -150.39 64.21 6.5 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.156 -0.475 . . . . 72.140000000000001 110.715 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 756' ' ' PRO . . . . . 0.472 ' O ' ' HA ' ' A' ' 775' ' ' HIS . 14.4 Cg_exo -68.42 92.15 0.41 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.711 2.274 . . . . 71.230000000000004 111.33 178.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 757' ' ' LYS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 775' ' ' HIS . 15.0 ttmt -89.05 111.73 22.53 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.522 0.677 . . . . 65.329999999999998 111.262 -174.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 758' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -90.76 130.85 36.7 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.943 -1.026 . . . . 74.040000000000006 109.832 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 29.2 t -92.87 109.04 21.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.609 -0.515 . . . . 73.150000000000006 109.609 175.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -111.92 141.19 45.87 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.303 -0.408 . . . . 71.140000000000001 110.646 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -126.97 137.82 53.17 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.977 -0.556 . . . . 72.150000000000006 109.92 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 762' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' A' ' 769' ' ' PHE . . . -85.44 109.82 18.73 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.402 0.62 . . . . 74.239999999999995 110.428 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 763' ' ' LYS . . . . . 0.426 ' HB3' ' HB2' ' A' ' 743' ' ' GLU . 75.1 tttt -94.08 104.29 16.33 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.228 -0.896 . . . . 61.310000000000002 109.483 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 48.4 t -117.2 98.04 6.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 120.939 0.4 . . . . 62.420000000000002 111.176 -175.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 60.5 37.27 93.03 Favored Glycine 0 CA--C 1.517 0.193 0 CA-C-N 115.716 -0.674 . . . . 61.009999999999998 113.143 176.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 94.86 -16.11 61.98 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.545 -0.836 . . . . 72.230000000000004 112.62 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 767' ' ' ARG . . . . . . . . . . . . . 79.0 mtt180 -90.64 129.28 36.78 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.054 -0.35 . . . . 63.420000000000002 110.054 176.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 768' ' ' TRP . . . . . . . . . . . . . 68.3 m95 -106.58 99.15 8.74 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.408 -0.36 . . . . 72.239999999999995 110.484 -176.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 769' ' ' PHE . . . . . 0.473 ' HA ' ' HA ' ' A' ' 770' ' ' PRO . 36.3 p90 -170.22 136.86 1.29 Allowed Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.533 -0.303 . . . . 71.019999999999996 110.327 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 770' ' ' PRO . . . . . 0.572 ' HG3' ' HB3' ' A' ' 787' ' ' ALA . 62.5 Cg_endo -94.89 179.02 9.23 Favored 'Cis proline' 0 N--CA 1.45 -1.04 0 C-N-CA 123.484 -1.465 . . . . 72.140000000000001 111.978 -3.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -115.56 104.14 11.43 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.938 -0.393 . . . . 62.340000000000003 109.938 175.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 29.6 m -113.67 164.27 9.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.001 0.429 . . . . 72.0 111.05 -175.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 773' ' ' CYS . . . . . 0.475 ' HB2' ' HG2' ' A' ' 757' ' ' LYS . 10.6 p -127.87 119.19 25.1 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.082 -0.508 . . . . 63.25 110.193 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -135.91 144.33 45.46 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.41 -0.359 . . . . 73.439999999999998 110.612 -178.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 775' ' ' HIS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 757' ' ' LYS . 1.1 p-80 -76.45 16.5 0.47 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.496 0.554 . . . . 73.349999999999994 112.496 -177.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 776' ' ' SER . . . . . 0.571 ' HB2' ' CG ' ' A' ' 779' ' ' GLN . 11.8 m -147.13 140.32 25.3 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.654 -0.498 . . . . 42.439999999999998 109.654 177.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 777' ' ' LYS . . . . . 0.434 ' HE3' ' HB3' ' A' ' 777' ' ' LYS . 2.2 tmmt? -61.46 -46.25 90.84 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.435 -0.348 . . . . 65.209999999999994 111.227 -178.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 778' ' ' LYS . . . . . 0.501 ' O ' ' HG3' ' A' ' 782' ' ' GLN . 63.7 pttt -66.5 -35.48 80.37 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.929 -0.308 . . . . 62.119999999999997 110.442 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 779' ' ' GLN . . . . . 0.571 ' CG ' ' HB2' ' A' ' 776' ' ' SER . 16.0 mm100 -63.79 -43.9 94.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.337 -0.392 . . . . 61.420000000000002 110.05 177.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -57.52 -40.46 92.38 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.002 -0.618 . . . . 42.32 111.92 178.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 30.3 mtpp -66.5 -47.0 74.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.639 0.257 . . . . 75.329999999999998 110.831 178.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 782' ' ' GLN . . . . . 0.501 ' HG3' ' O ' ' A' ' 778' ' ' LYS . 22.8 mt-30 -68.25 -48.17 65.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.221 -0.445 . . . . 65.329999999999998 111.228 -177.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -58.76 -46.15 88.12 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 123.25 0.344 . . . . 62.240000000000002 110.999 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -63.17 -48.01 80.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.305 -0.407 . . . . 75.510000000000005 110.893 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 785' ' ' ALA . . . . . 0.631 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -62.64 -42.19 99.46 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.268 -0.424 . . . . 31.32 111.089 -178.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 786' ' ' ASP . . . . . 0.523 ' O ' ' HG2' ' A' ' 790' ' ' ARG . 11.7 t70 -59.48 -55.74 30.77 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.04 -0.527 . . . . 72.430000000000007 110.129 179.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 787' ' ' ALA . . . . . 0.572 ' HB3' ' HG3' ' A' ' 770' ' ' PRO . . . -61.52 -34.68 75.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.75 -0.659 . . . . 71.209999999999994 111.203 -178.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 788' ' ' ALA . . . . . 0.592 ' O ' ' HG ' ' A' ' 792' ' ' LEU . . . -61.22 -42.78 99.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.421 -0.354 . . . . 65.239999999999995 110.888 178.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 789' ' ' LEU . . . . . 0.705 HD22 HD12 ' A' ' 719' ' ' LEU . 35.5 mt -66.05 -33.93 76.92 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.421 -0.354 . . . . 74.340000000000003 110.122 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 790' ' ' ARG . . . . . 0.523 ' HG2' ' O ' ' A' ' 786' ' ' ASP . 6.2 mmm180 -61.71 -44.47 96.85 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.493 -0.558 . . . . 72.409999999999997 109.493 178.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 791' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 787' ' ' ALA . 41.2 t -57.69 -44.26 85.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.512 -0.767 . . . . 74.219999999999999 110.559 178.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 792' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 30.3 mt -68.15 -52.06 38.95 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.732 -0.667 . . . . 73.549999999999997 110.713 -178.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 793' ' ' ILE . . . . . 0.537 ' HA ' HG23 ' A' ' 716' ' ' ILE . 95.7 mt -60.23 -47.33 92.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.539 -0.755 . . . . 75.030000000000001 111.456 -177.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -68.71 -26.36 74.54 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.766 -0.731 . . . . 55.130000000000003 112.506 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -77.81 -44.28 27.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.876 0.37 . . . . 61.439999999999998 110.921 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 796' ' ' ASN . . . . . 0.401 ' HB3' HG13 ' A' ' 716' ' ' ILE . 1.6 t30 . . . . . 0 C--N 1.324 -0.513 0 CA-C-O 121.007 0.432 . . . . 74.420000000000002 110.664 -176.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 716' ' ' ILE . . . . . 0.567 HG23 HG12 ' A' ' 793' ' ' ILE . 44.7 mm . . . . . 0 N--CA 1.455 -0.216 0 CA-C-O 120.768 0.318 . . . . 75.409999999999997 111.166 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -58.71 -29.1 63.81 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.742 -0.742 . . . . 74.340000000000003 111.645 175.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 718' ' ' GLU . . . . . 0.715 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 43.7 mm-40 -70.17 -40.43 74.71 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-O 120.707 0.289 . . . . 65.219999999999999 110.77 178.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 719' ' ' LEU . . . . . 0.581 HD12 HD22 ' A' ' 789' ' ' LEU . 3.1 mm? -64.4 -27.08 68.76 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.127 0.489 . . . . 65.140000000000001 109.929 177.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 720' ' ' VAL . . . . . 0.433 HG22 HD13 ' A' ' 793' ' ' ILE . 98.2 t -76.18 -36.85 31.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.789 -0.641 . . . . 74.310000000000002 111.346 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 721' ' ' ARG . . . . . 0.715 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 5.9 ptm180 -67.89 -22.77 65.08 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.34 0.591 . . . . 71.120000000000005 109.762 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -77.22 -31.02 54.88 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.929 -0.578 . . . . 73.450000000000003 110.622 175.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 723' ' ' LEU . . . . . 0.551 HD21 ' HB2' ' A' ' 789' ' ' LEU . 85.3 mt -60.13 -30.41 69.27 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.284 0.564 . . . . 71.140000000000001 109.894 174.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -87.98 -39.49 14.66 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.352 -0.84 . . . . 72.430000000000007 111.303 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 30.7 m -90.23 -76.17 0.44 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.756 0.312 . . . . 71.209999999999994 111.761 -177.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 726' ' ' ASN . . . . . 0.468 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 25.2 t30 -150.84 105.56 3.03 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.458 -0.337 . . . . 71.340000000000003 110.453 -178.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 727' ' ' PRO . . . . . 0.468 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 18.1 Cg_endo -60.63 -32.55 93.44 Favored 'Trans proline' 0 N--CA 1.464 -0.207 0 C-N-CA 123.131 2.554 . . . . 74.420000000000002 112.47 -178.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 43.4 t -61.88 -48.05 90.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.09 -0.505 . . . . 52.409999999999997 110.47 -177.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -63.06 -32.66 84.91 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.925 -0.655 . . . . 72.219999999999999 112.183 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -73.88 -44.48 30.76 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.753 -0.737 . . . . 71.450000000000003 112.5 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -64.1 -40.97 97.38 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.85 0.357 . . . . 72.400000000000006 110.147 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 732' ' ' LEU . . . . . . . . . . . . . 93.3 mt -64.19 -40.85 96.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.119 -0.492 . . . . 71.439999999999998 111.523 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 733' ' ' GLU . . . . . 0.511 ' HA ' ' HG2' ' A' ' 736' ' ' ARG . 6.5 pt-20 -78.35 -31.24 48.46 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.404 -0.518 . . . . 73.510000000000005 110.971 -178.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 734' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -53.76 -45.61 70.67 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 121.056 0.455 . . . . 75.319999999999993 109.942 175.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -66.06 -53.28 40.3 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.727 -0.67 . . . . 63.340000000000003 110.708 -178.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 736' ' ' ARG . . . . . 0.511 ' HG2' ' HA ' ' A' ' 733' ' ' GLU . 19.2 ptt85 -61.36 -34.42 75.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.092 -0.504 . . . . 73.329999999999998 111.209 -175.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 15.6 t -73.44 -36.4 65.91 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.815 -0.63 . . . . 63.140000000000001 111.137 178.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 13.4 m170 -95.64 3.19 54.21 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.948 0.351 . . . . 73.439999999999998 111.948 -173.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 95.08 0.01 63.88 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.519 -0.848 . . . . 74.030000000000001 113.367 173.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -94.27 -179.1 4.82 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.798 0.332 . . . . 64.010000000000005 110.393 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 741' ' ' ALA . . . . . 0.423 ' O ' ' HA ' ' A' ' 764' ' ' VAL . . . -127.2 134.64 50.1 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.212 -0.662 . . . . 64.099999999999994 109.212 173.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 742' ' ' ALA . . . . . . . . . . . . . . . -110.89 131.39 55.09 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.741 0.305 . . . . 45.109999999999999 111.166 -176.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 743' ' ' GLU . . . . . 0.487 ' HG3' ' HB3' ' A' ' 763' ' ' LYS . 12.7 pt-20 -147.57 153.27 39.23 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.92 -0.582 . . . . 73.310000000000002 110.435 178.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -120.6 118.26 29.69 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.061 -0.518 . . . . 72.239999999999995 109.781 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -122.2 138.19 54.57 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.524 -0.47 . . . . 74.209999999999994 111.246 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 746' ' ' LEU . . . . . 0.421 HD11 ' HD2' ' A' ' 758' ' ' PHE . 6.8 tt -74.24 119.14 18.03 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.501 -0.772 . . . . 73.299999999999997 109.176 176.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 43.9 t -94.89 -44.99 13.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.279 -0.419 . . . . 74.230000000000004 110.959 -177.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -149.29 158.02 43.83 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.402 -0.363 . . . . 74.25 110.77 -176.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -141.36 113.41 7.93 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.332 -0.618 . . . . 60.439999999999998 109.332 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 6.1 t -143.83 -167.29 2.56 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.869 -0.332 . . . . 62.439999999999998 110.324 -177.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 97.23 -150.38 19.52 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.853 -0.689 . . . . 72.219999999999999 111.787 -177.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 752' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -80.06 158.38 23.71 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.364 2.042 . . . . 73.420000000000002 111.802 178.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -73.13 -36.17 4.51 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.661 2.24 . . . . 64.420000000000002 112.376 -177.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -76.33 -29.27 57.21 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.96 -0.564 . . . . 73.340000000000003 110.834 -177.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -130.98 74.02 80.37 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 72.439999999999998 110.614 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 756' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -62.95 132.05 35.35 Favored 'Trans proline' 0 N--CA 1.465 -0.152 0 C-N-CA 122.685 2.257 . . . . 73.409999999999997 112.018 -177.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 757' ' ' LYS . . . . . 0.554 ' HG2' ' HB2' ' A' ' 773' ' ' CYS . 39.1 ttmt -98.83 111.83 24.1 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.279 0.561 . . . . 65.120000000000005 109.796 178.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 758' ' ' PHE . . . . . 0.436 ' O ' ' HA ' ' A' ' 773' ' ' CYS . 61.3 m-85 -90.27 123.25 33.89 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.116 -0.947 . . . . 74.510000000000005 110.595 -175.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 56.4 t -88.91 108.0 18.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.998 -0.547 . . . . 54.109999999999999 109.725 176.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -111.22 135.19 52.11 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.795 -0.639 . . . . 74.319999999999993 110.676 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -120.76 126.85 51.18 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.829 -0.623 . . . . 64.549999999999997 109.658 178.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 762' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 769' ' ' PHE . . . -83.94 120.92 26.68 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.179 0.514 . . . . 52.0 110.19 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 763' ' ' LYS . . . . . 0.69 ' HD2' ' CH2' ' A' ' 768' ' ' TRP . 49.4 tttm -104.32 107.3 18.15 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.842 -0.617 . . . . 65.150000000000006 110.054 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 764' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 741' ' ' ALA . 48.4 t -114.94 102.66 14.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.988 -0.551 . . . . 52.100000000000001 109.868 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 72.77 -123.15 8.67 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 110.821 -0.912 . . . . 74.230000000000004 110.821 -174.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -101.2 2.54 54.66 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.123 -0.791 . . . . 63.100000000000001 111.123 173.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 767' ' ' ARG . . . . . 0.44 ' NE ' ' HA ' ' A' ' 767' ' ' ARG . 2.6 mmp_? -97.28 127.52 43.31 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.099 0.476 . . . . 64.519999999999996 110.839 -177.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 768' ' ' TRP . . . . . 0.69 ' CH2' ' HD2' ' A' ' 763' ' ' LYS . 51.1 m95 -103.63 112.15 24.94 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.669 -0.696 . . . . 75.209999999999994 109.27 178.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 769' ' ' PHE . . . . . 0.491 ' HA ' ' HA ' ' A' ' 770' ' ' PRO . 27.0 p90 -176.78 136.98 0.43 Allowed Pre-proline 0 C--N 1.323 -0.584 0 CA-C-O 120.955 0.407 . . . . 73.430000000000007 110.248 -178.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 770' ' ' PRO . . . . . 0.623 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 55.6 Cg_endo -95.51 -170.74 2.81 Favored 'Cis proline' 0 N--CA 1.451 -0.976 0 C-N-CA 123.395 -1.502 . . . . 52.25 111.828 -3.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -120.83 100.18 6.95 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.431 -0.581 . . . . 73.310000000000002 109.431 175.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 28.6 m -109.88 163.98 6.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.243 -0.435 . . . . 75.519999999999996 110.973 -175.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 773' ' ' CYS . . . . . 0.554 ' HB2' ' HG2' ' A' ' 757' ' ' LYS . 6.3 p -138.21 110.69 7.49 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.975 -0.557 . . . . 62.409999999999997 110.002 178.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -118.17 147.61 43.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.539 -0.3 . . . . 73.129999999999995 111.023 -176.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 775' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -76.33 13.33 0.96 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.316 -0.402 . . . . 73.450000000000003 111.828 -177.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 49.9 m -150.02 136.56 19.09 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.249 -0.648 . . . . 62.210000000000001 109.249 174.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 777' ' ' LYS . . . . . 0.428 ' HE3' ' HB3' ' A' ' 777' ' ' LYS . 0.8 OUTLIER -61.87 -40.57 95.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.384 -0.371 . . . . 75.109999999999999 111.372 -174.709 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -66.68 -29.23 69.19 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.11 0.481 . . . . 65.239999999999995 110.39 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 779' ' ' GLN . . . . . 0.5 ' O ' ' HG2' ' A' ' 783' ' ' GLU . 96.4 mt-30 -74.7 -38.38 62.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.944 -0.571 . . . . 75.540000000000006 110.03 178.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -53.18 -44.89 64.15 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 121.324 -0.465 . . . . 65.019999999999996 112.391 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -62.46 -46.63 87.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.976 0.417 . . . . 71.349999999999994 110.649 177.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -66.92 -48.04 69.88 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.869 -0.605 . . . . 74.219999999999999 111.596 -177.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 783' ' ' GLU . . . . . 0.5 ' HG2' ' O ' ' A' ' 779' ' ' GLN . 34.5 mm-40 -59.66 -41.43 90.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.758 0.313 . . . . 73.120000000000005 110.527 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -62.39 -48.01 81.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.07 -0.514 . . . . 55.549999999999997 110.493 178.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 785' ' ' ALA . . . . . 0.576 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -65.26 -40.07 93.46 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.333 -0.394 . . . . 70.299999999999997 110.858 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 786' ' ' ASP . . . . . 0.599 ' O ' ' HD3' ' A' ' 790' ' ' ARG . 13.7 t70 -60.61 -55.65 30.81 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.961 -0.563 . . . . 64.129999999999995 110.299 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 787' ' ' ALA . . . . . 0.534 ' HB3' ' HG3' ' A' ' 770' ' ' PRO . . . -64.14 -31.09 72.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.078 -0.51 . . . . 74.219999999999999 110.904 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 788' ' ' ALA . . . . . 0.69 ' O ' ' HG ' ' A' ' 792' ' ' LEU . . . -62.14 -46.56 88.47 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.286 -0.264 . . . . 72.430000000000007 110.286 176.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 789' ' ' LEU . . . . . 0.581 HD22 HD12 ' A' ' 719' ' ' LEU . 70.1 mt -63.69 -34.78 78.62 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.741 -0.466 . . . . 65.340000000000003 109.741 178.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 790' ' ' ARG . . . . . 0.599 ' HD3' ' O ' ' A' ' 786' ' ' ASP . 0.3 OUTLIER -57.43 -45.71 84.35 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.223 -0.444 . . . . 71.310000000000002 110.185 174.897 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 791' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 787' ' ' ALA . 48.4 t -61.63 -49.69 83.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.028 -0.533 . . . . 70.540000000000006 110.381 177.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 792' ' ' LEU . . . . . 0.69 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 39.6 mt -59.92 -50.79 72.37 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.988 -0.551 . . . . 72.519999999999996 110.901 -177.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 793' ' ' ILE . . . . . 0.567 HG12 HG23 ' A' ' 716' ' ' ILE . 95.9 mt -60.72 -49.51 84.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.844 -0.616 . . . . 65.530000000000001 110.578 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -61.8 -36.64 93.06 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 121.057 -0.592 . . . . 63.109999999999999 112.625 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -65.51 -43.91 88.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.049 0.452 . . . . 70.129999999999995 110.129 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 116.07 -0.514 . . . . 74.209999999999994 110.925 179.686 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 716' ' ' ILE . . . . . 0.587 ' HA ' HD23 ' A' ' 719' ' ' LEU . 37.0 mm . . . . . 0 C--O 1.234 0.253 0 CA-C-O 121.013 0.435 . . . . 71.140000000000001 111.117 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -60.55 -29.69 70.16 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 121.008 -0.615 . . . . 55.229999999999997 112.518 175.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 718' ' ' GLU . . . . . 0.4 ' HA ' ' HB3' ' A' ' 721' ' ' ARG . 43.0 mt-10 -75.54 -25.4 57.14 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 122.651 -0.323 . . . . 75.340000000000003 110.654 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 719' ' ' LEU . . . . . 0.587 HD23 ' HA ' ' A' ' 716' ' ' ILE . 4.2 mm? -66.38 -34.77 78.72 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.464 -0.569 . . . . 73.540000000000006 109.464 174.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 720' ' ' VAL . . . . . 0.618 HG22 HD13 ' A' ' 793' ' ' ILE . 22.0 t -68.15 -33.09 58.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.826 -0.625 . . . . 74.019999999999996 109.979 175.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 721' ' ' ARG . . . . . 0.4 ' HB3' ' HA ' ' A' ' 718' ' ' GLU . 0.1 OUTLIER -61.29 -35.71 78.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.722 -0.672 . . . . 71.510000000000005 110.04 178.774 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -71.05 -32.33 69.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.0 -0.546 . . . . 71.510000000000005 111.1 178.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 723' ' ' LEU . . . . . 0.42 HD21 ' HB2' ' A' ' 789' ' ' LEU . 95.3 mt -58.02 -32.03 67.55 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.119 0.485 . . . . 74.430000000000007 109.928 175.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 54.0 m-20 -71.54 -49.9 36.43 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.622 -0.717 . . . . 73.329999999999998 110.839 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 47.4 m -93.12 -70.78 0.68 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.049 0.388 . . . . 73.319999999999993 112.049 -174.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 726' ' ' ASN . . . . . 0.414 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 43.5 t30 -145.12 104.79 4.41 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-O 120.827 0.346 . . . . 75.329999999999998 110.86 -178.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 727' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 18.6 Cg_endo -60.57 -34.52 92.4 Favored 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.821 2.347 . . . . 61.210000000000001 112.064 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 47.6 t -61.76 -48.37 88.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 64.409999999999997 110.364 -178.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -63.15 -31.2 79.92 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 121.026 -0.607 . . . . 55.399999999999999 111.811 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -70.35 -41.98 66.45 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.948 -0.644 . . . . 73.239999999999995 112.376 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 731' ' ' LEU . . . . . 0.422 ' N ' HD21 ' A' ' 789' ' ' LEU . 3.0 tm? -65.57 -40.33 92.66 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.412 -0.588 . . . . 71.140000000000001 109.412 178.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 732' ' ' LEU . . . . . . . . . . . . . 79.4 mt -66.16 -39.25 89.63 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.702 -0.681 . . . . 74.319999999999993 110.78 176.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 733' ' ' GLU . . . . . 0.483 ' O ' ' HG2' ' A' ' 736' ' ' ARG . 4.1 tp10 -65.8 -46.31 79.13 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 116.266 -0.425 . . . . 63.420000000000002 110.57 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 734' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -54.96 -48.2 73.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.994 -0.548 . . . . 73.049999999999997 110.677 177.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -65.92 -48.26 72.01 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.122 -0.49 . . . . 43.539999999999999 111.236 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 736' ' ' ARG . . . . . 0.483 ' HG2' ' O ' ' A' ' 733' ' ' GLU . 31.9 ptt180 -65.22 -33.03 75.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.14 0.495 . . . . 74.530000000000001 111.345 -175.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 38.0 t -78.12 -36.64 47.62 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.859 -0.61 . . . . 75.400000000000006 111.156 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 15.5 m170 -89.02 -29.21 19.64 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.43 -0.35 . . . . 73.219999999999999 111.846 -174.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 109.07 21.93 7.14 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.555 -0.831 . . . . 73.409999999999997 112.273 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -96.99 167.46 11.06 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.738 0.304 . . . . 64.439999999999998 110.405 175.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -109.91 114.11 27.38 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.461 -0.57 . . . . 72.010000000000005 109.461 175.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 742' ' ' ALA . . . . . . . . . . . . . . . -93.6 110.2 21.81 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.968 0.413 . . . . 61.420000000000002 110.433 -178.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 743' ' ' GLU . . . . . 0.543 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 44.7 mt-10 -120.82 117.09 26.52 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.942 -0.572 . . . . 75.310000000000002 111.281 -177.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 744' ' ' PHE . . . . . 0.424 ' CB ' ' HE3' ' A' ' 781' ' ' LYS . 96.2 m-85 -100.16 100.81 11.7 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.785 -0.643 . . . . 74.450000000000003 109.285 175.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 745' ' ' LYS . . . . . 0.44 ' HB3' ' HE2' ' A' ' 745' ' ' LYS . 16.9 ptpt -120.76 152.81 37.84 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.238 -0.585 . . . . 62.530000000000001 111.116 -177.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 746' ' ' LEU . . . . . 0.576 HD21 ' HB2' ' A' ' 749' ' ' GLN . 51.9 tp -80.14 128.12 33.13 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.426 -0.806 . . . . 75.409999999999997 110.089 -178.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 56.4 t -90.46 -47.56 14.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.109 0.48 . . . . 61.229999999999997 109.879 178.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -154.75 149.35 26.4 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.771 -0.65 . . . . 75.099999999999994 110.331 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 749' ' ' GLN . . . . . 0.576 ' HB2' HD21 ' A' ' 746' ' ' LEU . 24.5 tt0 -125.19 106.64 10.04 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.509 -0.552 . . . . 73.099999999999994 109.509 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 56.7 m -141.86 178.18 7.68 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.658 0.266 . . . . 53.100000000000001 110.285 -178.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 117.52 172.61 16.04 Favored Glycine 0 N--CA 1.443 -0.899 0 C-N-CA 120.331 -0.938 . . . . 65.439999999999998 112.822 177.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 752' ' ' PRO . . . . . 0.748 ' HG2' ' HB2' ' A' ' 755' ' ' GLU . 34.3 Cg_endo -64.8 166.4 18.26 Favored 'Trans proline' 0 CA--C 1.529 0.272 0 C-N-CA 123.473 2.782 . . . . 71.109999999999999 112.752 178.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -65.44 -31.74 51.09 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.592 2.194 . . . . 64.230000000000004 112.534 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 754' ' ' HIS . . . . . 0.554 ' CD2' ' HG3' ' A' ' 755' ' ' GLU . 54.0 p-80 -83.02 -23.41 33.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.522 -0.308 . . . . 63.140000000000001 110.938 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 755' ' ' GLU . . . . . 0.748 ' HB2' ' HG2' ' A' ' 752' ' ' PRO . 45.8 mt-10 -132.24 78.07 69.39 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.445 -0.343 . . . . 72.409999999999997 111.503 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 756' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -68.12 105.86 1.26 Allowed 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 121.936 1.757 . . . . 53.409999999999997 110.73 172.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 757' ' ' LYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 774' ' ' ALA . 57.8 mtmt -92.8 108.67 20.17 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.733 0.777 . . . . 72.140000000000001 110.973 -175.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 758' ' ' PHE . . . . . 0.447 ' O ' ' HA ' ' A' ' 773' ' ' CYS . 89.4 m-85 -87.63 116.69 25.94 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.722 -1.127 . . . . 72.349999999999994 110.478 -178.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 21.5 t -84.28 101.39 8.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.468 -0.567 . . . . 61.329999999999998 109.468 176.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 760' ' ' TYR . . . . . 0.413 ' CE2' ' HG2' ' A' ' 777' ' ' LYS . 3.2 m-85 -106.48 145.56 31.65 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.048 -0.524 . . . . 70.310000000000002 111.113 -178.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -132.54 135.12 45.75 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.871 -0.604 . . . . 73.209999999999994 109.663 177.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 762' ' ' ALA . . . . . . . . . . . . . . . -89.89 110.82 21.74 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.804 -0.635 . . . . 71.439999999999998 110.421 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 763' ' ' LYS . . . . . 0.543 ' HB3' ' HB2' ' A' ' 743' ' ' GLU . 50.5 tttt -94.64 107.02 19.03 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.494 -0.775 . . . . 71.299999999999997 109.607 177.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 47.5 t -112.88 100.48 10.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 120.977 0.418 . . . . 72.239999999999995 110.844 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 68.86 22.59 75.68 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.731 -0.668 . . . . 73.140000000000001 112.74 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 99.8 -2.64 57.1 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.712 -0.756 . . . . 64.010000000000005 112.103 -178.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 767' ' ' ARG . . . . . . . . . . . . . 18.3 ttm180 -100.91 122.3 43.23 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.292 -0.633 . . . . 64.510000000000005 109.292 178.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 768' ' ' TRP . . . . . . . . . . . . . 42.4 m95 -99.31 100.08 11.11 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.407 -0.36 . . . . 73.019999999999996 110.765 -172.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 769' ' ' PHE . . . . . 0.465 ' HA ' ' HA ' ' A' ' 770' ' ' PRO . 25.9 p90 -166.5 136.25 2.52 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.331 -0.395 . . . . 74.099999999999994 110.419 -178.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 770' ' ' PRO . . . . . 0.715 ' HG3' ' HB3' ' A' ' 787' ' ' ALA . 68.5 Cg_endo -94.66 -173.31 4.31 Favored 'Cis proline' 0 N--CA 1.451 -0.974 0 C-N-CA 123.412 -1.495 . . . . 73.299999999999997 111.424 -4.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -122.52 107.83 12.46 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.33 -0.248 . . . . 45.329999999999998 110.33 175.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 29.1 m -130.35 167.28 25.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.533 -0.303 . . . . 54.340000000000003 111.195 -176.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 773' ' ' CYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 758' ' ' PHE . 17.7 p -132.78 145.12 50.73 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.458 -0.337 . . . . 71.450000000000003 110.573 178.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 774' ' ' ALA . . . . . 0.463 ' O ' ' HA ' ' A' ' 757' ' ' LYS . . . -146.2 154.52 41.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.432 -0.349 . . . . 43.409999999999997 110.544 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 775' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -75.4 -2.62 29.41 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.068 0.461 . . . . 73.219999999999999 111.458 -176.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 776' ' ' SER . . . . . 0.629 ' HB2' ' HG3' ' A' ' 779' ' ' GLN . 36.3 m -131.19 140.2 49.86 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.206 -0.665 . . . . 70.319999999999993 109.206 175.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 777' ' ' LYS . . . . . 0.413 ' HG2' ' CE2' ' A' ' 760' ' ' TYR . 6.1 tmmm? -61.12 -45.75 93.39 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 123.431 0.457 . . . . 73.099999999999994 111.274 -174.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 778' ' ' LYS . . . . . 0.426 ' HE2' ' OE1' ' A' ' 782' ' ' GLN . 87.9 tttt -64.56 -39.28 93.46 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.981 -0.288 . . . . 73.310000000000002 110.644 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 779' ' ' GLN . . . . . 0.629 ' HG3' ' HB2' ' A' ' 776' ' ' SER . 23.6 mt-30 -60.35 -39.38 86.94 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.658 -0.246 . . . . 63.450000000000003 110.563 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -60.51 -43.53 98.72 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.88 -0.676 . . . . 50.009999999999998 111.694 177.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 781' ' ' LYS . . . . . 0.424 ' HE3' ' CB ' ' A' ' 744' ' ' PHE . 50.6 mtpt -68.13 -40.55 82.44 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.735 0.302 . . . . 73.129999999999995 110.729 178.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 782' ' ' GLN . . . . . 0.426 ' OE1' ' HE2' ' A' ' 778' ' ' LYS . 26.6 mt-30 -62.04 -51.66 67.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.047 -0.524 . . . . 73.120000000000005 111.047 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -65.27 -33.92 77.12 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 123.063 0.227 . . . . 74.510000000000005 110.909 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -59.62 -53.86 53.11 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.893 -0.41 . . . . 74.430000000000007 109.893 175.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 785' ' ' ALA . . . . . 0.613 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -65.38 -40.01 92.97 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.18 -0.463 . . . . 75.150000000000006 110.897 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 786' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -54.28 -56.08 21.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.903 -0.59 . . . . 72.430000000000007 110.83 178.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 787' ' ' ALA . . . . . 0.715 ' HB3' ' HG3' ' A' ' 770' ' ' PRO . . . -65.7 -38.32 88.91 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.838 -0.619 . . . . 62.140000000000001 110.768 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 788' ' ' ALA . . . . . 0.6 ' HB2' ' HD3' ' A' ' 770' ' ' PRO . . . -60.61 -45.8 92.65 Favored 'General case' 0 CA--C 1.521 -0.159 0 O-C-N 123.327 0.392 . . . . 74.420000000000002 111.23 -177.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 789' ' ' LEU . . . . . 0.613 ' HG ' ' O ' ' A' ' 785' ' ' ALA . 69.2 mt -58.86 -45.67 89.56 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 109.977 -0.379 . . . . 74.209999999999994 109.977 179.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 790' ' ' ARG . . . . . . . . . . . . . 78.6 mtt180 -65.07 -26.58 68.3 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.138 0.422 . . . . 61.310000000000002 112.138 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 791' ' ' VAL . . . . . 0.671 HG23 ' O ' ' A' ' 787' ' ' ALA . 60.1 t -66.5 -45.17 89.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 109.456 -0.572 . . . . 72.340000000000003 109.456 173.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 792' ' ' LEU . . . . . 0.59 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 18.2 mt -67.84 -44.82 76.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.221 -0.899 . . . . 65.319999999999993 110.188 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 793' ' ' ILE . . . . . 0.618 HD13 HG22 ' A' ' 720' ' ' VAL . 97.0 mt -58.38 -55.21 23.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.162 -0.926 . . . . 74.140000000000001 110.647 177.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -58.47 -40.51 94.45 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 121.14 -0.552 . . . . 62.219999999999999 112.244 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -55.98 -46.69 78.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.951 0.405 . . . . 72.129999999999995 110.218 178.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 6.5 t30 . . . . . 0 C--N 1.323 -0.562 0 CA-C-N 116.06 -0.518 . . . . 71.219999999999999 111.246 -175.268 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 716' ' ' ILE . . . . . 0.649 HG23 HG12 ' A' ' 793' ' ' ILE . 48.4 mm . . . . . 0 C--O 1.235 0.326 0 N-CA-C 112.316 0.488 . . . . 75.420000000000002 112.316 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -56.3 -31.41 59.49 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.009 -0.615 . . . . 74.329999999999998 112.12 178.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -72.01 -41.62 67.38 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.355 -0.239 . . . . 74.430000000000007 110.355 178.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 719' ' ' LEU . . . . . 0.641 HD23 ' HA ' ' A' ' 716' ' ' ILE . 3.0 mm? -62.79 -36.11 82.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.479 -0.328 . . . . 63.43 110.727 -179.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 720' ' ' VAL . . . . . 0.519 HG22 HD13 ' A' ' 793' ' ' ILE . 48.0 t -66.65 -39.03 82.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.118 0.485 . . . . 74.129999999999995 109.963 175.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 721' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.08 -35.03 74.28 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.871 -0.604 . . . . 64.400000000000006 110.172 177.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -74.32 -29.0 61.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.05 -0.523 . . . . 74.150000000000006 111.4 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 723' ' ' LEU . . . . . 0.577 HD21 ' HB2' ' A' ' 789' ' ' LEU . 51.0 mt -59.02 -39.35 81.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.856 0.36 . . . . 75.409999999999997 110.726 177.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -86.51 -17.37 34.29 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.108 -0.496 . . . . 72.400000000000006 111.341 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 16.3 m -108.37 -83.3 0.55 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.637 0.256 . . . . 60.229999999999997 111.421 -176.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 726' ' ' ASN . . . . . 0.413 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 30.0 t30 -138.97 104.01 7.41 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.801 0.334 . . . . 70.439999999999998 110.373 -177.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 727' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 25.4 Cg_endo -62.75 -41.4 30.89 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.758 2.305 . . . . 62.439999999999998 112.552 -177.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 48.3 t -61.71 -46.07 97.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.275 -0.421 . . . . 72.150000000000006 110.659 -176.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -64.65 -32.64 84.87 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.868 -0.682 . . . . 74.099999999999994 112.0 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -72.45 -42.66 47.95 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 121.134 -0.555 . . . . 65.519999999999996 112.827 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -63.24 -41.06 99.03 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.623 -0.51 . . . . 71.420000000000002 109.623 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 732' ' ' LEU . . . . . 0.504 HD23 ' HB3' ' A' ' 742' ' ' ALA . 96.2 mt -64.83 -42.66 94.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.94 -0.573 . . . . 65.120000000000005 110.649 176.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 733' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -64.69 -42.64 95.17 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 116.201 -0.454 . . . . 64.430000000000007 110.802 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 734' ' ' TYR . . . . . 0.549 ' HB2' HD11 ' A' ' 719' ' ' LEU . 14.4 t80 -54.43 -53.18 57.59 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.349 -0.387 . . . . 74.430000000000007 110.621 176.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -62.73 -48.45 79.16 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.093 -0.503 . . . . 72.329999999999998 110.395 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 736' ' ' ARG . . . . . . . . . . . . . 62.3 ttt180 -54.96 -50.87 67.84 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.544 -0.753 . . . . 75.129999999999995 111.939 -178.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 18.1 t -73.95 -24.58 59.66 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.424 -0.353 . . . . 74.239999999999995 111.404 -175.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -94.7 -19.78 20.11 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.821 -0.352 . . . . 52.310000000000002 111.935 -175.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 104.39 14.0 25.07 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.17 -1.014 . . . . 35.25 112.837 177.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -101.81 166.29 10.74 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.816 -0.439 . . . . 64.230000000000004 109.816 175.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -110.14 126.43 54.06 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.708 -0.479 . . . . 64.310000000000002 109.708 173.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 742' ' ' ALA . . . . . 0.504 ' HB3' HD23 ' A' ' 732' ' ' LEU . . . -99.03 108.59 21.3 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.059 0.457 . . . . 72.239999999999995 110.361 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 743' ' ' GLU . . . . . 0.543 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 40.8 mt-10 -113.93 116.75 29.75 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.796 -0.638 . . . . 72.150000000000006 111.466 -176.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -93.28 121.62 34.84 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.679 -0.691 . . . . 74.209999999999994 109.401 176.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -132.38 147.94 52.4 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.282 0.563 . . . . 64.409999999999997 111.663 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 746' ' ' LEU . . . . . 0.53 HD21 ' HB2' ' A' ' 749' ' ' GLN . 6.8 tt -86.87 108.09 18.61 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.143 -0.935 . . . . 62.25 108.992 177.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 49.0 t -82.56 -53.99 10.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.136 -0.484 . . . . 64.310000000000002 110.771 -176.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 748' ' ' ASP . . . . . 0.499 ' HB3' ' CG2' ' A' ' 759' ' ' VAL . 25.7 t70 -129.8 149.76 51.4 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.283 -0.417 . . . . 75.420000000000002 111.19 -176.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 749' ' ' GLN . . . . . 0.53 ' HB2' HD21 ' A' ' 746' ' ' LEU . 8.1 tt0 -145.84 100.07 3.36 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.514 -0.767 . . . . 64.530000000000001 108.971 177.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 10.0 t -144.98 -173.71 4.16 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.484 -0.326 . . . . 72.120000000000005 110.476 -174.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 100.77 -173.74 24.94 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.924 -0.655 . . . . 54.420000000000002 112.473 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 752' ' ' PRO . . . . . 0.711 ' HG2' ' HB2' ' A' ' 755' ' ' GLU . 52.8 Cg_endo -69.11 164.35 34.24 Favored 'Trans proline' 0 N--CA 1.465 -0.154 0 C-N-CA 122.908 2.406 . . . . 74.239999999999995 111.993 178.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -69.81 -34.68 13.93 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 122.469 2.112 . . . . 75.0 112.065 -177.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 754' ' ' HIS . . . . . 0.425 ' CE1' ' HB2' ' A' ' 752' ' ' PRO . 35.2 p-80 -76.09 -26.81 56.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.174 -0.466 . . . . 73.430000000000007 110.936 179.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 755' ' ' GLU . . . . . 0.711 ' HB2' ' HG2' ' A' ' 752' ' ' PRO . 28.5 mm-40 -126.53 72.76 73.72 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.566 -0.288 . . . . 61.409999999999997 110.885 178.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 756' ' ' PRO . . . . . 0.515 ' O ' ' HA ' ' A' ' 775' ' ' HIS . 40.0 Cg_endo -68.82 113.66 3.29 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.222 1.948 . . . . 73.519999999999996 111.453 177.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 757' ' ' LYS . . . . . 0.408 ' HE3' ' HB3' ' A' ' 757' ' ' LYS . 1.5 tmmt? -89.51 112.4 23.56 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.322 0.582 . . . . 72.25 110.538 -176.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 758' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 773' ' ' CYS . 79.0 m-85 -99.59 123.34 43.76 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.204 -0.907 . . . . 72.140000000000001 110.115 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 759' ' ' VAL . . . . . 0.499 ' CG2' ' HB3' ' A' ' 748' ' ' ASP . 48.6 t -98.4 106.6 18.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.564 -0.532 . . . . 71.439999999999998 109.564 175.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -105.61 141.05 37.74 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.005 -0.543 . . . . 74.319999999999993 110.691 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 761' ' ' GLN . . . . . 0.44 ' HA ' ' O ' ' A' ' 770' ' ' PRO . 33.7 tt0 -133.46 134.61 43.75 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.865 -0.607 . . . . 64.099999999999994 109.503 177.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 762' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 769' ' ' PHE . . . -92.9 117.08 29.65 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.25 0.548 . . . . 63.439999999999998 110.706 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 763' ' ' LYS . . . . . 0.601 ' HD2' ' CH2' ' A' ' 768' ' ' TRP . 54.7 tttm -93.77 103.53 15.66 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.681 -0.69 . . . . 73.150000000000006 109.893 177.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 61.7 t -109.01 101.58 12.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.136 0.493 . . . . 53.299999999999997 109.739 178.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 69.17 -115.69 6.63 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 110.955 -0.858 . . . . 71.010000000000005 110.955 -173.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -110.62 13.99 29.91 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.003 -0.618 . . . . 74.219999999999999 111.684 176.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 767' ' ' ARG . . . . . 0.602 ' HD2' ' CD1' ' A' ' 769' ' ' PHE . 0.6 OUTLIER -110.43 120.45 42.46 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.507 -0.553 . . . . 71.540000000000006 109.507 -179.766 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 768' ' ' TRP . . . . . 0.601 ' CH2' ' HD2' ' A' ' 763' ' ' LYS . 69.4 m95 -94.88 108.15 20.18 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.645 -0.502 . . . . 74.099999999999994 109.645 178.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 769' ' ' PHE . . . . . 0.602 ' CD1' ' HD2' ' A' ' 767' ' ' ARG . 9.8 p90 -168.86 139.9 2.01 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-O 120.838 0.351 . . . . 74.219999999999999 110.915 -178.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 770' ' ' PRO . . . . . 0.799 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 96.1 Cg_endo -98.4 -170.69 1.95 Allowed 'Cis proline' 0 N--CA 1.449 -1.121 0 C-N-CA 123.71 -1.371 . . . . 63.140000000000001 111.677 -3.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 771' ' ' ALA . . . . . 0.438 ' HB2' HE21 ' A' ' 761' ' ' GLN . . . -114.81 104.29 11.8 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.518 -0.549 . . . . 62.439999999999998 109.518 174.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 33.5 m -118.94 161.97 17.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.303 -0.408 . . . . 73.239999999999995 110.846 -176.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 773' ' ' CYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 758' ' ' PHE . 8.8 p -137.0 141.91 42.53 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.249 -0.432 . . . . 60.240000000000002 110.425 177.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -149.53 161.15 42.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.054 -0.521 . . . . 71.430000000000007 109.829 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 775' ' ' HIS . . . . . 0.515 ' HA ' ' O ' ' A' ' 756' ' ' PRO . 0.8 OUTLIER -87.14 -0.75 57.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.251 0.548 . . . . 73.120000000000005 110.889 179.501 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 51.1 m -134.04 135.16 43.16 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.634 -0.712 . . . . 71.010000000000005 109.292 175.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 777' ' ' LYS . . . . . . . . . . . . . 25.4 ttmt -57.24 -48.82 77.89 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.103 -0.499 . . . . 71.239999999999995 111.448 -175.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -57.95 -38.59 76.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.848 -0.614 . . . . 64.140000000000001 110.822 -177.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 779' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -68.25 -37.88 81.24 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-N 116.36 -0.382 . . . . 72.319999999999993 110.146 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -60.5 -47.17 92.48 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.827 -0.701 . . . . 43.340000000000003 111.881 178.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -62.55 -44.79 95.47 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.746 0.308 . . . . 72.530000000000001 110.649 177.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -62.37 -50.43 71.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.056 -0.52 . . . . 64.549999999999997 111.206 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -60.09 -36.57 77.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.298 -0.41 . . . . 53.109999999999999 111.445 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -60.05 -55.08 38.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.871 0.367 . . . . 74.510000000000005 110.373 177.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 785' ' ' ALA . . . . . 0.652 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -63.09 -41.81 99.47 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.134 -0.485 . . . . 53.119999999999997 110.897 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 786' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -56.83 -54.88 41.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.546 -0.752 . . . . 73.319999999999993 110.934 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 787' ' ' ALA . . . . . 0.468 ' O ' HG23 ' A' ' 791' ' ' VAL . . . -65.29 -35.09 79.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.832 -0.622 . . . . 75.450000000000003 111.254 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 788' ' ' ALA . . . . . 0.799 ' HB2' ' HD3' ' A' ' 770' ' ' PRO . . . -64.64 -35.64 81.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.313 -0.403 . . . . 63.549999999999997 111.391 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 789' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' A' ' 785' ' ' ALA . 59.1 mt -64.66 -42.04 95.69 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 121.048 -0.261 . . . . 65.340000000000003 110.445 -179.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 790' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.67 -31.71 72.65 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 120.734 -0.386 . . . . 75.310000000000002 111.207 177.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 791' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 787' ' ' ALA . 57.2 t -61.67 -51.89 67.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.104 0.478 . . . . 71.510000000000005 109.773 175.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 792' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 32.9 mt -61.84 -47.53 84.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.349 -0.842 . . . . 71.540000000000006 110.83 -178.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 793' ' ' ILE . . . . . 0.649 HG12 HG23 ' A' ' 716' ' ' ILE . 95.9 mt -58.8 -56.26 17.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.521 -0.763 . . . . 72.299999999999997 111.24 179.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -60.79 -37.69 94.05 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 121.079 -0.582 . . . . 62.049999999999997 112.321 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -63.25 -44.0 96.41 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.905 0.383 . . . . 73.400000000000006 110.734 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 . . . . . 0 C--N 1.33 -0.275 0 CA-C-O 120.909 0.385 . . . . 70.5 110.822 -177.299 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 716' ' ' ILE . . . . . 0.592 ' HA ' HD23 ' A' ' 719' ' ' LEU . 46.8 mm . . . . . 0 N--CA 1.454 -0.245 0 CA-C-O 120.73 0.3 . . . . 42.439999999999998 111.489 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -59.95 -24.87 61.04 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.97 -0.633 . . . . 64.150000000000006 112.112 176.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 718' ' ' GLU . . . . . 0.669 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 47.1 mt-10 -76.85 -38.73 53.18 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 122.787 -0.243 . . . . 75.120000000000005 110.658 177.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 719' ' ' LEU . . . . . 0.592 HD12 HD22 ' A' ' 789' ' ' LEU . 3.1 mm? -61.38 -32.98 72.92 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.155 0.502 . . . . 72.430000000000007 109.769 176.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 720' ' ' VAL . . . . . 0.54 HG22 HD13 ' A' ' 793' ' ' ILE . 58.1 t -68.4 -38.49 79.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.809 -0.632 . . . . 72.510000000000005 110.757 175.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 721' ' ' ARG . . . . . 0.669 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 4.4 ptm180 -64.74 -28.2 69.43 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 109.841 -0.429 . . . . 72.329999999999998 109.841 179.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -73.12 -31.9 64.61 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 116.312 -0.404 . . . . 61.439999999999998 110.782 177.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 723' ' ' LEU . . . . . 0.565 HD21 ' HB2' ' A' ' 789' ' ' LEU . 98.1 mt -62.24 -28.67 69.87 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.407 0.622 . . . . 72.329999999999998 110.033 174.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -90.81 -15.07 30.7 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.492 -0.776 . . . . 71.319999999999993 111.234 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 11.1 m -118.69 -73.48 0.64 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.856 0.36 . . . . 75.150000000000006 111.666 -175.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 726' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -149.13 101.58 3.37 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.174 -0.467 . . . . 34.119999999999997 110.112 -177.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 727' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -61.87 -40.33 45.16 Favored 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 122.906 2.404 . . . . 63.350000000000001 112.115 -178.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 57.5 t -62.21 -45.32 99.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.096 -0.502 . . . . 63.130000000000003 110.809 -178.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -65.49 -35.15 90.93 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.664 -0.779 . . . . 72.239999999999995 111.669 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -70.17 -41.58 69.29 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 121.073 -0.584 . . . . 74.230000000000004 112.573 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -65.48 -43.3 90.66 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.989 -0.374 . . . . 72.010000000000005 109.989 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 732' ' ' LEU . . . . . . . . . . . . . 96.8 mt -66.17 -38.07 87.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.244 -0.435 . . . . 63.329999999999998 110.745 178.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 733' ' ' GLU . . . . . 0.471 ' O ' ' HG2' ' A' ' 736' ' ' ARG . 1.8 tp10 -66.14 -43.99 85.44 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 116.325 -0.398 . . . . 73.010000000000005 110.355 177.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 734' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -53.47 -48.66 68.67 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.141 -0.481 . . . . 71.439999999999998 110.658 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 735' ' ' ALA . . . . . 0.41 ' HB2' ' HB2' ' A' ' 742' ' ' ALA . . . -65.62 -50.22 65.83 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.232 -0.44 . . . . 70.349999999999994 110.927 -177.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 736' ' ' ARG . . . . . 0.471 ' HG2' ' O ' ' A' ' 733' ' ' GLU . 33.8 ptt180 -64.35 -31.48 72.7 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.11 0.481 . . . . 62.350000000000001 110.914 -175.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 28.8 t -78.07 -29.12 49.02 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.599 -0.728 . . . . 63.210000000000001 111.451 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -101.13 -3.09 29.84 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 111.885 0.328 . . . . 74.430000000000007 111.885 -173.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 90.98 12.88 59.79 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.407 -0.901 . . . . 72.340000000000003 112.675 177.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -95.98 169.36 10.03 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.791 0.329 . . . . 73.439999999999998 110.165 175.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -121.68 105.81 10.76 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.284 -0.636 . . . . 72.140000000000001 109.284 175.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 742' ' ' ALA . . . . . 0.419 ' HA ' ' HA ' ' A' ' 764' ' ' VAL . . . -90.4 122.55 33.37 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.311 -0.404 . . . . 73.540000000000006 111.454 -174.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 743' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -127.79 166.13 18.78 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.782 -0.644 . . . . 75.430000000000007 110.698 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -134.25 108.8 8.45 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.961 -0.563 . . . . 73.439999999999998 109.996 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -110.84 148.55 32.16 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.007 0.432 . . . . 74.209999999999994 111.155 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 746' ' ' LEU . . . . . 0.432 HD11 ' CD1' ' A' ' 758' ' ' PHE . 6.1 tt -87.58 106.82 18.27 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.384 -0.969 . . . . 64.230000000000004 108.384 174.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 54.0 t -83.16 -53.06 12.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.982 -0.554 . . . . 71.319999999999993 110.938 -174.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -128.39 146.01 50.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.083 -0.508 . . . . 63.210000000000001 110.798 -176.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -132.7 93.59 3.25 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.284 0.564 . . . . 73.439999999999998 110.026 176.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 20.6 m -104.64 82.36 1.89 Allowed 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.242 -1.021 . . . . 52.130000000000003 108.242 173.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 751' ' ' GLY . . . . . 0.612 ' CA ' ' HA ' ' A' ' 756' ' ' PRO . . . -127.39 94.74 0.41 Allowed Glycine 0 N--CA 1.439 -1.101 0 C-N-CA 119.92 -1.133 . . . . 75.0 114.278 -170.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 752' ' ' PRO . . . . . 0.402 ' HD2' ' HA2' ' A' ' 751' ' ' GLY . 18.1 Cg_endo -60.95 165.61 11.85 Favored 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 122.474 2.116 . . . . 42.109999999999999 110.225 164.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -58.54 -36.51 97.26 Favored 'Trans proline' 0 CA--C 1.528 0.191 0 C-N-CA 122.109 1.873 . . . . 73.420000000000002 112.495 -177.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 49.9 p-80 -82.28 -25.01 34.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.364 -0.38 . . . . 61.240000000000002 111.644 -177.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -141.06 74.31 25.48 Favored Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 112.043 0.386 . . . . 53.530000000000001 112.043 -176.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 756' ' ' PRO . . . . . 0.612 ' HA ' ' CA ' ' A' ' 751' ' ' GLY . 52.3 Cg_endo -72.23 84.84 1.09 Allowed 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.0 1.8 . . . . 44.039999999999999 111.632 175.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 757' ' ' LYS . . . . . 0.531 ' HA ' ' HA ' ' A' ' 775' ' ' HIS . 27.4 ttpp -91.58 113.69 26.03 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.545 0.688 . . . . 71.040000000000006 111.247 -174.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 758' ' ' PHE . . . . . 0.463 ' O ' ' HA ' ' A' ' 773' ' ' CYS . 60.9 m-85 -99.44 144.77 28.16 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.286 -0.87 . . . . 70.010000000000005 110.171 -178.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 759' ' ' VAL . . . . . 0.468 HG22 ' HB3' ' A' ' 773' ' ' CYS . 47.7 t -109.57 112.13 39.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.996 -0.372 . . . . 64.129999999999995 109.996 176.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -107.27 138.14 44.0 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.263 -0.426 . . . . 71.329999999999998 110.517 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 761' ' ' GLN . . . . . 0.441 ' HA ' ' O ' ' A' ' 770' ' ' PRO . 62.2 tt0 -125.5 135.48 52.34 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.916 -0.583 . . . . 75.430000000000007 109.432 177.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 762' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' A' ' 769' ' ' PHE . . . -91.52 119.5 31.52 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.252 0.549 . . . . 74.019999999999996 110.586 -178.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -98.16 97.28 8.73 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.713 -0.676 . . . . 72.430000000000007 109.339 177.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 764' ' ' VAL . . . . . 0.419 ' HA ' ' HA ' ' A' ' 742' ' ' ALA . 57.7 t -99.9 98.3 6.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.125 0.488 . . . . 72.239999999999995 109.854 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 68.54 -108.03 2.31 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 110.743 -0.943 . . . . 33.340000000000003 110.743 -175.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -114.72 9.4 21.63 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.626 -0.797 . . . . 71.409999999999997 111.821 176.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 767' ' ' ARG . . . . . 0.576 ' HD2' ' CD1' ' A' ' 769' ' ' PHE . 0.2 OUTLIER -107.65 120.69 42.92 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.93 -0.396 . . . . 72.120000000000005 109.93 -178.615 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 768' ' ' TRP . . . . . . . . . . . . . 58.6 m95 -94.3 110.91 22.63 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.158 -0.474 . . . . 75.420000000000002 109.857 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 769' ' ' PHE . . . . . 0.576 ' CD1' ' HD2' ' A' ' 767' ' ' ARG . 15.7 p90 -174.76 138.32 0.62 Allowed Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 120.692 0.282 . . . . 64.239999999999995 110.65 -179.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 770' ' ' PRO . . . . . 0.786 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 69.7 Cg_endo -99.15 -170.25 1.6 Allowed 'Cis proline' 0 N--CA 1.449 -1.14 0 C-N-CA 123.675 -1.386 . . . . 71.010000000000005 111.164 -6.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -121.14 105.52 10.68 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.797 -0.445 . . . . 74.120000000000005 109.797 174.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 35.3 m -121.32 160.29 22.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.487 -0.324 . . . . 61.25 111.006 -176.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 773' ' ' CYS . . . . . 0.468 ' HB3' HG22 ' A' ' 759' ' ' VAL . 20.2 p -126.01 145.81 50.15 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.073 -0.512 . . . . 74.450000000000003 110.565 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -158.14 146.86 19.06 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.22 -0.445 . . . . 75.519999999999996 110.226 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 775' ' ' HIS . . . . . 0.538 ' HA ' ' O ' ' A' ' 756' ' ' PRO . 1.4 p-80 -78.95 17.4 0.74 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.147 0.499 . . . . 70.420000000000002 111.538 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 42.4 t -142.84 130.62 21.51 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.994 -0.743 . . . . 71.109999999999999 108.994 175.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 777' ' ' LYS . . . . . 0.436 ' HD2' ' C ' ' A' ' 777' ' ' LYS . 5.3 tmmm? -58.34 -42.68 87.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.864 0.364 . . . . 74.239999999999995 110.125 -178.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -58.12 -46.99 84.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.62 -0.718 . . . . 64.329999999999998 110.542 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 779' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -62.52 -41.82 99.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.914 -0.584 . . . . 63.420000000000002 110.717 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -56.35 -43.83 89.77 Favored Glycine 0 C--N 1.329 0.187 0 C-N-CA 121.161 -0.543 . . . . 63.340000000000003 112.398 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -71.93 -43.79 64.71 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.699 0.285 . . . . 73.430000000000007 111.046 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -66.42 -45.63 79.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.222 -0.445 . . . . 75.120000000000005 111.505 -176.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -66.67 -33.87 76.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.709 0.29 . . . . 72.340000000000003 110.686 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -60.56 -52.04 66.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.347 -0.388 . . . . 65.519999999999996 110.177 177.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 785' ' ' ALA . . . . . 0.586 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -65.4 -38.59 90.45 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.167 -0.469 . . . . 73.230000000000004 110.744 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 786' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -59.9 -51.07 71.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.919 -0.582 . . . . 75.310000000000002 110.852 178.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 787' ' ' ALA . . . . . 0.571 ' HA ' ' HD2' ' A' ' 790' ' ' ARG . . . -67.85 -35.8 79.2 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.071 -0.513 . . . . 43.43 111.039 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 788' ' ' ALA . . . . . 0.786 ' HB2' ' HD3' ' A' ' 770' ' ' PRO . . . -60.96 -41.05 95.59 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.361 -0.382 . . . . 32.409999999999997 111.032 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 789' ' ' LEU . . . . . 0.592 HD22 HD12 ' A' ' 719' ' ' LEU . 75.9 mt -64.23 -40.36 95.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.406 -0.361 . . . . 72.109999999999999 110.21 178.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 790' ' ' ARG . . . . . 0.571 ' HD2' ' HA ' ' A' ' 787' ' ' ALA . 84.9 mtt180 -60.01 -35.06 74.25 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.501 -0.318 . . . . 61.5 111.209 177.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 791' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 787' ' ' ALA . 62.1 t -61.5 -50.53 79.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.249 0.547 . . . . 65.420000000000002 109.898 175.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 792' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 23.7 mt -61.98 -47.88 82.84 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.395 -0.82 . . . . 64.239999999999995 110.743 -179.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 793' ' ' ILE . . . . . 0.54 HD13 HG22 ' A' ' 720' ' ' VAL . 95.8 mt -59.85 -45.36 94.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.481 -0.781 . . . . 75.230000000000004 110.904 178.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -68.32 -33.8 78.57 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.833 -0.699 . . . . 52.450000000000003 112.703 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -70.66 -41.09 72.54 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.902 0.382 . . . . 74.109999999999999 110.642 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 5.4 t30 . . . . . 0 C--N 1.325 -0.46 0 C-N-CA 120.786 -0.366 . . . . 54.119999999999997 110.188 179.326 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 716' ' ' ILE . . . . . 0.526 ' HA ' HD23 ' A' ' 719' ' ' LEU . 42.1 mm . . . . . 0 C--O 1.233 0.222 0 CA-C-O 120.852 0.358 . . . . 73.310000000000002 110.85 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -60.63 -26.1 64.28 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 121.008 -0.615 . . . . 73.329999999999998 112.014 175.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 718' ' ' GLU . . . . . 0.8 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 9.0 mm-40 -68.75 -34.39 75.51 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-O 120.543 0.211 . . . . 64.430000000000007 110.551 178.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 719' ' ' LEU . . . . . 0.556 HD12 HD22 ' A' ' 789' ' ' LEU . 2.7 mm? -69.04 -29.25 67.37 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.522 -0.471 . . . . 73.010000000000005 109.917 177.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 720' ' ' VAL . . . . . 0.488 HG22 HD13 ' A' ' 793' ' ' ILE . 60.3 t -67.52 -40.96 85.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.844 -0.616 . . . . 74.430000000000007 110.804 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 721' ' ' ARG . . . . . 0.8 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 12.9 ptm180 -64.86 -29.92 70.9 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.4 -0.364 . . . . 65.010000000000005 110.249 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -71.83 -35.48 69.9 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-N 116.341 -0.39 . . . . 73.420000000000002 110.69 177.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 723' ' ' LEU . . . . . 0.586 HD21 ' HB2' ' A' ' 789' ' ' LEU . 82.0 mt -56.3 -30.68 62.84 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.138 0.494 . . . . 73.340000000000003 110.407 175.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -83.86 -55.37 4.28 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.835 -0.62 . . . . 73.200000000000003 110.935 176.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 27.2 m -75.44 -73.06 0.27 Allowed 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.119 0.414 . . . . 64.450000000000003 112.119 -176.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 726' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -148.49 100.31 3.56 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 120.804 0.335 . . . . 64.219999999999999 110.633 -175.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 727' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -61.7 -39.97 49.39 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.021 2.481 . . . . 55.439999999999998 112.667 -176.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 30.1 t -59.24 -47.88 88.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.008 -0.542 . . . . 72.010000000000005 110.787 -176.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -65.66 -31.35 79.7 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.86 -0.609 . . . . 54.119999999999997 111.812 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -68.24 -41.73 85.33 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.903 -0.665 . . . . 64.439999999999998 112.269 178.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -65.04 -41.29 95.35 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.526 -0.546 . . . . 73.120000000000005 109.526 178.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 732' ' ' LEU . . . . . . . . . . . . . 83.8 mt -68.79 -31.55 70.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.88 -0.6 . . . . 74.25 110.99 178.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 733' ' ' GLU . . . . . 0.501 ' O ' ' HG2' ' A' ' 736' ' ' ARG . 0.7 OUTLIER -73.28 -43.54 60.83 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 116.165 -0.471 . . . . 71.129999999999995 110.392 178.901 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 734' ' ' TYR . . . . . 0.466 ' HB2' HD11 ' A' ' 719' ' ' LEU . 7.6 t80 -55.45 -46.41 76.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.978 -0.556 . . . . 74.450000000000003 110.615 176.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -64.78 -48.12 75.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.923 -0.581 . . . . 73.319999999999993 111.095 -178.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 736' ' ' ARG . . . . . 0.501 ' HG2' ' O ' ' A' ' 733' ' ' GLU . 11.3 ptt180 -64.54 -35.74 81.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.009 0.433 . . . . 64.219999999999999 111.078 -175.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 48.4 t -74.2 -35.06 63.9 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.013 -0.539 . . . . 75.310000000000002 111.036 -178.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -89.0 -32.02 17.82 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.286 -0.415 . . . . 74.129999999999995 111.803 -174.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 112.45 22.07 5.94 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.47 -0.872 . . . . 61.32 112.013 -178.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -99.51 169.99 8.92 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.869 0.366 . . . . 65.120000000000005 110.543 176.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -117.25 111.49 19.48 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.457 -0.572 . . . . 71.450000000000003 109.457 174.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 742' ' ' ALA . . . . . . . . . . . . . . . -94.58 130.26 41.09 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.909 0.385 . . . . 73.239999999999995 111.464 -175.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 743' ' ' GLU . . . . . 0.572 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 49.5 mt-10 -132.98 140.52 47.82 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.959 -0.564 . . . . 74.310000000000002 110.738 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -114.94 100.28 8.08 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.195 -0.668 . . . . 65.549999999999997 109.195 174.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 745' ' ' LYS . . . . . 0.471 ' HE2' ' HB3' ' A' ' 745' ' ' LYS . 14.4 ptpt -121.45 144.11 48.87 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.495 0.664 . . . . 63.340000000000003 111.909 -175.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 746' ' ' LEU . . . . . . . . . . . . . 6.6 tt -78.91 112.59 16.25 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.824 -1.08 . . . . 71.109999999999999 109.509 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 61.3 t -80.18 -50.01 18.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.985 0.422 . . . . 60.399999999999999 110.634 -178.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -155.56 148.93 24.88 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.929 -0.578 . . . . 62.549999999999997 110.252 -178.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 749' ' ' GLN . . . . . 0.42 ' O ' ' HG3' ' A' ' 749' ' ' GLN . 10.5 pt20 -133.69 108.59 8.62 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.194 0.521 . . . . 72.310000000000002 110.281 172.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 18.6 m -131.47 78.63 1.84 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.905 -0.588 . . . . 64.219999999999999 110.236 178.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . -139.24 150.31 21.21 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.658 -0.782 . . . . 74.230000000000004 112.138 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 752' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -62.67 160.55 32.04 Favored 'Trans proline' 0 CA--C 1.528 0.197 0 C-N-CA 123.019 2.479 . . . . 71.409999999999997 111.976 178.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -57.45 -34.63 98.29 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.797 2.332 . . . . 72.519999999999996 112.897 -178.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 47.9 p-80 -83.89 -15.91 46.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.268 -0.424 . . . . 54.200000000000003 111.357 -177.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -149.18 70.98 10.09 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.455 -0.339 . . . . 64.209999999999994 110.73 -177.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 756' ' ' PRO . . . . . 0.511 ' O ' ' HA ' ' A' ' 775' ' ' HIS . 51.8 Cg_exo -54.81 146.59 55.1 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.738 2.292 . . . . 72.450000000000003 112.176 178.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 757' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -129.96 113.33 14.46 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.254 -0.43 . . . . 64.409999999999997 109.911 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 758' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -112.74 117.54 32.49 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.799 -0.637 . . . . 54.340000000000003 110.79 -177.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 30.9 t -85.14 101.39 9.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.92 -0.582 . . . . 72.420000000000002 109.543 175.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -106.05 136.91 44.89 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.67 -0.695 . . . . 74.150000000000006 110.483 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 761' ' ' GLN . . . . . 0.526 ' HA ' ' O ' ' A' ' 770' ' ' PRO . 30.0 tt0 -135.18 131.95 37.37 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.749 -0.659 . . . . 72.150000000000006 110.033 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 762' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 769' ' ' PHE . . . -89.17 122.19 32.21 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.892 -0.594 . . . . 45.119999999999997 110.636 -178.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 763' ' ' LYS . . . . . 0.572 ' HB3' ' HB2' ' A' ' 743' ' ' GLU . 61.5 tttm -97.62 105.54 17.71 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.622 -0.717 . . . . 73.25 109.512 178.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 59.8 t -108.93 98.59 7.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.098 0.475 . . . . 72.040000000000006 109.792 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 70.72 -107.76 2.26 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 111.26 -0.736 . . . . 34.119999999999997 111.26 -176.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -109.6 1.05 30.65 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.743 -0.741 . . . . 73.040000000000006 112.068 177.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 767' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -102.75 138.74 39.24 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.16 0.505 . . . . 63.43 111.373 -177.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 768' ' ' TRP . . . . . 0.429 ' CH2' ' HD2' ' A' ' 763' ' ' LYS . 80.4 m95 -108.64 108.76 19.75 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.521 -0.763 . . . . 74.25 109.39 175.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 769' ' ' PHE . . . . . 0.5 ' HA ' ' HA ' ' A' ' 770' ' ' PRO . 31.6 p90 -168.99 138.9 1.81 Allowed Pre-proline 0 C--N 1.322 -0.613 0 CA-C-O 120.946 0.403 . . . . 71.230000000000004 110.497 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 770' ' ' PRO . . . . . 0.704 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 59.7 Cg_endo -97.99 -175.64 3.95 Favored 'Cis proline' 0 N--CA 1.451 -1.028 0 C-N-CA 123.454 -1.478 . . . . 74.400000000000006 111.768 -4.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -110.9 106.54 15.7 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.605 -0.517 . . . . 75.530000000000001 109.605 173.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 30.0 m -114.52 146.49 18.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.018 0.437 . . . . 45.039999999999999 111.409 -177.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 5.7 p -111.98 95.87 5.72 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.792 -0.64 . . . . 70.510000000000005 109.847 178.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -94.18 166.73 11.97 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.05 -0.523 . . . . 75.340000000000003 111.776 -174.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 775' ' ' HIS . . . . . 0.511 ' HA ' ' O ' ' A' ' 756' ' ' PRO . 32.6 m-70 -91.84 -4.3 55.0 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.722 -0.672 . . . . 72.409999999999997 110.853 -178.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 63.5 p -159.13 173.58 16.19 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.693 -0.484 . . . . 73.430000000000007 109.693 176.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 777' ' ' LYS . . . . . 0.701 ' HE2' ' HD2' ' A' ' 781' ' ' LYS . 31.4 tttt -65.83 -52.51 49.89 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.709 0.263 . . . . 65.120000000000005 111.709 -176.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 51.9 tttp -63.5 -37.79 88.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.466 -0.334 . . . . 50.049999999999997 110.636 -174.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 779' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -60.61 -39.15 87.14 Favored 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 109.852 -0.425 . . . . 74.150000000000006 109.852 175.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -61.91 -48.49 83.35 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.991 -0.623 . . . . 75.25 112.061 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 781' ' ' LYS . . . . . 0.701 ' HD2' ' HE2' ' A' ' 777' ' ' LYS . 8.2 mtpm? -62.59 -38.25 89.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.652 0.263 . . . . 72.219999999999999 111.04 178.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -73.17 -50.54 22.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.539 -0.301 . . . . 74.409999999999997 111.316 -178.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -60.67 -38.4 84.78 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.67 0.271 . . . . 73.519999999999996 110.974 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -60.11 -51.2 70.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 74.150000000000006 110.146 177.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 785' ' ' ALA . . . . . 0.609 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -66.39 -41.72 88.94 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.252 -0.431 . . . . 61.520000000000003 110.923 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 786' ' ' ASP . . . . . 0.444 ' O ' ' HD3' ' A' ' 790' ' ' ARG . 9.9 t0 -56.34 -57.49 12.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.903 -0.59 . . . . 73.129999999999995 110.082 179.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 787' ' ' ALA . . . . . 0.63 ' HB3' ' HG3' ' A' ' 770' ' ' PRO . . . -64.77 -33.39 75.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.695 -0.684 . . . . 71.409999999999997 111.196 -178.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 788' ' ' ALA . . . . . 0.704 ' HB2' ' HD3' ' A' ' 770' ' ' PRO . . . -64.64 -44.47 90.38 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 123.174 0.296 . . . . 54.43 110.937 179.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 789' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 785' ' ' ALA . 80.0 mt -61.35 -40.34 93.92 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.742 -0.466 . . . . 71.319999999999993 109.742 178.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 790' ' ' ARG . . . . . 0.444 ' HD3' ' O ' ' A' ' 786' ' ' ASP . 13.0 mtp180 -59.54 -35.34 74.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.032 -0.531 . . . . 63.329999999999998 111.162 176.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 791' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 787' ' ' ALA . 54.3 t -66.19 -52.09 51.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 109.753 -0.462 . . . . 72.219999999999999 109.753 175.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 792' ' ' LEU . . . . . 0.624 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 31.3 mt -57.23 -49.09 77.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.647 -0.706 . . . . 75.540000000000006 110.575 -178.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 793' ' ' ILE . . . . . 0.488 HD13 HG22 ' A' ' 720' ' ' VAL . 94.2 mt -60.02 -51.46 72.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.414 -0.812 . . . . 74.340000000000003 110.734 177.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -61.83 -40.53 98.96 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 121.014 -0.612 . . . . 73.239999999999995 112.697 -178.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -60.29 -53.17 60.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.375 0.131 . . . . 73.209999999999994 111.24 178.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 . . . . . 0 C--N 1.326 -0.427 0 CA-C-O 120.928 0.394 . . . . 72.439999999999998 111.08 -176.189 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 716' ' ' ILE . . . . . 0.779 HG23 HG12 ' A' ' 793' ' ' ILE . 25.8 mm . . . . . 0 N--CA 1.452 -0.338 0 N-CA-C 111.961 0.356 . . . . 71.329999999999998 111.961 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -57.17 -28.69 58.93 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.959 -0.639 . . . . 74.420000000000002 112.293 176.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 718' ' ' GLU . . . . . 0.711 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 9.2 mm-40 -70.59 -36.42 73.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.841 0.353 . . . . 73.25 110.289 178.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 719' ' ' LEU . . . . . 0.593 HD23 ' HA ' ' A' ' 716' ' ' ILE . 3.2 mm? -66.86 -32.23 73.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.17 0.509 . . . . 53.119999999999997 109.864 177.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 720' ' ' VAL . . . . . 0.459 HG22 HD13 ' A' ' 793' ' ' ILE . 61.0 t -68.81 -34.81 66.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.696 -0.684 . . . . 74.140000000000001 110.636 177.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 721' ' ' ARG . . . . . 0.711 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 21.5 ptt180 -63.47 -28.93 70.3 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.261 0.553 . . . . 71.120000000000005 109.643 178.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -77.76 -30.79 51.69 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.908 -0.587 . . . . 71.140000000000001 111.392 178.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 723' ' ' LEU . . . . . 0.521 HD21 ' HB2' ' A' ' 789' ' ' LEU . 92.9 mt -58.18 -33.56 69.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.146 0.498 . . . . 73.150000000000006 110.052 175.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -82.83 -44.28 15.66 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.491 -0.777 . . . . 45.149999999999999 110.887 176.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 8.2 m -84.22 -79.82 0.21 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.358 -0.383 . . . . 54.210000000000001 111.46 -175.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 726' ' ' ASN . . . . . 0.432 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 52.6 t-20 -148.08 109.58 3.73 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 109.768 -0.456 . . . . 71.120000000000005 109.768 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 727' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 28.0 Cg_endo -63.06 -33.79 72.32 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.826 2.35 . . . . 75.420000000000002 112.467 -178.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 59.7 t -63.39 -48.45 87.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.044 0.45 . . . . 72.310000000000002 110.183 -178.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -66.03 -24.55 71.76 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.668 -0.696 . . . . 71.5 111.881 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -79.1 -39.15 20.58 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 121.149 -0.548 . . . . 64.329999999999998 112.644 178.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -65.35 -41.83 93.47 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.576 -0.527 . . . . 72.140000000000001 109.576 178.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 732' ' ' LEU . . . . . 0.423 HD23 ' HB3' ' A' ' 742' ' ' ALA . 90.0 mt -64.13 -37.77 88.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.83 -0.623 . . . . 71.439999999999998 110.193 175.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 733' ' ' GLU . . . . . 0.553 ' O ' ' HG2' ' A' ' 736' ' ' ARG . 4.1 tp10 -65.18 -49.45 69.74 Favored 'General case' 0 N--CA 1.437 -1.12 0 C-N-CA 123.423 0.689 . . . . 74.109999999999999 110.857 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 734' ' ' TYR . . . . . 0.52 ' HB2' HD11 ' A' ' 719' ' ' LEU . 11.0 t80 -54.7 -48.13 72.82 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.634 -0.712 . . . . 72.329999999999998 110.716 178.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -67.14 -47.93 69.6 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.88 -0.6 . . . . 75.230000000000004 111.22 -177.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 736' ' ' ARG . . . . . 0.553 ' HG2' ' O ' ' A' ' 733' ' ' GLU . 18.5 ptt180 -61.99 -32.95 73.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.997 0.427 . . . . 53.240000000000002 111.314 -175.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 44.6 t -80.3 -36.87 33.75 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.075 -0.511 . . . . 75.450000000000003 110.981 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -91.81 -2.35 56.95 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.105 0.409 . . . . 65.209999999999994 112.105 -172.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 89.47 13.37 61.57 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.61 -0.805 . . . . 74.439999999999998 112.936 175.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -97.93 157.89 15.84 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.849 0.357 . . . . 65.219999999999999 110.691 177.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -102.42 114.85 29.4 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.519 -0.548 . . . . 52.109999999999999 109.519 175.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 742' ' ' ALA . . . . . 0.423 ' HB3' HD23 ' A' ' 732' ' ' LEU . . . -92.38 114.81 27.46 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 123.237 0.336 . . . . 61.109999999999999 111.021 -177.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 743' ' ' GLU . . . . . 0.431 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 47.1 mt-10 -126.68 132.74 51.1 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.3 -0.409 . . . . 65.299999999999997 110.966 -178.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -106.14 100.76 10.28 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.181 -0.463 . . . . 72.530000000000001 110.292 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 10.4 ptpt -103.72 140.89 37.0 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.171 0.51 . . . . 65.239999999999995 111.204 -179.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 746' ' ' LEU . . . . . . . . . . . . . 6.6 tt -86.42 110.01 19.43 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.303 -0.999 . . . . 72.219999999999999 108.303 175.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 40.4 t -74.88 -53.88 15.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.077 -0.51 . . . . 72.409999999999997 110.347 -176.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -157.04 155.19 30.76 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.991 -0.55 . . . . 52.240000000000002 109.53 -178.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -139.62 96.81 3.14 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.514 0.673 . . . . 74.019999999999996 110.974 177.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 34.0 t -89.73 101.85 14.55 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.548 -0.908 . . . . 63.240000000000002 108.548 174.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 751' ' ' GLY . . . . . 0.667 ' HA2' ' HA ' ' A' ' 756' ' ' PRO . . . -120.25 81.17 0.33 Allowed Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.172 -1.013 . . . . 54.409999999999997 113.671 -173.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 752' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -64.59 160.24 40.95 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.169 1.913 . . . . 55.439999999999998 110.466 170.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.41 -27.36 84.79 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.513 2.142 . . . . 75.019999999999996 113.188 -174.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 50.9 p-80 -92.19 -15.18 27.95 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.499 -0.319 . . . . 74.140000000000001 111.596 -176.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -158.89 71.72 3.62 Favored Pre-proline 0 C--N 1.329 -0.289 0 N-CA-C 112.289 0.478 . . . . 64.540000000000006 112.289 -176.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 756' ' ' PRO . . . . . 0.667 ' HA ' ' HA2' ' A' ' 751' ' ' GLY . 40.2 Cg_exo -58.13 115.29 2.43 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 121.934 1.756 . . . . 61.240000000000002 111.199 171.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 757' ' ' LYS . . . . . 0.488 ' HD3' ' HB2' ' A' ' 773' ' ' CYS . 36.4 ttmt -122.4 137.06 54.99 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.958 0.408 . . . . 72.549999999999997 110.822 -176.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 758' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -123.21 119.61 30.73 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.813 -0.631 . . . . 74.129999999999995 110.45 -176.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 759' ' ' VAL . . . . . 0.527 HG22 ' HB3' ' A' ' 773' ' ' CYS . 25.3 t -94.49 115.92 34.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.005 -0.543 . . . . 62.130000000000003 110.761 -177.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -116.76 147.56 41.94 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.754 -0.657 . . . . 75.540000000000006 110.724 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 761' ' ' GLN . . . . . 0.452 HE21 ' HB2' ' A' ' 771' ' ' ALA . 34.4 tt0 -132.62 138.13 47.27 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.942 -0.572 . . . . 74.230000000000004 109.677 177.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 762' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 769' ' ' PHE . . . -95.19 112.66 24.34 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.316 0.579 . . . . 73.439999999999998 110.514 -177.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 763' ' ' LYS . . . . . 0.488 ' HD2' ' CH2' ' A' ' 768' ' ' TRP . 48.8 tttm -91.67 104.02 16.54 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.493 -0.776 . . . . 70.209999999999994 109.441 177.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 88.8 t -109.35 101.77 13.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.182 0.515 . . . . 73.329999999999998 109.851 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 71.68 -119.13 7.47 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 110.775 -0.93 . . . . 55.530000000000001 110.775 -174.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -102.14 7.06 54.24 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.635 -0.793 . . . . 73.140000000000001 111.224 175.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 767' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -99.9 148.56 24.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.054 0.454 . . . . 75.540000000000006 110.976 -177.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 768' ' ' TRP . . . . . 0.488 ' CH2' ' HD2' ' A' ' 763' ' ' LYS . 54.1 m95 -124.76 99.9 6.37 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.688 -0.687 . . . . 73.430000000000007 110.064 -179.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 769' ' ' PHE . . . . . 0.414 ' HA ' ' HA ' ' A' ' 770' ' ' PRO . 34.5 p90 -171.04 141.57 1.41 Allowed Pre-proline 0 C--N 1.325 -0.468 0 CA-C-O 120.706 0.289 . . . . 64.219999999999999 110.397 -178.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 770' ' ' PRO . . . . . 0.58 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 60.7 Cg_endo -96.59 -168.54 1.78 Allowed 'Cis proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.755 -1.352 . . . . 64.030000000000001 112.126 -2.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 771' ' ' ALA . . . . . 0.452 ' HB2' HE21 ' A' ' 761' ' ' GLN . . . -120.95 108.53 14.0 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.771 -0.455 . . . . 70.140000000000001 109.771 175.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 772' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 759' ' ' VAL . 32.9 m -116.87 157.54 17.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.83 0.348 . . . . 60.039999999999999 110.998 -176.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 773' ' ' CYS . . . . . 0.527 ' HB3' HG22 ' A' ' 759' ' ' VAL . 2.6 p -134.99 100.53 4.6 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.069 -0.514 . . . . 73.420000000000002 110.175 178.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -103.22 177.49 4.82 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.824 -0.626 . . . . 61.520000000000003 111.221 -174.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 775' ' ' HIS . . . . . . . . . . . . . 46.8 m-70 -85.32 -16.63 39.35 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.14 0.495 . . . . 73.129999999999995 110.324 -177.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 776' ' ' SER . . . . . 0.605 ' HB2' ' HB2' ' A' ' 779' ' ' GLN . 12.5 m -129.71 152.57 49.07 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.954 -0.567 . . . . 75.439999999999998 110.281 -177.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 777' ' ' LYS . . . . . . . . . . . . . 6.1 tmmm? -63.9 -49.69 71.67 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.372 -0.376 . . . . 75.0 110.96 -178.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -70.41 -26.56 63.74 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.644 -0.423 . . . . 71.400000000000006 110.231 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 779' ' ' GLN . . . . . 0.605 ' HB2' ' HB2' ' A' ' 776' ' ' SER . 6.5 mm-40 -66.71 -37.33 84.48 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 116.28 -0.418 . . . . 74.409999999999997 110.261 173.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -58.15 -45.98 93.31 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.787 -0.72 . . . . 74.340000000000003 111.501 175.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -61.94 -46.13 90.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.773 0.321 . . . . 73.450000000000003 110.76 176.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -64.56 -46.87 80.92 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.337 -0.392 . . . . 61.450000000000003 111.399 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -63.14 -39.57 95.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.496 -0.32 . . . . 73.540000000000006 111.235 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -63.19 -46.11 88.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.82 0.343 . . . . 54.210000000000001 110.11 177.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 785' ' ' ALA . . . . . 0.578 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -65.14 -45.11 86.35 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.902 -0.59 . . . . 62.329999999999998 110.986 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 786' ' ' ASP . . . . . 0.718 ' O ' ' HG2' ' A' ' 790' ' ' ARG . 14.1 t70 -58.41 -54.49 46.46 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 116.317 -0.401 . . . . 73.030000000000001 110.012 178.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 787' ' ' ALA . . . . . 0.52 ' O ' HG23 ' A' ' 791' ' ' VAL . . . -61.75 -33.79 74.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.759 -0.655 . . . . 73.329999999999998 111.21 -178.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 788' ' ' ALA . . . . . 0.716 ' O ' ' HG ' ' A' ' 792' ' ' LEU . . . -62.84 -46.62 87.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.363 -0.381 . . . . 63.530000000000001 110.448 177.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 789' ' ' LEU . . . . . 0.587 HD22 HD12 ' A' ' 719' ' ' LEU . 65.5 mt -62.58 -36.36 82.47 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.812 -0.44 . . . . 75.230000000000004 109.812 179.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 790' ' ' ARG . . . . . 0.718 ' HG2' ' O ' ' A' ' 786' ' ' ASP . 26.6 mmm-85 -58.95 -42.18 89.22 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.868 0.366 . . . . 75.230000000000004 110.033 177.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 791' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 787' ' ' ALA . 59.0 t -64.31 -49.68 79.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.054 -0.521 . . . . 73.129999999999995 110.465 177.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 792' ' ' LEU . . . . . 0.716 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 22.5 mt -59.19 -46.59 88.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.033 -0.531 . . . . 52.100000000000001 110.457 -178.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 793' ' ' ILE . . . . . 0.779 HG12 HG23 ' A' ' 716' ' ' ILE . 96.7 mt -63.02 -45.49 98.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.422 -0.808 . . . . 74.409999999999997 110.675 177.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -65.69 -40.16 95.69 Favored Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 115.934 -0.575 . . . . 53.420000000000002 112.934 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -74.23 -16.58 60.96 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 122.377 -0.484 . . . . 73.230000000000004 111.277 -178.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 5.1 t30 . . . . . 0 C--N 1.323 -0.545 0 CA-C-O 121.436 0.636 . . . . 75.310000000000002 109.424 174.998 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 716' ' ' ILE . . . . . 0.447 ' HA ' HD23 ' A' ' 719' ' ' LEU . 48.1 mm . . . . . 0 C--O 1.233 0.192 0 CA-C-O 121.022 0.439 . . . . 75.129999999999995 110.68 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -60.29 -29.73 69.49 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.944 -0.646 . . . . 53.329999999999998 112.085 178.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 718' ' ' GLU . . . . . 0.671 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 30.0 mm-40 -57.87 -50.12 74.38 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-O 120.965 0.412 . . . . 73.540000000000006 110.168 176.004 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 719' ' ' LEU . . . . . 0.567 HD11 ' HB2' ' A' ' 734' ' ' TYR . 2.4 mm? -62.71 -29.67 70.84 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.164 0.507 . . . . 73.140000000000001 110.096 -177.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 720' ' ' VAL . . . . . 0.448 HG22 HD13 ' A' ' 793' ' ' ILE . 65.1 t -72.07 -42.96 67.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.617 -0.72 . . . . 74.319999999999993 110.639 178.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 721' ' ' ARG . . . . . 0.671 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 15.5 ptm180 -65.5 -24.05 67.04 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.919 0.39 . . . . 74.120000000000005 110.446 -179.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -76.91 -31.56 56.78 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 116.483 -0.326 . . . . 74.530000000000001 111.098 176.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 723' ' ' LEU . . . . . 0.479 HD21 ' HB2' ' A' ' 789' ' ' LEU . 92.3 mt -60.78 -30.9 70.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.266 0.555 . . . . 71.329999999999998 109.99 174.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -87.95 -17.26 31.69 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.281 -0.872 . . . . 70.299999999999997 111.317 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 21.2 m -118.04 -79.9 0.6 Allowed 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 120.674 0.274 . . . . 60.130000000000003 111.595 -177.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 726' ' ' ASN . . . . . 0.436 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 39.4 t30 -139.19 106.71 7.29 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 120.71 0.29 . . . . 64.549999999999997 110.669 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 727' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 21.1 Cg_endo -62.03 -38.48 56.91 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.745 2.297 . . . . 34.520000000000003 112.838 -178.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 29.9 t -63.12 -46.32 96.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.355 -0.384 . . . . 72.239999999999995 110.669 -175.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -61.58 -36.1 92.12 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.833 -0.698 . . . . 45.399999999999999 112.026 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -67.54 -42.07 89.17 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 121.095 -0.574 . . . . 73.109999999999999 112.593 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -65.66 -42.05 91.81 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.964 0.411 . . . . 75.299999999999997 109.933 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 732' ' ' LEU . . . . . . . . . . . . . 96.1 mt -65.37 -46.44 80.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.944 -0.571 . . . . 75.129999999999995 111.14 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 733' ' ' GLU . . . . . 0.515 ' HA ' ' HG2' ' A' ' 736' ' ' ARG . 0.0 OUTLIER -72.75 -31.38 64.88 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.899 -0.321 . . . . 75.109999999999999 110.994 -176.187 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 734' ' ' TYR . . . . . 0.567 ' HB2' HD11 ' A' ' 719' ' ' LEU . 11.8 t80 -57.22 -48.88 77.69 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 120.918 0.39 . . . . 71.319999999999993 110.089 175.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -65.02 -52.26 57.0 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.874 -0.603 . . . . 73.409999999999997 110.709 -176.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 736' ' ' ARG . . . . . 0.515 ' HG2' ' HA ' ' A' ' 733' ' ' GLU . 32.5 ptt180 -62.47 -33.04 74.05 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.686 -0.688 . . . . 72.400000000000006 111.399 -175.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 47.9 t -83.47 -11.68 57.21 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.909 -0.587 . . . . 42.340000000000003 111.673 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -113.03 -8.44 13.64 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.008 0.373 . . . . 64.409999999999997 112.008 -177.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 100.08 8.01 51.48 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.597 -0.811 . . . . 51.439999999999998 112.733 178.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -97.42 163.75 12.74 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 110.091 -0.337 . . . . 74.140000000000001 110.091 177.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -113.0 118.61 35.3 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.6 -0.519 . . . . 64.349999999999994 109.6 174.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 742' ' ' ALA . . . . . . . . . . . . . . . -94.06 128.3 40.35 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.21 -0.45 . . . . 53.539999999999999 111.029 -176.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 743' ' ' GLU . . . . . 0.567 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 45.6 mt-10 -139.54 154.81 47.74 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.872 -0.603 . . . . 71.510000000000005 110.393 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -128.5 113.18 15.17 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.209 -0.451 . . . . 73.420000000000002 109.795 178.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 745' ' ' LYS . . . . . 0.511 ' HE3' ' CZ3' ' A' ' 768' ' ' TRP . 13.1 ptpt -111.74 149.34 31.79 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.305 -0.558 . . . . 52.240000000000002 111.197 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 746' ' ' LEU . . . . . . . . . . . . . 6.7 tt -95.49 104.85 16.77 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.236 -1.024 . . . . 61.219999999999999 108.236 177.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 48.3 t -76.84 -44.14 32.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 116.226 -0.443 . . . . 74.450000000000003 111.009 -174.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -152.88 148.49 27.21 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.324 -0.398 . . . . 73.319999999999993 111.12 -175.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 749' ' ' GLN . . . . . 0.514 ' HA ' ' O ' ' A' ' 757' ' ' LYS . 18.1 pt20 -138.75 97.02 3.24 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.924 0.869 . . . . 72.140000000000001 109.759 173.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 9.8 p -129.5 -179.18 5.02 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.414 -0.812 . . . . 61.399999999999999 111.004 -174.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 103.64 178.5 25.87 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.586 -0.816 . . . . 31.100000000000001 112.229 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 752' ' ' PRO . . . . . 0.663 ' HG2' ' HB2' ' A' ' 755' ' ' GLU . 38.7 Cg_endo -64.98 160.3 42.15 Favored 'Trans proline' 0 CA--C 1.528 0.218 0 C-N-CA 123.118 2.545 . . . . 53.109999999999999 111.963 -178.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.37 -28.2 71.58 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.645 2.23 . . . . 70.200000000000003 112.658 -178.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 49.0 p-80 -86.49 -14.82 41.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.76 0.314 . . . . 54.420000000000002 110.989 -179.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 755' ' ' GLU . . . . . 0.663 ' HB2' ' HG2' ' A' ' 752' ' ' PRO . 18.8 mm-40 -138.9 74.0 38.5 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.252 -0.431 . . . . 64.519999999999996 110.718 178.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 756' ' ' PRO . . . . . 0.671 ' O ' ' HA ' ' A' ' 775' ' ' HIS . 56.1 Cg_endo -73.5 113.32 3.75 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.495 2.13 . . . . 74.099999999999994 111.723 177.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 757' ' ' LYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 749' ' ' GLN . 6.1 ttpm? -88.61 114.08 24.85 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.903 0.382 . . . . 71.25 110.718 -177.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 758' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -99.06 115.11 28.22 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.532 -0.758 . . . . 70.209999999999994 110.013 179.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 22.1 t -88.24 105.69 15.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.627 -0.715 . . . . 71.099999999999994 109.373 177.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -107.63 144.43 34.69 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.981 -0.554 . . . . 62.039999999999999 110.669 -178.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 761' ' ' GLN . . . . . 0.473 ' HA ' ' O ' ' A' ' 770' ' ' PRO . 60.4 tt0 -136.6 128.18 28.72 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.703 -0.68 . . . . 74.319999999999993 109.512 178.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 762' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 769' ' ' PHE . . . -86.29 129.56 34.81 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.332 0.587 . . . . 41.109999999999999 110.502 -178.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 763' ' ' LYS . . . . . 0.567 ' HB3' ' HB2' ' A' ' 743' ' ' GLU . 66.0 tttt -104.6 112.28 25.29 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.584 -0.735 . . . . 75.030000000000001 109.783 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 58.9 t -119.27 95.92 3.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.175 0.512 . . . . 53.219999999999999 109.758 177.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 72.86 -116.5 5.65 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.091 -0.803 . . . . 52.140000000000001 111.091 -175.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -101.36 -2.97 53.89 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.752 -0.737 . . . . 60.340000000000003 111.818 175.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 767' ' ' ARG . . . . . 0.455 ' HB3' ' CD1' ' A' ' 769' ' ' PHE . 0.2 OUTLIER -95.08 121.91 37.2 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.959 0.409 . . . . 72.530000000000001 111.457 -178.01 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 768' ' ' TRP . . . . . 0.511 ' CZ3' ' HE3' ' A' ' 745' ' ' LYS . 70.2 m95 -102.17 105.14 15.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.917 -0.583 . . . . 75.239999999999995 110.062 177.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 769' ' ' PHE . . . . . 0.455 ' CD1' ' HB3' ' A' ' 767' ' ' ARG . 41.6 p90 -168.39 144.94 3.2 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 109.873 -0.417 . . . . 74.230000000000004 109.873 -177.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 770' ' ' PRO . . . . . 0.666 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 65.3 Cg_endo -97.56 -176.16 4.45 Favored 'Cis proline' 0 N--CA 1.451 -1.006 0 C-N-CA 123.736 -1.36 . . . . 53.329999999999998 112.188 -2.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -106.41 109.1 20.93 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.596 -0.52 . . . . 50.200000000000003 109.596 174.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 35.9 m -117.72 155.79 19.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.969 0.414 . . . . 70.310000000000002 110.997 -177.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 7.0 p -129.91 112.78 13.86 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.17 0.51 . . . . 65.019999999999996 110.442 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 774' ' ' ALA . . . . . 0.421 ' O ' ' HA ' ' A' ' 757' ' ' LYS . . . -116.73 -178.4 3.42 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.816 -0.629 . . . . 64.340000000000003 109.784 178.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 775' ' ' HIS . . . . . 0.671 ' HA ' ' O ' ' A' ' 756' ' ' PRO . 5.6 p80 -121.86 19.01 11.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.772 0.796 . . . . 65.109999999999999 110.187 176.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 49.3 m -148.35 139.22 23.05 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.837 -1.074 . . . . 73.420000000000002 108.405 171.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 777' ' ' LYS . . . . . . . . . . . . . 5.6 tmmm? -61.45 -44.77 96.53 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 123.018 0.199 . . . . 65.129999999999995 111.291 -172.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -64.85 -31.56 72.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.71 0.291 . . . . 60.149999999999999 110.799 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 779' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -72.03 -35.51 69.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.365 -0.38 . . . . 75.230000000000004 110.335 177.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -59.94 -42.94 98.48 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.904 -0.665 . . . . 45.310000000000002 111.493 176.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -61.25 -49.01 78.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.835 0.35 . . . . 72.540000000000006 110.488 176.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -61.73 -51.21 69.31 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 115.896 -0.593 . . . . 72.129999999999995 111.254 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -57.95 -43.34 86.34 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 123.196 0.31 . . . . 60.539999999999999 111.44 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -59.92 -50.68 72.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.373 -0.376 . . . . 64.209999999999994 110.622 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 785' ' ' ALA . . . . . 0.596 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -67.48 -42.46 82.94 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.318 -0.401 . . . . 54.140000000000001 111.025 -178.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 786' ' ' ASP . . . . . 0.461 ' O ' ' HG3' ' A' ' 790' ' ' ARG . 11.8 t70 -59.1 -51.74 68.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.984 -0.553 . . . . 65.200000000000003 110.717 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 787' ' ' ALA . . . . . 0.55 ' O ' HG23 ' A' ' 791' ' ' VAL . . . -66.84 -35.46 80.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.034 -0.53 . . . . 64.120000000000005 110.8 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 788' ' ' ALA . . . . . 0.676 ' O ' ' HG ' ' A' ' 792' ' ' LEU . . . -61.46 -42.75 99.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.425 -0.352 . . . . 65.420000000000002 110.854 178.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 789' ' ' LEU . . . . . 0.596 ' HG ' ' O ' ' A' ' 785' ' ' ALA . 81.3 mt -58.92 -43.98 91.22 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 110.008 -0.367 . . . . 73.239999999999995 110.008 177.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 790' ' ' ARG . . . . . 0.548 ' HD2' ' HA ' ' A' ' 787' ' ' ALA . 53.9 mtt-85 -58.36 -37.53 75.39 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.206 -0.452 . . . . 75.530000000000001 111.009 177.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 791' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 787' ' ' ALA . 48.3 t -65.81 -48.67 81.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.416 -0.356 . . . . 72.430000000000007 110.237 177.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 792' ' ' LEU . . . . . 0.676 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 39.6 mt -61.67 -46.37 90.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.747 -0.661 . . . . 73.049999999999997 110.749 -179.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 793' ' ' ILE . . . . . 0.448 HD13 HG22 ' A' ' 720' ' ' VAL . 89.5 mt -62.17 -47.53 92.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.51 -0.768 . . . . 70.439999999999998 110.366 177.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -62.92 -36.4 93.36 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 121.018 -0.611 . . . . 71.030000000000001 112.342 178.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -57.56 -51.22 70.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.977 0.418 . . . . 71.329999999999998 110.44 177.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 . . . . . 0 C--N 1.327 -0.396 0 CA-C-O 121.171 0.51 . . . . 72.129999999999995 110.667 -177.514 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 716' ' ' ILE . . . . . 0.416 ' O ' HG23 ' A' ' 720' ' ' VAL . 46.1 mm . . . . . 0 N--CA 1.454 -0.243 0 CA-C-O 120.75 0.31 . . . . 72.319999999999993 110.587 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -61.09 -28.94 69.77 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.974 -0.631 . . . . 41.049999999999997 111.702 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 718' ' ' GLU . . . . . 0.759 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 5.8 mp0 -59.68 -46.94 87.55 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.913 0.387 . . . . 64.109999999999999 110.173 175.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 719' ' ' LEU . . . . . 0.641 HD12 HD22 ' A' ' 789' ' ' LEU . 2.9 mm? -67.61 -33.75 75.62 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.997 0.427 . . . . 75.340000000000003 110.36 -178.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 720' ' ' VAL . . . . . 0.496 HG22 HD13 ' A' ' 793' ' ' ILE . 61.6 t -63.39 -41.19 91.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 115.991 -0.55 . . . . 64.5 110.672 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 721' ' ' ARG . . . . . 0.759 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 14.7 ptm180 -68.92 -24.57 64.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 73.0 109.981 -178.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -76.73 -30.15 56.49 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.356 -0.384 . . . . 75.120000000000005 111.404 177.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 723' ' ' LEU . . . . . 0.564 HD21 ' HB2' ' A' ' 789' ' ' LEU . 84.7 mt -59.18 -32.57 70.04 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.476 -0.565 . . . . 74.239999999999995 109.476 172.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -82.97 -41.06 19.22 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.276 -0.875 . . . . 60.240000000000002 110.976 177.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 29.3 m -96.26 -78.49 0.46 Allowed 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 112.32 0.489 . . . . 72.540000000000006 112.32 -176.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 726' ' ' ASN . . . . . 0.422 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 37.7 t30 -142.11 100.9 5.82 Favored Pre-proline 0 C--O 1.234 0.27 0 CA-C-O 120.817 0.342 . . . . 75.120000000000005 111.065 -173.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 727' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 19.2 Cg_endo -61.86 -38.5 58.7 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 123.041 2.494 . . . . 55.399999999999999 112.844 -176.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 42.0 t -61.48 -48.49 88.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 75.510000000000005 110.939 -175.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -61.98 -38.46 96.09 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.765 -0.731 . . . . 54.130000000000003 112.12 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -66.85 -42.68 92.8 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.876 -0.678 . . . . 72.349999999999994 112.584 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -62.52 -40.36 96.5 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.807 -0.442 . . . . 71.219999999999999 109.807 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 732' ' ' LEU . . . . . . . . . . . . . 90.7 mt -64.74 -42.98 94.77 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.928 -0.578 . . . . 72.530000000000001 111.399 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 733' ' ' GLU . . . . . 0.522 ' O ' ' HG2' ' A' ' 736' ' ' ARG . 12.7 pt-20 -80.2 -25.95 39.43 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.924 -0.311 . . . . 74.450000000000003 111.55 -176.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 734' ' ' TYR . . . . . 0.52 ' HB2' HD11 ' A' ' 719' ' ' LEU . 3.2 t80 -56.89 -44.24 82.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.061 0.457 . . . . 71.030000000000001 109.84 173.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -66.93 -47.6 71.22 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.612 -0.722 . . . . 63.350000000000001 110.666 -177.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 736' ' ' ARG . . . . . 0.522 ' HG2' ' O ' ' A' ' 733' ' ' GLU . 34.4 ptt180 -63.39 -31.77 73.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.13 0.49 . . . . 74.310000000000002 110.992 -176.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 10.4 t -75.46 -33.59 60.87 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.756 -0.656 . . . . 74.230000000000004 110.993 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 18.2 m170 -97.02 -13.29 22.38 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.317 0.488 . . . . 73.540000000000006 112.317 -173.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 100.56 13.56 34.85 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.439 -0.886 . . . . 42.420000000000002 112.614 178.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -98.57 -174.14 2.73 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.025 0.44 . . . . 60.340000000000003 110.284 176.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 741' ' ' ALA . . . . . 0.564 ' O ' ' HA ' ' A' ' 764' ' ' VAL . . . -128.06 139.43 52.53 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.796 -0.638 . . . . 71.409999999999997 109.281 173.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 742' ' ' ALA . . . . . . . . . . . . . . . -110.11 115.73 30.28 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.773 0.32 . . . . 74.010000000000005 110.895 -176.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 743' ' ' GLU . . . . . 0.561 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 43.4 mt-10 -126.63 146.53 50.14 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.274 -0.421 . . . . 72.239999999999995 110.979 -178.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -123.15 104.3 9.09 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.37 -0.604 . . . . 71.040000000000006 109.37 176.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 8.0 ptpt -119.16 157.9 27.02 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.095 0.474 . . . . 44.439999999999998 111.307 -176.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 746' ' ' LEU . . . . . 0.471 HD13 ' HB3' ' A' ' 758' ' ' PHE . 57.2 tp -85.78 122.98 30.63 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.509 -0.769 . . . . 63.450000000000003 109.756 175.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 54.3 t -94.58 -47.73 13.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 120.959 0.409 . . . . 74.230000000000004 110.537 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -143.92 148.9 36.03 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.044 -0.525 . . . . 64.019999999999996 110.003 -177.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -133.32 102.5 5.57 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.691 -0.485 . . . . 71.209999999999994 109.691 176.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 33.7 m -143.65 131.61 21.63 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.243 -0.435 . . . . 74.310000000000002 110.562 -177.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 160.62 -165.52 35.08 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.653 -0.784 . . . . 64.140000000000001 112.261 178.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 752' ' ' PRO . . . . . 0.489 ' HG2' ' HB2' ' A' ' 755' ' ' GLU . 72.7 Cg_endo -78.0 163.81 27.96 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 123.015 2.477 . . . . 73.310000000000002 112.084 177.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 753' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 752' ' ' PRO . 3.8 Cg_exo -76.51 -27.94 7.23 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.543 2.162 . . . . 75.209999999999994 112.379 -179.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 754' ' ' HIS . . . . . 0.415 ' CE1' ' HB2' ' A' ' 752' ' ' PRO . 39.8 p-80 -79.33 -19.4 50.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.914 0.387 . . . . 72.549999999999997 110.709 178.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 755' ' ' GLU . . . . . 0.489 ' HB2' ' HG2' ' A' ' 752' ' ' PRO . 29.3 mt-10 -138.99 79.74 26.09 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.929 -0.578 . . . . 62.43 110.332 175.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 756' ' ' PRO . . . . . 0.493 ' O ' ' HA ' ' A' ' 775' ' ' HIS . 34.9 Cg_endo -65.94 102.38 0.53 Allowed 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.165 1.91 . . . . 73.319999999999993 111.3 177.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 757' ' ' LYS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 775' ' ' HIS . 37.9 ttmt -87.69 114.69 24.54 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.437 0.637 . . . . 65.120000000000005 110.686 -176.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 758' ' ' PHE . . . . . 0.471 ' HB3' HD13 ' A' ' 746' ' ' LEU . 78.8 m-85 -97.95 126.12 43.19 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.016 -0.993 . . . . 75.319999999999993 110.48 -178.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 62.0 t -88.86 102.95 13.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 109.488 -0.56 . . . . 54.130000000000003 109.488 174.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 760' ' ' TYR . . . . . 0.469 ' OH ' ' HG3' ' A' ' 777' ' ' LYS . 7.1 m-85 -102.29 142.13 34.01 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.875 -0.602 . . . . 64.409999999999997 110.764 -178.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 761' ' ' GLN . . . . . 0.483 ' OE1' ' HB3' ' A' ' 768' ' ' TRP . 32.0 tt0 -133.75 136.04 44.33 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.717 -0.674 . . . . 73.329999999999998 110.084 179.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 762' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 769' ' ' PHE . . . -87.43 116.28 25.43 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.94 -0.573 . . . . 74.120000000000005 110.441 -178.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 763' ' ' LYS . . . . . 0.561 ' HB3' ' HB2' ' A' ' 743' ' ' GLU . 58.6 tttm -94.94 100.39 12.25 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.716 -0.674 . . . . 53.109999999999999 109.631 178.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 764' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' A' ' 741' ' ' ALA . 58.3 t -104.75 100.7 11.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.965 -0.562 . . . . 74.049999999999997 109.842 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 69.84 -111.65 3.96 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 110.881 -0.888 . . . . 53.130000000000003 110.881 -174.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -112.13 10.99 26.86 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 111.407 -0.677 . . . . 71.010000000000005 111.407 175.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 767' ' ' ARG . . . . . . . . . . . . . 79.7 mtm180 -107.82 131.51 54.4 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.939 0.4 . . . . 72.549999999999997 110.567 -178.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 768' ' ' TRP . . . . . 0.483 ' HB3' ' OE1' ' A' ' 761' ' ' GLN . 43.1 m95 -108.39 101.25 10.46 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.906 -0.588 . . . . 74.329999999999998 109.991 -177.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 769' ' ' PHE . . . . . 0.446 ' HA ' ' HA ' ' A' ' 770' ' ' PRO . 27.2 p90 -167.86 139.8 2.49 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-O 120.74 0.305 . . . . 73.120000000000005 110.61 -178.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 770' ' ' PRO . . . . . 0.694 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 68.7 Cg_endo -95.13 -170.09 2.71 Favored 'Cis proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.648 -1.397 . . . . 63.32 111.797 -3.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 771' ' ' ALA . . . . . 0.412 ' HB2' HE21 ' A' ' 761' ' ' GLN . . . -122.17 101.49 7.56 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.996 -0.372 . . . . 72.409999999999997 109.996 176.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 27.0 m -110.51 168.04 4.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.135 -0.484 . . . . 54.119999999999997 110.81 -176.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 5.8 p -133.6 113.83 12.85 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.244 0.545 . . . . 71.329999999999998 110.995 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -132.03 149.4 52.43 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.866 -0.606 . . . . 54.420000000000002 109.926 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 775' ' ' HIS . . . . . 0.493 ' HA ' ' O ' ' A' ' 756' ' ' PRO . 1.3 p-80 -83.67 18.29 1.98 Allowed 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.592 -0.443 . . . . 73.230000000000004 111.669 -176.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 32.5 t -148.39 143.26 26.7 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.896 -0.409 . . . . 73.019999999999996 109.896 176.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 777' ' ' LYS . . . . . 0.469 ' HG3' ' OH ' ' A' ' 760' ' ' TYR . 8.4 ttmm -57.97 -49.8 75.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 72.510000000000005 110.752 178.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -58.94 -45.36 90.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.51 -0.768 . . . . 71.349999999999994 110.376 -178.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 779' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -63.58 -41.47 98.36 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-N 116.086 -0.506 . . . . 64.349999999999994 110.626 177.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -55.6 -44.85 86.04 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.028 -0.606 . . . . 51.340000000000003 112.036 178.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -66.24 -43.65 85.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.649 0.261 . . . . 72.040000000000006 111.024 177.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 782' ' ' GLN . . . . . 0.401 HE21 ' HB2' ' A' ' 782' ' ' GLN . 20.6 mt-30 -63.88 -48.13 77.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.393 -0.367 . . . . 53.109999999999999 110.969 -179.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -61.51 -43.52 98.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 64.439999999999998 110.927 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -63.2 -48.93 76.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.038 -0.528 . . . . 64.5 110.845 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 785' ' ' ALA . . . . . 0.608 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -65.1 -42.02 94.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.319 -0.401 . . . . 53.109999999999999 110.983 -178.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 786' ' ' ASP . . . . . 0.41 ' O ' ' HG3' ' A' ' 790' ' ' ARG . 12.7 t70 -57.64 -50.17 74.02 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.052 -0.522 . . . . 74.420000000000002 110.667 178.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 787' ' ' ALA . . . . . 0.523 ' O ' HG23 ' A' ' 791' ' ' VAL . . . -67.4 -38.75 85.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.043 -0.526 . . . . 72.25 110.968 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 788' ' ' ALA . . . . . 0.694 ' HB2' ' HD3' ' A' ' 770' ' ' PRO . . . -61.48 -43.58 98.62 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.326 -0.397 . . . . 53.340000000000003 111.41 -178.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 789' ' ' LEU . . . . . 0.641 HD22 HD12 ' A' ' 719' ' ' LEU . 52.1 mt -59.81 -43.57 94.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.565 -0.289 . . . . 61.439999999999998 110.409 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 790' ' ' ARG . . . . . 0.41 ' HG3' ' O ' ' A' ' 786' ' ' ASP . 67.0 mtt-85 -60.77 -34.34 74.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 75.040000000000006 110.989 178.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 791' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 787' ' ' ALA . 56.8 t -64.9 -49.66 78.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.947 -0.39 . . . . 71.0 109.947 175.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 792' ' ' LEU . . . . . 0.624 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 29.6 mt -60.8 -51.49 69.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.859 -0.609 . . . . 72.25 110.884 -178.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 793' ' ' ILE . . . . . 0.496 HD13 HG22 ' A' ' 720' ' ' VAL . 81.9 mt -58.31 -54.33 34.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.399 -0.819 . . . . 64.400000000000006 111.18 178.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -64.49 -26.57 70.88 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 121.098 -0.572 . . . . 52.399999999999999 112.809 -177.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -66.74 -46.53 75.16 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.925 -0.398 . . . . 52.100000000000001 109.925 177.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 . . . . . 0 CA--C 1.516 -0.327 0 CA-C-N 116.27 -0.423 . . . . 75.439999999999998 110.498 179.738 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 716' ' ' ILE . . . . . 0.5 ' HA ' HD23 ' A' ' 719' ' ' LEU . 47.8 mm . . . . . 0 N--CA 1.452 -0.363 0 CA-C-O 120.951 0.405 . . . . 75.519999999999996 110.913 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -56.95 -25.13 52.65 Favored Glycine 0 N--CA 1.453 -0.232 0 CA-C-N 115.879 -0.601 . . . . 53.200000000000003 111.649 175.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 718' ' ' GLU . . . . . 0.743 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 13.6 mm-40 -62.67 -49.59 74.53 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 115.77 -0.215 . . . . 62.109999999999999 110.692 175.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 719' ' ' LEU . . . . . 0.604 HD12 HD22 ' A' ' 789' ' ' LEU . 2.5 mm? -62.03 -31.67 72.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.016 0.436 . . . . 71.239999999999995 110.436 -176.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 720' ' ' VAL . . . . . 0.456 HG22 HD13 ' A' ' 793' ' ' ILE . 63.4 t -64.58 -39.69 86.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.757 -0.656 . . . . 73.030000000000001 111.088 178.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 721' ' ' ARG . . . . . 0.743 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 11.5 ptt180 -67.38 -26.05 66.26 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.071 0.462 . . . . 70.129999999999995 109.932 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -79.02 -29.53 43.66 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.177 -0.465 . . . . 74.439999999999998 110.913 179.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 723' ' ' LEU . . . . . 0.537 HD21 ' HB2' ' A' ' 789' ' ' LEU . 96.5 mt -57.61 -38.94 75.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.176 0.512 . . . . 70.310000000000002 109.898 174.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -80.36 -42.16 23.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.333 -0.849 . . . . 72.299999999999997 111.151 177.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 22.1 m -82.16 -81.5 0.15 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.91 0.386 . . . . 61.329999999999998 111.591 -177.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 726' ' ' ASN . . . . . 0.434 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 38.4 t30 -148.19 105.88 3.6 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 109.756 -0.461 . . . . 50.32 109.756 -179.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 727' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 14.0 Cg_endo -58.32 -36.43 97.65 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.79 2.326 . . . . 71.209999999999994 112.351 -176.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 728' ' ' VAL . . . . . 0.412 ' O ' ' HG ' ' A' ' 732' ' ' LEU . 40.3 t -61.26 -49.02 86.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.005 -0.543 . . . . 61.539999999999999 110.936 -177.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -64.87 -28.77 73.87 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.901 -0.666 . . . . 51.340000000000003 111.907 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -71.85 -42.53 52.89 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 121.035 -0.603 . . . . 75.219999999999999 112.353 179.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -64.83 -40.43 95.17 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.48 -0.563 . . . . 51.409999999999997 109.48 178.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 732' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 728' ' ' VAL . 95.4 mt -62.78 -44.14 96.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.873 -0.603 . . . . 55.130000000000003 110.691 176.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 733' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -65.81 -42.82 90.18 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 122.929 0.492 . . . . 53.520000000000003 110.721 -178.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 734' ' ' TYR . . . . . 0.537 ' HB2' HD11 ' A' ' 719' ' ' LEU . 20.3 t80 -58.13 -51.64 68.86 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.278 -0.419 . . . . 73.409999999999997 110.356 176.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -63.95 -51.46 64.26 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.176 -0.466 . . . . 61.299999999999997 110.857 -177.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 736' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -60.88 -35.58 76.99 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.087 -0.506 . . . . 75.040000000000006 111.429 -174.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 8.1 t -83.25 -25.39 31.69 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.458 -0.337 . . . . 43.100000000000001 111.196 -177.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -95.29 -1.59 51.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.515 0.198 . . . . 73.319999999999993 111.445 -177.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 98.59 -5.91 60.56 Favored Glycine 0 CA--C 1.516 0.15 0 C-N-CA 120.783 -0.722 . . . . 61.25 112.771 175.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 740' ' ' PHE . . . . . 0.41 ' HD1' ' HA3' ' A' ' 765' ' ' GLY . 95.0 m-85 -81.82 167.4 19.08 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.941 0.401 . . . . 65.129999999999995 110.766 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -119.64 110.9 17.39 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.387 -0.597 . . . . 73.0 109.387 175.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 742' ' ' ALA . . . . . . . . . . . . . . . -85.28 132.14 34.31 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.0 0.428 . . . . 62.32 111.74 -175.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 743' ' ' GLU . . . . . 0.505 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 38.1 mt-10 -135.13 142.75 46.25 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.645 -0.707 . . . . 74.349999999999994 110.879 176.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -119.15 101.81 8.27 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.141 -0.688 . . . . 62.329999999999998 109.141 175.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 745' ' ' LYS . . . . . 0.458 ' HB3' ' HZ3' ' A' ' 745' ' ' LYS . 1.1 ptpm? -124.66 144.2 50.32 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.066 0.46 . . . . 70.219999999999999 111.114 -175.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 746' ' ' LEU . . . . . 0.417 HD13 ' HB3' ' A' ' 758' ' ' PHE . 56.8 tp -77.08 117.91 19.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.502 -0.772 . . . . 64.200000000000003 110.037 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 54.5 t -88.03 -49.63 14.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.202 0.525 . . . . 62.530000000000001 110.108 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 748' ' ' ASP . . . . . 0.448 ' O ' ' HB ' ' A' ' 759' ' ' VAL . 26.5 t70 -148.22 154.82 40.6 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.403 -0.817 . . . . 73.340000000000003 109.331 -178.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.87 112.86 12.26 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.447 0.642 . . . . 55.020000000000003 110.369 173.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 750' ' ' SER . . . . . 0.457 ' O ' ' HB3' ' A' ' 757' ' ' LYS . 11.3 m -101.78 89.53 3.71 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.363 -0.835 . . . . 61.100000000000001 109.438 177.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 751' ' ' GLY . . . . . 0.535 ' HA3' ' HA ' ' A' ' 756' ' ' PRO . . . -152.95 123.5 1.45 Allowed Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 119.48 -1.343 . . . . 61.5 113.855 -174.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 752' ' ' PRO . . . . . 0.458 ' HD2' ' HA2' ' A' ' 751' ' ' GLY . 26.4 Cg_endo -63.51 167.95 12.3 Favored 'Trans proline' 0 CA--C 1.533 0.425 0 C-N-CA 123.002 2.468 . . . . 65.140000000000001 111.105 169.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -56.59 -33.65 93.6 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 122.523 2.148 . . . . 74.209999999999994 112.792 -178.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 39.2 p-80 -88.35 -9.35 53.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.199 -0.455 . . . . 75.239999999999995 111.984 -177.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -152.59 73.69 7.33 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 111.792 0.293 . . . . 71.239999999999995 111.792 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 756' ' ' PRO . . . . . 0.535 ' HA ' ' HA3' ' A' ' 751' ' ' GLY . 42.8 Cg_endo -70.1 103.05 1.16 Allowed 'Trans proline' 0 CA--C 1.528 0.224 0 C-N-CA 122.36 2.04 . . . . 62.420000000000002 112.198 176.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 757' ' ' LYS . . . . . 0.504 ' H ' ' HA3' ' A' ' 751' ' ' GLY . 40.1 ttmt -96.6 133.0 41.65 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.894 -0.41 . . . . 74.099999999999994 109.894 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 758' ' ' PHE . . . . . 0.417 ' HB3' HD13 ' A' ' 746' ' ' LEU . 95.5 m-85 -110.08 126.03 53.58 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.299 -0.41 . . . . 55.509999999999998 111.147 -176.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 759' ' ' VAL . . . . . 0.512 HG22 ' HB3' ' A' ' 773' ' ' CYS . 97.3 t -94.03 104.04 15.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-N 115.78 -0.646 . . . . 71.420000000000002 109.853 177.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -102.6 144.6 30.8 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.606 -0.725 . . . . 64.109999999999999 111.179 -177.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 761' ' ' GLN . . . . . 0.4 ' HA ' ' O ' ' A' ' 770' ' ' PRO . 33.9 tt0 -132.46 131.7 41.98 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.305 -0.861 . . . . 75.299999999999997 109.385 178.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 762' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 769' ' ' PHE . . . -90.17 123.46 34.01 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.3 0.571 . . . . 63.549999999999997 110.646 -177.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 763' ' ' LYS . . . . . 0.564 ' HE2' ' HA2' ' A' ' 766' ' ' GLY . 45.5 tttt -99.29 105.88 17.94 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.044 -0.724 . . . . 72.030000000000001 109.044 177.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 50.7 t -108.33 91.87 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.233 0.539 . . . . 73.430000000000007 110.689 -178.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 765' ' ' GLY . . . . . 0.41 ' HA3' ' HD1' ' A' ' 740' ' ' PHE . . . 77.8 -7.59 41.15 Favored Glycine 0 N--CA 1.454 -0.132 0 CA-C-N 115.627 -0.715 . . . . 63.210000000000001 112.56 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 766' ' ' GLY . . . . . 0.564 ' HA2' ' HE2' ' A' ' 763' ' ' LYS . . . 136.77 -29.62 2.74 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.31 -0.716 . . . . 63.32 111.31 -177.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 767' ' ' ARG . . . . . 0.472 ' HD2' ' CD1' ' A' ' 769' ' ' PHE . 0.7 OUTLIER -72.57 118.75 15.87 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.078 -0.712 . . . . 74.340000000000003 109.078 177.21 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 768' ' ' TRP . . . . . 0.402 ' CZ3' ' HD2' ' A' ' 745' ' ' LYS . 76.4 m95 -88.45 105.48 17.63 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.032 -0.531 . . . . 71.230000000000004 110.267 -178.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 769' ' ' PHE . . . . . 0.472 ' CD1' ' HD2' ' A' ' 767' ' ' ARG . 13.0 p90 -168.43 137.83 1.94 Allowed Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 109.875 -0.417 . . . . 73.540000000000006 109.875 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 770' ' ' PRO . . . . . 0.739 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 58.5 Cg_endo -97.24 -167.75 1.41 Allowed 'Cis proline' 0 N--CA 1.451 -1.012 0 C-N-CA 123.779 -1.342 . . . . 62.350000000000001 112.018 -2.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -119.45 101.19 7.77 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.744 -0.465 . . . . 63.240000000000002 109.744 175.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 34.8 m -117.19 170.77 6.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.504 -0.317 . . . . 61.119999999999997 111.135 -174.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 773' ' ' CYS . . . . . 0.512 ' HB3' HG22 ' A' ' 759' ' ' VAL . 4.7 p -142.48 121.67 13.01 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.137 -0.483 . . . . 60.020000000000003 110.606 178.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -124.9 154.52 40.96 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.202 -0.454 . . . . 53.140000000000001 110.222 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 775' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -79.87 -4.45 52.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.007 0.432 . . . . 62.329999999999998 110.986 -177.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 54.9 m -131.22 144.62 51.46 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.134 -0.485 . . . . 54.299999999999997 109.998 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 777' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -65.33 -42.97 92.39 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.162 -0.472 . . . . 65.420000000000002 111.158 -175.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -65.88 -37.76 86.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.972 0.415 . . . . 73.109999999999999 110.078 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 779' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -66.72 -33.13 74.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.026 -0.533 . . . . 72.209999999999994 110.916 177.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -56.96 -42.99 93.01 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.845 -0.693 . . . . 54.140000000000001 111.714 177.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -64.79 -43.26 93.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.946 0.403 . . . . 61.399999999999999 110.418 176.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -67.24 -46.86 72.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.978 -0.555 . . . . 63.219999999999999 111.181 -178.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -61.51 -40.87 96.17 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 123.163 0.289 . . . . 72.219999999999999 110.894 -179.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -60.97 -52.3 65.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 72.109999999999999 110.431 178.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 785' ' ' ALA . . . . . 0.639 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -63.9 -42.05 97.53 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.091 -0.504 . . . . 71.299999999999997 111.095 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 786' ' ' ASP . . . . . 0.603 ' O ' ' HG2' ' A' ' 790' ' ' ARG . 21.3 t70 -57.09 -56.56 20.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.954 -0.566 . . . . 63.420000000000002 110.871 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 787' ' ' ALA . . . . . 0.574 ' O ' HG23 ' A' ' 791' ' ' VAL . . . -63.92 -33.58 76.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.873 -0.603 . . . . 63.450000000000003 110.972 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 788' ' ' ALA . . . . . 0.739 ' HB2' ' HD3' ' A' ' 770' ' ' PRO . . . -62.67 -41.85 99.3 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.637 0.256 . . . . 62.420000000000002 110.704 177.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 789' ' ' LEU . . . . . 0.639 ' HG ' ' O ' ' A' ' 785' ' ' ALA . 62.9 mt -64.82 -38.81 92.22 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.621 -0.511 . . . . 73.010000000000005 109.621 178.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 790' ' ' ARG . . . . . 0.603 ' HG2' ' O ' ' A' ' 786' ' ' ASP . 13.5 mmm180 -59.41 -39.42 83.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.853 -0.612 . . . . 74.140000000000001 110.254 177.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 791' ' ' VAL . . . . . 0.574 HG23 ' O ' ' A' ' 787' ' ' ALA . 83.4 t -59.84 -52.12 64.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.858 -0.61 . . . . 74.239999999999995 110.51 176.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 792' ' ' LEU . . . . . 0.6 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 25.0 mt -60.94 -49.59 76.83 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.624 -0.716 . . . . 65.400000000000006 110.767 -177.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 793' ' ' ILE . . . . . 0.456 HD13 HG22 ' A' ' 720' ' ' VAL . 85.9 mt -59.72 -41.34 85.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.596 -0.729 . . . . 72.409999999999997 110.965 178.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -65.78 -43.93 93.14 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 116.072 -0.513 . . . . 60.439999999999998 112.735 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -62.62 -44.8 95.39 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.676 0.274 . . . . 72.010000000000005 111.006 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 796' ' ' ASN . . . . . 0.427 ' CG ' HG13 ' A' ' 716' ' ' ILE . 10.8 t30 . . . . . 0 C--N 1.325 -0.492 0 CA-C-N 116.344 -0.389 . . . . 65.510000000000005 110.712 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 716' ' ' ILE . . . . . 0.553 ' HA ' HD23 ' A' ' 719' ' ' LEU . 50.7 mm . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 121.011 0.434 . . . . 60.130000000000003 110.88 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -57.2 -23.19 46.44 Favored Glycine 0 CA--C 1.521 0.412 0 CA-C-N 115.881 -0.599 . . . . 74.319999999999993 112.926 178.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 718' ' ' GLU . . . . . 0.737 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 4.7 mm-40 -73.83 -40.54 63.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.184 0.516 . . . . 73.129999999999995 110.136 178.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 719' ' ' LEU . . . . . 0.563 HD12 HD22 ' A' ' 789' ' ' LEU . 3.0 mm? -65.1 -31.78 73.15 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.282 0.563 . . . . 74.129999999999995 109.496 178.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 720' ' ' VAL . . . . . 0.425 HG22 HD13 ' A' ' 793' ' ' ILE . 89.8 t -64.07 -41.41 92.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.533 -0.758 . . . . 62.140000000000001 110.798 177.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 721' ' ' ARG . . . . . 0.737 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 26.7 ptt180 -63.59 -25.39 68.21 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.064 0.459 . . . . 73.25 110.28 -178.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -79.07 -26.62 43.05 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.392 -0.367 . . . . 74.230000000000004 111.622 178.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 723' ' ' LEU . . . . . 0.482 HD21 ' HB2' ' A' ' 789' ' ' LEU . 87.3 mt -65.08 -23.75 67.25 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.197 -0.668 . . . . 54.409999999999997 109.197 171.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -81.4 -54.66 5.27 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.378 -0.828 . . . . 72.439999999999998 110.538 174.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 15.7 m -89.41 -72.47 0.55 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.571 0.582 . . . . 73.140000000000001 112.571 -174.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 726' ' ' ASN . . . . . 0.436 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 26.6 t30 -145.65 101.53 4.3 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.693 0.282 . . . . 53.32 111.008 -172.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 727' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 17.8 Cg_endo -61.21 -38.59 65.08 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.913 2.409 . . . . 72.329999999999998 112.374 -178.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 728' ' ' VAL . . . . . 0.422 ' O ' ' HG ' ' A' ' 732' ' ' LEU . 41.5 t -60.64 -45.82 96.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.083 -0.508 . . . . 73.25 110.96 -177.036 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -65.52 -39.89 95.85 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.618 -0.801 . . . . 73.140000000000001 112.179 -177.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 730' ' ' GLY . . . . . 0.417 ' HA2' ' HG2' ' A' ' 733' ' ' GLU . . . -67.8 -38.45 89.48 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.908 -0.663 . . . . 51.439999999999998 112.583 -178.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -63.38 -41.05 98.77 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.13 0.49 . . . . 64.510000000000005 109.684 178.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 732' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 728' ' ' VAL . 94.0 mt -65.66 -43.64 88.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.701 -0.681 . . . . 72.319999999999993 111.27 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 733' ' ' GLU . . . . . 0.525 ' HA ' ' HG2' ' A' ' 736' ' ' ARG . 11.4 pt-20 -79.51 -25.26 41.81 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 120.544 -0.462 . . . . 72.209999999999994 111.783 -176.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 734' ' ' TYR . . . . . 0.51 ' HB2' HD11 ' A' ' 719' ' ' LEU . 7.1 t80 -56.63 -46.43 81.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.275 0.56 . . . . 73.420000000000002 109.493 171.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -68.02 -46.8 70.22 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.348 -0.842 . . . . 74.409999999999997 111.047 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 736' ' ' ARG . . . . . 0.525 ' HG2' ' HA ' ' A' ' 733' ' ' GLU . 29.7 ptt180 -60.76 -34.25 74.17 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.097 0.475 . . . . 75.109999999999999 110.706 -176.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 31.5 t -76.7 -38.07 55.02 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.75 -0.659 . . . . 32.420000000000002 110.909 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 16.6 m170 -95.59 0.66 53.15 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.0 0.37 . . . . 73.230000000000004 112.0 -172.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 90.65 4.94 69.52 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.693 -0.765 . . . . 73.549999999999997 113.34 174.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -91.47 173.92 7.64 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.99 0.424 . . . . 72.129999999999995 110.743 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 741' ' ' ALA . . . . . 0.628 ' O ' ' HA ' ' A' ' 764' ' ' VAL . . . -108.45 147.31 31.82 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.29 -0.633 . . . . 74.109999999999999 109.29 173.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 742' ' ' ALA . . . . . . . . . . . . . . . -128.89 110.88 12.49 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.825 0.345 . . . . 73.400000000000006 110.521 -178.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 743' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -136.12 154.41 51.0 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.286 -0.416 . . . . 71.530000000000001 110.922 -177.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -122.67 118.64 28.6 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.307 -0.406 . . . . 74.329999999999998 109.985 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 7.1 ptpt -117.65 148.49 41.91 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.051 0.453 . . . . 72.209999999999994 111.251 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 746' ' ' LEU . . . . . . . . . . . . . 6.9 tt -92.25 102.79 15.29 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.014 -1.106 . . . . 74.140000000000001 108.014 175.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 38.5 t -72.56 -45.74 57.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.101 -0.5 . . . . 71.409999999999997 110.654 -174.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -160.64 164.21 31.97 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.105 -0.702 . . . . 74.109999999999999 109.105 -179.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 749' ' ' GLN . . . . . 0.427 HE21 ' HB2' ' A' ' 749' ' ' GLN . 0.0 OUTLIER -138.69 125.67 21.21 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.11 0.481 . . . . 73.040000000000006 110.725 178.819 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 17.1 m -125.39 101.19 6.84 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.676 -0.693 . . . . 72.040000000000006 109.356 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 751' ' ' GLY . . . . . 0.874 ' HA3' ' HA ' ' A' ' 756' ' ' PRO . . . -174.27 134.62 2.88 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 119.534 -1.317 . . . . 74.120000000000005 113.779 -178.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 752' ' ' PRO . . . . . 0.453 ' HD2' ' HA2' ' A' ' 751' ' ' GLY . 25.6 Cg_endo -62.04 168.9 8.31 Favored 'Trans proline' 0 CA--C 1.529 0.262 0 C-N-CA 123.535 2.824 . . . . 64.340000000000003 111.432 171.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.71 -28.36 87.14 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.368 2.046 . . . . 72.25 112.6 -179.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 38.7 p-80 -87.6 -17.05 32.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.443 -0.344 . . . . 63.219999999999999 111.476 -178.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -153.1 69.43 6.85 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 111.94 0.348 . . . . 53.310000000000002 111.94 -175.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 756' ' ' PRO . . . . . 0.874 ' HA ' ' HA3' ' A' ' 751' ' ' GLY . 71.9 Cg_endo -80.28 108.2 2.14 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.27 1.98 . . . . 61.409999999999997 112.695 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 757' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -91.44 115.09 27.75 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.975 0.417 . . . . 75.310000000000002 110.476 176.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 758' ' ' PHE . . . . . 0.499 ' O ' ' HA ' ' A' ' 773' ' ' CYS . 58.9 m-85 -97.13 130.22 44.42 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.955 -0.566 . . . . 75.219999999999999 110.2 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 759' ' ' VAL . . . . . 0.487 HG22 ' HB3' ' A' ' 773' ' ' CYS . 48.3 t -92.96 105.27 16.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.989 0.424 . . . . 75.450000000000003 110.201 178.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -102.46 143.86 31.64 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.262 -0.881 . . . . 75.150000000000006 110.671 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 761' ' ' GLN . . . . . 0.58 ' HA ' ' O ' ' A' ' 770' ' ' PRO . 36.5 tt0 -135.06 135.09 41.01 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.978 -0.556 . . . . 74.230000000000004 109.978 177.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 762' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 769' ' ' PHE . . . -91.51 126.58 36.65 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.159 0.504 . . . . 72.420000000000002 111.025 -178.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -97.32 107.76 20.34 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.595 -0.73 . . . . 72.329999999999998 109.293 176.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 764' ' ' VAL . . . . . 0.628 ' HA ' ' O ' ' A' ' 741' ' ' ALA . 63.0 t -116.37 103.84 15.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.234 0.54 . . . . 64.439999999999998 110.055 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 70.09 -115.1 5.91 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 110.896 -0.882 . . . . 61.340000000000003 110.896 -174.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -109.57 9.82 32.72 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.77 -0.729 . . . . 52.450000000000003 111.328 175.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 767' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -106.84 143.56 34.75 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.075 0.464 . . . . 64.319999999999993 110.5 -177.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 768' ' ' TRP . . . . . 0.454 ' HB3' ' OE1' ' A' ' 761' ' ' GLN . 68.3 m95 -116.55 102.48 9.51 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.629 -0.714 . . . . 72.030000000000001 109.902 -178.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 769' ' ' PHE . . . . . 0.43 ' HA ' ' HA ' ' A' ' 770' ' ' PRO . 33.1 p90 -168.91 141.83 2.27 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.343 -0.39 . . . . 74.0 110.23 -176.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 770' ' ' PRO . . . . . 0.634 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 62.5 Cg_endo -98.88 -179.7 5.64 Favored 'Cis proline' 0 N--CA 1.45 -1.034 0 C-N-CA 123.564 -1.432 . . . . 55.119999999999997 111.979 -4.12 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 771' ' ' ALA . . . . . 0.439 ' HB2' HE21 ' A' ' 761' ' ' GLN . . . -110.98 112.43 24.24 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.553 -0.536 . . . . 52.020000000000003 109.553 174.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 34.3 m -124.47 149.48 28.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.356 -0.384 . . . . 73.019999999999996 110.937 -177.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 773' ' ' CYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 758' ' ' PHE . 7.7 p -118.02 115.3 24.6 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.938 0.399 . . . . 72.010000000000005 110.453 178.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -123.07 157.51 32.66 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.177 -0.465 . . . . 63.409999999999997 110.619 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 775' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -83.29 11.44 6.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.847 0.356 . . . . 70.299999999999997 111.759 -176.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 776' ' ' SER . . . . . 0.439 ' HB3' ' CG ' ' A' ' 779' ' ' GLN . 8.5 t -153.28 145.62 23.97 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.82 -0.437 . . . . 62.210000000000001 109.82 -178.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 777' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -59.63 -50.36 74.18 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.062 -0.517 . . . . 73.109999999999999 111.303 -177.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -62.4 -36.53 82.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.848 0.356 . . . . 71.200000000000003 110.401 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 779' ' ' GLN . . . . . 0.439 ' CG ' ' HB3' ' A' ' 776' ' ' SER . 16.2 mm100 -64.19 -41.92 96.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 54.439999999999998 110.2 178.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -55.87 -48.44 72.51 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.038 -0.601 . . . . 75.25 112.3 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -65.1 -45.47 85.03 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.852 0.358 . . . . 73.5 111.189 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -66.01 -47.2 75.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.23 -0.441 . . . . 72.239999999999995 111.519 -176.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -62.58 -39.07 92.53 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.684 0.278 . . . . 61.219999999999999 110.494 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -62.58 -46.85 86.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.269 -0.423 . . . . 61.32 110.748 177.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 785' ' ' ALA . . . . . 0.444 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -65.38 -42.55 92.57 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.234 -0.439 . . . . 62.240000000000002 110.953 -179.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 786' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -56.98 -51.17 70.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.337 0.589 . . . . 73.340000000000003 110.404 176.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 787' ' ' ALA . . . . . 0.644 ' O ' HG23 ' A' ' 791' ' ' VAL . . . -64.66 -38.72 91.96 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.333 -0.849 . . . . 72.549999999999997 111.066 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 788' ' ' ALA . . . . . 0.634 ' HB2' ' HD3' ' A' ' 770' ' ' PRO . . . -61.62 -47.0 87.4 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.383 -0.371 . . . . 71.0 111.077 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 789' ' ' LEU . . . . . 0.563 HD22 HD12 ' A' ' 719' ' ' LEU . 79.6 mt -60.97 -43.57 98.58 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.842 -0.429 . . . . 73.450000000000003 109.842 177.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 790' ' ' ARG . . . . . . . . . . . . . 30.7 mtt180 -63.52 -26.43 68.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 72.329999999999998 111.684 178.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 791' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 787' ' ' ALA . 98.2 t -68.68 -50.43 55.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.747 -0.464 . . . . 70.140000000000001 109.747 172.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 792' ' ' LEU . . . . . 0.581 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 27.2 mt -61.44 -49.92 74.88 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.431 -0.804 . . . . 65.209999999999994 110.349 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 793' ' ' ILE . . . . . 0.432 HG12 ' CG2' ' A' ' 716' ' ' ILE . 95.7 mt -59.61 -43.45 91.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.258 -0.883 . . . . 74.439999999999998 110.881 178.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -68.01 -32.47 77.06 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 121.002 -0.618 . . . . 63.409999999999997 112.644 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -69.37 -44.16 72.09 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.169 0.509 . . . . 72.439999999999998 110.404 178.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 796' ' ' ASN . . . . . 0.526 ' HB3' HG13 ' A' ' 716' ' ' ILE . 2.7 t30 . . . . . 0 C--N 1.325 -0.486 0 CA-C-N 115.851 -0.613 . . . . 71.209999999999994 110.376 -175.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 716' ' ' ILE . . . . . 0.495 ' HA ' HD23 ' A' ' 719' ' ' LEU . 46.7 mm . . . . . 0 C--O 1.233 0.185 0 CA-C-O 120.791 0.329 . . . . 62.130000000000003 111.445 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -60.97 -27.89 67.82 Favored Glycine 0 C--N 1.33 0.208 0 C-N-CA 120.98 -0.629 . . . . 62.149999999999999 112.101 -179.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 718' ' ' GLU . . . . . 0.782 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 2.8 mp0 -63.19 -39.49 94.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.894 0.378 . . . . 72.140000000000001 110.593 177.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 719' ' ' LEU . . . . . 0.625 HD12 HD22 ' A' ' 789' ' ' LEU . 3.0 mm? -67.48 -29.78 69.31 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.073 0.463 . . . . 74.140000000000001 110.139 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 720' ' ' VAL . . . . . 0.517 HG22 HD13 ' A' ' 793' ' ' ILE . 56.6 t -66.65 -41.61 88.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.819 -0.628 . . . . 62.409999999999997 110.737 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 721' ' ' ARG . . . . . 0.782 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 11.8 ptm180 -65.11 -28.47 69.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.016 0.436 . . . . 70.340000000000003 109.907 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -74.19 -30.17 62.09 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.34 -0.391 . . . . 52.140000000000001 110.853 177.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 723' ' ' LEU . . . . . 0.575 HD21 ' HB2' ' A' ' 789' ' ' LEU . 90.9 mt -60.74 -27.55 68.01 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.252 0.549 . . . . 72.25 109.893 173.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 724' ' ' ASN . . . . . 0.507 ' N ' HD22 ' A' ' 724' ' ' ASN . 0.8 OUTLIER -86.45 -44.65 11.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.476 -0.784 . . . . 74.299999999999997 110.817 176.765 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 51.0 m -89.57 -76.64 0.41 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.296 -0.411 . . . . 74.0 112.043 -175.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 726' ' ' ASN . . . . . 0.442 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 53.8 t-20 -144.82 105.77 4.55 Favored Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 109.997 -0.371 . . . . 53.409999999999997 109.997 -177.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 727' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 20.0 Cg_endo -61.3 -35.97 81.73 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.881 2.387 . . . . 73.310000000000002 112.246 -179.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 728' ' ' VAL . . . . . 0.445 ' O ' ' HG ' ' A' ' 732' ' ' LEU . 59.7 t -64.31 -45.53 95.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.019 -0.537 . . . . 74.450000000000003 110.459 -178.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -61.63 -34.48 88.67 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.945 -0.645 . . . . 62.539999999999999 112.355 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -74.79 -41.32 34.44 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.796 -0.716 . . . . 54.340000000000003 112.56 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -63.12 -40.33 97.3 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.863 -0.421 . . . . 75.140000000000001 109.863 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 732' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 728' ' ' VAL . 95.5 mt -64.19 -46.28 84.62 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.027 -0.533 . . . . 74.25 111.281 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 733' ' ' GLU . . . . . 0.5 ' HA ' ' HG2' ' A' ' 736' ' ' ARG . 6.3 pt-20 -73.97 -31.47 63.02 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.41 -0.516 . . . . 72.340000000000003 110.981 -177.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 734' ' ' TYR . . . . . 0.402 ' HB2' HD11 ' A' ' 719' ' ' LEU . 9.3 t80 -57.29 -48.6 78.5 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 120.895 0.378 . . . . 71.310000000000002 110.063 175.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 735' ' ' ALA . . . . . 0.43 ' HA ' ' HB2' ' A' ' 740' ' ' PHE . . . -65.04 -51.18 63.0 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.985 -0.552 . . . . 64.329999999999998 110.643 -177.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 736' ' ' ARG . . . . . 0.5 ' HG2' ' HA ' ' A' ' 733' ' ' GLU . 12.2 ptm180 -61.7 -34.99 76.73 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.807 -0.633 . . . . 71.420000000000002 111.515 -174.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 47.0 t -77.56 -37.14 51.31 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.038 -0.528 . . . . 74.150000000000006 111.096 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -91.51 -2.53 57.16 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.119 0.414 . . . . 72.129999999999995 112.119 -171.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 94.81 7.93 59.66 Favored Glycine 0 CA--C 1.516 0.143 0 C-N-CA 120.45 -0.881 . . . . 54.340000000000003 112.719 176.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 740' ' ' PHE . . . . . 0.43 ' HB2' ' HA ' ' A' ' 735' ' ' ALA . 98.3 m-85 -93.15 177.81 5.94 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.032 0.444 . . . . 54.119999999999997 110.538 177.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -129.69 124.6 33.98 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.882 -0.599 . . . . 62.200000000000003 109.526 175.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 742' ' ' ALA . . . . . . . . . . . . . . . -94.05 115.7 28.05 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.774 0.321 . . . . 54.219999999999999 111.148 -176.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 743' ' ' GLU . . . . . 0.573 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 40.8 mt-10 -127.48 125.36 40.34 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.016 -0.538 . . . . 74.030000000000001 111.051 -179.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -105.25 117.27 33.59 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.115 -0.493 . . . . 75.329999999999998 110.414 179.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -134.2 150.42 51.07 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.184 0.516 . . . . 62.240000000000002 111.342 178.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 746' ' ' LEU . . . . . 0.462 HD21 ' HB3' ' A' ' 749' ' ' GLN . 4.9 tt -85.96 111.52 20.33 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.065 -1.087 . . . . 72.340000000000003 108.065 173.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 58.7 t -82.96 -46.25 18.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.895 0.379 . . . . 70.140000000000001 111.143 -174.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -152.03 149.69 29.14 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.407 -0.361 . . . . 61.229999999999997 110.374 -178.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 749' ' ' GLN . . . . . 0.462 ' HB3' HD21 ' A' ' 746' ' ' LEU . 0.0 OUTLIER -144.68 153.09 41.37 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.787 0.327 . . . . 65.340000000000003 110.946 179.515 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 20.9 t -174.75 -169.81 0.44 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.818 -0.808 . . . . 71.230000000000004 108.818 -178.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 107.83 175.18 22.25 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.524 -0.846 . . . . 43.310000000000002 112.733 176.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 752' ' ' PRO . . . . . 0.839 ' HG2' ' HB2' ' A' ' 755' ' ' GLU . 44.9 Cg_endo -69.32 164.35 34.45 Favored 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 123.084 2.523 . . . . 72.25 112.721 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -64.43 -33.65 56.94 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.62 2.213 . . . . 61.219999999999999 112.685 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 42.3 p-80 -82.95 -15.55 50.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.307 -0.406 . . . . 73.329999999999998 111.102 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 755' ' ' GLU . . . . . 0.839 ' HB2' ' HG2' ' A' ' 752' ' ' PRO . 45.0 mt-10 -135.27 73.75 63.28 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.401 -0.363 . . . . 75.219999999999999 110.798 177.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 756' ' ' PRO . . . . . 0.543 ' O ' ' HA ' ' A' ' 775' ' ' HIS . 42.1 Cg_endo -69.15 114.69 3.69 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.09 1.86 . . . . 65.340000000000003 111.329 178.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 757' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -100.43 117.42 34.57 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.032 0.444 . . . . 71.329999999999998 110.727 -176.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 758' ' ' PHE . . . . . 0.445 ' CZ ' ' HB2' ' A' ' 756' ' ' PRO . 53.5 m-85 -115.12 121.23 42.39 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.602 -0.726 . . . . 72.450000000000003 109.872 -179.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 26.3 t -90.58 106.41 17.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 120.996 0.427 . . . . 70.200000000000003 110.313 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -99.26 139.26 35.16 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.688 -0.687 . . . . 71.549999999999997 110.285 178.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 761' ' ' GLN . . . . . 0.479 ' HA ' ' O ' ' A' ' 770' ' ' PRO . 55.9 tt0 -130.07 135.73 48.56 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.033 -0.53 . . . . 75.420000000000002 109.725 178.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 762' ' ' ALA . . . . . . . . . . . . . . . -90.56 112.42 24.1 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.967 -0.56 . . . . 72.329999999999998 110.71 -178.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 763' ' ' LYS . . . . . 0.573 ' HB3' ' HB2' ' A' ' 743' ' ' GLU . 61.0 tttm -88.32 104.66 16.95 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.065 -0.717 . . . . 70.439999999999998 109.065 175.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 56.9 t -109.9 100.72 11.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.349 0.595 . . . . 73.310000000000002 109.975 -179.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 75.19 -117.9 5.43 Favored Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 110.834 -0.906 . . . . 53.43 110.834 -175.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -103.36 3.97 47.48 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.662 -0.78 . . . . 63.219999999999999 111.627 176.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 767' ' ' ARG . . . . . . . . . . . . . 50.3 mtt180 -103.58 152.86 21.24 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.052 0.454 . . . . 72.219999999999999 111.029 -176.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 768' ' ' TRP . . . . . 0.567 ' CH2' ' HD2' ' A' ' 763' ' ' LYS . 59.2 m95 -118.83 105.15 11.23 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.687 -0.688 . . . . 72.310000000000002 109.386 176.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 769' ' ' PHE . . . . . 0.434 ' HA ' ' HA ' ' A' ' 770' ' ' PRO . 21.4 p90 -171.47 139.09 1.14 Allowed Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 120.854 0.359 . . . . 72.349999999999994 110.925 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 770' ' ' PRO . . . . . 0.607 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 79.6 Cg_endo -99.54 -176.8 3.79 Favored 'Cis proline' 0 N--CA 1.453 -0.908 0 C-N-CA 123.718 -1.367 . . . . 63.119999999999997 111.947 -4.134 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -113.88 116.18 28.87 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.771 -0.455 . . . . 34.009999999999998 109.771 175.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 29.1 m -118.94 140.74 41.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.145 0.498 . . . . 72.450000000000003 111.269 -176.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 3.9 p -95.72 102.54 14.35 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.89 -0.596 . . . . 71.150000000000006 110.508 178.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -107.15 177.63 4.79 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.147 -0.479 . . . . 73.310000000000002 110.817 -177.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 775' ' ' HIS . . . . . 0.543 ' HA ' ' O ' ' A' ' 756' ' ' PRO . 28.5 m-70 -117.38 12.45 14.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.127 0.489 . . . . 65.530000000000001 110.066 178.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 33.7 t -167.76 154.06 7.72 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.533 -0.758 . . . . 65.340000000000003 109.692 -176.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 777' ' ' LYS . . . . . . . . . . . . . 5.4 tmmm? -62.53 -42.66 99.67 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.649 -0.5 . . . . 72.230000000000004 109.649 177.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -58.31 -40.46 82.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.417 -0.811 . . . . 65.420000000000002 110.723 178.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 779' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -70.06 -45.55 66.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.318 -0.401 . . . . 62.039999999999999 110.438 177.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -54.55 -47.59 69.31 Favored Glycine 0 C--O 1.226 -0.398 0 CA-C-N 115.909 -0.587 . . . . 61.310000000000002 113.072 -176.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -66.79 -44.79 80.39 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.621 0.248 . . . . 72.439999999999998 111.258 -178.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -67.63 -49.39 63.17 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.541 -0.3 . . . . 75.430000000000007 111.358 -177.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -63.68 -39.89 95.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.572 0.225 . . . . 65.129999999999995 110.938 -178.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -62.05 -50.78 70.62 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 116.486 -0.325 . . . . 64.439999999999998 110.527 178.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 785' ' ' ALA . . . . . 0.555 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -65.75 -39.11 90.74 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.324 -0.398 . . . . 62.240000000000002 110.968 -179.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 786' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -57.75 -54.17 49.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.031 -0.531 . . . . 71.200000000000003 110.476 177.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 787' ' ' ALA . . . . . 0.606 ' O ' HG23 ' A' ' 791' ' ' VAL . . . -64.82 -36.69 85.13 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.855 -0.611 . . . . 25.43 110.723 179.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 788' ' ' ALA . . . . . 0.634 ' O ' ' HG ' ' A' ' 792' ' ' LEU . . . -59.49 -48.61 80.98 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.556 -0.293 . . . . 75.430000000000007 110.98 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 789' ' ' LEU . . . . . 0.625 HD22 HD12 ' A' ' 719' ' ' LEU . 63.1 mt -61.49 -39.97 92.85 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.837 -0.431 . . . . 63.210000000000001 109.837 178.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 790' ' ' ARG . . . . . . . . . . . . . 65.4 mtp180 -64.31 -30.91 71.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.607 -0.724 . . . . 75.310000000000002 111.488 178.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 791' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 787' ' ' ALA . 91.5 t -66.94 -48.26 80.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.758 -0.46 . . . . 75.310000000000002 109.758 173.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 792' ' ' LEU . . . . . 0.634 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 23.0 mt -60.58 -54.57 43.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.724 -0.671 . . . . 64.120000000000005 110.436 -179.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 793' ' ' ILE . . . . . 0.517 HD13 HG22 ' A' ' 720' ' ' VAL . 76.6 mt -58.15 -45.73 88.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.382 -0.826 . . . . 75.439999999999998 110.594 177.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -59.5 -48.4 86.18 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 121.121 -0.561 . . . . 75.120000000000005 112.276 179.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -60.88 -31.3 70.78 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.568 0.211 . . . . 70.439999999999998 111.568 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 . . . . . 0 C--N 1.324 -0.535 0 CA-C-O 121.192 0.52 . . . . 72.430000000000007 110.518 176.439 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 716' ' ' ILE . . . . . 0.559 ' HA ' HD23 ' A' ' 719' ' ' LEU . 47.0 mm . . . . . 0 C--O 1.234 0.288 0 CA-C-O 120.89 0.376 . . . . 74.099999999999994 111.626 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -56.92 -30.63 60.36 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 121.196 -0.526 . . . . 65.310000000000002 112.893 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -66.32 -41.04 90.23 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.762 0.315 . . . . 73.299999999999997 110.79 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 719' ' ' LEU . . . . . 0.602 HD12 HD22 ' A' ' 789' ' ' LEU . 2.9 mm? -65.02 -36.3 83.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.016 0.436 . . . . 65.430000000000007 109.998 -178.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 720' ' ' VAL . . . . . 0.507 HG22 HD13 ' A' ' 793' ' ' ILE . 52.3 t -64.08 -37.5 80.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-N 115.82 -0.627 . . . . 53.539999999999999 110.173 176.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 721' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.12 -30.32 71.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.794 -0.639 . . . . 55.219999999999999 109.775 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -78.47 -25.04 45.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.898 -0.592 . . . . 74.420000000000002 111.471 179.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 91.1 mt -60.03 -30.6 69.28 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.425 0.631 . . . . 71.25 109.461 173.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -84.87 -56.59 3.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.312 -0.858 . . . . 73.540000000000006 111.219 174.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 24.4 m -77.91 -64.23 1.2 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.916 0.709 . . . . 62.32 112.916 -171.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 726' ' ' ASN . . . . . 0.42 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 30.6 t30 -159.94 100.76 1.45 Allowed Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 120.834 0.349 . . . . 73.129999999999995 110.914 -175.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 727' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 20.9 Cg_endo -62.36 -39.61 45.58 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.875 2.384 . . . . 71.010000000000005 112.317 -177.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 39.5 t -59.97 -42.3 89.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.998 -0.546 . . . . 70.530000000000001 110.958 -177.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 729' ' ' GLY . . . . . 0.473 ' O ' ' HG2' ' A' ' 733' ' ' GLU . . . -65.02 -47.38 82.99 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.611 -0.804 . . . . 72.329999999999998 111.939 -179.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -64.14 -39.31 97.02 Favored Glycine 0 C--O 1.226 -0.349 0 C-N-CA 121.09 -0.576 . . . . 72.129999999999995 113.259 -176.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -61.67 -39.76 92.56 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.894 -0.41 . . . . 53.119999999999997 109.894 179.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 732' ' ' LEU . . . . . . . . . . . . . 96.3 mt -68.04 -47.34 68.64 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.929 -0.578 . . . . 65.0 111.276 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 733' ' ' GLU . . . . . 0.502 ' HA ' ' HB3' ' A' ' 736' ' ' ARG . 9.1 pt-20 -75.15 -26.47 59.14 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.715 -0.394 . . . . 74.230000000000004 111.683 -176.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 734' ' ' TYR . . . . . 0.426 ' HB2' HD11 ' A' ' 719' ' ' LEU . 17.5 t80 -56.99 -50.17 73.52 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.347 -0.612 . . . . 74.230000000000004 109.347 172.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -64.29 -46.29 84.29 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.903 -0.589 . . . . 72.109999999999999 110.533 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 736' ' ' ARG . . . . . 0.502 ' HB3' ' HA ' ' A' ' 733' ' ' GLU . 1.4 ttt180 -55.49 -48.73 74.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.07 -0.514 . . . . 73.219999999999999 112.011 -178.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 22.7 t -81.59 -11.82 58.99 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.678 0.275 . . . . 64.519999999999996 111.224 -174.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -110.49 -2.61 16.44 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.817 -0.353 . . . . 71.230000000000004 111.592 -176.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 88.9 9.96 67.37 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.538 -0.839 . . . . 74.319999999999993 113.258 174.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -95.61 168.72 10.51 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.906 0.353 . . . . 64.340000000000003 110.4 177.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -114.1 114.48 26.14 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.219 -0.446 . . . . 60.119999999999997 110.025 176.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 742' ' ' ALA . . . . . . . . . . . . . . . -92.48 133.22 36.13 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.262 -0.427 . . . . 64.420000000000002 110.886 -178.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 743' ' ' GLU . . . . . 0.455 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 9.7 mm-40 -144.98 157.65 44.06 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.271 -0.422 . . . . 73.400000000000006 111.142 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -130.16 132.03 45.89 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.815 -0.63 . . . . 72.430000000000007 109.76 177.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -136.37 137.92 41.06 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.126 0.489 . . . . 65.019999999999996 111.748 177.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 746' ' ' LEU . . . . . . . . . . . . . 5.0 tt -82.69 105.33 13.63 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.385 -0.969 . . . . 75.150000000000006 108.385 173.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 46.0 t -70.98 -56.13 11.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.919 0.39 . . . . 53.399999999999999 110.686 -176.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -154.94 152.37 29.64 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.977 -0.556 . . . . 73.109999999999999 110.276 -178.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -134.06 122.75 23.4 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.951 -0.759 . . . . 74.549999999999997 108.951 174.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 67.3 m -146.56 148.28 31.99 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.722 0.296 . . . . 62.520000000000003 110.942 -176.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 139.77 -177.65 20.34 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.93 -0.652 . . . . 74.040000000000006 112.163 177.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 752' ' ' PRO . . . . . 0.433 ' HG2' ' CB ' ' A' ' 755' ' ' GLU . 54.9 Cg_endo -71.47 166.76 28.34 Favored 'Trans proline' 0 CA--C 1.533 0.442 0 C-N-CA 122.793 2.329 . . . . 73.340000000000003 111.962 176.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -63.76 -34.99 59.76 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.684 2.256 . . . . 55.140000000000001 112.824 -178.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 54.7 p-80 -84.51 -7.26 59.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.958 0.408 . . . . 70.109999999999999 111.069 -178.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 755' ' ' GLU . . . . . 0.433 ' CB ' ' HG2' ' A' ' 752' ' ' PRO . 0.4 OUTLIER -141.95 68.95 23.76 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 116.132 -0.485 . . . . 73.510000000000005 109.972 -178.694 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 756' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -79.64 109.26 2.42 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.405 2.07 . . . . 71.540000000000006 111.936 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 757' ' ' LYS . . . . . 0.435 ' NZ ' ' HB2' ' A' ' 757' ' ' LYS . 4.4 ttmp? -93.73 112.99 24.95 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.237 0.541 . . . . 73.329999999999998 110.58 -178.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 758' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -99.05 119.29 37.57 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.363 -0.835 . . . . 75.319999999999993 110.454 -178.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 16.7 t -92.67 105.85 17.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.19 -0.459 . . . . 74.299999999999997 109.904 178.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 760' ' ' TYR . . . . . 0.41 ' HE1' ' HG2' ' A' ' 777' ' ' LYS . 1.5 m-85 -108.92 141.9 40.32 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.984 -0.553 . . . . 72.530000000000001 110.735 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 761' ' ' GLN . . . . . 0.542 ' HA ' ' O ' ' A' ' 770' ' ' PRO . 35.4 tt0 -133.96 135.96 43.85 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.751 -0.658 . . . . 73.439999999999998 109.613 176.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 762' ' ' ALA . . . . . . . . . . . . . . . -96.86 147.69 23.69 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.799 -0.637 . . . . 73.540000000000006 110.443 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 763' ' ' LYS . . . . . 0.557 ' HE3' ' CZ2' ' A' ' 768' ' ' TRP . 68.1 tttt -118.46 127.86 54.06 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.295 -0.631 . . . . 73.319999999999993 109.295 178.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 62.9 t -127.64 102.0 8.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.146 0.498 . . . . 60.140000000000001 109.869 178.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 76.41 -101.99 1.56 Allowed Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 110.96 -0.856 . . . . 72.140000000000001 110.96 -176.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -121.0 4.81 11.37 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 111.219 -0.752 . . . . 71.540000000000006 111.219 174.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 767' ' ' ARG . . . . . . . . . . . . . 39.7 mmt180 -98.5 146.29 25.92 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.974 0.416 . . . . 72.239999999999995 110.903 -178.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 768' ' ' TRP . . . . . 0.557 ' CZ2' ' HE3' ' A' ' 763' ' ' LYS . 55.6 m95 -117.28 107.41 14.37 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.617 -0.719 . . . . 74.540000000000006 109.777 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 769' ' ' PHE . . . . . 0.469 ' HA ' ' HA ' ' A' ' 770' ' ' PRO . 47.2 p90 -169.87 143.23 2.08 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 110.198 -0.297 . . . . 74.129999999999995 110.198 -177.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 770' ' ' PRO . . . . . 0.592 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 62.1 Cg_endo -99.07 178.53 6.38 Favored 'Cis proline' 0 N--CA 1.452 -0.933 0 C-N-CA 123.633 -1.403 . . . . 64.0 111.875 -4.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 771' ' ' ALA . . . . . 0.452 ' HB2' HE21 ' A' ' 761' ' ' GLN . . . -105.13 102.24 11.75 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.626 -0.509 . . . . 51.149999999999999 109.626 173.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 24.0 m -116.92 135.44 57.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.077 0.465 . . . . 72.549999999999997 111.176 -176.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 773' ' ' CYS . . . . . 0.408 ' HB2' ' CG ' ' A' ' 757' ' ' LYS . 1.5 p -110.22 102.71 11.36 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.0 -0.545 . . . . 74.340000000000003 110.174 177.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -100.29 178.97 4.61 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.726 -0.67 . . . . 75.200000000000003 111.175 -175.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 775' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -94.44 -8.82 37.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.052 0.453 . . . . 70.310000000000002 110.516 -176.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 55.2 m -145.91 158.02 43.88 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.693 -0.685 . . . . 75.230000000000004 109.765 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 777' ' ' LYS . . . . . 0.41 ' HG2' ' HE1' ' A' ' 760' ' ' TYR . 6.1 tmmm? -69.3 -39.71 78.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.589 -0.278 . . . . 62.43 110.539 -177.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 778' ' ' LYS . . . . . 0.414 ' HE3' ' OE1' ' A' ' 782' ' ' GLN . 58.1 tptt -60.89 -47.41 86.52 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.861 -0.422 . . . . 54.530000000000001 109.861 175.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 779' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -52.92 -47.98 67.59 Favored 'General case' 0 C--O 1.226 -0.137 0 CA-C-N 115.709 -0.678 . . . . 64.420000000000002 110.966 174.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -53.83 -47.97 63.58 Favored Glycine 0 C--O 1.228 -0.24 0 CA-C-N 116.028 -0.533 . . . . 64.030000000000001 113.035 -177.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -66.42 -45.18 80.78 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.857 0.361 . . . . 73.209999999999994 110.982 -178.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 782' ' ' GLN . . . . . 0.414 ' OE1' ' HE3' ' A' ' 778' ' ' LYS . 25.5 mt-30 -71.59 -37.0 71.05 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.233 -0.439 . . . . 73.140000000000001 111.399 -176.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -72.08 -35.68 69.31 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.524 0.202 . . . . 61.399999999999999 110.742 177.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -60.06 -49.53 77.27 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.949 -0.389 . . . . 64.519999999999996 109.949 176.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 785' ' ' ALA . . . . . 0.622 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -65.78 -42.16 91.1 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.073 -0.512 . . . . 44.399999999999999 110.793 178.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 786' ' ' ASP . . . . . 0.52 ' O ' ' HG2' ' A' ' 790' ' ' ARG . 12.4 t70 -56.71 -55.83 29.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.022 -0.535 . . . . 74.430000000000007 110.755 179.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 787' ' ' ALA . . . . . 0.544 ' O ' HG23 ' A' ' 791' ' ' VAL . . . -68.22 -31.07 70.32 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.952 -0.567 . . . . 71.439999999999998 111.212 -178.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 788' ' ' ALA . . . . . 0.683 ' O ' ' HG ' ' A' ' 792' ' ' LEU . . . -62.63 -42.83 99.81 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 120.812 0.339 . . . . 73.219999999999999 110.168 177.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 789' ' ' LEU . . . . . 0.622 ' HG ' ' O ' ' A' ' 785' ' ' ALA . 79.8 mt -61.82 -40.16 94.3 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.08 -0.509 . . . . 73.239999999999995 109.749 176.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 790' ' ' ARG . . . . . 0.52 ' HG2' ' O ' ' A' ' 786' ' ' ASP . 47.2 mmm-85 -59.79 -38.05 80.82 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.98 -0.554 . . . . 75.209999999999994 110.471 177.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 791' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 787' ' ' ALA . 48.7 t -62.46 -53.18 50.66 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.31 0 N-CA-C 109.881 -0.414 . . . . 53.32 109.881 175.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 792' ' ' LEU . . . . . 0.683 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 22.1 mt -55.32 -48.01 74.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.263 0.554 . . . . 73.109999999999999 110.681 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 793' ' ' ILE . . . . . 0.517 HG12 HG23 ' A' ' 716' ' ' ILE . 90.6 mt -61.76 -48.59 87.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.1 -0.955 . . . . 72.439999999999998 111.079 177.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -66.28 -34.88 89.35 Favored Glycine 0 CA--C 1.519 0.299 0 CA-C-N 116.145 -0.479 . . . . 61.119999999999997 113.122 -178.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 795' ' ' GLU . . . . . 0.518 ' HG2' ' O ' ' A' ' 791' ' ' VAL . 44.7 mm-40 -66.64 -32.24 73.44 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.81 0.338 . . . . 74.409999999999997 110.782 178.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 . . . . . 0 C--N 1.327 -0.404 0 CA-C-O 120.998 0.427 . . . . 65.409999999999997 109.977 177.974 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 716' ' ' ILE . . . . . 0.576 ' HA ' HD23 ' A' ' 719' ' ' LEU . 42.1 mm . . . . . 0 C--O 1.235 0.337 0 CA-C-O 121.306 0.574 . . . . 72.230000000000004 110.715 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -58.27 -23.13 52.42 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.873 -0.603 . . . . 73.450000000000003 112.311 176.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 718' ' ' GLU . . . . . 0.599 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 44.1 mt-10 -68.25 -36.67 79.8 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 122.747 -0.267 . . . . 74.129999999999995 110.287 176.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 719' ' ' LEU . . . . . 0.641 HD12 HD22 ' A' ' 789' ' ' LEU . 3.4 mm? -61.02 -33.88 73.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.235 0.541 . . . . 72.129999999999995 110.009 175.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 720' ' ' VAL . . . . . 0.576 HG22 HD13 ' A' ' 793' ' ' ILE . 27.4 t -62.86 -36.3 74.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.624 -0.717 . . . . 74.349999999999994 110.949 177.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 721' ' ' ARG . . . . . 0.599 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 10.5 ptt180 -68.75 -28.62 66.97 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.892 0.377 . . . . 71.239999999999995 110.178 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -73.02 -32.05 64.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 72.239999999999995 110.629 177.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 723' ' ' LEU . . . . . 0.576 HD21 ' HB2' ' A' ' 789' ' ' LEU . 89.9 mt -57.81 -36.65 72.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.292 0.567 . . . . 74.200000000000003 109.939 173.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -69.49 -40.34 77.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.179 -0.919 . . . . 31.129999999999999 111.501 178.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 46.1 m -103.26 -80.87 0.51 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.055 0.391 . . . . 65.230000000000004 112.055 -176.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 726' ' ' ASN . . . . . 0.467 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 28.0 t30 -135.06 106.82 10.38 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-O 121.032 0.444 . . . . 70.109999999999999 110.8 -174.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 727' ' ' PRO . . . . . 0.467 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 20.4 Cg_endo -62.2 -36.33 69.52 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 122.894 2.396 . . . . 44.43 112.579 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 34.4 t -61.47 -47.09 95.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.254 -0.43 . . . . 74.150000000000006 110.538 -177.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -61.09 -36.55 92.5 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.923 -0.656 . . . . 73.150000000000006 112.041 178.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 730' ' ' GLY . . . . . 0.473 ' O ' ' HG3' ' A' ' 733' ' ' GLU . . . -68.32 -45.3 70.44 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 121.106 -0.569 . . . . 75.040000000000006 112.532 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -64.46 -41.23 96.63 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.973 0.416 . . . . 72.140000000000001 110.06 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 732' ' ' LEU . . . . . . . . . . . . . 94.9 mt -67.24 -32.85 74.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.158 -0.474 . . . . 74.230000000000004 111.495 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 733' ' ' GLU . . . . . 0.473 ' HG3' ' O ' ' A' ' 730' ' ' GLY . 1.1 pp20? -85.17 -33.52 22.29 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.557 -0.457 . . . . 75.25 110.495 -178.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 734' ' ' TYR . . . . . 0.537 ' HB2' HD11 ' A' ' 719' ' ' LEU . 4.0 t80 -55.06 -45.18 75.27 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.837 0.351 . . . . 75.409999999999997 110.463 174.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -65.38 -52.92 50.27 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.112 -0.494 . . . . 62.039999999999999 110.299 -176.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 736' ' ' ARG . . . . . 0.437 ' HG2' ' O ' ' A' ' 733' ' ' GLU . 36.5 ptt180 -60.48 -37.84 82.34 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.971 -0.559 . . . . 60.229999999999997 110.94 -176.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 28.5 t -70.37 -32.26 69.85 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.875 -0.602 . . . . 75.219999999999999 111.452 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -97.19 -8.78 29.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.717 0.294 . . . . 74.439999999999998 111.689 -175.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 98.25 9.21 54.06 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.63 -0.795 . . . . 52.130000000000003 112.959 176.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -96.51 170.4 9.24 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.178 -0.304 . . . . 72.319999999999993 110.178 177.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -117.37 129.22 55.73 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.602 -0.518 . . . . 43.240000000000002 109.602 172.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 742' ' ' ALA . . . . . . . . . . . . . . . -100.87 120.97 40.92 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.913 0.387 . . . . 71.340000000000003 111.352 -175.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 743' ' ' GLU . . . . . 0.566 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 38.7 mt-10 -122.44 135.24 54.64 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.199 -0.455 . . . . 73.129999999999995 110.964 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -114.32 97.96 6.64 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.269 -0.641 . . . . 75.219999999999999 109.269 175.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -113.8 140.8 48.0 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.345 -0.542 . . . . 74.209999999999994 111.198 -177.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 746' ' ' LEU . . . . . . . . . . . . . 59.8 tp -74.72 116.05 14.99 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.643 -0.708 . . . . 74.340000000000003 109.332 174.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 60.2 t -75.35 -49.78 26.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.691 -0.485 . . . . 61.310000000000002 109.691 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -167.05 -175.42 3.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.833 -0.621 . . . . 73.519999999999996 109.667 178.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -138.72 128.8 25.4 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.382 -0.599 . . . . 74.0 109.382 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 750' ' ' SER . . . . . 0.418 ' O ' ' HB3' ' A' ' 757' ' ' LYS . 6.4 t -137.65 90.88 2.54 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.868 -0.419 . . . . 74.319999999999993 109.868 -177.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 179.54 154.33 13.09 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.353 -0.927 . . . . 63.439999999999998 112.477 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 752' ' ' PRO . . . . . 0.628 ' HG2' ' HB2' ' A' ' 755' ' ' GLU . 37.6 Cg_endo -66.59 168.38 16.7 Favored 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 123.309 2.673 . . . . 71.230000000000004 112.238 177.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -56.48 -33.13 91.68 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.751 2.301 . . . . 55.140000000000001 112.759 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 45.9 p-80 -87.83 -4.19 58.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.383 -0.371 . . . . 63.5 111.359 -178.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 755' ' ' GLU . . . . . 0.628 ' HB2' ' HG2' ' A' ' 752' ' ' PRO . 16.6 mm-40 -152.93 61.97 4.04 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.354 -0.385 . . . . 71.420000000000002 111.306 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 756' ' ' PRO . . . . . 0.428 ' O ' ' HA ' ' A' ' 775' ' ' HIS . 59.6 Cg_endo -73.2 99.3 1.09 Allowed 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.175 1.917 . . . . 70.25 111.583 -177.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 757' ' ' LYS . . . . . 0.437 ' HD3' ' HB2' ' A' ' 773' ' ' CYS . 38.3 ttmt -87.05 107.76 18.57 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.247 0.546 . . . . 50.109999999999999 110.384 -177.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 758' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -86.93 130.61 34.39 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.274 -0.876 . . . . 74.239999999999995 110.151 -179.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 43.4 t -95.45 104.34 15.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.841 -0.429 . . . . 75.349999999999994 109.841 177.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -105.98 138.89 41.4 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.048 -0.524 . . . . 70.319999999999993 110.644 -179.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 761' ' ' GLN . . . . . 0.431 ' HA ' ' O ' ' A' ' 770' ' ' PRO . 52.4 tt0 -128.65 128.87 45.0 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.557 -0.534 . . . . 65.129999999999995 109.557 177.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 762' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' A' ' 769' ' ' PHE . . . -87.09 122.11 30.46 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.184 0.516 . . . . 51.340000000000003 110.407 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 763' ' ' LYS . . . . . 0.646 ' HD2' ' CH2' ' A' ' 768' ' ' TRP . 55.1 tttm -104.32 115.26 30.07 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.916 -0.584 . . . . 70.319999999999993 110.041 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 764' ' ' VAL . . . . . 0.422 HG11 ' HE2' ' A' ' 734' ' ' TYR . 59.0 t -118.7 100.72 10.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.058 0.456 . . . . 62.409999999999997 110.114 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 74.54 -102.89 1.44 Allowed Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.681 -0.69 . . . . 51.420000000000002 111.408 -176.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -120.45 10.88 10.56 Favored Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 111.162 -0.775 . . . . 71.420000000000002 111.162 174.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 767' ' ' ARG . . . . . 0.483 ' HG3' ' CD1' ' A' ' 769' ' ' PHE . 13.9 tpt180 -108.18 121.98 45.98 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.825 0.345 . . . . 71.409999999999997 110.879 -177.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 768' ' ' TRP . . . . . 0.646 ' CH2' ' HD2' ' A' ' 763' ' ' LYS . 48.0 m95 -95.44 107.44 19.59 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.787 -0.642 . . . . 73.349999999999994 109.571 177.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 769' ' ' PHE . . . . . 0.483 ' CD1' ' HG3' ' A' ' 767' ' ' ARG . 8.7 p90 -170.89 136.84 1.12 Allowed Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 120.888 0.375 . . . . 70.219999999999999 110.472 -178.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 770' ' ' PRO . . . . . 0.593 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 74.5 Cg_endo -97.36 -179.27 6.3 Favored 'Cis proline' 0 N--CA 1.447 -1.221 0 C-N-CA 123.475 -1.469 . . . . 54.219999999999999 111.773 -4.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -109.91 105.78 15.09 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.473 -0.566 . . . . 73.349999999999994 109.473 173.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 33.7 m -111.72 163.29 8.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.995 0.426 . . . . 73.239999999999995 111.147 -175.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 773' ' ' CYS . . . . . 0.437 ' HB2' ' HD3' ' A' ' 757' ' ' LYS . 5.1 p -133.52 117.99 17.79 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.889 -0.596 . . . . 51.43 110.017 179.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -132.67 143.75 49.86 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.287 -0.415 . . . . 73.310000000000002 110.705 -177.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 775' ' ' HIS . . . . . 0.428 ' HA ' ' O ' ' A' ' 756' ' ' PRO . 0.5 OUTLIER -80.14 24.34 0.43 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.146 0.498 . . . . 73.430000000000007 111.442 -178.521 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 776' ' ' SER . . . . . 0.548 ' HB3' ' HB2' ' A' ' 779' ' ' GLN . 24.9 t -152.76 137.96 17.42 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.578 -0.897 . . . . 73.0 108.578 175.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 777' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -66.92 -42.69 84.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.78 0.324 . . . . 74.409999999999997 110.327 -176.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -63.23 -38.09 89.79 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.178 -0.465 . . . . 63.310000000000002 110.379 178.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 779' ' ' GLN . . . . . 0.548 ' HB2' ' HB3' ' A' ' 776' ' ' SER . 76.6 mm-40 -71.72 -33.07 68.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.93 -0.577 . . . . 74.530000000000001 110.975 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -56.11 -43.91 88.56 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.112 -0.566 . . . . 61.310000000000002 112.107 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -69.04 -43.34 74.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.583 0.23 . . . . 74.239999999999995 110.985 178.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -63.42 -45.19 92.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.334 -0.393 . . . . 72.420000000000002 110.953 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -61.96 -44.44 96.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.303 -0.408 . . . . 75.340000000000003 110.924 178.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -61.29 -43.92 98.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.272 -0.422 . . . . 64.120000000000005 110.745 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 785' ' ' ALA . . . . . 0.559 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -65.45 -46.04 81.44 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.012 -0.54 . . . . 24.120000000000001 111.106 -178.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 786' ' ' ASP . . . . . 0.643 ' O ' ' HG2' ' A' ' 790' ' ' ARG . 14.9 t70 -60.31 -54.22 48.34 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 109.879 -0.415 . . . . 74.109999999999999 109.879 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 787' ' ' ALA . . . . . 0.537 ' O ' HG23 ' A' ' 791' ' ' VAL . . . -59.55 -35.48 74.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.67 -0.695 . . . . 73.409999999999997 111.229 -178.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 788' ' ' ALA . . . . . 0.632 ' O ' ' HG ' ' A' ' 792' ' ' LEU . . . -62.14 -45.2 94.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.508 -0.315 . . . . 71.219999999999999 110.63 177.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 789' ' ' LEU . . . . . 0.641 HD22 HD12 ' A' ' 719' ' ' LEU . 50.4 mt -64.29 -35.26 80.28 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 109.835 -0.431 . . . . 73.549999999999997 109.835 179.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 790' ' ' ARG . . . . . 0.643 ' HG2' ' O ' ' A' ' 786' ' ' ASP . 13.0 mmm-85 -59.63 -41.27 90.08 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 109.794 -0.447 . . . . 74.140000000000001 109.794 177.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 791' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 787' ' ' ALA . 43.5 t -63.67 -51.27 72.16 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 CA-C-N 115.625 -0.716 . . . . 75.120000000000005 110.111 177.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 792' ' ' LEU . . . . . 0.632 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 47.3 mt -57.16 -52.68 64.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.017 -0.538 . . . . 54.030000000000001 111.171 -177.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 793' ' ' ILE . . . . . 0.576 HD13 HG22 ' A' ' 720' ' ' VAL . 70.3 mt -60.12 -52.55 59.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.709 -0.678 . . . . 73.450000000000003 111.176 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -62.77 -41.62 99.82 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.855 -0.688 . . . . 64.010000000000005 112.681 -178.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -66.57 -39.36 88.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.833 0.349 . . . . 62.0 110.529 -178.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 8.3 t30 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.031 -0.531 . . . . 71.519999999999996 110.037 179.452 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 716' ' ' ILE . . . . . 0.514 HG21 ' HA ' ' A' ' 793' ' ' ILE . 42.4 mm . . . . . 0 C--O 1.235 0.32 0 CA-C-O 121.221 0.534 . . . . 73.530000000000001 110.387 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -63.69 -21.17 64.8 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.787 -0.642 . . . . 70.310000000000002 111.971 177.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 718' ' ' GLU . . . . . 0.712 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 15.8 mm-40 -65.57 -40.75 93.12 Favored 'General case' 0 C--O 1.225 -0.234 0 N-CA-C 109.592 -0.521 . . . . 71.150000000000006 109.592 176.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 719' ' ' LEU . . . . . 0.554 HD12 HD22 ' A' ' 789' ' ' LEU . 2.9 mm? -65.37 -33.01 74.97 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.624 -0.51 . . . . 70.549999999999997 109.624 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 720' ' ' VAL . . . . . 0.512 HG22 HD13 ' A' ' 793' ' ' ILE . 57.6 t -65.76 -38.04 81.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.668 -0.696 . . . . 70.430000000000007 110.822 178.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 721' ' ' ARG . . . . . 0.712 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 22.5 ptt180 -65.71 -26.2 67.65 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.191 0.52 . . . . 51.310000000000002 109.785 179.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -80.52 -27.01 37.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.983 -0.553 . . . . 62.119999999999997 110.991 178.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 723' ' ' LEU . . . . . 0.551 HD21 ' HB2' ' A' ' 789' ' ' LEU . 87.7 mt -62.43 -27.2 68.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.137 0.494 . . . . 74.019999999999996 109.708 172.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -89.68 -38.96 13.51 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.336 -0.847 . . . . 71.400000000000006 110.938 177.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 18.5 m -93.89 -74.64 0.53 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.973 0.36 . . . . 55.210000000000001 111.973 -174.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 726' ' ' ASN . . . . . 0.468 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 38.0 t30 -153.36 106.84 2.59 Favored Pre-proline 0 C--O 1.236 0.359 0 CA-C-O 120.894 0.378 . . . . 73.010000000000005 110.354 -178.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 727' ' ' PRO . . . . . 0.468 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 17.9 Cg_endo -60.0 -36.68 88.89 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 123.217 2.611 . . . . 74.340000000000003 112.964 -177.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 46.0 t -58.64 -49.96 80.73 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 CA-C-N 116.361 -0.381 . . . . 74.040000000000006 110.776 -177.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -61.54 -35.22 90.77 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.918 -0.658 . . . . 73.299999999999997 112.377 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -71.79 -44.19 48.54 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.837 -0.697 . . . . 53.149999999999999 112.811 -179.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -64.27 -39.5 94.06 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.777 -0.453 . . . . 74.019999999999996 109.777 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 732' ' ' LEU . . . . . 0.43 HD23 ' HB3' ' A' ' 742' ' ' ALA . 95.7 mt -63.83 -43.38 96.35 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.881 -0.6 . . . . 71.340000000000003 111.485 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 733' ' ' GLU . . . . . 0.555 ' HA ' ' HG2' ' A' ' 736' ' ' ARG . 8.4 pt-20 -77.42 -29.94 53.22 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 120.549 -0.46 . . . . 43.520000000000003 111.239 -176.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 734' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -55.42 -49.28 72.81 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.074 0.464 . . . . 63.43 109.793 173.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -66.5 -52.77 42.43 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.705 -0.68 . . . . 45.0 111.021 -177.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 736' ' ' ARG . . . . . 0.555 ' HG2' ' HA ' ' A' ' 733' ' ' GLU . 35.7 ptt180 -58.74 -36.07 73.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.036 -0.529 . . . . 62.049999999999997 111.384 -174.098 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 18.9 t -76.04 -37.09 58.73 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.008 -0.542 . . . . 44.020000000000003 110.842 -178.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -88.36 -7.64 56.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.467 -0.333 . . . . 74.510000000000005 111.483 -174.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 103.79 -3.31 45.45 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.611 -0.804 . . . . 72.409999999999997 113.096 175.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -88.56 170.26 11.01 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.928 0.394 . . . . 53.130000000000003 110.413 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -115.51 131.43 56.93 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.49 -0.559 . . . . 73.140000000000001 109.49 173.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 742' ' ' ALA . . . . . 0.43 ' HB3' HD23 ' A' ' 732' ' ' LEU . . . -98.87 110.28 22.91 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 123.22 0.325 . . . . 64.319999999999993 110.538 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 743' ' ' GLU . . . . . 0.562 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 47.0 mt-10 -115.04 132.73 56.5 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.103 -0.499 . . . . 53.520000000000003 111.074 -177.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -113.13 109.76 19.33 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.072 -0.513 . . . . 75.109999999999999 109.783 175.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -122.41 152.76 39.89 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.081 0.467 . . . . 75.230000000000004 111.393 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 746' ' ' LEU . . . . . . . . . . . . . 6.5 tt -82.92 113.8 20.77 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.833 -0.803 . . . . 75.200000000000003 108.833 175.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 54.8 t -82.36 -50.35 16.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.181 0.515 . . . . 73.510000000000005 110.671 -176.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -155.69 147.14 22.81 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.717 -0.674 . . . . 72.310000000000002 109.495 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.91 109.94 20.73 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.442 0.639 . . . . 72.200000000000003 110.167 175.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 6.6 m -108.88 80.64 1.35 Allowed 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.8 -0.815 . . . . 73.120000000000005 108.8 176.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 751' ' ' GLY . . . . . 0.514 ' HA2' ' HD2' ' A' ' 752' ' ' PRO . . . -131.41 113.46 1.36 Allowed Glycine 0 N--CA 1.439 -1.124 0 C-N-CA 119.895 -1.145 . . . . 62.240000000000002 114.131 -170.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 752' ' ' PRO . . . . . 0.514 ' HD2' ' HA2' ' A' ' 751' ' ' GLY . 20.1 Cg_endo -60.92 169.95 5.27 Favored 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 123.095 2.53 . . . . 55.119999999999997 111.029 167.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -61.42 -35.39 83.36 Favored 'Trans proline' 0 CA--C 1.529 0.228 0 C-N-CA 122.177 1.918 . . . . 75.209999999999994 112.777 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 55.7 p-80 -83.41 -20.95 33.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.752 0.311 . . . . 73.140000000000001 111.349 -177.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -142.4 74.8 19.96 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 111.923 0.342 . . . . 72.109999999999999 111.923 -176.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 756' ' ' PRO . . . . . 0.454 ' HA ' ' HA3' ' A' ' 751' ' ' GLY . 33.4 Cg_exo -58.06 92.87 0.06 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 122.096 1.864 . . . . 75.349999999999994 111.191 170.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 757' ' ' LYS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 775' ' ' HIS . 36.1 ttpt -101.13 130.06 47.13 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.007 -0.542 . . . . 75.200000000000003 110.359 -175.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 758' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -113.72 135.08 54.33 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.94 -0.573 . . . . 60.109999999999999 110.632 -175.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 759' ' ' VAL . . . . . 0.476 HG22 ' HB3' ' A' ' 773' ' ' CYS . 26.3 t -94.19 112.62 27.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.812 -0.631 . . . . 61.210000000000001 109.876 177.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -111.11 143.18 42.24 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.917 -0.583 . . . . 55.219999999999999 110.565 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 761' ' ' GLN . . . . . 0.5 ' HA ' ' O ' ' A' ' 770' ' ' PRO . 53.1 tt0 -131.39 130.96 43.26 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.521 -0.548 . . . . 74.310000000000002 109.521 178.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 762' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 769' ' ' PHE . . . -87.7 113.77 23.68 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.352 0.596 . . . . 71.099999999999994 110.631 -179.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 763' ' ' LYS . . . . . 0.579 ' HD2' ' CH2' ' A' ' 768' ' ' TRP . 57.4 tttm -93.2 105.13 17.26 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.789 -0.641 . . . . 55.140000000000001 109.545 178.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 57.4 t -108.04 103.46 15.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.25 -0.648 . . . . 73.109999999999999 109.25 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 71.25 -117.21 6.63 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 110.683 -0.967 . . . . 53.140000000000001 110.683 -173.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -110.07 15.72 30.66 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.615 -0.803 . . . . 65.120000000000005 112.066 176.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 767' ' ' ARG . . . . . 0.547 ' HD2' ' CD1' ' A' ' 769' ' ' PHE . 0.0 OUTLIER -115.5 128.2 55.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.853 0.358 . . . . 74.040000000000006 110.218 -178.891 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 768' ' ' TRP . . . . . 0.579 ' CH2' ' HD2' ' A' ' 763' ' ' LYS . 40.6 m95 -97.43 103.14 15.05 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.065 -0.516 . . . . 73.540000000000006 110.018 -179.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 769' ' ' PHE . . . . . 0.547 ' CD1' ' HD2' ' A' ' 767' ' ' ARG . 16.5 p90 -162.16 136.39 5.01 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 120.853 0.359 . . . . 73.319999999999993 111.044 -178.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 770' ' ' PRO . . . . . 0.63 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 75.1 Cg_endo -99.34 -177.83 4.41 Favored 'Cis proline' 0 N--CA 1.449 -1.122 0 C-N-CA 123.684 -1.382 . . . . 61.450000000000003 111.496 -5.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -111.05 107.36 16.73 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.919 -0.4 . . . . 75.450000000000003 109.919 174.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 34.0 m -119.26 164.95 15.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.203 -0.453 . . . . 74.549999999999997 110.667 -176.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 773' ' ' CYS . . . . . 0.476 ' HB3' HG22 ' A' ' 759' ' ' VAL . 7.0 p -136.61 124.01 22.03 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.383 -0.371 . . . . 72.019999999999996 110.275 177.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -129.56 152.52 49.0 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.27 -0.423 . . . . 31.539999999999999 110.185 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 775' ' ' HIS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 757' ' ' LYS . 13.2 p80 -78.22 17.47 0.62 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.859 0.362 . . . . 64.329999999999998 111.695 -176.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 15.7 t -153.15 139.88 18.95 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.484 -0.561 . . . . 45.140000000000001 109.484 177.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 777' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -60.82 -40.46 92.83 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.453 -0.339 . . . . 64.239999999999995 111.123 -177.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -67.65 -37.25 82.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.852 0.358 . . . . 60.100000000000001 110.517 179.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 779' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -70.2 -37.37 75.06 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.147 -0.479 . . . . 73.340000000000003 110.738 -178.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -57.57 -41.84 93.76 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.966 -0.635 . . . . 74.439999999999998 112.279 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -63.83 -44.31 93.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.974 0.416 . . . . 72.450000000000003 110.622 177.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -69.44 -41.31 76.47 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.876 -0.602 . . . . 74.439999999999998 111.341 -177.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -61.26 -42.69 99.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.787 0.327 . . . . 73.129999999999995 110.838 177.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -62.72 -50.29 71.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.792 -0.64 . . . . 70.5 110.634 178.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 785' ' ' ALA . . . . . 0.547 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -62.95 -39.64 95.25 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.296 -0.411 . . . . 74.310000000000002 111.073 -178.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 786' ' ' ASP . . . . . 0.612 ' O ' ' HG2' ' A' ' 790' ' ' ARG . 11.7 t70 -60.48 -57.34 13.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.461 . . . . 60.539999999999999 110.447 179.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 787' ' ' ALA . . . . . 0.571 ' O ' HG23 ' A' ' 791' ' ' VAL . . . -62.68 -32.46 73.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.792 -0.64 . . . . 63.549999999999997 110.992 -178.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 788' ' ' ALA . . . . . 0.655 ' O ' ' HG ' ' A' ' 792' ' ' LEU . . . -62.12 -43.5 98.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.363 -0.38 . . . . 43.200000000000003 110.693 177.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 789' ' ' LEU . . . . . 0.554 HD22 HD12 ' A' ' 719' ' ' LEU . 79.2 mt -64.41 -37.32 87.12 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.782 -0.451 . . . . 72.209999999999994 109.782 178.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 790' ' ' ARG . . . . . 0.612 ' HG2' ' O ' ' A' ' 786' ' ' ASP . 8.7 mmm180 -59.86 -40.62 89.23 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 109.694 -0.484 . . . . 74.150000000000006 109.694 177.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 791' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 787' ' ' ALA . 61.0 t -62.02 -50.7 79.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.816 -0.629 . . . . 75.030000000000001 110.56 176.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 792' ' ' LEU . . . . . 0.655 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 49.7 mt -60.27 -52.13 66.59 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.693 -0.685 . . . . 75.5 110.979 -177.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 793' ' ' ILE . . . . . 0.514 ' HA ' HG21 ' A' ' 716' ' ' ILE . 72.2 mt -59.55 -48.84 85.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.755 -0.657 . . . . 75.140000000000001 110.742 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -61.35 -44.02 98.6 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 121.06 -0.59 . . . . 72.510000000000005 112.774 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -57.64 -40.96 80.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.064 0.459 . . . . 54.219999999999999 110.15 178.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 4.4 t30 . . . . . 0 C--N 1.325 -0.46 0 CA-C-N 115.807 -0.633 . . . . 62.509999999999998 111.44 178.462 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 708' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.482 1.163 0 CA-C-O 120.778 0.323 . . . . 73.129999999999995 110.763 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 22.4 ttt -62.55 127.09 89.6 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.887 -0.597 . . . . 71.530000000000001 110.681 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.39 94.69 0.98 Allowed 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.313 2.009 . . . . 62.210000000000001 111.78 176.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 711' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -94.61 108.58 20.55 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.179 -0.464 . . . . 65.200000000000003 110.019 -178.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 712' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -115.93 96.18 5.47 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.256 -0.646 . . . . 63.43 109.256 177.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 713' ' ' VAL . . . . . . . . . . . . . 11.0 p -98.53 159.93 3.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.71 -0.677 . . . . 61.350000000000001 110.439 -176.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.414 ' H ' ' HG2' ' A' ' 714' ' ' ARG . 12.8 ptp180 -68.24 87.14 0.28 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.543 0.687 . . . . 65.439999999999998 110.964 177.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 715' ' ' LYS . . . . . 0.486 ' HG2' ' OE2' ' A' ' 718' ' ' GLU . 22.5 tptm -83.07 72.98 10.09 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.546 -0.752 . . . . 74.409999999999997 109.996 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 716' ' ' ILE . . . . . 0.561 ' HA ' HD23 ' A' ' 719' ' ' LEU . 47.9 mm -67.19 -28.3 42.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.487 -0.779 . . . . 74.510000000000005 110.861 -175.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -59.36 -32.41 72.45 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 121.086 -0.578 . . . . 72.129999999999995 112.634 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 718' ' ' GLU . . . . . 0.706 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 39.3 mt-10 -79.69 -21.83 44.17 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.856 -0.338 . . . . 62.140000000000001 111.266 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 719' ' ' LEU . . . . . 0.563 HD12 HD22 ' A' ' 789' ' ' LEU . 3.5 mm? -67.02 -32.11 73.11 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.225 -0.657 . . . . 61.009999999999998 109.225 172.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 720' ' ' VAL . . . . . 0.575 HG22 HD13 ' A' ' 793' ' ' ILE . 39.3 t -70.49 -31.81 47.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.364 -0.835 . . . . 64.329999999999998 110.379 176.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 721' ' ' ARG . . . . . 0.706 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 6.1 ptt180 -66.61 -28.12 68.24 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 120.943 0.401 . . . . 74.510000000000005 110.16 179.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -77.17 -31.86 55.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.239 -0.437 . . . . 73.549999999999997 111.322 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 723' ' ' LEU . . . . . 0.551 HD21 ' HB2' ' A' ' 789' ' ' LEU . 96.3 mt -61.11 -32.3 71.98 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.514 0.673 . . . . 71.140000000000001 109.629 173.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -84.95 -16.6 40.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.851 -1.068 . . . . 60.229999999999997 110.905 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 23.5 m -119.37 -81.61 0.63 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.783 0.325 . . . . 75.519999999999996 111.536 -176.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 726' ' ' ASN . . . . . 0.415 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 37.5 t30 -139.25 104.9 7.19 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.292 -0.413 . . . . 65.120000000000005 110.21 -178.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 727' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 24.6 Cg_endo -62.23 -37.61 61.06 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.822 2.348 . . . . 65.5 112.584 -177.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 49.4 t -61.33 -49.0 86.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.23 -0.441 . . . . 64.430000000000007 110.544 -177.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -63.41 -31.49 80.93 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.899 -0.667 . . . . 62.119999999999997 111.887 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -71.03 -40.04 62.65 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.06 -0.591 . . . . 40.509999999999998 112.633 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -66.05 -39.65 90.3 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.401 -0.592 . . . . 75.030000000000001 109.401 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 732' ' ' LEU . . . . . 0.443 HD23 ' HB3' ' A' ' 742' ' ' ALA . 83.1 mt -65.45 -38.53 90.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.926 -0.579 . . . . 72.340000000000003 110.427 175.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 733' ' ' GLU . . . . . 0.578 ' O ' ' HG2' ' A' ' 736' ' ' ARG . 4.2 tp10 -66.41 -48.17 70.93 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.809 -0.632 . . . . 73.5 110.928 -179.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 734' ' ' TYR . . . . . 0.54 ' HB2' HD11 ' A' ' 719' ' ' LEU . 12.4 t80 -56.75 -47.74 79.39 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.132 -0.485 . . . . 64.409999999999997 110.752 178.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -66.43 -46.14 77.53 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.139 -0.482 . . . . 72.5 111.184 -177.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 736' ' ' ARG . . . . . 0.578 ' HG2' ' O ' ' A' ' 733' ' ' GLU . 22.4 ptt180 -62.12 -35.33 78.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.015 0.436 . . . . 62.420000000000002 110.85 -176.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 33.1 t -81.19 -23.72 37.97 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.922 -0.581 . . . . 63.420000000000002 111.304 -178.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -104.71 2.84 30.78 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.781 0.289 . . . . 54.219999999999999 111.781 -175.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 79.82 17.82 74.17 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.574 -0.822 . . . . 74.219999999999999 113.002 176.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -102.27 162.16 13.13 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 122.628 -0.336 . . . . 63.130000000000003 110.263 176.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 741' ' ' ALA . . . . . 0.52 ' O ' ' HA ' ' A' ' 764' ' ' VAL . . . -105.43 135.42 46.85 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.865 -0.42 . . . . 44.439999999999998 109.865 175.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 742' ' ' ALA . . . . . 0.443 ' HB3' HD23 ' A' ' 732' ' ' LEU . . . -103.46 108.77 20.16 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.224 -0.444 . . . . 71.530000000000001 110.505 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 743' ' ' GLU . . . . . 0.572 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 41.2 mt-10 -115.73 113.35 23.35 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.033 -0.531 . . . . 71.430000000000007 111.121 -178.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -93.91 100.91 12.98 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.644 -0.707 . . . . 73.409999999999997 109.605 175.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -113.99 155.96 24.92 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.04 0.448 . . . . 75.310000000000002 110.783 -178.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 746' ' ' LEU . . . . . . . . . . . . . 1.7 tt -94.06 120.42 34.3 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.759 -0.83 . . . . 71.409999999999997 108.759 177.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 84.6 t -81.98 -52.3 13.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.315 -0.402 . . . . 65.239999999999995 111.182 -176.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -155.58 151.33 27.43 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.386 -0.37 . . . . 51.109999999999999 110.803 -175.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -126.75 87.11 2.6 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.702 -0.481 . . . . 73.450000000000003 109.702 -178.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 750' ' ' SER . . . . . 0.402 ' O ' ' HB3' ' A' ' 757' ' ' LYS . 5.3 p -128.1 98.93 5.28 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.177 0.513 . . . . 72.230000000000004 111.261 -176.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . -166.54 158.04 30.79 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 111.57 -0.612 . . . . 70.120000000000005 111.57 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 752' ' ' PRO . . . . . 0.693 ' HG2' ' HB2' ' A' ' 755' ' ' GLU . 20.5 Cg_endo -60.45 162.15 18.45 Favored 'Trans proline' 0 CA--C 1.531 0.35 0 C-N-CA 122.846 2.364 . . . . 74.0 112.038 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.68 -31.91 92.59 Favored 'Trans proline' 0 CA--C 1.527 0.16 0 C-N-CA 122.71 2.273 . . . . 72.430000000000007 112.612 -178.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 37.5 p-80 -86.82 -17.82 32.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.206 -0.452 . . . . 72.409999999999997 111.309 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 755' ' ' GLU . . . . . 0.693 ' HB2' ' HG2' ' A' ' 752' ' ' PRO . 37.9 mm-40 -136.48 70.88 60.02 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.461 -0.336 . . . . 74.450000000000003 110.751 178.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 756' ' ' PRO . . . . . 0.485 ' HB2' ' CE2' ' A' ' 758' ' ' PHE . 28.9 Cg_endo -63.42 116.99 3.96 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.264 1.976 . . . . 71.209999999999994 111.414 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 757' ' ' LYS . . . . . 0.411 ' CG ' ' HB2' ' A' ' 773' ' ' CYS . 23.1 ttmm -97.7 115.46 28.01 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.251 -0.432 . . . . 74.209999999999994 110.427 -176.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 758' ' ' PHE . . . . . 0.485 ' CE2' ' HB2' ' A' ' 756' ' ' PRO . 90.4 m-85 -108.05 113.21 26.21 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.008 -0.542 . . . . 74.420000000000002 110.355 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 24.3 t -85.82 111.28 20.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.74 -0.664 . . . . 65.25 109.8 179.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 760' ' ' TYR . . . . . 0.421 ' OH ' ' HG2' ' A' ' 777' ' ' LYS . 2.1 m-85 -110.81 143.13 41.85 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.248 -0.433 . . . . 71.519999999999996 110.758 -179.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 761' ' ' GLN . . . . . 0.519 ' HA ' ' O ' ' A' ' 770' ' ' PRO . 56.8 tt0 -135.77 135.19 39.73 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.141 -0.481 . . . . 72.409999999999997 109.743 178.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 762' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 769' ' ' PHE . . . -93.56 112.84 24.82 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.306 0.574 . . . . 74.129999999999995 110.605 -178.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 763' ' ' LYS . . . . . 0.607 ' HD2' ' CH2' ' A' ' 768' ' ' TRP . 59.3 tttm -91.82 101.84 14.43 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.844 -0.617 . . . . 65.109999999999999 109.778 177.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 764' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 741' ' ' ALA . 59.4 t -107.57 100.86 11.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.02 -0.536 . . . . 70.019999999999996 109.986 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 71.71 -115.25 5.49 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 115.586 -0.733 . . . . 64.219999999999999 111.482 -177.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -106.22 8.1 41.18 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.828 -0.701 . . . . 72.040000000000006 112.012 177.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 767' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 767' ' ' ARG . 55.0 mtt180 -108.07 147.17 31.56 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.963 0.411 . . . . 74.010000000000005 110.797 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 768' ' ' TRP . . . . . 0.607 ' CH2' ' HD2' ' A' ' 763' ' ' LYS . 53.0 m95 -118.21 100.76 7.72 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.764 -0.653 . . . . 75.200000000000003 109.284 178.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 769' ' ' PHE . . . . . 0.487 ' HA ' ' HA ' ' A' ' 770' ' ' PRO . 21.4 p90 -167.49 139.3 2.58 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 120.777 0.322 . . . . 74.530000000000001 110.969 -176.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 770' ' ' PRO . . . . . 0.635 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 71.5 Cg_endo -97.54 -171.46 2.46 Favored 'Cis proline' 0 N--CA 1.453 -0.872 0 C-N-CA 123.716 -1.368 . . . . 64.239999999999995 111.751 -4.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -122.23 112.44 18.16 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.63 -0.508 . . . . 74.510000000000005 109.63 175.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 36.0 m -122.46 159.24 25.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.247 -0.433 . . . . 60.340000000000003 110.839 -176.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 773' ' ' CYS . . . . . 0.411 ' HB2' ' CG ' ' A' ' 757' ' ' LYS . 8.0 p -124.45 107.65 11.32 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.007 0.432 . . . . 71.530000000000001 109.948 177.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -103.11 -179.66 4.01 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.07 -0.514 . . . . 71.209999999999994 111.203 -176.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 775' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -93.28 -5.39 49.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 71.200000000000003 110.349 -177.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 19.4 t -161.01 170.44 20.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.338 -0.392 . . . . 73.209999999999994 110.518 -177.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 777' ' ' LYS . . . . . 0.421 ' HG2' ' OH ' ' A' ' 760' ' ' TYR . 1.4 tmtp? -69.72 -50.15 46.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.065 -0.516 . . . . 75.409999999999997 111.447 -174.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -60.48 -40.75 92.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.965 0.412 . . . . 63.140000000000001 110.308 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 779' ' ' GLN . . . . . 0.54 ' O ' ' HG2' ' A' ' 783' ' ' GLU . 76.9 mt-30 -58.3 -49.18 78.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.696 -0.683 . . . . 73.219999999999999 111.099 175.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -52.73 -44.12 60.34 Favored Glycine 0 C--N 1.334 0.434 0 CA-C-N 116.168 -0.469 . . . . 73.140000000000001 113.095 -176.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -59.23 -47.71 84.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.273 0.559 . . . . 44.100000000000001 110.772 178.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -70.91 -42.83 69.4 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.443 -0.799 . . . . 63.109999999999999 111.61 -175.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 783' ' ' GLU . . . . . 0.54 ' HG2' ' O ' ' A' ' 779' ' ' GLN . 21.2 mm-40 -60.44 -41.48 94.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.978 0.418 . . . . 72.450000000000003 110.301 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -66.17 -47.84 72.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.845 -0.616 . . . . 75.510000000000005 110.662 178.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 785' ' ' ALA . . . . . 0.524 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -63.08 -41.93 99.53 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.218 -0.446 . . . . 73.099999999999994 111.324 -178.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 786' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -57.21 -53.31 59.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.242 0.544 . . . . 71.450000000000003 110.277 178.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 787' ' ' ALA . . . . . 0.603 ' O ' HG23 ' A' ' 791' ' ' VAL . . . -64.01 -37.78 88.67 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.597 -0.729 . . . . 63.509999999999998 111.052 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 788' ' ' ALA . . . . . 0.635 ' HB2' ' HD3' ' A' ' 770' ' ' PRO . . . -60.38 -47.44 86.07 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.425 -0.352 . . . . 63.109999999999999 111.582 -178.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 789' ' ' LEU . . . . . 0.563 HD22 HD12 ' A' ' 719' ' ' LEU . 64.4 mt -62.74 -39.36 93.86 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.641 -0.503 . . . . 73.150000000000006 109.641 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 790' ' ' ARG . . . . . . . . . . . . . 54.6 mtp180 -64.46 -32.09 73.57 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.594 -0.73 . . . . 75.209999999999994 111.197 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 791' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 787' ' ' ALA . 60.7 t -63.51 -52.94 51.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 109.433 -0.58 . . . . 52.329999999999998 109.433 173.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 792' ' ' LEU . . . . . 0.563 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 32.8 mt -57.39 -50.44 72.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.339 -0.846 . . . . 71.519999999999996 110.836 -177.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 793' ' ' ILE . . . . . 0.575 HD13 HG22 ' A' ' 720' ' ' VAL . 77.5 mt -57.94 -49.47 81.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.642 -0.708 . . . . 73.219999999999999 110.568 177.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -63.28 -30.71 78.37 Favored Glycine 0 CA--C 1.519 0.325 0 CA-C-N 115.952 -0.567 . . . . 54.340000000000003 112.814 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 795' ' ' GLU . . . . . 0.613 ' O ' ' HB2' ' A' ' 799' ' ' ALA . 59.7 mm-40 -67.26 -36.73 82.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.46 0.13 . . . . 74.540000000000006 110.874 178.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -83.31 -33.77 25.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.533 -0.303 . . . . 53.520000000000003 111.15 -175.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 797' ' ' GLU . . . . . 0.48 ' HG3' ' O ' ' A' ' 793' ' ' ILE . 46.7 mt-10 -65.19 121.78 15.56 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.568 -0.287 . . . . 74.519999999999996 110.401 178.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 798' ' ' LYS . . . . . 0.507 ' NZ ' ' HB2' ' A' ' 798' ' ' LYS . 8.4 mtmp? 71.26 18.28 5.73 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 123.549 0.531 . . . . 74.409999999999997 110.936 -178.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 799' ' ' ALA . . . . . 0.613 ' HB2' ' O ' ' A' ' 795' ' ' GLU . . . -89.77 146.97 24.1 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.289 0.566 . . . . 51.340000000000003 111.656 -178.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 800' ' ' GLU . . . . . 0.532 ' H ' ' CD ' ' A' ' 800' ' ' GLU . 0.3 OUTLIER -99.27 -3.46 34.09 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.067 -0.97 . . . . 74.319999999999993 109.328 174.465 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 801' ' ' ARG . . . . . 0.494 ' HD3' ' H ' ' A' ' 801' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.135 0 CA-C-N 115.069 -0.969 . . . . 60.450000000000003 109.661 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 708' ' ' MET . . . . . 0.423 ' O ' ' HG3' ' A' ' 708' ' ' MET . 14.8 tpt . . . . . 0 N--CA 1.477 0.924 0 CA-C-O 121.476 0.655 . . . . 75.450000000000003 109.942 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . 0.428 ' HB2' ' OE2' ' A' ' 718' ' ' GLU . 48.0 ttp -126.43 96.69 35.55 Favored Pre-proline 0 C--N 1.326 -0.425 0 O-C-N 122.053 -0.404 . . . . 73.230000000000004 110.996 -177.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -77.02 -68.58 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 123.085 2.524 . . . . 61.409999999999997 110.978 174.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 711' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -79.68 109.97 14.58 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.271 -1.011 . . . . 74.329999999999998 108.271 172.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 712' ' ' LYS . . . . . . . . . . . . . 33.0 mtpt -72.48 132.69 44.19 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.627 0.727 . . . . 64.030000000000001 112.293 -166.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 713' ' ' VAL . . . . . 0.462 HG22 ' H ' ' A' ' 714' ' ' ARG . 7.0 p -148.61 174.6 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 107.687 -1.227 . . . . 72.439999999999998 107.687 -178.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.462 ' H ' HG22 ' A' ' 713' ' ' VAL . 14.7 ttm180 -75.98 74.01 2.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 118.776 0.716 . . . . 74.5 109.666 176.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 715' ' ' LYS . . . . . 0.542 ' HG2' ' OE2' ' A' ' 718' ' ' GLU . 4.7 tppp? -83.71 84.05 7.69 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.842 -0.617 . . . . 72.230000000000004 110.051 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 716' ' ' ILE . . . . . 0.545 ' HA ' HD23 ' A' ' 719' ' ' LEU . 47.1 mm -71.81 -22.3 21.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.907 -0.588 . . . . 64.450000000000003 110.803 -176.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -62.11 -34.03 87.71 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.828 -0.701 . . . . 70.409999999999997 111.992 176.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 718' ' ' GLU . . . . . 0.707 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 38.1 mt-10 -77.26 -25.0 51.04 Favored 'General case' 0 C--O 1.222 -0.385 0 O-C-N 122.623 -0.34 . . . . 73.140000000000001 111.125 178.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 719' ' ' LEU . . . . . 0.57 HD12 HD22 ' A' ' 789' ' ' LEU . 4.4 mm? -61.51 -32.94 73.0 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.473 -0.565 . . . . 63.109999999999999 109.473 172.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 720' ' ' VAL . . . . . 0.495 HG22 HD13 ' A' ' 793' ' ' ILE . 58.2 t -70.21 -36.26 66.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.477 -0.783 . . . . 74.400000000000006 110.76 177.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 721' ' ' ARG . . . . . 0.707 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 8.9 ptt180 -62.72 -29.52 70.73 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.02 0.438 . . . . 64.319999999999993 110.167 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -76.28 -31.55 58.3 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.197 -0.456 . . . . 73.510000000000005 110.596 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 723' ' ' LEU . . . . . 0.606 HD21 ' HB2' ' A' ' 789' ' ' LEU . 89.3 mt -63.76 -24.89 67.95 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.177 0.513 . . . . 72.439999999999998 110.601 174.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -92.07 -23.87 19.34 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.756 -0.656 . . . . 62.100000000000001 110.872 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 10.9 m -111.04 -76.79 0.6 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.423 -0.353 . . . . 73.420000000000002 111.241 -175.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 726' ' ' ASN . . . . . 0.408 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 38.5 t30 -141.6 103.52 5.9 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 120.628 0.251 . . . . 44.229999999999997 110.768 -179.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 727' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 19.0 Cg_endo -59.77 -37.09 89.1 Favored 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 123.032 2.488 . . . . 61.329999999999998 112.348 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 728' ' ' VAL . . . . . 0.417 ' O ' ' HG ' ' A' ' 732' ' ' LEU . 48.9 t -59.96 -47.94 89.75 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 CA-C-N 116.007 -0.542 . . . . 71.140000000000001 110.162 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -62.35 -35.33 91.5 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.656 -0.702 . . . . 42.350000000000001 112.01 178.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -65.41 -43.16 95.38 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.097 -0.573 . . . . 61.109999999999999 112.641 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -65.93 -40.27 91.28 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.725 -0.472 . . . . 61.25 109.725 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 732' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 728' ' ' VAL . 85.7 mt -65.37 -38.02 88.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.949 -0.569 . . . . 62.32 110.602 176.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 733' ' ' GLU . . . . . 0.462 ' O ' ' HG2' ' A' ' 736' ' ' ARG . 5.2 tp10 -66.98 -47.12 72.52 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 115.967 -0.56 . . . . 73.310000000000002 110.911 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 734' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -56.64 -46.69 80.85 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.214 -0.448 . . . . 71.150000000000006 110.458 177.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -65.28 -44.66 87.3 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.093 -0.503 . . . . 32.520000000000003 111.232 -177.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 736' ' ' ARG . . . . . 0.462 ' HG2' ' O ' ' A' ' 733' ' ' GLU . 14.5 ptm180 -68.85 -33.04 73.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.598 0.713 . . . . 72.340000000000003 109.825 -173.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 73.2 m -75.01 -36.47 61.95 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 114.792 -1.095 . . . . 75.120000000000005 111.766 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 12.7 m170 -94.27 0.57 55.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.338 -0.392 . . . . 74.209999999999994 111.327 -175.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 85.86 9.17 78.24 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.735 -0.745 . . . . 74.0 112.987 175.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -93.45 162.15 14.09 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.698 0.285 . . . . 71.530000000000001 110.336 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -107.48 115.99 31.14 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.993 -0.373 . . . . 64.239999999999995 109.993 176.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 742' ' ' ALA . . . . . 0.417 ' HB3' HD23 ' A' ' 732' ' ' LEU . . . -81.94 112.17 18.79 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.238 -0.437 . . . . 65.129999999999995 110.888 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 743' ' ' GLU . . . . . 0.479 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 43.9 mt-10 -123.06 127.74 49.17 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.297 -0.41 . . . . 73.129999999999995 110.945 -177.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -105.85 114.34 28.43 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.02 -0.536 . . . . 65.019999999999996 110.021 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -121.34 153.66 37.46 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.164 0.507 . . . . 72.439999999999998 110.803 177.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 746' ' ' LEU . . . . . 0.451 HD13 ' CE2' ' A' ' 760' ' ' TYR . 51.3 tp -95.93 101.33 12.99 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.475 -0.784 . . . . 75.230000000000004 109.803 178.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 49.1 t -69.33 -43.88 80.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.796 -0.638 . . . . 61.340000000000003 111.275 -174.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -146.25 147.49 31.47 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.064 0.459 . . . . 74.219999999999999 111.246 -176.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -141.47 93.66 2.6 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.997 -0.742 . . . . 71.340000000000003 108.997 177.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 16.7 t -129.84 176.75 7.78 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.906 -0.588 . . . . 54.210000000000001 110.213 -173.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 104.88 -176.17 22.71 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.712 -0.756 . . . . 74.299999999999997 112.353 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 752' ' ' PRO . . . . . 0.56 ' HG2' ' HB2' ' A' ' 755' ' ' GLU . 60.4 Cg_endo -73.62 157.82 48.08 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.899 2.399 . . . . 75.219999999999999 111.88 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -62.98 -22.54 73.86 Favored 'Trans proline' 0 CA--C 1.529 0.246 0 C-N-CA 122.656 2.238 . . . . 73.099999999999994 112.773 -177.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 39.2 p-80 -91.85 -7.57 49.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.924 0.392 . . . . 75.209999999999994 110.907 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 755' ' ' GLU . . . . . 0.56 ' HB2' ' HG2' ' A' ' 752' ' ' PRO . 5.5 mm-40 -146.84 63.58 8.46 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.318 -0.401 . . . . 60.420000000000002 110.987 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 756' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.85 122.43 8.49 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.094 1.862 . . . . 72.519999999999996 111.317 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 757' ' ' LYS . . . . . 0.455 ' HG3' ' HB2' ' A' ' 773' ' ' CYS . 0.1 OUTLIER -92.95 112.2 24.08 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.07 0.462 . . . . 73.319999999999993 110.327 -178.181 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 758' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -95.1 107.52 19.58 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.579 -0.737 . . . . 73.040000000000006 110.501 -178.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 759' ' ' VAL . . . . . 0.47 HG22 ' HB3' ' A' ' 773' ' ' CYS . 40.9 t -86.65 98.13 6.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.037 -0.528 . . . . 71.349999999999994 109.896 178.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 760' ' ' TYR . . . . . 0.451 ' CE2' HD13 ' A' ' 746' ' ' LEU . 7.5 m-85 -98.08 141.07 31.48 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.074 -0.512 . . . . 74.25 110.379 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 761' ' ' GLN . . . . . 0.496 ' HA ' ' O ' ' A' ' 770' ' ' PRO . 54.6 tt0 -135.41 129.3 33.08 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.993 -0.549 . . . . 75.239999999999995 109.784 178.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 762' ' ' ALA . . . . . . . . . . . . . . . -85.99 117.23 24.71 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.474 0.654 . . . . 74.540000000000006 110.819 -177.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 763' ' ' LYS . . . . . 0.479 ' HB3' ' HB2' ' A' ' 743' ' ' GLU . 58.9 tttt -93.71 108.8 20.5 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.184 -0.916 . . . . 71.0 109.572 178.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 38.7 t -128.78 108.26 17.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.805 0.336 . . . . 65.340000000000003 110.936 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 69.16 25.1 75.7 Favored Glycine 0 CA--C 1.51 -0.219 0 C-N-CA 121.112 -0.566 . . . . 41.149999999999999 112.585 176.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 91.31 -10.27 75.3 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.652 -0.785 . . . . 73.109999999999999 111.859 -177.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 767' ' ' ARG . . . . . 0.434 ' HD3' ' HA ' ' A' ' 767' ' ' ARG . 30.1 mmt180 -91.32 128.51 37.17 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.033 0.445 . . . . 73.409999999999997 110.303 177.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 768' ' ' TRP . . . . . . . . . . . . . 51.0 m95 -104.1 96.1 6.43 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.519 -0.764 . . . . 73.230000000000004 109.94 -176.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 769' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -162.42 138.59 5.78 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.314 -0.403 . . . . 72.239999999999995 110.412 -177.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 770' ' ' PRO . . . . . 0.668 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 64.8 Cg_endo -95.0 175.15 12.68 Favored 'Cis proline' 0 N--CA 1.451 -0.978 0 C-N-CA 123.351 -1.521 . . . . 72.120000000000005 111.873 -3.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -107.66 98.15 7.78 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.681 -0.489 . . . . 61.310000000000002 109.681 174.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 29.2 m -112.73 131.31 64.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.358 0.599 . . . . 75.420000000000002 111.183 -175.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 773' ' ' CYS . . . . . 0.47 ' HB3' HG22 ' A' ' 759' ' ' VAL . 7.3 p -99.46 98.75 9.62 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.776 -0.647 . . . . 53.520000000000003 110.462 177.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -100.55 146.32 27.25 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.107 -0.497 . . . . 53.530000000000001 110.233 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 775' ' ' HIS . . . . . . . . . . . . . 1.1 p80 -86.11 17.3 3.67 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.272 0.558 . . . . 72.120000000000005 111.068 -178.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 34.3 t -150.02 140.51 22.44 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.633 -0.712 . . . . 62.539999999999999 109.282 175.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 777' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -66.04 -42.54 89.44 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.5 -0.318 . . . . 62.140000000000001 110.614 -175.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -60.49 -36.39 78.2 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.967 -0.56 . . . . 53.25 110.498 177.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 779' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -70.15 -42.77 72.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.034 -0.53 . . . . 73.030000000000001 110.802 177.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -50.2 -46.66 43.1 Favored Glycine 0 C--N 1.331 0.272 0 O-C-N 123.398 0.436 . . . . 44.219999999999999 113.083 -177.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -65.76 -49.25 69.07 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.781 0.324 . . . . 71.340000000000003 110.911 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -67.66 -46.89 71.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.149 -0.478 . . . . 73.099999999999994 111.771 -175.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -64.59 -37.47 87.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.683 -0.235 . . . . 73.420000000000002 110.63 -177.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -62.34 -52.0 65.39 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.272 -0.422 . . . . 71.0 110.438 177.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 785' ' ' ALA . . . . . 0.651 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -61.58 -43.68 98.41 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.22 -0.445 . . . . 74.120000000000005 110.648 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 786' ' ' ASP . . . . . 0.604 ' O ' ' HG2' ' A' ' 790' ' ' ARG . 8.2 t70 -57.5 -52.67 64.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.869 -0.605 . . . . 63.100000000000001 110.648 178.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 787' ' ' ALA . . . . . 0.514 ' O ' HG23 ' A' ' 791' ' ' VAL . . . -68.09 -27.19 66.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.916 -0.584 . . . . 64.120000000000005 111.285 -176.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 788' ' ' ALA . . . . . 0.668 ' HB2' ' HD3' ' A' ' 770' ' ' PRO . . . -66.72 -41.41 87.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.406 -0.361 . . . . 51.039999999999999 110.567 177.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 789' ' ' LEU . . . . . 0.651 ' HG ' ' O ' ' A' ' 785' ' ' ALA . 21.2 mt -67.27 -34.4 77.34 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.547 -0.538 . . . . 73.030000000000001 109.547 178.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 790' ' ' ARG . . . . . 0.604 ' HG2' ' O ' ' A' ' 786' ' ' ASP . 28.3 mmt180 -55.47 -45.9 76.89 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.142 -0.481 . . . . 73.209999999999994 109.837 175.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 791' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 787' ' ' ALA . 48.7 t -58.66 -52.35 60.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.468 -0.787 . . . . 73.049999999999997 110.581 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 792' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 27.7 mt -61.16 -49.13 78.46 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.522 -0.763 . . . . 71.040000000000006 111.003 -177.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 793' ' ' ILE . . . . . 0.495 HD13 HG22 ' A' ' 720' ' ' VAL . 93.5 mt -63.62 -42.78 97.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.621 -0.718 . . . . 74.239999999999995 110.516 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -62.31 -27.18 68.85 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 121.029 -0.605 . . . . 51.340000000000003 112.569 178.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -77.71 -23.63 49.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.625 0.25 . . . . 75.230000000000004 111.437 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 796' ' ' ASN . . . . . 0.408 ' CB ' HG13 ' A' ' 716' ' ' ILE . 27.6 t-20 -103.95 -25.77 12.89 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 111.942 0.349 . . . . 75.239999999999995 111.942 -177.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 797' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -57.96 110.03 0.85 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.823 0.344 . . . . 74.230000000000004 111.176 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 798' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm 63.7 17.14 10.25 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.407 -0.815 . . . . 72.140000000000001 111.846 176.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 799' ' ' ALA . . . . . . . . . . . . . . . -130.92 149.58 52.48 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.456 -0.338 . . . . 64.230000000000004 110.223 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 800' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -119.43 90.11 3.27 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.947 -0.39 . . . . 63.030000000000001 109.947 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 801' ' ' ARG . . . . . 0.708 ' NE ' ' HA ' ' A' ' 801' ' ' ARG . 3.9 mmp_? . . . . . 0 C--O 1.246 0.912 0 CA-C-O 118.644 -0.694 . . . . 75.120000000000005 109.704 174.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 708' ' ' MET . . . . . 0.417 ' SD ' ' HG3' ' A' ' 709' ' ' MET . 1.3 tmt? . . . . . 0 N--CA 1.476 0.863 0 N-CA-C 109.603 -0.517 . . . . 74.239999999999995 109.603 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . 0.417 ' HG3' ' SD ' ' A' ' 708' ' ' MET . 59.5 mtt -155.32 159.21 31.91 Favored Pre-proline 0 CA--C 1.519 -0.219 0 N-CA-C 109.638 -0.504 . . . . 73.25 109.638 177.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -74.85 -163.97 0.21 Allowed 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.159 1.906 . . . . 71.400000000000006 110.364 167.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 711' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -74.19 76.79 1.79 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.232 0.539 . . . . 71.209999999999994 110.016 175.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 712' ' ' LYS . . . . . 0.437 ' O ' ' HD2' ' A' ' 714' ' ' ARG . 34.2 ttpt -126.45 20.77 7.28 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.883 -0.599 . . . . 72.409999999999997 109.68 176.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 713' ' ' VAL . . . . . . . . . . . . . 61.7 t -55.8 118.23 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 109.115 -0.698 . . . . 71.010000000000005 109.115 175.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.597 ' HB3' HG12 ' A' ' 716' ' ' ILE . 19.9 mmm180 -70.47 -27.24 64.07 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.256 -0.429 . . . . 73.319999999999993 111.336 -171.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt 63.76 24.42 13.81 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.085 -0.507 . . . . 75.439999999999998 110.767 178.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 716' ' ' ILE . . . . . 0.597 HG12 ' HB3' ' A' ' 714' ' ' ARG . 46.7 mm -75.86 -21.23 15.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.445 -0.798 . . . . 63.310000000000002 111.156 -174.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -58.19 -28.77 61.89 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.866 -0.683 . . . . 62.5 112.551 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -68.61 -35.79 77.79 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 122.869 -0.195 . . . . 73.439999999999998 111.275 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 719' ' ' LEU . . . . . 0.589 HD23 ' HA ' ' A' ' 716' ' ' ILE . 3.2 mm? -64.94 -33.82 76.93 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.614 -0.513 . . . . 72.310000000000002 109.614 178.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 720' ' ' VAL . . . . . 0.543 HG22 HD13 ' A' ' 793' ' ' ILE . 45.5 t -66.33 -37.12 78.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.881 -0.599 . . . . 70.430000000000007 109.997 176.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 721' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.49 -32.04 71.05 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.839 -0.619 . . . . 72.209999999999994 110.158 177.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -79.46 -25.7 41.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.844 -0.616 . . . . 72.040000000000006 111.275 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 723' ' ' LEU . . . . . 0.531 HD21 ' HB2' ' A' ' 789' ' ' LEU . 60.1 mt -63.71 -29.95 71.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.991 0.424 . . . . 71.450000000000003 110.282 175.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -85.4 -35.63 21.21 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.653 -0.703 . . . . 71.019999999999996 110.83 176.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 24.7 m -92.55 -79.69 0.39 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.216 -0.447 . . . . 63.32 111.764 -174.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 726' ' ' ASN . . . . . 0.437 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 30.8 t30 -146.29 109.05 4.23 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-O 120.809 0.338 . . . . 74.129999999999995 110.235 -179.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 727' ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 20.0 Cg_endo -61.24 -35.69 83.74 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.707 2.271 . . . . 62.329999999999998 112.436 -178.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 53.2 t -62.76 -48.08 89.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.244 -0.435 . . . . 74.109999999999999 110.615 -178.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -63.55 -33.16 86.5 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.825 -0.703 . . . . 72.310000000000002 111.944 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -71.19 -41.54 59.66 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.252 -0.499 . . . . 74.140000000000001 112.811 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -63.71 -38.94 93.0 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.469 -0.567 . . . . 62.439999999999998 109.469 178.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 732' ' ' LEU . . . . . . . . . . . . . 96.1 mt -69.63 -33.5 72.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.847 -0.615 . . . . 53.43 110.555 176.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 733' ' ' GLU . . . . . 0.568 ' O ' ' HG2' ' A' ' 736' ' ' ARG . 4.2 tp10 -67.95 -48.46 65.81 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 123.016 0.526 . . . . 73.209999999999994 110.417 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 734' ' ' TYR . . . . . 0.558 ' HB2' HD11 ' A' ' 719' ' ' LEU . 8.8 t80 -54.67 -47.19 73.91 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.777 -0.647 . . . . 70.450000000000003 110.642 176.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -67.37 -49.73 62.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.191 -0.459 . . . . 70.230000000000004 110.849 -177.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 736' ' ' ARG . . . . . 0.568 ' HG2' ' O ' ' A' ' 733' ' ' GLU . 13.5 ptm180 -60.41 -38.52 84.28 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.297 -0.41 . . . . 64.329999999999998 111.221 -175.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 32.9 t -77.36 -29.11 53.17 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.123 -0.489 . . . . 73.530000000000001 111.172 -177.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -95.58 -8.19 35.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.82 0.343 . . . . 64.25 111.433 -176.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 93.4 10.89 58.93 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.689 -0.767 . . . . 73.510000000000005 113.118 176.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -93.58 161.61 14.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.965 0.412 . . . . 72.120000000000005 110.734 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -106.89 113.03 26.27 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.796 -0.638 . . . . 72.239999999999995 109.631 176.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 742' ' ' ALA . . . . . . . . . . . . . . . -97.45 126.74 42.89 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.152 -0.477 . . . . 72.420000000000002 110.638 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 743' ' ' GLU . . . . . 0.468 ' HG3' ' HB3' ' A' ' 763' ' ' LYS . 13.4 pt-20 -140.26 140.18 35.69 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.026 0.441 . . . . 64.040000000000006 110.569 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -108.27 114.73 28.83 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.741 -0.663 . . . . 74.019999999999996 109.718 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -120.89 149.91 41.88 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.083 0.468 . . . . 73.409999999999997 111.191 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 746' ' ' LEU . . . . . 0.485 HD21 ' HB3' ' A' ' 749' ' ' GLN . 60.6 tp -91.58 116.82 29.18 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.596 -0.729 . . . . 52.310000000000002 109.825 177.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 47.7 t -79.29 -47.42 22.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.05 -0.523 . . . . 51.229999999999997 110.498 -178.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -154.62 147.46 24.45 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.449 -0.341 . . . . 55.229999999999997 111.064 -179.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 749' ' ' GLN . . . . . 0.485 ' HB3' HD21 ' A' ' 746' ' ' LEU . 17.2 pt20 -129.84 109.98 11.36 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.137 -0.483 . . . . 73.109999999999999 109.864 177.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 27.5 t -155.36 159.28 39.79 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.379 -0.373 . . . . 44.509999999999998 110.385 -175.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 141.25 171.72 12.81 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.699 -0.762 . . . . 70.129999999999995 112.433 176.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 752' ' ' PRO . . . . . 0.772 ' HG2' ' HB2' ' A' ' 755' ' ' GLU . 37.3 Cg_endo -66.94 167.97 18.38 Favored 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 123.089 2.526 . . . . 75.219999999999999 111.906 176.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.46 -31.06 94.09 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.658 2.238 . . . . 75.400000000000006 112.777 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 44.4 p-80 -86.33 -8.09 57.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.889 0.376 . . . . 74.230000000000004 111.022 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 755' ' ' GLU . . . . . 0.772 ' HB2' ' HG2' ' A' ' 752' ' ' PRO . 17.4 mm-40 -142.81 67.12 18.12 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.164 -0.471 . . . . 75.510000000000005 111.622 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 756' ' ' PRO . . . . . 0.519 ' O ' ' HA ' ' A' ' 775' ' ' HIS . 48.1 Cg_endo -71.1 88.13 0.7 Allowed 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 121.845 1.697 . . . . 75.319999999999993 110.084 173.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 757' ' ' LYS . . . . . 0.618 ' HB2' ' HZ2' ' A' ' 757' ' ' LYS . 3.6 ttmp? -87.26 116.25 25.22 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.583 0.706 . . . . 64.010000000000005 111.726 -168.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 758' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -97.83 120.87 39.0 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.88 -1.054 . . . . 72.319999999999993 110.133 177.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 15.9 t -88.84 100.14 10.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 109.239 -0.652 . . . . 42.310000000000002 109.239 177.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -103.93 141.88 35.39 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.012 -0.54 . . . . 74.230000000000004 110.812 -177.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -132.04 136.45 47.24 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.07 -0.513 . . . . 72.120000000000005 109.844 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 762' ' ' ALA . . . . . . . . . . . . . . . -94.5 117.49 30.2 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.226 0.536 . . . . 41.530000000000001 110.388 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 763' ' ' LYS . . . . . 0.68 ' HD2' ' CH2' ' A' ' 768' ' ' TRP . 56.5 tttm -101.74 112.02 24.47 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.996 -0.547 . . . . 65.329999999999998 110.025 178.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 764' ' ' VAL . . . . . 0.41 HG11 ' HE2' ' A' ' 734' ' ' TYR . 89.9 t -117.15 105.99 19.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.17 0.51 . . . . 53.299999999999997 110.041 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 74.22 -115.89 5.04 Favored Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 110.955 -0.858 . . . . 63.340000000000003 110.955 -175.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -110.21 4.24 29.98 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.524 -0.846 . . . . 73.340000000000003 112.348 177.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 767' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -103.48 149.21 25.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.933 0.397 . . . . 74.420000000000002 110.94 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 768' ' ' TRP . . . . . 0.68 ' CH2' ' HD2' ' A' ' 763' ' ' LYS . 58.4 m95 -117.76 104.38 10.92 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.698 -0.683 . . . . 75.510000000000005 109.822 -178.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 769' ' ' PHE . . . . . 0.429 ' HA ' ' HA ' ' A' ' 770' ' ' PRO . 20.0 p90 -172.86 137.84 0.82 Allowed Pre-proline 0 C--N 1.324 -0.524 0 CA-C-O 121.065 0.46 . . . . 74.109999999999999 110.925 -177.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 770' ' ' PRO . . . . . 0.615 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 71.4 Cg_endo -97.16 176.9 8.68 Favored 'Cis proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.381 -1.508 . . . . 73.540000000000006 112.093 -3.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -112.51 109.73 19.48 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.536 -0.542 . . . . 64.239999999999995 109.536 173.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 34.1 m -116.61 174.8 3.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.039 -0.528 . . . . 75.230000000000004 110.891 -174.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 11.8 p -138.08 129.05 27.12 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.856 -0.611 . . . . 70.329999999999998 110.615 178.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 774' ' ' ALA . . . . . 0.413 ' HB2' ' HG3' ' A' ' 783' ' ' GLU . . . -140.04 153.76 46.9 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.984 -0.553 . . . . 72.400000000000006 109.963 178.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 775' ' ' HIS . . . . . 0.519 ' HA ' ' O ' ' A' ' 756' ' ' PRO . 1.5 p-80 -86.3 12.58 9.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.181 0.515 . . . . 70.209999999999994 111.151 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 776' ' ' SER . . . . . 0.419 ' HB3' ' HB2' ' A' ' 779' ' ' GLN . 40.7 t -138.22 141.2 39.98 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.79 -0.641 . . . . 75.409999999999997 109.361 176.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 777' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -68.07 -41.91 81.25 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.267 -0.424 . . . . 75.340000000000003 110.17 -178.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -64.99 -40.74 95.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.991 -0.55 . . . . 63.439999999999998 110.075 178.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 779' ' ' GLN . . . . . 0.516 ' O ' ' HG2' ' A' ' 783' ' ' GLU . 49.1 mt-30 -63.18 -44.14 96.25 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 116.155 -0.475 . . . . 71.530000000000001 110.791 177.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -51.65 -42.21 51.6 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 121.317 -0.468 . . . . 55.229999999999997 112.857 -178.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -62.81 -47.65 82.54 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.349 0.595 . . . . 73.219999999999999 110.682 177.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -69.1 -41.9 76.85 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.291 -0.868 . . . . 74.019999999999996 111.401 -176.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 783' ' ' GLU . . . . . 0.516 ' HG2' ' O ' ' A' ' 779' ' ' GLN . 25.5 mm-40 -57.53 -46.3 84.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.069 0.462 . . . . 74.340000000000003 110.1 177.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -63.45 -49.53 73.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.675 -0.693 . . . . 53.439999999999998 110.803 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 785' ' ' ALA . . . . . 0.481 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -63.15 -40.66 98.21 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.284 -0.417 . . . . 74.0 111.33 -178.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 786' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -58.38 -54.75 43.5 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.148 0.499 . . . . 74.129999999999995 110.319 177.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 787' ' ' ALA . . . . . 0.617 ' O ' HG23 ' A' ' 791' ' ' VAL . . . -61.3 -40.43 94.15 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.425 -0.807 . . . . 64.239999999999995 110.708 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 788' ' ' ALA . . . . . 0.705 ' O ' ' HG ' ' A' ' 792' ' ' LEU . . . -56.93 -49.9 74.23 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.17 -0.468 . . . . 43.109999999999999 111.33 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 789' ' ' LEU . . . . . 0.575 HD22 HD12 ' A' ' 719' ' ' LEU . 80.2 mt -61.05 -43.16 99.3 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 110.156 -0.313 . . . . 70.129999999999995 110.156 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 790' ' ' ARG . . . . . . . . . . . . . 52.8 mtp180 -59.54 -36.17 75.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.124 -0.489 . . . . 73.310000000000002 111.328 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 791' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 787' ' ' ALA . 64.4 t -64.61 -54.05 35.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 109.845 -0.428 . . . . 73.140000000000001 109.845 173.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 792' ' ' LEU . . . . . 0.705 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 45.6 mt -55.73 -48.68 74.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.69 -0.686 . . . . 73.209999999999994 111.185 -177.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 793' ' ' ILE . . . . . 0.543 HD13 HG22 ' A' ' 720' ' ' VAL . 93.0 mt -59.41 -52.27 62.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.588 -0.733 . . . . 74.409999999999997 110.933 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -64.58 -44.0 95.7 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.672 -0.775 . . . . 53.310000000000002 112.48 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -64.82 -47.69 77.1 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.745 0.276 . . . . 74.319999999999993 111.745 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 796' ' ' ASN . . . . . 0.456 HD22 ' HA ' ' A' ' 796' ' ' ASN . 1.0 OUTLIER -72.14 -26.57 62.16 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.708 -0.397 . . . . 75.25 110.709 -175.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 797' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -72.92 -46.22 53.83 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.123 0.487 . . . . 71.219999999999999 109.967 174.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 798' ' ' LYS . . . . . . . . . . . . . 24.4 ttpp -64.42 -38.08 89.79 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.655 -0.702 . . . . 54.109999999999999 110.877 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 799' ' ' ALA . . . . . . . . . . . . . . . -72.77 -51.98 16.89 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.325 -0.398 . . . . 64.109999999999999 110.597 175.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 800' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 60.07 31.29 20.53 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.733 0.778 . . . . 75.150000000000006 110.285 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 801' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 . . . . . 0 C--O 1.245 0.868 0 CA-C-O 118.397 -0.811 . . . . 74.409999999999997 109.986 179.364 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 708' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 N--CA 1.479 1.004 0 CA-C-O 120.911 0.386 . . . . 72.400000000000006 110.274 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 60.1 mtm -131.62 92.24 31.74 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 116.396 -0.366 . . . . 73.109999999999999 111.376 -178.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -80.84 -5.95 13.2 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.184 1.923 . . . . 72.329999999999998 110.577 170.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 711' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -84.68 101.32 12.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.814 -1.084 . . . . 74.209999999999994 109.98 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 712' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -102.86 -14.73 16.45 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.162 0.506 . . . . 62.329999999999998 110.158 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 713' ' ' VAL . . . . . . . . . . . . . 12.4 p -140.82 146.04 24.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.494 -0.776 . . . . 64.409999999999997 109.182 176.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . . . . . . . . . 2.1 tpm_? -59.36 120.42 9.27 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 123.188 0.305 . . . . 74.140000000000001 110.419 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 715' ' ' LYS . . . . . 0.43 ' HD3' ' HA ' ' A' ' 715' ' ' LYS . 67.2 mmtt -117.05 163.19 16.62 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.091 0.472 . . . . 65.430000000000007 111.565 -177.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 716' ' ' ILE . . . . . 0.614 ' HA ' HD23 ' A' ' 719' ' ' LEU . 46.2 mm -73.03 -30.33 31.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 CA-C-N 115.651 -0.704 . . . . 74.230000000000004 111.43 -176.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -59.17 -24.5 58.78 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.967 -0.635 . . . . 72.340000000000003 112.0 177.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -71.42 -36.02 71.17 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 120.469 0.176 . . . . 75.120000000000005 110.783 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 719' ' ' LEU . . . . . 0.659 HD12 HD22 ' A' ' 789' ' ' LEU . 3.3 mm? -63.14 -32.87 74.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.026 0.441 . . . . 72.530000000000001 109.873 178.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 720' ' ' VAL . . . . . 0.499 HG22 HD13 ' A' ' 793' ' ' ILE . 47.7 t -63.68 -38.73 83.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 115.887 -0.597 . . . . 71.209999999999994 110.171 174.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 721' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -67.07 -32.32 73.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.769 -0.651 . . . . 51.329999999999998 110.049 178.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -70.99 -32.95 69.91 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-N 116.206 -0.452 . . . . 62.420000000000002 110.747 177.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 723' ' ' LEU . . . . . 0.591 HD21 ' HB2' ' A' ' 789' ' ' LEU . 96.1 mt -56.31 -33.51 65.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.232 0.539 . . . . 74.109999999999999 110.163 174.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -77.76 -48.7 15.99 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.574 -0.739 . . . . 73.040000000000006 111.654 177.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 33.7 m -92.28 -67.81 0.83 Allowed 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.445 0.535 . . . . 64.239999999999995 112.445 -172.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 726' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -146.36 102.85 4.03 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 120.64 0.257 . . . . 73.450000000000003 110.439 -178.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 727' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -62.86 -38.02 51.03 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.773 2.315 . . . . 74.530000000000001 112.035 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 46.7 t -62.69 -47.48 92.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.003 -0.544 . . . . 54.030000000000001 110.644 -177.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -62.68 -38.82 97.08 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.793 -0.717 . . . . 23.43 111.624 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -66.1 -42.84 94.27 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 121.069 -0.586 . . . . 74.120000000000005 112.728 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -62.21 -44.67 96.06 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.027 0.441 . . . . 74.340000000000003 109.991 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 732' ' ' LEU . . . . . . . . . . . . . 87.8 mt -67.93 -36.94 81.01 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.033 -0.531 . . . . 72.219999999999999 110.881 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 733' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -69.82 -43.35 72.19 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 122.834 0.454 . . . . 71.5 110.831 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 734' ' ' TYR . . . . . 0.514 ' HB2' HD11 ' A' ' 719' ' ' LEU . 8.5 t80 -55.21 -48.17 74.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.928 0.394 . . . . 64.5 110.373 176.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -66.46 -50.45 63.29 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.868 -0.605 . . . . 71.310000000000002 110.97 -177.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 736' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -63.66 -31.1 72.17 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.03 0.443 . . . . 74.439999999999998 111.191 -175.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 34.8 t -77.13 -29.39 54.69 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.905 -0.589 . . . . 53.219999999999999 111.011 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 16.4 m170 -98.63 -11.52 21.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.815 0.34 . . . . 73.219999999999999 111.655 -176.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 103.63 -4.26 46.71 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.733 -0.746 . . . . 64.219999999999999 112.971 177.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -79.26 157.77 27.71 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.847 0.356 . . . . 64.209999999999994 110.494 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -102.99 122.81 45.37 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.148 -0.686 . . . . 60.100000000000001 109.148 175.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 742' ' ' ALA . . . . . 0.514 ' HA ' ' O ' ' A' ' 763' ' ' LYS . . . -114.16 122.64 47.45 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 123.379 0.424 . . . . 63.310000000000002 111.076 -176.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 743' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -145.3 138.36 26.33 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.176 -0.465 . . . . 65.310000000000002 110.844 178.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -101.15 110.83 22.91 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.842 -0.617 . . . . 64.319999999999993 109.457 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -115.68 148.85 39.25 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.062 0.458 . . . . 74.150000000000006 110.886 -179.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 746' ' ' LEU . . . . . . . . . . . . . 59.2 tp -77.88 117.45 19.25 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.682 -0.69 . . . . 73.319999999999993 110.229 178.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 93.6 t -72.83 -51.45 27.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 116.111 -0.495 . . . . 72.239999999999995 109.807 176.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -169.57 155.65 6.18 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.655 -0.702 . . . . 64.299999999999997 109.899 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 749' ' ' GLN . . . . . 0.554 ' HA ' ' O ' ' A' ' 757' ' ' LYS . 14.7 pt20 -130.69 98.97 4.8 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.413 0.625 . . . . 63.200000000000003 110.323 175.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 35.7 m -141.96 133.57 26.86 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.676 -0.693 . . . . 63.409999999999997 110.695 -177.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 170.04 -172.6 43.91 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 121.081 -0.581 . . . . 55.229999999999997 111.764 178.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 752' ' ' PRO . . . . . 0.836 ' HG2' ' HB2' ' A' ' 755' ' ' GLU . 39.0 Cg_endo -67.56 157.9 59.61 Favored 'Trans proline' 0 N--CA 1.464 -0.217 0 C-N-CA 122.774 2.316 . . . . 71.019999999999996 111.569 177.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -58.73 -32.35 96.79 Favored 'Trans proline' 0 CA--C 1.532 0.405 0 C-N-CA 122.52 2.146 . . . . 73.5 113.109 -177.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 47.9 p-80 -83.04 -18.59 39.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.958 0.408 . . . . 75.430000000000007 111.081 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 755' ' ' GLU . . . . . 0.836 ' HB2' ' HG2' ' A' ' 752' ' ' PRO . 58.9 mm-40 -129.4 74.1 81.16 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.114 -0.493 . . . . 74.230000000000004 110.832 179.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 756' ' ' PRO . . . . . 0.725 ' O ' ' HA ' ' A' ' 775' ' ' HIS . 29.5 Cg_endo -64.51 102.6 0.41 Allowed 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.083 1.855 . . . . 65.120000000000005 110.23 174.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 757' ' ' LYS . . . . . 0.554 ' O ' ' HA ' ' A' ' 749' ' ' GLN . 0.8 OUTLIER -89.51 105.43 17.79 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.088 0.471 . . . . 73.140000000000001 111.366 -170.01 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 758' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -92.29 110.11 21.5 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.464 -0.789 . . . . 73.319999999999993 109.752 177.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 13.8 t -84.57 109.24 17.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.607 -0.724 . . . . 62.310000000000002 109.423 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -110.81 135.79 50.84 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.269 -0.423 . . . . 72.400000000000006 110.895 -178.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 761' ' ' GLN . . . . . 0.567 ' HA ' ' O ' ' A' ' 770' ' ' PRO . 57.7 tt0 -128.35 130.85 48.37 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.119 -0.491 . . . . 74.209999999999994 109.973 179.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 762' ' ' ALA . . . . . . . . . . . . . . . -89.59 117.73 28.7 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.18 0.514 . . . . 45.450000000000003 110.749 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 763' ' ' LYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 742' ' ' ALA . 60.5 tttm -89.62 113.98 25.51 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.222 -0.658 . . . . 64.430000000000007 109.222 175.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 92.8 t -124.0 101.35 8.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.363 0.601 . . . . 73.140000000000001 110.162 178.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 73.14 -116.05 5.39 Favored Glycine 0 N--CA 1.442 -0.923 0 CA-C-N 115.187 -0.915 . . . . 74.099999999999994 111.426 -177.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -102.36 -11.23 36.69 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.801 -0.714 . . . . 73.239999999999995 111.998 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 767' ' ' ARG . . . . . . . . . . . . . 62.9 mtt180 -99.81 146.28 26.78 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.259 0.552 . . . . 64.319999999999993 111.673 -178.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 768' ' ' TRP . . . . . 0.467 ' CH2' ' HD2' ' A' ' 763' ' ' LYS . 63.0 m95 -111.77 107.36 16.41 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.208 -0.905 . . . . 74.329999999999998 109.404 179.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 769' ' ' PHE . . . . . 0.503 ' HA ' ' HA ' ' A' ' 770' ' ' PRO . 43.1 p90 -169.19 141.0 2.02 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-O 121.048 0.452 . . . . 75.239999999999995 111.124 -176.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 770' ' ' PRO . . . . . 0.726 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 74.8 Cg_endo -98.46 176.94 7.65 Favored 'Cis proline' 0 N--CA 1.449 -1.089 0 C-N-CA 123.301 -1.541 . . . . 75.430000000000007 111.397 -5.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -111.55 99.29 8.07 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.991 0.424 . . . . 71.310000000000002 109.978 173.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 34.4 m -106.22 161.04 5.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.881 -0.6 . . . . 75.129999999999995 110.926 -177.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 773' ' ' CYS . . . . . 0.433 ' HB3' ' CG ' ' A' ' 757' ' ' LYS . 39.3 m -125.58 114.25 18.49 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.219 -0.446 . . . . 54.020000000000003 110.633 -178.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -128.61 153.48 47.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.224 -0.443 . . . . 53.32 109.947 178.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 775' ' ' HIS . . . . . 0.725 ' HA ' ' O ' ' A' ' 756' ' ' PRO . 1.9 p-80 -84.11 19.47 1.8 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.992 0.425 . . . . 73.299999999999997 111.492 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 24.9 t -153.32 143.19 22.06 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.396 -0.594 . . . . 75.219999999999999 109.396 175.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 777' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -60.65 -55.24 35.68 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.163 -0.472 . . . . 73.019999999999996 111.97 -175.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -65.92 -31.41 72.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.558 -0.292 . . . . 74.129999999999995 110.592 -175.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 779' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -62.0 -46.74 87.88 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.486 -0.561 . . . . 74.099999999999994 109.486 172.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -56.88 -47.73 84.19 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.698 -0.683 . . . . 52.439999999999998 112.169 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -59.21 -43.89 92.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.534 0.207 . . . . 75.450000000000003 111.364 177.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -68.58 -46.37 69.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.706 -0.225 . . . . 71.450000000000003 111.441 -178.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -64.05 -39.27 93.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.653 0.263 . . . . 72.340000000000003 110.522 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -62.37 -49.39 75.73 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 116.254 -0.43 . . . . 62.43 110.438 176.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 785' ' ' ALA . . . . . 0.596 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -61.38 -42.17 98.28 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.181 -0.463 . . . . 53.32 111.151 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 786' ' ' ASP . . . . . 0.622 ' O ' ' HG2' ' A' ' 790' ' ' ARG . 10.4 t70 -58.91 -54.22 49.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 70.129999999999995 110.375 178.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 787' ' ' ALA . . . . . 0.558 ' O ' HG23 ' A' ' 791' ' ' VAL . . . -65.41 -33.91 77.06 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.966 -0.561 . . . . 63.439999999999998 111.097 -178.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 788' ' ' ALA . . . . . 0.726 ' HB2' ' HD3' ' A' ' 770' ' ' PRO . . . -61.3 -44.52 97.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.476 -0.329 . . . . 61.200000000000003 110.729 177.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 789' ' ' LEU . . . . . 0.659 HD22 HD12 ' A' ' 719' ' ' LEU . 53.3 mt -63.19 -36.16 82.71 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.483 -0.326 . . . . 74.209999999999994 110.199 179.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 790' ' ' ARG . . . . . 0.622 ' HG2' ' O ' ' A' ' 786' ' ' ASP . 21.2 mmt180 -58.15 -45.63 87.06 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 109.739 -0.467 . . . . 71.120000000000005 109.739 177.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 791' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 787' ' ' ALA . 30.4 t -61.34 -46.71 96.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.62 -0.718 . . . . 74.140000000000001 110.388 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 792' ' ' LEU . . . . . 0.676 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 45.8 mt -62.2 -50.65 70.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.665 -0.698 . . . . 75.120000000000005 110.915 -178.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 793' ' ' ILE . . . . . 0.499 HD13 HG22 ' A' ' 720' ' ' VAL . 91.4 mt -59.25 -53.81 42.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.587 -0.733 . . . . 64.299999999999997 110.774 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -60.5 -31.85 75.92 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.857 -0.687 . . . . 61.420000000000002 112.615 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 795' ' ' GLU . . . . . 0.58 ' HA ' ' HE3' ' A' ' 798' ' ' LYS . 3.5 tm-20 -65.23 -48.27 73.89 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.145 0.497 . . . . 75.209999999999994 109.991 178.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -80.0 -24.94 40.5 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.054 -0.521 . . . . 71.310000000000002 111.623 -175.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 797' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -63.91 -21.63 66.56 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.043 0.386 . . . . 74.299999999999997 112.043 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 798' ' ' LYS . . . . . 0.58 ' HE3' ' HA ' ' A' ' 795' ' ' GLU . 0.0 OUTLIER -114.61 26.96 9.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.362 0.601 . . . . 70.140000000000001 110.866 177.842 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 799' ' ' ALA . . . . . . . . . . . . . . . -94.99 91.53 6.42 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.708 -0.678 . . . . 71.420000000000002 109.422 177.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 800' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 71.27 9.56 6.59 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.068 -0.969 . . . . 61.149999999999999 111.047 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 801' ' ' ARG . . . . . . . . . . . . . 26.0 mmm180 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.406 -0.806 . . . . 72.349999999999994 110.57 -177.413 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 708' ' ' MET . . . . . . . . . . . . . 22.8 ptp . . . . . 0 N--CA 1.479 0.98 0 CA-C-O 120.76 0.314 . . . . 70.109999999999999 110.495 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 67.4 mtt -93.32 158.81 36.46 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.231 -0.441 . . . . 63.450000000000003 110.076 177.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.46 46.64 1.67 Allowed 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 122.99 2.46 . . . . 74.420000000000002 112.231 177.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 711' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -57.55 140.96 49.47 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.862 -0.608 . . . . 75.25 111.698 -177.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 712' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -98.8 118.29 35.2 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.438 -0.801 . . . . 73.239999999999995 110.247 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 713' ' ' VAL . . . . . . . . . . . . . 27.4 m -80.46 -177.27 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.873 -0.603 . . . . 52.420000000000002 110.944 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . . . . . . . . . 9.8 ptp180 -75.41 64.15 1.53 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.367 0.604 . . . . 75.25 111.296 178.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -74.48 101.55 4.19 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.37 -0.832 . . . . 64.120000000000005 109.044 175.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 716' ' ' ILE . . . . . 0.436 ' HA ' HD23 ' A' ' 719' ' ' LEU . 50.1 mm -71.53 -27.76 29.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.906 -0.588 . . . . 64.219999999999999 111.398 -173.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -56.45 -29.53 57.35 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 121.187 -0.53 . . . . 41.450000000000003 112.435 177.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 718' ' ' GLU . . . . . 0.614 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 9.3 mm-40 -60.57 -53.36 58.42 Favored 'General case' 0 C--O 1.225 -0.236 0 N-CA-C 109.985 -0.376 . . . . 74.430000000000007 109.985 176.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 719' ' ' LEU . . . . . 0.547 HD12 HD22 ' A' ' 789' ' ' LEU . 2.7 mm? -60.35 -35.88 76.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.042 -0.527 . . . . 70.109999999999999 110.461 -177.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 720' ' ' VAL . . . . . 0.442 HG22 HD13 ' A' ' 793' ' ' ILE . 58.7 t -62.09 -41.37 90.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 116.07 -0.514 . . . . 73.319999999999993 110.871 178.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 721' ' ' ARG . . . . . 0.614 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 19.1 ptt180 -66.82 -26.05 66.74 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.308 -0.405 . . . . 54.200000000000003 110.064 -178.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -77.33 -30.67 54.12 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 116.293 -0.412 . . . . 74.409999999999997 110.787 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 723' ' ' LEU . . . . . 0.529 HD21 ' HB2' ' A' ' 789' ' ' LEU . 55.8 mt -64.01 -23.97 67.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.167 0.508 . . . . 74.030000000000001 110.002 173.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -89.51 -26.38 20.92 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.748 -0.66 . . . . 71.209999999999994 110.989 176.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 10.9 m -106.29 -77.47 0.59 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.909 0.385 . . . . 74.430000000000007 111.407 -175.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 726' ' ' ASN . . . . . 0.434 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 29.3 t30 -145.31 108.19 4.51 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.347 -0.388 . . . . 72.439999999999998 110.231 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 727' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 13.6 Cg_endo -57.6 -38.48 93.45 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.966 2.444 . . . . 60.030000000000001 112.413 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 728' ' ' VAL . . . . . 0.411 ' O ' ' HG ' ' A' ' 732' ' ' LEU . 55.8 t -60.57 -47.5 92.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.244 -0.434 . . . . 72.120000000000005 110.34 -179.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -62.43 -32.28 82.47 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.67 -0.695 . . . . 44.439999999999998 111.822 178.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -67.89 -43.73 81.92 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.092 -0.575 . . . . 71.439999999999998 112.461 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -64.9 -40.46 95.11 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.633 -0.506 . . . . 72.450000000000003 109.633 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 732' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 728' ' ' VAL . 84.6 mt -63.67 -41.51 98.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.842 -0.617 . . . . 64.040000000000006 110.451 176.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 733' ' ' GLU . . . . . 0.483 ' O ' ' HG2' ' A' ' 736' ' ' ARG . 2.5 tp10 -65.55 -44.59 86.31 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 123.052 0.541 . . . . 74.129999999999995 110.86 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 734' ' ' TYR . . . . . 0.478 ' HB2' HD11 ' A' ' 719' ' ' LEU . 27.1 t80 -56.23 -51.63 67.4 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.974 -0.557 . . . . 72.340000000000003 111.08 178.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -66.13 -46.86 76.04 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.393 -0.367 . . . . 64.010000000000005 111.291 -177.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 736' ' ' ARG . . . . . 0.483 ' HG2' ' O ' ' A' ' 733' ' ' GLU . 25.7 ptt180 -64.32 -29.34 70.42 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.201 0.524 . . . . 71.099999999999994 111.239 -175.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 33.8 t -83.64 -35.11 24.84 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.778 -0.646 . . . . 64.430000000000007 111.222 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 13.2 m170 -93.6 -10.29 35.18 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.201 0.445 . . . . 70.120000000000005 112.201 -172.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 103.1 3.92 48.05 Favored Glycine 0 N--CA 1.453 -0.172 0 C-N-CA 120.417 -0.897 . . . . 73.519999999999996 112.751 176.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -90.91 178.29 6.07 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.042 0.448 . . . . 71.099999999999994 110.542 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 741' ' ' ALA . . . . . 0.529 ' O ' ' HA ' ' A' ' 764' ' ' VAL . . . -120.16 134.55 55.23 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.847 -0.615 . . . . 55.140000000000001 109.492 174.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 742' ' ' ALA . . . . . 0.403 ' HB3' HD23 ' A' ' 732' ' ' LEU . . . -102.18 113.29 26.44 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.526 -0.306 . . . . 70.439999999999998 110.808 -177.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 743' ' ' GLU . . . . . 0.552 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 46.2 mt-10 -123.84 140.62 52.81 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.172 -0.467 . . . . 63.210000000000001 110.818 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -121.96 105.15 10.06 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.569 -0.53 . . . . 74.439999999999998 109.569 176.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.52 153.3 35.57 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.566 -0.454 . . . . 62.450000000000003 111.453 -177.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 746' ' ' LEU . . . . . . . . . . . . . 57.0 tp -82.03 116.14 21.5 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.473 -0.785 . . . . 54.32 109.407 173.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 52.2 t -88.06 -47.72 15.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 116.292 -0.413 . . . . 70.530000000000001 110.323 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -141.42 143.97 34.21 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.203 -0.453 . . . . 70.120000000000005 111.261 -176.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -130.06 100.6 5.49 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.816 -0.629 . . . . 74.430000000000007 109.395 174.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 750' ' ' SER . . . . . 0.418 ' O ' ' HB3' ' A' ' 757' ' ' LYS . 20.1 m -136.37 110.53 8.35 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.993 -0.548 . . . . 45.229999999999997 110.547 -177.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 174.15 177.9 43.67 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.976 -0.631 . . . . 64.450000000000003 111.803 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 752' ' ' PRO . . . . . 0.42 ' HG2' ' HB2' ' A' ' 755' ' ' GLU . 55.7 Cg_endo -71.01 155.87 61.06 Favored 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 122.85 2.367 . . . . 72.120000000000005 111.959 178.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -64.82 -30.29 58.62 Favored 'Trans proline' 0 CA--C 1.528 0.202 0 C-N-CA 122.603 2.202 . . . . 63.439999999999998 112.975 -176.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 56.0 p-80 -84.35 -23.61 30.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.772 0.32 . . . . 74.5 111.024 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 755' ' ' GLU . . . . . 0.42 ' HB2' ' HG2' ' A' ' 752' ' ' PRO . 23.8 mm-40 -133.01 71.7 77.55 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.147 -0.479 . . . . 73.420000000000002 110.431 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 756' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -64.41 143.13 81.55 Favored 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 122.362 2.041 . . . . 70.310000000000002 112.08 -176.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 757' ' ' LYS . . . . . 0.418 ' HB3' ' O ' ' A' ' 750' ' ' SER . 23.3 ttmm -116.44 114.93 24.92 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.054 -0.521 . . . . 64.340000000000003 109.735 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 758' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -107.02 113.08 26.34 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.889 -0.596 . . . . 71.319999999999993 110.663 -177.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 759' ' ' VAL . . . . . 0.471 HG22 ' HB3' ' A' ' 773' ' ' CYS . 29.1 t -87.26 98.11 7.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.848 -0.615 . . . . 60.350000000000001 109.556 176.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 760' ' ' TYR . . . . . 0.537 ' OH ' ' HG3' ' A' ' 777' ' ' LYS . 6.3 m-85 -100.1 143.04 30.77 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.893 -0.594 . . . . 45.149999999999999 110.236 179.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -131.77 137.44 48.18 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.12 -0.491 . . . . 53.310000000000002 109.695 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 762' ' ' ALA . . . . . . . . . . . . . . . -86.28 114.01 22.74 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.037 -0.529 . . . . 55.329999999999998 110.489 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 763' ' ' LYS . . . . . 0.552 ' HB3' ' HB2' ' A' ' 743' ' ' GLU . 59.3 tttm -96.82 100.44 11.98 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.771 -0.65 . . . . 65.030000000000001 109.699 178.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 764' ' ' VAL . . . . . 0.529 ' HA ' ' O ' ' A' ' 741' ' ' ALA . 61.1 t -104.21 100.81 11.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 N-CA-C 109.448 -0.575 . . . . 70.239999999999995 109.448 -179.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 69.96 -122.49 11.66 Favored Glycine 0 N--CA 1.442 -0.904 0 N-CA-C 110.479 -1.048 . . . . 73.549999999999997 110.479 -172.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -104.01 20.21 41.48 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.596 -0.811 . . . . 51.43 111.545 174.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 767' ' ' ARG . . . . . . . . . . . . . 41.6 ttt180 -115.53 122.76 46.65 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.735 0.302 . . . . 74.400000000000006 110.394 -176.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 768' ' ' TRP . . . . . 0.488 ' CH2' ' HD2' ' A' ' 763' ' ' LYS . 44.1 m95 -98.21 103.18 15.1 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.243 -0.435 . . . . 73.120000000000005 110.204 -178.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 769' ' ' PHE . . . . . 0.405 ' HA ' ' HA ' ' A' ' 770' ' ' PRO . 9.3 p90 -171.56 138.97 1.11 Allowed Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 120.822 0.344 . . . . 65.409999999999997 110.554 178.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 770' ' ' PRO . . . . . 0.633 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 82.8 Cg_endo -96.58 -176.49 5.16 Favored 'Cis proline' 0 N--CA 1.452 -0.947 0 C-N-CA 123.622 -1.407 . . . . 60.43 111.769 -4.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -117.4 129.79 56.07 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.077 -0.342 . . . . 32.130000000000003 110.077 176.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 30.7 m -136.63 145.97 29.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.748 0.309 . . . . 35.409999999999997 111.044 -178.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 773' ' ' CYS . . . . . 0.471 ' HB3' HG22 ' A' ' 759' ' ' VAL . 5.0 p -113.36 103.39 11.26 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.105 0.479 . . . . 74.030000000000001 110.695 178.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -106.43 -179.24 3.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.291 -0.413 . . . . 53.409999999999997 111.125 -176.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 775' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 -93.77 -8.65 40.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.286 0.565 . . . . 74.230000000000004 110.231 -177.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 63.6 m -150.75 166.05 31.63 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.754 -0.657 . . . . 50.539999999999999 110.403 -179.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 777' ' ' LYS . . . . . 0.537 ' HG3' ' OH ' ' A' ' 760' ' ' TYR . 31.2 ttmt -64.33 -57.64 8.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.269 -0.423 . . . . 74.219999999999999 111.741 -178.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -61.67 -35.96 79.47 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.054 -0.521 . . . . 65.340000000000003 110.039 -175.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 779' ' ' GLN . . . . . 0.474 ' O ' ' HG2' ' A' ' 783' ' ' GLU . 73.9 mt-30 -52.91 -56.2 17.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 75.25 110.18 170.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -57.37 -47.68 86.21 Favored Glycine 0 C--N 1.332 0.33 0 CA-C-N 115.698 -0.683 . . . . 34.340000000000003 112.764 -177.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -57.48 -44.52 84.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.754 0.311 . . . . 71.439999999999998 111.177 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -69.83 -45.18 68.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.418 -0.356 . . . . 74.120000000000005 111.176 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 783' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' A' ' 779' ' ' GLN . 30.0 mm-40 -59.86 -40.39 88.43 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.902 0.382 . . . . 52.520000000000003 110.768 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -65.38 -49.87 67.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 72.219999999999999 110.612 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 785' ' ' ALA . . . . . 0.513 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -64.79 -40.09 94.66 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.312 -0.404 . . . . 65.230000000000004 111.18 -178.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 786' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -60.76 -50.05 75.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.984 -0.553 . . . . 51.140000000000001 110.108 178.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 787' ' ' ALA . . . . . 0.616 ' O ' HG23 ' A' ' 791' ' ' VAL . . . -62.6 -39.64 94.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.757 -0.656 . . . . 72.239999999999995 110.712 178.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 788' ' ' ALA . . . . . 0.633 ' HB2' ' HD3' ' A' ' 770' ' ' PRO . . . -59.05 -47.36 85.53 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.072 -0.513 . . . . 64.109999999999999 111.338 -179.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 789' ' ' LEU . . . . . 0.547 HD22 HD12 ' A' ' 719' ' ' LEU . 77.9 mt -61.42 -41.77 97.69 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 110.109 -0.33 . . . . 75.200000000000003 110.109 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 790' ' ' ARG . . . . . 0.552 ' HD2' ' HA ' ' A' ' 787' ' ' ALA . 69.8 mtt-85 -57.38 -39.36 75.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 73.230000000000004 110.943 176.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 791' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 787' ' ' ALA . 60.1 t -63.33 -57.31 12.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.102 -0.499 . . . . 62.140000000000001 110.037 176.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 792' ' ' LEU . . . . . 0.595 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 37.1 mt -55.93 -47.72 77.01 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.487 -0.779 . . . . 75.409999999999997 111.522 -176.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 793' ' ' ILE . . . . . 0.442 HD13 HG22 ' A' ' 720' ' ' VAL . 95.7 mt -61.14 -46.47 96.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.795 -0.639 . . . . 72.329999999999998 110.934 178.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -60.69 -39.46 96.66 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.949 -0.643 . . . . 71.140000000000001 112.252 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 795' ' ' GLU . . . . . 0.935 ' HA ' ' HG3' ' A' ' 801' ' ' ARG . 21.5 mm-40 -52.44 -44.13 65.31 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.08 0.467 . . . . 74.549999999999997 110.901 177.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -84.26 -45.4 12.9 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.934 -0.575 . . . . 55.210000000000001 112.008 -175.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 797' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -66.16 -39.58 89.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.441 -0.345 . . . . 71.349999999999994 111.482 -174.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 798' ' ' LYS . . . . . . . . . . . . . 45.8 mtpt -78.14 -43.52 28.61 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.243 -0.651 . . . . 55.520000000000003 109.243 175.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 799' ' ' ALA . . . . . . . . . . . . . . . 63.6 8.37 3.62 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.594 -0.73 . . . . 54.439999999999998 112.322 175.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 800' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.27 20.32 18.8 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.823 0.82 . . . . 62.329999999999998 108.964 173.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 801' ' ' ARG . . . . . 0.935 ' HG3' ' HA ' ' A' ' 795' ' ' GLU . 30.9 mmm180 . . . . . 0 C--O 1.247 0.936 0 CA-C-N 114.288 -1.324 . . . . 75.400000000000006 109.826 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 708' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.998 0 N-CA-C 109.978 -0.379 . . . . 73.430000000000007 109.978 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 22.9 ptt? -109.11 112.36 59.83 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.309 -0.405 . . . . 64.25 110.122 177.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -67.34 101.25 0.61 Allowed 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.546 2.164 . . . . 65.549999999999997 111.896 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 711' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -110.5 85.27 2.08 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.235 -0.439 . . . . 75.129999999999995 110.963 -177.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 712' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -86.24 -25.12 25.74 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.379 -0.6 . . . . 72.120000000000005 109.379 173.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 713' ' ' VAL . . . . . . . . . . . . . 3.6 p -128.4 104.02 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-N 115.203 -0.908 . . . . 73.120000000000005 109.781 173.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -71.46 96.34 1.49 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.823 0.821 . . . . 74.349999999999994 109.948 177.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 715' ' ' LYS . . . . . 0.864 ' HG2' ' HB2' ' A' ' 718' ' ' GLU . 45.2 tttp -87.97 17.97 4.55 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.811 -1.086 . . . . 70.430000000000007 110.419 -174.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 716' ' ' ILE . . . . . 0.537 HG23 ' HA ' ' A' ' 793' ' ' ILE . 38.5 mm -52.48 -47.15 48.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.345 -0.843 . . . . 70.530000000000001 112.694 -171.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -63.81 -30.66 78.35 Favored Glycine 0 C--O 1.237 0.29 0 C-N-CA 120.785 -0.721 . . . . 34.549999999999997 112.358 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 718' ' ' GLU . . . . . 0.864 ' HB2' ' HG2' ' A' ' 715' ' ' LYS . 35.4 mt-10 -73.03 -37.84 66.75 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 110.127 -0.323 . . . . 75.030000000000001 110.127 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 719' ' ' LEU . . . . . 0.705 HD12 HD22 ' A' ' 789' ' ' LEU . 2.6 mm? -58.1 -35.04 70.85 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.013 0.435 . . . . 75.219999999999999 110.308 175.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 720' ' ' VAL . . . . . 0.48 HG22 HD13 ' A' ' 793' ' ' ILE . 71.6 t -61.92 -41.16 89.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.856 -0.611 . . . . 71.219999999999999 110.997 178.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 721' ' ' ARG . . . . . 0.658 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 8.2 ptt180 -65.15 -25.35 67.71 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.979 0.419 . . . . 73.310000000000002 110.506 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -77.14 -29.17 54.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.398 -0.365 . . . . 74.319999999999993 110.767 178.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 723' ' ' LEU . . . . . 0.561 HD21 ' HB2' ' A' ' 789' ' ' LEU . 95.8 mt -62.06 -30.03 70.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.371 0.605 . . . . 70.310000000000002 109.742 173.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -81.95 -40.1 22.72 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.283 -0.871 . . . . 72.010000000000005 110.428 176.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 12.1 m -93.02 -83.44 0.31 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.983 -0.553 . . . . 63.149999999999999 111.416 -176.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 726' ' ' ASN . . . . . 0.421 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 44.9 t30 -140.76 110.2 6.67 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.789 0.328 . . . . 61.240000000000002 110.504 -176.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 727' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 28.5 Cg_endo -63.68 -37.24 47.67 Favored 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 122.814 2.343 . . . . 73.299999999999997 112.312 -178.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 44.0 t -61.24 -49.03 86.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.187 -0.46 . . . . 60.530000000000001 110.501 -178.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -64.02 -35.83 92.49 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.963 -0.637 . . . . 74.310000000000002 111.836 178.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -66.8 -41.61 93.51 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 121.063 -0.589 . . . . 74.120000000000005 112.457 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -63.48 -41.2 98.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.095 0.474 . . . . 65.040000000000006 109.733 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 732' ' ' LEU . . . . . 0.42 HD23 ' HB3' ' A' ' 742' ' ' ALA . 75.4 mt -68.29 -39.14 82.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.829 -0.623 . . . . 71.310000000000002 110.65 177.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 733' ' ' GLU . . . . . 0.549 ' O ' ' HG2' ' A' ' 736' ' ' ARG . 2.2 tp10 -65.29 -45.11 85.72 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 123.391 0.676 . . . . 64.109999999999999 111.067 -179.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 734' ' ' TYR . . . . . 0.617 ' HB2' HD11 ' A' ' 719' ' ' LEU . 7.4 t80 -60.21 -46.78 88.56 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.389 -0.369 . . . . 54.100000000000001 110.66 176.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 735' ' ' ALA . . . . . 0.446 ' HA ' ' HB2' ' A' ' 740' ' ' PHE . . . -64.11 -49.02 73.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.133 -0.485 . . . . 61.109999999999999 110.891 -177.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 736' ' ' ARG . . . . . 0.549 ' HG2' ' O ' ' A' ' 733' ' ' GLU . 23.3 ptt180 -59.97 -38.58 82.96 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.869 -0.605 . . . . 73.349999999999994 111.111 -176.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 32.9 t -78.46 -23.27 46.58 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.969 -0.559 . . . . 71.109999999999999 111.461 -177.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -108.91 4.96 23.97 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.118 0.414 . . . . 71.329999999999998 112.118 -174.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 89.04 2.76 77.33 Favored Glycine 0 C--O 1.229 -0.177 0 C-N-CA 120.736 -0.745 . . . . 73.25 113.261 174.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 740' ' ' PHE . . . . . 0.446 ' HB2' ' HA ' ' A' ' 735' ' ' ALA . 90.3 m-85 -83.52 161.26 21.29 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.874 0.369 . . . . 72.420000000000002 110.842 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -115.01 104.24 11.71 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.879 -0.6 . . . . 62.140000000000001 109.538 176.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 742' ' ' ALA . . . . . 0.42 ' HB3' HD23 ' A' ' 732' ' ' LEU . . . -86.4 125.7 33.86 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.04 -0.527 . . . . 72.049999999999997 111.208 -176.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 743' ' ' GLU . . . . . 0.426 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 43.3 mt-10 -137.82 134.72 35.5 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.047 -0.524 . . . . 75.109999999999999 110.382 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -107.21 105.74 15.87 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.5 -0.556 . . . . 74.120000000000005 109.5 176.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.53 147.25 44.68 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.053 0.454 . . . . 61.100000000000001 111.131 -174.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 746' ' ' LEU . . . . . . . . . . . . . 51.3 tp -77.22 122.01 24.46 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.701 -0.681 . . . . 54.130000000000003 110.006 176.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 60.1 t -81.76 -50.35 16.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.09 -0.505 . . . . 74.349999999999994 109.694 177.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -165.99 156.26 12.68 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.697 -0.683 . . . . 74.030000000000001 110.032 -177.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -114.32 119.14 35.94 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.98 -0.378 . . . . 64.230000000000004 109.98 174.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 750' ' ' SER . . . . . 0.506 ' O ' ' HB3' ' A' ' 757' ' ' LYS . 67.6 m -135.56 107.38 7.05 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.107 -0.497 . . . . 41.140000000000001 110.142 179.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 174.81 153.38 10.01 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.261 -0.971 . . . . 71.010000000000005 112.745 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 752' ' ' PRO . . . . . 0.709 ' HG2' ' HB2' ' A' ' 755' ' ' GLU . 36.2 Cg_endo -66.53 168.69 15.85 Favored 'Trans proline' 0 CA--C 1.533 0.427 0 C-N-CA 123.348 2.698 . . . . 71.430000000000007 111.968 176.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.61 -31.88 95.09 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.595 2.197 . . . . 75.010000000000005 112.88 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 42.9 p-80 -87.5 -5.05 58.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.415 -0.357 . . . . 64.310000000000002 111.259 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 755' ' ' GLU . . . . . 0.709 ' HB2' ' HG2' ' A' ' 752' ' ' PRO . 12.2 mm-40 -150.39 64.21 6.5 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.156 -0.475 . . . . 72.140000000000001 110.715 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 756' ' ' PRO . . . . . 0.472 ' O ' ' HA ' ' A' ' 775' ' ' HIS . 14.4 Cg_exo -68.42 92.15 0.41 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.711 2.274 . . . . 71.230000000000004 111.33 178.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 757' ' ' LYS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 775' ' ' HIS . 15.0 ttmt -89.05 111.73 22.53 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.522 0.677 . . . . 65.329999999999998 111.262 -174.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 758' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -90.76 130.85 36.7 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.943 -1.026 . . . . 74.040000000000006 109.832 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 29.2 t -92.87 109.04 21.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.609 -0.515 . . . . 73.150000000000006 109.609 175.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -111.92 141.19 45.87 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.303 -0.408 . . . . 71.140000000000001 110.646 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -126.97 137.82 53.17 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.977 -0.556 . . . . 72.150000000000006 109.92 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 762' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' A' ' 769' ' ' PHE . . . -85.44 109.82 18.73 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.402 0.62 . . . . 74.239999999999995 110.428 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 763' ' ' LYS . . . . . 0.426 ' HB3' ' HB2' ' A' ' 743' ' ' GLU . 75.1 tttt -94.08 104.29 16.33 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.228 -0.896 . . . . 61.310000000000002 109.483 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 48.4 t -117.2 98.04 6.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 120.939 0.4 . . . . 62.420000000000002 111.176 -175.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 60.5 37.27 93.03 Favored Glycine 0 CA--C 1.517 0.193 0 CA-C-N 115.716 -0.674 . . . . 61.009999999999998 113.143 176.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 94.86 -16.11 61.98 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.545 -0.836 . . . . 72.230000000000004 112.62 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 767' ' ' ARG . . . . . . . . . . . . . 79.0 mtt180 -90.64 129.28 36.78 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.054 -0.35 . . . . 63.420000000000002 110.054 176.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 768' ' ' TRP . . . . . . . . . . . . . 68.3 m95 -106.58 99.15 8.74 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.408 -0.36 . . . . 72.239999999999995 110.484 -176.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 769' ' ' PHE . . . . . 0.473 ' HA ' ' HA ' ' A' ' 770' ' ' PRO . 36.3 p90 -170.22 136.86 1.29 Allowed Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.533 -0.303 . . . . 71.019999999999996 110.327 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 770' ' ' PRO . . . . . 0.572 ' HG3' ' HB3' ' A' ' 787' ' ' ALA . 62.5 Cg_endo -94.89 179.02 9.23 Favored 'Cis proline' 0 N--CA 1.45 -1.04 0 C-N-CA 123.484 -1.465 . . . . 72.140000000000001 111.978 -3.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -115.56 104.14 11.43 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.938 -0.393 . . . . 62.340000000000003 109.938 175.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 29.6 m -113.67 164.27 9.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.001 0.429 . . . . 72.0 111.05 -175.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 773' ' ' CYS . . . . . 0.475 ' HB2' ' HG2' ' A' ' 757' ' ' LYS . 10.6 p -127.87 119.19 25.1 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.082 -0.508 . . . . 63.25 110.193 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -135.91 144.33 45.46 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.41 -0.359 . . . . 73.439999999999998 110.612 -178.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 775' ' ' HIS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 757' ' ' LYS . 1.1 p-80 -76.45 16.5 0.47 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.496 0.554 . . . . 73.349999999999994 112.496 -177.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 776' ' ' SER . . . . . 0.571 ' HB2' ' CG ' ' A' ' 779' ' ' GLN . 11.8 m -147.13 140.32 25.3 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.654 -0.498 . . . . 42.439999999999998 109.654 177.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 777' ' ' LYS . . . . . 0.434 ' HE3' ' HB3' ' A' ' 777' ' ' LYS . 2.2 tmmt? -61.46 -46.25 90.84 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.435 -0.348 . . . . 65.209999999999994 111.227 -178.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 778' ' ' LYS . . . . . 0.501 ' O ' ' HG3' ' A' ' 782' ' ' GLN . 63.7 pttt -66.5 -35.48 80.37 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.929 -0.308 . . . . 62.119999999999997 110.442 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 779' ' ' GLN . . . . . 0.571 ' CG ' ' HB2' ' A' ' 776' ' ' SER . 16.0 mm100 -63.79 -43.9 94.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.337 -0.392 . . . . 61.420000000000002 110.05 177.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -57.52 -40.46 92.38 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.002 -0.618 . . . . 42.32 111.92 178.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 30.3 mtpp -66.5 -47.0 74.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.639 0.257 . . . . 75.329999999999998 110.831 178.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 782' ' ' GLN . . . . . 0.501 ' HG3' ' O ' ' A' ' 778' ' ' LYS . 22.8 mt-30 -68.25 -48.17 65.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.221 -0.445 . . . . 65.329999999999998 111.228 -177.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -58.76 -46.15 88.12 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 123.25 0.344 . . . . 62.240000000000002 110.999 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -63.17 -48.01 80.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.305 -0.407 . . . . 75.510000000000005 110.893 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 785' ' ' ALA . . . . . 0.631 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -62.64 -42.19 99.46 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.268 -0.424 . . . . 31.32 111.089 -178.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 786' ' ' ASP . . . . . 0.523 ' O ' ' HG2' ' A' ' 790' ' ' ARG . 11.7 t70 -59.48 -55.74 30.77 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.04 -0.527 . . . . 72.430000000000007 110.129 179.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 787' ' ' ALA . . . . . 0.572 ' HB3' ' HG3' ' A' ' 770' ' ' PRO . . . -61.52 -34.68 75.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.75 -0.659 . . . . 71.209999999999994 111.203 -178.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 788' ' ' ALA . . . . . 0.592 ' O ' ' HG ' ' A' ' 792' ' ' LEU . . . -61.22 -42.78 99.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.421 -0.354 . . . . 65.239999999999995 110.888 178.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 789' ' ' LEU . . . . . 0.705 HD22 HD12 ' A' ' 719' ' ' LEU . 35.5 mt -66.05 -33.93 76.92 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.421 -0.354 . . . . 74.340000000000003 110.122 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 790' ' ' ARG . . . . . 0.523 ' HG2' ' O ' ' A' ' 786' ' ' ASP . 6.2 mmm180 -61.71 -44.47 96.85 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.493 -0.558 . . . . 72.409999999999997 109.493 178.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 791' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 787' ' ' ALA . 41.2 t -57.69 -44.26 85.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.512 -0.767 . . . . 74.219999999999999 110.559 178.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 792' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 30.3 mt -68.15 -52.06 38.95 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.732 -0.667 . . . . 73.549999999999997 110.713 -178.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 793' ' ' ILE . . . . . 0.537 ' HA ' HG23 ' A' ' 716' ' ' ILE . 95.7 mt -60.23 -47.33 92.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.539 -0.755 . . . . 75.030000000000001 111.456 -177.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -68.71 -26.36 74.54 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.766 -0.731 . . . . 55.130000000000003 112.506 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -77.81 -44.28 27.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.876 0.37 . . . . 61.439999999999998 110.921 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 796' ' ' ASN . . . . . 0.464 ' HA ' ' HB2' ' A' ' 799' ' ' ALA . 1.6 t30 -90.58 4.26 51.77 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.007 0.432 . . . . 74.420000000000002 110.664 -176.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 797' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -57.97 -53.69 55.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.629 -0.714 . . . . 52.520000000000003 110.287 178.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 798' ' ' LYS . . . . . . . . . . . . . 53.1 tttp -123.62 55.99 1.23 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.586 0.707 . . . . 64.409999999999997 109.444 175.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 799' ' ' ALA . . . . . 0.464 ' HB2' ' HA ' ' A' ' 796' ' ' ASN . . . -96.79 -175.19 3.21 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.283 -0.871 . . . . 73.129999999999995 110.297 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 800' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -92.33 -9.64 41.18 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.896 0.379 . . . . 71.510000000000005 110.465 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 801' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.676 -0.678 . . . . 62.219999999999999 110.4 -174.394 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 708' ' ' MET . . . . . . . . . . . . . 67.6 mtt . . . . . 0 N--CA 1.48 1.047 0 N-CA-C 110.407 -0.22 . . . . 74.200000000000003 110.407 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 26.4 mmt 71.04 136.95 0.05 OUTLIER Pre-proline 0 N--CA 1.467 0.376 0 O-C-N 124.062 0.851 . . . . 64.129999999999995 112.199 178.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -83.98 38.29 0.69 Allowed 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 123.16 2.573 . . . . 64.530000000000001 112.288 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 711' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -62.21 -43.67 98.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.219 0.533 . . . . 75.349999999999994 110.165 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 712' ' ' LYS . . . . . 0.437 ' HD3' ' O ' ' A' ' 713' ' ' VAL . 1.2 tmtp? -124.97 108.31 11.73 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.997 -0.742 . . . . 65.129999999999995 108.997 175.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 713' ' ' VAL . . . . . 0.437 ' O ' ' HD3' ' A' ' 712' ' ' LYS . 12.0 p -59.22 149.05 6.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.755 -0.657 . . . . 61.240000000000002 110.552 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . . . . . . . . . 30.5 ptt180 -76.22 50.28 0.62 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.465 0.65 . . . . 62.149999999999999 111.104 -177.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 715' ' ' LYS . . . . . 0.477 ' HD2' ' HG2' ' A' ' 718' ' ' GLU . 39.0 ttmt -65.85 105.76 1.38 Allowed 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.651 -0.704 . . . . 74.25 109.723 178.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 716' ' ' ILE . . . . . 0.567 HG23 HG12 ' A' ' 793' ' ' ILE . 44.7 mm -67.93 -26.17 34.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.916 -0.583 . . . . 75.409999999999997 111.166 -174.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -58.71 -29.1 63.81 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.742 -0.742 . . . . 74.340000000000003 111.645 175.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 718' ' ' GLU . . . . . 0.715 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 43.7 mm-40 -70.17 -40.43 74.71 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-O 120.707 0.289 . . . . 65.219999999999999 110.77 178.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 719' ' ' LEU . . . . . 0.581 HD12 HD22 ' A' ' 789' ' ' LEU . 3.1 mm? -64.4 -27.08 68.76 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.127 0.489 . . . . 65.140000000000001 109.929 177.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 720' ' ' VAL . . . . . 0.433 HG22 HD13 ' A' ' 793' ' ' ILE . 98.2 t -76.18 -36.85 31.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.789 -0.641 . . . . 74.310000000000002 111.346 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 721' ' ' ARG . . . . . 0.715 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 5.9 ptm180 -67.89 -22.77 65.08 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.34 0.591 . . . . 71.120000000000005 109.762 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -77.22 -31.02 54.88 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.929 -0.578 . . . . 73.450000000000003 110.622 175.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 723' ' ' LEU . . . . . 0.551 HD21 ' HB2' ' A' ' 789' ' ' LEU . 85.3 mt -60.13 -30.41 69.27 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.284 0.564 . . . . 71.140000000000001 109.894 174.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -87.98 -39.49 14.66 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.352 -0.84 . . . . 72.430000000000007 111.303 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 30.7 m -90.23 -76.17 0.44 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.756 0.312 . . . . 71.209999999999994 111.761 -177.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 726' ' ' ASN . . . . . 0.468 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 25.2 t30 -150.84 105.56 3.03 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.458 -0.337 . . . . 71.340000000000003 110.453 -178.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 727' ' ' PRO . . . . . 0.468 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 18.1 Cg_endo -60.63 -32.55 93.44 Favored 'Trans proline' 0 N--CA 1.464 -0.207 0 C-N-CA 123.131 2.554 . . . . 74.420000000000002 112.47 -178.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 43.4 t -61.88 -48.05 90.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.09 -0.505 . . . . 52.409999999999997 110.47 -177.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -63.06 -32.66 84.91 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.925 -0.655 . . . . 72.219999999999999 112.183 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -73.88 -44.48 30.76 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.753 -0.737 . . . . 71.450000000000003 112.5 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -64.1 -40.97 97.38 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.85 0.357 . . . . 72.400000000000006 110.147 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 732' ' ' LEU . . . . . . . . . . . . . 93.3 mt -64.19 -40.85 96.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.119 -0.492 . . . . 71.439999999999998 111.523 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 733' ' ' GLU . . . . . 0.511 ' HA ' ' HG2' ' A' ' 736' ' ' ARG . 6.5 pt-20 -78.35 -31.24 48.46 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.404 -0.518 . . . . 73.510000000000005 110.971 -178.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 734' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -53.76 -45.61 70.67 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 121.056 0.455 . . . . 75.319999999999993 109.942 175.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -66.06 -53.28 40.3 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.727 -0.67 . . . . 63.340000000000003 110.708 -178.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 736' ' ' ARG . . . . . 0.511 ' HG2' ' HA ' ' A' ' 733' ' ' GLU . 19.2 ptt85 -61.36 -34.42 75.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.092 -0.504 . . . . 73.329999999999998 111.209 -175.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 15.6 t -73.44 -36.4 65.91 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.815 -0.63 . . . . 63.140000000000001 111.137 178.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 13.4 m170 -95.64 3.19 54.21 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.948 0.351 . . . . 73.439999999999998 111.948 -173.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 95.08 0.01 63.88 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.519 -0.848 . . . . 74.030000000000001 113.367 173.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -94.27 -179.1 4.82 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.798 0.332 . . . . 64.010000000000005 110.393 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 741' ' ' ALA . . . . . 0.423 ' O ' ' HA ' ' A' ' 764' ' ' VAL . . . -127.2 134.64 50.1 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.212 -0.662 . . . . 64.099999999999994 109.212 173.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 742' ' ' ALA . . . . . . . . . . . . . . . -110.89 131.39 55.09 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.741 0.305 . . . . 45.109999999999999 111.166 -176.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 743' ' ' GLU . . . . . 0.487 ' HG3' ' HB3' ' A' ' 763' ' ' LYS . 12.7 pt-20 -147.57 153.27 39.23 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.92 -0.582 . . . . 73.310000000000002 110.435 178.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -120.6 118.26 29.69 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.061 -0.518 . . . . 72.239999999999995 109.781 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -122.2 138.19 54.57 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.524 -0.47 . . . . 74.209999999999994 111.246 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 746' ' ' LEU . . . . . 0.421 HD11 ' HD2' ' A' ' 758' ' ' PHE . 6.8 tt -74.24 119.14 18.03 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.501 -0.772 . . . . 73.299999999999997 109.176 176.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 43.9 t -94.89 -44.99 13.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.279 -0.419 . . . . 74.230000000000004 110.959 -177.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -149.29 158.02 43.83 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.402 -0.363 . . . . 74.25 110.77 -176.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -141.36 113.41 7.93 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.332 -0.618 . . . . 60.439999999999998 109.332 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 6.1 t -143.83 -167.29 2.56 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.869 -0.332 . . . . 62.439999999999998 110.324 -177.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 97.23 -150.38 19.52 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.853 -0.689 . . . . 72.219999999999999 111.787 -177.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 752' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -80.06 158.38 23.71 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.364 2.042 . . . . 73.420000000000002 111.802 178.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -73.13 -36.17 4.51 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.661 2.24 . . . . 64.420000000000002 112.376 -177.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -76.33 -29.27 57.21 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.96 -0.564 . . . . 73.340000000000003 110.834 -177.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -130.98 74.02 80.37 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 72.439999999999998 110.614 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 756' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -62.95 132.05 35.35 Favored 'Trans proline' 0 N--CA 1.465 -0.152 0 C-N-CA 122.685 2.257 . . . . 73.409999999999997 112.018 -177.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 757' ' ' LYS . . . . . 0.554 ' HG2' ' HB2' ' A' ' 773' ' ' CYS . 39.1 ttmt -98.83 111.83 24.1 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.279 0.561 . . . . 65.120000000000005 109.796 178.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 758' ' ' PHE . . . . . 0.436 ' O ' ' HA ' ' A' ' 773' ' ' CYS . 61.3 m-85 -90.27 123.25 33.89 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.116 -0.947 . . . . 74.510000000000005 110.595 -175.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 56.4 t -88.91 108.0 18.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.998 -0.547 . . . . 54.109999999999999 109.725 176.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -111.22 135.19 52.11 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.795 -0.639 . . . . 74.319999999999993 110.676 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -120.76 126.85 51.18 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.829 -0.623 . . . . 64.549999999999997 109.658 178.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 762' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 769' ' ' PHE . . . -83.94 120.92 26.68 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.179 0.514 . . . . 52.0 110.19 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 763' ' ' LYS . . . . . 0.69 ' HD2' ' CH2' ' A' ' 768' ' ' TRP . 49.4 tttm -104.32 107.3 18.15 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.842 -0.617 . . . . 65.150000000000006 110.054 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 764' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 741' ' ' ALA . 48.4 t -114.94 102.66 14.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.988 -0.551 . . . . 52.100000000000001 109.868 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 72.77 -123.15 8.67 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 110.821 -0.912 . . . . 74.230000000000004 110.821 -174.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -101.2 2.54 54.66 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.123 -0.791 . . . . 63.100000000000001 111.123 173.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 767' ' ' ARG . . . . . 0.44 ' NE ' ' HA ' ' A' ' 767' ' ' ARG . 2.6 mmp_? -97.28 127.52 43.31 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.099 0.476 . . . . 64.519999999999996 110.839 -177.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 768' ' ' TRP . . . . . 0.69 ' CH2' ' HD2' ' A' ' 763' ' ' LYS . 51.1 m95 -103.63 112.15 24.94 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.669 -0.696 . . . . 75.209999999999994 109.27 178.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 769' ' ' PHE . . . . . 0.491 ' HA ' ' HA ' ' A' ' 770' ' ' PRO . 27.0 p90 -176.78 136.98 0.43 Allowed Pre-proline 0 C--N 1.323 -0.584 0 CA-C-O 120.955 0.407 . . . . 73.430000000000007 110.248 -178.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 770' ' ' PRO . . . . . 0.623 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 55.6 Cg_endo -95.51 -170.74 2.81 Favored 'Cis proline' 0 N--CA 1.451 -0.976 0 C-N-CA 123.395 -1.502 . . . . 52.25 111.828 -3.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -120.83 100.18 6.95 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.431 -0.581 . . . . 73.310000000000002 109.431 175.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 28.6 m -109.88 163.98 6.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.243 -0.435 . . . . 75.519999999999996 110.973 -175.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 773' ' ' CYS . . . . . 0.554 ' HB2' ' HG2' ' A' ' 757' ' ' LYS . 6.3 p -138.21 110.69 7.49 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.975 -0.557 . . . . 62.409999999999997 110.002 178.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -118.17 147.61 43.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.539 -0.3 . . . . 73.129999999999995 111.023 -176.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 775' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -76.33 13.33 0.96 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.316 -0.402 . . . . 73.450000000000003 111.828 -177.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 49.9 m -150.02 136.56 19.09 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.249 -0.648 . . . . 62.210000000000001 109.249 174.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 777' ' ' LYS . . . . . 0.428 ' HE3' ' HB3' ' A' ' 777' ' ' LYS . 0.8 OUTLIER -61.87 -40.57 95.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.384 -0.371 . . . . 75.109999999999999 111.372 -174.709 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -66.68 -29.23 69.19 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.11 0.481 . . . . 65.239999999999995 110.39 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 779' ' ' GLN . . . . . 0.5 ' O ' ' HG2' ' A' ' 783' ' ' GLU . 96.4 mt-30 -74.7 -38.38 62.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.944 -0.571 . . . . 75.540000000000006 110.03 178.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -53.18 -44.89 64.15 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 121.324 -0.465 . . . . 65.019999999999996 112.391 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -62.46 -46.63 87.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.976 0.417 . . . . 71.349999999999994 110.649 177.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -66.92 -48.04 69.88 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.869 -0.605 . . . . 74.219999999999999 111.596 -177.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 783' ' ' GLU . . . . . 0.5 ' HG2' ' O ' ' A' ' 779' ' ' GLN . 34.5 mm-40 -59.66 -41.43 90.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.758 0.313 . . . . 73.120000000000005 110.527 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -62.39 -48.01 81.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.07 -0.514 . . . . 55.549999999999997 110.493 178.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 785' ' ' ALA . . . . . 0.576 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -65.26 -40.07 93.46 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.333 -0.394 . . . . 70.299999999999997 110.858 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 786' ' ' ASP . . . . . 0.599 ' O ' ' HD3' ' A' ' 790' ' ' ARG . 13.7 t70 -60.61 -55.65 30.81 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.961 -0.563 . . . . 64.129999999999995 110.299 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 787' ' ' ALA . . . . . 0.534 ' HB3' ' HG3' ' A' ' 770' ' ' PRO . . . -64.14 -31.09 72.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.078 -0.51 . . . . 74.219999999999999 110.904 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 788' ' ' ALA . . . . . 0.69 ' O ' ' HG ' ' A' ' 792' ' ' LEU . . . -62.14 -46.56 88.47 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.286 -0.264 . . . . 72.430000000000007 110.286 176.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 789' ' ' LEU . . . . . 0.581 HD22 HD12 ' A' ' 719' ' ' LEU . 70.1 mt -63.69 -34.78 78.62 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.741 -0.466 . . . . 65.340000000000003 109.741 178.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 790' ' ' ARG . . . . . 0.599 ' HD3' ' O ' ' A' ' 786' ' ' ASP . 0.3 OUTLIER -57.43 -45.71 84.35 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.223 -0.444 . . . . 71.310000000000002 110.185 174.897 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 791' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 787' ' ' ALA . 48.4 t -61.63 -49.69 83.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.028 -0.533 . . . . 70.540000000000006 110.381 177.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 792' ' ' LEU . . . . . 0.69 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 39.6 mt -59.92 -50.79 72.37 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.988 -0.551 . . . . 72.519999999999996 110.901 -177.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 793' ' ' ILE . . . . . 0.567 HG12 HG23 ' A' ' 716' ' ' ILE . 95.9 mt -60.72 -49.51 84.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.844 -0.616 . . . . 65.530000000000001 110.578 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -61.8 -36.64 93.06 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 121.057 -0.592 . . . . 63.109999999999999 112.625 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 795' ' ' GLU . . . . . 0.554 ' HA ' ' HD3' ' A' ' 798' ' ' LYS . 9.7 tp10 -65.51 -43.91 88.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.049 0.452 . . . . 70.129999999999995 110.129 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -66.33 -32.34 73.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.07 -0.514 . . . . 74.209999999999994 110.925 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 797' ' ' GLU . . . . . 0.538 ' HG3' ' O ' ' A' ' 793' ' ' ILE . 47.2 mt-10 -65.47 -19.49 65.96 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.944 0.402 . . . . 74.420000000000002 110.916 177.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 798' ' ' LYS . . . . . 0.554 ' HD3' ' HA ' ' A' ' 795' ' ' GLU . 44.3 mtpt -81.38 -17.35 49.33 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.106 -0.497 . . . . 72.150000000000006 110.146 176.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 799' ' ' ALA . . . . . . . . . . . . . . . -97.62 -39.53 9.06 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.937 -0.574 . . . . 21.100000000000001 110.828 178.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 800' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -65.04 95.58 0.17 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.944 -0.571 . . . . 72.430000000000007 111.062 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 801' ' ' ARG . . . . . . . . . . . . . 61.0 mtm180 . . . . . 0 C--O 1.246 0.911 0 CA-C-N 115.244 -0.889 . . . . 65.219999999999999 109.931 177.459 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 708' ' ' MET . . . . . . . . . . . . . 12.5 tmm? . . . . . 0 N--CA 1.479 0.981 0 N-CA-C 109.422 -0.584 . . . . 64.540000000000006 109.422 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -112.18 110.08 53.93 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 116.324 -0.398 . . . . 43.219999999999999 110.7 -176.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -82.88 126.73 4.57 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.201 2.601 . . . . 71.230000000000004 111.665 178.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 711' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -63.1 112.87 2.81 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.246 0.546 . . . . 63.149999999999999 109.619 176.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 712' ' ' LYS . . . . . 0.908 ' HE2' ' HA ' ' A' ' 712' ' ' LYS . 10.6 mmpt? -81.69 162.12 23.13 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.609 -0.723 . . . . 74.120000000000005 112.537 -169.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 713' ' ' VAL . . . . . 0.745 HG22 ' H ' ' A' ' 715' ' ' LYS . 7.1 p -165.88 133.99 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.89 -1.05 . . . . 71.0 109.039 176.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 714' ' ' ARG . 58.7 mtt-85 -92.69 17.16 10.73 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.039 0.447 . . . . 63.32 111.01 -177.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 715' ' ' LYS . . . . . 0.745 ' H ' HG22 ' A' ' 713' ' ' VAL . 96.6 mttt -103.86 25.36 9.96 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.698 -0.683 . . . . 72.200000000000003 110.159 178.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 716' ' ' ILE . . . . . 0.587 ' HA ' HD23 ' A' ' 719' ' ' LEU . 37.0 mm -58.91 -30.57 43.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.837 -0.619 . . . . 71.140000000000001 111.117 -178.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -60.55 -29.69 70.16 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 121.008 -0.615 . . . . 55.229999999999997 112.518 175.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 718' ' ' GLU . . . . . 0.4 ' HA ' ' HB3' ' A' ' 721' ' ' ARG . 43.0 mt-10 -75.54 -25.4 57.14 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 122.651 -0.323 . . . . 75.340000000000003 110.654 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 719' ' ' LEU . . . . . 0.587 HD23 ' HA ' ' A' ' 716' ' ' ILE . 4.2 mm? -66.38 -34.77 78.72 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.464 -0.569 . . . . 73.540000000000006 109.464 174.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 720' ' ' VAL . . . . . 0.618 HG22 HD13 ' A' ' 793' ' ' ILE . 22.0 t -68.15 -33.09 58.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.826 -0.625 . . . . 74.019999999999996 109.979 175.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 721' ' ' ARG . . . . . 0.4 ' HB3' ' HA ' ' A' ' 718' ' ' GLU . 0.1 OUTLIER -61.29 -35.71 78.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.722 -0.672 . . . . 71.510000000000005 110.04 178.774 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -71.05 -32.33 69.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.0 -0.546 . . . . 71.510000000000005 111.1 178.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 723' ' ' LEU . . . . . 0.42 HD21 ' HB2' ' A' ' 789' ' ' LEU . 95.3 mt -58.02 -32.03 67.55 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.119 0.485 . . . . 74.430000000000007 109.928 175.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 54.0 m-20 -71.54 -49.9 36.43 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.622 -0.717 . . . . 73.329999999999998 110.839 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 47.4 m -93.12 -70.78 0.68 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.049 0.388 . . . . 73.319999999999993 112.049 -174.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 726' ' ' ASN . . . . . 0.414 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 43.5 t30 -145.12 104.79 4.41 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-O 120.827 0.346 . . . . 75.329999999999998 110.86 -178.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 727' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 18.6 Cg_endo -60.57 -34.52 92.4 Favored 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.821 2.347 . . . . 61.210000000000001 112.064 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 47.6 t -61.76 -48.37 88.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 64.409999999999997 110.364 -178.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -63.15 -31.2 79.92 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 121.026 -0.607 . . . . 55.399999999999999 111.811 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -70.35 -41.98 66.45 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.948 -0.644 . . . . 73.239999999999995 112.376 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 731' ' ' LEU . . . . . 0.422 ' N ' HD21 ' A' ' 789' ' ' LEU . 3.0 tm? -65.57 -40.33 92.66 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.412 -0.588 . . . . 71.140000000000001 109.412 178.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 732' ' ' LEU . . . . . . . . . . . . . 79.4 mt -66.16 -39.25 89.63 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.702 -0.681 . . . . 74.319999999999993 110.78 176.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 733' ' ' GLU . . . . . 0.483 ' O ' ' HG2' ' A' ' 736' ' ' ARG . 4.1 tp10 -65.8 -46.31 79.13 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 116.266 -0.425 . . . . 63.420000000000002 110.57 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 734' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -54.96 -48.2 73.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.994 -0.548 . . . . 73.049999999999997 110.677 177.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -65.92 -48.26 72.01 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.122 -0.49 . . . . 43.539999999999999 111.236 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 736' ' ' ARG . . . . . 0.483 ' HG2' ' O ' ' A' ' 733' ' ' GLU . 31.9 ptt180 -65.22 -33.03 75.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.14 0.495 . . . . 74.530000000000001 111.345 -175.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 38.0 t -78.12 -36.64 47.62 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.859 -0.61 . . . . 75.400000000000006 111.156 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 15.5 m170 -89.02 -29.21 19.64 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.43 -0.35 . . . . 73.219999999999999 111.846 -174.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 109.07 21.93 7.14 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.555 -0.831 . . . . 73.409999999999997 112.273 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -96.99 167.46 11.06 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.738 0.304 . . . . 64.439999999999998 110.405 175.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -109.91 114.11 27.38 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.461 -0.57 . . . . 72.010000000000005 109.461 175.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 742' ' ' ALA . . . . . . . . . . . . . . . -93.6 110.2 21.81 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.968 0.413 . . . . 61.420000000000002 110.433 -178.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 743' ' ' GLU . . . . . 0.543 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 44.7 mt-10 -120.82 117.09 26.52 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.942 -0.572 . . . . 75.310000000000002 111.281 -177.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 744' ' ' PHE . . . . . 0.424 ' CB ' ' HE3' ' A' ' 781' ' ' LYS . 96.2 m-85 -100.16 100.81 11.7 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.785 -0.643 . . . . 74.450000000000003 109.285 175.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 745' ' ' LYS . . . . . 0.44 ' HB3' ' HE2' ' A' ' 745' ' ' LYS . 16.9 ptpt -120.76 152.81 37.84 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.238 -0.585 . . . . 62.530000000000001 111.116 -177.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 746' ' ' LEU . . . . . 0.576 HD21 ' HB2' ' A' ' 749' ' ' GLN . 51.9 tp -80.14 128.12 33.13 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.426 -0.806 . . . . 75.409999999999997 110.089 -178.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 56.4 t -90.46 -47.56 14.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.109 0.48 . . . . 61.229999999999997 109.879 178.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -154.75 149.35 26.4 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.771 -0.65 . . . . 75.099999999999994 110.331 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 749' ' ' GLN . . . . . 0.576 ' HB2' HD21 ' A' ' 746' ' ' LEU . 24.5 tt0 -125.19 106.64 10.04 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.509 -0.552 . . . . 73.099999999999994 109.509 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 56.7 m -141.86 178.18 7.68 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.658 0.266 . . . . 53.100000000000001 110.285 -178.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 117.52 172.61 16.04 Favored Glycine 0 N--CA 1.443 -0.899 0 C-N-CA 120.331 -0.938 . . . . 65.439999999999998 112.822 177.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 752' ' ' PRO . . . . . 0.748 ' HG2' ' HB2' ' A' ' 755' ' ' GLU . 34.3 Cg_endo -64.8 166.4 18.26 Favored 'Trans proline' 0 CA--C 1.529 0.272 0 C-N-CA 123.473 2.782 . . . . 71.109999999999999 112.752 178.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -65.44 -31.74 51.09 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.592 2.194 . . . . 64.230000000000004 112.534 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 754' ' ' HIS . . . . . 0.554 ' CD2' ' HG3' ' A' ' 755' ' ' GLU . 54.0 p-80 -83.02 -23.41 33.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.522 -0.308 . . . . 63.140000000000001 110.938 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 755' ' ' GLU . . . . . 0.748 ' HB2' ' HG2' ' A' ' 752' ' ' PRO . 45.8 mt-10 -132.24 78.07 69.39 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.445 -0.343 . . . . 72.409999999999997 111.503 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 756' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -68.12 105.86 1.26 Allowed 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 121.936 1.757 . . . . 53.409999999999997 110.73 172.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 757' ' ' LYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 774' ' ' ALA . 57.8 mtmt -92.8 108.67 20.17 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.733 0.777 . . . . 72.140000000000001 110.973 -175.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 758' ' ' PHE . . . . . 0.447 ' O ' ' HA ' ' A' ' 773' ' ' CYS . 89.4 m-85 -87.63 116.69 25.94 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.722 -1.127 . . . . 72.349999999999994 110.478 -178.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 21.5 t -84.28 101.39 8.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.468 -0.567 . . . . 61.329999999999998 109.468 176.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 760' ' ' TYR . . . . . 0.413 ' CE2' ' HG2' ' A' ' 777' ' ' LYS . 3.2 m-85 -106.48 145.56 31.65 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.048 -0.524 . . . . 70.310000000000002 111.113 -178.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 761' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -132.54 135.12 45.75 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.871 -0.604 . . . . 73.209999999999994 109.663 177.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 762' ' ' ALA . . . . . . . . . . . . . . . -89.89 110.82 21.74 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.804 -0.635 . . . . 71.439999999999998 110.421 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 763' ' ' LYS . . . . . 0.543 ' HB3' ' HB2' ' A' ' 743' ' ' GLU . 50.5 tttt -94.64 107.02 19.03 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.494 -0.775 . . . . 71.299999999999997 109.607 177.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 47.5 t -112.88 100.48 10.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 120.977 0.418 . . . . 72.239999999999995 110.844 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 68.86 22.59 75.68 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.731 -0.668 . . . . 73.140000000000001 112.74 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 99.8 -2.64 57.1 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.712 -0.756 . . . . 64.010000000000005 112.103 -178.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 767' ' ' ARG . . . . . . . . . . . . . 18.3 ttm180 -100.91 122.3 43.23 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.292 -0.633 . . . . 64.510000000000005 109.292 178.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 768' ' ' TRP . . . . . . . . . . . . . 42.4 m95 -99.31 100.08 11.11 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.407 -0.36 . . . . 73.019999999999996 110.765 -172.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 769' ' ' PHE . . . . . 0.465 ' HA ' ' HA ' ' A' ' 770' ' ' PRO . 25.9 p90 -166.5 136.25 2.52 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.331 -0.395 . . . . 74.099999999999994 110.419 -178.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 770' ' ' PRO . . . . . 0.715 ' HG3' ' HB3' ' A' ' 787' ' ' ALA . 68.5 Cg_endo -94.66 -173.31 4.31 Favored 'Cis proline' 0 N--CA 1.451 -0.974 0 C-N-CA 123.412 -1.495 . . . . 73.299999999999997 111.424 -4.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -122.52 107.83 12.46 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.33 -0.248 . . . . 45.329999999999998 110.33 175.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 29.1 m -130.35 167.28 25.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.533 -0.303 . . . . 54.340000000000003 111.195 -176.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 773' ' ' CYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 758' ' ' PHE . 17.7 p -132.78 145.12 50.73 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.458 -0.337 . . . . 71.450000000000003 110.573 178.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 774' ' ' ALA . . . . . 0.463 ' O ' ' HA ' ' A' ' 757' ' ' LYS . . . -146.2 154.52 41.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.432 -0.349 . . . . 43.409999999999997 110.544 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 775' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -75.4 -2.62 29.41 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.068 0.461 . . . . 73.219999999999999 111.458 -176.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 776' ' ' SER . . . . . 0.629 ' HB2' ' HG3' ' A' ' 779' ' ' GLN . 36.3 m -131.19 140.2 49.86 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.206 -0.665 . . . . 70.319999999999993 109.206 175.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 777' ' ' LYS . . . . . 0.413 ' HG2' ' CE2' ' A' ' 760' ' ' TYR . 6.1 tmmm? -61.12 -45.75 93.39 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 123.431 0.457 . . . . 73.099999999999994 111.274 -174.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 778' ' ' LYS . . . . . 0.426 ' HE2' ' OE1' ' A' ' 782' ' ' GLN . 87.9 tttt -64.56 -39.28 93.46 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.981 -0.288 . . . . 73.310000000000002 110.644 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 779' ' ' GLN . . . . . 0.629 ' HG3' ' HB2' ' A' ' 776' ' ' SER . 23.6 mt-30 -60.35 -39.38 86.94 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.658 -0.246 . . . . 63.450000000000003 110.563 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -60.51 -43.53 98.72 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.88 -0.676 . . . . 50.009999999999998 111.694 177.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 781' ' ' LYS . . . . . 0.424 ' HE3' ' CB ' ' A' ' 744' ' ' PHE . 50.6 mtpt -68.13 -40.55 82.44 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.735 0.302 . . . . 73.129999999999995 110.729 178.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 782' ' ' GLN . . . . . 0.426 ' OE1' ' HE2' ' A' ' 778' ' ' LYS . 26.6 mt-30 -62.04 -51.66 67.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.047 -0.524 . . . . 73.120000000000005 111.047 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -65.27 -33.92 77.12 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 123.063 0.227 . . . . 74.510000000000005 110.909 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -59.62 -53.86 53.11 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.893 -0.41 . . . . 74.430000000000007 109.893 175.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 785' ' ' ALA . . . . . 0.613 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -65.38 -40.01 92.97 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.18 -0.463 . . . . 75.150000000000006 110.897 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 786' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -54.28 -56.08 21.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.903 -0.59 . . . . 72.430000000000007 110.83 178.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 787' ' ' ALA . . . . . 0.715 ' HB3' ' HG3' ' A' ' 770' ' ' PRO . . . -65.7 -38.32 88.91 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.838 -0.619 . . . . 62.140000000000001 110.768 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 788' ' ' ALA . . . . . 0.6 ' HB2' ' HD3' ' A' ' 770' ' ' PRO . . . -60.61 -45.8 92.65 Favored 'General case' 0 CA--C 1.521 -0.159 0 O-C-N 123.327 0.392 . . . . 74.420000000000002 111.23 -177.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 789' ' ' LEU . . . . . 0.613 ' HG ' ' O ' ' A' ' 785' ' ' ALA . 69.2 mt -58.86 -45.67 89.56 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 109.977 -0.379 . . . . 74.209999999999994 109.977 179.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 790' ' ' ARG . . . . . . . . . . . . . 78.6 mtt180 -65.07 -26.58 68.3 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.138 0.422 . . . . 61.310000000000002 112.138 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 791' ' ' VAL . . . . . 0.671 HG23 ' O ' ' A' ' 787' ' ' ALA . 60.1 t -66.5 -45.17 89.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 109.456 -0.572 . . . . 72.340000000000003 109.456 173.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 792' ' ' LEU . . . . . 0.59 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 18.2 mt -67.84 -44.82 76.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.221 -0.899 . . . . 65.319999999999993 110.188 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 793' ' ' ILE . . . . . 0.618 HD13 HG22 ' A' ' 720' ' ' VAL . 97.0 mt -58.38 -55.21 23.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.162 -0.926 . . . . 74.140000000000001 110.647 177.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 794' ' ' GLY . . . . . 0.418 ' O ' ' HG3' ' A' ' 798' ' ' LYS . . . -58.47 -40.51 94.45 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 121.14 -0.552 . . . . 62.219999999999999 112.244 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -55.98 -46.69 78.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.951 0.405 . . . . 72.129999999999995 110.218 178.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -73.94 -38.54 64.22 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.06 -0.518 . . . . 71.219999999999999 111.246 -175.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 797' ' ' GLU . . . . . 0.466 ' HG3' ' O ' ' A' ' 793' ' ' ILE . 29.6 mt-10 -72.17 -19.62 61.72 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.768 0.284 . . . . 61.399999999999999 111.768 -176.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 798' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' A' ' 794' ' ' GLY . 99.0 mttt -85.76 0.65 52.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.898 0.38 . . . . 65.049999999999997 111.162 178.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 799' ' ' ALA . . . . . . . . . . . . . . . -107.6 166.51 10.62 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.452 -0.34 . . . . 60.119999999999997 110.883 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 800' ' ' GLU . . . . . 0.448 ' H ' ' CD ' ' A' ' 800' ' ' GLU . 0.4 OUTLIER -92.64 20.96 5.85 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.416 0.627 . . . . 63.100000000000001 110.39 -177.669 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 801' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 . . . . . 0 C--O 1.248 1.015 0 CA-C-N 115.728 -0.669 . . . . 62.149999999999999 110.194 -176.059 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 708' ' ' MET . . . . . . . . . . . . . 22.9 mmt . . . . . 0 N--CA 1.481 1.097 0 CA-C-O 120.69 0.281 . . . . 70.129999999999995 111.66 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 67.9 mtm -132.43 86.67 44.76 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 109.77 -0.455 . . . . 35.439999999999998 109.77 176.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 710' ' ' PRO . . . . . 0.497 ' HB3' ' O ' ' A' ' 799' ' ' ALA . 38.7 Cg_endo -68.02 153.45 75.08 Favored 'Trans proline' 0 C--O 1.237 0.432 0 C-N-CA 122.524 2.149 . . . . 51.240000000000002 112.347 -177.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 711' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -58.58 -44.34 89.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.805 -0.634 . . . . 72.409999999999997 110.425 178.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 712' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -100.15 136.3 40.26 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.377 -0.601 . . . . 44.130000000000003 109.377 171.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 713' ' ' VAL . . . . . . . . . . . . . 18.5 m -75.19 165.69 3.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.148 0.499 . . . . 71.319999999999993 111.21 -175.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.457 ' HB2' HG12 ' A' ' 716' ' ' ILE . 1.4 ptp180 -111.37 126.67 55.16 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.998 -0.546 . . . . 75.409999999999997 110.352 175.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 17.1 tptm -110.58 25.24 11.99 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.122 -1.066 . . . . 63.420000000000002 108.122 175.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 716' ' ' ILE . . . . . 0.649 HG23 HG12 ' A' ' 793' ' ' ILE . 48.4 mm -61.81 -27.6 42.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 114.046 -1.434 . . . . 75.420000000000002 112.316 -172.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -56.3 -31.41 59.49 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.009 -0.615 . . . . 74.329999999999998 112.12 178.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -72.01 -41.62 67.38 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.355 -0.239 . . . . 74.430000000000007 110.355 178.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 719' ' ' LEU . . . . . 0.641 HD23 ' HA ' ' A' ' 716' ' ' ILE . 3.0 mm? -62.79 -36.11 82.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.479 -0.328 . . . . 63.43 110.727 -179.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 720' ' ' VAL . . . . . 0.519 HG22 HD13 ' A' ' 793' ' ' ILE . 48.0 t -66.65 -39.03 82.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.118 0.485 . . . . 74.129999999999995 109.963 175.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 721' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.08 -35.03 74.28 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.871 -0.604 . . . . 64.400000000000006 110.172 177.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -74.32 -29.0 61.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.05 -0.523 . . . . 74.150000000000006 111.4 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 723' ' ' LEU . . . . . 0.577 HD21 ' HB2' ' A' ' 789' ' ' LEU . 51.0 mt -59.02 -39.35 81.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.856 0.36 . . . . 75.409999999999997 110.726 177.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -86.51 -17.37 34.29 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.108 -0.496 . . . . 72.400000000000006 111.341 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 16.3 m -108.37 -83.3 0.55 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.637 0.256 . . . . 60.229999999999997 111.421 -176.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 726' ' ' ASN . . . . . 0.413 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 30.0 t30 -138.97 104.01 7.41 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.801 0.334 . . . . 70.439999999999998 110.373 -177.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 727' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 25.4 Cg_endo -62.75 -41.4 30.89 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.758 2.305 . . . . 62.439999999999998 112.552 -177.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 48.3 t -61.71 -46.07 97.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.275 -0.421 . . . . 72.150000000000006 110.659 -176.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -64.65 -32.64 84.87 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.868 -0.682 . . . . 74.099999999999994 112.0 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -72.45 -42.66 47.95 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 121.134 -0.555 . . . . 65.519999999999996 112.827 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -63.24 -41.06 99.03 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.623 -0.51 . . . . 71.420000000000002 109.623 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 732' ' ' LEU . . . . . 0.504 HD23 ' HB3' ' A' ' 742' ' ' ALA . 96.2 mt -64.83 -42.66 94.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.94 -0.573 . . . . 65.120000000000005 110.649 176.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 733' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -64.69 -42.64 95.17 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 116.201 -0.454 . . . . 64.430000000000007 110.802 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 734' ' ' TYR . . . . . 0.549 ' HB2' HD11 ' A' ' 719' ' ' LEU . 14.4 t80 -54.43 -53.18 57.59 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.349 -0.387 . . . . 74.430000000000007 110.621 176.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -62.73 -48.45 79.16 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.093 -0.503 . . . . 72.329999999999998 110.395 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 736' ' ' ARG . . . . . . . . . . . . . 62.3 ttt180 -54.96 -50.87 67.84 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.544 -0.753 . . . . 75.129999999999995 111.939 -178.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 18.1 t -73.95 -24.58 59.66 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.424 -0.353 . . . . 74.239999999999995 111.404 -175.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -94.7 -19.78 20.11 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.821 -0.352 . . . . 52.310000000000002 111.935 -175.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 104.39 14.0 25.07 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.17 -1.014 . . . . 35.25 112.837 177.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -101.81 166.29 10.74 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.816 -0.439 . . . . 64.230000000000004 109.816 175.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -110.14 126.43 54.06 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.708 -0.479 . . . . 64.310000000000002 109.708 173.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 742' ' ' ALA . . . . . 0.504 ' HB3' HD23 ' A' ' 732' ' ' LEU . . . -99.03 108.59 21.3 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.059 0.457 . . . . 72.239999999999995 110.361 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 743' ' ' GLU . . . . . 0.543 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 40.8 mt-10 -113.93 116.75 29.75 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.796 -0.638 . . . . 72.150000000000006 111.466 -176.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -93.28 121.62 34.84 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.679 -0.691 . . . . 74.209999999999994 109.401 176.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -132.38 147.94 52.4 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.282 0.563 . . . . 64.409999999999997 111.663 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 746' ' ' LEU . . . . . 0.53 HD21 ' HB2' ' A' ' 749' ' ' GLN . 6.8 tt -86.87 108.09 18.61 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.143 -0.935 . . . . 62.25 108.992 177.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 49.0 t -82.56 -53.99 10.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.136 -0.484 . . . . 64.310000000000002 110.771 -176.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 748' ' ' ASP . . . . . 0.499 ' HB3' ' CG2' ' A' ' 759' ' ' VAL . 25.7 t70 -129.8 149.76 51.4 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.283 -0.417 . . . . 75.420000000000002 111.19 -176.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 749' ' ' GLN . . . . . 0.53 ' HB2' HD21 ' A' ' 746' ' ' LEU . 8.1 tt0 -145.84 100.07 3.36 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.514 -0.767 . . . . 64.530000000000001 108.971 177.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 10.0 t -144.98 -173.71 4.16 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.484 -0.326 . . . . 72.120000000000005 110.476 -174.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 100.77 -173.74 24.94 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.924 -0.655 . . . . 54.420000000000002 112.473 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 752' ' ' PRO . . . . . 0.711 ' HG2' ' HB2' ' A' ' 755' ' ' GLU . 52.8 Cg_endo -69.11 164.35 34.24 Favored 'Trans proline' 0 N--CA 1.465 -0.154 0 C-N-CA 122.908 2.406 . . . . 74.239999999999995 111.993 178.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -69.81 -34.68 13.93 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 122.469 2.112 . . . . 75.0 112.065 -177.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 754' ' ' HIS . . . . . 0.425 ' CE1' ' HB2' ' A' ' 752' ' ' PRO . 35.2 p-80 -76.09 -26.81 56.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.174 -0.466 . . . . 73.430000000000007 110.936 179.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 755' ' ' GLU . . . . . 0.711 ' HB2' ' HG2' ' A' ' 752' ' ' PRO . 28.5 mm-40 -126.53 72.76 73.72 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.566 -0.288 . . . . 61.409999999999997 110.885 178.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 756' ' ' PRO . . . . . 0.515 ' O ' ' HA ' ' A' ' 775' ' ' HIS . 40.0 Cg_endo -68.82 113.66 3.29 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.222 1.948 . . . . 73.519999999999996 111.453 177.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 757' ' ' LYS . . . . . 0.408 ' HE3' ' HB3' ' A' ' 757' ' ' LYS . 1.5 tmmt? -89.51 112.4 23.56 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.322 0.582 . . . . 72.25 110.538 -176.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 758' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 773' ' ' CYS . 79.0 m-85 -99.59 123.34 43.76 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.204 -0.907 . . . . 72.140000000000001 110.115 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 759' ' ' VAL . . . . . 0.499 ' CG2' ' HB3' ' A' ' 748' ' ' ASP . 48.6 t -98.4 106.6 18.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.564 -0.532 . . . . 71.439999999999998 109.564 175.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -105.61 141.05 37.74 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.005 -0.543 . . . . 74.319999999999993 110.691 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 761' ' ' GLN . . . . . 0.44 ' HA ' ' O ' ' A' ' 770' ' ' PRO . 33.7 tt0 -133.46 134.61 43.75 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.865 -0.607 . . . . 64.099999999999994 109.503 177.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 762' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 769' ' ' PHE . . . -92.9 117.08 29.65 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.25 0.548 . . . . 63.439999999999998 110.706 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 763' ' ' LYS . . . . . 0.601 ' HD2' ' CH2' ' A' ' 768' ' ' TRP . 54.7 tttm -93.77 103.53 15.66 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.681 -0.69 . . . . 73.150000000000006 109.893 177.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 61.7 t -109.01 101.58 12.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.136 0.493 . . . . 53.299999999999997 109.739 178.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 69.17 -115.69 6.63 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 110.955 -0.858 . . . . 71.010000000000005 110.955 -173.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -110.62 13.99 29.91 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.003 -0.618 . . . . 74.219999999999999 111.684 176.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 767' ' ' ARG . . . . . 0.602 ' HD2' ' CD1' ' A' ' 769' ' ' PHE . 0.6 OUTLIER -110.43 120.45 42.46 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.507 -0.553 . . . . 71.540000000000006 109.507 -179.766 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 768' ' ' TRP . . . . . 0.601 ' CH2' ' HD2' ' A' ' 763' ' ' LYS . 69.4 m95 -94.88 108.15 20.18 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.645 -0.502 . . . . 74.099999999999994 109.645 178.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 769' ' ' PHE . . . . . 0.602 ' CD1' ' HD2' ' A' ' 767' ' ' ARG . 9.8 p90 -168.86 139.9 2.01 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-O 120.838 0.351 . . . . 74.219999999999999 110.915 -178.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 770' ' ' PRO . . . . . 0.799 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 96.1 Cg_endo -98.4 -170.69 1.95 Allowed 'Cis proline' 0 N--CA 1.449 -1.121 0 C-N-CA 123.71 -1.371 . . . . 63.140000000000001 111.677 -3.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 771' ' ' ALA . . . . . 0.438 ' HB2' HE21 ' A' ' 761' ' ' GLN . . . -114.81 104.29 11.8 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.518 -0.549 . . . . 62.439999999999998 109.518 174.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 33.5 m -118.94 161.97 17.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.303 -0.408 . . . . 73.239999999999995 110.846 -176.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 773' ' ' CYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 758' ' ' PHE . 8.8 p -137.0 141.91 42.53 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.249 -0.432 . . . . 60.240000000000002 110.425 177.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -149.53 161.15 42.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.054 -0.521 . . . . 71.430000000000007 109.829 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 775' ' ' HIS . . . . . 0.515 ' HA ' ' O ' ' A' ' 756' ' ' PRO . 0.8 OUTLIER -87.14 -0.75 57.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.251 0.548 . . . . 73.120000000000005 110.889 179.501 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 51.1 m -134.04 135.16 43.16 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.634 -0.712 . . . . 71.010000000000005 109.292 175.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 777' ' ' LYS . . . . . . . . . . . . . 25.4 ttmt -57.24 -48.82 77.89 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.103 -0.499 . . . . 71.239999999999995 111.448 -175.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -57.95 -38.59 76.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.848 -0.614 . . . . 64.140000000000001 110.822 -177.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 779' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -68.25 -37.88 81.24 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-N 116.36 -0.382 . . . . 72.319999999999993 110.146 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -60.5 -47.17 92.48 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.827 -0.701 . . . . 43.340000000000003 111.881 178.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -62.55 -44.79 95.47 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.746 0.308 . . . . 72.530000000000001 110.649 177.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -62.37 -50.43 71.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.056 -0.52 . . . . 64.549999999999997 111.206 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -60.09 -36.57 77.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.298 -0.41 . . . . 53.109999999999999 111.445 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -60.05 -55.08 38.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.871 0.367 . . . . 74.510000000000005 110.373 177.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 785' ' ' ALA . . . . . 0.652 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -63.09 -41.81 99.47 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.134 -0.485 . . . . 53.119999999999997 110.897 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 786' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -56.83 -54.88 41.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.546 -0.752 . . . . 73.319999999999993 110.934 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 787' ' ' ALA . . . . . 0.468 ' O ' HG23 ' A' ' 791' ' ' VAL . . . -65.29 -35.09 79.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.832 -0.622 . . . . 75.450000000000003 111.254 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 788' ' ' ALA . . . . . 0.799 ' HB2' ' HD3' ' A' ' 770' ' ' PRO . . . -64.64 -35.64 81.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.313 -0.403 . . . . 63.549999999999997 111.391 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 789' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' A' ' 785' ' ' ALA . 59.1 mt -64.66 -42.04 95.69 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 121.048 -0.261 . . . . 65.340000000000003 110.445 -179.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 790' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.67 -31.71 72.65 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 120.734 -0.386 . . . . 75.310000000000002 111.207 177.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 791' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 787' ' ' ALA . 57.2 t -61.67 -51.89 67.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.104 0.478 . . . . 71.510000000000005 109.773 175.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 792' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 32.9 mt -61.84 -47.53 84.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.349 -0.842 . . . . 71.540000000000006 110.83 -178.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 793' ' ' ILE . . . . . 0.649 HG12 HG23 ' A' ' 716' ' ' ILE . 95.9 mt -58.8 -56.26 17.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.521 -0.763 . . . . 72.299999999999997 111.24 179.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 794' ' ' GLY . . . . . 0.427 ' O ' ' HB2' ' A' ' 797' ' ' GLU . . . -60.79 -37.69 94.05 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 121.079 -0.582 . . . . 62.049999999999997 112.321 -178.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -63.25 -44.0 96.41 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.905 0.383 . . . . 73.400000000000006 110.734 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -73.86 -20.64 60.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.909 0.385 . . . . 70.5 110.822 -177.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 797' ' ' GLU . . . . . 0.427 ' HB2' ' O ' ' A' ' 794' ' ' GLY . 15.7 mm-40 -59.01 -21.51 59.16 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.103 0.478 . . . . 75.310000000000002 110.639 175.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 798' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -91.39 -8.97 46.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.926 -0.579 . . . . 72.099999999999994 111.309 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 799' ' ' ALA . . . . . 0.497 ' O ' ' HB3' ' A' ' 710' ' ' PRO . . . -94.5 -0.54 54.59 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.883 0.697 . . . . 54.439999999999998 112.883 -170.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 800' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -79.43 88.04 5.04 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.693 0.758 . . . . 72.239999999999995 111.237 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 801' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.064 -0.97 . . . . 73.129999999999995 110.219 179.211 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 708' ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 N--CA 1.482 1.155 0 N-CA-C 109.831 -0.433 . . . . 72.439999999999998 109.831 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.92 145.72 49.34 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 109.335 -0.617 . . . . 64.329999999999998 109.335 174.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -59.88 133.38 50.41 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.578 2.186 . . . . 72.409999999999997 111.631 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 711' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -73.47 177.8 5.05 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.076 0.465 . . . . 73.400000000000006 110.829 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 712' ' ' LYS . . . . . 0.478 ' HB3' ' OG ' ' A' ' 737' ' ' SER . 21.0 tptm -95.38 112.66 24.33 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.047 -0.524 . . . . 74.540000000000006 109.957 177.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 713' ' ' VAL . . . . . . . . . . . . . 34.5 m -67.4 158.11 5.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.913 -0.585 . . . . 74.25 110.659 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.51 ' HB3' ' CE1' ' A' ' 738' ' ' HIS . 22.0 ptt180 -80.3 78.7 6.96 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.453 0.644 . . . . 74.329999999999998 110.744 176.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 715' ' ' LYS . . . . . 0.421 ' HE3' ' HB2' ' A' ' 715' ' ' LYS . 30.3 ttmt -87.68 104.45 16.55 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.35 -0.841 . . . . 75.219999999999999 109.249 175.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 716' ' ' ILE . . . . . 0.592 ' HA ' HD23 ' A' ' 719' ' ' LEU . 46.8 mm -67.85 -27.89 39.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.449 -0.796 . . . . 42.439999999999998 111.489 -170.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -59.95 -24.87 61.04 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.97 -0.633 . . . . 64.150000000000006 112.112 176.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 718' ' ' GLU . . . . . 0.669 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 47.1 mt-10 -76.85 -38.73 53.18 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 122.787 -0.243 . . . . 75.120000000000005 110.658 177.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 719' ' ' LEU . . . . . 0.592 HD12 HD22 ' A' ' 789' ' ' LEU . 3.1 mm? -61.38 -32.98 72.92 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.155 0.502 . . . . 72.430000000000007 109.769 176.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 720' ' ' VAL . . . . . 0.54 HG22 HD13 ' A' ' 793' ' ' ILE . 58.1 t -68.4 -38.49 79.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.809 -0.632 . . . . 72.510000000000005 110.757 175.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 721' ' ' ARG . . . . . 0.669 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 4.4 ptm180 -64.74 -28.2 69.43 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 109.841 -0.429 . . . . 72.329999999999998 109.841 179.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -73.12 -31.9 64.61 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 116.312 -0.404 . . . . 61.439999999999998 110.782 177.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 723' ' ' LEU . . . . . 0.565 HD21 ' HB2' ' A' ' 789' ' ' LEU . 98.1 mt -62.24 -28.67 69.87 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.407 0.622 . . . . 72.329999999999998 110.033 174.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -90.81 -15.07 30.7 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.492 -0.776 . . . . 71.319999999999993 111.234 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 11.1 m -118.69 -73.48 0.64 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.856 0.36 . . . . 75.150000000000006 111.666 -175.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 726' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -149.13 101.58 3.37 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.174 -0.467 . . . . 34.119999999999997 110.112 -177.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 727' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -61.87 -40.33 45.16 Favored 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 122.906 2.404 . . . . 63.350000000000001 112.115 -178.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 57.5 t -62.21 -45.32 99.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.096 -0.502 . . . . 63.130000000000003 110.809 -178.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -65.49 -35.15 90.93 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.664 -0.779 . . . . 72.239999999999995 111.669 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -70.17 -41.58 69.29 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 121.073 -0.584 . . . . 74.230000000000004 112.573 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -65.48 -43.3 90.66 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.989 -0.374 . . . . 72.010000000000005 109.989 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 732' ' ' LEU . . . . . . . . . . . . . 96.8 mt -66.17 -38.07 87.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.244 -0.435 . . . . 63.329999999999998 110.745 178.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 733' ' ' GLU . . . . . 0.471 ' O ' ' HG2' ' A' ' 736' ' ' ARG . 1.8 tp10 -66.14 -43.99 85.44 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 116.325 -0.398 . . . . 73.010000000000005 110.355 177.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 734' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -53.47 -48.66 68.67 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.141 -0.481 . . . . 71.439999999999998 110.658 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 735' ' ' ALA . . . . . 0.41 ' HB2' ' HB2' ' A' ' 742' ' ' ALA . . . -65.62 -50.22 65.83 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.232 -0.44 . . . . 70.349999999999994 110.927 -177.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 736' ' ' ARG . . . . . 0.471 ' HG2' ' O ' ' A' ' 733' ' ' GLU . 33.8 ptt180 -64.35 -31.48 72.7 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.11 0.481 . . . . 62.350000000000001 110.914 -175.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 737' ' ' SER . . . . . 0.478 ' OG ' ' HB3' ' A' ' 712' ' ' LYS . 28.8 t -78.07 -29.12 49.02 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.599 -0.728 . . . . 63.210000000000001 111.451 178.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 738' ' ' HIS . . . . . 0.51 ' CE1' ' HB3' ' A' ' 714' ' ' ARG . 12.1 m170 -101.13 -3.09 29.84 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 111.885 0.328 . . . . 74.430000000000007 111.885 -173.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 90.98 12.88 59.79 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.407 -0.901 . . . . 72.340000000000003 112.675 177.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -95.98 169.36 10.03 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.791 0.329 . . . . 73.439999999999998 110.165 175.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -121.68 105.81 10.76 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.284 -0.636 . . . . 72.140000000000001 109.284 175.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 742' ' ' ALA . . . . . 0.419 ' HA ' ' HA ' ' A' ' 764' ' ' VAL . . . -90.4 122.55 33.37 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.311 -0.404 . . . . 73.540000000000006 111.454 -174.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 743' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -127.79 166.13 18.78 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.782 -0.644 . . . . 75.430000000000007 110.698 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -134.25 108.8 8.45 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.961 -0.563 . . . . 73.439999999999998 109.996 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -110.84 148.55 32.16 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.007 0.432 . . . . 74.209999999999994 111.155 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 746' ' ' LEU . . . . . 0.432 HD11 ' CD1' ' A' ' 758' ' ' PHE . 6.1 tt -87.58 106.82 18.27 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.384 -0.969 . . . . 64.230000000000004 108.384 174.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 54.0 t -83.16 -53.06 12.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.982 -0.554 . . . . 71.319999999999993 110.938 -174.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -128.39 146.01 50.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.083 -0.508 . . . . 63.210000000000001 110.798 -176.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -132.7 93.59 3.25 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.284 0.564 . . . . 73.439999999999998 110.026 176.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 20.6 m -104.64 82.36 1.89 Allowed 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.242 -1.021 . . . . 52.130000000000003 108.242 173.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 751' ' ' GLY . . . . . 0.612 ' CA ' ' HA ' ' A' ' 756' ' ' PRO . . . -127.39 94.74 0.41 Allowed Glycine 0 N--CA 1.439 -1.101 0 C-N-CA 119.92 -1.133 . . . . 75.0 114.278 -170.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 752' ' ' PRO . . . . . 0.402 ' HD2' ' HA2' ' A' ' 751' ' ' GLY . 18.1 Cg_endo -60.95 165.61 11.85 Favored 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 122.474 2.116 . . . . 42.109999999999999 110.225 164.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -58.54 -36.51 97.26 Favored 'Trans proline' 0 CA--C 1.528 0.191 0 C-N-CA 122.109 1.873 . . . . 73.420000000000002 112.495 -177.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 49.9 p-80 -82.28 -25.01 34.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.364 -0.38 . . . . 61.240000000000002 111.644 -177.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -141.06 74.31 25.48 Favored Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 112.043 0.386 . . . . 53.530000000000001 112.043 -176.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 756' ' ' PRO . . . . . 0.612 ' HA ' ' CA ' ' A' ' 751' ' ' GLY . 52.3 Cg_endo -72.23 84.84 1.09 Allowed 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.0 1.8 . . . . 44.039999999999999 111.632 175.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 757' ' ' LYS . . . . . 0.531 ' HA ' ' HA ' ' A' ' 775' ' ' HIS . 27.4 ttpp -91.58 113.69 26.03 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.545 0.688 . . . . 71.040000000000006 111.247 -174.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 758' ' ' PHE . . . . . 0.463 ' O ' ' HA ' ' A' ' 773' ' ' CYS . 60.9 m-85 -99.44 144.77 28.16 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.286 -0.87 . . . . 70.010000000000005 110.171 -178.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 759' ' ' VAL . . . . . 0.468 HG22 ' HB3' ' A' ' 773' ' ' CYS . 47.7 t -109.57 112.13 39.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.996 -0.372 . . . . 64.129999999999995 109.996 176.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -107.27 138.14 44.0 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.263 -0.426 . . . . 71.329999999999998 110.517 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 761' ' ' GLN . . . . . 0.441 ' HA ' ' O ' ' A' ' 770' ' ' PRO . 62.2 tt0 -125.5 135.48 52.34 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.916 -0.583 . . . . 75.430000000000007 109.432 177.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 762' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' A' ' 769' ' ' PHE . . . -91.52 119.5 31.52 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.252 0.549 . . . . 74.019999999999996 110.586 -178.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -98.16 97.28 8.73 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.713 -0.676 . . . . 72.430000000000007 109.339 177.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 764' ' ' VAL . . . . . 0.419 ' HA ' ' HA ' ' A' ' 742' ' ' ALA . 57.7 t -99.9 98.3 6.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.125 0.488 . . . . 72.239999999999995 109.854 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 68.54 -108.03 2.31 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 110.743 -0.943 . . . . 33.340000000000003 110.743 -175.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -114.72 9.4 21.63 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.626 -0.797 . . . . 71.409999999999997 111.821 176.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 767' ' ' ARG . . . . . 0.576 ' HD2' ' CD1' ' A' ' 769' ' ' PHE . 0.2 OUTLIER -107.65 120.69 42.92 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.93 -0.396 . . . . 72.120000000000005 109.93 -178.615 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 768' ' ' TRP . . . . . . . . . . . . . 58.6 m95 -94.3 110.91 22.63 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.158 -0.474 . . . . 75.420000000000002 109.857 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 769' ' ' PHE . . . . . 0.576 ' CD1' ' HD2' ' A' ' 767' ' ' ARG . 15.7 p90 -174.76 138.32 0.62 Allowed Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 120.692 0.282 . . . . 64.239999999999995 110.65 -179.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 770' ' ' PRO . . . . . 0.786 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 69.7 Cg_endo -99.15 -170.25 1.6 Allowed 'Cis proline' 0 N--CA 1.449 -1.14 0 C-N-CA 123.675 -1.386 . . . . 71.010000000000005 111.164 -6.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -121.14 105.52 10.68 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.797 -0.445 . . . . 74.120000000000005 109.797 174.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 35.3 m -121.32 160.29 22.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.487 -0.324 . . . . 61.25 111.006 -176.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 773' ' ' CYS . . . . . 0.468 ' HB3' HG22 ' A' ' 759' ' ' VAL . 20.2 p -126.01 145.81 50.15 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.073 -0.512 . . . . 74.450000000000003 110.565 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -158.14 146.86 19.06 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.22 -0.445 . . . . 75.519999999999996 110.226 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 775' ' ' HIS . . . . . 0.538 ' HA ' ' O ' ' A' ' 756' ' ' PRO . 1.4 p-80 -78.95 17.4 0.74 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.147 0.499 . . . . 70.420000000000002 111.538 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 42.4 t -142.84 130.62 21.51 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.994 -0.743 . . . . 71.109999999999999 108.994 175.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 777' ' ' LYS . . . . . 0.436 ' HD2' ' C ' ' A' ' 777' ' ' LYS . 5.3 tmmm? -58.34 -42.68 87.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.864 0.364 . . . . 74.239999999999995 110.125 -178.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -58.12 -46.99 84.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.62 -0.718 . . . . 64.329999999999998 110.542 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 779' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -62.52 -41.82 99.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.914 -0.584 . . . . 63.420000000000002 110.717 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -56.35 -43.83 89.77 Favored Glycine 0 C--N 1.329 0.187 0 C-N-CA 121.161 -0.543 . . . . 63.340000000000003 112.398 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -71.93 -43.79 64.71 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.699 0.285 . . . . 73.430000000000007 111.046 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -66.42 -45.63 79.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.222 -0.445 . . . . 75.120000000000005 111.505 -176.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -66.67 -33.87 76.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.709 0.29 . . . . 72.340000000000003 110.686 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -60.56 -52.04 66.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.347 -0.388 . . . . 65.519999999999996 110.177 177.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 785' ' ' ALA . . . . . 0.586 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -65.4 -38.59 90.45 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.167 -0.469 . . . . 73.230000000000004 110.744 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 786' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -59.9 -51.07 71.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.919 -0.582 . . . . 75.310000000000002 110.852 178.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 787' ' ' ALA . . . . . 0.571 ' HA ' ' HD2' ' A' ' 790' ' ' ARG . . . -67.85 -35.8 79.2 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.071 -0.513 . . . . 43.43 111.039 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 788' ' ' ALA . . . . . 0.786 ' HB2' ' HD3' ' A' ' 770' ' ' PRO . . . -60.96 -41.05 95.59 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.361 -0.382 . . . . 32.409999999999997 111.032 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 789' ' ' LEU . . . . . 0.592 HD22 HD12 ' A' ' 719' ' ' LEU . 75.9 mt -64.23 -40.36 95.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.406 -0.361 . . . . 72.109999999999999 110.21 178.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 790' ' ' ARG . . . . . 0.571 ' HD2' ' HA ' ' A' ' 787' ' ' ALA . 84.9 mtt180 -60.01 -35.06 74.25 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.501 -0.318 . . . . 61.5 111.209 177.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 791' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 787' ' ' ALA . 62.1 t -61.5 -50.53 79.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.249 0.547 . . . . 65.420000000000002 109.898 175.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 792' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 23.7 mt -61.98 -47.88 82.84 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.395 -0.82 . . . . 64.239999999999995 110.743 -179.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 793' ' ' ILE . . . . . 0.54 HD13 HG22 ' A' ' 720' ' ' VAL . 95.8 mt -59.85 -45.36 94.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.481 -0.781 . . . . 75.230000000000004 110.904 178.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -68.32 -33.8 78.57 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.833 -0.699 . . . . 52.450000000000003 112.703 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -70.66 -41.09 72.54 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.902 0.382 . . . . 74.109999999999999 110.642 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 796' ' ' ASN . . . . . 0.449 HD21 ' HB3' ' A' ' 801' ' ' ARG . 5.4 t30 -79.1 -18.98 52.35 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.786 -0.366 . . . . 54.119999999999997 110.188 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 797' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -57.88 -40.39 80.12 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.595 -0.52 . . . . 75.239999999999995 109.595 176.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 798' ' ' LYS . . . . . . . . . . . . . 11.5 ptmm? -92.96 16.84 11.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.815 -0.629 . . . . 73.319999999999993 110.855 178.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 799' ' ' ALA . . . . . . . . . . . . . . . -118.07 149.13 41.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.202 -0.454 . . . . 65.450000000000003 110.079 177.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 800' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -84.54 111.62 19.68 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.622 0.725 . . . . 74.319999999999993 110.419 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 801' ' ' ARG . . . . . 0.449 ' HB3' HD21 ' A' ' 796' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.542 -0.742 . . . . 75.439999999999998 110.016 -178.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 708' ' ' MET . . . . . . . . . . . . . 64.9 mtt . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 120.72 0.295 . . . . 72.049999999999997 110.243 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -92.15 150.7 40.8 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 109.322 -0.622 . . . . 73.219999999999999 109.322 178.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.24 111.63 0.98 Allowed 'Trans proline' 0 C--O 1.236 0.382 0 C-N-CA 122.421 2.081 . . . . 53.240000000000002 111.869 178.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 711' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -59.1 126.68 28.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 71.010000000000005 110.451 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 712' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -74.94 142.44 43.97 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.886 -0.597 . . . . 71.409999999999997 111.419 -175.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 713' ' ' VAL . . . . . . . . . . . . . 10.3 p -64.58 146.36 13.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.766 -0.652 . . . . 62.32 109.413 172.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.769 ' HA ' ' HG3' ' A' ' 718' ' ' GLU . 32.4 mmt180 -70.35 101.16 1.87 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.067 0.461 . . . . 73.219999999999999 110.665 -179.02 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 715' ' ' LYS . . . . . 0.434 ' O ' ' HB2' ' A' ' 718' ' ' GLU . 74.3 mmtt -82.85 -176.18 6.18 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.875 -0.602 . . . . 74.239999999999995 110.094 175.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 716' ' ' ILE . . . . . 0.526 ' HA ' HD23 ' A' ' 719' ' ' LEU . 42.1 mm -65.48 -36.99 78.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.852 0.358 . . . . 73.310000000000002 110.85 -177.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -60.63 -26.1 64.28 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 121.008 -0.615 . . . . 73.329999999999998 112.014 175.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 718' ' ' GLU . . . . . 0.8 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 9.0 mm-40 -68.75 -34.39 75.51 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-O 120.543 0.211 . . . . 64.430000000000007 110.551 178.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 719' ' ' LEU . . . . . 0.556 HD12 HD22 ' A' ' 789' ' ' LEU . 2.7 mm? -69.04 -29.25 67.37 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.522 -0.471 . . . . 73.010000000000005 109.917 177.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 720' ' ' VAL . . . . . 0.488 HG22 HD13 ' A' ' 793' ' ' ILE . 60.3 t -67.52 -40.96 85.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.844 -0.616 . . . . 74.430000000000007 110.804 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 721' ' ' ARG . . . . . 0.8 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 12.9 ptm180 -64.86 -29.92 70.9 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.4 -0.364 . . . . 65.010000000000005 110.249 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -71.83 -35.48 69.9 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-N 116.341 -0.39 . . . . 73.420000000000002 110.69 177.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 723' ' ' LEU . . . . . 0.586 HD21 ' HB2' ' A' ' 789' ' ' LEU . 82.0 mt -56.3 -30.68 62.84 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.138 0.494 . . . . 73.340000000000003 110.407 175.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -83.86 -55.37 4.28 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.835 -0.62 . . . . 73.200000000000003 110.935 176.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 27.2 m -75.44 -73.06 0.27 Allowed 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.119 0.414 . . . . 64.450000000000003 112.119 -176.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 726' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -148.49 100.31 3.56 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 120.804 0.335 . . . . 64.219999999999999 110.633 -175.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 727' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -61.7 -39.97 49.39 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.021 2.481 . . . . 55.439999999999998 112.667 -176.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 30.1 t -59.24 -47.88 88.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.008 -0.542 . . . . 72.010000000000005 110.787 -176.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -65.66 -31.35 79.7 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.86 -0.609 . . . . 54.119999999999997 111.812 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -68.24 -41.73 85.33 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.903 -0.665 . . . . 64.439999999999998 112.269 178.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -65.04 -41.29 95.35 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.526 -0.546 . . . . 73.120000000000005 109.526 178.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 732' ' ' LEU . . . . . . . . . . . . . 83.8 mt -68.79 -31.55 70.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.88 -0.6 . . . . 74.25 110.99 178.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 733' ' ' GLU . . . . . 0.501 ' O ' ' HG2' ' A' ' 736' ' ' ARG . 0.7 OUTLIER -73.28 -43.54 60.83 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 116.165 -0.471 . . . . 71.129999999999995 110.392 178.901 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 734' ' ' TYR . . . . . 0.466 ' HB2' HD11 ' A' ' 719' ' ' LEU . 7.6 t80 -55.45 -46.41 76.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.978 -0.556 . . . . 74.450000000000003 110.615 176.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -64.78 -48.12 75.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.923 -0.581 . . . . 73.319999999999993 111.095 -178.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 736' ' ' ARG . . . . . 0.501 ' HG2' ' O ' ' A' ' 733' ' ' GLU . 11.3 ptt180 -64.54 -35.74 81.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.009 0.433 . . . . 64.219999999999999 111.078 -175.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 48.4 t -74.2 -35.06 63.9 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.013 -0.539 . . . . 75.310000000000002 111.036 -178.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -89.0 -32.02 17.82 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.286 -0.415 . . . . 74.129999999999995 111.803 -174.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 112.45 22.07 5.94 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.47 -0.872 . . . . 61.32 112.013 -178.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -99.51 169.99 8.92 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.869 0.366 . . . . 65.120000000000005 110.543 176.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -117.25 111.49 19.48 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.457 -0.572 . . . . 71.450000000000003 109.457 174.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 742' ' ' ALA . . . . . . . . . . . . . . . -94.58 130.26 41.09 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.909 0.385 . . . . 73.239999999999995 111.464 -175.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 743' ' ' GLU . . . . . 0.572 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 49.5 mt-10 -132.98 140.52 47.82 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.959 -0.564 . . . . 74.310000000000002 110.738 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -114.94 100.28 8.08 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.195 -0.668 . . . . 65.549999999999997 109.195 174.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 745' ' ' LYS . . . . . 0.471 ' HE2' ' HB3' ' A' ' 745' ' ' LYS . 14.4 ptpt -121.45 144.11 48.87 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.495 0.664 . . . . 63.340000000000003 111.909 -175.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 746' ' ' LEU . . . . . . . . . . . . . 6.6 tt -78.91 112.59 16.25 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.824 -1.08 . . . . 71.109999999999999 109.509 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 61.3 t -80.18 -50.01 18.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.985 0.422 . . . . 60.399999999999999 110.634 -178.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -155.56 148.93 24.88 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.929 -0.578 . . . . 62.549999999999997 110.252 -178.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 749' ' ' GLN . . . . . 0.42 ' O ' ' HG3' ' A' ' 749' ' ' GLN . 10.5 pt20 -133.69 108.59 8.62 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.194 0.521 . . . . 72.310000000000002 110.281 172.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 18.6 m -131.47 78.63 1.84 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.905 -0.588 . . . . 64.219999999999999 110.236 178.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . -139.24 150.31 21.21 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.658 -0.782 . . . . 74.230000000000004 112.138 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 752' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -62.67 160.55 32.04 Favored 'Trans proline' 0 CA--C 1.528 0.197 0 C-N-CA 123.019 2.479 . . . . 71.409999999999997 111.976 178.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -57.45 -34.63 98.29 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.797 2.332 . . . . 72.519999999999996 112.897 -178.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 47.9 p-80 -83.89 -15.91 46.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.268 -0.424 . . . . 54.200000000000003 111.357 -177.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -149.18 70.98 10.09 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.455 -0.339 . . . . 64.209999999999994 110.73 -177.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 756' ' ' PRO . . . . . 0.511 ' O ' ' HA ' ' A' ' 775' ' ' HIS . 51.8 Cg_exo -54.81 146.59 55.1 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.738 2.292 . . . . 72.450000000000003 112.176 178.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 757' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -129.96 113.33 14.46 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.254 -0.43 . . . . 64.409999999999997 109.911 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 758' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -112.74 117.54 32.49 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.799 -0.637 . . . . 54.340000000000003 110.79 -177.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 30.9 t -85.14 101.39 9.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.92 -0.582 . . . . 72.420000000000002 109.543 175.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -106.05 136.91 44.89 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.67 -0.695 . . . . 74.150000000000006 110.483 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 761' ' ' GLN . . . . . 0.526 ' HA ' ' O ' ' A' ' 770' ' ' PRO . 30.0 tt0 -135.18 131.95 37.37 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.749 -0.659 . . . . 72.150000000000006 110.033 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 762' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 769' ' ' PHE . . . -89.17 122.19 32.21 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.892 -0.594 . . . . 45.119999999999997 110.636 -178.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 763' ' ' LYS . . . . . 0.572 ' HB3' ' HB2' ' A' ' 743' ' ' GLU . 61.5 tttm -97.62 105.54 17.71 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.622 -0.717 . . . . 73.25 109.512 178.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 59.8 t -108.93 98.59 7.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.098 0.475 . . . . 72.040000000000006 109.792 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 70.72 -107.76 2.26 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 111.26 -0.736 . . . . 34.119999999999997 111.26 -176.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -109.6 1.05 30.65 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.743 -0.741 . . . . 73.040000000000006 112.068 177.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 767' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -102.75 138.74 39.24 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.16 0.505 . . . . 63.43 111.373 -177.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 768' ' ' TRP . . . . . 0.429 ' CH2' ' HD2' ' A' ' 763' ' ' LYS . 80.4 m95 -108.64 108.76 19.75 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.521 -0.763 . . . . 74.25 109.39 175.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 769' ' ' PHE . . . . . 0.5 ' HA ' ' HA ' ' A' ' 770' ' ' PRO . 31.6 p90 -168.99 138.9 1.81 Allowed Pre-proline 0 C--N 1.322 -0.613 0 CA-C-O 120.946 0.403 . . . . 71.230000000000004 110.497 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 770' ' ' PRO . . . . . 0.704 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 59.7 Cg_endo -97.99 -175.64 3.95 Favored 'Cis proline' 0 N--CA 1.451 -1.028 0 C-N-CA 123.454 -1.478 . . . . 74.400000000000006 111.768 -4.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -110.9 106.54 15.7 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.605 -0.517 . . . . 75.530000000000001 109.605 173.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 30.0 m -114.52 146.49 18.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.018 0.437 . . . . 45.039999999999999 111.409 -177.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 5.7 p -111.98 95.87 5.72 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.792 -0.64 . . . . 70.510000000000005 109.847 178.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -94.18 166.73 11.97 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.05 -0.523 . . . . 75.340000000000003 111.776 -174.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 775' ' ' HIS . . . . . 0.511 ' HA ' ' O ' ' A' ' 756' ' ' PRO . 32.6 m-70 -91.84 -4.3 55.0 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.722 -0.672 . . . . 72.409999999999997 110.853 -178.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 63.5 p -159.13 173.58 16.19 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.693 -0.484 . . . . 73.430000000000007 109.693 176.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 777' ' ' LYS . . . . . 0.701 ' HE2' ' HD2' ' A' ' 781' ' ' LYS . 31.4 tttt -65.83 -52.51 49.89 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.709 0.263 . . . . 65.120000000000005 111.709 -176.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 51.9 tttp -63.5 -37.79 88.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.466 -0.334 . . . . 50.049999999999997 110.636 -174.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 779' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -60.61 -39.15 87.14 Favored 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 109.852 -0.425 . . . . 74.150000000000006 109.852 175.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -61.91 -48.49 83.35 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.991 -0.623 . . . . 75.25 112.061 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 781' ' ' LYS . . . . . 0.701 ' HD2' ' HE2' ' A' ' 777' ' ' LYS . 8.2 mtpm? -62.59 -38.25 89.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.652 0.263 . . . . 72.219999999999999 111.04 178.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -73.17 -50.54 22.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.539 -0.301 . . . . 74.409999999999997 111.316 -178.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -60.67 -38.4 84.78 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.67 0.271 . . . . 73.519999999999996 110.974 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -60.11 -51.2 70.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 74.150000000000006 110.146 177.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 785' ' ' ALA . . . . . 0.609 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -66.39 -41.72 88.94 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.252 -0.431 . . . . 61.520000000000003 110.923 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 786' ' ' ASP . . . . . 0.444 ' O ' ' HD3' ' A' ' 790' ' ' ARG . 9.9 t0 -56.34 -57.49 12.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.903 -0.59 . . . . 73.129999999999995 110.082 179.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 787' ' ' ALA . . . . . 0.63 ' HB3' ' HG3' ' A' ' 770' ' ' PRO . . . -64.77 -33.39 75.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.695 -0.684 . . . . 71.409999999999997 111.196 -178.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 788' ' ' ALA . . . . . 0.704 ' HB2' ' HD3' ' A' ' 770' ' ' PRO . . . -64.64 -44.47 90.38 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 123.174 0.296 . . . . 54.43 110.937 179.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 789' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 785' ' ' ALA . 80.0 mt -61.35 -40.34 93.92 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.742 -0.466 . . . . 71.319999999999993 109.742 178.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 790' ' ' ARG . . . . . 0.444 ' HD3' ' O ' ' A' ' 786' ' ' ASP . 13.0 mtp180 -59.54 -35.34 74.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.032 -0.531 . . . . 63.329999999999998 111.162 176.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 791' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 787' ' ' ALA . 54.3 t -66.19 -52.09 51.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 109.753 -0.462 . . . . 72.219999999999999 109.753 175.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 792' ' ' LEU . . . . . 0.624 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 31.3 mt -57.23 -49.09 77.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.647 -0.706 . . . . 75.540000000000006 110.575 -178.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 793' ' ' ILE . . . . . 0.488 HD13 HG22 ' A' ' 720' ' ' VAL . 94.2 mt -60.02 -51.46 72.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.414 -0.812 . . . . 74.340000000000003 110.734 177.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -61.83 -40.53 98.96 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 121.014 -0.612 . . . . 73.239999999999995 112.697 -178.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -60.29 -53.17 60.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.375 0.131 . . . . 73.209999999999994 111.24 178.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -71.22 -29.94 65.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.928 0.394 . . . . 72.439999999999998 111.08 -176.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 797' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -63.29 -34.37 77.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.542 0.687 . . . . 75.349999999999994 110.028 175.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 798' ' ' LYS . . . . . 0.512 ' HB3' ' NZ ' ' A' ' 798' ' ' LYS . 0.0 OUTLIER -90.55 -39.72 12.39 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.196 -0.911 . . . . 63.450000000000003 111.352 -177.401 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 799' ' ' ALA . . . . . . . . . . . . . . . -94.8 121.69 36.65 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.203 0.445 . . . . 52.009999999999998 112.203 -174.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 800' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -79.92 120.35 24.01 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.766 -0.652 . . . . 74.109999999999999 109.466 171.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 801' ' ' ARG . . . . . . . . . . . . . 1.9 ptm180 . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.76 -0.638 . . . . 71.510000000000005 110.664 -179.652 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 708' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 N--CA 1.479 1.004 0 N-CA-C 110.279 -0.267 . . . . 72.420000000000002 110.279 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . 0.401 ' HA ' ' HD3' ' A' ' 710' ' ' PRO . 4.5 mpp? -93.37 137.87 23.29 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 116.413 -0.358 . . . . 63.149999999999999 110.121 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 710' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 709' ' ' MET . 6.5 Cg_exo -74.07 172.55 15.73 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 123.011 2.474 . . . . 62.039999999999999 111.865 178.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 711' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -101.55 -24.48 14.13 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.899 0.381 . . . . 73.409999999999997 110.205 178.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 712' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.47 3.48 47.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.235 -0.439 . . . . 73.219999999999999 111.847 -179.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 713' ' ' VAL . . . . . . . . . . . . . 12.9 p -78.66 136.79 23.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.106 0.479 . . . . 71.409999999999997 110.317 -178.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.618 ' HG2' ' HB2' ' A' ' 801' ' ' ARG . 0.0 OUTLIER -125.01 85.19 2.37 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.207 0.527 . . . . 74.25 110.985 177.202 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -92.25 103.27 15.76 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.089 -0.708 . . . . 43.43 109.089 175.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 716' ' ' ILE . . . . . 0.779 HG23 HG12 ' A' ' 793' ' ' ILE . 25.8 mm -65.35 -26.99 40.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.533 -0.758 . . . . 71.329999999999998 111.961 -173.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -57.17 -28.69 58.93 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.959 -0.639 . . . . 74.420000000000002 112.293 176.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 718' ' ' GLU . . . . . 0.711 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 9.2 mm-40 -70.59 -36.42 73.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.841 0.353 . . . . 73.25 110.289 178.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 719' ' ' LEU . . . . . 0.593 HD23 ' HA ' ' A' ' 716' ' ' ILE . 3.2 mm? -66.86 -32.23 73.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.17 0.509 . . . . 53.119999999999997 109.864 177.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 720' ' ' VAL . . . . . 0.459 HG22 HD13 ' A' ' 793' ' ' ILE . 61.0 t -68.81 -34.81 66.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.696 -0.684 . . . . 74.140000000000001 110.636 177.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 721' ' ' ARG . . . . . 0.711 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 21.5 ptt180 -63.47 -28.93 70.3 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.261 0.553 . . . . 71.120000000000005 109.643 178.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -77.76 -30.79 51.69 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.908 -0.587 . . . . 71.140000000000001 111.392 178.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 723' ' ' LEU . . . . . 0.521 HD21 ' HB2' ' A' ' 789' ' ' LEU . 92.9 mt -58.18 -33.56 69.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.146 0.498 . . . . 73.150000000000006 110.052 175.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -82.83 -44.28 15.66 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.491 -0.777 . . . . 45.149999999999999 110.887 176.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 8.2 m -84.22 -79.82 0.21 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.358 -0.383 . . . . 54.210000000000001 111.46 -175.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 726' ' ' ASN . . . . . 0.432 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 52.6 t-20 -148.08 109.58 3.73 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 109.768 -0.456 . . . . 71.120000000000005 109.768 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 727' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 28.0 Cg_endo -63.06 -33.79 72.32 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.826 2.35 . . . . 75.420000000000002 112.467 -178.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 59.7 t -63.39 -48.45 87.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.044 0.45 . . . . 72.310000000000002 110.183 -178.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -66.03 -24.55 71.76 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.668 -0.696 . . . . 71.5 111.881 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -79.1 -39.15 20.58 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 121.149 -0.548 . . . . 64.329999999999998 112.644 178.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -65.35 -41.83 93.47 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.576 -0.527 . . . . 72.140000000000001 109.576 178.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 732' ' ' LEU . . . . . 0.423 HD23 ' HB3' ' A' ' 742' ' ' ALA . 90.0 mt -64.13 -37.77 88.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.83 -0.623 . . . . 71.439999999999998 110.193 175.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 733' ' ' GLU . . . . . 0.553 ' O ' ' HG2' ' A' ' 736' ' ' ARG . 4.1 tp10 -65.18 -49.45 69.74 Favored 'General case' 0 N--CA 1.437 -1.12 0 C-N-CA 123.423 0.689 . . . . 74.109999999999999 110.857 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 734' ' ' TYR . . . . . 0.52 ' HB2' HD11 ' A' ' 719' ' ' LEU . 11.0 t80 -54.7 -48.13 72.82 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.634 -0.712 . . . . 72.329999999999998 110.716 178.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -67.14 -47.93 69.6 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.88 -0.6 . . . . 75.230000000000004 111.22 -177.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 736' ' ' ARG . . . . . 0.553 ' HG2' ' O ' ' A' ' 733' ' ' GLU . 18.5 ptt180 -61.99 -32.95 73.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.997 0.427 . . . . 53.240000000000002 111.314 -175.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 44.6 t -80.3 -36.87 33.75 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.075 -0.511 . . . . 75.450000000000003 110.981 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -91.81 -2.35 56.95 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.105 0.409 . . . . 65.209999999999994 112.105 -172.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 89.47 13.37 61.57 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.61 -0.805 . . . . 74.439999999999998 112.936 175.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -97.93 157.89 15.84 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.849 0.357 . . . . 65.219999999999999 110.691 177.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -102.42 114.85 29.4 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.519 -0.548 . . . . 52.109999999999999 109.519 175.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 742' ' ' ALA . . . . . 0.423 ' HB3' HD23 ' A' ' 732' ' ' LEU . . . -92.38 114.81 27.46 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 123.237 0.336 . . . . 61.109999999999999 111.021 -177.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 743' ' ' GLU . . . . . 0.431 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 47.1 mt-10 -126.68 132.74 51.1 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.3 -0.409 . . . . 65.299999999999997 110.966 -178.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -106.14 100.76 10.28 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.181 -0.463 . . . . 72.530000000000001 110.292 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 10.4 ptpt -103.72 140.89 37.0 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.171 0.51 . . . . 65.239999999999995 111.204 -179.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 746' ' ' LEU . . . . . . . . . . . . . 6.6 tt -86.42 110.01 19.43 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.303 -0.999 . . . . 72.219999999999999 108.303 175.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 40.4 t -74.88 -53.88 15.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.077 -0.51 . . . . 72.409999999999997 110.347 -176.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -157.04 155.19 30.76 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.991 -0.55 . . . . 52.240000000000002 109.53 -178.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -139.62 96.81 3.14 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.514 0.673 . . . . 74.019999999999996 110.974 177.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 34.0 t -89.73 101.85 14.55 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.548 -0.908 . . . . 63.240000000000002 108.548 174.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 751' ' ' GLY . . . . . 0.667 ' HA2' ' HA ' ' A' ' 756' ' ' PRO . . . -120.25 81.17 0.33 Allowed Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.172 -1.013 . . . . 54.409999999999997 113.671 -173.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 752' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -64.59 160.24 40.95 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.169 1.913 . . . . 55.439999999999998 110.466 170.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.41 -27.36 84.79 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.513 2.142 . . . . 75.019999999999996 113.188 -174.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 50.9 p-80 -92.19 -15.18 27.95 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.499 -0.319 . . . . 74.140000000000001 111.596 -176.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -158.89 71.72 3.62 Favored Pre-proline 0 C--N 1.329 -0.289 0 N-CA-C 112.289 0.478 . . . . 64.540000000000006 112.289 -176.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 756' ' ' PRO . . . . . 0.667 ' HA ' ' HA2' ' A' ' 751' ' ' GLY . 40.2 Cg_exo -58.13 115.29 2.43 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 121.934 1.756 . . . . 61.240000000000002 111.199 171.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 757' ' ' LYS . . . . . 0.488 ' HD3' ' HB2' ' A' ' 773' ' ' CYS . 36.4 ttmt -122.4 137.06 54.99 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.958 0.408 . . . . 72.549999999999997 110.822 -176.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 758' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -123.21 119.61 30.73 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.813 -0.631 . . . . 74.129999999999995 110.45 -176.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 759' ' ' VAL . . . . . 0.527 HG22 ' HB3' ' A' ' 773' ' ' CYS . 25.3 t -94.49 115.92 34.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.005 -0.543 . . . . 62.130000000000003 110.761 -177.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -116.76 147.56 41.94 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.754 -0.657 . . . . 75.540000000000006 110.724 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 761' ' ' GLN . . . . . 0.452 HE21 ' HB2' ' A' ' 771' ' ' ALA . 34.4 tt0 -132.62 138.13 47.27 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.942 -0.572 . . . . 74.230000000000004 109.677 177.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 762' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 769' ' ' PHE . . . -95.19 112.66 24.34 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.316 0.579 . . . . 73.439999999999998 110.514 -177.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 763' ' ' LYS . . . . . 0.488 ' HD2' ' CH2' ' A' ' 768' ' ' TRP . 48.8 tttm -91.67 104.02 16.54 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.493 -0.776 . . . . 70.209999999999994 109.441 177.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 88.8 t -109.35 101.77 13.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.182 0.515 . . . . 73.329999999999998 109.851 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 71.68 -119.13 7.47 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 110.775 -0.93 . . . . 55.530000000000001 110.775 -174.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -102.14 7.06 54.24 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.635 -0.793 . . . . 73.140000000000001 111.224 175.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 767' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -99.9 148.56 24.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.054 0.454 . . . . 75.540000000000006 110.976 -177.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 768' ' ' TRP . . . . . 0.488 ' CH2' ' HD2' ' A' ' 763' ' ' LYS . 54.1 m95 -124.76 99.9 6.37 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.688 -0.687 . . . . 73.430000000000007 110.064 -179.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 769' ' ' PHE . . . . . 0.414 ' HA ' ' HA ' ' A' ' 770' ' ' PRO . 34.5 p90 -171.04 141.57 1.41 Allowed Pre-proline 0 C--N 1.325 -0.468 0 CA-C-O 120.706 0.289 . . . . 64.219999999999999 110.397 -178.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 770' ' ' PRO . . . . . 0.58 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 60.7 Cg_endo -96.59 -168.54 1.78 Allowed 'Cis proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.755 -1.352 . . . . 64.030000000000001 112.126 -2.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 771' ' ' ALA . . . . . 0.452 ' HB2' HE21 ' A' ' 761' ' ' GLN . . . -120.95 108.53 14.0 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.771 -0.455 . . . . 70.140000000000001 109.771 175.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 772' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 759' ' ' VAL . 32.9 m -116.87 157.54 17.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.83 0.348 . . . . 60.039999999999999 110.998 -176.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 773' ' ' CYS . . . . . 0.527 ' HB3' HG22 ' A' ' 759' ' ' VAL . 2.6 p -134.99 100.53 4.6 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.069 -0.514 . . . . 73.420000000000002 110.175 178.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -103.22 177.49 4.82 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.824 -0.626 . . . . 61.520000000000003 111.221 -174.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 775' ' ' HIS . . . . . . . . . . . . . 46.8 m-70 -85.32 -16.63 39.35 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.14 0.495 . . . . 73.129999999999995 110.324 -177.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 776' ' ' SER . . . . . 0.605 ' HB2' ' HB2' ' A' ' 779' ' ' GLN . 12.5 m -129.71 152.57 49.07 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.954 -0.567 . . . . 75.439999999999998 110.281 -177.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 777' ' ' LYS . . . . . . . . . . . . . 6.1 tmmm? -63.9 -49.69 71.67 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.372 -0.376 . . . . 75.0 110.96 -178.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -70.41 -26.56 63.74 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.644 -0.423 . . . . 71.400000000000006 110.231 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 779' ' ' GLN . . . . . 0.605 ' HB2' ' HB2' ' A' ' 776' ' ' SER . 6.5 mm-40 -66.71 -37.33 84.48 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 116.28 -0.418 . . . . 74.409999999999997 110.261 173.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -58.15 -45.98 93.31 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.787 -0.72 . . . . 74.340000000000003 111.501 175.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -61.94 -46.13 90.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.773 0.321 . . . . 73.450000000000003 110.76 176.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -64.56 -46.87 80.92 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.337 -0.392 . . . . 61.450000000000003 111.399 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -63.14 -39.57 95.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.496 -0.32 . . . . 73.540000000000006 111.235 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -63.19 -46.11 88.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.82 0.343 . . . . 54.210000000000001 110.11 177.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 785' ' ' ALA . . . . . 0.578 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -65.14 -45.11 86.35 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.902 -0.59 . . . . 62.329999999999998 110.986 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 786' ' ' ASP . . . . . 0.718 ' O ' ' HG2' ' A' ' 790' ' ' ARG . 14.1 t70 -58.41 -54.49 46.46 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 116.317 -0.401 . . . . 73.030000000000001 110.012 178.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 787' ' ' ALA . . . . . 0.52 ' O ' HG23 ' A' ' 791' ' ' VAL . . . -61.75 -33.79 74.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.759 -0.655 . . . . 73.329999999999998 111.21 -178.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 788' ' ' ALA . . . . . 0.716 ' O ' ' HG ' ' A' ' 792' ' ' LEU . . . -62.84 -46.62 87.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.363 -0.381 . . . . 63.530000000000001 110.448 177.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 789' ' ' LEU . . . . . 0.587 HD22 HD12 ' A' ' 719' ' ' LEU . 65.5 mt -62.58 -36.36 82.47 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.812 -0.44 . . . . 75.230000000000004 109.812 179.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 790' ' ' ARG . . . . . 0.718 ' HG2' ' O ' ' A' ' 786' ' ' ASP . 26.6 mmm-85 -58.95 -42.18 89.22 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.868 0.366 . . . . 75.230000000000004 110.033 177.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 791' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 787' ' ' ALA . 59.0 t -64.31 -49.68 79.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.054 -0.521 . . . . 73.129999999999995 110.465 177.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 792' ' ' LEU . . . . . 0.716 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 22.5 mt -59.19 -46.59 88.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.033 -0.531 . . . . 52.100000000000001 110.457 -178.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 793' ' ' ILE . . . . . 0.779 HG12 HG23 ' A' ' 716' ' ' ILE . 96.7 mt -63.02 -45.49 98.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.422 -0.808 . . . . 74.409999999999997 110.675 177.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -65.69 -40.16 95.69 Favored Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 115.934 -0.575 . . . . 53.420000000000002 112.934 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -74.23 -16.58 60.96 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 122.377 -0.484 . . . . 73.230000000000004 111.277 -178.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -89.41 -12.94 38.84 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.436 0.636 . . . . 75.310000000000002 109.424 174.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 797' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.29 -32.18 64.49 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.949 -0.76 . . . . 70.310000000000002 108.949 175.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 798' ' ' LYS . . . . . . . . . . . . . 2.7 ptpp? -92.41 15.87 13.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.723 -0.671 . . . . 72.510000000000005 110.451 176.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 799' ' ' ALA . . . . . . . . . . . . . . . -145.79 -176.01 4.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.883 0.373 . . . . 65.140000000000001 111.226 -176.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 800' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -124.96 122.82 38.42 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.914 -0.585 . . . . 70.25 109.875 174.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 801' ' ' ARG . . . . . 0.618 ' HB2' ' HG2' ' A' ' 714' ' ' ARG . 8.0 ppt_? . . . . . 0 C--O 1.245 0.85 0 CA-C-N 115.938 -0.574 . . . . 71.409999999999997 111.736 -178.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 708' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 N--CA 1.478 0.957 0 CA-C-O 120.741 0.305 . . . . 74.150000000000006 110.38 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -105.71 151.69 39.94 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 110.075 -0.343 . . . . 74.010000000000005 110.075 178.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -58.29 -50.81 8.84 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 122.878 2.386 . . . . 75.310000000000002 113.148 -178.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 711' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -111.12 171.23 7.59 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.594 -0.275 . . . . 71.340000000000003 110.765 -177.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 712' ' ' LYS . . . . . 0.589 ' HE3' ' HG3' ' A' ' 718' ' ' GLU . 21.5 pttm -115.56 169.43 9.19 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.972 0.415 . . . . 71.209999999999994 111.156 -178.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 713' ' ' VAL . . . . . 0.853 HG22 ' H ' ' A' ' 714' ' ' ARG . 7.8 p -92.37 -167.14 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.705 -0.68 . . . . 71.349999999999994 109.363 177.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.853 ' H ' HG22 ' A' ' 713' ' ' VAL . 6.2 ptp85 -65.34 87.1 0.07 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.44 0.638 . . . . 65.510000000000005 110.955 175.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -107.36 105.63 15.67 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.815 -0.63 . . . . 74.420000000000002 109.997 177.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 716' ' ' ILE . . . . . 0.447 ' HA ' HD23 ' A' ' 719' ' ' LEU . 48.1 mm -78.31 -26.13 14.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.068 -0.514 . . . . 75.129999999999995 110.68 -176.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -60.29 -29.73 69.49 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.944 -0.646 . . . . 53.329999999999998 112.085 178.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 718' ' ' GLU . . . . . 0.671 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 30.0 mm-40 -57.87 -50.12 74.38 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-O 120.965 0.412 . . . . 73.540000000000006 110.168 176.004 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 719' ' ' LEU . . . . . 0.567 HD11 ' HB2' ' A' ' 734' ' ' TYR . 2.4 mm? -62.71 -29.67 70.84 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.164 0.507 . . . . 73.140000000000001 110.096 -177.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 720' ' ' VAL . . . . . 0.448 HG22 HD13 ' A' ' 793' ' ' ILE . 65.1 t -72.07 -42.96 67.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.617 -0.72 . . . . 74.319999999999993 110.639 178.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 721' ' ' ARG . . . . . 0.671 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 15.5 ptm180 -65.5 -24.05 67.04 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.919 0.39 . . . . 74.120000000000005 110.446 -179.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -76.91 -31.56 56.78 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 116.483 -0.326 . . . . 74.530000000000001 111.098 176.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 723' ' ' LEU . . . . . 0.479 HD21 ' HB2' ' A' ' 789' ' ' LEU . 92.3 mt -60.78 -30.9 70.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.266 0.555 . . . . 71.329999999999998 109.99 174.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -87.95 -17.26 31.69 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.281 -0.872 . . . . 70.299999999999997 111.317 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 21.2 m -118.04 -79.9 0.6 Allowed 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 120.674 0.274 . . . . 60.130000000000003 111.595 -177.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 726' ' ' ASN . . . . . 0.436 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 39.4 t30 -139.19 106.71 7.29 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 120.71 0.29 . . . . 64.549999999999997 110.669 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 727' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 21.1 Cg_endo -62.03 -38.48 56.91 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.745 2.297 . . . . 34.520000000000003 112.838 -178.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 29.9 t -63.12 -46.32 96.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.355 -0.384 . . . . 72.239999999999995 110.669 -175.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -61.58 -36.1 92.12 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.833 -0.698 . . . . 45.399999999999999 112.026 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -67.54 -42.07 89.17 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 121.095 -0.574 . . . . 73.109999999999999 112.593 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -65.66 -42.05 91.81 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.964 0.411 . . . . 75.299999999999997 109.933 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 732' ' ' LEU . . . . . . . . . . . . . 96.1 mt -65.37 -46.44 80.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.944 -0.571 . . . . 75.129999999999995 111.14 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 733' ' ' GLU . . . . . 0.515 ' HA ' ' HG2' ' A' ' 736' ' ' ARG . 0.0 OUTLIER -72.75 -31.38 64.88 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.899 -0.321 . . . . 75.109999999999999 110.994 -176.187 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 734' ' ' TYR . . . . . 0.567 ' HB2' HD11 ' A' ' 719' ' ' LEU . 11.8 t80 -57.22 -48.88 77.69 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 120.918 0.39 . . . . 71.319999999999993 110.089 175.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -65.02 -52.26 57.0 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.874 -0.603 . . . . 73.409999999999997 110.709 -176.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 736' ' ' ARG . . . . . 0.515 ' HG2' ' HA ' ' A' ' 733' ' ' GLU . 32.5 ptt180 -62.47 -33.04 74.05 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.686 -0.688 . . . . 72.400000000000006 111.399 -175.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 47.9 t -83.47 -11.68 57.21 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.909 -0.587 . . . . 42.340000000000003 111.673 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -113.03 -8.44 13.64 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.008 0.373 . . . . 64.409999999999997 112.008 -177.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 100.08 8.01 51.48 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.597 -0.811 . . . . 51.439999999999998 112.733 178.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -97.42 163.75 12.74 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 110.091 -0.337 . . . . 74.140000000000001 110.091 177.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -113.0 118.61 35.3 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.6 -0.519 . . . . 64.349999999999994 109.6 174.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 742' ' ' ALA . . . . . . . . . . . . . . . -94.06 128.3 40.35 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.21 -0.45 . . . . 53.539999999999999 111.029 -176.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 743' ' ' GLU . . . . . 0.567 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 45.6 mt-10 -139.54 154.81 47.74 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.872 -0.603 . . . . 71.510000000000005 110.393 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -128.5 113.18 15.17 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.209 -0.451 . . . . 73.420000000000002 109.795 178.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 745' ' ' LYS . . . . . 0.511 ' HE3' ' CZ3' ' A' ' 768' ' ' TRP . 13.1 ptpt -111.74 149.34 31.79 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.305 -0.558 . . . . 52.240000000000002 111.197 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 746' ' ' LEU . . . . . . . . . . . . . 6.7 tt -95.49 104.85 16.77 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.236 -1.024 . . . . 61.219999999999999 108.236 177.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 48.3 t -76.84 -44.14 32.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 116.226 -0.443 . . . . 74.450000000000003 111.009 -174.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -152.88 148.49 27.21 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.324 -0.398 . . . . 73.319999999999993 111.12 -175.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 749' ' ' GLN . . . . . 0.514 ' HA ' ' O ' ' A' ' 757' ' ' LYS . 18.1 pt20 -138.75 97.02 3.24 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.924 0.869 . . . . 72.140000000000001 109.759 173.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 9.8 p -129.5 -179.18 5.02 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.414 -0.812 . . . . 61.399999999999999 111.004 -174.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 103.64 178.5 25.87 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.586 -0.816 . . . . 31.100000000000001 112.229 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 752' ' ' PRO . . . . . 0.663 ' HG2' ' HB2' ' A' ' 755' ' ' GLU . 38.7 Cg_endo -64.98 160.3 42.15 Favored 'Trans proline' 0 CA--C 1.528 0.218 0 C-N-CA 123.118 2.545 . . . . 53.109999999999999 111.963 -178.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.37 -28.2 71.58 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.645 2.23 . . . . 70.200000000000003 112.658 -178.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 49.0 p-80 -86.49 -14.82 41.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.76 0.314 . . . . 54.420000000000002 110.989 -179.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 755' ' ' GLU . . . . . 0.663 ' HB2' ' HG2' ' A' ' 752' ' ' PRO . 18.8 mm-40 -138.9 74.0 38.5 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.252 -0.431 . . . . 64.519999999999996 110.718 178.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 756' ' ' PRO . . . . . 0.671 ' O ' ' HA ' ' A' ' 775' ' ' HIS . 56.1 Cg_endo -73.5 113.32 3.75 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.495 2.13 . . . . 74.099999999999994 111.723 177.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 757' ' ' LYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 749' ' ' GLN . 6.1 ttpm? -88.61 114.08 24.85 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.903 0.382 . . . . 71.25 110.718 -177.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 758' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -99.06 115.11 28.22 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.532 -0.758 . . . . 70.209999999999994 110.013 179.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 22.1 t -88.24 105.69 15.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.627 -0.715 . . . . 71.099999999999994 109.373 177.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -107.63 144.43 34.69 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.981 -0.554 . . . . 62.039999999999999 110.669 -178.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 761' ' ' GLN . . . . . 0.473 ' HA ' ' O ' ' A' ' 770' ' ' PRO . 60.4 tt0 -136.6 128.18 28.72 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.703 -0.68 . . . . 74.319999999999993 109.512 178.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 762' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 769' ' ' PHE . . . -86.29 129.56 34.81 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.332 0.587 . . . . 41.109999999999999 110.502 -178.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 763' ' ' LYS . . . . . 0.567 ' HB3' ' HB2' ' A' ' 743' ' ' GLU . 66.0 tttt -104.6 112.28 25.29 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.584 -0.735 . . . . 75.030000000000001 109.783 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 58.9 t -119.27 95.92 3.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.175 0.512 . . . . 53.219999999999999 109.758 177.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 72.86 -116.5 5.65 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.091 -0.803 . . . . 52.140000000000001 111.091 -175.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -101.36 -2.97 53.89 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.752 -0.737 . . . . 60.340000000000003 111.818 175.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 767' ' ' ARG . . . . . 0.455 ' HB3' ' CD1' ' A' ' 769' ' ' PHE . 0.2 OUTLIER -95.08 121.91 37.2 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.959 0.409 . . . . 72.530000000000001 111.457 -178.01 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 768' ' ' TRP . . . . . 0.511 ' CZ3' ' HE3' ' A' ' 745' ' ' LYS . 70.2 m95 -102.17 105.14 15.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.917 -0.583 . . . . 75.239999999999995 110.062 177.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 769' ' ' PHE . . . . . 0.455 ' CD1' ' HB3' ' A' ' 767' ' ' ARG . 41.6 p90 -168.39 144.94 3.2 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 109.873 -0.417 . . . . 74.230000000000004 109.873 -177.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 770' ' ' PRO . . . . . 0.666 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 65.3 Cg_endo -97.56 -176.16 4.45 Favored 'Cis proline' 0 N--CA 1.451 -1.006 0 C-N-CA 123.736 -1.36 . . . . 53.329999999999998 112.188 -2.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -106.41 109.1 20.93 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.596 -0.52 . . . . 50.200000000000003 109.596 174.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 35.9 m -117.72 155.79 19.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.969 0.414 . . . . 70.310000000000002 110.997 -177.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 7.0 p -129.91 112.78 13.86 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.17 0.51 . . . . 65.019999999999996 110.442 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 774' ' ' ALA . . . . . 0.421 ' O ' ' HA ' ' A' ' 757' ' ' LYS . . . -116.73 -178.4 3.42 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.816 -0.629 . . . . 64.340000000000003 109.784 178.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 775' ' ' HIS . . . . . 0.671 ' HA ' ' O ' ' A' ' 756' ' ' PRO . 5.6 p80 -121.86 19.01 11.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.772 0.796 . . . . 65.109999999999999 110.187 176.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 49.3 m -148.35 139.22 23.05 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.837 -1.074 . . . . 73.420000000000002 108.405 171.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 777' ' ' LYS . . . . . . . . . . . . . 5.6 tmmm? -61.45 -44.77 96.53 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 123.018 0.199 . . . . 65.129999999999995 111.291 -172.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -64.85 -31.56 72.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.71 0.291 . . . . 60.149999999999999 110.799 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 779' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -72.03 -35.51 69.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.365 -0.38 . . . . 75.230000000000004 110.335 177.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -59.94 -42.94 98.48 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.904 -0.665 . . . . 45.310000000000002 111.493 176.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -61.25 -49.01 78.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.835 0.35 . . . . 72.540000000000006 110.488 176.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -61.73 -51.21 69.31 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 115.896 -0.593 . . . . 72.129999999999995 111.254 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -57.95 -43.34 86.34 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 123.196 0.31 . . . . 60.539999999999999 111.44 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -59.92 -50.68 72.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.373 -0.376 . . . . 64.209999999999994 110.622 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 785' ' ' ALA . . . . . 0.596 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -67.48 -42.46 82.94 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.318 -0.401 . . . . 54.140000000000001 111.025 -178.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 786' ' ' ASP . . . . . 0.461 ' O ' ' HG3' ' A' ' 790' ' ' ARG . 11.8 t70 -59.1 -51.74 68.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.984 -0.553 . . . . 65.200000000000003 110.717 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 787' ' ' ALA . . . . . 0.55 ' O ' HG23 ' A' ' 791' ' ' VAL . . . -66.84 -35.46 80.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.034 -0.53 . . . . 64.120000000000005 110.8 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 788' ' ' ALA . . . . . 0.676 ' O ' ' HG ' ' A' ' 792' ' ' LEU . . . -61.46 -42.75 99.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.425 -0.352 . . . . 65.420000000000002 110.854 178.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 789' ' ' LEU . . . . . 0.596 ' HG ' ' O ' ' A' ' 785' ' ' ALA . 81.3 mt -58.92 -43.98 91.22 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 110.008 -0.367 . . . . 73.239999999999995 110.008 177.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 790' ' ' ARG . . . . . 0.548 ' HD2' ' HA ' ' A' ' 787' ' ' ALA . 53.9 mtt-85 -58.36 -37.53 75.39 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.206 -0.452 . . . . 75.530000000000001 111.009 177.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 791' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 787' ' ' ALA . 48.3 t -65.81 -48.67 81.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.416 -0.356 . . . . 72.430000000000007 110.237 177.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 792' ' ' LEU . . . . . 0.676 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 39.6 mt -61.67 -46.37 90.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.747 -0.661 . . . . 73.049999999999997 110.749 -179.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 793' ' ' ILE . . . . . 0.448 HD13 HG22 ' A' ' 720' ' ' VAL . 89.5 mt -62.17 -47.53 92.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.51 -0.768 . . . . 70.439999999999998 110.366 177.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 794' ' ' GLY . . . . . 0.401 ' O ' ' HG2' ' A' ' 798' ' ' LYS . . . -62.92 -36.4 93.36 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 121.018 -0.611 . . . . 71.030000000000001 112.342 178.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -57.56 -51.22 70.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.977 0.418 . . . . 71.329999999999998 110.44 177.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 796' ' ' ASN . . . . . 0.498 ' HA ' ' HB3' ' A' ' 799' ' ' ALA . 2.6 t-20 -86.44 0.39 54.24 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.171 0.51 . . . . 72.129999999999995 110.667 -177.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 797' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -83.05 -45.85 13.53 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.159 -0.682 . . . . 74.109999999999999 109.159 173.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 798' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 794' ' ' GLY . 72.0 mmtt -75.01 -24.51 58.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.652 -0.704 . . . . 74.420000000000002 109.783 177.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 799' ' ' ALA . . . . . 0.498 ' HB3' ' HA ' ' A' ' 796' ' ' ASN . . . -85.84 153.86 21.95 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.498 -0.774 . . . . 64.209999999999994 109.554 173.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 800' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -122.45 86.06 2.52 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.974 0.416 . . . . 63.439999999999998 110.471 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 801' ' ' ARG . . . . . 0.443 ' HE ' ' HA ' ' A' ' 801' ' ' ARG . 2.8 mmp_? . . . . . 0 C--O 1.246 0.904 0 CA-C-O 118.634 -0.698 . . . . 64.230000000000004 109.69 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 708' ' ' MET . . . . . . . . . . . . . 22.2 ptp . . . . . 0 N--CA 1.48 1.054 0 CA-C-O 120.754 0.312 . . . . 54.399999999999999 110.425 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . 0.424 ' HA ' ' HD3' ' A' ' 710' ' ' PRO . 20.7 ptp -162.72 147.77 9.62 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 109.54 -0.541 . . . . 63.149999999999999 109.54 176.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 710' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 709' ' ' MET . 16.8 Cg_exo -66.85 150.96 83.14 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.322 2.015 . . . . 41.240000000000002 111.7 178.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 711' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -65.44 -40.88 93.8 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.24 -0.652 . . . . 73.510000000000005 109.24 175.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 712' ' ' LYS . . . . . 0.562 ' HA ' ' HE3' ' A' ' 712' ' ' LYS . 0.0 OUTLIER -126.31 127.01 44.88 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.109 -1.071 . . . . 65.329999999999998 108.109 169.865 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 713' ' ' VAL . . . . . . . . . . . . . 14.9 p -55.61 133.45 19.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 121.061 0.457 . . . . 71.349999999999994 110.717 -175.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.567 ' HG2' HG12 ' A' ' 716' ' ' ILE . 10.9 ttp180 -86.32 89.51 7.89 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.233 -0.44 . . . . 65.549999999999997 111.108 -172.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 715' ' ' LYS . . . . . 0.413 ' HD3' ' HA ' ' A' ' 715' ' ' LYS . 72.4 mmtt -98.37 93.35 6.14 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.669 -0.863 . . . . 70.540000000000006 108.669 171.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 716' ' ' ILE . . . . . 0.567 HG12 ' HG2' ' A' ' 714' ' ' ARG . 46.1 mm -122.42 -36.34 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.76 -0.655 . . . . 72.319999999999993 110.587 -175.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -61.09 -28.94 69.77 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.974 -0.631 . . . . 41.049999999999997 111.702 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 718' ' ' GLU . . . . . 0.759 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 5.8 mp0 -59.68 -46.94 87.55 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.913 0.387 . . . . 64.109999999999999 110.173 175.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 719' ' ' LEU . . . . . 0.641 HD12 HD22 ' A' ' 789' ' ' LEU . 2.9 mm? -67.61 -33.75 75.62 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.997 0.427 . . . . 75.340000000000003 110.36 -178.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 720' ' ' VAL . . . . . 0.496 HG22 HD13 ' A' ' 793' ' ' ILE . 61.6 t -63.39 -41.19 91.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 115.991 -0.55 . . . . 64.5 110.672 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 721' ' ' ARG . . . . . 0.759 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 14.7 ptm180 -68.92 -24.57 64.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 73.0 109.981 -178.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -76.73 -30.15 56.49 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.356 -0.384 . . . . 75.120000000000005 111.404 177.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 723' ' ' LEU . . . . . 0.564 HD21 ' HB2' ' A' ' 789' ' ' LEU . 84.7 mt -59.18 -32.57 70.04 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.476 -0.565 . . . . 74.239999999999995 109.476 172.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -82.97 -41.06 19.22 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.276 -0.875 . . . . 60.240000000000002 110.976 177.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 29.3 m -96.26 -78.49 0.46 Allowed 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 112.32 0.489 . . . . 72.540000000000006 112.32 -176.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 726' ' ' ASN . . . . . 0.422 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 37.7 t30 -142.11 100.9 5.82 Favored Pre-proline 0 C--O 1.234 0.27 0 CA-C-O 120.817 0.342 . . . . 75.120000000000005 111.065 -173.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 727' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 19.2 Cg_endo -61.86 -38.5 58.7 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 123.041 2.494 . . . . 55.399999999999999 112.844 -176.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 42.0 t -61.48 -48.49 88.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 75.510000000000005 110.939 -175.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -61.98 -38.46 96.09 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.765 -0.731 . . . . 54.130000000000003 112.12 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -66.85 -42.68 92.8 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.876 -0.678 . . . . 72.349999999999994 112.584 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -62.52 -40.36 96.5 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.807 -0.442 . . . . 71.219999999999999 109.807 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 732' ' ' LEU . . . . . . . . . . . . . 90.7 mt -64.74 -42.98 94.77 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.928 -0.578 . . . . 72.530000000000001 111.399 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 733' ' ' GLU . . . . . 0.522 ' O ' ' HG2' ' A' ' 736' ' ' ARG . 12.7 pt-20 -80.2 -25.95 39.43 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.924 -0.311 . . . . 74.450000000000003 111.55 -176.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 734' ' ' TYR . . . . . 0.52 ' HB2' HD11 ' A' ' 719' ' ' LEU . 3.2 t80 -56.89 -44.24 82.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.061 0.457 . . . . 71.030000000000001 109.84 173.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -66.93 -47.6 71.22 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.612 -0.722 . . . . 63.350000000000001 110.666 -177.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 736' ' ' ARG . . . . . 0.522 ' HG2' ' O ' ' A' ' 733' ' ' GLU . 34.4 ptt180 -63.39 -31.77 73.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.13 0.49 . . . . 74.310000000000002 110.992 -176.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 10.4 t -75.46 -33.59 60.87 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.756 -0.656 . . . . 74.230000000000004 110.993 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 18.2 m170 -97.02 -13.29 22.38 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.317 0.488 . . . . 73.540000000000006 112.317 -173.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 100.56 13.56 34.85 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.439 -0.886 . . . . 42.420000000000002 112.614 178.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -98.57 -174.14 2.73 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.025 0.44 . . . . 60.340000000000003 110.284 176.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 741' ' ' ALA . . . . . 0.564 ' O ' ' HA ' ' A' ' 764' ' ' VAL . . . -128.06 139.43 52.53 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.796 -0.638 . . . . 71.409999999999997 109.281 173.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 742' ' ' ALA . . . . . . . . . . . . . . . -110.11 115.73 30.28 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.773 0.32 . . . . 74.010000000000005 110.895 -176.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 743' ' ' GLU . . . . . 0.561 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 43.4 mt-10 -126.63 146.53 50.14 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.274 -0.421 . . . . 72.239999999999995 110.979 -178.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -123.15 104.3 9.09 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.37 -0.604 . . . . 71.040000000000006 109.37 176.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 8.0 ptpt -119.16 157.9 27.02 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.095 0.474 . . . . 44.439999999999998 111.307 -176.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 746' ' ' LEU . . . . . 0.471 HD13 ' HB3' ' A' ' 758' ' ' PHE . 57.2 tp -85.78 122.98 30.63 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.509 -0.769 . . . . 63.450000000000003 109.756 175.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 54.3 t -94.58 -47.73 13.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 120.959 0.409 . . . . 74.230000000000004 110.537 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -143.92 148.9 36.03 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.044 -0.525 . . . . 64.019999999999996 110.003 -177.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -133.32 102.5 5.57 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.691 -0.485 . . . . 71.209999999999994 109.691 176.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 33.7 m -143.65 131.61 21.63 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.243 -0.435 . . . . 74.310000000000002 110.562 -177.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 160.62 -165.52 35.08 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.653 -0.784 . . . . 64.140000000000001 112.261 178.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 752' ' ' PRO . . . . . 0.489 ' HG2' ' HB2' ' A' ' 755' ' ' GLU . 72.7 Cg_endo -78.0 163.81 27.96 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 123.015 2.477 . . . . 73.310000000000002 112.084 177.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 753' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 752' ' ' PRO . 3.8 Cg_exo -76.51 -27.94 7.23 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.543 2.162 . . . . 75.209999999999994 112.379 -179.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 754' ' ' HIS . . . . . 0.415 ' CE1' ' HB2' ' A' ' 752' ' ' PRO . 39.8 p-80 -79.33 -19.4 50.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.914 0.387 . . . . 72.549999999999997 110.709 178.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 755' ' ' GLU . . . . . 0.489 ' HB2' ' HG2' ' A' ' 752' ' ' PRO . 29.3 mt-10 -138.99 79.74 26.09 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.929 -0.578 . . . . 62.43 110.332 175.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 756' ' ' PRO . . . . . 0.493 ' O ' ' HA ' ' A' ' 775' ' ' HIS . 34.9 Cg_endo -65.94 102.38 0.53 Allowed 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.165 1.91 . . . . 73.319999999999993 111.3 177.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 757' ' ' LYS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 775' ' ' HIS . 37.9 ttmt -87.69 114.69 24.54 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.437 0.637 . . . . 65.120000000000005 110.686 -176.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 758' ' ' PHE . . . . . 0.471 ' HB3' HD13 ' A' ' 746' ' ' LEU . 78.8 m-85 -97.95 126.12 43.19 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.016 -0.993 . . . . 75.319999999999993 110.48 -178.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 62.0 t -88.86 102.95 13.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 109.488 -0.56 . . . . 54.130000000000003 109.488 174.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 760' ' ' TYR . . . . . 0.469 ' OH ' ' HG3' ' A' ' 777' ' ' LYS . 7.1 m-85 -102.29 142.13 34.01 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.875 -0.602 . . . . 64.409999999999997 110.764 -178.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 761' ' ' GLN . . . . . 0.483 ' OE1' ' HB3' ' A' ' 768' ' ' TRP . 32.0 tt0 -133.75 136.04 44.33 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.717 -0.674 . . . . 73.329999999999998 110.084 179.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 762' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 769' ' ' PHE . . . -87.43 116.28 25.43 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.94 -0.573 . . . . 74.120000000000005 110.441 -178.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 763' ' ' LYS . . . . . 0.561 ' HB3' ' HB2' ' A' ' 743' ' ' GLU . 58.6 tttm -94.94 100.39 12.25 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.716 -0.674 . . . . 53.109999999999999 109.631 178.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 764' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' A' ' 741' ' ' ALA . 58.3 t -104.75 100.7 11.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.965 -0.562 . . . . 74.049999999999997 109.842 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 69.84 -111.65 3.96 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 110.881 -0.888 . . . . 53.130000000000003 110.881 -174.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -112.13 10.99 26.86 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 111.407 -0.677 . . . . 71.010000000000005 111.407 175.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 767' ' ' ARG . . . . . . . . . . . . . 79.7 mtm180 -107.82 131.51 54.4 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.939 0.4 . . . . 72.549999999999997 110.567 -178.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 768' ' ' TRP . . . . . 0.483 ' HB3' ' OE1' ' A' ' 761' ' ' GLN . 43.1 m95 -108.39 101.25 10.46 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.906 -0.588 . . . . 74.329999999999998 109.991 -177.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 769' ' ' PHE . . . . . 0.446 ' HA ' ' HA ' ' A' ' 770' ' ' PRO . 27.2 p90 -167.86 139.8 2.49 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-O 120.74 0.305 . . . . 73.120000000000005 110.61 -178.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 770' ' ' PRO . . . . . 0.694 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 68.7 Cg_endo -95.13 -170.09 2.71 Favored 'Cis proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.648 -1.397 . . . . 63.32 111.797 -3.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 771' ' ' ALA . . . . . 0.412 ' HB2' HE21 ' A' ' 761' ' ' GLN . . . -122.17 101.49 7.56 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.996 -0.372 . . . . 72.409999999999997 109.996 176.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 27.0 m -110.51 168.04 4.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.135 -0.484 . . . . 54.119999999999997 110.81 -176.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 5.8 p -133.6 113.83 12.85 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.244 0.545 . . . . 71.329999999999998 110.995 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -132.03 149.4 52.43 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.866 -0.606 . . . . 54.420000000000002 109.926 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 775' ' ' HIS . . . . . 0.493 ' HA ' ' O ' ' A' ' 756' ' ' PRO . 1.3 p-80 -83.67 18.29 1.98 Allowed 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.592 -0.443 . . . . 73.230000000000004 111.669 -176.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 32.5 t -148.39 143.26 26.7 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.896 -0.409 . . . . 73.019999999999996 109.896 176.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 777' ' ' LYS . . . . . 0.469 ' HG3' ' OH ' ' A' ' 760' ' ' TYR . 8.4 ttmm -57.97 -49.8 75.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 72.510000000000005 110.752 178.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -58.94 -45.36 90.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.51 -0.768 . . . . 71.349999999999994 110.376 -178.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 779' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -63.58 -41.47 98.36 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-N 116.086 -0.506 . . . . 64.349999999999994 110.626 177.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -55.6 -44.85 86.04 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.028 -0.606 . . . . 51.340000000000003 112.036 178.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -66.24 -43.65 85.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.649 0.261 . . . . 72.040000000000006 111.024 177.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 782' ' ' GLN . . . . . 0.401 HE21 ' HB2' ' A' ' 782' ' ' GLN . 20.6 mt-30 -63.88 -48.13 77.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.393 -0.367 . . . . 53.109999999999999 110.969 -179.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -61.51 -43.52 98.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 64.439999999999998 110.927 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -63.2 -48.93 76.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.038 -0.528 . . . . 64.5 110.845 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 785' ' ' ALA . . . . . 0.608 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -65.1 -42.02 94.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.319 -0.401 . . . . 53.109999999999999 110.983 -178.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 786' ' ' ASP . . . . . 0.41 ' O ' ' HG3' ' A' ' 790' ' ' ARG . 12.7 t70 -57.64 -50.17 74.02 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.052 -0.522 . . . . 74.420000000000002 110.667 178.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 787' ' ' ALA . . . . . 0.523 ' O ' HG23 ' A' ' 791' ' ' VAL . . . -67.4 -38.75 85.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.043 -0.526 . . . . 72.25 110.968 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 788' ' ' ALA . . . . . 0.694 ' HB2' ' HD3' ' A' ' 770' ' ' PRO . . . -61.48 -43.58 98.62 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.326 -0.397 . . . . 53.340000000000003 111.41 -178.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 789' ' ' LEU . . . . . 0.641 HD22 HD12 ' A' ' 719' ' ' LEU . 52.1 mt -59.81 -43.57 94.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.565 -0.289 . . . . 61.439999999999998 110.409 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 790' ' ' ARG . . . . . 0.41 ' HG3' ' O ' ' A' ' 786' ' ' ASP . 67.0 mtt-85 -60.77 -34.34 74.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 75.040000000000006 110.989 178.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 791' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 787' ' ' ALA . 56.8 t -64.9 -49.66 78.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.947 -0.39 . . . . 71.0 109.947 175.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 792' ' ' LEU . . . . . 0.624 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 29.6 mt -60.8 -51.49 69.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.859 -0.609 . . . . 72.25 110.884 -178.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 793' ' ' ILE . . . . . 0.496 HD13 HG22 ' A' ' 720' ' ' VAL . 81.9 mt -58.31 -54.33 34.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.399 -0.819 . . . . 64.400000000000006 111.18 178.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 794' ' ' GLY . . . . . 0.41 ' O ' ' HB2' ' A' ' 798' ' ' LYS . . . -64.49 -26.57 70.88 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 121.098 -0.572 . . . . 52.399999999999999 112.809 -177.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -66.74 -46.53 75.16 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.925 -0.398 . . . . 52.100000000000001 109.925 177.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 796' ' ' ASN . . . . . 0.415 ' OD1' ' HD2' ' A' ' 714' ' ' ARG . 26.2 t-20 -67.1 -50.23 62.26 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 116.27 -0.423 . . . . 75.439999999999998 110.498 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 797' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -69.02 -13.34 62.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.754 0.311 . . . . 75.439999999999998 111.74 -175.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 798' ' ' LYS . . . . . 0.437 ' NZ ' ' HB2' ' A' ' 798' ' ' LYS . 0.1 OUTLIER -69.74 -20.43 63.51 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.621 0.724 . . . . 71.049999999999997 109.167 174.003 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 799' ' ' ALA . . . . . . . . . . . . . . . -113.21 -33.7 5.9 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.015 -0.993 . . . . 72.340000000000003 110.573 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 800' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 62.1 85.19 0.13 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.034 -0.984 . . . . 63.229999999999997 110.22 -174.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 801' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 . . . . . 0 C--O 1.246 0.909 0 CA-C-O 117.655 -1.164 . . . . 74.329999999999998 110.075 -178.43 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 708' ' ' MET . . . . . . . . . . . . . 92.4 mtp . . . . . 0 N--CA 1.481 1.085 0 CA-C-O 120.822 0.344 . . . . 73.25 110.251 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 43.8 ttm -138.0 132.22 17.02 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 116.155 -0.475 . . . . 63.32 109.863 177.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -63.12 91.97 0.14 Allowed 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.476 2.117 . . . . 64.140000000000001 110.821 172.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 711' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -87.62 84.59 7.08 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.602 -0.727 . . . . 62.039999999999999 110.632 -172.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 712' ' ' LYS . . . . . 0.601 ' HD3' ' H ' ' A' ' 712' ' ' LYS . 0.0 OUTLIER -110.71 -26.96 9.12 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.176 -0.675 . . . . 74.510000000000005 109.176 170.404 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 713' ' ' VAL . . . . . 0.508 HG13 ' HG2' ' A' ' 715' ' ' LYS . 11.3 p -76.24 154.79 5.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.315 -0.857 . . . . 54.140000000000001 108.722 172.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.26 79.74 0.72 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.138 0.494 . . . . 74.129999999999995 112.026 -177.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 715' ' ' LYS . . . . . 0.508 ' HG2' HG13 ' A' ' 713' ' ' VAL . 72.1 mmtt -90.79 86.24 6.27 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.099 -0.704 . . . . 75.540000000000006 109.099 170.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 716' ' ' ILE . . . . . 0.5 ' HA ' HD23 ' A' ' 719' ' ' LEU . 47.8 mm -89.48 -25.91 5.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.403 -0.817 . . . . 75.519999999999996 110.913 -172.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -56.95 -25.13 52.65 Favored Glycine 0 N--CA 1.453 -0.232 0 CA-C-N 115.879 -0.601 . . . . 53.200000000000003 111.649 175.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 718' ' ' GLU . . . . . 0.743 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 13.6 mm-40 -62.67 -49.59 74.53 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 115.77 -0.215 . . . . 62.109999999999999 110.692 175.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 719' ' ' LEU . . . . . 0.604 HD12 HD22 ' A' ' 789' ' ' LEU . 2.5 mm? -62.03 -31.67 72.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.016 0.436 . . . . 71.239999999999995 110.436 -176.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 720' ' ' VAL . . . . . 0.456 HG22 HD13 ' A' ' 793' ' ' ILE . 63.4 t -64.58 -39.69 86.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.757 -0.656 . . . . 73.030000000000001 111.088 178.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 721' ' ' ARG . . . . . 0.743 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 11.5 ptt180 -67.38 -26.05 66.26 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.071 0.462 . . . . 70.129999999999995 109.932 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -79.02 -29.53 43.66 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.177 -0.465 . . . . 74.439999999999998 110.913 179.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 723' ' ' LEU . . . . . 0.537 HD21 ' HB2' ' A' ' 789' ' ' LEU . 96.5 mt -57.61 -38.94 75.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.176 0.512 . . . . 70.310000000000002 109.898 174.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -80.36 -42.16 23.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.333 -0.849 . . . . 72.299999999999997 111.151 177.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 22.1 m -82.16 -81.5 0.15 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.91 0.386 . . . . 61.329999999999998 111.591 -177.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 726' ' ' ASN . . . . . 0.434 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 38.4 t30 -148.19 105.88 3.6 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 109.756 -0.461 . . . . 50.32 109.756 -179.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 727' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 14.0 Cg_endo -58.32 -36.43 97.65 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.79 2.326 . . . . 71.209999999999994 112.351 -176.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 728' ' ' VAL . . . . . 0.412 ' O ' ' HG ' ' A' ' 732' ' ' LEU . 40.3 t -61.26 -49.02 86.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.005 -0.543 . . . . 61.539999999999999 110.936 -177.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -64.87 -28.77 73.87 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.901 -0.666 . . . . 51.340000000000003 111.907 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -71.85 -42.53 52.89 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 121.035 -0.603 . . . . 75.219999999999999 112.353 179.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -64.83 -40.43 95.17 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.48 -0.563 . . . . 51.409999999999997 109.48 178.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 732' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 728' ' ' VAL . 95.4 mt -62.78 -44.14 96.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.873 -0.603 . . . . 55.130000000000003 110.691 176.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 733' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -65.81 -42.82 90.18 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 122.929 0.492 . . . . 53.520000000000003 110.721 -178.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 734' ' ' TYR . . . . . 0.537 ' HB2' HD11 ' A' ' 719' ' ' LEU . 20.3 t80 -58.13 -51.64 68.86 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.278 -0.419 . . . . 73.409999999999997 110.356 176.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -63.95 -51.46 64.26 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.176 -0.466 . . . . 61.299999999999997 110.857 -177.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 736' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -60.88 -35.58 76.99 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.087 -0.506 . . . . 75.040000000000006 111.429 -174.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 8.1 t -83.25 -25.39 31.69 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.458 -0.337 . . . . 43.100000000000001 111.196 -177.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -95.29 -1.59 51.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.515 0.198 . . . . 73.319999999999993 111.445 -177.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 98.59 -5.91 60.56 Favored Glycine 0 CA--C 1.516 0.15 0 C-N-CA 120.783 -0.722 . . . . 61.25 112.771 175.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 740' ' ' PHE . . . . . 0.41 ' HD1' ' HA3' ' A' ' 765' ' ' GLY . 95.0 m-85 -81.82 167.4 19.08 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.941 0.401 . . . . 65.129999999999995 110.766 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -119.64 110.9 17.39 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.387 -0.597 . . . . 73.0 109.387 175.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 742' ' ' ALA . . . . . . . . . . . . . . . -85.28 132.14 34.31 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.0 0.428 . . . . 62.32 111.74 -175.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 743' ' ' GLU . . . . . 0.505 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 38.1 mt-10 -135.13 142.75 46.25 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.645 -0.707 . . . . 74.349999999999994 110.879 176.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -119.15 101.81 8.27 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.141 -0.688 . . . . 62.329999999999998 109.141 175.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 745' ' ' LYS . . . . . 0.458 ' HB3' ' HZ3' ' A' ' 745' ' ' LYS . 1.1 ptpm? -124.66 144.2 50.32 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.066 0.46 . . . . 70.219999999999999 111.114 -175.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 746' ' ' LEU . . . . . 0.417 HD13 ' HB3' ' A' ' 758' ' ' PHE . 56.8 tp -77.08 117.91 19.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.502 -0.772 . . . . 64.200000000000003 110.037 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 54.5 t -88.03 -49.63 14.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.202 0.525 . . . . 62.530000000000001 110.108 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 748' ' ' ASP . . . . . 0.448 ' O ' ' HB ' ' A' ' 759' ' ' VAL . 26.5 t70 -148.22 154.82 40.6 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.403 -0.817 . . . . 73.340000000000003 109.331 -178.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.87 112.86 12.26 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.447 0.642 . . . . 55.020000000000003 110.369 173.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 750' ' ' SER . . . . . 0.457 ' O ' ' HB3' ' A' ' 757' ' ' LYS . 11.3 m -101.78 89.53 3.71 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.363 -0.835 . . . . 61.100000000000001 109.438 177.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 751' ' ' GLY . . . . . 0.535 ' HA3' ' HA ' ' A' ' 756' ' ' PRO . . . -152.95 123.5 1.45 Allowed Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 119.48 -1.343 . . . . 61.5 113.855 -174.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 752' ' ' PRO . . . . . 0.458 ' HD2' ' HA2' ' A' ' 751' ' ' GLY . 26.4 Cg_endo -63.51 167.95 12.3 Favored 'Trans proline' 0 CA--C 1.533 0.425 0 C-N-CA 123.002 2.468 . . . . 65.140000000000001 111.105 169.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -56.59 -33.65 93.6 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 122.523 2.148 . . . . 74.209999999999994 112.792 -178.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 39.2 p-80 -88.35 -9.35 53.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.199 -0.455 . . . . 75.239999999999995 111.984 -177.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -152.59 73.69 7.33 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 111.792 0.293 . . . . 71.239999999999995 111.792 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 756' ' ' PRO . . . . . 0.535 ' HA ' ' HA3' ' A' ' 751' ' ' GLY . 42.8 Cg_endo -70.1 103.05 1.16 Allowed 'Trans proline' 0 CA--C 1.528 0.224 0 C-N-CA 122.36 2.04 . . . . 62.420000000000002 112.198 176.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 757' ' ' LYS . . . . . 0.504 ' H ' ' HA3' ' A' ' 751' ' ' GLY . 40.1 ttmt -96.6 133.0 41.65 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.894 -0.41 . . . . 74.099999999999994 109.894 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 758' ' ' PHE . . . . . 0.417 ' HB3' HD13 ' A' ' 746' ' ' LEU . 95.5 m-85 -110.08 126.03 53.58 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.299 -0.41 . . . . 55.509999999999998 111.147 -176.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 759' ' ' VAL . . . . . 0.512 HG22 ' HB3' ' A' ' 773' ' ' CYS . 97.3 t -94.03 104.04 15.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-N 115.78 -0.646 . . . . 71.420000000000002 109.853 177.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -102.6 144.6 30.8 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.606 -0.725 . . . . 64.109999999999999 111.179 -177.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 761' ' ' GLN . . . . . 0.4 ' HA ' ' O ' ' A' ' 770' ' ' PRO . 33.9 tt0 -132.46 131.7 41.98 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.305 -0.861 . . . . 75.299999999999997 109.385 178.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 762' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 769' ' ' PHE . . . -90.17 123.46 34.01 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.3 0.571 . . . . 63.549999999999997 110.646 -177.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 763' ' ' LYS . . . . . 0.564 ' HE2' ' HA2' ' A' ' 766' ' ' GLY . 45.5 tttt -99.29 105.88 17.94 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.044 -0.724 . . . . 72.030000000000001 109.044 177.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 50.7 t -108.33 91.87 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.233 0.539 . . . . 73.430000000000007 110.689 -178.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 765' ' ' GLY . . . . . 0.41 ' HA3' ' HD1' ' A' ' 740' ' ' PHE . . . 77.8 -7.59 41.15 Favored Glycine 0 N--CA 1.454 -0.132 0 CA-C-N 115.627 -0.715 . . . . 63.210000000000001 112.56 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 766' ' ' GLY . . . . . 0.564 ' HA2' ' HE2' ' A' ' 763' ' ' LYS . . . 136.77 -29.62 2.74 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.31 -0.716 . . . . 63.32 111.31 -177.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 767' ' ' ARG . . . . . 0.472 ' HD2' ' CD1' ' A' ' 769' ' ' PHE . 0.7 OUTLIER -72.57 118.75 15.87 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.078 -0.712 . . . . 74.340000000000003 109.078 177.21 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 768' ' ' TRP . . . . . 0.402 ' CZ3' ' HD2' ' A' ' 745' ' ' LYS . 76.4 m95 -88.45 105.48 17.63 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.032 -0.531 . . . . 71.230000000000004 110.267 -178.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 769' ' ' PHE . . . . . 0.472 ' CD1' ' HD2' ' A' ' 767' ' ' ARG . 13.0 p90 -168.43 137.83 1.94 Allowed Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 109.875 -0.417 . . . . 73.540000000000006 109.875 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 770' ' ' PRO . . . . . 0.739 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 58.5 Cg_endo -97.24 -167.75 1.41 Allowed 'Cis proline' 0 N--CA 1.451 -1.012 0 C-N-CA 123.779 -1.342 . . . . 62.350000000000001 112.018 -2.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -119.45 101.19 7.77 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.744 -0.465 . . . . 63.240000000000002 109.744 175.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 34.8 m -117.19 170.77 6.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.504 -0.317 . . . . 61.119999999999997 111.135 -174.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 773' ' ' CYS . . . . . 0.512 ' HB3' HG22 ' A' ' 759' ' ' VAL . 4.7 p -142.48 121.67 13.01 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.137 -0.483 . . . . 60.020000000000003 110.606 178.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -124.9 154.52 40.96 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.202 -0.454 . . . . 53.140000000000001 110.222 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 775' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -79.87 -4.45 52.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.007 0.432 . . . . 62.329999999999998 110.986 -177.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 54.9 m -131.22 144.62 51.46 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.134 -0.485 . . . . 54.299999999999997 109.998 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 777' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -65.33 -42.97 92.39 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.162 -0.472 . . . . 65.420000000000002 111.158 -175.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -65.88 -37.76 86.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.972 0.415 . . . . 73.109999999999999 110.078 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 779' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -66.72 -33.13 74.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.026 -0.533 . . . . 72.209999999999994 110.916 177.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -56.96 -42.99 93.01 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.845 -0.693 . . . . 54.140000000000001 111.714 177.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -64.79 -43.26 93.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.946 0.403 . . . . 61.399999999999999 110.418 176.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -67.24 -46.86 72.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.978 -0.555 . . . . 63.219999999999999 111.181 -178.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -61.51 -40.87 96.17 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 123.163 0.289 . . . . 72.219999999999999 110.894 -179.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -60.97 -52.3 65.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 72.109999999999999 110.431 178.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 785' ' ' ALA . . . . . 0.639 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -63.9 -42.05 97.53 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.091 -0.504 . . . . 71.299999999999997 111.095 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 786' ' ' ASP . . . . . 0.603 ' O ' ' HG2' ' A' ' 790' ' ' ARG . 21.3 t70 -57.09 -56.56 20.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.954 -0.566 . . . . 63.420000000000002 110.871 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 787' ' ' ALA . . . . . 0.574 ' O ' HG23 ' A' ' 791' ' ' VAL . . . -63.92 -33.58 76.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.873 -0.603 . . . . 63.450000000000003 110.972 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 788' ' ' ALA . . . . . 0.739 ' HB2' ' HD3' ' A' ' 770' ' ' PRO . . . -62.67 -41.85 99.3 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.637 0.256 . . . . 62.420000000000002 110.704 177.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 789' ' ' LEU . . . . . 0.639 ' HG ' ' O ' ' A' ' 785' ' ' ALA . 62.9 mt -64.82 -38.81 92.22 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.621 -0.511 . . . . 73.010000000000005 109.621 178.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 790' ' ' ARG . . . . . 0.603 ' HG2' ' O ' ' A' ' 786' ' ' ASP . 13.5 mmm180 -59.41 -39.42 83.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.853 -0.612 . . . . 74.140000000000001 110.254 177.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 791' ' ' VAL . . . . . 0.574 HG23 ' O ' ' A' ' 787' ' ' ALA . 83.4 t -59.84 -52.12 64.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.858 -0.61 . . . . 74.239999999999995 110.51 176.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 792' ' ' LEU . . . . . 0.6 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 25.0 mt -60.94 -49.59 76.83 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.624 -0.716 . . . . 65.400000000000006 110.767 -177.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 793' ' ' ILE . . . . . 0.456 HD13 HG22 ' A' ' 720' ' ' VAL . 85.9 mt -59.72 -41.34 85.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.596 -0.729 . . . . 72.409999999999997 110.965 178.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -65.78 -43.93 93.14 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 116.072 -0.513 . . . . 60.439999999999998 112.735 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -62.62 -44.8 95.39 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.676 0.274 . . . . 72.010000000000005 111.006 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 796' ' ' ASN . . . . . 0.427 ' CG ' HG13 ' A' ' 716' ' ' ILE . 10.8 t30 -65.84 -37.14 85.4 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.344 -0.389 . . . . 65.510000000000005 110.712 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 797' ' ' GLU . . . . . 0.636 ' O ' ' HG2' ' A' ' 801' ' ' ARG . 7.6 tp10 -64.25 -56.53 13.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.236 -0.438 . . . . 72.209999999999994 110.203 178.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 798' ' ' LYS . . . . . 0.442 ' HA ' ' HD2' ' A' ' 798' ' ' LYS . 5.3 mmmp? -63.74 -17.38 62.97 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.984 0.364 . . . . 70.209999999999994 111.984 -177.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 799' ' ' ALA . . . . . . . . . . . . . . . -67.37 -25.24 65.87 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.037 0.446 . . . . 73.049999999999997 110.737 176.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 800' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -114.21 1.45 14.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.021 0.439 . . . . 64.420000000000002 110.881 178.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 801' ' ' ARG . . . . . 0.636 ' HG2' ' O ' ' A' ' 797' ' ' GLU . 22.5 mmt180 . . . . . 0 C--O 1.245 0.842 0 CA-C-O 118.407 -0.806 . . . . 71.439999999999998 109.551 178.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 708' ' ' MET . . . . . . . . . . . . . 72.1 mtm . . . . . 0 N--CA 1.48 1.06 0 CA-C-O 120.422 0.153 . . . . 72.420000000000002 110.664 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 63.7 mtt 63.58 83.77 0.19 Allowed Pre-proline 0 N--CA 1.465 0.306 0 CA-C-N 116.046 -0.525 . . . . 75.329999999999998 110.924 -177.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.06 107.01 2.39 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.914 2.409 . . . . 74.230000000000004 111.702 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 711' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -85.17 141.67 30.02 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.058 -0.519 . . . . 74.230000000000004 110.267 -177.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 712' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -78.71 79.1 5.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.437 0.637 . . . . 74.420000000000002 109.743 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 713' ' ' VAL . . . . . . . . . . . . . 32.1 m -86.43 159.25 3.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.624 -0.716 . . . . 75.019999999999996 111.779 -174.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -108.94 4.24 23.12 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.0 -1.0 . . . . 74.409999999999997 108.46 173.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -62.14 105.84 0.65 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.045 -0.979 . . . . 62.340000000000003 110.952 -177.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 716' ' ' ILE . . . . . 0.553 ' HA ' HD23 ' A' ' 719' ' ' LEU . 50.7 mm -73.34 -22.91 19.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.433 -0.803 . . . . 60.130000000000003 110.88 -178.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -57.2 -23.19 46.44 Favored Glycine 0 CA--C 1.521 0.412 0 CA-C-N 115.881 -0.599 . . . . 74.319999999999993 112.926 178.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 718' ' ' GLU . . . . . 0.737 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 4.7 mm-40 -73.83 -40.54 63.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.184 0.516 . . . . 73.129999999999995 110.136 178.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 719' ' ' LEU . . . . . 0.563 HD12 HD22 ' A' ' 789' ' ' LEU . 3.0 mm? -65.1 -31.78 73.15 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.282 0.563 . . . . 74.129999999999995 109.496 178.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 720' ' ' VAL . . . . . 0.425 HG22 HD13 ' A' ' 793' ' ' ILE . 89.8 t -64.07 -41.41 92.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.533 -0.758 . . . . 62.140000000000001 110.798 177.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 721' ' ' ARG . . . . . 0.737 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 26.7 ptt180 -63.59 -25.39 68.21 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.064 0.459 . . . . 73.25 110.28 -178.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -79.07 -26.62 43.05 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.392 -0.367 . . . . 74.230000000000004 111.622 178.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 723' ' ' LEU . . . . . 0.482 HD21 ' HB2' ' A' ' 789' ' ' LEU . 87.3 mt -65.08 -23.75 67.25 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.197 -0.668 . . . . 54.409999999999997 109.197 171.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -81.4 -54.66 5.27 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.378 -0.828 . . . . 72.439999999999998 110.538 174.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 15.7 m -89.41 -72.47 0.55 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.571 0.582 . . . . 73.140000000000001 112.571 -174.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 726' ' ' ASN . . . . . 0.436 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 26.6 t30 -145.65 101.53 4.3 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.693 0.282 . . . . 53.32 111.008 -172.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 727' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 17.8 Cg_endo -61.21 -38.59 65.08 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.913 2.409 . . . . 72.329999999999998 112.374 -178.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 728' ' ' VAL . . . . . 0.422 ' O ' ' HG ' ' A' ' 732' ' ' LEU . 41.5 t -60.64 -45.82 96.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.083 -0.508 . . . . 73.25 110.96 -177.036 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -65.52 -39.89 95.85 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.618 -0.801 . . . . 73.140000000000001 112.179 -177.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 730' ' ' GLY . . . . . 0.417 ' HA2' ' HG2' ' A' ' 733' ' ' GLU . . . -67.8 -38.45 89.48 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.908 -0.663 . . . . 51.439999999999998 112.583 -178.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -63.38 -41.05 98.77 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.13 0.49 . . . . 64.510000000000005 109.684 178.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 732' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 728' ' ' VAL . 94.0 mt -65.66 -43.64 88.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.701 -0.681 . . . . 72.319999999999993 111.27 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 733' ' ' GLU . . . . . 0.525 ' HA ' ' HG2' ' A' ' 736' ' ' ARG . 11.4 pt-20 -79.51 -25.26 41.81 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 120.544 -0.462 . . . . 72.209999999999994 111.783 -176.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 734' ' ' TYR . . . . . 0.51 ' HB2' HD11 ' A' ' 719' ' ' LEU . 7.1 t80 -56.63 -46.43 81.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.275 0.56 . . . . 73.420000000000002 109.493 171.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -68.02 -46.8 70.22 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.348 -0.842 . . . . 74.409999999999997 111.047 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 736' ' ' ARG . . . . . 0.525 ' HG2' ' HA ' ' A' ' 733' ' ' GLU . 29.7 ptt180 -60.76 -34.25 74.17 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.097 0.475 . . . . 75.109999999999999 110.706 -176.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 31.5 t -76.7 -38.07 55.02 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.75 -0.659 . . . . 32.420000000000002 110.909 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 16.6 m170 -95.59 0.66 53.15 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.0 0.37 . . . . 73.230000000000004 112.0 -172.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 90.65 4.94 69.52 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.693 -0.765 . . . . 73.549999999999997 113.34 174.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -91.47 173.92 7.64 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.99 0.424 . . . . 72.129999999999995 110.743 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 741' ' ' ALA . . . . . 0.628 ' O ' ' HA ' ' A' ' 764' ' ' VAL . . . -108.45 147.31 31.82 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.29 -0.633 . . . . 74.109999999999999 109.29 173.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 742' ' ' ALA . . . . . . . . . . . . . . . -128.89 110.88 12.49 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.825 0.345 . . . . 73.400000000000006 110.521 -178.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 743' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -136.12 154.41 51.0 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.286 -0.416 . . . . 71.530000000000001 110.922 -177.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -122.67 118.64 28.6 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.307 -0.406 . . . . 74.329999999999998 109.985 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 7.1 ptpt -117.65 148.49 41.91 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.051 0.453 . . . . 72.209999999999994 111.251 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 746' ' ' LEU . . . . . . . . . . . . . 6.9 tt -92.25 102.79 15.29 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.014 -1.106 . . . . 74.140000000000001 108.014 175.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 38.5 t -72.56 -45.74 57.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.101 -0.5 . . . . 71.409999999999997 110.654 -174.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -160.64 164.21 31.97 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.105 -0.702 . . . . 74.109999999999999 109.105 -179.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 749' ' ' GLN . . . . . 0.427 HE21 ' HB2' ' A' ' 749' ' ' GLN . 0.0 OUTLIER -138.69 125.67 21.21 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.11 0.481 . . . . 73.040000000000006 110.725 178.819 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 17.1 m -125.39 101.19 6.84 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.676 -0.693 . . . . 72.040000000000006 109.356 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 751' ' ' GLY . . . . . 0.874 ' HA3' ' HA ' ' A' ' 756' ' ' PRO . . . -174.27 134.62 2.88 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 119.534 -1.317 . . . . 74.120000000000005 113.779 -178.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 752' ' ' PRO . . . . . 0.453 ' HD2' ' HA2' ' A' ' 751' ' ' GLY . 25.6 Cg_endo -62.04 168.9 8.31 Favored 'Trans proline' 0 CA--C 1.529 0.262 0 C-N-CA 123.535 2.824 . . . . 64.340000000000003 111.432 171.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.71 -28.36 87.14 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.368 2.046 . . . . 72.25 112.6 -179.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 38.7 p-80 -87.6 -17.05 32.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.443 -0.344 . . . . 63.219999999999999 111.476 -178.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -153.1 69.43 6.85 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 111.94 0.348 . . . . 53.310000000000002 111.94 -175.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 756' ' ' PRO . . . . . 0.874 ' HA ' ' HA3' ' A' ' 751' ' ' GLY . 71.9 Cg_endo -80.28 108.2 2.14 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.27 1.98 . . . . 61.409999999999997 112.695 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 757' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -91.44 115.09 27.75 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.975 0.417 . . . . 75.310000000000002 110.476 176.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 758' ' ' PHE . . . . . 0.499 ' O ' ' HA ' ' A' ' 773' ' ' CYS . 58.9 m-85 -97.13 130.22 44.42 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.955 -0.566 . . . . 75.219999999999999 110.2 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 759' ' ' VAL . . . . . 0.487 HG22 ' HB3' ' A' ' 773' ' ' CYS . 48.3 t -92.96 105.27 16.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.989 0.424 . . . . 75.450000000000003 110.201 178.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -102.46 143.86 31.64 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.262 -0.881 . . . . 75.150000000000006 110.671 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 761' ' ' GLN . . . . . 0.58 ' HA ' ' O ' ' A' ' 770' ' ' PRO . 36.5 tt0 -135.06 135.09 41.01 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.978 -0.556 . . . . 74.230000000000004 109.978 177.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 762' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 769' ' ' PHE . . . -91.51 126.58 36.65 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.159 0.504 . . . . 72.420000000000002 111.025 -178.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -97.32 107.76 20.34 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.595 -0.73 . . . . 72.329999999999998 109.293 176.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 764' ' ' VAL . . . . . 0.628 ' HA ' ' O ' ' A' ' 741' ' ' ALA . 63.0 t -116.37 103.84 15.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.234 0.54 . . . . 64.439999999999998 110.055 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 70.09 -115.1 5.91 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 110.896 -0.882 . . . . 61.340000000000003 110.896 -174.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -109.57 9.82 32.72 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.77 -0.729 . . . . 52.450000000000003 111.328 175.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 767' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -106.84 143.56 34.75 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.075 0.464 . . . . 64.319999999999993 110.5 -177.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 768' ' ' TRP . . . . . 0.454 ' HB3' ' OE1' ' A' ' 761' ' ' GLN . 68.3 m95 -116.55 102.48 9.51 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.629 -0.714 . . . . 72.030000000000001 109.902 -178.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 769' ' ' PHE . . . . . 0.43 ' HA ' ' HA ' ' A' ' 770' ' ' PRO . 33.1 p90 -168.91 141.83 2.27 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.343 -0.39 . . . . 74.0 110.23 -176.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 770' ' ' PRO . . . . . 0.634 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 62.5 Cg_endo -98.88 -179.7 5.64 Favored 'Cis proline' 0 N--CA 1.45 -1.034 0 C-N-CA 123.564 -1.432 . . . . 55.119999999999997 111.979 -4.12 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 771' ' ' ALA . . . . . 0.439 ' HB2' HE21 ' A' ' 761' ' ' GLN . . . -110.98 112.43 24.24 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.553 -0.536 . . . . 52.020000000000003 109.553 174.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 34.3 m -124.47 149.48 28.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.356 -0.384 . . . . 73.019999999999996 110.937 -177.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 773' ' ' CYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 758' ' ' PHE . 7.7 p -118.02 115.3 24.6 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.938 0.399 . . . . 72.010000000000005 110.453 178.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -123.07 157.51 32.66 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.177 -0.465 . . . . 63.409999999999997 110.619 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 775' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -83.29 11.44 6.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.847 0.356 . . . . 70.299999999999997 111.759 -176.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 776' ' ' SER . . . . . 0.439 ' HB3' ' CG ' ' A' ' 779' ' ' GLN . 8.5 t -153.28 145.62 23.97 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.82 -0.437 . . . . 62.210000000000001 109.82 -178.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 777' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -59.63 -50.36 74.18 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.062 -0.517 . . . . 73.109999999999999 111.303 -177.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -62.4 -36.53 82.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.848 0.356 . . . . 71.200000000000003 110.401 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 779' ' ' GLN . . . . . 0.439 ' CG ' ' HB3' ' A' ' 776' ' ' SER . 16.2 mm100 -64.19 -41.92 96.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 54.439999999999998 110.2 178.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -55.87 -48.44 72.51 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.038 -0.601 . . . . 75.25 112.3 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -65.1 -45.47 85.03 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.852 0.358 . . . . 73.5 111.189 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -66.01 -47.2 75.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.23 -0.441 . . . . 72.239999999999995 111.519 -176.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -62.58 -39.07 92.53 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.684 0.278 . . . . 61.219999999999999 110.494 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -62.58 -46.85 86.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.269 -0.423 . . . . 61.32 110.748 177.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 785' ' ' ALA . . . . . 0.444 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -65.38 -42.55 92.57 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.234 -0.439 . . . . 62.240000000000002 110.953 -179.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 786' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -56.98 -51.17 70.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.337 0.589 . . . . 73.340000000000003 110.404 176.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 787' ' ' ALA . . . . . 0.644 ' O ' HG23 ' A' ' 791' ' ' VAL . . . -64.66 -38.72 91.96 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.333 -0.849 . . . . 72.549999999999997 111.066 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 788' ' ' ALA . . . . . 0.634 ' HB2' ' HD3' ' A' ' 770' ' ' PRO . . . -61.62 -47.0 87.4 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.383 -0.371 . . . . 71.0 111.077 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 789' ' ' LEU . . . . . 0.563 HD22 HD12 ' A' ' 719' ' ' LEU . 79.6 mt -60.97 -43.57 98.58 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.842 -0.429 . . . . 73.450000000000003 109.842 177.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 790' ' ' ARG . . . . . . . . . . . . . 30.7 mtt180 -63.52 -26.43 68.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 72.329999999999998 111.684 178.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 791' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 787' ' ' ALA . 98.2 t -68.68 -50.43 55.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.747 -0.464 . . . . 70.140000000000001 109.747 172.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 792' ' ' LEU . . . . . 0.581 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 27.2 mt -61.44 -49.92 74.88 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.431 -0.804 . . . . 65.209999999999994 110.349 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 793' ' ' ILE . . . . . 0.432 HG12 ' CG2' ' A' ' 716' ' ' ILE . 95.7 mt -59.61 -43.45 91.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.258 -0.883 . . . . 74.439999999999998 110.881 178.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -68.01 -32.47 77.06 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 121.002 -0.618 . . . . 63.409999999999997 112.644 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -69.37 -44.16 72.09 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.169 0.509 . . . . 72.439999999999998 110.404 178.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 796' ' ' ASN . . . . . 0.526 ' HB3' HG13 ' A' ' 716' ' ' ILE . 2.7 t30 -93.24 9.52 35.8 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.851 -0.613 . . . . 71.209999999999994 110.376 -175.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 797' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -65.46 107.52 1.7 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.838 -0.619 . . . . 64.519999999999996 110.338 -176.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 798' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm 61.07 21.44 11.82 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.859 -0.61 . . . . 73.409999999999997 111.177 -176.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 799' ' ' ALA . . . . . . . . . . . . . . . -119.01 116.23 26.0 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.958 0.408 . . . . 72.420000000000002 110.605 -179.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 800' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -81.65 98.23 8.27 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.318 -0.401 . . . . 61.43 109.962 176.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 801' ' ' ARG . . . . . . . . . . . . . 16.4 mmm180 . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.355 -0.831 . . . . 70.209999999999994 109.659 177.728 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 708' ' ' MET . . . . . . . . . . . . . 24.4 mmt . . . . . 0 N--CA 1.477 0.894 0 N-CA-C 110.546 -0.168 . . . . 72.439999999999998 110.546 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 20.6 mmt 51.9 76.73 0.51 Allowed Pre-proline 0 N--CA 1.464 0.261 0 O-C-N 123.439 0.462 . . . . 54.109999999999999 111.418 -176.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -73.44 89.93 0.93 Allowed 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.494 2.129 . . . . 72.109999999999999 111.733 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 711' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -69.11 -32.06 71.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.316 0.579 . . . . 72.0 109.718 175.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 712' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -90.9 117.01 29.16 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.595 -0.891 . . . . 61.140000000000001 108.595 172.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 713' ' ' VAL . . . . . 0.495 HG23 ' HG3' ' A' ' 715' ' ' LYS . 26.9 m -61.44 151.54 6.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-O 121.233 0.539 . . . . 70.310000000000002 111.442 -176.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.441 HH11 ' HD2' ' A' ' 714' ' ' ARG . 57.6 mtt180 -79.08 84.22 5.09 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.79 -0.641 . . . . 71.450000000000003 110.54 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 715' ' ' LYS . . . . . 0.495 ' HG3' HG23 ' A' ' 713' ' ' VAL . 7.5 mtpm? -76.75 106.51 8.46 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.601 -0.727 . . . . 71.120000000000005 109.901 177.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 716' ' ' ILE . . . . . 0.495 ' HA ' HD23 ' A' ' 719' ' ' LEU . 46.7 mm -117.01 -32.3 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.15 -0.477 . . . . 62.130000000000003 111.445 -172.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -60.97 -27.89 67.82 Favored Glycine 0 C--N 1.33 0.208 0 C-N-CA 120.98 -0.629 . . . . 62.149999999999999 112.101 -179.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 718' ' ' GLU . . . . . 0.782 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 2.8 mp0 -63.19 -39.49 94.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.894 0.378 . . . . 72.140000000000001 110.593 177.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 719' ' ' LEU . . . . . 0.625 HD12 HD22 ' A' ' 789' ' ' LEU . 3.0 mm? -67.48 -29.78 69.31 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.073 0.463 . . . . 74.140000000000001 110.139 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 720' ' ' VAL . . . . . 0.517 HG22 HD13 ' A' ' 793' ' ' ILE . 56.6 t -66.65 -41.61 88.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.819 -0.628 . . . . 62.409999999999997 110.737 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 721' ' ' ARG . . . . . 0.782 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 11.8 ptm180 -65.11 -28.47 69.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.016 0.436 . . . . 70.340000000000003 109.907 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -74.19 -30.17 62.09 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.34 -0.391 . . . . 52.140000000000001 110.853 177.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 723' ' ' LEU . . . . . 0.575 HD21 ' HB2' ' A' ' 789' ' ' LEU . 90.9 mt -60.74 -27.55 68.01 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.252 0.549 . . . . 72.25 109.893 173.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 724' ' ' ASN . . . . . 0.507 ' N ' HD22 ' A' ' 724' ' ' ASN . 0.8 OUTLIER -86.45 -44.65 11.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.476 -0.784 . . . . 74.299999999999997 110.817 176.765 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 51.0 m -89.57 -76.64 0.41 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.296 -0.411 . . . . 74.0 112.043 -175.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 726' ' ' ASN . . . . . 0.442 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 53.8 t-20 -144.82 105.77 4.55 Favored Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 109.997 -0.371 . . . . 53.409999999999997 109.997 -177.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 727' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 20.0 Cg_endo -61.3 -35.97 81.73 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.881 2.387 . . . . 73.310000000000002 112.246 -179.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 728' ' ' VAL . . . . . 0.445 ' O ' ' HG ' ' A' ' 732' ' ' LEU . 59.7 t -64.31 -45.53 95.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.019 -0.537 . . . . 74.450000000000003 110.459 -178.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -61.63 -34.48 88.67 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.945 -0.645 . . . . 62.539999999999999 112.355 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -74.79 -41.32 34.44 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.796 -0.716 . . . . 54.340000000000003 112.56 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -63.12 -40.33 97.3 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.863 -0.421 . . . . 75.140000000000001 109.863 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 732' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 728' ' ' VAL . 95.5 mt -64.19 -46.28 84.62 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.027 -0.533 . . . . 74.25 111.281 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 733' ' ' GLU . . . . . 0.5 ' HA ' ' HG2' ' A' ' 736' ' ' ARG . 6.3 pt-20 -73.97 -31.47 63.02 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.41 -0.516 . . . . 72.340000000000003 110.981 -177.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 734' ' ' TYR . . . . . 0.402 ' HB2' HD11 ' A' ' 719' ' ' LEU . 9.3 t80 -57.29 -48.6 78.5 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 120.895 0.378 . . . . 71.310000000000002 110.063 175.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 735' ' ' ALA . . . . . 0.43 ' HA ' ' HB2' ' A' ' 740' ' ' PHE . . . -65.04 -51.18 63.0 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.985 -0.552 . . . . 64.329999999999998 110.643 -177.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 736' ' ' ARG . . . . . 0.5 ' HG2' ' HA ' ' A' ' 733' ' ' GLU . 12.2 ptm180 -61.7 -34.99 76.73 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.807 -0.633 . . . . 71.420000000000002 111.515 -174.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 47.0 t -77.56 -37.14 51.31 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.038 -0.528 . . . . 74.150000000000006 111.096 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -91.51 -2.53 57.16 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.119 0.414 . . . . 72.129999999999995 112.119 -171.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 94.81 7.93 59.66 Favored Glycine 0 CA--C 1.516 0.143 0 C-N-CA 120.45 -0.881 . . . . 54.340000000000003 112.719 176.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 740' ' ' PHE . . . . . 0.43 ' HB2' ' HA ' ' A' ' 735' ' ' ALA . 98.3 m-85 -93.15 177.81 5.94 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.032 0.444 . . . . 54.119999999999997 110.538 177.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -129.69 124.6 33.98 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.882 -0.599 . . . . 62.200000000000003 109.526 175.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 742' ' ' ALA . . . . . . . . . . . . . . . -94.05 115.7 28.05 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.774 0.321 . . . . 54.219999999999999 111.148 -176.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 743' ' ' GLU . . . . . 0.573 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 40.8 mt-10 -127.48 125.36 40.34 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.016 -0.538 . . . . 74.030000000000001 111.051 -179.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -105.25 117.27 33.59 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.115 -0.493 . . . . 75.329999999999998 110.414 179.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -134.2 150.42 51.07 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.184 0.516 . . . . 62.240000000000002 111.342 178.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 746' ' ' LEU . . . . . 0.462 HD21 ' HB3' ' A' ' 749' ' ' GLN . 4.9 tt -85.96 111.52 20.33 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.065 -1.087 . . . . 72.340000000000003 108.065 173.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 58.7 t -82.96 -46.25 18.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.895 0.379 . . . . 70.140000000000001 111.143 -174.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -152.03 149.69 29.14 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.407 -0.361 . . . . 61.229999999999997 110.374 -178.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 749' ' ' GLN . . . . . 0.462 ' HB3' HD21 ' A' ' 746' ' ' LEU . 0.0 OUTLIER -144.68 153.09 41.37 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.787 0.327 . . . . 65.340000000000003 110.946 179.515 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 20.9 t -174.75 -169.81 0.44 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.818 -0.808 . . . . 71.230000000000004 108.818 -178.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 107.83 175.18 22.25 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.524 -0.846 . . . . 43.310000000000002 112.733 176.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 752' ' ' PRO . . . . . 0.839 ' HG2' ' HB2' ' A' ' 755' ' ' GLU . 44.9 Cg_endo -69.32 164.35 34.45 Favored 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 123.084 2.523 . . . . 72.25 112.721 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -64.43 -33.65 56.94 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.62 2.213 . . . . 61.219999999999999 112.685 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 42.3 p-80 -82.95 -15.55 50.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.307 -0.406 . . . . 73.329999999999998 111.102 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 755' ' ' GLU . . . . . 0.839 ' HB2' ' HG2' ' A' ' 752' ' ' PRO . 45.0 mt-10 -135.27 73.75 63.28 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.401 -0.363 . . . . 75.219999999999999 110.798 177.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 756' ' ' PRO . . . . . 0.543 ' O ' ' HA ' ' A' ' 775' ' ' HIS . 42.1 Cg_endo -69.15 114.69 3.69 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.09 1.86 . . . . 65.340000000000003 111.329 178.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 757' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -100.43 117.42 34.57 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.032 0.444 . . . . 71.329999999999998 110.727 -176.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 758' ' ' PHE . . . . . 0.445 ' CZ ' ' HB2' ' A' ' 756' ' ' PRO . 53.5 m-85 -115.12 121.23 42.39 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.602 -0.726 . . . . 72.450000000000003 109.872 -179.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 26.3 t -90.58 106.41 17.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 120.996 0.427 . . . . 70.200000000000003 110.313 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -99.26 139.26 35.16 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.688 -0.687 . . . . 71.549999999999997 110.285 178.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 761' ' ' GLN . . . . . 0.479 ' HA ' ' O ' ' A' ' 770' ' ' PRO . 55.9 tt0 -130.07 135.73 48.56 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.033 -0.53 . . . . 75.420000000000002 109.725 178.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 762' ' ' ALA . . . . . . . . . . . . . . . -90.56 112.42 24.1 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.967 -0.56 . . . . 72.329999999999998 110.71 -178.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 763' ' ' LYS . . . . . 0.573 ' HB3' ' HB2' ' A' ' 743' ' ' GLU . 61.0 tttm -88.32 104.66 16.95 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.065 -0.717 . . . . 70.439999999999998 109.065 175.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 56.9 t -109.9 100.72 11.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.349 0.595 . . . . 73.310000000000002 109.975 -179.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 75.19 -117.9 5.43 Favored Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 110.834 -0.906 . . . . 53.43 110.834 -175.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -103.36 3.97 47.48 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.662 -0.78 . . . . 63.219999999999999 111.627 176.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 767' ' ' ARG . . . . . . . . . . . . . 50.3 mtt180 -103.58 152.86 21.24 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.052 0.454 . . . . 72.219999999999999 111.029 -176.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 768' ' ' TRP . . . . . 0.567 ' CH2' ' HD2' ' A' ' 763' ' ' LYS . 59.2 m95 -118.83 105.15 11.23 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.687 -0.688 . . . . 72.310000000000002 109.386 176.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 769' ' ' PHE . . . . . 0.434 ' HA ' ' HA ' ' A' ' 770' ' ' PRO . 21.4 p90 -171.47 139.09 1.14 Allowed Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 120.854 0.359 . . . . 72.349999999999994 110.925 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 770' ' ' PRO . . . . . 0.607 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 79.6 Cg_endo -99.54 -176.8 3.79 Favored 'Cis proline' 0 N--CA 1.453 -0.908 0 C-N-CA 123.718 -1.367 . . . . 63.119999999999997 111.947 -4.134 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -113.88 116.18 28.87 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.771 -0.455 . . . . 34.009999999999998 109.771 175.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 29.1 m -118.94 140.74 41.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.145 0.498 . . . . 72.450000000000003 111.269 -176.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 3.9 p -95.72 102.54 14.35 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.89 -0.596 . . . . 71.150000000000006 110.508 178.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -107.15 177.63 4.79 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.147 -0.479 . . . . 73.310000000000002 110.817 -177.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 775' ' ' HIS . . . . . 0.543 ' HA ' ' O ' ' A' ' 756' ' ' PRO . 28.5 m-70 -117.38 12.45 14.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.127 0.489 . . . . 65.530000000000001 110.066 178.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 33.7 t -167.76 154.06 7.72 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.533 -0.758 . . . . 65.340000000000003 109.692 -176.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 777' ' ' LYS . . . . . . . . . . . . . 5.4 tmmm? -62.53 -42.66 99.67 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.649 -0.5 . . . . 72.230000000000004 109.649 177.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -58.31 -40.46 82.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.417 -0.811 . . . . 65.420000000000002 110.723 178.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 779' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -70.06 -45.55 66.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.318 -0.401 . . . . 62.039999999999999 110.438 177.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -54.55 -47.59 69.31 Favored Glycine 0 C--O 1.226 -0.398 0 CA-C-N 115.909 -0.587 . . . . 61.310000000000002 113.072 -176.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -66.79 -44.79 80.39 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.621 0.248 . . . . 72.439999999999998 111.258 -178.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -67.63 -49.39 63.17 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.541 -0.3 . . . . 75.430000000000007 111.358 -177.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -63.68 -39.89 95.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.572 0.225 . . . . 65.129999999999995 110.938 -178.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -62.05 -50.78 70.62 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 116.486 -0.325 . . . . 64.439999999999998 110.527 178.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 785' ' ' ALA . . . . . 0.555 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -65.75 -39.11 90.74 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.324 -0.398 . . . . 62.240000000000002 110.968 -179.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 786' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -57.75 -54.17 49.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.031 -0.531 . . . . 71.200000000000003 110.476 177.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 787' ' ' ALA . . . . . 0.606 ' O ' HG23 ' A' ' 791' ' ' VAL . . . -64.82 -36.69 85.13 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.855 -0.611 . . . . 25.43 110.723 179.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 788' ' ' ALA . . . . . 0.634 ' O ' ' HG ' ' A' ' 792' ' ' LEU . . . -59.49 -48.61 80.98 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.556 -0.293 . . . . 75.430000000000007 110.98 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 789' ' ' LEU . . . . . 0.625 HD22 HD12 ' A' ' 719' ' ' LEU . 63.1 mt -61.49 -39.97 92.85 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.837 -0.431 . . . . 63.210000000000001 109.837 178.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 790' ' ' ARG . . . . . . . . . . . . . 65.4 mtp180 -64.31 -30.91 71.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.607 -0.724 . . . . 75.310000000000002 111.488 178.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 791' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 787' ' ' ALA . 91.5 t -66.94 -48.26 80.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.758 -0.46 . . . . 75.310000000000002 109.758 173.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 792' ' ' LEU . . . . . 0.634 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 23.0 mt -60.58 -54.57 43.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.724 -0.671 . . . . 64.120000000000005 110.436 -179.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 793' ' ' ILE . . . . . 0.517 HD13 HG22 ' A' ' 720' ' ' VAL . 76.6 mt -58.15 -45.73 88.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.382 -0.826 . . . . 75.439999999999998 110.594 177.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 794' ' ' GLY . . . . . 0.648 ' O ' ' HG3' ' A' ' 798' ' ' LYS . . . -59.5 -48.4 86.18 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 121.121 -0.561 . . . . 75.120000000000005 112.276 179.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 795' ' ' GLU . . . . . 0.882 ' HA ' ' HD2' ' A' ' 798' ' ' LYS . 52.1 mm-40 -60.88 -31.3 70.78 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.568 0.211 . . . . 70.439999999999998 111.568 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -66.94 -42.77 84.7 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.192 0.52 . . . . 72.430000000000007 110.518 176.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 797' ' ' GLU . . . . . 0.436 ' HG3' ' O ' ' A' ' 793' ' ' ILE . 51.2 mt-10 -71.79 -24.6 61.77 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.585 -0.734 . . . . 73.340000000000003 111.966 -174.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 798' ' ' LYS . . . . . 0.882 ' HD2' ' HA ' ' A' ' 795' ' ' GLU . 0.0 OUTLIER -104.84 14.71 29.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.71 0.29 . . . . 75.340000000000003 111.542 178.616 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 799' ' ' ALA . . . . . . . . . . . . . . . -113.36 169.96 8.57 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.663 0.268 . . . . 63.310000000000002 110.497 177.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 800' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -84.07 104.63 14.3 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.44 -0.578 . . . . 71.340000000000003 109.44 177.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 801' ' ' ARG . . . . . . . . . . . . . 46.7 mtm180 . . . . . 0 C--O 1.247 0.958 0 CA-C-O 118.395 -0.812 . . . . 71.510000000000005 110.483 -177.418 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 708' ' ' MET . . . . . . . . . . . . . 25.8 mmt . . . . . 0 N--CA 1.482 1.157 0 CA-C-O 120.764 0.316 . . . . 64.129999999999995 111.257 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 63.9 mtm -121.56 110.01 34.13 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.389 -0.596 . . . . 23.399999999999999 109.389 174.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -56.58 111.3 0.75 Allowed 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 123.197 2.598 . . . . 71.109999999999999 112.95 -175.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 711' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -87.59 158.2 18.94 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.976 -0.556 . . . . 62.100000000000001 109.636 176.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 712' ' ' LYS . . . . . 0.467 ' NZ ' ' HB2' ' A' ' 712' ' ' LYS . 4.0 ttmp? -80.75 76.85 7.65 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.777 0.799 . . . . 74.239999999999995 109.809 179.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 713' ' ' VAL . . . . . . . . . . . . . 7.1 p -173.12 167.32 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 107.721 -1.215 . . . . 73.409999999999997 107.721 -179.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . . . . . . . . . 69.1 ttt180 -75.29 72.91 2.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.142 0.496 . . . . 62.200000000000003 110.332 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -92.5 106.11 18.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.724 -0.671 . . . . 53.310000000000002 109.644 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 716' ' ' ILE . . . . . 0.559 ' HA ' HD23 ' A' ' 719' ' ' LEU . 47.0 mm -78.79 -24.18 13.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.689 -0.687 . . . . 74.099999999999994 111.626 -173.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -56.92 -30.63 60.36 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 121.196 -0.526 . . . . 65.310000000000002 112.893 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -66.32 -41.04 90.23 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.762 0.315 . . . . 73.299999999999997 110.79 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 719' ' ' LEU . . . . . 0.602 HD12 HD22 ' A' ' 789' ' ' LEU . 2.9 mm? -65.02 -36.3 83.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.016 0.436 . . . . 65.430000000000007 109.998 -178.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 720' ' ' VAL . . . . . 0.507 HG22 HD13 ' A' ' 793' ' ' ILE . 52.3 t -64.08 -37.5 80.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-N 115.82 -0.627 . . . . 53.539999999999999 110.173 176.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 721' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.12 -30.32 71.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.794 -0.639 . . . . 55.219999999999999 109.775 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -78.47 -25.04 45.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.898 -0.592 . . . . 74.420000000000002 111.471 179.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 91.1 mt -60.03 -30.6 69.28 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.425 0.631 . . . . 71.25 109.461 173.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -84.87 -56.59 3.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.312 -0.858 . . . . 73.540000000000006 111.219 174.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 24.4 m -77.91 -64.23 1.2 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.916 0.709 . . . . 62.32 112.916 -171.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 726' ' ' ASN . . . . . 0.42 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 30.6 t30 -159.94 100.76 1.45 Allowed Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 120.834 0.349 . . . . 73.129999999999995 110.914 -175.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 727' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 20.9 Cg_endo -62.36 -39.61 45.58 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.875 2.384 . . . . 71.010000000000005 112.317 -177.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 39.5 t -59.97 -42.3 89.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.998 -0.546 . . . . 70.530000000000001 110.958 -177.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 729' ' ' GLY . . . . . 0.473 ' O ' ' HG2' ' A' ' 733' ' ' GLU . . . -65.02 -47.38 82.99 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.611 -0.804 . . . . 72.329999999999998 111.939 -179.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -64.14 -39.31 97.02 Favored Glycine 0 C--O 1.226 -0.349 0 C-N-CA 121.09 -0.576 . . . . 72.129999999999995 113.259 -176.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -61.67 -39.76 92.56 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.894 -0.41 . . . . 53.119999999999997 109.894 179.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 732' ' ' LEU . . . . . . . . . . . . . 96.3 mt -68.04 -47.34 68.64 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.929 -0.578 . . . . 65.0 111.276 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 733' ' ' GLU . . . . . 0.502 ' HA ' ' HB3' ' A' ' 736' ' ' ARG . 9.1 pt-20 -75.15 -26.47 59.14 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.715 -0.394 . . . . 74.230000000000004 111.683 -176.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 734' ' ' TYR . . . . . 0.426 ' HB2' HD11 ' A' ' 719' ' ' LEU . 17.5 t80 -56.99 -50.17 73.52 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.347 -0.612 . . . . 74.230000000000004 109.347 172.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -64.29 -46.29 84.29 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.903 -0.589 . . . . 72.109999999999999 110.533 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 736' ' ' ARG . . . . . 0.502 ' HB3' ' HA ' ' A' ' 733' ' ' GLU . 1.4 ttt180 -55.49 -48.73 74.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.07 -0.514 . . . . 73.219999999999999 112.011 -178.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 22.7 t -81.59 -11.82 58.99 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.678 0.275 . . . . 64.519999999999996 111.224 -174.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -110.49 -2.61 16.44 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.817 -0.353 . . . . 71.230000000000004 111.592 -176.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 88.9 9.96 67.37 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.538 -0.839 . . . . 74.319999999999993 113.258 174.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -95.61 168.72 10.51 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.906 0.353 . . . . 64.340000000000003 110.4 177.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -114.1 114.48 26.14 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.219 -0.446 . . . . 60.119999999999997 110.025 176.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 742' ' ' ALA . . . . . . . . . . . . . . . -92.48 133.22 36.13 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.262 -0.427 . . . . 64.420000000000002 110.886 -178.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 743' ' ' GLU . . . . . 0.455 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 9.7 mm-40 -144.98 157.65 44.06 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.271 -0.422 . . . . 73.400000000000006 111.142 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -130.16 132.03 45.89 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.815 -0.63 . . . . 72.430000000000007 109.76 177.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -136.37 137.92 41.06 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.126 0.489 . . . . 65.019999999999996 111.748 177.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 746' ' ' LEU . . . . . . . . . . . . . 5.0 tt -82.69 105.33 13.63 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.385 -0.969 . . . . 75.150000000000006 108.385 173.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 46.0 t -70.98 -56.13 11.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.919 0.39 . . . . 53.399999999999999 110.686 -176.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -154.94 152.37 29.64 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.977 -0.556 . . . . 73.109999999999999 110.276 -178.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -134.06 122.75 23.4 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.951 -0.759 . . . . 74.549999999999997 108.951 174.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 67.3 m -146.56 148.28 31.99 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.722 0.296 . . . . 62.520000000000003 110.942 -176.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 139.77 -177.65 20.34 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.93 -0.652 . . . . 74.040000000000006 112.163 177.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 752' ' ' PRO . . . . . 0.433 ' HG2' ' CB ' ' A' ' 755' ' ' GLU . 54.9 Cg_endo -71.47 166.76 28.34 Favored 'Trans proline' 0 CA--C 1.533 0.442 0 C-N-CA 122.793 2.329 . . . . 73.340000000000003 111.962 176.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -63.76 -34.99 59.76 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.684 2.256 . . . . 55.140000000000001 112.824 -178.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 54.7 p-80 -84.51 -7.26 59.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.958 0.408 . . . . 70.109999999999999 111.069 -178.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 755' ' ' GLU . . . . . 0.433 ' CB ' ' HG2' ' A' ' 752' ' ' PRO . 0.4 OUTLIER -141.95 68.95 23.76 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 116.132 -0.485 . . . . 73.510000000000005 109.972 -178.694 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 756' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -79.64 109.26 2.42 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.405 2.07 . . . . 71.540000000000006 111.936 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 757' ' ' LYS . . . . . 0.435 ' NZ ' ' HB2' ' A' ' 757' ' ' LYS . 4.4 ttmp? -93.73 112.99 24.95 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.237 0.541 . . . . 73.329999999999998 110.58 -178.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 758' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -99.05 119.29 37.57 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.363 -0.835 . . . . 75.319999999999993 110.454 -178.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 16.7 t -92.67 105.85 17.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.19 -0.459 . . . . 74.299999999999997 109.904 178.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 760' ' ' TYR . . . . . 0.41 ' HE1' ' HG2' ' A' ' 777' ' ' LYS . 1.5 m-85 -108.92 141.9 40.32 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.984 -0.553 . . . . 72.530000000000001 110.735 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 761' ' ' GLN . . . . . 0.542 ' HA ' ' O ' ' A' ' 770' ' ' PRO . 35.4 tt0 -133.96 135.96 43.85 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.751 -0.658 . . . . 73.439999999999998 109.613 176.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 762' ' ' ALA . . . . . . . . . . . . . . . -96.86 147.69 23.69 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.799 -0.637 . . . . 73.540000000000006 110.443 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 763' ' ' LYS . . . . . 0.557 ' HE3' ' CZ2' ' A' ' 768' ' ' TRP . 68.1 tttt -118.46 127.86 54.06 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.295 -0.631 . . . . 73.319999999999993 109.295 178.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 62.9 t -127.64 102.0 8.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.146 0.498 . . . . 60.140000000000001 109.869 178.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 76.41 -101.99 1.56 Allowed Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 110.96 -0.856 . . . . 72.140000000000001 110.96 -176.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -121.0 4.81 11.37 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 111.219 -0.752 . . . . 71.540000000000006 111.219 174.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 767' ' ' ARG . . . . . . . . . . . . . 39.7 mmt180 -98.5 146.29 25.92 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.974 0.416 . . . . 72.239999999999995 110.903 -178.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 768' ' ' TRP . . . . . 0.557 ' CZ2' ' HE3' ' A' ' 763' ' ' LYS . 55.6 m95 -117.28 107.41 14.37 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.617 -0.719 . . . . 74.540000000000006 109.777 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 769' ' ' PHE . . . . . 0.469 ' HA ' ' HA ' ' A' ' 770' ' ' PRO . 47.2 p90 -169.87 143.23 2.08 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 110.198 -0.297 . . . . 74.129999999999995 110.198 -177.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 770' ' ' PRO . . . . . 0.592 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 62.1 Cg_endo -99.07 178.53 6.38 Favored 'Cis proline' 0 N--CA 1.452 -0.933 0 C-N-CA 123.633 -1.403 . . . . 64.0 111.875 -4.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 771' ' ' ALA . . . . . 0.452 ' HB2' HE21 ' A' ' 761' ' ' GLN . . . -105.13 102.24 11.75 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.626 -0.509 . . . . 51.149999999999999 109.626 173.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 24.0 m -116.92 135.44 57.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.077 0.465 . . . . 72.549999999999997 111.176 -176.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 773' ' ' CYS . . . . . 0.408 ' HB2' ' CG ' ' A' ' 757' ' ' LYS . 1.5 p -110.22 102.71 11.36 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.0 -0.545 . . . . 74.340000000000003 110.174 177.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -100.29 178.97 4.61 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.726 -0.67 . . . . 75.200000000000003 111.175 -175.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 775' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -94.44 -8.82 37.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.052 0.453 . . . . 70.310000000000002 110.516 -176.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 55.2 m -145.91 158.02 43.88 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.693 -0.685 . . . . 75.230000000000004 109.765 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 777' ' ' LYS . . . . . 0.41 ' HG2' ' HE1' ' A' ' 760' ' ' TYR . 6.1 tmmm? -69.3 -39.71 78.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.589 -0.278 . . . . 62.43 110.539 -177.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 778' ' ' LYS . . . . . 0.414 ' HE3' ' OE1' ' A' ' 782' ' ' GLN . 58.1 tptt -60.89 -47.41 86.52 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.861 -0.422 . . . . 54.530000000000001 109.861 175.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 779' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -52.92 -47.98 67.59 Favored 'General case' 0 C--O 1.226 -0.137 0 CA-C-N 115.709 -0.678 . . . . 64.420000000000002 110.966 174.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -53.83 -47.97 63.58 Favored Glycine 0 C--O 1.228 -0.24 0 CA-C-N 116.028 -0.533 . . . . 64.030000000000001 113.035 -177.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -66.42 -45.18 80.78 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.857 0.361 . . . . 73.209999999999994 110.982 -178.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 782' ' ' GLN . . . . . 0.414 ' OE1' ' HE3' ' A' ' 778' ' ' LYS . 25.5 mt-30 -71.59 -37.0 71.05 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.233 -0.439 . . . . 73.140000000000001 111.399 -176.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -72.08 -35.68 69.31 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.524 0.202 . . . . 61.399999999999999 110.742 177.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -60.06 -49.53 77.27 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.949 -0.389 . . . . 64.519999999999996 109.949 176.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 785' ' ' ALA . . . . . 0.622 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -65.78 -42.16 91.1 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.073 -0.512 . . . . 44.399999999999999 110.793 178.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 786' ' ' ASP . . . . . 0.52 ' O ' ' HG2' ' A' ' 790' ' ' ARG . 12.4 t70 -56.71 -55.83 29.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.022 -0.535 . . . . 74.430000000000007 110.755 179.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 787' ' ' ALA . . . . . 0.544 ' O ' HG23 ' A' ' 791' ' ' VAL . . . -68.22 -31.07 70.32 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.952 -0.567 . . . . 71.439999999999998 111.212 -178.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 788' ' ' ALA . . . . . 0.683 ' O ' ' HG ' ' A' ' 792' ' ' LEU . . . -62.63 -42.83 99.81 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 120.812 0.339 . . . . 73.219999999999999 110.168 177.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 789' ' ' LEU . . . . . 0.622 ' HG ' ' O ' ' A' ' 785' ' ' ALA . 79.8 mt -61.82 -40.16 94.3 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.08 -0.509 . . . . 73.239999999999995 109.749 176.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 790' ' ' ARG . . . . . 0.52 ' HG2' ' O ' ' A' ' 786' ' ' ASP . 47.2 mmm-85 -59.79 -38.05 80.82 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.98 -0.554 . . . . 75.209999999999994 110.471 177.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 791' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 787' ' ' ALA . 48.7 t -62.46 -53.18 50.66 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.31 0 N-CA-C 109.881 -0.414 . . . . 53.32 109.881 175.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 792' ' ' LEU . . . . . 0.683 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 22.1 mt -55.32 -48.01 74.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.263 0.554 . . . . 73.109999999999999 110.681 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 793' ' ' ILE . . . . . 0.517 HG12 HG23 ' A' ' 716' ' ' ILE . 90.6 mt -61.76 -48.59 87.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.1 -0.955 . . . . 72.439999999999998 111.079 177.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -66.28 -34.88 89.35 Favored Glycine 0 CA--C 1.519 0.299 0 CA-C-N 116.145 -0.479 . . . . 61.119999999999997 113.122 -178.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 795' ' ' GLU . . . . . 0.518 ' HG2' ' O ' ' A' ' 791' ' ' VAL . 44.7 mm-40 -66.64 -32.24 73.44 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.81 0.338 . . . . 74.409999999999997 110.782 178.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -85.26 -23.91 28.0 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.998 0.427 . . . . 65.409999999999997 109.977 177.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 797' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -60.12 -32.5 71.05 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.786 -0.643 . . . . 70.329999999999998 110.205 176.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 798' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -101.47 16.62 25.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.552 -0.749 . . . . 75.25 110.929 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 799' ' ' ALA . . . . . . . . . . . . . . . -144.16 -173.45 4.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.033 0.444 . . . . 63.149999999999999 111.086 -176.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 800' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -114.6 127.07 55.59 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.981 -0.554 . . . . 52.409999999999997 109.556 174.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 801' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.951 0 CA-C-O 118.843 -0.598 . . . . 71.329999999999998 111.085 177.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 708' ' ' MET . . . . . . . . . . . . . 24.2 ttt . . . . . 0 N--CA 1.481 1.098 0 CA-C-O 120.987 0.422 . . . . 62.229999999999997 110.312 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 72.5 mtm -80.19 128.75 72.22 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.079 -0.51 . . . . 75.219999999999999 110.767 -177.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -89.55 -162.58 0.12 Allowed 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.181 2.587 . . . . 53.409999999999997 112.211 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 711' ' ' ASN . . . . . . . . . . . . . 20.0 m120 65.01 88.63 0.1 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.418 0.628 . . . . 74.519999999999996 111.085 177.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 712' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -117.88 159.27 23.38 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.49 -0.777 . . . . 55.350000000000001 109.702 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 713' ' ' VAL . . . . . . . . . . . . . 31.9 m -73.66 165.44 3.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.869 -0.419 . . . . 72.420000000000002 109.869 176.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.557 ' HD2' ' OE1' ' A' ' 718' ' ' GLU . 25.1 tpt180 -65.18 103.64 0.8 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.966 -0.383 . . . . 75.340000000000003 109.966 -179.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -148.56 -164.91 2.13 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.081 -0.509 . . . . 71.230000000000004 111.195 -178.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 716' ' ' ILE . . . . . 0.576 ' HA ' HD23 ' A' ' 719' ' ' LEU . 42.1 mm -89.32 -23.88 6.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.569 -0.741 . . . . 72.230000000000004 110.715 -175.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -58.27 -23.13 52.42 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.873 -0.603 . . . . 73.450000000000003 112.311 176.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 718' ' ' GLU . . . . . 0.599 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 44.1 mt-10 -68.25 -36.67 79.8 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 122.747 -0.267 . . . . 74.129999999999995 110.287 176.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 719' ' ' LEU . . . . . 0.641 HD12 HD22 ' A' ' 789' ' ' LEU . 3.4 mm? -61.02 -33.88 73.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.235 0.541 . . . . 72.129999999999995 110.009 175.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 720' ' ' VAL . . . . . 0.576 HG22 HD13 ' A' ' 793' ' ' ILE . 27.4 t -62.86 -36.3 74.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.624 -0.717 . . . . 74.349999999999994 110.949 177.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 721' ' ' ARG . . . . . 0.599 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 10.5 ptt180 -68.75 -28.62 66.97 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.892 0.377 . . . . 71.239999999999995 110.178 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -73.02 -32.05 64.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 72.239999999999995 110.629 177.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 723' ' ' LEU . . . . . 0.576 HD21 ' HB2' ' A' ' 789' ' ' LEU . 89.9 mt -57.81 -36.65 72.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.292 0.567 . . . . 74.200000000000003 109.939 173.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -69.49 -40.34 77.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.179 -0.919 . . . . 31.129999999999999 111.501 178.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 46.1 m -103.26 -80.87 0.51 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.055 0.391 . . . . 65.230000000000004 112.055 -176.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 726' ' ' ASN . . . . . 0.467 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 28.0 t30 -135.06 106.82 10.38 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-O 121.032 0.444 . . . . 70.109999999999999 110.8 -174.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 727' ' ' PRO . . . . . 0.467 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 20.4 Cg_endo -62.2 -36.33 69.52 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 122.894 2.396 . . . . 44.43 112.579 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 34.4 t -61.47 -47.09 95.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.254 -0.43 . . . . 74.150000000000006 110.538 -177.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -61.09 -36.55 92.5 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.923 -0.656 . . . . 73.150000000000006 112.041 178.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 730' ' ' GLY . . . . . 0.473 ' O ' ' HG3' ' A' ' 733' ' ' GLU . . . -68.32 -45.3 70.44 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 121.106 -0.569 . . . . 75.040000000000006 112.532 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -64.46 -41.23 96.63 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.973 0.416 . . . . 72.140000000000001 110.06 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 732' ' ' LEU . . . . . . . . . . . . . 94.9 mt -67.24 -32.85 74.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.158 -0.474 . . . . 74.230000000000004 111.495 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 733' ' ' GLU . . . . . 0.473 ' HG3' ' O ' ' A' ' 730' ' ' GLY . 1.1 pp20? -85.17 -33.52 22.29 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.557 -0.457 . . . . 75.25 110.495 -178.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 734' ' ' TYR . . . . . 0.537 ' HB2' HD11 ' A' ' 719' ' ' LEU . 4.0 t80 -55.06 -45.18 75.27 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.837 0.351 . . . . 75.409999999999997 110.463 174.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -65.38 -52.92 50.27 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.112 -0.494 . . . . 62.039999999999999 110.299 -176.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 736' ' ' ARG . . . . . 0.437 ' HG2' ' O ' ' A' ' 733' ' ' GLU . 36.5 ptt180 -60.48 -37.84 82.34 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.971 -0.559 . . . . 60.229999999999997 110.94 -176.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 737' ' ' SER . . . . . 0.431 ' CB ' HH21 ' A' ' 714' ' ' ARG . 28.5 t -70.37 -32.26 69.85 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.875 -0.602 . . . . 75.219999999999999 111.452 -179.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -97.19 -8.78 29.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.717 0.294 . . . . 74.439999999999998 111.689 -175.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 98.25 9.21 54.06 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.63 -0.795 . . . . 52.130000000000003 112.959 176.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -96.51 170.4 9.24 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.178 -0.304 . . . . 72.319999999999993 110.178 177.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -117.37 129.22 55.73 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.602 -0.518 . . . . 43.240000000000002 109.602 172.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 742' ' ' ALA . . . . . . . . . . . . . . . -100.87 120.97 40.92 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.913 0.387 . . . . 71.340000000000003 111.352 -175.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 743' ' ' GLU . . . . . 0.566 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 38.7 mt-10 -122.44 135.24 54.64 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.199 -0.455 . . . . 73.129999999999995 110.964 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -114.32 97.96 6.64 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.269 -0.641 . . . . 75.219999999999999 109.269 175.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -113.8 140.8 48.0 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.345 -0.542 . . . . 74.209999999999994 111.198 -177.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 746' ' ' LEU . . . . . . . . . . . . . 59.8 tp -74.72 116.05 14.99 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.643 -0.708 . . . . 74.340000000000003 109.332 174.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 60.2 t -75.35 -49.78 26.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.691 -0.485 . . . . 61.310000000000002 109.691 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -167.05 -175.42 3.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.833 -0.621 . . . . 73.519999999999996 109.667 178.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -138.72 128.8 25.4 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.382 -0.599 . . . . 74.0 109.382 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 750' ' ' SER . . . . . 0.418 ' O ' ' HB3' ' A' ' 757' ' ' LYS . 6.4 t -137.65 90.88 2.54 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.868 -0.419 . . . . 74.319999999999993 109.868 -177.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 179.54 154.33 13.09 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.353 -0.927 . . . . 63.439999999999998 112.477 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 752' ' ' PRO . . . . . 0.628 ' HG2' ' HB2' ' A' ' 755' ' ' GLU . 37.6 Cg_endo -66.59 168.38 16.7 Favored 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 123.309 2.673 . . . . 71.230000000000004 112.238 177.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -56.48 -33.13 91.68 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.751 2.301 . . . . 55.140000000000001 112.759 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 45.9 p-80 -87.83 -4.19 58.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.383 -0.371 . . . . 63.5 111.359 -178.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 755' ' ' GLU . . . . . 0.628 ' HB2' ' HG2' ' A' ' 752' ' ' PRO . 16.6 mm-40 -152.93 61.97 4.04 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.354 -0.385 . . . . 71.420000000000002 111.306 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 756' ' ' PRO . . . . . 0.428 ' O ' ' HA ' ' A' ' 775' ' ' HIS . 59.6 Cg_endo -73.2 99.3 1.09 Allowed 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.175 1.917 . . . . 70.25 111.583 -177.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 757' ' ' LYS . . . . . 0.437 ' HD3' ' HB2' ' A' ' 773' ' ' CYS . 38.3 ttmt -87.05 107.76 18.57 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.247 0.546 . . . . 50.109999999999999 110.384 -177.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 758' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -86.93 130.61 34.39 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.274 -0.876 . . . . 74.239999999999995 110.151 -179.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 759' ' ' VAL . . . . . . . . . . . . . 43.4 t -95.45 104.34 15.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.841 -0.429 . . . . 75.349999999999994 109.841 177.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -105.98 138.89 41.4 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.048 -0.524 . . . . 70.319999999999993 110.644 -179.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 761' ' ' GLN . . . . . 0.431 ' HA ' ' O ' ' A' ' 770' ' ' PRO . 52.4 tt0 -128.65 128.87 45.0 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.557 -0.534 . . . . 65.129999999999995 109.557 177.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 762' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' A' ' 769' ' ' PHE . . . -87.09 122.11 30.46 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.184 0.516 . . . . 51.340000000000003 110.407 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 763' ' ' LYS . . . . . 0.646 ' HD2' ' CH2' ' A' ' 768' ' ' TRP . 55.1 tttm -104.32 115.26 30.07 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.916 -0.584 . . . . 70.319999999999993 110.041 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 764' ' ' VAL . . . . . 0.422 HG11 ' HE2' ' A' ' 734' ' ' TYR . 59.0 t -118.7 100.72 10.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.058 0.456 . . . . 62.409999999999997 110.114 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 74.54 -102.89 1.44 Allowed Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.681 -0.69 . . . . 51.420000000000002 111.408 -176.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -120.45 10.88 10.56 Favored Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 111.162 -0.775 . . . . 71.420000000000002 111.162 174.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 767' ' ' ARG . . . . . 0.483 ' HG3' ' CD1' ' A' ' 769' ' ' PHE . 13.9 tpt180 -108.18 121.98 45.98 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.825 0.345 . . . . 71.409999999999997 110.879 -177.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 768' ' ' TRP . . . . . 0.646 ' CH2' ' HD2' ' A' ' 763' ' ' LYS . 48.0 m95 -95.44 107.44 19.59 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.787 -0.642 . . . . 73.349999999999994 109.571 177.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 769' ' ' PHE . . . . . 0.483 ' CD1' ' HG3' ' A' ' 767' ' ' ARG . 8.7 p90 -170.89 136.84 1.12 Allowed Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 120.888 0.375 . . . . 70.219999999999999 110.472 -178.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 770' ' ' PRO . . . . . 0.593 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 74.5 Cg_endo -97.36 -179.27 6.3 Favored 'Cis proline' 0 N--CA 1.447 -1.221 0 C-N-CA 123.475 -1.469 . . . . 54.219999999999999 111.773 -4.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -109.91 105.78 15.09 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.473 -0.566 . . . . 73.349999999999994 109.473 173.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 33.7 m -111.72 163.29 8.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.995 0.426 . . . . 73.239999999999995 111.147 -175.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 773' ' ' CYS . . . . . 0.437 ' HB2' ' HD3' ' A' ' 757' ' ' LYS . 5.1 p -133.52 117.99 17.79 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.889 -0.596 . . . . 51.43 110.017 179.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -132.67 143.75 49.86 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.287 -0.415 . . . . 73.310000000000002 110.705 -177.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 775' ' ' HIS . . . . . 0.428 ' HA ' ' O ' ' A' ' 756' ' ' PRO . 0.5 OUTLIER -80.14 24.34 0.43 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.146 0.498 . . . . 73.430000000000007 111.442 -178.521 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 776' ' ' SER . . . . . 0.548 ' HB3' ' HB2' ' A' ' 779' ' ' GLN . 24.9 t -152.76 137.96 17.42 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.578 -0.897 . . . . 73.0 108.578 175.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 777' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -66.92 -42.69 84.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.78 0.324 . . . . 74.409999999999997 110.327 -176.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -63.23 -38.09 89.79 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.178 -0.465 . . . . 63.310000000000002 110.379 178.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 779' ' ' GLN . . . . . 0.548 ' HB2' ' HB3' ' A' ' 776' ' ' SER . 76.6 mm-40 -71.72 -33.07 68.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.93 -0.577 . . . . 74.530000000000001 110.975 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -56.11 -43.91 88.56 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.112 -0.566 . . . . 61.310000000000002 112.107 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -69.04 -43.34 74.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.583 0.23 . . . . 74.239999999999995 110.985 178.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -63.42 -45.19 92.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.334 -0.393 . . . . 72.420000000000002 110.953 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -61.96 -44.44 96.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.303 -0.408 . . . . 75.340000000000003 110.924 178.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -61.29 -43.92 98.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.272 -0.422 . . . . 64.120000000000005 110.745 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 785' ' ' ALA . . . . . 0.559 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -65.45 -46.04 81.44 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.012 -0.54 . . . . 24.120000000000001 111.106 -178.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 786' ' ' ASP . . . . . 0.643 ' O ' ' HG2' ' A' ' 790' ' ' ARG . 14.9 t70 -60.31 -54.22 48.34 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 109.879 -0.415 . . . . 74.109999999999999 109.879 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 787' ' ' ALA . . . . . 0.537 ' O ' HG23 ' A' ' 791' ' ' VAL . . . -59.55 -35.48 74.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.67 -0.695 . . . . 73.409999999999997 111.229 -178.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 788' ' ' ALA . . . . . 0.632 ' O ' ' HG ' ' A' ' 792' ' ' LEU . . . -62.14 -45.2 94.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.508 -0.315 . . . . 71.219999999999999 110.63 177.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 789' ' ' LEU . . . . . 0.641 HD22 HD12 ' A' ' 719' ' ' LEU . 50.4 mt -64.29 -35.26 80.28 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 109.835 -0.431 . . . . 73.549999999999997 109.835 179.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 790' ' ' ARG . . . . . 0.643 ' HG2' ' O ' ' A' ' 786' ' ' ASP . 13.0 mmm-85 -59.63 -41.27 90.08 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 109.794 -0.447 . . . . 74.140000000000001 109.794 177.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 791' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 787' ' ' ALA . 43.5 t -63.67 -51.27 72.16 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 CA-C-N 115.625 -0.716 . . . . 75.120000000000005 110.111 177.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 792' ' ' LEU . . . . . 0.632 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 47.3 mt -57.16 -52.68 64.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.017 -0.538 . . . . 54.030000000000001 111.171 -177.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 793' ' ' ILE . . . . . 0.576 HD13 HG22 ' A' ' 720' ' ' VAL . 70.3 mt -60.12 -52.55 59.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.709 -0.678 . . . . 73.450000000000003 111.176 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 794' ' ' GLY . . . . . 0.629 ' O ' ' HG2' ' A' ' 798' ' ' LYS . . . -62.77 -41.62 99.82 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.855 -0.688 . . . . 64.010000000000005 112.681 -178.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -66.57 -39.36 88.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.833 0.349 . . . . 62.0 110.529 -178.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 796' ' ' ASN . . . . . 0.466 ' OD1' ' HB2' ' A' ' 801' ' ' ARG . 8.3 t30 -70.29 -29.17 65.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.031 -0.531 . . . . 71.519999999999996 110.037 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 797' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -69.0 -29.67 67.91 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.817 -0.629 . . . . 73.030000000000001 109.736 177.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 798' ' ' LYS . . . . . 0.629 ' HG2' ' O ' ' A' ' 794' ' ' GLY . 32.5 mmtp -76.48 -22.73 54.16 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.282 0.563 . . . . 72.0 110.052 176.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 799' ' ' ALA . . . . . . . . . . . . . . . -99.14 -166.36 1.34 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.627 -0.715 . . . . 64.409999999999997 110.361 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 800' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -127.09 88.45 2.81 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.994 0.426 . . . . 72.120000000000005 110.516 179.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 801' ' ' ARG . . . . . 0.466 ' HB2' ' OD1' ' A' ' 796' ' ' ASN . 36.7 mmt180 . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.617 -0.706 . . . . 75.239999999999995 109.667 178.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 708' ' ' MET . . . . . . . . . . . . . 66.0 mtm . . . . . 0 N--CA 1.478 0.959 0 CA-C-O 120.959 0.409 . . . . 71.540000000000006 110.461 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . 0.412 ' HA ' ' HD3' ' A' ' 710' ' ' PRO . 86.0 mtp -102.53 146.41 32.31 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.059 -0.519 . . . . 60.020000000000003 109.666 175.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 710' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 709' ' ' MET . 33.0 Cg_exo -60.01 84.82 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.158 2.572 . . . . 74.200000000000003 112.836 -179.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 711' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 165.83 -34.67 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.695 -1.224 . . . . 73.450000000000003 107.695 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 712' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -124.22 40.61 3.69 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.987 -1.006 . . . . 72.099999999999994 110.381 176.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 713' ' ' VAL . . . . . . . . . . . . . 47.6 t -67.63 129.03 31.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 108.847 -0.797 . . . . 64.439999999999998 108.847 176.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.456 ' HD2' HD21 ' A' ' 796' ' ' ASN . 54.3 ttp180 -68.33 95.26 0.59 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.116 0.484 . . . . 65.310000000000002 110.803 -175.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 715' ' ' LYS . . . . . 0.521 ' O ' ' HG2' ' A' ' 718' ' ' GLU . 12.8 tptp -104.25 22.99 13.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.85 0.833 . . . . 74.109999999999999 108.998 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 716' ' ' ILE . . . . . 0.514 HG21 ' HA ' ' A' ' 793' ' ' ILE . 42.4 mm -68.61 -13.76 17.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.002 -0.999 . . . . 73.530000000000001 110.387 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 717' ' ' GLY . . . . . . . . . . . . . . . -63.69 -21.17 64.8 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.787 -0.642 . . . . 70.310000000000002 111.971 177.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 718' ' ' GLU . . . . . 0.712 ' O ' ' HG2' ' A' ' 721' ' ' ARG . 15.8 mm-40 -65.57 -40.75 93.12 Favored 'General case' 0 C--O 1.225 -0.234 0 N-CA-C 109.592 -0.521 . . . . 71.150000000000006 109.592 176.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 719' ' ' LEU . . . . . 0.554 HD12 HD22 ' A' ' 789' ' ' LEU . 2.9 mm? -65.37 -33.01 74.97 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.624 -0.51 . . . . 70.549999999999997 109.624 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 720' ' ' VAL . . . . . 0.512 HG22 HD13 ' A' ' 793' ' ' ILE . 57.6 t -65.76 -38.04 81.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.668 -0.696 . . . . 70.430000000000007 110.822 178.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 721' ' ' ARG . . . . . 0.712 ' HG2' ' O ' ' A' ' 718' ' ' GLU . 22.5 ptt180 -65.71 -26.2 67.65 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.191 0.52 . . . . 51.310000000000002 109.785 179.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 722' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -80.52 -27.01 37.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.983 -0.553 . . . . 62.119999999999997 110.991 178.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 723' ' ' LEU . . . . . 0.551 HD21 ' HB2' ' A' ' 789' ' ' LEU . 87.7 mt -62.43 -27.2 68.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.137 0.494 . . . . 74.019999999999996 109.708 172.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 724' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -89.68 -38.96 13.51 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.336 -0.847 . . . . 71.400000000000006 110.938 177.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 725' ' ' THR . . . . . . . . . . . . . 18.5 m -93.89 -74.64 0.53 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.973 0.36 . . . . 55.210000000000001 111.973 -174.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 726' ' ' ASN . . . . . 0.468 ' HA ' ' HD2' ' A' ' 727' ' ' PRO . 38.0 t30 -153.36 106.84 2.59 Favored Pre-proline 0 C--O 1.236 0.359 0 CA-C-O 120.894 0.378 . . . . 73.010000000000005 110.354 -178.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 727' ' ' PRO . . . . . 0.468 ' HD2' ' HA ' ' A' ' 726' ' ' ASN . 17.9 Cg_endo -60.0 -36.68 88.89 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 123.217 2.611 . . . . 74.340000000000003 112.964 -177.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 46.0 t -58.64 -49.96 80.73 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 CA-C-N 116.361 -0.381 . . . . 74.040000000000006 110.776 -177.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 729' ' ' GLY . . . . . . . . . . . . . . . -61.54 -35.22 90.77 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.918 -0.658 . . . . 73.299999999999997 112.377 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -71.79 -44.19 48.54 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.837 -0.697 . . . . 53.149999999999999 112.811 -179.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 731' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -64.27 -39.5 94.06 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.777 -0.453 . . . . 74.019999999999996 109.777 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 732' ' ' LEU . . . . . 0.43 HD23 ' HB3' ' A' ' 742' ' ' ALA . 95.7 mt -63.83 -43.38 96.35 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.881 -0.6 . . . . 71.340000000000003 111.485 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 733' ' ' GLU . . . . . 0.555 ' HA ' ' HG2' ' A' ' 736' ' ' ARG . 8.4 pt-20 -77.42 -29.94 53.22 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 120.549 -0.46 . . . . 43.520000000000003 111.239 -176.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 734' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -55.42 -49.28 72.81 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.074 0.464 . . . . 63.43 109.793 173.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 735' ' ' ALA . . . . . . . . . . . . . . . -66.5 -52.77 42.43 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.705 -0.68 . . . . 45.0 111.021 -177.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 736' ' ' ARG . . . . . 0.555 ' HG2' ' HA ' ' A' ' 733' ' ' GLU . 35.7 ptt180 -58.74 -36.07 73.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.036 -0.529 . . . . 62.049999999999997 111.384 -174.098 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 737' ' ' SER . . . . . . . . . . . . . 18.9 t -76.04 -37.09 58.73 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.008 -0.542 . . . . 44.020000000000003 110.842 -178.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -88.36 -7.64 56.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.467 -0.333 . . . . 74.510000000000005 111.483 -174.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 739' ' ' GLY . . . . . . . . . . . . . . . 103.79 -3.31 45.45 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.611 -0.804 . . . . 72.409999999999997 113.096 175.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 740' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -88.56 170.26 11.01 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.928 0.394 . . . . 53.130000000000003 110.413 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 741' ' ' ALA . . . . . . . . . . . . . . . -115.51 131.43 56.93 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.49 -0.559 . . . . 73.140000000000001 109.49 173.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 742' ' ' ALA . . . . . 0.43 ' HB3' HD23 ' A' ' 732' ' ' LEU . . . -98.87 110.28 22.91 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 123.22 0.325 . . . . 64.319999999999993 110.538 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 743' ' ' GLU . . . . . 0.562 ' HB2' ' HB3' ' A' ' 763' ' ' LYS . 47.0 mt-10 -115.04 132.73 56.5 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.103 -0.499 . . . . 53.520000000000003 111.074 -177.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 744' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -113.13 109.76 19.33 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.072 -0.513 . . . . 75.109999999999999 109.783 175.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 745' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -122.41 152.76 39.89 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.081 0.467 . . . . 75.230000000000004 111.393 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 746' ' ' LEU . . . . . . . . . . . . . 6.5 tt -82.92 113.8 20.77 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.833 -0.803 . . . . 75.200000000000003 108.833 175.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 747' ' ' VAL . . . . . . . . . . . . . 54.8 t -82.36 -50.35 16.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.181 0.515 . . . . 73.510000000000005 110.671 -176.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -155.69 147.14 22.81 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.717 -0.674 . . . . 72.310000000000002 109.495 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 749' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.91 109.94 20.73 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.442 0.639 . . . . 72.200000000000003 110.167 175.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 750' ' ' SER . . . . . . . . . . . . . 6.6 m -108.88 80.64 1.35 Allowed 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.8 -0.815 . . . . 73.120000000000005 108.8 176.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 751' ' ' GLY . . . . . 0.514 ' HA2' ' HD2' ' A' ' 752' ' ' PRO . . . -131.41 113.46 1.36 Allowed Glycine 0 N--CA 1.439 -1.124 0 C-N-CA 119.895 -1.145 . . . . 62.240000000000002 114.131 -170.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 752' ' ' PRO . . . . . 0.514 ' HD2' ' HA2' ' A' ' 751' ' ' GLY . 20.1 Cg_endo -60.92 169.95 5.27 Favored 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 123.095 2.53 . . . . 55.119999999999997 111.029 167.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -61.42 -35.39 83.36 Favored 'Trans proline' 0 CA--C 1.529 0.228 0 C-N-CA 122.177 1.918 . . . . 75.209999999999994 112.777 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 754' ' ' HIS . . . . . . . . . . . . . 55.7 p-80 -83.41 -20.95 33.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.752 0.311 . . . . 73.140000000000001 111.349 -177.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 755' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -142.4 74.8 19.96 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 111.923 0.342 . . . . 72.109999999999999 111.923 -176.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 756' ' ' PRO . . . . . 0.454 ' HA ' ' HA3' ' A' ' 751' ' ' GLY . 33.4 Cg_exo -58.06 92.87 0.06 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 122.096 1.864 . . . . 75.349999999999994 111.191 170.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 757' ' ' LYS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 775' ' ' HIS . 36.1 ttpt -101.13 130.06 47.13 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.007 -0.542 . . . . 75.200000000000003 110.359 -175.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 758' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -113.72 135.08 54.33 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.94 -0.573 . . . . 60.109999999999999 110.632 -175.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 759' ' ' VAL . . . . . 0.476 HG22 ' HB3' ' A' ' 773' ' ' CYS . 26.3 t -94.19 112.62 27.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.812 -0.631 . . . . 61.210000000000001 109.876 177.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 760' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -111.11 143.18 42.24 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.917 -0.583 . . . . 55.219999999999999 110.565 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 761' ' ' GLN . . . . . 0.5 ' HA ' ' O ' ' A' ' 770' ' ' PRO . 53.1 tt0 -131.39 130.96 43.26 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.521 -0.548 . . . . 74.310000000000002 109.521 178.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 762' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 769' ' ' PHE . . . -87.7 113.77 23.68 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.352 0.596 . . . . 71.099999999999994 110.631 -179.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 763' ' ' LYS . . . . . 0.579 ' HD2' ' CH2' ' A' ' 768' ' ' TRP . 57.4 tttm -93.2 105.13 17.26 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.789 -0.641 . . . . 55.140000000000001 109.545 178.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 57.4 t -108.04 103.46 15.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.25 -0.648 . . . . 73.109999999999999 109.25 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 765' ' ' GLY . . . . . . . . . . . . . . . 71.25 -117.21 6.63 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 110.683 -0.967 . . . . 53.140000000000001 110.683 -173.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . -110.07 15.72 30.66 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.615 -0.803 . . . . 65.120000000000005 112.066 176.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 767' ' ' ARG . . . . . 0.547 ' HD2' ' CD1' ' A' ' 769' ' ' PHE . 0.0 OUTLIER -115.5 128.2 55.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.853 0.358 . . . . 74.040000000000006 110.218 -178.891 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 768' ' ' TRP . . . . . 0.579 ' CH2' ' HD2' ' A' ' 763' ' ' LYS . 40.6 m95 -97.43 103.14 15.05 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.065 -0.516 . . . . 73.540000000000006 110.018 -179.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 769' ' ' PHE . . . . . 0.547 ' CD1' ' HD2' ' A' ' 767' ' ' ARG . 16.5 p90 -162.16 136.39 5.01 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 120.853 0.359 . . . . 73.319999999999993 111.044 -178.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 770' ' ' PRO . . . . . 0.63 ' HD3' ' HB2' ' A' ' 788' ' ' ALA . 75.1 Cg_endo -99.34 -177.83 4.41 Favored 'Cis proline' 0 N--CA 1.449 -1.122 0 C-N-CA 123.684 -1.382 . . . . 61.450000000000003 111.496 -5.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 771' ' ' ALA . . . . . . . . . . . . . . . -111.05 107.36 16.73 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.919 -0.4 . . . . 75.450000000000003 109.919 174.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 772' ' ' VAL . . . . . . . . . . . . . 34.0 m -119.26 164.95 15.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.203 -0.453 . . . . 74.549999999999997 110.667 -176.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 773' ' ' CYS . . . . . 0.476 ' HB3' HG22 ' A' ' 759' ' ' VAL . 7.0 p -136.61 124.01 22.03 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.383 -0.371 . . . . 72.019999999999996 110.275 177.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 774' ' ' ALA . . . . . . . . . . . . . . . -129.56 152.52 49.0 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.27 -0.423 . . . . 31.539999999999999 110.185 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 775' ' ' HIS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 757' ' ' LYS . 13.2 p80 -78.22 17.47 0.62 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.859 0.362 . . . . 64.329999999999998 111.695 -176.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 776' ' ' SER . . . . . . . . . . . . . 15.7 t -153.15 139.88 18.95 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.484 -0.561 . . . . 45.140000000000001 109.484 177.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 777' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -60.82 -40.46 92.83 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.453 -0.339 . . . . 64.239999999999995 111.123 -177.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 778' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -67.65 -37.25 82.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.852 0.358 . . . . 60.100000000000001 110.517 179.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 779' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -70.2 -37.37 75.06 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.147 -0.479 . . . . 73.340000000000003 110.738 -178.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 780' ' ' GLY . . . . . . . . . . . . . . . -57.57 -41.84 93.76 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.966 -0.635 . . . . 74.439999999999998 112.279 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -63.83 -44.31 93.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.974 0.416 . . . . 72.450000000000003 110.622 177.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 782' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -69.44 -41.31 76.47 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.876 -0.602 . . . . 74.439999999999998 111.341 -177.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 783' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -61.26 -42.69 99.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.787 0.327 . . . . 73.129999999999995 110.838 177.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 784' ' ' ALA . . . . . . . . . . . . . . . -62.72 -50.29 71.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.792 -0.64 . . . . 70.5 110.634 178.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 785' ' ' ALA . . . . . 0.547 ' O ' ' HG ' ' A' ' 789' ' ' LEU . . . -62.95 -39.64 95.25 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.296 -0.411 . . . . 74.310000000000002 111.073 -178.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 786' ' ' ASP . . . . . 0.612 ' O ' ' HG2' ' A' ' 790' ' ' ARG . 11.7 t70 -60.48 -57.34 13.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.461 . . . . 60.539999999999999 110.447 179.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 787' ' ' ALA . . . . . 0.571 ' O ' HG23 ' A' ' 791' ' ' VAL . . . -62.68 -32.46 73.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.792 -0.64 . . . . 63.549999999999997 110.992 -178.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 788' ' ' ALA . . . . . 0.655 ' O ' ' HG ' ' A' ' 792' ' ' LEU . . . -62.12 -43.5 98.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.363 -0.38 . . . . 43.200000000000003 110.693 177.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 789' ' ' LEU . . . . . 0.554 HD22 HD12 ' A' ' 719' ' ' LEU . 79.2 mt -64.41 -37.32 87.12 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.782 -0.451 . . . . 72.209999999999994 109.782 178.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 790' ' ' ARG . . . . . 0.612 ' HG2' ' O ' ' A' ' 786' ' ' ASP . 8.7 mmm180 -59.86 -40.62 89.23 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 109.694 -0.484 . . . . 74.150000000000006 109.694 177.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 791' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 787' ' ' ALA . 61.0 t -62.02 -50.7 79.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.816 -0.629 . . . . 75.030000000000001 110.56 176.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 792' ' ' LEU . . . . . 0.655 ' HG ' ' O ' ' A' ' 788' ' ' ALA . 49.7 mt -60.27 -52.13 66.59 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.693 -0.685 . . . . 75.5 110.979 -177.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 793' ' ' ILE . . . . . 0.548 ' O ' ' HG3' ' A' ' 797' ' ' GLU . 72.2 mt -59.55 -48.84 85.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.755 -0.657 . . . . 75.140000000000001 110.742 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 794' ' ' GLY . . . . . . . . . . . . . . . -61.35 -44.02 98.6 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 121.06 -0.59 . . . . 72.510000000000005 112.774 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 795' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -57.64 -40.96 80.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.064 0.459 . . . . 54.219999999999999 110.15 178.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 796' ' ' ASN . . . . . 0.456 HD21 ' HD2' ' A' ' 714' ' ' ARG . 4.4 t30 -67.76 -44.58 77.17 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.807 -0.633 . . . . 62.509999999999998 111.44 178.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 797' ' ' GLU . . . . . 0.548 ' HG3' ' O ' ' A' ' 793' ' ' ILE . 47.9 mt-10 -62.53 -45.9 90.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.133 0.492 . . . . 54.039999999999999 111.474 -177.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 798' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -81.24 -0.96 43.06 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.748 -0.66 . . . . 64.510000000000005 111.502 -174.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 799' ' ' ALA . . . . . . . . . . . . . . . -84.67 -21.12 30.32 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.523 -0.308 . . . . 71.319999999999993 111.449 -178.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 800' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -103.45 6.16 37.44 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.758 -0.377 . . . . 74.549999999999997 111.867 -175.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 801' ' ' ARG . . . . . 0.467 ' O ' ' HG3' ' A' ' 801' ' ' ARG . 32.0 ptt180 . . . . . 0 C--O 1.245 0.85 0 C-N-CA 120.82 -0.352 . . . . 73.530000000000001 110.675 -178.702 . . . . . . . . 1 1 . 1 stop_ save_